YearStart;YearEnd;LocationAbbr;LocationDesc;DataSource;Topic;Question;Response;DataValueUnit;DataValueType;DataValue;DataValueAlt;DataValueFootnoteSymbol;DatavalueFootnote;LowConfidenceLimit;HighConfidenceLimit;StratificationCategory1;Stratification1;StratificationCategory2;Stratification2;StratificationCategory3;Stratification3;GeoLocation;ResponseID;LocationID;TopicID;QuestionID;DataValueTypeID;StratificationCategoryID1;StratificationID1;StratificationCategoryID2;StratificationID2;StratificationCategoryID3;StratificationID3
2015;2015;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.8;39.8;;;33.2;46.8;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.2;39.2;;;32;46.9;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.1;32.1;;;23.5;42.2;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2015;2015;OH;Ohio;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST3_1;NMBR;RACE;AIAN;;;;
2016;2016;US;United States;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.0;10;;;9.7;10.4;Overall;Overall;;;;;;;59;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;ND;North Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2012;2012;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;;Number;51;51;;;;;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;NMBR;GENDER;GENM;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.4;10.4;;;9.2;11.7;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29.0;29;;;21.1;38.4;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.0;83;;;71.2;90.6;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.8;89.8;;;83.5;93.8;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.9;8.9;;;7.7;10.2;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.7;39.7;;;29.8;50.6;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;24.0;24;;;14.7;36.7;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.3;7.3;;;4.9;10.9;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.0;35;;;25.2;46.4;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;52.4;52.4;;;40.1;64.4;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.5;9.5;;;7.9;11.5;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.5;44.5;;;33.4;56.1;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.6;9.6;;;8.9;10.3;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.1;10.1;;;9.5;10.7;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.7;32.7;;;22.7;44.6;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.3;31.3;;;20.1;45.2;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.6;12.6;;;11.4;13.9;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.4;66.4;;;60.2;72;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2018;2018;CA;California;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.2;11.2;;;8.6;14.4;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.6;35.6;;;28.4;43.6;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.7;12.7;;;10;16;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;54.2;54.2;;;46.7;61.5;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.2;47.2;;;38.3;56.3;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.0;5;;;3.8;6.4;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.8;34.8;;;27;43.6;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.5;13.5;;;8.6;20.4;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.1;6.1;;;4.5;8.3;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.8;11.8;;;9.5;14.6;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.6;7.6;;;6.3;9.2;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;27.5;27.5;;;22.1;33.7;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.3;41.3;;;36.6;46.2;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.6;48.6;;;36.7;60.7;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.5;86.5;;;77.3;92.3;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.1;86.1;;;75.5;92.6;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.7;65.7;;;55.3;74.7;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;;Number;25;25;;;;;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;NMBR;GENDER;GENM;;;;
2017;2017;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;;Number;75;75;;;;;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;NMBR;GENDER;GENF;;;;
2017;2017;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.4;12.4;;;8.5;17.5;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2017;2017;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.3;12.3;;;8.2;17.6;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.1;34.1;;;27.1;41.9;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2017;2017;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;CRDRATE;RACE;API;;;;
2017;2017;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;;Number;25;25;;;;;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;NMBR;GENDER;GENM;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.7;6.7;;;5.9;7.6;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2017;2017;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.4;7.4;;;5.9;9.2;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2017;2017;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.1;87.1;;;72.9;94.4;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.4;41.4;;;36.6;46.3;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.2;9.2;;;5.7;14;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2017;2017;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;;Number;52;52;;;;;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;NMBR;GENDER;GENM;;;;
2017;2017;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;NMBR;RACE;HIS;;;;
2017;2017;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.1;10.1;;;8.5;11.8;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2017;2017;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;16.5;16.5;;;14.1;19.3;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;;Number;49;49;;;;;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;NMBR;GENDER;GENF;;;;
2017;2017;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.0;9;;;6.7;11.8;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2017;2017;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;NMBR;RACE;HIS;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.2;7.2;;;6.2;8.5;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;17.3;17.3;;;13.2;22.2;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.9;10.9;;;8.2;14.2;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.6;42.6;;;33.6;52.2;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.4;10.4;;;8.1;13.1;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.3;32.3;;;26.1;39.2;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.4;46.4;;;38.5;54.5;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.5;8.5;;;6.1;11.8;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.7;7.7;;;5.3;10.7;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;116;116;;;;;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2017;2017;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;;Number;21;21;;;;;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;NMBR;GENDER;GENF;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.0;67;;;59.9;73.5;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2017;2017;US;United States;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.7;12.7;*;50 States + DC: US Median;11.9;13;Overall;Overall;;;;;;;59;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;22.7;22.7;;;17.8;28.4;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;ME;Maine;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;NMBR;GENDER;GENF;;;;
2017;2017;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.7;10.7;;;7.3;15.2;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;NMBR;RACE;HIS;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2017;2017;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;NMBR;GENDER;GENF;;;;
2017;2017;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.3;10.3;;;7.6;13.6;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2017;2017;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2017;2017;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.2;43.2;;;27.9;59.9;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2017;2017;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;NMBR;RACE;BLK;;;;
2017;2017;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;;Number;55;55;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;NMBR;RACE;WHT;;;;
2017;2017;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.5;6.5;;;5.6;7.6;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.1;46.1;;;40.6;51.7;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.7;46.7;;;33;60.8;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;;Number;50;50;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;NMBR;RACE;BLK;;;;
2017;2017;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;;Number;77;77;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;NMBR;RACE;BLK;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.5;7.5;;;6.8;8.3;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.907192, -77.036871);;11;AST;AST4_1;NMBR;RACE;AIAN;;;;
2017;2017;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;;Number;44;44;;;;;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;NMBR;GENDER;GENM;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.2;70.2;;;63.2;76.3;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.7;10.7;;;9.9;11.4;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.907192, -77.036871);;11;AST;AST4_1;NMBR;RACE;API;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;95.5;95.5;;;89.2;98.2;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;15.9;15.9;;;11.8;21.1;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2017;2017;TX;Texas;NVSS;Asthma;Asthma mortality rate;;;Number;232;232;;;;;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;52.5;52.5;;;41.5;63.2;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2017;2017;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.2;8.2;;;5.4;12;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2017;2017;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;NMBR;RACE;API;;;;
2017;2017;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;NMBR;GENDER;GENF;;;;
2017;2017;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.7;9.7;;;6.6;13.9;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.2;45.2;;;38;52.5;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;NMBR;RACE;HIS;;;;
2017;2017;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;;Number;24;24;;;;;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;NMBR;GENDER;GENF;;;;
2017;2017;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;;Number;68;68;;;;;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2017;2017;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;27.5;27.5;;;19.9;37;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2017;2017;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;;Number;94;94;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;NMBR;RACE;WHT;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.3;8.3;;;7.2;9.7;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.6;42.6;;;37.9;47.5;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2017;2017;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;;Number;55;55;;;;;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2017;2017;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;15.0;15;;;11.5;19.4;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2017;2017;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;NMBR;RACE;AIAN;;;;
2017;2017;WA;Washington;NVSS;Asthma;Asthma mortality rate;;;Number;88;88;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;NMBR;RACE;WHT;;;;
2017;2017;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;;Number;33;33;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;NMBR;RACE;BLK;;;;
2017;2017;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2017;2017;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;NMBR;GENDER;GENM;;;;
2017;2017;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.2;8.2;;;6.6;10;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.7;11.7;;;6.6;20.1;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.1;12.1;;;9.6;15.1;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;21.4;21.4;;;15.7;28.5;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.3;36.3;;;26.8;46.9;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2017;2017;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2017;2017;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;57.6;57.6;;;46.6;67.9;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2017;2017;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;;Number;119;119;;;;;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;57.4;57.4;;;42.1;71.4;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2017;2017;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;;Number;31;31;;;;;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;NMBR;GENDER;GENM;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.5;41.5;;;31;52.8;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;52.0;52;;;42.4;61.5;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.6;90.6;;;84.1;94.7;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.0;8;;;6.3;10.1;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;NMBR;RACE;BLK;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2017;2017;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;;Number;67;67;;;;;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;NMBR;GENDER;GENF;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2017;2017;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;13.8;13.8;;;9;20.3;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;CRDRATE;RACE;API;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.0;9;;;7.7;10.6;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;;Number;27;27;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;NMBR;RACE;WHT;;;;
2017;2017;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2017;2017;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.1;42.1;;;36.5;47.8;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.5;42.5;;;37.3;47.9;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;;Number;28;28;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;NMBR;RACE;WHT;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.8;49.8;;;41.7;57.8;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2016;2016;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.5;33.5;;;27.2;40.4;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.3;11.3;;;10.2;12.5;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.3;36.3;;;27.4;46.2;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.9;7.9;;;6.9;9.1;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;NY;New York;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.0;11;;;9.7;12.4;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;59.1;59.1;;;52.1;65.8;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.6;9.6;;;8.2;11.2;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.5;84.5;;;74;91.3;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.8;5.8;;;4.9;7;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.8;14.8;;;12.3;17.9;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;27.2;27.2;;;19.2;37;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.5;66.5;;;58.8;73.5;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.4;10.4;;;8.9;12.2;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;79.9;79.9;;;69.2;87.5;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.4;48.4;;;38.3;58.6;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;51.8;51.8;;;39.2;64.2;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;22.2;22.2;;;18;27;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.3;11.3;;;8.6;14.6;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.8;38.8;;;28.8;49.8;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;61.3;61.3;;;44.6;75.6;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;25.8;25.8;;;15.6;39.4;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.0;42;;;36.2;48.1;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;50.3;50.3;;;41.6;59;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;CA;California;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;8.2;8.2;;;7;9.6;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.0;49;;;34.6;63.5;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.0;86;;;75.4;92.5;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.5;11.5;;;10.6;12.4;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.0;42;;;35.5;48.9;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.7;39.7;;;29.9;50.3;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.7;91.7;;;81.4;96.5;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.6;12.6;;;10.8;14.6;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;73.8;73.8;;;62.5;82.7;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.3;68.3;;;60.4;75.3;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;17.8;17.8;;;9.7;30.7;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;15.1;15.1;;;10.9;20.5;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.0;30;;;19.5;43.1;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.1;34.1;;;24;46;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.9;43.9;;;32.5;55.9;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.7;10.7;;;6.8;16.6;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;17.4;17.4;;;14.3;20.9;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.4;12.4;;;11;13.8;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.7;63.7;;;55.1;71.4;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.6;44.6;;;37.8;51.6;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.2;8.2;;;7.4;8.9;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;17.9;17.9;;;13.1;23.8;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.9;38.9;;;30.7;47.7;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.1;11.1;;;9.5;12.9;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;NY;New York;NVSS;Asthma;Asthma mortality rate;;;Number;154;154;;;;;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;NMBR;GENDER;GENF;;;;
2016;2016;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;;Number;79;79;;;;;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2016;2016;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;;Number;58;58;;;;;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;NMBR;GENDER;GENF;;;;
2016;2016;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;;Number;93;93;;;;;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2016;2016;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.8;13.8;;;10.8;17.2;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2016;2016;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;;Number;40;40;;;;;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;NMBR;GENDER;GENM;;;;
2016;2016;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;;Number;85;85;;;;;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;NMBR;GENDER;GENF;;;;
2016;2016;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;NMBR;GENDER;GENM;;;;
2016;2016;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;;Number;21;21;;;;;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;NMBR;GENDER;GENF;;;;
2016;2016;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;;Number;37;37;;;;;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;NMBR;GENDER;GENM;;;;
2016;2016;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;;Number;46;46;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;NMBR;RACE;WHT;;;;
2016;2016;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;;Number;26;26;;;;;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;NMBR;GENDER;GENM;;;;
2016;2016;TX;Texas;NVSS;Asthma;Asthma mortality rate;;;Number;196;196;;;;;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2016;2016;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;;Number;42;42;;;;;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2016;2016;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;;Number;21;21;;;;;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;NMBR;RACE;HIS;;;;
2016;2016;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.0;8;;;5.8;10.8;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2016;2016;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;;Number;34;34;;;;;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2016;2016;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;;Number;75;75;;;;;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2016;2016;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;;Number;55;55;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;NMBR;RACE;WHT;;;;
2016;2016;FL;Florida;NVSS;Asthma;Asthma mortality rate;;;Number;60;60;;;;;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;NMBR;GENDER;GENM;;;;
2016;2016;TX;Texas;NVSS;Asthma;Asthma mortality rate;;;Number;130;130;;;;;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;NMBR;GENDER;GENF;;;;
2016;2016;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;NMBR;GENDER;GENF;;;;
2016;2016;TX;Texas;NVSS;Asthma;Asthma mortality rate;;;Number;26;26;;;;;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;NMBR;RACE;HIS;;;;
2016;2016;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.1;10.1;;;6.8;14.5;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2016;2016;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;44;44;;;;;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;NMBR;GENDER;GENF;;;;
2016;2016;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.9;8.9;;;6.5;12;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2016;2016;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;NMBR;RACE;API;;;;
2016;2016;UT;Utah;NVSS;Asthma;Asthma mortality rate;;;Number;22;22;;;;;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;NMBR;GENDER;GENF;;;;
2016;2016;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;;Number;36;36;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;NMBR;RACE;BLK;;;;
2016;2016;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2016;2016;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;;Number;48;48;;;;;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;NMBR;GENDER;GENM;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.9;13.9;;;8.1;22.9;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.7;42.7;;;37.1;48.5;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.4;10.4;;;7.3;14.8;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2015;2015;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.5;13.5;;;9.3;19.2;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;15.5;15.5;;;11.8;20.1;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.8;10.8;;;6.1;18.6;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;52.5;52.5;;;40.7;63.9;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.8;68.8;;;60.4;76.1;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.7;68.7;;;62;74.6;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.0;12;;;10.9;13.2;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.0;9;;;8.4;9.7;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.5;6.5;;;4.8;8.8;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.9;14.9;;;10.7;20.5;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;8.7;8.7;;;5.9;12.5;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;15.6;15.6;;;12.5;19.3;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.0;11;;;10;12.1;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.2;14.2;;;12.6;16;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.5;9.5;;;5.4;16.2;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.5;14.5;;;12.4;17;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;28.3;28.3;;;23.2;34;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.9;9.9;;;9;10.8;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;49.6;49.6;;;40.2;59;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.3;42.3;;;35.5;49.4;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.6;44.6;;;37.2;52.2;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2015;2015;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.6;46.6;*;50 States + DC: US Median;44.3;48.4;Gender;Female;;;;;;;59;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;52.4;52.4;;;42.2;62.5;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.1;40.1;;;33.6;47;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.2;5.2;;;4.1;6.6;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.8;83.8;;;71.6;91.3;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;76.2;76.2;;;63.3;85.6;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2015;2015;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.5;83.5;;;76.4;88.7;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.8;41.8;;;36.4;47.5;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.7;86.7;;;79.7;91.6;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.4;87.4;;;78.7;92.9;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.4;87.4;;;81.8;91.5;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.6;86.6;;;78.1;92.1;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.9;35.9;;;25.6;47.7;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;80.8;80.8;;;66.3;90;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;94.5;94.5;;;88.2;97.5;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.3;87.3;;;81.4;91.5;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.7;85.7;;;81.9;88.8;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;58.3;58.3;;;41.8;73.1;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.4;89.4;;;80.2;94.7;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.9;87.9;;;82.8;91.6;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.0;43;;;38.6;47.6;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.0;10;;;6.9;14.2;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;AK;Alaska;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.5;62.5;;;53.9;70.4;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;GU;Guam;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(13.444304, 144.793731);;66;AST;AST2_1;NMBR;RACE;API;;;;
2015;2015;SD;South Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST2_1;NMBR;RACE;API;;;;
2015;2015;VA;Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST2_1;NMBR;RACE;AIAN;;;;
2015;2015;VI;Virgin Islands;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;NMBR;RACE;BLK;;;;
2015;2015;ME;Maine;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2015;2015;TN;Tennessee;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST2_1;NMBR;GENDER;GENM;;;;
2015;2015;AL;Alabama;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST2_1;NMBR;RACE;HIS;;;;
2015;2015;CA;California;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2015;2015;NM;New Mexico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;DE;Delaware;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST2_1;NMBR;RACE;WHT;;;;
2015;2015;WY;Wyoming;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST2_1;NMBR;GENDER;GENF;;;;
2015;2015;KS;Kansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2015;2015;MT;Montana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2015;2015;PA;Pennsylvania;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST2_1;NMBR;GENDER;GENM;;;;
2015;2015;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;322;322;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;NMBR;RACE;AIAN;;;;
2015;2015;ID;Idaho;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2015;2015;CA;California;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2015;2015;CO;Colorado;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST2_1;NMBR;GENDER;GENF;;;;
2015;2015;GU;Guam;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;TX;Texas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2015;2015;SD;South Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST2_1;NMBR;RACE;WHT;;;;
2015;2015;PA;Pennsylvania;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST2_1;NMBR;RACE;HIS;;;;
2015;2015;TX;Texas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2015;2015;WV;West Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;62.51;62.51;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;61.9;63.12;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;AL;Alabama;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST2_1;NMBR;GENDER;GENM;;;;
2015;2015;ND;North Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST2_1;NMBR;GENDER;GENF;;;;
2015;2015;WY;Wyoming;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST2_1;NMBR;GENDER;GENM;;;;
2015;2015;WV;West Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST2_1;NMBR;GENDER;GENM;;;;
2015;2015;IN;Indiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2015;2015;MT;Montana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2015;2015;GU;Guam;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;PR;Puerto Rico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST2_1;NMBR;GENDER;GENF;;;;
2015;2015;CA;California;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST2_1;NMBR;RACE;HIS;;;;
2015;2015;UT;Utah;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST2_1;NMBR;GENDER;GENM;;;;
2015;2015;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.9;12.9;;;10.6;15.3;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;NMBR;RACE;BLK;;;;
2015;2015;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;NMBR;RACE;BLK;;;;
2015;2015;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.5;8.5;;;5.9;11.8;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;;Number;97;97;;;;;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;NMBR;GENDER;GENF;;;;
2015;2015;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;NMBR;RACE;WHT;;;;
2015;2015;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;NMBR;GENDER;GENM;;;;
2015;2015;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.4;9.4;;;6.4;13.4;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2015;2015;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;NMBR;RACE;BLK;;;;
2015;2015;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;;Number;30;30;;;;;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2015;2015;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;NMBR;GENDER;GENF;;;;
2015;2015;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;;Number;46;46;;;;;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2015;2015;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;25.0;25;;;17.6;34.5;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.2;8.2;;;5.8;11.1;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2015;2015;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2015;2015;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;;Number;21;21;;;;;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2015;2015;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;NMBR;RACE;HIS;;;;
2015;2015;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;16.6;16.6;;;12.6;21.4;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2015;2015;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.7;10.7;;;8;14;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;;Number;20;20;;;;;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;NMBR;GENDER;GENF;;;;
2015;2015;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;48;48;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;NMBR;RACE;WHT;;;;
2015;2015;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;;Number;22;22;;;;;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;NMBR;GENDER;GENM;;;;
2015;2015;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;;Number;25;25;;;;;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;NMBR;GENDER;GENF;;;;
2015;2015;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.4;13.4;;;9.9;17.7;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;;Number;72;72;;;;;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2015;2015;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;;Number;76;76;;;;;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2015;2015;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;;Number;49;49;;;;;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;NMBR;GENDER;GENF;;;;
2015;2015;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;NMBR;RACE;HIS;;;;
2015;2015;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;CRDRATE;RACE;API;;;;
2015;2015;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.4;14.4;;;9.9;20.4;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2015;2015;NY;New York;NVSS;Asthma;Asthma mortality rate;;;Number;106;106;;;;;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;NMBR;GENDER;GENM;;;;
2014;2014;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2014;2014;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;3904;3,904;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;NMBR;RACE;WHT;;;;
2014;2014;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;851;851;;;;;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;NMBR;GENDER;GENF;;;;
2014;2014;VA;Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;AK;Alaska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;OH;Ohio;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST3_1;NMBR;GENDER;GENF;;;;
2014;2014;LA;Louisiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;AK;Alaska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;MT;Montana;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST3_1;NMBR;RACE;BLK;;;;
2014;2014;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;318;318;;;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;NMBR;RACE;HIS;;;;
2014;2014;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;828;828;;;;;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;NMBR;GENDER;GENM;;;;
2014;2014;TX;Texas;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST3_1;NMBR;GENDER;GENM;;;;
2014;2014;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;2314;2,314;;;;;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;NMBR;GENDER;GENF;;;;
2014;2014;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;845;845;;;;;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;NMBR;RACE;HIS;;;;
2014;2014;AK;Alaska;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST3_1;NMBR;GENDER;GENF;;;;
2014;2014;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;NMBR;GENDER;GENM;;;;
2014;2014;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;CRDRATE;RACE;API;;;;
2014;2014;PR;Puerto Rico;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST3_1;NMBR;RACE;WHT;;;;
2014;2014;OK;Oklahoma;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2014;2014;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;3646;3,646;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;NMBR;RACE;WHT;;;;
2014;2014;GU;Guam;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2014;2014;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;12.93;12.93;;;12.7;13.15;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;IL;Illinois;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST3_1;NMBR;GENDER;GENM;;;;
2014;2014;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;3129;3,129;;;;;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;NMBR;GENDER;GENF;;;;
2014;2014;KS;Kansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST3_1;NMBR;RACE;WHT;;;;
2014;2014;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;8.34;8.34;;;8.01;8.67;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;PR;Puerto Rico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2014;2014;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;796;796;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;NMBR;RACE;BLK;;;;
2014;2014;NH;New Hampshire;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2014;2014;OK;Oklahoma;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST3_1;NMBR;GENDER;GENM;;;;
2014;2014;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;8.93;8.93;;;8.74;9.11;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;NMBR;GENDER;GENF;;;;
2014;2014;OH;Ohio;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2014;2014;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;7.81;7.81;;;7.49;8.14;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;840;840;;;;;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;NMBR;GENDER;GENF;;;;
2014;2014;ME;Maine;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;MN;Minnesota;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1359;1,359;;;;;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST3_1;NMBR;GENDER;GENM;;;;
2014;2014;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;8.10;8.1;;;7.54;8.66;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2014;2014;WY;Wyoming;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;ND;North Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2014;2014;KS;Kansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST3_1;NMBR;GENDER;GENF;;;;
2014;2014;MO;Missouri;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST3_1;NMBR;RACE;HIS;;;;
2014;2014;VA;Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2014;2014;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;18.60;18.6;;;18.33;18.87;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;KS;Kansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST3_1;NMBR;GENDER;GENM;;;;
2014;2014;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;28118;28,118;;;;;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2014;2014;ID;Idaho;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST2_1;NMBR;GENDER;GENM;;;;
2014;2014;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;NMBR;GENDER;GENM;;;;
2014;2014;TN;Tennessee;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2014;2014;VI;Virgin Islands;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST2_1;NMBR;GENDER;GENF;;;;
2014;2014;MD;Maryland;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;24552;24,552;;;;;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST2_1;NMBR;GENDER;GENF;;;;
2014;2014;ME;Maine;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST2_1;NMBR;RACE;HIS;;;;
2014;2014;PA;Pennsylvania;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;WA;Washington;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST2_1;NMBR;GENDER;GENM;;;;
2014;2014;AR;Arkansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;29.75;29.75;;;29.04;30.47;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2014;2014;OH;Ohio;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2014;2014;NH;New Hampshire;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;GU;Guam;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(13.444304, 144.793731);;66;AST;AST2_1;CRDRATE;RACE;API;;;;
2014;2014;GU;Guam;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST2_1;NMBR;RACE;HIS;;;;
2014;2014;AL;Alabama;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;VI;Virgin Islands;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;HI;Hawaii;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;1532;1,532;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST2_1;NMBR;RACE;WHT;;;;
2015;2015;ID;Idaho;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2015;2015;GA;Georgia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST3_1;NMBR;RACE;BLK;;;;
2015;2015;CT;Connecticut;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST3_1;NMBR;RACE;BLK;;;;
2015;2015;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;NMBR;GENDER;GENF;;;;
2015;2015;WA;Washington;NVSS;Asthma;Asthma mortality rate;;;Number;34;34;;;;;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;NMBR;GENDER;GENM;;;;
2015;2015;GU;Guam;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;ID;Idaho;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;12.10;12.1;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;9.54;14.66;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2015;2015;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;10.56;10.56;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;7.89;13.24;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2015;2015;TN;Tennessee;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2015;2015;LA;Louisiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2015;2015;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;NMBR;RACE;HIS;;;;
2015;2015;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;NMBR;RACE;API;;;;
2015;2015;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;NMBR;RACE;BLK;;;;
2015;2015;ND;North Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;9.61;9.61;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;8.82;10.4;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;KS;Kansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2015;2015;OH;Ohio;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;TX;Texas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;VA;Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;NH;New Hampshire;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST3_1;NMBR;RACE;API;;;;
2015;2015;LA;Louisiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST3_1;NMBR;RACE;HIS;;;;
2015;2015;PR;Puerto Rico;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2015;2015;ME;Maine;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST3_1;NMBR;RACE;WHT;;;;
2015;2015;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;7.32;7.32;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;7;7.65;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;IN;Indiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST3_1;NMBR;RACE;HIS;;;;
2015;2015;TN;Tennessee;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2015;2015;MO;Missouri;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST3_1;NMBR;GENDER;GENF;;;;
2015;2015;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2015;2015;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2015;2015;AK;Alaska;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST3_1;NMBR;RACE;HIS;;;;
2015;2015;ME;Maine;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST3_1;NMBR;RACE;BLK;;;;
2015;2015;TX;Texas;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST3_1;NMBR;RACE;HIS;;;;
2015;2015;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;270;270;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;NMBR;RACE;HIS;;;;
2015;2015;GA;Georgia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;OH;Ohio;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;2272;2,272;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;NMBR;RACE;WHT;;;;
2015;2015;IL;Illinois;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;WY;Wyoming;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;AK;Alaska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST2_1;NMBR;RACE;API;;;;
2015;2015;CT;Connecticut;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST2_1;NMBR;RACE;AIAN;;;;
2015;2015;OK;Oklahoma;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST2_1;NMBR;RACE;HIS;;;;
2015;2015;OR;Oregon;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;VI;Virgin Islands;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST2_1;NMBR;RACE;BLK;;;;
2015;2015;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2015;2015;WY;Wyoming;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2015;2015;PR;Puerto Rico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST2_1;NMBR;GENDER;GENM;;;;
2015;2015;DE;Delaware;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2015;2015;CT;Connecticut;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST2_1;NMBR;GENDER;GENM;;;;
2015;2015;OR;Oregon;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2015;2015;WA;Washington;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST2_1;NMBR;GENDER;GENM;;;;
2015;2015;ND;North Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST2_1;NMBR;RACE;WHT;;;;
2015;2015;VI;Virgin Islands;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST2_1;NMBR;GENDER;GENF;;;;
2015;2015;CA;California;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST2_1;NMBR;GENDER;GENM;;;;
2015;2015;MI;Michigan;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST2_1;NMBR;RACE;HIS;;;;
2015;2015;OK;Oklahoma;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;NM;New Mexico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST2_1;NMBR;RACE;HIS;;;;
2015;2015;ND;North Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.8;8.8;;;7.7;10;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.2;6.2;;;5.6;7;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2014;2014;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.4;9.4;;;7.7;11.5;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2014;2014;US;United States;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.7;11.7;*;50 States + DC: US Median;10.9;11.9;Gender;Female;;;;;;;59;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.1;5.1;;;4;6.4;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.3;6.3;;;4.9;7.9;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2014;2014;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;NY;New York;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.6;13.6;;;11.2;16.4;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2014;2014;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;;Number;96;96;;;;;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;NMBR;GENDER;GENF;;;;
2014;2014;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;NMBR;RACE;BLK;;;;
2014;2014;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;16.3;16.3;;;13.2;19.4;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2014;2014;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;;Number;23;23;;;;;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;NMBR;GENDER;GENF;;;;
2014;2014;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;;Number;55;55;;;;;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;NMBR;GENDER;GENF;;;;
2014;2014;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;;Number;47;47;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;NMBR;RACE;WHT;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.5;31.5;;;20;45.8;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;;Number;60;60;;;;;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;NMBR;GENDER;GENM;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;;Number;59;59;;;;;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;NMBR;GENDER;GENF;;;;
2014;2014;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.0;8;;;5.9;10.5;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.9;40.9;;;32.2;50.1;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;NMBR;RACE;HIS;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;72;72;;;54.9;84.4;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2014;2014;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;30.1;30.1;;;21.9;40.3;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;;Number;38;38;;;;;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;NMBR;GENDER;GENM;;;;
2014;2014;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;NMBR;RACE;BLK;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;NMBR;GENDER;GENF;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;51.3;51.3;;;44.5;58.1;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50.2;50.2;;;40.1;60.3;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;45;45;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;NMBR;RACE;BLK;;;;
2014;2014;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;NMBR;GENDER;GENF;;;;
2014;2014;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;;Number;45;45;;;;;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;NMBR;GENDER;GENF;;;;
2013;2013;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;752;752;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;NMBR;RACE;WHT;;;;
2014;2014;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.4;9.4;;;5.8;14.3;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.4;83.4;;;70.6;91.3;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.5;12.5;;;9.8;15.7;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2014;2014;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;46;46;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;NMBR;RACE;WHT;;;;
2014;2014;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;;Number;21;21;;;;;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;NMBR;GENDER;GENF;;;;
2014;2014;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;;Number;66;66;;;;;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.5;39.5;;;31.8;47.8;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40;40;;;34.8;45.5;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;;Number;116;116;;;;;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2014;2014;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;47;47;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;NMBR;RACE;BLK;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;;Number;77;77;;;;;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2014;2014;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;;Number;21;21;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;NMBR;RACE;WHT;;;;
2014;2014;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;;Number;36;36;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;NMBR;RACE;BLK;;;;
2014;2014;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;;Number;54;54;;;;;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2014;2014;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;;Number;53;53;;;;;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;NMBR;GENDER;GENF;;;;
2014;2014;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;NMBR;RACE;WHT;;;;
2014;2014;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.6;8.6;;;5.7;12.5;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2014;2014;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;;Number;34;34;;;;;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;NMBR;GENDER;GENM;;;;
2014;2014;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;;Number;22;22;;;;;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;NMBR;GENDER;GENM;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.2;47.2;;;41;53.5;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;;Number;24;24;;;;;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;NMBR;GENDER;GENM;;;;
2014;2014;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2014;2014;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;;Number;149;149;;;;;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2014;2014;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.4;13.4;;;8.9;19.4;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;15.9;15.9;;;10.8;22.8;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.3;72.3;;;63.6;79.6;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;MT;Montana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;NMBR;RACE;BLK;;;;
2014;2014;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.4;14.4;;;10.9;18.8;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.0;11;;;7.1;16.2;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;;Number;52;52;;;;;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;NMBR;GENDER;GENM;;;;
2014;2014;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;;Number;25;25;;;;;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2014;2014;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.1;8.1;;;5.7;11;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2014;2014;US;United States;NVSS;Asthma;Asthma mortality rate;;;Number;3651;3,651;;;;;Overall;Overall;;;;;;;59;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;30.2;30.2;;;23.5;37.9;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2014;2014;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.5;8.5;;;6.3;11.1;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2014;2014;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;;Number;48;48;;;;;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2014;2014;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;NMBR;GENDER;GENM;;;;
2014;2014;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;;Number;35;35;;;;;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;NMBR;GENDER;GENM;;;;
2014;2014;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.9;11.9;;;9.4;15;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;CRDRATE;RACE;API;;;;
2014;2014;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.5;10.5;;;9.5;11.5;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.4;36.4;;;27.7;46;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.4;38.4;;;29.9;47.6;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2014;2014;UT;Utah;NVSS;Asthma;Asthma mortality rate;;;Number;31;31;;;;;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2014;2014;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;;Number;86;86;;;;;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2014;2014;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;NMBR;RACE;AIAN;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.1;85.1;;;77.9;90.2;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2014;2014;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.1;34.1;;;27.8;41.1;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;NMBR;RACE;AIAN;;;;
2014;2014;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;NMBR;RACE;HIS;;;;
2014;2014;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.3;9.3;;;7.1;11.9;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.9;40.9;;;33.7;48.5;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;79;79;;;70.1;85.7;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;;Number;73;73;;;;;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2014;2014;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;NMBR;GENDER;GENM;;;;
2014;2014;CA;California;NVSS;Asthma;Asthma mortality rate;;;Number;148;148;;;;;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;NMBR;GENDER;GENM;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.6;41.6;;;28.8;55.6;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;3453;3,453;;;;;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;NMBR;GENDER;GENM;;;;
2013;2013;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;NMBR;GENDER;GENM;;;;
2013;2013;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;;Number;112;112;;;;;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;NMBR;GENDER;GENF;;;;
2013;2013;CA;California;NVSS;Asthma;Asthma mortality rate;;;Number;45;45;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;NMBR;RACE;BLK;;;;
2013;2013;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.0;10;;;7;13.9;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;112;112;;;;;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2013;2013;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.3;13.3;;;9.3;18.6;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2013;2013;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;503;503;;;;;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;NMBR;GENDER;GENM;;;;
2013;2013;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;3.15;3.15;;;2.69;3.61;Race/Ethnicity;Asian or Pacific Islander;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;CRDRATE;RACE;API;;;;
2013;2013;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;760;760;;;;;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;NMBR;GENDER;GENM;;;;
2013;2013;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2013;2013;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;;Number;24;24;;;;;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2013;2013;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;;Number;27;27;;;;;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;NMBR;GENDER;GENM;;;;
2013;2013;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;;Number;50;50;;;;;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;NMBR;GENDER;GENF;;;;
2013;2013;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;ME;Maine;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2013;2013;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2013;2013;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;9040;9,040;;;;;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2013;2013;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;;Number;42;42;;;;;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;NMBR;GENDER;GENF;;;;
2013;2013;CA;California;NVSS;Asthma;Asthma mortality rate;;;Number;258;258;;;;;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;NMBR;GENDER;GENF;;;;
2013;2013;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;55;55;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;NMBR;RACE;API;;;;
2013;2013;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;5.95;5.95;;;5.68;6.22;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2013;2013;OK;Oklahoma;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2013;2013;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;5.13;5.13;;;4.65;5.6;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2013;2013;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;;Number;50;50;;;;;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2013;2013;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;342;342;;;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;NMBR;RACE;HIS;;;;
2013;2013;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.6;11.6;;;8.9;14.9;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;;Number;75;75;;;;;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2013;2013;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2013;2013;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;334;334;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;NMBR;RACE;API;;;;
2013;2013;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2013;2013;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;13965;13,965;;;;;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2013;2013;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;;Number;27;27;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;NMBR;RACE;WHT;;;;
2013;2013;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;;Number;25;25;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;NMBR;RACE;WHT;;;;
2013;2013;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;NMBR;RACE;HIS;;;;
2013;2013;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;694;694;;;;;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;NMBR;GENDER;GENM;;;;
2013;2013;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;805;805;;;;;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;NMBR;GENDER;GENM;;;;
2013;2013;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;;Number;38;38;;;;;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;NMBR;GENDER;GENF;;;;
2013;2013;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;53;53;;;;;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;NMBR;RACE;HIS;;;;
2013;2013;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;18303;18,303;;;;;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;NMBR;GENDER;GENF;;;;
2013;2013;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;;Number;130;130;;;;;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2013;2013;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2013;2013;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;787;787;;;;;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;NMBR;GENDER;GENM;;;;
2013;2013;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;NMBR;RACE;HIS;;;;
2013;2013;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;5585;5,585;;;;;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;NMBR;GENDER;GENF;;;;
2013;2013;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;3974;3,974;;;;;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2013;2013;TX;Texas;NVSS;Asthma;Asthma mortality rate;;;Number;89;89;;;;;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;NMBR;GENDER;GENM;;;;
2013;2013;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;;Number;32;32;;;;;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2013;2013;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2013;2013;UT;Utah;NVSS;Asthma;Asthma mortality rate;;;Number;20;20;;;;;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;NMBR;GENDER;GENF;;;;
2013;2013;MT;Montana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;NMBR;RACE;BLK;;;;
2013;2013;ME;Maine;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;NMBR;RACE;BLK;;;;
2013;2013;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.4;13.4;;;11.8;15;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2013;2013;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;;Number;48;48;;;;;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;NMBR;GENDER;GENF;;;;
2013;2013;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2013;2013;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;20.2;20.2;;;14.2;28;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2013;2013;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;;Number;53;53;;;;;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;NMBR;GENDER;GENF;;;;
2013;2013;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;NMBR;RACE;WHT;;;;
2013;2013;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;;Number;50;50;;;;;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;NMBR;GENDER;GENM;;;;
2013;2013;CA;California;NVSS;Asthma;Asthma mortality rate;;;Number;410;410;;;;;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2013;2013;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;30;30;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;NMBR;RACE;WHT;;;;
2013;2013;PR;Puerto Rico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;IL;Illinois;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2014;2014;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;NMBR;GENDER;GENF;;;;
2014;2014;NH;New Hampshire;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2014;2014;MT;Montana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;ID;Idaho;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2014;2014;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;429;429;;;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;NMBR;RACE;AIAN;;;;
2014;2014;OR;Oregon;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2014;2014;MO;Missouri;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST2_1;NMBR;RACE;HIS;;;;
2014;2014;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;32449;32,449;;;;;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;NMBR;RACE;HIS;;;;
2014;2014;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;17422;17,422;;;;;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;NMBR;GENDER;GENF;;;;
2014;2014;DE;Delaware;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;GU;Guam;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2014;2014;HI;Hawaii;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;4298;4,298;;;;;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST2_1;NMBR;GENDER;GENF;;;;
2014;2014;VI;Virgin Islands;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;2839;2,839;;;;;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;NMBR;GENDER;GENM;;;;
2014;2014;MI;Michigan;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST2_1;NMBR;RACE;AIAN;;;;
2014;2014;WV;West Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2014;2014;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;12.72;12.72;;;11.97;13.47;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;CRDRATE;RACE;API;;;;
2014;2014;VA;Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST2_1;NMBR;GENDER;GENF;;;;
2014;2014;PR;Puerto Rico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(18.220833, -66.590149);;72;AST;AST2_1;NMBR;RACE;AIAN;;;;
2014;2014;IL;Illinois;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2014;2014;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;6342;6,342;;;;;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;NMBR;GENDER;GENF;;;;
2014;2014;OR;Oregon;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;2483;2,483;;;;;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2014;2014;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;40.45;40.45;;;39.9;41;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2014;2014;RI;Rhode Island;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;62.10;62.1;;;60;64.19;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2014;2014;MT;Montana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST2_1;NMBR;GENDER;GENF;;;;
2014;2014;VI;Virgin Islands;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;OK;Oklahoma;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2014;2014;ND;North Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST2_1;NMBR;RACE;AIAN;;;;
2014;2014;GA;Georgia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;67.81;67.81;;;67.1;68.52;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2014;2014;MI;Michigan;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;OR;Oregon;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;29717;29,717;;;;;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;NMBR;GENDER;GENM;;;;
2014;2014;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;214.16;214.16;;;211.51;216.81;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2014;2014;WV;West Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2014;2014;ND;North Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST2_1;NMBR;RACE;API;;;;
2014;2014;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;11826;11,826;;;;;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2014;2014;LA;Louisiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2014;2014;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;39.79;39.79;;;39.16;40.43;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2014;2014;GU;Guam;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;TX;Texas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST2_1;NMBR;RACE;BLK;;;;
2014;2014;ID;Idaho;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2014;2014;DE;Delaware;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.8;13.8;;;11.6;16.2;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.5;7.5;;;6.5;8.6;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.3;8.3;;;6.3;11;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42;42;;;29.5;55.8;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2012;2012;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;;Number;25;25;;;;;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2013;2013;PR;Puerto Rico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2013;2013;GU;Guam;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2013;2013;VI;Virgin Islands;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST2_1;NMBR;GENDER;GENF;;;;
2013;2013;GU;Guam;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;NM;New Mexico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2013;2013;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;22037;22,037;;;;;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.6;12.6;;;11.5;13.9;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;GA;Georgia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST2_1;NMBR;GENDER;GENF;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.6;9.6;;;8.8;10.3;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;DE;Delaware;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST2_1;NMBR;GENDER;GENF;;;;
2013;2013;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;12459;12,459;;;;;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;NMBR;GENDER;GENF;;;;
2013;2013;RI;Rhode Island;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2013;2013;OK;Oklahoma;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.7;8.7;;;7.1;10.6;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.1;14.1;;;11.9;16.5;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;AL;Alabama;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.2;9.2;;;8.3;10.1;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.1;9.1;;;8.2;10.2;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;AK;Alaska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2013;2013;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;7439;7,439;;;;;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;NMBR;GENDER;GENF;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.7;8.7;;;4.8;15.2;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.8;43.8;;;37.2;50.5;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.2;41.2;;;29.1;54.4;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;73.6;73.6;;;57.8;85.1;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.2;89.2;;;82.6;93.5;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29.6;29.6;;;25.4;34.2;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.7;37.7;;;25.2;52;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.5;42.5;;;35.5;49.8;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;59.9;59.9;;;46;72.3;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.8;49.8;;;43.7;55.9;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.1;84.1;;;73.6;90.9;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;19.3;19.3;;;15;24.3;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.3;69.3;;;54.3;81;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.4;89.4;;;82.6;93.8;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.1;11.1;;;10.2;12.2;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;56.7;56.7;;;47.9;65.1;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;60.6;60.6;;;52.8;67.8;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;6.0;6;;;3.6;9.9;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.5;8.5;;;7.3;9.8;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.7;66.7;;;58.6;73.9;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;78.7;78.7;;;63.5;88.7;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.1;40.1;;;34.8;45.5;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29.3;29.3;;;24.1;35.1;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;21.6;21.6;;;13.4;32.9;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;49.5;49.5;;;40.7;58.2;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.8;37.8;;;32.2;43.8;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;;Number;24;24;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;NMBR;RACE;WHT;;;;
2012;2012;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;;Number;39;39;;;;;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2012;2012;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2012;2012;MT;Montana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2012;2012;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;;Number;24;24;;;;;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;NMBR;GENDER;GENM;;;;
2012;2012;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;;Number;27;27;;;;;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2012;2012;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.9;8.9;;;5.8;13.2;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2012;2012;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;36;36;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;NMBR;RACE;BLK;;;;
2012;2012;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2012;2012;US;United States;NVSS;Asthma;Asthma mortality rate;;;Number;3531;3,531;;;;;Overall;Overall;;;;;;;59;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2012;2012;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;18.1;18.1;;;13.2;24.3;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2012;2012;CA;California;NVSS;Asthma;Asthma mortality rate;;;Number;384;384;;;;;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2012;2012;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;;Number;53;53;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;NMBR;RACE;BLK;;;;
2012;2012;NY;New York;NVSS;Asthma;Asthma mortality rate;;;Number;102;102;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;NMBR;RACE;BLK;;;;
2012;2012;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2012;2012;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.8;12.8;;;9.8;16.4;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.7;13.7;;;11;16.8;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;NMBR;GENDER;GENM;;;;
2012;2012;TX;Texas;NVSS;Asthma;Asthma mortality rate;;;Number;122;122;;;;;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;NMBR;GENDER;GENF;;;;
2012;2012;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;NMBR;RACE;HIS;;;;
2012;2012;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.3;11.3;;;9.4;13.2;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2012;2012;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;19.1;19.1;;;13.9;25.6;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2012;2012;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;;Number;98;98;;;;;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;NMBR;GENDER;GENF;;;;
2012;2012;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;;Number;28;28;;;;;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;NMBR;GENDER;GENM;;;;
2012;2012;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;NMBR;GENDER;GENM;;;;
2012;2012;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;;Number;103;103;;;;;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2012;2012;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;;Number;99;99;;;;;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;NMBR;GENDER;GENF;;;;
2012;2012;TX;Texas;NVSS;Asthma;Asthma mortality rate;;;Number;206;206;;;;;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2012;2012;WA;Washington;NVSS;Asthma;Asthma mortality rate;;;Number;24;24;;;;;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;NMBR;GENDER;GENM;;;;
2012;2012;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.7;7.7;;;5.7;10.1;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2012;2012;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.8;11.8;;;8.1;16.5;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2012;2012;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;5.7;5.7;;;3.7;8.4;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2012;2012;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;;Number;20;20;;;;;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;NMBR;GENDER;GENM;;;;
2012;2012;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.1;7.1;;;4.5;10.7;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2012;2012;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.0;7;;;4.4;10.6;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2012;2012;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;;Number;63;63;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;NMBR;RACE;WHT;;;;
2012;2012;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;13.2;13.2;;;9.7;17.6;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2012;2012;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;;Number;25;25;;;;;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;NMBR;GENDER;GENF;;;;
2012;2012;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;;Number;26;26;;;;;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;NMBR;GENDER;GENM;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;22.5;22.5;;;13;36.1;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;64.0;64;;;48.3;77.2;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;8.7;8.7;;;5.1;14.4;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;61.6;61.6;;;53.9;68.7;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.3;5.3;;;4.2;6.6;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2012;2012;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.6;40.6;;;34.6;46.8;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;17.0;17;;;12.7;22.5;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.9;87.9;;;71.5;95.4;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.9;13.9;;;10.1;18.5;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.4;8.4;;;7.2;9.7;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.2;82.2;;;68.1;90.9;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;73.4;73.4;;;63.9;81.2;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.3;8.3;;;7;9.7;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.8;10.8;;;6.5;17.4;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.4;9.4;;;5.7;15.2;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;61.2;61.2;;;53.4;68.5;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.5;44.5;;;37.1;52.1;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.0;36;;;32;40.3;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;US;United States;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.4;11.4;*;50 States + DC: US Median;10.7;12.7;Overall;Overall;;;;;;;59;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;81.0;81;;;74.7;86;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.3;37.3;;;25.9;50.4;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.2;82.2;;;65.1;91.9;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;78.0;78;;;65.8;86.7;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.0;12;;;9.3;15.2;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.2;45.2;;;40.6;49.8;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.8;10.8;;;7.8;14.8;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;50.7;50.7;;;32.9;68.3;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.7;34.7;;;26.6;43.9;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.6;8.6;;;7.1;10.2;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.1;65.1;;;54.3;74.6;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.7;38.7;*;50 States + DC: US Median;36.9;40.5;Gender;Female;;;;;;;59;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2011;2011;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2011;2011;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;NMBR;RACE;HIS;;;;
2011;2011;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.9;11.9;;;8.3;16.4;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2011;2011;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2011;2011;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;;Number;20;20;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;NMBR;RACE;BLK;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.4;9.4;;;8.4;10.4;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.2;12.2;;;10;14.8;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;NMBR;RACE;WHT;;;;
2011;2011;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;NMBR;RACE;API;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.9;38.9;;;33.5;44.7;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.5;37.5;;;32.8;42.4;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;FL;Florida;NVSS;Asthma;Asthma mortality rate;;;Number;42;42;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;NMBR;RACE;BLK;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.2;8.2;;;7.4;9;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.2;8.2;;;7;9.5;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.0;14;;;10.1;18.9;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2011;2011;ME;Maine;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;NMBR;RACE;HIS;;;;
2011;2011;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2011;2011;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.1;12.1;;;7.5;18.4;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2011;2011;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;;Number;96;96;;;;;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.4;5.4;;;3.1;9.3;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.8;70.8;;;58.7;80.5;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;NMBR;RACE;HIS;;;;
2011;2011;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;;Number;113;113;;;;;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2011;2011;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.4;11.4;;;9.3;13.6;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;19.5;19.5;;;14.8;25.1;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.3;9.3;;;7.8;11;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2011;2011;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.0;14;;;10.2;18.9;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2011;2011;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.4;8.4;;;5.6;12.1;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.4;11.4;;;7.5;16.8;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2011;2011;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;27.1;27.1;;;19.2;37.2;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2011;2011;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.1;40.1;;;32.8;47.8;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2011;2011;NY;New York;NVSS;Asthma;Asthma mortality rate;;;Number;116;116;;;;;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;NMBR;GENDER;GENM;;;;
2011;2011;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;35;35;;;;;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;NMBR;GENDER;GENM;;;;
2011;2011;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;;Number;31;31;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;NMBR;RACE;BLK;;;;
2011;2011;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;NMBR;RACE;HIS;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.5;83.5;;;75;89.4;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;5.7;5.7;;;4.4;7.6;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2011;2011;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.6;10.6;;;7.9;14;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.4;85.4;;;72.5;92.9;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.0;68;;;61.8;73.5;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2011;2011;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;;Number;26;26;;;;;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2011;2011;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;;Number;30;30;;;;;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;NMBR;GENDER;GENF;;;;
2011;2011;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2011;2011;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;;Number;52;52;;;;;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;NMBR;GENDER;GENF;;;;
2011;2011;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.7;7.7;;;5.6;10.4;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.6;9.6;;;8.8;10.5;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2011;2011;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;;Number;73;73;;;;;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;4.9;4.9;;;3.9;6.1;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2011;2011;NY;New York;NVSS;Asthma;Asthma mortality rate;;;Number;51;51;;;;;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;NMBR;RACE;HIS;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.1;89.1;;;78.4;94.8;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;;Number;54;54;;;;;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2011;2011;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;6.7;6.7;;;5.2;8.5;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2011;2011;FL;Florida;NVSS;Asthma;Asthma mortality rate;;;Number;22;22;;;;;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;NMBR;RACE;HIS;;;;
2011;2011;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.9;5.9;;;4.8;7.2;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.1;43.1;;;36.6;49.8;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.3;10.3;;;6.6;15.3;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2011;2011;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;;Number;54;54;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;NMBR;RACE;WHT;;;;
2011;2011;WA;Washington;NVSS;Asthma;Asthma mortality rate;;;Number;47;47;;;;;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;NMBR;GENDER;GENF;;;;
2011;2011;TX;Texas;NVSS;Asthma;Asthma mortality rate;;;Number;24;24;;;;;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;NMBR;RACE;HIS;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.6;6.6;;;5.1;8.5;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.4;37.4;;;32.2;42.9;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.8;9.8;;;6.6;14;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.6;9.6;;;8.7;10.5;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.6;85.6;;;78.8;90.5;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;NMBR;RACE;HIS;;;;
2011;2011;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2011;2011;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;35;35;;;;;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;NMBR;GENDER;GENM;;;;
2011;2011;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;;Number;35;35;;;;;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;NMBR;GENDER;GENF;;;;
2011;2011;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;NMBR;GENDER;GENF;;;;
2011;2011;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;99;99;;;;;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.6;7.6;;;6;9.5;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;CA;California;NVSS;Asthma;Asthma mortality rate;;;Number;403;403;;;;;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2011;2011;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2011;2011;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;;Number;94;94;;;;;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2011;2011;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;;Number;33;33;;;;;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;NMBR;GENDER;GENF;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.0;6;;;5.4;6.7;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2011;2011;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.6;9.6;;;8.9;10.4;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.8;63.8;;;46.8;78;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2011;2011;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.2;11.2;;;8.3;14.7;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.6;86.6;;;80.6;91;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;4.2;4.2;;;2.4;7.4;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;76.0;76;;;60.5;86.8;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.7;36.7;;;32.7;41;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.8;68.8;;;61.6;75.1;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.8;38.8;;;29.4;49.1;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.7;32.7;;;27.2;38.8;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.4;10.4;;;6.1;17.1;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.3;6.3;;;5.2;7.7;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.4;8.4;;;7.5;9.5;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;49.9;49.9;;;36.3;63.5;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2010;2010;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.9;9.9;;;7;13.7;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;9488;9,488;;;;;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;NMBR;RACE;HIS;;;;
2010;2010;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;13.14;13.14;;;12.78;13.51;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;2904;2,904;;;;;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2010;2010;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1487;1,487;;;;;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;NMBR;GENDER;GENF;;;;
2010;2010;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;12.99;12.99;;;12.38;13.6;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2010;2010;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;962;962;;;;;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;NMBR;GENDER;GENM;;;;
2010;2010;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;9.09;9.09;;;8.07;10.11;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2010;2010;OH;Ohio;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2010;2010;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;347;347;;;;;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;NMBR;GENDER;GENF;;;;
2010;2010;CT;Connecticut;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2010;2010;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;4688;4,688;;;;;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2010;2010;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;6604;6,604;;;;;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;NMBR;RACE;HIS;;;;
2010;2010;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;4.74;4.74;;;4.42;5.05;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;9046;9,046;;;;;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;NMBR;RACE;HIS;;;;
2010;2010;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;4046;4,046;;;;;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;NMBR;GENDER;GENM;;;;
2010;2010;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;20.14;20.14;;;19.53;20.75;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;9514;9,514;;;;;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2010;2010;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;45;45;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;NMBR;RACE;API;;;;
2010;2010;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.6;11.6;;;7.7;16.9;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1379;1,379;;;;;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;NMBR;GENDER;GENF;;;;
2010;2010;MN;Minnesota;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2010;2010;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;183;183;;;;;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;NMBR;GENDER;GENF;;;;
2010;2010;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;11.10;11.1;;;9.86;12.35;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.2;13.2;;;11.7;15;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.6;6.6;;;5.7;7.5;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2010;2010;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;16.00;16;;;15.82;16.18;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;ID;Idaho;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;759;759;;;;;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;NMBR;GENDER;GENM;;;;
2010;2010;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;7.17;7.17;;;6.38;7.95;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;5.81;5.81;;;4.97;6.66;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2010;2010;OH;Ohio;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;15088;15,088;;;;;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2010;2010;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;15.34;15.34;;;14.58;16.09;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;960;960;;;;;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;NMBR;GENDER;GENF;;;;
2010;2010;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;NMBR;RACE;HIS;;;;
2010;2010;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;;Number;20;20;;;;;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;NMBR;GENDER;GENF;;;;
2010;2010;PR;Puerto Rico;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2010;2010;FL;Florida;NVSS;Asthma;Asthma mortality rate;;;Number;25;25;;;;;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;NMBR;RACE;HIS;;;;
2010;2010;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;;Number;44;44;;;;;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;NMBR;GENDER;GENM;;;;
2010;2010;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;;Number;43;43;;;;;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;NMBR;GENDER;GENF;;;;
2010;2010;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.4;13.4;;;8.3;20.5;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;CRDRATE;RACE;API;;;;
2010;2010;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;;Number;183;183;;;;;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2010;2010;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;NMBR;RACE;HIS;;;;
2010;2010;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;;Number;80;80;;;;;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2010;2010;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;NMBR;GENDER;GENF;;;;
2010;2010;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2010;2010;FL;Florida;NVSS;Asthma;Asthma mortality rate;;;Number;116;116;;;;;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;NMBR;GENDER;GENF;;;;
2010;2010;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;;Number;71;71;;;;;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2010;2010;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.6;11.6;;;8;16.2;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;20.3;20.3;;;12.3;31.6;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.0;11;;;9.7;12.5;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2010;2010;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;NMBR;RACE;API;;;;
2010;2010;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;;Number;33;33;;;;;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2010;2010;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.0;10;;;6.7;14.5;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.5;7.5;;;6.3;8.7;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2010;2010;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;NMBR;RACE;HIS;;;;
2010;2010;CA;California;NVSS;Asthma;Asthma mortality rate;;;Number;403;403;;;;;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2010;2010;UT;Utah;NVSS;Asthma;Asthma mortality rate;;;Number;24;24;;;;;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;NMBR;GENDER;GENF;;;;
2010;2010;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;;Number;36;36;;;;;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;NMBR;GENDER;GENF;;;;
2010;2010;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;;Number;28;28;;;;;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;NMBR;GENDER;GENM;;;;
2010;2010;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;;Number;40;40;;;;;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;NMBR;GENDER;GENF;;;;
2010;2010;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;20;20;;;;;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;NMBR;GENDER;GENM;;;;
2010;2010;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;;Number;21;21;;;;;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;NMBR;GENDER;GENM;;;;
2010;2010;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;;Number;48;48;;;;;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2010;2010;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;;Number;109;109;;;;;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;NMBR;GENDER;GENF;;;;
2010;2010;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;NMBR;GENDER;GENM;;;;
2010;2010;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;16.3;16.3;;;10.5;24;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2010;2010;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;NMBR;GENDER;GENF;;;;
2010;2010;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;;Number;45;45;;;;;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.0;12;;;10.7;13.5;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2010;2010;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;;Number;28;28;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;NMBR;RACE;WHT;;;;
2010;2010;WA;Washington;NVSS;Asthma;Asthma mortality rate;;;Number;75;75;;;;;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2010;2010;CA;California;NVSS;Asthma;Asthma mortality rate;;;Number;251;251;;;;;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;NMBR;GENDER;GENF;;;;
2010;2010;FL;Florida;NVSS;Asthma;Asthma mortality rate;;;Number;61;61;;;;;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;NMBR;GENDER;GENM;;;;
2010;2010;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;26.0;26;;;18;36.4;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2010;2010;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;;Number;58;58;;;;;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2010;2010;WA;Washington;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2010;2010;MD;Maryland;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;30704;30,704;;;;;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST2_1;NMBR;GENDER;GENF;;;;
2010;2010;MD;Maryland;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;56070;56,070;;;;;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.6;12.6;;;11.6;13.6;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2010;2010;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;124704;124,704;;;;;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;NMBR;GENDER;GENF;;;;
2010;2010;IN;Indiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;SD;South Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2010;2010;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;10871;10,871;;;;;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;NMBR;GENDER;GENM;;;;
2010;2010;OH;Ohio;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST2_1;NMBR;GENDER;GENF;;;;
2010;2010;MT;Montana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2012;2012;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.7;11.7;;;10.3;13.3;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2010;2010;WV;West Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.6;8.6;;;7.8;9.5;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.8;13.8;;;12.5;15.1;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.2;10.2;;;9.2;11.3;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.2;13.2;;;12.1;14.5;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;17.1;17.1;;;9.7;28.2;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2012;2012;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.1;9.1;;;8.2;10.2;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.9;9.9;;;7.6;12.9;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.8;10.8;;;10.2;11.5;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.3;13.3;;;12;14.7;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.0;13;;;11.5;14.8;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.3;86.3;;;79.9;90.9;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;28.5;28.5;;;22.7;35.1;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2012;2012;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.5;10.5;;;8;13.6;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2012;2012;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;51.5;51.5;;;39.7;63.1;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2012;2012;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.0;10;;;7.4;13.1;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2012;2012;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;NMBR;RACE;AIAN;;;;
2012;2012;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2012;2012;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;26.7;26.7;;;19.1;36;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.6;6.6;;;3.9;10.9;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;28.8;28.8;;;20.7;38.5;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.2;44.2;;;36.7;52;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2015;2015;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;NMBR;RACE;BLK;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.6;12.6;;;9.5;16.5;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.8;11.8;;;7.7;17.6;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;;Number;67;67;;;;;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.0;32;;;24.4;40.7;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;KS;Kansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST2_1;NMBR;RACE;AIAN;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.8;9.8;;;6.1;15.5;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;50.4;50.4;;;38;62.8;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.5;87.5;**;US estimate/number is based on fewer than 50 states and the District of Columbia;85.1;88.3;Gender;Female;;;;;;;59;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;28.5;28.5;;;22.3;35.7;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.3;10.3;;;7.1;14.8;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.6;36.6;;;31.6;42;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;81.4;81.4;;;70.4;89;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.5;13.5;;;12;15.3;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;17.8;17.8;;;11.6;26.4;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.6;36.6;;;27.2;47.1;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;41.0;41;;;29;54.2;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;US;United States;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.5;11.5;;;11.1;11.8;Overall;Overall;;;;;;;59;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2018;2018;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;77.6;77.6;;;67.7;85.1;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2014;2014;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2015;2015;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.7;9.7;;;6.7;13.6;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.9;11.9;;;9.8;14.3;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.9;88.9;;;76.7;95.1;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;74.4;74.4;;;61.9;83.9;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.6;8.6;;;7.7;9.6;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;17.9;17.9;;;11.5;26.7;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.5;12.5;;;7.5;20.1;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;23.4;23.4;;;13.6;37.2;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.9;33.9;;;22.8;47.1;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;55.0;55;;;45.1;64.5;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;24.7;24.7;;;22.1;27.6;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.5;86.5;;;77.1;92.4;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.5;13.5;;;12.1;15;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.1;43.1;;;36.2;50.3;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2014;2014;CO;Colorado;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.1;13.1;;;10.8;15.7;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.5;84.5;;;75.9;90.5;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.6;12.6;;;11;14.2;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.3;63.3;;;52.7;72.7;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.9;9.9;;;7.1;13.6;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.8;31.8;;;20.2;46.2;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.1;13.1;;;7.2;22.5;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.0;38;;;29.7;47.1;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29.3;29.3;;;19.6;41.3;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;51.6;51.6;;;38.2;64.7;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.6;68.6;;;53.9;80.2;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.6;87.6;;;77.2;93.6;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90.1;90.1;;;81;95.1;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.9;10.9;;;9.8;12.2;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.3;40.3;;;34.4;46.5;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.8;6.8;;;4.6;10.1;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.6;39.6;;;32.9;46.6;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.3;34.3;;;25.8;43.9;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29.7;29.7;;;20.4;41.2;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;58.7;58.7;;;50.3;66.5;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.5;37.5;;;30.3;45.3;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;8.38;8.38;;;8.09;8.67;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2018;2018;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.1;10.1;;;9.6;10.7;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;61.9;61.9;;;51.9;71;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.7;37.7;;;29.6;46.6;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.3;39.3;;;33;46.1;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;76.9;76.9;;;65.5;85.4;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;US;United States;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.7;10.7;;;10.4;11.1;Overall;Overall;;;;;;;59;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29.0;29;;;22.1;37;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67.6;67.6;;;61.8;73;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.7;70.7;;;62.1;78;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;49.8;49.8;;;40;59.7;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.6;83.6;;;76.7;88.7;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;73.6;73.6;;;65.5;80.3;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.3;9.3;;;6.7;12.8;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2013;2013;MT;Montana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.8;11.8;;;10.5;13.1;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2018;2018;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.5;8.5;;;7.8;9.2;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.1;46.1;;;36.5;56;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2015;2015;VA;Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2018;2018;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;45.1;45.1;;;30.3;60.9;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;23.4;23.4;;;18.6;28.9;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.5;12.5;;;10.7;14.5;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;80.9;80.9;;;65.7;90.3;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.3;14.3;;;10.6;19.1;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;AL;Alabama;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;78.3;78.3;;;65.5;87.3;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.6;40.6;;;33.1;48.7;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.4;11.4;;;8.9;14.5;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.1;47.1;;;41.4;52.9;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.3;70.3;;;62.6;77;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.3;10.3;;;9.5;11.2;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;91.0;91;;;77.5;96.8;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.8;44.8;;;37.2;52.7;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.3;31.3;;;18.8;47.4;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;54.4;54.4;;;47.8;60.9;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.5;86.5;;;81.3;90.4;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.5;39.5;;;29.7;50.2;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.3;43.3;;;32.5;54.9;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;55.4;55.4;;;40.4;69.6;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.9;71.9;;;60.8;80.9;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;VI;Virgin Islands;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2013;2013;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.8;13.8;;;8.4;21.3;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.4;10.4;;;8.8;12.3;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;94.0;94;;;88.4;97;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;24.4;24.4;;;14.8;37.5;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;27.8;27.8;;;19.2;38.5;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29.9;29.9;;;21.3;40.1;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2018;2018;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.5;36.5;;;31.6;41.6;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;52.5;52.5;;;44.4;60.5;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;WY;Wyoming;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.5;46.5;;;38.7;54.5;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.3;62.3;;;47.5;75.2;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;VA;Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2015;2015;IL;Illinois;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST2_1;NMBR;RACE;BLK;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;49.6;49.6;;;39.7;59.6;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.9;13.9;;;12.2;15.8;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.6;70.6;;;59.6;79.5;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.6;42.6;;;36;49.4;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;74.0;74;;;63;82.7;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.4;11.4;;;9.9;13.1;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.6;69.6;;;62.5;75.9;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.5;35.5;;;30.1;41.2;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;22.9;22.9;;;16;31.5;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;27.5;27.5;;;17.8;40;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;81.4;81.4;;;69.5;89.4;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.9;69.9;;;57.6;79.9;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;18.0;18;;;13;24.4;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.6;62.6;;;51.4;72.6;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.7;9.7;;;8.9;10.6;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;54.4;54.4;;;42.2;66.1;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.4;34.4;;;28.9;40.3;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.7;6.7;;;5.5;8.2;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;29.7;29.7;;;19.8;42;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.1;11.1;;;10;12.3;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.8;88.8;;;83.1;92.8;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;;Number;41;41;;;;;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.8;9.8;;;9;10.6;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2018;2018;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.8;6.8;;;6;7.8;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.2;68.2;;;53.3;80.1;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.6;39.6;;;35.6;43.7;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;64.6;64.6;;;54.4;73.6;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.9;31.9;;;18.2;49.7;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;18.9;18.9;;;14;25;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.6;63.6;;;50.8;74.8;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.7;31.7;;;26;38;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.2;49.2;;;30.8;67.9;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.0;12;;;6.7;20.6;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;22.8;22.8;;;18.4;27.8;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.0;12;;;9.3;15.2;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;94.5;94.5;;;89.4;97.2;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.8;5.8;;;4.7;7.2;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2018;2018;CA;California;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;6.1;6.1;;;3.5;10.4;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;51.9;51.9;;;38.8;64.8;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.7;9.7;;;8.6;11;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;26.5;26.5;;;19.1;35.4;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.7;44.7;;;36.6;53;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.9;13.9;;;12.4;15.6;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.9;82.9;;;70.7;90.7;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.0;41;;;35.1;47.2;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.4;37.4;;;32.2;43;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;ME;Maine;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST2_1;NMBR;GENDER;GENM;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;23.7;23.7;;;17.5;31.2;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2014;2014;OR;Oregon;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;92.4;92.4;;;85.8;96.1;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2018;2018;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.3;10.3;;;7;14.8;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;30.0;30;;;24.4;36.2;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;56.2;56.2;;;45.7;66.2;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.4;40.4;;;33.9;47.3;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.9;31.9;;;22.1;43.6;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.9;7.9;;;6.8;9.1;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.4;85.4;;;79.4;89.9;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.0;9;;;8;10.2;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.0;12;;;8.3;16.9;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2013;2013;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.9;14.9;;;12.8;17;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.6;37.6;;;31.6;44;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;15.4;15.4;;;10.8;21.4;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.5;38.5;;;33.4;43.9;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.7;11.7;;;8.3;16.4;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.7;8.7;;;7.2;10.5;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.3;35.3;;;23.5;49.3;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.5;38.5;;;32;45.5;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.4;66.4;;;55.5;75.8;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;22.9;22.9;;;14.5;34.1;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;NMBR;RACE;WHT;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.1;11.1;;;10.1;12.3;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.5;13.5;;;8;22;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.9;39.9;;;33.8;46.4;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;23.2;23.2;;;14.9;34.4;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;60.3;60.3;;;39.4;77.9;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;57.4;57.4;;;45.5;68.5;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;55.4;55.4;;;46.3;64.1;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;MO;Missouri;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.6;5.6;;;4.4;7;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2015;2015;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.1;46.1;;;33.3;59.4;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.2;11.2;;;10.1;12.4;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;45.0;45;;;32;58.8;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.9;45.9;;;40.3;51.7;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.0;28;;;21.2;36;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.1;65.1;;;58.6;71;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.7;8.7;;;8;9.6;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.9;12.9;;;10;16.4;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.4;9.4;;;8.6;10.2;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.1;7.1;;;5.8;8.6;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.1;30.1;;;24.4;36.5;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;57.2;57.2;;;45.2;68.4;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.7;12.7;;;11.5;14;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.4;5.4;;;4.5;6.4;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.7;10.7;;;9.6;12.1;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.5;39.5;;;33.3;46.1;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.8;37.8;;;30.3;45.9;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;30.2;30.2;;;17.5;46.9;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.8;85.8;;;80.2;90.1;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;4.9;4.9;;;3.2;7.3;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.3;66.3;;;49.1;80;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;61.9;61.9;;;54.9;68.5;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.4;11.4;;;10.3;12.6;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.3;42.3;;;32.8;52.4;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.6;39.6;;;34.4;45;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.9;41.9;;;34.9;49.2;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;56.4;56.4;;;47.4;65.1;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.8;63.8;;;41.4;81.4;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.4;88.4;;;79.7;93.7;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.3;37.3;;;26.7;49.2;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.0;42;;;35.9;48.4;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2018;2018;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.6;86.6;*;50 States + DC: US Median;84.3;87.9;Overall;Overall;;;;;;;59;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.8;13.8;;;11.7;16.2;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;76.9;76.9;;;63.2;86.6;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.0;86;;;77;91.9;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.3;6.3;;;5.2;7.5;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.3;41.3;;;34;49.1;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2015;2015;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;NMBR;RACE;AIAN;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;24.4;24.4;;;19.8;29.7;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.9;9.9;;;6.6;14.3;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.8;87.8;;;80.2;92.8;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;27.3;27.3;;;20.5;35.3;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.1;10.1;;;7.6;13.2;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.7;8.7;;;7.9;9.5;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;26.0;26;;;16;39.4;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.8;10.8;;;7.1;16.1;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.3;42.3;;;31.1;54.3;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.9;5.9;;;4.9;7;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.6;87.6;;;74.3;94.5;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.5;9.5;;;8.6;10.4;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;79.0;79;;;64.4;88.6;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.6;91.6;;;86.1;95;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;21.0;21;;;15.6;27.8;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.9;37.9;;;31.4;44.9;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.4;12.4;;;8.9;17;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;17.4;17.4;;;11.1;26.2;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.0;44;;;31.8;57;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;49.4;49.4;;;38.4;60.4;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2014;2014;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;CRDRATE;RACE;API;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;50.6;50.6;;;39.6;61.6;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.9;37.9;;;32.4;43.7;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;60.1;60.1;;;49.1;70.2;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.1;31.1;;;22.2;41.6;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.4;82.4;**;US estimate/number is based on fewer than 50 states and the District of Columbia;79;84.4;Gender;Male;;;;;;;59;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.2;36.2;;;24.6;49.7;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.7;14.7;;;11.5;18.5;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.2;35.2;;;26.8;44.7;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;23.2;23.2;;;15.5;33.2;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.8;10.8;;;9.7;12;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.1;38.1;;;31.3;45.4;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;NMBR;RACE;AIAN;;;;
2014;2014;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;10.33;10.33;;;9.81;10.84;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;4.9;4.9;;;4;6.1;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.2;36.2;;;32;40.6;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.8;5.8;;;4.4;7.6;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.6;42.6;;;32.4;53.4;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;ME;Maine;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.0;90;;;84.4;93.7;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;28.4;28.4;;;17.9;42;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;27.8;27.8;;;14.7;46.3;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;51.4;51.4;;;36.2;66.3;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;US;United States;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.6;10.6;;;10.3;11;Overall;Overall;;;;;;;59;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.9;9.9;;;9;10.9;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.7;42.7;;;30.6;55.8;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2015;2015;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.9;8.9;;;6.8;11.4;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.9;85.9;;;70.2;94;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;27.0;27;;;18.8;37.2;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;44.4;44.4;;;32.5;56.9;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;16.8;16.8;;;14.6;19.4;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.9;68.9;;;60.1;76.6;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.5;65.5;;;54.5;75.1;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.9;9.9;;;8.9;10.9;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.6;87.6;;;82.7;91.3;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.8;37.8;;;29.8;46.6;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;IN;Indiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST3_1;NMBR;GENDER;GENF;;;;
2015;2015;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.5;12.5;;;8.3;18;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.6;33.6;;;23.1;46;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.1;31.1;;;24.2;39.1;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.7;90.7;;;84.8;94.5;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.5;12.5;;;7.9;18.8;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;13.7;13.7;;;9.8;18.7;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.2;11.2;;;10.1;12.4;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.4;8.4;;;7.3;9.5;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.4;8.4;;;7.3;9.5;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.6;66.6;;;57.8;74.4;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.4;42.4;;;36;49.1;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.4;38.4;;;30.1;47.4;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2014;2014;IN;Indiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST3_1;NMBR;GENDER;GENM;;;;
2015;2015;VA;Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;80.2;80.2;;;71;87.1;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.0;37;;;29;45.8;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.0;33;;;20.5;48.5;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2015;2015;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.4;12.4;;;9.9;15.3;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.3;47.3;;;40.5;54.2;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.5;34.5;;;22.6;48.8;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.7;87.7;;;76.2;94.1;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;44.1;44.1;;;32.2;56.8;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.5;45.5;;;39.2;52.1;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.2;8.2;;;6.3;10.4;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.6;46.6;;;40.4;52.9;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.4;37.4;;;32.7;42.4;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;15.3;15.3;;;11.9;19.4;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;58.2;58.2;;;45.8;69.7;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.6;42.6;;;31.3;54.7;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.8;65.8;;;58.5;72.5;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.7;34.7;;;21.1;51.3;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;25.5;25.5;;;17.5;35.5;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.8;13.8;;;11.6;16.3;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.3;39.3;;;26.6;53.6;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.2;39.2;;;34.5;44.2;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.1;28.1;;;23.2;33.7;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.9;49.9;;;43.3;56.4;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;54.4;54.4;;;44.6;63.9;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.6;30.6;;;26.6;34.9;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;25.1;25.1;;;16;37;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;75.5;75.5;;;62.4;85.1;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.4;41.4;;;32;51.4;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.6;83.6;;;74.2;90.1;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.9;84.9;;;69;93.4;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.6;41.6;;;33.2;50.6;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;19.9;19.9;;;13.3;28.7;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.9;38.9;;;32.7;45.4;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;29.4;29.4;;;17.6;44.9;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.0;37;;;29.4;45.3;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;NMBR;RACE;BLK;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.9;14.9;;;11.6;19;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2018;2018;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.8;36.8;;;21.4;55.4;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.1;35.1;;;29.1;41.7;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.5;37.5;;;30.2;45.4;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.7;63.7;;;52.5;73.6;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.9;62.9;;;56.8;68.5;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;74.0;74;;;60.1;84.3;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.8;34.8;;;24.9;46.2;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.7;6.7;;;5.5;8.1;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;15.4;15.4;;;9.5;24.1;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;27.1;27.1;;;19.4;36.6;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2013;2013;GA;Georgia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;18.7;18.7;;;10.4;31.5;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.3;65.3;;;53.9;75.1;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.0;10;;;7.2;13.7;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.1;11.1;;;9.8;12.5;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.4;8.4;;;4.9;14.2;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.5;34.5;;;23.2;47.9;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;64.1;64.1;;;52.1;74.6;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.5;12.5;;;7.3;20.5;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.8;5.8;;;4.5;7.3;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;VA;Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST3_1;NMBR;RACE;AIAN;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.8;31.8;;;26.2;38;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;US;United States;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.5;12.5;*;50 States + DC: US Median;11.6;12.9;Gender;Female;;;;;;;59;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.1;89.1;;;81.9;93.7;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.4;37.4;;;26.9;49.1;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;26.8;26.8;;;15.3;42.5;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.2;88.2;;;80;93.3;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.7;39.7;;;33.7;46.1;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.8;7.8;;;6.1;9.8;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.7;7.7;;;4.9;12;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.9;8.9;;;8;9.9;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;81.1;81.1;;;70.3;88.6;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;93.4;93.4;;;87.5;96.6;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;25.0;25;;;19.1;31.9;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.9;6.9;;;5.6;8.4;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.3;84.3;;;71.9;91.8;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67.6;67.6;;;61.6;73;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;GA;Georgia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.7;37.7;;;27.6;49.1;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.8;14.8;;;13.2;16.4;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.3;41.3;;;34.7;48.2;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.1;89.1;;;79.8;94.4;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;28.5;28.5;;;17.7;42.5;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.7;86.7;;;76.1;93;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;51.1;51.1;;;36;66;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.2;9.2;;;6.7;12.5;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.3;34.3;;;27.1;42.4;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.9;12.9;;;11.4;14.6;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.6;36.6;;;28.9;45;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2018;2018;US;United States;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.9;6.9;*;50 States + DC: US Median;6.4;7.2;Gender;Male;;;;;;;59;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;45.9;45.9;;;33.1;59.3;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;59.0;59;;;47.7;69.5;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;57.8;57.8;;;48.6;66.5;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.1;31.1;;;24.7;38.2;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.5;66.5;;;58.5;73.5;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;VI;Virgin Islands;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST2_1;NMBR;RACE;HIS;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.0;14;;;12.8;15.3;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.8;40.8;;;30.8;51.8;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.7;5.7;;;4.1;7.9;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.8;36.8;;;23.7;52.1;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.7;10.7;;;9.2;12.5;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;25.5;25.5;;;17.5;35.7;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;47.5;47.5;;;33.8;61.5;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2010;2010;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.2;14.2;;;9.3;20.9;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.4;44.4;;;33.5;55.8;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.7;35.7;;;26;46.6;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.0;41;;;35.2;47.1;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.5;5.5;;;4.4;6.9;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.2;14.2;;;12.5;16.2;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.5;9.5;;;7.8;11.4;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.5;28.5;;;18.1;41.8;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;30.8;30.8;;;25.8;36.3;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.0;41;;;34.6;47.7;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;56.2;56.2;;;48.1;64.1;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.0;9;;;7.5;10.7;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.1;62.1;;;55.1;68.7;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.3;39.3;;;32.3;46.8;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;18.4;18.4;;;14.5;23.1;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.1;34.1;;;22.8;47.6;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.6;86.6;;;78.6;91.9;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.9;8.9;;;8.1;9.6;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.8;83.8;;;68.4;92.5;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2014;2014;VA;Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2018;2018;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;53.9;53.9;;;42.2;65.2;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;72.5;72.5;;;55.5;84.8;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.6;34.6;;;29.8;39.7;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.7;70.7;;;60.5;79.2;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.3;89.3;;;82;93.9;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;55.5;55.5;;;46.3;64.3;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.9;10.9;;;10;11.9;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.9;72.9;;;63.8;80.5;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.5;62.5;;;45.1;77.1;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.1;35.1;;;30.3;40.3;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;56.8;56.8;;;43.6;69;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;25.2;25.2;;;19.1;32.5;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.5;42.5;;;25.2;61.9;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.5;11.5;;;7.3;17.6;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.5;7.5;;;5.5;10.1;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.7;36.7;;;31.4;42.3;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.7;8.7;;;7.8;9.7;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;17.2;17.2;;;12.3;23.6;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.5;13.5;;;7.9;22.1;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.5;11.5;;;10.3;12.7;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;19.2;19.2;;;12.7;28.1;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2017;2017;US;United States;NVSS;Asthma;Asthma mortality rate;;;Number;3564;3,564;;;;;Overall;Overall;;;;;;;59;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;73.4;73.4;;;62.2;82.3;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2014;2014;MD;Maryland;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;143.21;143.21;;;141.46;144.96;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;80.8;80.8;;;74.7;85.7;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.2;89.2;;;78.7;94.8;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.2;9.2;;;7.4;11.3;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.2;40.2;;;32.2;48.7;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.1;39.1;;;34;44.4;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.4;63.4;;;47.1;77.1;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;81.0;81;;;75.1;85.7;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.5;40.5;;;33.8;47.5;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;46.5;46.5;;;34.5;58.9;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.7;31.7;;;26.9;37;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.9;37.9;;;26.9;50.3;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.9;6.9;;;5.2;9.2;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.1;11.1;;;10.1;12.2;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;57.2;57.2;;;43.4;69.9;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;28.6;28.6;;;23.5;34.4;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2018;2018;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.4;10.4;;;8.9;12.1;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;29.3;29.3;;;16;47.5;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2018;2018;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.5;7.5;;;6.8;8.2;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2015;2015;TN;Tennessee;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.3;83.3;;;72.4;90.5;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.4;12.4;;;7;21.2;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;57.5;57.5;;;48.8;65.8;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.8;12.8;;;11.5;14.1;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.0;66;;;59.3;72.1;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.5;88.5;;;78.3;94.2;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.0;11;;;9.5;12.8;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;58.8;58.8;;;47.7;69.1;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2018;2018;NY;New York;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;15.7;15.7;;;9;25.9;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.5;65.5;;;59;71.5;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.7;36.7;;;25.1;50.1;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2014;2014;GU;Guam;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST3_1;NMBR;GENDER;GENF;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.3;8.3;;;7.2;9.7;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.3;12.3;;;10.7;14.2;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;21.7;21.7;;;12.7;34.6;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.6;30.6;;;24;38.1;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.1;6.1;;;5.3;7.1;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.3;31.3;;;25;38.3;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;17.8;17.8;;;10.4;28.9;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.3;32.3;;;22.6;44;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.5;48.5;;;41.2;55.9;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;24.7;24.7;;;17.1;34.3;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90.3;90.3;;;84.7;94;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.5;35.5;;;30.2;41.1;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;72.4;72.4;;;61.8;80.9;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.1;13.1;;;7.7;21.4;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.7;49.7;;;45.5;53.8;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;26.5;26.5;;;21.9;31.7;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.6;34.6;;;25.8;44.6;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2014;2014;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.4;36.4;;;26.2;47.9;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;52.1;52.1;;;42.5;61.5;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.3;11.3;;;8.3;15.1;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.1;13.1;;;10.4;16.3;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;51.0;51;;;41.7;60.3;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.3;5.3;;;4.1;6.8;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29.5;29.5;;;20.3;40.7;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.1;90.1;;;77.9;96;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.2;88.2;;;79.7;93.4;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.3;36.3;;;26.5;47.5;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;22.8;22.8;;;13.7;35.6;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.3;88.3;;;80.8;93.1;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;15.1;15.1;;;8.2;26.1;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.5;87.5;;;81.3;91.8;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2014;2014;OR;Oregon;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.8;9.8;;;8.5;11.3;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.4;7.4;;;4.2;12.8;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2014;2014;AK;Alaska;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST3_1;NMBR;RACE;BLK;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;15.5;15.5;;;9.5;24.5;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.4;38.4;;;29.3;48.5;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.8;30.8;;;21.2;42.4;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.9;10.9;;;7.1;16.5;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;77.7;77.7;;;65.9;86.2;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.1;47.1;;;37.5;57;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;57.9;57.9;;;46.9;68.2;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.0;9;;;8;10.2;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.4;7.4;;;4.2;12.8;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.4;11.4;;;8;16.2;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2018;2018;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.3;83.3;;;77.2;88;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.8;63.8;;;54.8;72;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;48.2;48.2;;;32.8;64;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;25.9;25.9;;;15.6;39.8;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2018;2018;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;75.4;75.4;;;67.7;81.7;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.5;6.5;;;5.3;7.9;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.1;38.1;;;32;44.6;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;27.5;27.5;;;20.2;36.2;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.6;38.6;;;33.2;44.2;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.7;41.7;;;26.4;58.9;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.1;33.1;;;21.5;47.3;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.5;5.5;;;4;7.5;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.9;7.9;;;7.3;8.6;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.9;8.9;;;7.7;10.3;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;16.5;16.5;;;10.7;24.6;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.9;8.9;;;8;9.8;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.1;41.1;;;35.5;46.9;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.8;46.8;;;33.7;60.3;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;15.1;15.1;;;13.4;17.1;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.1;38.1;;;34.5;41.8;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.8;35.8;;;28.6;43.7;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;25.7;25.7;;;19.2;33.3;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;77.6;77.6;;;68.8;84.5;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.5;69.5;;;58.3;78.8;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.9;34.9;;;17.8;56.9;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.0;9;;;7.6;10.7;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;25.3;25.3;;;14.6;40.2;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.8;11.8;;;10.2;13.5;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;64.5;64.5;;;46.8;79;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.4;12.4;;;8.2;18.3;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.0;70;;;61.5;77.3;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.5;33.5;;;26.6;41.3;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.9;33.9;;;26.3;42.3;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.0;13;;;11.3;14.9;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;48.9;48.9;;;48.1;49.7;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.1;45.1;;;35.6;55;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;30.6;30.6;;;24.9;36.9;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.6;82.6;;;71.4;90;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;ND;North Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.0;44;;;37.8;50.4;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.5;38.5;;;30.8;46.9;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.3;12.3;;;11.2;13.5;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.5;47.5;;;33.4;61.9;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.8;31.8;;;24.4;40.3;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.1;13.1;;;7.7;21.2;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;93.6;93.6;;;87.1;97;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;61.2;61.2;;;54.4;67.7;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.4;7.4;;;6.6;8.4;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.1;32.1;;;21.1;45.6;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;20.2;20.2;;;12.5;30.8;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;27.7;27.7;;;18.5;39.2;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.4;37.4;;;33.2;41.9;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;17.9;17.9;;;13.3;23.6;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.3;7.3;;;6.1;8.8;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.2;34.2;;;26.6;42.7;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.0;12;;;7.1;19.6;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.9;43.9;;;38.3;49.6;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;27.9;27.9;;;17.7;41;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.3;14.3;;;10.6;19.1;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;MI;Michigan;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;30.2;30.2;;;18.4;45.4;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;29.3;29.3;;;23.1;36.5;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;17.0;17;;;11.5;24.4;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.5;43.5;;;35.6;51.7;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;81.9;81.9;;;71.2;89.3;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.9;45.9;;;39.3;52.7;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;30.3;30.3;;;23.7;37.8;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.6;86.6;;;79.4;91.6;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.6;8.6;;;7.7;9.7;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;4.8;4.8;;;3.3;6.9;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;22.5;22.5;;;13.7;34.6;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.7;13.7;;;10.6;17.6;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.1;28.1;;;22;35.1;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.9;9.9;;;8.3;11.7;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.7;33.7;;;22.2;47.5;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;79.6;79.6;;;71.9;85.7;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;92.2;92.2;;;86;95.8;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.2;7.2;;;6.1;8.4;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.1;11.1;;;7.9;15.4;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;18.6;18.6;;;13.7;24.8;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.6;38.6;;;34.6;42.9;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.9;82.9;;;70.8;90.7;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;26.5;26.5;;;15.9;40.8;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.0;62;;;53.3;70.1;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;79.2;79.2;;;68.3;87.1;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29.7;29.7;;;25.9;33.9;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.9;8.9;;;6.6;11.9;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.8;63.8;;;56.1;70.8;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.6;35.6;;;23.3;50.1;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.0;84;;;76.3;89.6;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;23.5;23.5;;;19.3;28.2;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.7;11.7;;;9.5;14.3;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.9;13.9;;;12.3;15.7;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.0;84;;;68.8;92.6;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.9;41.9;;;30.7;54;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;64.1;64.1;;;53.4;73.6;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.5;9.5;;;7.9;11.3;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.1;32.1;;;27.7;36.9;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;18.7;18.7;;;12.9;26.3;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;29.4;29.4;;;20.5;40.2;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;5.7;5.7;;;3.3;9.5;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.0;11;;;9.3;12.9;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;47.83;47.83;;;46.88;48.77;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.4;14.4;;;8.3;23.7;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;NH;New Hampshire;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2018;2018;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.6;30.6;;;25.1;36.6;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.3;85.3;;;64.9;94.8;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2010;2010;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.8;7.8;;;5.4;10.9;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2018;2018;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.3;31.3;;;19.1;46.7;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;8.6;8.6;;;6;12.2;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.2;40.2;;;31.4;49.7;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;15.7;15.7;;;13.8;17.8;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2013;2013;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;8.10;8.1;;;7.9;8.3;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;19.3;19.3;;;12.3;29;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;30.3;30.3;;;16;49.9;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;30.3;30.3;;;22.5;39.4;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.1;33.1;;;24.4;43.3;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.4;66.4;;;56.2;75.3;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.5;70.5;;;56.8;81.2;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.3;7.3;;;5.7;9.2;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.8;67.8;;;54.5;78.8;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.0;48;;;33.6;62.7;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.5;37.5;;;31.8;43.5;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.6;45.6;;;40.4;50.9;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.4;33.4;;;22.8;46;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90.9;90.9;;;82.4;95.5;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.1;28.1;;;22.3;34.7;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;22.8;22.8;;;16.8;30;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.8;32.8;;;26.1;40.3;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.1;12.1;;;11.1;13.2;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29.6;29.6;;;24.5;35.1;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;26.7;26.7;;;14.3;44.2;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.9;38.9;;;29.5;49.2;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.9;6.9;;;5.6;8.4;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.7;28.7;;;22.3;36.1;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;51.7;51.7;;;51;52.3;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.1;31.1;;;24;39.3;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.5;89.5;;;82.7;93.8;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;61.9;61.9;;;53;70.1;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.8;35.8;;;29.6;42.6;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.5;13.5;;;12.2;14.9;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;3.9;3.9;;;2.2;6.8;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;17.3;17.3;;;9.6;29.2;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2013;2013;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.1;12.1;;;8;17.6;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.6;13.6;;;10.6;17.3;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.7;42.7;;;34.4;51.4;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.9;32.9;;;25.6;41.2;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.8;28.8;;;22;36.8;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.5;89.5;;;83.7;93.4;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.1;41.1;;;31.8;51;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.5;9.5;;;6.3;14.1;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.5;33.5;;;27.8;39.8;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.9;14.9;;;12.8;17.2;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;61.8;61.8;;;54.7;68.4;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.6;43.6;;;34.9;52.8;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2014;2014;LA;Louisiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;27.5;27.5;;;16.1;43;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;18.9;18.9;;;10.4;31.8;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.0;12;;;10.8;13.2;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;16.8;16.8;;;10;26.9;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;30.2;30.2;;;16.4;48.9;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2013;2013;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;5391;5,391;;;;;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.7;10.7;;;9.9;11.5;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.5;8.5;;;7.7;9.5;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.5;9.5;;;6.3;13.9;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.4;9.4;;;8.8;10.1;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;77.0;77;;;63.6;86.6;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.8;14.8;;;13.2;16.5;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.9;9.9;;;8.8;11.1;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.1;10.1;;;9;11.4;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.7;35.7;;;24.2;49.2;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.4;84.4;;;77.2;89.6;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;94.5;94.5;;;87.3;97.7;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.9;87.9;;;80.1;92.9;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.7;8.7;;;7.9;9.7;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;NMBR;GENDER;GENM;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;61.1;61.1;;;52.3;69.3;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;24.7;24.7;;;15.1;37.6;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.7;8.7;;;7.9;9.7;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.3;7.3;;;4.1;12.7;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.5;7.5;;;5.9;9.5;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.9;86.9;;;80.3;91.6;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.3;36.3;;;29.5;43.7;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.6;31.6;;;21.2;44.1;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.3;12.3;;;10.6;14.2;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.0;31;;;23.5;39.6;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;78.5;78.5;;;64.6;88;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.5;8.5;;;7.9;9.2;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.6;34.6;;;22.3;49.4;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2018;2018;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.3;36.3;*;50 States + DC: US Median;33.4;38;Gender;Female;;;;;;;59;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.5;40.5;;;33.8;47.5;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.6;39.6;;;33.7;45.8;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.7;7.7;;;6.2;9.4;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.2;45.2;;;26.6;65.2;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.8;65.8;;;50.2;78.6;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.9;69.9;;;57.4;80;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.1;7.1;;;6;8.3;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;49.4;49.4;;;38.8;60.2;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.9;89.9;;;74.5;96.4;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;26.7;26.7;;;18.2;37.3;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.6;9.6;;;8.7;10.5;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.1;8.1;;;6.7;9.8;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.2;40.2;;;31.8;49.2;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.7;44.7;;;36.8;52.9;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;53.5;53.5;;;47.1;59.8;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.3;34.3;;;27.2;42.1;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2018;2018;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.4;34.4;*;50 States + DC: US Median;31;37.4;Gender;Female;;;;;;;59;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;ND;North Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST3_1;NMBR;RACE;API;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.3;12.3;;;9.6;15.6;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.4;31.4;;;27;36.2;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.1;41.1;;;35.4;47.1;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.0;7;;;5.7;8.5;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;26.8;26.8;;;21.1;33.4;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.9;11.9;;;10.7;13.2;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;74.4;74.4;;;61.7;84;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;17.1;17.1;;;11.5;24.7;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.5;8.5;;;7.4;9.7;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.4;41.4;;;33.3;50.1;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.6;38.6;;;30.9;47;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;13.5;13.5;;;10;17.6;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.4;35.4;;;23.6;49.3;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.5;33.5;;;23.4;45.3;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.9;39.9;;;33.9;46.2;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.1;85.1;;;79;89.7;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29.3;29.3;;;21.8;38.1;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.2;47.2;;;38.6;55.9;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.5;9.5;;;8.4;10.8;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.0;36;;;29;43.6;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;57.3;57.3;;;48.9;65.2;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.4;65.4;;;50.8;77.6;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.4;87.4;;;75.1;94.1;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.8;46.8;;;38.6;55.2;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.7;72.7;;;60.3;82.4;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.8;11.8;;;10.2;13.6;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2016;2016;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.2;13.2;;;10.5;16.3;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2015;2015;KS;Kansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.8;37.8;;;33.3;42.6;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;79.9;79.9;;;69.5;87.4;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29.7;29.7;;;22.6;37.9;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.2;39.2;;;28.6;51;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;20.2;20.2;;;13.7;28.9;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.3;37.3;;;31.2;43.8;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.6;43.6;;;38.3;48.9;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.4;32.4;;;26.9;38.5;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;52.9;52.9;;;34;71;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.8;9.8;;;8.4;11.4;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.2;87.2;;;82;91;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;58.4;58.4;;;47.5;68.5;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;47.9;47.9;;;36.1;60;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.6;33.6;;;20.4;50;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.0;10;;;8.6;11.7;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;23.3;23.3;;;13.9;36.4;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;NMBR;GENDER;GENF;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.6;45.6;;;35.2;56.4;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.3;65.3;;;57.6;72.3;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.2;84.2;;;68.1;93.1;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;;Number;32;32;;;;;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;NMBR;GENDER;GENM;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.3;13.3;;;9.5;18.3;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.0;38;;;32.7;43.6;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.6;87.6;;;77.7;93.4;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;27.4;27.4;;;16.1;42.7;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.4;39.4;;;33.5;45.6;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;53.7;53.7;;;38.4;68.3;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;27.9;27.9;;;19.9;37.6;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.4;86.4;;;79.1;91.5;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.5;5.5;;;3.3;9.2;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.6;36.6;;;29.3;44.5;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;51.8;51.8;;;44.5;59;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.8;41.8;;;28.6;56.3;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.5;40.5;;;34.4;47;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.7;87.7;;;80.1;92.6;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.2;82.2;;;75.5;87.4;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;30.3;30.3;;;23.3;38.4;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;79.1;79.1;;;61.6;90;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.1;34.1;;;24.1;45.8;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.9;38.9;;;33.8;44.2;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;80.0;80;;;68.3;88.1;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;4.8;4.8;;;2.7;8.3;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;3.1;3.1;;;1.9;5.1;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.6;72.6;;;63;80.5;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;7.9;7.9;;;6.6;9.4;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;27.8;27.8;;;21.9;34.6;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.3;85.3;;;73.5;92.4;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.9;41.9;;;30.2;54.5;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;24.6;24.6;;;15.4;37;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.5;8.5;;;5.8;11.9;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;77.8;77.8;;;58.3;89.8;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.0;6;;;4.8;7.5;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.2;82.2;;;70.9;89.7;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;24.2;24.2;;;19.2;30.1;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.2;37.2;;;31.1;43.6;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.6;89.6;;;83.1;93.8;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;23.4;23.4;;;13.3;37.8;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.2;28.2;;;22.4;35;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.7;10.7;;;6.2;18;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.0;7;;;5.7;8.5;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2015;2015;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;22.1;22.1;;;14.9;31.5;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.8;32.8;;;26.9;39.3;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.5;41.5;;;37.7;45.5;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.3;11.3;;;10.2;12.6;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.2;88.2;;;78;94;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.9;8.9;;;8.2;9.7;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;29.4;29.4;;;22.9;36.9;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.3;10.3;;;9.3;11.5;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.0;45;;;37;53.3;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.9;6.9;;;6;7.9;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;27.3;27.3;;;21.6;33.9;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.2;39.2;;;32.5;46.4;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.4;14.4;;;8.7;23;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.1;7.1;;;4.1;12;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.0;6;;;4.1;8.6;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.2;37.2;;;28.2;47;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.2;12.2;;;11;13.6;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;48.7;48.7;;;39.4;58.1;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.0;36;;;29.2;43.4;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.5;41.5;;;33.7;49.8;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;42.2;42.2;;;32.6;52.4;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.4;6.4;;;5.3;7.7;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29.1;29.1;;;23.2;35.8;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;29.7;29.7;;;22.2;38.6;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2018;2018;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.4;37.4;;;33.2;41.9;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.7;5.7;;;4.9;6.5;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;WY;Wyoming;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.0;9;;;7.9;10.3;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.1;62.1;;;54.6;69.1;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.9;28.9;;;19.5;40.6;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29.6;29.6;;;22.5;37.7;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;56.8;56.8;;;45.2;67.6;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;26.3;26.3;;;15.7;40.6;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.4;13.4;;;11.9;15;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;76.8;76.8;;;64.3;85.8;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.8;12.8;;;9.8;16.5;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.2;42.2;;;35;49.8;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2015;2015;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.0;85;;;76.3;90.8;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.7;42.7;;;35.4;50.4;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.6;71.6;;;60.4;80.6;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;24.1;24.1;;;18.8;30.3;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;81.4;81.4;;;70.3;89;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.5;7.5;;;6.1;9.2;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;79.5;79.5;;;66.5;88.4;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.8;33.8;;;25.5;43.1;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.8;42.8;;;28.3;58.6;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.8;39.8;;;33.8;46.1;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.4;66.4;;;60.1;72.2;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.4;34.4;;;26.4;43.4;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.1;39.1;;;33.9;44.5;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.6;37.6;;;25.1;52;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;IN;Indiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.6;38.6;;;31.3;46.5;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2018;2018;US;United States;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.4;9.4;*;50 States + DC: US Median;9.1;10;Overall;Overall;;;;;;;59;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.0;47;;;36;58.3;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.7;30.7;;;18.8;45.8;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.1;39.1;;;28.6;50.6;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.3;14.3;;;13;15.7;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.2;10.2;;;9.1;11.5;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.9;5.9;;;5;6.9;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.7;6.7;;;5.5;8.3;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.2;37.2;;;30.7;44.2;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.7;12.7;;;11;14.6;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.5;6.5;;;4;10.6;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.4;6.4;;;5.5;7.4;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.7;7.7;;;7.2;8.3;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;;Number;28;28;;;;;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;NMBR;GENDER;GENF;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.9;88.9;;;80.5;94;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.1;91.1;;;84.8;94.9;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.9;8.9;;;7.7;10.3;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.0;12;;;10.5;13.6;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50.4;50.4;;;43.1;57.8;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.5;41.5;;;35.7;47.5;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;18.4;18.4;;;12.4;26.3;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.4;14.4;;;12.8;16.2;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;19.3;19.3;;;11.4;30.8;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.1;30.1;;;23.8;37.3;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.2;5.2;;;3.4;7.7;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2018;2018;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;58.2;58.2;;;47.1;68.6;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;27.7;27.7;;;15.3;44.9;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.3;6.3;;;4.6;8.6;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.9;14.9;;;9.3;23.2;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.6;6.6;;;5.6;7.9;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;60.9;60.9;;;52.1;69;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;29.8;29.8;;;23.5;37;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.2;9.2;;;7.8;10.8;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29.5;29.5;;;20.8;39.9;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.0;9;;;7.9;10.1;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.3;41.3;;;35;47.9;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.7;14.7;;;12.8;16.9;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.0;11;;;9.9;12.2;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;81.7;81.7;;;72;88.5;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;14.8;14.8;;;8.2;25.1;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.4;71.4;;;62.1;79.2;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.1;69.1;;;60.2;76.8;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.7;36.7;;;30.1;43.9;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.5;46.5;;;38.1;55.1;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.1;12.1;;;7.5;18.8;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;4.8;4.8;;;3.3;6.8;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.7;41.7;;;30;54.4;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.1;13.1;;;10.4;16.4;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29.2;29.2;;;22.5;37;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;22.1;22.1;;;12.5;36;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.9;31.9;;;25.8;38.7;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.4;40.4;;;34.6;46.5;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.1;47.1;;;37.9;56.5;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2018;2018;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.9;9.9;;;9.3;10.6;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;20.0;20;;;11.4;32.6;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.2;7.2;;;5.7;9.2;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.4;10.4;;;9.1;11.9;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.6;34.6;;;23.6;47.6;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.0;11;;;8.8;13.5;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.7;8.7;;;7.8;9.8;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.8;89.8;;;79.2;95.3;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2018;2018;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.8;6.8;;;4.8;9.6;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;21.5;21.5;;;12.7;33.9;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;22.1;22.1;;;15.9;29.9;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;8.3;8.3;;;5.9;11.4;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.5;11.5;;;7.1;18.1;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.5;5.5;;;4.5;6.7;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;30.2;30.2;;;24.8;36.1;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.6;85.6;;;76.7;91.5;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.1;35.1;;;27;44.2;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.4;33.4;;;27.4;40.1;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;52.5;52.5;;;43.1;61.7;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.3;6.3;;;3.7;10.7;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2018;2018;NY;New York;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.9;14.9;;;11.6;18.8;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2015;2015;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;4.6;4.6;;;3;6.8;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.2;35.2;;;29.7;41.2;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;60.8;60.8;;;48.8;71.6;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.3;14.3;;;9.8;20.4;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;53.2;53.2;;;39.2;66.7;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.8;36.8;;;29.3;45;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.5;44.5;;;35.3;54.2;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.4;12.4;;;9.3;16.2;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.0;70;;;58.8;79.3;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;49.4;49.4;;;38.8;60.2;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.3;84.3;;;77;89.6;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;79.8;79.8;;;67;88.5;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.1;11.1;;;10;12.3;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.7;8.7;;;7.6;9.8;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.1;8.1;;;6;10.9;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.8;35.8;;;29.9;42.1;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.8;32.8;*;50 States + DC: US Median;31.1;35.5;Overall;Overall;;;;;;;59;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2018;2018;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;55.0;55;;;45.7;63.9;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.6;42.6;;;36.9;48.4;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.0;35;;;20;53.6;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;91.7;91.7;;;85.5;95.4;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.9;85.9;;;78.6;91;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.9;28.9;;;19.3;40.8;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.7;8.7;;;7.7;9.9;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.7;90.7;;;79.5;96.1;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;MT;Montana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2018;2018;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.1;12.1;;;7.9;18.1;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;61.4;61.4;;;52.4;69.7;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.0;9;;;7.6;10.6;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;27.9;27.9;;;17.7;41.1;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;15.7;15.7;;;9.6;24.6;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.2;9.2;;;8.2;10.4;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.2;10.2;;;8.3;12.5;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.7;9.7;;;8.5;11;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.9;12.9;;;11.1;14.8;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.8;67.8;;;57.1;76.8;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.2;67.2;;;59.1;74.4;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.8;86.8;;;80;91.5;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;NY;New York;NVSS;Asthma;Asthma mortality rate;;;Number;256;256;;;;;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.3;65.3;;;47.9;79.4;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;61.1;61.1;;;47.5;73.2;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.1;9.1;;;6.9;11.9;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.6;11.6;;;10.6;12.7;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;91.8;91.8;;;86.6;95.1;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.9;41.9;;;36.6;47.4;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.3;41.3;;;34.9;48;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.0;10;;;7.5;13.2;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;23.0;23;;;17.6;29.4;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;22.9;22.9;;;13.1;36.8;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;28.9;28.9;;;20.3;39.5;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.0;10;;;9;11.2;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;64.7;64.7;;;54.8;73.4;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.2;8.2;;;7.1;9.3;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;CT;Connecticut;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;29.8;29.8;;;23.2;37.4;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;60.5;60.5;;;51.7;68.7;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.8;35.8;;;24;49.6;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;47.4;47.4;;;40.1;54.9;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.8;7.8;;;6.7;9.1;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.7;39.7;;;35;44.7;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.1;11.1;;;9.7;12.6;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.2;7.2;;;6;8.6;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.9;8.9;;;7.4;10.7;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.6;33.6;;;25.9;42.2;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.3;38.3;;;30.4;46.9;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;24.7;24.7;;;14.8;38.3;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.8;82.8;;;74.2;89;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;22.6;22.6;;;15.6;31.5;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1551;1,551;;;;;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;NMBR;GENDER;GENM;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.1;45.1;;;35.2;55.4;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;28.4;28.4;;;17.8;42;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.9;9.9;;;9.1;10.8;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.1;7.1;;;5.6;9.1;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.8;84.8;;;75.8;90.8;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;60.0;60;;;50;69.2;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.8;34.8;;;29.3;40.7;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2014;2014;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.0;10;;;9;11;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.8;14.8;;;12.4;17.7;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.2;42.2;;;28.4;57.2;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.5;9.5;;;6.2;14.2;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;43.4;43.4;;;28.8;59.4;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;3718;3,718;;;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;NMBR;RACE;HIS;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.7;11.7;;;10.7;12.8;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.7;31.7;;;18;49.4;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.3;86.3;;;80.2;90.7;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.6;7.6;;;6.3;9.1;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.7;83.7;;;72.9;90.8;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.6;11.6;;;10.2;13.2;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2018;2018;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.2;63.2;;;54.2;71.4;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.4;7.4;;;6.3;8.6;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2015;2015;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;NMBR;RACE;API;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.7;14.7;;;8.3;24.8;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.4;9.4;;;8.3;10.6;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.3;88.3;;;81.9;92.7;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;20.5;20.5;;;14.2;28.8;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.1;14.1;;;12.5;15.9;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;NY;New York;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.5;72.5;;;64;79.7;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.0;43;;;35.5;50.8;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.3;86.3;;;80;90.8;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.4;45.4;;;29.9;62;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.1;43.1;;;35.6;50.8;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.3;35.3;;;23.8;48.8;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;41.7;41.7;;;30.5;53.8;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2012;2012;MT;Montana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;NMBR;RACE;WHT;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;20.1;20.1;;;13.4;29.1;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;79.4;79.4;;;71.6;85.4;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.4;14.4;;;10.8;18.6;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.0;65;;;58.8;70.7;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;4.0;4;;;2.7;5.8;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.4;35.4;;;29.1;42.3;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.2;42.2;;;35.3;49.4;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;16.94;16.94;;;16.75;17.13;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.9;6.9;;;5.1;9.3;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.7;88.7;;;81.7;93.3;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;18.3;18.3;;;11;28.9;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;47.4;47.4;;;33.4;61.8;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.1;84.1;;;73.1;91.2;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;54.5;54.5;;;41.1;67.3;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.3;10.3;;;9.5;11.1;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;16.7;16.7;;;13.5;20.5;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;28.6;28.6;;;24.2;33.4;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;59.3;59.3;;;50.8;67.4;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;60.5;60.5;;;53.1;67.5;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2014;2014;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;11.61;11.61;;;10.43;12.78;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.5;62.5;;;50.1;73.5;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;28.0;28;;;20.2;37.4;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;59.9;59.9;;;51.6;67.7;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.2;6.2;;;5.5;6.8;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;4.9;4.9;;;3.6;6.6;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.9;12.9;;;8.1;19.9;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.5;9.5;;;6.6;13.4;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;CA;California;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;20.2;20.2;;;12.5;31;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.1;87.1;;;81.2;91.4;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.0;90;;;82;94.7;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;57.9;57.9;;;46.8;68.3;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.0;33;;;28.4;38;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.3;11.3;;;10.2;12.5;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;61.2;61.2;;;51.9;69.7;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.1;31.1;;;19.7;45.2;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.1;40.1;;;35.6;44.9;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;55.1;55.1;;;38.4;70.6;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;78.7;78.7;;;69.7;85.7;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;;Number;66;66;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;NMBR;RACE;WHT;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;55;55;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;NMBR;RACE;WHT;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.3;40.3;;;33.2;47.8;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.5;40.5;;;35.4;45.9;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.4;10.4;;;9.3;11.5;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;79.6;79.6;;;73.5;84.5;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.4;8.4;;;6.9;10.2;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.8;12.8;;;9.6;16.8;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.2;30.2;;;21.1;41.1;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;VA;Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.9;28.9;;;20.6;39;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.7;12.7;;;9.8;16.4;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.2;9.2;;;6;13.7;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.7;35.7;;;29.4;42.6;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2014;2014;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;9.57;9.57;;;9.26;9.88;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2015;2015;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.9;5.9;;;4.9;7;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;18.6;18.6;;;11;29.8;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;23.5;23.5;;;17.4;31;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.1;13.1;;;9.6;17.7;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;23.6;23.6;;;17.1;31.8;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.4;45.4;;;35.9;55.3;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2018;2018;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;16.3;16.3;;;12.6;20.9;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.3;34.3;;;26.4;43.2;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.3;34.3;;;23.9;46.5;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;NMBR;GENDER;GENF;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.5;86.5;;;78.1;92;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2018;2018;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29.0;29;;;22.9;36;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.2;90.2;;;81.5;95.1;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.8;11.8;;;9.9;14;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.6;37.6;;;29.6;46.3;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.5;8.5;;;7.7;9.3;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.0;28;;;19.9;37.9;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.9;30.9;;;23.7;39.1;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.5;9.5;;;6.1;14.3;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2014;2014;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;3463;3,463;;;;;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;NMBR;GENDER;GENM;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.8;11.8;;;8.8;15.7;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;54.4;54.4;;;48.1;60.5;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.8;43.8;;;36;51.9;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;51.3;51.3;;;34.1;68.2;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;19.3;19.3;;;14.4;25.2;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.5;36.5;;;30.2;43.3;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.2;11.2;;;10;12.5;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.4;38.4;;;29.3;48.4;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.3;69.3;;;62.7;75.2;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.6;12.6;;;10.5;14.9;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.8;12.8;;;11.2;14.7;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;60.5;60.5;;;48.9;71;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2018;2018;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.5;30.5;;;23.6;38.3;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;US;United States;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.4;12.4;*;50 States + DC: US Median;11.6;12.8;Gender;Female;;;;;;;59;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.8;9.8;;;8.7;11;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.2;7.2;;;5.9;8.7;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.9;7.9;;;7.2;8.6;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.7;39.7;;;31.5;48.5;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;55.4;55.4;;;48.9;61.7;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.7;8.7;;;7.8;9.7;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.2;36.2;;;28.1;45.2;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.3;8.3;;;7.4;9.4;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.1;8.1;;;7.5;8.7;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.5;42.5;;;32.8;52.8;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;80.4;80.4;;;67.6;89;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.5;12.5;;;10;15.5;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.9;8.9;;;7.7;10.2;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.3;42.3;;;34.8;50;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.1;88.1;;;83.4;91.6;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.6;63.6;;;53.9;72.3;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2014;2014;MN;Minnesota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.7;40.7;;;34.5;47.1;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.0;40;;;33.2;47.1;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.8;10.8;;;9.3;12.6;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.8;8.8;;;8;9.6;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2018;2018;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.6;32.6;;;20.6;47.4;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2018;2018;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.3;41.3;*;50 States + DC: US Median;39.5;42.2;Gender;Female;;;;;;;59;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.9;69.9;;;53.4;82.5;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.3;45.3;;;37;54;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.6;65.6;;;58.3;72.3;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.8;65.8;;;59.9;71.2;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.1;44.1;;;35.4;53.2;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2018;2018;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;57.4;57.4;;;47.3;66.9;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.5;5.5;;;4.4;7;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.7;8.7;;;7.4;10.2;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.3;36.3;;;26.2;47.7;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2014;2014;TX;Texas;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.8;37.8;;;33.1;42.6;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.2;34.2;;;28.2;40.8;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.6;12.6;;;8;19.5;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2014;2014;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;4.80;4.8;;;2.61;6.99;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.7;33.7;;;24.9;44;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.8;45.8;;;40.1;51.5;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;26.6;26.6;;;19.6;35.1;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;25.5;25.5;;;16.9;36.7;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.0;67;;;49.3;81;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.9;40.9;;;36.4;45.6;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2018;2018;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.8;32.8;;;18.9;50.4;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;52.3;52.3;;;39.5;64.7;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.1;65.1;;;53.6;75;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;25.6;25.6;;;17.7;35.6;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.3;69.3;;;56.5;79.7;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;73.2;73.2;;;60;83.3;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.0;33;;;28;38.3;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;15.4;15.4;;;12.3;19.2;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.1;9.1;;;5.5;14.6;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.4;6.4;;;3.6;11.1;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2015;2015;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;NMBR;RACE;BLK;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;60.2;60.2;;;50.2;69.4;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;WY;Wyoming;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2018;2018;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.6;37.6;*;50 States + DC: US Median;36.6;39;Overall;Overall;;;;;;;59;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;ID;Idaho;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.2;14.2;;;9.9;20.1;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.2;10.2;;;6.2;16.5;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.1;28.1;;;22.1;35.1;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.1;9.1;;;7.7;10.9;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.0;88;;;76.2;94.4;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;20.3;20.3;;;11.3;33.9;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.9;9.9;;;7;13.8;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.0;10;;;9.1;11;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.6;65.6;;;50.4;78.2;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.5;36.5;;;30.2;43.3;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.6;9.6;;;8.5;10.9;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;6.2;6.2;;;4;9.6;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;16.2;16.2;;;10.1;25.1;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.6;32.6;;;27.1;38.6;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.8;28.8;;;22.4;36.2;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;50.4;50.4;;;42.8;58;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.3;5.3;;;3;9.1;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;26.4;26.4;;;23;30.1;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.3;42.3;;;33.6;51.5;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.2;35.2;;;29.1;41.8;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.4;5.4;;;4.6;6.4;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;81.4;81.4;;;75.5;86.2;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.8;6.8;;;5.3;8.7;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.1;12.1;;;10.9;13.4;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.8;39.8;;;33;47;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.0;36;;;28.5;44.2;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.6;41.6;;;34.5;48.9;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.1;35.1;;;30.6;39.8;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.7;49.7;;;43;56.5;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.9;44.9;;;37.8;52.2;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.1;87.1;;;74.1;94.1;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;23.5;23.5;;;17.3;31;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;30.5;30.5;;;17.7;47.3;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.8;5.8;;;4.1;8.1;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.5;28.5;;;21.9;36.1;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;81.5;81.5;;;68.7;89.8;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.7;7.7;;;4.9;11.8;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.3;70.3;;;52;83.8;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.4;85.4;;;65.6;94.7;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;78.9;78.9;;;68;86.8;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2015;2015;OR;Oregon;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST2_1;NMBR;RACE;API;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.6;45.6;;;35.2;56.4;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;41.3;41.3;;;32;51.2;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.1;33.1;;;27.3;39.5;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.1;65.1;;;58.2;71.4;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.2;13.2;;;11.9;14.5;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.4;10.4;;;9.2;11.7;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2018;2018;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.4;70.4;;;55.5;81.9;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.2;31.2;;;21.2;43.3;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2018;2018;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.9;6.9;;;5.1;9.5;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.4;36.4;;;30.5;42.8;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.3;83.3;;;77.3;87.9;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;16.9;16.9;;;12.8;21.9;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2015;2015;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;39.2;39.2;;;28.8;52.1;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2012;2012;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.8;9.8;;;6.7;13.8;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.8;9.8;;;9.1;10.6;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;61.7;61.7;;;50.9;71.4;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.5;11.5;;;7.3;17.6;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.4;14.4;;;11.3;18.3;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.8;38.8;;;31.1;47.1;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;29.4;29.4;;;21.8;38.4;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;47.7;47.7;;;35.1;60.6;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.1;39.1;;;33.3;45.3;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.3;83.3;;;75.5;89;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.8;9.8;;;8.6;11.2;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;18.0;18;;;12.2;25.6;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.5;10.5;;;6.5;16.5;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.3;39.3;;;31.9;47.2;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.9;47.9;;;41.9;53.9;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.2;12.2;;;10.8;13.8;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;19.7;19.7;;;12.7;29.3;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67.1;67.1;;;57.2;75.7;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.9;88.9;;;84;92.5;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;46.5;46.5;;;37.2;56.1;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.5;12.5;;;8.3;18.3;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.8;86.8;;;80;91.5;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;80.4;80.4;;;65.8;89.8;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.4;32.4;;;22.3;44.5;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1282;1,282;;;;;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;NMBR;GENDER;GENF;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.3;38.3;;;32.8;44.1;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.6;38.6;;;25.7;53.2;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;60.6;60.6;;;44.9;74.3;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.8;31.8;;;26.1;38;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;15.3;15.3;;;12.1;19.2;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.2;5.2;;;3.1;8.7;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;26.5;26.5;;;14.5;43.5;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.9;83.9;;;78.2;88.4;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.7;7.7;;;5;11.8;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;NY;New York;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.4;14.4;;;11.2;18.3;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.1;42.1;;;36.2;48.1;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.9;10.9;;;8.4;14;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;30.8;30.8;;;21;42.7;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;29.9;29.9;;;22.1;39.1;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.0;40;;;35.1;45.1;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;46.3;46.3;;;34.5;58.6;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;25.3;25.3;;;18.4;33.9;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.0;5;;;4.2;6;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.8;37.8;;;32.5;43.4;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.3;41.3;;;34.1;48.9;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.3;8.3;;;7.2;9.6;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.8;38.8;;;31.3;46.8;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2018;2018;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;28.0;28;;;23.1;33.4;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.8;9.8;;;6.4;14.8;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.7;13.7;;;12.4;15.1;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.6;47.6;;;37.7;57.7;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.6;86.6;;;81;90.7;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.0;14;;;8.5;22.2;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.6;42.6;;;29.6;56.8;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.1;6.1;;;3.4;10.7;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2016;2016;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.3;44.3;;;22;69.3;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.2;11.2;;;9.6;12.9;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.9;35.9;;;26.6;46.5;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2018;2018;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;25.5;25.5;;;22.7;28.6;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.6;11.6;;;10.1;13;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;56.4;56.4;;;44.8;67.4;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.4;42.4;;;38;46.8;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.0;31;;;26.6;35.8;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2018;2018;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.4;31.4;;;25.9;37.5;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.8;87.8;;;82.8;91.5;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2013;2013;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;;Number;61;61;;;;;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;NMBR;GENDER;GENM;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.9;9.9;;;7.2;13.4;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.5;8.5;;;7.7;9.3;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;15.2;15.2;;;12.7;18;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.1;84.1;;;76.7;89.5;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.4;38.4;;;32.5;44.6;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.3;31.3;;;19.9;45.4;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;92.6;92.6;;;87;96;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;16.3;16.3;;;10.1;25.3;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;22.0;22;;;14.4;32;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;18.3;18.3;;;12;27;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.0;48;;;39.7;56.4;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;7.6;7.6;;;4.3;13.2;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;NMBR;RACE;AIAN;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.0;91;;;82.5;95.6;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;7.0;7;;;3.9;12.2;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;24.3;24.3;;;19.5;29.9;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.4;6.4;;;5.4;7.6;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.4;41.4;;;36.8;46.1;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.5;48.5;;;34.4;62.9;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.8;86.8;;;68.2;95.3;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;16.1;16.1;;;11.5;22.1;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.5;69.5;;;54.8;81;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50.3;50.3;;;36.9;63.6;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.1;34.1;;;27.4;41.6;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;;Number;43;43;;;;;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.1;91.1;;;82.4;95.8;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;DC;District of Columbia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST2_1;NMBR;RACE;WHT;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.5;8.5;;;7.4;9.8;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.4;12.4;;;11;14;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.8;36.8;;;30.5;43.6;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.8;8.8;;;7.9;9.8;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.4;11.4;;;10;13.1;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.9;36.9;;;32.5;41.6;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.8;6.8;;;5;9.2;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.5;37.5;;;29;46.7;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.8;10.8;;;6.3;17.7;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.0;39;;;34.4;43.7;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.7;12.7;;;7.2;21.5;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.8;11.8;;;10.6;13.1;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;52.4;52.4;;;37.7;66.6;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;OH;Ohio;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;30.9;30.9;;;23.6;39.4;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.9;8.9;;;8.2;9.7;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.1;8.1;;;6.8;9.7;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2014;2014;MN;Minnesota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST3_1;CRDRATE;RACE;API;;;;
2015;2015;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.7;84.7;**;US estimate/number is based on fewer than 50 states and the District of Columbia;81;87.4;Gender;Male;;;;;;;59;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.1;34.1;;;24.9;44.6;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;26.0;26;;;15.7;39.9;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.4;83.4;;;63.7;93.5;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;55.1;55.1;;;48;62;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.0;40;;;30.7;50;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.1;9.1;;;8.4;9.8;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.1;32.1;;;19.4;48.3;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.6;9.6;;;8.5;10.8;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.9;82.9;;;76.9;87.7;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;72.7;72.7;;;64.2;79.8;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.8;83.8;;;66.5;93;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.1;43.1;;;32;54.8;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.9;7.9;;;6.8;9.2;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.8;86.8;;;80.1;91.6;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.9;9.9;;;8.9;10.9;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.6;9.6;;;8.6;10.6;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.0;65;;;58.2;71.2;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.9;62.9;;;54.8;70.4;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.2;11.2;;;10.4;12.1;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;CT;Connecticut;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST2_1;NMBR;RACE;WHT;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.3;10.3;;;9.3;11.5;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.0;34;;;29.4;38.9;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.4;6.4;;;5.4;7.4;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.9;9.9;;;8.8;11;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.1;40.1;;;27;54.7;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.6;13.6;;;9;20;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;48.9;48.9;;;32.5;65.6;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.0;37;;;32.7;41.6;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;77.1;77.1;;;65.8;85.5;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.3;82.3;;;71.7;89.5;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;57.9;57.9;;;49.6;65.8;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.8;36.8;;;26.1;49;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.2;33.2;;;26.7;40.5;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.0;47;;;39.5;54.7;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;52.9;52.9;;;35.7;69.5;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.3;89.3;;;83.4;93.3;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;VI;Virgin Islands;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;45.6;45.6;;;34.2;57.4;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.3;31.3;;;25;38.5;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.1;14.1;;;10.3;18.9;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2014;2014;IN;Indiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST3_1;NMBR;RACE;AIAN;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.8;40.8;;;34.3;47.6;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.1;40.1;;;35;45.4;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2010;2010;DC;District of Columbia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.5;84.5;;;75.6;90.6;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2013;2013;MO;Missouri;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;NMBR;RACE;API;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;19.2;19.2;;;11.1;31.2;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.5;10.5;;;9.5;11.5;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;CT;Connecticut;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;4.0;4;;;2.4;6.6;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.5;69.5;;;54.2;81.4;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.1;91.1;;;84.8;94.9;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.2;11.2;;;7.2;17.1;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.4;46.4;;;34.7;58.5;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.6;45.6;;;37.3;54.2;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.4;62.4;;;55.6;68.7;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.0;83;;;68.7;91.6;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.6;9.6;;;8.6;10.7;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2018;2018;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.6;12.6;;;11.7;13.5;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.2;5.2;;;3.4;7.8;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.8;8.8;;;7.4;10.5;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90.0;90;;;82.9;94.4;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.0;6;;;4.5;8;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.8;66.8;;;57.7;74.8;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;54.3;54.3;;;39.8;68.2;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;24.8;24.8;;;18.9;31.9;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.8;40.8;;;25.6;57.9;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.2;88.2;;;79.7;93.5;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.0;69;;;61.9;75.2;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.1;13.1;;;11.3;15.1;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.4;7.4;;;6.5;8.4;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.8;11.8;;;10.1;13.8;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;80.8;80.8;;;67.3;89.6;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2018;2018;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.0;32;;;27.5;36.7;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.3;12.3;;;10.8;14;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.6;37.6;;;31;44.8;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.1;9.1;;;7.9;10.4;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.2;13.2;;;11.4;15.3;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.9;71.9;;;59.6;81.7;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.3;6.3;;;5.3;7.5;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.0;45;;;28;63.3;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.3;9.3;;;7.9;10.9;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.8;8.8;;;7.7;10.1;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;21.7;21.7;;;13.6;32.9;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2018;2018;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.1;31.1;*;50 States + DC: US Median;28.8;32.4;Gender;Male;;;;;;;59;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.7;12.7;;;10.4;15;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.2;42.2;;;37.4;47.2;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;49.3;49.3;;;33;65.8;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.2;35.2;;;28;43.1;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.7;83.7;;;76.7;88.8;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.4;7.4;;;5.6;9.8;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.7;30.7;;;25.3;36.7;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2018;2018;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.5;9.5;;;8.5;10.6;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.4;7.4;;;5.9;9.3;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;16.8;16.8;;;9.8;27.3;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.4;11.4;;;10.5;12.2;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;28.2;28.2;;;19;39.5;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;NM;New Mexico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST2_1;NMBR;GENDER;GENF;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;TX;Texas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST2_1;NMBR;GENDER;GENF;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.5;65.5;;;51.6;77.3;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.9;11.9;;;9;15.6;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.8;10.8;;;8;14.4;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.5;7.5;;;4.6;11.8;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2013;2013;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.3;13.3;;;10.3;16.9;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;51.7;51.7;;;41.2;62.1;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;77.1;77.1;;;56;89.9;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;30.3;30.3;;;25.4;35.7;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.1;5.1;;;3;8.4;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.5;32.5;;;26.8;38.7;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.4;88.4;;;82.4;92.6;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.4;65.4;;;52.9;76.1;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.2;86.2;;;77.6;91.9;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;25.4;25.4;;;16.6;36.8;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;OK;Oklahoma;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2014;2014;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;17.88;17.88;;;17.62;18.14;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.1;31.1;;;25;38;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;61.6;61.6;;;50.8;71.4;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;97.4;97.4;;;92.9;99.1;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.4;35.4;;;22.4;50.9;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.9;12.9;;;11.1;14.9;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29.1;29.1;;;23.3;35.5;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;73.3;73.3;;;65.2;80.1;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.7;12.7;;;9.6;16.6;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.9;40.9;;;32.9;49.5;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.5;88.5;;;81.4;93.1;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;15.8;15.8;;;13.2;18.8;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.2;86.2;;;68.5;94.7;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2013;2013;OK;Oklahoma;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.6;7.6;;;6.6;8.6;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.7;30.7;;;20.7;42.9;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;29.3;29.3;;;22;37.8;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;29.3;29.3;;;22.8;36.7;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.5;13.5;;;10.6;17.2;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67.6;67.6;;;57.9;75.9;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.3;10.3;;;9.1;11.6;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.9;30.9;;;25;37.4;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.8;86.8;;;74.5;93.6;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.3;88.3;;;75.6;94.8;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.2;83.2;;;73;90.1;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.6;37.6;;;30.6;45.2;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.2;7.2;;;5.8;8.9;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.3;30.3;;;26;35;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.3;8.3;;;7.8;8.8;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.8;12.8;;;11.1;14.6;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.0;13;;;10.5;15.9;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;57.0;57;;;43.9;69.2;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.5;37.5;;;27;49.4;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.7;82.7;;;76.2;87.7;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;23.5;23.5;;;15.1;34.7;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.6;34.6;;;30.1;39.4;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;17.0;17;;;12.7;22.4;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.7;8.7;;;7.6;9.9;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;59.6;59.6;;;51.4;67.2;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.8;34.8;;;26.2;44.4;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.0;69;;;59.9;76.9;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.0;10;;;9.1;10.9;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.6;12.6;;;11.2;14;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.4;41.4;;;32.7;50.7;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.9;35.9;;;26;47.3;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;3.7;3.7;;;2.2;6.3;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2018;2018;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.8;38.8;*;50 States + DC: US Median;36.6;41.2;Gender;Female;;;;;;;59;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.0;69;;;59.1;77.4;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;OK;Oklahoma;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90.0;90;;;81.9;94.7;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.0;11;;;7;16.7;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;15.2;15.2;;;8.3;26.2;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.7;32.7;;;25;41.5;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.7;85.7;;;79;90.5;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;26.7;26.7;;;22.4;31.6;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;51.46;51.46;;;50.7;52.23;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;29.6;29.6;;;22.6;37.7;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.4;35.4;;;25.8;46.3;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.0;41;;;27.9;55.5;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2018;2018;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.4;7.4;;;6.7;8.1;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.2;33.2;;;24.1;43.8;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.3;10.3;;;9.5;11.1;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.4;43.4;;;35.8;51.3;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2014;2014;NH;New Hampshire;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2015;2015;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.4;7.4;;;5.7;9.5;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2014;2014;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;8.16;8.16;;;6.09;10.22;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;53.0;53;;;39.4;66;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.5;63.5;;;45.8;78.2;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.7;63.7;;;53.9;72.5;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.3;8.3;;;6.8;9.9;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.4;10.4;;;9.4;11.6;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.0;8;;;6.8;9.5;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.5;64.5;;;58.4;70.2;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.9;39.9;;;34.2;45.9;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;49.6;49.6;;;34.1;65.1;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.3;88.3;;;83.2;92;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;81.1;81.1;;;72.6;87.4;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.1;46.1;;;36.9;55.5;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;NMBR;RACE;BLK;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;15.1;15.1;;;13.1;17.3;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.3;32.3;;;25.5;40.1;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.8;33.8;;;20.9;49.7;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.7;32.7;;;20.7;47.5;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;24.4;24.4;;;15.5;36.3;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.8;38.8;;;30;48.3;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;29.5;29.5;;;19.1;42.7;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.2;7.2;;;5.8;8.9;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;28.1;28.1;;;21.3;36.1;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.6;42.6;;;36.2;49.2;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2010;2010;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.0;10;;;8.1;12.2;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;MT;Montana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.5;9.5;;;7.2;12.3;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.5;66.5;;;58.9;73.3;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.1;42.1;;;35.6;48.9;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.0;13;;;8.6;19.2;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.3;62.3;;;55.7;68.4;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.9;9.9;;;6.1;15.7;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.6;10.6;;;8.7;12.8;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;60.4;60.4;;;38.7;78.7;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.6;11.6;;;7.4;17.7;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.2;82.2;;;73.7;88.4;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;4.6;4.6;;;3.3;6.5;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.2;45.2;;;37;53.6;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;24.9;24.9;;;15.2;38;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.9;13.9;;;10.2;18.7;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2018;2018;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.7;86.7;;;78.8;92;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.5;11.5;;;10.1;13;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.7;47.7;;;42.1;53.4;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2013;2013;ME;Maine;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.2;12.2;;;11.2;13.4;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.8;32.8;;;25.7;40.7;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.8;39.8;;;34.8;45;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;15.9;15.9;;;14.1;18;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2015;2015;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.5;40.5;*;50 States + DC: US Median;38.3;41.7;Overall;Overall;;;;;;;59;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.9;34.9;;;21.8;50.6;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90.8;90.8;;;85.3;94.4;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.2;38.2;;;26.8;51;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.4;44.4;;;38.7;50.3;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.7;5.7;;;4.4;7.3;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.3;83.3;;;71.2;90.9;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.7;13.7;;;11.5;16.1;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.9;43.9;;;38.6;49.2;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.9;35.9;;;24.4;49.3;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2015;2015;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.5;36.5;;;29.5;44;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.6;82.6;;;74.2;88.7;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.5;8.5;;;7.8;9.3;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.2;9.2;;;5.3;15.5;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.8;41.8;;;33.8;50.4;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.2;40.2;;;34.1;46.6;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.1;13.1;;;11.2;15.2;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.1;39.1;;;32.7;45.8;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.3;9.3;;;6.7;12.7;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;56.0;56;;;45.2;66.2;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.6;38.6;;;31.6;46.1;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.2;35.2;;;30.5;40.3;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.8;37.8;;;30.2;46.1;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.6;13.6;;;10.9;16.7;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;US;United States;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.5;9.5;*;50 States + DC: US Median;9.1;9.9;Overall;Overall;;;;;;;59;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.1;33.1;;;21.9;46.7;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.2;10.2;;;9.2;11.2;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.0;32;;;27.4;37;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.1;38.1;;;30.5;46.4;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.5;33.5;;;27;40.5;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.5;14.5;;;11.5;18.1;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.4;66.4;;;56.5;75;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.9;9.9;;;9.1;10.7;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.7;84.7;;;76.9;90.2;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;49.3;49.3;;;37.9;60.9;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.0;13;;;11.5;14.6;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;53.0;53;;;43.7;62.1;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.3;32.3;;;27.4;37.5;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.1;12.1;;;10.9;13.4;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.6;34.6;;;28.5;41.2;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.9;71.9;;;64;78.7;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.7;83.7;;;78.4;87.9;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.7;85.7;;;78.5;90.8;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.0;65;;;43;82;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;AK;Alaska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;51.2;51.2;;;40.6;61.7;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.1;6.1;;;5.2;7;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.0;6;;;4.2;8.4;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.6;32.6;;;20.4;47.8;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;72.0;72;;;57.9;82.7;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.1;8.1;;;6.6;9.9;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.8;66.8;;;52.5;78.5;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.6;39.6;;;23;59;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2015;2015;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2018;2018;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.8;33.8;;;30.5;37.2;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.0;63;;;53.6;71.5;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.7;44.7;;;35.9;53.9;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.0;11;;;9.5;12.7;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;56.2;56.2;;;43.7;68;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.9;7.9;;;6.7;9.3;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.0;14;;;12.4;15.8;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.3;35.3;;;25.1;47.1;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;15.1;15.1;;;8.4;25.6;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2015;2015;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.0;7;;;4.6;10.5;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.6;35.6;;;30.1;41.5;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2015;2015;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;25;25;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;NMBR;RACE;WHT;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.0;9;;;5.1;15.4;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2014;2014;GA;Georgia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;5.87;5.87;;;5.67;6.08;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.0;62;;;53.7;69.7;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.6;7.6;;;6;9.6;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;55.6;55.6;;;47;63.8;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.5;35.5;;;30.7;40.5;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;58.9;58.9;;;45.4;71.2;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.3;39.3;*;50 States + DC: US Median;37.8;40.9;Overall;Overall;;;;;;;59;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.3;35.3;;;23.4;49.4;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.2;7.2;;;5.8;9;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2018;2018;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.7;38.7;;;34.4;43.2;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.8;12.8;;;9.7;16.8;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.4;35.4;;;30;41.3;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.5;62.5;;;53.5;70.6;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.2;89.2;;;79.8;94.5;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.6;45.6;;;34.1;57.7;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.9;33.9;;;26.3;42.4;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2012;2012;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.1;8.1;;;5.3;11.8;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.4;41.4;;;31.4;52.1;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;79.1;79.1;;;65.8;88.2;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.0;10;;;8.9;11.2;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.8;62.8;;;50.1;73.9;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.2;5.2;;;3.8;7.2;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;44.6;44.6;;;32.5;57.3;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.1;38.1;;;29.9;47.1;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.4;82.4;;;68.6;91;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.8;30.8;;;18.2;47.1;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.5;48.5;;;40.6;56.4;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.6;6.6;;;5.6;7.7;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.4;46.4;;;36.5;56.6;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;93.5;93.5;;;85.2;97.3;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.1;42.1;;;32.2;52.7;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.5;5.5;;;4;7.5;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.5;66.5;;;59.4;73;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.4;37.4;;;31.8;43.4;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;94.9;94.9;;;88.1;97.9;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.0;44;;;33;55.5;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;51.3;51.3;;;42.9;59.6;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.8;33.8;;;26.8;41.6;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;NMBR;RACE;WHT;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2018;2018;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;51.38;51.38;;;50.52;52.23;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.0;43;;;37.1;49.2;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.9;34.9;;;25.7;45.5;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.5;40.5;;;33.9;47.4;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.2;11.2;;;10.2;12.3;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2013;2013;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.6;9.6;;;6.2;14.2;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2015;2015;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;NMBR;RACE;HIS;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.6;39.6;;;28.8;51.4;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.9;13.9;;;9.1;20.7;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.8;90.8;;;81.7;95.6;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.4;39.4;;;30.5;49.1;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.7;86.7;;;81.8;90.4;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.3;86.3;;;80.4;90.7;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.0;39;;;31.7;46.9;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.0;28;;;17.2;42.2;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.3;12.3;;;11.2;13.4;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.7;11.7;;;7.5;17.8;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.0;40;;;31.6;49.1;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.2;36.2;;;27.5;46;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.7;8.7;;;7.3;10.3;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;18.0;18;;;14.5;22.1;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.0;42;;;34.5;49.9;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.2;12.2;;;8.6;17;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.9;30.9;;;23.6;39.3;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.0;41;;;32.9;49.6;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;24.9;24.9;;;16;36.5;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;55.7;55.7;;;47;64;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.4;37.4;;;27;49;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.9;36.9;;;27.5;47.4;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2015;2015;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.9;8.9;;;8.1;9.6;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;30.3;30.3;;;23.8;37.8;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2011;2011;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;20.4;20.4;;;14.6;27.8;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2018;2018;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.1;10.1;;;9.1;11.1;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;DE;Delaware;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;27.4;27.4;;;22.9;32.4;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.9;87.9;;;81;92.5;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.7;32.7;;;24.3;42.3;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;97.4;97.4;;;93.1;99;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.4;33.4;;;17.4;54.5;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.6;38.6;;;30.2;47.7;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;54.8;54.8;;;45.2;64.1;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.0;66;;;46.3;81.3;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;15.6;15.6;;;9.6;24.2;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.6;30.6;;;25.9;35.8;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;13652;13,652;;;;;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;92.7;92.7;;;86;96.3;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.1;13.1;;;10.9;15.5;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2015;2015;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;21.7;21.7;;;14.4;31.3;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.5;7.5;;;5.6;9.9;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2014;2014;GU;Guam;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(13.444304, 144.793731);;66;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;MT;Montana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.1;43.1;;;33.3;53.4;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;25.7;25.7;;;14.2;42.2;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.3;11.3;;;8;15.6;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;;Number;29;29;;;;;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;NMBR;GENDER;GENF;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;17.7;17.7;;;13.2;23.5;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;17.1;17.1;;;10.7;26.3;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.6;47.6;;;41.6;53.7;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29.8;29.8;;;21.3;40;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2014;2014;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;10.07;10.07;;;9.73;10.41;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;7.0;7;;;4.1;11.8;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.3;11.3;;;8.6;14.6;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.6;49.6;;;41;58.2;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.7;11.7;;;9.3;14.7;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2018;2018;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.1;7.1;;;5.4;9.3;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.7;10.7;;;6.4;17.5;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;48;48;;;;;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;NMBR;GENDER;GENF;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.6;7.6;;;6.4;8.9;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.0;84;;;74.2;90.6;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.7;40.7;;;31.8;50.3;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.7;44.7;;;30.2;60.1;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2013;2013;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;15878;15,878;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;NMBR;RACE;WHT;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;27.6;27.6;;;19.7;37;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.1;33.1;;;22.2;46.2;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.7;5.7;;;4;8.1;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;27.5;27.5;;;18.8;38.4;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.6;38.6;;;30.6;47.2;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.5;6.5;;;4.6;9.1;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;81.5;81.5;;;66.5;90.7;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.6;69.6;;;52.8;82.4;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.9;12.9;;;10.4;15.8;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2015;2015;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.8;12.8;;;8;19.4;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.0;12;;;10.2;14.2;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.0;42;;;34.4;50;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.7;89.7;;;83.4;93.8;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.8;62.8;;;55.8;69.4;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.0;31;;;22.1;41.5;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.8;28.8;;;19.8;39.9;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;53.3;53.3;;;30.1;75.1;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.8;41.8;;;35.7;48.1;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.9;42.9;;;36.2;49.9;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.5;37.5;;;29.6;46.2;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.7;5.7;;;3.6;9.1;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.4;63.4;;;51.9;73.5;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.3;14.3;;;8.6;23;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;5.5;5.5;;;3.2;9.3;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;19.7;19.7;;;10.7;33.4;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.1;8.1;;;5.7;11.3;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.0;10;;;8.2;12;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2018;2018;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.9;7.9;;;6.8;9.2;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2015;2015;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;39.9;39.9;;;31.2;50.3;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;44.6;44.6;;;33.1;56.7;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;18.0;18;;;10.4;29.3;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29.9;29.9;;;23.7;36.8;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.5;35.5;;;30.6;40.7;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.1;48.1;;;35.7;60.8;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.8;66.8;;;56.2;76;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.8;9.8;;;9.1;10.6;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.7;8.7;;;7.7;9.8;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.7;12.7;;;9.8;16.3;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;51.9;51.9;;;38.5;65;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.2;13.2;;;11.9;14.8;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.7;11.7;;;8.5;15.8;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.4;9.4;;;8.7;10.3;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.4;35.4;;;26.9;45;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.7;89.7;;;76.3;95.9;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.3;7.3;;;6;8.8;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29.1;29.1;;;20.8;39.1;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;27.1;27.1;;;20.9;34.5;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.2;8.2;;;7.1;9.3;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;23.5;23.5;;;18.1;30;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;26.4;26.4;;;14.6;43;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.8;13.8;;;9;20.5;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;60.6;60.6;;;50.5;69.8;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;28.4;28.4;;;24.7;32.3;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.4;86.4;;;75.6;92.9;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.2;87.2;;;82.6;90.7;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.0;10;;;9;11.1;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.1;34.1;;;26.4;42.8;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.5;39.5;;;34.5;44.7;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;MI;Michigan;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.1;8.1;;;5.9;10.8;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.2;35.2;;;29.9;40.9;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.1;9.1;;;7.8;10.7;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.0;12;;;9.5;15.1;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.0;45;;;36.2;54.1;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;43.7;43.7;;;31.2;57;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.8;8.8;;;5.2;14.5;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.6;63.6;;;57;69.8;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.6;39.6;;;33.4;46.1;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.5;40.5;;;34.2;47.1;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;61.9;61.9;;;46.7;75;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.6;32.6;;;25.9;40.1;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.4;32.4;;;25.2;40.4;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.7;83.7;;;74.7;89.9;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90.2;90.2;;;79.8;95.5;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.7;6.7;;;5.9;7.5;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;15.3;15.3;;;11.3;20.4;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.4;9.4;;;8.2;10.8;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;80.3;80.3;;;65.2;89.9;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2015;2015;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;NMBR;RACE;BLK;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;15.4;15.4;;;12.1;19.5;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;49.6;49.6;;;38.2;61;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.6;71.6;;;60.4;80.7;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;52.2;52.2;;;45;59.3;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;54.9;54.9;;;41.3;67.8;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.3;11.3;;;8.5;14.8;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.5;11.5;;;9.5;13.9;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;54.1;54.1;;;43.6;64.2;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;51.6;51.6;;;41.1;61.9;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67.3;67.3;;;54.2;78.1;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.0;38;;;30.4;46.2;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;28.5;28.5;;;22.5;35.5;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.3;5.3;;;4.1;7;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.0;32;;;25.4;39.3;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2015;2015;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.2;38.2;;;32.1;44.7;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.7;89.7;;;81.5;94.6;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.1;88.1;;;81.3;92.7;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2018;2018;CA;California;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.8;34.8;;;29.5;40.6;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;51.7;51.7;;;37.8;65.4;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;AK;Alaska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.4;7.4;;;5;10.7;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;79.6;79.6;;;71.5;85.9;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;57.6;57.6;;;43.5;70.6;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;VA;Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST3_1;NMBR;GENDER;GENM;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.0;8;;;6.4;9.9;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.3;6.3;;;5.2;7.7;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2015;2015;KS;Kansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST3_1;NMBR;GENDER;GENF;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.7;43.7;;;37.9;49.7;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.2;6.2;;;5.5;6.9;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.6;87.6;;;81.8;91.8;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.8;34.8;;;28.8;41.3;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.5;64.5;;;47.2;78.8;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.9;33.9;;;25.7;43.2;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.1;84.1;;;74.2;90.7;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67.9;67.9;;;58.4;76;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.7;9.7;;;6.4;14.4;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;16.3;16.3;;;12;21.8;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.9;36.9;;;26.6;48.5;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2018;2018;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.3;9.3;;;8.3;10.5;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2015;2015;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;NMBR;GENDER;GENM;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.2;87.2;;;80.8;91.7;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.4;86.4;;;79.1;91.4;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.8;62.8;;;53.3;71.3;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.1;37.1;;;30.8;44;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;3.8;3.8;;;2.6;5.5;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.1;43.1;;;33.4;53.4;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.8;65.8;;;53;76.6;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.5;41.5;;;31;52.9;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.4;11.4;;;10.3;12.7;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.8;36.8;;;28.5;45.9;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.0;6;;;4.4;8.1;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;28.5;28.5;;;20.8;37.8;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29.6;29.6;;;21.8;38.7;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;80.6;80.6;;;71.7;87.2;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.4;33.4;;;28.7;38.4;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;AR;Arkansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;6572;6,572;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST2_1;NMBR;RACE;WHT;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.9;35.9;;;31.5;40.5;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;77.8;77.8;;;63.9;87.4;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.2;86.2;;;77.4;92;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.9;8.9;;;7.4;10.7;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.6;11.6;;;10.5;12.7;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.5;38.5;;;19.9;61.2;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.1;13.1;;;7.5;22.1;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.7;44.7;;;33.4;56.6;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.5;9.5;;;6.8;13.3;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.8;31.8;;;26.7;37.4;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.7;85.7;;;80.2;89.8;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.9;34.9;;;27.4;43.3;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;74.2;74.2;;;61.2;84;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.9;36.9;;;29.9;44.5;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;19.4;19.4;;;12.9;28.2;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.3;9.3;;;6.2;13.7;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;20.2;20.2;;;12.6;30.7;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;4.9;4.9;;;2.8;8.4;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.7;8.7;;;7.6;9.9;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2015;2015;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;15.4;15.4;;;11.4;20.3;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.3;66.3;;;59.7;72.3;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.7;28.7;;;23.6;34.4;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;23.8;23.8;;;13.7;37.9;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.8;70.8;;;62.6;77.9;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;29.0;29;;;16.9;45.1;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.4;11.4;;;10.3;12.5;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2014;2014;OR;Oregon;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST2_1;NMBR;RACE;API;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2015;2015;OK;Oklahoma;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST3_1;CRDRATE;RACE;API;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.7;13.7;;;7.5;23.6;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.5;38.5;;;32.7;44.7;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.4;39.4;;;28.5;51.4;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.2;35.2;;;30.6;40;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29.7;29.7;;;24.9;35;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.1;38.1;;;23.9;54.6;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.1;90.1;;;85.1;93.5;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.2;9.2;;;8.5;10;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.7;34.7;;;31.4;38.2;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.9;9.9;;;7.6;12.8;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.8;70.8;;;56.7;81.8;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.9;39.9;;;31.3;49.1;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;4.5;4.5;;;2.6;7.7;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.3;85.3;;;65.4;94.7;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.1;10.1;;;7.2;14;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2018;2018;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.8;6.8;;;5.9;7.8;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.4;35.4;;;24.9;47.5;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;93.8;93.8;;;88.5;96.8;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.4;8.4;;;7.1;10;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.5;12.5;;;7.3;20.6;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;15.0;15;;;11.7;19.2;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.3;10.3;;;8.7;12.1;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.8;34.8;;;28.3;41.9;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;80.3;80.3;;;55.4;93;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;29.6;29.6;;;20.6;40.5;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;92.5;92.5;;;85.3;96.4;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2014;2014;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.4;46.4;;;30.6;63;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.0;12;;;9.2;15.6;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.6;62.6;;;56.6;68.2;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.3;35.3;;;26.8;44.9;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.5;68.5;;;61.5;74.8;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.4;33.4;;;28;39.4;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.9;9.9;;;8.3;11.8;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.1;37.1;;;29.8;45.1;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.3;11.3;;;7.6;16.6;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.9;9.9;;;6.4;15;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2014;2014;ME;Maine;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST3_1;NMBR;RACE;HIS;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.3;9.3;;;8.3;10.5;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.1;38.1;;;28.5;48.7;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2014;2014;IN;Indiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.6;87.6;;;81.2;92;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.4;9.4;;;6.9;12.8;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;28.0;28;;;24.4;31.9;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.8;11.8;;;8.9;15.5;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2018;2018;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.2;45.2;;;30.4;60.8;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.7;10.7;;;7.3;15;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;77.8;77.8;;;61.7;88.4;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.1;9.1;;;5.2;15.5;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;78.8;78.8;;;64.8;88.2;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.4;9.4;;;8.3;10.6;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.2;10.2;;;7.6;13.6;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;17.2;17.2;;;11.2;25.5;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.8;87.8;;;80.1;92.8;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;17.3;17.3;;;10.2;27.8;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;77.4;77.4;;;62.9;87.4;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2018;2018;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;30.5;30.5;;;23.1;38.9;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.4;42.4;;;34.1;51.2;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.1;10.1;;;6.2;15.9;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;23.2;23.2;;;16.3;32;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.2;88.2;;;82.8;92;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;VA;Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.8;47.8;;;39.7;56;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.8;12.8;;;11.6;14;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.3;6.3;;;5.4;7.2;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;53.7;53.7;;;44.9;62.3;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2014;2014;IN;Indiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.0;9;;;7.8;10.5;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.7;30.7;;;24.6;37.4;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.6;8.6;;;7.4;10;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.0;38;;;25.6;52.3;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.5;5.5;;;4.5;6.7;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.7;69.7;;;56.2;80.5;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.6;85.6;;;78.1;90.9;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.4;9.4;;;8.4;10.5;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.7;6.7;;;5.8;7.7;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.2;11.2;;;8.5;14.5;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.8;37.8;;;32.7;43.1;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.2;9.2;;;8.6;10;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67.1;67.1;;;58.9;74.4;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.7;37.7;;;31.8;44;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.9;36.9;;;31.9;42.2;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;17.7;17.7;;;9.7;30.1;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;47.7;47.7;;;33.5;62.2;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;58.1;58.1;;;49;66.7;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.3;9.3;;;8.5;10.3;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.0;8;;;7.5;8.6;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.2;13.2;;;7.5;22;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.9;42.9;;;35;51.1;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;23.9;23.9;;;13.4;38.9;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;29.1;29.1;;;19.3;41.3;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2018;2018;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;25.3;25.3;;;19;32.8;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;18.4;18.4;;;10.9;29.5;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.1;71.1;;;61.4;79.3;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;26.9;26.9;;;21.9;32.5;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;NMBR;GENDER;GENF;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.6;65.6;;;57.9;72.5;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.3;13.3;;;10.9;16.1;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.0;37;;;32.5;41.6;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.5;12.5;;;9.2;16.9;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;55.8;55.8;;;48.1;63.3;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.0;9;;;8.2;10;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.4;36.4;;;25.2;49.3;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2018;2018;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.6;38.6;;;25.5;53.6;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.9;6.9;;;5.7;8.3;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.4;86.4;;;77.8;92.1;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2015;2015;CA;California;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.4;9.4;;;6.1;14.2;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.5;10.5;;;9.5;11.5;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;22.9;22.9;;;13.1;36.9;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;23.8;23.8;;;13.2;39.1;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;19.0;19;;;12.7;27.5;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.0;12;;;10.5;13.6;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.6;13.6;;;10.9;16.7;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.5;9.5;;;8.5;10.7;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;16.1;16.1;;;13.4;19.1;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.5;37.5;;;32.5;42.8;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.8;83.8;;;72.8;90.8;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;76.6;76.6;;;67.3;83.9;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.2;13.2;;;11.9;14.6;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.2;86.2;;;73.5;93.4;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.4;28.4;;;18.2;41.4;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.8;31.8;;;20.1;46.5;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2018;2018;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;73.5;73.5;;;61.5;82.8;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.8;28.8;;;22;36.6;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.0;10;;;9.1;10.9;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.6;36.6;;;28;46.1;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.1;36.1;;;30.9;41.7;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.4;87.4;;;77.3;93.4;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.5;9.5;;;6.4;13.8;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;23.7;23.7;;;16.8;32.4;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.2;44.2;;;34;55;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.1;84.1;;;73;91.2;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.1;8.1;;;6.5;10.2;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.7;9.7;;;8.7;10.7;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.2;32.2;;;26.7;38.4;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;93.7;93.7;;;88.2;96.7;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2013;2013;US;United States;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.0;9;*;50 States + DC: US Median;8.6;9.4;Overall;Overall;;;;;;;59;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;4.7;4.7;;;3.7;5.9;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.6;87.6;;;76.7;93.8;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.2;63.2;;;47.8;76.3;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.2;62.2;;;46.3;75.9;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;HI;Hawaii;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.6;34.6;;;24.5;46.3;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2014;2014;PA;Pennsylvania;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2018;2018;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.5;33.5;;;19.4;51.3;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2014;2014;IN;Indiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.7;85.7;;;76.3;91.7;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;51.3;51.3;;;38.6;63.8;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;61.1;61.1;;;52.5;69;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.7;8.7;;;7.8;9.7;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.3;32.3;;;26.2;38.9;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.5;9.5;;;8.4;10.7;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.5;90.5;;;82.6;95;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.2;87.2;;;81.1;91.6;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;77.9;77.9;;;61.7;88.5;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.5;6.5;;;5.6;7.5;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.2;42.2;;;33.6;51.4;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.9;40.9;;;35.3;46.8;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;64.7;64.7;;;53.7;74.3;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.6;41.6;;;34.6;49;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.7;34.7;;;22.6;49.1;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2014;2014;WA;Washington;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.7;38.7;;;33.3;44.4;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;US;United States;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.9;6.9;*;50 States + DC: US Median;6.4;7.2;Gender;Male;;;;;;;59;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.0;11;;;9.9;12.2;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.6;35.6;;;26;46.4;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2014;2014;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;NMBR;GENDER;GENM;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.0;37;;;21.6;55.7;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.0;33;;;27.1;39.4;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;4.5;4.5;;;3.1;6.5;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;30.7;30.7;;;24;38.4;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.3;70.3;;;55.6;81.7;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.8;13.8;;;12.2;15.6;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.5;10.5;;;8.7;12.7;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.8;85.8;;;75.9;92.1;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.4;28.4;;;20.9;37.4;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;59.2;59.2;;;46.5;70.8;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.2;31.2;;;19.8;45.5;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.3;82.3;;;72.4;89.1;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.2;63.2;;;51.8;73.4;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.9;32.9;;;25.7;41.1;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.6;30.6;;;22.3;40.5;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;44.5;44.5;;;30.9;58.9;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2018;2018;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.2;63.2;*;50 States + DC: US Median;61.4;63.8;Overall;Overall;;;;;;;59;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.1;88.1;;;81.1;92.7;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.3;90.3;;;84.2;94.2;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.2;42.2;;;34;50.8;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;92.0;92;;;83.9;96.3;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.8;7.8;;;5.6;10.6;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.6;37.6;;;28.2;48.1;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.7;63.7;;;47.3;77.5;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;60.9;60.9;;;40.5;78;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;49.6;49.6;;;39.7;59.6;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;55.1;55.1;;;45.4;64.5;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29.5;29.5;;;20.1;41.2;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2018;2018;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.2;34.2;*;50 States + DC: US Median;32;35.7;Overall;Overall;;;;;;;59;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.8;36.8;;;31;43;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;47.3;47.3;;;36.1;58.8;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.8;63.8;;;51.9;74.2;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.0;39;;;27.4;52;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.6;41.6;;;36;47.5;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.0;34;;;28.3;40.1;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.9;8.9;;;5.3;14.5;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;17.7;17.7;;;12.2;24.9;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;19.8;19.8;;;11.3;32.6;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;WA;Washington;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.5;41.5;;;30.5;53.4;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;23.7;23.7;;;16.1;33.6;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.8;7.8;;;6.7;9.2;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;81.1;81.1;;;67.8;89.8;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2013;2013;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;28.1;28.1;;;27.6;28.5;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.9;44.9;;;32.2;58.3;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.4;84.4;;;64.3;94.2;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.2;66.2;;;56.6;74.7;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.1;89.1;;;82.7;93.4;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;25.8;25.8;;;16.2;38.4;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.4;7.4;;;4.2;12.8;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.0;11;;;6.9;17.1;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.2;6.2;;;4.6;8.2;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.0;38;;;31.9;44.4;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.2;41.2;;;34.2;48.5;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.9;5.9;;;5;7;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.2;10.2;;;9.3;11.2;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.3;36.3;;;27.4;46.2;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;30.5;30.5;;;20.8;42.2;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.9;6.9;;;6.1;7.9;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.3;45.3;;;39.3;51.4;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.2;82.2;;;75.7;87.3;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.6;44.6;;;39.7;49.6;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.2;35.2;;;27.4;44;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.3;88.3;;;83;92.2;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.7;63.7;;;55.1;71.4;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.2;87.2;;;78.7;92.6;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;23.6;23.6;;;15.5;34.1;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.4;39.4;;;30.7;48.8;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.4;12.4;;;11.2;13.7;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.2;12.2;;;8;18.1;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;93.9;93.9;;;89.4;96.5;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;58.4;58.4;;;48.4;67.8;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;30.9;30.9;*;50 States + DC: US Median;29.5;32.7;Gender;Male;;;;;;;59;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.6;38.6;;;34.2;43.1;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;52.6;52.6;;;36.5;68.2;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.2;10.2;;;8.8;11.7;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2018;2018;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;21.6;21.6;;;17.4;26.5;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.0;85;;;74.8;91.6;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.5;11.5;;;10.2;13;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.2;8.2;;;6.9;9.8;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.1;10.1;;;8;12.6;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;51.5;51.5;;;31.7;70.9;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;6.7;6.7;;;5;8.9;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;43.1;43.1;;;32.7;54;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.7;37.7;;;28.6;47.7;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.7;88.7;;;74.5;95.5;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.2;71.2;;;49.4;86.3;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.5;11.5;;;6.6;19.3;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2018;2018;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;29.2;29.2;;;22.1;37.4;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.1;11.1;;;9.6;12.9;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;49.2;49.2;;;35.7;62.8;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;25.1;25.1;;;18.6;32.9;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.9;43.9;;;34.9;53.4;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.2;13.2;;;9.5;17.9;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.6;7.6;;;4.9;11.6;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.7;8.7;;;7.7;10;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;60.4;60.4;;;39.4;78.2;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;30.9;30.9;;;21.7;42;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.6;36.6;;;31.2;42.3;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.5;10.5;;;9.3;11.8;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.1;10.1;;;9.2;11.2;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.2;82.2;;;72.8;88.8;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;44.2;44.2;;;32;57.2;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.9;88.9;;;82.3;93.2;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.5;32.5;;;25.8;40.1;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;18.2;18.2;;;11.8;26.9;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;15.4;15.4;;;13.8;17.2;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.0;36;;;26.2;47.1;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.7;30.7;;;25.8;36.1;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.0;9;;;8.2;9.9;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.1;36.1;;;25.4;48.4;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;27.4;27.4;;;16.2;42.3;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;12.6;12.6;;;7.2;21.3;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.2;34.2;**;US estimate/number is based on fewer than 50 states and the District of Columbia;31.9;36.1;Gender;Male;;;;;;;59;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;23.3;23.3;;;16.3;32;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.0;10;;;8;12.5;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.9;89.9;;;85.4;93.2;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.8;69.8;;;60.8;77.5;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.8;7.8;;;6.2;9.8;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.3;8.3;;;7.2;9.4;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.7;10.7;;;7.8;14.3;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.8;9.8;;;8.4;11.4;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.9;6.9;;;6.1;7.9;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2018;2018;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;73.7;73.7;;;65.9;80.2;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;4.9;4.9;;;3.7;6.6;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;16.0;16;;;11.5;21.9;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2018;2018;NY;New York;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.6;13.6;;;11.7;15.7;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.9;5.9;;;3.4;10.1;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;27.5;27.5;;;19.5;37.3;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;4.5;4.5;;;2.6;7.8;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.7;8.7;;;4.9;15;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;92.6;92.6;;;87.1;95.9;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.2;84.2;;;76.4;89.8;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.1;87.1;;;80.2;91.8;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.6;13.6;;;12;15.3;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.2;38.2;;;31.7;45.2;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;49.5;49.5;;;42.5;56.6;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.0;5;;;3;8.2;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.8;13.8;;;10.7;17.7;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.6;42.6;;;36.3;49.1;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;55.8;55.8;;;37.9;72.2;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.5;43.5;;;31.4;56.4;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.9;11.9;;;10.6;13.3;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.6;37.6;;;34;41.3;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2018;2018;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;61.9;61.9;*;50 States + DC: US Median;57.3;62.8;Overall;Overall;;;;;;;59;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.4;8.4;;;7.1;9.9;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.6;89.6;;;77.3;95.6;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.2;9.2;;;7.5;11.2;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.6;39.6;;;30;50.2;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.1;11.1;;;9.7;12.7;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.9;40.9;;;33.7;48.4;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;4.8;4.8;;;3.6;6.5;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.0;10;;;9.2;10.8;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;92.0;92;;;80.1;97.1;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.4;11.4;;;8.9;14.6;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.0;87;;;78.3;92.6;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.1;84.1;;;64.6;93.9;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;77.8;77.8;;;61.8;88.4;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.1;91.1;;;86.1;94.4;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.1;41.1;;;32.4;50.3;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.2;33.2;;;26.7;40.4;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2018;2018;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.5;37.5;;;33.2;42;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.6;39.6;;;31.9;47.9;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.4;38.4;;;33.8;43.2;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;77.5;77.5;;;67.2;85.3;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.9;40.9;;;34.9;47.2;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.7;7.7;;;4.9;11.9;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.6;38.6;;;26.9;51.8;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.0;8;;;5.2;12.2;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.7;35.7;;;29;43.1;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.4;35.4;;;27.9;43.7;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.2;87.2;;;81.7;91.2;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.8;9.8;;;8.9;10.9;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;27.6;27.6;;;16.8;41.9;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2018;2018;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.1;7.1;;;5.4;9.4;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.3;84.3;;;71.1;92.2;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;30.7;30.7;;;25.6;36.2;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.3;43.3;;;32.3;55;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.6;37.6;;;28.4;47.8;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;79.3;79.3;;;66.1;88.3;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.4;9.4;;;5.4;15.8;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;24.0;24;;;19.2;29.5;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.5;88.5;;;82;92.9;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;74.6;74.6;;;64.2;82.8;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;75.9;75.9;;;60.9;86.4;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.9;35.9;;;27.8;44.8;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.5;82.5;;;72.8;89.2;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.9;10.9;;;7.3;15.9;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.5;37.5;;;31.2;44.2;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.1;41.1;;;34.3;48.3;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2018;2018;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.6;33.6;;;24.6;43.8;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.2;6.2;;;5.4;7.2;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.7;37.7;;;24.6;53;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.5;43.5;;;36.8;50.5;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.7;10.7;;;8.8;13;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.9;11.9;;;10.6;13.3;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.0;38;;;31.8;44.5;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.3;85.3;;;67.9;94.1;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.7;10.7;;;7.9;14.3;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.0;91;;;83.8;95.2;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.3;46.3;;;38.5;54.2;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.1;44.1;;;35.7;52.7;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.4;7.4;;;6.6;8.3;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.0;42;;;34.3;50.1;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.9;13.9;;;12.2;15.8;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;26.4;26.4;;;18.9;35.5;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;78.1;78.1;;;65.1;87.2;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.8;9.8;;;8.6;11.2;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.0;41;;;34.8;47.5;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.1;39.1;;;33.7;44.8;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;28.7;28.7;;;19;40.8;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;22.6;22.6;;;15.8;31.2;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.9;9.9;;;6.9;13.9;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2018;2018;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.7;39.7;;;35.6;43.9;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.7;11.7;;;10.6;12.9;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.7;40.7;;;25.9;57.5;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;29.6;29.6;;;25.7;33.8;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.2;35.2;;;25.4;46.5;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.6;12.6;;;11.1;14.3;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.5;34.5;;;26.9;42.9;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;47.4;47.4;;;38;57;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.0;68;;;61.3;74;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90.7;90.7;;;80.8;95.8;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;58.9;58.9;;;49;68.1;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.3;42.3;;;34.1;50.9;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;81.9;81.9;;;75.7;86.8;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.3;10.3;;;9.5;11.2;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.4;8.4;;;7.1;10;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.0;32;;;26.5;38.1;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;27.5;27.5;;;16.6;42;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2018;2018;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.2;10.2;;;9.2;11.3;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.3;63.3;;;53.1;72.4;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2012;2012;ME;Maine;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;NMBR;RACE;WHT;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.0;65;;;58.7;70.7;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;26.3;26.3;;;16.7;38.8;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.3;38.3;;;27.3;50.7;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;80.6;80.6;;;62.4;91.3;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.0;6;;;4.4;8.3;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.7;32.7;;;19.9;48.7;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.1;84.1;;;78.2;88.7;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.5;71.5;;;57.8;82.1;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.2;33.2;;;24.2;43.7;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;18.4;18.4;;;14;23.7;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.4;33.4;;;26.5;41.1;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.4;9.4;;;8.2;10.7;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;21.7;21.7;;;12;36.2;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.2;65.2;**;US estimate/number is based on fewer than 50 states and the District of Columbia;61.1;69.3;Gender;Male;;;;;;;59;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.8;12.8;;;11.2;14.5;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.7;87.7;;;77.8;93.6;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;50.4;50.4;;;43.3;57.4;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.7;5.7;;;3.3;9.9;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.7;86.7;;;78.8;91.9;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.7;35.7;;;30.6;41.2;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;77.5;77.5;;;65.6;86.1;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.9;87.9;;;80.7;92.7;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;52.5;52.5;;;34.3;70.1;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2018;2018;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.9;39.9;;;33.8;46.2;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;80.0;80;;;70.9;86.8;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.2;12.2;;;11.1;13.4;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.4;36.4;;;29.7;43.7;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.4;5.4;;;3.6;8;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.7;31.7;;;24.2;40.2;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.9;38.9;;;28.2;50.8;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.5;36.5;;;30.7;42.7;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.1;42.1;;;35.3;49.2;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90.2;90.2;;;83.4;94.5;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.1;9.1;;;8.3;10;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;15.5;15.5;;;10.7;21.8;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.5;84.5;;;74.9;90.8;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.3;48.3;;;41.1;55.5;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.2;12.2;;;8.6;17;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90.0;90;;;85.4;93.2;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.6;38.6;;;29.9;48;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29.3;29.3;;;21.1;39.2;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.7;42.7;;;34.3;51.7;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.6;10.6;;;9.7;11.6;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;53.6;53.6;;;32.5;73.4;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;49.2;49.2;;;37.1;61.3;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;75.6;75.6;;;61.1;85.9;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.8;30.8;;;25.1;37;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;6.1;6.1;;;3.6;10;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.9;34.9;;;28.3;42.3;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.6;83.6;;;73.9;90.2;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.0;12;;;10.8;13.3;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.0;37;;;30;44.6;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.3;39.3;;;33.6;45.3;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.4;10.4;;;8.9;12.3;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;79.7;79.7;;;51.6;93.5;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;61.6;61.6;;;50;72;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;27.1;27.1;;;19.2;36.8;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.4;35.4;;;28.4;43.2;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.3;89.3;;;78;95.1;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.7;39.7;;;32.8;47.2;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.7;31.7;;;23.1;41.8;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.9;12.9;;;11.2;14.8;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.4;35.4;;;29.7;41.6;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.2;8.2;;;7;9.6;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.2;38.2;;;31.5;45.5;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.1;35.1;;;29.7;41;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2012;2012;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.2;37.2;;;30.3;44.7;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2018;2018;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.6;14.6;;;10.6;19.6;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.8;70.8;;;55.7;82.4;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;50.0;50;;;36.7;63.2;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.2;63.2;;;56.5;69.4;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.1;9.1;;;8.3;9.9;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.5;40.5;;;32.4;49.2;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.8;38.8;;;34.2;43.7;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.1;91.1;;;82.5;95.7;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.4;86.4;;;80.7;90.7;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.1;39.1;;;34.6;43.8;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.0;10;;;9;11.2;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.4;40.4;;;32.3;49.1;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.4;5.4;;;3.9;7.4;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;18.3;18.3;;;14;23.7;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.1;30.1;;;23.9;37.2;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.1;8.1;;;6.8;9.7;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2018;2018;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.8;38.8;;;32.7;45.2;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.8;12.8;;;11.1;14.7;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.3;32.3;;;23.5;42.5;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.0;40;;;31.2;49.5;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.7;10.7;;;6.4;17.4;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;61.8;61.8;;;50;72.4;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.8;12.8;;;7.6;20.7;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;27.5;27.5;;;19;38;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;25.3;25.3;;;20.1;31.3;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.2;84.2;;;66.1;93.6;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.1;30.1;;;22.7;38.6;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.4;11.4;;;7.6;16.9;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.5;11.5;;;9.8;13.5;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.0;70;;;62;76.9;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.6;8.6;;;5.7;12.8;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.8;5.8;;;5.1;6.7;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.6;82.6;;;73.6;89;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;27.0;27;;;23.6;30.8;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.0;44;;;37.3;50.9;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.0;91;;;85.2;94.7;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.4;37.4;;;29.8;45.8;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.3;91.3;;;82.1;96;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.0;31;;;23.4;39.8;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.9;86.9;;;80.7;91.3;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.6;88.6;;;82.8;92.6;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.7;11.7;;;8;16.9;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.1;11.1;;;10;12.2;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.8;10.8;;;9.6;12.1;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2018;2018;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;76.2;76.2;;;66.1;84.1;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.5;11.5;;;10.4;12.7;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.5;69.5;;;62.4;75.8;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.3;36.3;;;30.7;42.4;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.4;11.4;;;6.9;18.3;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.3;11.3;;;9.7;13.1;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.7;82.7;;;70.6;90.5;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.7;5.7;;;3.8;8.3;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.5;65.5;;;42.4;83;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.1;38.1;;;22.6;56.5;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.0;46;;;36.7;55.5;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.8;33.8;;;24.8;44.1;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;51.4;51.4;;;42.8;60;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.6;32.6;;;23.6;43.2;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;47.7;47.7;;;39.3;56.3;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.7;14.7;;;12.9;16.7;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.9;39.9;;;28.7;52.2;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;54.3;54.3;;;47.4;61;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.5;88.5;;;81.7;93;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.4;34.4;;;28.4;40.9;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.3;9.3;;;8.7;10.1;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.5;89.5;;;81.1;94.4;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;92.5;92.5;;;85.9;96.1;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.0;86;;;74.9;92.7;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.3;62.3;;;54;70;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;61.4;61.4;;;46;74.8;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.1;11.1;;;8.3;14.8;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;16.7;16.7;;;9.6;27.5;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.6;6.6;;;5.5;7.9;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;29.6;29.6;;;17.7;45.1;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;51.9;51.9;;;39.5;64.2;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2018;2018;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.5;14.5;;;10.4;19.7;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;18.3;18.3;;;11.8;27.2;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;57.6;57.6;;;45.9;68.6;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.6;7.6;;;7;8.3;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;19.3;19.3;;;14.1;25.8;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.5;9.5;;;7.8;11.5;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.8;12.8;;;10.2;15.9;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.3;12.3;;;7.7;19.1;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.5;39.5;;;33.2;46.2;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;74.4;74.4;;;60.8;84.5;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.1;34.1;;;28.4;40.4;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67.7;67.7;;;54.3;78.7;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.9;85.9;;;74.4;92.7;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;15.0;15;;;13.5;16.6;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.5;62.5;;;51.9;72.1;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.9;85.9;;;72.2;93.5;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.4;9.4;;;6.6;13.2;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.3;8.3;;;6.2;11.1;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.8;37.8;;;29.1;47.3;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;53.3;53.3;;;42.8;63.6;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.2;62.2;;;53.9;69.9;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2018;2018;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29.1;29.1;;;22.3;37.1;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.4;88.4;;;81;93.2;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;59.5;59.5;;;43.4;73.8;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;30.2;30.2;;;22.5;39.2;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;20.6;20.6;;;11.5;34.1;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;48.1;48.1;;;35.4;61.1;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.5;83.5;;;75.8;89.1;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.4;5.4;;;4.6;6.2;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.4;9.4;;;6.4;13.6;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.5;67.5;;;61.5;72.9;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.2;88.2;**;US estimate/number is based on fewer than 50 states and the District of Columbia;86.4;89.6;Gender;Female;;;;;;;59;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.0;13;;;10.6;15.9;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.1;34.1;;;27.8;41;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.3;9.3;;;5.7;14.8;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.5;41.5;;;33.7;49.7;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.6;63.6;;;52.3;73.7;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2018;2018;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.6;63.6;**;US estimate/number is based on fewer than 50 states and the District of Columbia;57.2;67.8;Gender;Male;;;;;;;59;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.7;37.7;;;31.1;44.9;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;30.6;30.6;;;24.1;37.9;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.1;83.1;;;71.9;90.4;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.2;37.2;;;30.7;44.3;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.7;9.7;;;7.1;13;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;79.2;79.2;;;68;87.2;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;77.8;77.8;;;67.5;85.5;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.5;40.5;;;29.7;52.3;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;93.3;93.3;;;87.1;96.7;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.2;69.2;;;62.1;75.5;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;29.7;29.7;;;23.3;36.9;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.5;11.5;;;7.1;18.1;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;27.6;27.6;;;18.6;38.8;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.9;38.9;;;33.7;44.4;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.2;8.2;;;6.7;10;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.2;12.2;;;9.2;16;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;16.1;16.1;;;12.4;20.7;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.1;36.1;;;29;43.9;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;18.2;18.2;;;11.6;27.4;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;52.2;52.2;;;43.2;61.1;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;18.0;18;;;10;30;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.9;45.9;;;40.5;51.3;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;45.5;45.5;;;33.7;57.7;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.2;11.2;;;6.7;18.3;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.1;62.1;;;53.6;69.8;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;4.9;4.9;;;3.6;6.5;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.9;12.9;;;11.5;14.5;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;27.0;27;;;20.1;35.2;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.9;39.9;;;35.1;45;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.2;8.2;;;7.2;9.3;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.3;40.3;;;35.2;45.6;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.6;37.6;;;32;43.5;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.3;37.3;;;30.5;44.7;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;59.3;59.3;;;49.1;68.7;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.9;8.9;;;7.1;11.1;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;18.1;18.1;;;10.3;29.8;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;53.8;53.8;;;42.5;64.7;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.6;12.6;;;11.7;13.5;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.7;39.7;;;33.1;46.6;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;75.6;75.6;;;66.4;82.9;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.3;10.3;;;9.1;11.7;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;26.8;26.8;;;20.4;34.2;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;43.1;43.1;;;32.7;54;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;16.1;16.1;;;12.4;20.6;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.2;8.2;;;6.7;10;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.5;46.5;;;39.2;53.9;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.2;66.2;;;58.3;73.4;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;7.8;7.8;;;5.2;11.5;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.5;6.5;;;5.5;7.8;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.1;38.1;;;29;48.2;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.2;28.2;;;21.9;35.4;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.8;69.8;;;58.7;78.9;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.3;65.3;;;54.7;74.5;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.9;6.9;;;4.6;10.2;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;26.1;26.1;;;19;34.7;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2018;2018;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.9;82.9;**;US estimate/number is based on fewer than 50 states and the District of Columbia;80.9;85.6;Gender;Male;;;;;;;59;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;80.7;80.7;;;71.6;87.4;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;28.5;28.5;;;22.4;35.5;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2018;2018;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.1;62.1;**;US estimate/number is based on fewer than 50 states and the District of Columbia;58.4;64.5;Gender;Female;;;;;;;59;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;29.0;29;;;23.4;35.4;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.8;33.8;;;27.2;41.1;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.1;6.1;;;5;7.5;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.2;82.2;;;72.8;88.8;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.1;47.1;;;30.7;64;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2018;2018;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.6;10.6;;;9;12.3;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;15.7;15.7;;;12.5;19.6;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;53.5;53.5;;;40.1;66.4;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;58.8;58.8;;;48.9;68.1;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.7;49.7;;;35.4;64.1;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;93.0;93;;;78.3;98;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;73.5;73.5;;;64;81.2;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.9;10.9;;;9.1;13;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.3;70.3;;;53.6;82.9;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2018;2018;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;18.4;18.4;;;12.6;26.2;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.8;38.8;;;32.4;45.7;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.8;31.8;;;27.8;36.1;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.6;62.6;;;53.5;71;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.2;63.2;;;53;72.3;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.5;82.5;;;55.9;94.6;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.9;11.9;;;10.8;13.2;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2018;2018;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.7;71.7;;;53.3;85;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.5;6.5;;;5.4;7.7;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.1;32.1;;;25.1;40.1;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.7;47.7;;;39.9;55.6;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.9;63.9;;;49.7;76;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.7;11.7;;;10.1;13.4;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.0;89;;;82;93.4;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.2;87.2;;;79.9;92.1;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.9;11.9;;;8;17.4;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;27.3;27.3;;;17.2;40.3;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;48.0;48;;;39.4;56.8;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.4;43.4;;;26;62.6;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.5;88.5;;;82.3;92.8;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.3;9.3;;;7.8;11.1;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2018;2018;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.7;85.7;*;50 States + DC: US Median;83.7;86.9;Overall;Overall;;;;;;;59;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.6;31.6;;;25;39.1;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.8;64.8;;;54.5;73.9;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.3;46.3;;;38.2;54.6;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.8;6.8;;;5.5;8.4;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.0;5;;;4.1;6.1;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.5;7.5;;;6.6;8.5;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.6;35.6;;;27;45.3;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;16.1;16.1;;;9.1;26.8;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.4;6.4;;;3.7;11.1;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;93.8;93.8;;;86.2;97.4;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.0;84;;;74.7;90.4;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.8;62.8;;;47.6;75.9;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;51.1;51.1;;;39.2;63;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2018;2018;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.4;28.4;;;16.4;44.6;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.0;8;;;6.6;9.6;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.8;49.8;;;42;57.5;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.4;62.4;;;50;73.4;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29.2;29.2;;;23.1;36.1;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.2;84.2;;;76.8;89.5;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.4;12.4;;;11.4;13.5;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;55.6;55.6;;;41.1;69.1;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;50.9;50.9;;;42.6;59.1;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2018;2018;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.9;39.9;;;27.5;53.7;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.5;68.5;;;57.9;77.5;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.5;30.5;;;26;35.4;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.7;72.7;;;65.2;79;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.6;85.6;;;79.6;90;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.3;83.3;;;73.8;89.9;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.5;5.5;;;3.3;9;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;73.8;73.8;;;65.2;80.9;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.1;32.1;;;24.2;41.2;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.8;63.8;;;51.4;74.6;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;94.3;94.3;;;87.8;97.5;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.0;88;;;78.5;93.7;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;28.8;28.8;;;20.1;39.4;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;57.8;57.8;;;43.7;70.8;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.9;6.9;;;6;7.9;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;30.6;30.6;;;21.2;41.9;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.3;87.3;;;73.9;94.3;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;61.4;61.4;;;50.9;71;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.4;35.4;;;22.9;50.2;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.5;28.5;;;18.9;40.5;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.5;33.5;;;27.9;39.5;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.4;10.4;;;8.4;12.7;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.4;45.4;;;37.4;53.7;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.8;32.8;;;18.4;51.2;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;CA;California;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;7.7;7.7;;;6;9.8;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.5;71.5;;;57.2;82.5;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2018;2018;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.1;10.1;;;9.4;10.9;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.7;9.7;;;6.5;14.2;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.6;68.6;;;51.6;81.7;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.2;11.2;;;7.9;15.6;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;93.0;93;;;78.7;98;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;94.2;94.2;;;87.4;97.4;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.6;70.6;;;57.4;81;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.1;48.1;;;41;55.2;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.9;38.9;;;33.3;44.8;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.7;42.7;;;34.9;50.8;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;49.9;49.9;;;33.4;66.3;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.6;89.6;;;83.1;93.7;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.3;12.3;;;7;20.5;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.1;62.1;;;54.3;69.2;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.8;9.8;;;8.7;11.1;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.2;35.2;;;29.4;41.5;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.0;12;;;8;17.8;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.9;48.9;;;41.4;56.5;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.6;88.6;;;83.4;92.3;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.4;6.4;;;5.5;7.3;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.0;71;;;46.3;87.4;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;42.2;42.2;;;26.7;59.5;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.2;30.2;;;21.8;40.1;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.1;36.1;;;24.1;50.1;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.7;13.7;;;9.2;20.1;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;29.5;29.5;;;24.3;35.3;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.5;32.5;;;26.4;39.2;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.8;65.8;;;43.3;82.9;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.3;36.3;;;29.4;43.7;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.4;31.4;;;23.9;40;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.5;36.5;**;US estimate/number is based on fewer than 50 states and the District of Columbia;34.3;38.1;Gender;Male;;;;;;;59;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.6;36.6;;;28;46.2;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;22.9;22.9;;;13.8;35.5;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.7;68.7;;;59.1;76.9;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.1;8.1;;;7.1;9.3;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.4;70.4;;;53.9;82.9;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;92.9;92.9;;;77.9;98;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;53.0;53;;;37.1;68.4;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.2;31.2;;;21.3;43.2;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;29.6;29.6;;;23.7;36.3;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.8;36.8;;;26.8;48;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;91.6;91.6;;;85.9;95.1;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29.1;29.1;;;22.9;36.2;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.1;9.1;;;8.3;10;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.8;43.8;;;30.2;58.4;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.0;70;;;60.1;78.3;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.4;7.4;;;6.5;8.4;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.9;91.9;;;85.8;95.5;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.9;85.9;;;74.6;92.7;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.4;40.4;;;30.5;51.1;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90.3;90.3;;;83;94.7;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.5;37.5;;;32.7;42.6;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;16.2;16.2;;;11.4;22.5;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.6;9.6;;;7.3;12.7;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.5;39.5;;;32.8;46.7;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.9;6.9;;;6;7.8;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;26.3;26.3;;;21.3;31.9;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.3;6.3;;;4.7;8.4;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;56.4;56.4;;;48.9;63.7;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.6;8.6;;;7.5;10;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.3;7.3;;;5.3;9.8;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;55.2;55.2;;;41.3;68.4;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.3;12.3;;;9.2;16.4;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.6;34.6;;;22.9;48.6;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;60.5;60.5;**;US estimate/number is based on fewer than 50 states and the District of Columbia;57.6;63;Gender;Female;;;;;;;59;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.5;33.5;;;26.1;41.8;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.9;38.9;;;28.9;49.9;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.5;11.5;;;10.1;13;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.4;9.4;;;8.5;10.4;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;25.1;25.1;;;16.3;36.5;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.2;8.2;;;4.9;13.6;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;20.6;20.6;;;14;29.2;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.5;44.5;;;39.8;49.3;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;57.8;57.8;;;47.1;67.7;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.4;11.4;;;7;18.1;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.9;14.9;;;13.2;16.6;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;18.3;18.3;;;11.8;27.3;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.8;7.8;;;6.4;9.5;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.6;42.6;;;37.5;47.9;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.6;33.6;;;28.9;38.8;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.7;90.7;;;79.3;96.1;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;79.4;79.4;;;70.9;85.8;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.9;68.9;;;60.4;76.3;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.8;38.8;;;32.7;45.2;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.5;66.5;;;59.3;72.9;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;26.7;26.7;;;18.9;36.3;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.7;88.7;;;83;92.6;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.0;89;;;81.1;93.9;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.7;7.7;;;7;8.4;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.0;10;;;9.1;11.1;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.1;13.1;;;10.9;15.7;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.5;89.5;;;81.5;94.2;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.6;11.6;;;10.4;12.8;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.6;83.6;;;70.5;91.6;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.1;12.1;;;7.6;18.7;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.0;9;;;8.3;9.9;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.6;88.6;;;83.2;92.4;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;54.6;54.6;;;44.5;64.4;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.4;34.4;;;25.1;44.9;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.4;34.4;;;27;42.7;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.6;12.6;;;9.4;16.7;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;76.7;76.7;;;64.9;85.4;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;52.2;52.2;;;42.8;61.6;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;94.2;94.2;;;87.1;97.5;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;81.2;81.2;;;74.9;86.2;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.1;42.1;;;31.6;53.3;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;81.8;81.8;;;75.5;86.7;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;93.1;93.1;;;85.4;96.9;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.7;88.7;;;81.8;93.2;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;59.5;59.5;;;43.4;73.8;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;93.5;93.5;;;88.6;96.4;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;93.5;93.5;;;87.5;96.7;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.6;42.6;;;34.8;50.8;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.1;62.1;;;53.4;70.1;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;44.9;44.9;;;31.2;59.4;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.4;11.4;;;7.7;16.5;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;30.9;30.9;;;22.6;40.6;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.4;13.4;;;8.2;21.3;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;61.0;61;;;53.5;67.9;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.9;62.9;;;52.2;72.4;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.0;44;;;31.3;57.6;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.0;33;;;23.4;44.2;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;64.5;64.5;;;55.1;72.9;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.6;5.6;;;4.3;7.3;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.5;10.5;;;9.2;12;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.4;8.4;;;7.2;9.7;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2018;2018;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.2;67.2;;;54.7;77.7;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.8;11.8;;;10.6;13.1;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.2;9.2;;;7.8;10.7;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;55.7;55.7;;;45.6;65.3;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;15.0;15;;;13.3;16.8;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.2;11.2;;;9.9;12.7;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.5;84.5;;;71;92.4;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.7;35.7;;;30.5;41.2;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.9;38.9;;;32.2;46.1;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;81.2;81.2;;;69.5;89.1;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.2;28.2;;;22;35.4;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;20.7;20.7;;;14.2;29.1;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.9;5.9;;;4.6;7.6;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.4;40.4;;;33.6;47.7;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67.6;67.6;;;59.3;74.9;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.3;28.3;;;21.8;35.8;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.5;49.5;;;43.5;55.4;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.6;66.6;;;57.2;74.9;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.8;64.8;;;52.8;75.2;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90.7;90.7;;;80.8;95.7;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.8;88.8;;;83.5;92.6;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;17.8;17.8;;;10.5;28.5;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.9;12.9;;;11.1;14.9;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.7;14.7;;;12.7;17;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;30.9;30.9;;;22.6;40.5;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.0;41;;;34.2;48.1;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.7;10.7;;;7.5;15.1;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.7;8.7;;;6.4;11.6;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.3;9.3;;;8.6;10.1;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.2;45.2;;;39.6;50.9;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.1;38.1;;;32.5;44;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.4;64.4;;;57.4;70.8;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;48.2;48.2;;;40.8;55.6;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;4.7;4.7;;;3.8;6;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.9;36.9;;;31.3;42.9;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.8;33.8;;;28.7;39.2;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.6;32.6;;;24.8;41.5;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.5;30.5;;;22.5;39.9;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;23.5;23.5;;;15.3;34.3;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.8;68.8;;;54.3;80.4;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;4.4;4.4;;;2.7;7.1;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.8;11.8;;;10.5;13.2;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;78.7;78.7;;;70.6;85.1;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.3;11.3;;;10.2;12.6;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.9;47.9;;;31.4;64.8;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.2;7.2;;;5.9;8.7;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.6;11.6;;;10.3;13.1;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.0;83;;;68.7;91.6;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2018;2018;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.3;28.3;;;23.4;33.8;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.6;33.6;;;25.3;43.1;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.7;43.7;;;35.2;52.6;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.6;12.6;;;9.5;16.4;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.2;13.2;;;9;19.1;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.1;9.1;;;8;10.3;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.4;7.4;;;6.3;8.6;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.1;7.1;;;5.8;8.7;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;78.1;78.1;;;67.5;85.9;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.0;86;;;78.5;91.2;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.7;10.7;;;9.1;12.7;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.9;37.9;;;30.7;45.7;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.9;33.9;;;29.6;38.4;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;30.2;30.2;;;24.3;36.9;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;56.7;56.7;;;45.3;67.5;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;56.5;56.5;;;43.9;68.4;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.0;85;;;77.3;90.5;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.6;67.6;;;58.2;75.7;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;25.1;25.1;;;17.8;34.1;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.6;86.6;;;80;91.3;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.7;34.7;;;28.8;41;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.9;32.9;;;26.8;39.8;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.1;41.1;;;32.6;50.3;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.6;37.6;;;26.5;50.1;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.5;89.5;;;83.2;93.6;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.1;11.1;;;9;13.6;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;79.9;79.9;;;73.7;84.9;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;72.2;72.2;;;61.4;80.9;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.4;32.4;;;23.9;42.3;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.1;10.1;;;8.9;11.4;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;26.3;26.3;;;18.1;36.6;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.8;70.8;;;53.4;83.7;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;NY;New York;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.4;13.4;;;10.2;17.4;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.0;63;;;53.6;71.6;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.0;10;;;8.2;12.2;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.3;88.3;;;82.7;92.3;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.3;34.3;;;27;42.5;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.4;5.4;;;4.3;6.9;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;81.1;81.1;;;65.9;90.5;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;30.2;30.2;;;22.8;38.9;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.7;39.7;;;34.4;45.4;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.6;89.6;;;78;95.4;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.4;9.4;;;8.4;10.5;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.6;41.6;;;34.1;49.4;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.5;42.5;;;29.3;57;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2018;2018;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.0;87;;;79;92.2;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.1;38.1;;;32.1;44.6;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;91.2;91.2;;;85.6;94.8;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.4;87.4;;;81.4;91.6;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;92.1;92.1;;;73.7;98;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.9;7.9;;;6.7;9.3;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.0;10;;;9.3;10.8;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.6;12.6;;;11.5;13.8;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.4;9.4;;;8.4;10.6;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.7;28.7;;;23.7;34.2;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;17.1;17.1;;;9.6;28.6;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;28.3;28.3;;;21.7;35.9;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;15.9;15.9;;;8.9;26.7;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.9;14.9;;;12.4;17.9;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2018;2018;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;19.5;19.5;;;12.7;28.6;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.5;11.5;;;7.9;16.6;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.2;40.2;;;22.8;60.5;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.9;8.9;;;7;11.3;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.7;35.7;;;27.6;44.7;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;28.9;28.9;;;22.5;36.3;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.1;10.1;;;9.3;11;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.1;46.1;;;35.9;56.6;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;52.7;52.7;;;42.2;62.9;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2018;2018;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.5;38.5;;;31.3;46.2;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.5;63.5;;;55;71.2;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.5;35.5;;;29.4;42;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.7;67.7;;;58.8;75.4;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.7;87.7;;;82.4;91.7;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;55.7;55.7;;;48.4;62.8;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;54.0;54;;;36.5;70.6;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.9;31.9;;;21.6;44.4;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.9;38.9;;;32.2;46.1;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.2;37.2;;;28.9;46.3;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.7;11.7;;;10.7;12.9;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;4.7;4.7;;;2.7;8;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;77.5;77.5;;;58.8;89.2;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.5;10.5;;;6.8;15.9;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.8;11.8;;;10.5;13.1;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.7;9.7;;;8.8;10.7;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;81.3;81.3;;;71;88.5;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.0;10;;;7.2;13.7;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;93.1;93.1;;;83.8;97.2;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.6;36.6;;;31;42.7;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;73.6;73.6;;;55.7;86.1;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.0;8;;;6.6;9.8;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.7;39.7;;;34.6;45.1;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.0;9;;;7.5;10.8;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;51.9;51.9;;;44.6;59.1;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2018;2018;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.7;45.7;;;39.5;52.1;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.7;63.7;;;56;70.7;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.5;7.5;;;6.4;8.7;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.5;7.5;;;6.5;8.6;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.9;8.9;;;8;9.9;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.6;33.6;;;27.7;40.1;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.7;6.7;;;6;7.6;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;52.0;52;;;37.8;66;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.3;84.3;;;79.2;88.4;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.3;8.3;;;7.8;8.8;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.5;32.5;;;22.2;44.8;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.1;10.1;;;8.4;12.1;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.8;39.8;;;34.1;45.8;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.7;64.7;;;55.8;72.7;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.8;31.8;;;24.2;40.5;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;22.7;22.7;;;14.5;33.6;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.7;40.7;;;36.1;45.4;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;23.7;23.7;;;18.9;29.3;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;53.9;53.9;;;44;63.5;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.8;10.8;;;7.1;16.2;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.5;42.5;;;32.4;53.2;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.7;65.7;;;57;73.6;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.8;38.8;;;30.3;47.9;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.8;38.8;;;32.1;45.9;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;15.2;15.2;;;9.7;23.1;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;23.8;23.8;;;15.3;35.1;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.0;39;;;33.3;45.1;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.1;88.1;;;82;92.3;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;3.9;3.9;;;2.5;6.1;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.4;63.4;;;57;69.4;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.1;33.1;;;23.4;44.5;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.6;36.6;;;30.6;43;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.8;11.8;;;8.7;15.8;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.8;28.8;;;23.4;34.8;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.6;33.6;;;23.8;45.1;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;76.0;76;;;58.8;87.5;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;8.7;8.7;;;5;14.5;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.5;34.5;;;26.4;43.5;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.2;62.2;;;52.1;71.4;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;80.1;80.1;;;72;86.3;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2012;2012;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.0;88;;;78.8;93.5;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.4;9.4;;;6.9;12.4;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.6;84.6;;;74.4;91.2;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2018;2018;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.3;6.3;;;4.7;8.4;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.1;44.1;;;36.3;52.1;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.4;13.4;;;10.9;16.5;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.7;6.7;;;5.6;8.1;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;42.2;42.2;;;32.6;52.4;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2012;2012;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.3;86.3;;;79.6;91.1;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2012;2012;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.9;9.9;;;6.5;14.4;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.7;41.7;;;34.1;49.7;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.0;89;;;81.5;93.7;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;93.3;93.3;;;86.6;96.8;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.6;88.6;;;82.3;92.9;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.4;6.4;;;4.9;8.2;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.3;35.3;;;25.4;46.6;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.1;10.1;;;9.1;11.3;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.0;88;;;76.3;94.3;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;76.5;76.5;;;64.6;85.3;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;72.2;72.2;;;53.9;85.2;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.8;7.8;;;6.5;9.2;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2012;2012;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;93.9;93.9;;;88.2;96.9;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.8;70.8;;;62.4;78;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.3;89.3;;;83.3;93.2;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.6;90.6;;;85;94.3;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.0;7;;;4.9;9.9;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2012;2012;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.3;87.3;;;78.5;92.8;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2012;2012;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;NMBR;RACE;HIS;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.8;7.8;;;6.8;8.9;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.2;83.2;;;69.6;91.4;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.0;83;;;70.7;90.8;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2012;2012;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.0;91;;;84.4;95;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.4;84.4;;;72.9;91.5;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.5;35.5;;;21.7;52.2;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.9;71.9;;;55.2;84.1;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;NMBR;RACE;API;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.1;83.1;;;76.9;87.9;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.8;6.8;;;5.1;8.9;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.0;86;;;76.8;91.9;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;76.2;76.2;;;63.2;85.6;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2012;2012;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;5.7;5.7;;;4;7.9;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2012;2012;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;13.4;13.4;;;9.9;17.6;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.9;43.9;;;36;52.2;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;73.2;73.2;;;66.6;78.9;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;79.9;79.9;;;71.2;86.5;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.6;37.6;;;29.7;46.3;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;WA;Washington;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.3;11.3;;;9.7;13.3;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;TX;Texas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;8.5;8.5;;;6.6;10.8;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;MT;Montana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.0;14;;;11.1;17.5;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;61.4;61.4;;;44.9;75.7;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2018;2018;IN;Indiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.8;12.8;;;10.6;15.5;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;NC;North Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.4;13.4;;;10.6;16.8;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;TN;Tennessee;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.8;11.8;;;9.1;15.2;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;IA;Iowa;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.5;10.5;;;8.8;12.5;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.5;42.5;;;27.9;58.5;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2018;2018;DC;District of Columbia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.8;14.8;;;11.7;18.4;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;WI;Wisconsin;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.2;12.2;;;9.5;15.6;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;AZ;Arizona;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.4;11.4;;;9;14.3;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;NY;New York;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.7;12.7;;;11.4;14.2;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;MA;Massachusetts;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.3;14.3;;;11.7;17.3;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;KY;Kentucky;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.0;13;;;10.3;16.2;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2018;2018;DE;Delaware;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;15.1;15.1;;;11.9;18.9;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;ND;North Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.1;10.1;;;7.3;13.9;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;OH;Ohio;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.7;11.7;;;9.8;14;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.8;66.8;**;US estimate/number is based on fewer than 50 states and the District of Columbia;62.5;70;Gender;Male;;;;;;;59;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2018;2018;GA;Georgia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.5;10.5;;;8.8;12.4;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;MS;Mississippi;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.3;10.3;;;8.2;12.9;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2018;2018;SC;South Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.8;12.8;;;10.6;15.5;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;IL;Illinois;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.2;11.2;;;8.9;14;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;NV;Nevada;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.8;9.8;;;7;13.6;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;CA;California;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.3;9.3;;;8;10.9;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;LA;Louisiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.6;9.6;;;7.5;12.3;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.5;12.5;;;7.1;21;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;AR;Arkansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.7;12.7;;;9.7;16.4;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;ME;Maine;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;18.3;18.3;;;15;22.2;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.5;11.5;;;9.1;14.4;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;CA;California;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;NMBR;RACE;AIAN;;;;
2018;2018;MO;Missouri;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.0;12;;;9.3;15.4;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;VI;Virgin Islands;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;PR;Puerto Rico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;15.0;15;;;12.4;17.9;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;GU;Guam;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;5.5;5.5;;;3.3;9.3;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;VT;Vermont;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;16.2;16.2;;;13;20;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;AL;Alabama;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.1;14.1;;;11.4;17.2;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;VA;Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.8;10.8;;;9;13;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;RI;Rhode Island;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.9;12.9;;;10.1;16.4;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;61.7;61.7;;;50.2;72.1;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;NMBR;RACE;AIAN;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.6;36.6;;;22.6;53.4;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2018;2018;MD;Maryland;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.9;12.9;;;10.9;15.2;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;;Number;26;26;;;;;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2018;2018;NH;New Hampshire;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;19.2;19.2;;;15.3;23.9;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.2;8.2;;;7.4;9.1;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2018;2018;AK;Alaska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.0;12;;;8.5;16.6;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;NJ;New Jersey;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.3;11.3;;;8;15.9;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;CO;Colorado;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.4;12.4;;;10.5;14.5;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;NE;Nebraska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.4;11.4;;;9.6;13.6;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2018;2018;FL;Florida;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.2;12.2;;;9.9;15;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.3;36.3;;;30.3;42.7;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2018;2018;KS;Kansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.4;14.4;;;12.3;16.7;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.9;10.9;;;7.6;15.1;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2018;2018;OR;Oregon;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.7;14.7;;;12.2;17.6;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;OK;Oklahoma;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.0;14;;;11.4;17.1;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;MN;Minnesota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.3;10.3;;;9;11.8;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;NMBR;RACE;BLK;;;;
2018;2018;CT;Connecticut;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.5;11.5;;;9.6;13.8;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.3;9.3;;;8.6;10;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2018;2018;MI;Michigan;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;15.3;15.3;;;13.3;17.7;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;5.0;5;;;2.9;8.6;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;27.9;27.9;;;20.3;37;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.0;46;;;39.9;52.2;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.9;9.9;;;8.9;11;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2018;2018;PA;Pennsylvania;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.7;14.7;;;12.1;17.7;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.8;14.8;;;8.3;25.1;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2018;2018;WV;West Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.3;13.3;;;10.6;16.6;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;SD;South Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.3;10.3;;;7.3;14.4;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;ID;Idaho;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.4;12.4;;;9.2;16.6;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2018;2018;WY;Wyoming;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.6;11.6;;;8.8;15;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2014;2014;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;NMBR;RACE;AIAN;;;;
2012;2012;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.2;14.2;;;12.4;16.1;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2014;2014;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.6;13.6;;;9.6;18.7;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;57.1;57.1;;;47.4;66.3;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2012;2012;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;16.3;16.3;;;11.8;21.8;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.9;84.9;;;77.9;89.9;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;NM;New Mexico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.9;10.9;;;8.8;13.5;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2018;2018;HI;Hawaii;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.1;12.1;;;9.8;15;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.0;11;;;8.5;13.8;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2018;2018;UT;Utah;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.9;10.9;;;9.3;12.7;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41;41;;;32.2;50.5;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.4;34.4;;;27.1;42.5;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2012;2012;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;NMBR;RACE;HIS;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.3;44.3;;;33.8;55.3;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.4;14.4;;;10.1;20.3;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.2;45.2;;;40.7;49.9;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;NMBR;RACE;BLK;;;;
2014;2014;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2012;2012;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;NMBR;RACE;API;;;;
2018;2018;US;United States;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.2;12.2;*;50 States + DC: US Median;11.5;12.8;Overall;Overall;;;;;;;59;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.4;34.4;;;24;46.6;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;NMBR;RACE;API;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;61.8;61.8;;;44.9;76.3;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2017;2017;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2012;2012;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;NMBR;RACE;AIAN;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.5;36.5;;;25.1;49.7;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.8;12.8;;;9;17.5;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;15.5;15.5;;;11.3;20.8;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2012;2012;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.7;8.7;;;7;10.8;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.9;9.9;;;9;11;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2012;2012;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.7;9.7;;;7.6;12.2;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2012;2012;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.7;38.7;;;31;47;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.9;7.9;;;7.2;8.7;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.8;37.8;;;25;52.7;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2017;2017;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.0;11;;;9.8;12.4;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.8;43.8;;;36.3;51.6;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.7;44.7;;;36.7;53;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;24.7;24.7;;;13.7;40.3;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.2;38.2;;;31;45.9;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.9;13.9;;;11.4;16.8;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.7;65.7;;;50.3;78.4;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.1;10.1;;;6.6;15;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2013;2013;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;6.85;6.85;;;6.5;7.19;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;58.2;58.2;;;40.2;74.3;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2013;2013;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.5;36.5;;;28.7;45.1;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.8;66.8;;;56.2;75.9;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.5;6.5;;;5.4;7.8;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;60.6;60.6;;;44.5;74.7;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2013;2013;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;15.8;15.8;;;9.7;24.4;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;NMBR;RACE;WHT;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.5;39.5;;;25.5;55.4;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.0;7;;;4.3;11.3;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;TN;Tennessee;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;NMBR;RACE;BLK;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.6;46.6;;;40.5;52.8;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2013;2013;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;7.79;7.79;;;7.25;8.33;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2013;2013;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2013;2013;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.1;11.1;;;8.6;14.1;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.3;40.3;;;35.5;45.3;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.4;37.4;;;25.1;51.5;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;20.1;20.1;;;12.2;31.3;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.5;6.5;;;5.3;7.8;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;12.54;12.54;;;12.2;12.88;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;4.79;4.79;;;4.26;5.32;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.7;45.7;;;36.9;54.8;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.1;10.1;;;7;14.4;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2013;2013;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.4;7.4;;;4.9;10.6;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;TX;Texas;NVSS;Asthma;Asthma mortality rate;;;Number;31;31;;;;;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;NMBR;RACE;HIS;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.0;43;;;32.3;54.4;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2013;2013;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.7;12.7;;;8.6;18.1;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.7;6.7;;;5.3;8.3;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.7;14.7;;;10.5;20.2;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;58.3;58.3;;;50.1;66.1;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.6;7.6;;;6.7;8.6;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2013;2013;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;92.3;92.3;;;86.1;95.9;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2017;2017;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.9;11.9;;;9.8;14.1;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.2;90.2;;;84.1;94.1;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.2;33.2;;;27.9;39;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.0;34;;;29.2;39.1;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;NMBR;GENDER;GENM;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.2;37.2;;;31.3;43.4;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;57.1;57.1;;;47.4;66.2;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2017;2017;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;NMBR;RACE;HIS;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;73.2;73.2;;;65.5;79.8;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.5;83.5;;;73.1;90.4;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.2;86.2;;;72.9;93.5;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;4.5;4.5;;;3.6;5.6;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2017;2017;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;;Number;29;29;;;;;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;NMBR;GENDER;GENF;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2017;2017;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;15.0;15;;;11.1;19.7;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.7;86.7;;;66.9;95.5;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.6;7.6;;;6.7;8.6;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.3;62.3;;;50.5;72.8;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;50.2;50.2;;;43.3;57;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;19.5;19.5;;;11.3;31.5;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.5;13.5;;;10.5;17.1;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2017;2017;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.2;41.2;;;33.4;49.5;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;79.5;79.5;;;69.9;86.6;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.7;36.7;;;31.3;42.4;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.4;49.4;;;43.3;55.5;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2017;2017;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.7;82.7;;;74.7;88.5;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2017;2017;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;29.1;29.1;;;19;42.7;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.4;6.4;;;5.5;7.4;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.2;39.2;;;31.7;47.3;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2017;2017;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.2;9.2;;;8.1;10.4;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.6;47.6;;;42.4;52.9;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;41.6;41.6;;;27.6;57.2;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.8;35.8;;;28.1;44.2;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;;Number;54;54;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;NMBR;RACE;WHT;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.8;38.8;;;29.5;49.1;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;77.4;77.4;;;59.2;89;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.3;9.3;;;8.5;10.3;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90.0;90;;;85.4;93.3;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.9;12.9;;;11.3;14.5;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;80.7;80.7;;;69.8;88.3;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.4;48.4;;;37.8;59.2;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.6;45.6;;;36.3;55.3;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.5;10.5;;;9.4;11.8;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.6;40.6;;;36.9;44.4;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.5;34.5;;;29.3;40;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.4;44.4;;;33.7;55.6;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2017;2017;CA;California;NVSS;Asthma;Asthma mortality rate;;;Number;190;190;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;NMBR;RACE;WHT;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.6;65.6;;;36.6;86.3;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.2;5.2;;;3.5;7.8;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.2;8.2;;;5.7;11.7;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.4;37.4;;;25.2;51.5;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2017;2017;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.2;11.2;;;7.3;16.8;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;79.3;79.3;;;63.3;89.4;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2017;2017;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;6.7;6.7;;;4.8;9.1;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2017;2017;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2017;2017;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;NMBR;RACE;AIAN;;;;
2017;2017;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;NMBR;RACE;API;;;;
2017;2017;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;NMBR;RACE;AIAN;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.9;47.9;;;41.2;54.6;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.0;9;;;7.9;10.2;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;NMBR;RACE;BLK;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;20.7;20.7;;;14.3;28.9;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2017;2017;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.8;33.8;;;25;43.9;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2017;2017;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;NMBR;RACE;AIAN;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2017;2017;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.3;41.3;;;34.9;48;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2017;2017;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.5;8.5;;;7.1;10.1;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;;Number;78;78;;;;;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2017;2017;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;NMBR;RACE;HIS;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.3;86.3;;;78.9;91.4;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2017;2017;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.5;12.5;;;11.1;14;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2017;2017;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.8;44.8;*;50 States + DC: US Median;42.5;46.6;Gender;Female;;;;;;;59;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.3;44.3;;;33.9;55.2;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;MT;Montana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.3;82.3;;;75;87.8;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;MT;Montana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;NMBR;RACE;WHT;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.5;42.5;;;34.7;50.6;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.3;9.3;;;8.6;10.1;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.4;43.4;;;38.3;48.7;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.0;7;;;6.1;8;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.4;47.4;;;40.6;54.4;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.8;5.8;;;3.9;8.6;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2017;2017;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.6;41.6;;;27.4;57.3;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.0;40;;;24.7;57.6;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.8;37.8;;;33;42.9;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;77.5;77.5;;;67.1;85.4;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2017;2017;NY;New York;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.9;14.9;;;10.7;20.3;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.0;68;;;59.1;75.7;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.0;9;;;6.8;11.8;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2017;2017;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2017;2017;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;NMBR;GENDER;GENM;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.7;32.7;;;20.9;47.2;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;4.4;4.4;;;3.4;5.7;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2017;2017;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;30.1;30.1;;;24.2;37;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2017;2017;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.7;38.7;;;28.6;49.8;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.0;38;;;30.7;45.9;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;52.7;52.7;;;47.1;58.3;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.2;40.2;;;33.6;47.1;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.5;66.5;;;56.4;75.3;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.3;10.3;;;9;11.8;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.1;45.1;;;33.5;57.2;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2017;2017;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.2;12.2;;;10.9;13.7;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90.0;90;;;81.1;95;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.5;12.5;;;9.5;16.2;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.0;68;;;53.8;79.6;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.7;13.7;;;11.3;16.5;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;4.6;4.6;;;3.9;5.5;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2017;2017;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;NMBR;RACE;API;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.3;87.3;;;69.6;95.3;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.8;87.8;;;82.4;91.7;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;13.0;13;;;10.4;15.5;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2017;2017;NY;New York;NVSS;Asthma;Asthma mortality rate;;;Number;107;107;;;;;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;NMBR;GENDER;GENM;;;;
2017;2017;MT;Montana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;NMBR;RACE;HIS;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.3;45.3;;;32;59.2;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2017;2017;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.6;41.6;;;32.6;51.1;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;5.7;5.7;;;3.7;8.8;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2017;2017;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2017;2017;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.1;34.1;;;26.4;42.6;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.5;85.5;;;77.1;91.1;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.1;42.1;;;32.2;52.7;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.6;9.6;;;8.8;10.6;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.1;6.1;;;3.7;9.9;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.9;70.9;;;64.2;76.8;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.8;40.8;;;34.9;47.1;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.0;45;;;40;50.1;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;93.9;93.9;;;89.8;96.4;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.0;9;;;8.2;9.8;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;75.3;75.3;;;67.2;81.9;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.9;88.9;;;82.9;93;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.0;46;;;37;55.3;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.7;38.7;;;26.4;52.7;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.2;12.2;;;10.6;14;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;;Number;77;77;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;NMBR;RACE;WHT;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.2;45.2;;;36.2;54.6;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.9;89.9;;;79.6;95.3;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2017;2017;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;NMBR;RACE;HIS;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;26.9;26.9;;;16.5;40.8;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;75.3;75.3;;;64;84;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;;Number;59;59;;;;;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.6;71.6;;;63.1;78.7;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2017;2017;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.9;12.9;;;8.3;19.3;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2017;2017;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.4;8.4;;;5.4;12.5;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2017;2017;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.5;8.5;;;7.6;9.6;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.8;85.8;;;78.6;90.9;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;77.2;77.2;;;62.7;87.2;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;41.6;41.6;;;31.5;52.4;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.1;63.1;;;54.5;70.8;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.6;88.6;;;82.1;92.9;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;50.8;50.8;;;41.9;59.7;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.1;48.1;;;34.7;61.8;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.6;12.6;;;9.2;17.1;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2017;2017;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;;Number;47;47;;;;;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.7;9.7;;;9;10.5;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;15.6;15.6;;;9.2;25.2;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;52.8;52.8;;;45.2;60.3;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2017;2017;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.2;46.2;;;38.9;53.7;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.3;44.3;;;40;48.7;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.2;45.2;;;39.7;50.8;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.7;87.7;;;77.4;93.7;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2017;2017;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.8;43.8;;;35.9;52.1;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;4.7;4.7;;;3.6;6.2;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.0;85;;;74.5;91.7;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.3;11.3;;;10.2;12.4;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;NMBR;RACE;HIS;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2017;2017;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.4;68.4;;;58.8;76.6;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;18.1;18.1;;;13.6;23.6;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;;Number;90;90;;;;;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;NMBR;GENDER;GENF;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.9;8.9;;;7.6;10.5;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.2;47.2;;;37.6;57;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2017;2017;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.6;8.6;;;6.3;11.5;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.5;31.5;;;17.8;49.3;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.3;46.3;;;41.8;51;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.3;36.3;;;29.1;44.1;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.8;33.8;;;18.3;53.8;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;61.6;61.6;;;50.2;71.8;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.3;7.3;;;6;8.7;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.8;13.8;;;9.4;19.7;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.2;37.2;;;28.9;46.3;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2017;2017;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;NMBR;RACE;AIAN;;;;
2017;2017;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;NMBR;RACE;AIAN;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.1;63.1;;;49.8;74.6;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.3;83.3;;;73.3;90.1;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.1;10.1;;;6.4;15.5;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.6;9.6;;;7.2;12.7;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.8;5.8;;;4.8;6.9;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.3;83.3;;;70.1;91.4;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.9;46.9;;;41;52.8;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2017;2017;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;NMBR;RACE;API;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.7;6.7;;;5.4;8.2;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.4;71.4;;;62.9;78.6;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;6.1;6.1;;;4;9;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.3;10.3;;;9;11.8;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;14.7;14.7;;;10.8;19.8;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.3;88.3;;;72.9;95.5;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.6;10.6;;;7.5;14.5;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.4;37.4;;;30.8;44.5;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;49.3;49.3;;;38.3;60.3;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.6;8.6;;;7.5;9.8;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.2;10.2;;;9;11.5;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2017;2017;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.0;11;;;8.5;13.9;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.7;46.7;;;38.6;55;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;NMBR;RACE;WHT;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.9;41.9;;;34.7;49.4;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.4;40.4;;;31.7;49.8;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.9;46.9;;;41.1;52.7;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.1;10.1;;;8;12.6;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.7;10.7;;;7.3;15.1;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2017;2017;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;;Number;63;63;;;;;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;NMBR;GENDER;GENF;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;51.4;51.4;;;38.7;63.9;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.2;32.2;;;20.1;47.2;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.3;85.3;;;63.8;95;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2017;2017;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;28.3;28.3;;;22;35.8;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;;Number;24;24;;;;;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.6;32.6;;;25.1;41.1;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.8;42.8;;;35.6;50.3;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.0;11;;;7.6;15.4;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50.0;50;;;41.4;58.6;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2017;2017;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.1;7.1;;;5;9.8;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.3;84.3;;;69.9;92.6;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2017;2017;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;61;61;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;NMBR;RACE;WHT;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.4;40.4;;;34.5;46.6;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.1;32.1;;;23.1;42.6;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;54.0;54;;;41.1;66.4;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.9;71.9;;;64.4;78.3;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;55.9;55.9;;;45.3;65.9;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2017;2017;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;NMBR;RACE;WHT;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.4;12.4;;;9.2;16.4;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.1;9.1;;;7.6;10.7;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.3;7.3;;;5.6;9.4;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;NMBR;RACE;BLK;;;;
2017;2017;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.8;83.8;;;72.4;91;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.8;9.8;;;6.9;13.6;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2017;2017;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.9;47.9;;;36.7;59.4;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.0;9;;;8.1;10;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2017;2017;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;;Number;27;27;;;;;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.5;48.5;;;39.7;57.4;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;53.4;53.4;;;42.1;64.3;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.3;69.3;;;62.1;75.7;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;NMBR;GENDER;GENF;;;;
2017;2017;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.7;13.7;;;10.5;17.5;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;74.7;74.7;;;66.8;81.3;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;80.3;80.3;;;70.5;87.3;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;94.1;94.1;;;89.9;96.7;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.9;83.9;;;76.4;89.4;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.6;7.6;;;6.7;8.6;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.9;85.9;;;77.8;91.4;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.5;45.5;;;38.6;52.5;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.6;48.6;;;40.4;56.8;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;26.8;26.8;;;19.1;36.7;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2017;2017;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;NMBR;GENDER;GENM;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.2;9.2;;;8.3;10.3;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;26.2;26.2;;;18.1;36.2;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;73.9;73.9;;;60.3;84.1;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;NMBR;RACE;AIAN;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90.9;90.9;;;86.6;94;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.0;38;;;23.2;55.5;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2017;2017;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2017;2017;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;NMBR;RACE;API;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;51.0;51;;;44.2;57.7;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2017;2017;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;74.1;74.1;;;63.3;82.6;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.2;88.2;;;79.3;93.6;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.8;87.8;;;77.4;93.8;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2017;2017;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.8;43.8;;;29.1;59.7;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2017;2017;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2017;2017;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;CRDRATE;RACE;API;;;;
2017;2017;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.0;44;*;50 States + DC: US Median;42.3;45.2;Overall;Overall;;;;;;;59;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.3;40.3;;;34.5;46.4;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;94.3;94.3;;;87.2;97.5;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;UT;Utah;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;NMBR;RACE;HIS;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.0;13;;;10.3;16.4;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.5;86.5;;;76.5;92.7;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.9;87.9;;;80.7;92.6;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.2;12.2;;;11;13.5;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.8;7.8;;;6;10;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;75.2;75.2;;;59.3;86.3;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2017;2017;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;15.1;15.1;;;12.2;18.6;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2017;2017;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.7;86.7;;;80.7;91;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;7.0;7;;;4.3;11.3;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2017;2017;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;CRDRATE;RACE;API;;;;
2017;2017;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;NMBR;RACE;API;;;;
2017;2017;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2017;2017;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.2;64.2;;;54.5;72.8;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;80.4;80.4;;;69.5;88.1;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;CRDRATE;RACE;API;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.1;37.1;;;28.7;46.5;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.9;10.9;;;8.2;14.2;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.6;9.6;;;8.5;10.9;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;4.3;4.3;;;2.8;6.6;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.7;11.7;;;10.6;12.8;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.6;8.6;;;5.7;12.5;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;77.1;77.1;;;57.7;89.2;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.1;12.1;;;9.5;15.3;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.5;38.5;;;35.1;41.9;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;50.9;50.9;;;43.9;57.8;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.8;84.8;;;76.7;90.4;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2017;2017;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.9;9.9;;;8.7;11.1;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.5;43.5;;;36.8;50.4;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.4;38.4;;;30.8;46.7;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.1;36.1;;;22.4;52.6;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2017;2017;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.1;7.1;;;4.7;10.3;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.2;6.2;;;5;7.7;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.5;87.5;;;80.7;92.2;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.9;35.9;;;31.2;40.8;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2017;2017;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.9;5.9;;;5;6.8;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.0;37;;;24.2;51.9;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.9;44.9;;;34.4;55.7;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;NMBR;RACE;BLK;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.2;14.2;;;10.1;19.6;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;41.2;41.2;;;32.5;51.5;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.2;44.2;;;39;49.6;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;22.3;22.3;;;17.5;27.9;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;19.3;19.3;;;10.8;32.3;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2017;2017;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.3;9.3;;;6.4;13.3;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.4;13.4;;;10.6;16.9;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.2;6.2;;;5.1;7.5;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2017;2017;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.3;48.3;;;40.7;55.9;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.0;45;;;38.4;51.7;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;6.6;6.6;;;5.2;8.2;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2017;2017;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2017;2017;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.7;46.7;;;35.3;58.4;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.5;62.5;;;49;74.3;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.8;37.8;;;29.7;46.7;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.3;47.3;;;40.4;54.3;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2017;2017;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;NMBR;RACE;HIS;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.3;89.3;;;83.5;93.3;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;81.3;81.3;;;72.5;87.7;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;CA;California;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;NMBR;RACE;AIAN;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.9;40.9;;;30.9;51.7;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.6;82.6;;;75;88.3;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.4;34.4;;;24.3;46.2;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.4;34.4;;;24.7;45.6;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.7;40.7;;;32.6;49.3;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.7;12.7;;;10.8;14.8;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;53.7;53.7;;;46;61.3;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.0;9;;;7.5;10.8;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;73.2;73.2;;;66.2;79.2;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.6;9.6;;;6.5;14;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;64.4;64.4;;;48.1;78;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.2;45.2;;;38.6;52;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;92.9;92.9;;;88.2;95.8;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.4;8.4;;;7.1;9.8;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67.5;67.5;;;50.3;81;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;92.9;92.9;;;87.4;96.1;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2017;2017;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.907192, -77.036871);;11;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2017;2017;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2017;2017;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.4;14.4;;;11.8;17.5;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.3;12.3;;;11;13.7;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;NMBR;RACE;BLK;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.7;49.7;;;41.2;58.2;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.9;13.9;;;12.7;15.2;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;94.0;94;;;86.5;97.4;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2017;2017;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.7;9.7;;;6.6;14.1;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2017;2017;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;73.4;73.4;;;63.4;81.4;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;73.4;73.4;;;63.6;81.3;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2017;2017;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.6;9.6;;;7.1;12.7;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.8;8.8;;;8;9.7;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.3;44.3;;;33.7;55.3;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.2;43.2;;;34.6;52.1;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.4;9.4;;;5.5;15.5;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.7;11.7;;;9.3;14.4;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;73.8;73.8;;;58.5;84.9;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2017;2017;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.5;91.5;;;84.3;95.5;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.9;8.9;;;8.1;9.7;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;5.8;5.8;;;4.4;7.6;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2017;2017;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.5;14.5;;;10.7;19.2;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2017;2017;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;;Number;21;21;;;;;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;NMBR;GENDER;GENM;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.2;14.2;;;12.2;16.4;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.8;39.8;;;33;47;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;91.0;91;;;85.4;94.6;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;4.8;4.8;;;4;5.9;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.3;64.3;;;47.1;78.5;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.1;9.1;;;7.6;10.9;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2017;2017;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.5;11.5;;;7.9;16.3;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50.0;50;;;43.1;56.9;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2017;2017;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.1;45.1;;;36.6;53.9;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.1;48.1;;;40.7;55.5;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;92.5;92.5;;;88.1;95.3;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;NMBR;RACE;HIS;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.7;43.7;;;36.2;51.5;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.1;31.1;;;21.7;42.3;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2017;2017;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.3;37.3;;;25;51.4;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;60.3;60.3;;;55;65.4;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.1;69.1;;;60.6;76.5;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;49.5;49.5;;;41.3;57.8;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.7;36.7;;;24.9;50.3;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.7;11.7;;;9.9;13.6;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;4.1;4.1;;;2.8;6.2;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.6;48.6;;;42.7;54.5;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.3;11.3;;;6.4;19.1;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.2;11.2;;;10.2;12.3;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;NY;New York;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.8;10.8;;;7.7;15;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.5;45.5;;;39.8;51.3;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.3;11.3;;;10.3;12.5;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.7;5.7;;;3.5;9.2;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.8;7.8;;;6;10;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.3;41.3;;;32;51.2;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.2;33.2;;;24.1;43.7;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.5;83.5;;;75.7;89.2;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.2;34.2;;;21.9;49;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;50.4;50.4;;;43.2;57.6;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.3;7.3;;;6.8;7.9;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;92.9;92.9;;;88;95.8;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.8;68.8;;;62.4;74.5;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.9;11.9;;;10.7;13.2;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.1;12.1;;;11.2;13;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2017;2017;CA;California;NVSS;Asthma;Asthma mortality rate;;;Number;142;142;;;;;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;NMBR;GENDER;GENM;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;58.2;58.2;;;48;67.8;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.3;46.3;;;37.9;54.8;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.9;10.9;;;9.1;12.9;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;NMBR;RACE;AIAN;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2017;2017;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.2;11.2;;;8.7;14.2;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2017;2017;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;;Number;29;29;;;;;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;NMBR;GENDER;GENM;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.6;82.6;;;74.4;88.6;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.2;8.2;;;7.3;9.2;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.6;42.6;;;34.2;51.4;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.3;8.3;;;7;10;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.3;9.3;;;6.7;12.7;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.8;87.8;;;81;92.4;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;75.2;75.2;;;67.3;81.7;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.7;37.7;;;21.4;57.4;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2017;2017;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2017;2017;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.4;44.4;;;36.2;52.9;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.0;46;;;41.5;50.5;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.6;37.6;;;27;49.5;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.4;40.4;;;34.6;46.5;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.5;10.5;;;5.8;18.3;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.3;67.3;;;49.7;81.1;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2017;2017;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;NMBR;GENDER;GENF;;;;
2017;2017;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;NMBR;RACE;HIS;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;21.0;21;;;15.8;27.3;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;57.0;57;;;45.4;67.8;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;NMBR;RACE;AIAN;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;44.0;44;;;34.6;53.8;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;NMBR;RACE;HIS;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.3;42.3;;;33.3;51.8;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.3;9.3;;;8.2;10.5;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.9;44.9;;;38.5;51.4;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.3;9.3;;;8.5;10.2;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2017;2017;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2017;2017;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.8;11.8;;;8.5;16;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.6;5.6;;;4.4;7.3;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.8;82.8;;;68.7;91.4;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.4;42.4;;;36;49.2;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;15.5;15.5;;;12.6;18.9;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.7;84.7;;;75.5;90.9;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2017;2017;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;NMBR;RACE;API;;;;
2017;2017;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.2;9.2;;;6.7;12.4;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2017;2017;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.9;40.9;;;35.1;47;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;50.7;50.7;;;38.8;62.5;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.0;45;;;35.2;55.1;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2017;2017;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.2;43.2;;;36.2;50.5;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;91.4;91.4;;;83.7;95.6;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.6;45.6;;;37.3;54.1;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.3;11.3;;;8.8;14.3;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;CRDRATE;RACE;API;;;;
2017;2017;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;NMBR;RACE;HIS;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2017;2017;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2017;2017;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;NMBR;RACE;BLK;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.8;10.8;;;8.1;14.3;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.4;86.4;;;80.8;90.6;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.8;47.8;;;42.3;53.3;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50.7;50.7;;;40;61.3;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;6.1;6.1;;;4.2;8.6;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.8;11.8;;;10.1;13.8;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.3;38.3;;;32.1;44.9;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.1;47.1;;;36.7;57.8;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.3;10.3;;;6;17.2;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2017;2017;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;NMBR;GENDER;GENF;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.0;10;;;9.3;10.7;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2017;2017;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2017;2017;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2017;2017;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.9;44.9;;;33.8;56.6;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.3;46.3;;;36.6;56.3;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.7;66.7;;;44.1;83.6;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50.0;50;;;42.4;57.6;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.5;84.5;;;76.6;90.1;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.3;9.3;;;6.9;12.4;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.9;11.9;;;10.3;13.8;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.3;65.3;;;55.5;74;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.4;63.4;;;55.3;70.8;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.6;11.6;;;10.6;12.7;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2017;2017;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;27.2;27.2;;;18.6;38.4;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.4;7.4;;;5.9;9.2;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;NY;New York;NVSS;Asthma;Asthma mortality rate;;;Number;149;149;;;;;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;NMBR;GENDER;GENF;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;20.0;20;;;12.1;31.3;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.1;89.1;;;79.9;94.4;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;26.0;26;;;20.3;32.6;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.0;37;;;25.2;50.5;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.8;7.8;;;5.7;10.5;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.5;14.5;;;12.6;16.6;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.4;8.4;;;6.9;10.3;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.6;6.6;;;6;7.3;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;CRDRATE;RACE;API;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.8;90.8;;;87;93.5;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.3;6.3;;;4.1;9.4;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;55.7;55.7;;;49.1;62.2;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;NMBR;GENDER;GENM;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.0;10;;;8.2;12.2;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.3;12.3;;;11;13.8;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;NMBR;RACE;HIS;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.6;41.6;;;35.4;48;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.1;10.1;;;5.6;17.6;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2017;2017;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2017;2017;CA;California;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;5.5;5.5;;;3.9;7.5;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.2;13.2;;;12.1;14.3;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;27.8;27.8;;;19.1;38.6;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.8;38.8;;;29.5;49;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;64.7;64.7;;;56.2;72.4;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;93.7;93.7;;;87.3;96.9;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.1;10.1;;;7.8;12.8;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.8;7.8;;;5.1;11.5;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2017;2017;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.2;6.2;;;3.9;9.6;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.2;7.2;;;6;8.4;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.7;8.7;;;7.2;10.3;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.4;40.4;;;30.3;51.4;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.0;12;;;10.2;14.1;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2017;2017;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.2;8.2;;;5.5;11.8;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.7;33.7;;;24.7;44.1;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;49.1;49.1;;;43.5;54.7;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.0;40;;;28.3;52.9;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.6;87.6;;;74.4;94.5;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.3;6.3;;;5.1;7.8;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.3;45.3;;;39.7;51.1;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.3;71.3;;;64.8;77;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2017;2017;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.8;85.8;;;78.4;90.9;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.4;30.4;;;24.8;36.7;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;NY;New York;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.7;10.7;;;9.2;12.5;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2017;2017;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.8;12.8;;;8.3;18.9;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.3;47.3;;;39.8;55;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.6;12.6;;;11.1;14.3;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2017;2017;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2017;2017;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.1;11.1;;;8.7;14.1;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.4;9.4;;;8.4;10.5;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.2;48.2;;;42.4;54.1;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.3;9.3;;;8.5;10.1;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.1;88.1;;;79.4;93.5;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.8;38.8;;;30.2;48.1;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2017;2017;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;;Number;28;28;;;;;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;NMBR;GENDER;GENM;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.7;44.7;;;37.5;52.1;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;17.2;17.2;;;11.6;24.6;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.1;10.1;;;8.6;12;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.3;47.3;;;38.2;56.5;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;74.4;74.4;;;62.1;83.7;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.7;9.7;;;8.3;11.3;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.5;34.5;;;28.8;40.7;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.0;10;;;8.3;12;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.8;44.8;;;35.8;54.2;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.4;41.4;;;35.3;47.8;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2017;2017;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;NMBR;RACE;WHT;;;;
2017;2017;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.2;42.2;;;34.9;49.9;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.8;88.8;;;80.2;94;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.2;11.2;;;10.2;12.2;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;NMBR;RACE;AIAN;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2017;2017;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;NMBR;RACE;API;;;;
2017;2017;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.0;87;;;83.1;90.2;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;15.5;15.5;;;10.3;22.5;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2017;2017;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;;Number;29;29;;;;;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;NMBR;GENDER;GENF;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.4;10.4;;;9.1;11.9;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.9;10.9;;;7.1;16.4;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.9;88.9;;;81.9;93.5;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;19.5;19.5;;;11;32.2;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.5;8.5;;;4.8;14.7;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;19.2;19.2;;;14.4;25.1;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.7;10.7;;;9.8;11.6;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.9;46.9;;;37;57.1;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.3;43.3;;;21.8;67.6;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.2;46.2;;;41.6;50.9;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.2;37.2;;;32;42.7;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;TX;Texas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;NMBR;RACE;AIAN;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;53.1;53.1;;;45;61.1;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.8;33.8;;;24.3;44.8;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.5;9.5;;;7.7;11.7;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.4;8.4;;;7.5;9.5;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;15.2;15.2;;;13.2;17.4;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.2;43.2;;;37.9;48.6;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;27.5;27.5;;;19.5;37.1;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2017;2017;US;United States;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.0;12;*;50 States + DC: US Median;11.7;12.6;Gender;Female;;;;;;;59;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.6;45.6;;;38.7;52.6;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.9;45.9;;;37.8;54.3;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2017;2017;MT;Montana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;NMBR;GENDER;GENF;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.5;33.5;;;29.7;37.6;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;18.4;18.4;;;10.8;29.6;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.5;44.5;;;33.4;56.1;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;19.2;19.2;;;15.8;23;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.9;39.9;;;29.2;51.7;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.2;48.2;;;39.3;57.2;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;NMBR;RACE;BLK;;;;
2013;2013;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;NMBR;RACE;BLK;;;;
2017;2017;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2017;2017;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;NMBR;RACE;API;;;;
2017;2017;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.3;10.3;;;9.2;11.4;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.5;42.5;;;33.8;51.7;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50.9;50.9;;;42.7;59.2;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.7;9.7;;;8.6;10.9;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.5;47.5;;;42.4;52.7;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2017;2017;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2017;2017;FL;Florida;NVSS;Asthma;Asthma mortality rate;;;Number;49;49;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;NMBR;RACE;BLK;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.3;6.3;;;4;9.5;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2017;2017;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;5.7;5.7;;;3.3;9.1;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.1;9.1;;;8.5;9.6;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2017;2017;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.9;41.9;;;30.9;53.7;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90.1;90.1;;;82.6;94.6;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;3.1;3.1;;;1.9;5.1;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.9;32.9;;;20.3;48.4;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;59.2;59.2;;;48.1;69.4;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;53.4;53.4;;;45.6;61;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.8;46.8;;;40.3;53.5;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;NMBR;RACE;AIAN;;;;
2017;2017;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.5;43.5;;;38.5;48.7;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.5;44.5;;;40.1;48.9;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.2;9.2;;;8.3;10.2;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.1;89.1;;;79.3;94.6;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2017;2017;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.2;8.2;;;5.7;11.2;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.1;10.1;;;9.2;11.2;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2017;2017;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2017;2017;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;;Number;47;47;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;NMBR;RACE;WHT;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.9;45.9;;;41.3;50.5;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;73.4;73.4;;;64.1;81;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2017;2017;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.0;38;;;27.9;49.2;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;58.1;58.1;;;43.9;71;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.4;68.4;;;60.5;75.3;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;93.7;93.7;;;89.2;96.5;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.0;45;;;35.9;54.6;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.8;5.8;;;4.5;7.4;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.3;12.3;;;11;13.7;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2017;2017;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.4;10.4;;;8.4;12.3;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.7;9.7;;;9.1;10.4;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;;Number;34;34;;;;;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;NMBR;GENDER;GENF;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2017;2017;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;95.5;95.5;;;88.9;98.2;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.1;42.1;;;34.8;49.7;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;NMBR;RACE;AIAN;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.0;46;;;36.3;56.1;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2017;2017;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.4;89.4;;;80.1;94.6;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.0;42;;;35;49.3;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;77.6;77.6;;;67.7;85.1;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.2;48.2;;;42.2;54.2;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2017;2017;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.2;14.2;;;11.5;16.9;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2017;2017;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;NMBR;RACE;BLK;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;91.9;91.9;;;85.8;95.5;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2017;2017;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;CRDRATE;RACE;API;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.0;5;;;3.5;7.1;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2017;2017;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;15.2;15.2;;;10.8;21.1;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.0;87;;;79.4;92.1;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.7;5.7;;;4.8;6.8;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.1;47.1;;;41.1;53.2;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.6;5.6;;;3.7;8.4;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;WA;Washington;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;NMBR;RACE;API;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.2;48.2;;;41.1;55.4;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.4;86.4;;;81;90.5;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.6;39.6;;;34.5;44.9;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.9;10.9;;;9.5;12.5;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.8;43.8;;;38;49.9;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.3;7.3;;;5;10.5;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2017;2017;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.4;42.4;;;34.9;50.2;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.8;39.8;;;29.1;51.6;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.6;13.6;;;12;15.3;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.5;46.5;;;42;50.9;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.6;5.6;;;4.4;7.1;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2017;2017;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;NMBR;RACE;AIAN;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.8;10.8;;;7.6;15;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.8;84.8;;;70.7;92.8;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.7;10.7;;;8.4;13.5;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.9;43.9;;;39;48.9;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;23.0;23;;;12.8;37.6;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;14.7;14.7;;;10.8;19.8;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2017;2017;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;6.2;6.2;;;4.8;7.8;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.5;8.5;;;7.2;10.1;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.7;46.7;;;34.7;59.1;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.0;41;;;28;55.4;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.9;49.9;;;39.7;60.1;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;41.6;41.6;;;31.5;52.4;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;64.2;64.2;;;55.5;72.1;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.6;43.6;;;35;52.6;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.9;64.9;;;59.8;69.7;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.2;91.2;;;86.8;94.2;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;50.1;50.1;;;43;57.2;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.6;37.6;;;26;50.7;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.8;10.8;;;9.4;12.3;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.9;86.9;;;79.6;91.9;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.9;13.9;;;10.8;17.7;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2017;2017;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.0;11;;;6.7;17.6;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;97.1;97.1;;;93.3;98.8;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2017;2017;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.3;8.3;;;7.2;9.3;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.0;63;;;50.1;74.4;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2017;2017;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;NMBR;RACE;HIS;;;;
2017;2017;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;92.8;92.8;;;85.4;96.6;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.5;13.5;;;12;15.1;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;NMBR;RACE;HIS;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2017;2017;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;92.5;92.5;;;86.9;95.9;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;5.8;5.8;;;3.6;9.1;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.8;43.8;;;36.8;51.2;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;NMBR;GENDER;GENF;;;;
2017;2017;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;NMBR;RACE;API;;;;
2017;2017;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;20.5;20.5;;;16.8;24.7;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.0;11;;;8.3;14.5;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.0;43;;;34.5;51.9;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.8;10.8;;;10.1;11.7;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;72.6;72.6;;;64.1;79.8;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.8;43.8;;;38.6;49.1;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;75.0;75;;;63.6;83.7;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.5;11.5;;;8.1;16.1;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.2;62.2;;;55.4;68.6;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.3;8.3;;;7.3;9.4;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.6;40.6;;;29.9;52.4;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;52.3;52.3;;;38.4;65.9;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;18.3;18.3;;;10.6;29.7;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;NMBR;RACE;API;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;72.3;72.3;;;53.4;85.6;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2017;2017;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2017;2017;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.5;85.5;;;77.9;90.8;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;NMBR;RACE;HIS;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;24.3;24.3;;;16.2;34.6;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;55.4;55.4;;;41.3;68.6;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.9;12.9;;;10.8;15.3;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.5;86.5;;;78.9;91.7;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.0;10;;;8.5;11.7;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2017;2017;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;53.0;53;;;45.4;60.5;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;91.5;91.5;;;85.3;95.3;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2017;2017;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2017;2017;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.5;45.5;;;39.5;51.7;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.9;6.9;;;5.7;8.4;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.8;11.8;;;10.2;13.6;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.3;9.3;;;8.4;10.3;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.4;65.4;;;57.2;72.7;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;74.0;74;;;64.3;81.8;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.0;14;;;12.4;15.7;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2017;2017;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;;Number;43;43;;;;;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;NMBR;GENDER;GENF;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;16.7;16.7;;;10.1;26.3;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.9;65.9;;;60.6;70.9;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.8;14.8;;;10.7;19.9;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2017;2017;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;CRDRATE;RACE;API;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.9;70.9;;;61.9;78.5;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.6;48.6;;;41.2;56.1;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.4;35.4;;;28.4;43.1;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;4.2;4.2;;;3;5.8;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2017;2017;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;;Number;59;59;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;NMBR;RACE;WHT;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.9;11.9;;;10.7;13.2;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2017;2017;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;19.1;19.1;;;12.7;27.6;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2017;2017;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;NMBR;RACE;API;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.3;9.3;;;8.5;10.1;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.0;11;;;8.9;13.1;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2017;2017;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.5;7.5;;;5.8;9.5;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.0;66;;;57.8;73.3;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.4;12.4;;;9.9;15.4;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.3;10.3;;;8.4;12.2;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.6;39.6;;;30.8;49.3;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2017;2017;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;61.1;61.1;;;37.7;80.4;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;92.3;92.3;;;87.8;95.2;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.1;13.1;;;9.5;17.5;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.3;33.3;;;19.7;50.3;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.3;71.3;;;63.4;78.1;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.6;11.6;;;7.9;16.4;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2017;2017;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.0;66;;;58.5;72.8;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2017;2017;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.8;13.8;;;10;18.8;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.0;44;;;36.2;52.1;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.0;39;;;35.7;42.4;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.1;47.1;;;37.3;57.1;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.2;46.2;;;37.9;54.7;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.0;38;;;30.2;46.4;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.8;71.8;;;56.6;83.3;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2017;2017;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.9;10.9;;;9.9;12;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.1;47.1;;;39.4;55;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.5;47.5;;;38.3;56.9;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.7;42.7;;;29.2;57.5;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.3;37.3;;;29.9;45.4;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2017;2017;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;CRDRATE;RACE;API;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.2;87.2;;;69.2;95.4;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.1;44.1;;;33.3;55.5;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.4;45.4;;;40.1;50.7;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.1;66.1;;;59.9;71.8;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;78.5;78.5;;;66.3;87.1;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2017;2017;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.8;13.8;;;11.1;16.9;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;97.2;97.2;;;93.3;98.9;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;;Number;70;70;;;;;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;NMBR;GENDER;GENM;;;;
2017;2017;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;18.0;18;;;11.5;26.7;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90.9;90.9;;;81.4;95.8;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;15.8;15.8;;;12.9;19.3;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;19.1;19.1;;;11.4;30.3;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;NMBR;GENDER;GENM;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2017;2017;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.1;10.1;;;7.4;13.6;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.7;11.7;;;10.1;13.5;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2017;2017;NY;New York;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.7;88.7;;;84.3;92;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;18.1;18.1;;;10;30.6;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;61.7;61.7;;;49.6;72.5;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.7;9.7;;;5.7;15.9;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.4;9.4;;;7.8;11.3;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.7;46.7;;;39;54.5;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.9;41.9;;;32.4;52.1;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2017;2017;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.1;12.1;;;10.8;13.6;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90.3;90.3;;;83.3;94.5;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;20.4;20.4;;;16.3;25.1;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2017;2017;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.2;12.2;;;9.9;14.5;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.1;84.1;;;70.9;91.9;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.1;36.1;;;24.2;49.9;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.3;9.3;;;7.9;10.9;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;52.3;52.3;;;47;57.7;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.6;5.6;;;5;6.3;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.3;43.3;;;36.6;50.2;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;57.5;57.5;;;41.7;71.9;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.0;70;;;63.9;75.4;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.8;69.8;;;60.6;77.7;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.5;11.5;;;9.9;13.4;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;31.8;31.8;;;17.6;50.4;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.0;66;;;53.2;76.8;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;49.8;49.8;;;42.9;56.7;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;81.9;81.9;;;66.2;91.3;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;CRDRATE;RACE;API;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;74.2;74.2;;;60.9;84.1;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.9;9.9;;;9.1;10.8;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.3;45.3;;;37.4;53.4;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;80.5;80.5;;;70.7;87.5;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;51.8;51.8;;;43.8;59.6;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;NMBR;RACE;AIAN;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;74.1;74.1;;;67.2;80;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.1;9.1;;;5.8;13.9;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2017;2017;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67.4;67.4;;;57;76.2;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;NMBR;RACE;AIAN;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.6;40.6;;;33.1;48.5;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2017;2017;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2017;2017;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;6.0;6;;;4.3;8.2;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.4;8.4;;;5.8;12;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;51.0;51;;;42.8;59.3;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;51.2;51.2;;;44.9;57.4;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;28.3;28.3;;;19.5;39.8;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.7;41.7;;;27.8;57;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.3;12.3;;;6.9;20.9;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2017;2017;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;13.7;13.7;;;10.7;17.3;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.3;7.3;;;6.3;8.5;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.0;10;;;8.9;11.3;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.2;44.2;;;27.3;62.6;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.0;66;;;57.9;73.3;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.8;47.8;;;34.9;61;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.5;89.5;;;81;94.5;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.5;7.5;;;6.7;8.4;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.9;34.9;;;20.9;52.1;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2017;2017;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;CRDRATE;RACE;API;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2017;2017;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;NMBR;RACE;HIS;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.8;40.8;;;32.6;49.4;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.7;7.7;;;4.8;12.1;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2017;2017;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;;Number;41;41;;;;;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;NMBR;GENDER;GENF;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.4;42.4;;;35.1;50;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2017;2017;FL;Florida;NVSS;Asthma;Asthma mortality rate;;;Number;94;94;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;NMBR;RACE;WHT;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.7;82.7;;;71.1;90.3;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.1;9.1;;;8.6;9.6;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.8;9.8;;;9;10.6;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;NMBR;RACE;BLK;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.8;62.8;;;51.3;73;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;;Number;46;46;;;;;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;73.0;73;;;65.4;79.4;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.1;47.1;;;39.4;54.9;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;58.9;58.9;;;46.5;70.2;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.8;34.8;;;19.1;54.7;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.0;9;;;7.5;10.8;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.3;9.3;;;6.9;12.4;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.8;41.8;;;34.8;49.1;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.7;11.7;;;7;18.2;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2017;2017;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;;Number;35;35;;;;;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;NMBR;GENDER;GENF;;;;
2017;2017;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.5;12.5;;;11.1;14.1;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.6;38.6;;;23.5;56.3;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.9;67.9;;;54.5;78.9;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;54.1;54.1;;;42.7;65.1;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.1;68.1;;;61;74.4;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.2;71.2;;;56.8;82.2;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;;Number;35;35;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;NMBR;RACE;WHT;;;;
2017;2017;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2017;2017;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;CRDRATE;RACE;API;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.2;46.2;;;39.2;53.3;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.9;39.9;;;33.1;47;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.3;7.3;;;6.8;7.8;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.6;45.6;;;39.2;52.1;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2017;2017;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;CRDRATE;RACE;API;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.0;46;;;38.7;53.6;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.5;9.5;;;7.7;11.6;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.3;90.3;;;85.8;93.4;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.7;10.7;;;8.3;13.7;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2017;2017;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.5;12.5;;;9.7;15.9;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.7;12.7;;;7.2;21.5;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;51.5;51.5;;;45.7;57.3;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2017;2017;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;CRDRATE;RACE;API;;;;
2017;2017;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.4;6.4;;;4.2;9.7;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;95.3;95.3;;;91.1;97.6;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2017;2017;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;6.2;6.2;;;4;9.1;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;8.9;8.9;;;6.9;11.4;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2017;2017;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.7;35.7;;;25.5;47.4;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;97.8;97.8;;;94.2;99.2;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.8;35.8;;;28;44.5;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.2;7.2;;;6.2;8.3;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.3;87.3;;;80;92.1;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.5;42.5;**;US estimate/number is based on fewer than 50 states and the District of Columbia;38.8;44.4;Gender;Male;;;;;;;59;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.2;47.2;;;38;56.7;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.9;33.9;;;25.1;44.1;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.2;13.2;;;11.7;14.9;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.1;46.1;;;39.7;52.6;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.0;10;;;9.4;10.8;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.3;48.3;;;43.2;53.4;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.0;8;;;6.6;9.7;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;;Number;25;25;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;NMBR;RACE;WHT;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;56.1;56.1;;;37.2;73.4;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2017;2017;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;26.2;26.2;;;15.4;41.1;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;37;37;;;;;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;NMBR;GENDER;GENM;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2017;2017;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.7;10.7;;;7.9;14.2;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2017;2017;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;5.8;5.8;;;3.7;8.6;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.8;10.8;;;10.1;11.6;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;93.7;93.7;;;87.4;96.9;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;27.2;27.2;;;16.7;41.1;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;53.5;53.5;;;42.7;63.9;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.3;10.3;;;8.6;12.3;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.8;10.8;;;8;14.5;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.3;13.3;;;11.9;14.9;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;48.9;48.9;;;31.8;66.2;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.6;11.6;;;10.1;13;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;93.1;93.1;;;88.6;95.9;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.1;7.1;;;4.1;12.1;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2017;2017;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;;Number;25;25;;;;;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;NMBR;GENDER;GENF;;;;
2017;2017;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.7;11.7;;;10.1;13.5;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;52.4;52.4;;;42.5;62.1;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.9;8.9;;;5;15.5;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2017;2017;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.8;39.8;;;31.2;49;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.0;7;;;5.2;9.2;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;49.5;49.5;;;41;58.1;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;57.4;57.4;;;46.1;68;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.3;62.3;;;42.7;78.5;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;TX;Texas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;NMBR;RACE;API;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.4;47.4;;;40.8;54.1;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.8;84.8;;;76.8;90.5;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.1;10.1;;;8;12.7;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.1;44.1;;;29.5;59.7;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;15.7;15.7;;;8.7;26.6;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.2;32.2;;;25.9;39.2;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;53.5;53.5;;;44.3;62.5;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.4;12.4;;;9.1;16.7;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;43.9;43.9;;;34.6;53.7;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.6;12.6;;;11.5;13.8;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.3;9.3;;;5.8;14.6;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.1;40.1;;;27.4;54.3;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.4;40.4;;;28.5;53.6;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.9;48.9;;;42.8;54.9;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;92.6;92.6;;;88.1;95.5;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2017;2017;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.7;63.7;;;45;79;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2017;2017;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;NMBR;RACE;API;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;16.1;16.1;;;11.7;21.6;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;NMBR;RACE;AIAN;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2017;2017;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.6;89.6;;;83.4;93.6;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.6;34.6;;;25.6;44.8;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST4_1;NMBR;GENDER;GENM;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.8;48.8;;;42.4;55.3;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;51.5;51.5;;;46.1;56.8;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;77.9;77.9;;;69.9;84.3;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.5;8.5;;;7.3;9.8;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2017;2017;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;NMBR;RACE;API;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;51.2;51.2;;;40.3;62;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.1;43.1;;;34.2;52.5;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.1;6.1;;;5.3;7;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;94.4;94.4;;;88.4;97.4;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.9;40.9;;;30;52.7;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;72.4;72.4;;;65.1;78.8;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.7;45.7;;;39.5;52.1;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2017;2017;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;NMBR;RACE;BLK;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;94.1;94.1;;;87.8;97.3;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2017;2017;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2017;2017;CA;California;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;16.1;16.1;;;9.3;26.5;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.2;62.2;;;53.3;70.4;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2017;2017;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.2;70.2;;;60.8;78.2;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;44.1;44.1;;;34.7;54.1;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.9;10.9;;;8;14.5;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.8;86.8;;;78.3;92.3;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.8;88.8;;;84.1;92.3;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90.6;90.6;;;82.1;95.3;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;47.8;47.8;;;37;58.8;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.3;86.3;;;76.7;92.3;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.9;43.9;;;37;51.1;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2017;2017;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2017;2017;CA;California;NVSS;Asthma;Asthma mortality rate;;;Number;399;399;;;;;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.6;8.6;;;7.7;9.6;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2017;2017;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;NMBR;RACE;WHT;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.5;66.5;;;52.8;77.8;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2017;2017;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;20.6;20.6;;;15.1;27.4;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.3;71.3;;;57.8;81.8;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90.1;90.1;;;86;93.1;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.5;10.5;;;7.7;14.2;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;72.4;72.4;;;53.9;85.5;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2017;2017;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;NMBR;GENDER;GENF;;;;
2017;2017;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;31.1;31.1;;;19.3;47.5;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.5;46.5;;;38.2;55;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;NMBR;RACE;API;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.1;91.1;;;87.2;93.9;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;52.7;52.7;;;43;62.2;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;NMBR;RACE;WHT;;;;
2017;2017;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.7;9.7;;;7.3;12.6;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.5;40.5;;;29.5;52.7;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.1;82.1;;;69.4;90.2;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.2;44.2;;;37.4;51.3;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.5;88.5;;;78;94.3;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.2;8.2;;;7.5;8.9;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.8;36.8;;;25.4;49.9;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.7;66.7;;;60.4;72.4;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2017;2017;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;;Number;36;36;;;;;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;NMBR;GENDER;GENF;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;73.3;73.3;;;55.4;85.9;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2017;2017;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.9;7.9;;;7.2;8.7;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.5;34.5;;;30.7;38.5;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67.4;67.4;;;60.6;73.6;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.8;40.8;;;32.1;50.1;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2017;2017;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.2;37.2;;;29.6;45.5;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.6;66.6;;;53.5;77.6;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.4;11.4;;;9.9;13.1;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.9;45.9;;;32.6;59.8;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.0;49;;;43.3;54.6;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;75.6;75.6;;;65.7;83.3;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;29.3;29.3;;;21.3;38.8;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2017;2017;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.4;8.4;;;6.9;9.9;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.6;89.6;;;82.3;94.1;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;54.0;54;;;46.7;61.2;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.0;43;;;34.8;51.5;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.9;6.9;;;5.7;8.2;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2017;2017;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.6;43.6;;;33;54.9;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.0;12;;;10.1;14.2;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;NMBR;RACE;HIS;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.2;38.2;;;27.6;50;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.3;45.3;;;38.1;52.7;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.6;8.6;;;7.5;10;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;15.5;15.5;;;11;21.5;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.7;7.7;;;6.2;9.6;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.1;7.1;;;5.8;8.6;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.1;43.1;;;33.5;53.3;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;94.0;94;;;88.2;97;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;81.7;81.7;;;71.2;88.9;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.4;36.4;;;26.7;47.2;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;18.1;18.1;;;10;30.6;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2017;2017;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.5;13.5;;;9.7;18.5;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;16.5;16.5;;;10.6;24.8;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.3;8.3;;;5.9;11.4;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.3;36.3;;;27.8;45.8;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.7;62.7;;;48.3;75.2;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.0;12;;;10.7;13.3;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.8;12.8;;;10.1;16.2;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;94.0;94;;;90.3;96.4;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.1;45.1;;;29.2;62.1;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.5;6.5;;;3.9;10.7;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.7;42.7;;;34.9;50.9;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2017;2017;US;United States;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.1;12.1;*;50 States + DC: US Median;11.8;12.6;Gender;Female;;;;;;;59;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;28.7;28.7;;;19.9;39.4;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.1;13.1;;;7.4;22.2;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.8;86.8;;;74.9;93.5;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;29.9;29.9;;;17.8;45.6;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.6;35.6;;;27.2;44.9;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;15.8;15.8;;;10.4;23.3;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.8;44.8;;;38.4;51.4;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;78.3;78.3;;;60.2;89.6;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2017;2017;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2017;2017;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;;Number;59;59;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;NMBR;RACE;WHT;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67.8;67.8;;;53.4;79.5;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.1;42.1;;;28.8;56.7;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.9;63.9;;;54.4;72.4;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50.7;50.7;;;43.7;57.7;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2017;2017;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.8;88.8;;;78;94.7;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;52.0;52;;;44.4;59.6;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2017;2017;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.6;11.6;;;9.8;13.5;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;57.7;57.7;;;42.6;71.4;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.7;38.7;;;28;50.6;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2017;2017;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;16.7;16.7;;;12.7;21.6;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;3.7;3.7;;;2.1;6.2;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.4;48.4;;;40;56.9;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.7;39.7;;;30.2;50;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.1;14.1;;;9.3;20.7;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.9;9.9;;;5.8;16.3;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.2;65.2;;;54.1;74.8;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;NMBR;RACE;HIS;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2017;2017;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2017;2017;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.0;66;**;US estimate/number is based on fewer than 50 states and the District of Columbia;64.4;69.1;Gender;Female;;;;;;;59;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.2;8.2;;;6.8;9.8;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;NMBR;RACE;HIS;;;;
2017;2017;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.3;11.3;;;9.2;13.3;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;73.3;73.3;;;64.1;80.8;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;16.8;16.8;;;12.4;22.3;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2017;2017;UT;Utah;NVSS;Asthma;Asthma mortality rate;;;Number;31;31;;;;;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.3;7.3;;;5.5;9.6;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2017;2017;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;18.2;18.2;;;12.9;25;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.2;8.2;;;7.1;9.6;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;16.1;16.1;;;10.5;23.5;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;48.9;48.9;;;31.1;67.1;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;NMBR;RACE;API;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.6;62.6;;;50.8;73;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;29.1;29.1;;;24.3;34.5;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.9;47.9;;;41.4;54.4;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2017;2017;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;23.4;23.4;;;17.3;31;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2013;2013;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;9.23;9.23;;;8.96;9.5;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2017;2017;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.1;88.1;**;US estimate/number is based on fewer than 50 states and the District of Columbia;85.8;90.3;Gender;Female;;;;;;;59;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50.4;50.4;;;44.1;56.7;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2017;2017;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.9;90.9;;;80.8;95.9;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;3.7;3.7;;;2.2;6.1;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.5;41.5;;;35.4;47.9;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.4;10.4;;;9.5;11.4;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;49.8;49.8;;;42.7;57;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.8;49.8;;;42.9;56.7;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;58.6;58.6;;;46.8;69.4;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.3;7.3;;;5.8;9.1;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.4;8.4;;;7.5;9.4;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2017;2017;US;United States;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.7;6.7;*;50 States + DC: US Median;6.4;7.1;Gender;Male;;;;;;;59;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2017;2017;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.7;84.7;;;78.1;89.6;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.0;88;;;76.9;94.1;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2017;2017;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2017;2017;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;;Number;45;45;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;NMBR;RACE;WHT;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.2;37.2;;;23.3;53.5;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2017;2017;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2017;2017;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.4;9.4;;;6.9;12.5;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90.1;90.1;;;84.2;93.9;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.4;7.4;;;5.4;10.1;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.4;12.4;;;8.9;17.1;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.9;8.9;;;6;12.6;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2017;2017;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;15.8;15.8;;;11.6;20.9;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.9;72.9;;;57.9;84.1;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.8;47.8;;;41.4;54.4;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.2;9.2;;;7.6;11.2;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.7;67.7;;;57.1;76.7;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.8;10.8;;;9.3;12.5;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.9;7.9;;;4.6;13.4;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.3;34.3;;;20.5;51.5;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.0;9;;;7.9;10.1;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.1;40.1;;;29.7;51.5;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.6;43.6;;;36.6;50.8;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2017;2017;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;92.1;92.1;;;87;95.4;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;27.8;27.8;;;19.3;38.2;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.4;11.4;;;9.1;14.3;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.9;5.9;;;5;6.9;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;15.2;15.2;;;11.6;19.7;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.2;11.2;;;6.3;19;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.7;65.7;;;48.6;79.5;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.4;84.4;;;69.2;92.8;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2017;2017;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.8;45.8;;;34.6;57.5;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.2;11.2;;;6.3;19.1;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.5;91.5;;;84.3;95.5;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.8;88.8;;;82.6;92.9;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;19.3;19.3;;;13.7;26.5;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2017;2017;WA;Washington;NVSS;Asthma;Asthma mortality rate;;;Number;105;105;;;;;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.7;40.7;;;31.3;50.9;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.7;47.7;;;42.2;53.2;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.7;14.7;;;12.2;17.6;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;NY;New York;NVSS;Asthma;Asthma mortality rate;;;Number;93;93;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;NMBR;RACE;BLK;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.7;33.7;;;25.8;42.6;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.7;8.7;;;5.6;12.8;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2017;2017;US;United States;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.7;6.7;*;50 States + DC: US Median;6.4;7.1;Gender;Male;;;;;;;59;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.0;36;;;26.5;46.6;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;NMBR;RACE;HIS;;;;
2017;2017;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;;Number;21;21;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;NMBR;RACE;WHT;;;;
2017;2017;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.0;41;;;27.9;55.5;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.9;66.9;;;58.1;74.7;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.7;9.7;;;8.5;11;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.3;44.3;;;33.5;55.7;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;NMBR;RACE;WHT;;;;
2017;2017;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;NMBR;GENDER;GENM;;;;
2017;2017;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;NMBR;GENDER;GENF;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.3;7.3;;;4.2;12.6;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2017;2017;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.6;10.6;;;6.6;16;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.0;9;;;5.7;13.9;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2017;2017;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;21.1;21.1;;;14.7;29.4;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.6;62.6;;;51.6;72.5;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2017;2017;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;NMBR;RACE;BLK;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.5;8.5;;;6.7;10.8;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.5;39.5;;;24.6;56.6;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;71;71;;;;;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.0;36;;;26.6;46.6;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;92.2;92.2;;;85.9;95.9;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.4;9.4;;;8.5;10.4;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;60.2;60.2;;;49.7;69.8;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2017;2017;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;NMBR;RACE;AIAN;;;;
2017;2017;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.0;88;*;50 States + DC: US Median;86.8;89.6;Overall;Overall;;;;;;;59;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.4;8.4;;;7.3;9.6;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2017;2017;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.4;41.4;;;33.8;49.6;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2017;2017;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2017;2017;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.1;7.1;;;5.4;9.3;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.1;71.1;;;63;78;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;60.3;60.3;;;50.2;69.6;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.1;38.1;;;33;43.5;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;CA;California;NVSS;Asthma;Asthma mortality rate;;;Number;257;257;;;;;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;NMBR;GENDER;GENF;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.6;10.6;;;8.2;13.6;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.4;43.4;;;34.1;53.2;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.5;9.5;;;8.5;10.6;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.4;12.4;;;8.6;17.6;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.8;47.8;;;35;60.8;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.4;88.4;;;84.1;91.6;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;;Number;33;33;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;NMBR;RACE;BLK;;;;
2017;2017;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.4;6.4;;;5.5;7.4;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.5;83.5;;;67.4;92.6;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;54.5;54.5;;;44.3;64.3;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;19.4;19.4;;;12.4;29.1;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2017;2017;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;25.4;25.4;;;15.3;39;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2017;2017;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.4;7.4;;;5.7;9.6;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2017;2017;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;NMBR;RACE;API;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;53.3;53.3;;;44.8;61.6;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.9;9.9;;;8.7;11.1;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;NMBR;GENDER;GENM;;;;
2017;2017;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.6;10.6;;;9.5;11.8;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.7;71.7;;;60.7;80.7;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2017;2017;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.4;39.4;;;34.1;44.9;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2017;2017;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;19.6;19.6;;;14.1;26.6;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.3;13.3;;;10.4;16.7;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.3;9.3;;;5.4;15.8;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2017;2017;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.3;40.3;;;33.7;47.3;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2017;2017;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.0;8;;;6;10.5;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.4;6.4;;;5.2;7.8;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.2;38.2;;;28.4;49;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;NMBR;RACE;API;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.3;91.3;;;82.7;95.9;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.8;43.8;;;31.2;57.3;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;47.8;47.8;;;37.1;58.6;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;16.6;16.6;;;11;23.9;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2017;2017;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.9;8.9;;;5.9;12.9;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;17.4;17.4;;;12.2;24.1;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.0;88;;;78.4;93.7;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.8;69.8;;;60.9;77.4;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2017;2017;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.1;46.1;;;40.5;51.8;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;ME;Maine;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;NMBR;RACE;WHT;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.1;85.1;;;76.1;91.1;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.5;12.5;;;9.9;15.6;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;30.9;30.9;;;20.8;43.2;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.3;12.3;;;10.2;14.7;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.1;39.1;;;34.6;43.9;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;28.2;28.2;;;21.8;35.8;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.5;45.5;;;37.2;54.1;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;97.1;97.1;;;93.4;98.7;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.9;34.9;;;24.8;46.5;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;;Number;135;135;;;;;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.5;11.5;;;10.1;13.2;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.9;35.9;;;22.7;51.5;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.2;14.2;;;7.9;24.3;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.7;9.7;;;8.5;11;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2017;2017;NY;New York;NVSS;Asthma;Asthma mortality rate;;;Number;58;58;;;;;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;NMBR;RACE;HIS;;;;
2017;2017;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2017;2017;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2017;2017;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;57.4;57.4;;;47.6;66.7;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;17.4;17.4;;;12.8;23.2;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;76.9;76.9;;;64.8;85.7;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.5;65.5;;;56.3;73.6;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2017;2017;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;;Number;27;27;;;;;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;NMBR;GENDER;GENM;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.9;39.9;;;29.3;51.5;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2017;2017;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.1;70.1;**;US estimate/number is based on fewer than 50 states and the District of Columbia;66.6;73.4;Gender;Male;;;;;;;59;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;49.4;49.4;;;43.3;55.5;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.9;38.9;;;31.5;46.8;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;59.7;59.7;;;47.5;70.8;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.6;10.6;;;9.9;11.3;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.0;11;;;9;13;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;NMBR;GENDER;GENM;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.0;40;;;27.7;53.7;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2017;2017;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;74.0;74;;;66.6;80.2;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;49.7;49.7;;;42.8;56.7;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;22.7;22.7;;;17.9;28.5;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2017;2017;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;80.2;80.2;;;66.9;89;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.3;9.3;;;8.5;10.2;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;NMBR;RACE;WHT;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.5;13.5;;;11.2;16.2;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;NMBR;RACE;API;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2017;2017;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;;Number;35;35;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;NMBR;RACE;WHT;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.1;42.1;;;32.2;52.7;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;20.1;20.1;;;10.9;34.1;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.4;36.4;;;31.2;42;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.2;10.2;;;6.2;16.2;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;NMBR;RACE;API;;;;
2017;2017;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;18.1;18.1;;;14;23;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.1;49.1;;;42.3;55.9;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2017;2017;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.4;85.4;;;79.4;89.9;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.1;89.1;;;81;94;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.2;14.2;;;11.6;17.4;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.9;32.9;;;23.8;43.5;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.5;7.5;;;4.6;11.8;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.1;7.1;;;4.2;11.2;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2017;2017;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.4;33.4;;;26.3;41.2;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.5;10.5;;;9.2;11.9;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.5;32.5;;;23.8;42.7;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2017;2017;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.6;49.6;;;40.2;59;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2017;2017;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;;Number;110;110;;;;;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2017;2017;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;6.1;6.1;;;4.8;7.5;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2017;2017;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;NMBR;RACE;AIAN;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.2;66.2;;;58.8;73;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.1;41.1;;;34.2;48.3;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2017;2017;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;;Number;46;46;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;NMBR;RACE;WHT;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.4;43.4;;;32.4;55;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2017;2017;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.1;47.1;;;40.6;53.8;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.3;45.3;;;39.9;50.8;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.9;35.9;;;24.5;49;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29.7;29.7;;;23.6;36.7;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.4;87.4;;;78.1;93.2;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.4;84.4;;;78.1;89.1;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.9;88.9;;;82.3;93.2;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29.6;29.6;;;18.6;43.5;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;CRDRATE;RACE;API;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.7;64.7;;;46.2;79.6;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2017;2017;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.5;10.5;;;8.2;13.2;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.0;43;;;34.9;51.5;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.9;48.9;;;42.4;55.4;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2017;2017;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2017;2017;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;8.9;8.9;;;5.3;14.6;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.3;13.3;;;12.2;14.5;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.9;7.9;;;6;10.3;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;51.5;51.5;;;43.3;59.6;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2017;2017;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.7;8.7;;;7.3;10.3;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2017;2017;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;NMBR;GENDER;GENF;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.7;46.7;;;35.1;58.7;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;NMBR;RACE;AIAN;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.6;45.6;;;35.2;56.5;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.9;12.9;;;10.7;15.4;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;17.2;17.2;;;12.5;23.1;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;81.3;81.3;;;71.9;88.1;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2017;2017;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;48;48;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;NMBR;RACE;BLK;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.1;47.1;;;35.2;59.3;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.7;5.7;;;4.7;6.8;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;;Number;132;132;;;;;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.7;46.7;;;38.6;54.9;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2017;2017;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;14.9;14.9;;;11.5;19.1;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2017;2017;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;26;26;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;NMBR;RACE;BLK;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.0;9;;;8;10.2;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.4;10.4;;;9;11.9;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.6;47.6;;;41.1;54.2;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;52.6;52.6;;;36.7;68;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.8;40.8;;;30.2;52.2;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.9;8.9;;;7.2;10.9;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2017;2017;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.0;7;;;6;8.1;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.2;63.2;;;53.6;71.8;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;61.5;61.5;;;50.7;71.4;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.4;85.4;;;77.9;90.7;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;CRDRATE;RACE;API;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.0;88;;;70.7;95.7;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;94.3;94.3;;;89.2;97.1;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;15.6;15.6;;;13.6;17.9;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;80.9;80.9;;;68.8;89;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.4;89.4;;;79.2;95;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.2;47.2;;;42;52.4;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2017;2017;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.0;49;;;34.1;64.1;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.8;48.8;;;42;55.7;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2017;2017;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;;Number;37;37;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;NMBR;RACE;BLK;;;;
2017;2017;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;NMBR;RACE;AIAN;;;;
2017;2017;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;NMBR;RACE;HIS;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;51.7;51.7;;;41.3;61.9;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.6;12.6;;;11.1;14.2;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.2;30.2;;;17.5;47;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.7;14.7;;;12.3;17.5;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;77.0;77;;;61.2;87.6;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.2;89.2;;;84.5;92.7;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.1;6.1;;;5.3;7;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2017;2017;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;NMBR;GENDER;GENM;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.4;9.4;;;5.2;16.3;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;16.8;16.8;;;13.5;20.7;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.5;12.5;;;9.9;15.6;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2017;2017;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;NMBR;RACE;BLK;;;;
2017;2017;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;26.7;26.7;;;18.3;37.7;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.1;10.1;;;8.3;12.1;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2017;2017;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.1;63.1;;;52.3;72.7;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;94.2;94.2;;;85.7;97.8;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2017;2017;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;15.2;15.2;;;11.9;19.1;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67.7;67.7;;;57.2;76.7;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;50.3;50.3;;;32;68.5;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2017;2017;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.4;90.4;;;82;95.1;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.5;39.5;;;28.5;51.7;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2017;2017;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2017;2017;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.8;9.8;;;8.6;11.1;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.8;6.8;;;4;11.2;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.3;10.3;;;6.1;16.9;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.5;47.5;;;34;61.4;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;27.5;27.5;;;16.4;42.2;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.2;39.2;;;28;51.7;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.0;11;;;9.9;12.1;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.0;7;;;4.8;9.7;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.9;6.9;;;5.8;8.2;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.0;82;;;66.3;91.4;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.3;9.3;;;8.5;10;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;15.8;15.8;;;10.9;22.2;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;58.8;58.8;;;48.5;68.5;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2017;2017;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;25.8;25.8;;;17.9;36.1;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2017;2017;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.9;13.9;;;11.2;17.1;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.4;10.4;;;9;12.1;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.3;10.3;;;6.6;15.6;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2017;2017;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.1;11.1;;;9;13.2;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;17.4;17.4;;;10.5;27.3;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.6;44.6;;;39.5;49.9;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.5;8.5;;;5.4;13.1;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.3;45.3;;;37.1;53.8;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2017;2017;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.5;12.5;;;10.7;14.2;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;;Number;49;49;;;;;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;NMBR;GENDER;GENF;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.8;62.8;;;53.4;71.3;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.0;14;;;11.6;16.7;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;95.1;95.1;;;85.4;98.5;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;61.4;61.4;;;52.2;69.8;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;;Number;54;54;;;;;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.2;88.2;;;83;92;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.3;38.3;;;27.8;50.1;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;NMBR;RACE;API;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;50.8;50.8;;;41.8;59.9;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.3;43.3;;;36.5;50.5;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;51.9;51.9;;;42.8;60.8;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;44.1;44.1;;;34.6;54;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.7;8.7;;;4.9;15;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.8;70.8;;;59.3;80.1;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.3;44.3;;;39.7;49.1;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.1;11.1;;;9.1;13.3;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.1;43.1;;;34.8;51.8;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2017;2017;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.5;11.5;;;10.5;12.6;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.3;44.3;;;40.7;48;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;US;United States;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.4;9.4;*;50 States + DC: US Median;9.1;9.9;Overall;Overall;;;;;;;59;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;75.7;75.7;;;60.5;86.4;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2017;2017;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.7;90.7;;;85.7;94.1;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;21.1;21.1;;;15.6;28;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.2;7.2;;;5.9;8.7;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.7;64.7;;;53.7;74.3;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;78.3;78.3;;;63.4;88.2;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2017;2017;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;15.9;15.9;;;10.9;22.8;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2017;2017;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;5.7;5.7;;;3.9;7.9;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.0;66;;;54;76.3;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;27.4;27.4;;;18.9;38.5;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.2;10.2;;;6;16.8;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;16.2;16.2;;;11.2;23;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2017;2017;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.6;14.6;;;10.5;19.9;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.5;12.5;;;11;14;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;16.8;16.8;;;10.8;25;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.8;40.8;;;35.5;46.4;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2017;2017;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;NMBR;RACE;API;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.1;33.1;;;26.4;40.5;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;NMBR;RACE;API;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.3;72.3;;;53.6;85.5;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.6;62.6;;;43.3;78.5;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.8;42.8;;;32.1;54.1;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;94.3;94.3;;;85.8;97.9;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;NMBR;RACE;AIAN;;;;
2017;2017;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.6;45.6;;;40.5;50.8;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2017;2017;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.3;9.3;;;7.7;11.3;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2017;2017;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;74.2;74.2;;;63.6;82.6;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2017;2017;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.0;9;;;6.7;11.9;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2017;2017;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.8;37.8;;;28.3;48.3;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2017;2017;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.8;8.8;;;5.9;12.7;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.3;36.3;;;25.1;49.3;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.4;8.4;;;7.5;9.4;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.5;43.5;;;36.3;50.9;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.8;43.8;;;38.9;48.7;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.7;44.7;;;36.8;52.9;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.6;64.6;;;47.2;78.8;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.0;71;;;55.3;82.9;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.4;35.4;;;22.8;50.4;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.4;37.4;;;29.4;46.1;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2017;2017;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;CRDRATE;RACE;API;;;;
2017;2017;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;5.1;5.1;;;3.8;6.6;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.2;11.2;;;9.6;13;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.6;62.6;;;46.1;76.6;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.9;49.9;;;39.9;59.9;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;13.6;13.6;;;9.1;19.7;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;3.6;3.6;;;2;6.2;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.1;11.1;;;8.6;14.1;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.2;10.2;;;7.6;13.6;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.3;71.3;;;58.5;81.4;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.3;6.3;;;5.3;7.4;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.9;11.9;;;10.6;13.3;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2017;2017;UT;Utah;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;NMBR;GENDER;GENF;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;73.9;73.9;;;60.9;83.8;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.6;90.6;;;86.7;93.5;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;43.5;43.5;;;28;60.5;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.7;8.7;;;4.8;15.3;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2017;2017;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.6;9.6;;;8.1;11.4;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.6;9.6;;;8.7;10.5;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;58.0;58;;;45.8;69.4;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.5;46.5;;;38.5;54.7;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;60.9;60.9;;;44.3;75.3;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.1;10.1;;;8.8;11.5;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50.9;50.9;;;42.9;58.8;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2017;2017;NY;New York;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;NMBR;RACE;API;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;61.7;61.7;;;50.2;72;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2017;2017;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;NMBR;GENDER;GENM;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;92.1;92.1;;;87.6;95;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;18.8;18.8;;;10.5;31.4;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;CA;California;NVSS;Asthma;Asthma mortality rate;;;Number;69;69;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;NMBR;RACE;BLK;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.2;11.2;;;10;12.6;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.7;43.7;;;35.2;52.6;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.2;39.2;;;29.9;49.4;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;NMBR;RACE;HIS;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.3;42.3;;;30.9;54.6;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.4;91.4;;;86;94.8;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;18.3;18.3;;;10.9;29.1;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.8;7.8;;;6;10.2;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2017;2017;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.2;13.2;;;8.5;19.7;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.3;47.3;;;41.1;53.7;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2017;2017;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.4;11.4;;;7.1;17.5;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.7;9.7;;;8.8;10.7;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2017;2017;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;CRDRATE;RACE;API;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.5;41.5;;;35.5;47.7;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.2;5.2;;;3;8.8;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.9;41.9;;;35.2;49;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2017;2017;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.9;10.9;;;9.8;12.1;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.9;38.9;;;23.3;57.2;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.1;9.1;;;8.1;10.3;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.8;10.8;;;8.3;14;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.6;49.6;;;40.9;58.2;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.2;6.2;;;3.8;10.1;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.2;34.2;;;28.1;40.8;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.4;40.4;;;28.1;54;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.4;14.4;;;11.7;17.6;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;81.4;81.4;;;68.6;89.7;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.6;69.6;;;58.4;78.9;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.1;10.1;;;8.8;11.6;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.3;87.3;;;81.9;91.2;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.4;9.4;;;7.7;11.5;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90.6;90.6;;;86.4;93.6;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2017;2017;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.5;11.5;;;8.8;14.9;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2017;2017;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;NMBR;RACE;AIAN;;;;
2017;2017;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;NMBR;RACE;AIAN;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;80.0;80;;;69.9;87.3;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.2;44.2;;;38.4;50.3;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2017;2017;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;NMBR;RACE;WHT;;;;
2017;2017;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;NMBR;RACE;AIAN;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.7;40.7;;;28.5;54;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.0;42;;;31;53.9;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.5;8.5;;;7.7;9.3;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.9;11.9;;;8.3;16.7;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2017;2017;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;20.7;20.7;;;13;31.4;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2017;2017;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.0;12;;;7.4;18.3;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2017;2017;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.5;42.5;;;33.3;52.3;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.1;45.1;;;39.6;50.7;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.9;46.9;;;42.2;51.7;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.8;11.8;;;10.3;13.6;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.8;36.8;;;30;44.2;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.1;9.1;;;7.6;10.7;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.2;6.2;;;4;9.3;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.0;38;;;29;47.9;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.4;83.4;;;71.7;90.9;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.3;10.3;;;8.4;12.4;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;91.4;91.4;;;82.1;96.1;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.1;10.1;;;8.4;12.1;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.0;40;;;29.2;52;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2017;2017;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;NMBR;RACE;API;;;;
2017;2017;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;CRDRATE;RACE;API;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.2;87.2;;;82.8;90.7;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;55.8;55.8;;;48.6;62.7;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;73.0;73;;;63.2;81;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.6;87.6;;;78.2;93.3;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.0;38;;;29.7;46.9;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2017;2017;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;CRDRATE;RACE;API;;;;
2017;2017;UT;Utah;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;NMBR;GENDER;GENM;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.4;47.4;;;40.2;54.7;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST4_1;NMBR;GENDER;GENF;;;;
2017;2017;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;15.7;15.7;;;11.5;20.9;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.9;12.9;;;10.1;16.3;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;60.0;60;;;54.1;65.6;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.0;11;;;8.8;13.6;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;60.1;60.1;;;44.9;73.5;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.3;84.3;;;73.5;91.2;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.9;8.9;;;8.1;9.9;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.9;47.9;;;43.2;52.7;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2017;2017;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2017;2017;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2017;2017;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2017;2017;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;26.9;26.9;;;19;36.9;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2017;2017;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;NMBR;RACE;BLK;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;94.2;94.2;;;88;97.3;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.8;36.8;;;26.4;48.6;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2017;2017;FL;Florida;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;NMBR;RACE;AIAN;;;;
2017;2017;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;92.7;92.7;;;87.9;95.7;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.5;35.5;;;25;47.6;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.5;65.5;;;53.1;76.1;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.7;10.7;;;8.6;12.7;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.8;40.8;;;27.7;55.3;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.2;10.2;;;7.1;14.1;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.1;45.1;;;37.1;53.5;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.9;42.9;;;32.6;53.9;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2017;2017;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;20.0;20;;;14.1;27.5;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.0;40;;;31.7;49;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.9;11.9;;;9.9;14.2;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;NY;New York;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.5;10.5;;;8.4;13.1;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.9;84.9;;;74.7;91.4;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.3;38.3;;;31.9;45;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.0;84;;;71.5;91.7;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;TX;Texas;NVSS;Asthma;Asthma mortality rate;;;Number;58;58;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;NMBR;RACE;BLK;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.1;9.1;;;8;10.3;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.5;47.5;;;34.3;61;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2017;2017;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;73.9;73.9;;;58;85.3;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;32;32;;;;;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;NMBR;GENDER;GENF;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.1;35.1;;;28.9;41.8;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.5;44.5;;;36.4;52.8;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.6;9.6;;;8;11.2;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2017;2017;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;;Number;28;28;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;NMBR;RACE;BLK;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.5;31.5;;;18.8;47.6;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.9;30.9;;;18.4;46.9;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;;Number;32;32;;;;;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;76.3;76.3;;;65;84.8;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.1;71.1;;;62.2;78.7;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.9;86.9;;;77.5;92.7;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.9;11.9;;;10.8;13.1;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2017;2017;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.8;45.8;;;33.9;58.1;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2017;2017;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.7;45.7;;;34.3;57.7;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.5;14.5;;;10.7;19.2;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;74.5;74.5;;;64.9;82.2;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;76.4;76.4;;;56.4;89;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;57.3;57.3;;;48.9;65.3;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.1;46.1;;;38.4;53.9;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.7;65.7;;;51.3;77.7;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.9;7.9;;;6;10.3;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.2;10.2;;;9.1;11.4;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2017;2017;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2017;2017;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;NMBR;RACE;HIS;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.9;48.9;;;40;57.8;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2017;2017;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.1;11.1;;;8.6;14.2;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2017;2017;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2017;2017;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.1;44.1;;;33.1;55.6;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.5;10.5;;;7.1;14.9;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.4;8.4;;;7.6;9.2;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2017;2017;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2017;2017;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.0;9;;;5.5;14;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.7;35.7;;;25.4;47.5;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2017;2017;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;NMBR;RACE;BLK;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.7;13.7;;;10.5;17.6;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;76.6;76.6;;;67.1;84;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.5;40.5;;;33.1;48.5;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.0;82;;;69;90.3;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.3;62.3;;;46.1;76.1;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;93.3;93.3;;;85.7;97;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;;Number;28;28;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;NMBR;RACE;BLK;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.1;40.1;;;35.4;45.1;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2017;2017;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;17.1;17.1;;;11.1;25.3;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2017;2017;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2017;2017;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;16.2;16.2;;;14.3;18.3;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.8;11.8;;;10.1;13.7;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.6;11.6;;;9.7;13.8;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;48;48;;;;;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;NMBR;GENDER;GENM;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.0;41;;;33.6;48.7;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.2;64.2;;;45.9;79.2;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;NMBR;RACE;AIAN;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.3;7.3;;;4.2;12.2;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2017;2017;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.8;45.8;;;34.7;57.3;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;19.2;19.2;;;15.3;23.8;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.9;11.9;;;10.7;13.1;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.0;37;;;31.7;42.7;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2017;2017;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;6.5;6.5;;;4.5;9.2;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;61.2;61.2;;;45.9;74.6;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2017;2017;FL;Florida;NVSS;Asthma;Asthma mortality rate;;;Number;33;33;;;;;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;NMBR;RACE;HIS;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.8;12.8;;;9.7;16.5;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.4;9.4;;;6.4;13.5;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;29.2;29.2;;;18.8;42.4;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2017;2017;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.6;6.6;;;5.6;7.8;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.7;37.7;;;25.4;51.8;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.3;38.3;;;27.6;50.4;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.6;42.6;;;37.2;48.2;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.4;41.4;;;33.7;49.5;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;76.2;76.2;;;64.1;85.2;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2017;2017;US;United States;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.9;10.9;;;10.6;11.3;Overall;Overall;;;;;;;59;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.4;8.4;;;7.6;9.4;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;92.5;92.5;;;86.4;95.9;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.1;8.1;;;5.8;11;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.1;43.1;;;33.7;53;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.8;87.8;;;82.1;91.8;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2017;2017;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.4;46.4;;;39.5;53.3;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.1;47.1;;;38.2;56.3;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.1;45.1;;;39;51.4;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.3;44.3;;;33;56.2;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;ME;Maine;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;NMBR;GENDER;GENM;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.5;32.5;;;22.3;44.7;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2017;2017;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;NMBR;RACE;WHT;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.0;45;;;36.7;53.7;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2017;2017;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;25.3;25.3;;;17.3;35.8;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2017;2017;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;51.0;51;;;38.5;63.3;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2017;2017;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.2;10.2;;;7;14.4;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.1;71.1;;;63.6;77.6;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.0;38;;;31.5;44.9;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.0;87;;;66.2;95.8;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.8;65.8;;;55.4;74.8;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.1;39.1;;;33.6;44.8;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2017;2017;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.0;88;;;71;95.7;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2017;2017;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.1;8.1;;;6.3;10.3;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2017;2017;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;14.2;14.2;;;9.1;21.2;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.6;48.6;;;38;59.3;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.5;45.5;*;50 States + DC: US Median;43.5;46.9;Overall;Overall;;;;;;;59;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.3;90.3;;;82.8;94.7;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.3;88.3;;;79.8;93.5;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2017;2017;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.3;8.3;;;5.9;11.4;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.1;11.1;;;7.4;16.2;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.9;11.9;;;6.7;20.4;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.3;38.3;;;28.8;48.7;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.3;7.3;;;6.1;8.8;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.7;11.7;;;9.1;15;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.8;44.8;;;36.9;53;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.2;66.2;;;57.1;74.3;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;25.6;25.6;;;17;36.6;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.0;38;;;31.6;44.9;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;55.6;55.6;;;37.1;72.7;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.9;6.9;;;5.9;8.1;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.2;9.2;;;6.5;12.8;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.9;5.9;;;4.5;7.6;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2017;2017;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2017;2017;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2017;2017;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;28;28;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;NMBR;RACE;BLK;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;93.7;93.7;;;89.3;96.3;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;93.1;93.1;;;86.4;96.6;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;54.5;54.5;;;43.2;65.3;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2017;2017;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;NMBR;RACE;API;;;;
2017;2017;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;;Number;45;45;;;;;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;NMBR;GENDER;GENF;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;92.8;92.8;;;87.1;96.1;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.5;45.5;;;36;55.3;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.5;46.5;;;35.3;58.1;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.0;12;;;9.7;14.8;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.4;6.4;;;4.2;9.5;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.5;10.5;;;7.5;14.4;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.4;62.4;;;50.3;73.1;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2017;2017;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.3;48.3;;;42.2;54.5;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.1;85.1;;;69;93.6;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.5;43.5;;;35.3;52;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2017;2017;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.2;7.2;;;6.2;8.4;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.6;10.6;;;9.5;11.8;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.8;43.8;;;37;50.9;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2017;2017;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.3;41.3;;;35.1;47.9;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.1;8.1;;;7;9.5;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2017;2017;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;NMBR;GENDER;GENM;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;ME;Maine;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;NMBR;RACE;API;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50.2;50.2;;;38.8;61.5;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.9;44.9;;;33.3;57.1;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.8;85.8;;;75.1;92.4;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;CRDRATE;RACE;API;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.8;33.8;;;18;54.4;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.6;13.6;;;10.7;17.1;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.3;41.3;;;34;49;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.3;13.3;;;9.9;17.6;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.3;45.3;;;36.5;54.4;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.6;11.6;;;9;15;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.9;68.9;;;60.5;76.2;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.0;46;;;39.7;52.4;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.6;63.6;;;44.9;79;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.4;44.4;;;32.8;56.6;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.6;12.6;;;9;17.6;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2017;2017;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;;Number;32;32;;;;;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2017;2017;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;NMBR;GENDER;GENM;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.0;14;;;12.2;15.9;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;NMBR;GENDER;GENF;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;15.3;15.3;;;11.9;19.4;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.4;71.4;;;65.1;77;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.0;48;;;38.4;57.7;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;79.8;79.8;;;66.6;88.7;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2017;2017;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;NMBR;RACE;API;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2017;2017;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.6;9.6;;;6.8;13.1;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.0;9;;;7.9;10.2;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.4;47.4;;;41.8;53;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;60.5;60.5;;;45.4;73.8;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;91.3;91.3;;;84.9;95.2;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.3;72.3;;;57.8;83.3;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.9;42.9;;;35;51.1;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.8;6.8;;;5.7;8.3;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.3;6.3;;;5.2;7.6;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2017;2017;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2017;2017;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;CRDRATE;RACE;API;;;;
2017;2017;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.2;37.2;;;23.9;52.9;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;NMBR;RACE;BLK;;;;
2017;2017;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;CRDRATE;RACE;API;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.9;33.9;;;25.4;43.5;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2017;2017;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;NMBR;RACE;WHT;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.3;5.3;;;3.2;8.6;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;;Number;31;31;;;;;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;NMBR;GENDER;GENF;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.7;39.7;;;31.2;48.9;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.2;12.2;;;9.2;15.9;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2017;2017;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.0;9;;;8.3;9.9;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90.7;90.7;;;82.5;95.2;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.3;47.3;;;32.3;62.8;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.6;14.6;;;13.4;16;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.6;65.6;;;56.4;73.7;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.8;9.8;;;8.2;11.7;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2017;2017;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;NMBR;RACE;API;;;;
2017;2017;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;NMBR;RACE;BLK;;;;
2017;2017;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.0;48;;;39.1;57.1;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67.3;67.3;;;57.2;76;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;53.2;53.2;;;45.6;60.7;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2017;2017;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.4;89.4;**;US estimate/number is based on fewer than 50 states and the District of Columbia;87.4;90.6;Gender;Female;;;;;;;59;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.6;45.6;;;40.5;50.7;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.0;7;;;4.9;9.8;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2017;2017;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2017;2017;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;CRDRATE;RACE;API;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.4;10.4;;;9.3;11.6;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.9;13.9;;;8;22.9;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.2;14.2;;;11.4;17.5;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;77.6;77.6;;;59.2;89.2;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.8;38.8;;;26.1;53.3;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2017;2017;WA;Washington;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;NMBR;RACE;AIAN;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.7;13.7;;;11.4;16.3;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.6;11.6;;;8.3;16;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.4;44.4;;;29.8;60;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2017;2017;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.8;88.8;;;82.4;93;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.6;42.6;;;28.3;58.2;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.4;66.4;;;52.1;78.2;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.1;63.1;;;40.2;81.3;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.0;31;;;19.1;46.1;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2017;2017;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.2;8.2;;;7.1;9.3;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;74.0;74;;;67.5;79.7;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.9;36.9;;;30.7;43.7;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2017;2017;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;24.4;24.4;;;15.9;35.5;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.6;66.6;;;54;77.2;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;92.4;92.4;;;86.5;95.8;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.0;41;;;34.3;48.1;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;91.5;91.5;;;84.5;95.5;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2017;2017;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;15.3;15.3;;;9.7;23.3;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.9;13.9;;;12.5;15.4;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.4;64.4;;;55.3;72.6;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2017;2017;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2017;2017;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;17.3;17.3;;;9.8;28.8;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.8;43.8;;;39;48.8;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.3;45.3;*;50 States + DC: US Median;43.3;47.2;Gender;Female;;;;;;;59;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.3;7.3;;;6.1;8.5;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.5;40.5;;;31.5;50.3;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.8;37.8;;;28.2;48.4;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;30.7;30.7;;;20.2;43.6;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.3;12.3;;;11;13.7;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.3;9.3;;;7.1;11.9;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2017;2017;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;19.3;19.3;;;14.1;25.8;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.6;86.6;;;80.1;91.2;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.6;32.6;;;25.5;40.5;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.3;36.3;;;27.4;46.1;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;61.7;61.7;;;51.9;70.7;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.5;8.5;;;7.2;10;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;25.6;25.6;;;16.6;37.3;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2017;2017;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;NMBR;RACE;BLK;;;;
2017;2017;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;;Number;55;55;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;NMBR;RACE;WHT;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;54.6;54.6;;;47;62;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.6;12.6;;;11.3;14.1;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.5;5.5;;;4.9;6.2;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.7;9.7;;;8.7;10.8;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.0;13;;;9.7;17.2;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;NMBR;RACE;AIAN;;;;
2017;2017;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;NMBR;GENDER;GENM;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.0;45;;;41;49.1;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;67.8;67.8;;;49.7;81.8;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2017;2017;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;CRDRATE;RACE;API;;;;
2017;2017;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.3;83.3;;;73.5;90;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.8;34.8;;;23.6;48;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.3;67.3;;;58.9;74.7;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.2;7.2;;;6.3;8.1;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.1;71.1;;;59.5;80.4;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;MT;Montana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;NMBR;RACE;BLK;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.3;43.3;;;29.5;58.1;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.7;30.7;;;19.9;44.2;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;81.7;81.7;;;69.4;89.8;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.2;47.2;;;39.4;55.2;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.3;43.3;;;36.7;50.2;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.3;35.3;;;23.5;49.3;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2017;2017;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.5;42.5;;;35.4;50;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;91.9;91.9;;;77.5;97.4;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2017;2017;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;NMBR;RACE;HIS;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.5;7.5;;;6.4;8.8;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.9;89.9;;;84.2;93.7;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.3;7.3;;;6.1;8.7;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.5;31.5;;;20.6;44.9;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;59.2;59.2;;;47.7;69.7;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.1;9.1;;;8;10.3;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.9;66.9;;;56.6;75.9;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;;Number;72;72;;;;;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.4;48.4;;;39.1;57.7;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.5;43.5;;;34.6;52.9;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2017;2017;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.5;48.5;;;40.6;56.5;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.7;65.7;;;60.6;70.4;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.9;45.9;;;39.2;52.7;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.9;44.9;;;39.1;50.7;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;NMBR;RACE;API;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.8;9.8;;;8.3;11.7;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.1;14.1;;;12.1;16.3;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;91.7;91.7;;;81;96.6;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.7;9.7;;;7;13.3;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.4;13.4;;;10.5;16.9;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2017;2017;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;;Number;68;68;;;;;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2017;2017;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.8;11.8;;;9.8;14.1;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.8;38.8;;;32.1;46;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;73.7;73.7;;;65.6;80.4;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.6;11.6;;;9.3;14.3;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.8;47.8;;;41.9;53.7;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2017;2017;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;NMBR;RACE;AIAN;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;64.7;64.7;;;53.7;74.3;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;CRDRATE;RACE;API;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50.9;50.9;;;41.9;59.8;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2017;2017;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;3.1;3.1;;;2.2;4.4;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2017;2017;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.1;12.1;;;10.6;13.8;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2017;2017;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.6;13.6;;;12;15.4;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;NMBR;RACE;API;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.9;42.9;;;34.5;51.7;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.4;63.4;;;53.2;72.5;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST4_1;NMBR;RACE;BLK;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.0;87;;;75;93.7;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.2;45.2;;;40.5;50;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.9;70.9;;;62.8;77.9;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2017;2017;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.7;8.7;;;7.4;10.4;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2017;2017;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;76.6;76.6;;;65.5;84.9;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2017;2017;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.5;69.5;;;45.3;86.3;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.3;7.3;;;6.4;8.4;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;15.2;15.2;;;10.7;20.9;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2017;2017;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;NMBR;RACE;API;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;27.1;27.1;;;15.2;43.7;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.7;36.7;;;28.5;45.9;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.8;9.8;;;8.9;10.8;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2017;2017;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;29.3;29.3;;;15.7;48;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.3;44.3;;;36.3;52.6;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.3;8.3;;;7.1;9.7;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.5;90.5;;;82.4;95.1;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.9;43.9;;;38.2;49.7;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.9;84.9;;;76.6;90.6;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;WA;Washington;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;NMBR;RACE;HIS;;;;
2017;2017;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.6;49.6;;;43.8;55.5;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2017;2017;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;57.9;57.9;;;46.2;68.8;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;ME;Maine;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;NMBR;RACE;BLK;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2017;2017;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;NMBR;GENDER;GENM;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;19.0;19;;;10.7;31.6;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2017;2017;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.3;41.3;;;27.6;56.4;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.7;64.7;;;54.7;73.5;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.6;70.6;;;55.4;82.3;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.4;11.4;;;9.9;13.2;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;8.8;8.8;;;7.5;10.3;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.4;7.4;;;6.2;8.8;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2017;2017;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.1;12.1;;;8.2;17.3;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.4;89.4;;;84.4;92.9;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.5;87.5;;;80.8;92.1;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.6;5.6;;;3.7;8.5;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2017;2017;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.2;12.2;;;8.8;16.4;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.2;40.2;;;31.2;49.8;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2017;2017;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;59.5;59.5;;;50;68.4;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.5;11.5;;;7.7;16.4;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;77.6;77.6;;;63.1;87.5;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2017;2017;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2017;2017;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2017;2017;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.2;46.2;;;40.8;51.7;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.6;6.6;;;5.8;7.5;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;7.6;7.6;;;5;11.3;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.1;6.1;;;3.9;9.3;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.3;12.3;;;11;13.7;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;;Number;34;34;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;NMBR;RACE;BLK;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.4;7.4;;;5.7;9.5;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.6;83.6;;;63.5;93.7;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2017;2017;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2017;2017;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.8;14.8;;;11.7;18.6;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.1;43.1;;;37.7;48.6;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.2;42.2;;;31.3;54;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.6;9.6;;;8.3;11.2;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.4;86.4;;;79.8;91.2;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.0;9;;;6.2;12.6;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.7;72.7;;;62.5;81;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.6;41.6;;;31;53.1;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.4;44.4;;;38.4;50.5;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.3;10.3;;;8.1;12.9;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;CA;California;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.1;40.1;;;28;53.5;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.2;63.2;;;53.8;71.7;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.3;42.3;;;36.5;48.4;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.8;7.8;;;7.1;8.7;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.3;42.3;;;34.2;50.9;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.8;12.8;;;10.5;15.5;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.8;44.8;;;35.9;54.1;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;FL;Florida;NVSS;Asthma;Asthma mortality rate;;;Number;179;179;;;;;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;73.8;73.8;;;61.6;83.2;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.5;48.5;;;38.6;58.5;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.5;9.5;;;8;11.3;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.7;8.7;;;7.2;10.5;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;52.2;52.2;;;41.2;63.1;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;NMBR;RACE;HIS;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.2;13.2;;;11.9;14.7;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29.8;29.8;;;19.7;42.5;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;52.2;52.2;;;43.8;60.4;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;56.0;56;;;45.3;66.2;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;59.3;59.3;;;48.2;69.6;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;59.0;59;;;46.3;70.6;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.2;28.2;;;19.5;38.9;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.0;87;;;80.4;91.6;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;93.1;93.1;;;86.8;96.5;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50.9;50.9;;;41.7;60.1;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;74.6;74.6;;;67.1;80.9;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;ME;Maine;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.0;10;;;8.9;11.2;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.5;34.5;;;23.9;46.9;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;18.1;18.1;;;11.7;26.8;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.8;33.8;;;23.3;46.2;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;15.3;15.3;;;9.1;24.5;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;19.1;19.1;;;13.4;26.4;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.7;37.7;;;31.1;44.7;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.1;42.1;;;33.6;51;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.0;8;;;6.9;9.4;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.0;49;;;39.5;58.5;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.8;86.8;;;72.4;94.3;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.6;89.6;;;80.5;94.7;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2017;2017;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;19.4;19.4;;;14.4;25.6;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;15.9;15.9;;;12.3;20.3;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.1;88.1;;;80.9;92.8;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.3;65.3;;;55;74.3;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.4;70.4;;;64.3;75.8;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.0;13;;;10;16.7;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2017;2017;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;24.8;24.8;;;16.4;35.8;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.0;46;;;40.1;52;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90.6;90.6;;;85.8;93.9;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.2;37.2;;;30;45;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2017;2017;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.7;7.7;;;4.7;12.2;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.7;34.7;;;27;43.3;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;NMBR;RACE;AIAN;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.6;38.6;;;31.1;46.8;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.9;32.9;;;20.9;47.7;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.4;12.4;;;11.2;13.8;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;79.5;79.5;;;67.4;87.9;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;74.1;74.1;;;65;81.5;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.0;84;;;72.7;91.2;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.3;35.3;;;25.6;46.4;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2017;2017;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.2;5.2;;;3.5;7.7;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.4;89.4;;;79.2;94.9;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.6;46.6;;;38.5;54.8;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2017;2017;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.1;9.1;;;8.4;9.8;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.1;86.1;;;76.2;92.3;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.2;9.2;;;8.5;10;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;17.5;17.5;;;11.7;25.3;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.2;12.2;;;11;13.5;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.7;35.7;;;25.9;46.8;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2017;2017;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2017;2017;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.907192, -77.036871);;11;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2017;2017;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;NMBR;RACE;BLK;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;46.4;46.4;;;36.6;56.5;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.3;8.3;;;6.3;10.8;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2017;2017;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;79.7;79.7;;;65.3;89.1;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.3;46.3;;;40.2;52.6;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;4.4;4.4;;;3.5;5.5;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;59.3;59.3;;;48.4;69.3;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.8;39.8;;;25.8;55.7;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2017;2017;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;;Number;39;39;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;NMBR;RACE;BLK;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.1;44.1;;;39.9;48.4;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.6;64.6;;;53.8;74.2;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.0;38;;;25.3;52.5;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.3;10.3;;;9.5;11.2;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.7;33.7;;;25.3;43.2;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2017;2017;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2017;2017;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;15.2;15.2;;;10.8;21.1;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;80.1;80.1;;;71.5;86.5;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.5;12.5;;;9.1;16.6;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.6;13.6;;;10;18.2;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.9;14.9;;;13.3;16.7;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2017;2017;NY;New York;NVSS;Asthma;Asthma mortality rate;;;Number;91;91;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;NMBR;RACE;WHT;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;80.1;80.1;;;70.8;87;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.9;6.9;;;6;8;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2017;2017;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.2;8.2;;;6;10.9;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.5;85.5;;;72.6;93;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2017;2017;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.8;40.8;;;29.8;52.8;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.8;10.8;;;9.9;11.8;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.4;11.4;;;8.9;14.2;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.5;45.5;;;36.2;55.1;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;NMBR;GENDER;GENM;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.1;41.1;;;31.5;51.4;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2017;2017;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.6;10.6;;;6.5;16.8;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2017;2017;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.8;8.8;;;7.9;9.8;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;15.5;15.5;;;13;18.3;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;64.9;64.9;;;53.7;74.7;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.4;70.4;;;62.7;77.1;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;61.3;61.3;;;47;73.9;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.6;89.6;;;68.4;97.2;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2017;2017;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;19.5;19.5;;;11.4;31.5;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;;Number;49;49;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;NMBR;RACE;WHT;;;;
2017;2017;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.6;11.6;;;9.6;13.5;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.9;12.9;;;7.8;20.7;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;NMBR;RACE;HIS;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;75.9;75.9;;;67.3;82.8;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.6;86.6;;;75.6;93;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;TX;Texas;NVSS;Asthma;Asthma mortality rate;;;Number;88;88;;;;;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;NMBR;GENDER;GENM;;;;
2017;2017;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;;Number;41;41;;;;;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;NMBR;GENDER;GENM;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.3;42.3;;;36.9;47.9;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.8;63.8;;;53.1;73.3;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;17.0;17;;;14.8;19.5;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;69;69;;;;;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;54.6;54.6;;;47.4;61.6;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2017;2017;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;CRDRATE;RACE;API;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.0;12;;;9.5;15.1;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.9;35.9;;;27.3;45.5;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;75.9;75.9;;;63.7;85;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.5;39.5;;;33.3;46.1;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;75.5;75.5;;;67.5;82;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2017;2017;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2017;2017;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.8;44.8;;;33.9;56.2;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.9;89.9;;;81.9;94.6;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;76.9;76.9;;;57.2;89.2;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.8;47.8;;;40.1;55.6;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.7;90.7;;;86;94;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.3;62.3;;;47.5;75.2;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.2;10.2;;;5.7;17.4;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.3;43.3;;;37.1;49.7;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.7;83.7;;;64.6;93.6;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;28.0;28;;;18.5;39.9;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.4;11.4;;;9.4;13.8;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;CRDRATE;RACE;API;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2017;2017;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.4;39.4;;;33.5;45.6;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.2;9.2;;;8.5;9.9;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;;Number;149;149;;;;;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2017;2017;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;NMBR;RACE;API;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.3;83.3;;;66;92.8;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.5;48.5;;;43.1;54;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.3;41.3;;;27.8;56.2;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.2;87.2;**;US estimate/number is based on fewer than 50 states and the District of Columbia;84;89.5;Gender;Male;;;;;;;59;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.5;41.5;;;34.6;48.7;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.8;41.8;;;30.9;53.7;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.3;47.3;;;42.9;51.7;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;18.7;18.7;;;16.1;21.5;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;73.5;73.5;;;63.9;81.3;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.4;87.4;**;US estimate/number is based on fewer than 50 states and the District of Columbia;84.3;89.1;Gender;Male;;;;;;;59;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29.7;29.7;;;21.5;39.4;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;72.6;72.6;;;60.1;82.3;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;46.3;46.3;;;36.6;56.4;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.0;11;;;7.7;15.6;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.2;88.2;;;82.5;92.1;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;59.4;59.4;;;49.7;68.4;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;NMBR;RACE;API;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.5;14.5;;;12.3;16.9;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.8;42.8;;;35.7;50.2;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.9;13.9;;;7.6;24;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;94.6;94.6;;;90.1;97.1;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.5;13.5;;;8.5;21;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.8;9.8;;;7.7;12.4;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.8;36.8;;;29.6;44.7;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.4;88.4;;;83.9;91.7;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;77.5;77.5;;;66;86;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2017;2017;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;61.5;61.5;;;51;71;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;75.8;75.8;;;66.4;83.3;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;51.5;51.5;;;45.6;57.4;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.4;71.4;;;64.8;77.1;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.1;7.1;;;5.9;8.4;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.1;37.1;;;25.5;50.4;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;91.5;91.5;;;83.2;95.8;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;72.7;72.7;;;65.6;78.8;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2017;2017;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;NMBR;RACE;API;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.0;43;;;38.6;47.5;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.6;36.6;;;29.5;44.4;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.8;47.8;;;36.3;59.5;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;CRDRATE;RACE;API;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.0;32;;;20.4;46.3;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.7;47.7;;;36;59.6;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.8;86.8;;;76.5;93;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.1;12.1;;;10.9;13.5;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.0;12;;;9;15.8;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2017;2017;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.2;38.2;;;31.2;45.8;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.5;44.5;;;37.1;52.1;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.5;10.5;;;9.4;11.6;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2017;2017;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.3;41.3;;;33.2;50;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2017;2017;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.0;14;;;11.1;17.3;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;4.6;4.6;;;3;7.1;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67.4;67.4;;;57.6;75.9;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.8;42.8;;;34.9;51;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.1;35.1;;;26;45.5;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2017;2017;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;NMBR;RACE;AIAN;;;;
2017;2017;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.4;11.4;;;8.1;15.7;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2017;2017;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;6.0;6;;;4.5;7.8;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.2;47.2;;;40;54.5;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;NMBR;RACE;HIS;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.3;89.3;;;84.5;92.8;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.2;37.2;;;28.9;46.4;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2017;2017;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;38;38;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;NMBR;RACE;WHT;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;91.3;91.3;;;84.1;95.4;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;81.4;81.4;;;65.7;90.9;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2017;2017;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2017;2017;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;6.1;6.1;;;4.2;8.6;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.0;38;;;32.4;44;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.6;46.6;;;39.1;54.3;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;16.6;16.6;;;10.6;25.1;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50.8;50.8;;;43.1;58.4;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2017;2017;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;NMBR;RACE;HIS;;;;
2017;2017;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;14.5;14.5;;;10.1;20.1;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.7;68.7;;;56.9;78.6;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.3;12.3;;;10.2;14.8;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2017;2017;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.7;42.7;*;50 States + DC: US Median;41.2;44.8;Overall;Overall;;;;;;;59;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.1;12.1;;;10.5;13.9;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;52.6;52.6;;;45.4;59.8;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.6;11.6;;;9.6;14;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.4;8.4;;;7.2;9.8;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.1;7.1;;;6.1;8.2;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.2;7.2;;;5.8;9;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.8;71.8;;;64.5;78;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.9;12.9;;;8.2;19.8;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;73.6;73.6;;;65.3;80.6;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.2;66.2;;;56.5;74.7;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.4;84.4;;;71.1;92.3;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.3;38.3;;;30.1;47.3;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.2;6.2;;;5.1;7.4;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.3;62.3;;;48;74.7;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.9;11.9;;;8;17.2;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2017;2017;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.4;69.4;**;US estimate/number is based on fewer than 50 states and the District of Columbia;65.6;72.4;Gender;Male;;;;;;;59;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.6;38.6;;;29.7;48.2;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;17.0;17;;;11.9;23.6;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.1;37.1;;;23.4;53.2;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.0;9;;;6.3;12.6;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50.9;50.9;;;40.6;61.1;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;24;24;;;;;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;NMBR;GENDER;GENM;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.9;11.9;;;7.5;18.6;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.9;47.9;;;35.5;60.6;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.3;83.3;;;62.6;93.7;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.2;12.2;;;8.8;16.8;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2017;2017;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;CRDRATE;RACE;API;;;;
2017;2017;UT;Utah;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;NMBR;RACE;BLK;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.7;69.7;;;51.7;83.2;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.6;7.6;;;5.9;9.7;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2017;2017;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2017;2017;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.2;7.2;;;4.9;10.1;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;49.2;49.2;;;39.7;58.7;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.6;66.6;;;50.7;79.5;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2017;2017;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;NMBR;RACE;AIAN;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.2;46.2;;;39.2;53.4;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;21.0;21;;;15.7;27.6;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;NMBR;RACE;BLK;;;;
2017;2017;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;CRDRATE;RACE;API;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;80.3;80.3;;;68.3;88.5;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.3;13.3;;;7.3;23;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.2;62.2;;;46;76;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.7;46.7;;;33.8;59.9;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2017;2017;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.0;10;;;6.1;15.5;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2017;2017;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;NMBR;RACE;BLK;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.1;66.1;;;56;74.9;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.7;6.7;;;5.5;8.2;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;;Number;32;32;;;;;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;NMBR;GENDER;GENM;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;93.9;93.9;;;89.2;96.6;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.0;34;;;20.9;50.2;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.8;32.8;;;21.4;46.6;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.7;41.7;;;34.7;49.1;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.3;8.3;;;5.3;12.4;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;75.5;75.5;;;59;86.8;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;17.9;17.9;;;11.1;27.7;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.2;14.2;;;13;15.5;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2017;2017;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.5;9.5;;;7;12.7;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.1;83.1;;;71;90.8;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;;Number;89;89;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;NMBR;RACE;WHT;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.2;36.2;;;26.1;47.7;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.1;47.1;;;40.9;53.4;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.2;45.2;;;39.4;51.1;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2017;2017;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;52.8;52.8;;;44;61.5;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2017;2017;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.7;40.7;;;24.8;58.7;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;51.0;51;;;44.8;57.1;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.9;82.9;;;69.5;91.1;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.1;41.1;;;33.7;49;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.4;34.4;;;26.1;43.9;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.5;10.5;;;8.3;13.3;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.5;62.5;;;50.7;72.9;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2017;2017;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2017;2017;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.1;66.1;;;56.6;74.4;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.6;7.6;;;5.8;9.8;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;76.9;76.9;;;58.2;88.8;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.5;83.5;;;74;89.9;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2017;2017;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.3;41.3;;;33.7;49.4;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2017;2017;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;NMBR;RACE;WHT;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.0;33;;;21.4;47.1;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.5;44.5;;;37.8;51.5;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.3;13.3;;;11.8;15;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.3;9.3;;;8.5;10.3;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;49.2;49.2;;;40.4;58;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.3;62.3;;;47.2;75.3;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2017;2017;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.3;88.3;;;80.6;93.2;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;13.4;13.4;;;8.4;20.3;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.9;5.9;;;4.1;8.4;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.4;48.4;;;41.2;55.6;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2017;2017;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;CRDRATE;RACE;API;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;NMBR;RACE;BLK;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.3;91.3;;;85.8;94.8;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2017;2017;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.4;42.4;;;33.7;51.6;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;61.3;61.3;;;55.2;67.1;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.3;46.3;;;35.4;57.5;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.5;88.5;;;78.3;94.3;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.8;10.8;;;9.8;11.9;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.7;11.7;;;8.1;16.3;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.4;10.4;;;8.4;12.8;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.5;63.5;;;55.8;70.5;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.3;39.3;;;33.1;45.8;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.2;44.2;;;36.8;52;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.9;45.9;*;50 States + DC: US Median;43.9;48.6;Gender;Female;;;;;;;59;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2017;2017;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.7;68.7;;;59.9;76.4;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;95.3;95.3;;;91.8;97.3;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.9;39.9;;;28.9;51.9;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.5;49.5;;;41.9;57.1;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.2;36.2;;;31.6;41;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50.2;50.2;;;42.5;57.9;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;18.0;18;;;10.8;28.5;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;NMBR;RACE;AIAN;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.1;41.1;;;27.2;56.6;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;61.2;61.2;;;47.4;73.4;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.6;9.6;;;8.8;10.6;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.8;41.8;;;36.4;47.5;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;61.9;61.9;;;50.3;72.2;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.3;6.3;;;5.4;7.4;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.5;43.5;;;36;51.4;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;60.1;60.1;;;44.4;74;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;UT;Utah;NVSS;Asthma;Asthma mortality rate;;;Number;30;30;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;NMBR;RACE;WHT;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.7;41.7;;;36.1;47.6;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.3;10.3;;;8.5;12.1;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.1;10.1;;;9.1;11.2;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.1;46.1;;;33.6;59.1;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;60.5;60.5;;;55.1;65.6;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.4;36.4;;;29.9;43.5;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.6;10.6;;;9.6;11.7;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.5;10.5;;;9.1;12;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.9;30.9;;;22.6;40.6;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.5;44.5;;;39.1;50;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.6;35.6;;;26.2;46.3;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.2;5.2;;;2.9;9;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2017;2017;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.7;8.7;;;5.7;13.1;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.2;85.2;;;71.9;92.8;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.0;44;;;37.8;50.4;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.3;63.3;;;55.2;70.7;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.2;87.2;;;80.6;91.8;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.5;38.5;;;29;49.1;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;60.3;60.3;;;47.3;72;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;NMBR;RACE;AIAN;;;;
2017;2017;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.6;43.6;;;34.7;52.8;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.1;14.1;;;11.4;17.3;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.4;39.4;;;34.3;44.9;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;76.4;76.4;;;68.6;82.8;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.1;88.1;;;79.1;93.5;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.1;6.1;;;5.1;7.2;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.7;10.7;;;9.6;11.9;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.6;41.6;;;35.2;48.3;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;CRDRATE;RACE;API;;;;
2016;2016;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.9;46.9;;;42.3;51.6;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;55.2;55.2;;;39.7;69.7;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.7;8.7;;;7.1;10.8;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.8;11.8;;;10.1;13.6;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2017;2017;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.7;45.7;;;40.3;51.1;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2017;2017;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.7;10.7;;;8.4;13.5;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.1;36.1;;;29.3;43.5;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.8;40.8;;;33.3;48.7;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.3;10.3;;;6.4;16.4;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;58.5;58.5;;;48.2;68.1;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2016;2016;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;73.1;73.1;;;60.3;83;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.3;12.3;;;11;13.7;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.7;71.7;;;65.4;77.2;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.9;37.9;;;29.4;47.1;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.2;6.2;;;4.1;9.4;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2017;2017;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;16.0;16;;;11.5;21.6;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2017;2017;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.5;12.5;;;10.3;15;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;78.3;78.3;;;60.8;89.3;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.7;9.7;;;8.9;10.6;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.7;43.7;;;36;51.8;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;80.4;80.4;;;71.2;87.2;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.3;8.3;;;7.3;9.5;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.8;32.8;;;26.9;39.3;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;23.7;23.7;;;17.8;30.9;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.4;8.4;;;7.4;9.5;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.9;41.9;;;35.2;48.9;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.1;41.1;;;35.3;47.2;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.6;7.6;;;6.1;9.4;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;53.8;53.8;;;43.5;63.8;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.3;8.3;;;7.5;9.1;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;60.5;60.5;;;43.2;75.6;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.1;89.1;;;79.8;94.4;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.9;83.9;;;77.6;88.7;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;72.7;72.7;;;64.4;79.7;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.9;13.9;;;12.4;15.5;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;14.2;14.2;;;10.4;18.9;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.0;89;;;81.4;93.8;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.4;13.4;;;12.4;14.5;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.8;43.8;;;36.1;51.7;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.9;70.9;;;63.3;77.5;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.6;8.6;;;7.8;9.6;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.4;46.4;;;40.7;52.3;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;25.4;25.4;;;16;38;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67.2;67.2;*;50 States + DC: US Median;62.8;69.6;Gender;Female;;;;;;;59;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.9;62.9;;;55.8;69.4;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;55.4;55.4;;;42;68.1;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;53.1;53.1;;;42.5;63.4;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.0;5;;;2.8;8.7;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.1;84.1;;;72.9;91.2;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.3;8.3;;;7.3;9.4;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;51.3;51.3;;;42.1;60.4;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.7;10.7;;;9.9;11.5;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.0;36;;;28.8;43.8;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.6;69.6;;;58.9;78.5;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.0;46;;;32.7;59.9;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.2;10.2;;;6;16.8;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.4;44.4;;;38.2;50.7;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.3;40.3;;;35.4;45.3;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;55.5;55.5;;;41.4;68.7;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2017;2017;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.7;42.7;;;34;51.8;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.4;43.4;;;34.4;52.7;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;29.3;29.3;;;19.3;41.9;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.9;48.9;;;40.1;57.7;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.6;48.6;;;40.6;56.7;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;92.2;92.2;;;83.6;96.5;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;51.9;51.9;;;44.1;59.6;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2017;2017;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.5;8.5;;;6;11.6;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.9;37.9;;;24.7;53.2;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.0;48;;;40.6;55.4;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.4;36.4;;;29;44.5;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;51.6;51.6;;;38.3;64.6;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.8;7.8;;;6.2;9.7;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.5;10.5;;;9.7;11.4;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;;Number;27;27;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;NMBR;RACE;WHT;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.9;91.9;;;86;95.4;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2017;2017;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.7;9.7;;;5.8;15.4;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.6;36.6;;;28.8;45.3;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.6;46.6;;;39.9;53.4;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.3;38.3;;;30.8;46.3;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.8;12.8;;;9.4;17.1;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;46.5;46.5;;;36.6;56.6;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.4;85.4;;;80.3;89.3;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.2;9.2;;;8.7;9.8;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.0;9;;;6;13.2;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2017;2017;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2017;2017;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2016;2016;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.0;45;;;40.2;49.8;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.4;6.4;;;5.3;7.8;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;80.9;80.9;;;66.7;90;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;60.6;60.6;;;47.2;72.6;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;93.5;93.5;;;89;96.3;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.8;85.8;;;76.6;91.8;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.7;34.7;;;24.6;46.4;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.0;45;;;36.2;54.1;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.5;31.5;;;18.8;47.8;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.5;9.5;;;8.2;11.1;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.3;63.3;;;38.2;82.8;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;61.5;61.5;;;49.7;72;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.1;9.1;;;7.9;10.5;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.6;41.6;;;33.6;50.1;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;72.2;72.2;;;63.7;79.3;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.8;39.8;;;32.1;48;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;64.0;64;;;54.3;72.6;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.6;39.6;;;34.7;44.7;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.5;5.5;;;4.4;6.9;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.3;8.3;;;7.2;9.6;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2017;2017;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.9;10.9;;;7.5;15.4;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2017;2017;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;NMBR;RACE;AIAN;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.8;39.8;;;33.3;46.6;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.4;28.4;;;18.8;40.5;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.4;8.4;;;6.5;10.6;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.7;12.7;;;10.2;15.6;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.2;85.2;;;77.8;90.5;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.2;83.2;;;71.3;90.7;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;53.8;53.8;;;42.4;64.8;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.2;38.2;;;32.5;44.4;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.6;70.6;;;64.4;76.1;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2017;2017;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;NMBR;GENDER;GENF;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.3;37.3;;;27.1;48.7;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.9;11.9;;;10.6;13.3;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.1;71.1;;;65.2;76.5;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.2;42.2;;;32.3;52.7;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.4;12.4;;;9;16.7;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.7;42.7;;;37.6;47.9;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.1;9.1;;;8.1;10.2;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.2;41.2;;;31.7;51.5;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.8;36.8;;;26.1;49;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2017;2017;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.7;44.7;;;36.8;52.9;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;72.5;72.5;;;61.7;81.2;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2016;2016;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.0;87;**;US estimate/number is based on fewer than 50 states and the District of Columbia;86.1;89.2;Gender;Female;;;;;;;59;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;92.6;92.6;;;73.8;98.3;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;77.7;77.7;;;70.3;83.6;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;18.6;18.6;;;11.2;29.1;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.1;44.1;;;37.2;51.3;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.9;44.9;;;35.9;54.2;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.4;9.4;;;8.1;10.8;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.2;48.2;;;41;55.3;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;18.8;18.8;;;12.3;27.6;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.6;8.6;;;5.5;13.3;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2016;2016;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.9;9.9;;;9;11;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;64.1;64.1;;;57.3;70.3;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.5;13.5;;;9.7;18.5;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.4;8.4;;;6.9;10.2;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.4;36.4;;;26.4;47.6;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.3;71.3;;;59.9;80.4;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;76.9;76.9;;;64.1;86.1;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.3;12.3;;;6.8;21.4;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;79.4;79.4;;;67.8;87.6;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;NMBR;GENDER;GENF;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50.0;50;;;43.2;56.8;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;74.2;74.2;;;59.4;84.9;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.7;46.7;;;38.1;55.5;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;94.5;94.5;;;87.5;97.6;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.0;11;;;9.7;12.5;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.7;14.7;;;12.9;16.7;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.3;31.3;;;20.1;45.3;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;7.5;7.5;;;4.7;12;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;91.2;91.2;;;86.4;94.4;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.4;13.4;;;8.4;20.5;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;27.7;27.7;;;23.3;32.6;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90.0;90;;;80.5;95.1;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.9;11.9;;;10.2;13.9;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;93.8;93.8;;;89;96.6;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.0;43;;;35.9;50.5;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.8;47.8;;;38.4;57.3;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.2;38.2;;;31;45.9;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.1;6.1;;;5;7.4;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.5;8.5;;;7.4;9.7;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67.2;67.2;;;59.3;74.2;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;NMBR;RACE;WHT;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.5;8.5;;;7.3;9.9;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;CA;California;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;8.7;8.7;;;7;10.8;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.9;43.9;;;37;51;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.3;42.3;;;35.6;49.4;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.1;9.1;;;5.6;14.4;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;74.0;74;;;66.6;80.2;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.5;91.5;;;86.1;95;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.8;6.8;;;4.2;10.8;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.7;9.7;;;8.8;10.7;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.5;11.5;;;10.8;12.3;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.3;14.3;;;12;17;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;23.9;23.9;;;14.1;37.7;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.5;83.5;;;72.2;90.8;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2017;2017;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50.1;50.1;;;43.3;56.9;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.2;43.2;;;36.4;50.3;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.0;46;;;40.6;51.6;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;78.6;78.6;;;69.9;85.3;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2017;2017;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.6;36.6;;;25.9;48.8;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.6;40.6;;;30.7;51.3;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.1;87.1;;;76.1;93.5;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.0;32;;;21.3;45;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.5;48.5;;;34.4;62.9;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2016;2016;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.1;5.1;;;3.8;6.8;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.7;89.7;;;83.6;93.7;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2017;2017;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;13.4;13.4;;;10.6;16.6;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;29.4;29.4;;;17.8;44.4;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.0;39;;;32.9;45.5;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.9;10.9;;;9.1;13;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2017;2017;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2017;2017;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50.1;50.1;;;44.3;55.9;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2016;2016;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.5;40.5;;;36;45.2;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.1;42.1;;;30;55.2;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2017;2017;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;NMBR;RACE;HIS;;;;
2017;2017;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.2;11.2;;;7.8;15.6;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.8;34.8;;;24;47.4;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2016;2016;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90.6;90.6;;;84.3;94.6;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;17.0;17;;;10.6;26;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.8;62.8;;;50;74;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;79.4;79.4;;;67.7;87.6;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.7;45.7;;;25.7;67.3;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2017;2017;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;NMBR;RACE;AIAN;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;92.7;92.7;;;87.8;95.7;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.3;84.3;;;77.7;89.1;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;51.1;51.1;;;47.1;55.1;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.9;6.9;;;5.9;8;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.9;5.9;;;4.8;7.2;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.6;41.6;;;36.5;46.8;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.9;85.9;;;77.6;91.5;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;95.4;95.4;;;78.4;99.2;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.5;71.5;;;64.2;77.9;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;CA;California;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2017;2017;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.0;14;;;10.2;19;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.6;40.6;;;33.2;48.4;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.5;85.5;;;77.6;90.9;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;16.0;16;;;9.2;26.3;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.7;45.7;;;29.9;62.4;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.9;5.9;;;5.2;6.7;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.7;10.7;;;6.7;16.7;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.2;9.2;;;7.3;11.7;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.2;44.2;;;29.3;60.3;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.4;32.4;;;24.5;41.5;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.5;44.5;;;37.5;51.7;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2016;2016;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;NY;New York;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.4;10.4;;;6.1;17;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.3;9.3;;;8.3;10.3;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.4;33.4;;;25.5;42.2;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.9;68.9;;;60.4;76.4;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.6;48.6;;;38.1;59.2;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.7;62.7;;;51.6;72.6;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;CA;California;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;7.0;7;;;5.4;9.1;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.5;43.5;;;34;53.6;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;75.1;75.1;;;65.6;82.8;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.9;6.9;;;5.3;9;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.5;86.5;;;73.1;93.8;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.5;49.5;;;34.4;64.8;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2017;2017;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.3;13.3;;;10.7;16.6;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.0;45;;;35.1;55.3;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2017;2017;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.6;43.6;**;US estimate/number is based on fewer than 50 states and the District of Columbia;40.6;45.8;Gender;Male;;;;;;;59;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.6;45.6;;;33;58.9;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;72.3;72.3;;;61.3;81.1;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.6;10.6;;;9.7;11.6;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.8;11.8;;;7.4;18.3;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.8;40.8;;;34.9;46.9;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;53.5;53.5;;;45.7;61.1;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.5;36.5;;;26.8;47.4;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;27.1;27.1;;;18.5;37.8;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2017;2017;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.6;68.6;;;58.8;77.1;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.0;8;;;4.5;13.8;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2016;2016;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.9;38.9;;;33.9;44.1;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;;Number;21;21;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;NMBR;RACE;BLK;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.4;45.4;;;35.5;55.6;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.3;10.3;;;9.2;11.5;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.8;8.8;;;7.4;10.4;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;NMBR;RACE;HIS;;;;
2017;2017;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;NMBR;RACE;AIAN;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;79.7;79.7;;;67.1;88.4;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.7;35.7;;;29.6;42.2;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2017;2017;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.7;66.7;;;55.6;76.2;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.0;84;;;71.1;91.8;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.1;10.1;;;9.1;11.3;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.7;49.7;;;40.3;59.1;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.0;33;;;26.5;40.2;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.6;44.6;;;39.3;50.2;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.3;9.3;;;6.3;13.5;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.4;32.4;;;19.7;48.3;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.4;13.4;;;10;17.7;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.0;48;;;40.8;55.2;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;17.0;17;;;14.8;19.5;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;5.4;5.4;;;3.3;8.9;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.3;82.3;;;72.4;89.2;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2017;2017;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.5;9.5;;;6.4;13.5;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.4;10.4;;;5.8;17.9;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2017;2017;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.0;11;;;8.7;13.7;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;78.2;78.2;;;61;89.1;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.9;12.9;;;11.1;14.9;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2017;2017;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;;Number;43;43;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;NMBR;RACE;BLK;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;80.9;80.9;;;73.3;86.8;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.7;38.7;;;25.8;53.5;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.7;47.7;;;43;52.5;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.1;46.1;;;32.3;60.4;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;92.0;92;;;82.9;96.5;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.3;37.3;;;29.6;45.7;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.4;12.4;;;10.2;15.1;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.0;47;;;42.2;51.8;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2017;2017;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;NMBR;RACE;HIS;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.4;38.4;;;26.1;52.3;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2017;2017;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;NMBR;GENDER;GENM;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.8;87.8;;;81;92.4;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.3;48.3;;;38.3;58.4;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.4;10.4;;;9.3;11.6;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.1;86.1;;;75.3;92.6;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.5;68.5;;;51.1;81.9;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.8;90.8;;;82.6;95.4;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.4;13.4;;;11.6;15.4;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;59.0;59;;;46.2;70.7;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.0;8;;;6.8;9.3;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2017;2017;ME;Maine;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;NMBR;RACE;AIAN;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2017;2017;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.5;7.5;;;6;9.3;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.2;8.2;;;7.4;9.1;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.7;68.7;;;55;79.7;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.1;32.1;;;22.9;43;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2017;2017;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.6;14.6;;;11.2;18.8;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.9;38.9;;;33;45.2;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.6;34.6;;;27.9;42;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2016;2016;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.4;5.4;;;4.7;6.1;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.5;87.5;;;80.7;92.1;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.6;87.6;;;77.7;93.5;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.7;48.7;;;42.8;54.6;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.8;82.8;;;73.5;89.4;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.0;44;;;38.6;49.6;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;74.8;74.8;;;67.8;80.7;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2017;2017;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;NMBR;RACE;HIS;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.5;44.5;;;32.9;56.7;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2016;2016;NY;New York;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;8.4;8.4;;;6.1;11.4;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;55.6;55.6;;;43.5;67.1;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;94.2;94.2;;;90.1;96.6;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.1;39.1;;;35;43.2;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.7;7.7;;;6.6;9;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.7;13.7;;;8.5;20.9;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.5;44.5;;;38.5;50.7;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.6;6.6;;;4.1;10.4;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2016;2016;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90.9;90.9;;;81.4;95.8;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.1;7.1;;;6.3;8;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.8;11.8;;;8.4;16.4;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.6;7.6;;;4.8;12;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;61.3;61.3;;;52.6;69.3;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.2;69.2;;;59.7;77.3;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2017;2017;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;68;68;;;;;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;NMBR;GENDER;GENF;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.9;13.9;;;12.5;15.5;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.0;40;;;35.6;44.6;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.1;44.1;;;37.9;50.4;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;80.3;80.3;;;69.5;87.9;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.9;45.9;;;36.4;55.6;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2017;2017;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;NMBR;RACE;AIAN;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.8;46.8;;;36.6;57.3;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.7;42.7;;;33.5;52.3;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2017;2017;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.3;9.3;;;6.8;12.5;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.8;45.8;;;40.9;50.8;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.1;8.1;;;5.4;11.8;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2016;2016;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.4;37.4;;;32;43.1;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;58.3;58.3;;;41.6;73.2;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;76.3;76.3;;;66.7;83.9;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.1;66.1;;;56.1;74.8;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.9;36.9;;;27.1;47.9;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.2;10.2;;;8.9;11.6;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;41.2;41.2;;;31.8;51.4;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.7;39.7;;;27.1;53.8;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.6;86.6;;;72.8;93.9;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.9;86.9;;;80.5;91.4;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.4;41.4;;;32.5;51;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.1;6.1;;;5.1;7.4;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.3;11.3;;;8.8;14.2;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2017;2017;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.8;38.8;;;33;44.9;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.2;41.2;;;30.6;52.7;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.1;44.1;;;34.8;53.8;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.2;7.2;;;6;8.7;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.8;72.8;;;58.9;83.4;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.3;69.3;;;62.4;75.5;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;NMBR;RACE;AIAN;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.8;47.8;;;37.5;58.4;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.2;48.2;;;41.1;55.4;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;49.7;49.7;;;36.6;62.9;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.4;44.4;;;39.6;49.3;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.6;48.6;;;33.7;63.8;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;27.5;27.5;;;14.5;46;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.3;40.3;;;34.9;46;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;56.0;56;;;49.4;62.5;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.7;68.7;;;50.5;82.5;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.9;7.9;;;6.8;9.3;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;74.5;74.5;;;60.9;84.6;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;30.3;30.3;;;23.9;37.5;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.3;42.3;;;29.4;56.3;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.9;39.9;;;31.3;49.1;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;NMBR;RACE;AIAN;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.1;14.1;;;11.3;17.5;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2017;2017;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.0;11;;;8.7;13.8;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.6;65.6;;;47.4;80.1;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2017;2017;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;15.7;15.7;;;12.1;20;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2017;2017;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.5;8.5;;;7.2;9.8;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.5;90.5;;;83.1;94.8;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;53.4;53.4;;;45.1;61.5;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.5;5.5;;;4;7.5;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.6;85.6;;;74.6;92.3;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;57.8;57.8;;;44.6;70;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.5;45.5;;;38.3;53;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.4;42.4;;;37.4;47.5;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;61.5;61.5;;;55.1;67.5;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.0;47;;;33.9;60.6;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2017;2017;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.9;10.9;;;6.8;16.5;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.1;13.1;;;10.8;15.7;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;77.1;77.1;;;68.3;84;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;73.7;73.7;;;65.3;80.7;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.6;70.6;;;59.3;79.8;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.7;11.7;;;10.6;12.9;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.8;88.8;;;81.1;93.6;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.2;83.2;;;74.3;89.5;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.3;86.3;;;79.9;90.8;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.3;12.3;;;10.6;14.2;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.5;8.5;;;7.2;10;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.2;38.2;;;28.4;49.1;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;;Number;33;33;;;;;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;NMBR;GENDER;GENM;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;93.6;93.6;;;85.5;97.3;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.6;40.6;;;33.7;47.9;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.3;8.3;;;7;9.8;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.3;67.3;;;58.9;74.7;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2017;2017;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.9;84.9;;;67.9;93.7;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;17.5;17.5;;;11.3;25.8;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.8;70.8;;;58.1;81;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.5;66.5;;;50.4;79.5;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.7;88.7;;;80.3;93.8;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.3;44.3;;;36.8;52;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.8;41.8;;;35.9;47.8;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;23.1;23.1;;;15.8;32.5;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2017;2017;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.3;12.3;;;10.9;13.9;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.0;12;;;10.8;13.4;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;CRDRATE;RACE;API;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.6;10.6;;;9.9;11.4;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.6;44.6;;;40.3;49;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;NMBR;GENDER;GENM;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.8;35.8;;;30.6;41.5;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;CRDRATE;RACE;API;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.0;88;;;82.3;92.1;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.0;47;;;38.4;55.9;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2016;2016;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;81.3;81.3;;;74.2;86.8;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.3;47.3;;;41.6;53.1;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2017;2017;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.1;6.1;;;4.4;8.4;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.7;8.7;;;7;10.8;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;74.6;74.6;;;66.1;81.7;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.5;89.5;;;81.2;94.4;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;74.6;74.6;;;59.4;85.5;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.9;9.9;;;7.7;12.7;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.8;41.8;;;33.5;50.6;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2017;2017;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;14.3;14.3;;;10.4;19.1;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.7;6.7;;;4.9;9.1;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;92.3;92.3;;;85.2;96.1;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;75.1;75.1;;;59.3;86.2;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.5;6.5;;;4.3;9.6;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.6;88.6;;;76.3;94.9;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;5.8;5.8;;;3.6;9.1;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.2;38.2;;;31.4;45.4;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;79.6;79.6;;;66.2;88.6;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;76.1;76.1;;;69;81.9;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2017;2017;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.6;10.6;;;7.2;15.1;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;79.8;79.8;;;67.2;88.4;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.3;48.3;;;41.4;55.2;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.9;46.9;;;43.2;50.7;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.0;31;;;22.6;40.7;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;25.5;25.5;;;17.2;36;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.7;10.7;;;9.7;11.7;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.6;12.6;;;10.9;14.5;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;73.6;73.6;;;64.4;81.2;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2017;2017;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.5;8.5;;;7.6;9.6;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.1;48.1;;;38.4;57.9;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.3;71.3;;;60.9;79.9;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2017;2017;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.1;10.1;;;7.8;12.9;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.9;12.9;;;10.3;16.1;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.6;7.6;;;6.7;8.6;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.5;8.5;;;6.1;11.5;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2016;2016;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;72.4;72.4;;;60.1;82;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.6;89.6;;;81.7;94.3;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.4;42.4;;;37;47.9;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;15.9;15.9;;;14;18;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.1;44.1;;;33.3;55.5;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.8;72.8;;;64.2;80;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.6;46.6;;;41.1;52.3;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.3;43.3;;;31.7;55.7;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.0;37;;;26.4;49.1;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;94.3;94.3;;;88.8;97.2;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;CA;California;NVSS;Asthma;Asthma mortality rate;;;Number;70;70;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;NMBR;RACE;API;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.1;42.1;;;35.4;49.1;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;US;United States;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.3;9.3;*;50 States + DC: US Median;8.6;9.7;Overall;Overall;;;;;;;59;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;55.5;55.5;;;42.5;67.7;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;51.5;51.5;;;37.3;65.5;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.2;11.2;;;9.3;13.4;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.4;86.4;;;71.8;94.1;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.0;28;;;16.9;42.7;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;14.9;14.9;;;10.1;21.6;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.8;11.8;;;10.9;12.7;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;23.9;23.9;;;17.8;31.2;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;15.7;15.7;;;10.4;22.9;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.4;38.4;;;21;59.3;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2017;2017;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;75.1;75.1;;;57.2;87.2;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.9;86.9;;;77.9;92.6;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.5;43.5;;;36.6;50.8;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2016;2016;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.0;40;**;US estimate/number is based on fewer than 50 states and the District of Columbia;39.2;43.9;Gender;Male;;;;;;;59;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;3.5;3.5;;;2.1;5.6;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.2;47.2;;;40.4;54;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.5;46.5;;;38.9;54.3;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2016;2016;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.3;7.3;;;6.5;8.1;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.5;9.5;;;8.3;10.9;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.2;46.2;;;38.7;54;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2016;2016;NY;New York;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;21.9;21.9;;;12;36.7;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.8;70.8;;;64.3;76.6;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.7;12.7;;;10;16.1;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.2;9.2;;;8.5;10;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.3;11.3;;;8.5;14.9;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.9;43.9;;;35.5;52.7;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;61.9;61.9;;;56;67.5;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;;Number;47;47;;;;;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;NMBR;GENDER;GENM;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.5;90.5;;;84.9;94.2;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29.2;29.2;;;21.2;38.9;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.4;6.4;;;4.3;9.4;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.0;88;;;82.5;91.9;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;55.0;55;;;50.1;59.8;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.1;37.1;;;28.3;46.8;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.6;14.6;;;12.2;17.3;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.9;38.9;;;28.2;50.9;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.3;38.3;;;30.5;46.8;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2017;2017;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.1;90.1;;;83;94.5;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.1;43.1;;;27;60.7;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.7;14.7;;;12;17.9;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.8;13.8;;;7.7;23.4;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.5;46.5;;;37.4;55.8;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.0;7;;;5.9;8.5;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.1;11.1;;;7.8;15.5;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.6;40.6;;;34;47.5;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;45.2;45.2;;;34.5;56.4;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.2;9.2;;;6;13.8;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.2;10.2;;;9.4;11;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.3;87.3;;;82.4;90.9;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2017;2017;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.7;8.7;;;7.8;9.8;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.9;69.9;;;61.9;76.9;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.7;7.7;;;4.4;13;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.6;35.6;;;27.8;44.2;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;51.2;51.2;;;44;58.4;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.0;43;;;35.1;51.3;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.6;13.6;;;12.3;15.1;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.9;89.9;;;85.7;93;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.3;69.3;;;61.9;75.9;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.8;8.8;;;7.6;10.2;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;93.1;93.1;;;88.7;95.9;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.7;12.7;;;7.5;20.8;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;NMBR;RACE;HIS;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.3;11.3;;;7;17.6;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.2;87.2;;;81.2;91.5;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.0;9;;;7.4;11;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.6;45.6;;;33.3;58.4;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.4;11.4;;;10.2;12.9;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.8;32.8;;;26.9;39.4;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;8.2;8.2;;;5.2;12.6;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.3;85.3;;;78.8;90.1;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.3;6.3;;;5.4;7.4;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;93.5;93.5;;;87.8;96.6;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.8;41.8;;;35.3;48.6;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.4;83.4;;;73.6;90.1;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;75.5;75.5;;;61.8;85.4;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.6;12.6;;;11.5;13.7;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2017;2017;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.1;7.1;;;4.1;12.2;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.1;9.1;;;6.4;12.9;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.9;40.9;;;34.1;48.1;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.2;63.2;;;54.1;71.4;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;64.0;64;;;51.3;75.1;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.7;44.7;;;34;55.9;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.8;89.8;;;84.1;93.6;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.2;43.2;;;33.4;53.5;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.4;14.4;;;9.9;20.4;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.3;38.3;;;28;49.7;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;93.8;93.8;;;85.8;97.4;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.0;65;;;58;71.4;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.7;7.7;;;6.3;9.4;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;53.2;53.2;;;37.5;68.3;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.2;87.2;;;76.9;93.3;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.9;42.9;;;37.5;48.5;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;NMBR;GENDER;GENM;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.3;35.3;;;25.6;46.3;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.2;89.2;;;83.2;93.2;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.0;31;;;24.8;38;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.6;62.6;;;55.8;68.9;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;17.0;17;;;10.5;26.4;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.9;64.9;;;53.8;74.5;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.4;38.4;;;31.9;45.4;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90.5;90.5;;;84.7;94.3;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.7;48.7;;;34.2;63.4;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.9;9.9;;;8.8;11.1;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;49.6;49.6;;;42.4;56.8;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.1;9.1;;;8.1;10.2;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.9;6.9;;;4.9;9.6;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.2;38.2;**;US estimate/number is based on fewer than 50 states and the District of Columbia;36.6;40.6;Gender;Male;;;;;;;59;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;NMBR;GENDER;GENM;;;;
2016;2016;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.8;67.8;;;60.4;74.4;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2017;2017;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.6;66.6;;;58.7;73.6;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.4;13.4;;;9.6;18.5;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;26.3;26.3;;;15.7;40.7;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.5;34.5;;;25.4;45;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.4;68.4;;;62;74.1;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.0;33;;;25.8;41.1;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;15.2;15.2;;;10.1;22.2;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.4;12.4;;;9.5;16;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.5;87.5;;;81.3;91.9;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67.8;67.8;;;60;74.7;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.0;13;;;11.5;14.6;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;77.1;77.1;;;67.2;84.7;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.4;41.4;;;31.7;51.8;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.5;44.5;;;38.2;51;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.5;40.5;;;33.4;48;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;97.9;97.9;;;94.6;99.2;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.3;12.3;;;9.5;15.7;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.9;67.9;;;57.3;76.9;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.9;44.9;;;39.3;50.5;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.3;39.3;;;27.9;51.9;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;50.9;50.9;;;39.7;62;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.5;91.5;;;87.5;94.3;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;NMBR;GENDER;GENM;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.0;46;;;38.1;54.1;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;53.8;53.8;;;46.7;60.8;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.0;46;;;38.6;53.6;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.8;63.8;;;53;73.4;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.9;8.9;;;7.1;11.1;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2017;2017;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.7;14.7;;;10.7;19.7;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.9;87.9;;;77.8;93.8;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;17.6;17.6;;;12.8;23.7;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2017;2017;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;;Number;61;61;;;;;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;NMBR;GENDER;GENF;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.7;42.7;;;38.2;47.3;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2016;2016;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.4;10.4;;;6.7;15.8;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.2;89.2;;;84.5;92.6;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.4;46.4;;;36.2;57;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.9;41.9;;;37;47;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.7;43.7;;;34.8;53.1;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.9;41.9;;;32.7;51.6;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2017;2017;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;;Number;20;20;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;NMBR;RACE;WHT;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.8;38.8;;;32;46;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.2;47.2;;;40.1;54.4;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.9;41.9;;;37.5;46.5;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.3;42.3;;;32.1;53.2;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;92.9;92.9;;;87.3;96.1;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.7;68.7;;;58.7;77.2;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.7;8.7;;;8;9.4;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;NMBR;RACE;API;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.5;39.5;;;31;48.7;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2017;2017;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.9;46.9;;;34.7;59.5;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2016;2016;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.8;36.8;;;32.4;41.5;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;92.9;92.9;;;88.3;95.8;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;MT;Montana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;NMBR;RACE;API;;;;
2017;2017;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.0;6;;;4.4;8.2;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.4;14.4;;;13;15.9;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.3;71.3;;;59.8;80.6;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.6;89.6;;;83.6;93.6;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.8;85.8;;;76.9;91.7;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.5;62.5;;;48.1;75;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.6;10.6;;;7.4;14.9;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.0;69;;;59.6;77.1;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;50.4;50.4;;;43.5;57.3;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.8;8.8;;;8.2;9.5;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.4;40.4;;;32.9;48.4;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.8;48.8;;;39;58.7;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.1;9.1;;;8.4;9.8;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.1;41.1;;;35;47.4;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.7;72.7;;;65.9;78.6;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.6;11.6;;;9.9;13.5;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2017;2017;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.8;8.8;;;7.8;9.8;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.8;34.8;;;27.7;42.6;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;15.2;15.2;;;11;20.6;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50.8;50.8;;;38.6;63;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.0;43;;;33;53.6;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.9;10.9;;;8.2;14.4;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.6;44.6;;;39;50.5;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.0;69;;;61.8;75.4;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;57.8;57.8;;;50;65.3;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.4;68.4;;;56.5;78.3;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;72.9;72.9;;;65.3;79.3;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.0;13;;;10.4;16.1;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;54.3;54.3;;;46.9;61.5;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;75.7;75.7;;;62.4;85.4;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.5;10.5;;;7.7;14.1;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;51.3;51.3;;;47.3;55.3;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;72.4;72.4;;;56.7;84.1;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.5;7.5;;;6.8;8.4;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.4;35.4;;;22.8;50.3;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.1;12.1;;;7.5;19.2;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.1;83.1;;;74.4;89.2;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;19.7;19.7;;;12.7;29.1;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.0;69;;;61.6;75.5;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.3;8.3;;;7.4;9.4;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.8;9.8;;;8.6;11.1;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.2;37.2;;;30.6;44.3;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.3;10.3;;;8.8;12.1;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.4;12.4;;;10.1;15.1;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.8;9.8;;;8.8;10.9;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.5;14.5;;;12.1;17.2;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.7;45.7;;;36.5;55.1;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;98.4;98.4;;;94.6;99.5;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;NMBR;RACE;API;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.1;45.1;;;38;52.5;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.4;46.4;;;34.9;58.4;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.3;33.3;;;24.2;43.9;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.7;69.7;;;55.1;81.2;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.2;10.2;;;8.1;12.8;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.7;42.7;;;27.5;59.4;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.8;35.8;;;24.5;48.9;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;15.0;15;;;11.3;19.8;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.4;46.4;;;41.8;51.1;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.2;7.2;;;5.8;8.9;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;19.1;19.1;;;11.3;30.5;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.4;8.4;;;7;10.1;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.6;42.6;;;35.9;49.6;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.4;9.4;;;6;14.4;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.9;49.9;;;28.7;71.2;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.8;82.8;;;71.9;90.1;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.6;12.6;;;7.5;20.4;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2016;2016;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.3;43.3;;;39.5;47.3;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.8;7.8;;;4.7;12.6;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.5;9.5;;;6.6;13.4;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.2;7.2;;;6.2;8.3;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2017;2017;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;15.0;15;;;12.2;18.5;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;8.1;8.1;;;4.7;13.5;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2017;2017;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.5;65.5;;;57.4;72.8;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;75.2;75.2;;;67.1;81.9;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.1;34.1;;;23.8;46.1;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.8;9.8;;;9.2;10.5;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.5;34.5;;;23.5;47.5;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2017;2017;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.5;7.5;;;5.8;9.4;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.6;88.6;;;83.2;92.4;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;72.0;72;;;66;77.4;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.7;10.7;;;9.7;11.8;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.9;11.9;;;10.4;13.6;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.0;48;;;43;53.1;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.6;68.6;;;50.6;82.4;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;CRDRATE;RACE;API;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.0;8;;;6.8;9.3;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;52.1;52.1;;;42.8;61.2;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.9;39.9;;;27.2;54.1;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;59.6;59.6;;;53.8;65.1;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.0;44;;;36.1;52.1;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.7;88.7;;;82.7;92.9;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.3;35.3;;;27.3;44.2;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.3;38.3;;;25;53.6;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.6;13.6;;;12.2;15.1;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.4;33.4;;;20.4;49.5;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2017;2017;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.7;48.7;;;41.4;56.1;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;60.3;60.3;;;42.2;76;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;75.8;75.8;;;61;86.3;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.7;33.7;;;25.2;43.4;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.7;38.7;;;31.5;46.5;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.7;48.7;;;37.3;60.2;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2017;2017;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.3;10.3;;;7.8;13.4;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2017;2017;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.8;10.8;;;7.7;14.9;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.0;46;;;32;60.7;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.6;6.6;;;5.4;8;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.7;13.7;;;7.6;23.4;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.1;44.1;;;37.9;50.5;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;CRDRATE;RACE;API;;;;
2017;2017;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;;Number;83;83;;;;;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;NMBR;GENDER;GENF;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;75.1;75.1;;;65.3;82.8;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.5;34.5;;;30;39.3;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.7;68.7;;;59.3;76.7;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.0;13;;;11.1;15.2;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;94.2;94.2;;;86;97.7;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;57.2;57.2;;;42.6;70.7;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.6;71.6;;;64.2;77.9;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;61.3;61.3;;;51.3;70.5;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.8;12.8;;;10.1;16;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.2;86.2;;;71.2;94.1;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.4;31.4;;;21.5;43.3;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;54.9;54.9;;;43.8;65.6;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.7;5.7;;;3.9;8.1;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;74.8;74.8;;;66.3;81.8;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.7;7.7;;;7.2;8.2;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.8;44.8;;;37.9;51.9;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.1;44.1;;;33.2;55.6;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67.0;67;;;58.8;74.2;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;;Number;42;42;;;;;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;NMBR;GENDER;GENM;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.6;82.6;;;67.3;91.6;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.3;14.3;;;11.8;17.3;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;55.5;55.5;;;45.1;65.4;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.9;10.9;;;8.1;14.4;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;74.6;74.6;;;64;82.9;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;81.6;81.6;;;58.9;93.2;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2017;2017;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;;Number;35;35;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;NMBR;RACE;WHT;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.5;41.5;;;26.1;58.7;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.6;42.6;;;33.8;51.8;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.2;14.2;;;10.3;19.3;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.3;35.3;;;26.8;44.8;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.1;44.1;;;37.7;50.8;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.5;11.5;;;9;14.5;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;17.6;17.6;;;13.9;22.1;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.2;12.2;;;11.1;13.5;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;CRDRATE;RACE;API;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.5;6.5;;;3.9;10.7;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.9;42.9;;;31.6;55;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.1;90.1;;;83.5;94.2;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.6;14.6;;;12.7;16.8;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;;Number;29;29;;;;;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;NMBR;GENDER;GENM;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;49.8;49.8;;;42.6;57;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.7;7.7;;;5.6;10.4;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.1;65.1;;;59.8;70.1;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.9;9.9;;;8.8;11.2;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.6;11.6;;;10.7;12.6;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.5;7.5;;;6.3;8.8;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;81.8;81.8;;;74.5;87.3;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;21.7;21.7;;;14.7;30.8;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;95.1;95.1;;;86;98.4;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.1;9.1;;;8.1;10.3;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;17.1;17.1;;;9.4;29.1;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;24.1;24.1;;;15.9;34.6;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.0;11;;;9.9;12.2;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.8;12.8;;;9.9;16.5;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.8;82.8;;;68.8;91.3;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;5.1;5.1;;;2.8;9;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2017;2017;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;61.3;61.3;;;54.4;67.9;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.3;91.3;;;86.6;94.5;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.7;10.7;;;6.1;18.4;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.9;13.9;;;12.1;15.8;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.7;38.7;;;33.7;44;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;51.1;51.1;;;44;58.2;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.0;42;;;38;46.1;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.0;86;;;81;89.8;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.2;38.2;;;28.3;49.1;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2017;2017;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.1;10.1;;;8.2;12;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.6;5.6;;;4.6;6.8;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.4;31.4;;;23.2;41;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.2;10.2;;;8.8;11.8;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.4;9.4;;;7.1;12.2;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50.5;50.5;;;40.9;60.1;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;75.7;75.7;;;65.5;83.6;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2016;2016;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.3;41.3;;;36.7;46.1;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.1;87.1;;;80;92;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.8;13.8;;;9;20.7;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2016;2016;US;United States;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.6;11.6;*;50 States + DC: US Median;11.1;12.7;Overall;Overall;;;;;;;59;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;61.5;61.5;;;53.9;68.6;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.6;8.6;;;7.8;9.6;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.0;42;;;34.6;49.8;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.7;90.7;;;86.4;93.8;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;80.5;80.5;;;66.3;89.7;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2016;2016;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.9;65.9;;;59;72.2;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.7;40.7;;;31.8;50.3;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;97.3;97.3;;;94;98.8;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.3;32.3;;;18.1;50.6;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2017;2017;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.9;10.9;;;8.9;13;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.2;9.2;;;6.3;13.3;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.7;37.7;;;24.6;52.8;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.2;43.2;;;29.5;58.1;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;15.2;15.2;;;11.9;19.2;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.6;44.6;;;33.7;56.1;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;56.2;56.2;;;44.4;67.3;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.0;84;;;69.3;92.5;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.5;37.5;;;33.6;41.6;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.8;89.8;;;85.2;93.1;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.7;36.7;;;29.1;44.9;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2017;2017;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2017;2017;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2016;2016;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.0;41;*;50 States + DC: US Median;39.7;43.3;Overall;Overall;;;;;;;59;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.8;9.8;;;6.1;15.5;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.6;41.6;;;34.7;48.9;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2017;2017;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.0;45;;;36.5;53.8;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;26.2;26.2;;;15.4;41;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.3;63.3;;;53.9;71.8;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.9;8.9;;;6.9;11.3;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.3;72.3;;;64.7;78.8;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.4;6.4;;;5;8.1;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.5;39.5;;;30.8;49;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.4;42.4;;;34;51.3;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.5;8.5;;;7.5;9.7;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.8;49.8;;;37.5;62.1;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;61.1;61.1;;;55.1;66.7;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.6;36.6;;;24.3;51;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.8;36.8;;;25.4;49.9;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.6;63.6;;;55;71.4;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;17.9;17.9;;;15.2;21.1;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.7;13.7;;;11.1;16.7;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.9;6.9;;;5.6;8.5;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;51.6;51.6;;;45.1;58.1;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.4;12.4;;;11.1;13.9;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.9;35.9;;;28.4;44.2;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;92.9;92.9;;;84;97;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.9;85.9;;;77.8;91.4;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.6;44.6;;;38.2;51.2;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.2;35.2;;;25.3;46.7;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.5;12.5;;;10.1;15.3;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;94.5;94.5;;;89.5;97.2;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.1;11.1;;;7.9;15.3;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.3;37.3;;;28.2;47.3;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.8;35.8;;;27.3;45.3;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2017;2017;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.6;10.6;;;9.3;12.1;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.9;43.9;;;37.9;50.2;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;16.4;16.4;;;12.3;21.5;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;US;United States;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.6;11.6;*;50 States + DC: US Median;11.2;12.6;Gender;Female;;;;;;;59;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.8;85.8;;;74.3;92.7;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2017;2017;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;CRDRATE;RACE;API;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.8;36.8;;;27.3;47.6;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;77.7;77.7;;;66.4;86;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.0;89;;;82.7;93.1;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.0;62;;;55.2;68.3;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.4;7.4;;;6.3;8.8;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.0;13;;;11;15.2;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;92.0;92;;;84.4;96;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.7;11.7;;;9.8;14;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.7;8.7;;;7.7;9.8;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.6;12.6;;;8.9;17.5;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.2;72.2;;;63.1;79.7;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.5;65.5;;;56.3;73.7;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;80.4;80.4;;;69.9;87.9;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.3;45.3;;;41;49.7;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.6;70.6;;;63.6;76.8;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.3;91.3;;;84;95.5;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;78.7;78.7;;;60.1;90.1;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.7;11.7;;;10.5;13;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.4;11.4;;;9.9;13.2;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.8;36.8;;;30;44.2;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.1;46.1;;;37.9;54.6;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.1;10.1;;;8.6;11.8;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.6;6.6;;;3.8;11.3;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.7;12.7;;;10.5;15.4;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2017;2017;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.9;5.9;;;4.3;8;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.8;70.8;;;54.4;83.1;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.2;68.2;;;60.1;75.3;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.9;65.9;;;59.9;71.5;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.4;12.4;;;10.3;14.8;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2017;2017;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;53.8;53.8;;;45.6;61.9;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;59.0;59;;;43.9;72.6;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.8;9.8;;;8.4;11.5;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.9;11.9;;;10.5;13.4;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.8;89.8;;;83;94.1;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2017;2017;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.9;38.9;;;26.9;52.4;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.3;41.3;;;29.5;54.2;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;80.3;80.3;;;67;89.1;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.3;35.3;;;25.3;46.9;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.4;8.4;;;7.4;9.5;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.0;34;;;27.2;41.5;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.0;30;;;19.8;42.6;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.3;40.3;;;28.7;53.1;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.5;39.5;;;29.8;50;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.0;7;;;4.6;10.4;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.9;33.9;;;25.3;43.8;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.6;12.6;;;10.9;14.4;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.7;38.7;;;32.7;45.1;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;15.4;15.4;;;10.4;22.2;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.6;42.6;;;28.4;58.1;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.9;82.9;;;71.5;90.3;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.6;44.6;;;38.5;50.9;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;74.0;74;;;61.3;83.7;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.1;86.1;;;79.6;90.8;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;73.6;73.6;;;60.3;83.6;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;13.4;13.4;;;10;17.6;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.3;86.3;;;79.5;91.2;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.0;6;;;5;7.1;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.8;43.8;;;39;48.8;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;79.5;79.5;;;70.1;86.5;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.4;6.4;;;3.6;10.9;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.9;40.9;;;36.9;45;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;;Number;23;23;;;;;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.6;84.6;;;75.6;90.7;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.7;45.7;;;34;57.9;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.5;38.5;;;33.1;44.2;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.2;66.2;;;57.4;74;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.9;40.9;;;29.6;53.3;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;75.4;75.4;;;61.8;85.3;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;NMBR;GENDER;GENF;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;16.0;16;;;10.9;22.9;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;92.7;92.7;;;86.9;96;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.5;9.5;;;8.8;10.2;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.9;8.9;;;7.1;11.1;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;75.7;75.7;;;67.8;82.1;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.8;44.8;;;38.2;51.5;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;25.1;25.1;;;13.5;41.8;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.4;38.4;;;30.8;46.6;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.9;35.9;;;28;44.7;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.0;90;;;80.4;95.2;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.4;44.4;*;50 States + DC: US Median;41.4;46.2;Gender;Female;;;;;;;59;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2017;2017;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.5;12.5;;;9.8;15.9;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.7;87.7;**;US estimate/number is based on fewer than 50 states and the District of Columbia;84.8;90.9;Gender;Male;;;;;;;59;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.5;69.5;;;60.9;77;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.4;42.4;;;37.6;47.4;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.8;5.8;;;4.8;7;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.8;5.8;;;3.9;8.4;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.6;11.6;;;10.6;12.7;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;18.7;18.7;;;11;30;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.6;88.6;;;79.1;94.1;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.3;66.3;;;52.4;78;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2017;2017;US;United States;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.4;9.4;*;50 States + DC: US Median;9.1;9.9;Overall;Overall;;;;;;;59;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;15.1;15.1;;;9.8;22.5;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.0;11;;;10;12;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2017;2017;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.7;41.7;;;30.2;54.2;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;96.3;96.3;;;90.2;98.6;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.7;41.7;;;31.4;52.8;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.7;9.7;;;8.8;10.6;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.9;10.9;;;9.3;12.8;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2017;2017;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.7;12.7;;;8.5;18.2;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2017;2017;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.0;13;;;9;18;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.9;45.9;;;40.2;51.7;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.1;8.1;;;6.4;10.1;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;50.1;50.1;;;25.2;74.9;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;75.8;75.8;;;67.7;82.5;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;50.5;50.5;;;37.4;63.5;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;74.8;74.8;;;59.4;85.8;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.6;38.6;;;32.7;44.8;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;53.2;53.2;;;38.6;67.2;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.7;87.7;;;75.4;94.3;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.3;11.3;;;9.8;13.1;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.7;30.7;;;24.7;37.3;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.5;43.5;;;31.4;56.5;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.3;48.3;;;40.3;56.3;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.8;11.8;;;10.5;13.2;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.0;33;;;23.4;44.2;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.0;12;;;7.3;19.1;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.9;90.9;;;84.7;94.7;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.4;11.4;;;10.4;12.4;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.4;85.4;;;77.9;90.6;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.3;11.3;;;6.8;18.4;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.5;45.5;;;39.7;51.5;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.7;44.7;;;39.2;50.3;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;41.3;41.3;;;31.7;51.7;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.4;11.4;;;7.7;16.4;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.8;88.8;;;78.2;94.6;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.2;47.2;;;37.7;56.8;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;50.5;50.5;;;44.1;56.9;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2017;2017;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.0;6;;;5;7.1;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.4;13.4;;;10.8;16.6;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.9;13.9;;;8.5;21.9;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.6;82.6;;;72.6;89.4;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;80.6;80.6;;;74;85.8;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;3.9;3.9;;;2.3;6.4;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;;Number;40;40;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;NMBR;RACE;WHT;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;59.0;59;;;51.9;65.7;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;73.9;73.9;;;61.6;83.4;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.2;44.2;;;29;60.5;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.2;82.2;;;71.1;89.7;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2017;2017;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.1;13.1;;;10.6;16.1;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.9;31.9;;;26.3;38.2;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.8;10.8;;;6.9;16.6;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.8;45.8;;;40;51.7;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;7.1;7.1;;;4.6;10.8;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90.9;90.9;;;78.9;96.4;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.9;10.9;;;10.1;11.8;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.1;84.1;;;70.7;92.1;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;61.7;61.7;;;49.4;72.7;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.4;6.4;;;5.6;7.3;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;92.0;92;;;84.5;96.1;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.6;9.6;;;5.3;16.9;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.0;82;;;72.6;88.7;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.7;69.7;;;62.9;75.8;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.0;85;;;75.7;91.2;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.4;40.4;;;30.2;51.6;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.0;9;;;7.3;11.1;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.3;91.3;;;85;95.2;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;77.9;77.9;;;60.7;89;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.9;44.9;;;39;51;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2017;2017;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.0;9;;;6.5;12;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;79.6;79.6;;;69.8;86.8;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.8;34.8;;;27.7;42.6;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.4;86.4;;;80.2;90.9;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;72.6;72.6;;;57.5;83.9;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.1;36.1;;;29.5;43.1;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.9;10.9;;;9.8;12.2;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50.0;50;;;44;56;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.8;45.8;;;35.2;56.8;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.1;13.1;;;7.9;21;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.1;30.1;;;25.3;35.3;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.7;41.7;;;32.3;51.7;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2017;2017;TX;Texas;NVSS;Asthma;Asthma mortality rate;;;Number;127;127;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;NMBR;RACE;WHT;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.2;41.2;;;33.9;48.9;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;58.1;58.1;;;47.6;67.9;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;55.1;55.1;;;47.5;62.5;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.5;45.5;;;37.5;53.7;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.5;83.5;;;74;90;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.2;11.2;;;10;12.5;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.1;13.1;;;11.5;15;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.1;13.1;;;11.7;14.7;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.8;8.8;;;5.2;14.5;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;79.5;79.5;;;59.5;91.1;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;17.9;17.9;;;10.4;29.2;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.6;84.6;;;75.6;90.7;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.4;42.4;;;33.6;51.8;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.1;90.1;;;85.8;93.2;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.1;40.1;;;33.2;47.4;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;75.5;75.5;;;68.6;81.3;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.4;65.4;;;57.2;72.7;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.7;89.7;;;76.2;95.9;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.3;8.3;;;7.3;9.5;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.0;7;;;5.8;8.5;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.2;8.2;;;7.3;9.2;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.0;62;;;52.9;70.4;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2017;2017;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;42;42;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;NMBR;RACE;WHT;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.4;42.4;;;36;49;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.2;9.2;;;8.2;10.3;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.1;65.1;;;54.1;74.8;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.2;10.2;;;8;12.9;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;22.6;22.6;;;15.5;31.7;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;91.9;91.9;;;81;96.8;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.5;11.5;;;8.6;15.3;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;14.9;14.9;;;10.5;20.7;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;7.7;7.7;;;4.8;12.3;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.6;5.6;;;3.8;8.2;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2016;2016;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.5;10.5;;;9;12.2;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.7;42.7;;;35.1;50.7;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;81.8;81.8;;;68;90.4;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.4;35.4;;;27.3;44.4;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.8;8.8;;;7.7;10;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;80.3;80.3;;;68.3;88.5;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2017;2017;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;NMBR;RACE;HIS;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.0;46;;;39.4;52.7;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.5;39.5;;;27.9;52.3;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.6;33.6;;;20.3;50;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.7;63.7;;;54.4;72.1;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.2;42.2;;;34.3;50.6;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.6;42.6;;;36;49.4;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;49.0;49;;;39.3;58.7;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.9;62.9;;;53.9;71.1;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2017;2017;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2017;2017;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.5;12.5;;;9.3;16.5;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.3;41.3;;;36.6;46.1;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;18.3;18.3;;;11.6;27.8;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2017;2017;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;NMBR;RACE;HIS;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.4;89.4;;;81.8;94;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.2;9.2;;;7.7;10.8;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.5;46.5;;;37.4;55.7;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.5;37.5;;;22.6;55.1;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2017;2017;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.7;47.7;;;38.9;56.6;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.1;90.1;;;84.8;93.7;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.3;88.3;;;77.5;94.3;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.6;45.6;;;39.7;51.6;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.5;44.5;;;38.4;50.8;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;28.7;28.7;;;21.5;37.1;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.6;41.6;;;32.2;51.7;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.8;7.8;;;5.8;10.4;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.5;6.5;;;4;10.4;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.2;39.2;;;28.7;50.9;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.2;14.2;;;12.5;16;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;26.1;26.1;;;14.3;42.6;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.1;9.1;;;8.1;10.1;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.7;12.7;;;11.6;13.8;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.2;87.2;;;77.4;93.2;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.0;6;;;4.2;8.3;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.2;9.2;;;6.2;13.5;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2017;2017;FL;Florida;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;NMBR;RACE;API;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;78.0;78;;;64.7;87.2;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.8;84.8;;;77.2;90.2;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.0;11;;;8.7;13.8;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.1;41.1;;;33.7;49;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.4;46.4;;;36.8;56.2;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.6;8.6;;;8;9.3;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.9;43.9;;;35.3;52.8;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.8;84.8;;;72.8;92;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2017;2017;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.9;12.9;;;9.3;17.5;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.2;45.2;;;38.6;52;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.7;10.7;;;9.4;12.2;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;91.7;91.7;;;87.7;94.5;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.8;9.8;;;9.1;10.6;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2017;2017;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;19.4;19.4;;;12.8;28.2;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.4;13.4;;;11.9;15.1;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.9;33.9;;;23.2;46.5;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;74.5;74.5;;;66;81.5;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;21.0;21;;;14.6;29.3;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.8;87.8;;;82.4;91.7;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.2;6.2;;;3.5;10.6;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.5;63.5;;;55.7;70.6;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.8;41.8;;;34.4;49.7;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.0;63;;;56.1;69.3;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;59.3;59.3;;;53.5;64.8;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.2;7.2;;;6.3;8.2;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.5;8.5;;;7.5;9.6;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.6;40.6;;;32.8;48.9;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.3;85.3;;;77.7;90.7;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.1;46.1;;;35.9;56.6;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2016;2016;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;24.8;24.8;;;17.8;33.3;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.9;35.9;;;31.4;40.7;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.1;34.1;;;23.3;46.9;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.0;42;*;50 States + DC: US Median;39.1;43.8;Overall;Overall;;;;;;;59;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.3;11.3;;;9.4;13.7;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.2;36.2;;;27.9;45.5;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.3;8.3;;;7.4;9.5;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.2;45.2;;;38.5;52;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;73.8;73.8;;;59.5;84.5;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.9;5.9;;;4;8.7;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.3;6.3;;;5.2;7.7;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.4;40.4;;;32.1;49.2;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;27.5;27.5;;;18.9;38.1;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.2;9.2;;;8.4;10.1;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;17.8;17.8;;;14.6;21.6;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.0;34;;;28.6;39.8;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;94.4;94.4;;;90.1;96.9;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.3;43.3;;;38.3;48.4;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;80.7;80.7;;;73.6;86.3;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.0;11;;;7.3;16.2;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.0;83;;;74.4;89.2;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.3;5.3;;;4.1;7;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.0;36;;;31.9;40.3;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50.6;50.6;;;33.5;67.6;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.5;39.5;;;31.3;48.5;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.8;45.8;;;41.1;50.7;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.3;12.3;;;10.6;14.2;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.0;69;;;62.2;75.2;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;60.3;60.3;;;51.8;68.2;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2017;2017;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;;Number;32;32;;;;;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;78.5;78.5;;;68.5;86;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2017;2017;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2017;2017;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2017;2017;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.4;11.4;;;7.5;16.6;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.3;6.3;;;3.7;10.5;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.5;89.5;;;81.7;94.2;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;74.5;74.5;;;64.2;82.6;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.4;32.4;;;24.1;41.9;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.8;38.8;;;32.9;45;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.6;37.6;;;27.3;49.1;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.6;8.6;;;7.7;9.6;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;8.0;8;;;5.4;11.8;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.8;30.8;;;19.4;45.3;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.8;65.8;;;51.5;77.7;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.0;33;;;22.5;45.4;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.5;38.5;;;25.6;53.2;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.8;8.8;;;8.1;9.6;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.0;12;;;11;13;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.4;43.4;;;37.2;49.7;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.4;11.4;;;9.6;13.5;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.2;33.2;;;23.1;45.1;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50.2;50.2;;;40.7;59.7;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.2;14.2;;;12.1;16.5;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;NMBR;RACE;BLK;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.9;91.9;;;86.7;95.1;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;;Number;43;43;;;;;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2016;2016;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.5;9.5;;;8.9;10.1;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.8;39.8;;;33.8;46.2;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.8;70.8;;;56.6;81.8;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.6;66.6;;;54.3;76.9;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.7;39.7;;;31.8;48.1;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.1;88.1;;;82.5;92.1;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;18.8;18.8;;;14.6;23.8;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;78.8;78.8;;;65.9;87.8;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2017;2017;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.907192, -77.036871);;11;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.2;43.2;;;36.5;50.1;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;15.8;15.8;;;12.2;20.1;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.8;42.8;;;26.8;60.5;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.1;68.1;;;59;75.9;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.2;65.2;;;54.3;74.7;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;16.6;16.6;;;14.4;19.2;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2017;2017;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.1;9.1;;;8.1;10.2;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.3;14.3;;;12.5;16.4;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.9;42.9;;;38.2;47.7;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2017;2017;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.2;8.2;;;7.6;8.9;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.4;46.4;;;39.1;53.9;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.6;37.6;;;29.8;46.1;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.3;6.3;;;5.5;7.2;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.0;88;;;76.1;94.4;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67.4;67.4;;;56.1;76.9;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.0;87;;;78.2;92.6;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.8;38.8;;;31.2;46.8;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.8;38.8;;;33.7;44.1;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;6.1;6.1;;;3.4;10.7;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.9;41.9;;;36.8;47.1;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;13.2;13.2;;;9.1;18.6;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90.0;90;;;83.8;94;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.3;87.3;;;75.9;93.8;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.8;62.8;;;49.6;74.3;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.7;90.7;;;84.4;94.7;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2017;2017;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.5;10.5;;;8.6;12.3;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.7;14.7;;;13;16.5;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.5;8.5;;;5.8;12.1;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.7;33.7;;;27.8;40.1;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.5;11.5;;;10.5;12.5;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.9;31.9;;;21.5;44.6;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;78.2;78.2;;;68;85.9;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;78.9;78.9;;;70.7;85.3;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.5;6.5;;;5.5;7.5;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.7;48.7;;;42.6;54.8;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2017;2017;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.9;40.9;;;31.9;50.7;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;56.5;56.5;;;37.2;74.1;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.3;72.3;;;63.7;79.5;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.5;87.5;;;81.2;91.9;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;18.7;18.7;;;10.1;31.9;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.1;91.1;;;87.2;94;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;59.1;59.1;;;44.1;72.5;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.3;89.3;;;77.1;95.4;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.4;44.4;;;33.4;56;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.4;46.4;;;36.6;56.6;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2017;2017;CA;California;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;55.0;55;;;42.2;67.1;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.5;33.5;;;25;43.2;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.9;28.9;;;18.3;42.4;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.2;38.2;;;28.2;49.3;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.0;11;;;9.8;12.3;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.2;87.2;;;77.2;93.2;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.2;38.2;;;28.5;49;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;52.8;52.8;;;34;70.9;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.4;10.4;;;9.2;11.8;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.9;88.9;;;80.1;94.1;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.5;89.5;;;85.3;92.5;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.2;38.2;;;30.5;46.5;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;42.9;42.9;;;32.6;54;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.6;41.6;;;34.9;48.5;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.5;32.5;;;24.6;41.6;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.7;9.7;;;9;10.6;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;61.8;61.8;;;55.5;67.8;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2017;2017;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.2;12.2;;;10.1;14.2;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.1;45.1;;;36.6;53.9;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.9;90.9;;;82.5;95.5;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.1;5.1;;;3.8;6.8;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.8;8.8;;;8.2;9.5;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2017;2017;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;NMBR;RACE;BLK;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.2;85.2;;;76.6;91;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.7;71.7;;;60;81;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;56.2;56.2;;;48.3;63.8;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.2;33.2;;;27.1;40;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;NMBR;RACE;WHT;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.6;32.6;;;25.8;40.2;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.6;10.6;;;9.6;11.6;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.1;10.1;;;6.2;16;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.2;85.2;;;73.8;92.2;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;CA;California;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;4.4;4.4;;;2.6;7.5;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.6;45.6;;;38.7;52.8;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.3;11.3;;;8.4;14.9;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2017;2017;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.7;87.7;;;80.3;92.6;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.5;8.5;;;7.5;9.6;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.9;9.9;;;6.2;15.5;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.2;8.2;;;6.6;10;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;20.8;20.8;;;15.4;27.6;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.8;85.8;;;80.4;89.8;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.3;38.3;;;31.3;45.9;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.8;70.8;;;60;79.7;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.5;14.5;;;13.3;15.7;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.1;45.1;;;35.5;55;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.6;45.6;;;39.2;52.1;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.0;46;;;35.9;56.5;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.1;37.1;;;29.7;45.2;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.9;14.9;;;9.6;22.3;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.3;11.3;;;8.5;15;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.8;44.8;;;37.5;52.4;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.2;35.2;;;26.6;44.9;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50.3;50.3;;;39.3;61.3;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;55.1;55.1;;;45.3;64.6;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;18.9;18.9;;;14.1;24.9;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2016;2016;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;NMBR;RACE;API;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.6;34.6;;;27.6;42.4;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.5;40.5;;;31;50.8;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.7;84.7;;;71.1;92.6;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.2;86.2;;;82.2;89.4;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;53.0;53;;;44;61.8;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.3;40.3;;;24.2;58.8;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST4_1;NMBR;RACE;HIS;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.8;34.8;;;28.2;42.1;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.8;12.8;;;9.2;17.5;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.1;44.1;;;33.8;54.9;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.0;41;;;33.6;48.8;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.9;86.9;;;77.7;92.7;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.4;40.4;;;35.4;45.5;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;24.9;24.9;;;14.9;38.5;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.3;14.3;;;10;20.1;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;24.3;24.3;;;13.2;40.5;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.2;45.2;;;35;55.8;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2016;2016;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.5;34.5;;;27.4;42.5;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.6;43.6;;;32.7;55.2;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.8;86.8;;;72.7;94.2;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;74.2;74.2;;;64.7;81.8;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.8;12.8;;;9;18;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2017;2017;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;;Number;59;59;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;NMBR;RACE;WHT;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;CRDRATE;RACE;API;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.4;12.4;;;8.8;17.1;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.5;36.5;;;30.4;43;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.1;38.1;;;32;44.7;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.6;45.6;;;39.8;51.6;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2017;2017;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.9;12.9;;;11.3;14.5;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.2;9.2;;;8.1;10.5;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2017;2017;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.3;83.3;;;74.3;89.6;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.6;31.6;;;22.8;42;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.1;14.1;;;12.6;15.8;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.0;8;;;5.2;11.9;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.8;7.8;;;7;8.7;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2017;2017;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;20;20;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;NMBR;RACE;WHT;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.9;9.9;;;9;10.9;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;26.8;26.8;;;19.4;35.9;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;52.2;52.2;;;46;58.4;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2016;2016;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.0;6;;;5.1;7;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.2;8.2;;;7.5;8.9;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.6;11.6;;;10.8;12.4;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.1;5.1;;;3.7;7.1;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;20.0;20;;;16.1;24.5;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;18.5;18.5;;;11.5;28.5;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90.9;90.9;;;82.7;95.4;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.3;42.3;;;33.9;51.2;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.4;6.4;;;4.9;8.3;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;US;United States;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.6;6.6;*;50 States + DC: US Median;6.3;6.9;Gender;Male;;;;;;;59;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.2;37.2;;;27.7;47.8;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.9;14.9;;;13.5;16.5;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.5;14.5;;;10.7;19.3;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;4.9;4.9;;;3.8;6.4;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.4;31.4;;;22.8;41.6;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.6;38.6;;;29.6;48.4;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.1;44.1;;;36.7;51.7;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.9;40.9;;;31.1;51.6;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.7;35.7;;;25.5;47.5;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.9;14.9;;;13;17;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.8;89.8;;;85.2;93.2;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.5;13.5;;;10.1;17.8;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.5;9.5;;;7.2;12.5;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.2;8.2;;;7.6;9;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.7;84.7;;;76;90.6;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.6;9.6;;;9;10.3;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.9;11.9;;;10.3;13.6;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2016;2016;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.5;42.5;;;35.9;49.4;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.1;13.1;;;10.2;16.7;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.8;7.8;;;4.9;12.1;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.8;71.8;;;60.8;80.7;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2017;2017;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.8;7.8;;;4.7;12.2;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.1;7.1;;;3.9;12.4;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.0;42;;;36.7;47.5;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.3;72.3;;;66.1;77.8;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;91.2;91.2;;;85.7;94.7;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.9;36.9;;;28.3;46.3;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.0;41;;;35;47.2;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.6;7.6;;;6.1;9.4;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.0;41;;;31.7;51;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;CA;California;NVSS;Asthma;Asthma mortality rate;;;Number;66;66;;;;;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;NMBR;RACE;HIS;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.3;66.3;;;55.2;75.9;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.7;41.7;;;34.9;48.8;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.3;44.3;;;36.4;52.6;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.0;45;;;34.1;56.4;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.1;5.1;;;4.1;6.2;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.9;85.9;;;79.3;90.6;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.7;87.7;;;76.8;93.9;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;92.7;92.7;;;80.4;97.5;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.9;10.9;;;10;11.8;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;19.7;19.7;;;11.9;30.8;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.9;8.9;;;7.6;10.5;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;76.2;76.2;;;66.5;83.8;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.8;40.8;;;34.9;47.1;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2016;2016;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.1;68.1;;;51.3;81.3;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.7;37.7;;;27.6;48.9;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.9;14.9;;;11.4;19.2;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2017;2017;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.1;68.1;;;57.8;76.8;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.9;9.9;;;8.2;11.9;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50.8;50.8;;;36.1;65.3;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.7;32.7;;;23;44;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2016;2016;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.5;11.5;;;10.6;12.4;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.4;9.4;;;8.6;10.3;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.7;39.7;;;29.4;51;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67.7;67.7;;;58.1;75.9;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.5;69.5;;;50.4;83.6;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2016;2016;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.7;7.7;;;7.1;8.3;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.6;34.6;;;21.6;50.3;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;15.1;15.1;;;8.4;25.8;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.6;6.6;;;4.5;9.5;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.7;6.7;;;5.6;8;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.4;11.4;;;10.2;12.7;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.3;10.3;;;9.4;11.3;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;60.2;60.2;;;46.2;72.7;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;56.6;56.6;;;43.7;68.7;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2017;2017;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;;Number;45;45;;;;;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;NMBR;GENDER;GENF;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.2;42.2;;;36.6;48;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;NMBR;RACE;BLK;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.7;10.7;;;9.6;11.9;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.8;13.8;;;8.3;22;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.1;87.1;;;76.4;93.4;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2017;2017;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2016;2016;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.3;5.3;;;3.7;7.6;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2016;2016;NY;New York;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.7;12.7;;;10.9;14.9;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.2;49.2;;;34.2;64.4;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;17.7;17.7;;;12.9;23.9;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.9;87.9;;;83.5;91.2;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.0;6;;;4.7;7.6;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.8;7.8;;;4.4;13.5;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90.0;90;;;84.4;93.8;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.7;36.7;;;27.7;46.7;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.0;40;;;28.4;52.8;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.2;7.2;;;6;8.7;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2017;2017;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.1;13.1;;;8.5;19.8;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.7;10.7;;;9.5;12;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.4;42.4;;;33.8;51.4;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.6;43.6;;;37.2;50.2;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.1;13.1;;;10.6;16;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.2;45.2;;;38;52.5;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2017;2017;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;;Number;24;24;;;;;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;NMBR;GENDER;GENF;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.6;7.6;;;6.8;8.6;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.6;88.6;;;83.3;92.3;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.0;43;;;35.7;50.7;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;80.1;80.1;;;67;88.8;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;54.0;54;;;46.9;61;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;NMBR;RACE;AIAN;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;91.0;91;;;84.5;95;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2017;2017;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.4;41.4;;;36.9;46.1;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.8;44.8;;;38.7;51.1;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.0;35;;;24.2;47.5;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.5;66.5;;;57.8;74.2;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.5;7.5;;;6.9;8;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.2;11.2;;;7.6;16.1;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.6;10.6;;;7.9;14.1;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.5;45.5;;;37.5;53.7;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2017;2017;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.4;34.4;;;26.3;43.6;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;19.6;19.6;;;12.1;30.2;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.7;91.7;;;81;96.6;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.2;43.2;;;38.1;48.5;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2017;2017;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;24;24;;;;;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.6;82.6;;;73.1;89.2;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;30.6;30.6;;;17.1;48.6;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.5;86.5;;;79.8;91.3;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;WA;Washington;NVSS;Asthma;Asthma mortality rate;;;Number;67;67;;;;;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;NMBR;GENDER;GENF;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.1;5.1;;;3.9;6.6;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.0;83;;;73.1;89.8;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.9;43.9;;;39.4;48.5;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;NMBR;RACE;API;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.6;10.6;;;9.4;11.9;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2017;2017;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;;Number;41;41;;;;;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2017;2017;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.2;85.2;;;72.7;92.5;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.6;89.6;;;83.1;93.8;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.3;35.3;;;29.1;42;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.5;43.5;;;35.7;51.6;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.3;30.3;;;21.3;41;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2017;2017;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;;Number;71;71;;;;;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.2;10.2;;;8.9;11.6;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.6;9.6;;;6.9;13;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.5;89.5;;;81;94.5;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;22.4;22.4;;;17.6;28.1;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.6;44.6;;;38.4;51;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;NMBR;RACE;HIS;;;;
2016;2016;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.1;11.1;;;8.2;14.9;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.0;6;;;4.6;7.7;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.1;45.1;;;39.9;50.4;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.0;45;;;36.2;54.2;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;79.2;79.2;;;63.8;89.2;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.6;11.6;;;10.6;12.7;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.5;36.5;;;26.6;47.7;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;78.9;78.9;;;70.7;85.3;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2017;2017;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.6;38.6;;;28.2;50.2;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.9;65.9;;;55.9;74.7;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.7;7.7;;;6.5;9.1;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.2;7.2;;;6.3;8.2;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.9;87.9;;;78.1;93.7;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;27.6;27.6;;;17.5;40.6;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.6;9.6;;;8.1;11.4;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.8;46.8;;;39.8;54;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.2;13.2;;;9.9;17.4;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;;Number;74;74;;;;;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2016;2016;US;United States;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.5;6.5;*;50 States + DC: US Median;6.3;6.9;Gender;Male;;;;;;;59;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.4;6.4;;;5.5;7.4;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.4;9.4;;;7.3;12.1;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.1;70.1;;;63.5;76.1;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.1;41.1;;;31;52;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;42.8;42.8;;;33.8;52.2;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.9;43.9;;;29.2;59.8;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;26.5;26.5;;;18.1;37.1;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.6;43.6;;;37.3;50.1;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.3;13.3;;;10.6;16.5;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;72.5;72.5;;;65.3;78.7;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.2;33.2;;;26.7;40.5;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.3;40.3;;;30.1;51.3;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;91.9;91.9;;;87.2;94.9;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.8;41.8;;;36.1;47.7;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.2;41.2;;;33.6;49.3;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2017;2017;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;;Number;36;36;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;NMBR;RACE;WHT;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;WA;Washington;NVSS;Asthma;Asthma mortality rate;;;Number;38;38;;;;;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;NMBR;GENDER;GENM;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.6;71.6;;;64.8;77.5;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2017;2017;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;29.7;29.7;;;20.6;40.7;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.5;7.5;;;6.7;8.3;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.2;40.2;;;35;45.7;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.9;72.9;;;64.2;80.1;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.9;9.9;;;9;10.9;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.1;71.1;;;62.1;78.7;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.5;42.5;;;37.9;47.2;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;74.7;74.7;;;64.4;82.8;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.6;46.6;;;33.6;59.9;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2016;2016;CA;California;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.5;43.5;;;39.1;48.1;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;49.8;49.8;;;39.6;60;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;95.8;95.8;;;92.1;97.8;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.9;87.9;;;82.6;91.7;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.2;71.2;;;64.6;77;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.2;42.2;;;33.1;52;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.3;47.3;;;35.7;59.2;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.9;6.9;;;5.7;8.4;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.0;47;;;40.8;53.3;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.3;39.3;;;33.7;45.3;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.6;10.6;;;6.6;16.8;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.5;39.5;;;34.4;44.9;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.3;6.3;;;5.5;7.3;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;26.5;26.5;;;15.6;41.4;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.0;36;;;28.6;44.2;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.1;40.1;;;31.6;49.4;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.3;13.3;;;10.2;17.1;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.3;44.3;;;31;58.5;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.4;85.4;;;70.2;93.6;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2017;2017;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.2;10.2;;;7.7;13.1;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;4.7;4.7;;;2.8;7.7;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.5;14.5;;;12.8;16.4;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;54.8;54.8;;;49.9;59.6;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;93.9;93.9;;;90.5;96.2;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.0;37;;;20.5;57.2;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.1;41.1;;;36.1;46.2;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.3;32.3;;;24.2;41.6;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;17.7;17.7;;;12.4;24.8;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.7;66.7;;;58.8;73.8;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.4;87.4;;;77.3;93.4;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;61.5;61.5;;;46.9;74.2;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.1;42.1;;;36.7;47.7;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.4;43.4;;;33.9;53.5;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;15.5;15.5;;;11.1;21.3;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;61.0;61;;;51.8;69.5;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;78.2;78.2;;;67.4;86.1;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;;Number;32;32;;;;;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2017;2017;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;CRDRATE;RACE;API;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.3;91.3;;;83.3;95.7;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.5;65.5;;;52.8;76.4;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2017;2017;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.8;11.8;;;7.2;18.2;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.8;13.8;;;8.8;21;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67.5;67.5;;;52;79.9;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.4;37.4;;;31.6;43.5;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.1;42.1;;;34.6;50;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.7;38.7;;;29.7;48.5;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;18.0;18;;;10.2;29.7;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.9;70.9;;;63.7;77.1;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.7;87.7;*;50 States + DC: US Median;86.4;89.1;Overall;Overall;;;;;;;59;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.8;6.8;;;5.8;7.9;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.4;5.4;;;4.4;6.4;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;18.3;18.3;;;10.5;29.9;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.0;46;;;38.2;53.9;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.9;35.9;;;30.5;41.7;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.3;35.3;;;29.4;41.8;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.0;34;;;25.5;43.8;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.2;90.2;;;84.2;94.1;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.4;13.4;;;9.3;19.1;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.4;38.4;;;27.7;50.2;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90.1;90.1;;;84.9;93.6;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;20.8;20.8;;;11.2;35.3;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;92.4;92.4;;;85.5;96.2;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.1;9.1;;;8.6;9.6;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.2;9.2;;;8.4;10;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;22.9;22.9;;;13.3;36.6;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.1;49.1;;;28.7;69.8;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.4;39.4;;;22.9;58.7;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.2;12.2;;;10.8;13.8;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;16.5;16.5;;;14.3;18.8;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.0;8;;;6.8;9.5;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.9;36.9;;;27.5;47.4;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.2;87.2;;;79.7;92.2;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.4;39.4;;;28.9;51;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;4.4;4.4;;;2.8;6.9;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.2;82.2;;;73.4;88.6;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2017;2017;US;United States;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.9;9.9;;;9.5;10.2;Overall;Overall;;;;;;;59;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.9;46.9;;;39.9;54;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90.5;90.5;;;84.4;94.4;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.9;40.9;;;34.2;48;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;92.1;92.1;;;86.5;95.5;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.5;86.5;;;82.1;90;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.6;47.6;;;35.1;60.4;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.4;8.4;;;7.5;9.4;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.0;40;;;34.5;45.7;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.0;48;;;31.9;64.5;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;92.3;92.3;;;86.6;95.8;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.2;87.2;;;81.3;91.4;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.7;7.7;;;6.3;9.3;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.9;11.9;;;6.8;20;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;57.4;57.4;;;46.8;67.3;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.0;43;;;30;57;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.3;31.3;;;22.4;41.7;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;18.3;18.3;;;14;23.7;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.2;71.2;;;65.4;76.3;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.9;66.9;;;58.8;74;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;92.7;92.7;;;87.2;95.9;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2017;2017;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2017;2017;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;59.2;59.2;;;38.4;77.2;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.1;48.1;;;37.5;58.9;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.5;12.5;;;9.9;15.8;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.0;33;;;26.2;40.5;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.7;69.7;;;51;83.5;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.3;7.3;;;5.5;9.6;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.9;39.9;;;33.7;46.4;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;17.3;17.3;;;14.3;20.8;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.8;41.8;;;37;46.8;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.5;9.5;;;5.3;16.3;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2017;2017;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.3;39.3;;;33.5;45.5;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.9;7.9;;;6.7;9.3;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.7;86.7;;;81.6;90.6;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;5.9;5.9;;;4.5;7.6;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.1;42.1;;;30.6;54.4;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;57.2;57.2;;;44.1;69.4;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.6;70.6;;;59.5;79.7;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.7;37.7;;;33.4;42.3;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;NMBR;RACE;HIS;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.3;48.3;;;40.7;55.9;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;NY;New York;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;NMBR;RACE;AIAN;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.8;13.8;;;7.7;23.4;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.8;6.8;;;5.6;8.3;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2017;2017;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.5;5.5;;;4.2;7.1;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;TX;Texas;NVSS;Asthma;Asthma mortality rate;;;Number;35;35;;;;;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;NMBR;RACE;HIS;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;75.7;75.7;;;67.3;82.5;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.6;14.6;;;9.8;21;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.4;89.4;;;82.3;93.9;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2017;2017;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.9;7.9;;;6.3;9.8;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;16.1;16.1;;;10.9;23.1;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.4;10.4;;;9.4;11.7;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.1;8.1;;;7.3;9;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;91.9;91.9;;;86.3;95.3;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.1;85.1;;;73.1;92.3;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.4;44.4;;;38.5;50.6;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.2;7.2;;;5.8;9.1;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;75.7;75.7;;;67.6;82.3;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;79.1;79.1;;;62.6;89.5;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.5;10.5;;;9.1;12.1;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.6;91.6;;;83;96.1;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.3;35.3;;;24.4;47.9;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.8;86.8;;;75.4;93.4;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;17.0;17;;;13.2;21.6;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.3;88.3;;;77.3;94.4;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;97.7;97.7;;;92.4;99.4;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2017;2017;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;NMBR;RACE;HIS;;;;
2017;2017;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;3.6;3.6;;;2.5;5.1;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.2;44.2;;;27.4;62.4;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2017;2017;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.7;13.7;;;10.3;17.9;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.8;85.8;;;79.3;90.5;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;73.1;73.1;;;62.5;81.5;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.9;68.9;;;60.5;76.3;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;55.0;55;;;41.9;67.5;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;4.7;4.7;;;3.6;6.1;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.5;6.5;;;5.3;7.9;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.6;14.6;;;10.7;19.7;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.1;9.1;;;5.9;13.8;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;15.8;15.8;;;11.3;21.7;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2017;2017;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.7;9.7;;;8.3;11.3;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2017;2017;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;NMBR;RACE;API;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.5;5.5;;;3.8;7.9;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.4;7.4;;;4.6;11.8;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.3;10.3;;;8.7;12.2;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.6;38.6;;;34.3;43;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.6;10.6;;;8.9;12.6;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;61.3;61.3;;;55;67.2;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.1;10.1;;;9.1;11.2;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.1;6.1;;;4.8;7.7;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.4;9.4;;;8.3;10.5;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.8;63.8;;;46.5;78.2;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.3;14.3;;;12.7;16.1;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.3;71.3;;;59.6;80.7;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.9;14.9;;;12.4;17.7;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.5;36.5;;;25.7;48.8;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.2;12.2;;;8.8;16.6;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.2;41.2;;;34.7;48.1;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.0;71;;;57.1;81.9;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.5;7.5;;;5.9;9.5;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.8;88.8;;;81.1;93.6;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.1;6.1;;;5.1;7.2;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.6;6.6;;;5.4;8;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;4.9;4.9;;;3.5;6.9;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.7;83.7;;;74;90.3;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.7;68.7;;;61.8;74.9;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.3;36.3;;;27.8;45.7;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.1;42.1;;;36;48.5;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.7;39.7;;;32.9;46.8;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.3;91.3;;;83;95.7;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2017;2017;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;77.9;77.9;;;62;88.4;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2017;2017;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;6.3;6.3;;;5;7.7;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2017;2017;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.6;33.6;;;25.8;42.5;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.0;8;;;6.1;10.3;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;17.1;17.1;;;10.7;26.2;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.9;6.9;;;5.8;8.1;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.6;83.6;;;73.6;90.4;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.0;9;;;5.7;14.1;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;92.6;92.6;;;85.8;96.3;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2017;2017;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.4;87.4;;;79.6;92.5;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.4;12.4;;;10.7;14.4;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.3;34.3;;;27.3;42;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.3;71.3;;;64.5;77.3;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.6;40.6;;;33.1;48.7;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.1;8.1;;;7.3;8.9;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.8;37.8;;;31.2;44.8;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;16.6;16.6;;;11.2;24;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.0;64;;;54.4;72.6;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.1;43.1;;;33.5;53.2;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.5;11.5;;;8.1;16;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2017;2017;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;CRDRATE;RACE;API;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.8;39.8;;;31;49.3;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;56.7;56.7;;;45;67.7;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;4.8;4.8;;;3.2;7.1;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.6;5.6;;;3.4;9.2;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.1;41.1;;;34.8;47.8;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;15.9;15.9;;;14.4;17.6;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.8;10.8;;;9.5;12.1;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.8;83.8;;;72;91.2;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.3;12.3;;;9.3;16.2;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2016;2016;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.0;91;;;81;96;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.1;67.1;;;60.3;73.3;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;78.4;78.4;;;62.6;88.7;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.4;88.4;;;83.8;91.9;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.3;41.3;;;33.3;49.8;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.7;91.7;;;86.5;95;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;52.5;52.5;;;33.9;70.4;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;50.4;50.4;;;42.1;58.7;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.5;64.5;;;53.7;74;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.6;39.6;;;25;56.4;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.3;70.3;;;64;76;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;28.6;28.6;;;19.2;40.2;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;51.3;51.3;;;43.9;58.5;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.5;38.5;;;28.3;49.8;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;19.5;19.5;;;14.5;25.8;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.0;9;;;5.6;14.2;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.6;67.6;;;57.9;76;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;CRDRATE;RACE;API;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;72.6;72.6;;;63.3;80.2;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.8;40.8;;;34.2;47.8;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.5;37.5;;;22.6;55.3;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;NMBR;GENDER;GENF;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;18.5;18.5;;;12.8;25.9;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.8;12.8;;;8.4;19;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.4;38.4;;;29.4;48.2;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.5;5.5;;;3.1;9.6;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.5;10.5;;;7.8;13.9;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2016;2016;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;92.8;92.8;;;85.5;96.6;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.8;5.8;;;3.5;9.6;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.9;49.9;;;44.2;55.6;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;81.0;81;;;68.7;89.2;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.9;9.9;;;9;10.9;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;51.8;51.8;;;44.3;59.3;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.6;6.6;;;5.7;7.7;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;60.5;60.5;;;45.2;73.9;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.5;9.5;;;8.9;10.1;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.2;8.2;;;4.6;14.3;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.2;86.2;;;80;90.7;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.4;13.4;;;11;16.3;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.2;88.2;;;77.5;94.2;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;51.6;51.6;;;46.1;57;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.9;36.9;**;US estimate/number is based on fewer than 50 states and the District of Columbia;34.8;38.2;Gender;Male;;;;;;;59;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.3;6.3;;;4.9;8.1;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.0;7;;;5.9;8.3;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;74.9;74.9;;;62.3;84.3;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.5;37.5;;;31.1;44.4;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;6.4;6.4;;;4.5;9;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.0;13;;;10.8;15.5;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.7;28.7;;;20;39.3;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.5;38.5;;;31.5;46;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;77.4;77.4;;;67.5;84.9;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;18.8;18.8;;;10.6;31;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.2;42.2;;;33.3;51.6;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.2;70.2;;;61.8;77.4;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;;Number;38;38;;;;;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2017;2017;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST4_1;NMBR;RACE;WHT;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;NMBR;RACE;BLK;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.2;40.2;;;35.2;45.4;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.1;39.1;;;20.1;62.1;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.9;42.9;;;34.5;51.7;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2017;2017;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.1;10.1;;;7.4;13.5;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.3;41.3;;;33.6;49.4;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.3;9.3;;;8.2;10.5;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;13.3;13.3;;;10;17.3;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.7;7.7;;;4.5;12.9;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.2;8.2;;;5;13.1;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.9;43.9;;;38.6;49.3;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.5;12.5;;;7.9;18.8;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.8;8.8;;;8.1;9.5;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2017;2017;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2017;2017;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;NMBR;RACE;API;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2016;2016;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;92.8;92.8;;;85.2;96.6;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;19.4;19.4;;;11.2;31.5;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2017;2017;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.7;13.7;;;10.7;17.4;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.4;12.4;;;11.2;13.6;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.0;8;;;6.6;9.6;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;30.9;30.9;;;26;36.3;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;75.5;75.5;;;67.6;82;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.7;40.7;;;34.5;47.3;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.9;13.9;;;12.8;15.1;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.7;41.7;;;36;47.7;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.7;34.7;;;24.9;45.9;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2017;2017;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;NMBR;GENDER;GENF;;;;
2017;2017;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2017;2017;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2017;2017;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.8;8.8;;;5.9;12.6;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2017;2017;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;NMBR;RACE;HIS;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;55.9;55.9;;;49.4;62.2;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;60.9;60.9;;;51;70;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;50.0;50;;;39.2;60.7;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;77.9;77.9;;;70.4;84;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.3;13.3;;;8.4;20.4;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.0;46;;;35.3;57.1;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.2;37.2;;;31.5;43.3;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2017;2017;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.6;8.6;;;7.5;9.9;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;5.5;5.5;;;3.6;8.2;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;15.6;15.6;;;8.9;26;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.7;12.7;;;9.7;16.4;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.2;9.2;;;8.2;10.3;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;57.3;57.3;;;48.7;65.5;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.2;87.2;;;78.1;92.9;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.7;39.7;;;29.2;51.3;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.4;85.4;;;72.3;92.9;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.9;35.9;;;25.7;47.6;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2016;2016;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;74.9;74.9;;;65.3;82.6;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.5;5.5;;;4;7.4;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;16.7;16.7;;;10;26.8;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.8;47.8;;;42.1;53.6;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.0;39;;;23.8;56.7;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.6;82.6;;;72.5;89.5;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2017;2017;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.907192, -77.036871);;11;AST;AST4_1;CRDRATE;RACE;API;;;;
2017;2017;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;;Number;39;39;;;;;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;23.6;23.6;;;12.7;39.5;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.1;7.1;;;4.2;11.7;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.3;11.3;;;7.9;15.9;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.4;38.4;;;31.6;45.6;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.0;38;;;32.9;43.3;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;55.7;55.7;;;43.7;67;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.0;86;;;78.1;91.4;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.6;41.6;;;36.1;47.3;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;78.8;78.8;;;71.4;84.8;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;80.6;80.6;;;67.6;89.2;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.1;12.1;;;10.3;14.3;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.9;7.9;;;5.9;10.3;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;79.2;79.2;;;69.2;86.6;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;53.2;53.2;;;38.4;67.5;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.1;37.1;;;22.8;54;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;92.0;92;;;86.7;95.3;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;76.2;76.2;;;66.2;84;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.1;11.1;;;8.6;14.4;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.9;32.9;;;24.9;42;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2017;2017;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;NMBR;RACE;AIAN;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;55.2;55.2;;;46.4;63.7;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.1;84.1;;;77.9;88.9;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;NMBR;GENDER;GENF;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.4;89.4;;;82.4;93.9;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.4;43.4;;;28.9;59.2;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.3;86.3;;;73.9;93.4;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.0;42;;;37.5;46.7;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.6;45.6;;;38.1;53.2;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.3;10.3;;;6.1;16.9;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.0;87;;;74.1;94;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.0;7;;;4.3;11.2;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.2;85.2;;;75.7;91.3;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.1;85.1;;;75.4;91.4;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.3;12.3;;;9.5;15.8;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.0;40;;;34.1;46.3;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.3;39.3;;;31.3;47.9;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;25.0;25;;;15.5;37.9;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.3;46.3;;;39.3;53.4;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.9;83.9;;;76.3;89.4;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.3;43.3;;;35.1;51.8;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.4;10.4;;;9.2;11.6;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2017;2017;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.9;10.9;;;9.6;12.3;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.8;82.8;;;71.3;90.3;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.0;63;;;52.5;72.4;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.9;91.9;;;87.5;94.8;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.0;89;;;82.3;93.4;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2017;2017;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;CRDRATE;RACE;API;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.7;10.7;;;9.2;12.5;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.8;33.8;;;23.4;46;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;32.1;32.1;;;23.3;42.4;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.2;11.2;;;8.1;15.2;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.4;14.4;;;8.6;22.9;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2017;2017;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;NMBR;RACE;HIS;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.8;88.8;;;81.6;93.3;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.6;62.6;;;47.9;75.3;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.7;82.7;;;70.9;90.4;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.5;43.5;;;37.4;49.9;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.6;82.6;;;73.8;88.9;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.2;7.2;;;6;8.5;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2017;2017;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.6;8.6;;;6.5;11.3;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.9;12.9;;;9.1;17.9;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.8;11.8;;;10.8;12.8;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.3;35.3;;;26.6;45;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.6;38.6;;;33.1;44.4;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.2;7.2;;;6.1;8.5;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.6;89.6;;;84.6;93.1;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;16.2;16.2;;;9.7;25.6;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.9;87.9;;;78.4;93.6;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.9;43.9;;;34.8;53.3;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.6;8.6;;;7.9;9.4;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.0;38;;;25.1;52.9;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.1;11.1;;;9;13.6;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.5;46.5;;;35.2;58.1;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.4;43.4;;;33.9;53.4;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.1;71.1;;;56.7;82.2;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;NMBR;RACE;API;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.6;39.6;;;33.9;45.6;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.8;46.8;;;36.7;57.1;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.7;41.7;;;36.2;47.5;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.7;48.7;;;40.7;56.7;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;19.4;19.4;;;13.9;26.5;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.8;8.8;;;8.2;9.5;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.7;39.7;;;31.7;48.3;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;95.7;95.7;;;89.2;98.4;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.5;10.5;;;8.6;12.8;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.4;39.4;;;33;46.1;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.4;37.4;;;25;51.6;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;15.2;15.2;;;9.8;22.9;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.8;82.8;;;72.2;89.9;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.2;6.2;;;4.1;9.2;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.0;85;;;68.9;93.6;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.1;36.1;;;29.9;42.9;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2017;2017;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.7;8.7;;;7.1;10.4;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.3;11.3;;;7.2;17.4;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.3;10.3;;;7.3;14.1;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.0;14;;;8.8;21.7;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;64.6;64.6;;;47.9;78.4;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.0;64;;;52.4;74.2;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;60.8;60.8;;;44.6;75;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2017;2017;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;NMBR;RACE;BLK;;;;
2016;2016;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;;Number;20;20;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;NMBR;RACE;WHT;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;51.5;51.5;;;40.4;62.5;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.0;82;;;72.2;88.9;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;54.7;54.7;;;42.8;66.1;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2017;2017;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;NMBR;GENDER;GENM;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.2;13.2;;;11.9;14.6;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;74.5;74.5;;;67.5;80.4;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;22.6;22.6;;;12.2;38;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.1;39.1;;;31.8;47;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.2;30.2;;;22.5;39.1;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.6;11.6;;;10.3;13;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.8;11.8;;;10.7;13;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;72.4;72.4;;;62.3;80.6;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2017;2017;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;4.5;4.5;;;2.8;7;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.0;46;;;34.1;58.3;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.8;69.8;;;61.4;77;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.9;45.9;;;37.8;54.2;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.3;32.3;;;22.8;43.6;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.0;37;;;27.8;47.3;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.4;13.4;;;11.6;15.5;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.4;9.4;;;8.2;10.7;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.0;11;;;9.9;12.1;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.7;42.7;;;35.8;49.8;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;22.8;22.8;;;14.6;33.9;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2017;2017;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.7;12.7;;;7.7;20.4;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2017;2017;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.0;62;;;51.5;71.5;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;52.5;52.5;;;43.9;60.9;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.5;13.5;;;11.3;16;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.6;46.6;;;39.2;54.2;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.1;36.1;;;32.2;40.2;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.7;31.7;;;23.6;41;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.4;43.4;;;36.7;50.3;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;91.9;91.9;;;85.5;95.7;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.9;37.9;;;24.3;53.8;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;74.2;74.2;;;66.6;80.7;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;CRDRATE;RACE;API;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.0;39;;;28.9;50.2;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.7;41.7;;;34.9;48.8;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.8;12.8;;;10;16.3;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;73.2;73.2;;;66.1;79.3;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.8;9.8;;;6.1;15.3;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.0;36;;;25.9;47.5;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.5;44.5;;;38;51.3;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.2;62.2;;;52.9;70.7;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.2;69.2;;;54.7;80.7;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;27.0;27;;;15.8;42;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.1;68.1;;;58.5;76.4;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.3;12.3;;;8;18.6;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.4;31.4;;;22.5;41.9;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.2;13.2;;;11.8;14.8;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2017;2017;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.7;87.7;;;81.1;92.2;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.9;86.9;;;80.2;91.5;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;92.0;92;;;84.4;96.1;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2016;2016;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.5;41.5;;;35.1;48.3;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;72.3;72.3;;;60;81.9;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;23.6;23.6;;;13.4;38.2;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.7;44.7;;;38.3;51.4;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;4.7;4.7;;;2.7;8;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.4;42.4;;;34.7;50.4;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;15.6;15.6;;;10.8;21.7;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.2;63.2;;;52.6;72.6;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2016;2016;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;96.3;96.3;;;90.6;98.6;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2017;2017;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.5;9.5;;;8.5;10.6;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.1;37.1;;;30.1;44.7;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.4;41.4;;;32.6;50.8;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.2;9.2;;;5.6;14.9;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.4;68.4;;;54.2;79.8;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.8;8.8;;;7.8;10;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.3;6.3;;;5.2;7.7;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;19.7;19.7;;;11.4;31.8;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.5;8.5;;;6.9;10.5;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.5;69.5;;;56.3;80.1;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.2;46.2;;;40.2;52.2;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.4;5.4;;;3.8;7.6;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.5;42.5;;;37.2;47.9;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.9;40.9;;;29.3;53.6;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.4;10.4;;;9.4;11.5;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.4;6.4;;;5;8.3;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2017;2017;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.1;5.1;;;4.1;6.4;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.2;7.2;;;6.3;8.1;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;64.3;64.3;;;53.3;74;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2017;2017;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.9;10.9;;;9.1;12.7;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2017;2017;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.3;89.3;;;78.5;95;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.2;38.2;;;24.4;54.1;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2017;2017;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;NMBR;RACE;AIAN;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.0;62;;;54.5;69.1;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.4;38.4;;;25.1;53.6;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;15.2;15.2;;;9.7;22.6;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.4;9.4;;;7.6;11.6;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.0;88;;;80.3;93;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;19.0;19;;;14.1;25.1;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.2;63.2;;;49.2;75.3;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;18.9;18.9;;;11.2;30;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.3;10.3;;;6.3;16.3;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.5;37.5;;;29.9;45.8;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.2;62.2;;;50.3;72.8;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.4;44.4;;;37.7;51.3;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.7;33.7;;;23.3;46;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.3;8.3;;;7.2;9.7;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.9;14.9;;;11.8;18.7;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.3;35.3;;;28.7;42.5;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;59.4;59.4;;;47.5;70.3;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.6;69.6;;;60.4;77.5;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;ME;Maine;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;NMBR;RACE;HIS;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.5;48.5;;;42.9;54.2;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.7;88.7;;;78.7;94.3;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.3;71.3;;;55.4;83.2;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.6;64.6;;;55.9;72.3;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;92.7;92.7;;;84.7;96.7;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.3;8.3;;;4.9;13.8;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.5;10.5;;;9.1;12.1;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;74.0;74;;;62.7;82.8;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.5;6.5;;;4.5;9.2;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2016;2016;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.0;34;;;24.3;45.2;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.5;8.5;;;7.5;9.7;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2017;2017;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.6;63.6;;;52.4;73.4;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.7;47.7;;;36.9;58.7;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;61.1;61.1;;;53.9;67.9;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.6;8.6;;;7.8;9.4;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;40.8;40.8;;;32;51.2;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2016;2016;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2017;2017;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.8;70.8;;;64.4;76.5;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.4;46.4;;;40.5;52.4;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.9;38.9;;;25;54.9;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.3;6.3;;;4.6;8.7;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.2;66.2;*;50 States + DC: US Median;64.7;70.1;Overall;Overall;;;;;;;59;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.8;46.8;;;37.3;56.5;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;64.1;64.1;;;27.2;89.5;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.5;42.5;;;33.9;51.5;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.8;42.8;;;38.5;47.1;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.0;38;;;26.2;51.5;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.8;65.8;;;57.5;73.2;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;58.0;58;;;43.6;71.1;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.5;11.5;;;8.8;14.9;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.7;10.7;;;9.5;12;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.0;28;;;19.4;38.6;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;51.9;51.9;;;37.1;66.5;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.2;5.2;;;3.9;6.8;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.7;45.7;;;38.9;52.6;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;54.5;54.5;;;34.6;73;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.4;42.4;;;35.3;49.7;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.8;83.8;;;73.6;90.5;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.6;12.6;;;11.2;14.2;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.9;6.9;;;4.9;9.6;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.0;42;*;50 States + DC: US Median;40.4;44.1;Overall;Overall;;;;;;;59;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.3;83.3;;;73.3;90.1;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.9;68.9;;;55.7;79.6;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;77.0;77;;;67.7;84.3;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.6;7.6;;;7.1;8.1;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.7;11.7;;;8.5;15.8;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.4;9.4;;;8.2;10.8;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.5;34.5;;;29.7;39.6;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.1;87.1;;;78.8;92.5;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;WA;Washington;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;NMBR;RACE;BLK;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.6;69.6;;;62.7;75.6;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.1;9.1;;;7.8;10.5;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.7;46.7;;;41.4;52.2;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.4;85.4;;;76.5;91.2;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.4;42.4;;;35.6;49.6;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;79.5;79.5;;;71.8;85.5;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.5;41.5;;;35.1;48.3;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.4;35.4;;;28.1;43.5;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;59.5;59.5;;;49.3;69;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.1;10.1;;;8.7;11.7;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.0;10;;;9;11;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;58.7;58.7;;;45.7;70.6;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.4;6.4;;;5.1;7.9;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.4;42.4;;;35.4;49.7;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.1;13.1;;;7.8;21.4;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.8;45.8;;;38.4;53.3;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.0;43;;;32.5;54.1;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;56.5;56.5;;;43.4;68.8;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;22.4;22.4;;;15.4;31.4;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.6;38.6;;;33.1;44.4;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.6;9.6;;;8.5;10.8;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.5;88.5;;;79.2;94;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.1;12.1;;;8.9;16.4;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;4.2;4.2;;;2.6;6.7;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.9;6.9;;;4.1;11.4;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.6;48.6;;;39.5;57.9;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.0;11;;;7.5;15.8;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.6;46.6;;;37.4;56;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;76.2;76.2;;;64.1;85.2;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;CRDRATE;RACE;API;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;22.0;22;;;17.7;27;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.0;36;;;26.4;46.9;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.2;33.2;;;17.6;53.7;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2017;2017;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;17.9;17.9;;;13.1;23.9;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2016;2016;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.8;8.8;;;6;12.8;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.3;10.3;;;8.8;12;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;19.8;19.8;;;10.9;33.3;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2017;2017;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.5;45.5;*;50 States + DC: US Median;44.1;47.1;Gender;Female;;;;;;;59;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;29.3;29.3;;;18.6;42.9;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2017;2017;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.5;10.5;;;8.7;12.3;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;47;47;;;;;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;NMBR;GENDER;GENF;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;24.9;24.9;;;17.8;33.6;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;64.0;64;;;45.3;79.3;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;94.0;94;;;87.2;97.3;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.2;37.2;;;32.3;42.5;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.3;12.3;;;10.9;13.8;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.6;44.6;;;39.4;50;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.0;13;;;10.3;16.3;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.3;89.3;;;83.2;93.3;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.6;47.6;;;43.6;51.6;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.9;5.9;;;4.7;7.5;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.9;47.9;;;36.4;59.6;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;51.3;51.3;;;43.7;58.8;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;26.8;26.8;;;15.4;42.5;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.9;12.9;;;10.2;16.2;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.3;13.3;;;10.6;16.6;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.9;41.9;;;36;48;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;CRDRATE;RACE;API;;;;
2016;2016;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.3;86.3;*;50 States + DC: US Median;85.2;88.3;Overall;Overall;;;;;;;59;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;MT;Montana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;NMBR;GENDER;GENM;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;21.1;21.1;;;13.1;32.2;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;60.8;60.8;;;53;68.1;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29.0;29;;;16.8;45.1;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.1;47.1;;;42.2;52;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.4;36.4;;;28.8;44.6;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;27.2;27.2;;;18.2;38.7;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;25.2;25.2;;;14.4;40.4;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2017;2017;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.0;12;;;10.6;13.5;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;UT;Utah;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;NMBR;RACE;API;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.9;9.9;;;8.7;11.1;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.0;10;;;9;11;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.8;65.8;;;58.3;72.6;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.9;28.9;;;20.3;39.4;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.6;41.6;;;36.3;47.1;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;76.7;76.7;;;62.3;86.8;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;80.1;80.1;;;67.1;88.9;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2017;2017;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.6;11.6;;;7.7;17.3;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;46.4;46.4;;;36.5;56.5;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.3;8.3;;;7.1;9.6;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.8;87.8;;;75.7;94.3;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.4;71.4;;;63.7;78;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.8;36.8;;;29.8;44.4;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;75.3;75.3;;;65.1;83.2;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.4;6.4;;;4.9;8.3;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.2;89.2;;;81.2;94;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.8;89.8;;;85.3;93.1;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.4;37.4;;;28.5;47.3;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;49.7;49.7;;;38.5;61;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;US;United States;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.6;11.6;*;50 States + DC: US Median;11.1;12.5;Gender;Female;;;;;;;59;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.3;65.3;;;52.8;75.9;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.8;68.8;;;61.7;75.2;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.4;63.4;;;54.1;71.8;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.5;7.5;;;6.4;8.8;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2017;2017;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;57.2;57.2;;;45.5;68.1;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;78.7;78.7;;;68.4;86.3;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.2;71.2;;;63.4;78;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.3;47.3;;;39.5;55.3;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.4;84.4;;;72.3;91.9;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.1;47.1;;;35.9;58.6;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2017;2017;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.6;36.6;*;50 States + DC: US Median;35.5;39.2;Gender;Male;;;;;;;59;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.2;39.2;;;32.7;46.2;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.6;49.6;;;42.8;56.4;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.3;8.3;;;5.5;12.3;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.5;87.5;;;78.8;93;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.0;14;;;11.2;17.3;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.5;7.5;;;6.5;8.7;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.8;41.8;;;34.2;49.8;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.2;36.2;;;29.7;43.2;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.6;34.6;;;26;44.3;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.7;39.7;;;33.1;46.6;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.3;10.3;;;5.8;17.8;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.1;41.1;;;37.4;44.8;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2016;2016;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.4;5.4;;;4.7;6.2;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;51.9;51.9;;;47.5;56.3;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.7;87.7;;;70.9;95.4;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.9;69.9;;;63.6;75.4;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.2;11.2;;;8.7;14.3;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.1;35.1;;;28.8;42;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.1;89.1;;;83.3;93.1;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.6;48.6;;;33.1;64.5;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.2;37.2;;;29.5;45.7;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.0;11;;;9.2;13.2;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2017;2017;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;;Number;65;65;;;;;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.5;6.5;;;5.4;7.9;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2017;2017;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.7;8.7;;;6.6;11.4;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.1;40.1;;;32.8;47.9;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;76.3;76.3;;;63.5;85.6;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.6;44.6;;;38.5;50.9;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;53.2;53.2;;;39;67;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.2;63.2;;;53.3;72;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;91.9;91.9;;;86.1;95.4;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2017;2017;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;NMBR;RACE;API;;;;
2017;2017;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2017;2017;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2017;2017;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;21.5;21.5;;;15.8;28.7;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2017;2017;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;17.4;17.4;;;13.1;22.7;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2017;2017;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.4;8.4;;;7;10.1;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.0;34;;;24.8;44.7;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.3;10.3;;;7.4;14.2;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;16.3;16.3;;;14.7;18;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;26.8;26.8;;;19.6;35.5;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.1;44.1;;;35.9;52.7;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;56.8;56.8;;;48.8;64.3;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.8;11.8;;;9.6;14.3;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.1;87.1;;;79.7;92;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;14.0;14;;;9.5;20.2;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.6;43.6;;;37.8;49.7;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.4;5.4;;;3.9;7.4;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.4;11.4;;;9.1;14.2;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90.7;90.7;;;82.9;95.2;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.0;10;;;6.8;14.2;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.9;68.9;;;62.1;75;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.1;9.1;;;6.8;11.9;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67.0;67;;;61.1;72.4;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.4;6.4;;;5.3;7.8;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;74.6;74.6;;;64.2;82.8;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.7;44.7;;;38.4;51.1;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2016;2016;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.9;38.9;;;34.3;43.7;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;78.5;78.5;;;65;87.8;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.0;12;;;7.6;18;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.3;35.3;;;24.9;47.2;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.8;48.8;;;42.6;55;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.0;37;;;28.1;46.8;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.0;45;;;38.3;51.9;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;56.1;56.1;;;42.7;68.7;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;19.5;19.5;;;13;28.2;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;78.7;78.7;;;68.6;86.2;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.8;43.8;;;30.7;57.9;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.5;89.5;;;81.9;94.1;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2017;2017;CA;California;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.5;13.5;;;9.5;18.8;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2017;2017;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.6;87.6;;;79.4;92.8;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.1;39.1;;;29.9;49.1;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.4;83.4;;;76.5;88.6;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.7;8.7;;;7.2;10.4;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;;Number;79;79;;;;;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;NMBR;GENDER;GENF;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;93.4;93.4;;;88.1;96.5;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.9;62.9;;;45.6;77.4;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67.6;67.6;;;58.4;75.6;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.1;36.1;;;26.6;46.7;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;51.2;51.2;;;43.2;59.2;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;94.1;94.1;;;90.7;96.4;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.1;11.1;;;9.6;12.9;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.5;6.5;;;5.6;7.5;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;15.7;15.7;;;12.5;19.6;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;15.6;15.6;;;10.7;22.1;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.8;9.8;;;8.7;11;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.4;9.4;;;8.4;10.4;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;5.6;5.6;;;3.5;8.4;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;8.1;8.1;;;6.7;9.9;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.1;47.1;;;29.5;65.3;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.9;39.9;;;28.7;52.3;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.2;13.2;;;10.4;16.5;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.5;33.5;;;25.4;42.8;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2017;2017;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;NMBR;GENDER;GENM;;;;
2017;2017;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.3;9.3;;;7.4;11.5;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.1;85.1;;;79.1;89.7;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.7;48.7;;;34.4;63.3;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.9;9.9;;;8.5;11.5;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.1;41.1;;;32.7;50.1;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;30.9;30.9;;;25;37.9;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;26.8;26.8;;;17.8;38.2;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.4;89.4;;;77.1;95.5;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.7;8.7;;;7.9;9.5;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2016;2016;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.3;40.3;;;33.5;47.6;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;79.5;79.5;;;68.9;87.2;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;26.0;26;;;18.6;35.1;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50.0;50;;;40.9;59.2;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.7;37.7;;;32.1;43.7;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.3;10.3;;;9.4;11.3;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.2;40.2;;;28.1;53.6;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.6;88.6;;;75.3;95.2;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;91.5;91.5;;;81.6;96.3;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.7;34.7;;;25.6;45.1;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.7;66.7;;;54.8;76.9;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.5;37.5;;;30.2;45.4;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.8;41.8;;;26.1;59.3;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.9;43.9;;;37;51.1;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.5;32.5;;;23;43.7;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;92.3;92.3;;;86.7;95.6;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.8;9.8;;;9;10.7;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.9;7.9;;;6.9;9;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;94.0;94;;;90.8;96.1;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.2;14.2;;;10.1;19.7;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2017;2017;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;80.8;80.8;;;69.1;88.8;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2017;2017;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;18.1;18.1;;;13.7;23.6;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;53.9;53.9;;;45.9;61.7;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.2;83.2;;;65.7;92.7;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2017;2017;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.7;44.7;;;38.5;51;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.5;66.5;*;50 States + DC: US Median;62.9;68.7;Gender;Female;;;;;;;59;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.3;42.3;;;33.2;51.9;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.0;70;;;59.1;79;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.7;7.7;;;6.3;9.3;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.3;71.3;;;60.1;80.4;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;79.8;79.8;;;65.8;89;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.4;43.4;;;31.2;56.5;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;15.1;15.1;;;12;18.8;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.5;40.5;;;34.9;46.4;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;16.0;16;;;14.5;17.6;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67.9;67.9;;;58.3;76.1;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;93.5;93.5;;;86.8;97;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.8;6.8;;;5;9.1;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.8;39.8;;;27.1;54;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.1;6.1;;;5.4;6.9;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.4;48.4;;;43;53.8;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.7;6.7;;;5;9;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.1;11.1;;;9.4;13.2;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;16.7;16.7;;;10.5;25.4;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.5;87.5;;;77.1;93.6;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.7;31.7;;;19.6;46.9;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;26.5;26.5;;;18.5;36.4;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.4;37.4;;;32.6;42.4;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;92.1;92.1;;;87.3;95.2;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.9;11.9;;;9.4;15;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.3;13.3;;;12;14.6;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;92.0;92;;;83.6;96.2;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.9;5.9;;;3.8;8.8;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.1;7.1;;;5.9;8.5;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.9;13.9;;;12.2;15.8;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2017;2017;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.5;46.5;;;40.3;52.9;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.3;39.3;;;28.9;50.7;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;94.7;94.7;;;86.9;98;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.3;41.3;;;34.5;48.4;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.3;46.3;;;41.3;51.5;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.4;47.4;;;35.7;59.5;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.3;39.3;;;27.9;52.1;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.9;10.9;;;9.1;13.1;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.0;9;;;8.1;9.9;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.2;84.2;;;71.5;91.9;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;23.8;23.8;;;15.6;34.5;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.1;14.1;;;7.7;24.5;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;43.5;43.5;;;33.4;54.2;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.9;42.9;;;31.9;54.6;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.7;47.7;;;41.1;54.3;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.3;46.3;;;41.3;51.4;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90.3;90.3;;;86.2;93.3;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.9;9.9;;;8.3;11.7;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;55.5;55.5;;;44.7;65.8;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2016;2016;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;51.9;51.9;;;42.6;61;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;26.6;26.6;;;16.3;40.4;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.8;41.8;;;35.7;48.2;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2017;2017;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.4;37.4;*;50 States + DC: US Median;35.7;40.1;Gender;Male;;;;;;;59;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2017;2017;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.3;6.3;;;5.4;7.4;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.3;44.3;;;38.6;50.2;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.7;10.7;;;9.7;11.9;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.4;34.4;;;25.6;44.4;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;56.2;56.2;;;39;72;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.2;87.2;;;69.3;95.4;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2017;2017;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;61.4;61.4;;;49.5;72;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.4;67.4;;;60.8;73.4;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;15.0;15;;;11.3;19.4;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.8;46.8;;;39.5;54.2;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.7;37.7;;;29.7;46.4;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2017;2017;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;NMBR;RACE;AIAN;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2017;2017;MT;Montana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;NMBR;RACE;AIAN;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;3.7;3.7;;;2.3;6;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;79.8;79.8;;;68.7;87.7;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.3;38.3;;;30.1;47.3;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.0;42;;;30.6;54.3;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2017;2017;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.0;10;;;7.3;13.3;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.3;88.3;;;83.4;91.8;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.9;9.9;;;8.9;11;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.2;43.2;*;50 States + DC: US Median;40.6;45;Gender;Female;;;;;;;59;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2017;2017;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;54.6;54.6;;;43.9;64.9;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.3;66.3;;;60.1;72;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.0;10;;;8.6;11.6;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.9;41.9;;;37.2;46.8;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90.0;90;;;83.5;94.2;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.6;31.6;;;25.8;38;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.2;14.2;;;11.6;17.2;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;93.5;93.5;;;84;97.5;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.9;33.9;;;27.2;41.3;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2017;2017;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.5;9.5;;;8.6;10.5;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.8;12.8;;;10.7;15.2;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.1;10.1;;;8.9;11.4;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.2;41.2;;;31.9;51.2;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;76.0;76;;;67.7;82.6;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.1;11.1;;;9.6;12.8;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.4;41.4;;;34.3;48.7;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;18.9;18.9;;;12.6;27.1;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.3;46.3;;;39;53.8;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;51.5;51.5;;;35.9;66.8;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.5;66.5;**;US estimate/number is based on fewer than 50 states and the District of Columbia;64.7;69.5;Gender;Female;;;;;;;59;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.8;14.8;;;10.5;20.4;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.5;37.5;;;22.9;54.7;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.8;33.8;;;23.7;45.7;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.8;8.8;;;8;9.6;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.6;36.6;;;27.5;46.8;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.7;13.7;;;11.9;15.7;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.1;89.1;;;81.2;93.9;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2016;2016;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.7;40.7;;;34.2;47.5;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2017;2017;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.2;49.2;;;42.4;56.1;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.2;39.2;;;26.5;53.6;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2017;2017;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.1;7.1;;;5.1;9.6;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.3;43.3;;;33;54.2;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;41.3;41.3;;;32;51.2;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.6;10.6;;;9.4;12;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;NY;New York;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.2;39.2;;;26.4;53.7;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;64.7;64.7;;;56.2;72.4;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.3;44.3;;;36.8;52;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.6;66.6;;;55.2;76.4;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.9;13.9;;;7.8;23.4;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;57.3;57.3;;;48.1;65.9;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.7;83.7;;;73.8;90.4;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.1;6.1;;;4.1;8.9;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.5;82.5;;;76;87.5;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.6;9.6;;;7.8;11.8;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.5;6.5;;;5.3;7.9;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.1;90.1;;;82.2;94.7;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.8;43.8;;;36.8;51;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.7;86.7;;;74;93.8;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2017;2017;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;;Number;108;108;;;;;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.9;69.9;;;60.3;78;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;50.9;50.9;;;32.5;69.1;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.0;11;;;9.7;12.4;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.8;43.8;;;32.3;56.1;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;51.4;51.4;;;44.6;58.2;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.5;41.5;;;37.4;45.7;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.9;9.9;;;8.5;11.6;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.3;63.3;;;55.9;70.1;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;20.2;20.2;;;10.9;34.5;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.9;41.9;;;30.9;53.7;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.8;36.8;;;29.3;45;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2017;2017;TX;Texas;NVSS;Asthma;Asthma mortality rate;;;Number;144;144;;;;;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;NMBR;GENDER;GENF;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.2;89.2;;;81.8;93.8;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.2;44.2;;;32;57.1;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.7;28.7;;;22.5;35.9;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;NMBR;RACE;API;;;;
2017;2017;FL;Florida;NVSS;Asthma;Asthma mortality rate;;;Number;61;61;;;;;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;NMBR;GENDER;GENM;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.5;43.5;;;37.7;49.4;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.4;42.4;;;35.5;49.6;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2017;2017;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.5;71.5;;;60.5;80.4;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.8;35.8;;;26.5;46.4;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.0;10;;;8.2;12.2;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.3;13.3;;;11.7;15;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;93.5;93.5;;;89;96.2;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.1;44.1;;;38;50.4;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.8;39.8;;;34.8;45.1;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.9;12.9;;;10;16.4;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.1;41.1;;;34.6;47.9;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.1;44.1;;;35.6;53;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.3;44.3;;;40;48.6;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.5;11.5;;;10.5;12.6;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.8;32.8;;;26.9;39.2;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.2;84.2;;;73.2;91.2;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.5;68.5;;;59.3;76.5;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.9;30.9;;;19.3;45.5;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;6.1;6.1;;;4.2;8.8;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;79.7;79.7;;;72;85.8;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.0;36;;;31.1;41.1;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.9;88.9;;;82.3;93.3;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.3;10.3;;;6.8;14.9;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.6;10.6;;;9.5;11.8;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.2;8.2;;;7.4;9;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.3;9.3;;;8.4;10.3;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.6;62.6;;;48.3;75.1;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;NMBR;RACE;BLK;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.4;38.4;;;25.7;53;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.9;11.9;;;7.3;18.8;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.9;65.9;;;55.7;74.9;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.9;8.9;;;8.2;9.6;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;52.8;52.8;;;33.7;71.1;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;15.1;15.1;;;12.7;18;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.4;11.4;;;8.8;14.6;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;4.7;4.7;;;3.6;6.1;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.7;11.7;;;7;19.1;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.8;48.8;;;42.6;55.1;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.3;43.3;;;36.3;50.6;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.5;42.5;;;36.1;49.2;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.1;87.1;;;80.1;91.9;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;91.5;91.5;;;83.9;95.7;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.5;6.5;;;5.4;7.9;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.3;11.3;;;6.6;18.5;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.2;10.2;;;9.2;11.3;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.6;88.6;;;79.7;93.8;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.6;7.6;;;5;11.5;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.6;40.6;;;27.7;55;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.0;10;;;7.7;12.7;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;14.7;14.7;;;9.9;21.2;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.2;7.2;;;4.1;12.1;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.2;62.2;;;49.8;73.1;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;80.3;80.3;;;66.1;89.5;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;58.8;58.8;;;51;66.1;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.4;5.4;;;3;9.5;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;51.8;51.8;;;39.6;63.8;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.2;71.2;;;63.5;77.8;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2017;2017;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.4;43.4;;;38.4;48.5;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.8;7.8;;;6.9;8.9;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;CA;California;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.9;11.9;;;9.5;14.9;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2017;2017;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;CRDRATE;RACE;API;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2017;2017;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.4;11.4;;;10.3;12.5;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;22.9;22.9;;;16.3;31.2;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.3;36.3;;;30;43.2;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.6;6.6;;;6.1;7.3;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.8;37.8;;;29.2;47.2;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.4;39.4;;;30.9;48.6;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.1;9.1;;;6.2;13.1;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.5;70.5;;;63.8;76.5;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.6;7.6;;;7;8.3;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.6;33.6;;;23.7;45.3;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.6;32.6;;;26.6;39.2;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.7;6.7;;;6.2;7.3;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.0;38;;;32.6;43.6;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.6;42.6;;;34.8;50.9;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.4;46.4;;;41.2;51.7;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.0;39;;;31.7;46.9;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.2;46.2;;;35.1;57.8;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.1;11.1;;;7.6;15.8;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.2;37.2;;;32;42.7;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.9;6.9;;;5.7;8.3;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.4;86.4;;;75.7;92.8;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;18.3;18.3;;;10.7;29.4;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.2;9.2;;;5.9;13.9;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;27.9;27.9;;;17.9;40.8;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2017;2017;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.7;66.7;;;50.8;79.5;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.8;64.8;;;48.4;78.3;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.1;7.1;;;6.4;7.8;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.0;11;;;9.1;13.2;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;92.0;92;;;87.6;94.9;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;59.0;59;;;47.4;69.6;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.8;46.8;;;41.2;52.4;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.6;7.6;;;6.8;8.6;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.9;37.9;;;28.4;48.4;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.1;46.1;;;40;52.4;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.2;39.2;;;31.7;47.2;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;ID;Idaho;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2017;2017;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;34.5;34.5;;;21.1;53.3;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.7;48.7;;;44.3;53.2;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;53.0;53;;;41.1;64.6;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.0;30;;;20.1;42.3;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.3;13.3;;;7.8;21.8;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.7;89.7;;;84.3;93.4;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.8;89.8;;;84.2;93.6;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.6;8.6;;;7.1;10.4;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.7;12.7;;;11.3;14.2;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.4;12.4;;;7.3;20.1;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.2;11.2;;;9.6;12.9;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.9;12.9;;;8.6;18.9;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29.2;29.2;;;20.8;39.2;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.7;70.7;;;63.9;76.6;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;15.6;15.6;;;13.9;17.5;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.8;39.8;;;36;43.7;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.7;41.7;;;34.5;49.2;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.0;10;;;9;11.1;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;28.8;28.8;;;20.7;39.1;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.2;10.2;;;6.2;16.4;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2017;2017;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.7;43.7;;;33.6;54.3;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;79.5;79.5;;;65.1;88.9;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.2;44.2;;;36.5;52.3;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.9;44.9;;;36.8;53.2;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;50.5;50.5;;;38.5;62.4;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67.9;67.9;*;50 States + DC: US Median;64.1;70.7;Overall;Overall;;;;;;;59;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.5;65.5;;;57.7;72.5;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.6;32.6;;;18.5;50.7;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.0;70;;;58.5;79.5;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;95.7;95.7;;;92.8;97.5;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.0;35;;;28.5;42.1;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;76.1;76.1;;;61.9;86.2;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.6;83.6;;;71.3;91.3;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.4;37.4;;;22.7;54.9;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;29.1;29.1;;;18.8;42.2;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.9;30.9;;;23.5;39.5;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.6;66.6;;;59.3;73.2;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.0;47;;;38.3;55.9;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.6;11.6;;;10.4;12.9;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.8;7.8;;;4.4;13.4;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2017;2017;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;73.4;73.4;;;55.6;85.9;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.7;9.7;;;8.6;10.9;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2016;2016;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.6;37.6;;;24.4;52.9;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;77.0;77;;;67.3;84.4;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.4;45.4;;;36.5;54.6;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.3;40.3;;;33.7;47.2;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.0;11;;;8.5;14;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;49.6;49.6;;;43.6;55.6;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.6;68.6;;;50.5;82.4;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2017;2017;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;23.0;23;;;14.7;34.1;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2017;2017;ND;North Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.6;45.6;;;29.8;62.4;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2016;2016;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.0;37;;;30.5;44;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.4;44.4;;;38.3;50.6;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.6;43.6;;;37.1;50.3;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.2;40.2;;;30;51.4;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2017;2017;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2017;2017;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.0;38;;;28.2;48.9;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.6;44.6;;;40.8;48.5;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2016;2016;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;77.7;77.7;;;68.6;84.8;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.0;10;;;7.6;13.1;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;7.9;7.9;;;4.6;13.3;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.6;63.6;;;54.8;71.6;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.9;6.9;;;4.3;10.8;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;NMBR;RACE;AIAN;;;;
2016;2016;US;United States;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.2;9.2;*;50 States + DC: US Median;8.6;9.8;Overall;Overall;;;;;;;59;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2017;2017;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.9;63.9;;;55.2;71.7;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.7;86.7;;;67;95.5;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2017;2017;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.6;86.6;;;76.8;92.7;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;92.3;92.3;;;83.9;96.5;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.4;6.4;;;5.5;7.3;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2017;2017;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.0;67;;;57;75.7;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29.2;29.2;;;21.7;38;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;80.8;80.8;;;70.8;87.9;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;81.4;81.4;;;72.9;87.7;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;58.3;58.3;;;44.8;70.8;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.8;36.8;;;23.9;52;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.1;6.1;;;5.2;7.1;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.1;49.1;;;42.8;55.4;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2017;2017;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;CRDRATE;RACE;API;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;52.7;52.7;;;38.3;66.6;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.5;14.5;;;9.8;20.8;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.0;38;;;29.8;46.9;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;60.9;60.9;;;54.6;66.8;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.7;39.7;;;30.5;49.6;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.0;42;;;35.3;48.9;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;94.4;94.4;;;89.8;97;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.3;42.3;;;34.1;51;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;7.2;7.2;;;4.3;11.7;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2017;2017;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.1;39.1;;;33.5;45;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.1;13.1;;;7.5;21.9;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.9;47.9;;;40.5;55.3;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.7;39.7;;;27.3;53.6;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.2;12.2;;;11.2;13.3;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;CT;Connecticut;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;15.6;15.6;;;12.6;19.2;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.4;11.4;;;9.7;13.4;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.4;12.4;;;9.5;16.1;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;19.9;19.9;;;11.3;32.5;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;57.8;57.8;;;48.3;66.8;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.9;42.9;;;35.8;50.4;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.1;88.1;;;82.9;91.8;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.3;69.3;;;63;74.9;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.4;14.4;;;12.7;16.4;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2017;2017;UT;Utah;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;NMBR;RACE;AIAN;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;18.8;18.8;;;12.3;27.6;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2016;2016;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.0;42;*;50 States + DC: US Median;41.6;44.3;Overall;Overall;;;;;;;59;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2017;2017;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.9;82.9;;;69.8;91;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;74.1;74.1;;;64.4;81.9;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.0;14;;;12;16.2;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.6;28.6;;;21.6;37;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.6;8.6;;;7.3;10.1;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.8;12.8;;;10.5;15.5;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.6;14.6;;;12.2;16.9;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.3;40.3;;;31.3;49.9;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.1;43.1;;;36;50.6;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.0;8;;;6.8;9.4;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;FL;Florida;NVSS;Asthma;Asthma mortality rate;;;Number;118;118;;;;;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;NMBR;GENDER;GENF;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.8;7.8;;;5.4;11;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.5;37.5;;;32.1;43.2;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.1;83.1;;;75.2;88.9;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.9;6.9;;;6.4;7.5;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.7;46.7;;;32.8;61;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.0;85;;;78.1;89.9;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2017;2017;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;4.8;4.8;;;3.2;7.1;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;61.8;61.8;;;49.2;72.9;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.7;40.7;;;30.8;51.3;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2017;2017;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;27.7;27.7;;;20.5;36.3;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;57.8;57.8;;;44.9;69.8;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.8;40.8;;;32.7;49.5;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.7;49.7;;;44.4;55;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.4;8.4;;;7.4;9.5;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;78.5;78.5;;;65.1;87.7;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.2;43.2;;;31.4;55.8;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2017;2017;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;;Number;92;92;;;;;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;53.3;53.3;;;39.3;66.8;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.1;46.1;;;34.3;58.4;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;81.2;81.2;;;74.3;86.6;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.4;9.4;;;8.2;10.7;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2017;2017;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;AR;Arkansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.1;12.1;;;8.2;17.4;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.7;40.7;;;33.1;48.6;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.2;12.2;;;10.2;14.6;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.1;14.1;;;11.3;17.3;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.4;44.4;;;35.4;53.7;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.8;39.8;;;26.3;55;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2016;2016;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.0;14;;;12.5;15.7;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2017;2017;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.8;7.8;;;7.2;8.4;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.5;7.5;;;6.2;8.9;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.9;10.9;;;10.2;11.7;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.9;44.9;;;39.6;50.4;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2017;2017;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.9;9.9;;;7.4;12.8;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2017;2017;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.2;8.2;;;5;12.7;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.5;38.5;;;32.7;44.7;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.5;12.5;;;9.9;15.7;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2016;2016;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.5;40.5;*;50 States + DC: US Median;38.6;42.1;Gender;Female;;;;;;;59;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.3;9.3;;;6.3;13.6;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2017;2017;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;4.7;4.7;;;3;7.2;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2017;2017;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.1;9.1;;;7.4;11.1;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.3;35.3;;;23.1;49.8;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.3;33.3;;;24.6;43.4;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2017;2017;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.0;42;;;36.9;47.3;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.2;36.2;;;28.7;44.5;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;15.5;15.5;;;11;21.4;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;49.8;49.8;;;40.8;58.8;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.2;90.2;;;84.9;93.8;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;AZ;Arizona;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.8;11.8;;;10.2;13.5;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.8;47.8;;;40;55.7;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2017;2017;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.5;11.5;;;9.5;13.8;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;6.6;6.6;;;4.5;9.5;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;WI;Wisconsin;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.7;9.7;;;6.4;14.6;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;15.8;15.8;;;13.8;17.9;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.0;7;;;5.7;8.7;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;74.1;74.1;;;65.2;81.3;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.1;44.1;;;37.2;51.2;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.8;87.8;;;77;93.9;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.8;33.8;;;23.3;46.2;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.9;69.9;;;63.2;75.9;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2017;2017;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.9;12.9;;;10.9;15.3;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2017;2017;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.1;10.1;;;9.1;11.1;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2017;2017;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.9;9.9;;;9;11;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.3;44.3;;;39.1;49.6;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.2;5.2;;;4.5;6.1;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.6;88.6;;;81.4;93.2;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.4;32.4;;;25.4;40.2;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.3;36.3;;;24.7;49.6;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;53.3;53.3;;;35.6;70.2;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.7;11.7;;;9.2;14.6;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.9;82.9;;;76.2;88;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.5;36.5;;;26.4;48;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2017;2017;IA;Iowa;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.9;10.9;;;8.1;14.6;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.0;37;;;30.3;44.3;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.6;40.6;;;33.3;48.5;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2017;2017;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.4;8.4;;;5.6;12.2;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;20.4;20.4;;;12.3;31.9;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.1;72.1;;;64.5;78.6;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.7;10.7;;;9.9;11.5;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.5;45.5;;;36.8;54.6;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.4;11.4;;;10.1;12.8;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.9;35.9;;;27.3;45.6;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2017;2017;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2017;2017;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;4.3;4.3;;;3.3;5.4;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.5;48.5;;;41.1;56;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;42.8;42.8;;;33.8;52.2;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.1;8.1;;;4.7;13.8;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2017;2017;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.4;12.4;;;9.6;15.8;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.2;88.2;;;79.3;93.6;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2017;2017;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.8;12.8;;;9.9;16.5;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.2;87.2;;;73.8;94.3;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.4;7.4;;;6.2;8.7;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2017;2017;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.4;12.4;;;8.8;16.8;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.1;11.1;;;8.4;14.5;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2017;2017;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2017;2017;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2017;2017;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.5;5.5;;;3.7;8.1;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;20.9;20.9;;;15.8;27.1;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2017;2017;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.1;70.1;;;61.8;77.3;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.9;7.9;;;5.6;11.1;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.0;10;;;9.2;10.8;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2017;2017;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.3;11.3;;;10.3;12.4;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2017;2017;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.8;7.8;;;5.6;10.6;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2016;2016;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.4;36.4;**;US estimate/number is based on fewer than 50 states and the District of Columbia;34.7;38.3;Gender;Male;;;;;;;59;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2017;2017;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.7;66.7;*;50 States + DC: US Median;63.5;69;Overall;Overall;;;;;;;59;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.2;5.2;;;4.3;6.4;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.4;10.4;;;6.9;15.2;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.6;44.6;;;38.5;50.8;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2016;2016;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.4;69.4;**;US estimate/number is based on fewer than 50 states and the District of Columbia;67.4;72.8;Gender;Male;;;;;;;59;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;15.3;15.3;;;11.5;19.9;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2017;2017;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;20.6;20.6;;;14.3;28.8;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;6.8;6.8;;;3.9;11.7;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.6;12.6;;;10.4;15.1;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2017;2017;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2017;2017;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.4;87.4;;;80.6;92;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.3;37.3;;;22.4;55.2;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2017;2017;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2017;2017;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.3;40.3;;;34.3;46.6;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.3;8.3;;;4.7;14.3;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.3;34.3;;;27.8;41.4;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.4;41.4;;;36.2;46.8;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.0;38;;;23.7;54.8;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2017;2017;MS;Mississippi;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.1;9.1;;;7;11.9;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.1;5.1;;;3.9;6.7;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2017;2017;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2017;2017;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2017;2017;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2016;2016;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.4;35.4;;;31;40.1;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2017;2017;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.7;30.7;;;25.3;36.7;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.3;31.3;;;21.9;42.5;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2017;2017;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;4.5;4.5;;;2.6;7.7;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.9;86.9;;;78.2;92.5;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.9;88.9;;;82.3;93.3;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.2;38.2;;;30.3;46.8;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;22.3;22.3;;;15.5;31.1;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;56.2;56.2;;;36;74.5;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.9;11.9;;;9.1;15.5;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.0;42;;;33.3;51.3;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.0;39;;;25.5;54.4;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;52.5;52.5;;;46.2;58.7;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.4;63.4;;;52.2;73.3;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.8;42.8;;;37.7;48;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.5;34.5;;;27.8;42;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.9;86.9;;;80.2;91.6;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.2;43.2;;;35.4;51.4;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;73.0;73;;;61.9;81.7;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.9;43.9;;;34.1;54.2;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.1;90.1;;;83;94.5;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.1;39.1;;;30.1;49;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.1;7.1;;;4;12.2;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.4;41.4;;;34.5;48.8;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.5;7.5;;;4.9;11.2;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;73.9;73.9;;;65.6;80.8;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;73.3;73.3;;;63.7;81.1;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;30.3;30.3;;;23.7;37.7;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.6;39.6;;;35.1;44.2;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.5;14.5;;;12.5;16.6;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.1;65.1;;;57.8;71.8;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;60.3;60.3;;;42.7;75.6;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.5;10.5;;;9.6;11.5;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.3;6.3;;;4.4;9.1;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;15.9;15.9;;;12.2;20.4;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.3;89.3;;;82.7;93.6;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.8;45.8;;;39.8;51.8;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.1;34.1;;;24.3;45.4;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;72.8;72.8;;;59.3;83.1;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;75.2;75.2;;;68.2;81.1;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.0;6;;;5.1;7;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.0;65;;;52.9;75.5;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;43.8;43.8;;;35;53;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.9;83.9;;;74.4;90.3;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.2;89.2;;;83;93.3;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.1;36.1;;;23.8;50.5;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2016;2016;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.6;11.6;;;10.7;12.5;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.5;30.5;;;17.8;47.2;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.0;11;;;8.8;13.7;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;80.5;80.5;;;73;86.3;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.6;6.6;;;5.1;8.5;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;92.5;92.5;;;84.8;96.5;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;74.7;74.7;;;60.7;85;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.2;47.2;;;38.8;55.8;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.6;62.6;;;48.6;74.8;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.8;38.8;;;31.8;46.4;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.1;10.1;;;9.2;11;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50.5;50.5;;;43.6;57.4;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.6;43.6;;;38.6;48.6;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.2;84.2;;;71.3;92;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.2;8.2;;;7.2;9.3;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.4;88.4;;;82.9;92.2;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.2;90.2;;;83.5;94.4;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.3;14.3;;;12.6;16.2;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.6;71.6;;;56.2;83.3;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.1;38.1;;;28.8;48.4;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.8;37.8;;;27.1;49.9;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;57.9;57.9;;;41.6;72.6;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.3;5.3;;;4.7;6;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.7;36.7;;;29.9;44.1;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.5;8.5;;;7.6;9.6;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;55.2;55.2;;;45.7;64.3;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.7;44.7;;;35.2;54.5;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.6;69.6;;;55.9;80.4;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.3;5.3;;;4.4;6.4;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;76.0;76;;;63.4;85.3;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.6;7.6;;;4.7;12.1;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.2;11.2;;;9.4;13.3;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;49.7;49.7;;;44.4;55;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.6;44.6;;;27.1;63.7;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29.1;29.1;;;20.5;39.4;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.6;46.6;;;34.7;58.9;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;75.4;75.4;;;61.3;85.6;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.3;39.3;;;30.6;48.8;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.0;72;;;60.5;81.2;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.3;9.3;;;7.5;11.5;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;55.3;55.3;;;48.7;61.7;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.4;89.4;;;83.9;93.1;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.1;46.1;;;29.9;63.2;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.9;39.9;;;29.4;51.5;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.3;10.3;;;9.3;11.4;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;15.3;15.3;;;11.9;19.5;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.9;89.9;;;83.4;94;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;49.4;49.4;;;41.7;57.2;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.6;7.6;;;6.5;8.8;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;92.5;92.5;;;81.2;97.2;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.6;38.6;;;33.5;43.9;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;60.0;60;;;42.2;75.5;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;15.7;15.7;;;10.8;22.4;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.3;44.3;;;39.5;49.2;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.6;32.6;;;17.7;52;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.2;11.2;;;9.1;13.7;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.0;89;;;76.7;95.2;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.3;7.3;;;6.5;8.2;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;73.2;73.2;;;63.5;81.1;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.1;82.1;;;70.4;89.8;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.9;44.9;;;31.4;59.1;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;59.0;59;;;50.3;67.2;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;53.0;53;;;44.9;61;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.1;44.1;;;35.1;53.6;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.5;12.5;;;10.8;14.4;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;93.9;93.9;;;83.9;97.8;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.5;34.5;;;30.4;38.9;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.0;8;;;7.3;8.9;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;17.0;17;;;13.2;21.6;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.9;6.9;;;5.8;8.2;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.1;9.1;;;5.2;15.5;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.4;7.4;;;6.3;8.7;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.6;35.6;;;24.4;48.5;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.6;70.6;;;64.6;75.9;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.1;10.1;;;7.5;13.4;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.6;5.6;;;4.7;6.7;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.8;8.8;;;7.4;10.3;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.6;13.6;;;12;15.4;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.2;49.2;;;37.2;61.4;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;79.6;79.6;;;62.7;90;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.2;84.2;;;76.5;89.7;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2013;2013;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.4;39.4;;;32.7;46.5;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.5;9.5;;;7.6;11.8;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;23.6;23.6;;;17.5;31.1;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.9;38.9;;;27.7;51.5;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.6;6.6;;;5.4;8;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;19.6;19.6;;;14;26.8;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.3;48.3;;;41.7;54.9;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.4;41.4;;;35.1;48.1;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.4;39.4;;;31.5;47.9;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2016;2016;NY;New York;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.6;12.6;;;9.3;16.8;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.9;14.9;;;12.6;17.5;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;52.9;52.9;;;44.6;61.1;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.2;85.2;;;79.8;89.4;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;15.6;15.6;;;13.8;17.5;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.4;9.4;;;5.8;15;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.6;89.6;;;82.4;94;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;29.6;29.6;;;23.2;37;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;25.7;25.7;;;16;38.5;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.4;13.4;;;9.3;18.9;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.2;63.2;;;48.8;75.6;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.5;41.5;;;35.7;47.5;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.2;11.2;;;10.2;12.4;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.2;88.2;;;77.8;94.1;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.3;38.3;;;33.2;43.7;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.5;63.5;;;53.1;72.8;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.1;32.1;;;24.8;40.3;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.7;46.7;;;39.4;54.1;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;76.3;76.3;;;68;83;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.9;9.9;;;9.2;10.6;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.5;70.5;;;63.8;76.5;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.2;69.2;;;61.7;75.8;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;92.3;92.3;;;86.4;95.8;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.4;11.4;;;8.3;15.5;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.8;11.8;;;8.6;15.9;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.7;89.7;;;77.8;95.6;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.5;43.5;;;38.7;48.3;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.9;9.9;;;7.3;13.4;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.4;13.4;;;12.2;14.8;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.0;45;;;36.9;53.5;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;74.4;74.4;;;65.7;81.5;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.7;40.7;;;31.9;50;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.5;42.5;;;37;48.3;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.0;8;;;6.8;9.5;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.3;42.3;;;32.4;52.8;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.1;37.1;;;30.3;44.5;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;5.7;5.7;;;3.2;9.7;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;59.4;59.4;;;51.3;67;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.4;9.4;;;8.1;11;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.2;36.2;;;28.3;45;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;76.4;76.4;;;69;82.5;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.1;13.1;;;7.6;21.5;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.0;64;;;55.1;71.9;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.9;43.9;;;28;61.1;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.9;30.9;;;18.1;47.5;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.3;86.3;;;81.2;90.2;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.4;84.4;;;74.9;90.8;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;54.2;54.2;;;41.7;66.1;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.6;44.6;;;36.9;52.6;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.6;11.6;;;8.5;15.6;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.0;9;;;7.4;10.8;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;81.6;81.6;;;71.3;88.8;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;4.6;4.6;;;2.8;7.5;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.5;5.5;;;3.7;8.2;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.1;11.1;;;10;12.2;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.1;39.1;;;30.6;48.2;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.0;63;;;49.2;75;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.8;41.8;;;36.7;47.2;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.6;28.6;;;21.8;36.6;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.9;45.9;;;35.8;56.4;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.2;70.2;;;60.8;78.2;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;4.5;4.5;;;2.6;7.5;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.6;47.6;;;36.6;58.8;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50.6;50.6;;;44;57.3;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.0;13;;;10;16.8;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.1;47.1;;;35.6;58.8;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.7;68.7;;;59.8;76.4;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.8;39.8;;;26.1;55.2;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.3;65.3;;;49.1;78.6;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;58.5;58.5;;;43.8;71.8;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.8;7.8;;;7;8.8;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.7;6.7;;;5.5;8.3;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.2;43.2;;;36.9;49.7;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.8;8.8;;;5.8;13.2;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.2;45.2;;;32.6;58.5;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.1;14.1;;;10.4;18.7;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.6;82.6;;;71.5;89.9;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.0;8;;;7;9.1;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.8;85.8;;;77;91.6;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.1;44.1;;;37;51.5;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.1;86.1;;;75.1;92.7;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;72.8;72.8;;;66.3;78.5;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;59.0;59;;;47.8;69.3;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;53.0;53;;;41.5;64.1;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.5;13.5;;;10.2;17.6;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.4;43.4;;;38.5;48.6;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.3;90.3;;;84.2;94.2;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.9;87.9;;;79.8;93.1;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.7;70.7;;;57.5;81.1;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.7;12.7;;;11.5;14;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.2;63.2;;;47.5;76.6;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;57.2;57.2;;;42.5;70.8;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.6;31.6;;;22.8;41.8;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.2;38.2;;;30.2;47;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.4;9.4;;;8.3;10.8;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.3;43.3;;;32.3;55;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.9;42.9;;;37.2;48.8;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.3;9.3;;;7.5;11.6;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.0;7;;;6;8.3;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2016;2016;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;18.7;18.7;;;11.5;28.8;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;58.3;58.3;;;47.8;68;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;33.6;33.6;;;24;44.7;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.9;5.9;;;4.1;8.4;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.7;10.7;;;9.5;11.9;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;52.3;52.3;;;31.2;72.6;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.3;39.3;;;31.5;47.7;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;92.5;92.5;;;67.5;98.6;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.2;49.2;;;42;56.5;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.0;41;;;33;49.4;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.5;86.5;;;80.3;90.9;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.0;68;;;60.1;75;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.3;6.3;;;5.2;7.7;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.0;40;;;31.1;49.7;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2016;2016;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.1;70.1;**;US estimate/number is based on fewer than 50 states and the District of Columbia;68.4;74;Gender;Male;;;;;;;59;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.3;87.3;;;77.1;93.3;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.4;37.4;;;32.2;42.8;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.8;6.8;;;5.7;8.2;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.0;8;;;6.1;10.5;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.1;71.1;;;59.1;80.7;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.3;44.3;;;27.2;62.9;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.8;66.8;;;54.9;76.9;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.1;36.1;;;28.8;44.2;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;44.7;44.7;;;33.8;56.2;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;75.1;75.1;;;67.2;81.6;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.8;14.8;;;13.5;16.2;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;80.1;80.1;;;73.3;85.5;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.9;37.9;;;30.6;45.7;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.6;9.6;;;5.9;15.3;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.8;41.8;;;37.3;46.3;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.5;12.5;;;9.9;15.8;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.9;6.9;;;5.7;8.4;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.1;8.1;;;4.9;13.3;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.4;8.4;;;7.2;9.9;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.5;41.5;;;34.3;49;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;16.1;16.1;;;10.6;23.5;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90.5;90.5;;;84.2;94.4;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.7;7.7;;;7.1;8.3;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;91.8;91.8;;;86.1;95.2;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.7;10.7;;;9.3;12.2;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.0;9;;;8;10.1;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.3;45.3;;;34.3;56.7;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2016;2016;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.1;41.1;;;34.4;48.1;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;75.8;75.8;;;61.1;86.1;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.3;91.3;;;83.5;95.6;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.5;43.5;;;36.1;51.1;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.4;41.4;;;35.6;47.4;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;58.8;58.8;;;44.3;72;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;51.3;51.3;;;45.8;56.8;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.4;67.4;;;51.9;79.8;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.2;43.2;;;37.9;48.6;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.5;62.5;;;51.9;72.1;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.4;10.4;;;7.7;13.8;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.2;38.2;;;32.5;44.4;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.1;5.1;;;4.2;6.2;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;54.6;54.6;;;41.1;67.4;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2016;2016;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.3;68.3;;;61.9;74;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;81.3;81.3;;;70.9;88.6;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;54.0;54;;;39.2;68;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.4;45.4;;;29.4;62.5;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.1;31.1;;;22.9;40.6;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90.4;90.4;;;83.1;94.7;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.1;70.1;;;52.5;83.3;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;22.1;22.1;;;15.3;30.8;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.0;47;;;41.1;52.9;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;94.8;94.8;;;87.3;98;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.6;6.6;;;5.9;7.4;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2016;2016;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.9;36.9;;;28;46.7;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.1;8.1;;;7.3;9;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.2;47.2;;;29.5;65.5;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;92.7;92.7;;;83.5;97;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2016;2016;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.5;11.5;;;10.6;12.4;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.1;34.1;;;26.2;43;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.8;37.8;;;24.4;53.4;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.7;6.7;;;5.8;7.7;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.6;10.6;;;9.5;11.9;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.3;32.3;;;23.2;43;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.6;42.6;;;35.6;49.8;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.7;91.7;;;86.8;94.9;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;27.7;27.7;;;15.7;44.2;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;64.8;64.8;;;51.5;76.1;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.0;44;;;37.6;50.7;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.3;46.3;;;39.6;53.1;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.8;46.8;;;32.6;61.6;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.5;42.5;;;37.6;47.6;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.2;12.2;;;7.2;20;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.7;70.7;;;55.7;82.3;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.7;84.7;;;77.1;90.2;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;54.0;54;;;44.9;62.9;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.4;5.4;;;3.9;7.3;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.0;43;;;37.1;49.1;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.9;40.9;;;31.2;51.4;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.2;63.2;;;50.6;74.3;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.8;89.8;;;84.5;93.4;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.4;11.4;;;8.4;15.3;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.4;48.4;;;36.2;60.7;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.0;7;;;5.8;8.5;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.6;10.6;;;8.9;12.6;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.4;44.4;;;37.7;51.4;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.5;46.5;;;34.8;58.6;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.7;44.7;;;38.8;50.7;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.7;40.7;;;33.7;48;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.5;68.5;;;61.5;74.7;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;93.0;93;;;86.5;96.5;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.5;46.5;;;39.5;53.7;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;41.3;41.3;;;31.7;51.7;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.4;40.4;;;31.5;49.9;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.0;43;;;34.4;52;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.2;9.2;;;8;10.6;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.6;39.6;;;30.7;49.4;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.3;37.3;;;23.6;53.4;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.1;8.1;;;7.3;9;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.2;8.2;;;5.8;11.7;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.6;71.6;;;62.3;79.4;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.1;9.1;;;7.9;10.6;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;4.9;4.9;;;3.7;6.6;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.9;5.9;;;4.8;7.2;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.9;65.9;;;57.8;73.1;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;13.62;13.62;;;12.91;14.32;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;49.7;49.7;;;42.9;56.5;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;51.5;51.5;;;40;62.8;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.9;43.9;;;37.6;50.5;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.1;6.1;;;4.1;9;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.7;85.7;;;77.2;91.4;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.4;10.4;;;9.1;12;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.4;8.4;;;7.5;9.4;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.4;63.4;;;42.4;80.3;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.1;9.1;;;7.1;11.5;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.3;40.3;;;36.3;44.6;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.7;84.7;;;78.8;89.3;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.5;35.5;;;28.4;43.3;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.7;70.7;;;62.4;77.7;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.1;72.1;;;61;81.1;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;52.2;52.2;;;47.9;56.6;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.5;39.5;;;32.7;46.8;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.3;89.3;;;82.9;93.4;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.2;10.2;;;8.4;12.4;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.7;41.7;;;34.5;49.2;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.0;10;;;9.2;10.9;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.5;87.5;;;80.7;92.1;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.8;14.8;;;13.3;16.4;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.5;12.5;;;11.6;13.6;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;53.1;53.1;;;41.4;64.5;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.4;88.4;;;83.8;91.9;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.4;66.4;;;57.4;74.4;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.8;9.8;;;8.3;11.5;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.1;10.1;;;9.2;11.1;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.7;7.7;;;6.2;9.5;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.7;87.7;;;82.8;91.4;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.9;90.9;;;83.6;95.2;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;61.5;61.5;;;55.2;67.5;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.7;34.7;;;25.5;45.3;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.3;84.3;;;77.5;89.3;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.0;40;;;31.1;49.7;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.2;14.2;;;9;21.6;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.6;83.6;;;73.8;90.2;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.7;69.7;;;62.9;75.8;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;55.0;55;;;43.5;66;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.3;40.3;;;34.3;46.6;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.4;47.4;;;40;54.9;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;0.0;0;##;Estimate is 0.0% because no cases were reported with this condition;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.0;67;;;57.6;75.2;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.4;45.4;;;35.7;55.5;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;4.9;4.9;;;2.8;8.3;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.2;11.2;;;10.3;12.2;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;43.8;43.8;;;35;53;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.2;69.2;;;50.8;83;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2016;2016;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.5;36.5;;;26.7;47.6;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;76.4;76.4;;;67.8;83.3;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.3;5.3;;;4.7;6;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.8;83.8;;;73.5;90.6;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.0;42;;;32;52.6;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.7;43.7;;;34.1;53.8;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.2;13.2;;;9.3;18.5;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.7;8.7;;;7;10.7;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.9;10.9;;;10.1;11.9;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.5;11.5;;;10.5;12.6;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.6;10.6;;;6.5;17;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.0;49;;;38.4;59.6;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.6;36.6;;;31.3;42.3;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.9;62.9;;;50.6;73.7;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;73.3;73.3;;;64.6;80.5;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.1;38.1;;;20.9;58.9;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.6;6.6;;;3.8;11.1;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.9;85.9;;;79.7;90.5;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.4;39.4;;;32.7;46.6;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.7;13.7;;;10.1;18.4;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.1;6.1;;;4.7;7.8;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.6;42.6;;;34.3;51.4;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.8;9.8;;;8.9;10.8;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.6;6.6;;;5.9;7.4;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.3;40.3;;;32.2;49;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.9;38.9;;;29.6;48.9;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;93.6;93.6;;;87.9;96.7;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.8;14.8;;;12.4;17.6;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;57.5;57.5;;;47.6;66.9;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.5;32.5;;;21.4;46.1;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.3;40.3;;;35.5;45.2;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.5;39.5;;;32;47.5;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.3;38.3;;;28.5;49.1;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.4;14.4;;;9.9;20.5;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.5;87.5;;;77.5;93.4;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.7;87.7;**;US estimate/number is based on fewer than 50 states and the District of Columbia;86.5;89.4;Gender;Female;;;;;;;59;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.7;46.7;;;38.8;54.7;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.7;7.7;;;6.9;8.6;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.4;7.4;;;6.2;8.8;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;15.2;15.2;;;11.2;20.5;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.0;67;;;59.6;73.6;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.7;42.7;*;50 States + DC: US Median;41.1;44.4;Gender;Female;;;;;;;59;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.5;85.5;;;79.7;89.9;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;92.3;92.3;;;88.3;95;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.9;10.9;;;9;13.1;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.0;49;;;41.4;56.7;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.6;36.6;;;29.4;44.5;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.5;10.5;;;7.3;14.8;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;7.9;7.9;;;4.5;13.6;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;94.0;94;;;86.2;97.5;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;80.7;80.7;;;68.6;88.9;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.0;38;;;27.3;50;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;55.1;55.1;;;42.2;67.3;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.4;46.4;;;37.4;55.7;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.7;36.7;;;28.4;45.9;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.3;38.3;;;30.6;46.7;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;79.8;79.8;;;63.1;90.2;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.9;7.9;;;4.5;13.5;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.8;8.8;;;6.2;12.2;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;91.4;91.4;;;86.8;94.5;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.1;39.1;;;34;44.5;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;79.6;79.6;;;63;89.9;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.8;38.8;;;31.2;47;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.7;13.7;;;10.6;17.6;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.1;36.1;;;24.5;49.5;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.4;85.4;;;78.5;90.4;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;28.9;28.9;;;17.5;43.7;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.8;8.8;;;7.1;10.9;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;4.8;4.8;;;3.3;6.9;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2016;2016;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.0;6;;;5.1;7;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;61.5;61.5;;;49.5;72.3;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.7;44.7;;;37.9;51.6;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.8;86.8;;;77.2;92.7;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.0;34;;;25.4;43.7;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;60.8;60.8;;;47.2;72.8;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2016;2016;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.2;8.2;;;7.5;8.9;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;61.3;61.3;;;47.8;73.2;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.0;46;;;40.2;52;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2016;2016;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.3;8.3;;;7.2;9.5;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.4;33.4;;;26.3;41.5;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.2;10.2;;;9.2;11.2;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2016;2016;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;78.6;78.6;;;72.4;83.7;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.8;47.8;;;36.3;59.6;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.6;13.6;;;12.5;14.9;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.9;69.9;;;61.4;77.1;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.2;66.2;;;58.8;72.9;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.2;38.2;;;31.7;45.1;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.1;48.1;;;41;55.2;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.9;10.9;;;9.1;13;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;64.9;64.9;;;55.2;73.5;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.4;8.4;;;7.5;9.5;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.2;12.2;;;10.8;13.6;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.3;7.3;;;5.8;9.2;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.9;12.9;;;8.2;19.7;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90.6;90.6;;;83.1;95;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.9;35.9;;;25.5;47.8;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.0;62;;;52.2;70.9;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.7;38.7;;;33.5;44.1;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.1;40.1;;;34.9;45.5;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.1;71.1;;;59.8;80.3;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.4;39.4;**;US estimate/number is based on fewer than 50 states and the District of Columbia;37.9;42.2;Gender;Male;;;;;;;59;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;53.6;53.6;;;42.6;64.4;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.1;41.1;;;36;46.3;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.0;46;;;37.3;55;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.7;89.7;;;78.9;95.3;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.6;28.6;;;21.5;36.9;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.2;8.2;;;7.2;9.3;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.0;40;;;28.4;52.9;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;74.2;74.2;;;61.5;83.7;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;51.7;51.7;;;33.3;69.7;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.2;43.2;;;38.3;48.3;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.3;36.3;;;28.1;45.4;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.8;38.8;;;32.3;45.8;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.1;64.1;;;51.8;74.8;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.7;66.7;;;56.7;75.4;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.9;37.9;;;29;47.7;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.6;5.6;;;4.6;6.8;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;52.0;52;;;45.8;58.1;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;17.2;17.2;;;11.5;25.1;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;7.8;7.8;;;6.7;9.1;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;58.8;58.8;;;48.1;68.8;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.6;41.6;;;31.8;52;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.9;36.9;;;31.3;42.8;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.2;11.2;;;7.5;16.4;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.4;40.4;;;35.2;45.8;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;23.1;23.1;;;15.2;33.6;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.4;11.4;;;9.5;13.8;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.8;45.8;;;32.3;59.9;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;61.0;61;;;52;69.2;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.8;8.8;;;8.2;9.4;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.3;35.3;;;28;43.5;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.3;10.3;;;7.8;13.5;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.6;7.6;;;6.7;8.6;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.1;9.1;;;5.4;15;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;23.9;23.9;;;13.3;39.3;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;20.1;20.1;;;11.7;32.1;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;17.0;17;;;11;25.2;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.4;10.4;;;7.4;14.4;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.5;47.5;;;38;57.2;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;51.2;51.2;;;41.5;60.8;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.3;62.3;;;51.6;71.9;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.8;9.8;;;8.6;11.2;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.2;43.2;;;36.7;49.9;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;58.0;58;;;49.3;66.2;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.4;6.4;;;5.6;7.2;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.2;5.2;;;4.5;6;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.8;37.8;;;31.3;44.8;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.0;6;;;4.6;8;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2016;2016;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;75.2;75.2;;;65.2;83.1;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.5;66.5;;;55.1;76.3;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.7;5.7;;;3.8;8.5;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.3;62.3;;;54.2;69.8;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;94.9;94.9;;;87.9;97.9;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.1;66.1;;;60.2;71.5;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;17.7;17.7;;;9.6;30.5;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;51.3;51.3;;;38.5;63.9;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.6;9.6;;;8.9;10.3;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.6;38.6;;;22.9;57;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.9;40.9;;;34.3;47.8;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.5;8.5;;;7.5;9.6;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.8;42.8;;;27.7;59.4;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.8;39.8;;;27.8;53.1;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;61.7;61.7;;;51.5;70.9;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.2;66.2;;;58.9;72.8;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.6;88.6;;;82.3;92.9;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;51.0;51;;;42;60;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.0;39;;;34.3;43.9;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.6;5.6;;;3.8;8.1;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;16.0;16;;;13.2;19.4;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.4;12.4;;;11.2;13.7;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.5;8.5;;;7.8;9.4;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.2;40.2;;;33.6;47.2;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.2;42.2;;;29.9;55.6;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2016;2016;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29.6;29.6;;;21.9;38.6;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;17.3;17.3;;;10.7;26.7;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.4;8.4;;;7.4;9.5;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.7;6.7;;;6.2;7.3;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.4;14.4;;;7.8;24.9;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;16.3;16.3;;;9.4;26.7;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;55.5;55.5;;;46.8;63.8;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.5;43.5;;;35.5;51.9;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;53.5;53.5;;;45.3;61.5;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.0;36;;;28.9;43.7;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.6;8.6;;;7.6;9.8;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;51.5;51.5;;;44.8;58.2;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.8;90.8;;;84.4;94.8;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.7;88.7;;;80.5;93.7;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.2;6.2;;;5.2;7.3;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.8;64.8;;;45;80.5;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.9;40.9;;;33;49.4;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.4;40.4;;;34;47.3;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.2;63.2;;;54.8;70.9;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.3;88.3;;;80.4;93.3;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.0;7;;;5.9;8.3;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.4;9.4;;;8.5;10.3;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;24.8;24.8;;;14;39.9;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.5;10.5;;;9.1;12.1;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;22.5;22.5;;;15;32.3;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;58.7;58.7;;;44.3;71.8;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.0;45;;;36.9;53.4;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.8;49.8;;;37.8;61.8;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.2;12.2;;;10.8;13.8;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.1;86.1;;;78.2;91.5;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.8;9.8;;;8.7;11;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.7;46.7;;;40.8;52.6;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;61.4;61.4;;;55.4;67;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.8;42.8;;;29.7;57.1;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.8;11.8;;;10.8;12.9;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.4;87.4;;;75.6;93.9;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;23.3;23.3;;;15.1;34.3;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.8;89.8;;;84.9;93.2;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.9;33.9;;;24.7;44.4;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.2;48.2;;;41.9;54.5;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;4.9;4.9;;;3.6;6.7;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.0;84;;;71.3;91.7;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.6;40.6;;;32.9;48.7;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.3;11.3;;;10.1;12.6;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;55.8;55.8;;;49.2;62.3;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.9;34.9;;;28.1;42.4;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.7;44.7;;;40.5;49.1;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.1;32.1;;;22.7;43.1;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2016;2016;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.6;6.6;;;4.4;9.8;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.4;31.4;;;23.3;40.8;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.8;6.8;;;4.8;9.7;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.6;8.6;;;7.4;9.9;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.9;11.9;;;10;14.2;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.2;9.2;;;6.5;12.8;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.7;42.7;;;30.7;55.7;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.6;11.6;;;10.5;12.9;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2016;2016;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;76.2;76.2;;;68.5;82.5;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.8;87.8;;;78.6;93.3;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.7;43.7;;;34.3;53.5;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;92.0;92;;;84.7;95.9;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;19.1;19.1;;;13.3;26.6;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.2;45.2;;;36.7;53.9;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;20.1;20.1;;;13.8;28.4;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.9;89.9;;;85.3;93.1;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.1;30.1;;;23.3;38;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.0;37;;;30.9;43.6;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;93.2;93.2;;;81.7;97.7;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.3;86.3;;;81.6;89.9;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.2;45.2;;;29.6;61.8;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.8;38.8;;;33.4;44.5;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;91.1;91.1;;;82.4;95.7;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.1;11.1;;;10.3;11.9;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.8;9.8;;;8.8;10.9;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;81.1;81.1;;;74.3;86.5;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;49.7;49.7;;;38.3;61.1;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;58.6;58.6;;;50.7;66.1;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.8;7.8;;;6.8;8.8;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;24.6;24.6;;;17;34.3;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.0;42;;;34.6;49.8;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.6;88.6;;;82.6;92.7;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.0;35;;;27.4;43.6;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2016;2016;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.1;32.1;;;24.3;41.1;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;56.0;56;;;38.6;72.1;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.9;34.9;;;28.3;42.3;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.9;42.9;;;36.3;49.9;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.4;9.4;;;6.2;14.1;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;13.8;13.8;;;9.3;19.9;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.5;39.5;;;34.2;45;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.1;35.1;;;25.3;46.5;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.4;9.4;;;5.8;14.8;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.4;11.4;;;9.4;13.8;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.0;7;;;5.5;8.9;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.3;14.3;;;10.4;19.2;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.4;9.4;;;8.3;10.7;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;51.5;51.5;;;34.4;68.2;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.7;10.7;;;8.4;13.7;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.4;44.4;;;32.6;56.9;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.2;10.2;;;7.3;14;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.0;70;;;52;83.4;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;92.8;92.8;;;75.2;98.2;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.9;9.9;;;8.7;11.3;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;51.5;51.5;;;34.2;68.4;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.1;36.1;;;26.2;47.4;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.1;5.1;;;4;6.3;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.4;67.4;;;54.2;78.2;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.7;38.7;;;30.5;47.6;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;96.3;96.3;;;90.6;98.6;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;8.8;8.8;;;5.1;14.8;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.0;7;;;5.7;8.6;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.6;70.6;;;64.9;75.7;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.3;40.3;;;35.5;45.3;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.1;31.1;;;20.3;44.4;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.6;7.6;;;6.3;9.2;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;18.1;18.1;;;14.3;22.7;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;51.3;51.3;;;44.7;57.9;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;21.5;21.5;;;16.1;28.1;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;6.9;6.9;;;4.1;11.3;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.5;86.5;;;79.7;91.2;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.8;8.8;;;7.2;10.6;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.9;46.9;;;41.9;51.9;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;74.9;74.9;;;64.2;83.3;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;74.5;74.5;;;61.9;84;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.3;30.3;;;20.3;42.5;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;15.3;15.3;;;12.9;18;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.8;44.8;;;40.6;49.2;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.8;38.8;;;28.1;50.8;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.4;11.4;;;9.2;14.1;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.7;11.7;;;10.2;13.5;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.2;5.2;;;3.9;6.9;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.7;36.7;;;31.8;41.8;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.0;46;;;38.7;53.6;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.0;11;;;9.5;12.8;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;92.9;92.9;;;86.5;96.4;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.9;34.9;;;27.1;43.6;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.5;65.5;;;57.6;72.7;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.5;86.5;;;79.8;91.2;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.0;67;*;50 States + DC: US Median;64;69.8;Overall;Overall;;;;;;;59;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.4;9.4;;;8.8;10.1;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.3;13.3;;;11.4;15.6;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.2;7.2;;;5.5;9.4;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;16.2;16.2;;;13;19.9;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.8;9.8;;;7.6;12.4;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.7;39.7;;;35.2;44.5;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.2;42.2;;;37.2;47.3;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;15.3;15.3;;;10.7;21.4;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.4;36.4;;;29.2;44.2;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.2;7.2;;;4.8;10.7;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.6;11.6;;;9.5;14.1;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.6;14.6;;;11.5;18.3;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.9;12.9;;;9;18.2;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.1;66.1;;;55.3;75.5;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.2;62.2;;;48.6;74.1;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.7;43.7;;;37.2;50.4;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2016;2016;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.6;91.6;;;87.2;94.6;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.7;86.7;*;50 States + DC: US Median;85.9;88.6;Overall;Overall;;;;;;;59;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.8;9.8;;;5.8;16.2;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.0;40;;;33.6;46.8;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;79.0;79;;;67;87.5;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.5;7.5;;;7;8;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2016;2016;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.9;87.9;**;US estimate/number is based on fewer than 50 states and the District of Columbia;86;91.1;Gender;Male;;;;;;;59;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.8;68.8;;;59.1;77;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;28.1;28.1;;;20.9;36.6;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;93.5;93.5;;;86.4;97.1;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.5;10.5;;;9.5;11.6;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.5;8.5;;;5.3;13.1;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.7;41.7;;;37.3;46.3;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.2;41.2;;;35.7;47;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2013;2013;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;NMBR;RACE;BLK;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.9;10.9;;;8.9;13.3;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.3;39.3;;;23.6;57.5;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.6;42.6;;;37;48.5;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2016;2016;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.8;43.8;;;38;49.8;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.9;83.9;;;73.9;90.5;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.4;41.4;;;36.5;46.4;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90.2;90.2;;;84.8;93.8;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.0;12;;;10.7;13.4;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67.2;67.2;;;59.4;74.1;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.0;44;;;36;52.3;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.8;40.8;;;33.4;48.8;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;26.3;26.3;;;17.9;36.9;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.3;5.3;;;4.3;6.4;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;41.0;41;;;31.2;51.5;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.7;8.7;;;7.6;10.1;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.9;62.9;;;47.3;76.2;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.9;8.9;;;7.9;10;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.7;12.7;;;9.1;17.5;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;55.4;55.4;;;46.4;64.1;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2016;2016;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.0;13;;;11.6;14.6;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.4;44.4;;;37.1;51.8;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.0;38;;;27.6;49.6;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.5;43.5;;;33.3;54.3;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.6;88.6;;;80.6;93.6;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2016;2016;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2016;2016;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.1;38.1;;;34.2;42.2;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2016;2016;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.3;44.3;;;22.9;68.1;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.0;6;;;3.7;9.6;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.5;11.5;;;10.1;13.1;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67.6;67.6;;;54.1;78.8;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.2;40.2;;;33.3;47.4;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.1;68.1;;;60.8;74.6;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;22.2;22.2;;;17.2;28.2;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.6;42.6;;;35.1;50.6;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.3;6.3;;;5.6;7.1;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;20.2;20.2;;;12.2;31.6;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.8;83.8;;;72.1;91.2;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.9;83.9;;;73.5;90.7;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.8;10.8;;;9.2;12.5;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.9;68.9;;;60;76.5;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;80.4;80.4;;;73.2;86;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.5;12.5;;;9.7;15.9;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.6;44.6;;;33.5;56.3;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.8;7.8;;;6.5;9.2;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.4;44.4;;;38.1;50.9;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;57.6;57.6;;;47;67.6;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.1;38.1;;;30.4;46.4;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.4;44.4;;;37.2;51.9;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.6;34.6;;;21.6;50.4;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2016;2016;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2016;2016;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.7;86.7;;;80;91.4;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;75.7;75.7;;;67.5;82.3;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.6;10.6;;;9.4;12;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.1;42.1;;;37.8;46.6;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.5;90.5;;;83.6;94.6;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.8;36.8;;;23;53.1;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.4;9.4;;;8.6;10.2;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.3;90.3;;;84.8;94;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2016;2016;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.2;47.2;;;35;59.7;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2016;2016;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;CO;Colorado;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.6;11.6;;;10;13.5;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.1;62.1;;;49.2;73.5;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.2;67.2;;;57.6;75.5;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;56.5;56.5;;;43.8;68.5;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.4;65.4;;;48.7;79;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;76.1;76.1;;;69.6;81.6;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.6;5.6;;;4;7.7;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.4;37.4;;;31.1;44.1;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;78.1;78.1;;;70;84.5;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.6;68.6;;;55.9;79;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.9;46.9;;;39.1;54.8;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2016;2016;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.9;44.9;;;39.3;50.7;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.1;38.1;;;32.6;43.9;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.9;40.9;;;33;49.3;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.9;10.9;;;7.4;15.8;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2016;2016;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;15.4;15.4;;;9.6;23.9;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;WI;Wisconsin;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2016;2016;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.5;10.5;;;9.4;11.7;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.1;12.1;;;9.9;14.9;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2016;2016;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.0;88;;;83.6;91.3;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.6;65.6;;;54.5;75.3;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.7;10.7;;;9.7;11.8;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2016;2016;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2016;2016;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.9;89.9;;;84.1;93.7;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.7;36.7;;;31.1;42.8;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.3;41.3;;;35.9;46.9;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.4;9.4;;;8.7;10.1;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.4;91.4;;;85.5;95.1;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.1;88.1;;;82.4;92.1;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.1;41.1;*;50 States + DC: US Median;39.3;42.1;Overall;Overall;;;;;;;59;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.2;68.2;;;54.8;79;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2016;2016;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;23.8;23.8;;;17.6;31.4;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.1;42.1;;;30.4;54.8;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;15.1;15.1;;;12.6;17.9;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;20.0;20;;;13.8;28.1;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.5;40.5;;;27.3;55.3;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.2;10.2;;;8.8;11.8;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2016;2016;TN;Tennessee;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2016;2016;MS;Mississippi;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2016;2016;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;76.0;76;;;68.9;81.9;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.6;45.6;;;38.8;52.5;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2016;2016;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2016;2016;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2016;2016;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.5;35.5;;;28.6;43.2;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.6;64.6;;;54.7;73.5;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2016;2016;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.8;34.8;;;25.2;45.9;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2016;2016;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.4;86.4;;;79.9;91;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2016;2016;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.3;36.3;;;27.1;46.7;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2016;2016;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.9;10.9;;;8.1;14.5;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.2;41.2;;;36.4;46.3;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;81.2;81.2;;;73.9;86.8;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2016;2016;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2016;2016;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2016;2016;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.8;66.8;;;55.7;76.4;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2016;2016;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.4;42.4;;;31.4;54.1;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2016;2016;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.4;43.4;;;37.2;49.8;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2016;2016;KS;Kansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2016;2016;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2016;2016;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2016;2016;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.7;65.7;;;53.9;75.8;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.4;82.4;;;73.9;88.6;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2015;2015;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;51.6;51.6;;;45.5;57.7;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.3;64.3;;;58.3;69.8;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.9;37.9;;;30;46.5;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.8;6.8;;;5.5;8.3;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2013;2013;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;NMBR;RACE;WHT;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.3;32.3;;;25.9;39.5;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.8;14.8;;;11.8;18.5;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;81.2;81.2;;;70.5;88.7;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.7;63.7;;;50.2;75.3;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.1;37.1;;;31.1;43.5;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2013;2013;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.5;13.5;;;9.9;17.9;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.6;10.6;;;9.9;11.3;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2012;2012;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;UT;Utah;NVSS;Asthma;Asthma mortality rate;;;Number;31;31;;;;;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;49.6;49.6;;;38.5;60.8;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;16.6;16.6;;;9.5;27.3;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;77.9;77.9;;;69.4;84.6;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;5.26;5.26;;;5.03;5.5;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2015;2015;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.3;36.3;;;31.3;41.6;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2013;2013;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;10.92;10.92;;;10.71;11.13;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;74.9;74.9;;;66.1;82.1;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.4;70.4;;;57.2;80.8;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2013;2013;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;NMBR;RACE;API;;;;
2013;2013;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;7.05;7.05;;;6.65;7.46;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2013;2013;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;7.85;7.85;;;7.31;8.4;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.0;40;;;31.2;49.6;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.0;35;;;27.3;43.6;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.6;11.6;;;9.2;14.4;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.2;37.2;;;29.4;45.7;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;24.8;24.8;;;16.6;35.2;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.3;13.3;;;10.2;17.2;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.0;47;;;43;50.9;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.2;67.2;**;US estimate/number is based on fewer than 50 states and the District of Columbia;63.9;69.1;Gender;Male;;;;;;;59;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2013;2013;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.5;8.5;;;6.1;11.4;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2013;2013;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.2;7.2;;;4.9;10.3;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;25.95;25.95;;;24.31;27.58;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2013;2013;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;7.16;7.16;;;6.61;7.7;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2013;2013;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;NMBR;RACE;BLK;;;;
2013;2013;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;11036;11,036;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;NMBR;RACE;BLK;;;;
2013;2013;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;NMBR;RACE;HIS;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;7.43;7.43;;;6.88;7.98;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2016;2016;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;4.93;4.93;;;4.41;5.46;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;60.1;60.1;;;52.5;67.2;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.2;6.2;;;5.3;7.2;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.1;34.1;;;27;42.1;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.1;13.1;;;11.6;14.7;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2013;2013;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;8612;8,612;;;;;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;NMBR;GENDER;GENF;;;;
2013;2013;DE;Delaware;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;22.0;22;;;15;31.1;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2016;2016;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;15.7;15.7;;;9.3;24.9;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2012;2012;CA;California;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.9;10.9;;;9.4;12.5;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;15.8;15.8;;;13;19;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.2;46.2;;;39.4;53.2;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;75.4;75.4;;;63.7;84.3;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.8;7.8;;;5.9;10.3;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.9;35.9;;;28.6;43.9;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2013;2013;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2016;2016;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2016;2016;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;NMBR;RACE;API;;;;
2016;2016;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2016;2016;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2016;2016;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;CRDRATE;RACE;API;;;;
2016;2016;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.6;12.6;;;8;18.8;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2016;2016;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.6;34.6;;;27.4;42.6;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.2;7.2;;;6.1;8.2;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2016;2016;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.2;8.2;;;6.6;10.2;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2016;2016;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;;Number;57;57;;;;;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;NMBR;GENDER;GENF;;;;
2016;2016;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.0;14;;;10.4;18.4;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2016;2016;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;13.9;13.9;;;10.7;17.8;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2016;2016;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2016;2016;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;CRDRATE;RACE;API;;;;
2016;2016;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2016;2016;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;NMBR;GENDER;GENM;;;;
2016;2016;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2016;2016;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;;Number;62;62;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;NMBR;RACE;WHT;;;;
2016;2016;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2016;2016;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.8;10.8;;;7.7;14.6;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2016;2016;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2016;2016;NY;New York;NVSS;Asthma;Asthma mortality rate;;;Number;273;273;;;;;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2016;2016;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2016;2016;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2016;2016;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;;Number;47;47;;;;;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;NMBR;GENDER;GENF;;;;
2016;2016;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2016;2016;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2016;2016;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2016;2016;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;18.4;18.4;;;14.4;23.2;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2016;2016;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.2;7.2;;;4.4;11.1;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2016;2016;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;NMBR;GENDER;GENM;;;;
2016;2016;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;CRDRATE;RACE;API;;;;
2016;2016;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;NMBR;RACE;HIS;;;;
2016;2016;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.0;13;;;8.6;18.9;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2016;2016;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;NMBR;GENDER;GENF;;;;
2016;2016;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;33;33;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;NMBR;RACE;BLK;;;;
2016;2016;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;NMBR;RACE;API;;;;
2016;2016;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2016;2016;ME;Maine;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;NMBR;RACE;API;;;;
2016;2016;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;NMBR;RACE;HIS;;;;
2016;2016;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2016;2016;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2016;2016;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.6;12.6;;;10.1;15.6;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2016;2016;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2016;2016;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;6.6;6.6;;;4.8;8.9;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2016;2016;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2016;2016;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2016;2016;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;NMBR;RACE;AIAN;;;;
2016;2016;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.0;11;;;7.5;15.5;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2016;2016;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;16.4;16.4;;;10.3;24.8;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2016;2016;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;NMBR;RACE;WHT;;;;
2016;2016;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2016;2016;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.3;8.3;;;5;12.9;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2016;2016;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.3;9.3;;;7.7;10.9;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2016;2016;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;NMBR;RACE;HIS;;;;
2016;2016;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2016;2016;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.2;9.2;;;7.3;11.5;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2016;2016;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2016;2016;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;NMBR;RACE;API;;;;
2016;2016;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2016;2016;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2016;2016;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;;Number;43;43;;;;;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;NMBR;GENDER;GENF;;;;
2016;2016;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;14.0;14;;;9.2;20.4;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2016;2016;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2016;2016;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;NMBR;RACE;HIS;;;;
2016;2016;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.3;8.3;;;6.1;11.1;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2016;2016;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2016;2016;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2016;2016;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2016;2016;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;NMBR;RACE;HIS;;;;
2016;2016;UT;Utah;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;NMBR;RACE;HIS;;;;
2016;2016;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2016;2016;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.0;10;;;7.4;13.1;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2016;2016;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2016;2016;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.4;10.4;;;7.2;14.5;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2016;2016;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;CRDRATE;RACE;API;;;;
2016;2016;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST4_1;NMBR;RACE;BLK;;;;
2016;2016;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2016;2016;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.1;10.1;;;7.8;12.9;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2016;2016;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;;Number;27;27;;;;;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;NMBR;GENDER;GENM;;;;
2016;2016;UT;Utah;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;NMBR;RACE;API;;;;
2016;2016;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;;Number;45;45;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;NMBR;RACE;WHT;;;;
2016;2016;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;NMBR;RACE;AIAN;;;;
2016;2016;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.4;8.4;;;6.1;11.3;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2016;2016;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;;Number;82;82;;;;;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;NMBR;GENDER;GENF;;;;
2016;2016;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.6;11.6;;;9.8;13.5;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2016;2016;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;CRDRATE;RACE;API;;;;
2016;2016;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2016;2016;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2016;2016;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;22;22;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;NMBR;RACE;WHT;;;;
2016;2016;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2016;2016;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.5;10.5;;;7.5;14.3;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2016;2016;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;NMBR;RACE;AIAN;;;;
2016;2016;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2016;2016;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.7;8.7;;;5.3;13.5;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2016;2016;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2016;2016;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;33;33;;;;;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;NMBR;GENDER;GENM;;;;
2016;2016;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.7;13.7;;;8.8;20.2;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2016;2016;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2016;2016;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;NMBR;RACE;API;;;;
2016;2016;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.0;14;;;10.3;18.7;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2016;2016;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2016;2016;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;NMBR;RACE;WHT;;;;
2016;2016;ME;Maine;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;NMBR;GENDER;GENM;;;;
2016;2016;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;;Number;48;48;;;;;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2016;2016;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2016;2016;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;NMBR;GENDER;GENF;;;;
2016;2016;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2016;2016;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2016;2016;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;;Number;59;59;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;NMBR;RACE;BLK;;;;
2016;2016;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.1;8.1;;;5.6;11.3;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2016;2016;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2016;2016;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;23.8;23.8;;;16.2;33.8;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2016;2016;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.8;9.8;;;7.7;12.3;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2016;2016;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2016;2016;US;United States;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.9;10.9;;;10.5;11.2;Overall;Overall;;;;;;;59;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2016;2016;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;NMBR;RACE;API;;;;
2016;2016;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;NMBR;RACE;API;;;;
2016;2016;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;NMBR;RACE;BLK;;;;
2016;2016;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;14.5;14.5;;;10.1;20.2;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2016;2016;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;;Number;20;20;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;NMBR;RACE;BLK;;;;
2016;2016;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2016;2016;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;60;60;;;;;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2016;2016;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.907192, -77.036871);;11;AST;AST4_1;NMBR;RACE;API;;;;
2016;2016;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;NMBR;RACE;BLK;;;;
2016;2016;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;NMBR;RACE;API;;;;
2016;2016;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2016;2016;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2016;2016;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2016;2016;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;;Number;29;29;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;NMBR;RACE;WHT;;;;
2016;2016;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2016;2016;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2016;2016;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.4;12.4;;;10.2;14.6;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2016;2016;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;CRDRATE;RACE;API;;;;
2016;2016;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2016;2016;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;23.4;23.4;;;17.7;30.3;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2016;2016;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.3;7.3;;;4.6;11;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2016;2016;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;CRDRATE;RACE;API;;;;
2016;2016;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2016;2016;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;;Number;33;33;;;;;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;NMBR;GENDER;GENM;;;;
2016;2016;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2016;2016;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;NMBR;GENDER;GENM;;;;
2016;2016;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;NMBR;RACE;AIAN;;;;
2016;2016;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;16.2;16.2;;;10.3;24.3;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2016;2016;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;NMBR;GENDER;GENF;;;;
2016;2016;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;NMBR;RACE;AIAN;;;;
2016;2016;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;NMBR;RACE;API;;;;
2016;2016;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.1;10.1;;;7.3;13.5;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2016;2016;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;NMBR;RACE;AIAN;;;;
2016;2016;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2016;2016;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;;Number;68;68;;;;;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;NMBR;GENDER;GENF;;;;
2016;2016;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;NMBR;RACE;WHT;;;;
2016;2016;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.7;9.7;;;6.4;14.1;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2016;2016;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2016;2016;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2016;2016;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2016;2016;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2016;2016;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;NMBR;RACE;AIAN;;;;
2016;2016;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;15.6;15.6;;;12.6;18.5;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2016;2016;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;NMBR;RACE;BLK;;;;
2016;2016;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2016;2016;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;NMBR;GENDER;GENM;;;;
2016;2016;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.1;9.1;;;7.4;11.2;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2016;2016;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2016;2016;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.4;8.4;;;6.5;10.5;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2016;2016;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;CRDRATE;RACE;API;;;;
2016;2016;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2016;2016;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.4;11.4;;;9.2;13.6;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2016;2016;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2016;2016;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2016;2016;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2016;2016;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2016;2016;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;NMBR;RACE;AIAN;;;;
2016;2016;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;CRDRATE;RACE;API;;;;
2016;2016;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;16.9;16.9;;;13;21.6;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2016;2016;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.6;12.6;;;10.6;14.7;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2016;2016;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;NMBR;RACE;AIAN;;;;
2016;2016;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2016;2016;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2016;2016;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.3;12.3;;;8.9;16.5;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2016;2016;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2016;2016;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2016;2016;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;CRDRATE;RACE;API;;;;
2016;2016;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2016;2016;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2016;2016;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.4;9.4;;;7.6;11.5;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2016;2016;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;NMBR;RACE;AIAN;;;;
2016;2016;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;NMBR;RACE;HIS;;;;
2016;2016;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.1;12.1;;;10.6;13.7;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2016;2016;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2016;2016;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;NMBR;RACE;API;;;;
2016;2016;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2016;2016;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2016;2016;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;;Number;44;44;;;;;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;NMBR;GENDER;GENM;;;;
2016;2016;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;NMBR;RACE;API;;;;
2016;2016;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.7;14.7;;;9.8;21.2;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2016;2016;MT;Montana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;NMBR;RACE;HIS;;;;
2016;2016;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;NMBR;RACE;AIAN;;;;
2016;2016;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;NMBR;RACE;AIAN;;;;
2016;2016;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2016;2016;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;CRDRATE;RACE;API;;;;
2016;2016;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2016;2016;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.907192, -77.036871);;11;AST;AST4_1;NMBR;RACE;AIAN;;;;
2016;2016;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.2;12.2;;;9.9;14.4;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2016;2016;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.3;12.3;;;8.4;17.5;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2016;2016;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.9;8.9;;;5.7;13.2;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2016;2016;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2016;2016;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2016;2016;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.3;11.3;;;6.9;17.4;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2016;2016;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;NMBR;RACE;API;;;;
2016;2016;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.3;10.3;;;8.3;12.4;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2016;2016;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.0;8;;;5.2;11.7;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2016;2016;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;;Number;54;54;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;NMBR;RACE;WHT;;;;
2016;2016;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;CRDRATE;RACE;API;;;;
2016;2016;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2016;2016;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2016;2016;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2016;2016;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2016;2016;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2016;2016;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.8;10.8;;;7.3;15.3;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2016;2016;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;;Number;29;29;;;;;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;NMBR;GENDER;GENM;;;;
2016;2016;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.8;11.8;;;7.2;18.3;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2016;2016;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;NMBR;GENDER;GENF;;;;
2016;2016;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;;Number;32;32;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;NMBR;RACE;BLK;;;;
2016;2016;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;NMBR;RACE;API;;;;
2016;2016;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2016;2016;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2016;2016;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2016;2016;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;NMBR;RACE;HIS;;;;
2016;2016;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2016;2016;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2016;2016;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;18.6;18.6;;;12.3;27.1;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2016;2016;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;16.5;16.5;;;10.6;24.6;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2016;2016;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;17.2;17.2;;;12.5;23.1;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2016;2016;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;NMBR;RACE;BLK;;;;
2016;2016;TX;Texas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;NMBR;RACE;AIAN;;;;
2016;2016;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.7;11.7;;;9.3;14.6;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2016;2016;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;6.0;6;;;3.9;8.7;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2016;2016;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;;Number;31;31;;;;;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;NMBR;GENDER;GENM;;;;
2016;2016;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;NMBR;RACE;AIAN;;;;
2016;2016;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;15.0;15;;;13.1;17;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2016;2016;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;5.6;5.6;;;4.2;7.3;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2016;2016;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;NMBR;RACE;AIAN;;;;
2016;2016;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2016;2016;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2016;2016;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2016;2016;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2016;2016;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;19.6;19.6;;;15;25.1;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2016;2016;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2016;2016;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.0;10;;;8.3;11.7;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2016;2016;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;;Number;78;78;;;;;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2016;2016;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2016;2016;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;NMBR;RACE;HIS;;;;
2016;2016;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2016;2016;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;;Number;21;21;;;;;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;NMBR;GENDER;GENM;;;;
2016;2016;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2016;2016;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2016;2016;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;22.0;22;;;15.2;30.8;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2016;2016;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;NMBR;RACE;HIS;;;;
2016;2016;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;NMBR;RACE;API;;;;
2016;2016;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2016;2016;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2016;2016;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2016;2016;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;NMBR;GENDER;GENF;;;;
2016;2016;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2016;2016;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2016;2016;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.9;9.9;;;7.9;11.8;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2016;2016;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2016;2016;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;NMBR;RACE;BLK;;;;
2016;2016;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;;Number;28;28;;;;;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;NMBR;GENDER;GENF;;;;
2016;2016;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2016;2016;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.0;7;;;6;8;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2016;2016;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;2.4;2.4;;;1.6;3.5;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2016;2016;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2016;2016;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;NMBR;GENDER;GENM;;;;
2016;2016;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;6.8;6.8;;;5.4;8.4;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2016;2016;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2016;2016;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.2;10.2;;;8.2;12.1;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2016;2016;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2016;2016;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;;Number;149;149;;;;;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2016;2016;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;;Number;26;26;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;NMBR;RACE;WHT;;;;
2016;2016;MT;Montana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;NMBR;GENDER;GENM;;;;
2016;2016;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;NMBR;RACE;AIAN;;;;
2016;2016;NY;New York;NVSS;Asthma;Asthma mortality rate;;;Number;95;95;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;NMBR;RACE;BLK;;;;
2016;2016;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;NMBR;RACE;WHT;;;;
2016;2016;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;21.0;21;;;16.1;26.8;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2016;2016;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;NMBR;RACE;API;;;;
2016;2016;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;5.9;5.9;;;4;8.5;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2016;2016;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;CRDRATE;RACE;API;;;;
2016;2016;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;6.7;6.7;;;4.8;9.1;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2016;2016;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2016;2016;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;;Number;26;26;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;NMBR;RACE;WHT;;;;
2016;2016;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;NMBR;RACE;AIAN;;;;
2016;2016;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;NMBR;RACE;API;;;;
2016;2016;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;;Number;57;57;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;NMBR;RACE;WHT;;;;
2016;2016;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2016;2016;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2016;2016;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.2;7.2;;;5.3;9.6;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2016;2016;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;NMBR;RACE;HIS;;;;
2016;2016;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;CRDRATE;RACE;API;;;;
2016;2016;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.6;8.6;;;6.2;11.7;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2016;2016;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2016;2016;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;47;47;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;NMBR;RACE;WHT;;;;
2016;2016;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.1;12.1;;;9.5;15.1;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2016;2016;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2016;2016;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.3;8.3;;;6.2;10.8;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2016;2016;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.3;10.3;;;7.9;13.2;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2016;2016;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2016;2016;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2016;2016;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2016;2016;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.1;12.1;;;8.6;16.6;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2016;2016;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;NMBR;GENDER;GENM;;;;
2016;2016;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2016;2016;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.9;12.9;;;9.2;17.6;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2016;2016;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2016;2016;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.4;7.4;;;5.2;10.3;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2016;2016;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;NMBR;RACE;API;;;;
2016;2016;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2016;2016;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.6;12.6;;;10;15.6;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2016;2016;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;NMBR;GENDER;GENF;;;;
2016;2016;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;NMBR;RACE;BLK;;;;
2016;2016;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;CRDRATE;RACE;API;;;;
2016;2016;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2016;2016;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.5;8.5;;;6.9;10.2;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2016;2016;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2016;2016;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;NMBR;RACE;BLK;;;;
2016;2016;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;NMBR;RACE;AIAN;;;;
2016;2016;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.9;12.9;;;8.5;18.8;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2016;2016;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;;Number;22;22;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;NMBR;RACE;BLK;;;;
2016;2016;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;14.2;14.2;;;9.6;20.3;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2016;2016;NY;New York;NVSS;Asthma;Asthma mortality rate;;;Number;99;99;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;NMBR;RACE;WHT;;;;
2016;2016;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.8;11.8;;;7.3;18;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2016;2016;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.0;10;;;8.3;11.8;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2016;2016;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;NMBR;RACE;AIAN;;;;
2016;2016;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.1;12.1;;;9.2;15.6;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2016;2016;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2016;2016;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;;Number;46;46;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;NMBR;RACE;BLK;;;;
2016;2016;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;NMBR;RACE;HIS;;;;
2016;2016;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2016;2016;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2016;2016;FL;Florida;NVSS;Asthma;Asthma mortality rate;;;Number;53;53;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;NMBR;RACE;BLK;;;;
2016;2016;TX;Texas;NVSS;Asthma;Asthma mortality rate;;;Number;103;103;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;NMBR;RACE;WHT;;;;
2016;2016;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2016;2016;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;NMBR;GENDER;GENF;;;;
2016;2016;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;;Number;73;73;;;;;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2016;2016;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2016;2016;CA;California;NVSS;Asthma;Asthma mortality rate;;;Number;57;57;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;NMBR;RACE;BLK;;;;
2016;2016;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.1;10.1;;;8.1;12.3;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2016;2016;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2016;2016;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2016;2016;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2016;2016;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2016;2016;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;6.6;6.6;;;3.9;10.2;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2016;2016;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.2;9.2;;;7.4;11.3;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2016;2016;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;NMBR;RACE;HIS;;;;
2016;2016;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;NMBR;RACE;AIAN;;;;
2016;2016;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;;Number;93;93;;;;;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2016;2016;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2016;2016;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;25;25;;;;;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2016;2016;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;18.4;18.4;;;12.2;26.6;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2016;2016;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2016;2016;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2016;2016;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2016;2016;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;NMBR;RACE;WHT;;;;
2016;2016;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST4_1;NMBR;GENDER;GENF;;;;
2016;2016;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2016;2016;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;NMBR;RACE;AIAN;;;;
2016;2016;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2016;2016;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2016;2016;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;16.8;16.8;;;10.5;25.4;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2016;2016;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2016;2016;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.2;8.2;;;5.3;12.1;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2016;2016;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2016;2016;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;31.4;31.4;;;21.2;44.8;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2016;2016;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2016;2016;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;CRDRATE;RACE;API;;;;
2016;2016;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2016;2016;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2016;2016;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;NMBR;RACE;API;;;;
2016;2016;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2016;2016;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.5;12.5;;;11;14;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2016;2016;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;22.0;22;;;13.6;33.6;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2016;2016;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.6;14.6;;;9.8;21;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2016;2016;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;NMBR;RACE;HIS;;;;
2016;2016;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;;Number;102;102;;;;;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2016;2016;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2016;2016;WA;Washington;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;NMBR;RACE;BLK;;;;
2016;2016;ME;Maine;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;NMBR;RACE;WHT;;;;
2016;2016;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;6.4;6.4;;;4.5;8.9;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2016;2016;WA;Washington;NVSS;Asthma;Asthma mortality rate;;;Number;78;78;;;;;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2016;2016;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2016;2016;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;15.2;15.2;;;10.9;20.6;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2016;2016;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2016;2016;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.1;10.1;;;7.6;13.2;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2016;2016;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.1;9.1;;;6.3;12.6;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2016;2016;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2016;2016;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;NMBR;GENDER;GENM;;;;
2016;2016;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;24.1;24.1;;;16.6;33.8;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2016;2016;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2016;2016;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;NMBR;RACE;BLK;;;;
2016;2016;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;;Number;20;20;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;NMBR;RACE;WHT;;;;
2016;2016;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;NMBR;RACE;AIAN;;;;
2016;2016;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2016;2016;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;NMBR;RACE;BLK;;;;
2016;2016;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;NMBR;RACE;HIS;;;;
2016;2016;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;NMBR;RACE;BLK;;;;
2016;2016;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;;Number;65;65;;;;;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2016;2016;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2016;2016;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2016;2016;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.0;9;;;6.2;12.7;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2016;2016;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.5;9.5;;;6.2;14;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2016;2016;MT;Montana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2016;2016;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.3;7.3;;;5.2;10;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2016;2016;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2016;2016;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;6.4;6.4;;;4;9.8;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2016;2016;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2016;2016;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2016;2016;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2016;2016;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;CRDRATE;RACE;API;;;;
2016;2016;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;;Number;23;23;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;NMBR;RACE;WHT;;;;
2016;2016;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.3;11.3;;;8.8;14.4;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;CRDRATE;RACE;API;;;;
2016;2016;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;6.0;6;;;4.5;7.7;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2016;2016;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2016;2016;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;NMBR;GENDER;GENM;;;;
2016;2016;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.6;10.6;;;8;13.7;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2016;2016;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;;Number;128;128;;;;;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2016;2016;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2016;2016;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;;Number;40;40;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;NMBR;RACE;WHT;;;;
2016;2016;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2016;2016;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.7;8.7;;;6.5;11.5;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2016;2016;WA;Washington;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;NMBR;RACE;AIAN;;;;
2016;2016;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;NMBR;RACE;API;;;;
2016;2016;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2016;2016;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2016;2016;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;13.0;13;;;8.2;19.5;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2016;2016;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2016;2016;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;;Number;39;39;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;NMBR;RACE;WHT;;;;
2016;2016;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;NMBR;GENDER;GENM;;;;
2016;2016;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;NMBR;RACE;AIAN;;;;
2016;2016;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;NMBR;GENDER;GENM;;;;
2016;2016;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2016;2016;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.9;9.9;;;7.3;13.1;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2016;2016;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.9;9.9;;;7.1;13.3;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2016;2016;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2016;2016;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2016;2016;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2016;2016;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2016;2016;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;NMBR;GENDER;GENM;;;;
2016;2016;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;NMBR;RACE;HIS;;;;
2016;2016;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.2;7.2;;;5.5;9.4;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2016;2016;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;CRDRATE;RACE;API;;;;
2016;2016;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;;Number;133;133;;;;;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2016;2016;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2016;2016;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2016;2016;UT;Utah;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;NMBR;RACE;BLK;;;;
2016;2016;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;CRDRATE;RACE;API;;;;
2016;2016;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;NMBR;RACE;BLK;;;;
2016;2016;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.6;12.6;;;8;18.9;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2016;2016;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;NMBR;RACE;AIAN;;;;
2016;2016;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2016;2016;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.0;11;;;8.2;14.3;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2016;2016;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.8;10.8;;;6.7;16.5;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2016;2016;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;14.2;14.2;;;11.4;16.9;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2016;2016;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.4;10.4;;;7.8;13.5;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2016;2016;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2016;2016;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;;Number;60;60;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;NMBR;RACE;WHT;;;;
2016;2016;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;NMBR;RACE;AIAN;;;;
2016;2016;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2016;2016;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2016;2016;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.0;9;;;7.3;11.1;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2016;2016;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2016;2016;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.8;10.8;;;8;14.3;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2016;2016;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.4;12.4;;;8.7;17.1;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2016;2016;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;NMBR;RACE;API;;;;
2016;2016;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;;Number;32;32;;;;;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;NMBR;GENDER;GENM;;;;
2016;2016;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;NMBR;RACE;AIAN;;;;
2016;2016;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2016;2016;CA;California;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;NMBR;RACE;AIAN;;;;
2016;2016;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;CRDRATE;RACE;API;;;;
2016;2016;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2016;2016;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2016;2016;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2016;2016;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2016;2016;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2016;2016;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2016;2016;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;NMBR;GENDER;GENF;;;;
2016;2016;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2016;2016;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;CRDRATE;RACE;API;;;;
2016;2016;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2016;2016;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2016;2016;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.9;8.9;;;7.2;10.8;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2016;2016;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;CRDRATE;RACE;API;;;;
2016;2016;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2016;2016;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;5.7;5.7;;;4.3;7.3;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2016;2016;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;;Number;86;86;;;;;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2016;2016;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;16.0;16;;;12;21;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2016;2016;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;24.1;24.1;;;18.2;31.4;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2016;2016;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.0;8;;;5.2;11.7;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2016;2016;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;15.5;15.5;;;11.2;20.9;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2016;2016;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2016;2016;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2016;2016;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.8;11.8;;;8.3;16.3;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2016;2016;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.6;9.6;;;7.6;12;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2016;2016;CA;California;NVSS;Asthma;Asthma mortality rate;;;Number;151;151;;;;;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;NMBR;GENDER;GENM;;;;
2016;2016;WA;Washington;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;NMBR;RACE;HIS;;;;
2016;2016;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;6.3;6.3;;;3.8;9.7;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2016;2016;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;NMBR;RACE;WHT;;;;
2016;2016;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2016;2016;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2016;2016;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.2;9.2;;;5.8;13.9;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2016;2016;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;34.2;34.2;;;24.5;46.4;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2016;2016;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.6;8.6;;;6.9;10.7;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2016;2016;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2016;2016;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;;Number;26;26;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;NMBR;RACE;WHT;;;;
2016;2016;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2016;2016;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;;Number;86;86;;;;;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;NMBR;GENDER;GENF;;;;
2016;2016;UT;Utah;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;NMBR;GENDER;GENM;;;;
2016;2016;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;NMBR;RACE;HIS;;;;
2016;2016;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.4;9.4;;;5.9;14.1;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2016;2016;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2016;2016;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.7;10.7;;;8;14.1;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2016;2016;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;CRDRATE;RACE;API;;;;
2016;2016;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;24.8;24.8;;;17.4;34.4;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2016;2016;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;NMBR;RACE;HIS;;;;
2016;2016;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.0;8;;;5.5;11.2;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2016;2016;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2016;2016;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2016;2016;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2016;2016;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;NMBR;RACE;HIS;;;;
2016;2016;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;;Number;44;44;;;;;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2016;2016;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;;Number;41;41;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;NMBR;RACE;BLK;;;;
2016;2016;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.0;9;;;6.5;12.1;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2016;2016;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;;Number;28;28;;;;;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2016;2016;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;6.7;6.7;;;4.3;9.9;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2016;2016;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;4.5;4.5;;;3.5;5.6;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2016;2016;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.4;8.4;;;6.2;11.2;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2016;2016;UT;Utah;NVSS;Asthma;Asthma mortality rate;;;Number;32;32;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;NMBR;RACE;WHT;;;;
2016;2016;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;NMBR;RACE;API;;;;
2016;2016;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;NMBR;RACE;API;;;;
2016;2016;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;NMBR;RACE;AIAN;;;;
2016;2016;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2016;2016;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2016;2016;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;NMBR;GENDER;GENM;;;;
2016;2016;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2016;2016;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;CRDRATE;RACE;API;;;;
2016;2016;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.5;12.5;;;8.5;17.9;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2016;2016;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.0;7;;;5.6;8.4;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2016;2016;FL;Florida;NVSS;Asthma;Asthma mortality rate;;;Number;37;37;;;;;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;NMBR;RACE;HIS;;;;
2016;2016;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;NMBR;RACE;BLK;;;;
2016;2016;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2016;2016;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;15.5;15.5;;;11.7;20.1;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2016;2016;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.5;9.5;;;6.3;13.7;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2016;2016;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;;Number;108;108;;;;;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2016;2016;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.6;12.6;;;9;17.3;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2016;2016;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST4_1;NMBR;GENDER;GENM;;;;
2016;2016;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;;Number;40;40;;;;;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;NMBR;GENDER;GENF;;;;
2016;2016;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;NMBR;RACE;API;;;;
2016;2016;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2016;2016;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2016;2016;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2016;2016;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2016;2016;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;;Number;21;21;;;;;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;NMBR;GENDER;GENF;;;;
2016;2016;TX;Texas;NVSS;Asthma;Asthma mortality rate;;;Number;66;66;;;;;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;NMBR;GENDER;GENM;;;;
2016;2016;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2016;2016;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;NMBR;RACE;HIS;;;;
2016;2016;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2016;2016;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2016;2016;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;;Number;45;45;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;NMBR;RACE;WHT;;;;
2016;2016;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.9;10.9;;;8.3;14.1;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2016;2016;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;22.6;22.6;;;16.7;30;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2016;2016;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.7;12.7;;;9.8;16.1;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2016;2016;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.5;7.5;;;5.4;10;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2016;2016;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2016;2016;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;103;103;;;;;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2016;2016;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;CRDRATE;RACE;API;;;;
2016;2016;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.0;8;;;5.8;10.7;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2016;2016;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.0;10;;;7.9;12.5;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2016;2016;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;;Number;51;51;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;NMBR;RACE;BLK;;;;
2016;2016;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;27;27;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;NMBR;RACE;WHT;;;;
2016;2016;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2016;2016;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2016;2016;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;;Number;37;37;;;;;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2016;2016;CA;California;NVSS;Asthma;Asthma mortality rate;;;Number;391;391;;;;;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2016;2016;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;22.7;22.7;;;16.9;29.9;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2016;2016;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;14.3;14.3;;;10.3;19.3;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2016;2016;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2016;2016;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2016;2016;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.3;10.3;;;7.8;13.4;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2016;2016;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2016;2016;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;NMBR;RACE;HIS;;;;
2016;2016;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2016;2016;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.8;11.8;;;9.7;13.8;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2016;2016;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2016;2016;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.4;11.4;;;8.9;14.3;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2016;2016;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;NMBR;RACE;HIS;;;;
2016;2016;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2016;2016;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;19.5;19.5;;;15.1;24.7;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2016;2016;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;NMBR;RACE;AIAN;;;;
2016;2016;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.3;14.3;;;8.9;21.9;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2016;2016;UT;Utah;NVSS;Asthma;Asthma mortality rate;;;Number;36;36;;;;;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2016;2016;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;22.7;22.7;;;15.9;31.4;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2016;2016;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;NMBR;RACE;BLK;;;;
2016;2016;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;NMBR;RACE;BLK;;;;
2016;2016;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;CRDRATE;RACE;API;;;;
2016;2016;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2016;2016;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2016;2016;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2016;2016;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2016;2016;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2016;2016;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.0;12;;;9.4;15.1;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2016;2016;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;16.3;16.3;;;12.3;21.1;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2016;2016;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.2;8.2;;;6.7;9.7;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2016;2016;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;;Number;25;25;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;NMBR;RACE;WHT;;;;
2016;2016;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2016;2016;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;NMBR;RACE;BLK;;;;
2016;2016;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2016;2016;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.1;9.1;;;6.7;12.2;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2016;2016;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2016;2016;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;;Number;64;64;;;;;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;NMBR;GENDER;GENF;;;;
2016;2016;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.5;8.5;;;5.6;12.3;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2016;2016;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.6;10.6;;;8.3;13.2;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2016;2016;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.2;8.2;;;6;10.9;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2016;2016;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;NMBR;RACE;HIS;;;;
2016;2016;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2016;2016;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2016;2016;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2016;2016;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2016;2016;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2016;2016;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2016;2016;TX;Texas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;NMBR;RACE;API;;;;
2016;2016;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;15.3;15.3;;;11.4;20;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2016;2016;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2016;2016;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.6;12.6;;;8.9;17.3;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2016;2016;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2016;2016;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;CRDRATE;RACE;API;;;;
2016;2016;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2016;2016;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2016;2016;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2016;2016;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2016;2016;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;NMBR;RACE;HIS;;;;
2016;2016;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;17.3;17.3;;;11.3;25.3;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2016;2016;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.5;7.5;;;6.3;8.6;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2016;2016;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;;Number;38;38;;;;;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;NMBR;GENDER;GENF;;;;
2016;2016;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;81;81;;;;;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2016;2016;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2016;2016;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.7;10.7;;;8.5;13.4;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2016;2016;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;NMBR;GENDER;GENF;;;;
2016;2016;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2016;2016;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;CRDRATE;RACE;API;;;;
2016;2016;CA;California;NVSS;Asthma;Asthma mortality rate;;;Number;194;194;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;NMBR;RACE;WHT;;;;
2016;2016;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;;Number;91;91;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;NMBR;RACE;WHT;;;;
2016;2016;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2016;2016;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2016;2016;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;15.2;15.2;;;11.1;20.1;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2016;2016;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.907192, -77.036871);;11;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2016;2016;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2016;2016;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;;Number;35;35;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;NMBR;RACE;WHT;;;;
2016;2016;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2016;2016;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;13.1;13.1;;;9.6;17.6;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2016;2016;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2016;2016;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2016;2016;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;NMBR;RACE;HIS;;;;
2016;2016;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.7;7.7;;;5.5;10.6;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2016;2016;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.4;11.4;;;8.8;14.5;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2016;2016;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;16.7;16.7;;;10.4;25.6;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2016;2016;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.0;11;;;8.4;14.3;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2016;2016;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.2;9.2;;;7.3;11.5;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2016;2016;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.7;11.7;;;8.3;16.2;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2016;2016;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2016;2016;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;NMBR;RACE;AIAN;;;;
2016;2016;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.1;10.1;;;7.8;12.8;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2016;2016;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;NMBR;RACE;BLK;;;;
2016;2016;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2016;2016;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;30.5;30.5;;;23.1;39.5;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2016;2016;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2016;2016;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;;Number;72;72;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;NMBR;RACE;WHT;;;;
2016;2016;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;NMBR;GENDER;GENM;;;;
2016;2016;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2016;2016;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2016;2016;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.1;11.1;;;8;15.1;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2016;2016;WA;Washington;NVSS;Asthma;Asthma mortality rate;;;Number;51;51;;;;;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;NMBR;GENDER;GENF;;;;
2016;2016;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2016;2016;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2016;2016;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2016;2016;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;59;59;;;;;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;NMBR;GENDER;GENF;;;;
2016;2016;FL;Florida;NVSS;Asthma;Asthma mortality rate;;;Number;124;124;;;;;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;NMBR;GENDER;GENF;;;;
2016;2016;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;6.3;6.3;;;3.9;9.6;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2016;2016;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2016;2016;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2016;2016;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2016;2016;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.4;14.4;;;11.5;17.7;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2016;2016;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2016;2016;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.3;12.3;;;9.6;15.5;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2016;2016;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2016;2016;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;NMBR;RACE;HIS;;;;
2016;2016;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2016;2016;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;;Number;33;33;;;;;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;NMBR;GENDER;GENF;;;;
2016;2016;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;;Number;66;66;;;;;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2016;2016;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2016;2016;NY;New York;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;NMBR;RACE;AIAN;;;;
2016;2016;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2016;2016;CA;California;NVSS;Asthma;Asthma mortality rate;;;Number;68;68;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;NMBR;RACE;API;;;;
2016;2016;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2016;2016;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;NMBR;RACE;API;;;;
2016;2016;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2016;2016;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2016;2016;MT;Montana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;NMBR;RACE;BLK;;;;
2016;2016;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2016;2016;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;NMBR;RACE;AIAN;;;;
2016;2016;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2016;2016;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.3;9.3;;;8.4;10.3;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2016;2016;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;;Number;35;35;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;NMBR;RACE;BLK;;;;
2016;2016;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2016;2016;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;NMBR;RACE;API;;;;
2016;2016;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2016;2016;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;NMBR;RACE;AIAN;;;;
2016;2016;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;;Number;52;52;;;;;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;NMBR;GENDER;GENF;;;;
2016;2016;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2016;2016;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;NMBR;RACE;BLK;;;;
2016;2016;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2016;2016;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.6;10.6;;;8.3;13.5;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2016;2016;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2016;2016;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.7;7.7;;;6.5;9;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2016;2016;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;NMBR;RACE;AIAN;;;;
2016;2016;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;;Number;23;23;;;;;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;NMBR;GENDER;GENF;;;;
2016;2016;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.1;13.1;;;8;20.2;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2016;2016;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.3;11.3;;;8.6;14.6;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2016;2016;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.5;11.5;;;9.5;13.4;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2016;2016;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2016;2016;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.1;11.1;;;7.9;15.3;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2016;2016;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;5.8;5.8;;;4.5;7.3;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2016;2016;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2016;2016;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;NMBR;RACE;AIAN;;;;
2016;2016;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2016;2016;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2016;2016;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;NMBR;RACE;HIS;;;;
2016;2016;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;38;38;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;NMBR;RACE;BLK;;;;
2016;2016;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2016;2016;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;CRDRATE;RACE;API;;;;
2016;2016;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;CRDRATE;RACE;API;;;;
2016;2016;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2016;2016;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2016;2016;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;NMBR;GENDER;GENM;;;;
2016;2016;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2016;2016;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;;Number;42;42;;;;;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;NMBR;GENDER;GENM;;;;
2016;2016;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2016;2016;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2016;2016;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2016;2016;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;21.3;21.3;;;15.5;28.6;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2016;2016;ME;Maine;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;NMBR;RACE;BLK;;;;
2016;2016;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2016;2016;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2016;2016;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2016;2016;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2016;2016;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;NMBR;RACE;AIAN;;;;
2016;2016;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2016;2016;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;39;39;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;NMBR;RACE;WHT;;;;
2016;2016;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;;Number;34;34;;;;;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;NMBR;GENDER;GENF;;;;
2016;2016;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;24.7;24.7;;;17.5;33.9;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2016;2016;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2016;2016;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2016;2016;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;NMBR;RACE;AIAN;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.2;44.2;;;33.6;55.4;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;50.0;50;;;40.3;59.8;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.6;7.6;;;4.5;12.5;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.7;34.7;;;27.2;43;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;58.3;58.3;;;46.2;69.4;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.3;39.3;;;31.1;48.3;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;19.5;19.5;;;12.5;29.2;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;4.9;4.9;;;4.4;5.6;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2015;2015;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.9;43.9;;;37.2;50.8;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.0;7;;;5.7;8.6;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.9;82.9;;;69.6;91.1;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.6;6.6;;;4.6;9.4;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2016;2016;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.3;33.3;;;26.6;40.8;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;ME;Maine;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;NMBR;RACE;AIAN;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67.0;67;;;58.7;74.5;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;49.4;49.4;;;43.2;55.6;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;26.5;26.5;;;18.7;36.1;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.8;9.8;;;7.8;12.3;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.3;62.3;;;50.8;72.5;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.4;44.4;;;29.1;60.8;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2016;2016;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.2;7.2;;;5.1;9.9;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2016;2016;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;NMBR;RACE;API;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.8;37.8;;;24;53.9;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.3;7.3;;;5;10.7;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.9;47.9;;;42.6;53.2;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;57.0;57;;;49;64.6;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.3;11.3;;;10.4;12.3;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2015;2015;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.6;11.6;;;9.6;14;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.6;9.6;;;8.1;11.4;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.3;38.3;;;29.2;48.3;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2016;2016;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.7;41.7;;;35;48.8;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.1;44.1;;;29.4;60;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.6;9.6;;;8.2;11.1;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.0;63;;;52.1;72.7;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;27.7;27.7;;;18.9;38.6;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.8;44.8;;;30.9;59.5;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.2;11.2;;;8.3;14.9;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;52.5;52.5;;;41.4;63.4;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;6.0;6;;;3.9;9.1;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.3;49.3;;;40.7;57.9;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.7;42.7;;;34.3;51.6;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2015;2015;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.1;12.1;;;11;13.2;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2016;2016;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;25.3;25.3;;;17.6;35.1;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2016;2016;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2016;2016;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;NMBR;RACE;HIS;;;;
2016;2016;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.3;36.3;;;26.2;47.7;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.0;45;;;33.9;56.6;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.7;71.7;;;61.6;80.1;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.2;71.2;;;62.5;78.6;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.9;34.9;;;29.5;40.6;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;76.6;76.6;;;60;87.7;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.4;32.4;;;25.8;39.7;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2015;2015;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2016;2016;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;NMBR;RACE;AIAN;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;16.1;16.1;;;12.8;20;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;53.2;53.2;;;41.6;64.4;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;18.0;18;;;11.6;27;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;NMBR;RACE;AIAN;;;;
2016;2016;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;19.8;19.8;;;12.9;29;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2015;2015;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.7;42.7;;;34.1;51.7;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2016;2016;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.7;6.7;;;5.3;8.4;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.2;9.2;;;8.5;10;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;28.3;28.3;;;19.6;39.1;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.4;10.4;;;7.1;15;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.1;10.1;;;7.5;13.6;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.7;38.7;;;31.9;46;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.3;11.3;;;9.4;13.6;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2016;2016;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.4;10.4;;;7.9;13.6;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;58.6;58.6;;;50.1;66.7;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;14.9;14.9;;;10.1;21.2;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2016;2016;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.3;83.3;;;70.2;91.3;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;17.8;17.8;;;11.4;26.7;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;55.2;55.2;;;45.8;64.3;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2016;2016;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.2;8.2;;;6;11;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2015;2015;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.3;5.3;;;4.7;6.1;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.3;37.3;;;19.4;59.4;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.9;47.9;;;44.5;51.3;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;64.3;64.3;;;50.8;75.9;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;59.4;59.4;;;48.4;69.4;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.1;71.1;;;62.2;78.7;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2015;2015;NY;New York;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.8;11.8;;;8.2;16.9;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.6;44.6;;;33.4;56.4;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.4;8.4;;;7.4;9.4;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;52.3;52.3;;;46.8;57.7;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2016;2016;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.0;12;;;10.7;13.5;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.6;48.6;;;40.7;56.7;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;5.9;5.9;;;4.4;7.7;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.6;12.6;;;9.8;16.1;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.5;36.5;;;27.8;46.3;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.1;46.1;;;34.7;57.9;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.7;36.7;;;28.4;45.7;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;;Number;21;21;;;;;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;NMBR;GENDER;GENM;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.1;11.1;;;9.9;12.5;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.6;8.6;;;7.1;10.4;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.2;8.2;;;7.2;9.3;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2016;2016;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;;Number;51;51;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;NMBR;RACE;WHT;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;54.6;54.6;;;40.5;68.1;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2016;2016;TX;Texas;NVSS;Asthma;Asthma mortality rate;;;Number;53;53;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;NMBR;RACE;BLK;;;;
2016;2016;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;NMBR;RACE;HIS;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.4;43.4;;;31.7;55.8;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.5;6.5;;;4.9;8.6;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST4_1;NMBR;RACE;HIS;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.0;46;;;39;53.1;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.2;6.2;;;5.1;7.6;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.2;11.2;;;7.4;16.1;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2016;2016;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;NMBR;GENDER;GENM;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;16.0;16;;;10.4;23.7;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.0;35;;;24.4;47.3;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.9;11.9;;;10.2;13.8;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.5;45.5;;;35.6;55.8;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;52.5;52.5;;;41.1;63.7;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.3;42.3;;;35.6;49.3;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;CRDRATE;RACE;API;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.1;13.1;;;7.3;22.3;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2016;2016;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.0;63;;;50.9;73.7;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;57.3;57.3;;;39.6;73.4;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.8;63.8;;;53.6;72.9;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2016;2016;FL;Florida;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;NMBR;RACE;API;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;8.9;8.9;;;7.3;10.8;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.5;8.5;;;7.4;9.7;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.0;8;;;6.7;9.3;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;75.1;75.1;;;68.2;81;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.4;43.4;;;29.9;57.9;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2016;2016;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2016;2016;ME;Maine;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;NMBR;GENDER;GENF;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.8;9.8;;;8.6;11.1;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.6;38.6;;;29.9;48.1;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.2;6.2;;;5;7.7;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.3;11.3;;;7.7;16.4;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2016;2016;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.0;48;;;39.2;56.9;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.2;30.2;;;19.6;43.4;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;30.9;30.9;;;21.5;43;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2016;2016;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;NMBR;RACE;AIAN;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.9;33.9;;;24.8;44.5;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.7;42.7;;;34.8;51;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.4;9.4;;;5.3;16;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;7.0;7;;;4.7;10.3;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.9;37.9;;;29.9;46.5;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.3;33.3;;;21;48.3;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;53.6;53.6;;;48;59.1;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.5;41.5;;;33.9;49.4;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.3;67.3;;;62.3;71.8;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.4;11.4;;;7.6;16.8;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.0;41;;;31.7;51.1;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;63.1;63.1;;;52.7;72.4;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;74.1;74.1;;;66.1;80.7;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;60.2;60.2;;;48.7;70.7;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.8;41.8;;;33.6;50.6;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.5;49.5;;;42.4;56.6;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.3;9.3;;;8.4;10.3;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.7;47.7;;;40.5;55.1;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.4;47.4;;;40;55;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;NMBR;RACE;HIS;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.7;11.7;;;8.4;16;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.8;48.8;;;43;54.6;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.2;47.2;;;39.1;55.4;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.9;39.9;;;31.6;48.8;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;NMBR;GENDER;GENM;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.2;34.2;;;24.1;45.9;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.3;12.3;;;8;18.4;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;16.4;16.4;;;13.4;19.8;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.6;43.6;;;35.7;52;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.0;41;;;33.6;48.9;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.7;6.7;;;5;8.9;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.4;47.4;;;33.6;61.6;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.4;9.4;;;7.2;12.2;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.7;47.7;;;38.5;57;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;51.0;51;;;34;67.8;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.8;13.8;;;11.7;16.3;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.8;8.8;;;7.8;9.9;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2016;2016;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.5;12.5;;;7.7;19.1;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.9;7.9;;;5.1;12.1;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.0;5;;;4.1;5.9;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;61.0;61;;;50;70.9;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.9;48.9;;;34.7;63.4;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.6;10.6;;;9.5;11.9;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.3;7.3;;;5.4;9.7;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.3;7.3;;;6.7;7.9;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;58.6;58.6;;;48.3;68.1;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;17.8;17.8;;;11.3;26.9;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2016;2016;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.9;35.9;;;25.5;47.8;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.4;48.4;;;43.1;53.8;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;4.4;4.4;;;3.1;6.2;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.6;36.6;;;22.8;53;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.4;34.4;;;27;42.8;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.0;10;;;8.5;11.8;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.3;12.3;;;10.8;13.9;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;53.2;53.2;;;45.4;60.9;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.2;33.2;;;18.7;51.8;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2015;2015;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.2;6.2;;;4.2;9.2;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;NMBR;RACE;HIS;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.0;42;;;35.5;48.7;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;78.6;78.6;;;71.2;84.5;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;61.9;61.9;;;50;72.5;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.6;46.6;;;36.3;57.2;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;51.6;51.6;;;46.3;56.9;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.2;8.2;;;4.9;12.8;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.4;33.4;;;21.7;47.6;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;16.0;16;;;12.2;20.9;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2016;2016;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;NMBR;GENDER;GENM;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2015;2015;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.5;49.5;;;43.5;55.4;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.1;9.1;;;8.1;10.2;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;16.9;16.9;;;11.3;24.3;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2016;2016;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;NMBR;RACE;API;;;;
2016;2016;NY;New York;NVSS;Asthma;Asthma mortality rate;;;Number;65;65;;;;;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;NMBR;RACE;HIS;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.8;42.8;;;31.9;54.5;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.5;62.5;;;48.8;74.5;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2016;2016;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;NMBR;RACE;HIS;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.9;10.9;;;7.2;16;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.7;68.7;;;61;75.6;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.3;65.3;*;50 States + DC: US Median;62.3;69.9;Gender;Female;;;;;;;59;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2016;2016;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;NMBR;GENDER;GENF;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.1;8.1;;;5.6;11.4;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;61.9;61.9;;;47.2;74.6;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.1;10.1;;;8.4;12.2;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.4;63.4;;;52.1;73.5;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.3;8.3;;;7.1;9.6;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;19.5;19.5;;;12.5;29.1;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2015;2015;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.0;39;;;31.4;47.3;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.4;9.4;;;8.3;10.5;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.1;39.1;;;24.3;56.2;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.2;38.2;;;25.7;52.5;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.0;31;;;23.2;40.2;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;NMBR;RACE;BLK;;;;
2015;2015;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;4.6;4.6;;;2.6;8.1;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.8;14.8;;;11.7;18.7;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2016;2016;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;CRDRATE;RACE;API;;;;
2016;2016;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.6;7.6;;;6.7;8.5;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.5;47.5;;;38.7;56.4;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;77.5;77.5;;;69.9;83.6;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2016;2016;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.2;10.2;;;7.2;14.4;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;CRDRATE;RACE;API;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.3;8.3;;;7.4;9.3;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;56.9;56.9;;;40.1;72.3;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.3;45.3;;;36.4;54.4;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.9;43.9;;;36.5;51.5;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;15.7;15.7;;;11.1;21.8;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.2;72.2;;;63.1;79.8;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.0;11;;;6;19.3;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.8;11.8;;;8.3;16.6;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.5;9.5;;;8.6;10.4;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2016;2016;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;;Number;33;33;;;;;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;NMBR;GENDER;GENM;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.2;7.2;;;5.7;9.1;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.1;11.1;;;9.2;13.4;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.8;39.8;;;30.3;50.1;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;NMBR;RACE;HIS;;;;
2015;2015;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.2;66.2;*;50 States + DC: US Median;61.9;69.3;Gender;Female;;;;;;;59;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.7;10.7;;;6.9;16.1;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.4;13.4;;;11.8;15.1;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.6;10.6;;;7.9;14;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.2;37.2;;;29.3;45.8;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.1;9.1;;;8;10.3;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;56.7;56.7;;;46.6;66.3;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;51.0;51;;;42.4;59.4;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2016;2016;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;;Number;29;29;;;;;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;NMBR;GENDER;GENM;;;;
2016;2016;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.2;7.2;;;6;8.7;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2015;2015;US;United States;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.1;9.1;*;50 States + DC: US Median;8.8;9.9;Overall;Overall;;;;;;;59;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.1;11.1;;;9.2;13.4;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2015;2015;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.3;5.3;;;4.6;6;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.5;14.5;;;9.1;22;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.1;14.1;;;11;17.9;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.7;11.7;;;9.7;14;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.2;65.2;;;44.6;81.3;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.8;10.8;;;9.8;11.8;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.3;70.3;;;60.3;78.7;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.8;72.8;;;58;83.8;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.5;9.5;;;7;12.7;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.5;49.5;;;43;56.1;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;56.2;56.2;;;43.7;67.9;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2016;2016;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.6;11.6;;;8.3;15.8;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;49.8;49.8;;;43.6;55.9;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.4;47.4;;;39.2;55.9;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.1;13.1;;;10.6;16;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.2;9.2;;;8.1;10.5;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.5;36.5;;;27.8;46.1;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2016;2016;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.7;14.7;;;10.1;20.6;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.6;10.6;;;8.9;12.4;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.6;44.6;;;39.9;49.3;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;7.4;7.4;;;4.8;11.3;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;22.9;22.9;;;14.4;34.5;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.9;14.9;;;10.3;21;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2016;2016;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;NMBR;RACE;WHT;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.9;10.9;;;7.7;15.3;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.2;14.2;;;9.8;20.2;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.6;9.6;;;8.9;10.4;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;76.2;76.2;;;69.4;81.9;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.5;37.5;;;26.5;50;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.0;49;;;44;54;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.5;63.5;;;51.2;74.3;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;60.6;60.6;;;52.6;68;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;3.7;3.7;;;2.2;6.3;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.1;62.1;;;54.5;69.2;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.1;72.1;;;60;81.7;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.5;12.5;;;11.3;13.7;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.8;7.8;;;6.7;9;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2015;2015;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2016;2016;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.1;45.1;;;37.9;52.5;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.6;44.6;;;31.8;58.1;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;60.5;60.5;;;49.1;70.9;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;56.0;56;;;47.2;64.3;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.4;9.4;;;8.8;10;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.0;33;;;27.8;38.5;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.3;35.3;;;22.9;50;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;15.9;15.9;;;10.4;23.6;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.2;44.2;;;33.2;55.8;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;78.8;78.8;;;68;86.6;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.6;49.6;;;45.4;53.9;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.0;13;;;11.5;14.7;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2016;2016;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.7;8.7;;;8.2;9.1;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2015;2015;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;;Number;23;23;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;NMBR;RACE;WHT;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;75.4;75.4;;;66.8;82.4;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2016;2016;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.0;11;;;7.6;15.5;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.0;14;;;11.4;17.2;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.7;10.7;;;9.8;11.6;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;61.2;61.2;;;51.1;70.3;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.7;62.7;;;52.7;71.6;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.1;13.1;;;10.5;16.1;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;49.1;49.1;;;41;57.2;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.8;38.8;;;30.1;48.3;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2016;2016;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;CRDRATE;RACE;API;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.5;38.5;;;29.1;48.9;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.0;7;;;5.6;8.7;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.2;43.2;;;38.5;48.1;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.6;8.6;;;8.1;9.1;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;50.7;50.7;;;44.8;56.7;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;17.6;17.6;;;9.6;30;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;;Number;29;29;;;;;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;NMBR;GENDER;GENM;;;;
2016;2016;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;5.8;5.8;;;4;8.1;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;16.3;16.3;;;11.6;22.5;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.2;46.2;;;34.5;58.3;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.8;43.8;;;35.8;52.1;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.4;46.4;;;36;57;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.9;68.9;;;55.4;79.8;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.5;62.5;;;54.3;70;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.7;63.7;;;52.8;73.4;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.0;65;;;53.9;74.6;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.4;46.4;;;41.3;51.6;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.4;34.4;;;26.4;43.5;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.6;9.6;;;8.3;11;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;53.8;53.8;;;44.2;63.1;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.3;43.3;;;33.4;53.7;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2016;2016;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.4;44.4;;;37.4;51.5;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.7;45.7;;;37.8;53.9;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2016;2016;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.7;34.7;;;28.9;41;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.7;44.7;;;33.5;56.5;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.5;7.5;;;6.7;8.3;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2016;2016;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;CRDRATE;RACE;API;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.2;28.2;;;21.6;35.9;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;CRDRATE;RACE;API;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.5;45.5;;;38.2;52.9;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.5;6.5;;;5.8;7.4;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.9;10.9;;;8.5;14;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.2;7.2;;;6.6;7.8;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.1;33.1;;;26.3;40.7;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;NMBR;RACE;AIAN;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.2;63.2;;;50.5;74.3;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.3;48.3;;;36.8;60;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.3;71.3;;;63.5;78;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.5;7.5;;;5.4;10.2;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2016;2016;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.0;11;;;7.5;15.6;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.6;11.6;;;9.6;13.8;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.4;34.4;;;24.4;46.1;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.9;38.9;;;32.3;46;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.3;7.3;;;4.6;10.9;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.4;6.4;;;3.8;10.6;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2016;2016;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.0;68;;;43.2;85.6;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.1;67.1;;;53.5;78.4;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.1;7.1;;;5.3;9.6;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;NMBR;RACE;HIS;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.2;32.2;;;21.8;44.7;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.2;7.2;;;6.6;7.8;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.8;41.8;;;26.4;58.9;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;52.6;52.6;;;45.5;59.7;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;CRDRATE;RACE;API;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.8;40.8;;;33;49.2;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2016;2016;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;27.7;27.7;;;19;39.2;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.8;47.8;;;39.9;55.9;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2015;2015;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.3;13.3;;;9.1;18.9;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.6;40.6;;;31.2;50.8;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.0;41;;;32.2;50.5;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.2;69.2;;;59.6;77.4;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.5;48.5;;;40.2;56.9;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;22.8;22.8;;;15.6;32.1;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.9;47.9;;;40.3;55.6;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.1;7.1;;;5.9;8.6;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2016;2016;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2013;2013;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;774;774;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;NMBR;RACE;API;;;;
2016;2016;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;15.3;15.3;;;10.4;21.7;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.4;37.4;;;31.1;44.1;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.2;6.2;;;4;9.5;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;3.6;3.6;;;2.4;5.5;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.0;42;;;33.9;50.5;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.6;9.6;;;8;11.4;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;57.5;57.5;;;46.2;68;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.4;41.4;;;33.4;49.8;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.1;13.1;;;11;15.6;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.9;42.9;;;35.7;50.3;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.5;12.5;;;10.6;14.7;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.7;35.7;;;25.7;47.1;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;64.8;64.8;;;53.4;74.8;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.7;12.7;;;10;16.1;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.1;11.1;;;9.5;13;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;22.3;22.3;;;13.1;35.3;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.7;11.7;;;9.2;14.6;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.4;37.4;;;25.9;50.5;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;58.3;58.3;;;46.9;68.8;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.8;6.8;;;5.2;8.8;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.7;30.7;;;20.3;43.5;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.2;13.2;;;10.7;16.2;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.3;71.3;;;64;77.7;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2016;2016;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST4_1;NMBR;RACE;WHT;;;;
2016;2016;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.5;7.5;;;5.4;10.2;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2016;2016;MT;Montana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;NMBR;RACE;WHT;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.3;10.3;;;9;11.8;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.4;41.4;;;35.8;47.2;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.6;12.6;;;10.5;15.1;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.3;8.3;;;5.9;11.5;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;58.3;58.3;;;47.6;68.3;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;49.7;49.7;;;32.9;66.6;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.5;40.5;;;32.2;49.3;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.2;10.2;;;7.4;13.6;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2016;2016;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.8;11.8;;;8.3;16.4;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2016;2016;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.4;45.4;;;38.5;52.6;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2016;2016;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.6;14.6;;;13.2;16.1;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.1;41.1;;;28.3;55.3;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.4;68.4;;;52.5;80.9;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.1;9.1;;;8;10.3;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;73.5;73.5;;;66.2;79.7;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.3;65.3;;;52.8;76;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.0;12;;;7.4;18.4;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.6;42.6;;;34.4;51.2;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.3;45.3;;;39.5;51.3;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.6;35.6;;;27.3;44.8;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.4;11.4;;;10.4;12.4;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.0;9;;;8.3;9.6;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;55.8;55.8;;;46.8;64.4;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.6;40.6;;;36.2;45.2;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;22.9;22.9;;;17.8;28.9;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;75.6;75.6;;;59.3;86.9;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.3;8.3;;;6.8;10.1;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.6;13.6;;;11.8;15.5;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2016;2016;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;78.9;78.9;;;62.4;89.4;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.4;42.4;;;34.7;50.4;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2016;2016;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;NMBR;RACE;BLK;;;;
2016;2016;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.5;11.5;;;10.5;12.7;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.6;35.6;;;22;51.9;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.8;45.8;;;38.1;53.6;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2016;2016;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;;Number;21;21;;;;;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2016;2016;NY;New York;NVSS;Asthma;Asthma mortality rate;;;Number;119;119;;;;;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;NMBR;GENDER;GENM;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.5;47.5;;;41.6;53.5;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;61.2;61.2;;;49.8;71.6;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2016;2016;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;13.6;13.6;;;10;17.9;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.3;9.3;;;7.6;11.4;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.9;12.9;;;11.5;14.3;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.7;40.7;;;33.4;48.5;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;CRDRATE;RACE;API;;;;
2016;2016;ME;Maine;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.6;37.6;;;27.8;48.6;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.9;65.9;;;54.9;75.4;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.3;10.3;;;8;13.2;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.7;10.7;;;9.7;11.9;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.2;5.2;;;3.2;8.2;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;61.2;61.2;;;47.9;73;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.7;42.7;;;32.5;53.6;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;51.0;51;;;33.9;67.8;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.2;34.2;;;25.2;44.6;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;23.4;23.4;;;12.9;38.4;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2016;2016;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.9;45.9;;;36.6;55.5;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.1;12.1;;;9.1;16;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2016;2016;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.4;5.4;;;3.1;9.1;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;78.4;78.4;;;67.9;86.2;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.7;14.7;;;11.6;18.4;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;58.3;58.3;;;44;71.4;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.4;5.4;;;4.7;6.2;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.1;41.1;;;28.6;54.8;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;49.7;49.7;;;45.5;54;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.6;40.6;*;50 States + DC: US Median;39.2;41.5;Gender;Female;;;;;;;59;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.9;35.9;;;22.9;51.3;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2015;2015;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.0;8;;;6.5;9.9;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.6;67.6;;;53.3;79.2;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2015;2015;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.9;69.9;;;58.9;79;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.7;13.7;;;12.4;15.2;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.6;11.6;;;7.7;17.1;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2015;2015;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.8;40.8;;;30.2;52.3;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.3;66.3;;;57.6;74;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.9;10.9;;;9.9;12;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2016;2016;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;15.2;15.2;;;12.8;17.6;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;30.3;30.3;;;19.8;43.3;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;12.9;12.9;;;7.4;21.4;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;20.1;20.1;;;12.7;30.4;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.1;7.1;;;4;12.1;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2016;2016;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;NMBR;RACE;AIAN;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.0;67;;;56.7;75.9;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.2;7.2;;;6.6;7.9;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.8;45.8;;;36;55.8;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;55.1;55.1;;;44.4;65.3;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2016;2016;WA;Washington;NVSS;Asthma;Asthma mortality rate;;;Number;66;66;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;NMBR;RACE;WHT;;;;
2016;2016;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.8;13.8;;;12.2;15.5;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;NMBR;RACE;WHT;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;75.0;75;;;61.7;84.8;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.6;12.6;;;7.3;20.8;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.7;12.7;;;9.6;16.4;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.6;6.6;;;5.2;8.3;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.4;66.4;;;55;76.2;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.0;5;;;3;8.5;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;53.1;53.1;;;47.6;58.5;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.0;43;;;30.1;56.9;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;16.6;16.6;;;12.6;21.6;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2016;2016;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;21.6;21.6;;;15.6;29;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.4;8.4;;;7.3;9.5;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.4;41.4;;;34.7;48.4;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.8;37.8;;;31.8;44.1;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.1;32.1;;;22.4;43.7;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.3;46.3;;;37.4;55.5;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.1;8.1;;;6.7;9.8;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.2;13.2;;;10.1;16.9;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2015;2015;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.5;42.5;;;33.4;52.1;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;18.3;18.3;;;10.4;30.2;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2016;2016;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;NMBR;RACE;API;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.6;48.6;;;39.5;57.7;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.3;43.3;;;36;51;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.8;72.8;;;61.6;81.6;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.2;48.2;;;35.3;61.4;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.7;8.7;;;7.1;10.6;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.6;6.6;;;5.1;8.6;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;NMBR;RACE;API;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;17.7;17.7;;;10;29.4;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.2;10.2;;;6.6;15.3;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.6;40.6;;;35.2;46.3;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.9;9.9;;;9.1;10.8;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;NY;New York;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.7;9.7;;;7.3;12.6;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.2;69.2;;;58.5;78.2;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.8;45.8;;;34.7;57.3;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.9;36.9;;;23.7;52.4;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2016;2016;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.8;8.8;;;5.9;12.6;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;18.1;18.1;;;13.5;23.8;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.0;72;;;63;79.5;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.9;38.9;;;30.2;48.3;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.7;34.7;;;26.6;43.7;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.6;13.6;;;8.1;22;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;54.6;54.6;;;46;62.9;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.7;12.7;;;10.9;14.4;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2015;2015;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.8;45.8;;;39.6;52.2;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2016;2016;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.3;71.3;;;62.5;78.7;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;55.3;55.3;;;38.8;70.7;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.5;41.5;;;34.9;48.4;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.5;9.5;;;8.5;10.6;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.1;13.1;;;7.6;21.6;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.7;40.7;;;32.3;49.7;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.7;6.7;;;5.2;8.7;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2016;2016;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;NMBR;RACE;WHT;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.1;6.1;;;4.8;7.5;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.6;7.6;;;6.5;8.9;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;14.6;14.6;;;9.6;21.2;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.1;40.1;;;28.9;52.5;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;8.5;8.5;;;4.9;14.4;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.5;47.5;;;41.2;53.9;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2016;2016;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;18.0;18;;;10.1;30.2;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;17.6;17.6;;;11.9;25.2;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2016;2016;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.8;34.8;;;28.5;41.7;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.4;6.4;;;5.1;8;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.2;39.2;;;31.8;47;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.6;6.6;;;5.2;8.3;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.2;39.2;;;31.3;47.8;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.2;66.2;;;54.4;76.4;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;51.3;51.3;;;33.9;68.4;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;49.7;49.7;;;36.3;63.2;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.9;6.9;;;5.8;8.1;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.8;10.8;;;6.8;16.7;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.3;7.3;;;6.3;8.5;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.9;11.9;;;7.9;17.3;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;30.3;30.3;;;20.7;42.1;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.5;31.5;;;19.9;46;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.0;9;;;7.9;10.1;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.1;33.1;;;22.9;45.2;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.4;66.4;;;55;76.1;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;29.8;29.8;;;18.1;44.8;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.5;12.5;;;9.1;17;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;74.4;74.4;;;64.4;82.3;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.1;5.1;;;4.2;6.2;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2016;2016;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;NMBR;RACE;API;;;;
2015;2015;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.2;41.2;;;36.5;46.1;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.0;43;;;31.3;55.5;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.9;72.9;;;59;83.4;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.9;13.9;;;12.4;15.5;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2016;2016;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;;Number;46;46;;;;;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;15.5;15.5;;;8.7;26.1;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.0;10;;;8.9;11.2;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2016;2016;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;;Number;55;55;;;;;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2016;2016;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.6;11.6;;;7.9;16.4;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.3;11.3;;;9.7;13.1;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.4;7.4;;;4.4;12.2;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.907192, -77.036871);;11;AST;AST4_1;CRDRATE;RACE;API;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.8;5.8;;;3.4;9.7;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;21.2;21.2;;;14.9;29.4;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.5;9.5;;;8.2;11;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.8;40.8;;;31.9;50.4;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.8;45.8;;;41.9;49.9;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.7;44.7;;;33.1;56.9;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.0;13;;;9.5;17.5;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;58.1;58.1;;;42.5;72.2;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.6;36.6;;;28.7;45.2;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.3;62.3;;;53.7;70.3;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.6;72.6;;;65;79.1;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.8;10.8;;;7.1;15.7;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.9;42.9;;;31.4;55.4;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.9;9.9;;;6.6;14.5;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.8;10.8;;;9.3;12.5;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.8;47.8;;;39.2;56.5;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.5;8.5;;;5.2;13.1;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2016;2016;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.3;7.3;;;4.5;11.3;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.3;38.3;;;32.8;44.1;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.9;37.9;;;26.6;50.6;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2016;2016;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.8;10.8;;;7.5;15.2;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2016;2016;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;NMBR;RACE;API;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.9;9.9;;;7.6;12.8;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.1;48.1;;;35.9;60.6;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.3;10.3;;;7.5;14.1;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;16.0;16;;;12.5;20.2;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.8;39.8;;;25.8;55.8;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.4;14.4;;;12.7;16.2;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;64.3;64.3;;;51.2;75.5;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2016;2016;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.0;8;;;6.9;9.2;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.1;39.1;;;23.3;57.6;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.9;71.9;;;56.6;83.4;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2016;2016;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.6;7.6;;;4.9;11.1;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.5;38.5;;;33;44.3;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;23.9;23.9;;;19.5;28.8;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.2;13.2;;;10.7;16.2;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.6;9.6;;;8.1;11.2;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2016;2016;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;CRDRATE;RACE;API;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.9;7.9;;;5.6;11;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67.6;67.6;;;57.7;76.2;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.1;12.1;;;9.4;15.4;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.4;63.4;;;53.4;72.4;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.7;41.7;;;34.3;49.5;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2015;2015;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.3;7.3;;;5.7;9.4;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;28.5;28.5;;;20.7;38;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;8.3;8.3;;;6.8;10.1;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.9;44.9;;;33.4;56.9;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;NMBR;RACE;BLK;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;53.8;53.8;;;48.8;58.8;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2016;2016;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.5;34.5;;;26;44;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.6;11.6;;;8.3;16;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.7;39.7;;;30.7;49.4;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.7;68.7;;;58.7;77.3;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;CRDRATE;RACE;API;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.6;35.6;;;28.4;43.6;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;23.1;23.1;;;15.7;32.8;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.5;9.5;;;8.3;10.8;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.9;38.9;;;33.2;44.9;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;61.4;61.4;;;53;69.2;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;21.5;21.5;;;12.8;33.9;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.0;40;;;34;46.3;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.5;42.5;;;33.9;51.6;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.2;13.2;;;7.2;23;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.5;44.5;;;35.3;54.1;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.5;67.5;;;59.2;74.9;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2016;2016;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;51;51;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;NMBR;RACE;BLK;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;51.9;51.9;;;41.9;61.7;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.7;44.7;;;36.6;53.2;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;76.5;76.5;;;64.3;85.5;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;78.2;78.2;;;59.9;89.7;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2016;2016;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;;Number;33;33;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;NMBR;RACE;WHT;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.0;43;;;37.6;48.6;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;22.7;22.7;;;16.1;31.2;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.2;32.2;;;25.5;39.7;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.5;5.5;;;3.1;9.5;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.6;13.6;;;11.2;16.3;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;27.1;27.1;;;19.6;36.1;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.9;35.9;;;29.3;43.2;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;77.5;77.5;;;62.9;87.4;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.4;33.4;;;22.1;47;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.5;10.5;;;9.7;11.3;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.9;12.9;;;8.6;18.5;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.4;7.4;;;6;9.2;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;53.0;53;;;42.2;63.5;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2016;2016;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.3;11.3;;;7.7;15.9;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.5;70.5;;;59.2;79.7;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.6;36.6;;;30.3;43.4;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.0;40;;;30.9;50;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.4;11.4;;;7;18;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.5;9.5;;;8.5;10.6;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67.5;67.5;;;51.8;80;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.6;7.6;;;6.8;8.4;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.6;39.6;;;34.5;45;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.6;9.6;;;6.3;14;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.7;13.7;;;11;16.9;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.8;66.8;;;55.2;76.7;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.1;8.1;;;4.7;13.7;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.0;5;;;2.8;8.8;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;59.9;59.9;;;51.8;67.4;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2015;2015;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2016;2016;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;;Number;34;34;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;NMBR;RACE;BLK;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.0;35;;;21.7;51.2;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.6;6.6;;;5.8;7.5;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.5;9.5;;;5.4;16.2;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;61.5;61.5;;;48.3;73.1;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.2;11.2;;;10.3;12.2;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2016;2016;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.0;11;;;6.7;17.1;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.6;41.6;;;31.7;52.1;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.4;48.4;;;39.5;57.3;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;57.6;57.6;;;39.7;73.8;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.2;36.2;;;22.7;52.4;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;25.9;25.9;;;14;42.8;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;NMBR;RACE;AIAN;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;21.7;21.7;;;16.8;27.7;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;48.7;48.7;;;31.5;66.3;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.3;70.3;;;58.6;79.9;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;56.9;56.9;;;42.6;70.1;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.3;64.3;;;54.9;72.7;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.8;43.8;;;35;52.9;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.7;32.7;;;24.8;41.7;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2015;2015;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;72.4;72.4;;;63.8;79.6;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.9;11.9;;;9.7;14.5;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;73.1;73.1;;;63.7;80.9;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2016;2016;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.0;9;;;7.6;10.3;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.5;31.5;;;20.2;45.5;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.7;43.7;;;34.1;53.9;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.7;37.7;;;25.8;51.2;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.9;39.9;;;26.8;54.5;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2016;2016;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;14.9;14.9;;;10.8;20.1;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;15.6;15.6;;;11.7;20.4;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.4;46.4;;;37.8;55.2;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;57.4;57.4;;;43.2;70.5;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.7;10.7;;;6;18.3;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.9;35.9;;;28.4;44.2;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.8;11.8;;;7.8;17.5;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;NMBR;RACE;HIS;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.2;44.2;;;35.1;53.7;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2016;2016;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.6;9.6;;;5.7;15.9;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.8;5.8;;;4.5;7.3;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;56.9;56.9;;;43.3;69.4;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.5;14.5;;;11.8;17.8;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;33.1;33.1;;;18.4;52;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.7;8.7;;;7.1;10.6;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.8;39.8;;;34;45.9;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;50.4;50.4;;;44.4;56.4;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.0;5;;;3.1;8;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;50.8;50.8;;;38.3;63.2;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;53.9;53.9;;;47.3;60.3;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2016;2016;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2016;2016;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.7;12.7;;;9.8;16.2;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.6;44.6;;;37.5;52;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.9;13.9;;;10.8;17.8;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.8;40.8;;;33.9;48.1;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.0;10;;;8.6;11.6;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;55.2;55.2;;;45.9;64.2;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.6;46.6;;;41.3;51.9;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.4;9.4;;;8.3;10.6;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50.5;50.5;;;32.8;68.1;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2016;2016;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;NMBR;RACE;BLK;;;;
2015;2015;NY;New York;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.3;12.3;;;10.4;14.4;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.0;65;;;42.4;82.4;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;UT;Utah;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;NMBR;RACE;AIAN;;;;
2015;2015;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.7;47.7;*;50 States + DC: US Median;44.7;49.4;Gender;Female;;;;;;;59;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.0;72;;;64.8;78.3;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29.6;29.6;;;23.6;36.3;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;CA;California;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.7;9.7;;;7.8;12;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2015;2015;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.7;9.7;;;8.8;10.7;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;74.0;74;;;66;80.7;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.4;13.4;;;11.1;16.1;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.8;47.8;;;38.4;57.4;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.2;36.2;;;22;53.4;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.5;10.5;;;6.1;17.4;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.6;6.6;;;4.9;9;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.8;10.8;;;10;11.8;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2016;2016;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.5;11.5;;;8.5;15.3;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.9;69.9;;;62;76.7;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;22.2;22.2;;;14.6;32.2;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.2;41.2;;;29.2;54.3;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;16.7;16.7;;;12.5;21.9;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.1;41.1;;;35.9;46.6;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.5;10.5;;;7.8;14.1;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.1;14.1;;;10.1;19.1;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;53.2;53.2;;;41.4;64.7;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.4;47.4;;;34.4;60.8;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;NMBR;RACE;AIAN;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.1;9.1;;;6.5;12.6;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.7;42.7;;;36.9;48.8;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.8;46.8;;;37.3;56.5;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2016;2016;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.4;42.4;;;34.5;50.6;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.7;68.7;;;48.8;83.4;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.9;65.9;;;46.4;81.2;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;61.2;61.2;;;49.5;71.8;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2015;2015;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.4;64.4;*;50 States + DC: US Median;63.1;68;Overall;Overall;;;;;;;59;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.7;13.7;;;11.6;16;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2016;2016;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.6;8.6;;;5.4;13.2;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.9;39.9;;;33.1;47.1;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.1;8.1;;;6.8;9.7;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.6;40.6;;;33.6;48.1;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.2;8.2;;;6.7;10;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.1;8.1;;;7.3;8.8;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2016;2016;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;NMBR;RACE;API;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.2;9.2;;;7.9;10.7;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;75.4;75.4;;;61.4;85.5;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.5;67.5;;;56.5;76.9;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.9;40.9;;;28.3;54.9;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;NMBR;RACE;BLK;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.4;6.4;;;3.8;10.6;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;;Number;32;32;;;;;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;NMBR;GENDER;GENF;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.5;46.5;;;35.3;58.1;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.9;10.9;;;9.5;12.6;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.5;38.5;;;33.2;44.1;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;77.8;77.8;;;69.2;84.5;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;22.9;22.9;;;18.1;28.6;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.6;7.6;;;5.7;10;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.1;8.1;;;7.1;9.3;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.4;32.4;;;23.3;43;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.6;62.6;;;53.4;71;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.8;5.8;;;3.8;8.9;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.8;66.8;;;52.1;78.8;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;NMBR;RACE;HIS;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.5;44.5;;;35.1;54.4;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;19.4;19.4;;;11.2;31.5;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;ME;Maine;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;NMBR;RACE;HIS;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.8;43.8;;;33.4;54.8;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;49.5;49.5;;;36.2;62.8;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.1;42.1;;;29.3;56.1;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.0;5;;;4.1;6.1;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;61.3;61.3;;;52.9;69.1;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.1;10.1;;;8.8;11.7;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;49.9;49.9;;;36.2;63.6;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.1;72.1;;;65.2;78;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2016;2016;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;;Number;20;20;;;;;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;NMBR;GENDER;GENM;;;;
2016;2016;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;NMBR;RACE;HIS;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.5;42.5;;;32.5;53.1;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2016;2016;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;;Number;37;37;;;;;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;NMBR;GENDER;GENF;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.4;6.4;;;3.7;11;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;NMBR;RACE;AIAN;;;;
2016;2016;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.9;42.9;;;31.3;55.3;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.5;13.5;;;9.9;18.1;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;51.8;51.8;;;41.8;61.7;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;NMBR;RACE;BLK;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;61.8;61.8;;;53.5;69.5;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.8;9.8;;;6.1;15.4;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.7;8.7;;;4.7;15.3;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.1;10.1;;;8.8;11.7;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.8;45.8;;;35.1;56.8;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;NMBR;RACE;API;;;;
2016;2016;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2016;2016;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2016;2016;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.9;70.9;;;60.2;79.7;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.7;35.7;;;28.7;43.5;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.8;12.8;;;9.4;17.2;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.8;10.8;;;9.8;11.9;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2015;2015;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.9;62.9;;;54.2;70.8;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.3;9.3;;;5.2;16;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2016;2016;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;;Number;76;76;;;;;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.1;14.1;;;8.6;22.4;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67.2;67.2;;;60.7;73;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;78.2;78.2;;;67.6;86;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29.8;29.8;;;21.7;39.5;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.5;9.5;;;8.3;10.7;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2016;2016;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.9;6.9;;;5.7;8.3;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;US;United States;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.2;9.2;*;50 States + DC: US Median;8.9;9.9;Overall;Overall;;;;;;;59;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;15.1;15.1;;;13.5;16.9;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.3;69.3;;;62;75.8;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.9;10.9;;;8.7;13.6;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2016;2016;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.4;11.4;;;9.2;14;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.3;64.3;;;53.6;73.8;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.1;7.1;;;5.8;8.6;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;61.3;61.3;;;53.1;68.9;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;NMBR;GENDER;GENM;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.3;43.3;;;30.3;57.3;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;53.7;53.7;;;45.3;61.8;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.5;11.5;;;10.4;12.8;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.9;12.9;;;11.6;14.4;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.3;37.3;;;31.9;43;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;58.9;58.9;;;41.2;74.6;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2016;2016;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;52.7;52.7;;;36.9;67.9;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;27.8;27.8;;;18;40.3;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;17.3;17.3;;;13.4;22.1;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2015;2015;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.9;38.9;;;26.3;53.3;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.2;9.2;;;8.3;10.2;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.7;69.7;;;59.1;78.6;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;74.0;74;;;63.1;82.5;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;53.7;53.7;;;46.6;60.5;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.4;11.4;;;9.8;13.3;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.5;10.5;;;8.8;12.3;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;73.6;73.6;;;56.2;85.8;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.5;6.5;;;4.5;9.2;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2016;2016;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.0;11;;;7.9;14.8;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2016;2016;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.3;8.3;;;6.1;11.1;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2015;2015;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.6;44.6;;;38;51.4;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.4;42.4;;;27.3;59;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2016;2016;MT;Montana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;NMBR;RACE;API;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.2;10.2;;;9.5;11;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.2;63.2;;;48.7;75.6;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.3;10.3;;;9.4;11.4;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.2;7.2;;;6.5;8;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;17.0;17;;;13.1;21.8;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.1;10.1;;;6.9;14.6;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.2;10.2;;;9.1;11.3;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.0;49;;;38.9;59.2;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2015;2015;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.1;63.1;;;52.9;72.3;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.7;44.7;;;35.6;54.2;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.2;14.2;;;9.1;21.5;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;74.0;74;;;66.2;80.5;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.5;8.5;;;6;11.9;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.8;48.8;;;41.3;56.3;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.8;12.8;;;8.3;18.7;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.4;7.4;;;6.8;8.2;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;4.1;4.1;;;3.1;5.4;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.6;7.6;;;7.1;8.2;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;51.4;51.4;;;45.4;57.5;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2016;2016;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.1;13.1;;;9;18.5;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2016;2016;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;31.5;31.5;;;24;40.6;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.3;42.3;;;34.6;50.4;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.5;36.5;;;21.8;54.3;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.3;48.3;;;35.4;61.4;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.9;9.9;;;9.1;10.8;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.8;40.8;;;30.1;52.4;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.9;47.9;;;39.9;56;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.1;39.1;;;30.4;48.7;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.5;10.5;;;8.7;12.5;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;61.3;61.3;;;44.2;76;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.3;34.3;;;19;53.7;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.6;7.6;;;6.8;8.4;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.6;44.6;;;35.9;53.6;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;75.6;75.6;;;66.8;82.6;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.6;70.6;;;58.3;80.5;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;75.3;75.3;;;62.5;84.8;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2016;2016;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.3;11.3;;;8.6;14.7;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.5;13.5;;;11.1;16.4;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.4;71.4;;;63.7;78;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.9;30.9;;;21.4;42.5;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.5;33.5;;;27.8;39.7;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;57.5;57.5;;;40.4;73;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.5;6.5;;;5.8;7.4;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.0;37;;;26.7;48.7;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.2;11.2;;;9.4;13.3;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.1;72.1;;;63.9;79;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.1;67.1;;;55.1;77.2;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;50.9;50.9;;;43.2;58.6;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;7.0;7;;;4.1;11.9;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.7;33.7;;;25.5;43;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;27.9;27.9;;;17.9;40.7;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;72.8;72.8;;;66.3;78.4;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2016;2016;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;;Number;80;80;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;NMBR;RACE;WHT;;;;
2016;2016;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.9;8.9;;;7.6;10.5;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.1;11.1;;;10;12.4;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.6;6.6;;;5.9;7.5;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.4;11.4;;;7.3;17.4;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;16.3;16.3;;;12.1;21.5;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.2;7.2;;;4;12.5;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.9;41.9;;;30.8;53.8;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;74.1;74.1;;;66.5;80.5;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.4;70.4;;;63;76.8;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;61.0;61;;;48.9;71.9;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.3;39.3;;;32.8;46.2;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.8;9.8;;;7.9;12.1;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.5;39.5;;;32;47.5;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.3;63.3;;;49.8;75;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.3;12.3;;;9.2;16.1;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.0;83;;;73.3;89.6;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;74.3;74.3;;;64.3;82.3;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.6;39.6;;;32.8;46.8;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2016;2016;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;20.1;20.1;;;11.4;33;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.3;10.3;;;8.5;12.4;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;CRDRATE;RACE;API;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.6;43.6;;;38.7;48.7;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.9;41.9;;;35.7;48.5;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2016;2016;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;NMBR;RACE;BLK;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50.7;50.7;;;31.7;69.5;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.6;45.6;;;39.2;52.1;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.0;35;;;28.9;41.6;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;55.4;55.4;;;37.2;72.3;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.1;13.1;;;10.2;16.6;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.6;48.6;;;44.2;53;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.3;43.3;;;34;53;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.4;14.4;;;12.7;16.4;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.0;13;;;9.4;17.6;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.1;11.1;;;10.2;12;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.5;7.5;;;4.9;11.1;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.4;11.4;;;10;12.9;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.0;9;;;7.9;10.2;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.3;48.3;;;39.6;57.2;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.6;67.6;;;62.3;72.4;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.1;35.1;;;22;50.8;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;20.6;20.6;;;13.9;29.3;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;51.1;51.1;;;43;59.2;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.3;35.3;;;27;44.5;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.8;8.8;;;7.8;9.9;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.7;10.7;;;9.6;12.1;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.0;39;;;30.9;47.8;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;NMBR;RACE;API;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.1;14.1;;;11.6;17;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.7;7.7;;;5.4;10.8;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.2;43.2;;;34;53;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2016;2016;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;NMBR;RACE;WHT;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.1;7.1;;;6.6;7.7;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2016;2016;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;15.5;15.5;;;9.3;24.2;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.1;38.1;;;29.5;47.5;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.2;36.2;;;28.9;44.4;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;58.0;58;;;45.1;69.9;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.2;11.2;;;9.7;13;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;;Number;27;27;;;;;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.4;7.4;;;5;10.9;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.8;40.8;;;29.9;52.6;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2016;2016;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2016;2016;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.3;13.3;;;10.2;17.1;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.7;38.7;;;30.2;47.9;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2016;2016;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2016;2016;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;;Number;29;29;;;;;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;NMBR;GENDER;GENF;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.0;40;;;34.8;45.6;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;50.3;50.3;;;36;64.6;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;17.0;17;;;12.8;22;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2016;2016;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.0;9;;;6.6;12;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;64.1;64.1;;;53.7;73.4;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.6;45.6;;;37.4;54.2;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67.0;67;;;55;77.1;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.0;8;;;6.7;9.5;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.0;9;;;7.3;10.7;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.7;6.7;;;5.7;7.8;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.5;5.5;;;4.4;6.8;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2016;2016;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2016;2016;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;CRDRATE;RACE;API;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.6;63.6;;;55.5;71;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;21.0;21;;;16.1;26.9;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.4;10.4;;;7.4;14.5;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.5;9.5;;;8;11.2;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.9;71.9;;;56.9;83.2;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.5;45.5;;;33.2;58.3;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.4;64.4;;;56.9;71.2;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;72.1;72.1;;;62.5;80;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.2;9.2;;;8.2;10.3;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2016;2016;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2016;2016;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.9;8.9;;;7.6;10.2;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2016;2016;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.1;37.1;;;29.4;45.4;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;6.9;6.9;;;5.5;8.5;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.0;13;;;11.6;14.6;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;13.6;13.6;;;8.3;21;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2016;2016;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.1;6.1;;;5.1;7.3;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.4;72.4;;;63.6;79.7;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.2;11.2;;;10.2;12.4;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.907192, -77.036871);;11;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;61.8;61.8;;;43.6;77.3;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;55.0;55;;;46;63.6;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.8;66.8;;;48.6;81.1;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;NMBR;GENDER;GENM;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.0;10;;;6.6;15;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;NMBR;RACE;API;;;;
2016;2016;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.2;10.2;;;9.1;11.3;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.3;14.3;;;9.3;21.3;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.5;10.5;;;7.2;15;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.2;67.2;;;52.9;78.9;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.6;9.6;;;7.6;12.1;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.5;9.5;;;8.2;10.9;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.6;42.6;;;31.5;54.5;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;NMBR;RACE;HIS;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.0;11;;;9.6;12.6;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;16.4;16.4;;;12.2;21.6;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.0;47;;;37.8;56.5;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.9;47.9;;;39.3;56.7;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2016;2016;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;58.9;58.9;;;50.1;67.2;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.4;42.4;;;35.6;49.5;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2015;2015;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.3;43.3;;;35.4;51.6;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.1;14.1;;;9.6;20.2;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.7;44.7;;;36.5;53.2;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;16.3;16.3;;;10.5;24;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;MT;Montana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;NMBR;RACE;AIAN;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.1;35.1;;;27.5;43.5;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.4;40.4;;;34;47.2;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2016;2016;FL;Florida;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;NMBR;RACE;AIAN;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.4;10.4;;;8.5;12.6;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.6;42.6;;;36;49.4;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.8;9.8;;;8.5;11.4;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2016;2016;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2016;2016;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.5;30.5;;;17.6;47.3;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.4;6.4;;;4.5;8.9;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.1;14.1;;;12.2;16.3;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.1;46.1;;;38.3;54;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.1;8.1;;;6.8;9.7;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;15.9;15.9;;;8.9;26.8;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2015;2015;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;64.2;64.2;;;56.4;71.3;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.6;66.6;;;53.4;77.7;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;59.0;59;;;44.9;71.9;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.7;43.7;;;38.2;49.5;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2016;2016;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.8;49.8;;;44;55.6;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.6;7.6;;;6.5;9;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.2;31.2;;;18.9;46.8;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.1;48.1;;;42.4;53.8;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;52.1;52.1;;;45.2;59;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;;Number;45;45;;;;;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.9;48.9;;;33.6;64.4;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;52.1;52.1;;;42.1;61.8;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.5;9.5;;;6.9;12.9;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.9;33.9;;;26.3;42.5;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.4;45.4;;;39.3;51.5;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;74.9;74.9;;;65.9;82.1;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2016;2016;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.0;48;;;38.5;57.6;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.3;41.3;;;35.2;47.7;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.3;13.3;;;9.8;18;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.3;6.3;;;4.9;8;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.4;7.4;;;5.2;10.2;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;60.9;60.9;;;50.9;70;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2016;2016;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;6.5;6.5;;;4.6;8.8;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.5;12.5;;;7.7;19.4;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.8;7.8;;;6.8;9;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;;Number;48;48;;;;;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.5;10.5;;;8.7;12.6;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.3;11.3;;;10.2;12.5;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.5;44.5;;;36.7;52.5;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.9;69.9;;;60.5;77.8;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.1;9.1;;;6.5;12.6;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;31.6;31.6;;;21.8;44.4;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.2;45.2;;;38.5;52;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.3;38.3;;;31.7;45.3;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.2;47.2;;;39.3;55.3;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2016;2016;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;49.5;49.5;;;34.1;65;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.7;6.7;;;4;11;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.0;44;;;33.6;54.8;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.1;9.1;;;8.4;9.9;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2015;2015;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;24.9;24.9;;;16.6;35.6;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.8;45.8;;;42.2;49.4;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.0;67;;;56.7;75.9;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.8;41.8;;;32.3;51.9;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.3;46.3;;;35.7;57.3;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2016;2016;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;17.8;17.8;;;12.7;24.2;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;55.1;55.1;;;45.9;64;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;58.3;58.3;;;43.8;71.4;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2016;2016;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.3;10.3;;;8.1;13.1;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.1;46.1;;;40.6;51.7;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.7;40.7;;;31.5;50.5;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.9;41.9;;;35.9;48.2;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.3;41.3;;;36.4;46.4;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.8;43.8;;;36.8;51;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.7;11.7;;;9.1;14.8;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.8;10.8;;;9.2;12.7;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.2;10.2;;;5.8;17.5;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.5;62.5;;;50;73.6;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.7;67.7;;;51.3;80.6;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.9;7.9;;;7.2;8.7;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.0;11;;;10;12.1;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;77.4;77.4;;;65.7;86;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.4;8.4;;;7.4;9.5;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;8.2;8.2;;;5.2;12.5;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2016;2016;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;;Number;41;41;;;;;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.7;46.7;;;39.3;54.4;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.2;10.2;;;9.2;11.2;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.0;44;;;35.7;52.6;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.9;44.9;;;35.9;54.1;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.9;37.9;;;30;46.6;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.5;13.5;;;11.7;15.5;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;75.1;75.1;;;66.4;82.2;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.3;69.3;;;58.5;78.3;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.7;47.7;;;43.4;52.1;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2016;2016;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2016;2016;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;CRDRATE;RACE;API;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.1;9.1;;;8.1;10.3;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.0;9;;;8.3;9.8;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2015;2015;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.5;38.5;;;29.4;48.4;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.6;35.6;;;29.1;42.6;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.0;44;;;36.3;52;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;52.1;52.1;;;46.1;57.9;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.6;42.6;;;34.6;51.1;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2016;2016;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;;Number;30;30;;;;;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;NMBR;GENDER;GENF;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.0;70;;;54.9;81.7;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.2;62.2;;;45.8;76.2;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.7;9.7;;;7.6;12.4;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;60.5;60.5;;;48.7;71.1;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.1;10.1;;;7;14.1;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.6;36.6;;;28;46;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.3;42.3;;;32.2;53.1;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.4;45.4;;;31.6;60.1;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;15.5;15.5;;;12.7;18.8;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.6;37.6;;;29.3;46.8;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;6.6;6.6;;;4.2;10.1;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.0;41;;;29.6;53.5;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67.9;67.9;;;62.6;72.8;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.6;33.6;;;21.1;49;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.1;66.1;;;55.3;75.4;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;23.5;23.5;;;19.1;28.5;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.2;46.2;;;39.6;53;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.2;13.2;;;11.6;15;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.1;40.1;;;33.7;46.8;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;55.7;55.7;;;46.1;64.8;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.6;42.6;;;38.3;46.9;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;27.5;27.5;;;15.2;44.4;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.5;6.5;;;5.5;7.7;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;19.5;19.5;;;13.1;28.1;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2016;2016;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;NMBR;RACE;API;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.2;47.2;;;39.8;54.6;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;NMBR;RACE;BLK;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;29.5;29.5;;;20.8;40.1;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;16.4;16.4;;;12.7;20.9;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.8;46.8;;;39;54.8;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.1;8.1;;;7.1;9.3;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.3;69.3;;;55.4;80.4;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;78.4;78.4;;;54;91.8;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.4;8.4;;;6.9;10.2;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;NY;New York;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;NMBR;RACE;API;;;;
2016;2016;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;53.2;53.2;;;41.8;64.3;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;7.4;7.4;;;5;10.9;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.5;6.5;;;5.7;7.5;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.6;43.6;;;37.2;50.3;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.8;9.8;;;6.1;15;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.9;42.9;;;30.3;56.4;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.9;7.9;;;5.5;11.1;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2015;2015;CA;California;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;7.3;7.3;;;5.6;9.4;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2016;2016;WA;Washington;NVSS;Asthma;Asthma mortality rate;;;Number;27;27;;;;;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;NMBR;GENDER;GENM;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;30.0;30;;;23.9;36.9;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2016;2016;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.4;10.4;;;9;11.9;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.5;13.5;;;11.5;15.8;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;73.0;73;;;65.8;79.2;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.9;9.9;;;8.9;10.9;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.4;9.4;;;6.8;12.9;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2016;2016;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.8;7.8;;;6.3;9.6;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2016;2016;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;NMBR;GENDER;GENM;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;4.4;4.4;;;3.3;5.7;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.7;43.7;*;50 States + DC: US Median;41.5;46.2;Overall;Overall;;;;;;;59;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.4;48.4;;;39.4;57.5;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2016;2016;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;27.3;27.3;;;20.2;36.1;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50.0;50;;;42.7;57.3;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.6;35.6;;;23.4;50;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.4;7.4;;;4.9;10.8;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2016;2016;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;51.4;51.4;;;45.5;57.2;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.3;6.3;;;5;8;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.4;62.4;;;46;76.5;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.2;12.2;;;8.4;17.3;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.8;43.8;;;35.8;52.1;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67.5;67.5;;;48.7;81.9;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.8;12.8;;;8.6;18.4;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.7;10.7;;;9.6;11.8;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.7;5.7;;;4.8;6.8;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.2;14.2;;;10.6;18.6;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2016;2016;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.7;47.7;;;40.6;54.8;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.6;43.6;;;36.2;51.4;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.8;9.8;;;8.4;11.4;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.9;6.9;;;5.7;8.4;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.1;12.1;;;10.6;13.8;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.9;10.9;;;8.3;14.2;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2016;2016;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;NMBR;RACE;API;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.9;11.9;;;10.7;13.2;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;4.2;4.2;;;2.5;7.2;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50.0;50;;;42.5;57.4;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.8;9.8;;;8.6;11;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2015;2015;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.7;39.7;;;29.8;50.5;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2016;2016;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;17.0;17;;;11.3;24.5;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.9;9.9;;;9;10.9;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.3;34.3;;;27.9;41.3;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.7;41.7;;;35.1;48.6;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2015;2015;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.1;39.1;**;US estimate/number is based on fewer than 50 states and the District of Columbia;37;41.7;Gender;Male;;;;;;;59;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2016;2016;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.7;12.7;;;9;17.6;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2016;2016;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;4.8;4.8;;;3.7;6.1;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;64.0;64;;;53.3;73.6;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;4.2;4.2;;;2.7;6.6;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.5;12.5;;;10.8;14.4;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.0;44;;;38.7;49.4;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.9;9.9;;;8.8;11.1;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;61.3;61.3;;;48.5;72.8;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.8;48.8;;;42;55.7;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.8;10.8;;;7;16.4;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.1;47.1;;;41.2;53.1;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.1;13.1;;;10.4;16.4;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.7;45.7;;;39.6;51.9;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.8;45.8;;;35.8;56.2;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;NY;New York;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.0;12;;;9.7;14.9;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.4;47.4;;;35;60;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.3;10.3;;;9.3;11.3;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2016;2016;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;NMBR;RACE;API;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.3;37.3;;;27;48.8;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;76.6;76.6;;;64.5;85.5;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;CA;California;NVSS;Asthma;Asthma mortality rate;;;Number;68;68;;;;;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;NMBR;RACE;HIS;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.2;71.2;;;56.2;82.7;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.6;40.6;;;33.2;48.5;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.9;12.9;;;8.1;19.5;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2016;2016;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;NMBR;RACE;API;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.1;35.1;;;25;46.6;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;16.0;16;;;10.4;23.7;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2016;2016;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;27.8;27.8;;;20.7;36.5;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.6;9.6;;;8.1;11.5;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.3;8.3;;;6.9;9.9;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.0;9;;;7.8;10.3;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.8;40.8;;;33.3;48.7;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.0;44;;;33.9;54.6;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;60.1;60.1;;;45.8;72.9;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.3;40.3;;;32.6;48.6;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.0;10;;;8.8;11.4;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.5;38.5;;;32.8;44.5;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.9;63.9;;;57.8;69.5;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.0;9;;;8.1;10;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.4;8.4;;;7.5;9.4;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.7;44.7;;;36;53.7;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;74.2;74.2;;;64.4;82;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;;Number;20;20;;;;;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;NMBR;GENDER;GENM;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.4;8.4;;;5.5;12.2;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2016;2016;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2016;2016;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.7;8.7;;;7.2;10.3;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;55.3;55.3;;;34.9;74.1;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.2;63.2;;;47.2;76.8;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.1;7.1;;;4.7;10.6;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2015;2015;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.3;39.3;;;31.5;47.6;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;17.8;17.8;;;13.7;22.8;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2016;2016;MT;Montana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;NMBR;GENDER;GENF;;;;
2016;2016;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;15.1;15.1;;;11;20.2;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.6;35.6;;;21.3;52.9;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.4;44.4;;;32.7;56.8;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.7;12.7;;;11.4;14;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.7;8.7;;;4.8;15.1;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;;Number;44;44;;;;;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;NMBR;GENDER;GENF;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2016;2016;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2016;2016;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2016;2016;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;61.3;61.3;;;49.4;72;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.8;31.8;;;17.7;50.1;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.5;42.5;;;30.1;56;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2016;2016;CA;California;NVSS;Asthma;Asthma mortality rate;;;Number;240;240;;;;;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;NMBR;GENDER;GENF;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.3;65.3;;;59;71.2;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2016;2016;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.3;69.3;;;59.7;77.4;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.6;7.6;;;6.8;8.5;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2016;2016;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;CRDRATE;RACE;API;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.3;47.3;;;42;52.6;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.4;11.4;;;10.2;12.6;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.0;47;;;35.1;59.2;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;FL;Florida;NVSS;Asthma;Asthma mortality rate;;;Number;90;90;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;NMBR;RACE;WHT;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.6;12.6;;;10.9;14.5;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.9;31.9;;;22.7;42.8;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.7;45.7;;;38.4;53.3;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.5;8.5;;;7.5;9.7;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.2;10.2;;;7.5;13.6;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.5;40.5;;;28.2;54.2;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2016;2016;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.8;10.8;;;9.7;12;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;4.9;4.9;;;3.8;6.3;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.3;45.3;;;28.5;63.4;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2016;2016;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.2;36.2;;;22.8;52.1;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;58.1;58.1;;;34.8;78.3;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.9;49.9;;;42.7;57.1;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.5;6.5;;;5.9;7.1;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.4;12.4;;;11;14.1;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2016;2016;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;31.4;31.4;;;25.3;38.5;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2016;2016;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.907192, -77.036871);;11;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.7;42.7;;;33.6;52.2;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.6;68.6;;;59.2;76.7;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;58.2;58.2;;;40.9;73.7;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.5;10.5;;;9.1;12.2;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.1;9.1;;;7.9;10.4;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.5;46.5;;;35.5;57.8;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;61.3;61.3;;;44.8;75.6;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;60.3;60.3;;;49.5;70.1;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;74.2;74.2;;;59.1;85.2;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.1;69.1;;;53.5;81.3;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.1;45.1;;;37.7;52.7;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2016;2016;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;NMBR;RACE;BLK;;;;
2015;2015;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;61.1;61.1;;;50;71.1;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.1;9.1;;;7.9;10.6;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.9;6.9;;;5.6;8.4;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.1;9.1;;;7.6;10.7;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;8.7;8.7;;;6.4;11.8;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.9;45.9;;;35.4;56.8;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.7;7.7;;;6.6;8.9;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2016;2016;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.4;14.4;;;10.1;20.1;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;52.8;52.8;;;36.6;68.5;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.1;66.1;;;54.5;76.1;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;52.5;52.5;;;45.3;59.6;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2016;2016;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.3;43.3;;;36.3;50.6;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.5;41.5;;;35.3;47.9;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.6;47.6;;;39.7;55.5;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;53.3;53.3;;;39.1;67;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2016;2016;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.0;10;;;9;10.9;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2016;2016;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.8;37.8;;;29.4;47;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;57.8;57.8;;;43.9;70.6;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;54.4;54.4;;;45;63.5;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;16.3;16.3;;;12.6;20.8;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.3;9.3;;;8.4;10.3;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.4;68.4;;;58;77.3;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.1;45.1;;;32.3;58.5;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.9;10.9;;;9.9;11.9;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.2;9.2;;;8.4;10.1;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2015;2015;US;United States;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.1;12.1;*;50 States + DC: US Median;11.1;12.5;Gender;Female;;;;;;;59;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.0;63;;;51;73.7;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2016;2016;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;44;44;;;;;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;NMBR;GENDER;GENM;;;;
2016;2016;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.1;11.1;;;8.1;15;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;76.8;76.8;;;62.2;87;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2016;2016;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;;Number;21;21;;;;;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;NMBR;RACE;HIS;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.3;46.3;;;39.9;52.8;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;58.3;58.3;;;50;66.3;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;53.5;53.5;;;48.3;58.6;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.4;9.4;;;8.4;10.6;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.5;8.5;;;6.8;10.7;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.1;37.1;;;31.4;43.3;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;NMBR;RACE;HIS;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.8;32.8;;;20.4;48.2;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2016;2016;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.8;9.8;;;7.1;13.1;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2016;2016;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;CRDRATE;RACE;API;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.0;39;;;34.1;44.1;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.7;40.7;;;32.9;48.9;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;US;United States;NVSS;Asthma;Asthma mortality rate;;;Number;3518;3,518;;;;;Overall;Overall;;;;;;;59;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2016;2016;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;16.6;16.6;;;11.6;23;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.0;8;;;4.5;13.8;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2015;2015;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;15.5;15.5;;;9.5;24.2;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;55.6;55.6;;;49.3;61.7;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;54.1;54.1;;;47.4;60.7;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2016;2016;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;NMBR;RACE;HIS;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.0;68;;;59.2;75.6;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2016;2016;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2016;2016;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;;Number;29;29;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;NMBR;RACE;WHT;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.4;14.4;;;12.4;16.7;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.7;47.7;;;42.3;53.2;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;72.5;72.5;;;63.2;80.2;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;17.2;17.2;;;9.9;28.1;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;56.6;56.6;;;46.7;66;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.8;69.8;;;60.2;77.9;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.0;68;;;52.2;80.5;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;56.4;56.4;;;37.3;73.8;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;;Number;94;94;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;NMBR;RACE;WHT;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2016;2016;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;4.3;4.3;;;2.8;6.4;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2016;2016;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;64.2;64.2;;;52.3;74.6;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2015;2015;US;United States;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.6;6.6;*;50 States + DC: US Median;6.3;6.9;Gender;Male;;;;;;;59;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2015;2015;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.2;8.2;;;7.5;9.1;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.6;13.6;;;11.9;15.6;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.1;45.1;;;35;55.7;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;4.0;4;;;2.3;7;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.8;5.8;;;4.9;6.9;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.0;70;;;57.3;80.3;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.3;5.3;;;4.2;6.6;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;NMBR;RACE;BLK;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.2;11.2;;;8.6;14.5;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;4.8;4.8;;;3.2;7.2;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.1;44.1;;;29.6;59.7;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;54.6;54.6;;;46.3;62.6;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2016;2016;WA;Washington;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;NMBR;RACE;API;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;27.7;27.7;;;15.7;44.1;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.7;40.7;;;34.4;47.3;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.1;43.1;;;26.7;61.1;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.2;45.2;;;38.2;52.5;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;FL;Florida;NVSS;Asthma;Asthma mortality rate;;;Number;184;184;;;;;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.7;65.7;;;55.1;74.9;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;CA;California;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;19.2;19.2;;;12.9;27.7;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2016;2016;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;NMBR;RACE;API;;;;
2016;2016;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;NMBR;RACE;HIS;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;78.1;78.1;;;66;86.8;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.7;9.7;;;8.3;11.3;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;NMBR;RACE;API;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.9;40.9;;;29.5;53.2;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.4;46.4;;;40.7;52.2;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;NMBR;GENDER;GENF;;;;
2016;2016;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;5.3;5.3;;;4.1;6.8;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.4;6.4;;;5;8.2;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;51.0;51;;;38.9;62.9;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.2;8.2;;;7.5;8.9;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;24.2;24.2;;;16.4;34.1;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;NMBR;RACE;WHT;;;;
2016;2016;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.3;9.3;;;6.3;13.2;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;57.4;57.4;;;38.9;74;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;54.2;54.2;;;47.4;60.8;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.0;41;;;26.7;57.1;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;52.8;52.8;;;37.1;68;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2016;2016;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;CRDRATE;RACE;API;;;;
2016;2016;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.0;35;;;25.7;45.6;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2016;2016;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.2;11.2;;;9.9;12.6;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;52.5;52.5;;;41.9;62.9;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.0;37;;;27.6;47.4;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.5;9.5;;;8.4;10.8;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.3;10.3;;;9.2;11.6;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.4;8.4;;;7.2;9.9;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.3;43.3;;;36;50.9;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2016;2016;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;18.1;18.1;;;11.4;27.4;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.9;65.9;;;59.7;71.6;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.0;31;;;23.8;39.3;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.8;6.8;;;5.6;8.4;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.8;44.8;;;38.9;50.8;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.3;43.3;;;37.1;49.8;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;70.2;70.2;;;42.3;88.3;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.6;40.6;;;34.4;47;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.8;62.8;;;55.5;69.5;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.7;7.7;;;6.6;9.1;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;60.7;60.7;;;47.1;72.9;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2016;2016;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;NMBR;RACE;API;;;;
2016;2016;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;;Number;56;56;;;;;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;NMBR;GENDER;GENF;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.5;39.5;;;27.2;53.2;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;78.7;78.7;;;69.6;85.7;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.1;31.1;;;25.9;36.8;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.6;42.6;;;32.7;53.1;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67.6;67.6;;;53.2;79.2;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.1;47.1;;;41.7;52.5;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.0;10;;;9.1;10.9;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.9;7.9;;;6.3;9.8;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67.6;67.6;;;62.5;72.3;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2016;2016;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;19.4;19.4;;;14.9;24.8;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;51.0;51;;;43.9;58.1;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.6;9.6;;;8.9;10.3;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.4;9.4;;;8.3;10.6;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.2;9.2;;;8.1;10.5;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;23.6;23.6;;;19.2;28.6;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.5;5.5;;;4.5;6.7;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.1;40.1;;;31.3;49.7;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.7;71.7;;;60.3;80.9;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.8;68.8;;;62.3;74.7;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.1;11.1;;;9.9;12.4;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.9;70.9;;;62.8;77.9;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.8;45.8;;;41.6;50.1;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2016;2016;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.9;12.9;;;11.6;14.4;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.6;11.6;;;10;13.5;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;53.6;53.6;;;40.7;66;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.9;8.9;;;5;15.4;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.1;10.1;;;8.9;11.4;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.0;43;;;35.1;51.3;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.1;12.1;;;9.8;14.8;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;CRDRATE;RACE;API;;;;
2016;2016;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;;Number;67;67;;;;;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;NMBR;GENDER;GENM;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.4;36.4;;;24.6;50;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.6;9.6;;;8.6;10.7;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.4;9.4;;;6.9;12.7;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;4.9;4.9;;;2.8;8.6;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.5;33.5;;;24.6;43.6;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2016;2016;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.8;11.8;;;9.8;14.1;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.4;44.4;;;34.7;54.6;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2016;2016;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.1;12.1;;;9;15.9;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2016;2016;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.9;43.9;;;31;57.7;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;78.1;78.1;;;66.8;86.3;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.6;40.6;;;31;51;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.4;12.4;;;11;13.9;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;8.4;8.4;;;5.1;13.6;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.7;40.7;;;34.8;46.9;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.4;48.4;;;43.5;53.4;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;17.9;17.9;;;12.2;25.4;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;23.8;23.8;;;19.4;28.7;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;NMBR;RACE;BLK;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.5;41.5;;;35.3;48;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.3;34.3;;;27.1;42.3;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.8;7.8;;;5.8;10.2;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.6;45.6;;;34.6;57.1;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.3;44.3;;;36.7;52.1;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2016;2016;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;NMBR;GENDER;GENF;;;;
2015;2015;CA;California;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.3;9.3;;;8;10.8;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2015;2015;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.1;48.1;;;43.4;53;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.6;11.6;;;9.5;14.1;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.4;7.4;;;6.4;8.5;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;49.5;49.5;;;38.8;60.3;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;16.3;16.3;;;12.6;20.8;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;20.6;20.6;;;11.6;33.7;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;51.7;51.7;;;45.9;57.5;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2016;2016;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.9;41.9;;;33.5;50.7;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.6;10.6;;;8;14;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;18.1;18.1;;;11.2;27.8;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.0;49;;;40.5;57.6;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;4.5;4.5;;;2.9;7.1;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;31.8;31.8;;;25.7;38.8;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.6;6.6;;;5.4;7.9;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;59.7;59.7;;;48.9;69.6;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2016;2016;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.8;65.8;;;54.8;75.4;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.2;33.2;;;21.2;47.9;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.3;69.3;;;62.7;75.2;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2016;2016;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.0;10;;;7.7;12.7;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2016;2016;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2016;2016;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;CRDRATE;RACE;API;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.6;12.6;;;9.8;16;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.9;37.9;;;32;44.2;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.8;11.8;;;9.4;14.6;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2016;2016;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.4;36.4;;;28.6;44.9;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.7;12.7;;;11.1;14.5;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.9;7.9;;;6.7;9.4;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.1;63.1;;;52.6;72.6;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.2;12.2;;;10.6;14.1;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.7;40.7;;;29;53.6;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2016;2016;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;NMBR;RACE;WHT;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.3;13.3;;;10.9;16;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2016;2016;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;;Number;24;24;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;NMBR;RACE;BLK;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.2;6.2;;;5.1;7.6;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.7;7.7;;;6.7;9;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;66.3;66.3;;;56.2;75.1;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2016;2016;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.2;9.2;;;6.6;12.5;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.9;44.9;;;35.9;54.2;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.9;70.9;;;63.7;77.1;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2015;2015;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.8;9.8;;;7.7;12.3;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.2;71.2;;;59.4;80.7;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.7;11.7;;;9.9;13.8;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;56.9;56.9;;;45.2;67.9;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.5;6.5;;;4.6;9;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;48.9;48.9;;;31.8;66.2;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.5;42.5;;;36.9;48.3;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;60.3;60.3;;;51.1;68.8;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.3;48.3;;;35;61.7;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2016;2016;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;18.3;18.3;;;14.4;23;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;57.7;57.7;;;49.6;65.4;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.2;39.2;;;29.4;50;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2016;2016;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.7;42.7;;;35.3;50.5;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;US;United States;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.5;6.5;*;50 States + DC: US Median;6.3;6.9;Gender;Male;;;;;;;59;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.1;40.1;;;30.8;50.3;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.3;39.3;;;30.9;48.4;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.4;40.4;;;32.4;48.9;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.9;42.9;;;33.6;52.6;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.2;10.2;;;6;16.8;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2016;2016;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;17.6;17.6;;;10.6;27.5;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2016;2016;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.3;10.3;;;9;11.7;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;16.2;16.2;;;12.8;20.2;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2016;2016;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;;Number;22;22;;;;;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;NMBR;GENDER;GENF;;;;
2016;2016;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;CRDRATE;RACE;API;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;49.8;49.8;;;35.7;63.9;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.9;8.9;;;8;9.9;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2016;2016;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;3.4;3.4;;;2.1;5.1;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.2;35.2;;;30;40.9;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2016;2016;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2016;2016;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;34.5;34.5;;;24.6;46.9;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;25.4;25.4;;;15.3;39.2;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;57.6;57.6;;;47.9;66.8;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;51.6;51.6;;;45.9;57.3;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.4;82.4;;;69.5;90.6;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.6;6.6;;;5.5;7.9;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.9;11.9;;;9.7;14.7;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.8;8.8;;;6.2;12.2;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.5;84.5;;;68.7;93.1;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;91.4;91.4;;;85;95.2;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2015;2015;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.7;86.7;*;50 States + DC: US Median;85.7;88.2;Overall;Overall;;;;;;;59;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.9;63.9;;;53.3;73.3;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.5;86.5;;;78.8;91.6;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.7;82.7;;;74;89;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.7;70.7;;;62.8;77.6;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.0;10;;;6.8;14.6;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;92.0;92;;;82.5;96.6;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.7;34.7;;;24.7;46.3;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.5;9.5;;;8.5;10.7;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.1;10.1;;;9.1;11.2;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;25.4;25.4;;;17.4;35.6;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.0;85;;;71.1;92.9;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.3;37.3;;;28;47.6;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.1;47.1;;;41.2;53.2;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.4;45.4;;;37.9;53.2;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.1;35.1;;;29.6;41.1;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50.1;50.1;;;42.7;57.5;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;75.2;75.2;;;53.2;89;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.6;88.6;;;79.6;94;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.8;40.8;;;28.8;54;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.9;86.9;;;67.9;95.4;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.4;13.4;;;10.1;17.5;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.7;40.7;;;32.4;49.5;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.4;7.4;;;6.4;8.5;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.5;63.5;;;55.7;70.6;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67.8;67.8;;;59;75.5;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.6;11.6;;;9.7;13.9;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.8;89.8;;;81.3;94.7;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.7;41.7;;;31.1;53.1;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.8;62.8;;;54.2;70.7;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.1;5.1;;;4.1;6.2;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.4;11.4;;;10.4;12.5;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.4;86.4;;;77.8;92.1;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90.1;90.1;;;83.8;94.1;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.4;85.4;;;78.9;90.1;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2015;2015;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.5;7.5;;;6.6;8.6;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;53.0;53;;;46.4;59.5;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.6;6.6;;;5.5;7.9;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.1;44.1;;;35.8;52.7;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.6;10.6;;;7.1;15.6;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.8;85.8;;;76.9;91.6;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.7;43.7;;;35.6;52;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;92.0;92;;;86;95.6;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.2;67.2;;;56.6;76.3;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.0;9;;;7.8;10.5;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.2;13.2;;;9.1;18.7;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;73.7;73.7;;;55.6;86.3;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.6;47.6;;;42.5;52.8;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.5;70.5;;;52;84;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;79.6;79.6;;;68.5;87.5;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.8;71.8;;;54.7;84.3;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.5;12.5;;;10;15.4;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.3;70.3;;;60;78.9;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.2;41.2;;;33.8;48.9;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.4;9.4;;;7.7;11.3;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;78.2;78.2;;;65.2;87.2;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.4;86.4;;;69.2;94.8;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.1;40.1;;;32.6;48.2;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.7;10.7;;;10;11.5;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.9;42.9;;;31.8;54.8;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.1;9.1;;;7.9;10.3;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.0;7;;;4.8;10.2;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.3;42.3;;;33.1;52.1;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;25.7;25.7;;;15;40.2;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.1;36.1;;;26.9;46.5;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.5;43.5;;;30.4;57.6;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.1;14.1;;;11.3;17.5;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.9;7.9;;;7.1;8.8;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.8;36.8;;;25.7;49.6;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2015;2015;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.5;45.5;;;37.8;53.5;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.3;9.3;;;8.6;9.9;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.4;7.4;;;6.9;8;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;76.7;76.7;;;64.7;85.6;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.1;42.1;;;28.7;56.9;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.9;9.9;;;7.1;13.8;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.8;10.8;;;8.6;13.5;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.5;9.5;;;7.3;12.4;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.9;13.9;;;10.7;17.9;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.7;70.7;;;55.5;82.4;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.3;88.3;;;82;92.5;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.7;38.7;;;32.6;45.2;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.7;88.7;;;81.7;93.2;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.5;63.5;;;53.1;72.7;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.7;71.7;;;47.9;87.5;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.1;42.1;;;34.6;50;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.3;9.3;;;8.3;10.5;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.6;69.6;;;54.8;81.3;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.3;84.3;;;79.3;88.2;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.3;91.3;;;85.3;95;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.1;63.1;;;50.9;73.9;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.3;10.3;;;9.3;11.5;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.2;83.2;;;75.9;88.6;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.2;90.2;;;84.2;94;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;78.6;78.6;;;54.9;91.7;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.2;11.2;;;9.5;13.3;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.5;39.5;;;27.6;52.8;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;81.2;81.2;;;72.2;87.8;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.9;37.9;;;24.6;53.3;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;94.5;94.5;;;87.6;97.6;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.5;65.5;;;56.1;73.8;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.9;38.9;;;31.2;47.1;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.1;39.1;;;23.8;56.8;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.2;9.2;;;6.2;13.5;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.9;6.9;;;5.3;8.8;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;79.9;79.9;;;71.2;86.5;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.2;83.2;;;77.3;87.8;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.7;14.7;;;12;17.9;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.1;10.1;;;7.9;12.8;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.5;8.5;;;8;9;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.9;48.9;;;32.2;66;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.2;47.2;;;32.8;62.1;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;50.9;50.9;;;46.2;55.6;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.7;49.7;;;42.1;57.3;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.3;42.3;;;34.8;50.2;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.2;62.2;;;46;76.1;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.7;32.7;;;21.3;46.6;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.5;7.5;;;6.4;8.6;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.1;10.1;;;9.4;10.8;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.4;44.4;;;37.2;51.9;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.7;72.7;;;52.2;86.7;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.1;69.1;;;60.8;76.4;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.8;7.8;;;6.8;9;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.2;13.2;;;7.4;22.2;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;58.7;58.7;;;45.4;70.9;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2015;2015;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;54.3;54.3;;;47.6;60.8;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;72.7;72.7;;;64.6;79.4;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.0;39;;;34.2;44;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.6;90.6;;;81.8;95.3;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;61.5;61.5;;;45.6;75.2;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.4;86.4;;;78.7;91.6;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.0;65;;;56.4;72.8;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.7;13.7;;;11.5;16.2;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.1;8.1;;;6.8;9.7;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.5;85.5;;;80;89.7;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.7;85.7;;;70.3;93.8;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.2;86.2;;;69;94.6;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.3;31.3;;;23.3;40.5;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.0;91;;;84;95.1;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.8;37.8;;;31.8;44.3;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.7;88.7;;;80.7;93.6;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.8;40.8;;;30.1;52.4;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.1;71.1;;;56.2;82.5;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.6;41.6;;;35.9;47.5;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.5;42.5;;;36.5;48.6;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;32.6;32.6;;;18.6;50.6;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;94.4;94.4;;;87.2;97.7;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.8;46.8;;;37.9;55.8;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.1;83.1;;;74.6;89.2;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;61.6;61.6;;;45.3;75.8;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.5;86.5;;;79.9;91.1;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.4;87.4;;;77;93.4;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.5;11.5;;;7;18.3;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.9;85.9;;;76.9;91.7;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.5;5.5;;;4.5;6.7;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.7;43.7;;;33.8;54.1;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.1;38.1;;;30.3;46.6;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;17.1;17.1;;;9.4;29;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.5;11.5;;;9.1;14.4;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;56.7;56.7;;;48.6;64.5;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.7;13.7;;;11.8;15.8;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;76.6;76.6;;;67.3;84;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.4;87.4;;;80.6;92.1;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.3;86.3;;;77.4;92;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.8;83.8;;;73.4;90.7;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.4;46.4;;;41.1;51.8;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.9;12.9;;;11.7;14.3;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.1;89.1;;;82.1;93.6;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.0;33;;;21.2;47.4;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.0;42;;;37.4;46.8;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;93.5;93.5;;;83.5;97.6;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.2;13.2;;;11.1;15.6;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.0;5;;;4;6.4;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.4;88.4;;;82.6;92.5;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.5;42.5;;;32.3;53.4;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.9;12.9;;;8.8;18.6;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.3;37.3;;;30.6;44.5;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.3;42.3;;;31.1;54.3;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;22.4;22.4;;;13.3;35.2;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.4;87.4;;;80.2;92.2;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.4;40.4;;;34.4;46.8;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.6;42.6;;;35.6;49.8;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.5;85.5;;;67.7;94.3;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.0;91;;;85.8;94.4;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.2;9.2;;;8;10.6;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90.6;90.6;;;83.7;94.8;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.3;47.3;;;38.5;56.2;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2015;2015;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.7;46.7;;;37.2;56.4;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.5;41.5;;;34.4;48.9;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;73.0;73;;;50.6;87.7;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.8;10.8;;;5.9;19;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.4;87.4;;;79.9;92.3;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.7;5.7;;;4.6;7;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.1;85.1;;;78.5;89.9;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.5;36.5;;;27.3;46.8;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;NY;New York;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;72.2;72.2;;;59.8;81.9;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;74.2;74.2;;;54.4;87.4;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.3;85.3;;;81.4;88.5;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.3;87.3;;;80.5;92;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.0;89;;;80.8;94;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.0;14;;;10.9;17.8;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;81.0;81;;;62.1;91.7;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.2;85.2;;;77.2;90.7;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.0;62;;;43.9;77.3;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;75.1;75.1;;;67.5;81.5;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.7;41.7;;;34.2;49.6;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.2;71.2;;;64;77.5;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.4;39.4;;;26.9;53.4;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2015;2015;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;15.3;15.3;;;9.2;24.4;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;58.4;58.4;;;48;68.1;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.9;88.9;;;77.4;94.9;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;79.8;79.8;;;62.4;90.4;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;29.6;29.6;;;16.5;47;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;52.0;52;;;42.1;61.8;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.8;40.8;;;33.6;48.3;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.7;9.7;;;9;10.6;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.7;37.7;;;27.3;49.5;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.7;33.7;;;25.6;42.9;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.1;11.1;;;9.9;12.4;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;81.5;81.5;;;67.5;90.3;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.1;84.1;;;74;90.8;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.4;11.4;;;10;12.9;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;80.2;80.2;;;70.8;87.1;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.6;40.6;;;33.8;47.8;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.5;90.5;;;79.1;96;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.7;70.7;;;55.5;82.4;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;92.0;92;;;86.2;95.4;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;81.4;81.4;;;66.2;90.8;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.1;88.1;;;80.9;92.9;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.3;83.3;;;65.4;93;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.5;47.5;;;38.2;57;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.4;71.4;;;62.4;79;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.2;10.2;;;9.4;11.1;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.1;69.1;;;57.1;78.9;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.1;45.1;;;38.9;51.4;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.3;36.3;;;30.3;42.8;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.2;7.2;;;5.7;9;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.4;45.4;;;39.2;51.8;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.5;39.5;;;29.1;51.1;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;79.2;79.2;;;68.7;86.9;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.8;5.8;;;4.6;7.4;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.9;62.9;;;44.8;78;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.3;44.3;;;39.4;49.4;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;79.6;79.6;;;67.6;88;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.9;7.9;;;6.5;9.5;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.0;12;;;7.5;18.8;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.5;36.5;;;25.5;49.1;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;80.0;80;;;70.7;86.8;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.3;43.3;;;33.4;53.7;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.9;8.9;;;7.6;10.3;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.6;84.6;;;79.8;88.4;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.0;88;;;69.3;96;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.1;7.1;;;5.8;8.8;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.3;13.3;;;11.9;14.9;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2015;2015;CA;California;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.8;70.8;;;52.9;84;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;93.8;93.8;;;87.6;97;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.2;42.2;;;35.7;48.9;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.9;6.9;;;5.5;8.7;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.6;82.6;;;61.5;93.4;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.7;32.7;;;23.6;43.3;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;59.7;59.7;;;43;74.4;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.3;45.3;;;30.9;60.6;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.4;49.4;;;38.7;60.1;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2015;2015;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;18.5;18.5;;;11.6;28.1;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.7;8.7;;;5.6;13.3;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.4;88.4;;;73.7;95.4;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;62.1;62.1;;;48.2;74.3;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.9;40.9;;;34.4;47.7;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.5;87.5;;;82.8;91;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;55.6;55.6;;;43;67.6;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.1;85.1;;;72.9;92.4;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;48.1;48.1;;;37.9;58.4;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.2;70.2;;;54.6;82.2;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.3;39.3;;;32.6;46.5;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.0;88;;;83.4;91.5;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.3;63.3;;;53.3;72.2;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2015;2015;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90.1;90.1;;;80.5;95.3;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.7;47.7;;;43.9;51.5;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.3;14.3;;;8.1;23.8;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.6;37.6;;;27.3;49.1;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.4;7.4;;;6.9;7.9;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;91.8;91.8;;;85.2;95.6;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.7;47.7;;;40.9;54.6;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;93.7;93.7;;;88.3;96.7;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.5;43.5;;;37;50.3;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.4;72.4;;;66;77.9;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.8;12.8;;;11.6;14.2;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.2;39.2;;;33.4;45.3;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.5;9.5;;;8.5;10.5;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;51.6;51.6;;;34;68.8;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.4;8.4;;;7.2;9.7;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.0;86;;;75.9;92.3;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.3;7.3;;;6.7;8.1;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.7;91.7;;;82;96.4;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;25.0;25;;;16.8;35.5;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.9;11.9;;;7.8;17.7;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.0;34;;;21.7;49;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.7;83.7;;;74.1;90.2;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.2;38.2;;;25;53.4;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;17.6;17.6;;;11.8;25.4;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.1;7.1;;;5.8;8.6;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;59.8;59.8;;;45.8;72.3;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.2;47.2;;;35.8;58.9;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.0;41;;;33;49.5;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.1;43.1;;;25.5;62.7;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.7;46.7;;;36;57.7;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.3;88.3;;;83.2;92;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;92.6;92.6;;;86.1;96.2;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;93.5;93.5;;;87.5;96.7;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.4;13.4;;;11.8;15.1;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.4;10.4;;;9.4;11.4;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.0;84;;;74.7;90.3;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.6;86.6;;;76.3;92.8;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.5;44.5;;;37.7;51.4;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.3;12.3;;;8.5;17.4;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.3;47.3;;;43.7;50.8;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;4.9;4.9;;;4.1;6;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.0;40;;;33.1;47.4;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.2;84.2;;;67.6;93.1;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.8;83.8;;;77.5;88.7;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.0;87;;;80;91.8;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.9;87.9;;;80.3;92.9;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.3;37.3;;;29.4;45.8;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.9;85.9;;;75.4;92.4;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2015;2015;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.3;6.3;;;4.9;8;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29.2;29.2;;;22.8;36.5;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.9;9.9;;;9.1;10.9;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.4;44.4;;;29.2;60.6;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.8;84.8;;;77.9;89.9;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2015;2015;US;United States;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.0;12;*;50 States + DC: US Median;11.1;12.7;Gender;Female;;;;;;;59;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.0;66;;;50.6;78.7;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2015;2015;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.6;42.6;**;US estimate/number is based on fewer than 50 states and the District of Columbia;39.3;44.9;Gender;Male;;;;;;;59;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.5;44.5;;;36.3;53.1;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.4;41.4;;;32.9;50.3;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.3;39.3;;;28.2;51.7;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;55.3;55.3;;;48.2;62.3;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;58.4;58.4;;;44.5;71;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.8;67.8;;;52.6;80;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.7;47.7;;;41.7;53.7;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.5;36.5;;;28.4;45.6;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.4;45.4;;;40.8;50;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.9;13.9;;;10.9;17.6;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.0;37;;;24.7;51.2;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2015;2015;NY;New York;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.2;14.2;;;10;19.7;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;80.8;80.8;;;67.9;89.3;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.6;9.6;;;8.6;10.7;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.1;82.1;;;66.4;91.5;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.4;63.4;;;56.4;69.9;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;76.0;76;;;52.5;90.1;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.0;13;;;11.5;14.7;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2015;2015;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.4;40.4;**;US estimate/number is based on fewer than 50 states and the District of Columbia;37.7;43.1;Gender;Male;;;;;;;59;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.3;10.3;;;7.5;14;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;4.3;4.3;;;2.6;7;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.0;32;;;20.1;46.8;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;4.9;4.9;;;4.3;5.6;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.6;39.6;;;30.9;49;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.2;13.2;;;9.6;17.9;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;4.3;4.3;;;2.8;6.3;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;92.0;92;;;86.3;95.4;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2015;2015;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;27.0;27;;;17;40.1;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.7;71.7;;;63.5;78.7;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.6;43.6;;;38.8;48.6;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;92.4;92.4;;;84.9;96.3;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.6;13.6;;;7.4;23.5;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.4;30.4;;;19.1;44.7;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;92.1;92.1;;;85.7;95.8;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.2;84.2;;;67.9;93.1;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.8;85.8;;;79.5;90.4;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.4;40.4;;;32;49.5;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.5;44.5;;;33.3;56.2;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2015;2015;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.8;45.8;;;41.4;50.3;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.5;7.5;;;5.5;10.1;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.7;85.7;;;78;91;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;58.5;58.5;;;47.2;68.9;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;79.3;79.3;;;61.4;90.2;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.3;37.3;;;30.2;45;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.5;47.5;;;35.3;60.1;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.9;84.9;;;75;91.3;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.6;36.6;;;23;52.7;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.0;45;;;39.3;50.7;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;15.4;15.4;;;12;19.5;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;15.8;15.8;;;12.9;19.1;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90.3;90.3;;;81.9;95;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.8;48.8;;;36.6;61.3;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.8;84.8;;;78.4;89.6;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.6;89.6;;;77.2;95.6;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.0;47;;;35.1;59.3;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.0;11;;;9.6;12.5;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.2;34.2;;;25.7;43.8;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.7;42.7;;;35.4;50.4;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.8;34.8;;;25.4;45.7;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.0;49;;;42;56.1;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.8;32.8;;;24.7;42;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.3;9.3;;;7.7;11.3;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.4;71.4;;;59.5;80.9;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.8;63.8;;;54.2;72.4;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.2;88.2;;;76.6;94.4;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.2;9.2;;;7.7;11.1;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.1;42.1;;;35.7;48.7;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.9;33.9;;;20.9;49.9;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;22.0;22;;;12.3;36.2;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2015;2015;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.5;41.5;;;30.1;54;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.3;5.3;;;4.2;6.7;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;16.5;16.5;;;11.7;22.7;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.4;7.4;;;6.4;8.6;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.4;88.4;;;78.5;94.1;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.5;6.5;;;4.6;9.2;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90.6;90.6;;;85.3;94.2;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;78.7;78.7;;;69.4;85.7;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2015;2015;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.0;88;;;82.2;92.1;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.2;87.2;;;80.9;91.6;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.9;84.9;;;75.7;91;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.7;85.7;;;75.2;92.3;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;92.8;92.8;;;86.9;96.1;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.6;9.6;;;6.7;13.6;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.7;69.7;;;59.2;78.5;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;74.0;74;;;60.8;83.9;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.1;43.1;;;37.3;49.1;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;56.1;56.1;;;36.8;73.7;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;95.0;95;;;83.8;98.6;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.8;33.8;;;22.8;46.8;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;76.5;76.5;;;61.4;86.9;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;58.8;58.8;;;47.5;69.2;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.3;35.3;;;22;51.5;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;48.3;48.3;;;38.2;58.5;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.7;9.7;;;6.4;14.5;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.4;87.4;;;76.5;93.6;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;19.4;19.4;;;15;24.8;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.9;33.9;;;27.6;40.9;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50.2;50.2;;;41.8;58.6;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.0;43;;;39.1;46.9;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.4;86.4;;;74.5;93.3;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.5;42.5;;;37.4;47.8;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;4.3;4.3;;;3;6;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;54.9;54.9;;;35.5;72.9;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.6;90.6;;;84.1;94.6;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.1;65.1;;;54.8;74.2;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.0;63;;;52.6;72.3;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;52.9;52.9;;;43.9;61.7;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;61.2;61.2;;;53.2;68.7;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.6;85.6;;;79.1;90.2;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;16.4;16.4;;;13.2;20.2;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.9;10.9;;;9.6;12.4;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;72.8;72.8;;;65;79.5;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.6;45.6;;;39;52.3;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.5;46.5;;;41;52;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.2;10.2;;;9.4;11.1;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.5;89.5;;;83.7;93.3;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.2;46.2;;;37.5;55.1;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2015;2015;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.8;84.8;;;78.1;89.8;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.3;68.3;;;48.2;83.3;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.9;86.9;;;77.9;92.5;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;74.9;74.9;;;57.3;86.9;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.8;8.8;;;7.7;9.9;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.2;44.2;;;36.3;52.4;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.8;87.8;;;74.7;94.6;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.1;85.1;;;76.7;90.9;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.7;11.7;;;10.6;12.9;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.6;42.6;;;28.7;57.8;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.4;39.4;;;32.2;47.1;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.9;39.9;;;31.3;49.2;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;94.3;94.3;;;89;97.2;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.6;13.6;;;8.4;21.3;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.2;46.2;;;35.7;57;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.4;43.4;;;35.8;51.3;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.5;39.5;;;26.4;54.3;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.4;42.4;;;32.9;52.5;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;93.3;93.3;;;81.8;97.7;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.1;9.1;;;8;10.5;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.7;5.7;;;3.5;9.1;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.0;45;;;31.4;59.4;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.8;7.8;;;6.6;9.2;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.9;89.9;;;82.6;94.4;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;76.5;76.5;;;62.3;86.5;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.7;69.7;;;60.6;77.5;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.2;8.2;;;7.3;9.3;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.8;35.8;;;27.7;44.7;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.4;7.4;;;6.3;8.7;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.8;13.8;;;12.4;15.4;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.9;87.9;;;69.6;95.8;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;61.4;61.4;;;48.3;72.9;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.9;84.9;;;74;91.7;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.2;42.2;;;36.9;47.6;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.2;10.2;;;9.4;11.2;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.9;89.9;;;83.3;94;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.5;84.5;;;77.3;89.7;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.8;89.8;;;83.7;93.8;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.5;34.5;;;27.5;42.3;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.0;89;;;81;93.9;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.9;44.9;;;37.9;52.2;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.4;42.4;;;30.4;55.4;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.8;86.8;;;76.3;93;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.7;71.7;;;48;87.5;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.5;12.5;;;10.2;15.1;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.3;5.3;;;4.4;6.2;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.0;46;;;34.1;58.5;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;74.1;74.1;;;64.5;81.9;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.1;12.1;;;11.2;13.1;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.1;85.1;;;71.8;92.8;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.7;7.7;;;6.8;8.8;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.5;8.5;;;8;9.1;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.0;45;;;34.2;56.3;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.1;14.1;;;12.3;16.1;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.8;41.8;;;34.7;49.2;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2015;2015;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.3;90.3;;;82.1;94.9;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.0;88;;;80;93.1;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90.7;90.7;;;83.9;94.8;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.4;39.4;;;30.1;49.5;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;54.4;54.4;;;47.2;61.4;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.9;86.9;;;73.4;94.1;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.5;34.5;;;26.4;43.5;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.1;64.1;;;54.5;72.7;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;73.4;73.4;;;58.6;84.3;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;51.7;51.7;;;38.9;64.3;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.2;12.2;;;7.3;19.7;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.6;71.6;;;59.1;81.4;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.8;13.8;;;7.9;23;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67.4;67.4;;;57.9;75.7;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.6;13.6;;;11.8;15.6;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.1;82.1;;;72.6;88.8;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.5;13.5;;;9.2;19.4;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;93.3;93.3;;;88.4;96.2;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.9;7.9;;;4.6;13.4;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67.2;67.2;;;57.2;75.8;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.4;44.4;;;32.7;56.7;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2015;2015;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.6;86.6;;;81.4;90.5;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.9;41.9;;;35.1;49;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.2;7.2;;;5.7;9.2;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;92.7;92.7;;;85.2;96.5;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.6;9.6;;;8.4;10.9;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.2;71.2;;;60.7;79.8;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.0;88;;;79.6;93.3;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.4;44.4;;;33;56.3;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.7;88.7;;;81.5;93.4;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.2;12.2;;;10.7;14;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;17.4;17.4;;;13.7;21.9;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2015;2015;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.9;83.9;;;76.5;89.3;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.2;43.2;;;38.4;48.2;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.2;45.2;;;35.6;55.1;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.2;42.2;;;33.7;51.1;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.2;82.2;;;69.8;90.2;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.1;67.1;;;60.8;72.8;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;56.7;56.7;;;48.9;64.2;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2015;2015;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.5;66.5;;;49.5;80.1;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.4;70.4;;;61.4;78;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.0;31;;;23.9;39.1;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.5;43.5;;;29.8;58.4;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;93.8;93.8;;;87;97.1;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;52.1;52.1;;;41.3;62.7;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;81.9;81.9;;;72.8;88.5;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.7;6.7;;;6.1;7.3;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.9;87.9;;;79.1;93.3;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.5;48.5;;;40.9;56.2;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2015;2015;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.7;84.7;;;68.6;93.3;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;16.9;16.9;;;13.6;20.8;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.1;82.1;;;69.2;90.4;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.6;88.6;;;80.1;93.8;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.0;12;;;9;16;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.9;88.9;;;84.1;92.4;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.9;88.9;;;81.3;93.6;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.3;7.3;;;6.3;8.4;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.6;82.6;;;74.8;88.3;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.2;37.2;;;23.1;53.9;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.2;41.2;;;33.7;49.1;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.8;86.8;;;80.8;91.1;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.0;12;;;11;13;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50.8;50.8;;;46.3;55.3;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.4;47.4;;;39;55.9;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.8;84.8;;;78.3;89.7;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.5;86.5;;;75.3;93.1;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90.5;90.5;;;78.5;96.1;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;93.4;93.4;;;86.8;96.9;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.5;42.5;*;50 States + DC: US Median;41.5;44.2;Gender;Female;;;;;;;59;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.4;40.4;;;32.6;48.8;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.7;65.7;;;54.6;75.4;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.2;87.2;;;78.1;92.8;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.1;6.1;;;5.1;7.3;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.8;43.8;;;33.5;54.6;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.0;91;;;85;94.8;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.3;35.3;;;26.8;44.9;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.1;33.1;;;20.5;48.6;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.7;11.7;;;7.9;17;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2015;2015;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.9;9.9;;;9.2;10.6;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.2;87.2;;;78.5;92.7;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.1;85.1;;;71.3;92.9;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.9;44.9;*;50 States + DC: US Median;42.6;46.6;Overall;Overall;;;;;;;59;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.7;13.7;;;7.6;23.6;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.6;39.6;;;27;53.9;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;79.3;79.3;;;67.7;87.5;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.0;38;;;31.4;45.1;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;6.7;6.7;;;4.1;10.9;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.7;87.7;;;80.4;92.5;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.1;11.1;;;7.7;15.7;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.9;46.9;;;39.2;54.7;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.8;70.8;;;59.8;79.8;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.6;44.6;;;38.2;51.2;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.0;10;;;9.1;11;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.5;38.5;;;32.6;44.8;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2015;2015;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.1;86.1;*;50 States + DC: US Median;85.2;87.7;Overall;Overall;;;;;;;59;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.6;10.6;;;9.4;12;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.2;13.2;;;9.3;18.5;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.4;87.4;;;83.8;90.3;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.7;65.7;;;54;75.7;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;92.3;92.3;;;87.3;95.4;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;94.5;94.5;;;88.2;97.5;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.6;84.6;;;72.6;92;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;60.2;60.2;;;49.4;70.1;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.7;7.7;;;6.7;8.9;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.6;89.6;;;81;94.6;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2015;2015;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.1;39.1;;;26.6;53.2;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.1;86.1;;;77.8;91.5;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.9;9.9;;;9.1;10.7;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.8;91.8;;;85.3;95.6;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;94.7;94.7;;;86.9;97.9;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.6;48.6;;;36.3;61;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.6;82.6;;;73.4;89.1;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.8;11.8;;;9.6;14.5;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;75.3;75.3;;;64.2;83.8;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;16.3;16.3;;;12.6;20.9;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.8;7.8;;;6.6;9.2;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.1;9.1;;;7.9;10.6;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.9;86.9;;;81;91.2;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.1;90.1;;;74.1;96.7;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.9;71.9;;;65.7;77.5;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2015;2015;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.2;42.2;;;36.3;48.3;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.6;89.6;;;80.7;94.6;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;52.2;52.2;;;38.7;65.3;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;92.7;92.7;;;86.2;96.3;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90.7;90.7;;;79.9;96;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.6;12.6;;;7.1;21.5;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;92.4;92.4;;;84.2;96.5;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.5;90.5;;;80.9;95.6;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;95.3;95.3;;;89.5;97.9;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.8;44.8;;;33.1;57.1;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;27.6;27.6;;;22.4;33.4;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;81.4;81.4;;;69.5;89.4;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.1;49.1;;;40.6;57.6;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.7;47.7;;;41.5;54;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;50.1;50.1;;;42.4;57.8;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.9;47.9;;;42.4;53.4;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;80.8;80.8;;;68.1;89.3;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;94.6;94.6;;;89.1;97.4;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.2;37.2;;;29.9;45.1;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.0;69;;;61.5;75.6;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.5;85.5;;;78;90.7;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.7;91.7;;;84.7;95.6;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;17.8;17.8;;;10.5;28.7;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.6;46.6;;;33.9;59.7;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.5;84.5;;;74.9;90.9;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.8;7.8;;;5.8;10.3;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;4.3;4.3;;;2.7;6.7;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;75.7;75.7;;;68.2;81.8;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;78.5;78.5;;;68.1;86.2;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.5;10.5;;;8.6;12.6;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.2;46.2;;;39.8;52.7;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.9;87.9;;;80.6;92.7;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;81.0;81;;;71.7;87.7;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.4;45.4;;;37.6;53.5;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.6;84.6;;;67.5;93.5;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;4.9;4.9;;;3.9;6.2;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.0;12;;;7.1;19.4;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;51.8;51.8;;;44.1;59.5;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.8;85.8;;;79.3;90.5;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.5;85.5;;;77.4;91.1;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.8;85.8;;;75.5;92.2;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;54.7;54.7;;;42.8;66.2;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.4;91.4;;;85.9;94.9;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.6;36.6;;;30.6;43.1;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.4;9.4;;;6.8;12.9;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.5;46.5;;;32;61.6;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.7;89.7;;;83.4;93.8;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.8;9.8;;;8.7;11;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.9;48.9;;;42.9;54.9;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.6;12.6;;;9.6;16.4;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.1;11.1;;;9.6;12.7;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.7;87.7;;;79.7;92.8;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2015;2015;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.4;13.4;;;12.2;14.6;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.3;7.3;;;6.5;8.1;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.8;85.8;;;74.8;92.4;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.9;42.9;;;35.8;50.3;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.0;83;;;66.2;92.4;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.5;41.5;;;35.1;48.2;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;80.8;80.8;;;67.8;89.4;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;59.7;59.7;;;44.3;73.3;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.3;85.3;;;77.5;90.8;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.5;47.5;;;41.3;53.8;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.3;44.3;;;36.1;52.8;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;93.1;93.1;;;82.8;97.5;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.0;10;;;9;11;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.1;41.1;;;36.4;46;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.4;40.4;;;35.1;45.9;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.4;85.4;;;76.6;91.3;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.3;5.3;;;3.4;8.2;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.2;47.2;;;42.5;52;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.5;46.5;;;35.5;57.9;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.6;86.6;;;78.1;92.2;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.3;33.3;;;25;42.9;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.6;5.6;;;4.6;6.8;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.5;41.5;;;32.7;50.9;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.6;42.6;;;30.7;55.5;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.2;87.2;*;50 States + DC: US Median;84.8;88.9;Gender;Female;;;;;;;59;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67.5;67.5;;;59.5;74.5;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.6;40.6;;;32.7;48.9;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.8;13.8;;;10.1;18.6;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.3;90.3;;;84.3;94.2;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.9;8.9;;;7.8;10;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.8;87.8;;;80.8;92.4;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.8;83.8;;;72.3;91.2;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.3;84.3;;;77.2;89.5;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.1;85.1;;;79.6;89.4;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;56.8;56.8;;;47.6;65.5;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.8;44.8;;;37.6;52.2;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.9;44.9;;;34.9;55.3;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.6;13.6;;;11.1;16.5;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.1;48.1;;;35.7;60.7;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.6;39.6;;;33;46.6;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.2;10.2;;;9.1;11.4;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.4;31.4;;;23.7;40.2;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.3;10.3;;;6.4;16.2;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.1;38.1;;;33.1;43.4;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.7;41.7;;;30.1;54.2;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.6;88.6;;;81.4;93.3;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;58.2;58.2;;;41.3;73.3;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.9;46.9;;;42.3;51.6;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.7;40.7;;;32.4;49.6;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2015;2015;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.7;65.7;*;50 States + DC: US Median;63.8;67.6;Overall;Overall;;;;;;;59;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.0;89;;;81.3;93.7;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.6;35.6;;;26.2;46.4;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.5;82.5;;;74.4;88.4;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.3;42.3;;;34.8;50.2;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50.3;50.3;;;37.8;62.7;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;80.4;80.4;;;71.7;86.9;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.7;86.7;;;77.4;92.5;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90.5;90.5;;;80.4;95.6;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;61.2;61.2;;;48.2;72.9;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;77.3;77.3;;;69.8;83.3;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.3;63.3;;;52.9;72.6;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.5;47.5;;;41.7;53.4;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;18.4;18.4;;;10.8;29.5;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.3;85.3;;;69.3;93.7;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;78.6;78.6;;;65.9;87.5;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;59.4;59.4;;;39.4;76.8;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;77.5;77.5;;;68.7;84.3;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;US;United States;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.3;12.3;*;50 States + DC: US Median;11.2;13.4;Overall;Overall;;;;;;;59;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;64.2;64.2;;;55.6;72;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.8;84.8;;;76.2;90.7;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2015;2015;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;4.6;4.6;;;2.8;7.6;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.0;88;;;79.7;93.2;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.1;42.1;;;29.4;55.9;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.9;86.9;;;77.8;92.6;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;50.3;50.3;;;39.4;61.1;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.5;33.5;;;25;43.1;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.9;88.9;;;82.9;93;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.1;42.1;;;34;50.6;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.9;42.9;;;35.8;50.3;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.7;71.7;;;60.1;81;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.7;82.7;;;74.8;88.5;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.5;88.5;;;82.4;92.7;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.4;11.4;;;8.5;15.1;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.7;36.7;;;26.3;48.5;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.0;31;;;18.6;47;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2015;2015;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.7;7.7;;;7.1;8.3;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.9;87.9;;;79.8;93;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.9;46.9;;;40.3;53.6;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;73.8;73.8;;;56.9;85.7;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;21.1;21.1;;;12;34.3;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.1;43.1;;;37.1;49.3;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.0;46;;;36.2;56.2;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.8;41.8;;;34.5;49.5;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.6;13.6;;;10.6;17.4;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.9;41.9;;;33.9;50.5;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.9;63.9;;;40.7;82.1;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.8;48.8;;;30.7;67.2;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.2;42.2;;;31.3;54;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;50.3;50.3;;;41.3;59.3;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.7;87.7;;;78.2;93.4;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.0;46;;;36.8;55.4;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.6;41.6;;;34.7;48.9;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.1;5.1;;;4.2;6.1;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.1;62.1;;;49.1;73.5;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;77.2;77.2;;;57.2;89.5;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.5;87.5;;;80.4;92.3;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;54.2;54.2;;;47.6;60.7;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.5;46.5;;;39.5;53.6;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.5;12.5;;;10.9;14.2;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.2;37.2;;;30.5;44.5;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.8;6.8;;;5.5;8.5;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;93.2;93.2;;;88;96.3;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.8;39.8;;;29;51.6;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.2;37.2;;;30.3;44.7;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;78.3;78.3;;;70.9;84.2;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.5;11.5;;;9.9;13.4;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.0;45;;;36.6;53.7;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.2;10.2;;;9.3;11.3;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.1;12.1;;;10.6;13.6;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.3;64.3;;;46.5;78.8;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.1;91.1;;;85;94.9;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50.1;50.1;;;37.9;62.3;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.0;63;;;55.2;70.2;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.5;40.5;;;33.8;47.5;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;79.9;79.9;;;69;87.6;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;16.1;16.1;;;13.3;19.3;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.8;87.8;;;84.3;90.6;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;93.2;93.2;;;87.3;96.4;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.9;40.9;;;35.1;46.9;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;79.4;79.4;;;67.7;87.6;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.3;87.3;;;79.5;92.4;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.6;69.6;;;61.6;76.6;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.8;42.8;;;34.9;51.2;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.4;7.4;;;6.7;8.3;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;80.1;80.1;;;68.8;88;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.5;87.5;;;77.7;93.3;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2015;2015;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.3;42.3;;;27.4;58.8;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.5;47.5;;;43;52;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2015;2015;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.6;62.6;;;53.2;71;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.8;8.8;;;7.8;10;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.9;28.9;;;20.4;39.3;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.3;39.3;;;27.4;52.6;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;26.6;26.6;;;21.3;32.6;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.0;46;;;31.2;61.5;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;59.3;59.3;;;50.3;67.8;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;81.1;81.1;;;71.8;87.9;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.9;11.9;;;10.6;13.3;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.4;6.4;;;5.3;7.6;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.6;36.6;;;25.7;49.1;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.2;42.2;;;35.8;49;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.7;42.7;;;35.7;50;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.0;42;;;28.6;56.7;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.0;49;;;38.4;59.6;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2015;2015;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.1;35.1;;;19.2;55.1;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;48.1;48.1;;;38;58.4;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.5;71.5;;;62.9;78.7;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;81.9;81.9;;;72.1;88.8;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.8;88.8;;;82.5;93.1;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50.9;50.9;;;43;58.8;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.2;88.2;;;73;95.4;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.1;36.1;;;25.2;48.7;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.3;7.3;;;6.1;8.7;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50.1;50.1;;;31.8;68.3;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.4;82.4;;;72.4;89.4;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.0;10;;;9.1;10.9;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.4;8.4;;;6.8;10.2;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.6;9.6;;;5.5;16.2;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.7;47.7;;;41.5;54;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;80.9;80.9;;;67.5;89.6;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.0;6;;;4.7;7.7;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.9;39.9;;;33.2;47;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.5;6.5;;;5;8.5;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.4;40.4;;;31.1;50.5;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.6;37.6;;;30.7;45.1;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.0;45;;;36.3;54;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.7;11.7;;;7;18.8;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;78.7;78.7;;;60.3;90;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;77.8;77.8;;;67.2;85.6;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.4;85.4;;;76.1;91.5;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.6;37.6;;;29.7;46.3;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;15.1;15.1;;;12.1;18.5;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.2;40.2;;;27.5;54.5;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;93.6;93.6;;;88.1;96.6;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.6;66.6;;;50.2;79.7;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;16.7;16.7;;;13.3;20.7;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.8;37.8;;;30;46.3;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.2;42.2;;;33.6;51.3;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.2;37.2;;;25.9;50.1;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;72.1;72.1;;;63.2;79.6;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.9;86.9;;;79.6;91.9;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.2;10.2;;;9.2;11.2;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.3;34.3;;;26.6;43.1;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.8;45.8;;;35.5;56.4;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.1;69.1;;;52.6;81.8;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.2;44.2;;;35.1;53.6;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.5;66.5;;;55.9;75.6;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.9;45.9;;;34.3;57.9;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.3;87.3;*;50 States + DC: US Median;85.3;89.1;Gender;Female;;;;;;;59;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.3;46.3;;;36.4;56.5;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.5;12.5;;;10;15.6;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.8;39.8;;;33.8;46.1;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;94.5;94.5;;;88.6;97.4;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.7;43.7;;;37.4;50.2;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.1;88.1;;;79.6;93.4;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;GA;Georgia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST3_1;NMBR;RACE;API;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.3;85.3;;;77.6;90.7;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.6;90.6;;;81.4;95.5;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.1;88.1;;;76.8;94.3;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;49.9;49.9;;;39.2;60.7;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;81.4;81.4;;;73.1;87.6;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;91.8;91.8;;;86.1;95.4;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;30.4;30.4;;;20.7;42.2;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;92.4;92.4;;;86.9;95.7;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.5;66.5;;;45.9;82.3;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;73.3;73.3;;;57.8;84.7;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.2;47.2;;;41.4;53;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.3;85.3;;;74.6;91.9;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2013;2013;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;3.35;3.35;;;2.71;3.99;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.8;45.8;;;41.1;50.6;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;72.9;72.9;;;61.4;82;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;54.1;54.1;;;44.1;63.7;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.3;83.3;;;66.9;92.5;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.7;32.7;;;25.5;40.9;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;ID;Idaho;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST3_1;NMBR;RACE;API;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;WY;Wyoming;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST3_1;NMBR;RACE;HIS;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.5;82.5;;;73.9;88.8;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2015;2015;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.2;84.2;**;US estimate/number is based on fewer than 50 states and the District of Columbia;80.8;86.2;Gender;Male;;;;;;;59;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.5;38.5;;;30.8;46.7;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.9;70.9;;;56;82.3;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.4;89.4;;;77.6;95.3;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.6;83.6;;;71.9;91.1;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;92.4;92.4;;;85;96.3;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.8;45.8;;;37;54.8;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;92.1;92.1;;;83.6;96.4;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.5;11.5;;;7.8;16.5;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.2;83.2;;;65.7;92.8;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;80.3;80.3;;;67.4;88.9;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2015;2015;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.3;87.3;;;78.6;92.8;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;73.2;73.2;;;44;90.4;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.5;89.5;;;82.4;93.9;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;91.2;91.2;;;85.2;95;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.6;48.6;;;38.9;58.4;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.5;88.5;;;83.9;91.9;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.9;46.9;;;33.1;61.1;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.1;35.1;;;26.9;44.2;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;81.0;81;;;60.3;92.3;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.2;46.2;;;35.9;56.7;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.4;89.4;;;82.1;94;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2015;2015;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90.7;90.7;;;82.7;95.2;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.6;86.6;;;74;93.6;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2015;2015;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.7;87.7;;;75.2;94.4;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.2;90.2;;;84;94.2;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.2;41.2;;;36.9;45.6;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.8;87.8;;;68.8;95.9;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.3;38.3;;;32.5;44.4;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.9;40.9;;;33.3;48.9;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.4;68.4;;;46;84.6;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.8;34.8;;;24.6;46.6;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2015;2015;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.4;88.4;;;81.1;93.1;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;75.7;75.7;;;61.2;86.1;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;48.2;48.2;;;38.1;58.5;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.5;89.5;;;75.7;95.9;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.2;42.2;*;50 States + DC: US Median;40.6;44;Overall;Overall;;;;;;;59;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.0;85;;;78.9;89.5;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.5;88.5;;;81.7;93;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.8;87.8;;;81.1;92.3;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.7;82.7;;;73.1;89.3;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.1;89.1;;;81.5;93.8;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.6;83.6;;;76.4;88.9;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;91.7;91.7;;;81.6;96.5;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;79.3;79.3;;;69;86.9;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.0;39;;;33.2;45.3;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2015;2015;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.8;91.8;;;87.3;94.8;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2015;2015;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.9;71.9;;;55.7;83.8;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.2;46.2;;;39;53.5;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.4;90.4;;;86.1;93.5;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2015;2015;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.8;90.8;;;85.7;94.3;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.9;39.9;;;33.6;46.4;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.9;86.9;;;74.1;93.9;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.2;87.2;;;73.7;94.4;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.0;46;;;37.9;54.3;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2015;2015;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;95.0;95;;;83.5;98.6;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2015;2015;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.9;85.9;;;72.9;93.3;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2015;2015;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.7;87.7;;;79.3;93;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2015;2015;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.4;86.4;;;80.1;90.9;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2015;2015;PR;Puerto Rico;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST3_1;NMBR;RACE;BLK;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.3;40.3;;;29.4;52.3;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2015;2015;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.8;36.8;;;29.8;44.4;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.8;48.8;;;40.5;57.2;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.3;39.3;;;33;45.9;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;75.7;75.7;;;59;87.1;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;13.5;13.5;;;7.8;22.6;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.4;44.4;;;38;51;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;94.2;94.2;;;85.5;97.8;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;29.9;29.9;;;22.3;38.8;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90.8;90.8;;;84.5;94.7;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2015;2015;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.7;48.7;;;37.1;60.5;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2015;2015;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.7;83.7;;;69.2;92.1;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.2;41.2;;;35.7;46.9;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2015;2015;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;79.5;79.5;;;66.8;88.1;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.9;89.9;;;85.4;93.1;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2015;2015;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2015;2015;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;NMBR;RACE;API;;;;
2015;2015;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.9;89.9;;;78.6;95.6;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.0;84;;;71.3;91.7;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.5;86.5;;;80.5;90.9;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;81.8;81.8;;;70.3;89.5;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2015;2015;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.4;11.4;;;9.8;13.3;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;51.9;51.9;;;39.8;63.8;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2015;2015;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.1;46.1;;;39.2;53.2;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.7;84.7;;;69.5;93.1;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.8;45.8;;;36.8;55;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2015;2015;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;95.4;95.4;;;90.2;97.9;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2015;2015;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;81.2;81.2;;;69.8;89;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2015;2015;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2015;2015;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2015;2015;UT;Utah;NVSS;Asthma;Asthma mortality rate;;;Number;37;37;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;NMBR;RACE;WHT;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;17.5;17.5;;;13.8;22;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90.1;90.1;;;81.9;94.8;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2015;2015;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.0;88;;;81.9;92.3;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2015;2015;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.1;87.1;;;80.2;91.8;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2015;2015;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.3;86.3;;;75.8;92.7;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2015;2015;LA;Louisiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST3_1;NMBR;GENDER;GENF;;;;
2015;2015;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;91.3;91.3;;;85.2;95;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2015;2015;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2015;2015;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2015;2015;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2015;2015;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2015;2015;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2015;2015;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.3;38.3;;;33.3;43.6;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.3;82.3;;;74.6;88;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2015;2015;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2015;2015;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2015;2015;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2015;2015;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2015;2015;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.1;89.1;;;82.5;93.4;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2015;2015;MS;Mississippi;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST2_1;NMBR;RACE;HIS;;;;
2015;2015;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.7;9.7;;;7.5;12.4;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;CT;Connecticut;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST2_1;NMBR;GENDER;GENF;;;;
2015;2015;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;7.65;7.65;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;5;10.29;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;23.5;23.5;;;16.1;33.2;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.2;9.2;;;8.1;10.5;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;VI;Virgin Islands;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(18.335765, -64.896335);;78;AST;AST3_1;NMBR;RACE;AIAN;;;;
2015;2015;MO;Missouri;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST3_1;NMBR;RACE;API;;;;
2015;2015;TX;Texas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;10.14;10.14;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;9.28;11;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2015;2015;OH;Ohio;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;MT;Montana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST3_1;CRDRATE;RACE;API;;;;
2015;2015;NH;New Hampshire;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2015;2015;PA;Pennsylvania;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2015;2015;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;943;943;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;NMBR;RACE;BLK;;;;
2015;2015;TX;Texas;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST3_1;NMBR;RACE;AIAN;;;;
2015;2015;TN;Tennessee;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;ME;Maine;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST3_1;CRDRATE;RACE;API;;;;
2015;2015;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;5.00;5;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;4.81;5.19;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;VA;Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST3_1;NMBR;RACE;API;;;;
2015;2015;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;12.56;12.56;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;12.31;12.82;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;TX;Texas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;7.63;7.63;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;7.28;7.98;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2015;2015;ME;Maine;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;KS;Kansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST3_1;NMBR;RACE;WHT;;;;
2015;2015;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;15.01;15.01;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;14.74;15.28;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;VA;Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;LA;Louisiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST3_1;NMBR;GENDER;GENF;;;;
2015;2015;PR;Puerto Rico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(18.220833, -66.590149);;72;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2015;2015;DE;Delaware;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;PR;Puerto Rico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;MN;Minnesota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;5.74;5.74;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;5.41;6.06;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;VA;Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;35.47;35.47;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;34.32;36.62;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2015;2015;ME;Maine;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;8.70;8.7;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;7.77;9.63;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2015;2015;GU;Guam;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2015;2015;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;4.64;4.64;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;4.1;5.18;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2015;2015;AK;Alaska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;5693;5,693;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;NMBR;GENDER;GENF;;;;
2015;2015;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;11.34;11.34;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;9.91;12.76;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;MN;Minnesota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;IN;Indiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;5.70;5.7;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;5.33;6.06;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2015;2015;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;211;211;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2015;2015;DC;District of Columbia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;20.24;20.24;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;18.91;21.58;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;NMBR;RACE;HIS;;;;
2015;2015;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;6.03;6.03;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;5.38;6.67;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;5.75;5.75;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;4.93;6.56;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;MT;Montana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;MO;Missouri;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST3_1;NMBR;RACE;WHT;;;;
2015;2015;LA;Louisiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2015;2015;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;NMBR;RACE;HIS;;;;
2015;2015;ND;North Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;VI;Virgin Islands;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;8.99;8.99;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;8.59;9.4;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;PA;Pennsylvania;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST3_1;NMBR;GENDER;GENF;;;;
2015;2015;GA;Georgia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;PA;Pennsylvania;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;5732;5,732;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;NMBR;RACE;BLK;;;;
2015;2015;OK;Oklahoma;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST3_1;NMBR;RACE;WHT;;;;
2015;2015;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;448;448;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;NMBR;RACE;BLK;;;;
2015;2015;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2015;2015;TX;Texas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2015;2015;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;8.52;8.52;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;8.31;8.73;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;9.31;9.31;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;8.73;9.89;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;101;101;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;NMBR;RACE;AIAN;;;;
2015;2015;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;LA;Louisiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2015;2015;IL;Illinois;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2015;2015;VI;Virgin Islands;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2015;2015;NH;New Hampshire;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST3_1;NMBR;GENDER;GENF;;;;
2015;2015;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;7.86;7.86;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;7.49;8.23;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;672;672;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;NMBR;RACE;WHT;;;;
2015;2015;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;11.64;11.64;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;11.34;11.93;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;KS;Kansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;175;175;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;NMBR;RACE;AIAN;;;;
2015;2015;GA;Georgia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2015;2015;MN;Minnesota;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST3_1;NMBR;RACE;HIS;;;;
2015;2015;CT;Connecticut;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST3_1;NMBR;RACE;WHT;;;;
2015;2015;ND;North Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2015;2015;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;2015;2,015;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;NMBR;RACE;WHT;;;;
2015;2015;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;11.94;11.94;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;8.53;15.36;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;GU;Guam;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(13.444304, 144.793731);;66;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;TN;Tennessee;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2015;2015;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;NMBR;RACE;AIAN;;;;
2015;2015;VA;Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST3_1;NMBR;RACE;WHT;;;;
2015;2015;OK;Oklahoma;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;ND;North Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2015;2015;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;CRDRATE;RACE;API;;;;
2015;2015;CT;Connecticut;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2015;2015;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1738;1,738;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;NMBR;RACE;HIS;;;;
2015;2015;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1928;1,928;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;NMBR;GENDER;GENM;;;;
2015;2015;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;62;62;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;NMBR;RACE;BLK;;;;
2015;2015;KS;Kansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;IN;Indiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST3_1;NMBR;RACE;BLK;;;;
2015;2015;ID;Idaho;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2015;2015;DE;Delaware;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST3_1;NMBR;RACE;WHT;;;;
2015;2015;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;171;171;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;NMBR;RACE;API;;;;
2015;2015;CT;Connecticut;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST3_1;CRDRATE;RACE;API;;;;
2015;2015;MN;Minnesota;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;882;882;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST3_1;NMBR;GENDER;GENM;;;;
2015;2015;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;8.38;8.38;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;7.32;9.44;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2015;2015;DC;District of Columbia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;23.77;23.77;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;21.81;25.73;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;AK;Alaska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2015;2015;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;6.76;6.76;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;6.29;7.23;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;GA;Georgia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2015;2015;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;8.42;8.42;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;8.06;8.77;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;VI;Virgin Islands;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(18.335765, -64.896335);;78;AST;AST3_1;NMBR;RACE;API;;;;
2015;2015;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;7.63;7.63;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;5.5;9.75;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2015;2015;OK;Oklahoma;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2015;2015;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;7.95;7.95;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;7.24;8.66;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2015;2015;AL;Alabama;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2015;2015;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2015;2015;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;35;35;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;NMBR;RACE;AIAN;;;;
2015;2015;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;NMBR;RACE;AIAN;;;;
2015;2015;MO;Missouri;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;114;114;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;NMBR;RACE;BLK;;;;
2015;2015;MT;Montana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2015;2015;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;7.82;7.82;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;7.56;8.09;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;NMBR;GENDER;GENF;;;;
2015;2015;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;841;841;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2015;2015;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1822;1,822;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;NMBR;RACE;WHT;;;;
2015;2015;MO;Missouri;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;6.63;6.63;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;6.19;7.08;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2015;2015;KS;Kansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST3_1;CRDRATE;RACE;API;;;;
2015;2015;CT;Connecticut;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;KS;Kansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;WY;Wyoming;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2015;2015;DE;Delaware;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;13.16;13.16;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;12.72;13.59;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;18.07;18.07;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;14.96;21.19;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;774;774;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;NMBR;RACE;WHT;;;;
2015;2015;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;13323;13,323;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;NMBR;GENDER;GENF;;;;
2015;2015;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;6.36;6.36;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;3.83;8.89;Race/Ethnicity;American Indian or Alaska Native;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;NMBR;RACE;AIAN;;;;
2015;2015;ID;Idaho;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;AK;Alaska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2015;2015;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2015;2015;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;2469;2,469;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;NMBR;RACE;WHT;;;;
2015;2015;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;698;698;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;NMBR;RACE;API;;;;
2015;2015;OH;Ohio;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST3_1;NMBR;GENDER;GENF;;;;
2015;2015;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;5.91;5.91;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;5.51;6.31;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;ID;Idaho;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST3_1;NMBR;RACE;AIAN;;;;
2015;2015;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;6.51;6.51;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;6.13;6.9;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;KS;Kansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2015;2015;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;5.07;5.07;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;4.88;5.26;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;AK;Alaska;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST3_1;NMBR;RACE;API;;;;
2015;2015;OH;Ohio;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST3_1;NMBR;RACE;WHT;;;;
2015;2015;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;12.03;12.03;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;10.38;13.67;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;13.22;13.22;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;12.37;14.07;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2015;2015;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;11.25;11.25;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;10.77;11.72;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2015;2015;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;5.07;5.07;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;4.04;6.1;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;CRDRATE;RACE;API;;;;
2015;2015;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;7.19;7.19;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;6.58;7.8;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2015;2015;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;NMBR;RACE;HIS;;;;
2015;2015;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;86;86;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;NMBR;RACE;BLK;;;;
2015;2015;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;6.86;6.86;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;6.52;7.19;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;ND;North Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST3_1;NMBR;RACE;AIAN;;;;
2015;2015;ME;Maine;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;GU;Guam;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;2.90;2.9;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;2.2;3.59;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2015;2015;MN;Minnesota;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST3_1;NMBR;RACE;API;;;;
2015;2015;IL;Illinois;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST3_1;NMBR;RACE;AIAN;;;;
2015;2015;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;10.20;10.2;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;9.75;10.65;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;31.86;31.86;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;29.83;33.9;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2015;2015;ID;Idaho;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST3_1;NMBR;GENDER;GENM;;;;
2015;2015;PR;Puerto Rico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;TN;Tennessee;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;11.78;11.78;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;11.26;12.29;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;KS;Kansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST3_1;NMBR;RACE;API;;;;
2015;2015;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;IL;Illinois;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST3_1;NMBR;GENDER;GENF;;;;
2015;2015;MO;Missouri;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;398;398;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;NMBR;GENDER;GENM;;;;
2015;2015;PA;Pennsylvania;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;PA;Pennsylvania;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST3_1;NMBR;RACE;API;;;;
2015;2015;DE;Delaware;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2015;2015;KS;Kansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2015;2015;MO;Missouri;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2015;2015;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2015;2015;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;3334;3,334;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;NMBR;GENDER;GENM;;;;
2015;2015;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;8.51;8.51;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;8.21;8.81;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;PA;Pennsylvania;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2015;2015;MT;Montana;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST3_1;NMBR;RACE;BLK;;;;
2015;2015;GA;Georgia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST3_1;NMBR;RACE;WHT;;;;
2015;2015;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;7.54;7.54;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;7.3;7.78;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2015;2015;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;5.26;5.26;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;3.93;6.59;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2015;2015;OK;Oklahoma;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2015;2015;MO;Missouri;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2015;2015;TX;Texas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;4.68;4.68;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;4.03;5.33;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2015;2015;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;16.77;16.77;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;14.13;19.41;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2015;2015;MN;Minnesota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST3_1;CRDRATE;RACE;API;;;;
2015;2015;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;537;537;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;NMBR;GENDER;GENF;;;;
2015;2015;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2015;2015;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2015;2015;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;435;435;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;NMBR;RACE;BLK;;;;
2015;2015;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;16.58;16.58;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;15.33;17.83;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2015;2015;MO;Missouri;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST3_1;NMBR;RACE;BLK;;;;
2015;2015;IL;Illinois;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;9.33;9.33;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;9.11;9.55;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2015;2015;MO;Missouri;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST3_1;NMBR;GENDER;GENM;;;;
2015;2015;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;10.70;10.7;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;10.38;11.03;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2015;2015;KS;Kansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2015;2015;WY;Wyoming;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2015;2015;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;CRDRATE;RACE;API;;;;
2015;2015;WY;Wyoming;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2015;2015;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;7.48;7.48;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;6.86;8.1;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;LA;Louisiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST3_1;NMBR;RACE;AIAN;;;;
2015;2015;OH;Ohio;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2015;2015;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;4.59;4.59;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;4.37;4.8;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2015;2015;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;8.79;8.79;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;8.42;9.16;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2015;2015;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;11.88;11.88;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;11.63;12.13;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;GU;Guam;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2015;2015;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;NMBR;RACE;API;;;;
2015;2015;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2015;2015;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;6.31;6.31;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;6.09;6.53;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2015;2015;MT;Montana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2015;2015;MT;Montana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;DE;Delaware;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2015;2015;LA;Louisiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST3_1;NMBR;RACE;BLK;;;;
2015;2015;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2015;2015;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;4.32;4.32;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;4.11;4.53;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;42;42;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;NMBR;RACE;AIAN;;;;
2015;2015;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;2336;2,336;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;NMBR;RACE;WHT;;;;
2015;2015;DC;District of Columbia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.907192, -77.036871);;11;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;GU;Guam;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2015;2015;OK;Oklahoma;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST3_1;NMBR;RACE;AIAN;;;;
2015;2015;IN;Indiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2015;2015;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;4.96;4.96;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;4.74;5.19;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;GA;Georgia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2015;2015;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;21.71;21.71;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;19.67;23.75;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2015;2015;WY;Wyoming;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2015;2015;MT;Montana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;677;677;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;NMBR;GENDER;GENM;;;;
2015;2015;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;10.85;10.85;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;9.2;12.49;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;OK;Oklahoma;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;CRDRATE;RACE;API;;;;
2015;2015;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1064;1,064;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;NMBR;RACE;WHT;;;;
2015;2015;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;2326;2,326;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;NMBR;GENDER;GENF;;;;
2015;2015;DE;Delaware;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2015;2015;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;17.93;17.93;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;16.14;19.73;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;61;61;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;NMBR;RACE;BLK;;;;
2015;2015;PA;Pennsylvania;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2015;2015;LA;Louisiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2015;2015;MT;Montana;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST3_1;NMBR;RACE;WHT;;;;
2015;2015;CT;Connecticut;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2015;2015;DE;Delaware;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST3_1;CRDRATE;RACE;API;;;;
2015;2015;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;67;67;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;NMBR;GENDER;GENM;;;;
2015;2015;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;152;152;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;NMBR;RACE;HIS;;;;
2015;2015;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;NMBR;RACE;AIAN;;;;
2015;2015;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;3387;3,387;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.5;14.5;;;10.6;19.5;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2015;2015;LA;Louisiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST3_1;CRDRATE;RACE;API;;;;
2015;2015;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;14.90;14.9;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;12.66;17.14;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2015;2015;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1771;1,771;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;NMBR;RACE;WHT;;;;
2015;2015;MN;Minnesota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;4.31;4.31;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;4.03;4.6;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;GU;Guam;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST3_1;NMBR;GENDER;GENF;;;;
2015;2015;IL;Illinois;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST3_1;NMBR;RACE;BLK;;;;
2015;2015;DE;Delaware;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST3_1;NMBR;GENDER;GENM;;;;
2015;2015;NH;New Hampshire;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2015;2015;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;126;126;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;NMBR;RACE;API;;;;
2015;2015;NH;New Hampshire;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;12.11;12.11;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;7.46;16.77;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2014;2014;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2015;2015;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;NMBR;RACE;AIAN;;;;
2015;2015;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;4.05;4.05;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;3.58;4.52;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2015;2015;ME;Maine;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2015;2015;OH;Ohio;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2015;2015;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;224;224;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;NMBR;RACE;API;;;;
2015;2015;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;3804;3,804;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;NMBR;RACE;BLK;;;;
2015;2015;MT;Montana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2015;2015;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;217;217;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;NMBR;RACE;BLK;;;;
2015;2015;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;DC;District of Columbia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;33.64;33.64;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;31.3;35.99;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;ND;North Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;PA;Pennsylvania;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2015;2015;DE;Delaware;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST3_1;NMBR;RACE;BLK;;;;
2015;2015;AL;Alabama;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;9.51;9.51;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;8.93;10.09;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2015;2015;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;4623;4,623;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;NMBR;RACE;WHT;;;;
2015;2015;ME;Maine;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST3_1;NMBR;RACE;AIAN;;;;
2015;2015;GU;Guam;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST3_1;NMBR;GENDER;GENM;;;;
2015;2015;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;LA;Louisiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST3_1;NMBR;RACE;API;;;;
2015;2015;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;486;486;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;NMBR;GENDER;GENM;;;;
2015;2015;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;416;416;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;NMBR;GENDER;GENM;;;;
2015;2015;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;3.38;3.38;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;2.33;4.43;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2015;2015;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;CRDRATE;RACE;API;;;;
2015;2015;TN;Tennessee;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST3_1;NMBR;RACE;AIAN;;;;
2015;2015;DE;Delaware;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;8.12;8.12;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;6.92;9.33;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2015;2015;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2015;2015;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;4.73;4.73;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;4.44;5.03;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;11.04;11.04;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;9.73;12.34;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2015;2015;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;CT;Connecticut;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;AK;Alaska;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST3_1;NMBR;RACE;WHT;;;;
2015;2015;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;23.51;23.51;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;22.9;24.11;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2015;2015;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;2144;2,144;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;NMBR;GENDER;GENF;;;;
2015;2015;OH;Ohio;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST3_1;NMBR;RACE;API;;;;
2015;2015;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;NMBR;RACE;AIAN;;;;
2015;2015;ME;Maine;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2015;2015;IN;Indiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;GA;Georgia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;11.47;11.47;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;11.15;11.78;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;10.60;10.6;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;7.24;13.96;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;WY;Wyoming;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;AL;Alabama;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST3_1;NMBR;RACE;AIAN;;;;
2015;2015;VA;Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2015;2015;OH;Ohio;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST3_1;CRDRATE;RACE;API;;;;
2015;2015;GU;Guam;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;GU;Guam;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;PR;Puerto Rico;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST3_1;NMBR;GENDER;GENM;;;;
2015;2015;MT;Montana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2015;2015;GA;Georgia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST3_1;NMBR;RACE;HIS;;;;
2015;2015;IL;Illinois;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2015;2015;VI;Virgin Islands;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;MN;Minnesota;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST3_1;NMBR;RACE;WHT;;;;
2015;2015;ID;Idaho;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2015;2015;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;6.42;6.42;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;6.03;6.81;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;NMBR;RACE;AIAN;;;;
2015;2015;AK;Alaska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;NH;New Hampshire;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST3_1;NMBR;GENDER;GENM;;;;
2015;2015;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;146;146;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;NMBR;RACE;API;;;;
2015;2015;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;18.72;18.72;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;13.99;23.44;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1704;1,704;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2015;2015;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;NMBR;RACE;BLK;;;;
2015;2015;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;3237;3,237;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;NMBR;GENDER;GENF;;;;
2015;2015;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;11.15;11.15;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;10.84;11.46;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;WY;Wyoming;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2015;2015;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;9.02;9.02;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;8.66;9.39;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2015;2015;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2015;2015;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;2.76;2.76;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;2.12;3.4;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2015;2015;PR;Puerto Rico;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST3_1;NMBR;RACE;HIS;;;;
2015;2015;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;677;677;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;NMBR;GENDER;GENF;;;;
2015;2015;MN;Minnesota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;6.45;6.45;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;6.2;6.7;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;DC;District of Columbia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;35;35;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST3_1;NMBR;RACE;WHT;;;;
2015;2015;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;2.40;2.4;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;1.85;2.95;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;CRDRATE;RACE;API;;;;
2015;2015;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2015;2015;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;7.96;7.96;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;7.64;8.29;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;LA;Louisiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;VI;Virgin Islands;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(18.335765, -64.896335);;78;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2015;2015;GU;Guam;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(13.444304, 144.793731);;66;AST;AST3_1;NMBR;RACE;API;;;;
2015;2015;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1420;1,420;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;NMBR;RACE;WHT;;;;
2015;2015;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;925;925;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;NMBR;GENDER;GENF;;;;
2015;2015;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;42;42;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;NMBR;RACE;HIS;;;;
2015;2015;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;7.32;7.32;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;6.6;8.03;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2015;2015;CT;Connecticut;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST3_1;NMBR;RACE;AIAN;;;;
2015;2015;CT;Connecticut;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2015;2015;GA;Georgia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST3_1;NMBR;GENDER;GENF;;;;
2015;2015;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1586;1,586;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2015;2015;OK;Oklahoma;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2015;2015;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;6.05;6.05;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;5.06;7.03;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2015;2015;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2015;2015;AL;Alabama;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2015;2015;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;DE;Delaware;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2015;2015;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;6.08;6.08;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;3.79;8.37;Race/Ethnicity;American Indian or Alaska Native;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2015;2015;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;20.67;20.67;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;19.49;21.85;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2015;2015;DC;District of Columbia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;14.15;14.15;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;12.64;15.65;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2015;2015;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;9.89;9.89;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;9.12;10.65;Race/Ethnicity;Asian or Pacific Islander;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2015;2015;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;2767;2,767;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;NMBR;RACE;BLK;;;;
2015;2015;CT;Connecticut;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST3_1;NMBR;RACE;HIS;;;;
2015;2015;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;2.05;2.05;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;1.29;2.81;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2015;2015;IN;Indiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;7.77;7.77;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;7.12;8.41;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2015;2015;KS;Kansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST3_1;NMBR;RACE;HIS;;;;
2015;2015;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;CRDRATE;RACE;API;;;;
2015;2015;WY;Wyoming;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;GU;Guam;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(13.444304, 144.793731);;66;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2015;2015;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;20.50;20.5;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;16.91;24.09;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;AK;Alaska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST3_1;CRDRATE;RACE;API;;;;
2015;2015;DE;Delaware;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2015;2015;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;193;193;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;NMBR;GENDER;GENM;;;;
2015;2015;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2015;2015;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;7.28;7.28;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;6.65;7.9;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;CT;Connecticut;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;OH;Ohio;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2015;2015;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;13.94;13.94;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;13.46;14.42;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2015;2015;IL;Illinois;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2015;2015;MN;Minnesota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2015;2015;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;8.69;8.69;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;7.67;9.71;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2015;2015;DC;District of Columbia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;838;838;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST3_1;NMBR;RACE;BLK;;;;
2015;2015;NH;New Hampshire;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;3505;3,505;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;NMBR;RACE;WHT;;;;
2015;2015;PR;Puerto Rico;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(18.220833, -66.590149);;72;AST;AST3_1;NMBR;RACE;AIAN;;;;
2015;2015;ID;Idaho;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST3_1;NMBR;GENDER;GENF;;;;
2015;2015;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1130;1,130;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;NMBR;GENDER;GENM;;;;
2015;2015;IL;Illinois;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2015;2015;ID;Idaho;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2015;2015;VI;Virgin Islands;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;5.34;5.34;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;4.98;5.69;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;37;37;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;NMBR;RACE;HIS;;;;
2015;2015;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;493;493;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;NMBR;RACE;HIS;;;;
2015;2015;PA;Pennsylvania;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;NMBR;RACE;AIAN;;;;
2015;2015;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;9.73;9.73;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;9.41;10.04;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2015;2015;TN;Tennessee;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;GA;Georgia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;OH;Ohio;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST3_1;NMBR;RACE;HIS;;;;
2015;2015;MN;Minnesota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2015;2015;ND;North Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST3_1;NMBR;GENDER;GENM;;;;
2015;2015;VI;Virgin Islands;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST3_1;NMBR;RACE;HIS;;;;
2015;2015;DC;District of Columbia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;1.89;1.89;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;1.26;2.51;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2015;2015;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;8.93;8.93;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;8.38;9.48;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2015;2015;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;5.20;5.2;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;4.78;5.63;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2015;2015;LA;Louisiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1273;1,273;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;NMBR;GENDER;GENM;;;;
2015;2015;VI;Virgin Islands;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;OK;Oklahoma;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2015;2015;NH;New Hampshire;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;PA;Pennsylvania;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2015;2015;ND;North Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;5.39;5.39;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;4.88;5.9;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;NH;New Hampshire;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST3_1;NMBR;RACE;WHT;;;;
2015;2015;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;CRDRATE;RACE;API;;;;
2014;2014;AK;Alaska;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST3_1;NMBR;RACE;HIS;;;;
2015;2015;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2015;2015;WY;Wyoming;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;AL;Alabama;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST3_1;NMBR;GENDER;GENF;;;;
2015;2015;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;7.90;7.9;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;5.2;10.59;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2015;2015;CT;Connecticut;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;22.17;22.17;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;18.1;26.24;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2015;2015;PA;Pennsylvania;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST3_1;NMBR;GENDER;GENM;;;;
2015;2015;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;NMBR;RACE;API;;;;
2015;2015;NH;New Hampshire;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2015;2015;CT;Connecticut;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2015;2015;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;21.84;21.84;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;20.13;23.55;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2015;2015;TN;Tennessee;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST3_1;NMBR;RACE;HIS;;;;
2015;2015;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;4.14;4.14;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;3.81;4.48;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;626;626;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;NMBR;RACE;BLK;;;;
2015;2015;IL;Illinois;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2015;2015;OK;Oklahoma;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2015;2015;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;6.77;6.77;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;6.44;7.1;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2015;2015;IL;Illinois;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;4.12;4.12;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;3.75;4.5;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;TN;Tennessee;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;DC;District of Columbia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.907192, -77.036871);;11;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2015;2015;DE;Delaware;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;16.30;16.3;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;15.89;16.71;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2015;2015;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;32.77;32.77;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;31.59;33.95;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2015;2015;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;12.88;12.88;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;12.42;13.33;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;ME;Maine;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;GU;Guam;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(13.444304, 144.793731);;66;AST;AST3_1;CRDRATE;RACE;API;;;;
2015;2015;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;9.94;9.94;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;6.93;12.95;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2015;2015;OK;Oklahoma;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2015;2015;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;DC;District of Columbia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.907192, -77.036871);;11;AST;AST3_1;NMBR;RACE;API;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2015;2015;OK;Oklahoma;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST3_1;NMBR;GENDER;GENF;;;;
2015;2015;MO;Missouri;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2015;2015;NH;New Hampshire;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;MO;Missouri;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;240;240;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;NMBR;RACE;HIS;;;;
2015;2015;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;201;201;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;NMBR;RACE;HIS;;;;
2015;2015;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;NMBR;RACE;API;;;;
2015;2015;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;62;62;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;NMBR;RACE;API;;;;
2015;2015;VA;Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST3_1;CRDRATE;RACE;API;;;;
2015;2015;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;AK;Alaska;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST3_1;NMBR;RACE;BLK;;;;
2015;2015;IN;Indiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;9443;9,443;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;NMBR;RACE;WHT;;;;
2015;2015;MN;Minnesota;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;2164;2,164;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2015;2015;PR;Puerto Rico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2015;2015;MT;Montana;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST3_1;NMBR;RACE;API;;;;
2015;2015;IN;Indiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2015;2015;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;CRDRATE;RACE;API;;;;
2015;2015;OH;Ohio;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;2563;2,563;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2015;2015;MT;Montana;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST3_1;NMBR;RACE;AIAN;;;;
2015;2015;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;32.44;32.44;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;31.25;33.63;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;AK;Alaska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;VA;Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2015;2015;DE;Delaware;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST3_1;NMBR;RACE;HIS;;;;
2015;2015;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;13.44;13.44;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;13.16;13.71;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;PR;Puerto Rico;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST3_1;NMBR;RACE;WHT;;;;
2015;2015;GU;Guam;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(13.444304, 144.793731);;66;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2015;2015;AK;Alaska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2015;2015;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;NMBR;RACE;BLK;;;;
2015;2015;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;2114;2,114;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;NMBR;GENDER;GENF;;;;
2015;2015;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;8.17;8.17;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;7.96;8.37;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;MN;Minnesota;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST3_1;NMBR;RACE;AIAN;;;;
2015;2015;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;15.26;15.26;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;14.49;16.03;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;7.92;7.92;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;6.96;8.89;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;GU;Guam;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;NMBR;RACE;WHT;;;;
2015;2015;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1015;1,015;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;NMBR;GENDER;GENF;;;;
2015;2015;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2015;2015;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;951;951;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;NMBR;RACE;HIS;;;;
2015;2015;AK;Alaska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;TX;Texas;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST3_1;NMBR;GENDER;GENF;;;;
2015;2015;IL;Illinois;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST2_1;NMBR;GENDER;GENF;;;;
2014;2014;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;754;754;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;NMBR;RACE;API;;;;
2015;2015;DE;Delaware;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2015;2015;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2015;2015;AK;Alaska;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST3_1;NMBR;RACE;AIAN;;;;
2015;2015;MO;Missouri;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;867;867;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;NMBR;GENDER;GENF;;;;
2015;2015;GA;Georgia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2015;2015;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;CRDRATE;RACE;API;;;;
2015;2015;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;NMBR;RACE;AIAN;;;;
2015;2015;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;9.22;9.22;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;8.89;9.55;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;VA;Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;9348;9,348;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2015;2015;OH;Ohio;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2015;2015;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;4.03;4.03;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;3.78;4.27;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;MO;Missouri;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST3_1;NMBR;RACE;AIAN;;;;
2015;2015;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;2281;2,281;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;NMBR;GENDER;GENM;;;;
2015;2015;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;2.56;2.56;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;1.92;3.2;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;CRDRATE;RACE;API;;;;
2015;2015;PA;Pennsylvania;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;AL;Alabama;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2015;2015;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;11.32;11.32;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;10.47;12.18;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2015;2015;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;9.47;9.47;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;7.97;10.98;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2015;2015;TN;Tennessee;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2015;2015;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;10.17;10.17;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;9.82;10.51;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2015;2015;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;50;50;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;NMBR;RACE;AIAN;;;;
2015;2015;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;NMBR;GENDER;GENM;;;;
2015;2015;VI;Virgin Islands;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST3_1;NMBR;RACE;BLK;;;;
2015;2015;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;11.19;11.19;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;9;13.37;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2015;2015;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;4.35;4.35;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;3.72;4.98;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;NMBR;GENDER;GENM;;;;
2015;2015;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;6167;6,167;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;NMBR;GENDER;GENF;;;;
2015;2015;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;33.58;33.58;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;31.31;35.85;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;9027;9,027;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2015;2015;CT;Connecticut;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST3_1;NMBR;GENDER;GENM;;;;
2015;2015;PA;Pennsylvania;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;MO;Missouri;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST3_1;CRDRATE;RACE;API;;;;
2015;2015;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;7.97;7.97;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;7.53;8.41;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;MN;Minnesota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2015;2015;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;7.74;7.74;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;6.28;9.21;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;ME;Maine;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;GU;Guam;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2015;2015;ND;North Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2015;2015;MN;Minnesota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;6.19;6.19;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;5.85;6.53;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2015;2015;NH;New Hampshire;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST3_1;NMBR;RACE;HIS;;;;
2015;2015;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;11.66;11.66;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;10.11;13.21;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2015;2015;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;3.91;3.91;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;3.38;4.45;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2015;2015;NH;New Hampshire;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2015;2015;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;275;275;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;NMBR;RACE;BLK;;;;
2015;2015;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;6.23;6.23;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;5.93;6.52;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2015;2015;KS;Kansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2015;2015;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;NMBR;RACE;API;;;;
2015;2015;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;11.31;11.31;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;9.04;13.58;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;MN;Minnesota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2015;2015;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;NMBR;RACE;API;;;;
2015;2015;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;NH;New Hampshire;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2015;2015;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;4.49;4.49;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;3.89;5.1;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;LA;Louisiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2015;2015;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;487;487;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;NMBR;RACE;WHT;;;;
2015;2015;LA;Louisiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;LA;Louisiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST3_1;NMBR;GENDER;GENM;;;;
2015;2015;OK;Oklahoma;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2015;2015;AL;Alabama;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;AL;Alabama;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST3_1;NMBR;GENDER;GENM;;;;
2015;2015;ND;North Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;11.30;11.3;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;11;11.59;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;VA;Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2015;2015;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;7.13;7.13;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;6.92;7.35;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;ND;North Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2015;2015;TN;Tennessee;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST3_1;NMBR;GENDER;GENM;;;;
2015;2015;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;NMBR;RACE;BLK;;;;
2015;2015;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;7.92;7.92;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;6.44;9.4;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2015;2015;MT;Montana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2015;2015;DC;District of Columbia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;596;596;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST3_1;NMBR;GENDER;GENF;;;;
2015;2015;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;5.01;5.01;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;4.09;5.93;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;ME;Maine;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST3_1;NMBR;RACE;API;;;;
2015;2015;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;AK;Alaska;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST3_1;NMBR;GENDER;GENM;;;;
2015;2015;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;205;205;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;NMBR;RACE;WHT;;;;
2015;2015;IN;Indiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST3_1;NMBR;RACE;API;;;;
2015;2015;VI;Virgin Islands;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2015;2015;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;8.12;8.12;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;7.83;8.4;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;MO;Missouri;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2015;2015;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;15.42;15.42;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;14.66;16.18;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2015;2015;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;5.82;5.82;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;5.41;6.23;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1214;1,214;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;NMBR;RACE;WHT;;;;
2015;2015;WY;Wyoming;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST3_1;CRDRATE;RACE;API;;;;
2015;2015;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2015;2015;MT;Montana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;KS;Kansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;PR;Puerto Rico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2015;2015;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;3.29;3.29;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;2.5;4.07;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;CRDRATE;RACE;API;;;;
2015;2015;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2015;2015;MO;Missouri;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;WY;Wyoming;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2015;2015;AL;Alabama;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST3_1;NMBR;RACE;BLK;;;;
2015;2015;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2015;2015;MO;Missouri;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;13.15;13.15;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;12.53;13.77;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2015;2015;GU;Guam;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;TX;Texas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;9.09;9.09;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;8.7;9.48;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;GA;Georgia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;6.09;6.09;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;5.5;6.67;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2015;2015;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;8.07;8.07;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;7.53;8.6;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;ME;Maine;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2015;2015;AK;Alaska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2015;2015;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;3.92;3.92;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;3.69;4.16;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2015;2015;ME;Maine;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST3_1;NMBR;GENDER;GENF;;;;
2015;2015;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;12.75;12.75;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;12.49;13.02;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;IN;Indiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2015;2015;PA;Pennsylvania;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST3_1;NMBR;RACE;WHT;;;;
2015;2015;ME;Maine;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2015;2015;OK;Oklahoma;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;ME;Maine;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2015;2015;OK;Oklahoma;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;NMBR;RACE;HIS;;;;
2015;2015;PR;Puerto Rico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;232;232;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;NMBR;RACE;HIS;;;;
2015;2015;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;8.67;8.67;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;8.19;9.16;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;DC;District of Columbia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;22.47;22.47;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;20.67;24.28;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2015;2015;GU;Guam;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST3_1;NMBR;RACE;HIS;;;;
2015;2015;VI;Virgin Islands;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;7.41;7.41;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;6.8;8.01;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2015;2015;PR;Puerto Rico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1341;1,341;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2015;2015;GA;Georgia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST3_1;CRDRATE;RACE;API;;;;
2015;2015;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2015;2015;VI;Virgin Islands;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;IN;Indiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;672;672;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;NMBR;GENDER;GENF;;;;
2015;2015;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;8.26;8.26;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;7.45;9.08;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;DC;District of Columbia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.907192, -77.036871);;11;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2015;2015;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;NMBR;RACE;BLK;;;;
2015;2015;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;364;364;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;NMBR;RACE;WHT;;;;
2015;2015;GA;Georgia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST3_1;NMBR;GENDER;GENM;;;;
2015;2015;LA;Louisiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST3_1;NMBR;RACE;WHT;;;;
2015;2015;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;NMBR;RACE;AIAN;;;;
2015;2015;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;5.17;5.17;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;4.32;6.02;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1246;1,246;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2015;2015;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;NMBR;RACE;API;;;;
2015;2015;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;571;571;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;NMBR;GENDER;GENM;;;;
2015;2015;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;NH;New Hampshire;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST3_1;NMBR;RACE;AIAN;;;;
2015;2015;AL;Alabama;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST3_1;CRDRATE;RACE;API;;;;
2015;2015;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;NMBR;RACE;API;;;;
2015;2015;PR;Puerto Rico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(18.220833, -66.590149);;72;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2015;2015;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2015;2015;ID;Idaho;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;WY;Wyoming;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST3_1;NMBR;GENDER;GENM;;;;
2015;2015;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;93;93;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;NMBR;RACE;API;;;;
2015;2015;TN;Tennessee;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;16.76;16.76;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;16.13;17.4;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;1.84;1.84;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;1.25;2.43;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2015;2015;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;37;37;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;NMBR;RACE;HIS;;;;
2015;2015;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;5.19;5.19;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;4.88;5.5;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2015;2015;AK;Alaska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;IL;Illinois;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST3_1;CRDRATE;RACE;API;;;;
2015;2015;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;4.97;4.97;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;4.71;5.23;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2015;2015;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;8.03;8.03;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;7.71;8.36;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2015;2015;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2015;2015;CT;Connecticut;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST3_1;NMBR;RACE;API;;;;
2015;2015;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;5.83;5.83;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;5.49;6.18;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;AK;Alaska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;8.52;8.52;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;7.98;9.06;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;2.76;2.76;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;1.87;3.65;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2015;2015;ID;Idaho;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST3_1;NMBR;RACE;WHT;;;;
2015;2015;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;CRDRATE;RACE;API;;;;
2015;2015;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;NMBR;RACE;HIS;;;;
2015;2015;MT;Montana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2015;2015;OH;Ohio;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST3_1;NMBR;RACE;BLK;;;;
2015;2015;PR;Puerto Rico;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(18.220833, -66.590149);;72;AST;AST3_1;NMBR;RACE;API;;;;
2015;2015;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2015;2015;VA;Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2015;2015;VA;Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;42;42;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;NMBR;RACE;API;;;;
2015;2015;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;7.80;7.8;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;7.56;8.04;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;MO;Missouri;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;MN;Minnesota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;5.26;5.26;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;5.03;5.48;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;CT;Connecticut;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2015;2015;WY;Wyoming;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;GA;Georgia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;554;554;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;NMBR;GENDER;GENF;;;;
2015;2015;VA;Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;3.35;3.35;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;2.79;3.9;Race/Ethnicity;Asian or Pacific Islander;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2015;2015;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;9.71;9.71;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;9.29;10.12;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2015;2015;WY;Wyoming;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;3.59;3.59;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;2.7;4.47;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2015;2015;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1177;1,177;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;NMBR;RACE;HIS;;;;
2015;2015;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;12.22;12.22;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;11.86;12.58;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;14.32;14.32;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;13.86;14.78;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2015;2015;OK;Oklahoma;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST3_1;NMBR;RACE;BLK;;;;
2015;2015;TN;Tennessee;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST3_1;NMBR;RACE;BLK;;;;
2015;2015;PR;Puerto Rico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;6.26;6.26;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;6.02;6.51;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;11.06;11.06;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;10.84;11.29;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2015;2015;ND;North Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2015;2015;TX;Texas;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST3_1;NMBR;RACE;WHT;;;;
2015;2015;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;6.12;6.12;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;5.73;6.52;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2015;2015;DC;District of Columbia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;18.53;18.53;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;17.34;19.71;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;2123;2,123;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;NMBR;GENDER;GENF;;;;
2015;2015;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;4.96;4.96;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;3.72;6.19;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;CRDRATE;RACE;API;;;;
2015;2015;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;9.17;9.17;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;8.86;9.47;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2015;2015;PA;Pennsylvania;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;NMBR;RACE;WHT;;;;
2015;2015;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;24.67;24.67;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;23.1;26.24;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;8.85;8.85;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;8.07;9.63;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;5.70;5.7;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;5.32;6.08;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;IN;Indiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2015;2015;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;24.82;24.82;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;20.12;29.53;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;2825;2,825;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;NMBR;RACE;BLK;;;;
2015;2015;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;8.73;8.73;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;7.77;9.7;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;NH;New Hampshire;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;MT;Montana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;MO;Missouri;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2015;2015;IL;Illinois;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2015;2015;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;13.32;13.32;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;13.14;13.5;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;ND;North Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST3_1;NMBR;GENDER;GENF;;;;
2015;2015;TX;Texas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;DC;District of Columbia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;VA;Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2015;2015;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2015;2015;OH;Ohio;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2015;2015;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;5.65;5.65;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;5.15;6.14;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2015;2015;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;15.42;15.42;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;14.64;16.19;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;LA;Louisiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;IN;Indiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST3_1;CRDRATE;RACE;API;;;;
2015;2015;KS;Kansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;KS;Kansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2015;2015;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2015;2015;IL;Illinois;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2015;2015;ND;North Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2015;2015;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;3283;3,283;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2015;2015;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;9.70;9.7;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;9.18;10.21;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;6.22;6.22;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;5.75;6.69;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2015;2015;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;9.32;9.32;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;9.09;9.55;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;ND;North Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST3_1;NMBR;RACE;API;;;;
2015;2015;MN;Minnesota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;3.86;3.86;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;3.41;4.32;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;2.90;2.9;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;2.18;3.63;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2015;2015;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;5.55;5.55;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;4.59;6.51;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;8.69;8.69;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;7.17;10.21;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;CRDRATE;RACE;API;;;;
2015;2015;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;3.77;3.77;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;2.63;4.9;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2015;2015;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;287;287;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;NMBR;GENDER;GENM;;;;
2015;2015;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;17.38;17.38;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;15.71;19.05;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2015;2015;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;4.18;4.18;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;3.39;4.97;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2015;2015;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1573;1,573;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;NMBR;RACE;BLK;;;;
2015;2015;IN;Indiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;8.88;8.88;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;8.49;9.27;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;VI;Virgin Islands;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2015;2015;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;WY;Wyoming;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;4.18;4.18;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;3.8;4.55;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2015;2015;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1674;1,674;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;NMBR;GENDER;GENF;;;;
2015;2015;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;9.82;9.82;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;9.52;10.13;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;VA;Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST3_1;NMBR;RACE;BLK;;;;
2015;2015;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1606;1,606;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;NMBR;RACE;WHT;;;;
2015;2015;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;12.66;12.66;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;7.68;17.63;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;8.33;8.33;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;7.68;8.98;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;5.13;5.13;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;4.88;5.39;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;IN;Indiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2015;2015;VI;Virgin Islands;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2015;2015;LA;Louisiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2015;2015;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;5.61;5.61;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;5.4;5.82;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;6.91;6.91;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;6.56;7.26;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;TX;Texas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2015;2015;PR;Puerto Rico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2015;2015;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;8.94;8.94;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;8.63;9.25;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;6.22;6.22;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;5.96;6.47;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2015;2015;DC;District of Columbia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;34.74;34.74;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;32.39;37.09;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2015;2015;PA;Pennsylvania;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST3_1;NMBR;RACE;HIS;;;;
2015;2015;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2015;2015;LA;Louisiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;61;61;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;NMBR;RACE;API;;;;
2015;2015;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;759;759;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;NMBR;RACE;BLK;;;;
2015;2015;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;MN;Minnesota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;5.06;5.06;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;4.84;5.28;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;KS;Kansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;5.77;5.77;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;5.47;6.08;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;6.04;6.04;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;5.66;6.43;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2015;2015;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;3.15;3.15;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;2.64;3.66;Race/Ethnicity;Asian or Pacific Islander;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;CRDRATE;RACE;API;;;;
2015;2015;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;AL;Alabama;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2015;2015;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;110;110;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;NMBR;RACE;AIAN;;;;
2015;2015;AL;Alabama;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST3_1;NMBR;RACE;WHT;;;;
2015;2015;DE;Delaware;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2015;2015;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;6.97;6.97;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;4.7;9.24;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;ME;Maine;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;KS;Kansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST3_1;NMBR;GENDER;GENM;;;;
2015;2015;DC;District of Columbia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.907192, -77.036871);;11;AST;AST3_1;NMBR;RACE;AIAN;;;;
2015;2015;TN;Tennessee;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2015;2015;MN;Minnesota;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1282;1,282;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST3_1;NMBR;GENDER;GENF;;;;
2015;2015;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;3.30;3.3;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;2.8;3.79;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;CRDRATE;RACE;API;;;;
2015;2015;WY;Wyoming;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2015;2015;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;7.32;7.32;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;6.65;7.98;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;GA;Georgia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2015;2015;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;3.49;3.49;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;3.04;3.94;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2015;2015;GU;Guam;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(13.444304, 144.793731);;66;AST;AST3_1;NMBR;RACE;AIAN;;;;
2015;2015;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;6.64;6.64;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;4.44;8.84;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2015;2015;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;14.93;14.93;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;14.53;15.34;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;11.93;11.93;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;11.58;12.28;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2015;2015;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;3072;3,072;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;NMBR;RACE;WHT;;;;
2015;2015;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;944;944;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;NMBR;RACE;WHT;;;;
2015;2015;AK;Alaska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;20.20;20.2;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;18.77;21.64;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2015;2015;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2015;2015;DE;Delaware;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2015;2015;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;9.34;9.34;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;9.13;9.55;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;DE;Delaware;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;2.69;2.69;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;1.88;3.5;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;CRDRATE;RACE;API;;;;
2015;2015;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;NMBR;RACE;AIAN;;;;
2015;2015;NH;New Hampshire;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2015;2015;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;21.75;21.75;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;19.67;23.82;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;ID;Idaho;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2015;2015;NH;New Hampshire;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;KS;Kansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST3_1;NMBR;RACE;BLK;;;;
2015;2015;IL;Illinois;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;ND;North Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST3_1;NMBR;RACE;WHT;;;;
2015;2015;AL;Alabama;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1055;1,055;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;NMBR;GENDER;GENM;;;;
2015;2015;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;12.54;12.54;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;9.77;15.31;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;VI;Virgin Islands;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST3_1;NMBR;RACE;WHT;;;;
2015;2015;PA;Pennsylvania;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;27;27;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;NMBR;RACE;AIAN;;;;
2015;2015;WY;Wyoming;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;6.79;6.79;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;6.28;7.3;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;VI;Virgin Islands;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2015;2015;AL;Alabama;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2015;2015;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;5.86;5.86;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;4.64;7.09;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2015;2015;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;17.81;17.81;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;13.37;22.24;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2015;2015;OK;Oklahoma;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2015;2015;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2015;2015;ME;Maine;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST3_1;NMBR;GENDER;GENM;;;;
2015;2015;PR;Puerto Rico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2015;2015;ID;Idaho;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2015;2015;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1669;1,669;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;NMBR;GENDER;GENM;;;;
2015;2015;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;5.13;5.13;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;4.84;5.41;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2015;2015;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;NMBR;RACE;AIAN;;;;
2015;2015;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;NMBR;GENDER;GENF;;;;
2015;2015;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;7.35;7.35;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;6.86;7.84;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2015;2015;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;15.44;15.44;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;12.24;18.64;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;IN;Indiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;8.11;8.11;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;7.88;8.35;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2015;2015;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1433;1,433;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;NMBR;GENDER;GENF;;;;
2015;2015;CT;Connecticut;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2015;2015;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;8.52;8.52;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;7.88;9.16;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2015;2015;TN;Tennessee;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;PR;Puerto Rico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;6.84;6.84;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;6.21;7.47;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;8.83;8.83;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;8.44;9.22;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2015;2015;DC;District of Columbia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;15.85;15.85;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;14.11;17.59;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;WY;Wyoming;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST3_1;NMBR;RACE;WHT;;;;
2015;2015;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;159;159;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;NMBR;RACE;WHT;;;;
2015;2015;MO;Missouri;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2015;2015;GU;Guam;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST3_1;NMBR;RACE;BLK;;;;
2015;2015;NH;New Hampshire;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;AL;Alabama;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST3_1;NMBR;RACE;API;;;;
2015;2015;TN;Tennessee;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST3_1;NMBR;GENDER;GENF;;;;
2015;2015;GA;Georgia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;5.15;5.15;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;4.87;5.42;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;7.90;7.9;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;7.52;8.28;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;NMBR;RACE;BLK;;;;
2015;2015;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;5.46;5.46;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;5.16;5.75;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;4.26;4.26;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;3.65;4.86;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;8.71;8.71;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;8.15;9.27;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2015;2015;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;17.26;17.26;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;10.36;24.17;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2015;2015;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;20.62;20.62;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;19.84;21.39;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;DC;District of Columbia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;934;934;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2015;2015;IL;Illinois;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST3_1;NMBR;RACE;API;;;;
2015;2015;VI;Virgin Islands;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST3_1;NMBR;GENDER;GENF;;;;
2015;2015;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;3205;3,205;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2015;2015;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;11.12;11.12;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;8.26;13.98;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;6.56;6.56;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;6.25;6.88;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2015;2015;OH;Ohio;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;PA;Pennsylvania;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2015;2015;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;NMBR;RACE;API;;;;
2015;2015;IL;Illinois;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2015;2015;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;114;114;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;NMBR;RACE;API;;;;
2015;2015;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;12.73;12.73;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;12.19;13.27;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2015;2015;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;16.66;16.66;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;16.03;17.28;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2015;2015;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;5.18;5.18;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;4.74;5.61;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;11.30;11.3;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;10.53;12.07;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;20.04;20.04;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;10.78;29.3;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;OK;Oklahoma;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST3_1;NMBR;RACE;API;;;;
2015;2015;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;NMBR;RACE;HIS;;;;
2015;2015;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;8.64;8.64;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;8.3;8.98;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2015;2015;VI;Virgin Islands;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(18.335765, -64.896335);;78;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;MO;Missouri;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST3_1;NMBR;RACE;HIS;;;;
2015;2015;AK;Alaska;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST3_1;NMBR;GENDER;GENF;;;;
2015;2015;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2015;2015;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;4.79;4.79;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;4.5;5.07;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;TX;Texas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;3691;3,691;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;NMBR;RACE;WHT;;;;
2015;2015;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;7.04;7.04;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;6.68;7.41;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2015;2015;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;33;33;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;NMBR;RACE;AIAN;;;;
2015;2015;IN;Indiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST3_1;NMBR;GENDER;GENM;;;;
2015;2015;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2015;2015;OK;Oklahoma;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;NMBR;GENDER;GENM;;;;
2015;2015;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;11.95;11.95;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;11.19;12.72;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;MT;Montana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;LA;Louisiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;5929;5,929;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2015;2015;PA;Pennsylvania;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2015;2015;TN;Tennessee;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2015;2015;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;17.13;17.13;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;16.84;17.42;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2015;2015;CT;Connecticut;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2015;2015;IL;Illinois;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST3_1;NMBR;RACE;WHT;;;;
2015;2015;DE;Delaware;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST3_1;NMBR;RACE;API;;;;
2015;2015;MN;Minnesota;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST3_1;NMBR;RACE;BLK;;;;
2015;2015;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;5.89;5.89;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;5.6;6.18;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;TX;Texas;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST3_1;NMBR;RACE;API;;;;
2015;2015;ND;North Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;TX;Texas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2015;2015;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;10.87;10.87;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;10.06;11.67;Race/Ethnicity;Asian or Pacific Islander;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;CRDRATE;RACE;API;;;;
2015;2015;VA;Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST3_1;NMBR;RACE;HIS;;;;
2015;2015;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;278;278;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;NMBR;GENDER;GENF;;;;
2015;2015;IN;Indiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2015;2015;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;NMBR;RACE;API;;;;
2015;2015;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;144;144;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;NMBR;GENDER;GENF;;;;
2015;2015;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;5.96;5.96;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;5.12;6.8;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2015;2015;AK;Alaska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;ME;Maine;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2015;2015;WY;Wyoming;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2015;2015;TX;Texas;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST3_1;NMBR;GENDER;GENM;;;;
2015;2015;GA;Georgia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2015;2015;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;8.69;8.69;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;8.38;9;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;5165;5,165;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2015;2015;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;CRDRATE;RACE;API;;;;
2015;2015;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;5.92;5.92;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;5.59;6.24;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2015;2015;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2015;2015;DC;District of Columbia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.907192, -77.036871);;11;AST;AST3_1;CRDRATE;RACE;API;;;;
2015;2015;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;CRDRATE;RACE;API;;;;
2015;2015;OH;Ohio;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;8.69;8.69;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;8.39;9;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2015;2015;OK;Oklahoma;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;TN;Tennessee;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST3_1;NMBR;RACE;WHT;;;;
2015;2015;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;5.91;5.91;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;5.58;6.24;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;OH;Ohio;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2015;2015;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;6.05;6.05;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;5.74;6.36;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;IN;Indiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2015;2015;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;8.07;8.07;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;6.84;9.3;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;ID;Idaho;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST3_1;CRDRATE;RACE;API;;;;
2015;2015;ID;Idaho;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;VI;Virgin Islands;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;283;283;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;NMBR;RACE;HIS;;;;
2015;2015;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;NMBR;RACE;WHT;;;;
2015;2015;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2015;2015;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;24;24;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;NMBR;RACE;BLK;;;;
2015;2015;MT;Montana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2015;2015;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;616;616;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;NMBR;GENDER;GENM;;;;
2015;2015;MT;Montana;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST3_1;NMBR;GENDER;GENF;;;;
2015;2015;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;5.62;5.62;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;5.23;6;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;AL;Alabama;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;MT;Montana;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2015;2015;AL;Alabama;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2015;2015;AK;Alaska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2015;2015;TX;Texas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2015;2015;ID;Idaho;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;AL;Alabama;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;ME;Maine;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;3757;3,757;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;NMBR;GENDER;GENF;;;;
2015;2015;ND;North Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;IL;Illinois;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;NMBR;RACE;AIAN;;;;
2015;2015;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2015;2015;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;NMBR;RACE;HIS;;;;
2015;2015;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;MO;Missouri;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2015;2015;PR;Puerto Rico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(18.220833, -66.590149);;72;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;DE;Delaware;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;WY;Wyoming;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST3_1;NMBR;RACE;BLK;;;;
2015;2015;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;6.49;6.49;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;6.1;6.88;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2015;2015;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;18.7;18.7;;;13.2;25.6;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2015;2015;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;CRDRATE;RACE;API;;;;
2015;2015;OH;Ohio;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;6.85;6.85;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;6.26;7.44;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;CT;Connecticut;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST3_1;NMBR;GENDER;GENF;;;;
2015;2015;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;113;113;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;NMBR;RACE;HIS;;;;
2015;2015;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;AK;Alaska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST2_1;CRDRATE;RACE;API;;;;
2015;2015;GA;Georgia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2015;2015;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;2172;2,172;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;NMBR;GENDER;GENM;;;;
2015;2015;TN;Tennessee;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST2_1;NMBR;RACE;WHT;;;;
2015;2015;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;4134;4,134;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;NMBR;GENDER;GENF;;;;
2015;2015;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;156.03;156.03;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;150.59;161.48;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;NMBR;RACE;AIAN;;;;
2015;2015;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2015;2015;TN;Tennessee;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2015;2015;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;30.24;30.24;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;29.45;31.04;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;58.03;58.03;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;55.24;60.82;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2015;2015;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;40006;40,006;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2015;2015;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1061;1,061;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;NMBR;GENDER;GENM;;;;
2015;2015;AR;Arkansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;5159;5,159;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST2_1;NMBR;GENDER;GENF;;;;
2015;2015;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1011;1,011;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2015;2015;KS;Kansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;MT;Montana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;IN;Indiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;HI;Hawaii;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;6425;6,425;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2015;2015;AL;Alabama;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST2_1;NMBR;RACE;API;;;;
2015;2015;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;NMBR;RACE;AIAN;;;;
2015;2015;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;18.76;18.76;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;15.79;21.73;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2015;2015;ME;Maine;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST2_1;NMBR;RACE;HIS;;;;
2015;2015;TN;Tennessee;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;IL;Illinois;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2015;2015;MD;Maryland;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;135;135;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST2_1;NMBR;RACE;AIAN;;;;
2015;2015;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;NMBR;RACE;BLK;;;;
2015;2015;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;10735;10,735;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;NMBR;RACE;WHT;;;;
2015;2015;AL;Alabama;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;MS;Mississippi;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2015;2015;VI;Virgin Islands;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(18.335765, -64.896335);;78;AST;AST2_1;NMBR;RACE;AIAN;;;;
2015;2015;CA;California;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST2_1;NMBR;RACE;BLK;;;;
2015;2015;NH;New Hampshire;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;ID;Idaho;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2015;2015;IN;Indiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;11.27;11.27;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;11.05;11.5;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2015;2015;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;206.27;206.27;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;203.28;209.27;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;DE;Delaware;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST2_1;NMBR;GENDER;GENF;;;;
2015;2015;DC;District of Columbia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST2_1;NMBR;GENDER;GENM;;;;
2015;2015;VA;Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2015;2015;GU;Guam;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(13.444304, 144.793731);;66;AST;AST2_1;CRDRATE;RACE;API;;;;
2015;2015;MT;Montana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST2_1;NMBR;RACE;AIAN;;;;
2015;2015;WA;Washington;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST2_1;NMBR;GENDER;GENF;;;;
2015;2015;SD;South Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;8023;8,023;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;NMBR;RACE;HIS;;;;
2015;2015;RI;Rhode Island;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST2_1;NMBR;RACE;AIAN;;;;
2015;2015;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;21155;21,155;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;NMBR;GENDER;GENM;;;;
2015;2015;IL;Illinois;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST2_1;CRDRATE;RACE;API;;;;
2015;2015;MO;Missouri;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2015;2015;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;67;67;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;NMBR;RACE;API;;;;
2015;2015;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;WY;Wyoming;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2015;2015;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;21506;21,506;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;NMBR;RACE;BLK;;;;
2015;2015;AL;Alabama;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2015;2015;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;334;334;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;NMBR;GENDER;GENM;;;;
2015;2015;IN;Indiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2015;2015;CT;Connecticut;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2015;2015;AL;Alabama;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;39.34;39.34;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;37.54;41.13;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;6.22;6.22;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;5.96;6.48;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;OR;Oregon;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST2_1;NMBR;RACE;BLK;;;;
2015;2015;MD;Maryland;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;31152;31,152;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2015;2015;RI;Rhode Island;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;980;980;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST2_1;NMBR;RACE;HIS;;;;
2015;2015;NH;New Hampshire;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2015;2015;NM;New Mexico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2015;2015;WA;Washington;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;ND;North Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;192.12;192.12;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;182.77;201.46;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;WA;Washington;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2015;2015;SD;South Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2015;2015;MI;Michigan;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST2_1;NMBR;RACE;API;;;;
2015;2015;AR;Arkansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;9564;9,564;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2015;2015;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2015;2015;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;49.98;49.98;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;49.2;50.77;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;OK;Oklahoma;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST2_1;NMBR;RACE;AIAN;;;;
2015;2015;PR;Puerto Rico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(18.220833, -66.590149);;72;AST;AST2_1;NMBR;RACE;API;;;;
2015;2015;OK;Oklahoma;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2015;2015;MD;Maryland;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;368;368;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST2_1;NMBR;RACE;API;;;;
2015;2015;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;5.46;5.46;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;4.55;6.37;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;MA;Massachusetts;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;133.21;133.21;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;129.99;136.43;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;AK;Alaska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2015;2015;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2015;2015;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;139.81;139.81;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;135.08;144.55;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2015;2015;TX;Texas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;42.32;42.32;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;27.88;56.76;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2015;2015;OH;Ohio;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2015;2015;OH;Ohio;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST2_1;CRDRATE;RACE;API;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.7;10.7;;;9.6;12;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;TN;Tennessee;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2015;2015;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;165;165;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;NMBR;RACE;API;;;;
2015;2015;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;123.80;123.8;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;121.64;125.96;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2015;2015;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;43.83;43.83;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;42.79;44.88;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;46.43;46.43;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;43.51;49.35;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;TX;Texas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2015;2015;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;29.97;29.97;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;28.68;31.27;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;NM;New Mexico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST2_1;NMBR;RACE;API;;;;
2015;2015;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;34.35;34.35;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;32.95;35.76;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;OR;Oregon;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2015;2015;NM;New Mexico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;RI;Rhode Island;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;58.30;58.3;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;55.84;60.76;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;WY;Wyoming;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST3_1;NMBR;RACE;AIAN;;;;
2015;2015;TX;Texas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST2_1;NMBR;RACE;AIAN;;;;
2015;2015;WA;Washington;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2014;2014;PR;Puerto Rico;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST3_1;NMBR;GENDER;GENM;;;;
2015;2015;CA;California;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2015;2015;HI;Hawaii;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;3338;3,338;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST2_1;NMBR;GENDER;GENF;;;;
2015;2015;MN;Minnesota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2015;2015;OH;Ohio;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2015;2015;LA;Louisiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2015;2015;VA;Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;MN;Minnesota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;37.37;37.37;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;36.76;37.98;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;204;204;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;NMBR;RACE;AIAN;;;;
2015;2015;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;11522;11,522;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;NMBR;GENDER;GENF;;;;
2015;2015;NM;New Mexico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2015;2015;IL;Illinois;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;KS;Kansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2015;2015;KS;Kansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2015;2015;LA;Louisiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2015;2015;AR;Arkansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;112.55;112.55;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;109.06;116.04;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2015;2015;OH;Ohio;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST3_1;NMBR;GENDER;GENM;;;;
2015;2015;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;38.90;38.9;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;38.15;39.65;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;TN;Tennessee;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2015;2015;ID;Idaho;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;ND;North Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST2_1;NMBR;RACE;BLK;;;;
2015;2015;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;57.74;57.74;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;56.99;58.5;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2015;2015;OK;Oklahoma;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2015;2015;SD;South Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;LA;Louisiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2015;2015;RI;Rhode Island;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;40.30;40.3;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;38.53;42.07;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;IN;Indiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST3_1;NMBR;RACE;WHT;;;;
2015;2015;OH;Ohio;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST2_1;NMBR;GENDER;GENF;;;;
2015;2015;LA;Louisiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;VA;Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2015;2015;MD;Maryland;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;33.64;33.64;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;32.9;34.37;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2015;2015;IN;Indiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;TX;Texas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2015;2015;TN;Tennessee;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;NH;New Hampshire;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST2_1;NMBR;RACE;HIS;;;;
2015;2015;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;2374;2,374;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;NMBR;GENDER;GENF;;;;
2015;2015;PA;Pennsylvania;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST2_1;CRDRATE;RACE;API;;;;
2015;2015;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;50.98;50.98;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;49.86;52.09;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2015;2015;LA;Louisiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;DC;District of Columbia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;AL;Alabama;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;IL;Illinois;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;20.67;20.67;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;16.78;24.57;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;CRDRATE;RACE;API;;;;
2015;2015;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;5.49;5.49;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;5.17;5.81;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2015;2015;CT;Connecticut;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;8.74;8.74;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;8.44;9.04;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;MA;Massachusetts;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;17.58;17.58;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;16.07;19.09;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2015;2015;PA;Pennsylvania;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2015;2015;ID;Idaho;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;MD;Maryland;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;36.56;36.56;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;34.62;38.5;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;IN;Indiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;AR;Arkansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;30.25;30.25;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;29.36;31.14;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;MS;Mississippi;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST2_1;NMBR;RACE;BLK;;;;
2015;2015;KS;Kansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2015;2015;DE;Delaware;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2015;2015;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;1024;1,024;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;NMBR;RACE;AIAN;;;;
2015;2015;WV;West Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2015;2015;IL;Illinois;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST3_1;NMBR;RACE;HIS;;;;
2015;2015;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;56.71;56.71;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;55.25;58.17;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;TX;Texas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;MO;Missouri;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST2_1;NMBR;GENDER;GENF;;;;
2015;2015;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;7.48;7.48;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;4.67;10.3;Race/Ethnicity;American Indian or Alaska Native;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;3.31;3.31;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;2.7;3.92;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;CRDRATE;RACE;API;;;;
2015;2015;KS;Kansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST2_1;NMBR;GENDER;GENF;;;;
2015;2015;ND;North Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST2_1;CRDRATE;RACE;API;;;;
2015;2015;GA;Georgia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST2_1;NMBR;RACE;AIAN;;;;
2015;2015;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;16007;16,007;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2015;2015;GU;Guam;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST2_1;NMBR;RACE;HIS;;;;
2015;2015;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;129.45;129.45;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;127.72;131.18;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2015;2015;TN;Tennessee;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST3_1;NMBR;RACE;API;;;;
2015;2015;MI;Michigan;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST2_1;CRDRATE;RACE;API;;;;
2015;2015;MA;Massachusetts;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;129.45;129.45;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;125.81;133.09;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2015;2015;OR;Oregon;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2015;2015;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;136.21;136.21;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;108.77;163.65;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;7.95;7.95;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;7.5;8.4;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;20.65;20.65;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;19.15;22.14;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;7.39;7.39;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;6.26;8.52;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;CRDRATE;RACE;API;;;;
2015;2015;GA;Georgia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2015;2015;GU;Guam;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2015;2015;RI;Rhode Island;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;2311;2,311;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST2_1;NMBR;GENDER;GENF;;;;
2015;2015;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;25815;25,815;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;NMBR;GENDER;GENF;;;;
2015;2015;TX;Texas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;8726;8,726;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2015;2015;UT;Utah;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST2_1;NMBR;RACE;BLK;;;;
2015;2015;OR;Oregon;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;NH;New Hampshire;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2015;2015;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;6927;6,927;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;NMBR;GENDER;GENM;;;;
2015;2015;DC;District of Columbia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;GA;Georgia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST2_1;CRDRATE;RACE;API;;;;
2015;2015;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;10.94;10.94;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;8.2;13.69;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2015;2015;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;WY;Wyoming;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST3_1;NMBR;GENDER;GENF;;;;
2015;2015;UT;Utah;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;OK;Oklahoma;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;ID;Idaho;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;MN;Minnesota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;OK;Oklahoma;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST2_1;NMBR;RACE;BLK;;;;
2015;2015;NH;New Hampshire;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;9825;9,825;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;NMBR;RACE;WHT;;;;
2015;2015;LA;Louisiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST2_1;NMBR;RACE;WHT;;;;
2015;2015;OR;Oregon;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2015;2015;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;2099;2,099;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;NMBR;GENDER;GENM;;;;
2015;2015;CA;California;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST2_1;NMBR;RACE;WHT;;;;
2015;2015;NM;New Mexico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2015;2015;CO;Colorado;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;GA;Georgia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2015;2015;OK;Oklahoma;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST3_1;NMBR;GENDER;GENM;;;;
2015;2015;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;10577;10,577;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;NMBR;RACE;HIS;;;;
2015;2015;IN;Indiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2015;2015;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;31.64;31.64;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;30.21;33.08;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;CRDRATE;RACE;API;;;;
2015;2015;GA;Georgia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2015;2015;CO;Colorado;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;IN;Indiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST3_1;NMBR;RACE;AIAN;;;;
2015;2015;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;147;147;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;NMBR;RACE;API;;;;
2015;2015;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;130.37;130.37;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;128.61;132.13;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;CO;Colorado;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2015;2015;TX;Texas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST2_1;NMBR;RACE;BLK;;;;
2015;2015;MT;Montana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2015;2015;DE;Delaware;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;MA;Massachusetts;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;554;554;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST2_1;NMBR;RACE;API;;;;
2015;2015;ME;Maine;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2015;2015;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;12627;12,627;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;NMBR;RACE;BLK;;;;
2015;2015;RI;Rhode Island;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;111.54;111.54;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;102.15;120.94;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;3.95;3.95;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;3.31;4.6;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2015;2015;NH;New Hampshire;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;6.47;6.47;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;4.27;8.66;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;PR;Puerto Rico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;MI;Michigan;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;20250;20,250;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2015;2015;MN;Minnesota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;DC;District of Columbia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2015;2015;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2015;2015;WY;Wyoming;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;WY;Wyoming;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2015;2015;MN;Minnesota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST2_1;NMBR;RACE;API;;;;
2015;2015;RI;Rhode Island;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;568;568;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST2_1;NMBR;RACE;BLK;;;;
2015;2015;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2015;2015;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;540;540;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;NMBR;RACE;HIS;;;;
2015;2015;AL;Alabama;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;SD;South Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2015;2015;MD;Maryland;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;66.49;66.49;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;65.41;67.57;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2015;2015;PA;Pennsylvania;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST2_1;NMBR;RACE;BLK;;;;
2015;2015;HI;Hawaii;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;182;182;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST2_1;NMBR;RACE;BLK;;;;
2015;2015;AK;Alaska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2015;2015;MN;Minnesota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2015;2015;MO;Missouri;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST2_1;NMBR;RACE;HIS;;;;
2015;2015;CT;Connecticut;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;NMBR;RACE;BLK;;;;
2015;2015;AR;Arkansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;28.05;28.05;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;27.24;28.85;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2015;2015;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;AR;Arkansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;614;614;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST2_1;NMBR;RACE;HIS;;;;
2015;2015;WY;Wyoming;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2015;2015;MA;Massachusetts;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;7535;7,535;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST2_1;NMBR;RACE;HIS;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;30.3;30.3;;;19.1;44.4;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2015;2015;MT;Montana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST2_1;NMBR;GENDER;GENM;;;;
2015;2015;OK;Oklahoma;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;ND;North Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2015;2015;MS;Mississippi;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;NH;New Hampshire;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;NH;New Hampshire;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST3_1;CRDRATE;RACE;API;;;;
2015;2015;OH;Ohio;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2015;2015;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2015;2015;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;44.52;44.52;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;28.69;60.35;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;6.52;6.52;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;6.21;6.84;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;62.62;62.62;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;61.45;63.8;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;35.02;35.02;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;33.9;36.13;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;VA;Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;PA;Pennsylvania;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;33;33;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;NMBR;RACE;AIAN;;;;
2015;2015;IN;Indiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2015;2015;ID;Idaho;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST2_1;NMBR;RACE;WHT;;;;
2015;2015;GU;Guam;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(13.444304, 144.793731);;66;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2015;2015;OR;Oregon;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST2_1;NMBR;GENDER;GENM;;;;
2015;2015;CA;California;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST2_1;NMBR;RACE;API;;;;
2015;2015;TX;Texas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2015;2015;ID;Idaho;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST2_1;NMBR;GENDER;GENM;;;;
2015;2015;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;GA;Georgia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST2_1;NMBR;RACE;API;;;;
2015;2015;CA;California;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;ND;North Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST3_1;CRDRATE;RACE;API;;;;
2015;2015;NH;New Hampshire;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST3_1;NMBR;RACE;BLK;;;;
2015;2015;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;5787;5,787;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;NMBR;RACE;BLK;;;;
2015;2015;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2015;2015;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;NMBR;RACE;AIAN;;;;
2015;2015;ID;Idaho;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST2_1;NMBR;RACE;AIAN;;;;
2015;2015;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;50.90;50.9;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;49.85;51.94;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2015;2015;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;6.74;6.74;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;6.05;7.43;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2015;2015;DE;Delaware;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST2_1;NMBR;RACE;BLK;;;;
2015;2015;CA;California;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;NMBR;RACE;API;;;;
2015;2015;WV;West Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;55.03;55.03;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;54.49;55.58;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;GU;Guam;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;RI;Rhode Island;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;45.29;45.29;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;43.16;47.42;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2015;2015;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;79.86;79.86;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;78.29;81.44;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;NMBR;RACE;HIS;;;;
2015;2015;TN;Tennessee;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;NM;New Mexico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;GA;Georgia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST2_1;NMBR;GENDER;GENF;;;;
2015;2015;ND;North Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;NH;New Hampshire;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2015;2015;IL;Illinois;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST2_1;NMBR;RACE;HIS;;;;
2015;2015;WV;West Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;CO;Colorado;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;61.03;61.03;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;59.92;62.15;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2015;2015;GU;Guam;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2015;2015;DC;District of Columbia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST2_1;NMBR;RACE;WHT;;;;
2015;2015;VI;Virgin Islands;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2015;2015;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;37.24;37.24;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;36.46;38.03;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;NMBR;RACE;HIS;;;;
2015;2015;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;40.82;40.82;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;40;41.63;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;CO;Colorado;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2015;2015;OR;Oregon;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;MA;Massachusetts;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;38.04;38.04;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;37.42;38.66;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2015;2015;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;48.23;48.23;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;47.48;48.98;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;MT;Montana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST2_1;NMBR;RACE;HIS;;;;
2015;2015;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;4508;4,508;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;NMBR;RACE;WHT;;;;
2015;2015;HI;Hawaii;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;60.91;60.91;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;59.38;62.43;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;CA;California;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST2_1;NMBR;RACE;AIAN;;;;
2015;2015;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2015;2015;DE;Delaware;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;MN;Minnesota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST2_1;CRDRATE;RACE;API;;;;
2015;2015;PA;Pennsylvania;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST2_1;NMBR;RACE;AIAN;;;;
2015;2015;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;CRDRATE;RACE;API;;;;
2015;2015;AL;Alabama;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;PA;Pennsylvania;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2015;2015;OH;Ohio;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2015;2015;MO;Missouri;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;84;84;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;NMBR;RACE;BLK;;;;
2015;2015;NH;New Hampshire;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;WA;Washington;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST2_1;CRDRATE;RACE;API;;;;
2015;2015;UT;Utah;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2015;2015;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;56.07;56.07;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;55.53;56.61;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2015;2015;MI;Michigan;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST2_1;NMBR;RACE;BLK;;;;
2015;2015;MA;Massachusetts;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;28735;28,735;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2015;2015;HI;Hawaii;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;1130;1,130;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST2_1;NMBR;RACE;WHT;;;;
2015;2015;LA;Louisiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2015;2015;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;784;784;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;NMBR;GENDER;GENM;;;;
2015;2015;RI;Rhode Island;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;37.64;37.64;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;36.08;39.2;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2015;2015;AL;Alabama;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2015;2015;PR;Puerto Rico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2015;2015;VI;Virgin Islands;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2015;2015;PA;Pennsylvania;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2015;2015;IL;Illinois;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;AK;Alaska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST2_1;NMBR;RACE;HIS;;;;
2015;2015;MN;Minnesota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2015;2015;OR;Oregon;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2015;2015;IN;Indiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST2_1;NMBR;RACE;WHT;;;;
2015;2015;KS;Kansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;WV;West Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST2_1;NMBR;RACE;WHT;;;;
2015;2015;WV;West Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;IL;Illinois;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2015;2015;VA;Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2015;2015;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;NMBR;RACE;WHT;;;;
2015;2015;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;4.62;4.62;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;3.99;5.26;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2015;2015;DC;District of Columbia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;DC;District of Columbia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.907192, -77.036871);;11;AST;AST2_1;NMBR;RACE;API;;;;
2015;2015;DE;Delaware;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST3_1;NMBR;RACE;AIAN;;;;
2015;2015;MN;Minnesota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;37.19;37.19;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;36.36;38.02;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2015;2015;LA;Louisiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;55.06;55.06;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;53.66;56.46;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2015;2015;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;47.84;47.84;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;46.54;49.14;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2015;2015;SD;South Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST2_1;NMBR;RACE;BLK;;;;
2015;2015;NM;New Mexico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2015;2015;MT;Montana;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST3_1;NMBR;GENDER;GENM;;;;
2015;2015;AK;Alaska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2015;2015;CA;California;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;PA;Pennsylvania;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;17699;17,699;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;NMBR;GENDER;GENM;;;;
2015;2015;AL;Alabama;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2015;2015;ND;North Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST2_1;NMBR;GENDER;GENM;;;;
2015;2015;MA;Massachusetts;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;14437;14,437;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST2_1;NMBR;RACE;WHT;;;;
2015;2015;MO;Missouri;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST2_1;NMBR;RACE;AIAN;;;;
2015;2015;MD;Maryland;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;8035;8,035;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST2_1;NMBR;RACE;WHT;;;;
2015;2015;GU;Guam;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2015;2015;ND;North Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;NMBR;GENDER;GENF;;;;
2015;2015;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;3181;3,181;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;NMBR;GENDER;GENM;;;;
2015;2015;WY;Wyoming;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2015;2015;KS;Kansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST2_1;NMBR;RACE;WHT;;;;
2015;2015;SD;South Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;MI;Michigan;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.9;8.9;;;7.9;10.1;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2015;2015;PA;Pennsylvania;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2015;2015;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;9081;9,081;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;NMBR;GENDER;GENM;;;;
2015;2015;VA;Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2015;2015;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;MA;Massachusetts;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;59.17;59.17;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;58.47;59.87;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;CO;Colorado;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST2_1;NMBR;GENDER;GENM;;;;
2015;2015;VI;Virgin Islands;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;IN;Indiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2015;2015;WA;Washington;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2015;2015;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;11153;11,153;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2015;2015;CT;Connecticut;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST2_1;NMBR;RACE;WHT;;;;
2015;2015;DE;Delaware;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2015;2015;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;27.45;27.45;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;26.91;28;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2015;2015;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;935;935;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;NMBR;GENDER;GENF;;;;
2015;2015;MO;Missouri;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;CT;Connecticut;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;IN;Indiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;6.51;6.51;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;6.06;6.96;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;TN;Tennessee;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2015;2015;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;7.23;7.23;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;6.5;7.95;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;LA;Louisiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;MS;Mississippi;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;MS;Mississippi;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2015;2015;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;3.83;3.83;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;3.24;4.41;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2015;2015;SD;South Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST2_1;NMBR;GENDER;GENF;;;;
2015;2015;VI;Virgin Islands;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(18.335765, -64.896335);;78;AST;AST3_1;CRDRATE;RACE;API;;;;
2015;2015;MA;Massachusetts;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;4.84;4.84;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;4.21;5.47;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;GU;Guam;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(13.444304, 144.793731);;66;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;MN;Minnesota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;35.96;35.96;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;35.38;36.54;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;ID;Idaho;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST2_1;NMBR;RACE;API;;;;
2015;2015;AR;Arkansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;20;20;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST2_1;NMBR;RACE;AIAN;;;;
2015;2015;TX;Texas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST2_1;CRDRATE;RACE;API;;;;
2015;2015;CT;Connecticut;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2015;2015;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;NMBR;RACE;API;;;;
2015;2015;OK;Oklahoma;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST2_1;NMBR;GENDER;GENF;;;;
2015;2015;MI;Michigan;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST2_1;NMBR;GENDER;GENF;;;;
2015;2015;MO;Missouri;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2015;2015;MD;Maryland;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;73.31;73.31;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;72.18;74.45;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;PR;Puerto Rico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2015;2015;ID;Idaho;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST2_1;CRDRATE;RACE;API;;;;
2015;2015;PR;Puerto Rico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(18.220833, -66.590149);;72;AST;AST3_1;CRDRATE;RACE;API;;;;
2015;2015;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;NMBR;GENDER;GENF;;;;
2015;2015;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;34.55;34.55;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;33.08;36.03;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2015;2015;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2015;2015;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;14.79;14.79;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;14.4;15.17;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;AR;Arkansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;4647;4,647;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST2_1;NMBR;RACE;WHT;;;;
2015;2015;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;IL;Illinois;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2015;2015;AR;Arkansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;42.82;42.82;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;41.96;43.68;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;GU;Guam;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2015;2015;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;80.03;80.03;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;78.5;81.55;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2015;2015;MT;Montana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;TN;Tennessee;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2015;2015;TX;Texas;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST3_1;NMBR;RACE;BLK;;;;
2015;2015;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2015;2015;AK;Alaska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2015;2015;GA;Georgia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;GA;Georgia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2015;2015;AL;Alabama;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;IL;Illinois;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2015;2015;WY;Wyoming;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;GU;Guam;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST2_1;NMBR;GENDER;GENF;;;;
2015;2015;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;NMBR;GENDER;GENF;;;;
2015;2015;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;10554;10,554;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;NMBR;GENDER;GENF;;;;
2015;2015;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;9.57;9.57;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;9.36;9.79;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;RI;Rhode Island;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;2234;2,234;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST2_1;NMBR;RACE;WHT;;;;
2015;2015;KS;Kansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;41641;41,641;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;NMBR;GENDER;GENM;;;;
2015;2015;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2015;2015;VI;Virgin Islands;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(18.335765, -64.896335);;78;AST;AST2_1;NMBR;RACE;API;;;;
2015;2015;ID;Idaho;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2015;2015;OH;Ohio;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST2_1;NMBR;RACE;WHT;;;;
2015;2015;PA;Pennsylvania;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST3_1;CRDRATE;RACE;API;;;;
2015;2015;AL;Alabama;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST2_1;NMBR;GENDER;GENF;;;;
2015;2015;GA;Georgia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST2_1;NMBR;RACE;WHT;;;;
2015;2015;PA;Pennsylvania;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;MS;Mississippi;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST2_1;NMBR;RACE;AIAN;;;;
2015;2015;MD;Maryland;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;14517;14,517;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST2_1;NMBR;GENDER;GENM;;;;
2015;2015;MA;Massachusetts;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;15765;15,765;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST2_1;NMBR;GENDER;GENF;;;;
2015;2015;WV;West Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST2_1;NMBR;RACE;AIAN;;;;
2015;2015;WY;Wyoming;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST2_1;NMBR;RACE;BLK;;;;
2015;2015;WV;West Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST2_1;NMBR;RACE;HIS;;;;
2015;2015;SD;South Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2015;2015;MO;Missouri;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;VI;Virgin Islands;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;74.42;74.42;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;66.06;82.77;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;TX;Texas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST2_1;NMBR;GENDER;GENF;;;;
2015;2015;WY;Wyoming;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;18.59;18.59;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;16.72;20.47;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;CRDRATE;RACE;API;;;;
2015;2015;MO;Missouri;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2015;2015;IL;Illinois;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;NMBR;RACE;API;;;;
2015;2015;WV;West Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2015;2015;MN;Minnesota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;34.72;34.72;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;33.91;35.52;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2015;2015;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;6.83;6.83;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;6.35;7.32;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2015;2015;MI;Michigan;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2015;2015;MT;Montana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2015;2015;ME;Maine;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2015;2015;ID;Idaho;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST2_1;NMBR;RACE;HIS;;;;
2015;2015;WY;Wyoming;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2015;2015;GA;Georgia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;3215;3,215;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;NMBR;RACE;BLK;;;;
2015;2015;ID;Idaho;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2015;2015;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;50.02;50.02;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;49.28;50.76;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;22307;22,307;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;NMBR;GENDER;GENF;;;;
2015;2015;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;24.17;24.17;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;23.54;24.81;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.3;42.3;;;34.6;50.5;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2015;2015;OH;Ohio;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST2_1;NMBR;RACE;AIAN;;;;
2015;2015;TX;Texas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST3_1;CRDRATE;RACE;API;;;;
2015;2015;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;471;471;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2015;2015;OK;Oklahoma;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2015;2015;IN;Indiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST2_1;NMBR;RACE;HIS;;;;
2015;2015;VA;Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;WY;Wyoming;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2015;2015;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;1699;1,699;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;NMBR;RACE;WHT;;;;
2015;2015;DC;District of Columbia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.907192, -77.036871);;11;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;GU;Guam;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(13.444304, 144.793731);;66;AST;AST2_1;NMBR;RACE;AIAN;;;;
2015;2015;PR;Puerto Rico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2015;2015;AL;Alabama;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST2_1;NMBR;RACE;AIAN;;;;
2012;2012;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.0;67;;;60.3;73.1;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;20603;20,603;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2015;2015;PA;Pennsylvania;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;MN;Minnesota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;38.47;38.47;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;37.6;39.35;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;MA;Massachusetts;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST2_1;NMBR;RACE;AIAN;;;;
2015;2015;PR;Puerto Rico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;UT;Utah;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;MI;Michigan;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST2_1;NMBR;RACE;WHT;;;;
2015;2015;MI;Michigan;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2015;2015;WY;Wyoming;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST2_1;NMBR;RACE;HIS;;;;
2015;2015;TX;Texas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;4.12;4.12;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;3.8;4.45;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2015;2015;UT;Utah;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;GA;Georgia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST2_1;NMBR;RACE;HIS;;;;
2015;2015;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;13.33;13.33;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;12.39;14.27;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2015;2015;OR;Oregon;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;7.10;7.1;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;6.75;7.45;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;AL;Alabama;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2015;2015;KS;Kansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;MT;Montana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;VA;Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST2_1;NMBR;RACE;BLK;;;;
2015;2015;LA;Louisiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2015;2015;DC;District of Columbia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2015;2015;AK;Alaska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;29.61;29.61;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;28.34;30.88;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2015;2015;MA;Massachusetts;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;4863;4,863;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST2_1;NMBR;RACE;BLK;;;;
2015;2015;LA;Louisiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;DC;District of Columbia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;2.60;2.6;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;1.69;3.51;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;ME;Maine;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;MO;Missouri;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2015;2015;CT;Connecticut;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;DE;Delaware;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2015;2015;MO;Missouri;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2015;2015;DC;District of Columbia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;IL;Illinois;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2015;2015;MD;Maryland;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;145.96;145.96;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;143.94;147.99;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2015;2015;DE;Delaware;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2015;2015;AL;Alabama;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;NM;New Mexico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST2_1;NMBR;GENDER;GENM;;;;
2015;2015;MO;Missouri;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST2_1;NMBR;RACE;WHT;;;;
2015;2015;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;619;619;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;NMBR;RACE;HIS;;;;
2015;2015;OH;Ohio;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;PA;Pennsylvania;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST2_1;NMBR;RACE;WHT;;;;
2015;2015;OK;Oklahoma;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.7;40.7;;;34.1;47.8;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2015;2015;PR;Puerto Rico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2015;2015;MN;Minnesota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;OH;Ohio;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;DC;District of Columbia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST3_1;NMBR;RACE;HIS;;;;
2015;2015;MS;Mississippi;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;WV;West Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2015;2015;GU;Guam;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(13.444304, 144.793731);;66;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2015;2015;OK;Oklahoma;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2015;2015;KS;Kansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2015;2015;ID;Idaho;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2015;2015;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;44.64;44.64;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;41.95;47.32;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2015;2015;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;11051;11,051;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;NMBR;GENDER;GENM;;;;
2015;2015;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;9.66;9.66;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;9.32;9.99;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;WA;Washington;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;GA;Georgia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST2_1;NMBR;RACE;BLK;;;;
2015;2015;OH;Ohio;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST2_1;NMBR;RACE;BLK;;;;
2015;2015;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;574;574;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;NMBR;GENDER;GENM;;;;
2015;2015;AK;Alaska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2015;2015;TN;Tennessee;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2015;2015;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;75.06;75.06;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;74.14;75.97;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2015;2015;DE;Delaware;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2015;2015;ND;North Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;OK;Oklahoma;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;49.99;49.99;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;49.01;50.97;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;CO;Colorado;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST2_1;NMBR;RACE;BLK;;;;
2015;2015;AK;Alaska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST2_1;NMBR;RACE;BLK;;;;
2015;2015;GU;Guam;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;PR;Puerto Rico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2015;2015;GU;Guam;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2015;2015;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;46.09;46.09;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;43.2;48.97;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;SD;South Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2015;2015;OH;Ohio;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2015;2015;AK;Alaska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;ME;Maine;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;GU;Guam;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;431;431;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;NMBR;RACE;AIAN;;;;
2015;2015;PR;Puerto Rico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(18.220833, -66.590149);;72;AST;AST2_1;CRDRATE;RACE;API;;;;
2015;2015;AL;Alabama;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST3_1;NMBR;RACE;HIS;;;;
2015;2015;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;12.34;12.34;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;12.17;12.52;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;MS;Mississippi;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST2_1;NMBR;RACE;WHT;;;;
2015;2015;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1551;1,551;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2015;2015;ND;North Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2015;2015;MT;Montana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;28.38;28.38;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;27.65;29.1;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2015;2015;ME;Maine;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2015;2015;SD;South Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;ID;Idaho;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;30;30;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;NMBR;RACE;AIAN;;;;
2015;2015;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;NMBR;RACE;AIAN;;;;
2015;2015;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;3.24;3.24;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;2.37;4.1;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2015;2015;AR;Arkansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;40.15;40.15;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;38.96;41.34;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2015;2015;UT;Utah;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST2_1;NMBR;RACE;HIS;;;;
2015;2015;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;17.74;17.74;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;15.9;19.58;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2015;2015;AR;Arkansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;47.49;47.49;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;46.17;48.8;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;MA;Massachusetts;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;40.14;40.14;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;39.45;40.82;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;TN;Tennessee;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;MI;Michigan;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;DC;District of Columbia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.907192, -77.036871);;11;AST;AST2_1;NMBR;RACE;AIAN;;;;
2015;2015;LA;Louisiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2015;2015;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2015;2015;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;NH;New Hampshire;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;GA;Georgia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;MO;Missouri;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2015;2015;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;CRDRATE;RACE;API;;;;
2015;2015;KS;Kansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;SD;South Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2015;2015;AR;Arkansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;108.48;108.48;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;105.07;111.9;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;WA;Washington;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST2_1;NMBR;RACE;API;;;;
2015;2015;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;12.61;12.61;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;11.44;13.77;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2015;2015;IN;Indiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2015;2015;MO;Missouri;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;NMBR;RACE;HIS;;;;
2014;2014;KS;Kansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2015;2015;RI;Rhode Island;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;16.71;16.71;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;12.03;21.39;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST2_1;CRDRATE;RACE;API;;;;
2015;2015;MN;Minnesota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST2_1;NMBR;RACE;BLK;;;;
2015;2015;MS;Mississippi;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2015;2015;ND;North Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2015;2015;ME;Maine;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;198;198;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;NMBR;RACE;API;;;;
2015;2015;AR;Arkansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;51;51;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST2_1;NMBR;RACE;API;;;;
2015;2015;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;935;935;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2015;2015;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;69.91;69.91;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;69.28;70.54;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;PR;Puerto Rico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(18.220833, -66.590149);;72;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2015;2015;WV;West Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;VA;Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST2_1;NMBR;GENDER;GENF;;;;
2015;2015;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;123.53;123.53;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;121.35;125.72;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;MT;Montana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST2_1;NMBR;RACE;WHT;;;;
2015;2015;IL;Illinois;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2015;2015;WY;Wyoming;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST2_1;CRDRATE;RACE;API;;;;
2015;2015;WV;West Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST2_1;NMBR;RACE;BLK;;;;
2015;2015;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;41.16;41.16;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;39.12;43.2;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;IN;Indiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2015;2015;SD;South Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST2_1;NMBR;GENDER;GENM;;;;
2015;2015;OH;Ohio;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;MT;Montana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2015;2015;NH;New Hampshire;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST2_1;NMBR;GENDER;GENF;;;;
2015;2015;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2015;2015;CO;Colorado;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;ID;Idaho;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;21.88;21.88;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;20.13;23.64;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;2948;2,948;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;NMBR;RACE;BLK;;;;
2015;2015;CT;Connecticut;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST2_1;NMBR;RACE;HIS;;;;
2015;2015;TX;Texas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;KS;Kansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2015;2015;NH;New Hampshire;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2015;2015;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;2.69;2.69;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;2.09;3.28;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;MN;Minnesota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;14805;14,805;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2015;2015;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;14.69;14.69;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;13.53;15.85;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;5948;5,948;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;NMBR;GENDER;GENF;;;;
2015;2015;AR;Arkansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;38.26;38.26;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;35.24;41.29;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2015;2015;ID;Idaho;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST3_1;NMBR;RACE;BLK;;;;
2015;2015;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;30.95;30.95;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;30.42;31.47;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;34.26;34.26;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;32.59;35.94;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;TX;Texas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;SD;South Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2015;2015;TN;Tennessee;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2015;2015;MD;Maryland;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;71.57;71.57;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;70.76;72.37;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;PR;Puerto Rico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(18.220833, -66.590149);;72;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2015;2015;OR;Oregon;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2015;2015;MI;Michigan;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2015;2015;KS;Kansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST2_1;NMBR;RACE;BLK;;;;
2015;2015;MT;Montana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2015;2015;PR;Puerto Rico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2015;2015;TN;Tennessee;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;50.15;50.15;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;48.78;51.53;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;ND;North Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST3_1;NMBR;RACE;BLK;;;;
2015;2015;TX;Texas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;44.41;44.41;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;43.05;45.76;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;SD;South Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;AR;Arkansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;10.65;10.65;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;5.98;15.32;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2015;2015;GA;Georgia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;KS;Kansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;94;94;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;NMBR;RACE;API;;;;
2015;2015;DC;District of Columbia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;LA;Louisiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST2_1;NMBR;GENDER;GENF;;;;
2015;2015;AK;Alaska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;HI;Hawaii;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;63.46;63.46;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;61.24;65.67;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;39.29;39.29;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;38.46;40.13;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;MD;Maryland;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;100.35;100.35;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;83.42;117.27;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2015;2015;CA;California;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;OH;Ohio;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;HI;Hawaii;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;68.47;68.47;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;39.86;97.08;Race/Ethnicity;American Indian or Alaska Native;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2015;2015;WA;Washington;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2015;2015;WV;West Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST2_1;NMBR;GENDER;GENF;;;;
2015;2015;IN;Indiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;OK;Oklahoma;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;MO;Missouri;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2015;2015;WV;West Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2015;2015;CT;Connecticut;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;DE;Delaware;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2015;2015;NM;New Mexico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST2_1;NMBR;RACE;AIAN;;;;
2015;2015;PA;Pennsylvania;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2015;2015;MN;Minnesota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;7108;7,108;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST2_1;NMBR;GENDER;GENM;;;;
2015;2015;IL;Illinois;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2015;2015;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;2108;2,108;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;NMBR;RACE;HIS;;;;
2015;2015;PA;Pennsylvania;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2015;2015;IN;Indiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST2_1;NMBR;RACE;AIAN;;;;
2015;2015;WY;Wyoming;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;13865;13,865;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;NMBR;RACE;WHT;;;;
2015;2015;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;60;60;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;NMBR;RACE;HIS;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.4;7.4;;;5;11;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;MN;Minnesota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2015;2015;UT;Utah;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST2_1;CRDRATE;RACE;API;;;;
2015;2015;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;7154;7,154;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;NMBR;RACE;WHT;;;;
2015;2015;ME;Maine;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST2_1;NMBR;RACE;AIAN;;;;
2015;2015;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;NMBR;RACE;WHT;;;;
2015;2015;ME;Maine;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2015;2015;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;160.44;160.44;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;154.9;165.99;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2015;2015;IN;Indiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;DC;District of Columbia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2015;2015;DE;Delaware;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST2_1;NMBR;RACE;HIS;;;;
2015;2015;IL;Illinois;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST3_1;NMBR;GENDER;GENM;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2015;2015;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;12.37;12.37;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;12.01;12.73;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;CO;Colorado;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;ID;Idaho;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;6.43;6.43;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;5.94;6.92;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;48.24;48.24;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;47.53;48.95;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2015;2015;CT;Connecticut;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2015;2015;WV;West Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2015;2015;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;33.26;33.26;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;32.22;34.31;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2015;2015;PA;Pennsylvania;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;AR;Arkansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;41.55;41.55;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;40.32;42.79;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;ID;Idaho;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;WV;West Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;IL;Illinois;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;33.28;33.28;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;31.94;34.62;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2015;2015;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;203.35;203.35;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;194.15;212.54;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2015;2015;VA;Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST3_1;NMBR;GENDER;GENF;;;;
2015;2015;UT;Utah;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2015;2015;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;42.42;42.42;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;41.52;43.32;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;56.11;56.11;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;55.34;56.87;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;5817;5,817;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;NMBR;RACE;WHT;;;;
2015;2015;RI;Rhode Island;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;110.48;110.48;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;101.39;119.56;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2015;2015;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;10693;10,693;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;NMBR;RACE;WHT;;;;
2015;2015;NH;New Hampshire;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2015;2015;GA;Georgia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;DC;District of Columbia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2015;2015;MS;Mississippi;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2015;2015;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;115.18;115.18;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;90.55;139.81;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2015;2015;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;32;32;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;NMBR;RACE;API;;;;
2015;2015;MI;Michigan;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;40.28;40.28;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;39.44;41.13;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2015;2015;CA;California;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2015;2015;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;46.30;46.3;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;45.64;46.97;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;NH;New Hampshire;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST2_1;NMBR;RACE;WHT;;;;
2015;2015;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;5.63;5.63;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;5.38;5.88;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2015;2015;CT;Connecticut;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2015;2015;ID;Idaho;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;51.44;51.44;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;50.49;52.4;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;3.87;3.87;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;3.21;4.54;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;856;856;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;NMBR;RACE;WHT;;;;
2015;2015;MS;Mississippi;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;WA;Washington;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2015;2015;UT;Utah;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;GA;Georgia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST2_1;NMBR;GENDER;GENM;;;;
2015;2015;GU;Guam;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2015;2015;NM;New Mexico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2015;2015;OH;Ohio;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2015;2015;MT;Montana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2015;2015;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;26;26;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;NMBR;RACE;AIAN;;;;
2015;2015;MI;Michigan;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST2_1;NMBR;RACE;AIAN;;;;
2015;2015;MS;Mississippi;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;ND;North Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;4.95;4.95;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;4.69;5.2;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;DE;Delaware;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST2_1;NMBR;RACE;API;;;;
2015;2015;ID;Idaho;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2015;2015;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;29.78;29.78;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;26.86;32.71;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2015;2015;HI;Hawaii;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;41.51;41.51;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;38.97;44.04;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;HI;Hawaii;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;22;22;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST2_1;NMBR;RACE;AIAN;;;;
2015;2015;ID;Idaho;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST2_1;NMBR;RACE;BLK;;;;
2015;2015;OK;Oklahoma;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST3_1;NMBR;RACE;HIS;;;;
2015;2015;PR;Puerto Rico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2015;2015;GA;Georgia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2015;2015;HI;Hawaii;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;359;359;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST2_1;NMBR;RACE;HIS;;;;
2015;2015;OR;Oregon;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;CA;California;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2015;2015;CT;Connecticut;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;CA;California;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;4473;4,473;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2015;2015;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;2.94;2.94;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;2.4;3.49;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2015;2015;WA;Washington;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2015;2015;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;51.05;51.05;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;50.15;51.95;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;OR;Oregon;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST2_1;NMBR;RACE;HIS;;;;
2015;2015;ND;North Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;CT;Connecticut;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;4311;4,311;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;NMBR;RACE;BLK;;;;
2015;2015;MD;Maryland;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;11.94;11.94;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;10.72;13.16;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST2_1;CRDRATE;RACE;API;;;;
2015;2015;MA;Massachusetts;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;16.09;16.09;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;14.75;17.43;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST2_1;CRDRATE;RACE;API;;;;
2015;2015;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;20.69;20.69;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;19.93;21.46;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2015;2015;AL;Alabama;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;WA;Washington;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2015;2015;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;21.06;21.06;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;16.8;25.31;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2015;2015;DE;Delaware;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;CT;Connecticut;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;50.2;50.2;;;34.5;65.9;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2015;2015;OK;Oklahoma;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;HI;Hawaii;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;56.01;56.01;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;47.87;64.14;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2015;2015;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2015;2015;AR;Arkansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;44.74;44.74;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;43.83;45.65;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;OH;Ohio;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST2_1;NMBR;GENDER;GENM;;;;
2015;2015;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;28.46;28.46;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;27.88;29.05;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;RI;Rhode Island;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;18.29;18.29;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;12.74;23.83;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2015;2015;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;NMBR;GENDER;GENM;;;;
2015;2015;GU;Guam;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST2_1;NMBR;RACE;WHT;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67.2;67.2;;;60.2;73.4;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;GU;Guam;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;NM;New Mexico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;VA;Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;VA;Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2015;2015;VI;Virgin Islands;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST2_1;NMBR;RACE;WHT;;;;
2015;2015;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;4854;4,854;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;NMBR;GENDER;GENF;;;;
2015;2015;MI;Michigan;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2015;2015;SD;South Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2015;2015;TN;Tennessee;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST2_1;CRDRATE;RACE;API;;;;
2015;2015;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1160;1,160;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;NMBR;GENDER;GENM;;;;
2015;2015;TX;Texas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST2_1;NMBR;GENDER;GENM;;;;
2015;2015;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;23.58;23.58;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;15.77;31.39;Race/Ethnicity;American Indian or Alaska Native;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2015;2015;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;34.94;34.94;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;33.83;36.05;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2015;2015;AL;Alabama;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2015;2015;MN;Minnesota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;36.07;36.07;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;35.23;36.92;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;VI;Virgin Islands;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(18.335765, -64.896335);;78;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;2488;2,488;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;NMBR;RACE;HIS;;;;
2015;2015;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;31.77;31.77;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;31.01;32.53;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;36.26;36.26;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;35.66;36.86;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2015;2015;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;42.03;42.03;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;40.04;44.02;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2015;2015;MN;Minnesota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2015;2015;MN;Minnesota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;4.31;4.31;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;4.02;4.59;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2015;2015;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.2;11.2;;;10.1;12.5;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2015;2015;ND;North Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST3_1;NMBR;RACE;HIS;;;;
2015;2015;CO;Colorado;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2015;2015;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;6.76;6.76;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;4.34;9.17;Race/Ethnicity;American Indian or Alaska Native;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2015;2015;HI;Hawaii;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;81.15;81.15;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;44.91;117.4;Race/Ethnicity;American Indian or Alaska Native;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;VI;Virgin Islands;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(18.335765, -64.896335);;78;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2015;2015;AL;Alabama;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST2_1;NMBR;RACE;WHT;;;;
2015;2015;MD;Maryland;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;19925;19,925;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST2_1;NMBR;RACE;BLK;;;;
2015;2015;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;155;155;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;NMBR;RACE;BLK;;;;
2015;2015;HI;Hawaii;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;58.56;58.56;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;56.46;60.65;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;RI;Rhode Island;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2015;2015;AK;Alaska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;TX;Texas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;SD;South Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST2_1;NMBR;RACE;HIS;;;;
2015;2015;ME;Maine;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;DE;Delaware;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2015;2015;UT;Utah;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2015;2015;NH;New Hampshire;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2015;2015;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;38.74;38.74;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;38.06;39.41;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;OH;Ohio;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2015;2015;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;3354;3,354;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;NMBR;RACE;BLK;;;;
2015;2015;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;12.08;12.08;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;11.73;12.44;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2015;2015;ME;Maine;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2015;2015;AK;Alaska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2015;2015;VA;Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2015;2015;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;58.02;58.02;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;54.77;61.27;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;IL;Illinois;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2015;2015;UT;Utah;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2015;2015;IL;Illinois;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;DC;District of Columbia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2015;2015;WA;Washington;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;OH;Ohio;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;NH;New Hampshire;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST2_1;NMBR;GENDER;GENM;;;;
2015;2015;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;20.44;20.44;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;18.32;22.56;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2015;2015;VA;Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST2_1;NMBR;RACE;WHT;;;;
2015;2015;WV;West Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2015;2015;CO;Colorado;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2015;2015;LA;Louisiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;TN;Tennessee;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST2_1;NMBR;RACE;BLK;;;;
2015;2015;CA;California;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2015;2015;VA;Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;KS;Kansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2015;2015;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;95.05;95.05;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;82.01;108.09;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2015;2015;TX;Texas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST2_1;NMBR;RACE;WHT;;;;
2015;2015;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;3.93;3.93;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;3.46;4.4;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2015;2015;NH;New Hampshire;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2015;2015;MT;Montana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST2_1;NMBR;GENDER;GENF;;;;
2015;2015;OK;Oklahoma;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2015;2015;PR;Puerto Rico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2015;2015;KS;Kansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;NH;New Hampshire;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST2_1;NMBR;RACE;API;;;;
2015;2015;IL;Illinois;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST2_1;NMBR;RACE;AIAN;;;;
2015;2015;TX;Texas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2015;2015;VI;Virgin Islands;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2015;2015;OR;Oregon;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST2_1;NMBR;GENDER;GENF;;;;
2015;2015;AL;Alabama;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST2_1;CRDRATE;RACE;API;;;;
2015;2015;TN;Tennessee;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2015;2015;VI;Virgin Islands;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2015;2015;KS;Kansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST2_1;CRDRATE;RACE;API;;;;
2015;2015;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;44.40;44.4;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;43.77;45.03;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;ND;North Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2015;2015;ND;North Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;32.23;32.23;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;31.27;33.19;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;53.11;53.11;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;52.59;53.63;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;AL;Alabama;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2015;2015;ME;Maine;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;MS;Mississippi;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST2_1;NMBR;GENDER;GENM;;;;
2015;2015;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;12.76;12.76;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;11.97;13.55;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;MO;Missouri;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2015;2015;DC;District of Columbia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2015;2015;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;KS;Kansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST2_1;NMBR;GENDER;GENM;;;;
2015;2015;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;7.75;7.75;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;5.14;10.35;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;OR;Oregon;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;IL;Illinois;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;DC;District of Columbia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.907192, -77.036871);;11;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2015;2015;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;74;74;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;NMBR;RACE;API;;;;
2015;2015;IN;Indiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;MT;Montana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;42.34;42.34;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;41.34;43.34;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2015;2015;ND;North Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST2_1;NMBR;RACE;API;;;;
2015;2015;VI;Virgin Islands;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;OR;Oregon;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST2_1;NMBR;RACE;AIAN;;;;
2015;2015;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;417;417;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;NMBR;RACE;BLK;;;;
2015;2015;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;103;103;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;NMBR;RACE;AIAN;;;;
2015;2015;AK;Alaska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2015;2015;VA;Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST2_1;NMBR;RACE;API;;;;
2015;2015;MA;Massachusetts;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;55.98;55.98;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;55;56.96;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;27.53;27.53;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;24.99;30.08;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2015;2015;OH;Ohio;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;MD;Maryland;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;38.86;38.86;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;36.99;40.72;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2015;2015;WY;Wyoming;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST2_1;NMBR;RACE;WHT;;;;
2015;2015;AR;Arkansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;4000;4,000;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST2_1;NMBR;RACE;BLK;;;;
2015;2015;MA;Massachusetts;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;56.39;56.39;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;55.74;57.04;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;PA;Pennsylvania;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST2_1;NMBR;RACE;API;;;;
2015;2015;MI;Michigan;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;MT;Montana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;LA;Louisiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;TX;Texas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2015;2015;DC;District of Columbia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;WA;Washington;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST2_1;NMBR;RACE;AIAN;;;;
2015;2015;MI;Michigan;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;AR;Arkansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;44.74;44.74;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;40.15;49.34;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;CO;Colorado;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST2_1;NMBR;RACE;HIS;;;;
2015;2015;PA;Pennsylvania;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2015;2015;SD;South Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2015;2015;TX;Texas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST2_1;NMBR;RACE;API;;;;
2015;2015;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;3.11;3.11;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;1.84;4.37;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;WA;Washington;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST2_1;NMBR;RACE;WHT;;;;
2015;2015;ME;Maine;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST2_1;NMBR;RACE;WHT;;;;
2015;2015;MN;Minnesota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST2_1;NMBR;RACE;HIS;;;;
2015;2015;HI;Hawaii;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;60.03;60.03;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;50.36;69.7;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;GA;Georgia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2015;2015;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;18565;18,565;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;NMBR;RACE;BLK;;;;
2015;2015;CA;California;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST2_1;NMBR;GENDER;GENF;;;;
2015;2015;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;5.60;5.6;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;4.73;6.47;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2015;2015;ND;North Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;UT;Utah;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;VI;Virgin Islands;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(18.335765, -64.896335);;78;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2015;2015;DE;Delaware;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2015;2015;ND;North Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2015;2015;TX;Texas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2015;2015;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;47.72;47.72;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;43.15;52.29;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;VI;Virgin Islands;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(18.335765, -64.896335);;78;AST;AST2_1;CRDRATE;RACE;API;;;;
2015;2015;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;NMBR;RACE;API;;;;
2015;2015;LA;Louisiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST2_1;NMBR;RACE;HIS;;;;
2015;2015;MT;Montana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;12737;12,737;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;NMBR;GENDER;GENF;;;;
2015;2015;DC;District of Columbia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST2_1;NMBR;RACE;BLK;;;;
2015;2015;TN;Tennessee;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2015;2015;WV;West Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST2_1;CRDRATE;RACE;API;;;;
2015;2015;TX;Texas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2015;2015;VI;Virgin Islands;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST2_1;NMBR;GENDER;GENM;;;;
2015;2015;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;23788;23,788;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2015;2015;LA;Louisiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2015;2015;TN;Tennessee;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2015;2015;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;29.51;29.51;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;29.02;29.99;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2015;2015;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;8664;8,664;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;NMBR;GENDER;GENM;;;;
2015;2015;UT;Utah;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;NH;New Hampshire;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2015;2015;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;43.45;43.45;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;42.64;44.26;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2015;2015;MA;Massachusetts;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2015;2015;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;4499;4,499;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;NMBR;RACE;HIS;;;;
2015;2015;GU;Guam;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2015;2015;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;51;51;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;NMBR;RACE;API;;;;
2015;2015;ND;North Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2015;2015;VI;Virgin Islands;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;15.82;15.82;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;13.62;18.03;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;CRDRATE;RACE;API;;;;
2015;2015;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;150.42;150.42;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;145.93;154.91;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2015;2015;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;6415;6,415;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2015;2015;WV;West Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2015;2015;GU;Guam;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST2_1;NMBR;GENDER;GENM;;;;
2015;2015;MT;Montana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2015;2015;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2015;2015;UT;Utah;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST2_1;NMBR;RACE;API;;;;
2015;2015;AL;Alabama;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2015;2015;MS;Mississippi;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST2_1;CRDRATE;RACE;API;;;;
2015;2015;UT;Utah;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2015;2015;DC;District of Columbia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;338;338;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST3_1;NMBR;GENDER;GENM;;;;
2015;2015;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;46.45;46.45;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;45.86;47.04;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;OH;Ohio;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;KS;Kansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST2_1;NMBR;RACE;API;;;;
2015;2015;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;NMBR;RACE;AIAN;;;;
2015;2015;CA;California;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;TX;Texas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;AR;Arkansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;11.60;11.6;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;8.37;14.83;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2015;2015;CO;Colorado;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST2_1;NMBR;RACE;API;;;;
2015;2015;ND;North Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2015;2015;AK;Alaska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;NMBR;RACE;AIAN;;;;
2015;2015;GU;Guam;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;37.23;37.23;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;34.55;39.91;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.7;68.7;;;54.1;80.3;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2015;2015;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;64.51;64.51;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;63.65;65.38;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2015;2015;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;6.02;6.02;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;4.35;7.69;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2015;2015;ME;Maine;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2015;2015;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;CRDRATE;RACE;API;;;;
2015;2015;HI;Hawaii;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;4478;4,478;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST2_1;NMBR;RACE;API;;;;
2015;2015;CT;Connecticut;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2015;2015;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;48.03;48.03;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;47.41;48.65;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;HI;Hawaii;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;59.84;59.84;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;58.38;61.3;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;6.99;6.99;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;6.62;7.36;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;UT;Utah;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;DE;Delaware;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2015;2015;ME;Maine;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;MD;Maryland;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;69.15;69.15;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;68.38;69.92;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;UT;Utah;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2015;2015;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;1879;1,879;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;NMBR;RACE;BLK;;;;
2015;2015;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;9087;9,087;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;NMBR;GENDER;GENF;;;;
2015;2015;GU;Guam;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST3_1;NMBR;RACE;WHT;;;;
2015;2015;ME;Maine;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2015;2015;CO;Colorado;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2015;2015;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;16.55;16.55;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;16.12;16.98;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2015;2015;RI;Rhode Island;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;51.12;51.12;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;49.55;52.7;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;VI;Virgin Islands;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST3_1;NMBR;GENDER;GENM;;;;
2015;2015;NM;New Mexico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST2_1;CRDRATE;RACE;API;;;;
2015;2015;PR;Puerto Rico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(18.220833, -66.590149);;72;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;WA;Washington;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2015;2015;MD;Maryland;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;35.65;35.65;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;34.85;36.46;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;9.53;9.53;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;7.85;11.21;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2015;2015;VA;Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;WA;Washington;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;55.78;55.78;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;42.28;69.28;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;GU;Guam;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2015;2015;TX;Texas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2015;2015;OK;Oklahoma;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2015;2015;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;6.17;6.17;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;4.38;7.96;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;LA;Louisiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST2_1;NMBR;RACE;API;;;;
2015;2015;TN;Tennessee;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2015;2015;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;357;357;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;NMBR;RACE;HIS;;;;
2015;2015;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;23.73;23.73;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;23.12;24.34;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2015;2015;CO;Colorado;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST2_1;CRDRATE;RACE;API;;;;
2015;2015;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;5.81;5.81;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;5.24;6.39;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;OH;Ohio;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2015;2015;CO;Colorado;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2015;2015;CO;Colorado;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;73.26;73.26;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;72.61;73.9;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;25.64;25.64;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;23.32;27.95;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;CRDRATE;RACE;API;;;;
2015;2015;AK;Alaska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;10.16;10.16;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;9.81;10.51;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;SD;South Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;ME;Maine;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;PR;Puerto Rico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;5.53;5.53;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;4.6;6.47;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2015;2015;MT;Montana;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST3_1;NMBR;RACE;HIS;;;;
2015;2015;PR;Puerto Rico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST2_1;NMBR;RACE;BLK;;;;
2015;2015;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2015;2015;MI;Michigan;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST2_1;NMBR;GENDER;GENM;;;;
2015;2015;ID;Idaho;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;CO;Colorado;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;TX;Texas;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2015;2015;RI;Rhode Island;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;1739;1,739;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST2_1;NMBR;GENDER;GENM;;;;
2015;2015;IL;Illinois;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;OH;Ohio;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;IL;Illinois;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST2_1;NMBR;GENDER;GENM;;;;
2015;2015;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;1063;1,063;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;NMBR;GENDER;GENF;;;;
2015;2015;MO;Missouri;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;AK;Alaska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST2_1;NMBR;GENDER;GENM;;;;
2015;2015;CO;Colorado;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;UT;Utah;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST2_1;NMBR;GENDER;GENF;;;;
2015;2015;SD;South Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;CT;Connecticut;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST2_1;CRDRATE;RACE;API;;;;
2015;2015;PA;Pennsylvania;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1353;1,353;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2015;2015;MI;Michigan;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;VA;Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST2_1;CRDRATE;RACE;API;;;;
2015;2015;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1027;1,027;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;NMBR;GENDER;GENF;;;;
2015;2015;WY;Wyoming;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST2_1;NMBR;RACE;AIAN;;;;
2015;2015;NM;New Mexico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2015;2015;IN;Indiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2015;2015;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2015;2015;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.7;39.7;;;33.6;46.2;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2015;2015;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;95018;95,018;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2015;2015;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;68.64;68.64;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;68.06;69.22;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2015;2015;GA;Georgia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;TX;Texas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2015;2015;OK;Oklahoma;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST2_1;NMBR;RACE;WHT;;;;
2015;2015;RI;Rhode Island;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;48.98;48.98;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;46.64;51.33;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;ME;Maine;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST3_1;NMBR;RACE;HIS;;;;
2015;2015;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;1847;1,847;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2015;2015;MS;Mississippi;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2015;2015;OK;Oklahoma;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST2_1;NMBR;GENDER;GENM;;;;
2015;2015;MA;Massachusetts;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;12970;12,970;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST2_1;NMBR;GENDER;GENM;;;;
2015;2015;PA;Pennsylvania;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;CT;Connecticut;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST2_1;NMBR;RACE;BLK;;;;
2015;2015;NH;New Hampshire;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2015;2015;MS;Mississippi;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST2_1;NMBR;GENDER;GENF;;;;
2015;2015;TN;Tennessee;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST2_1;NMBR;RACE;API;;;;
2015;2015;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;144;144;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;NMBR;RACE;HIS;;;;
2015;2015;IN;Indiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2015;2015;ME;Maine;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2015;2015;MO;Missouri;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2015;2015;PR;Puerto Rico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST2_1;NMBR;RACE;HIS;;;;
2015;2015;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;6.50;6.5;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;6.13;6.88;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2015;2015;WA;Washington;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;DE;Delaware;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;6920;6,920;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;NMBR;GENDER;GENM;;;;
2015;2015;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;4442;4,442;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;NMBR;RACE;HIS;;;;
2015;2015;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;NMBR;RACE;API;;;;
2015;2015;DE;Delaware;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;LA;Louisiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2015;2015;KS;Kansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST3_1;NMBR;RACE;AIAN;;;;
2015;2015;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;1.63;1.63;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;0.99;2.26;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;DE;Delaware;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST3_1;NMBR;GENDER;GENF;;;;
2015;2015;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;146.26;146.26;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;141.81;150.7;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;LA;Louisiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2015;2015;OR;Oregon;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;ND;North Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST2_1;NMBR;RACE;HIS;;;;
2015;2015;ME;Maine;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;PR;Puerto Rico;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST3_1;NMBR;GENDER;GENF;;;;
2015;2015;MT;Montana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST2_1;NMBR;RACE;BLK;;;;
2015;2015;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;31.45;31.45;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;30.53;32.37;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;NM;New Mexico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST2_1;NMBR;RACE;BLK;;;;
2015;2015;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;1.43;1.43;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;0.94;1.93;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;CRDRATE;RACE;API;;;;
2015;2015;VA;Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2015;2015;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;226.36;226.36;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;220.94;231.78;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2015;2015;WA;Washington;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST2_1;NMBR;RACE;HIS;;;;
2015;2015;NH;New Hampshire;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST2_1;NMBR;RACE;AIAN;;;;
2015;2015;MN;Minnesota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;8.78;8.78;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;6.28;11.29;Race/Ethnicity;Asian or Pacific Islander;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2015;2015;IN;Indiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST2_1;NMBR;GENDER;GENF;;;;
2015;2015;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;816;816;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;NMBR;RACE;API;;;;
2015;2015;PR;Puerto Rico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST2_1;NMBR;RACE;WHT;;;;
2015;2015;NM;New Mexico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;WY;Wyoming;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST2_1;NMBR;RACE;API;;;;
2015;2015;UT;Utah;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2015;2015;OR;Oregon;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2015;2015;KS;Kansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2015;2015;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;6699;6,699;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;NMBR;RACE;BLK;;;;
2015;2015;VA;Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;MN;Minnesota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2015;2015;CA;California;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2015;2015;SD;South Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;30.15;30.15;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;29.45;30.85;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2015;2015;HI;Hawaii;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;32.19;32.19;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;28.86;35.52;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2015;2015;MO;Missouri;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST2_1;NMBR;RACE;API;;;;
2015;2015;RI;Rhode Island;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;89.25;89.25;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;83.02;95.47;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;WV;West Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;133.71;133.71;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;129.08;138.34;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;26.95;26.95;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;23.84;30.06;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;MT;Montana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST2_1;CRDRATE;RACE;API;;;;
2015;2015;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;3995;3,995;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2015;2015;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;NMBR;GENDER;GENM;;;;
2015;2015;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;23.95;23.95;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;23.32;24.58;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;NM;New Mexico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;GA;Georgia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST3_1;NMBR;RACE;AIAN;;;;
2015;2015;WA;Washington;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;MS;Mississippi;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;12.59;12.59;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;11.4;13.78;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;VA;Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST2_1;NMBR;GENDER;GENM;;;;
2015;2015;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;7.44;7.44;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;7.18;7.69;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;TN;Tennessee;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;76.92;76.92;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;75.96;77.88;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;ME;Maine;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST2_1;NMBR;RACE;API;;;;
2015;2015;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;170;170;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;NMBR;RACE;HIS;;;;
2015;2015;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;NMBR;RACE;API;;;;
2015;2015;AL;Alabama;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;WV;West Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;IL;Illinois;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST2_1;NMBR;RACE;WHT;;;;
2015;2015;MA;Massachusetts;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;52.47;52.47;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;51.56;53.37;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2015;2015;ME;Maine;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST2_1;NMBR;RACE;BLK;;;;
2015;2015;MS;Mississippi;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;HI;Hawaii;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;56.74;56.74;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;54.74;58.75;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2015;2015;NM;New Mexico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2015;2015;DE;Delaware;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;CT;Connecticut;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2015;2015;CO;Colorado;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2015;2015;HI;Hawaii;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;41.92;41.92;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;36.92;46.91;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;DC;District of Columbia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;53.10;53.1;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;51.99;54.2;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;PA;Pennsylvania;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST3_1;NMBR;RACE;AIAN;;;;
2015;2015;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;2729;2,729;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2015;2015;ND;North Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;41.17;41.17;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;40.02;42.33;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2015;2015;ID;Idaho;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST3_1;NMBR;RACE;HIS;;;;
2015;2015;MT;Montana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST2_1;NMBR;RACE;API;;;;
2015;2015;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;141.65;141.65;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;114.3;169.01;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2015;2015;ID;Idaho;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2015;2015;UT;Utah;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST2_1;NMBR;RACE;AIAN;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;75.7;75.7;;;66.7;83;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2015;2015;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;60;60;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;NMBR;RACE;AIAN;;;;
2015;2015;OK;Oklahoma;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;LA;Louisiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29.0;29;;;18.2;42.9;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2015;2015;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;47.74;47.74;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;43.23;52.24;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2015;2015;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;44.69;44.69;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;43.85;45.53;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;3.17;3.17;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;2.66;3.69;Race/Ethnicity;Asian or Pacific Islander;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;CRDRATE;RACE;API;;;;
2015;2015;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;58.30;58.3;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;57.49;59.11;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;PR;Puerto Rico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;WY;Wyoming;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST3_1;NMBR;RACE;API;;;;
2015;2015;VA;Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2015;2015;WV;West Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST2_1;NMBR;RACE;API;;;;
2015;2015;RI;Rhode Island;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;4050;4,050;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2015;2015;MI;Michigan;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2015;2015;NH;New Hampshire;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;12.35;12.35;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;11.5;13.2;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;CRDRATE;RACE;API;;;;
2015;2015;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;36.19;36.19;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;34.76;37.61;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2015;2015;GA;Georgia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;NMBR;RACE;WHT;;;;
2015;2015;MO;Missouri;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST2_1;NMBR;GENDER;GENM;;;;
2015;2015;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;68.27;68.27;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;67.83;68.72;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;ME;Maine;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;OR;Oregon;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST2_1;NMBR;RACE;WHT;;;;
2015;2015;TN;Tennessee;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST3_1;CRDRATE;RACE;API;;;;
2015;2015;MT;Montana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;DC;District of Columbia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST2_1;NMBR;GENDER;GENF;;;;
2015;2015;CT;Connecticut;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;52.78;52.78;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;40.24;65.33;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2015;2015;NM;New Mexico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2015;2015;OK;Oklahoma;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2015;2015;LA;Louisiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;3.39;3.39;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;2.95;3.83;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;CRDRATE;RACE;API;;;;
2015;2015;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;37.41;37.41;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;36.7;38.12;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2015;2015;MA;Massachusetts;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;127.10;127.1;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;123.48;130.72;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;;Number;155;155;;;;;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2015;2015;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2015;2015;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;NMBR;RACE;AIAN;;;;
2015;2015;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.8;11.8;;;7.8;17.2;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2015;2015;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.5;9.5;;;6.3;13.8;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;CRDRATE;RACE;API;;;;
2015;2015;MO;Missouri;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST2_1;NMBR;RACE;BLK;;;;
2015;2015;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.3;9.3;;;6.8;12.5;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2015;2015;RI;Rhode Island;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;54.06;54.06;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;52.35;55.77;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.2;12.2;;;10.7;13.8;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2015;2015;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;CRDRATE;RACE;API;;;;
2015;2015;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;NMBR;RACE;WHT;;;;
2015;2015;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;CRDRATE;RACE;API;;;;
2015;2015;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;14.8;14.8;;;9.5;22;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;NMBR;RACE;AIAN;;;;
2015;2015;MI;Michigan;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2015;2015;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;62.50;62.5;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;62.1;62.9;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.2;14.2;;;11.5;17.4;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2015;2015;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;;Number;75;75;;;;;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;NMBR;GENDER;GENF;;;;
2015;2015;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.8;12.8;;;9.2;17.3;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;NMBR;GENDER;GENM;;;;
2015;2015;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.1;11.1;;;8.5;14.3;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.2;13.2;;;10.4;16.4;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;CT;Connecticut;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2015;2015;AR;Arkansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;12.07;12.07;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;8.76;15.39;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST2_1;CRDRATE;RACE;API;;;;
2015;2015;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;470;470;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;NMBR;RACE;API;;;;
2015;2015;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;68;68;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;NMBR;RACE;AIAN;;;;
2015;2015;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;TN;Tennessee;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST2_1;NMBR;GENDER;GENF;;;;
2015;2015;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;;Number;41;41;;;;;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;NMBR;GENDER;GENM;;;;
2015;2015;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2015;2015;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.0;8;;;5.2;11.7;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2015;2015;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;;Number;52;52;;;;;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2015;2015;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2015;2015;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2015;2015;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;CRDRATE;RACE;API;;;;
2015;2015;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;NMBR;GENDER;GENF;;;;
2015;2015;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;;Number;28;28;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;NMBR;RACE;WHT;;;;
2015;2015;CO;Colorado;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2015;2015;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2015;2015;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2015;2015;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;NMBR;RACE;BLK;;;;
2015;2015;CA;California;NVSS;Asthma;Asthma mortality rate;;;Number;202;202;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;NMBR;RACE;WHT;;;;
2015;2015;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2015;2015;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;CO;Colorado;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST2_1;NMBR;RACE;WHT;;;;
2015;2015;ID;Idaho;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;16.3;16.3;;;11.9;21.8;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2015;2015;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.3;12.3;;;9.8;15.1;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;NY;New York;NVSS;Asthma;Asthma mortality rate;;;Number;189;189;;;;;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;NMBR;GENDER;GENF;;;;
2015;2015;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;NMBR;GENDER;GENM;;;;
2015;2015;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;;Number;29;29;;;;;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2015;2015;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;18.4;18.4;;;12.2;26.6;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.5;40.5;;;35.2;46.1;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2015;2015;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;NMBR;RACE;HIS;;;;
2015;2015;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;NMBR;RACE;HIS;;;;
2015;2015;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.8;7.8;;;5.5;10.9;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;ME;Maine;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST2_1;CRDRATE;RACE;API;;;;
2015;2015;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;;Number;50;50;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;NMBR;RACE;WHT;;;;
2015;2015;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2015;2015;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;29.5;29.5;;;18.5;44.7;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2015;2015;TN;Tennessee;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST2_1;NMBR;RACE;HIS;;;;
2015;2015;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;NMBR;RACE;HIS;;;;
2015;2015;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2015;2015;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;;Number;46;46;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;NMBR;RACE;WHT;;;;
2015;2015;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.0;8;;;5.2;11.6;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2015;2015;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.1;10.1;;;7.4;13.4;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.1;9.1;;;6.5;12.3;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.4;11.4;;;8.8;14.4;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;NMBR;RACE;HIS;;;;
2015;2015;MS;Mississippi;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2015;2015;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;NMBR;RACE;API;;;;
2015;2015;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;NMBR;GENDER;GENM;;;;
2015;2015;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2015;2015;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;15.2;15.2;;;11.3;20.1;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2015;2015;NH;New Hampshire;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST2_1;CRDRATE;RACE;API;;;;
2015;2015;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;3872;3,872;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;NMBR;GENDER;GENM;;;;
2015;2015;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;FL;Florida;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;NMBR;RACE;AIAN;;;;
2015;2015;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;8.04;8.04;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;5.84;10.25;Race/Ethnicity;Asian or Pacific Islander;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;CRDRATE;RACE;API;;;;
2015;2015;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2015;2015;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;23.1;23.1;;;16.6;31.3;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;RI;Rhode Island;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;85.92;85.92;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;80.54;91.3;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2015;2015;MD;Maryland;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;12.95;12.95;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;11.61;14.29;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2015;2015;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;CRDRATE;RACE;API;;;;
2015;2015;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;NMBR;GENDER;GENM;;;;
2015;2015;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;;Number;40;40;;;;;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;NMBR;GENDER;GENF;;;;
2015;2015;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2015;2015;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.3;13.3;;;9.9;17.4;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;31;31;;;;;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;NMBR;GENDER;GENM;;;;
2015;2015;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;NMBR;RACE;AIAN;;;;
2015;2015;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;120.12;120.12;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;92.15;148.1;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;NMBR;RACE;AIAN;;;;
2015;2015;SD;South Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST2_1;NMBR;RACE;AIAN;;;;
2015;2015;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2015;2015;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;NMBR;GENDER;GENM;;;;
2015;2015;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;;Number;43;43;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;NMBR;RACE;BLK;;;;
2015;2015;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;CRDRATE;RACE;API;;;;
2015;2015;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.3;12.3;;;10.3;14.3;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;17.4;17.4;;;13;22.8;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2015;2015;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2015;2015;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;17.9;17.9;;;11.6;26.4;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;NMBR;RACE;API;;;;
2015;2015;CA;California;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST2_1;CRDRATE;RACE;API;;;;
2015;2015;TN;Tennessee;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2015;2015;OR;Oregon;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;DC;District of Columbia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.907192, -77.036871);;11;AST;AST2_1;CRDRATE;RACE;API;;;;
2015;2015;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2015;2015;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;14.8;14.8;;;10.3;20.6;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;9621;9,621;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;NMBR;RACE;WHT;;;;
2015;2015;AK;Alaska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2015;2015;MS;Mississippi;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2015;2015;CA;California;NVSS;Asthma;Asthma mortality rate;;;Number;393;393;;;;;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2015;2015;TN;Tennessee;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST2_1;NMBR;RACE;AIAN;;;;
2015;2015;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;NMBR;RACE;HIS;;;;
2015;2015;MT;Montana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2015;2015;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;NMBR;GENDER;GENM;;;;
2015;2015;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2015;2015;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2015;2015;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;NMBR;RACE;BLK;;;;
2015;2015;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.2;10.2;;;8.6;11.9;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.4;9.4;;;6.9;12.4;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2015;2015;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2015;2015;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;NMBR;RACE;API;;;;
2015;2015;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;13.2;13.2;;;9.6;17.8;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2015;2015;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;36.91;36.91;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;36.21;37.61;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2015;2015;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.0;12;;;8.1;17.1;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2015;2015;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.1;9.1;;;6.1;13;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.4;8.4;;;6.3;11;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2015;2015;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;NMBR;RACE;API;;;;
2015;2015;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;NMBR;RACE;WHT;;;;
2015;2015;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.4;9.4;;;8;10.8;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.6;8.6;;;6.1;11.8;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;47.53;47.53;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;44.61;50.44;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2015;2015;HI;Hawaii;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;69.71;69.71;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;67.67;71.76;Race/Ethnicity;Asian or Pacific Islander;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST2_1;CRDRATE;RACE;API;;;;
2015;2015;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;;Number;48;48;;;;;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2015;2015;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2015;2015;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;54.22;54.22;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;49.95;58.49;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2015;2015;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;59;59;;;;;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;NMBR;GENDER;GENF;;;;
2015;2015;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.3;11.3;;;9.2;13.4;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;NMBR;RACE;HIS;;;;
2015;2015;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;PR;Puerto Rico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.7;12.7;;;9;17.6;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2015;2015;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.5;11.5;;;7;17.7;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.9;7.9;;;5.1;11.7;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2015;2015;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;NMBR;RACE;AIAN;;;;
2015;2015;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;NMBR;RACE;API;;;;
2015;2015;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;NMBR;RACE;AIAN;;;;
2015;2015;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2015;2015;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;NMBR;RACE;BLK;;;;
2015;2015;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.907192, -77.036871);;11;AST;AST4_1;NMBR;RACE;API;;;;
2015;2015;DE;Delaware;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST2_1;CRDRATE;RACE;API;;;;
2015;2015;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;;Number;38;38;;;;;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2015;2015;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.3;9.3;;;6.2;13.3;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;NMBR;RACE;WHT;;;;
2015;2015;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;NMBR;RACE;BLK;;;;
2015;2015;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;;Number;84;84;;;;;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2015;2015;VI;Virgin Islands;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;29.6;29.6;;;21.4;39.9;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2015;2015;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;16.1;16.1;;;12.3;20.7;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2015;2015;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;IN;Indiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST2_1;CRDRATE;RACE;API;;;;
2015;2015;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;NMBR;RACE;WHT;;;;
2015;2015;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2015;2015;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;5.8;5.8;;;4.6;7.2;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;NY;New York;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;NMBR;RACE;AIAN;;;;
2015;2015;CA;California;NVSS;Asthma;Asthma mortality rate;;;Number;152;152;;;;;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;NMBR;GENDER;GENM;;;;
2015;2015;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2015;2015;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.4;7.4;;;4.9;10.6;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2015;2015;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;NMBR;RACE;BLK;;;;
2015;2015;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;;Number;37;37;;;;;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;NMBR;GENDER;GENF;;;;
2015;2015;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;;Number;53;53;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;NMBR;RACE;WHT;;;;
2015;2015;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;NMBR;RACE;HIS;;;;
2015;2015;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2015;2015;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;NMBR;GENDER;GENM;;;;
2015;2015;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.6;11.6;;;9.4;13.8;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;CA;California;NVSS;Asthma;Asthma mortality rate;;;Number;63;63;;;;;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;NMBR;RACE;HIS;;;;
2015;2015;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;NMBR;RACE;HIS;;;;
2015;2015;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2015;2015;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;NMBR;RACE;AIAN;;;;
2015;2015;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;NMBR;RACE;BLK;;;;
2015;2015;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;NMBR;RACE;HIS;;;;
2015;2015;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;30.6;30.6;;;21.3;42.5;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2015;2015;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;;Number;36;36;;;;;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2015;2015;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;4.6;4.6;;;2.9;7;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2015;2015;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST4_1;NMBR;RACE;WHT;;;;
2015;2015;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2015;2015;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;15.1;15.1;;;11.3;19.7;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2015;2015;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;NMBR;RACE;WHT;;;;
2015;2015;DC;District of Columbia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2015;2015;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;22.61;22.61;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;14.91;30.3;Race/Ethnicity;American Indian or Alaska Native;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;CRDRATE;RACE;API;;;;
2015;2015;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;19218;19,218;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2015;2015;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;;Number;30;30;;;;;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;NMBR;GENDER;GENM;;;;
2015;2015;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;;Number;64;64;;;;;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;NMBR;GENDER;GENM;;;;
2015;2015;IN;Indiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST2_1;NMBR;GENDER;GENM;;;;
2015;2015;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2015;2015;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2015;2015;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;20.4;20.4;;;14.2;28.6;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2015;2015;LA;Louisiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.9;10.9;;;8.4;14;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2015;2015;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;NMBR;RACE;AIAN;;;;
2015;2015;VA;Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST2_1;NMBR;RACE;HIS;;;;
2015;2015;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;;Number;30;30;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;NMBR;RACE;WHT;;;;
2015;2015;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2015;2015;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;NMBR;RACE;AIAN;;;;
2015;2015;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;NMBR;GENDER;GENM;;;;
2015;2015;TX;Texas;NVSS;Asthma;Asthma mortality rate;;;Number;241;241;;;;;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2015;2015;GA;Georgia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2015;2015;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.6;8.6;;;7.4;9.9;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;MO;Missouri;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;MD;Maryland;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;71.66;71.66;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;70.57;72.75;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2015;2015;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;CRDRATE;RACE;API;;;;
2015;2015;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;4.6;4.6;;;3.2;6.4;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2015;2015;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.2;9.2;;;6.7;12.2;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;LA;Louisiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST2_1;NMBR;GENDER;GENM;;;;
2015;2015;TX;Texas;NVSS;Asthma;Asthma mortality rate;;;Number;126;126;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;NMBR;RACE;WHT;;;;
2015;2015;CA;California;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.3;7.3;;;4.8;10.6;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2015;2015;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;NMBR;RACE;API;;;;
2015;2015;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;NMBR;RACE;API;;;;
2015;2015;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;;Number;70;70;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;NMBR;RACE;WHT;;;;
2015;2015;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;NMBR;RACE;AIAN;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.6;9.6;;;8.2;11.3;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2015;2015;NH;New Hampshire;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2015;2015;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;NMBR;RACE;AIAN;;;;
2015;2015;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;90;90;;;;;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2015;2015;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;;Number;43;43;;;;;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;NMBR;GENDER;GENM;;;;
2015;2015;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2015;2015;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2015;2015;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.0;10;;;9;11;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2015;2015;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.0;9;;;7.3;11;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;NMBR;GENDER;GENF;;;;
2015;2015;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2015;2015;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;NMBR;GENDER;GENF;;;;
2015;2015;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2015;2015;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;16.8;16.8;;;12.3;22.4;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2015;2015;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2015;2015;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;CRDRATE;RACE;API;;;;
2015;2015;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;;Number;49;49;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;NMBR;RACE;BLK;;;;
2015;2015;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;;Number;34;34;;;;;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;NMBR;GENDER;GENF;;;;
2015;2015;AR;Arkansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;10.37;10.37;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;5.76;14.98;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2015;2015;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;217.75;217.75;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;212.34;223.16;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;81.5;81.5;;;73.8;87.3;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2015;2015;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2015;2015;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;NMBR;GENDER;GENM;;;;
2015;2015;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;GA;Georgia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2015;2015;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.1;11.1;;;8.3;14.5;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2015;2015;NH;New Hampshire;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;;Number;52;52;;;;;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2015;2015;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;20.4;20.4;;;14;28.6;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;AR;Arkansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;4405;4,405;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST2_1;NMBR;GENDER;GENM;;;;
2015;2015;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.2;13.2;;;9.9;17.2;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;MS;Mississippi;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2015;2015;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2015;2015;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;WA;Washington;NVSS;Asthma;Asthma mortality rate;;;Number;54;54;;;;;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;NMBR;GENDER;GENF;;;;
2015;2015;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2015;2015;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2015;2015;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.8;9.8;;;6.6;14.1;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;NMBR;RACE;API;;;;
2015;2015;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;34;34;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;NMBR;RACE;BLK;;;;
2015;2015;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2015;2015;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;NMBR;RACE;API;;;;
2015;2015;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;29.2;29.2;;;21.1;39.5;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;TN;Tennessee;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2015;2015;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;15.0;15;;;10.2;21.4;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2015;2015;ME;Maine;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;NMBR;RACE;HIS;;;;
2015;2015;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2015;2015;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;NMBR;RACE;HIS;;;;
2015;2015;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.5;10.5;;;6.8;15.5;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2015;2015;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;NMBR;RACE;WHT;;;;
2015;2015;WA;Washington;NVSS;Asthma;Asthma mortality rate;;;Number;71;71;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;NMBR;RACE;WHT;;;;
2015;2015;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.7;12.7;;;8.7;17.9;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2015;2015;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;NMBR;RACE;HIS;;;;
2015;2015;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.2;10.2;;;8.1;12.7;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.8;42.8;;;35.9;50.1;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2015;2015;IL;Illinois;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2015;2015;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;NMBR;GENDER;GENF;;;;
2015;2015;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;NMBR;GENDER;GENM;;;;
2015;2015;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.6;9.6;;;7.7;11.7;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;6.4;6.4;;;4.9;8.2;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;CRDRATE;RACE;API;;;;
2015;2015;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2015;2015;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.2;10.2;;;6.9;14.6;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;CA;California;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2015;2015;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;CRDRATE;RACE;API;;;;
2015;2015;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;1662;1,662;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;NMBR;RACE;HIS;;;;
2015;2015;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;NMBR;RACE;BLK;;;;
2015;2015;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.2;8.2;;;5.2;12.3;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2015;2015;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2015;2015;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;53377;53,377;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;NMBR;GENDER;GENF;;;;
2015;2015;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;CRDRATE;RACE;API;;;;
2015;2015;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.1;12.1;;;10.2;14;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;CRDRATE;RACE;API;;;;
2015;2015;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;;Number;39;39;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;NMBR;RACE;BLK;;;;
2015;2015;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;CRDRATE;RACE;API;;;;
2015;2015;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2015;2015;WA;Washington;NVSS;Asthma;Asthma mortality rate;;;Number;88;88;;;;;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2015;2015;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;NMBR;RACE;HIS;;;;
2015;2015;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;;Number;61;61;;;;;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2015;2015;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2015;2015;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2015;2015;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2015;2015;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.2;42.2;;;32.5;52.6;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2015;2015;DE;Delaware;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;NMBR;RACE;API;;;;
2015;2015;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;16.01;16.01;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;12.77;19.24;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;CRDRATE;RACE;API;;;;
2015;2015;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;17.9;17.9;;;13.6;23;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2015;2015;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2015;2015;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;NMBR;RACE;WHT;;;;
2015;2015;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2015;2015;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2015;2015;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;18.6;18.6;;;12.3;27.1;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2015;2015;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2015;2015;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;NMBR;RACE;HIS;;;;
2015;2015;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2015;2015;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2015;2015;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2015;2015;CO;Colorado;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST2_1;NMBR;RACE;AIAN;;;;
2015;2015;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;NMBR;RACE;API;;;;
2015;2015;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;46970;46,970;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2015;2015;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;NMBR;RACE;AIAN;;;;
2015;2015;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2015;2015;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;55.73;55.73;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;54.57;56.9;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;28.7;28.7;;;22.9;35.5;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2015;2015;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;;Number;62;62;;;;;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;NMBR;GENDER;GENM;;;;
2015;2015;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.3;11.3;;;7.8;15.9;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2015;2015;TX;Texas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST2_1;NMBR;RACE;HIS;;;;
2015;2015;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;WA;Washington;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;NMBR;RACE;HIS;;;;
2015;2015;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2015;2015;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.0;11;;;8.9;13;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;ME;Maine;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2015;2015;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2015;2015;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;;Number;93;93;;;;;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;NMBR;GENDER;GENF;;;;
2015;2015;FL;Florida;NVSS;Asthma;Asthma mortality rate;;;Number;50;50;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;NMBR;RACE;BLK;;;;
2015;2015;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;NMBR;RACE;WHT;;;;
2015;2015;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;;Number;60;60;;;;;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;NMBR;GENDER;GENF;;;;
2015;2015;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;16.44;16.44;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;14.48;18.39;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;NMBR;RACE;AIAN;;;;
2015;2015;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2015;2015;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;26.5;26.5;;;20.4;33.9;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;;Number;62;62;;;;;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;NMBR;GENDER;GENF;;;;
2015;2015;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2015;2015;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.4;11.4;;;8.8;14.5;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;ME;Maine;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;NMBR;RACE;AIAN;;;;
2015;2015;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;CRDRATE;RACE;API;;;;
2015;2015;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2015;2015;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2015;2015;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;16.4;16.4;;;12.9;20.5;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2015;2015;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.5;8.5;;;6.2;11.4;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.6;10.6;;;8.6;12.6;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2015;2015;ID;Idaho;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;;Number;25;25;;;;;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;NMBR;GENDER;GENF;;;;
2015;2015;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;8.08;8.08;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;6.77;9.38;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2015;2015;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2015;2015;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.3;11.3;;;7.7;16.1;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2015;2015;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;NMBR;RACE;API;;;;
2015;2015;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.0;10;;;8.4;11.7;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;5205;5,205;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;NMBR;GENDER;GENM;;;;
2015;2015;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2015;2015;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;CRDRATE;RACE;API;;;;
2015;2015;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.0;10;;;7.6;13;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;19.0;19;;;13.3;26.3;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2015;2015;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;96;96;;;;;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2015;2015;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.6;11.6;;;7.1;17.9;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2015;2015;IL;Illinois;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;RI;Rhode Island;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;56.61;56.61;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;54.3;58.91;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2015;2015;ME;Maine;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST2_1;NMBR;GENDER;GENF;;;;
2015;2015;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;CRDRATE;RACE;API;;;;
2015;2015;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;;Number;47;47;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;NMBR;RACE;BLK;;;;
2015;2015;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.9;12.9;;;9.6;17;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2015;2015;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2015;2015;IN;Indiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST2_1;NMBR;RACE;API;;;;
2015;2015;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2015;2015;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.9;12.9;;;9.2;17.6;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2015;2015;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;;Number;34;34;;;;;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;NMBR;GENDER;GENF;;;;
2015;2015;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.7;9.7;;;6.4;14;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;CA;California;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;NMBR;GENDER;GENF;;;;
2015;2015;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;3.37;3.37;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;2.81;3.93;Race/Ethnicity;Asian or Pacific Islander;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2015;2015;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;6.5;6.5;;;4.8;8.5;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.8;10.8;;;7.4;15.2;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.0;10;;;6.7;14.3;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2015;2015;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;6.8;6.8;;;4.4;10.1;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.3;9.3;;;7;12.1;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;CRDRATE;RACE;API;;;;
2015;2015;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;21.0;21;;;12.8;32.5;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2015;2015;ID;Idaho;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2015;2015;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;NMBR;RACE;HIS;;;;
2015;2015;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;TX;Texas;NVSS;Asthma;Asthma mortality rate;;;Number;142;142;;;;;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;NMBR;GENDER;GENF;;;;
2015;2015;AK;Alaska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2015;2015;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;NMBR;RACE;API;;;;
2015;2015;PA;Pennsylvania;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2015;2015;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.2;11.2;;;8.3;14.8;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;SD;South Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST2_1;CRDRATE;RACE;API;;;;
2015;2015;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;;Number;29;29;;;;;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;NMBR;GENDER;GENM;;;;
2015;2015;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2015;2015;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.0;12;;;8.7;16.1;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;18.6;18.6;;;15.9;21.2;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2015;2015;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;;Number;25;25;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;NMBR;RACE;BLK;;;;
2015;2015;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;;Number;26;26;;;;;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2015;2015;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;25;25;;;;;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;NMBR;GENDER;GENM;;;;
2015;2015;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;6.6;6.6;;;5.1;8.4;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2015;2015;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2015;2015;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2015;2015;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;NMBR;RACE;API;;;;
2015;2015;MO;Missouri;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2015;2015;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2015;2015;AR;Arkansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;45.39;45.39;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;44.15;46.63;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2015;2015;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;CRDRATE;RACE;API;;;;
2015;2015;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;;Number;30;30;;;;;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;NMBR;GENDER;GENM;;;;
2015;2015;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2015;2015;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2015;2015;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2015;2015;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2015;2015;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;17.0;17;;;11.9;23.6;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;CRDRATE;RACE;API;;;;
2015;2015;MI;Michigan;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2015;2015;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.1;10.1;;;6.8;14.4;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;GU;Guam;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;NM;New Mexico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;;Number;26;26;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;NMBR;RACE;WHT;;;;
2015;2015;KS;Kansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2015;2015;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;NMBR;RACE;API;;;;
2015;2015;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2015;2015;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;CRDRATE;RACE;API;;;;
2015;2015;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;NMBR;RACE;AIAN;;;;
2015;2015;OH;Ohio;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2015;2015;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;;Number;28;28;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;NMBR;RACE;WHT;;;;
2015;2015;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;KS;Kansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2015;2015;ID;Idaho;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2015;2015;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;NMBR;RACE;API;;;;
2015;2015;CA;California;NVSS;Asthma;Asthma mortality rate;;;Number;66;66;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;NMBR;RACE;BLK;;;;
2015;2015;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;NMBR;RACE;API;;;;
2015;2015;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;NMBR;RACE;AIAN;;;;
2015;2015;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.6;9.6;;;6.4;13.9;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;NMBR;RACE;HIS;;;;
2015;2015;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;WY;Wyoming;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;NMBR;RACE;BLK;;;;
2015;2015;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;;Number;24;24;;;;;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2015;2015;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;OK;Oklahoma;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2015;2015;IN;Indiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2015;2015;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.3;8.3;;;6.7;10;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;;Number;26;26;;;;;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;NMBR;GENDER;GENM;;;;
2015;2015;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;DE;Delaware;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST2_1;NMBR;RACE;AIAN;;;;
2015;2015;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2015;2015;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2015;2015;PA;Pennsylvania;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;399;399;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;NMBR;RACE;HIS;;;;
2015;2015;HI;Hawaii;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;63.02;63.02;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;60.88;65.16;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2015;2015;UT;Utah;NVSS;Asthma;Asthma mortality rate;;;Number;25;25;;;;;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;NMBR;GENDER;GENF;;;;
2015;2015;PR;Puerto Rico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(18.220833, -66.590149);;72;AST;AST2_1;NMBR;RACE;AIAN;;;;
2015;2015;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;NMBR;RACE;API;;;;
2015;2015;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;32;32;;;;;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;NMBR;GENDER;GENF;;;;
2015;2015;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.2;12.2;;;10.3;14.1;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.9;13.9;;;10.5;17.9;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2015;2015;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2015;2015;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;NMBR;RACE;BLK;;;;
2015;2015;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.3;9.3;;;6.3;13.3;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2015;2015;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;NMBR;RACE;HIS;;;;
2015;2015;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;NMBR;RACE;API;;;;
2015;2015;AK;Alaska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST2_1;NMBR;RACE;WHT;;;;
2015;2015;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2015;2015;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;;Number;52;52;;;;;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2015;2015;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;NMBR;RACE;WHT;;;;
2015;2015;ID;Idaho;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST2_1;NMBR;GENDER;GENF;;;;
2015;2015;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.2;9.2;;;6.2;13.1;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2015;2015;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2015;2015;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.5;11.5;;;8.7;14.8;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2015;2015;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.907192, -77.036871);;11;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2015;2015;WA;Washington;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;NMBR;RACE;AIAN;;;;
2015;2015;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;NMBR;RACE;AIAN;;;;
2015;2015;FL;Florida;NVSS;Asthma;Asthma mortality rate;;;Number;110;110;;;;;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;NMBR;GENDER;GENF;;;;
2015;2015;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2015;2015;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;;Number;79;79;;;;;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2015;2015;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.1;9.1;;;7.9;10.3;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.8;9.8;;;7.3;12.9;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.3;11.3;;;8.4;14.9;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2015;2015;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;NMBR;RACE;API;;;;
2015;2015;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.9;12.9;;;10.3;15.9;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2015;2015;MA;Massachusetts;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;60.09;60.09;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;59.15;61.02;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2015;2015;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;NMBR;RACE;WHT;;;;
2015;2015;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2015;2015;VA;Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;NMBR;RACE;AIAN;;;;
2015;2015;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;NMBR;RACE;BLK;;;;
2015;2015;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2015;2015;US;United States;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.2;11.2;;;10.9;11.6;Overall;Overall;;;;;;;59;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2015;2015;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2015;2015;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.1;13.1;;;9.4;17.8;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;ND;North Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2015;2015;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;CRDRATE;RACE;API;;;;
2015;2015;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2015;2015;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST4_1;NMBR;RACE;HIS;;;;
2015;2015;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.4;14.4;;;10.9;18.8;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2015;2015;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;NMBR;RACE;BLK;;;;
2015;2015;MT;Montana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;NMBR;RACE;BLK;;;;
2015;2015;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;15.2;15.2;;;12.9;17.4;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2015;2015;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;59.27;59.27;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;58.48;60.06;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;;Number;92;92;;;;;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2015;2015;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;16.0;16;;;11.9;21.1;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;AL;Alabama;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2015;2015;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;NMBR;RACE;AIAN;;;;
2015;2015;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;NMBR;RACE;API;;;;
2015;2015;VA;Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2015;2015;US;United States;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.3;10.3;;;10;10.7;Overall;Overall;;;;;;;59;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;OK;Oklahoma;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;17.28;17.28;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;13.44;21.12;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2015;2015;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;5.4;5.4;;;3.6;7.9;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2015;2015;MT;Montana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;NMBR;GENDER;GENF;;;;
2015;2015;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2015;2015;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;HI;Hawaii;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;39.77;39.77;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;37.45;42.09;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2015;2015;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;IL;Illinois;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2015;2015;TX;Texas;NVSS;Asthma;Asthma mortality rate;;;Number;38;38;;;;;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;NMBR;RACE;HIS;;;;
2015;2015;LA;Louisiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST2_1;CRDRATE;RACE;API;;;;
2015;2015;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;NMBR;RACE;API;;;;
2015;2015;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.5;10.5;;;7.9;13.7;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;ME;Maine;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;NMBR;RACE;WHT;;;;
2015;2015;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;CRDRATE;RACE;API;;;;
2015;2015;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;WV;West Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2015;2015;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.6;8.6;;;6.2;11.6;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2015;2015;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2015;2015;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.0;9;;;7.3;11;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;CT;Connecticut;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2015;2015;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.3;9.3;;;5.9;14.2;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2015;2015;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2015;2015;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;47.08;47.08;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;46;48.16;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2015;2015;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2015;2015;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2015;2015;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;NMBR;RACE;AIAN;;;;
2015;2015;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2015;2015;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.4;7.4;;;6.2;8.5;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2015;2015;UT;Utah;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;NMBR;GENDER;GENM;;;;
2015;2015;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;NMBR;GENDER;GENM;;;;
2015;2015;CT;Connecticut;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;ME;Maine;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;NMBR;GENDER;GENF;;;;
2015;2015;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;MN;Minnesota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;7697;7,697;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST2_1;NMBR;GENDER;GENF;;;;
2015;2015;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;GA;Georgia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;NMBR;GENDER;GENM;;;;
2015;2015;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;UT;Utah;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;NMBR;RACE;HIS;;;;
2015;2015;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2015;2015;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.3;12.3;;;9.4;15.8;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2015;2015;NY;New York;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;NMBR;RACE;API;;;;
2015;2015;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;NMBR;RACE;HIS;;;;
2015;2015;WY;Wyoming;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2015;2015;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;;Number;33;33;;;;;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;NMBR;GENDER;GENM;;;;
2015;2015;PR;Puerto Rico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;15.5;15.5;;;11.5;20.5;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2015;2015;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;17.0;17;;;13.8;20.1;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2015;2015;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;MI;Michigan;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;VI;Virgin Islands;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2015;2015;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;NMBR;RACE;HIS;;;;
2015;2015;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;40;40;;;;;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;NMBR;GENDER;GENM;;;;
2015;2015;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;CRDRATE;RACE;API;;;;
2015;2015;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2015;2015;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.5;11.5;;;9.2;14.2;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;HI;Hawaii;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;72.66;72.66;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;70.47;74.84;Race/Ethnicity;Asian or Pacific Islander;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2015;2015;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2015;2015;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.4;8.4;;;6.2;11.2;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;VI;Virgin Islands;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST2_1;NMBR;RACE;HIS;;;;
2015;2015;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2015;2015;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.5;9.5;;;6.6;13.3;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2015;2015;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;NMBR;RACE;API;;;;
2015;2015;GU;Guam;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST2_1;NMBR;RACE;BLK;;;;
2015;2015;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.3;10.3;;;8.6;12;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2015;2015;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;NMBR;RACE;WHT;;;;
2015;2015;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;NMBR;GENDER;GENM;;;;
2015;2015;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2015;2015;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2015;2015;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.5;11.5;;;8.9;14.6;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.3;10.3;;;6.9;14.9;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2015;2015;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2015;2015;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;NMBR;GENDER;GENM;;;;
2015;2015;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.5;7.5;;;5.5;10;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;;Number;44;44;;;;;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;NMBR;GENDER;GENM;;;;
2015;2015;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.1;8.1;;;5.7;11;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2015;2015;MO;Missouri;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST2_1;CRDRATE;RACE;API;;;;
2015;2015;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2015;2015;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2015;2015;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;NMBR;RACE;HIS;;;;
2015;2015;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;CRDRATE;RACE;API;;;;
2015;2015;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2015;2015;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.9;7.9;;;5.2;11.6;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2015;2015;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2015;2015;NH;New Hampshire;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST2_1;NMBR;RACE;BLK;;;;
2015;2015;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;NMBR;GENDER;GENF;;;;
2015;2015;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;6.7;6.7;;;4.4;9.8;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2015;2015;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;CRDRATE;RACE;API;;;;
2015;2015;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2015;2015;NY;New York;NVSS;Asthma;Asthma mortality rate;;;Number;295;295;;;;;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2015;2015;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;;Number;39;39;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;NMBR;RACE;WHT;;;;
2015;2015;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.3;10.3;;;8.3;12.7;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;PR;Puerto Rico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2015;2015;MA;Massachusetts;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;132.33;132.33;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;129.35;135.32;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2015;2015;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;13.7;13.7;;;10.6;17.3;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;LA;Louisiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST2_1;NMBR;RACE;AIAN;;;;
2015;2015;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;NMBR;RACE;HIS;;;;
2015;2015;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;MN;Minnesota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST2_1;NMBR;RACE;AIAN;;;;
2015;2015;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.8;13.8;;;10.8;17.4;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2015;2015;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;108;108;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;NMBR;RACE;API;;;;
2015;2015;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;NMBR;RACE;HIS;;;;
2015;2015;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;17.3;17.3;;;11.1;25.7;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;;Number;28;28;;;;;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;NMBR;GENDER;GENF;;;;
2015;2015;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2015;2015;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2015;2015;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;15.9;15.9;;;11.7;21;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;NMBR;RACE;HIS;;;;
2015;2015;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2015;2015;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;;Number;43;43;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;NMBR;RACE;BLK;;;;
2015;2015;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2015;2015;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.4;8.4;;;5.1;12.9;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2015;2015;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;NMBR;GENDER;GENM;;;;
2015;2015;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;CRDRATE;RACE;API;;;;
2015;2015;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.7;10.7;;;8.6;13.2;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;ME;Maine;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;NMBR;RACE;BLK;;;;
2015;2015;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;CRDRATE;RACE;API;;;;
2015;2015;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;NMBR;RACE;BLK;;;;
2015;2015;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2015;2015;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.907192, -77.036871);;11;AST;AST4_1;CRDRATE;RACE;API;;;;
2015;2015;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2015;2015;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;76.21;76.21;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;67.89;84.54;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2015;2015;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2015;2015;ME;Maine;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2015;2015;DE;Delaware;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST2_1;NMBR;GENDER;GENM;;;;
2015;2015;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2015;2015;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;21.7;21.7;;;16.7;27.8;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;CRDRATE;RACE;API;;;;
2015;2015;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.1;13.1;;;11.3;14.9;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2015;2015;UT;Utah;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;NMBR;RACE;API;;;;
2015;2015;AK;Alaska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2015;2015;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.1;11.1;;;7.8;15.4;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;ND;North Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST2_1;NMBR;RACE;AIAN;;;;
2015;2015;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.3;12.3;;;9.9;15.2;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;OH;Ohio;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST2_1;NMBR;RACE;HIS;;;;
2015;2015;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2015;2015;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.907192, -77.036871);;11;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2015;2015;TX;Texas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;NMBR;RACE;AIAN;;;;
2015;2015;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;NMBR;RACE;BLK;;;;
2015;2015;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2015;2015;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.8;8.8;;;8;9.7;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;NMBR;RACE;HIS;;;;
2015;2015;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.4;9.4;;;6.6;13.1;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2015;2015;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;CRDRATE;RACE;API;;;;
2015;2015;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.5;9.5;;;8.5;10.4;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;16.0;16;;;11.4;21.8;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;OK;Oklahoma;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST2_1;NMBR;RACE;API;;;;
2015;2015;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.5;12.5;;;8.1;18.3;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2015;2015;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;CT;Connecticut;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST2_1;NMBR;RACE;API;;;;
2015;2015;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;NMBR;GENDER;GENM;;;;
2015;2015;WA;Washington;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;NMBR;RACE;API;;;;
2015;2015;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2015;2015;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.4;9.4;;;6.7;12.7;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2015;2015;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;15.0;15;;;9.7;22.1;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;MT;Montana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;NMBR;RACE;API;;;;
2015;2015;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;OK;Oklahoma;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST2_1;CRDRATE;RACE;API;;;;
2015;2015;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;17.7;17.7;;;12.3;24.6;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;DC;District of Columbia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.907192, -77.036871);;11;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2015;2015;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2015;2015;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;CRDRATE;RACE;API;;;;
2015;2015;MD;Maryland;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;114.65;114.65;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;95.03;134.28;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.3;8.3;;;6.4;10.6;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2015;2015;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.4;13.4;;;9.5;18.2;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;NMBR;RACE;AIAN;;;;
2015;2015;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;5.6;5.6;;;3.9;7.8;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;NMBR;RACE;AIAN;;;;
2015;2015;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2015;2015;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.8;9.8;;;7.4;12.6;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;NMBR;RACE;AIAN;;;;
2015;2015;CT;Connecticut;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2015;2015;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;NMBR;GENDER;GENF;;;;
2015;2015;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2015;2015;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;35;35;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;NMBR;RACE;AIAN;;;;
2015;2015;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;38.8;38.8;;;30.4;48.8;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2015;2015;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.7;10.7;;;7.5;14.6;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;UT;Utah;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2015;2015;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2015;2015;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2015;2015;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2015;2015;WA;Washington;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;NMBR;GENDER;GENM;;;;
2015;2015;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2015;2015;HI;Hawaii;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;3087;3,087;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST2_1;NMBR;GENDER;GENM;;;;
2015;2015;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2015;2015;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;;Number;49;49;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;NMBR;RACE;WHT;;;;
2015;2015;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.0;9;;;7.3;10.6;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;16.4;16.4;;;13.3;20;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2015;2015;KS;Kansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2015;2015;MO;Missouri;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;;Number;53;53;;;;;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2015;2015;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;;Number;47;47;;;;;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2015;2015;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;NMBR;RACE;BLK;;;;
2015;2015;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2015;2015;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;53;53;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;NMBR;RACE;WHT;;;;
2015;2015;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.2;8.2;;;6.1;10.7;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2015;2015;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2015;2015;GA;Georgia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2015;2015;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;NMBR;RACE;AIAN;;;;
2015;2015;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.9;8.9;;;6.6;11.8;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;NMBR;GENDER;GENF;;;;
2015;2015;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;CRDRATE;RACE;API;;;;
2015;2015;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;NMBR;RACE;API;;;;
2015;2015;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.1;12.1;;;8.4;17;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2015;2015;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;33.88;33.88;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;31.51;36.25;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2015;2015;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.7;10.7;;;7.3;15.1;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2015;2015;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2015;2015;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;3.6;3.6;;;2.5;4.9;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2015;2015;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2015;2015;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;NMBR;RACE;HIS;;;;
2015;2015;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.8;9.8;;;7.3;12.9;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2015;2015;IN;Indiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST2_1;NMBR;RACE;BLK;;;;
2015;2015;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.7;12.7;;;7.9;19.4;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST4_1;NMBR;GENDER;GENF;;;;
2015;2015;MD;Maryland;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;1668;1,668;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST2_1;NMBR;RACE;HIS;;;;
2015;2015;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;VI;Virgin Islands;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2015;2015;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2015;2015;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.8;9.8;;;7.5;12.5;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;NMBR;RACE;API;;;;
2015;2015;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2015;2015;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;NMBR;RACE;API;;;;
2015;2015;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;CRDRATE;RACE;API;;;;
2015;2015;FL;Florida;NVSS;Asthma;Asthma mortality rate;;;Number;95;95;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;NMBR;RACE;WHT;;;;
2015;2015;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;NMBR;RACE;AIAN;;;;
2015;2015;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;NMBR;RACE;API;;;;
2015;2015;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;NMBR;RACE;AIAN;;;;
2015;2015;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.8;12.8;;;10.2;15.3;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;IL;Illinois;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST2_1;NMBR;RACE;API;;;;
2015;2015;UT;Utah;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;NMBR;RACE;AIAN;;;;
2015;2015;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2015;2015;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;NMBR;RACE;HIS;;;;
2015;2015;MD;Maryland;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;68.82;68.82;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;67.7;69.95;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;NMBR;RACE;AIAN;;;;
2015;2015;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;15.4;15.4;;;10.8;21.2;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2015;2015;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;NMBR;RACE;HIS;;;;
2015;2015;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2015;2015;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;NMBR;RACE;BLK;;;;
2015;2015;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.6;9.6;;;5.9;14.6;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;NMBR;RACE;AIAN;;;;
2015;2015;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;32;32;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;NMBR;RACE;BLK;;;;
2015;2015;KS;Kansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST2_1;NMBR;RACE;HIS;;;;
2015;2015;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2015;2015;FL;Florida;NVSS;Asthma;Asthma mortality rate;;;Number;175;175;;;;;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2015;2015;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;;Number;32;32;;;;;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;NMBR;GENDER;GENM;;;;
2015;2015;UT;Utah;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST2_1;NMBR;RACE;WHT;;;;
2015;2015;OH;Ohio;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST2_1;NMBR;RACE;API;;;;
2015;2015;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.8;7.8;;;6.6;9.1;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2015;2015;MS;Mississippi;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST2_1;NMBR;RACE;API;;;;
2015;2015;CT;Connecticut;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2015;2015;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2015;2015;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.5;7.5;;;5.1;10.7;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2015;2015;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2015;2015;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.1;10.1;;;6.8;14.5;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2015;2015;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;CRDRATE;RACE;API;;;;
2015;2015;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2015;2015;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;6.4;6.4;;;4.5;8.9;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2015;2015;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;NMBR;RACE;API;;;;
2015;2015;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;43.51;43.51;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;42.26;44.76;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;NMBR;RACE;BLK;;;;
2015;2015;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2015;2015;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.2;10.2;;;6.5;15.1;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2015;2015;MS;Mississippi;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2015;2015;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2015;2015;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.3;9.3;;;6.4;13;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;18.7;18.7;;;13.2;25.8;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2015;2015;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2015;2015;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2015;2015;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2015;2015;LA;Louisiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST2_1;NMBR;RACE;BLK;;;;
2015;2015;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.5;8.5;;;6.1;11.5;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.0;12;;;8.8;16;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;VA;Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2015;2015;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;39.2;39.2;;;28.7;52.3;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.3;8.3;;;6;11.2;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;NMBR;RACE;HIS;;;;
2015;2015;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;38.31;38.31;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;36.49;40.14;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2015;2015;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;;Number;36;36;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;NMBR;RACE;WHT;;;;
2015;2015;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2015;2015;WY;Wyoming;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;18.3;18.3;;;12.1;26.4;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2015;2015;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2015;2015;MN;Minnesota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;CRDRATE;RACE;API;;;;
2015;2015;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2015;2015;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;;Number;157;157;;;;;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2015;2015;RI;Rhode Island;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;NM;New Mexico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.4;11.4;;;9.3;13.5;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2015;2015;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;NMBR;RACE;AIAN;;;;
2015;2015;AL;Alabama;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2015;2015;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;379;379;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;NMBR;RACE;API;;;;
2015;2015;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;CRDRATE;RACE;API;;;;
2015;2015;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2015;2015;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;NM;New Mexico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST2_1;NMBR;RACE;WHT;;;;
2015;2015;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.9;10.9;;;8.2;14.1;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2015;2015;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;NY;New York;NVSS;Asthma;Asthma mortality rate;;;Number;122;122;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;NMBR;RACE;WHT;;;;
2015;2015;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.2;12.2;;;9.6;15.2;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.3;14.3;;;10.5;18.9;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2015;2015;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;39.81;39.81;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;38.65;40.97;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2015;2015;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;NMBR;GENDER;GENM;;;;
2015;2015;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.1;10.1;;;7;14;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2015;2015;OR;Oregon;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST2_1;CRDRATE;RACE;API;;;;
2015;2015;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;PA;Pennsylvania;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2015;2015;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;24.8;24.8;;;17.5;34;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2015;2015;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;NMBR;RACE;AIAN;;;;
2015;2015;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;WA;Washington;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;NMBR;RACE;BLK;;;;
2015;2015;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.7;8.7;;;7;10.5;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;CRDRATE;RACE;API;;;;
2015;2015;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;25;25;;;;;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2015;2015;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2015;2015;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2015;2015;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.3;7.3;;;5.9;8.8;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2015;2015;AL;Alabama;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2015;2015;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.3;8.3;;;6.8;10.2;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2015;2015;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;;Number;27;27;;;;;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;NMBR;GENDER;GENM;;;;
2015;2015;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;;Number;58;58;;;;;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;NMBR;GENDER;GENF;;;;
2015;2015;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;CRDRATE;RACE;API;;;;
2015;2015;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2015;2015;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;CRDRATE;RACE;API;;;;
2015;2015;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;;Number;90;90;;;;;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2015;2015;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;;Number;112;112;;;;;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2015;2015;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2015;2015;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST4_1;NMBR;GENDER;GENM;;;;
2015;2015;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2015;2015;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;4.9;4.9;;;3.1;7.4;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.7;13.7;;;11.6;15.8;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;14369;14,369;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;NMBR;RACE;WHT;;;;
2015;2015;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;;Number;114;114;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;NMBR;RACE;WHT;;;;
2015;2015;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;CA;California;NVSS;Asthma;Asthma mortality rate;;;Number;55;55;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;NMBR;RACE;API;;;;
2015;2015;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;;Number;28;28;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;NMBR;RACE;BLK;;;;
2015;2015;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2015;2015;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;;Number;66;66;;;;;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2015;2015;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.9;14.9;;;13.2;16.6;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.4;9.4;;;7.1;12.3;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;MA;Massachusetts;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;61.62;61.62;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;60.63;62.61;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;NM;New Mexico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST2_1;NMBR;GENDER;GENF;;;;
2015;2015;UT;Utah;NVSS;Asthma;Asthma mortality rate;;;Number;40;40;;;;;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2015;2015;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;NMBR;RACE;AIAN;;;;
2015;2015;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;NMBR;RACE;API;;;;
2015;2015;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;NMBR;RACE;BLK;;;;
2015;2015;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;;Number;49;49;;;;;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;NMBR;GENDER;GENF;;;;
2015;2015;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.0;9;;;6.6;11.9;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2015;2015;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2015;2015;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;19.2;19.2;;;14.5;24.9;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;CRDRATE;RACE;API;;;;
2015;2015;RI;Rhode Island;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;49;49;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST2_1;NMBR;RACE;API;;;;
2015;2015;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.1;10.1;;;7.8;12.9;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2015;2015;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.9;10.9;;;6.8;16.5;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;TX;Texas;NVSS;Asthma;Asthma mortality rate;;;Number;99;99;;;;;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;NMBR;GENDER;GENM;;;;
2015;2015;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.1;12.1;;;7.8;17.8;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;NMBR;RACE;API;;;;
2015;2015;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.6;11.6;;;9.7;13.4;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;206.37;206.37;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;203.4;209.34;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2015;2015;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.8;10.8;;;7.5;15;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;;Number;51;51;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;NMBR;RACE;WHT;;;;
2015;2015;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;NMBR;RACE;BLK;;;;
2015;2015;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;NMBR;RACE;API;;;;
2015;2015;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.6;13.6;;;8.8;20;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.8;8.8;;;7.7;9.9;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2015;2015;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.4;10.4;;;7.7;13.8;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;MT;Montana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;NMBR;RACE;AIAN;;;;
2015;2015;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;29.0;29;;;23.2;35.8;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2015;2015;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;CRDRATE;RACE;API;;;;
2015;2015;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;19.1;19.1;;;12.4;28.2;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2015;2015;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2015;2015;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;56;56;;;;;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;NMBR;GENDER;GENF;;;;
2015;2015;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2015;2015;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;NMBR;RACE;HIS;;;;
2015;2015;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;NMBR;RACE;API;;;;
2015;2015;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.2;7.2;;;4.7;10.6;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2015;2015;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;;Number;38;38;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;NMBR;RACE;BLK;;;;
2015;2015;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;NMBR;RACE;BLK;;;;
2015;2015;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2015;2015;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2015;2015;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2015;2015;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;NMBR;RACE;BLK;;;;
2015;2015;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2015;2015;MT;Montana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;NMBR;RACE;HIS;;;;
2015;2015;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;53.94;53.94;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;52.84;55.05;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2015;2015;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2015;2015;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2015;2015;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.7;7.7;;;5.2;11;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;PA;Pennsylvania;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;;Number;38;38;;;;;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;NMBR;GENDER;GENF;;;;
2015;2015;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2015;2015;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;NMBR;RACE;HIS;;;;
2015;2015;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;13.1;13.1;;;11.6;14.7;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;MD;Maryland;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;16635;16,635;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;;;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST2_1;NMBR;GENDER;GENF;;;;
2015;2015;KS;Kansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2015;2015;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2015;2015;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;NMBR;RACE;WHT;;;;
2015;2015;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;;Number;35;35;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;NMBR;RACE;BLK;;;;
2015;2015;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;NMBR;RACE;AIAN;;;;
2015;2015;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;DC;District of Columbia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST2_1;NMBR;RACE;HIS;;;;
2015;2015;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;OH;Ohio;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2015;2015;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;;Number;119;119;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;NMBR;RACE;WHT;;;;
2015;2015;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;MD;Maryland;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;146.36;146.36;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;144.3;148.41;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;NMBR;RACE;API;;;;
2015;2015;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;;Number;20;20;;;;;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;NMBR;GENDER;GENF;;;;
2015;2015;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;NMBR;GENDER;GENF;;;;
2015;2015;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.3;8.3;;;5.3;12.4;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;5.9;5.9;;;4.5;7.7;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;FL;Florida;NVSS;Asthma;Asthma mortality rate;;;Number;65;65;;;;;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;NMBR;GENDER;GENM;;;;
2015;2015;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.2;10.2;;;7.6;13.5;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2015;2015;OH;Ohio;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2015;2015;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.2;7.2;;;5.2;9.8;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;OK;Oklahoma;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;MT;Montana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;NMBR;RACE;WHT;;;;
2015;2015;MI;Michigan;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2015;2015;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2015;2015;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;;Number;64;64;;;;;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2015;2015;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2015;2015;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;98.14;98.14;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;84.48;111.8;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;;Number;56;56;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;NMBR;RACE;WHT;;;;
2015;2015;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2015;2015;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2015;2015;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2015;2015;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;49.42;49.42;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;48.56;50.28;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2015;2015;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2015;2015;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;NMBR;GENDER;GENM;;;;
2015;2015;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.8;12.8;;;8.6;18.3;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2015;2015;AK;Alaska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST2_1;NMBR;GENDER;GENF;;;;
2015;2015;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;NMBR;RACE;HIS;;;;
2015;2015;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.6;11.6;;;8.8;15.1;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;TX;Texas;NVSS;Asthma;Asthma mortality rate;;;Number;66;66;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;NMBR;RACE;BLK;;;;
2015;2015;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;;Number;33;33;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;NMBR;RACE;WHT;;;;
2015;2015;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;NMBR;GENDER;GENM;;;;
2015;2015;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2015;2015;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;NMBR;RACE;AIAN;;;;
2015;2015;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;NMBR;RACE;HIS;;;;
2015;2015;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;CRDRATE;RACE;API;;;;
2015;2015;ID;Idaho;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2015;2015;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;;Number;63;63;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;NMBR;RACE;WHT;;;;
2015;2015;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;50.48;50.48;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;45.87;55.09;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2015;2015;MN;Minnesota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST2_1;NMBR;RACE;WHT;;;;
2015;2015;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;VI;Virgin Islands;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(18.335765, -64.896335);;78;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2015;2015;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.6;8.6;;;6.4;11.4;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;UT;Utah;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2015;2015;AL;Alabama;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2015;2015;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;6.9;6.9;;;5.2;8.9;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;53.52;53.52;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;52.52;54.52;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;48.46;48.46;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;47.54;49.39;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2015;2015;OR;Oregon;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2015;2015;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.5;10.5;;;8.6;12.3;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2015;2015;WA;Washington;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST2_1;NMBR;RACE;BLK;;;;
2015;2015;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;34.5;34.5;;;24.6;47.2;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2015;2015;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;CRDRATE;RACE;API;;;;
2015;2015;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;NMBR;RACE;API;;;;
2015;2015;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;WA;Washington;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;16.5;16.5;;;9.8;26.1;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;NH;New Hampshire;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2015;2015;NY;New York;NVSS;Asthma;Asthma mortality rate;;;Number;60;60;;;;;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;NMBR;RACE;HIS;;;;
2015;2015;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.5;10.5;;;9.2;11.9;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;15.9;15.9;;;10.3;23.5;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2015;2015;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;66.65;66.65;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;65.74;67.56;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2015;2015;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2015;2015;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2015;2015;WY;Wyoming;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;57;57;;;;;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2015;2015;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;72.14;72.14;‡‡‡;Estimate is based on the first 3 quarters of 2015 and is not directly comparable to estimates in prior years due to changes in ICD codes;71.48;72.8;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;ND;North Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2015;2015;DE;Delaware;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;LA;Louisiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2015;2015;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;6.9;6.9;;;4.2;10.8;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.2;10.2;;;7.9;13.1;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.3;11.3;;;7.4;16.6;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;AL;Alabama;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST2_1;NMBR;RACE;BLK;;;;
2015;2015;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2015;2015;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.0;7;;;5.1;9.4;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2015;2015;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;CRDRATE;RACE;API;;;;
2015;2015;AK;Alaska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST2_1;NMBR;RACE;AIAN;;;;
2014;2014;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;7.00;7;;;6.61;7.4;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;AK;Alaska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST3_1;CRDRATE;RACE;API;;;;
2014;2014;PA;Pennsylvania;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2014;2014;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;3.56;3.56;;;3.16;3.96;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;CRDRATE;RACE;API;;;;
2014;2014;VI;Virgin Islands;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2014;2014;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;NMBR;RACE;AIAN;;;;
2015;2015;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2014;2014;TX;Texas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;2.65;2.65;;;2.03;3.28;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;CRDRATE;RACE;API;;;;
2014;2014;PR;Puerto Rico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;30;30;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;NMBR;RACE;BLK;;;;
2014;2014;MT;Montana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2014;2014;ND;North Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;DC;District of Columbia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.907192, -77.036871);;11;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2014;2014;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;14.55;14.55;;;13.52;15.57;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2014;2014;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;132;132;;;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;NMBR;RACE;HIS;;;;
2014;2014;CT;Connecticut;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;ND;North Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST3_1;NMBR;RACE;HIS;;;;
2014;2014;NH;New Hampshire;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2014;2014;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;5.45;5.45;;;4.83;6.06;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2014;2014;ID;Idaho;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2014;2014;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;7.01;7.01;;;6.7;7.31;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2014;2014;NH;New Hampshire;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2014;2014;KS;Kansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2014;2014;PR;Puerto Rico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;CRDRATE;RACE;API;;;;
2015;2015;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2014;2014;GU;Guam;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2014;2014;GA;Georgia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;5.34;5.34;;;5.15;5.53;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;MO;Missouri;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST3_1;NMBR;RACE;WHT;;;;
2014;2014;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;9.04;9.04;;;8.85;9.23;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;OH;Ohio;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST3_1;NMBR;RACE;API;;;;
2014;2014;MT;Montana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2014;2014;ID;Idaho;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2014;2014;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;18.90;18.9;;;18.31;19.48;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;LA;Louisiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST3_1;NMBR;RACE;HIS;;;;
2014;2014;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;13.37;13.37;;;11.3;15.44;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2014;2014;MN;Minnesota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2014;2014;OH;Ohio;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;3.19;3.19;;;2.68;3.69;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2014;2014;MO;Missouri;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;KS;Kansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST3_1;NMBR;RACE;API;;;;
2014;2014;ME;Maine;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST3_1;NMBR;GENDER;GENF;;;;
2014;2014;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;22.20;22.2;;;21.5;22.9;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;GU;Guam;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;VI;Virgin Islands;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(18.335765, -64.896335);;78;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;NMBR;RACE;BLK;;;;
2014;2014;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;7.46;7.46;;;7.27;7.66;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;13.38;13.38;;;10.61;16.15;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;WY;Wyoming;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST3_1;NMBR;RACE;BLK;;;;
2014;2014;VA;Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST3_1;NMBR;RACE;AIAN;;;;
2014;2014;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;6.58;6.58;;;6.24;6.93;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.1;13.1;;;10.2;16.5;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2014;2014;CT;Connecticut;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;ME;Maine;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST3_1;CRDRATE;RACE;API;;;;
2014;2014;TX;Texas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2015;2015;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;377;377;;;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;NMBR;RACE;HIS;;;;
2014;2014;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;6.13;6.13;;;5.56;6.7;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;ID;Idaho;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2014;2014;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;5.97;5.97;;;5.75;6.19;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;CRDRATE;RACE;API;;;;
2014;2014;KS;Kansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2014;2014;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;5.15;5.15;;;4.52;5.79;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2014;2014;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;MN;Minnesota;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST3_1;NMBR;RACE;BLK;;;;
2014;2014;MT;Montana;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST3_1;NMBR;RACE;API;;;;
2014;2014;CT;Connecticut;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2014;2014;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;NMBR;RACE;BLK;;;;
2014;2014;IN;Indiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;AL;Alabama;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST3_1;NMBR;RACE;API;;;;
2014;2014;GA;Georgia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2014;2014;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;34.39;34.39;;;33.44;35.34;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2014;2014;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2014;2014;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;806;806;;;;;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;NMBR;RACE;HIS;;;;
2014;2014;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2014;2014;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1948;1,948;;;;;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;NMBR;GENDER;GENM;;;;
2014;2014;GA;Georgia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;10.99;10.99;;;10.7;11.27;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2014;2014;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;14.73;14.73;;;14.48;14.98;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;GU;Guam;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(13.444304, 144.793731);;66;AST;AST3_1;NMBR;RACE;AIAN;;;;
2014;2014;AL;Alabama;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST3_1;NMBR;RACE;BLK;;;;
2014;2014;LA;Louisiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST3_1;NMBR;RACE;AIAN;;;;
2014;2014;CT;Connecticut;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST3_1;NMBR;RACE;API;;;;
2014;2014;VI;Virgin Islands;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2014;2014;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2014;2014;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;25.86;25.86;;;25.31;26.42;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2014;2014;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;8985;8,985;;;;;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2014;2014;IN;Indiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST3_1;CRDRATE;RACE;API;;;;
2014;2014;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;VI;Virgin Islands;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST3_1;NMBR;RACE;WHT;;;;
2014;2014;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;3.06;3.06;;;2.32;3.8;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2014;2014;GA;Georgia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST3_1;NMBR;RACE;AIAN;;;;
2014;2014;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;10.20;10.2;;;9.99;10.4;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2014;2014;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;9.64;9.64;;;9.31;9.97;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;IN;Indiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;20.54;20.54;;;18.79;22.29;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2014;2014;LA;Louisiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;MN;Minnesota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;6.04;6.04;;;5.84;6.25;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.9;14.9;;;10.9;19.8;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2014;2014;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;14.10;14.1;;;13.6;14.59;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2014;2014;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2014;2014;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;9.45;9.45;;;8.57;10.34;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1968;1,968;;;;;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2014;2014;GU;Guam;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(13.444304, 144.793731);;66;AST;AST3_1;NMBR;RACE;API;;;;
2014;2014;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;798;798;;;;;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;NMBR;GENDER;GENM;;;;
2014;2014;VI;Virgin Islands;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;VA;Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;2217;2,217;;;;;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2014;2014;PA;Pennsylvania;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;5702;5,702;;;;;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2014;2014;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;5.95;5.95;;;4.12;7.78;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;4.81;4.81;;;4.57;5.06;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2014;2014;AK;Alaska;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST3_1;NMBR;RACE;AIAN;;;;
2014;2014;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;8.80;8.8;;;8.17;9.43;Race/Ethnicity;Asian or Pacific Islander;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2014;2014;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;994;994;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;NMBR;RACE;BLK;;;;
2014;2014;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;8.78;8.78;;;8.09;9.48;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2014;2014;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;741;741;;;;;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;NMBR;GENDER;GENM;;;;
2014;2014;TN;Tennessee;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;158;158;;;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;NMBR;RACE;AIAN;;;;
2014;2014;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1055;1,055;;;;;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;NMBR;GENDER;GENF;;;;
2014;2014;GA;Georgia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;5681;5,681;;;;;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST3_1;NMBR;GENDER;GENF;;;;
2014;2014;IL;Illinois;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST3_1;NMBR;RACE;WHT;;;;
2015;2015;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;VI;Virgin Islands;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2014;2014;OK;Oklahoma;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2014;2014;KS;Kansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;20.29;20.29;;;17.43;23.14;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;29;29;;;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;NMBR;RACE;AIAN;;;;
2014;2014;ME;Maine;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;PA;Pennsylvania;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2014;2014;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;26.33;26.33;;;25.75;26.9;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;AK;Alaska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2014;2014;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;97;97;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;NMBR;RACE;BLK;;;;
2014;2014;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;115;115;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;NMBR;RACE;API;;;;
2014;2014;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2014;2014;VI;Virgin Islands;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2015;2015;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2015;2015;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.5;10.5;;;8.4;12.5;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;CT;Connecticut;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2014;2014;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2014;2014;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;10.83;10.83;;;10.55;11.12;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2014;2014;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;NMBR;RACE;HIS;;;;
2014;2014;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;9.02;9.02;;;8.37;9.67;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2014;2014;WY;Wyoming;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST3_1;NMBR;RACE;HIS;;;;
2015;2015;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;NMBR;RACE;HIS;;;;
2014;2014;IN;Indiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2014;2014;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;19.30;19.3;;;19.03;19.57;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2014;2014;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;8.53;8.53;;;3.97;13.08;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;462;462;;;;;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;NMBR;GENDER;GENM;;;;
2014;2014;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;9.14;9.14;;;8.64;9.64;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2014;2014;DE;Delaware;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2014;2014;OK;Oklahoma;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;7.79;7.79;;;7.15;8.42;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;17.0;17;;;11.8;23.7;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;AL;Alabama;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;NMBR;RACE;AIAN;;;;
2014;2014;PR;Puerto Rico;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(18.220833, -66.590149);;72;AST;AST3_1;NMBR;RACE;AIAN;;;;
2014;2014;TX;Texas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;5.74;5.74;;;5.35;6.13;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2014;2014;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;7.01;7.01;;;5.05;8.97;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2014;2014;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;12.58;12.58;;;12.35;12.8;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;MO;Missouri;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2014;2014;ND;North Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2014;2014;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;GA;Georgia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;1.30;1.3;;;0.95;1.65;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST3_1;CRDRATE;RACE;API;;;;
2014;2014;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;3.84;3.84;;;3.32;4.36;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;13.52;13.52;;;11.8;15.25;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2014;2014;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;NMBR;RACE;AIAN;;;;
2014;2014;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;NMBR;RACE;HIS;;;;
2015;2015;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2014;2014;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;10.83;10.83;;;10.52;11.13;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2015;2015;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;;Number;36;36;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;NMBR;RACE;WHT;;;;
2015;2015;CA;California;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;NMBR;RACE;AIAN;;;;
2014;2014;MN;Minnesota;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST3_1;NMBR;RACE;HIS;;;;
2014;2014;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;3158;3,158;;;;;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;NMBR;GENDER;GENF;;;;
2015;2015;FL;Florida;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;NMBR;RACE;API;;;;
2014;2014;ID;Idaho;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;CT;Connecticut;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST3_1;NMBR;RACE;AIAN;;;;
2014;2014;AK;Alaska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2014;2014;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;7.03;7.03;;;6.61;7.45;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;926;926;;;;;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;NMBR;GENDER;GENM;;;;
2014;2014;AL;Alabama;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;LA;Louisiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2014;2014;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;NH;New Hampshire;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;MT;Montana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2014;2014;OK;Oklahoma;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2014;2014;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;5.21;5.21;;;4.95;5.47;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;ME;Maine;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;NMBR;RACE;API;;;;
2014;2014;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;4.95;4.95;;;4.24;5.66;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2014;2014;PA;Pennsylvania;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;VA;Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;KS;Kansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;IL;Illinois;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST3_1;NMBR;RACE;HIS;;;;
2014;2014;PA;Pennsylvania;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST3_1;NMBR;RACE;HIS;;;;
2014;2014;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;14.83;14.83;;;14.58;15.08;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;14.08;14.08;;;13.32;14.84;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2014;2014;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;9.69;9.69;;;8.98;10.4;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;9.70;9.7;;;9.42;9.98;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2014;2014;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;62;62;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;NMBR;RACE;API;;;;
2015;2015;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;NMBR;GENDER;GENM;;;;
2014;2014;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;8.41;8.41;;;7.54;9.29;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;WY;Wyoming;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST3_1;NMBR;RACE;WHT;;;;
2014;2014;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;IN;Indiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2014;2014;OK;Oklahoma;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;TX;Texas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;MO;Missouri;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;DC;District of Columbia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;22.95;22.95;;;21.7;24.2;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;CRDRATE;RACE;API;;;;
2014;2014;ME;Maine;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.3;14.3;;;10.1;19.5;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2014;2014;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;6.29;6.29;;;5.88;6.69;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2014;2014;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;7.49;7.49;;;7.12;7.86;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;171;171;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;NMBR;RACE;BLK;;;;
2014;2014;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;7.83;7.83;;;7.5;8.17;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;GA;Georgia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;1.78;1.78;;;1.26;2.31;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2014;2014;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;286;286;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;NMBR;RACE;API;;;;
2014;2014;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;13.18;13.18;;;10.52;15.85;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2015;2015;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;;Number;27;27;;;;;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;NMBR;GENDER;GENM;;;;
2015;2015;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;NMBR;RACE;WHT;;;;
2015;2015;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.9;12.9;;;9.6;17;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;10.11;10.11;;;9.59;10.62;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;OH;Ohio;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST3_1;NMBR;RACE;AIAN;;;;
2014;2014;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;NMBR;RACE;API;;;;
2014;2014;OH;Ohio;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST3_1;NMBR;RACE;BLK;;;;
2014;2014;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;4.52;4.52;;;4.29;4.74;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;DC;District of Columbia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1368;1,368;;;;;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2014;2014;NH;New Hampshire;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2015;2015;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.5;12.5;;;10;15.4;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;DC;District of Columbia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.907192, -77.036871);;11;AST;AST3_1;NMBR;RACE;API;;;;
2015;2015;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2014;2014;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1619;1,619;;;;;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;NMBR;GENDER;GENM;;;;
2014;2014;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;3.88;3.88;;;3.39;4.36;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;MN;Minnesota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;5.90;5.9;;;5.69;6.1;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;20.51;20.51;;;18.74;22.29;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.4;38.4;;;32.6;44.4;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2014;2014;WY;Wyoming;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST3_1;NMBR;GENDER;GENF;;;;
2014;2014;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2014;2014;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2014;2014;NH;New Hampshire;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST3_1;NMBR;RACE;WHT;;;;
2014;2014;CT;Connecticut;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST3_1;NMBR;RACE;WHT;;;;
2014;2014;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;9.07;9.07;;;8.66;9.49;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2014;2014;PR;Puerto Rico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;IN;Indiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST3_1;NMBR;RACE;API;;;;
2014;2014;GU;Guam;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(13.444304, 144.793731);;66;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2014;2014;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;75;75;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;NMBR;RACE;API;;;;
2015;2015;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;NMBR;GENDER;GENF;;;;
2015;2015;ME;Maine;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;NMBR;GENDER;GENM;;;;
2014;2014;VI;Virgin Islands;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST3_1;NMBR;RACE;BLK;;;;
2014;2014;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;NMBR;RACE;WHT;;;;
2014;2014;AK;Alaska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2014;2014;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;NMBR;RACE;API;;;;
2015;2015;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2014;2014;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;NMBR;RACE;API;;;;
2015;2015;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;30.4;30.4;;;18.8;46.4;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;ME;Maine;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST3_1;NMBR;RACE;WHT;;;;
2014;2014;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;10.47;10.47;;;10.17;10.78;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;TN;Tennessee;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST3_1;NMBR;RACE;HIS;;;;
2014;2014;DC;District of Columbia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.907192, -77.036871);;11;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;9.55;9.55;;;8.8;10.31;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;VA;Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST3_1;NMBR;RACE;HIS;;;;
2014;2014;OK;Oklahoma;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST3_1;NMBR;RACE;API;;;;
2014;2014;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;15.48;15.48;;;13.69;17.28;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;CRDRATE;RACE;API;;;;
2015;2015;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;NMBR;GENDER;GENF;;;;
2015;2015;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2014;2014;VI;Virgin Islands;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST3_1;NMBR;GENDER;GENF;;;;
2014;2014;ID;Idaho;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST3_1;NMBR;GENDER;GENF;;;;
2014;2014;TN;Tennessee;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;MT;Montana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2015;2015;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2014;2014;MO;Missouri;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2014;2014;LA;Louisiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2014;2014;TX;Texas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;NH;New Hampshire;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2014;2014;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;11.37;11.37;;;11.17;11.57;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2014;2014;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;12.98;12.98;;;12.66;13.31;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;GU;Guam;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2014;2014;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;3224;3,224;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;NMBR;RACE;WHT;;;;
2015;2015;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;NMBR;RACE;API;;;;
2014;2014;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;5.12;5.12;;;4.74;5.49;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2015;2015;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;NMBR;RACE;AIAN;;;;
2014;2014;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;3983;3,983;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;NMBR;RACE;BLK;;;;
2014;2014;DC;District of Columbia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;895;895;;;;;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST3_1;NMBR;GENDER;GENF;;;;
2014;2014;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1889;1,889;;;;;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2014;2014;OK;Oklahoma;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST3_1;NMBR;RACE;WHT;;;;
2014;2014;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;9916;9,916;;;;;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;NMBR;GENDER;GENM;;;;
2014;2014;TN;Tennessee;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;7.28;7.28;;;6.74;7.82;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2014;2014;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;CRDRATE;RACE;API;;;;
2014;2014;GU;Guam;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST3_1;NMBR;RACE;BLK;;;;
2014;2014;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;1.20;1.2;;;1.05;1.34;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;;Number;111;111;;;;;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;NMBR;GENDER;GENF;;;;
2014;2014;IL;Illinois;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;VA;Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;TN;Tennessee;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST3_1;NMBR;RACE;BLK;;;;
2014;2014;KS;Kansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2014;2014;PA;Pennsylvania;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST3_1;NMBR;GENDER;GENF;;;;
2014;2014;KS;Kansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2014;2014;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;6.58;6.58;;;5.99;7.18;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2014;2014;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;16.73;16.73;;;16.36;17.1;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;9.03;9.03;;;8.53;9.53;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;PR;Puerto Rico;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(18.220833, -66.590149);;72;AST;AST3_1;NMBR;RACE;API;;;;
2014;2014;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2014;2014;TX;Texas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;MT;Montana;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST3_1;NMBR;GENDER;GENF;;;;
2014;2014;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;13.55;13.55;;;10.59;16.5;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;TN;Tennessee;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2014;2014;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;2294;2,294;;;;;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;NMBR;GENDER;GENM;;;;
2014;2014;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;8.96;8.96;;;8.06;9.86;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2014;2014;MT;Montana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST3_1;CRDRATE;RACE;API;;;;
2014;2014;AL;Alabama;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;GU;Guam;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(13.444304, 144.793731);;66;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2014;2014;CT;Connecticut;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST3_1;CRDRATE;RACE;API;;;;
2014;2014;TN;Tennessee;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2014;2014;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;9.90;9.9;;;9.44;10.36;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;26.29;26.29;;;24.66;27.93;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2014;2014;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;14.28;14.28;;;14.04;14.52;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2014;2014;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;12.45;12.45;;;11.77;13.12;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;CT;Connecticut;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2014;2014;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;7.30;7.3;;;5.7;8.9;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2014;2014;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;OK;Oklahoma;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;4.51;4.51;;;4.08;4.94;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2014;2014;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;37;37;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;NMBR;RACE;BLK;;;;
2014;2014;TX;Texas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2014;2014;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;7.18;7.18;;;5.07;9.29;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.5;34.5;;;28.4;41.2;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2015;2015;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;CRDRATE;RACE;API;;;;
2014;2014;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2014;2014;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;6.77;6.77;;;6.42;7.13;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2014;2014;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;2080;2,080;;;;;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2014;2014;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2014;2014;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;13.24;13.24;;;11.79;14.69;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2014;2014;TN;Tennessee;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST3_1;NMBR;RACE;WHT;;;;
2014;2014;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;NMBR;RACE;API;;;;
2014;2014;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;11.70;11.7;;;7.47;15.94;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.9;7.9;;;6.7;9.2;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;IN;Indiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.3;31.3;;;24.2;39.5;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;MN;Minnesota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;TX;Texas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.4;10.4;;;6.8;15.3;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;PR;Puerto Rico;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST3_1;NMBR;RACE;HIS;;;;
2014;2014;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;5.07;5.07;;;4.6;5.53;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2014;2014;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;NMBR;RACE;API;;;;
2015;2015;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;NMBR;RACE;WHT;;;;
2014;2014;WY;Wyoming;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;CT;Connecticut;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2014;2014;MN;Minnesota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;6.66;6.66;;;6.35;6.96;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;IN;Indiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST3_1;NMBR;RACE;WHT;;;;
2014;2014;OH;Ohio;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;3.31;3.31;;;2.74;3.87;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2014;2014;OK;Oklahoma;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;5.45;5.45;;;4.3;6.6;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;PA;Pennsylvania;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;NMBR;RACE;API;;;;
2014;2014;LA;Louisiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;16.09;16.09;;;15.84;16.34;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;;Number;50;50;;;;;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;NMBR;GENDER;GENM;;;;
2014;2014;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;3.51;3.51;;;2.57;4.44;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2014;2014;VI;Virgin Islands;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;4242;4,242;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;NMBR;RACE;BLK;;;;
2014;2014;ND;North Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2014;2014;DC;District of Columbia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;2.90;2.9;;;2.05;3.75;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;152;152;;;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;NMBR;RACE;HIS;;;;
2015;2015;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;NMBR;RACE;API;;;;
2014;2014;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;38.20;38.2;;;37.48;38.91;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;4.21;4.21;;;3.72;4.71;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2014;2014;TX;Texas;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST3_1;NMBR;RACE;API;;;;
2014;2014;LA;Louisiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.9;10.9;;;8.9;12.8;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2015;2015;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;8.30;8.3;;;8.08;8.52;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;96;96;;;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;NMBR;RACE;AIAN;;;;
2014;2014;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;256;256;;;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;NMBR;RACE;HIS;;;;
2014;2014;TX;Texas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2014;2014;VA;Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2014;2014;NH;New Hampshire;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2014;2014;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2014;2014;ND;North Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2014;2014;DC;District of Columbia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;5.10;5.1;;;3.41;6.79;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2014;2014;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;15.03;15.03;;;12.52;17.54;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2014;2014;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;CRDRATE;RACE;API;;;;
2014;2014;WY;Wyoming;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;2.45;2.45;;;1.9;3.01;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;CRDRATE;RACE;API;;;;
2014;2014;OH;Ohio;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;LA;Louisiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2014;2014;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;1.80;1.8;;;1.23;2.37;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2014;2014;KS;Kansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2015;2015;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.907192, -77.036871);;11;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;36.7;36.7;;;25.8;50.6;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;NMBR;RACE;WHT;;;;
2014;2014;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;12.33;12.33;;;11.99;12.66;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;17.51;17.51;;;16.8;18.21;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;15.05;15.05;;;14.71;15.38;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;AL;Alabama;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;187;187;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;NMBR;RACE;WHT;;;;
2014;2014;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;31;31;;;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;NMBR;RACE;AIAN;;;;
2014;2014;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;15.55;15.55;;;14.96;16.13;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2015;2015;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2015;2015;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2014;2014;VA;Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2015;2015;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.0;10;;;7.8;12.6;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;LA;Louisiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST3_1;CRDRATE;RACE;API;;;;
2014;2014;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;18.10;18.1;;;17.71;18.49;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2014;2014;DE;Delaware;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST3_1;NMBR;RACE;AIAN;;;;
2014;2014;MT;Montana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2014;2014;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;7.23;7.23;;;6.91;7.55;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;4.15;4.15;;;3.72;4.58;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2014;2014;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;6.70;6.7;;;6.21;7.18;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2014;2014;DE;Delaware;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST3_1;NMBR;GENDER;GENM;;;;
2014;2014;WY;Wyoming;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2014;2014;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;24;24;;;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;NMBR;RACE;AIAN;;;;
2014;2014;GU;Guam;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;4726;4,726;;;;;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;NMBR;GENDER;GENM;;;;
2014;2014;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;1.52;1.52;;;1.06;1.97;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;CRDRATE;RACE;API;;;;
2015;2015;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.7;11.7;;;9;14.9;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;OH;Ohio;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2014;2014;LA;Louisiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST3_1;NMBR;GENDER;GENM;;;;
2014;2014;ND;North Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;;Number;58;58;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;NMBR;RACE;WHT;;;;
2014;2014;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2014;2014;VI;Virgin Islands;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;IN;Indiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2014;2014;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;6035;6,035;;;;;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;NMBR;RACE;HIS;;;;
2014;2014;CT;Connecticut;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2014;2014;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;NMBR;RACE;AIAN;;;;
2015;2015;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;22;22;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;NMBR;RACE;WHT;;;;
2014;2014;MN;Minnesota;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST3_1;NMBR;RACE;WHT;;;;
2014;2014;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;320;320;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;NMBR;RACE;BLK;;;;
2014;2014;PA;Pennsylvania;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2015;2015;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;NMBR;RACE;HIS;;;;
2015;2015;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;;Number;25;25;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;NMBR;RACE;BLK;;;;
2015;2015;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2014;2014;VI;Virgin Islands;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2014;2014;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;GA;Georgia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;3.88;3.88;;;3.27;4.5;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;IL;Illinois;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2014;2014;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;13.22;13.22;;;12.74;13.69;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;TN;Tennessee;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST3_1;NMBR;GENDER;GENF;;;;
2015;2015;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.1;11.1;;;8;14.8;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;AL;Alabama;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;33302;33,302;;;;;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2014;2014;GU;Guam;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;TN;Tennessee;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST3_1;NMBR;RACE;AIAN;;;;
2014;2014;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2014;2014;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2014;2014;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2014;2014;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1535;1,535;;;;;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2014;2014;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;8094;8,094;;;;;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;NMBR;GENDER;GENF;;;;
2014;2014;DE;Delaware;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST3_1;NMBR;RACE;HIS;;;;
2015;2015;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.3;9.3;;;6.8;12.4;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;17.7;17.7;;;11.6;25.7;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;CRDRATE;RACE;API;;;;
2014;2014;NH;New Hampshire;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2014;2014;WY;Wyoming;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;UT;Utah;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;NMBR;RACE;BLK;;;;
2015;2015;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;NMBR;RACE;AIAN;;;;
2014;2014;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;8.02;8.02;;;7.82;8.22;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2014;2014;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1392;1,392;;;;;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;NMBR;RACE;HIS;;;;
2015;2015;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;;Number;27;27;;;;;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;NMBR;GENDER;GENM;;;;
2014;2014;AL;Alabama;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2014;2014;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;7.37;7.37;;;6.8;7.95;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;ME;Maine;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;8261;8,261;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;NMBR;RACE;BLK;;;;
2014;2014;WY;Wyoming;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2014;2014;AK;Alaska;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2014;2014;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;227;227;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;NMBR;RACE;API;;;;
2014;2014;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;6.39;6.39;;;6.04;6.74;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2014;2014;LA;Louisiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;MN;Minnesota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;7.06;7.06;;;6.75;7.37;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2014;2014;GA;Georgia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;8.89;8.89;;;8.71;9.08;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;CRDRATE;RACE;API;;;;
2015;2015;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;MO;Missouri;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2014;2014;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;NMBR;GENDER;GENF;;;;
2014;2014;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;10.49;10.49;;;9.77;11.2;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2014;2014;MO;Missouri;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST3_1;NMBR;RACE;API;;;;
2014;2014;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;23.65;23.65;;;23.15;24.14;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2014;2014;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;6.36;6.36;;;5.61;7.12;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;MO;Missouri;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST3_1;NMBR;RACE;AIAN;;;;
2014;2014;PA;Pennsylvania;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;10.64;10.64;;;10.26;11.01;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2015;2015;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;;Number;28;28;;;;;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;NMBR;GENDER;GENF;;;;
2014;2014;ME;Maine;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1496;1,496;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;NMBR;RACE;WHT;;;;
2014;2014;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;13.43;13.43;;;8.06;18.81;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2014;2014;MO;Missouri;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;6.97;6.97;;;6.43;7.5;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;NMBR;RACE;BLK;;;;
2014;2014;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2014;2014;OH;Ohio;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;5.63;5.63;;;4.43;6.84;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2014;2014;LA;Louisiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2014;2014;TN;Tennessee;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2014;2014;GA;Georgia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;229;229;;;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST3_1;NMBR;RACE;HIS;;;;
2014;2014;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1313;1,313;;;;;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2014;2014;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;15.17;15.17;;;14.92;15.43;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;TX;Texas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;CRDRATE;RACE;API;;;;
2014;2014;TX;Texas;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST3_1;NMBR;RACE;BLK;;;;
2014;2014;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;CRDRATE;RACE;API;;;;
2014;2014;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;7.64;7.64;;;7.29;7.98;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;180;180;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;NMBR;RACE;API;;;;
2014;2014;ND;North Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST3_1;NMBR;GENDER;GENM;;;;
2014;2014;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;6.39;6.39;;;6.01;6.77;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;MN;Minnesota;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;3297;3,297;;;;;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2014;2014;PR;Puerto Rico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(18.220833, -66.590149);;72;AST;AST3_1;CRDRATE;RACE;API;;;;
2014;2014;NH;New Hampshire;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;OK;Oklahoma;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;ID;Idaho;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST3_1;NMBR;RACE;AIAN;;;;
2014;2014;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;NMBR;RACE;AIAN;;;;
2014;2014;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;20.54;20.54;;;13.5;27.58;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;4.39;4.39;;;4.05;4.73;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;19.7;19.7;;;12.5;29.6;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;IL;Illinois;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST3_1;CRDRATE;RACE;API;;;;
2015;2015;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2014;2014;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;KS;Kansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST3_1;NMBR;RACE;HIS;;;;
2014;2014;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;233;233;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;NMBR;RACE;WHT;;;;
2015;2015;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;NMBR;RACE;AIAN;;;;
2015;2015;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;NMBR;RACE;API;;;;
2015;2015;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;OK;Oklahoma;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2014;2014;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;NMBR;GENDER;GENM;;;;
2014;2014;AL;Alabama;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST3_1;NMBR;RACE;AIAN;;;;
2014;2014;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;5.54;5.54;;;4.5;6.58;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2014;2014;WY;Wyoming;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST3_1;NMBR;RACE;AIAN;;;;
2014;2014;KS;Kansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST3_1;CRDRATE;RACE;API;;;;
2014;2014;MO;Missouri;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;TX;Texas;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST3_1;NMBR;RACE;HIS;;;;
2014;2014;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;2083;2,083;;;;;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;NMBR;GENDER;GENF;;;;
2014;2014;WY;Wyoming;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2014;2014;ME;Maine;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2014;2014;GU;Guam;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST3_1;NMBR;RACE;WHT;;;;
2014;2014;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;GA;Georgia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;2.46;2.46;;;2.14;2.77;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2014;2014;ND;North Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;ME;Maine;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST3_1;NMBR;RACE;API;;;;
2014;2014;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1506;1,506;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;NMBR;RACE;WHT;;;;
2014;2014;GA;Georgia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;9057;9,057;;;;;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2014;2014;MT;Montana;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST3_1;NMBR;RACE;AIAN;;;;
2014;2014;ID;Idaho;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST3_1;NMBR;GENDER;GENM;;;;
2015;2015;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.907192, -77.036871);;11;AST;AST4_1;NMBR;RACE;AIAN;;;;
2014;2014;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;3.03;3.03;;;2.59;3.48;Race/Ethnicity;Asian or Pacific Islander;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;CRDRATE;RACE;API;;;;
2014;2014;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;6.55;6.55;;;6.28;6.82;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2015;2015;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;NMBR;RACE;AIAN;;;;
2014;2014;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;6.57;6.57;;;5.8;7.34;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2014;2014;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;5397;5,397;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;NMBR;RACE;WHT;;;;
2014;2014;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;134;134;;;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;NMBR;RACE;HIS;;;;
2014;2014;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;3.97;3.97;;;3.46;4.49;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;KS;Kansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;7795;7,795;;;;;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2014;2014;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;5.44;5.44;;;5.26;5.61;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;DC;District of Columbia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;37.78;37.78;;;35.62;39.93;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;16.8;16.8;;;10.9;24.8;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2015;2015;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;NMBR;RACE;API;;;;
2014;2014;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;WY;Wyoming;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;8.56;8.56;;;7.23;9.9;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2014;2014;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;7.18;7.18;;;4.18;10.18;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2014;2014;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2014;2014;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2014;2014;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;5.71;5.71;;;4.97;6.45;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;IN;Indiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2014;2014;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;8.39;8.39;;;6.43;10.35;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;VA;Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2014;2014;MT;Montana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2015;2015;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;NMBR;RACE;API;;;;
2014;2014;ME;Maine;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2014;2014;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;16.50;16.5;;;14.43;18.57;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2014;2014;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;6.35;6.35;;;6.12;6.58;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2014;2014;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;270;270;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;NMBR;RACE;WHT;;;;
2014;2014;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;57;57;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;NMBR;RACE;API;;;;
2014;2014;PR;Puerto Rico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(18.220833, -66.590149);;72;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2014;2014;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;3033;3,033;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;NMBR;RACE;WHT;;;;
2014;2014;OH;Ohio;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;DE;Delaware;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2014;2014;PR;Puerto Rico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2014;2014;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;11.87;11.87;;;10.61;13.14;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;ID;Idaho;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2014;2014;TX;Texas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2014;2014;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;3.37;3.37;;;2.8;3.94;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;CRDRATE;RACE;API;;;;
2014;2014;GU;Guam;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST3_1;NMBR;RACE;HIS;;;;
2014;2014;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2014;2014;TN;Tennessee;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;423;423;;;;;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;NMBR;GENDER;GENM;;;;
2014;2014;TN;Tennessee;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2014;2014;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;NMBR;RACE;AIAN;;;;
2015;2015;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.1;8.1;;;6.1;10.5;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;IL;Illinois;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;;Number;159;159;;;;;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2014;2014;MN;Minnesota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;5.01;5.01;;;4.74;5.28;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2014;2014;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;ID;Idaho;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST3_1;NMBR;RACE;BLK;;;;
2014;2014;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;NMBR;RACE;API;;;;
2015;2015;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;16.2;16.2;;;10.5;24;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2014;2014;ME;Maine;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2014;2014;MO;Missouri;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2014;2014;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;16.70;16.7;;;15.52;17.89;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;4.91;4.91;;;4.72;5.1;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2014;2014;ME;Maine;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2014;2014;VA;Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST3_1;CRDRATE;RACE;API;;;;
2014;2014;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;4.93;4.93;;;4.57;5.28;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;NMBR;RACE;API;;;;
2014;2014;OK;Oklahoma;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST3_1;NMBR;GENDER;GENF;;;;
2014;2014;KS;Kansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;74;74;;;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;NMBR;RACE;HIS;;;;
2014;2014;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;745;745;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;NMBR;RACE;WHT;;;;
2014;2014;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;2004;2,004;;;;;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;NMBR;GENDER;GENM;;;;
2014;2014;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;DC;District of Columbia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;473;473;;;;;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST3_1;NMBR;GENDER;GENM;;;;
2015;2015;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2014;2014;DE;Delaware;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2014;2014;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2014;2014;MO;Missouri;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST3_1;CRDRATE;RACE;API;;;;
2014;2014;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;3.80;3.8;;;3.14;4.45;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2014;2014;VI;Virgin Islands;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2014;2014;AK;Alaska;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST3_1;NMBR;RACE;WHT;;;;
2015;2015;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2014;2014;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;NMBR;GENDER;GENF;;;;
2014;2014;IL;Illinois;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;241;241;;;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;NMBR;RACE;AIAN;;;;
2014;2014;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;94;94;;;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;NMBR;RACE;AIAN;;;;
2014;2014;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;5.74;5.74;;;5.39;6.08;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2015;2015;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.1;8.1;;;5.6;11.4;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;TX;Texas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST3_1;CRDRATE;RACE;API;;;;
2014;2014;OK;Oklahoma;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST3_1;NMBR;RACE;HIS;;;;
2014;2014;DC;District of Columbia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;17.12;17.12;;;15.53;18.71;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2015;2015;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;NMBR;GENDER;GENM;;;;
2014;2014;OH;Ohio;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST3_1;NMBR;RACE;HIS;;;;
2014;2014;ME;Maine;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;VI;Virgin Islands;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST3_1;NMBR;GENDER;GENM;;;;
2014;2014;IL;Illinois;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;DC;District of Columbia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;35;35;;;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST3_1;NMBR;RACE;HIS;;;;
2014;2014;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;12.20;12.2;;;11.52;12.88;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;4.69;4.69;;;4.35;5.04;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2014;2014;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;34.84;34.84;;;33.86;35.82;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;WY;Wyoming;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST3_1;CRDRATE;RACE;API;;;;
2014;2014;DC;District of Columbia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;27.80;27.8;;;25.92;29.68;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2014;2014;DC;District of Columbia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;20.73;20.73;;;19.63;21.83;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;IN;Indiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2015;2015;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2014;2014;DC;District of Columbia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;2.07;2.07;;;1.5;2.65;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2014;2014;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;916;916;;;;;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;NMBR;GENDER;GENM;;;;
2014;2014;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;2686;2,686;;;;;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;NMBR;RACE;HIS;;;;
2015;2015;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2014;2014;OK;Oklahoma;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST3_1;CRDRATE;RACE;API;;;;
2014;2014;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;4.39;4.39;;;4.17;4.61;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2014;2014;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;7.43;7.43;;;7;7.87;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2014;2014;VA;Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2015;2015;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST4_1;NMBR;RACE;BLK;;;;
2014;2014;VA;Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2014;2014;ND;North Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2014;2014;VI;Virgin Islands;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(18.335765, -64.896335);;78;AST;AST3_1;CRDRATE;RACE;API;;;;
2014;2014;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;12.73;12.73;;;10.19;15.28;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2014;2014;PA;Pennsylvania;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST3_1;NMBR;RACE;API;;;;
2014;2014;DC;District of Columbia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1242;1,242;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST3_1;NMBR;RACE;BLK;;;;
2014;2014;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;25.31;25.31;;;21.51;29.1;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2014;2014;ME;Maine;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2014;2014;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;19.12;19.12;;;16.63;21.6;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2014;2014;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;7.54;7.54;;;7.38;7.7;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2014;2014;IL;Illinois;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST3_1;NMBR;GENDER;GENF;;;;
2014;2014;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;5.29;5.29;;;3.36;7.21;Race/Ethnicity;American Indian or Alaska Native;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;650;650;;;;;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;NMBR;GENDER;GENM;;;;
2014;2014;PA;Pennsylvania;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2014;2014;TX;Texas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2014;2014;ME;Maine;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2014;2014;OH;Ohio;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST3_1;NMBR;RACE;WHT;;;;
2014;2014;IN;Indiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;KS;Kansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2014;2014;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;306;306;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;NMBR;RACE;API;;;;
2015;2015;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2015;2015;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;;Number;116;116;;;;;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2014;2014;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1195;1,195;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;NMBR;RACE;WHT;;;;
2014;2014;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;3.59;3.59;;;2.62;4.57;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2014;2014;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;4.80;4.8;;;4.45;5.14;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2014;2014;TN;Tennessee;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2014;2014;ID;Idaho;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;5.22;5.22;;;4.95;5.49;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2015;2015;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;12.59;12.59;;;11.88;13.31;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;NH;New Hampshire;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST3_1;NMBR;RACE;API;;;;
2015;2015;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.1;11.1;;;8.8;13.9;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;TN;Tennessee;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;9.03;9.03;;;8.62;9.44;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;5133;5,133;;;;;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2014;2014;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;NMBR;RACE;AIAN;;;;
2015;2015;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;;Number;45;45;;;;;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;NMBR;GENDER;GENF;;;;
2014;2014;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;3.11;3.11;;;2.49;3.73;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2014;2014;ND;North Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST3_1;NMBR;RACE;AIAN;;;;
2014;2014;GU;Guam;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(13.444304, 144.793731);;66;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;AK;Alaska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;19.96;19.96;;;13.25;26.67;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2015;2015;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2014;2014;IL;Illinois;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2014;2014;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;13.58;13.58;;;10.53;16.64;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2014;2014;DE;Delaware;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2014;2014;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;5.01;5.01;;;3.17;6.85;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;AK;Alaska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2014;2014;NH;New Hampshire;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST3_1;NMBR;RACE;HIS;;;;
2014;2014;PR;Puerto Rico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;22.09;22.09;;;21.4;22.77;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2014;2014;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;NMBR;RACE;BLK;;;;
2014;2014;AK;Alaska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;3080;3,080;;;;;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;NMBR;GENDER;GENM;;;;
2015;2015;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.3;13.3;;;9.2;18.7;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2014;2014;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;NMBR;RACE;HIS;;;;
2014;2014;GA;Georgia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;13.10;13.1;;;12.67;13.52;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;NMBR;RACE;BLK;;;;
2014;2014;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;4.22;4.22;;;3.49;4.94;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;10.65;10.65;;;10.17;11.12;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;WY;Wyoming;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;DC;District of Columbia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;38.83;38.83;;;36.67;40.99;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2014;2014;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;3.83;3.83;;;3.32;4.33;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;DE;Delaware;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;6.60;6.6;;;6;7.2;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;WY;Wyoming;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2014;2014;AK;Alaska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2014;2014;IL;Illinois;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2014;2014;GA;Georgia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;53;53;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST3_1;NMBR;RACE;API;;;;
2014;2014;ID;Idaho;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST3_1;CRDRATE;RACE;API;;;;
2014;2014;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;5.45;5.45;;;3.88;7.01;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2014;2014;PA;Pennsylvania;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST3_1;NMBR;RACE;AIAN;;;;
2014;2014;MN;Minnesota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2014;2014;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;6.31;6.31;;;5.9;6.72;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;6.4;6.4;;;4.1;9.6;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;DE;Delaware;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;3.93;3.93;;;3.42;4.43;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2014;2014;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;12.57;12.57;;;12.26;12.89;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2015;2015;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.3;10.3;;;8.3;12.2;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;OK;Oklahoma;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2014;2014;IN;Indiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST3_1;NMBR;GENDER;GENF;;;;
2014;2014;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2015;2015;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2014;2014;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;7.41;7.41;;;5.74;9.09;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;80;80;;;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;NMBR;RACE;AIAN;;;;
2014;2014;GA;Georgia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;6.90;6.9;;;6.66;7.13;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;2.97;2.97;;;2.24;3.7;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2014;2014;KS;Kansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST3_1;NMBR;RACE;BLK;;;;
2014;2014;NH;New Hampshire;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2014;2014;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;243;243;;;;;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2014;2014;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;NMBR;RACE;API;;;;
2015;2015;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;;Number;46;46;;;;;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;NMBR;GENDER;GENF;;;;
2014;2014;LA;Louisiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2014;2014;DE;Delaware;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;6.86;6.86;;;6.58;7.14;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2014;2014;DE;Delaware;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST3_1;CRDRATE;RACE;API;;;;
2014;2014;PR;Puerto Rico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;ND;North Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;MT;Montana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;CT;Connecticut;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;;Number;73;73;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;NMBR;RACE;BLK;;;;
2014;2014;AK;Alaska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;NH;New Hampshire;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;32.6;32.6;;;22.5;45.8;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;4.41;4.41;;;4.1;4.72;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;CRDRATE;RACE;API;;;;
2014;2014;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;37.74;37.74;;;37.04;38.43;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2014;2014;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;76;76;;;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;NMBR;RACE;AIAN;;;;
2014;2014;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;357;357;;;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;NMBR;RACE;HIS;;;;
2015;2015;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;CRDRATE;RACE;API;;;;
2014;2014;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;NMBR;RACE;AIAN;;;;
2015;2015;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;19.9;19.9;;;15.4;25.3;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2014;2014;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;14.44;14.44;;;14.02;14.87;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;5278;5,278;;;;;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;NMBR;GENDER;GENM;;;;
2014;2014;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;21.21;21.21;;;16.99;25.43;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2014;2014;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1318;1,318;;;;;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;NMBR;GENDER;GENF;;;;
2014;2014;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2014;2014;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;375;375;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;NMBR;RACE;BLK;;;;
2014;2014;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;7.24;7.24;;;6.92;7.56;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2014;2014;GU;Guam;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;13.05;13.05;;;12.76;13.33;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;7.16;7.16;;;7;7.32;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2014;2014;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;138;138;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;NMBR;RACE;BLK;;;;
2014;2014;MT;Montana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2014;2014;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;2073;2,073;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;NMBR;RACE;WHT;;;;
2014;2014;OK;Oklahoma;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2014;2014;KS;Kansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2014;2014;VA;Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2014;2014;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;6.85;6.85;;;6.56;7.13;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;MT;Montana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2014;2014;IL;Illinois;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2015;2015;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2014;2014;MO;Missouri;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2014;2014;PR;Puerto Rico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2014;2014;MT;Montana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2014;2014;VI;Virgin Islands;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(18.335765, -64.896335);;78;AST;AST3_1;NMBR;RACE;API;;;;
2014;2014;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;4.26;4.26;;;3.29;5.23;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2014;2014;CT;Connecticut;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST3_1;NMBR;GENDER;GENM;;;;
2014;2014;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;4.62;4.62;;;3.88;5.37;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2014;2014;MN;Minnesota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;VA;Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST3_1;NMBR;GENDER;GENF;;;;
2014;2014;GU;Guam;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2015;2015;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2014;2014;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;TN;Tennessee;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;CT;Connecticut;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2014;2014;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;10.88;10.88;;;10.49;11.27;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;9.03;9.03;;;8.73;9.33;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;DC;District of Columbia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;6.16;6.16;;;3.86;8.45;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;AK;Alaska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2014;2014;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;NMBR;RACE;HIS;;;;
2014;2014;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;6.08;6.08;;;5.23;6.93;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;21;21;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;NMBR;RACE;BLK;;;;
2014;2014;ID;Idaho;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2014;2014;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2014;2014;TN;Tennessee;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2014;2014;MO;Missouri;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2015;2015;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2014;2014;PA;Pennsylvania;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2014;2014;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;20.21;20.21;;;13.7;26.72;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2014;2014;PA;Pennsylvania;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2014;2014;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;ID;Idaho;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;VA;Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;147;147;;;;;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;NMBR;GENDER;GENF;;;;
2014;2014;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;TX;Texas;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST3_1;NMBR;RACE;WHT;;;;
2014;2014;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;22;22;;;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;NMBR;RACE;HIS;;;;
2014;2014;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;19.28;19.28;;;16.52;22.04;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;7.15;7.15;;;6.91;7.39;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2014;2014;ID;Idaho;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST3_1;NMBR;RACE;API;;;;
2014;2014;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1092;1,092;;;;;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2015;2015;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;TX;Texas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;NMBR;RACE;API;;;;
2014;2014;ID;Idaho;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;NMBR;RACE;WHT;;;;
2014;2014;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;10.12;10.12;;;9.93;10.32;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;19619;19,619;;;;;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;NMBR;GENDER;GENF;;;;
2014;2014;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;13.95;13.95;;;10.68;17.22;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;5.08;5.08;;;4.8;5.35;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;IL;Illinois;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;VI;Virgin Islands;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(18.335765, -64.896335);;78;AST;AST3_1;NMBR;RACE;AIAN;;;;
2014;2014;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;10.21;10.21;;;9.85;10.58;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;ID;Idaho;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2014;2014;AL;Alabama;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2014;2014;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;8695;8,695;;;;;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;NMBR;RACE;HIS;;;;
2014;2014;DE;Delaware;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;21.84;21.84;;;17.4;26.27;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;5.81;5.81;;;5.41;6.21;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;807;807;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;NMBR;RACE;API;;;;
2014;2014;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;6.48;6.48;;;6.2;6.76;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;GU;Guam;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;6.06;6.06;;;3.51;8.61;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;5.13;5.13;;;2.93;7.32;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2014;2014;ME;Maine;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2014;2014;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2014;2014;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;7.78;7.78;;;7.54;8.02;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;VI;Virgin Islands;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(18.335765, -64.896335);;78;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2014;2014;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;472;472;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;NMBR;RACE;WHT;;;;
2015;2015;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;NH;New Hampshire;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;NMBR;RACE;AIAN;;;;
2014;2014;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2014;2014;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;7.44;7.44;;;6.94;7.94;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2014;2014;CT;Connecticut;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;LA;Louisiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2014;2014;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;835;835;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;NMBR;RACE;WHT;;;;
2014;2014;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1559;1,559;;;;;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;NMBR;GENDER;GENF;;;;
2014;2014;IL;Illinois;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2014;2014;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;CRDRATE;RACE;API;;;;
2014;2014;WY;Wyoming;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;CT;Connecticut;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2014;2014;ND;North Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;CT;Connecticut;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST3_1;NMBR;RACE;HIS;;;;
2014;2014;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;302;302;;;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;NMBR;RACE;HIS;;;;
2014;2014;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;6.42;6.42;;;5.34;7.51;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2014;2014;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;7.76;7.76;;;7.17;8.35;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;AL;Alabama;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;OH;Ohio;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2014;2014;OH;Ohio;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2014;2014;PA;Pennsylvania;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;IL;Illinois;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;KS;Kansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;AL;Alabama;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST3_1;NMBR;GENDER;GENF;;;;
2014;2014;AL;Alabama;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2015;2015;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;NMBR;RACE;HIS;;;;
2014;2014;PR;Puerto Rico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(18.220833, -66.590149);;72;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;27.48;27.48;;;23.21;31.74;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2014;2014;ID;Idaho;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2014;2014;TN;Tennessee;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;AK;Alaska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;DE;Delaware;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST3_1;NMBR;RACE;WHT;;;;
2014;2014;ND;North Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;43;43;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;NMBR;RACE;API;;;;
2014;2014;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;8.34;8.34;;;7.02;9.66;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;3865;3,865;;;;;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2014;2014;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;NMBR;RACE;API;;;;
2014;2014;AL;Alabama;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST3_1;NMBR;RACE;WHT;;;;
2014;2014;AK;Alaska;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST3_1;NMBR;RACE;API;;;;
2014;2014;MO;Missouri;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST3_1;NMBR;GENDER;GENF;;;;
2014;2014;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;5.24;5.24;;;5.01;5.46;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;4.61;4.61;;;4.37;4.86;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;GA;Georgia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;6.85;6.85;;;6.62;7.08;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2014;2014;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;13.33;13.33;;;11.84;14.83;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;5.47;5.47;;;5.3;5.64;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;NMBR;RACE;HIS;;;;
2014;2014;DE;Delaware;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;7.33;7.33;;;6.91;7.76;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2014;2014;DE;Delaware;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2014;2014;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;7.10;7.1;;;6.8;7.39;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2014;2014;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;14.13;14.13;;;13.96;14.29;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;ID;Idaho;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2014;2014;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;13.44;13.44;;;13.27;13.6;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;PA;Pennsylvania;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST3_1;NMBR;RACE;WHT;;;;
2014;2014;VA;Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST3_1;NMBR;RACE;WHT;;;;
2014;2014;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2015;2015;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.8;7.8;;;6.4;9.3;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;IL;Illinois;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;4.91;4.91;;;4.01;5.81;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;CRDRATE;RACE;API;;;;
2014;2014;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;CRDRATE;RACE;API;;;;
2014;2014;PA;Pennsylvania;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2014;2014;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1418;1,418;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;NMBR;RACE;BLK;;;;
2014;2014;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;15.64;15.64;;;14.59;16.69;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2014;2014;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;13.59;13.59;;;7.92;19.25;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;NH;New Hampshire;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;NMBR;RACE;HIS;;;;
2014;2014;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;35.40;35.4;;;34.32;36.48;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;AL;Alabama;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST3_1;NMBR;GENDER;GENM;;;;
2014;2014;ID;Idaho;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST3_1;NMBR;RACE;HIS;;;;
2014;2014;DE;Delaware;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;5522;5,522;;;;;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;NMBR;GENDER;GENF;;;;
2014;2014;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;NMBR;RACE;AIAN;;;;
2014;2014;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;4.18;4.18;;;3.88;4.47;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;6.05;6.05;;;5.86;6.24;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2014;2014;MN;Minnesota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2014;2014;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;NMBR;RACE;AIAN;;;;
2014;2014;PR;Puerto Rico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2014;2014;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1148;1,148;;;;;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;NMBR;GENDER;GENF;;;;
2014;2014;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1291;1,291;;;;;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;NMBR;GENDER;GENF;;;;
2014;2014;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;10.50;10.5;;;10.22;10.78;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2014;2014;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;18202;18,202;;;;;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;NMBR;GENDER;GENF;;;;
2014;2014;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;CRDRATE;RACE;API;;;;
2014;2014;IN;Indiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST3_1;NMBR;RACE;HIS;;;;
2014;2014;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;96;96;;;;;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;NMBR;GENDER;GENM;;;;
2015;2015;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.0;11;;;8.9;13.1;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2014;2014;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;6.63;6.63;;;6.2;7.06;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;ND;North Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2014;2014;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;8.01;8.01;;;7.47;8.56;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2014;2014;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;4.08;4.08;;;3.59;4.58;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;3408;3,408;;;;;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;NMBR;GENDER;GENF;;;;
2015;2015;FL;Florida;NVSS;Asthma;Asthma mortality rate;;;Number;23;23;;;;;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;NMBR;RACE;HIS;;;;
2014;2014;LA;Louisiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST3_1;NMBR;RACE;BLK;;;;
2014;2014;VI;Virgin Islands;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;6.6;6.6;;;4.7;8.9;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2014;2014;MO;Missouri;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2015;2015;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;NMBR;RACE;AIAN;;;;
2014;2014;ND;North Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;7.82;7.82;;;7.48;8.15;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2014;2014;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;15.34;15.34;;;12.69;18;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;AL;Alabama;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2014;2014;GU;Guam;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;5.38;5.38;;;3.08;7.67;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2014;2014;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;688;688;;;;;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;NMBR;GENDER;GENF;;;;
2014;2014;ME;Maine;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST3_1;NMBR;GENDER;GENM;;;;
2015;2015;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;NMBR;RACE;API;;;;
2014;2014;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;3.43;3.43;;;2.98;3.87;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;CRDRATE;RACE;API;;;;
2014;2014;GA;Georgia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;12.48;12.48;;;12.09;12.87;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2014;2014;TX;Texas;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST3_1;NMBR;GENDER;GENF;;;;
2014;2014;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2014;2014;MT;Montana;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST3_1;NMBR;GENDER;GENM;;;;
2015;2015;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2014;2014;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;NMBR;RACE;API;;;;
2014;2014;MT;Montana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2014;2014;ND;North Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST3_1;NMBR;RACE;BLK;;;;
2014;2014;OK;Oklahoma;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST3_1;NMBR;RACE;BLK;;;;
2014;2014;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2014;2014;MN;Minnesota;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST3_1;NMBR;RACE;API;;;;
2014;2014;VI;Virgin Islands;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;;Number;22;22;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;NMBR;RACE;BLK;;;;
2014;2014;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;10.34;10.34;;;10.06;10.62;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;OH;Ohio;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST3_1;CRDRATE;RACE;API;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.3;11.3;;;8.5;14.8;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2014;2014;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;21;21;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;NMBR;RACE;BLK;;;;
2014;2014;PA;Pennsylvania;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;TN;Tennessee;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2015;2015;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;;Number;37;37;;;;;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;NMBR;GENDER;GENF;;;;
2015;2015;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;4.1;4.1;;;3.2;5.3;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2014;2014;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;4715;4,715;;;;;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;NMBR;GENDER;GENF;;;;
2014;2014;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;13683;13,683;;;;;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;NMBR;GENDER;GENM;;;;
2014;2014;WY;Wyoming;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2014;2014;OH;Ohio;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2015;2015;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.1;9.1;;;7.3;11.2;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;ND;North Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2014;2014;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;4.06;4.06;;;3.78;4.34;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2014;2014;LA;Louisiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST3_1;NMBR;RACE;API;;;;
2014;2014;PR;Puerto Rico;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST3_1;NMBR;RACE;BLK;;;;
2014;2014;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;616;616;;;;;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;NMBR;GENDER;GENF;;;;
2014;2014;KS;Kansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;6.45;6.45;;;3.54;9.35;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;6.62;6.62;;;6.03;7.22;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2015;2015;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;IL;Illinois;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2014;2014;OH;Ohio;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST3_1;NMBR;GENDER;GENM;;;;
2014;2014;LA;Louisiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2014;2014;AL;Alabama;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2014;2014;IL;Illinois;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST3_1;NMBR;RACE;BLK;;;;
2014;2014;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;52;52;;;;;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;NMBR;RACE;HIS;;;;
2014;2014;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;NMBR;RACE;HIS;;;;
2014;2014;NH;New Hampshire;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST3_1;NMBR;RACE;AIAN;;;;
2014;2014;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2014;2014;LA;Louisiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2014;2014;GU;Guam;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2014;2014;MT;Montana;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2014;2014;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;69;69;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;NMBR;RACE;API;;;;
2014;2014;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;9.47;9.47;;;8.81;10.12;Race/Ethnicity;Asian or Pacific Islander;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;CRDRATE;RACE;API;;;;
2015;2015;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;MT;Montana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;21.62;21.62;;;19.92;23.32;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;DE;Delaware;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST3_1;NMBR;GENDER;GENF;;;;
2014;2014;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;13561;13,561;;;;;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2014;2014;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;5.72;5.72;;;5.53;5.91;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;36.14;36.14;;;34.25;38.02;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2014;2014;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;8.91;8.91;;;8.67;9.16;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;MN;Minnesota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2014;2014;KS;Kansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;7.00;7;;;6.45;7.56;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;9.89;9.89;;;9.28;10.5;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;NMBR;RACE;AIAN;;;;
2014;2014;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;8.48;8.48;;;7.41;9.55;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2014;2014;PA;Pennsylvania;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2014;2014;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;380;380;;;;;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;NMBR;GENDER;GENF;;;;
2014;2014;DC;District of Columbia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.907192, -77.036871);;11;AST;AST3_1;CRDRATE;RACE;API;;;;
2014;2014;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;MO;Missouri;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;60;60;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;NMBR;RACE;BLK;;;;
2014;2014;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;6.77;6.77;;;6.43;7.12;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2014;2014;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;2.86;2.86;;;2.12;3.61;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;CRDRATE;RACE;API;;;;
2014;2014;LA;Louisiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;NMBR;RACE;API;;;;
2014;2014;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;8.76;8.76;;;8.51;9;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;10.42;10.42;;;10.21;10.63;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2014;2014;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;ID;Idaho;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;VA;Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST3_1;NMBR;RACE;API;;;;
2014;2014;IN;Indiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2014;2014;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;7.69;7.69;;;7.23;8.14;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;160;160;;;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;NMBR;RACE;AIAN;;;;
2014;2014;LA;Louisiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST3_1;NMBR;RACE;WHT;;;;
2014;2014;ME;Maine;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST3_1;NMBR;RACE;AIAN;;;;
2014;2014;OH;Ohio;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2014;2014;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;134;134;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;NMBR;RACE;API;;;;
2014;2014;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;3.97;3.97;;;3.23;4.7;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;DE;Delaware;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2014;2014;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2014;2014;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;7.80;7.8;;;7.25;8.35;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;12.10;12.1;;;11.77;12.43;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2014;2014;TN;Tennessee;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;9.04;9.04;;;8.22;9.87;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2014;2014;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2014;2014;IL;Illinois;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2014;2014;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;34;34;;;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;NMBR;RACE;AIAN;;;;
2014;2014;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;6.92;6.92;;;6.52;7.31;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2015;2015;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.1;10.1;;;7.4;13.4;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;AK;Alaska;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST3_1;NMBR;GENDER;GENM;;;;
2014;2014;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;4991;4,991;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;NMBR;RACE;BLK;;;;
2014;2014;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;5.87;5.87;;;5.61;6.13;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;IL;Illinois;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2014;2014;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;16.05;16.05;;;15.7;16.4;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2014;2014;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;6.31;6.31;;;6.05;6.57;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;MO;Missouri;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;MN;Minnesota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2015;2015;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;NMBR;RACE;AIAN;;;;
2014;2014;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;452;452;;;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;NMBR;RACE;HIS;;;;
2014;2014;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;NMBR;RACE;WHT;;;;
2014;2014;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2015;2015;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;4.03;4.03;;;3.59;4.47;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2014;2014;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;4.75;4.75;;;4.56;4.94;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;VA;Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2014;2014;ME;Maine;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;PA;Pennsylvania;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST3_1;NMBR;RACE;BLK;;;;
2015;2015;NY;New York;NVSS;Asthma;Asthma mortality rate;;;Number;87;87;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;NMBR;RACE;BLK;;;;
2015;2015;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1117;1,117;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;NMBR;RACE;WHT;;;;
2014;2014;VA;Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST3_1;NMBR;GENDER;GENM;;;;
2014;2014;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;21.50;21.5;;;19.86;23.13;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2015;2015;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;19.5;19.5;;;12.5;29;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;13.57;13.57;;;11.43;15.7;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;CT;Connecticut;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2014;2014;MT;Montana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;WY;Wyoming;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2014;2014;ID;Idaho;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;10.79;10.79;;;10.42;11.17;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2014;2014;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;NMBR;RACE;HIS;;;;
2014;2014;GA;Georgia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;3268;3,268;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST3_1;NMBR;RACE;WHT;;;;
2014;2014;TX;Texas;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST3_1;NMBR;RACE;AIAN;;;;
2014;2014;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;8283;8,283;;;;;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;NMBR;GENDER;GENF;;;;
2014;2014;NH;New Hampshire;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST3_1;NMBR;GENDER;GENF;;;;
2014;2014;TX;Texas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2015;2015;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;;Number;30;30;;;;;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;NMBR;GENDER;GENF;;;;
2014;2014;AL;Alabama;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST3_1;CRDRATE;RACE;API;;;;
2014;2014;KS;Kansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST3_1;NMBR;RACE;AIAN;;;;
2014;2014;PR;Puerto Rico;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST3_1;NMBR;GENDER;GENF;;;;
2014;2014;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;6.49;6.49;;;6.08;6.91;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2014;2014;OK;Oklahoma;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;PR;Puerto Rico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;6.07;6.07;;;5.73;6.41;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;3.85;3.85;;;2.89;4.8;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;CRDRATE;RACE;API;;;;
2014;2014;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;NMBR;GENDER;GENM;;;;
2014;2014;TN;Tennessee;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2014;2014;VI;Virgin Islands;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(18.335765, -64.896335);;78;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2014;2014;LA;Louisiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2015;2015;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.6;7.6;;;5;11.1;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;695;695;;;;;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;NMBR;GENDER;GENM;;;;
2015;2015;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;;Number;27;27;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;NMBR;RACE;WHT;;;;
2014;2014;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;2475;2,475;;;;;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2014;2014;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;6106;6,106;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;NMBR;RACE;WHT;;;;
2014;2014;GU;Guam;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;DC;District of Columbia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;15.11;15.11;;;13.75;16.48;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2014;2014;NH;New Hampshire;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST3_1;CRDRATE;RACE;API;;;;
2014;2014;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;6.63;6.63;;;4.83;8.44;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;AL;Alabama;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;CRDRATE;RACE;API;;;;
2014;2014;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;2508;2,508;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;NMBR;RACE;WHT;;;;
2015;2015;CA;California;NVSS;Asthma;Asthma mortality rate;;;Number;241;241;;;;;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;NMBR;GENDER;GENF;;;;
2014;2014;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1427;1,427;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;NMBR;RACE;WHT;;;;
2014;2014;CT;Connecticut;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;PR;Puerto Rico;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2015;2015;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;6.2;6.2;;;4.7;7.9;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;AL;Alabama;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2014;2014;ND;North Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST3_1;NMBR;GENDER;GENF;;;;
2014;2014;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;49;49;;;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;NMBR;RACE;AIAN;;;;
2014;2014;IL;Illinois;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST3_1;NMBR;RACE;API;;;;
2014;2014;IL;Illinois;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST3_1;NMBR;RACE;AIAN;;;;
2014;2014;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;25.59;25.59;;;25.03;26.14;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;WY;Wyoming;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST3_1;NMBR;GENDER;GENM;;;;
2014;2014;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;32;32;;;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;NMBR;RACE;AIAN;;;;
2014;2014;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;3.79;3.79;;;3.29;4.29;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2014;2014;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;NMBR;RACE;WHT;;;;
2014;2014;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;4777;4,777;;;;;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2014;2014;GA;Georgia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;3376;3,376;;;;;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST3_1;NMBR;GENDER;GENM;;;;
2015;2015;US;United States;NVSS;Asthma;Asthma mortality rate;;;Number;3615;3,615;;;;;Overall;Overall;;;;;;;59;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2014;2014;TN;Tennessee;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST3_1;NMBR;RACE;API;;;;
2014;2014;DC;District of Columbia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.907192, -77.036871);;11;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2015;2015;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2014;2014;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;NMBR;RACE;API;;;;
2014;2014;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;15.31;15.31;;;14.87;15.75;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2014;2014;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;476;476;;;;;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;NMBR;GENDER;GENM;;;;
2014;2014;AK;Alaska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;DE;Delaware;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST3_1;NMBR;RACE;BLK;;;;
2014;2014;DE;Delaware;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2014;2014;MS;Mississippi;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST2_1;CRDRATE;RACE;API;;;;
2014;2014;MT;Montana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2014;2014;WV;West Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;NMBR;RACE;WHT;;;;
2014;2014;MD;Maryland;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;2218;2,218;;;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST2_1;NMBR;RACE;HIS;;;;
2014;2014;KS;Kansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;15.14;15.14;;;12.8;17.48;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2014;2014;RI;Rhode Island;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;1423;1,423;;;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST2_1;NMBR;RACE;HIS;;;;
2014;2014;MS;Mississippi;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2014;2014;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;114;114;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;NMBR;RACE;API;;;;
2014;2014;NH;New Hampshire;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;TN;Tennessee;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;CT;Connecticut;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;NM;New Mexico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST2_1;NMBR;RACE;BLK;;;;
2014;2014;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;MN;Minnesota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2014;2014;HI;Hawaii;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;424;424;;;;;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST2_1;NMBR;RACE;HIS;;;;
2014;2014;TN;Tennessee;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;ME;Maine;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST2_1;CRDRATE;RACE;API;;;;
2014;2014;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;48.66;48.66;;;48.19;49.13;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;14.64;14.64;;;11.7;17.59;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2014;2014;AK;Alaska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2014;2014;MI;Michigan;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2014;2014;VA;Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST2_1;NMBR;RACE;API;;;;
2014;2014;CA;California;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2013;2013;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;;Number;63;63;;;;;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;NMBR;GENDER;GENF;;;;
2014;2014;LA;Louisiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST2_1;NMBR;RACE;HIS;;;;
2014;2014;CO;Colorado;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;TN;Tennessee;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;CT;Connecticut;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2014;2014;PA;Pennsylvania;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST2_1;CRDRATE;RACE;API;;;;
2014;2014;ND;North Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST2_1;NMBR;RACE;HIS;;;;
2014;2014;IN;Indiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;7.24;7.24;;;6.8;7.68;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;OH;Ohio;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2014;2014;WV;West Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;AR;Arkansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;121.00;121;;;117.87;124.13;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;AK;Alaska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;MI;Michigan;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2014;2014;ND;North Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2014;2014;AL;Alabama;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST2_1;NMBR;RACE;BLK;;;;
2014;2014;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;6.56;6.56;;;5.52;7.61;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;6008;6,008;;;;;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2014;2014;VA;Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST2_1;NMBR;RACE;AIAN;;;;
2014;2014;ND;North Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;39.96;39.96;;;38.32;41.61;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;MO;Missouri;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2014;2014;MD;Maryland;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;32.92;32.92;;;32.29;33.55;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2014;2014;AL;Alabama;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST2_1;NMBR;RACE;HIS;;;;
2014;2014;TN;Tennessee;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2014;2014;GU;Guam;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;VI;Virgin Islands;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2014;2014;OR;Oregon;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST2_1;NMBR;RACE;AIAN;;;;
2014;2014;PA;Pennsylvania;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST2_1;NMBR;RACE;AIAN;;;;
2014;2014;ND;North Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2014;2014;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;529;529;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;NMBR;RACE;BLK;;;;
2014;2014;DE;Delaware;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST2_1;NMBR;RACE;API;;;;
2014;2014;OK;Oklahoma;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;CT;Connecticut;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;72.00;72;;;71.48;72.52;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2014;2014;NM;New Mexico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2014;2014;MA;Massachusetts;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;178;178;;;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;NMBR;RACE;AIAN;;;;
2014;2014;MS;Mississippi;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST2_1;NMBR;RACE;WHT;;;;
2014;2014;MT;Montana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST2_1;NMBR;RACE;API;;;;
2014;2014;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;74.01;74.01;;;73.45;74.58;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;AK;Alaska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2014;2014;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;154.67;154.67;;;150.27;159.06;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2014;2014;HI;Hawaii;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;74.09;74.09;;;72.17;76.01;Race/Ethnicity;Asian or Pacific Islander;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2014;2014;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;6449;6,449;;;;;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;NMBR;GENDER;GENM;;;;
2014;2014;GU;Guam;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2014;2014;PR;Puerto Rico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST2_1;NMBR;RACE;WHT;;;;
2014;2014;OH;Ohio;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST2_1;NMBR;RACE;WHT;;;;
2014;2014;UT;Utah;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;34.31;34.31;;;32.5;36.13;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2014;2014;GA;Georgia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;16394;16,394;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST2_1;NMBR;RACE;WHT;;;;
2014;2014;MS;Mississippi;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2014;2014;WA;Washington;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;MN;Minnesota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;39.97;39.97;;;39.44;40.5;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;DE;Delaware;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;NM;New Mexico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST2_1;NMBR;RACE;WHT;;;;
2014;2014;PR;Puerto Rico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;CA;California;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2014;2014;AK;Alaska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2014;2014;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;73295;73,295;;;;;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;NMBR;GENDER;GENF;;;;
2014;2014;AK;Alaska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;32699;32,699;;;;;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2014;2014;IN;Indiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2014;2014;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;10.10;10.1;;;9.08;11.12;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2014;2014;WA;Washington;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST2_1;NMBR;RACE;API;;;;
2014;2014;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;56.82;56.82;;;55.83;57.81;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2014;2014;TX;Texas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2014;2014;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;68.39;68.39;;;67.64;69.13;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;5.90;5.9;;;3.54;8.26;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2014;2014;SD;South Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2014;2014;VA;Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2014;2014;IN;Indiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;ND;North Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2014;2014;VA;Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;8.60;8.6;;;7.48;9.72;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;TN;Tennessee;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2014;2014;PA;Pennsylvania;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2014;2014;AL;Alabama;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2014;2014;DC;District of Columbia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.907192, -77.036871);;11;AST;AST3_1;NMBR;RACE;AIAN;;;;
2014;2014;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;58.68;58.68;;;58.2;59.16;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;MA;Massachusetts;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;MN;Minnesota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST2_1;CRDRATE;RACE;API;;;;
2014;2014;OK;Oklahoma;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2014;2014;WY;Wyoming;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;HI;Hawaii;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;55.54;55.54;;;47.57;63.51;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;KS;Kansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST2_1;NMBR;GENDER;GENF;;;;
2014;2014;MI;Michigan;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2014;2014;SD;South Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2014;2014;MS;Mississippi;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2014;2014;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;3.34;3.34;;;2.84;3.84;Race/Ethnicity;Asian or Pacific Islander;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2014;2014;TN;Tennessee;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2014;2014;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;174.21;174.21;;;147.81;200.61;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;68.13;68.13;;;67.35;68.9;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2014;2014;MT;Montana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2014;2014;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;KS;Kansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2014;2014;MO;Missouri;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;2545;2,545;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;NMBR;RACE;BLK;;;;
2014;2014;WV;West Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2014;2014;WY;Wyoming;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2014;2014;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;29.63;29.63;;;29.14;30.12;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2014;2014;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;48.81;48.81;;;46.25;51.38;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2014;2014;DC;District of Columbia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;NMBR;RACE;AIAN;;;;
2014;2014;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;NMBR;GENDER;GENF;;;;
2014;2014;MT;Montana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST2_1;CRDRATE;RACE;API;;;;
2014;2014;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;NMBR;RACE;HIS;;;;
2014;2014;MO;Missouri;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2014;2014;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;58.60;58.6;;;55.66;61.54;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;SD;South Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;54.11;54.11;;;52.9;55.32;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2014;2014;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;146.05;146.05;;;144.44;147.67;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;IN;Indiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2014;2014;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1111;1,111;;;;;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2014;2014;TX;Texas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;94.44;94.44;;;82.81;106.07;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;46.07;46.07;;;45.14;46.99;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;MD;Maryland;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;80.23;80.23;;;79.49;80.97;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;WY;Wyoming;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST2_1;NMBR;RACE;API;;;;
2014;2014;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;213.38;213.38;;;205.09;221.67;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2014;2014;LA;Louisiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;AL;Alabama;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST2_1;NMBR;RACE;API;;;;
2014;2014;GU;Guam;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2014;2014;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;24.16;24.16;;;20.16;28.16;Race/Ethnicity;American Indian or Alaska Native;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2014;2014;TX;Texas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2014;2014;OK;Oklahoma;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;ID;Idaho;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;CO;Colorado;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST2_1;NMBR;RACE;WHT;;;;
2014;2014;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;8.14;8.14;;;7.58;8.7;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;3842;3,842;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;NMBR;RACE;BLK;;;;
2014;2014;AK;Alaska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;VI;Virgin Islands;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;OK;Oklahoma;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;TN;Tennessee;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST2_1;NMBR;RACE;BLK;;;;
2014;2014;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;NMBR;RACE;HIS;;;;
2014;2014;HI;Hawaii;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;60.66;60.66;;;58.81;62.52;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;PR;Puerto Rico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(18.220833, -66.590149);;72;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2014;2014;SD;South Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST2_1;NMBR;GENDER;GENF;;;;
2014;2014;AK;Alaska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2014;2014;GA;Georgia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;35066;35,066;;;;;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST2_1;NMBR;GENDER;GENF;;;;
2014;2014;CO;Colorado;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST2_1;NMBR;RACE;HIS;;;;
2014;2014;OR;Oregon;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST2_1;NMBR;RACE;HIS;;;;
2014;2014;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;4031;4,031;;;;;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2014;2014;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2014;2014;IN;Indiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;148;148;;;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;NMBR;RACE;AIAN;;;;
2014;2014;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;NMBR;RACE;AIAN;;;;
2014;2014;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;9683;9,683;;;;;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;NMBR;GENDER;GENM;;;;
2014;2014;KS;Kansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST2_1;NMBR;GENDER;GENM;;;;
2014;2014;DE;Delaware;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;WV;West Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST2_1;NMBR;RACE;BLK;;;;
2014;2014;MO;Missouri;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2014;2014;IL;Illinois;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;MI;Michigan;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST2_1;CRDRATE;RACE;API;;;;
2014;2014;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;49.65;49.65;;;48.83;50.47;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;NM;New Mexico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;GA;Georgia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;89;89;;;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST2_1;NMBR;RACE;AIAN;;;;
2014;2014;MD;Maryland;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;25825;25,825;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST2_1;NMBR;RACE;BLK;;;;
2014;2014;PR;Puerto Rico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2014;2014;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;50.58;50.58;;;49.76;51.4;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2014;2014;VI;Virgin Islands;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2014;2014;TX;Texas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;ND;North Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST3_1;NMBR;RACE;WHT;;;;
2014;2014;NM;New Mexico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST2_1;CRDRATE;RACE;API;;;;
2014;2014;ND;North Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST2_1;NMBR;RACE;BLK;;;;
2014;2014;NH;New Hampshire;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST2_1;NMBR;RACE;HIS;;;;
2014;2014;PR;Puerto Rico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(18.220833, -66.590149);;72;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;PA;Pennsylvania;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2014;2014;AL;Alabama;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST2_1;CRDRATE;RACE;API;;;;
2014;2014;NH;New Hampshire;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2014;2014;NH;New Hampshire;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;MI;Michigan;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST2_1;NMBR;RACE;HIS;;;;
2014;2014;LA;Louisiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST2_1;NMBR;RACE;AIAN;;;;
2014;2014;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;31943;31,943;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;NMBR;RACE;BLK;;;;
2014;2014;PA;Pennsylvania;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;244;244;;;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;NMBR;RACE;HIS;;;;
2014;2014;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;14290;14,290;;;;;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;NMBR;RACE;HIS;;;;
2014;2014;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;NMBR;RACE;BLK;;;;
2014;2014;NM;New Mexico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;IL;Illinois;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2014;2014;DC;District of Columbia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;DC;District of Columbia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;50;50;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST3_1;NMBR;RACE;WHT;;;;
2014;2014;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;CRDRATE;RACE;API;;;;
2014;2014;LA;Louisiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST2_1;NMBR;GENDER;GENM;;;;
2014;2014;MD;Maryland;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;46109;46,109;;;;;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2014;2014;MN;Minnesota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2014;2014;KS;Kansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2014;2014;TX;Texas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;CA;California;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;NMBR;RACE;BLK;;;;
2014;2014;PA;Pennsylvania;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST3_1;NMBR;GENDER;GENM;;;;
2014;2014;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;7.53;7.53;;;7.29;7.76;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;8.47;8.47;;;8.25;8.69;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2014;2014;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2014;2014;PR;Puerto Rico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST2_1;NMBR;RACE;BLK;;;;
2014;2014;IN;Indiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST2_1;NMBR;RACE;API;;;;
2014;2014;GU;Guam;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2014;2014;CA;California;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2014;2014;OK;Oklahoma;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST2_1;NMBR;GENDER;GENF;;;;
2014;2014;TX;Texas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST2_1;NMBR;RACE;AIAN;;;;
2014;2014;AR;Arkansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2014;2014;WA;Washington;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST2_1;NMBR;GENDER;GENF;;;;
2014;2014;PA;Pennsylvania;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST2_1;NMBR;RACE;BLK;;;;
2014;2014;MA;Massachusetts;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;GA;Georgia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;301;301;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST2_1;NMBR;RACE;API;;;;
2014;2014;NH;New Hampshire;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST2_1;NMBR;RACE;API;;;;
2014;2014;WY;Wyoming;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST2_1;NMBR;RACE;AIAN;;;;
2014;2014;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;5.14;5.14;;;4.87;5.4;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;HI;Hawaii;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;41.46;41.46;;;39.28;43.63;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;DE;Delaware;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2014;2014;NM;New Mexico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;UT;Utah;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;68.94;68.94;;;59.58;78.3;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;UT;Utah;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;16.21;16.21;;;15.7;16.72;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2014;2014;OK;Oklahoma;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST2_1;NMBR;RACE;BLK;;;;
2014;2014;MI;Michigan;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST2_1;NMBR;GENDER;GENF;;;;
2014;2014;ME;Maine;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2014;2014;ID;Idaho;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;CRDRATE;RACE;API;;;;
2014;2014;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;28.70;28.7;;;28.07;29.34;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2014;2014;MS;Mississippi;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;AK;Alaska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST2_1;NMBR;RACE;WHT;;;;
2014;2014;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;8.62;8.62;;;6.4;10.84;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;MT;Montana;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST3_1;NMBR;RACE;WHT;;;;
2014;2014;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;77.80;77.8;;;77.22;78.38;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;12820;12,820;;;;;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2014;2014;CO;Colorado;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;245;245;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;NMBR;RACE;API;;;;
2014;2014;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;6022;6,022;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;NMBR;RACE;WHT;;;;
2014;2014;DC;District of Columbia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST2_1;NMBR;GENDER;GENF;;;;
2014;2014;CT;Connecticut;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;MS;Mississippi;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2014;2014;IL;Illinois;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2014;2014;WV;West Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST2_1;NMBR;GENDER;GENM;;;;
2014;2014;PA;Pennsylvania;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2014;2014;MT;Montana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST2_1;NMBR;RACE;BLK;;;;
2014;2014;CT;Connecticut;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST3_1;NMBR;GENDER;GENF;;;;
2014;2014;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;158.48;158.48;;;154.47;162.5;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2014;2014;CA;California;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST2_1;NMBR;RACE;AIAN;;;;
2014;2014;WV;West Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;45.35;45.35;;;43.01;47.69;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2014;2014;CO;Colorado;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2014;2014;SD;South Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2014;2014;MT;Montana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;KS;Kansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2014;2014;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;94.96;94.96;;;74.45;115.47;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;GU;Guam;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;MN;Minnesota;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST3_1;NMBR;RACE;AIAN;;;;
2014;2014;MA;Massachusetts;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST2_1;NMBR;RACE;AIAN;;;;
2014;2014;AR;Arkansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;48.05;48.05;;;47.23;48.86;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;WY;Wyoming;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2014;2014;CA;California;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST2_1;NMBR;RACE;API;;;;
2014;2014;LA;Louisiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST2_1;NMBR;GENDER;GENF;;;;
2014;2014;TN;Tennessee;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;MT;Montana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;41.41;41.41;;;41.04;41.79;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2014;2014;VI;Virgin Islands;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(18.335765, -64.896335);;78;AST;AST2_1;NMBR;RACE;API;;;;
2014;2014;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;12060;12,060;;;;;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;NMBR;GENDER;GENM;;;;
2014;2014;NM;New Mexico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2014;2014;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;NMBR;RACE;AIAN;;;;
2014;2014;KS;Kansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;10.79;10.79;;;9.95;11.62;Race/Ethnicity;Asian or Pacific Islander;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;CRDRATE;RACE;API;;;;
2014;2014;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;50.79;50.79;;;50.13;51.46;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;10.96;10.96;;;7.1;14.82;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2014;2014;UT;Utah;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;25.01;25.01;;;19.2;30.81;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;31.49;31.49;;;30.96;32.03;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;48083;48,083;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;NMBR;RACE;BLK;;;;
2014;2014;WY;Wyoming;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2014;2014;VA;Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;36441;36,441;;;;;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;NMBR;GENDER;GENF;;;;
2014;2014;LA;Louisiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;MO;Missouri;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;IN;Indiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2014;2014;CT;Connecticut;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;OK;Oklahoma;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;16.86;16.86;;;16.68;17.04;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;47;47;;;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;NMBR;RACE;AIAN;;;;
2014;2014;OH;Ohio;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2014;2014;WY;Wyoming;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;9.74;9.74;;;9.46;10.01;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;WY;Wyoming;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST2_1;NMBR;GENDER;GENF;;;;
2014;2014;MT;Montana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;MS;Mississippi;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;CA;California;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST2_1;NMBR;GENDER;GENF;;;;
2014;2014;GU;Guam;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(13.444304, 144.793731);;66;AST;AST2_1;NMBR;RACE;API;;;;
2014;2014;KS;Kansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2014;2014;GA;Georgia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;35832;35,832;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST2_1;NMBR;RACE;BLK;;;;
2014;2014;ND;North Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST3_1;CRDRATE;RACE;API;;;;
2014;2014;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;38.38;38.38;;;37.76;38.99;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2014;2014;LA;Louisiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2014;2014;VA;Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;OH;Ohio;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2014;2014;OK;Oklahoma;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;6.00;6;;;5.73;6.28;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;48.62;48.62;;;48.03;49.21;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.8;9.8;;;7.5;12.5;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;NM;New Mexico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2014;2014;UT;Utah;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;16.17;16.17;;;15.65;16.69;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;OR;Oregon;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST2_1;NMBR;GENDER;GENF;;;;
2014;2014;TN;Tennessee;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST2_1;NMBR;RACE;HIS;;;;
2014;2014;OH;Ohio;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;MO;Missouri;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST3_1;NMBR;RACE;BLK;;;;
2014;2014;WY;Wyoming;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST2_1;NMBR;RACE;HIS;;;;
2014;2014;PA;Pennsylvania;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2014;2014;MN;Minnesota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST2_1;NMBR;RACE;HIS;;;;
2014;2014;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;12803;12,803;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;NMBR;RACE;WHT;;;;
2014;2014;OH;Ohio;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;MA;Massachusetts;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;TX;Texas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST2_1;NMBR;RACE;HIS;;;;
2014;2014;MT;Montana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2014;2014;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;33.04;33.04;;;32.2;33.88;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.1;11.1;;;8.8;14;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;WV;West Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;MT;Montana;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST3_1;NMBR;RACE;HIS;;;;
2014;2014;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2014;2014;WA;Washington;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;TX;Texas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2014;2014;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;12730;12,730;;;;;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;NMBR;GENDER;GENF;;;;
2014;2014;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;32.21;32.21;;;31.4;33.02;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;14663;14,663;;;;;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;NMBR;GENDER;GENF;;;;
2014;2014;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;2292;2,292;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;NMBR;RACE;WHT;;;;
2014;2014;AL;Alabama;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST2_1;NMBR;RACE;WHT;;;;
2014;2014;DC;District of Columbia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2014;2014;MT;Montana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST2_1;NMBR;RACE;AIAN;;;;
2014;2014;SD;South Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST2_1;NMBR;RACE;BLK;;;;
2014;2014;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;NMBR;RACE;BLK;;;;
2014;2014;GA;Georgia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;28.85;28.85;;;27.76;29.94;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2014;2014;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;150.54;150.54;;;149.19;151.88;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2014;2014;KS;Kansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST2_1;NMBR;RACE;AIAN;;;;
2014;2014;ME;Maine;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;38.03;38.03;;;37.35;38.72;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;NMBR;RACE;BLK;;;;
2014;2014;KS;Kansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;MD;Maryland;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;106.91;106.91;;;91.75;122.08;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2014;2014;NM;New Mexico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2014;2014;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;8.64;8.64;;;7.56;9.73;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;CRDRATE;RACE;API;;;;
2014;2014;GU;Guam;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;MA;Massachusetts;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST2_1;NMBR;RACE;BLK;;;;
2014;2014;CO;Colorado;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;DE;Delaware;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST2_1;NMBR;RACE;AIAN;;;;
2014;2014;HI;Hawaii;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;61.28;61.28;;;59.45;63.11;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2014;2014;NH;New Hampshire;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST2_1;NMBR;RACE;BLK;;;;
2014;2014;VI;Virgin Islands;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2014;2014;ME;Maine;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST2_1;NMBR;GENDER;GENF;;;;
2014;2014;PA;Pennsylvania;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;OH;Ohio;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2014;2014;AR;Arkansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;38.16;38.16;;;35.5;40.81;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2014;2014;ND;North Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2014;2014;ME;Maine;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2014;2014;IL;Illinois;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST2_1;NMBR;RACE;BLK;;;;
2014;2014;GU;Guam;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2014;2014;WY;Wyoming;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2014;2014;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;46635;46,635;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;NMBR;RACE;WHT;;;;
2014;2014;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2014;2014;PR;Puerto Rico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST2_1;NMBR;GENDER;GENM;;;;
2014;2014;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;AL;Alabama;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;17.96;17.96;;;14.44;21.48;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2014;2014;VI;Virgin Islands;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2014;2014;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;575;575;;;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;NMBR;RACE;HIS;;;;
2014;2014;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;1041;1,041;;;;;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;NMBR;GENDER;GENM;;;;
2014;2014;MT;Montana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2014;2014;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;33.35;33.35;;;32.87;33.82;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;MD;Maryland;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;74.45;74.45;;;73.45;75.44;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2014;2014;MT;Montana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2014;2014;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;NMBR;RACE;AIAN;;;;
2014;2014;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;17.51;17.51;;;15.77;19.25;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2014;2014;ID;Idaho;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2014;2014;CO;Colorado;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2014;2014;KS;Kansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2014;2014;WV;West Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;149.15;149.15;;;144.43;153.86;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2014;2014;IN;Indiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2014;2014;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2014;2014;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;4138;4,138;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;NMBR;RACE;BLK;;;;
2014;2014;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2014;2014;OK;Oklahoma;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST2_1;CRDRATE;RACE;API;;;;
2014;2014;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;10.03;10.03;;;9.42;10.63;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2014;2014;PA;Pennsylvania;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;11269;11,269;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;NMBR;RACE;BLK;;;;
2014;2014;LA;Louisiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2014;2014;PR;Puerto Rico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;31.04;31.04;;;30.61;31.47;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2014;2014;IN;Indiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;KS;Kansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST2_1;NMBR;RACE;API;;;;
2014;2014;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;1442;1,442;;;;;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;NMBR;GENDER;GENF;;;;
2014;2014;VA;Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2014;2014;VI;Virgin Islands;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST2_1;NMBR;RACE;BLK;;;;
2014;2014;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;5.90;5.9;;;5.55;6.25;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;WV;West Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST2_1;NMBR;RACE;API;;;;
2014;2014;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2014;2014;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;OK;Oklahoma;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2014;2014;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;67.61;67.61;;;66.88;68.35;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2014;2014;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;7.45;7.45;;;7.09;7.82;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2014;2014;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;7841;7,841;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;NMBR;RACE;WHT;;;;
2014;2014;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;5.52;5.52;;;3.61;7.44;Race/Ethnicity;American Indian or Alaska Native;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2014;2014;WV;West Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2014;2014;OH;Ohio;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2014;2014;CA;California;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;LA;Louisiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;MN;Minnesota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;11288;11,288;;;;;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST2_1;NMBR;GENDER;GENF;;;;
2014;2014;UT;Utah;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;1370;1,370;;;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST2_1;NMBR;RACE;HIS;;;;
2014;2014;RI;Rhode Island;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;94.44;94.44;;;89.08;99.79;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2014;2014;DC;District of Columbia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.907192, -77.036871);;11;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;KS;Kansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST2_1;CRDRATE;RACE;API;;;;
2014;2014;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;144.24;144.24;;;139.64;148.85;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;OK;Oklahoma;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;GA;Georgia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;61.07;61.07;;;60.38;61.76;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;IN;Indiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST2_1;NMBR;GENDER;GENM;;;;
2014;2014;DC;District of Columbia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.907192, -77.036871);;11;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2014;2014;PA;Pennsylvania;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;NM;New Mexico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;MI;Michigan;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;MO;Missouri;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2014;2014;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;15.27;15.27;;;12.47;18.07;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;CRDRATE;RACE;API;;;;
2014;2014;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;15158;15,158;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;NMBR;RACE;WHT;;;;
2014;2014;RI;Rhode Island;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;59.74;59.74;;;58.17;61.3;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;1.14;1.14;;;1;1.28;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2014;2014;MD;Maryland;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;36.90;36.9;;;35.19;38.62;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;66.09;66.09;;;65.73;66.45;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;40.06;40.06;;;39.05;41.08;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2014;2014;DE;Delaware;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;ID;Idaho;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2014;2014;OR;Oregon;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;CT;Connecticut;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST2_1;NMBR;RACE;HIS;;;;
2014;2014;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;72.78;72.78;;;72.38;73.18;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;MN;Minnesota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;5.07;5.07;;;4.8;5.34;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;ID;Idaho;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST2_1;NMBR;RACE;API;;;;
2014;2014;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;4.67;4.67;;;3.97;5.38;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;VA;Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;5484;5,484;;;;;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;NMBR;GENDER;GENM;;;;
2014;2014;IL;Illinois;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;PA;Pennsylvania;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2014;2014;MO;Missouri;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST2_1;CRDRATE;RACE;API;;;;
2014;2014;CO;Colorado;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST2_1;NMBR;GENDER;GENF;;;;
2014;2014;AK;Alaska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;13.82;13.82;;;12.97;14.66;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2014;2014;CO;Colorado;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;46.75;46.75;;;32.15;61.35;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;NMBR;RACE;AIAN;;;;
2014;2014;MI;Michigan;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST2_1;NMBR;RACE;API;;;;
2014;2014;AL;Alabama;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;MS;Mississippi;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2014;2014;MT;Montana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2014;2014;WV;West Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;MI;Michigan;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;MO;Missouri;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST2_1;NMBR;RACE;WHT;;;;
2014;2014;VI;Virgin Islands;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(18.335765, -64.896335);;78;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;MT;Montana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2014;2014;WA;Washington;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;VI;Virgin Islands;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(18.335765, -64.896335);;78;AST;AST2_1;NMBR;RACE;AIAN;;;;
2014;2014;IL;Illinois;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;OR;Oregon;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2014;2014;WY;Wyoming;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;UT;Utah;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;26.80;26.8;;;25.96;27.64;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2014;2014;OK;Oklahoma;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;OK;Oklahoma;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;CO;Colorado;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST2_1;NMBR;RACE;AIAN;;;;
2014;2014;DC;District of Columbia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;MA;Massachusetts;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2014;2014;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;66.98;66.98;;;66.43;67.53;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;CO;Colorado;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2014;2014;RI;Rhode Island;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2014;2014;DC;District of Columbia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.907192, -77.036871);;11;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2014;2014;CT;Connecticut;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2014;2014;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;42.16;42.16;;;41.41;42.91;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2014;2014;DE;Delaware;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2014;2014;WA;Washington;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2014;2014;VA;Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;AR;Arkansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;51.37;51.37;;;50.17;52.56;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;RI;Rhode Island;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;MO;Missouri;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2014;2014;GA;Georgia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;30.80;30.8;;;30.32;31.28;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;CT;Connecticut;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;5.52;5.52;;;5.29;5.76;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2014;2014;CA;California;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST2_1;NMBR;RACE;BLK;;;;
2014;2014;DE;Delaware;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST2_1;NMBR;RACE;HIS;;;;
2014;2014;MA;Massachusetts;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST2_1;NMBR;RACE;HIS;;;;
2014;2014;MA;Massachusetts;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2014;2014;IL;Illinois;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST2_1;NMBR;RACE;API;;;;
2014;2014;TN;Tennessee;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST2_1;NMBR;RACE;API;;;;
2014;2014;SD;South Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST2_1;NMBR;RACE;AIAN;;;;
2014;2014;LA;Louisiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2014;2014;AK;Alaska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST2_1;NMBR;RACE;AIAN;;;;
2014;2014;OH;Ohio;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;58.95;58.95;;;57.91;59.99;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;MN;Minnesota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2014;2014;MN;Minnesota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;40.18;40.18;;;39.4;40.95;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;ND;North Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST2_1;NMBR;RACE;WHT;;;;
2014;2014;MA;Massachusetts;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST2_1;NMBR;GENDER;GENF;;;;
2014;2014;IL;Illinois;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2014;2014;MI;Michigan;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST2_1;NMBR;RACE;WHT;;;;
2014;2014;MO;Missouri;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST2_1;NMBR;GENDER;GENF;;;;
2014;2014;WY;Wyoming;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST2_1;NMBR;RACE;WHT;;;;
2014;2014;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;17.72;17.72;;;14.52;20.92;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;CRDRATE;RACE;API;;;;
2014;2014;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2014;2014;IL;Illinois;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;228;228;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;NMBR;RACE;BLK;;;;
2014;2014;PA;Pennsylvania;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2014;2014;AL;Alabama;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;GU;Guam;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST2_1;NMBR;RACE;WHT;;;;
2014;2014;ID;Idaho;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST2_1;NMBR;RACE;BLK;;;;
2014;2014;SD;South Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;WY;Wyoming;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2014;2014;VA;Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST2_1;CRDRATE;RACE;API;;;;
2014;2014;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2014;2014;ME;Maine;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2014;2014;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;43.89;43.89;;;43.27;44.51;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;RI;Rhode Island;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;65.56;65.56;;;63.28;67.83;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;AR;Arkansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;32.19;32.19;;;31.4;32.99;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;DE;Delaware;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST2_1;CRDRATE;RACE;API;;;;
2014;2014;PA;Pennsylvania;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2014;2014;WA;Washington;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2014;2014;ID;Idaho;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2014;2014;AR;Arkansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;44.28;44.28;;;43.17;45.38;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;GA;Georgia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;HI;Hawaii;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;54.18;54.18;;;32.04;76.32;Race/Ethnicity;American Indian or Alaska Native;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2014;2014;MD;Maryland;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;12.29;12.29;;;11.16;13.43;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2014;2014;OH;Ohio;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2014;2014;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;13.15;13.15;;;11.38;14.93;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;CRDRATE;RACE;API;;;;
2014;2014;NH;New Hampshire;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;2546;2,546;;;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;NMBR;RACE;HIS;;;;
2014;2014;DE;Delaware;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2014;2014;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2014;2014;RI;Rhode Island;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;15.43;15.43;;;10.86;20;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2014;2014;NH;New Hampshire;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2014;2014;IN;Indiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;56.58;56.58;;;55.9;57.27;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;LA;Louisiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST2_1;NMBR;RACE;BLK;;;;
2014;2014;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;20789;20,789;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;NMBR;RACE;WHT;;;;
2014;2014;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;10830;10,830;;;;;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;NMBR;RACE;HIS;;;;
2014;2014;CA;California;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;WA;Washington;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST2_1;CRDRATE;RACE;API;;;;
2014;2014;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2014;2014;VA;Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2014;2014;GU;Guam;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;KS;Kansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2014;2014;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;84;84;;;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;NMBR;RACE;HIS;;;;
2014;2014;OR;Oregon;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2014;2014;GA;Georgia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;3952;3,952;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST3_1;NMBR;RACE;BLK;;;;
2014;2014;AL;Alabama;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;AK;Alaska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST2_1;NMBR;RACE;API;;;;
2014;2014;NM;New Mexico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;NH;New Hampshire;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2014;2014;AK;Alaska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST2_1;NMBR;RACE;HIS;;;;
2014;2014;LA;Louisiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2014;2014;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;75.40;75.4;;;70.4;80.4;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;ME;Maine;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2014;2014;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;7.12;7.12;;;6.57;7.67;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2014;2014;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;5.16;5.16;;;4.93;5.38;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;213.83;213.83;;;211.2;216.45;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2014;2014;MN;Minnesota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2014;2014;MN;Minnesota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST2_1;NMBR;RACE;BLK;;;;
2014;2014;AK;Alaska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST2_1;CRDRATE;RACE;API;;;;
2014;2014;MA;Massachusetts;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2014;2014;DC;District of Columbia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;46.71;46.71;;;45.97;47.46;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;IL;Illinois;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2014;2014;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;47.10;47.1;;;44.56;49.64;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;NH;New Hampshire;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST2_1;NMBR;RACE;AIAN;;;;
2014;2014;MD;Maryland;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;119.57;119.57;;;102.36;136.78;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;OH;Ohio;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST2_1;NMBR;RACE;AIAN;;;;
2014;2014;CO;Colorado;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST2_1;NMBR;GENDER;GENM;;;;
2014;2014;DE;Delaware;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST2_1;NMBR;RACE;WHT;;;;
2014;2014;AK;Alaska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST2_1;NMBR;GENDER;GENF;;;;
2014;2014;ND;North Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST2_1;NMBR;GENDER;GENF;;;;
2014;2014;TN;Tennessee;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;14763;14,763;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;NMBR;RACE;WHT;;;;
2014;2014;AR;Arkansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;98;98;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST2_1;NMBR;RACE;API;;;;
2014;2014;DC;District of Columbia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2014;2014;TN;Tennessee;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2014;2014;GA;Georgia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;29.47;29.47;;;29.02;29.92;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2014;2014;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;212;212;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;NMBR;RACE;API;;;;
2014;2014;OH;Ohio;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;RI;Rhode Island;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;3378;3,378;;;;;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST2_1;NMBR;GENDER;GENF;;;;
2014;2014;LA;Louisiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST2_1;CRDRATE;RACE;API;;;;
2014;2014;TN;Tennessee;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST2_1;NMBR;GENDER;GENF;;;;
2014;2014;WA;Washington;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;OR;Oregon;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;WV;West Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2013;2013;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;36;36;;;;;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;NMBR;GENDER;GENF;;;;
2014;2014;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;61.10;61.1;;;60.6;61.6;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;IL;Illinois;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST2_1;NMBR;RACE;HIS;;;;
2014;2014;IN;Indiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2014;2014;GU;Guam;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST3_1;NMBR;GENDER;GENM;;;;
2014;2014;SD;South Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2014;2014;ND;North Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;ME;Maine;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST3_1;NMBR;RACE;BLK;;;;
2014;2014;AK;Alaska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2014;2014;CT;Connecticut;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;74.63;74.63;;;69.74;79.53;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2014;2014;ME;Maine;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;UT;Utah;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;270;270;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST2_1;NMBR;RACE;BLK;;;;
2014;2014;ID;Idaho;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST2_1;NMBR;RACE;WHT;;;;
2014;2014;HI;Hawaii;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;8526;8,526;;;;;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2014;2014;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2014;2014;VA;Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;DC;District of Columbia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;26723;26,723;;;;;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2014;2014;OK;Oklahoma;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;25549;25,549;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;NMBR;RACE;BLK;;;;
2014;2014;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;229.35;229.35;;;224.61;234.09;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2014;2014;SD;South Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST2_1;NMBR;RACE;API;;;;
2014;2014;OH;Ohio;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST2_1;NMBR;RACE;BLK;;;;
2014;2014;GA;Georgia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;113.17;113.17;;;112;114.34;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2014;2014;MD;Maryland;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;35.44;35.44;;;34.74;36.14;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;TN;Tennessee;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST2_1;CRDRATE;RACE;API;;;;
2014;2014;MT;Montana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;OR;Oregon;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST2_1;NMBR;GENDER;GENM;;;;
2014;2014;VA;Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST2_1;NMBR;GENDER;GENM;;;;
2014;2014;ND;North Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2014;2014;IL;Illinois;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2014;2014;DE;Delaware;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;VI;Virgin Islands;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;92.67;92.67;;;81.45;103.89;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2014;2014;CA;California;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;35.50;35.5;;;34.43;36.57;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2014;2014;MN;Minnesota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;NMBR;RACE;AIAN;;;;
2014;2014;AK;Alaska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST2_1;NMBR;RACE;BLK;;;;
2014;2014;HI;Hawaii;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;53.47;53.47;;;46.39;60.55;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2014;2014;CA;California;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST2_1;NMBR;RACE;HIS;;;;
2014;2014;AL;Alabama;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2014;2014;DC;District of Columbia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2014;2014;WA;Washington;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2014;2014;MS;Mississippi;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;662;662;;;;;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2014;2014;MS;Mississippi;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2014;2014;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;32.26;32.26;;;31.01;33.51;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2014;2014;NM;New Mexico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2014;2014;TX;Texas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST2_1;NMBR;RACE;WHT;;;;
2014;2014;AL;Alabama;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2014;2014;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;47.76;47.76;;;43.85;51.67;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;RI;Rhode Island;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;41.05;41.05;;;39.65;42.46;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2014;2014;KS;Kansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;131559;131,559;;;;;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2014;2014;DE;Delaware;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST3_1;NMBR;RACE;API;;;;
2014;2014;TX;Texas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2014;2014;ND;North Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;RI;Rhode Island;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;53.09;53.09;;;50.97;55.21;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;59.91;59.91;;;59.42;60.39;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2014;2014;TX;Texas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST2_1;NMBR;GENDER;GENM;;;;
2014;2014;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2014;2014;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;3.34;3.34;;;2.65;4.02;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;CT;Connecticut;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;SD;South Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST2_1;CRDRATE;RACE;API;;;;
2014;2014;CT;Connecticut;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST2_1;NMBR;GENDER;GENF;;;;
2014;2014;MO;Missouri;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;IN;Indiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2014;2014;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;42.23;42.23;;;40.44;44.02;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;AR;Arkansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;CT;Connecticut;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2014;2014;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;12.85;12.85;;;12.56;13.14;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;MD;Maryland;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;40.01;40.01;;;38.35;41.68;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2014;2014;MA;Massachusetts;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST2_1;NMBR;RACE;WHT;;;;
2014;2014;VI;Virgin Islands;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST2_1;NMBR;GENDER;GENM;;;;
2014;2014;DE;Delaware;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2014;2014;GA;Georgia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;7.37;7.37;;;6.54;8.21;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST2_1;CRDRATE;RACE;API;;;;
2014;2014;IL;Illinois;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST2_1;CRDRATE;RACE;API;;;;
2014;2014;IN;Indiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;MI;Michigan;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2014;2014;PR;Puerto Rico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2014;2014;AK;Alaska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2014;2014;OK;Oklahoma;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2014;2014;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;27.81;27.81;;;25.17;30.46;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;46.40;46.4;;;45.84;46.95;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;CA;California;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.7;37.7;;;31.2;44.8;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2014;2014;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2014;2014;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;29;29;;;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;NMBR;RACE;HIS;;;;
2014;2014;CA;California;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST2_1;NMBR;GENDER;GENM;;;;
2014;2014;WY;Wyoming;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST2_1;CRDRATE;RACE;API;;;;
2014;2014;GU;Guam;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST2_1;NMBR;RACE;BLK;;;;
2014;2014;OR;Oregon;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;CO;Colorado;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2014;2014;HI;Hawaii;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;70.20;70.2;;;68.42;71.98;Race/Ethnicity;Asian or Pacific Islander;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST2_1;CRDRATE;RACE;API;;;;
2014;2014;AL;Alabama;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST2_1;NMBR;RACE;AIAN;;;;
2014;2014;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;26.36;26.36;;;24.68;28.04;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;MT;Montana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST2_1;NMBR;RACE;HIS;;;;
2014;2014;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2014;2014;MS;Mississippi;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST2_1;NMBR;GENDER;GENF;;;;
2014;2014;MO;Missouri;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;SD;South Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;CO;Colorado;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;OR;Oregon;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST2_1;CRDRATE;RACE;API;;;;
2014;2014;ME;Maine;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;TX;Texas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;MN;Minnesota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;41.12;41.12;;;40.36;41.88;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2014;2014;VI;Virgin Islands;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST3_1;NMBR;RACE;HIS;;;;
2014;2014;TX;Texas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;ME;Maine;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2014;2014;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;NMBR;RACE;WHT;;;;
2014;2014;PA;Pennsylvania;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2014;2014;GU;Guam;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;37.13;37.13;;;36.14;38.12;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;PA;Pennsylvania;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST3_1;CRDRATE;RACE;API;;;;
2014;2014;TX;Texas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2014;2014;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;7.82;7.82;;;7.53;8.11;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;IL;Illinois;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;CA;California;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;26.96;26.96;;;24.77;29.15;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2014;2014;GU;Guam;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(13.444304, 144.793731);;66;AST;AST2_1;NMBR;RACE;AIAN;;;;
2014;2014;MS;Mississippi;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;GA;Georgia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;8.10;8.1;;;7.13;9.08;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2014;2014;NH;New Hampshire;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST3_1;NMBR;RACE;BLK;;;;
2014;2014;ND;North Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;ME;Maine;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;MS;Mississippi;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST2_1;NMBR;RACE;HIS;;;;
2014;2014;MA;Massachusetts;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2014;2014;IN;Indiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2014;2014;CA;California;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST2_1;CRDRATE;RACE;API;;;;
2014;2014;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;45.77;45.77;;;32.68;58.85;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2014;2014;AL;Alabama;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST3_1;NMBR;RACE;HIS;;;;
2014;2014;TX;Texas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;CO;Colorado;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;39.62;39.62;;;38.06;41.17;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;NMBR;RACE;API;;;;
2014;2014;KS;Kansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;44.53;44.53;;;43.36;45.7;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;TX;Texas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;MS;Mississippi;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2014;2014;KS;Kansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;415;415;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;NMBR;RACE;API;;;;
2014;2014;CA;California;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;NMBR;RACE;WHT;;;;
2014;2014;MO;Missouri;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;SD;South Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;WA;Washington;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2014;2014;RI;Rhode Island;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;52;52;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST2_1;NMBR;RACE;API;;;;
2014;2014;AL;Alabama;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2014;2014;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;37.59;37.59;;;35.25;39.92;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;VI;Virgin Islands;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2014;2014;VI;Virgin Islands;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(18.335765, -64.896335);;78;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2014;2014;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;15277;15,277;;;;;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;NMBR;GENDER;GENM;;;;
2014;2014;NM;New Mexico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;OR;Oregon;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST2_1;NMBR;RACE;BLK;;;;
2014;2014;MO;Missouri;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2014;2014;DC;District of Columbia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST2_1;NMBR;GENDER;GENM;;;;
2014;2014;MO;Missouri;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST3_1;NMBR;GENDER;GENM;;;;
2014;2014;PR;Puerto Rico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(18.220833, -66.590149);;72;AST;AST2_1;CRDRATE;RACE;API;;;;
2014;2014;CT;Connecticut;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST2_1;NMBR;GENDER;GENM;;;;
2014;2014;WV;West Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST2_1;NMBR;GENDER;GENF;;;;
2014;2014;MO;Missouri;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST2_1;NMBR;GENDER;GENM;;;;
2014;2014;OR;Oregon;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2014;2014;AL;Alabama;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST2_1;NMBR;GENDER;GENM;;;;
2014;2014;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.4;13.4;;;10.6;16.7;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;UT;Utah;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;22.84;22.84;;;22.07;23.6;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2014;2014;MN;Minnesota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;42.83;42.83;;;42.03;43.63;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;66158;66,158;;;;;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2014;2014;ME;Maine;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST2_1;NMBR;GENDER;GENM;;;;
2014;2014;VI;Virgin Islands;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2014;2014;MN;Minnesota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;10526;10,526;;;;;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST2_1;NMBR;GENDER;GENM;;;;
2014;2014;AK;Alaska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2014;2014;PR;Puerto Rico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(18.220833, -66.590149);;72;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2014;2014;WV;West Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST2_1;CRDRATE;RACE;API;;;;
2014;2014;OH;Ohio;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;RI;Rhode Island;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;128.02;128.02;;;119.48;136.55;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2014;2014;GA;Georgia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;30197;30,197;;;;;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST2_1;NMBR;GENDER;GENM;;;;
2014;2014;AL;Alabama;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2014;2014;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;62.41;62.41;;;61.73;63.1;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2014;2014;OH;Ohio;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST2_1;NMBR;RACE;API;;;;
2014;2014;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2014;2014;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2014;2014;WV;West Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2014;2014;PA;Pennsylvania;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST2_1;NMBR;RACE;API;;;;
2014;2014;MI;Michigan;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2014;2014;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;NMBR;RACE;API;;;;
2014;2014;NH;New Hampshire;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;34.14;34.14;;;32.96;35.32;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2014;2014;CT;Connecticut;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2014;2014;DE;Delaware;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;NM;New Mexico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST2_1;NMBR;RACE;HIS;;;;
2014;2014;GU;Guam;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(13.444304, 144.793731);;66;AST;AST3_1;CRDRATE;RACE;API;;;;
2014;2014;AK;Alaska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;3226;3,226;;;;;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;NMBR;GENDER;GENF;;;;
2014;2014;WY;Wyoming;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST3_1;NMBR;RACE;API;;;;
2014;2014;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;25.99;25.99;;;16.53;35.45;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2014;2014;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;82.33;82.33;;;81.47;83.2;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;NMBR;RACE;HIS;;;;
2014;2014;OK;Oklahoma;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST3_1;NMBR;RACE;AIAN;;;;
2014;2014;IN;Indiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST3_1;NMBR;RACE;BLK;;;;
2014;2014;LA;Louisiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;OK;Oklahoma;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST2_1;NMBR;GENDER;GENM;;;;
2014;2014;RI;Rhode Island;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST2_1;NMBR;RACE;AIAN;;;;
2014;2014;PR;Puerto Rico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;GA;Georgia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;34.76;34.76;;;27.34;42.17;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;30.54;30.54;;;29.41;31.67;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;MI;Michigan;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST2_1;NMBR;RACE;BLK;;;;
2014;2014;SD;South Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;IL;Illinois;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2014;2014;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;282;282;;;;;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;NMBR;GENDER;GENM;;;;
2014;2014;AK;Alaska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;29.16;29.16;;;27.95;30.36;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;ME;Maine;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2014;2014;AR;Arkansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;45.87;45.87;;;45.1;46.64;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;NM;New Mexico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST2_1;NMBR;RACE;AIAN;;;;
2014;2014;DC;District of Columbia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;45.69;45.69;;;44.97;46.42;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2014;2014;WY;Wyoming;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;82.71;82.71;;;81.35;84.06;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2014;2014;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;16.37;16.37;;;14.46;18.27;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2014;2014;MD;Maryland;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;460;460;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST2_1;NMBR;RACE;API;;;;
2014;2014;IL;Illinois;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;MA;Massachusetts;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;MA;Massachusetts;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST2_1;CRDRATE;RACE;API;;;;
2014;2014;PR;Puerto Rico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST2_1;NMBR;GENDER;GENF;;;;
2014;2014;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;70.69;70.69;;;69.88;71.51;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;WY;Wyoming;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;217.83;217.83;;;213.13;222.53;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;OK;Oklahoma;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST2_1;NMBR;RACE;API;;;;
2014;2014;OH;Ohio;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2014;2014;VI;Virgin Islands;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(18.335765, -64.896335);;78;AST;AST2_1;CRDRATE;RACE;API;;;;
2014;2014;UT;Utah;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;37.71;37.71;;;33.99;41.42;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST2_1;CRDRATE;RACE;API;;;;
2014;2014;MN;Minnesota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2014;2014;ND;North Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;KS;Kansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST2_1;NMBR;RACE;BLK;;;;
2014;2014;WA;Washington;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST2_1;NMBR;RACE;HIS;;;;
2014;2014;VA;Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2014;2014;TX;Texas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2012;2012;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.3;30.3;;;24;37.4;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;OK;Oklahoma;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2014;2014;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;NMBR;GENDER;GENF;;;;
2014;2014;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;53.34;53.34;;;52.54;54.15;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;SD;South Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2014;2014;ID;Idaho;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;MI;Michigan;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;UT;Utah;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;69.11;69.11;;;60.87;77.35;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2014;2014;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;118;118;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;NMBR;RACE;API;;;;
2014;2014;TN;Tennessee;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST3_1;CRDRATE;RACE;API;;;;
2014;2014;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;26.59;26.59;;;22.05;31.13;Race/Ethnicity;American Indian or Alaska Native;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;PR;Puerto Rico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;15.95;15.95;;;14.42;17.49;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;CRDRATE;RACE;API;;;;
2014;2014;VI;Virgin Islands;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(18.335765, -64.896335);;78;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2014;2014;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;35.52;35.52;;;34.58;36.46;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2014;2014;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;46.93;46.93;;;45.78;48.08;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;TN;Tennessee;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;WY;Wyoming;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;GA;Georgia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;29.14;29.14;;;27.79;30.48;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;VI;Virgin Islands;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;MI;Michigan;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2014;2014;ID;Idaho;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST2_1;CRDRATE;RACE;API;;;;
2014;2014;VA;Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;WY;Wyoming;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST2_1;NMBR;RACE;BLK;;;;
2014;2014;ID;Idaho;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2014;2014;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;7.42;7.42;;;6.96;7.88;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;DC;District of Columbia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST2_1;NMBR;RACE;HIS;;;;
2014;2014;ND;North Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2014;2014;CA;California;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;IN;Indiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;PR;Puerto Rico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2014;2014;AR;Arkansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;48.69;48.69;;;47.57;49.8;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2014;2014;NM;New Mexico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2014;2014;MN;Minnesota;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1938;1,938;;;;;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST3_1;NMBR;GENDER;GENF;;;;
2014;2014;ND;North Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST2_1;CRDRATE;RACE;API;;;;
2014;2014;VA;Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST2_1;NMBR;RACE;WHT;;;;
2014;2014;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;55.79;55.79;;;54.53;57.06;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;IN;Indiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST2_1;NMBR;RACE;AIAN;;;;
2014;2014;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;90.15;90.15;;;75.38;104.92;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;48.10;48.1;;;45.52;50.68;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;PR;Puerto Rico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2014;2014;NM;New Mexico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;OK;Oklahoma;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;NMBR;RACE;AIAN;;;;
2014;2014;TN;Tennessee;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST3_1;NMBR;GENDER;GENM;;;;
2014;2014;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2014;2014;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;773;773;;;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;NMBR;RACE;HIS;;;;
2014;2014;ID;Idaho;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;MO;Missouri;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;6065;6,065;;;;;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2014;2014;AK;Alaska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;OK;Oklahoma;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2014;2014;OH;Ohio;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;GU;Guam;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST2_1;NMBR;GENDER;GENM;;;;
2014;2014;LA;Louisiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2014;2014;AR;Arkansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;13610;13,610;;;;;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2014;2014;SD;South Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2014;2014;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;52.74;52.74;;;52.04;53.44;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;OR;Oregon;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2014;2014;GU;Guam;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(13.444304, 144.793731);;66;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;WA;Washington;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST2_1;NMBR;RACE;WHT;;;;
2014;2014;ME;Maine;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;IN;Indiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2014;2014;CO;Colorado;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2014;2014;AL;Alabama;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2014;2014;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;31.00;31;;;30.3;31.7;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;CO;Colorado;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST2_1;NMBR;RACE;BLK;;;;
2014;2014;AL;Alabama;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2014;2014;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.6;7.6;;;5.5;10.3;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;CO;Colorado;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST2_1;CRDRATE;RACE;API;;;;
2014;2014;NH;New Hampshire;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;LA;Louisiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST2_1;NMBR;RACE;API;;;;
2014;2014;ID;Idaho;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST2_1;NMBR;GENDER;GENF;;;;
2014;2014;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;TX;Texas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST2_1;NMBR;RACE;API;;;;
2014;2014;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;38.64;38.64;;;37.06;40.23;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2014;2014;RI;Rhode Island;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;3269;3,269;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST2_1;NMBR;RACE;WHT;;;;
2014;2014;CO;Colorado;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;MN;Minnesota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;21814;21,814;;;;;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2014;2014;WV;West Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;CT;Connecticut;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST2_1;CRDRATE;RACE;API;;;;
2014;2014;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2014;2014;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;24;24;;;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;NMBR;RACE;AIAN;;;;
2014;2014;WA;Washington;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2014;2014;MO;Missouri;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;22.30;22.3;;;13.6;31;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;VA;Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2014;2014;LA;Louisiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;WA;Washington;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;TN;Tennessee;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2014;2014;ME;Maine;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST2_1;NMBR;RACE;BLK;;;;
2014;2014;TX;Texas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST2_1;NMBR;GENDER;GENF;;;;
2014;2014;GA;Georgia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;68.90;68.9;;;68.17;69.62;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;PR;Puerto Rico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;DE;Delaware;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST2_1;NMBR;GENDER;GENF;;;;
2014;2014;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;9000;9,000;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;NMBR;RACE;BLK;;;;
2014;2014;NM;New Mexico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST2_1;NMBR;RACE;API;;;;
2014;2014;TN;Tennessee;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST2_1;NMBR;RACE;WHT;;;;
2014;2014;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;603;603;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;NMBR;RACE;API;;;;
2014;2014;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;NMBR;RACE;HIS;;;;
2014;2014;HI;Hawaii;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;5985;5,985;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST2_1;NMBR;RACE;API;;;;
2014;2014;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;26514;26,514;;;;;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;NMBR;GENDER;GENM;;;;
2014;2014;TX;Texas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST2_1;CRDRATE;RACE;API;;;;
2014;2014;UT;Utah;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;3841;3,841;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST2_1;NMBR;RACE;WHT;;;;
2014;2014;OH;Ohio;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST2_1;NMBR;GENDER;GENM;;;;
2014;2014;PA;Pennsylvania;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2014;2014;MN;Minnesota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST2_1;NMBR;RACE;AIAN;;;;
2014;2014;PA;Pennsylvania;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;GA;Georgia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;10.55;10.55;;;10.27;10.83;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;AR;Arkansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;18.15;18.15;;;14.56;21.75;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST2_1;CRDRATE;RACE;API;;;;
2014;2014;KS;Kansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;AL;Alabama;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;DC;District of Columbia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.907192, -77.036871);;11;AST;AST2_1;NMBR;RACE;API;;;;
2014;2014;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;7.26;7.26;;;7.01;7.5;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;TN;Tennessee;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2014;2014;MS;Mississippi;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;CRDRATE;RACE;API;;;;
2014;2014;ME;Maine;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST2_1;NMBR;RACE;WHT;;;;
2014;2014;HI;Hawaii;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;37.15;37.15;;;33.12;41.18;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;;Number;30;30;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;NMBR;RACE;WHT;;;;
2014;2014;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;MI;Michigan;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;DE;Delaware;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST2_1;NMBR;RACE;BLK;;;;
2014;2014;VA;Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST3_1;NMBR;RACE;BLK;;;;
2014;2014;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;NMBR;RACE;API;;;;
2014;2014;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;76.50;76.5;;;68.93;84.06;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;GA;Georgia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;65.46;65.46;;;64.95;65.96;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;GA;Georgia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;8.97;8.97;;;8.79;9.15;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;AK;Alaska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2014;2014;PA;Pennsylvania;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST2_1;NMBR;RACE;WHT;;;;
2014;2014;IN;Indiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;UT;Utah;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;21.38;21.38;;;20.64;22.12;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;VA;Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST2_1;NMBR;RACE;HIS;;;;
2014;2014;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2014;2014;DE;Delaware;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST2_1;NMBR;GENDER;GENM;;;;
2014;2014;ME;Maine;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST2_1;NMBR;RACE;AIAN;;;;
2014;2014;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;640;640;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;NMBR;RACE;API;;;;
2014;2014;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;44.47;44.47;;;43.67;45.27;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;UT;Utah;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;24.33;24.33;;;23.76;24.9;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;CRDRATE;RACE;API;;;;
2014;2014;MS;Mississippi;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;22.61;22.61;;;13.18;32.03;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.4;8.4;;;6.6;10.7;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2014;2014;WY;Wyoming;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;TN;Tennessee;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;CT;Connecticut;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST3_1;NMBR;RACE;BLK;;;;
2014;2014;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;31816;31,816;;;;;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;NMBR;GENDER;GENF;;;;
2014;2014;PR;Puerto Rico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(18.220833, -66.590149);;72;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2014;2014;MO;Missouri;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;NMBR;RACE;HIS;;;;
2014;2014;OH;Ohio;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2014;2014;DC;District of Columbia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2014;2014;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;9.75;9.75;;;8.43;11.07;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2014;2014;PR;Puerto Rico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2014;2014;HI;Hawaii;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;23;23;;;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST2_1;NMBR;RACE;AIAN;;;;
2014;2014;GU;Guam;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;NH;New Hampshire;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST3_1;NMBR;GENDER;GENM;;;;
2014;2014;MS;Mississippi;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2014;2014;TX;Texas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2014;2014;ND;North Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2014;2014;OK;Oklahoma;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST2_1;NMBR;RACE;WHT;;;;
2014;2014;UT;Utah;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;3923;3,923;;;;;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST2_1;NMBR;GENDER;GENF;;;;
2014;2014;UT;Utah;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;395;395;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST2_1;NMBR;RACE;API;;;;
2014;2014;CA;California;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2014;2014;ID;Idaho;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;UT;Utah;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;38.99;38.99;;;34.94;43.04;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2014;2014;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;NMBR;RACE;API;;;;
2014;2014;AR;Arkansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;6260;6,260;;;;;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST2_1;NMBR;GENDER;GENM;;;;
2014;2014;RI;Rhode Island;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;127.64;127.64;;;118.93;136.34;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;OH;Ohio;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST2_1;NMBR;RACE;HIS;;;;
2014;2014;DE;Delaware;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2014;2014;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;50.17;50.17;;;49.62;50.72;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;NMBR;RACE;API;;;;
2014;2014;VA;Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;86.89;86.89;;;72.89;100.88;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2014;2014;GA;Georgia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;111.09;111.09;;;109.92;112.26;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;NH;New Hampshire;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST2_1;NMBR;RACE;WHT;;;;
2014;2014;OR;Oregon;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;CT;Connecticut;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST2_1;NMBR;RACE;API;;;;
2014;2014;UT;Utah;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;34.68;34.68;;;32.48;36.88;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;DC;District of Columbia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.907192, -77.036871);;11;AST;AST2_1;NMBR;RACE;AIAN;;;;
2014;2014;OK;Oklahoma;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST2_1;NMBR;RACE;AIAN;;;;
2014;2014;ND;North Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2014;2014;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;7642;7,642;;;;;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;NMBR;GENDER;GENF;;;;
2014;2014;MN;Minnesota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;RI;Rhode Island;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;55.60;55.6;;;54.17;57.02;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;OH;Ohio;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2014;2014;DC;District of Columbia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST2_1;NMBR;RACE;BLK;;;;
2014;2014;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;18.90;18.9;;;18.32;19.48;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2014;2014;MO;Missouri;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST2_1;NMBR;RACE;API;;;;
2014;2014;VI;Virgin Islands;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;IN;Indiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2014;2014;AR;Arkansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;7350;7,350;;;;;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST2_1;NMBR;GENDER;GENF;;;;
2014;2014;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;152.87;152.87;;;148.92;156.81;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;OH;Ohio;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;NH;New Hampshire;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2014;2014;WV;West Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST2_1;NMBR;RACE;HIS;;;;
2014;2014;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;44.58;44.58;;;43.69;45.46;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2014;2014;MA;Massachusetts;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;MD;Maryland;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;79.72;79.72;;;78.72;80.72;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2014;2014;MD;Maryland;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;21557;21,557;;;;;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST2_1;NMBR;GENDER;GENM;;;;
2014;2014;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;16.90;16.9;;;15.73;18.08;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2014;2014;AR;Arkansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;42.96;42.96;;;41.9;44.02;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2014;2014;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;145.89;145.89;;;144.29;147.49;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2014;2014;GU;Guam;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2014;2014;CT;Connecticut;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;ID;Idaho;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;94.0;94;;;82.4;98.1;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2014;2014;VA;Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2014;2014;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;40.14;40.14;;;39.41;40.88;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;DE;Delaware;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2014;2014;AL;Alabama;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2014;2014;WY;Wyoming;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST2_1;NMBR;GENDER;GENM;;;;
2014;2014;SD;South Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST2_1;NMBR;RACE;HIS;;;;
2014;2014;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;NMBR;RACE;WHT;;;;
2014;2014;VI;Virgin Islands;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;TX;Texas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2014;2014;KS;Kansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2014;2014;CT;Connecticut;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST2_1;NMBR;RACE;AIAN;;;;
2014;2014;IN;Indiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST2_1;NMBR;RACE;WHT;;;;
2014;2014;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;40.51;40.51;;;39.51;41.51;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2014;2014;MA;Massachusetts;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2014;2014;MT;Montana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;37.70;37.7;;;35.61;39.79;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;58330;58,330;;;;;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2014;2014;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2014;2014;DC;District of Columbia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;25.80;25.8;;;24.11;27.49;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2014;2014;RI;Rhode Island;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;45.23;45.23;;;43.6;46.85;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;MD;Maryland;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;11.56;11.56;;;10.5;12.61;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST2_1;CRDRATE;RACE;API;;;;
2014;2014;ID;Idaho;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;IL;Illinois;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2014;2014;DE;Delaware;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2014;2014;ID;Idaho;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST2_1;NMBR;RACE;AIAN;;;;
2014;2014;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;8527;8,527;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;NMBR;RACE;WHT;;;;
2014;2014;LA;Louisiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2014;2014;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;102.07;102.07;;;81.65;122.49;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2014;2014;AK;Alaska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST2_1;NMBR;GENDER;GENM;;;;
2014;2014;IL;Illinois;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST2_1;NMBR;GENDER;GENM;;;;
2014;2014;TN;Tennessee;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2014;2014;NM;New Mexico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2014;2014;MO;Missouri;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;PR;Puerto Rico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2014;2014;KS;Kansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST2_1;NMBR;RACE;HIS;;;;
2014;2014;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;30.27;30.27;;;29.15;31.38;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2014;2014;ID;Idaho;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST3_1;NMBR;RACE;WHT;;;;
2014;2014;NH;New Hampshire;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST2_1;CRDRATE;RACE;API;;;;
2014;2014;CO;Colorado;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2014;2014;DE;Delaware;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;43.08;43.08;;;41.33;44.83;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;MA;Massachusetts;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;DC;District of Columbia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.907192, -77.036871);;11;AST;AST2_1;CRDRATE;RACE;API;;;;
2014;2014;GU;Guam;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2014;2014;MO;Missouri;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;AR;Arkansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;37.59;37.59;;;34.15;41.03;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;WY;Wyoming;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2014;2014;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;262;262;;;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;NMBR;RACE;AIAN;;;;
2014;2014;SD;South Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST2_1;NMBR;GENDER;GENM;;;;
2014;2014;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;NMBR;GENDER;GENM;;;;
2014;2014;NM;New Mexico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2014;2014;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;662;662;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;NMBR;RACE;BLK;;;;
2014;2014;MS;Mississippi;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;WY;Wyoming;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;3.16;3.16;;;2.35;3.96;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;AL;Alabama;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2014;2014;KS;Kansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;HI;Hawaii;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;61.38;61.38;;;60.05;62.71;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;NMBR;GENDER;GENM;;;;
2014;2014;PR;Puerto Rico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2014;2014;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1883;1,883;;;;;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2014;2014;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;11.68;11.68;;;10.76;12.6;Race/Ethnicity;Asian or Pacific Islander;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2014;2014;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;TX;Texas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2014;2014;HI;Hawaii;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;40.56;40.56;;;38.53;42.59;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2014;2014;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;893;893;;;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;NMBR;RACE;AIAN;;;;
2014;2014;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;CRDRATE;RACE;API;;;;
2014;2014;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;52.69;52.69;;;51.69;53.68;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2014;2014;VI;Virgin Islands;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;146.36;146.36;;;142.12;150.61;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;ME;Maine;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2014;2014;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;13.7;13.7;;;10.1;18;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;HI;Hawaii;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;4228;4,228;;;;;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST2_1;NMBR;GENDER;GENM;;;;
2014;2014;SD;South Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST2_1;NMBR;RACE;WHT;;;;
2014;2014;GA;Georgia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;64.64;64.64;;;64.14;65.13;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;WV;West Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2014;2014;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;CRDRATE;RACE;API;;;;
2014;2014;RI;Rhode Island;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;2487;2,487;;;;;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST2_1;NMBR;GENDER;GENM;;;;
2014;2014;ND;North Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST2_1;NMBR;GENDER;GENM;;;;
2014;2014;WY;Wyoming;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2014;2014;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;96;96;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;NMBR;RACE;BLK;;;;
2014;2014;PA;Pennsylvania;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;ID;Idaho;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;ID;Idaho;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2014;2014;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;59.02;59.02;;;56.56;61.49;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2014;2014;IN;Indiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST2_1;CRDRATE;RACE;API;;;;
2014;2014;LA;Louisiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST2_1;NMBR;RACE;WHT;;;;
2014;2014;VA;Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST2_1;NMBR;RACE;BLK;;;;
2014;2014;NH;New Hampshire;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST2_1;NMBR;GENDER;GENM;;;;
2014;2014;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;8.30;8.3;;;7.96;8.63;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;MO;Missouri;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2014;2014;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;76.67;76.67;;;69.41;83.92;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2014;2014;RI;Rhode Island;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;13.73;13.73;;;10;17.46;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST2_1;CRDRATE;RACE;API;;;;
2014;2014;PA;Pennsylvania;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST2_1;NMBR;GENDER;GENF;;;;
2014;2014;WA;Washington;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;MS;Mississippi;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST2_1;NMBR;GENDER;GENM;;;;
2014;2014;WV;West Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST2_1;NMBR;RACE;WHT;;;;
2014;2014;IN;Indiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;WA;Washington;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.8;69.8;;;61.7;76.8;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2014;2014;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;NMBR;RACE;BLK;;;;
2014;2014;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;7.86;7.86;;;7.52;8.21;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;NH;New Hampshire;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2014;2014;MA;Massachusetts;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST2_1;NMBR;RACE;API;;;;
2014;2014;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;5.28;5.28;;;3.36;7.2;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2014;2014;ME;Maine;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;MS;Mississippi;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST2_1;NMBR;RACE;API;;;;
2014;2014;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;48.60;48.6;;;48.07;49.12;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;6.07;6.07;;;5.8;6.35;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;MA;Massachusetts;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST2_1;NMBR;GENDER;GENM;;;;
2014;2014;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;51.85;51.85;;;48.2;55.51;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2014;2014;MN;Minnesota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;AL;Alabama;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2014;2014;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;NMBR;RACE;API;;;;
2014;2014;TN;Tennessee;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST2_1;NMBR;RACE;AIAN;;;;
2014;2014;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;4.46;4.46;;;4.03;4.89;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;ND;North Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2014;2014;ID;Idaho;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST2_1;NMBR;RACE;HIS;;;;
2014;2014;LA;Louisiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2014;2014;MT;Montana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST2_1;NMBR;RACE;WHT;;;;
2014;2014;UT;Utah;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;78;78;;;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST2_1;NMBR;RACE;AIAN;;;;
2014;2014;SD;South Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2014;2014;MD;Maryland;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;77.17;77.17;;;76.46;77.87;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;SD;South Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;OK;Oklahoma;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2014;2014;HI;Hawaii;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;58.81;58.81;;;57.04;60.59;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2014;2014;MD;Maryland;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;82.28;82.28;;;81.23;83.32;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;9.83;9.83;;;9.54;10.11;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;MD;Maryland;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;77.11;77.11;;;76.08;78.15;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;CT;Connecticut;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;PR;Puerto Rico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST2_1;NMBR;RACE;HIS;;;;
2014;2014;AR;Arkansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;5939;5,939;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST2_1;NMBR;RACE;BLK;;;;
2014;2014;PR;Puerto Rico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;54.75;54.75;;;54.09;55.41;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2014;2014;CA;California;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2014;2014;MN;Minnesota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2014;2014;PR;Puerto Rico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;NH;New Hampshire;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;CT;Connecticut;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2014;2014;IN;Indiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST2_1;NMBR;GENDER;GENF;;;;
2014;2014;DC;District of Columbia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2014;2014;IL;Illinois;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST2_1;NMBR;RACE;WHT;;;;
2014;2014;KS;Kansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;HI;Hawaii;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;219;219;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST2_1;NMBR;RACE;BLK;;;;
2014;2014;WY;Wyoming;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;WV;West Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;OR;Oregon;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2014;2014;MS;Mississippi;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST2_1;NMBR;RACE;AIAN;;;;
2014;2014;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;192.22;192.22;;;184.17;200.26;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.2;7.2;;;5.5;9.2;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.2;12.2;;;8.3;17.6;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;26.3;26.3;;;18.2;36.3;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;15.0;15;;;12.4;18.1;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;6.2;6.2;;;3.7;9.6;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.6;8.6;;;7.9;9.4;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.5;12.5;;;6.9;21.4;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2014;2014;MI;Michigan;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.0;10;;;9.1;11;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2014;2014;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2014;2014;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.6;6.6;;;4.1;10.4;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.0;9;;;6.2;12.9;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.9;11.9;;;10.9;13;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;4.7;4.7;;;3.9;5.6;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.1;8.1;;;7.1;9.2;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.4;6.4;;;4;10.2;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.0;12;;;10.5;13.7;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;19.2;19.2;;;11.4;30.6;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.7;5.7;;;3.3;9.6;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2014;2014;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.8;7.8;;;7.1;8.5;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2014;2014;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.4;8.4;;;7.8;9.1;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;CA;California;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.9;14.9;;;11.6;18.9;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.2;7.2;;;4;12.6;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.0;11;;;10;12;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.3;8.3;;;7.6;9;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.5;7.5;;;6.5;8.6;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2014;2014;UT;Utah;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;3381;3,381;;;;;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST2_1;NMBR;GENDER;GENM;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.2;13.2;;;10.5;16.5;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.3;12.3;;;10.8;14;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.4;9.4;;;8.4;10.5;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2014;2014;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.2;11.2;;;9.9;12.7;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.6;6.6;;;4.4;9.9;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;LA;Louisiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;183.39;183.39;;;156.45;210.33;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.4;10.4;;;9.6;11.2;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;17.5;17.5;;;9.9;28.8;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;16.6;16.6;;;10.7;24.8;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.8;6.8;;;3.8;11.7;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;31.4;31.4;;;16.7;51.2;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2014;2014;NM;New Mexico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST2_1;NMBR;GENDER;GENM;;;;
2014;2014;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;4.8;4.8;;;4.1;5.6;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;4.6;4.6;;;3.8;5.5;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2014;2014;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;58264;58,264;;;;;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;NMBR;GENDER;GENM;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.2;10.2;;;9.2;11.3;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.9;7.9;;;6.7;9.2;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.9;12.9;;;10.9;15.2;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.3;8.3;;;6.9;10.1;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;OH;Ohio;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.6;10.6;;;8.9;12.6;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.2;13.2;;;9.1;18.9;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.7;12.7;;;10.3;15.5;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2014;2014;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.2;10.2;;;9.1;11.4;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2014;2014;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.6;8.6;;;5.2;13.3;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.5;13.5;;;7.7;22.5;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.5;5.5;;;4.1;7.4;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.5;12.5;;;11.1;14;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2014;2014;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2014;2014;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.3;13.3;;;10.1;17.3;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.2;12.2;;;10.9;13.7;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.3;8.3;;;7.6;9.1;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.6;7.6;;;5.6;10.3;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.5;8.5;;;7.4;9.7;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.3;13.3;;;10;17.4;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.1;7.1;;;5.4;9.4;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.7;10.7;;;9.2;12.5;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;VA;Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2014;2014;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;33.71;33.71;;;31.66;35.76;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.4;10.4;;;8.5;12.6;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.5;8.5;;;6.2;11.4;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.5;5.5;;;4.5;6.6;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.8;13.8;;;11.1;17;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2014;2014;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;16.1;16.1;;;12.4;20.6;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2014;2014;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.5;12.5;;;11.2;14;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.0;11;;;7.9;15.2;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2014;2014;IN;Indiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST2_1;NMBR;RACE;HIS;;;;
2014;2014;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.0;7;;;4.6;10.2;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.3;7.3;;;6.3;8.5;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.0;11;;;9.8;12.2;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.0;14;;;8.2;22.9;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.9;10.9;;;9.8;11.9;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.3;9.3;;;5.5;15.2;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.7;12.7;;;11.4;14.1;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.5;7.5;;;5.2;10.4;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.4;7.4;;;6.4;8.6;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.0;13;;;8.5;19.3;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.3;9.3;;;7.4;11.5;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2014;2014;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.6;9.6;;;7.3;12.4;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;8.4;8.4;;;5.2;13.4;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;2.9;2.9;;;1.7;4.7;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.4;11.4;;;8.8;14.6;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.4;7.4;;;6.2;9;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.7;9.7;;;8.7;10.9;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2014;2014;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.2;10.2;;;6.8;14.8;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.9;11.9;;;10.4;13.6;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;15.4;15.4;;;11.9;19.7;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2014;2014;PR;Puerto Rico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(18.220833, -66.590149);;72;AST;AST2_1;NMBR;RACE;API;;;;
2014;2014;SD;South Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.7;7.7;;;6.5;9.2;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2014;2014;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.4;8.4;;;5.5;12.4;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.9;8.9;;;8.2;9.6;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;IN;Indiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST2_1;NMBR;RACE;BLK;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.5;13.5;;;10.7;16.8;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.7;8.7;;;7;10.8;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.0;9;;;7.7;10.7;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.0;12;;;11.2;12.8;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.8;7.8;;;7;8.6;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.4;6.4;;;5.2;7.8;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;CO;Colorado;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.6;10.6;;;9.7;11.7;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2014;2014;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.8;9.8;;;5.7;16.2;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;15.6;15.6;;;12.7;19.2;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.6;13.6;;;11.9;15.5;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;OH;Ohio;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST2_1;CRDRATE;RACE;API;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.1;9.1;;;8.5;9.7;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;8.4;8.4;;;6;11.8;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.3;9.3;;;8.2;10.6;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.2;10.2;;;8.9;11.7;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;4.7;4.7;;;2.9;7.6;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2014;2014;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;13.7;13.7;;;10.9;16.9;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;NY;New York;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.4;14.4;;;9;22.2;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2014;2014;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.7;13.7;;;12.5;15.1;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2014;2014;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2014;2014;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.2;8.2;;;5.9;11.2;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;6.7;6.7;;;4.1;10.7;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2014;2014;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.7;11.7;;;9.6;14.2;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.1;9.1;;;5.6;14.3;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.5;9.5;;;6.2;14.4;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.3;12.3;;;8.2;18;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2014;2014;LA;Louisiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.2;6.2;;;5;7.6;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2014;2014;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.3;12.3;;;10.1;14.8;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.3;8.3;;;7.6;9.1;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.4;9.4;;;6.9;12.4;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.6;9.6;;;6.5;13.5;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;8.3;8.3;;;5.7;11.8;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.1;14.1;;;10;19.4;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.0;8;;;7;9.1;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.9;5.9;;;4.7;7.5;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2014;2014;CA;California;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.7;9.7;;;8;11.7;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;NH;New Hampshire;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.4;7.4;;;6;9.1;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.0;6;;;5.1;7.2;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2014;2014;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.6;10.6;;;7;15.3;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2014;2014;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.0;11;;;7.5;15.6;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;NH;New Hampshire;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.2;9.2;;;8;10.5;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.4;7.4;;;4.3;12.3;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.7;8.7;;;8.1;9.3;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;15.8;15.8;;;11.5;21.3;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.1;9.1;;;6.4;12.9;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.2;6.2;;;5.2;7.4;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.6;7.6;;;6.7;8.7;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2014;2014;OH;Ohio;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;20.5;20.5;;;12.9;30.9;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;4.9;4.9;;;2.8;8.7;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.0;12;;;9.7;14.9;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.2;7.2;;;5.9;8.7;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.9;5.9;;;3.9;8.8;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.3;14.3;;;12.9;15.8;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;17.4;17.4;;;11.5;25.4;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.5;7.5;;;6.5;8.7;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2014;2014;PA;Pennsylvania;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;14.7;14.7;;;9.1;22.5;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;VA;Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.4;8.4;;;4.7;14.7;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.1;7.1;;;4.8;10.5;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.0;12;;;8.4;16.7;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;IL;Illinois;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.3;12.3;;;7;20.7;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;WY;Wyoming;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.3;14.3;;;9;21.9;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.6;10.6;;;9.5;11.7;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.3;12.3;;;7.6;19.4;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.1;8.1;;;5;12.9;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.6;9.6;;;8.7;10.6;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2014;2014;MO;Missouri;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST2_1;NMBR;RACE;BLK;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;4.3;4.3;;;2.7;6.6;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.2;7.2;;;6.1;8.4;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;MT;Montana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.9;13.9;;;12.4;15.5;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.7;9.7;;;8.6;11;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.9;11.9;;;8.3;16.8;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2014;2014;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.5;12.5;;;7.5;19.5;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.9;6.9;;;5.9;8.1;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.2;8.2;;;5.6;11.8;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.4;10.4;;;8.7;12.3;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.8;13.8;;;12.4;15.3;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.4;9.4;;;6.6;13.3;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2014;2014;MO;Missouri;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST2_1;NMBR;RACE;AIAN;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.1;7.1;;;4.6;11;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.3;7.3;;;6.5;8.3;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.5;8.5;;;7.2;9.9;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.9;7.9;;;5.7;11;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.3;10.3;;;6.1;16.9;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2014;2014;VI;Virgin Islands;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST2_1;NMBR;RACE;WHT;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.6;5.6;;;3.8;8.2;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2014;2014;HI;Hawaii;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;29.29;29.29;;;26.51;32.08;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;15.6;15.6;;;11.6;20.5;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.6;10.6;;;9.7;11.6;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.1;8.1;;;7.2;9.1;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.1;10.1;;;9.2;11;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.2;7.2;;;6.1;8.6;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2014;2014;MT;Montana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.4;5.4;;;4.1;7;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2014;2014;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;4763;4,763;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;NMBR;RACE;BLK;;;;
2014;2014;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.6;10.6;;;9.5;11.9;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.3;11.3;;;8.4;15.1;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.3;6.3;;;5.6;7;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;15.3;15.3;;;9.7;23.3;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;ND;North Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.4;5.4;;;4;7.2;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.8;10.8;;;6.7;16.9;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;AR;Arkansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;19.09;19.09;;;14.96;23.21;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.8;10.8;;;9.7;11.9;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.1;10.1;;;7.2;13.6;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.3;11.3;;;9.7;13.2;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.1;11.1;;;10;12.3;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.4;7.4;;;4.6;11.5;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;76.88;76.88;;;76.28;77.47;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.8;9.8;;;8.8;11;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.4;8.4;;;6.3;11.1;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.4;11.4;;;8;16.1;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.2;6.2;;;5;7.6;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;UT;Utah;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;7304;7,304;;;;;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.3;12.3;;;10.2;14.8;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.4;9.4;;;8.3;10.6;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.2;8.2;;;7.1;9.4;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.1;13.1;;;8.2;20.2;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.2;10.2;;;8.4;12.3;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.9;10.9;;;7;16.2;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;GA;Georgia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;65263;65,263;;;;;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2014;2014;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.8;8.8;;;8.2;9.5;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2014;2014;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;41.67;41.67;;;40.33;43.01;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2014;2014;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;35.46;35.46;;;34.22;36.7;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;16.0;16;;;13.4;18.9;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2014;2014;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2014;2014;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;2203;2,203;;;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;NMBR;RACE;HIS;;;;
2014;2014;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;13.5;13.5;;;8.2;20.8;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.1;12.1;;;10.7;13.6;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2014;2014;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.8;6.8;;;5.8;8;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.2;6.2;;;3.7;10.1;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.8;7.8;;;6.5;9.3;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.5;9.5;;;8.2;10.9;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.8;10.8;;;7.9;14.5;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2014;2014;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.907192, -77.036871);;11;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;NY;New York;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;CO;Colorado;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST2_1;NMBR;RACE;API;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.3;9.3;;;8.3;10.3;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.7;10.7;;;9.6;11.9;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.7;8.7;;;8.1;9.2;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.3;7.3;;;6;9;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.6;6.6;;;5.1;8.6;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2014;2014;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.9;8.9;;;5.5;13.4;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.8;7.8;;;5;12.1;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;17.6;17.6;;;11.6;25.6;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.6;5.6;;;4.5;7;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.7;8.7;;;7.7;9.8;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.1;6.1;;;5.1;7.3;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.8;6.8;;;5.7;8;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.2;10.2;;;7.8;13.3;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.8;7.8;;;7.2;8.4;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.8;9.8;;;7.9;12;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;15.3;15.3;;;9.7;23.4;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.9;11.9;;;10.4;13.6;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.5;10.5;;;8.1;13.5;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.7;10.7;;;9.7;11.7;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.8;10.8;;;9.3;12.5;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.7;8.7;;;6;12.2;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;4.8;4.8;;;4.1;5.7;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.5;7.5;;;5;11.2;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;15.5;15.5;;;14.3;16.7;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.8;9.8;;;9;10.6;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.2;8.2;;;7.2;9.5;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.5;11.5;;;8.2;15.9;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2014;2014;AR;Arkansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;796;796;;;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST2_1;NMBR;RACE;HIS;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;20.8;20.8;;;11.6;34.5;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.9;13.9;;;10.5;18.2;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;AK;Alaska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.4;10.4;;;8.7;12.4;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;42.7;42.7;;;33.7;53.4;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.6;8.6;;;5;14.2;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.5;10.5;;;9.5;11.6;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2014;2014;NM;New Mexico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;16.4;16.4;;;13.1;20.3;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2014;2014;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.9;9.9;;;8;12.1;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2014;2014;IN;Indiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2014;2014;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.7;10.7;;;8.1;13.9;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.5;6.5;;;5;8.3;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.9;6.9;;;6.2;7.6;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.1;12.1;;;7.5;18.8;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;MD;Maryland;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;191;191;;;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST2_1;NMBR;RACE;AIAN;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.9;8.9;;;7.5;10.6;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.6;14.6;;;12.1;17.6;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;15.2;15.2;;;9.8;22.8;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.6;6.6;;;5.4;7.9;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;16.3;16.3;;;13.3;19.8;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.6;12.6;;;7.7;19.8;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.9;13.9;;;11.6;16.6;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;US;United States;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.1;12.1;*;50 States + DC: US Median;11.3;12.8;Overall;Overall;;;;;;;59;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.1;8.1;;;7;9.4;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.5;10.5;;;8.8;12.6;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2014;2014;RI;Rhode Island;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;865;865;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST2_1;NMBR;RACE;BLK;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;15.4;15.4;;;9.9;23.1;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.7;6.7;;;6.1;7.3;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2014;2014;AL;Alabama;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.5;5.5;;;4.2;7.2;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.4;13.4;;;8;21.5;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2014;2014;GU;Guam;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST2_1;NMBR;GENDER;GENF;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.5;9.5;;;8.6;10.4;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.3;5.3;;;4.2;6.6;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.4;9.4;;;7.2;12.2;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2014;2014;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.1;8.1;;;4.9;13.2;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.5;11.5;;;9.2;14.3;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2014;2014;US;United States;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.7;6.7;*;50 States + DC: US Median;6.2;7.3;Gender;Male;;;;;;;59;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.2;9.2;;;8.4;10.2;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.2;6.2;;;4.9;7.8;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;52.57;52.57;;;51.7;53.44;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;OR;Oregon;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2014;2014;MI;Michigan;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;RI;Rhode Island;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;96.22;96.22;;;91.22;101.22;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2014;2014;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.5;12.5;;;9.8;15.9;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.2;12.2;;;9.4;15.7;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;NH;New Hampshire;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.6;9.6;;;7.4;12.4;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.9;6.9;;;6.2;7.6;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2015;2015;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;NMBR;RACE;HIS;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.4;8.4;;;7.4;9.5;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2015;2015;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;NMBR;RACE;HIS;;;;
2015;2015;PA;Pennsylvania;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST2_1;NMBR;GENDER;GENF;;;;
2015;2015;PA;Pennsylvania;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST3_1;NMBR;RACE;BLK;;;;
2014;2014;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.5;7.5;;;6.1;9.2;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;CRDRATE;RACE;API;;;;
2015;2015;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.8;11.8;;;9.3;14.9;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2015;2015;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.2;11.2;;;8.6;14.5;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2015;2015;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;18.5;18.5;;;12.8;25.8;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2015;2015;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;15.9;15.9;;;12;20.6;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.7;6.7;;;3.8;11.7;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2015;2015;MT;Montana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;NMBR;GENDER;GENM;;;;
2015;2015;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;;Number;33;33;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;NMBR;RACE;WHT;;;;
2012;2012;UT;Utah;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;NMBR;RACE;AIAN;;;;
2015;2015;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.2;12.2;;;9.2;15.8;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2015;2015;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;NMBR;RACE;HIS;;;;
2015;2015;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.1;10.1;;;6.7;14.5;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2012;2012;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.8;10.8;;;9.7;12;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.8;8.8;;;7.6;10.2;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;MI;Michigan;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2014;2014;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;35.2;35.2;;;24.3;49.1;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;AK;Alaska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2014;2014;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;41.67;41.67;;;41;42.35;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;14.5;14.5;;;10.6;19.3;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.6;10.6;;;9.7;11.6;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;13.9;13.9;;;9.6;19.5;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.7;13.7;;;10.8;17.3;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2014;2014;CT;Connecticut;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2014;2014;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;AK;Alaska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.5;13.5;;;10.9;16.6;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.4;7.4;;;6.4;8.6;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.0;12;;;11.1;12.8;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.1;9.1;;;7.6;10.8;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2014;2014;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;WA;Washington;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST2_1;NMBR;RACE;BLK;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;16.0;16;;;9.1;26.6;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.7;9.7;;;8.7;10.8;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;17.0;17;;;11.7;23.8;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.5;8.5;;;7.9;9;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2014;2014;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;CT;Connecticut;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.2;9.2;;;8.4;10;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2014;2014;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.7;5.7;;;4.6;7.1;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.5;11.5;;;9.8;13.5;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;MO;Missouri;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;18.5;18.5;;;13.4;25;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.2;5.2;;;4.4;6.1;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.4;11.4;;;10.2;12.8;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;15.8;15.8;;;12.4;20;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.7;12.7;;;8.4;18.7;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.7;10.7;;;8;14.1;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.6;8.6;;;7.8;9.4;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;22413;22,413;;;;;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.8;5.8;;;4.7;7;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.5;8.5;;;5;14;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.5;5.5;;;4.1;7.4;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.2;8.2;;;6.7;9.9;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;HI;Hawaii;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;62.27;62.27;;;60.36;64.18;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.6;6.6;;;5.2;8.3;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;13.0;13;;;9.5;17.5;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.5;12.5;;;11;14.3;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.6;6.6;;;6;7.2;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.9;10.9;;;8.4;13.9;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.3;10.3;;;8.8;12.1;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.7;7.7;;;7.1;8.3;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.6;8.6;;;5.6;12.9;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.8;11.8;;;10.8;13;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2014;2014;HI;Hawaii;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;54.02;54.02;;;29.28;78.76;Race/Ethnicity;American Indian or Alaska Native;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.9;10.9;;;9.6;12.2;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.0;8;;;6.7;9.4;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;15.6;15.6;;;11.9;20.2;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.5;8.5;;;7.2;10.2;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2014;2014;TN;Tennessee;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.0;10;;;6.4;15.5;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.5;14.5;;;12.2;17.2;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;16.6;16.6;;;14.4;19;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2014;2014;ND;North Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.5;11.5;;;10.5;12.6;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.7;14.7;;;9.4;22.2;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.7;10.7;;;9.7;11.7;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;DC;District of Columbia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.5;11.5;;;8.8;15;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.3;8.3;;;7.6;9;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.4;8.4;;;7.5;9.3;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.2;6.2;;;4.1;9.3;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2014;2014;IL;Illinois;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST2_1;NMBR;GENDER;GENF;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.3;11.3;;;10.4;12.3;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.0;8;;;6.8;9.4;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;CA;California;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2014;2014;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.7;8.7;;;7.7;9.7;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.3;14.3;;;11.7;17.4;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.9;7.9;;;6.7;9.3;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.9;9.9;;;7.5;12.9;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.7;8.7;;;6.9;10.9;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;ME;Maine;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.7;13.7;;;7.8;23.1;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.3;10.3;;;5.8;17.7;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;27.4;27.4;;;16.5;42;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2014;2014;OK;Oklahoma;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2014;2014;WA;Washington;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST2_1;NMBR;RACE;AIAN;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.8;6.8;;;5.7;8;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;38.5;38.5;;;24.1;58.3;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2014;2014;GA;Georgia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;61.30;61.3;;;60.61;61.99;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.3;11.3;;;9.9;12.8;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.3;12.3;;;9.3;16;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.7;8.7;;;8.2;9.3;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;AR;Arkansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;126.11;126.11;;;122.9;129.31;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;16.3;16.3;;;9.7;26;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.2;11.2;;;6.4;18.9;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;CA;California;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;6.6;6.6;;;4.9;8.8;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.0;11;;;7.1;16.5;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.2;14.2;;;11.3;17.7;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.1;9.1;;;8.1;10.2;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;MT;Montana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.2;14.2;;;11.8;16.9;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.0;9;;;7.6;10.6;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.0;10;;;8.8;11.4;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;21.8;21.8;;;12;36.3;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.7;6.7;;;5.8;7.8;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2014;2014;US;United States;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.8;6.8;*;50 States + DC: US Median;6.2;7.2;Gender;Male;;;;;;;59;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.2;9.2;;;6.7;12.4;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;PA;Pennsylvania;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST2_1;NMBR;RACE;HIS;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.4;9.4;;;8.4;10.6;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.2;8.2;;;7.3;9.2;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.8;11.8;;;10.6;13;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.5;10.5;;;9.8;11.4;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2014;2014;US;United States;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.9;8.9;*;50 States + DC: US Median;8.7;9.8;Overall;Overall;;;;;;;59;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;OR;Oregon;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST2_1;NMBR;RACE;WHT;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.7;11.7;;;10.1;13.6;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.8;7.8;;;6.4;9.5;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.0;11;;;6.3;18.6;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2014;2014;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.8;7.8;;;6.3;9.6;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.4;7.4;;;6.2;8.8;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.0;8;;;7.1;8.9;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.3;7.3;;;6.4;8.3;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.2;6.2;;;5.2;7.5;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2014;2014;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;1387;1,387;;;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;NMBR;RACE;AIAN;;;;
2014;2014;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;13.7;13.7;;;10.2;18;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.0;11;;;9.7;12.5;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.7;10.7;;;6.5;17.2;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.3;9.3;;;8.4;10.3;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.0;7;;;4.6;10.2;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.7;14.7;;;13.3;16.2;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.8;11.8;;;10.1;13.7;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.8;9.8;;;8.7;11;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;15.8;15.8;;;11.4;21.5;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2014;2014;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;146.35;146.35;;;145.02;147.67;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2014;2014;WA;Washington;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2014;2014;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.2;8.2;;;7.3;9.2;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.1;10.1;;;9.1;11.2;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.9;11.9;;;10.5;13.5;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;20.5;20.5;;;13.5;29.8;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.2;11.2;;;10.3;12.2;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.0;13;;;9.8;17;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.7;9.7;;;8.1;11.6;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.4;12.4;;;9.8;15.7;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.3;8.3;;;7.7;9;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;NH;New Hampshire;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2014;2014;CA;California;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;19.2;19.2;;;13.1;27.1;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;15.7;15.7;;;12.6;19.3;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.1;10.1;;;8.8;11.5;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.0;8;;;7.3;8.8;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;4.6;4.6;;;3.9;5.4;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.6;11.6;;;10.7;12.5;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.0;13;;;11.2;15;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.7;9.7;;;8.7;10.7;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.5;13.5;;;10.6;17.1;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.5;5.5;;;4.1;7.2;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.5;13.5;;;12;15.2;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2014;2014;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.2;12.2;;;11;13.4;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.4;7.4;;;4.6;11.8;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.8;10.8;;;7.6;15.3;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2014;2014;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.9;8.9;;;6;12.7;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.9;11.9;;;10.7;13.1;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.4;8.4;;;5.6;12.2;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.1;12.1;;;10;14.7;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.6;9.6;;;6.4;13.8;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.4;10.4;;;7.3;14.3;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.2;7.2;;;5.2;9.7;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.0;11;;;8.3;14.3;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;15.7;15.7;;;11.7;20.7;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;NH;New Hampshire;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST2_1;NMBR;GENDER;GENF;;;;
2014;2014;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;16.2;16.2;;;12.2;21.1;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.7;5.7;;;5.1;6.5;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.7;11.7;;;10.8;12.6;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2014;2014;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2014;2014;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.5;11.5;;;7;18.3;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.3;7.3;;;6.3;8.5;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.907192, -77.036871);;11;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2014;2014;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.5;11.5;;;8;15.9;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2014;2014;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.4;10.4;;;8.2;13.1;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2014;2014;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;13.0;13;;;8.2;19.7;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.2;14.2;;;11.6;17.2;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.8;10.8;;;6.3;17.7;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2014;2014;CO;Colorado;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;4.1;4.1;;;2.7;6;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.4;12.4;;;9.6;15.7;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2014;2014;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;64.83;64.83;;;64.11;65.55;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.3;8.3;;;7.4;9.3;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.9;11.9;;;10.8;13.1;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.5;8.5;;;6.7;10.8;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.7;12.7;;;11.1;14.4;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.1;5.1;;;4.3;6;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.9;11.9;;;10.3;13.7;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;TX;Texas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2014;2014;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.4;8.4;;;7.4;9.6;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.8;9.8;;;8.9;10.6;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.2;9.2;;;8.4;10.1;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.4;9.4;;;5.4;15.8;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2014;2014;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;15.0;15;;;12.3;18.1;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;3.0;3;;;1.8;4.8;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.6;12.6;;;11.2;14.2;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2014;2014;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.8;9.8;;;8.4;11.4;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;81.77;81.77;;;80.38;83.16;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;MA;Massachusetts;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;CA;California;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.7;10.7;;;9.3;12.4;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2014;2014;MT;Montana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.6;7.6;;;6.4;9.1;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2014;2014;HI;Hawaii;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;60.03;60.03;;;58.76;61.31;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.3;5.3;;;4.2;6.6;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.6;6.6;;;4.2;10.4;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.6;11.6;;;9.2;14.5;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2014;2014;GA;Georgia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;33.60;33.6;;;26.62;40.58;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.3;8.3;;;7.3;9.5;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;RI;Rhode Island;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;48.68;48.68;;;46.77;50.59;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.2;14.2;;;12.2;16.6;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.9;6.9;;;4.5;10.6;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.8;8.8;;;8;9.6;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.7;11.7;;;7;18.8;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.5;13.5;;;7.9;22;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.3;7.3;;;6.1;8.8;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.5;13.5;;;12.2;14.8;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;7.7;7.7;;;6.4;9.3;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;4.6;4.6;;;3.9;5.4;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.2;6.2;;;5.2;7.3;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.4;12.4;;;7;21;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.6;14.6;;;11;19;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2014;2014;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.2;8.2;;;7.1;9.4;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.9;10.9;;;9.9;11.9;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2014;2014;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.0;14;;;10.9;17.8;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.8;5.8;;;4.5;7.4;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;18.2;18.2;;;11.6;27.5;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.5;6.5;;;3.7;11.1;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.2;9.2;;;8.3;10.1;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.2;7.2;;;4.7;10.8;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2014;2014;US;United States;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.9;8.9;*;50 States + DC: US Median;8.6;9.6;Overall;Overall;;;;;;;59;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.7;8.7;;;7.5;10;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.2;9.2;;;6.3;13.3;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2014;2014;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;5.8;5.8;;;3.8;8.5;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;NY;New York;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.7;13.7;;;9.4;19.5;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.9;6.9;;;4.3;10.8;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;15.7;15.7;;;12.8;19.1;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;16.2;16.2;;;13;19.9;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2014;2014;CT;Connecticut;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2014;2014;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;16.7;16.7;;;10.1;26.5;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2014;2014;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2014;2014;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;23.1;23.1;;;15.2;33.7;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.2;10.2;;;8.8;11.8;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;US;United States;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.7;11.7;*;50 States + DC: US Median;10.9;12.2;Gender;Female;;;;;;;59;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;14091;14,091;;;;;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.1;13.1;;;7.2;22.7;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.5;5.5;;;3.8;8.1;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.1;10.1;;;9.1;11.2;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.4;8.4;;;7.5;9.4;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.2;11.2;;;10.1;12.5;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2014;2014;CA;California;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST2_1;NMBR;RACE;WHT;;;;
2014;2014;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.1;8.1;;;6;10.7;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.3;9.3;;;8.5;10.1;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.6;10.6;;;8.4;13.5;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.8;6.8;;;5.3;8.5;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.9;7.9;;;6.7;9.2;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.2;10.2;;;6;16.7;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2014;2014;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.3;9.3;;;7.5;11.1;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;DE;Delaware;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.8;8.8;;;7.7;10.1;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2014;2014;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2014;2014;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;33.12;33.12;;;30.42;35.83;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2014;2014;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.6;8.6;;;7.3;9.8;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.3;9.3;;;8.3;10.4;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.8;7.8;;;6.5;9.3;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2014;2014;ME;Maine;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;18.1;18.1;;;14;23.1;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2014;2014;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;25.75;25.75;;;23.7;27.81;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;CRDRATE;RACE;API;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.2;13.2;;;7.8;21.7;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2014;2014;WA;Washington;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.3;7.3;;;4.5;11.7;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;WV;West Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST2_1;NMBR;RACE;AIAN;;;;
2014;2014;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.7;12.7;;;7.8;20;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2014;2014;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.6;12.6;;;9.9;16.1;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.0;12;;;10.6;13.5;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.1;9.1;;;8.1;10.2;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.9;7.9;;;6.8;9.1;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2014;2014;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.4;14.4;;;13;16;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.4;7.4;;;6.4;8.6;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.5;11.5;;;8.9;14.7;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.2;10.2;;;7.2;14.3;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.5;11.5;;;10.5;12.6;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;45.22;45.22;;;44.12;46.33;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.9;9.9;;;7.6;12.9;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.0;8;;;6.9;9.4;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.3;8.3;;;5.9;11.7;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.5;11.5;;;10.1;12.9;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;ND;North Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2014;2014;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;TX;Texas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.6;10.6;;;7.1;15.5;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.7;8.7;;;7.6;10;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.8;10.8;;;9.7;12.1;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.9;5.9;;;5.1;6.7;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.8;5.8;;;4.7;7.1;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.4;9.4;;;8.3;10.6;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.0;8;;;6.3;10;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;15.8;15.8;;;13.2;18.7;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2014;2014;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.1;13.1;;;9.7;17.5;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2014;2014;RI;Rhode Island;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;5865;5,865;;;;;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.9;5.9;;;3.9;8.7;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.0;11;;;9.4;12.9;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.5;8.5;;;7.4;9.8;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;26.9;26.9;;;19.7;35.9;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.3;7.3;;;5.3;10;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2014;2014;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.7;8.7;;;7;10.7;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;20035;20,035;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;NMBR;RACE;WHT;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.0;11;;;10.1;12;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2014;2014;MN;Minnesota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST2_1;NMBR;RACE;WHT;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.5;12.5;;;7;21.2;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.1;8.1;;;6.8;9.7;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.7;14.7;;;13.2;16.4;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;1093;1,093;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;NMBR;RACE;API;;;;
2014;2014;CT;Connecticut;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.9;7.9;;;6.3;9.9;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2014;2014;UT;Utah;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;24.81;24.81;;;24.24;25.37;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;6.8;6.8;;;4.8;9.3;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;27.6;27.6;;;21.3;35.3;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.5;11.5;;;7.9;16.2;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;OH;Ohio;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST2_1;NMBR;GENDER;GENF;;;;
2014;2014;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;CA;California;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2014;2014;WY;Wyoming;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.6;9.6;;;8.4;10.9;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;MI;Michigan;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST2_1;NMBR;GENDER;GENM;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.7;13.7;;;11.7;16;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;MO;Missouri;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2014;2014;TN;Tennessee;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST2_1;NMBR;GENDER;GENM;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2014;2014;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.4;12.4;;;9.4;16;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2014;2014;MS;Mississippi;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST2_1;NMBR;RACE;BLK;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;19.4;19.4;;;12.6;28.8;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.3;10.3;;;9.2;11.4;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;20.0;20;;;13.4;28.7;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2014;2014;MT;Montana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST2_1;NMBR;GENDER;GENM;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.5;8.5;;;5.9;12.2;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.0;7;;;6;8.2;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2014;2014;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.1;12.1;;;9.2;15.8;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.1;8.1;;;7.1;9.3;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2014;2014;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.1;9.1;;;6.8;11.9;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;23.4;23.4;;;14.4;35.5;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2014;2014;CT;Connecticut;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST2_1;NMBR;RACE;BLK;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.7;9.7;;;8.9;10.6;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;WV;West Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2014;2014;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.7;8.7;;;8.1;9.2;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.7;8.7;;;7.7;9.9;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.9;14.9;;;10.9;20;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2014;2014;MA;Massachusetts;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;15.8;15.8;;;9.9;24.3;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.5;10.5;;;9.3;11.7;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.8;12.8;;;10.4;15.8;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.2;9.2;;;8.4;10;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.4;13.4;;;12.1;14.7;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.4;13.4;;;9.4;18.8;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.7;5.7;;;5;6.4;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.9;9.9;;;8.1;12.1;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2014;2014;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.6;9.6;;;8.5;10.8;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.7;7.7;;;6.8;8.8;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2014;2014;MA;Massachusetts;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2014;2014;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.7;11.7;;;9.3;14.5;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;7.6;7.6;;;5.3;10.9;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.0;10;;;7;14.1;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2014;2014;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.1;9.1;;;8.1;10.2;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;7.1;7.1;;;4.7;10.6;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2014;2014;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.8;11.8;;;8.6;16.1;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.6;8.6;;;7.3;10.2;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.6;7.6;;;6.5;8.8;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.6;5.6;;;4.6;6.8;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.9;5.9;;;4.7;7.3;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2014;2014;MN;Minnesota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;38.81;38.81;;;38.07;39.55;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.1;12.1;;;10;14.7;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.2;6.2;;;5.1;7.5;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2014;2014;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.0;8;;;5.9;10.7;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;18.9;18.9;;;13.6;25.7;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.6;13.6;;;10.7;17.2;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;19.3;19.3;;;11.9;29.9;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;14153;14,153;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;NMBR;RACE;WHT;;;;
2014;2014;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.7;9.7;;;7.4;12.5;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.7;8.7;;;7.8;9.6;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2014;2014;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;6.5;6.5;;;4.9;8.5;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.9;10.9;;;9.8;12.1;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2014;2014;MI;Michigan;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.7;10.7;;;9.9;11.6;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.0;10;;;8.8;11.4;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;17.9;17.9;;;9.9;30.2;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.9;11.9;;;10.9;13;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.6;8.6;;;7.4;10;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.9;6.9;;;5.9;8.2;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.5;12.5;;;9.4;16.4;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.5;9.5;;;8.3;10.8;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.7;11.7;;;8.5;15.7;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;15.5;15.5;;;8.9;25.6;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.6;10.6;;;5.8;18.6;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.2;8.2;;;7.4;9.2;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;ME;Maine;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.4;8.4;;;7.6;9.4;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;20.3;20.3;;;12.1;31.9;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.9;7.9;;;5.5;11.3;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;17.1;17.1;;;10.3;27.1;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.5;8.5;;;7.6;9.4;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.9;10.9;;;10.1;11.8;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.9;11.9;;;10.8;13.1;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.8;12.8;;;11.1;14.8;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.4;9.4;;;5.6;15.3;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.8;8.8;;;7.7;10;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.6;12.6;;;9.9;15.9;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.6;7.6;;;6.8;8.5;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.5;10.5;;;8.9;12.3;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2014;2014;ID;Idaho;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;15.7;15.7;;;8.5;27.1;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.5;11.5;;;10.6;12.5;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2014;2014;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.8;11.8;;;10.6;13;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.5;9.5;;;8.4;10.7;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2014;2014;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.5;9.5;;;7.1;12.6;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.2;10.2;;;9;11.4;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2014;2014;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.5;10.5;;;9.4;11.8;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.5;8.5;;;7.7;9.4;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;22.1;22.1;;;15.1;31.1;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;19.9;19.9;;;14.9;25.9;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.4;8.4;;;7.9;9;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;DE;Delaware;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;19.0;19;;;10.7;31.3;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.7;10.7;;;9.7;11.7;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.2;14.2;;;11.8;17.1;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.0;11;;;9.3;12.9;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.5;14.5;;;10.2;20.3;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.9;13.9;;;8.5;21.9;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;21.8;21.8;;;12.9;34.5;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.8;12.8;;;9.9;16.4;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.7;5.7;;;4.5;7.2;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.6;9.6;;;8.8;10.4;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.5;8.5;;;7.9;9.2;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;6.4;6.4;;;4;10.3;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2014;2014;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.7;5.7;;;3.8;8.4;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.9;34.9;;;27.8;42.7;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.1;8.1;;;7;9.4;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;KS;Kansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST2_1;NMBR;RACE;WHT;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.8;8.8;;;7;11.1;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;17.8;17.8;;;12.9;24.1;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.6;8.6;;;7.6;9.7;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;UT;Utah;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;27.15;27.15;;;26.29;28.02;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;18.5;18.5;;;12.5;26.5;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;5992;5,992;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;NMBR;RACE;BLK;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.7;6.7;;;5.1;8.7;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.7;9.7;;;6.2;15;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.8;10.8;;;9.9;11.8;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.7;5.7;;;3.3;9.6;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.1;9.1;;;8.5;9.7;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.4;7.4;;;4.6;11.6;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.9;8.9;;;7.9;10;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.9;7.9;;;6.5;9.5;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.1;12.1;;;9.9;14.6;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;LA;Louisiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.4;7.4;;;5.9;9;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.1;9.1;;;5.5;14.5;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.2;12.2;;;10.4;14.1;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.0;8;;;6.7;9.3;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;CA;California;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2014;2014;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;21.8;21.8;;;15.3;30;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;KS;Kansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2014;2014;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.0;7;;;4.7;10;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.5;7.5;;;6.4;8.7;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.3;10.3;;;9.2;11.5;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.9;6.9;;;5.6;8.4;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2014;2014;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.6;7.6;;;6.6;8.8;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.6;10.6;;;6.1;17.7;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.4;9.4;;;8.5;10.3;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.5;11.5;;;8.7;14.9;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.5;12.5;;;10.3;15.2;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.0;6;;;3.8;9.3;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;23.6;23.6;;;14.6;35.8;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.6;8.6;;;7.7;9.5;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.8;10.8;;;9.6;12.3;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.5;10.5;;;9.3;11.9;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.8;9.8;;;7.3;12.9;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.9;5.9;;;5.2;6.7;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.7;13.7;;;12.2;15.4;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.3;9.3;;;8.1;10.7;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.9;11.9;;;10.9;13;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.1;8.1;;;5.5;11.6;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;16.3;16.3;;;13.6;19.4;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2014;2014;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;43.08;43.08;;;42;44.16;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.0;10;;;9;11.1;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.5;8.5;;;7.6;9.5;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;PA;Pennsylvania;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST2_1;NMBR;GENDER;GENM;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.5;6.5;;;5.1;8.1;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2014;2014;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;14.2;14.2;;;11.4;16.9;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.1;6.1;;;5.1;7.4;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2014;2014;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.4;8.4;;;5.6;12;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.1;11.1;;;6.1;19.3;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.8;8.8;;;7.7;10;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.0;8;;;7;9.2;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.9;9.9;;;6.2;15.6;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;22.2;22.2;;;13;35.3;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.7;33.7;;;26.9;41.2;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;IL;Illinois;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;MA;Massachusetts;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.3;12.3;;;10.6;14.1;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.7;7.7;;;4.3;13.3;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2014;2014;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.7;7.7;;;7;8.4;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;GA;Georgia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;2691;2,691;;;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST2_1;NMBR;RACE;HIS;;;;
2014;2014;AL;Alabama;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST2_1;NMBR;GENDER;GENF;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2014;2014;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.6;9.6;;;5.9;14.6;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.8;14.8;;;13.3;16.5;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2014;2014;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.6;14.6;;;13.1;16.3;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2014;2014;CA;California;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2014;2014;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.5;10.5;;;9.7;11.3;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.9;10.9;;;10;11.9;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.1;33.1;;;26.9;39.9;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.4;9.4;;;8.6;10.4;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.3;7.3;;;6;8.8;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.7;7.7;;;4.7;12.4;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;AL;Alabama;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.7;11.7;;;10.2;13.5;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2014;2014;SD;South Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;GU;Guam;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(13.444304, 144.793731);;66;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2014;2014;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.1;10.1;;;7;14.1;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2014;2014;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.5;9.5;;;8.7;10.5;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2014;2014;MN;Minnesota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;16.9;16.9;;;10.5;26.3;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.7;9.7;;;8.7;10.8;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.4;9.4;;;6.4;13.7;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2014;2014;DE;Delaware;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.3;7.3;;;4.4;11.9;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;AR;Arkansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST2_1;NMBR;RACE;AIAN;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.9;8.9;;;5.1;15.2;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.6;11.6;;;10.8;12.6;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;3.6;3.6;;;2.4;5.5;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.7;9.7;;;8.9;10.6;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.9;5.9;;;4.9;7;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.9;13.9;;;8.6;21.7;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.8;13.8;;;8.4;21.9;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.6;9.6;;;7.5;12.1;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.5;7.5;;;6.4;8.8;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;18.1;18.1;;;10.7;29.1;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.9;11.9;;;7.7;18;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2014;2014;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;45.0;45;;;30.6;63.9;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.3;14.3;;;12.6;16.2;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;42.65;42.65;;;41.93;43.37;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;MN;Minnesota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST2_1;NMBR;RACE;API;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.0;6;;;4.7;7.7;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.2;7.2;;;6.2;8.3;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.0;11;;;7.7;15.3;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.9;10.9;;;9.9;11.9;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2014;2014;MD;Maryland;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;10541;10,541;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST2_1;NMBR;RACE;WHT;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.3;9.3;;;7.5;11.3;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;15.7;15.7;;;9.2;25.5;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.1;8.1;;;7;9.3;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.6;9.6;;;8.6;10.6;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.3;14.3;;;12.2;16.6;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;7.3;7.3;;;5.1;10.5;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;15.6;15.6;;;14.3;17;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;ME;Maine;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.7;7.7;;;6.4;9.2;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.1;11.1;;;9.8;12.5;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2014;2014;DC;District of Columbia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.2;5.2;;;3;8.9;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.2;7.2;;;6;8.5;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.3;9.3;;;7.6;11.3;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.6;11.6;;;10.7;12.6;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;OK;Oklahoma;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST2_1;NMBR;RACE;HIS;;;;
2014;2014;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.4;9.4;;;7.1;12.2;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;140;140;;;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;NMBR;RACE;AIAN;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.8;13.8;;;8.2;22.4;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.5;7.5;;;6.4;8.8;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.8;6.8;;;5.8;7.9;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.7;8.7;;;7.4;10.2;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.3;8.3;;;7.1;9.7;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;4.4;4.4;;;3.2;6.2;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.4;10.4;;;9;12.1;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.6;11.6;;;9;14.8;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.2;8.2;;;7.2;9.3;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;79.62;79.62;;;78.8;80.44;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.3;10.3;;;6.7;15.4;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2014;2014;OH;Ohio;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.7;9.7;;;7.9;11.9;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;8.7;8.7;;;4.8;15.3;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;17.3;17.3;;;11.2;25.7;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.3;12.3;;;10.8;13.9;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;16.2;16.2;;;10.7;23.6;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.7;13.7;;;8.9;20.5;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.9;7.9;;;7;9;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;AL;Alabama;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.0;12;;;9.7;14.9;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;UT;Utah;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;24.74;24.74;;;19.25;30.23;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.3;9.3;;;7.8;11;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;IL;Illinois;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST2_1;NMBR;RACE;AIAN;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.7;9.7;;;8.7;11;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2014;2014;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.6;12.6;;;8.5;18.3;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.9;11.9;;;8.1;17.1;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;MD;Maryland;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;143.52;143.52;;;141.75;145.28;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;MN;Minnesota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;41.59;41.59;;;41.03;42.14;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;17.6;17.6;;;13;23.3;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;ME;Maine;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST2_1;NMBR;RACE;API;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.1;7.1;;;5.6;8.9;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2014;2014;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.9;9.9;;;5.7;16.6;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.7;14.7;;;12;17.8;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2014;2014;ID;Idaho;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.1;7.1;;;5.7;8.9;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;16.7;16.7;;;14;19.7;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.7;8.7;;;7.4;10.1;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2014;2014;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.7;8.7;;;8;9.5;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.3;9.3;;;7.7;11.1;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;15.0;15;;;9.4;23;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.7;7.7;;;6.9;8.5;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;17.0;17;;;9.6;28.3;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.2;9.2;;;7.7;10.9;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2014;2014;PR;Puerto Rico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.5;7.5;;;5.1;10.8;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.2;8.2;;;7.2;9.3;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.3;10.3;;;7.9;13.3;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.5;14.5;;;11.1;18.7;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.7;8.7;;;6.9;10.8;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2014;2014;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.9;10.9;;;9.9;11.9;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;23.4;23.4;;;15.6;33.7;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.0;10;;;6.9;14.3;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;OR;Oregon;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.3;8.3;;;7.5;9.3;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.7;10.7;;;6.1;17.9;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.7;7.7;;;6.6;8.9;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.8;11.8;;;8.6;16;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2014;2014;WY;Wyoming;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2014;2014;MS;Mississippi;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;SD;South Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2014;2014;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.7;10.7;;;9.8;11.5;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.9;10.9;;;9.9;11.9;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;18.2;18.2;;;15.4;21.4;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.6;43.6;;;30.5;57.6;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2014;2014;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.8;42.8;;;34.4;51.6;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.5;8.5;;;7.2;10;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.7;43.7;;;29.4;59.1;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.3;87.3;;;75.9;93.8;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2014;2014;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;CRDRATE;RACE;API;;;;
2014;2014;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;;Number;89;89;;;;;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.7;5.7;;;3.7;8.9;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.5;88.5;;;80;93.6;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.3;28.3;;;19.8;38.7;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2014;2014;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;MT;Montana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;NMBR;GENDER;GENM;;;;
2014;2014;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;26.7;26.7;;;18.7;37;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;59.5;59.5;;;42.7;74.4;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;19.6;19.6;;;13.2;28;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.1;43.1;;;36.9;49.6;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.7;88.7;;;81.8;93.2;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.3;13.3;;;12.1;14.5;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2014;2014;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;15.4;15.4;;;10.2;22.3;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.7;31.7;;;24.2;40.3;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.2;30.2;;;21.7;40.3;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.8;44.8;;;36.2;53.7;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;51.5;51.5;;;39.6;63.2;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.3;84.3;;;75.1;90.5;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;37.8;37.8;;;28.9;47.5;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.5;86.5;;;78.4;91.9;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;59.2;59.2;;;50.3;67.6;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.2;43.2;;;38;48.4;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.9;69.9;;;63.4;75.7;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.6;39.6;;;33.9;45.6;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;60.4;60.4;;;45.4;73.8;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.9;86.9;;;80;91.6;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2014;2014;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;NMBR;GENDER;GENF;;;;
2014;2014;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.5;9.5;;;7.7;11.6;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.5;36.5;;;31.8;41.5;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;NMBR;RACE;BLK;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.2;31.2;;;22.7;41.1;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;ME;Maine;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;NMBR;RACE;BLK;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2014;2014;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.9;31.9;;;23.6;41.4;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;CRDRATE;RACE;API;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2014;2014;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;NMBR;RACE;AIAN;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;25.7;25.7;;;17.3;36.3;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;53;53;;;42.8;62.9;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.5;33.5;;;26.8;40.9;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.2;9.2;;;7.4;11.4;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.2;69.2;;;59.8;77.2;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;36;36;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;NMBR;RACE;BLK;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.2;85.2;;;78.4;90.2;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.8;35.8;;;27.1;45.5;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2014;2014;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.7;68.7;*;50 States + DC: US Median;65.6;70.9;Overall;Overall;;;;;;;59;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;29.4;29.4;;;18.7;43.1;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.2;41.2;;;34.6;48.2;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36;36;;;30.2;42.2;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;NMBR;GENDER;GENM;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;81.8;81.8;;;66.4;91.1;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.1;62.1;;;46.3;75.7;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;NMBR;RACE;BLK;;;;
2014;2014;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.3;42.3;;;33.1;52.1;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.9;83.9;;;77.1;89;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.4;83.4;;;70.6;91.3;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;50.4;50.4;;;44;56.8;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.8;69.8;;;59.8;78.1;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2014;2014;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;NMBR;RACE;HIS;;;;
2014;2014;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.7;40.7;*;50 States + DC: US Median;38.9;41.6;Gender;Female;;;;;;;59;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2014;2014;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;NMBR;RACE;AIAN;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;NMBR;RACE;HIS;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.6;39.6;;;31.7;48;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.6;40.6;;;32.6;49;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.2;36.2;;;22.3;53;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;54.8;54.8;;;43.8;65.3;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2014;2014;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;;Number;68;68;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;NMBR;RACE;WHT;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.3;88.3;;;75.6;94.8;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2014;2014;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.6;10.6;;;9.1;12.4;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.3;49.3;;;38.3;60.3;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.3;84.3;;;75;90.5;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.6;43.6;;;37.8;49.7;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46;46;;;37.2;55.1;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;21.8;21.8;;;15.8;29.4;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.6;36.6;;;23.5;52;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.4;44.4;;;38.3;50.8;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86;86;;;78.3;91.3;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2014;2014;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;NMBR;RACE;AIAN;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.9;65.9;;;58.3;72.8;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.9;64.9;;;48.2;78.6;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.1;82.1;;;68.6;90.6;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2014;2014;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.9;7.9;;;5.7;10.6;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2014;2014;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;NMBR;RACE;HIS;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.1;84.1;;;77.5;89.1;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2014;2014;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.7;35.7;;;27.4;44.9;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43;43;;;38;48.2;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST4_1;NMBR;GENDER;GENF;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;53.1;53.1;;;42.9;63.1;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;;Number;22;22;;;;;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;NMBR;GENDER;GENM;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.9;36.9;;;27.3;47.8;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;26.9;26.9;;;21.5;33;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;NMBR;RACE;HIS;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31;31;;;23.8;39.1;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.3;44.3;;;36.1;52.7;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;21.0;21;;;11.4;35.6;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;53;53;;;48.2;57.7;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.4;45.4;;;39;51.9;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.9;36.9;;;29.4;45.1;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;73.6;73.6;;;65;80.7;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.9;40.9;;;36.1;45.8;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.1;33.1;;;20.4;48.8;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.6;46.6;;;35.5;58;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.7;34.7;;;25.1;45.8;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.6;65.6;;;55.5;74.4;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.1;36.1;;;26.3;47.1;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2014;2014;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;NMBR;RACE;BLK;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.7;11.7;;;6.9;19.2;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.4;85.4;;;78.4;90.4;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.5;47.5;;;32.4;63;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2014;2014;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.5;40.5;;;36.6;44.5;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2014;2014;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;;Number;41;41;;;;;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2014;2014;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;NMBR;RACE;WHT;;;;
2014;2014;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;;Number;27;27;;;;;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.8;48.8;;;42.7;55.1;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.1;28.1;;;17.1;42.5;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.1;44.1;;;33;55.8;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.6;38.6;;;32.8;44.9;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87;87;;;78.5;92.5;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.7;40.7;;;35.9;45.8;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;51;51;;;44;57.9;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.2;43.2;;;37.9;48.7;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2014;2014;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2014;2014;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2014;2014;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST4_1;NMBR;RACE;BLK;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.8;89.8;;;76.4;96;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;80.2;80.2;;;73;85.9;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.6;68.6;;;57.2;78;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.1;41.1;;;33.5;49.2;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.5;84.5;;;78.6;89;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.6;47.6;;;41.6;53.8;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.1;43.1;;;33.9;52.7;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2014;2014;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.8;71.8;;;61.3;80.4;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;NMBR;RACE;API;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;64.9;64.9;;;50.5;76.9;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2014;2014;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.9;13.9;;;10.2;18.6;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.4;40.4;;;28.2;53.8;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;74.3;74.3;;;62.3;83.4;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2014;2014;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.0;9;;;7.3;11.1;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.3;39.3;;;31;48.2;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.7;40.7;;;34.7;47;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2014;2014;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2014;2014;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2014;2014;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.9;82.9;;;76.7;87.6;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.2;41.2;;;34.5;48.3;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;91.2;91.2;;;82.4;95.8;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.1;48.1;;;41.6;54.7;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2014;2014;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.4;7.4;;;4.7;11.2;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;92.4;92.4;;;86.5;95.8;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;73.7;73.7;;;64.2;81.4;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.3;70.3;;;57.4;80.6;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.3;39.3;;;34.2;44.7;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;23.8;23.8;;;17.3;31.9;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.9;40.9;;;29.4;53.5;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;37.6;37.6;;;28.7;47.4;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;44.9;44.9;;;28.9;62;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.9;30.9;;;22.7;40.4;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.5;62.5;;;50;73.5;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;NMBR;RACE;AIAN;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.2;36.2;;;28;45.3;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.9;86.9;;;80.2;91.6;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;NMBR;RACE;AIAN;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.6;84.6;;;73.8;91.4;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.4;47.4;;;41.1;53.9;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33;33;;;21.7;46.7;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.2;44.2;;;34.2;54.7;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2014;2014;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;NMBR;RACE;AIAN;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.2;39.2;;;34.7;43.9;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.1;38.1;;;30.5;46.4;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2014;2014;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;13.6;13.6;;;10.2;17.7;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.9;35.9;;;28.5;44;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.7;37.7;;;27.5;49.1;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;74.5;74.5;;;65.2;82;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.5;86.5;;;80.7;90.8;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2014;2014;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;15.6;15.6;;;11.9;20.1;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;56.6;56.6;;;45.4;67.1;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.5;38.5;;;30.9;46.7;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;26.9;26.9;;;16.9;39.9;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.1;63.1;;;48.4;75.8;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.0;8;;;4.7;13.3;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.4;33.4;;;27.6;39.6;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.9;86.9;;;78.4;92.4;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.7;86.7;;;75.3;93.3;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;;Number;74;74;;;;;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;NMBR;GENDER;GENF;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.3;43.3;;;36.9;50;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2014;2014;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;;Number;51;51;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;NMBR;RACE;BLK;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.9;40.9;;;34.9;47.3;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;51.7;51.7;;;45;58.3;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.8;69.8;;;62.7;76.1;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;NMBR;RACE;API;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.2;85.2;;;78.7;90;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;CRDRATE;RACE;API;;;;
2014;2014;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.9;40.9;;;33.7;48.5;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2014;2014;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70;70;;;63.8;75.6;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.1;87.1;;;80.3;91.7;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.2;37.2;;;29.5;45.5;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.7;38.7;;;31.9;46;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.1;12.1;;;10;14.5;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.9;71.9;;;65.2;77.8;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;58.4;58.4;;;40.4;74.3;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.8;11.8;;;9.1;15.1;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50;50;;;37.2;62.8;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2014;2014;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.5;85.5;;;75.2;92;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.3;38.3;;;26.7;51.5;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;27.2;27.2;;;20.1;36;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2014;2014;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;NMBR;RACE;HIS;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.7;33.7;;;25.5;43;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.1;44.1;;;35.3;53.3;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.3;30.3;;;21.5;40.7;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.6;7.6;;;5.8;9.9;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.1;48.1;;;39.3;57;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.8;65.8;;;54.6;75.5;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.8;6.8;;;5.2;8.9;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.6;88.6;;;75.8;95.1;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2014;2014;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;;Number;76;76;;;;;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2014;2014;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.4;7.4;;;5.3;10;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33;33;;;19.4;50.1;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;73.2;73.2;;;65.2;79.9;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47;47;;;40.5;53.7;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2014;2014;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;;Number;33;33;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;NMBR;RACE;BLK;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.9;41.9;;;34.8;49.5;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.1;48.1;;;39.2;57.2;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2014;2014;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;74.6;74.6;;;64.8;82.5;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.7;48.7;;;39.3;58.2;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;16.1;16.1;;;12;21.2;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.3;34.3;;;29;40.1;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.6;87.6;;;83.7;90.7;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.8;64.8;;;52.6;75.3;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2014;2014;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.1;12.1;;;9.4;15.4;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;73.9;73.9;;;67.7;79.3;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;81.3;81.3;;;71.6;88.3;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;81.2;81.2;;;73.8;86.9;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.2;86.2;;;80.3;90.5;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;15.7;15.7;;;11.9;20.5;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;NMBR;RACE;AIAN;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;60.3;60.3;;;50.5;69.4;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;77.7;77.7;;;59.8;89.1;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.5;42.5;;;37.1;48.1;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2014;2014;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.8;48.8;;;37.1;60.7;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.7;64.7;;;57.7;71.2;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2014;2014;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2014;2014;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;52.2;52.2;;;45.7;58.6;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.8;32.8;;;24.4;42.5;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.5;37.5;;;30.5;45;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47;47;;;39;55.2;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2014;2014;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;NMBR;RACE;API;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;94.1;94.1;;;88.5;97.1;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.4;62.4;;;56.3;68.2;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90.7;90.7;;;86.1;93.9;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42;42;;;35.9;48.3;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.7;83.7;;;75.9;89.3;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.3;63.3;;;47;77.1;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.9;43.9;;;39.3;48.7;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.5;41.5;;;32.4;51.2;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.8;41.8;;;36.2;47.5;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;NMBR;RACE;AIAN;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.7;32.7;;;21.3;46.5;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.8;34.8;;;26.5;44.1;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;MT;Montana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;NMBR;RACE;HIS;;;;
2014;2014;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.5;9.5;;;7.2;12.2;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;72.9;72.9;;;63.1;80.8;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.9;70.9;;;61.4;79;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;;Number;64;64;;;;;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.9;67.9;;;50.4;81.5;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.5;70.5;;;64.5;76;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;50.4;50.4;;;46.4;54.3;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;94.6;94.6;;;86.5;98;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;81.9;81.9;;;68.7;90.3;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.1;85.1;;;74;91.9;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2014;2014;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.7;45.7;;;37.7;54;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.3;9.3;;;6.9;12.3;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;24.8;24.8;;;20.2;30;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90;90;;;83.3;94.2;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.8;39.8;;;29;51.6;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.9;47.9;;;41.8;54;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.8;69.8;;;52.6;82.8;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.6;33.6;;;23.8;45;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84;84;;;77.5;88.9;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.4;9.4;;;5.9;14.2;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.4;39.4;;;34.6;44.4;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.4;62.4;;;55.4;68.9;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.6;36.6;;;30.5;43.2;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2014;2014;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.2;8.2;;;5.7;11.3;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;24.4;24.4;;;14;39.1;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2014;2014;NY;New York;NVSS;Asthma;Asthma mortality rate;;;Number;118;118;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;NMBR;RACE;WHT;;;;
2014;2014;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;;Number;49;49;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;NMBR;RACE;BLK;;;;
2014;2014;WA;Washington;NVSS;Asthma;Asthma mortality rate;;;Number;93;93;;;;;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.6;62.6;;;56.7;68.2;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.8;38.8;;;27.8;51.1;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;24.3;24.3;;;17.4;33;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2014;2014;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.9;38.9;;;32.8;45.4;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.8;11.8;;;10.7;13;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2014;2014;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;53.3;53.3;;;45.6;61;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;14.1;14.1;;;8.3;23;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.2;89.2;;;83.2;93.2;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;96.2;96.2;;;90.1;98.6;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2014;2014;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2014;2014;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;;Number;25;25;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;NMBR;RACE;BLK;;;;
2014;2014;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.8;66.8;**;US estimate/number is based on fewer than 50 states and the District of Columbia;64.8;70.7;Gender;Male;;;;;;;59;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.5;44.5;;;35.3;54;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2014;2014;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;16.9;16.9;;;10.8;25.2;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;NMBR;RACE;API;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;75.2;75.2;;;53.9;88.7;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.8;69.8;;;60.7;77.6;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;81.7;81.7;;;70.3;89.4;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;NMBR;RACE;API;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;50.9;50.9;;;40.9;60.7;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;74.7;74.7;;;66.6;81.3;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.8;63.8;;;54.8;72;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.9;68.9;;;52.8;81.4;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.4;40.4;;;29.2;52.7;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.9;33.9;;;19.5;52.1;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;73.2;73.2;;;59.5;83.5;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2014;2014;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;16.7;16.7;;;13.1;21;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;58.6;58.6;;;50;66.7;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.1;38.1;;;33.1;43.5;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;NMBR;RACE;HIS;;;;
2014;2014;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.4;68.4;*;50 States + DC: US Median;64.8;71.8;Gender;Female;;;;;;;59;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.8;36.8;;;31.5;42.5;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;17.9;17.9;;;13.3;23.7;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.3;32.3;;;26.5;38.6;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87;87;;;79.1;92.3;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2014;2014;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.1;42.1;;;36.7;47.8;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.8;40.8;;;28.6;54.3;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2014;2014;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.9;83.9;;;73.3;90.8;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.9;37.9;;;32.6;43.5;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;;Number;35;35;;;;;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.9;43.9;;;37.9;50.1;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2014;2014;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;NMBR;RACE;HIS;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;64.3;64.3;;;57.9;70.3;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.3;36.3;;;30.5;42.5;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.6;69.6;;;60.6;77.4;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.2;67.2;;;59.8;73.8;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2013;2013;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;17.7;17.7;;;13.5;22.8;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.6;37.6;;;29.8;46;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2014;2014;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;;Number;28;28;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;NMBR;RACE;BLK;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.9;40.9;;;34.4;47.7;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.2;84.2;;;78;88.8;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;77.6;77.6;;;69.7;83.9;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.1;63.1;;;50.4;74.2;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.5;5.5;;;4.1;7.3;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.5;62.5;;;55.6;68.9;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2014;2014;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;NMBR;RACE;AIAN;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.5;40.5;;;29.4;52.7;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.2;8.2;;;5.3;12.3;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;20.5;20.5;;;15;27.5;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2014;2014;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.5;64.5;;;51.4;75.7;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;57;57;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;NMBR;RACE;WHT;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;52.4;52.4;;;44.6;60;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84;84;;;73.7;90.8;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.7;40.7;;;36.9;44.7;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;CRDRATE;RACE;API;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.2;43.2;;;31.3;55.9;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;64;64;;;53.1;73.7;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;NY;New York;NVSS;Asthma;Asthma mortality rate;;;Number;99;99;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;NMBR;RACE;BLK;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49;49;;;38.7;59.4;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.6;46.6;;;35.3;58.3;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39;39;;;35.3;42.8;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2014;2014;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;CRDRATE;RACE;API;;;;
2014;2014;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.5;9.5;;;7.8;11.6;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.8;9.8;;;8.2;11.7;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;77;77;;;65.7;85.4;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42;42;;;30.1;54.8;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.8;39.8;;;32.5;47.5;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.7;36.7;;;29.1;45.1;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2014;2014;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;CRDRATE;RACE;API;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.2;85.2;;;79.4;89.5;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;73.1;73.1;;;61.5;82.3;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.1;35.1;;;25.9;45.6;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.6;6.6;;;5;8.5;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;81;81;;;67;89.9;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67.9;67.9;;;61.2;74;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;79.2;79.2;;;69.5;86.4;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2014;2014;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;80.5;80.5;;;71.1;87.3;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;15.8;15.8;;;10.7;22.4;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.4;41.4;;;36.1;47;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;UT;Utah;NVSS;Asthma;Asthma mortality rate;;;Number;26;26;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;NMBR;RACE;WHT;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.9;36.9;;;28.4;46.2;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2014;2014;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;28.9;28.9;;;19.7;40.4;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.3;37.3;;;29.7;45.7;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2014;2014;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.3;44.3;;;34.2;54.8;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.6;86.6;;;77.4;92.4;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2014;2014;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;;Number;29;29;;;;;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;NMBR;GENDER;GENM;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;92.1;92.1;;;85.3;95.9;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.1;36.1;;;29;44;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2014;2014;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;CRDRATE;RACE;API;;;;
2014;2014;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;77.9;77.9;;;63;87.9;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2014;2014;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;CRDRATE;RACE;API;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.7;37.7;;;32;43.9;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.9;32.9;;;26.5;39.9;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2014;2014;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;NMBR;RACE;WHT;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.8;38.8;;;31.4;46.8;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.8;43.8;;;37.9;50;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2014;2014;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;NMBR;GENDER;GENM;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2014;2014;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2014;2014;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;NMBR;RACE;HIS;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.8;83.8;;;77.3;88.7;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.2;34.2;;;28.4;40.6;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;81.1;81.1;;;73.5;86.9;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;NMBR;RACE;HIS;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50.2;50.2;;;43.9;56.4;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.1;82.1;;;72.6;88.8;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;4.9;4.9;;;3.9;6.2;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2014;2014;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;CRDRATE;RACE;API;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.9;40.9;;;34;48.1;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.2;62.2;;;50.2;72.9;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;74.7;74.7;;;52.5;88.7;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2014;2014;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;5.6;5.6;;;3.8;7.8;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;73.7;73.7;;;66.8;79.6;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;76.5;76.5;;;56.9;88.9;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.1;63.1;;;55.5;70.1;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.3;41.3;;;31.9;51.4;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.8;38.8;;;30.3;48.1;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;74;74;;;59.4;84.7;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.8;45.8;;;35.4;56.7;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2014;2014;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.8;62.8;;;54.5;70.5;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2014;2014;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2014;2014;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.1;71.1;;;62;78.8;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.4;83.4;;;76.4;88.6;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2014;2014;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.907192, -77.036871);;11;AST;AST4_1;CRDRATE;RACE;API;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.5;35.5;;;29.6;41.9;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.6;89.6;;;83;93.9;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;46.8;46.8;;;29.2;65.1;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2014;2014;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.6;88.6;;;78.5;94.3;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.3;36.3;;;25.6;48.5;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;93;93;;;87.4;96.2;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.3;64.3;;;50.5;76.1;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.5;38.5;;;33.7;43.5;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.6;86.6;;;79.3;91.6;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;NMBR;RACE;AIAN;;;;
2014;2014;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.4;33.4;;;24.9;43;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;;Number;30;30;;;;;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.7;87.7;;;81.6;91.9;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.8;37.8;;;31.9;44;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;50.5;50.5;;;45.2;55.7;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.1;36.1;;;27.5;45.8;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;NMBR;RACE;AIAN;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.4;88.4;;;83.3;92.2;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.1;11.1;;;8.4;14.4;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.5;84.5;;;79.5;88.4;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.5;37.5;;;30.1;45.6;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.7;87.7;;;81.6;91.9;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;15.8;15.8;;;11.5;21.3;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.4;47.4;;;38.2;56.8;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.2;84.2;;;77.9;88.9;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;60.9;60.9;;;41.8;77.1;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.4;31.4;;;25.8;37.5;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.4;9.4;;;5.9;14.2;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;40.5;40.5;;;32.3;49.2;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;MT;Montana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;NMBR;RACE;API;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2014;2014;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.9;7.9;;;5.5;11;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2014;2014;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.0;14;;;9.8;19.5;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;60;60;;;49.7;69.4;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.1;10.1;;;8;12.5;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29;29;;;22.5;36.5;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.3;89.3;;;83.4;93.3;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.9;62.9;;;56.2;69.2;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.6;65.6;;;49.4;78.9;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.1;11.1;;;7.7;15.6;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.4;41.4;;;29.5;54.4;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.1;45.1;;;36.2;54.3;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.8;87.8;;;75.7;94.4;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;79.1;79.1;;;71.6;85;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.4;37.4;;;30;45.5;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.8;45.8;;;34.1;57.9;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.3;71.3;;;64.4;77.4;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.2;40.2;;;31.1;50;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2014;2014;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;;Number;49;49;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;NMBR;RACE;WHT;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.6;88.6;;;83.1;92.5;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.4;39.4;;;29.3;50.5;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;45.9;45.9;;;37.4;54.7;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;79.4;79.4;;;63.6;89.5;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.5;87.5;;;82.3;91.3;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2014;2014;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2014;2014;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.2;12.2;;;8;17.8;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;;Number;50;50;;;;;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;NMBR;GENDER;GENF;;;;
2014;2014;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.2;8.2;;;6;11.1;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.4;41.4;;;36.7;46.2;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.9;35.9;;;30.1;42.1;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.8;86.8;;;80.7;91.1;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.4;86.4;;;79.3;91.3;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.6;45.6;;;38.4;53;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;61.9;61.9;;;54.3;69;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;NMBR;RACE;BLK;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.6;46.6;;;42;51.2;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.9;33.9;;;30.1;37.8;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.8;37.8;;;33.5;42.2;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.4;47.4;;;40.4;54.4;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.3;48.3;;;41.8;54.8;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.4;43.4;;;34.6;52.6;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2014;2014;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;CRDRATE;RACE;API;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.6;87.6;;;78.8;93.1;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.2;39.2;;;32.9;45.9;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;30.6;30.6;;;21.3;42.5;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2014;2014;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;106;106;;;;;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2014;2014;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.6;67.6;;;57.7;76.1;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.5;31.5;;;22.7;41.9;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;21.5;21.5;;;14.3;31.1;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;53.3;53.3;;;43.5;62.8;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.5;86.5;;;78.9;91.7;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.1;89.1;;;79.4;94.5;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.9;45.9;;;38.1;53.9;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.3;84.3;;;74.1;91;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2014;2014;FL;Florida;NVSS;Asthma;Asthma mortality rate;;;Number;191;191;;;;;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;75.1;75.1;;;57.1;87.3;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.4;35.4;;;24.7;47.9;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.2;6.2;;;5.5;7;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.7;65.7;;;55.2;74.9;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2014;2014;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.5;12.5;;;8.4;17.8;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;78.8;78.8;;;64.2;88.5;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.2;37.2;;;26.5;49.2;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.5;84.5;;;74.8;90.9;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2014;2014;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.5;31.5;;;22.3;42.3;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.8;42.8;;;35.2;50.7;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.6;40.6;;;35.6;45.9;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85;85;;;76.2;90.9;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.1;84.1;;;77.5;89;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2014;2014;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2014;2014;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.3;44.3;;;39;49.7;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;TX;Texas;NVSS;Asthma;Asthma mortality rate;;;Number;125;125;;;;;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;NMBR;GENDER;GENF;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.6;32.6;;;22.3;44.9;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.3;33.3;;;24.2;43.9;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.6;40.6;;;31.1;50.9;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2014;2014;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;NMBR;RACE;WHT;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;16.0;16;;;12.2;20.7;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.2;87.2;;;78.1;92.9;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.7;46.7;;;40.7;52.8;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;55.5;55.5;;;48.2;62.5;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;54.4;54.4;;;36.3;71.5;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.8;32.8;;;26.4;39.8;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;NMBR;RACE;BLK;;;;
2014;2014;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;NMBR;RACE;BLK;;;;
2014;2014;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;15.6;15.6;;;12.1;19.8;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.6;33.6;;;18.3;53.2;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62;62;;;52.4;70.8;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83;83;;;74.7;89;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.8;62.8;;;54.9;70;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2014;2014;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.7;14.7;;;11.8;18.1;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2014;2014;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;NMBR;RACE;HIS;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.9;62.9;;;50;74.2;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.7;66.7;;;56.4;75.7;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2014;2014;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.7;7.7;;;5.5;10.6;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.1;43.1;;;36.4;50.1;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.6;84.6;;;78.7;89.2;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.1;44.1;;;37.5;51;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2014;2014;MT;Montana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;NMBR;GENDER;GENF;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.4;40.4;;;32.6;48.8;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.2;6.2;;;5.5;7.1;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.6;47.6;;;38.1;57.4;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.7;41.7;;;36.8;46.8;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.5;41.5;;;35.5;47.8;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;72.4;72.4;;;58.8;82.7;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.5;32.5;;;24.8;41.2;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.2;33.2;;;25.3;42.3;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;NMBR;RACE;API;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.3;44.3;;;36.8;52.1;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;75.5;75.5;;;65.5;83.3;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.1;45.1;;;39.6;50.7;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.4;14.4;;;8.9;22;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;24.2;24.2;;;16.1;34.7;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.9;43.9;;;38.4;49.6;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;NMBR;GENDER;GENM;;;;
2014;2014;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.5;39.5;;;34;45.2;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2014;2014;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.9;12.9;;;10.7;15.2;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.0;14;;;10.4;18.8;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;72.4;72.4;;;61;81.5;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2014;2014;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;20.9;20.9;;;15.6;27.5;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.6;48.6;;;42;55.4;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.8;46.8;;;42.2;51.4;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.7;40.7;;;35.3;46.2;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2014;2014;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;79.5;79.5;;;62.4;90;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.6;36.6;;;31.7;41.8;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.6;45.6;;;34.1;57.6;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;74.8;74.8;;;64.8;82.7;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;35.2;35.2;;;22.3;52.8;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.5;48.5;;;44.7;52.3;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.4;44.4;;;28.9;61.1;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39;39;;;33.9;44.2;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2014;2014;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;NMBR;RACE;WHT;;;;
2014;2014;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;CRDRATE;RACE;API;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;45.8;45.8;;;37.2;54.6;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69;69;;;54.7;80.4;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2014;2014;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.8;34.8;;;26.2;44.6;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2014;2014;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.5;67.5;;;54.4;78.3;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.2;44.2;;;32.8;56.3;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;NMBR;RACE;API;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2014;2014;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;NMBR;RACE;API;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.2;38.2;;;32.9;43.8;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.6;10.6;;;9.3;12.1;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68;68;;;59.3;75.5;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.1;48.1;;;42;54.2;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.2;65.2;;;55.5;73.9;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.5;33.5;;;24.4;44;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.2;84.2;;;74.1;90.9;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.7;44.7;;;36.6;53.2;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.7;68.7;;;59.9;76.3;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;CRDRATE;RACE;API;;;;
2014;2014;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2014;2014;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;NMBR;GENDER;GENM;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.4;37.4;;;23.8;53.4;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2014;2014;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;CRDRATE;RACE;API;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.8;69.8;;;47.6;85.5;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;79.3;79.3;;;69.1;86.8;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.6;71.6;;;62.7;79.2;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;81.7;81.7;;;65.4;91.3;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50.3;50.3;;;34.7;65.9;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;80.1;80.1;;;71.3;86.7;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.4;47.4;;;36.3;58.8;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2014;2014;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.6;41.6;;;34.7;48.7;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.5;32.5;;;23.6;42.9;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.9;37.9;;;32.6;43.5;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;74.4;74.4;;;65.9;81.4;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2014;2014;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2014;2014;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.5;13.5;;;9.5;18.6;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.3;70.3;;;60.5;78.5;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.5;71.5;;;65.4;76.9;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.5;10.5;;;9.6;11.3;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.8;35.8;;;29.3;42.8;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.9;10.9;;;7.3;15.6;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.8;33.8;;;23.9;45.2;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.9;86.9;;;75.8;93.4;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;75.3;75.3;;;65.1;83.3;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.6;36.6;;;29.4;44.4;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.1;12.1;;;9.2;15.5;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;;Number;94;94;;;;;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39;39;;;27.8;51.5;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.4;63.4;;;52.5;73.1;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87;87;;;82.1;90.7;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.1;40.1;;;32;48.7;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.6;83.6;;;73;90.6;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.5;49.5;;;40.7;58.3;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.5;34.5;;;27.6;42.1;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.5;30.5;;;22.3;40.3;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.7;63.7;;;49.6;75.7;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;76.5;76.5;;;64.3;85.5;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;75;75;;;59.6;85.9;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.6;32.6;;;27.5;38.2;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35;35;;;27.7;43;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.2;32.2;;;24.3;41.3;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;80.7;80.7;;;66.9;89.7;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2014;2014;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;77.4;77.4;;;58.9;89.1;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.1;70.1;;;54.7;82;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;NMBR;RACE;AIAN;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34;34;;;25.3;44;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2014;2014;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;22;22;;;;;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;NMBR;GENDER;GENM;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;51.2;51.2;;;43.3;59;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;53.6;53.6;;;45.4;61.7;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2014;2014;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;NMBR;RACE;HIS;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.1;35.1;;;26.5;44.9;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.9;33.9;;;29.1;39.2;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;76;76;;;65.1;84.3;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;91.4;91.4;;;83.5;95.7;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;CA;California;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;NMBR;RACE;AIAN;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.2;86.2;;;79.6;90.9;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.1;7.1;;;4.3;10.9;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29.8;29.8;;;23.9;36.5;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2014;2014;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;4.2;4.2;;;3;5.8;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;24.7;24.7;;;20.2;30;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;;Number;61;61;;;;;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.3;45.3;;;37;53.8;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;55.6;55.6;;;48.2;62.7;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;64.6;64.6;;;54.3;73.7;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.3;45.3;;;40.1;50.7;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.6;70.6;;;61.8;78;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;93.7;93.7;;;87.3;97;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.4;39.4;;;33.3;45.9;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2014;2014;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.6;40.6;*;50 States + DC: US Median;38.5;43.1;Overall;Overall;;;;;;;59;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.1;36.1;;;26.8;46.7;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.2;42.2;;;37.2;47.4;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.4;82.4;;;71.5;89.8;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.1;63.1;;;55.1;70.4;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.9;36.9;;;26.9;48.1;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.7;36.7;;;31.6;42.1;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.9;34.9;;;28.3;42.1;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2014;2014;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.7;7.7;;;6.4;8.9;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36;36;;;23.6;50.6;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2014;2014;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.6;8.6;;;7;10.3;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.7;42.7;;;36.7;49;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.2;30.2;;;21.4;40.7;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;80.7;80.7;;;70.7;87.8;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2014;2014;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST4_1;NMBR;RACE;WHT;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.6;32.6;;;22.9;44.1;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;TX;Texas;NVSS;Asthma;Asthma mortality rate;;;Number;87;87;;;;;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;NMBR;GENDER;GENM;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.4;63.4;;;56.4;69.9;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;15.0;15;;;8.5;25.3;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.4;41.4;;;34.5;48.7;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.5;35.5;;;28.2;43.5;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2014;2014;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;;Number;34;34;;;;;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;NMBR;GENDER;GENF;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91;91;;;84.1;95.1;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;FL;Florida;NVSS;Asthma;Asthma mortality rate;;;Number;77;77;;;;;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;NMBR;GENDER;GENM;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2014;2014;WA;Washington;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;NMBR;RACE;AIAN;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;58;58;;;49.9;65.7;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.1;84.1;;;77.7;89;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;;Number;28;28;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;NMBR;RACE;WHT;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2014;2014;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;NMBR;GENDER;GENM;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.5;14.5;;;11.4;18.2;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2014;2014;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.5;68.5;;;49.8;82.6;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67.2;67.2;;;52.1;79.3;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;NMBR;RACE;BLK;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.4;8.4;;;7.8;8.9;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2014;2014;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;NMBR;RACE;API;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;79.3;79.3;;;62.3;89.9;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;29.1;29.1;;;21.9;37.4;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.1;37.1;;;29;46;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.4;33.4;;;23.5;45.1;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.4;41.4;;;35.7;47.4;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.8;42.8;;;25.2;62.4;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.5;34.5;;;26.1;44;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.2;13.2;;;10.2;17;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;92.5;92.5;;;84.9;96.4;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2014;2014;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87;87;;;80.4;91.5;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.2;65.2;;;47;79.9;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.8;39.8;;;33.7;46.1;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50.5;50.5;;;44.3;56.6;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;60.1;60.1;;;47.2;71.8;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;51.6;51.6;;;45.9;57.3;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.8;44.8;;;39.2;50.6;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2014;2014;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;NMBR;RACE;BLK;;;;
2014;2014;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.1;46.1;;;41.6;50.8;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.3;40.3;;;36.7;44.1;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;;Number;28;28;;;;;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70;70;;;59.7;78.6;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.8;85.8;;;78.4;91;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2014;2014;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;28.3;28.3;;;15;46.8;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.6;10.6;;;7.3;15.2;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2014;2014;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39;39;**;US estimate/number is based on fewer than 50 states and the District of Columbia;37;41.4;Gender;Male;;;;;;;59;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;24;24;;;14.2;37.6;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2014;2014;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.7;13.7;;;9.1;20;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2014;2014;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.5;39.5;;;32.3;47.2;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.0;8;;;7.3;8.9;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.3;43.3;;;37.1;49.8;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.2;34.2;;;27.4;41.6;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.2;44.2;;;37.2;51.4;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.9;39.9;;;34.5;45.6;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.4;39.4;;;29.4;50.3;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84;84;;;75.8;89.9;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.7;45.7;;;35.1;56.8;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;64.8;64.8;;;55.4;73.2;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2014;2014;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;;Number;27;27;;;;;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;NMBR;GENDER;GENM;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.4;35.4;;;28.5;42.9;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.3;47.3;;;40.8;53.8;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;13.9;13.9;;;9.3;20;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;NMBR;GENDER;GENF;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.9;35.9;;;31.5;40.5;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.1;37.1;;;33.2;41.1;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.6;89.6;;;82;94.3;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90;90;;;84;93.9;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.5;85.5;;;79.3;90.1;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.8;70.8;;;52.2;84.4;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2014;2014;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;32.7;32.7;;;26.4;39.9;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;19.4;19.4;;;11.2;31.5;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.3;41.3;;;36.3;46.6;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.8;85.8;;;78.5;90.9;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;80.5;80.5;;;68.7;88.6;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;58.7;58.7;;;45.3;71;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;24.9;24.9;;;18.5;32.9;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;81.8;81.8;;;73.5;87.9;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.4;41.4;;;30.7;52.9;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2014;2014;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.9;12.9;;;9.8;16.6;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2014;2014;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;NMBR;RACE;HIS;;;;
2014;2014;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;NMBR;RACE;AIAN;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.7;9.7;;;8.7;10.8;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.9;40.9;;;26.6;56.8;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.4;5.4;;;4.1;7.1;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.5;40.5;;;34.2;47.1;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.6;10.6;;;7.4;14.8;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;16.5;16.5;;;9;28.3;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;;Number;58;58;;;;;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;NMBR;GENDER;GENF;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2014;2014;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;31.0;31;;;21.8;42.7;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.5;83.5;;;73.9;90.1;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2014;2014;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.3;8.3;;;7.2;9.4;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41;41;;;34.1;48.3;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;24.8;24.8;;;20.2;30;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29.4;29.4;;;22.5;37.4;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;;Number;56;56;;;;;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2014;2014;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;NMBR;RACE;HIS;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;35.9;35.9;;;27.2;45.6;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;54.7;54.7;;;46.2;62.8;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.8;8.8;;;6.7;11.4;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.2;36.2;;;24.1;50.3;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;;Number;82;82;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;NMBR;RACE;WHT;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.2;44.2;;;27.9;61.9;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;NMBR;RACE;API;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.5;36.5;;;26.1;48.3;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.0;10;;;8.2;11.8;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;92;92;;;84.6;96;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.8;13.8;;;8.2;22.3;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91;91;;;85.2;94.7;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;NMBR;RACE;BLK;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.9;42.9;;;33.8;52.6;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2014;2014;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;NMBR;RACE;API;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.4;43.4;;;35.1;52;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;73.3;73.3;;;66.6;79.1;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.9;10.9;;;8.8;13;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;NMBR;GENDER;GENM;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41;41;;;30.7;52.1;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;54;54;;;35;71.9;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;81.6;81.6;;;72.6;88.2;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.7;70.7;;;55.4;82.4;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.6;39.6;;;31.2;48.6;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2014;2014;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.9;86.9;;;78.8;92.2;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;25.0;25;;;17.5;34.6;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2014;2014;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;18.2;18.2;;;13.8;23.4;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40;40;;;28.3;52.9;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.9;7.9;;;6.4;9.7;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.9;49.9;;;36.3;63.5;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;73.3;73.3;;;54.3;86.4;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.6;85.6;;;79.6;90.1;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;76.4;76.4;;;64.4;85.3;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2014;2014;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.7;66.7;;;57.5;74.8;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.1;66.1;;;57.2;74;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;28.3;28.3;;;20.3;37.9;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2014;2014;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;CRDRATE;RACE;API;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.5;31.5;;;24.4;39.6;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;28.2;28.2;;;16.7;43.3;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.3;87.3;;;82.7;90.9;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;75.2;75.2;;;64.7;83.4;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.4;62.4;;;56.3;68.1;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.9;32.9;;;27.2;39.2;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89;89;;;80.7;94;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.7;34.7;;;26.8;43.5;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.7;89.7;;;77.6;95.6;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.2;39.2;;;32.1;46.7;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2014;2014;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.6;40.6;;;33.4;48.3;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.1;39.1;;;31.2;47.6;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2014;2014;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;51.4;51.4;;;43.5;59.2;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.1;38.1;;;30.2;46.6;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;17.4;17.4;;;13.1;22.7;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.4;31.4;;;18.9;47.3;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;40.6;40.6;;;32.5;49.3;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.0;12;;;6.7;20.5;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2014;2014;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;NMBR;GENDER;GENF;;;;
2014;2014;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;;Number;77;77;;;;;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;73.1;73.1;;;59.7;83.3;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;54.6;54.6;;;40.5;68;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.8;37.8;;;31.6;44.5;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;WA;Washington;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;NMBR;RACE;API;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;22.3;22.3;;;15.6;30.8;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83;83;;;77;87.8;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2014;2014;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.5;44.5;;;39.4;49.7;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.3;63.3;;;51.7;73.6;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.1;43.1;;;36.7;49.7;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;79.5;79.5;;;69.8;86.6;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;CRDRATE;RACE;API;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;76.8;76.8;;;68;83.8;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;80.6;80.6;;;68.1;89;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;75.5;75.5;;;59.9;86.4;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;75.8;75.8;;;65.5;83.8;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2014;2014;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2014;2014;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;NMBR;RACE;AIAN;;;;
2014;2014;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;NMBR;RACE;AIAN;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;57.9;57.9;;;50.4;65.1;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.7;65.7;;;54.9;75.1;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;59.4;59.4;;;47.9;69.8;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.6;71.6;;;60.2;80.9;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;58.1;58.1;;;47.9;67.6;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.3;41.3;;;30.4;53.1;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.9;46.9;;;39;54.9;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;CRDRATE;RACE;API;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.7;68.7;;;59.3;76.9;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.9;83.9;;;76.8;89.1;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.8;35.8;;;25.8;47.1;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2014;2014;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.5;9.5;;;7.6;11.7;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;15.5;15.5;;;12;19.8;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;15.2;15.2;;;9.2;24.2;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;NMBR;RACE;API;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2014;2014;FL;Florida;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;NMBR;RACE;AIAN;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.9;38.9;;;31.2;47.1;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;UT;Utah;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;NMBR;GENDER;GENF;;;;
2014;2014;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;NMBR;RACE;BLK;;;;
2014;2014;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2014;2014;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2014;2014;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;NMBR;RACE;API;;;;
2014;2014;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2014;2014;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;NMBR;RACE;API;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87;87;;;71.6;94.7;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;;Number;57;57;;;;;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2014;2014;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;CRDRATE;RACE;API;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;60.4;60.4;;;46.8;72.5;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.5;48.5;;;44.7;52.4;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.7;44.7;;;39.8;49.8;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.7;89.7;;;82.6;94.1;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.2;87.2;;;76.4;93.5;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.2;42.2;;;35.6;49.1;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.1;44.1;;;35.4;53.2;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;NMBR;RACE;HIS;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.5;71.5;;;63.6;78.2;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.8;34.8;;;28.6;41.6;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.1;43.1;;;37;49.4;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;;Number;38;38;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;NMBR;RACE;WHT;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.6;38.6;;;33.7;43.8;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2014;2014;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2014;2014;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;NMBR;GENDER;GENF;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.2;48.2;;;39.5;57.1;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.6;48.6;;;37;60.2;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.4;33.4;;;24.9;43.2;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;43.2;43.2;;;29.5;61;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2014;2014;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2014;2014;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;16.0;16;;;9.6;25.5;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;28.9;28.9;;;19.7;40.2;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.8;39.8;;;28.3;52.5;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.4;40.4;;;33.8;47.3;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2014;2014;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;64.8;64.8;;;48.2;78.5;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;;Number;60;60;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;NMBR;RACE;WHT;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.5;38.5;;;29.5;48.3;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2014;2014;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.8;8.8;;;5.7;13;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.5;86.5;;;80.8;90.7;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47;47;;;39;55.3;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.4;36.4;;;30.2;43;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2014;2014;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.7;41.7;;;34.9;48.9;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;21.6;21.6;;;12.7;34.3;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;78.9;78.9;;;69.2;86.1;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;55;55;;;41.1;68.1;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.8;40.8;;;31.9;50.3;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2014;2014;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.5;67.5;;;58.6;75.4;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;NMBR;RACE;AIAN;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50.3;50.3;;;41.1;59.5;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2014;2014;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;15.3;15.3;;;9.5;23.4;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.7;43.7;;;27.7;61.3;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;73.7;73.7;;;66.3;80.1;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.1;43.1;;;37.7;48.8;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67.2;67.2;;;58.6;74.8;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.4;44.4;;;31.5;58;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.9;71.9;;;59.7;81.5;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;73;73;;;60.9;82.5;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;NMBR;RACE;WHT;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.5;70.5;;;53.7;83.1;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;29.7;29.7;;;21.6;39.3;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.9;9.9;;;8.9;10.9;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.6;65.6;;;47;80.4;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.1;66.1;;;55.5;75.3;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.3;36.3;;;29.8;43.2;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.3;9.3;;;8.1;10.7;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.4;62.4;;;46;76.3;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2014;2014;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.9;7.9;;;6.2;9.9;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.7;39.7;;;34.1;45.5;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2014;2014;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;15.3;15.3;;;13;17.6;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.6;33.6;;;29.8;37.5;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.4;40.4;;;27.9;54.2;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;80;80;;;70.7;86.8;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.8;36.8;;;26.7;48.3;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;CRDRATE;RACE;API;;;;
2014;2014;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.9;34.9;;;27;43.7;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.1;65.1;;;57.2;72.3;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.8;47.8;;;38.9;56.9;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.8;69.8;;;60.6;77.7;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;NMBR;RACE;API;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2014;2014;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.907192, -77.036871);;11;AST;AST4_1;NMBR;RACE;AIAN;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2014;2014;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;;Number;37;37;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;NMBR;RACE;BLK;;;;
2014;2014;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;17.8;17.8;;;13.4;23.2;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2014;2014;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.2;35.2;;;26.2;45.4;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.4;48.4;;;41.9;55;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.2;43.2;;;37.9;48.5;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.8;45.8;;;34.9;57;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70;70;;;61.9;77;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;73.4;73.4;;;58;84.7;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;NMBR;GENDER;GENF;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;46.4;46.4;;;26.4;67.7;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.2;72.2;;;62;80.5;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;73.8;73.8;;;59.7;84.3;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.4;31.4;;;19.3;46.8;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.7;42.7;;;37.6;48;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69;69;;;53.4;81.2;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.4;63.4;;;47.2;77.1;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.6;30.6;;;24.1;37.9;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.9;36.9;**;US estimate/number is based on fewer than 50 states and the District of Columbia;35;40;Gender;Male;;;;;;;59;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;NMBR;RACE;AIAN;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.7;35.7;;;28.3;43.9;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;;Number;58;58;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;NMBR;RACE;WHT;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;73.8;73.8;;;63.2;82.3;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.1;39.1;;;29.1;50;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.5;36.5;;;30.7;42.8;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.0;6;;;4.8;7.5;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.2;40.2;;;34.4;46.3;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.4;85.4;;;78.9;90.2;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.2;88.2;;;82.9;92.1;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.6;11.6;;;8.4;15.9;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.7;45.7;;;36.4;55.3;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.8;66.8;;;54;77.5;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2014;2014;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.4;85.4;*;50 States + DC: US Median;84.4;86.3;Gender;Female;;;;;;;59;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.4;84.4;;;78.1;89.2;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.9;32.9;;;27.4;38.8;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.8;32.8;;;22.7;44.9;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.2;14.2;;;11.5;17.5;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.1;35.1;;;26.9;44.3;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.7;10.7;;;9.7;11.8;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;49;49;;;36.6;61.6;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;53.6;53.6;;;45.8;61.2;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2014;2014;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.6;85.6;;;75.6;91.9;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2014;2014;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2014;2014;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.6;8.6;;;5;14.6;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.3;69.3;;;58.6;78.3;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2014;2014;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.1;28.1;;;19.3;38.9;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.9;36.9;;;28.6;46;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.3;13.3;;;11.6;14.9;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.1;36.1;;;29.8;42.9;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;75;75;;;66.6;81.9;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.6;39.6;;;34.1;45.4;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;64.8;64.8;;;56.4;72.4;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;81.3;81.3;;;71.9;88.1;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.1;7.1;;;5.7;8.7;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;81.1;81.1;;;68.8;89.3;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;NMBR;RACE;API;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.1;82.1;;;74.1;88;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.8;37.8;;;27.5;49.4;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2014;2014;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.1;7.1;;;5.6;8.8;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.4;37.4;;;31.9;43.2;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2014;2014;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;77.3;77.3;;;68.5;84.2;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.4;85.4;;;78.2;90.4;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.4;40.4;;;34.7;46.4;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;57.5;57.5;;;49;65.5;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;;Number;22;22;;;;;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2014;2014;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;NMBR;RACE;API;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2014;2014;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.4;11.4;;;7.1;17.4;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;50.5;50.5;;;42.6;58.4;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38;38;;;30.8;45.6;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.3;88.3;;;82.6;92.4;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2014;2014;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;;Number;50;50;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;NMBR;RACE;WHT;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2014;2014;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.9;37.9;;;31.3;45;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.8;63.8;;;48;77.1;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37;37;;;29.8;44.7;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2014;2014;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.6;8.6;;;6.3;11.5;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.3;83.3;;;74.3;89.6;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;51.5;51.5;;;36.5;66.3;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;15.4;15.4;;;12.5;18.7;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;52.6;52.6;;;46.6;58.5;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67.9;67.9;;;49;82.4;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.4;8.4;;;5.2;12.8;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2014;2014;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.1;11.1;;;8.7;13.9;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.4;39.4;;;26.1;54.6;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.7;70.7;;;55.7;82.3;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;73.7;73.7;;;66;80.2;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.9;62.9;;;51.8;72.7;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.8;88.8;;;81.7;93.4;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.6;87.6;;;79.7;92.7;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.4;84.4;;;77;89.7;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2014;2014;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.5;43.5;;;38.3;48.9;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;53.9;53.9;;;48.3;59.4;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.7;63.7;;;54.8;71.7;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2014;2014;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;NMBR;RACE;AIAN;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37;37;;;27;48.2;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2013;2013;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.5;11.5;;;8.2;15.6;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;59.5;59.5;;;49.2;68.9;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;NMBR;GENDER;GENM;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.9;43.9;;;38.1;49.9;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36;36;;;30.6;41.8;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.4;37.4;;;30.1;45.2;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2014;2014;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.5;38.5;;;32.4;45;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;79.2;79.2;;;67.1;87.7;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39;39;;;31.3;47.2;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;80.4;80.4;;;64.7;90.2;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;74.3;74.3;;;65.6;81.4;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;NMBR;RACE;AIAN;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.5;85.5;;;74;92.4;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;MT;Montana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;64.8;64.8;;;57.3;71.7;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.1;35.1;;;26.2;45.2;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.4;86.4;;;73.9;93.4;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2014;2014;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.9;91.9;;;87.6;94.8;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2014;2014;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;NMBR;GENDER;GENF;;;;
2014;2014;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.3;37.3;;;26.6;49.3;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.9;44.9;;;37.1;53;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.3;41.3;;;35.6;47.3;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.4;40.4;;;30.9;50.6;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.3;63.3;;;55.1;70.9;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2014;2014;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;;Number;38;38;;;;;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;NMBR;GENDER;GENM;;;;
2014;2014;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.2;9.2;;;7.5;11;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.5;11.5;;;9.6;13.7;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;NMBR;GENDER;GENF;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;48.5;48.5;;;37.3;59.8;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2014;2014;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;CRDRATE;RACE;API;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.4;85.4;;;76.8;91.2;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;92.6;92.6;;;83.6;96.9;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2014;2014;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.0;11;;;6.8;16.8;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;27.3;27.3;;;19.4;37;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42;42;;;36;48.2;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2014;2014;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.5;7.5;;;5.6;9.8;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.9;43.9;;;35.2;53.1;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;81.7;81.7;;;74.5;87.2;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;75.8;75.8;;;60;86.8;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.4;7.4;;;5.3;10;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.3;64.3;;;58.5;69.8;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.9;35.9;;;31.6;40.6;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2014;2014;ME;Maine;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;NMBR;RACE;WHT;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;73.6;73.6;;;65.8;80.2;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;59;59;;;43.6;72.7;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.1;62.1;;;45.7;76.2;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;80.6;80.6;;;70.6;87.8;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.3;40.3;;;35.7;45;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;26.1;26.1;;;15.8;39.9;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.2;85.2;;;73.8;92.2;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41;41;;;34.8;47.4;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.5;47.5;;;38.2;57;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2014;2014;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;CRDRATE;RACE;API;;;;
2014;2014;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.1;13.1;;;10;16.9;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;23.6;23.6;;;12.7;39.8;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2014;2014;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;NMBR;RACE;HIS;;;;
2014;2014;WA;Washington;NVSS;Asthma;Asthma mortality rate;;;Number;36;36;;;;;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;NMBR;GENDER;GENM;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.3;87.3;;;78.9;92.7;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87;87;;;79.2;92.1;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.5;40.5;;;30.8;51.1;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.8;28.8;;;19.4;40.5;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47;47;;;41.6;52.5;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.5;14.5;;;9.1;22;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2013;2013;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.3;7.3;;;4.5;11.2;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46;46;;;41.4;50.6;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;91.2;91.2;;;84.1;95.3;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.3;88.3;;;79.1;93.8;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2014;2014;ME;Maine;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;15.7;15.7;;;11.6;20.9;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.6;65.6;;;51.8;77.1;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2014;2014;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;75.6;75.6;;;67;82.6;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2014;2014;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST4_1;NMBR;RACE;HIS;;;;
2014;2014;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;76.4;76.4;;;68;83.2;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86;86;;;80.1;90.3;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.1;86.1;;;78.6;91.3;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.0;11;;;8.2;14.3;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;NMBR;RACE;HIS;;;;
2014;2014;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;66;66;;;;;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;NMBR;GENDER;GENF;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.8;46.8;;;41.6;52;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2014;2014;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2014;2014;ME;Maine;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;NMBR;RACE;AIAN;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.4;71.4;;;63.7;78;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.2;41.2;;;37;45.5;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.2;41.2;;;32.4;50.6;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39;39;;;28.1;51.1;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.6;32.6;;;22.2;44.9;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;27.4;27.4;;;19.8;36.7;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.9;41.9;;;30.6;54.2;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;73.6;73.6;;;65.6;80.4;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.1;87.1;;;78;92.8;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.8;48.8;;;41.5;56.1;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.7;66.7;;;52.8;78.2;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;NMBR;RACE;HIS;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.9;65.9;;;58.6;72.6;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.9;40.9;;;37.4;44.6;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;NMBR;RACE;HIS;;;;
2014;2014;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.0;9;;;6.4;12.5;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.7;85.7;;;78.9;90.6;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;76.4;76.4;;;62.7;86.2;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.3;41.3;;;34.1;48.8;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2014;2014;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2014;2014;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;CRDRATE;RACE;API;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;59.6;59.6;;;46.3;71.7;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.9;69.9;;;61.2;77.3;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.4;87.4;;;82;91.3;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.8;45.8;;;37.5;54.3;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.3;67.3;;;53.2;78.9;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.5;91.5;;;82;96.2;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;23.1;23.1;;;18.3;28.8;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2014;2014;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.5;34.5;;;31;38.3;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42;42;;;35.3;49;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43;43;;;36.5;49.8;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69;69;;;56.2;79.5;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.3;11.3;;;7.5;16.4;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.1;33.1;;;27.1;39.7;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.7;47.7;;;39.3;56.1;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29.3;29.3;;;17;45.5;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;NMBR;RACE;BLK;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;73;73;;;64.4;80.1;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.8;43.8;;;38.3;49.5;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2014;2014;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;NMBR;RACE;BLK;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.9;35.9;;;26.9;46.1;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.7;64.7;;;53.3;74.6;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.2;37.2;;;32.9;41.8;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.1;48.1;;;33.1;63.4;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.2;41.2;;;34.5;48.1;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71;71;;;64.2;77;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.9;44.9;;;39.9;50;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;58.1;58.1;;;42.6;72.1;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.7;32.7;;;22.4;44.9;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2014;2014;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;77.1;77.1;;;62;87.4;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.7;36.7;;;31.4;42.4;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.2;12.2;;;9.2;16;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.2;82.2;;;75.9;87.2;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.9;46.9;;;38.5;55.5;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.8;69.8;;;63.5;75.5;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36;36;;;30.9;41.5;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.8;7.8;;;5.5;10.7;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2014;2014;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;NMBR;GENDER;GENM;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2014;2014;TX;Texas;NVSS;Asthma;Asthma mortality rate;;;Number;212;212;;;;;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2014;2014;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.8;37.8;;;31.9;44.2;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;;Number;39;39;;;;;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;NMBR;GENDER;GENF;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;72.1;72.1;;;60.8;81.2;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;78.5;78.5;;;69.1;85.6;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.3;28.3;;;16.4;44.3;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;25.1;25.1;;;17.5;34.5;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.1;38.1;;;28.1;49.3;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.2;35.2;;;21.3;52.1;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2014;2014;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.3;85.3;;;77.6;90.7;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.6;62.6;;;55.2;69.5;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;26.3;26.3;;;19.2;34.9;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.6;41.6;;;31.4;52.5;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2014;2014;MT;Montana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;NMBR;RACE;WHT;;;;
2014;2014;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.9;89.9;;;82.2;94.4;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.2;34.2;;;27.8;41.3;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2014;2014;ME;Maine;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;NMBR;RACE;API;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.8;36.8;;;31.9;42;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;CRDRATE;RACE;API;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2014;2014;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;NMBR;RACE;BLK;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.6;84.6;;;76.6;90.1;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.7;88.7;;;81.5;93.3;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.4;11.4;;;7.9;16;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2014;2014;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.9;12.9;;;8.4;18.9;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;79.6;79.6;;;61.6;90.4;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.3;8.3;;;7.3;9.5;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.7;70.7;;;53.8;83.3;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.4;36.4;;;29.8;43.6;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.6;37.6;;;26.2;50.4;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.2;39.2;*;50 States + DC: US Median;36.9;40;Gender;Female;;;;;;;59;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.3;37.3;;;30.6;44.7;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.2;36.2;;;29.9;43.1;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2014;2014;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;NMBR;RACE;AIAN;;;;
2014;2014;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;NMBR;RACE;HIS;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.7;41.7;;;34.2;49.6;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.6;69.6;;;60.6;77.3;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2014;2014;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;;Number;51;51;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;NMBR;RACE;WHT;;;;
2014;2014;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;NMBR;RACE;API;;;;
2014;2014;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.3;86.3;;;76.7;92.4;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2014;2014;TX;Texas;NVSS;Asthma;Asthma mortality rate;;;Number;111;111;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;NMBR;RACE;WHT;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.9;44.9;;;38.5;51.4;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.5;38.5;;;32.5;44.9;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.8;7.8;;;7.1;8.5;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.6;37.6;;;30.4;45.4;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.1;88.1;;;82.9;91.8;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;73.7;73.7;;;64.2;81.4;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29.5;29.5;;;24.5;35.1;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.8;64.8;;;53.5;74.7;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;80.7;80.7;;;72.8;86.7;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;59.4;59.4;;;50.5;67.8;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.8;34.8;;;27.9;42.3;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2014;2014;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;NMBR;GENDER;GENM;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;57.4;57.4;;;42.4;71.1;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.9;9.9;;;7.1;13.5;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2014;2014;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;22.5;22.5;;;15.6;31.4;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.9;42.9;;;28.5;58.7;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.5;41.5;;;27.2;57.4;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45;45;;;38.6;51.7;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2014;2014;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;15.2;15.2;;;10.6;21;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37;37;;;31.8;42.5;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36;36;;;27.3;45.8;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2014;2014;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;;Number;25;25;;;;;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;NMBR;GENDER;GENM;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.8;71.8;;;63.5;78.9;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.6;63.6;;;56.7;70;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.3;41.3;;;28.3;55.6;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2014;2014;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;;Number;21;21;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;NMBR;RACE;WHT;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2014;2014;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.4;10.4;;;9.3;11.5;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;;Number;20;20;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;NMBR;RACE;WHT;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.4;85.4;;;73.6;92.5;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2014;2014;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.0;8;;;6.4;9.5;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2014;2014;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.0;9;;;6.2;12.5;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;24;24;;;14.5;37;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2014;2014;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.2;39.2;;;31.6;47.4;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.3;11.3;;;8.4;14.9;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.6;40.6;;;32.5;49.4;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39;39;;;30.3;48.5;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.1;69.1;;;55.1;80.3;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2014;2014;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;;Number;28;28;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;NMBR;RACE;WHT;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.3;40.3;;;27.9;54.2;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;NY;New York;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2014;2014;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.9;39.9;;;34.1;46.1;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2014;2014;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.8;66.8;;;54.8;76.9;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;51;51;;;44.5;57.3;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;76.9;76.9;;;68.8;83.5;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.7;13.7;;;10.7;17.3;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84;84;;;74.3;90.5;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.1;45.1;;;39.4;51;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.5;42.5;;;37.7;47.4;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.5;67.5;*;50 States + DC: US Median;64.7;70.3;Overall;Overall;;;;;;;59;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.8;42.8;;;37.4;48.4;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46;46;;;40.4;51.6;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2014;2014;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;17.7;17.7;;;13.6;22.6;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.5;86.5;;;80.5;90.9;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.7;72.7;;;58.2;83.6;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.5;39.5;;;26.2;54.6;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65;65;;;53.2;75.2;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.2;42.2;;;27.5;58.5;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.6;48.6;;;29.2;68.4;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37;37;;;32.6;41.6;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.8;35.8;;;29.6;42.4;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.7;40.7;;;33.5;48.2;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2014;2014;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;NMBR;RACE;API;;;;
2014;2014;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.7;12.7;;;10.4;14.9;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.5;6.5;;;4.6;9.1;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.6;39.6;;;32.3;47.5;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.3;44.3;;;36.6;52.3;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.3;66.3;;;51.3;78.7;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.3;33.3;;;27.1;40.2;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.6;40.6;;;35.4;46;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2014;2014;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.5;7.5;;;5;10.8;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2014;2014;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.7;40.7;;;33.4;48.5;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2014;2014;CA;California;NVSS;Asthma;Asthma mortality rate;;;Number;67;67;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;NMBR;RACE;BLK;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;74.7;74.7;;;64.6;82.7;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.5;32.5;;;21.2;46.2;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.6;91.6;;;80.7;96.6;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.6;84.6;;;74.4;91.2;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;81.5;81.5;;;66.5;90.7;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2014;2014;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;16.0;16;;;11.8;21.3;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.6;33.6;;;27.5;40.4;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44;44;;;31.5;57.2;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.7;62.7;;;54.9;69.8;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.4;37.4;;;29.8;45.7;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;22.5;22.5;;;14.6;32.9;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.1;69.1;;;52.8;81.8;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;91.1;91.1;;;84.4;95.1;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.8;37.8;;;26;51.1;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.3;37.3;;;25.8;50.4;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;CRDRATE;RACE;API;;;;
2014;2014;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;;Number;30;30;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;NMBR;RACE;WHT;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.9;34.9;;;29.5;40.8;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;NMBR;RACE;AIAN;;;;
2013;2013;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;13.6;13.6;;;8.6;20.4;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;25.3;25.3;;;18;34.6;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.7;72.7;;;59.6;82.7;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;47.8;47.8;;;35.5;60.3;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.4;86.4;;;80.8;90.5;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;54.8;54.8;;;35.2;73;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;CRDRATE;RACE;API;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.3;40.3;;;33.8;47.1;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.8;86.8;;;82.7;90.1;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2014;2014;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;NMBR;RACE;AIAN;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2014;2014;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;;Number;35;35;;;;;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;NMBR;GENDER;GENF;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.5;47.5;;;40.2;54.9;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;NMBR;RACE;HIS;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;79.4;79.4;;;64.6;89;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2014;2014;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;NMBR;GENDER;GENF;;;;
2014;2014;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;NMBR;RACE;AIAN;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.2;14.2;;;10.2;19.6;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;NMBR;RACE;AIAN;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;CRDRATE;RACE;API;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34;34;;;21.3;49.6;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;25.4;25.4;;;16.6;36.8;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2014;2014;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.1;39.1;*;50 States + DC: US Median;38.3;40.9;Overall;Overall;;;;;;;59;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;67;67;;;;;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;NMBR;GENDER;GENF;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.2;63.2;;;54.4;71.1;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;81.4;81.4;;;68;90.1;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;CA;California;NVSS;Asthma;Asthma mortality rate;;;Number;259;259;;;;;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;NMBR;GENDER;GENF;;;;
2014;2014;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;;Number;36;36;;;;;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.4;47.4;;;39.4;55.5;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;NMBR;RACE;API;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2014;2014;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2014;2014;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.5;62.5;;;50.7;73;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.1;36.1;;;29.1;43.8;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.7;39.7;;;32.1;47.7;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2014;2014;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;;Number;38;38;;;;;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;NMBR;GENDER;GENF;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.7;41.7;;;32.2;51.8;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;NMBR;RACE;WHT;;;;
2014;2014;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2014;2014;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.3;8.3;;;5.3;12.4;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.3;82.3;;;74.2;88.3;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.1;47.1;;;36;58.6;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.7;40.7;;;30.9;51.3;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2014;2014;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.7;34.7;;;28.9;41;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.1;63.1;;;52.2;72.9;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.4;44.4;;;33.2;56.2;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2014;2014;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;17.5;17.5;;;14.9;20.1;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2014;2014;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;NMBR;RACE;WHT;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63;63;;;55.3;70;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2014;2014;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;17.0;17;;;10;27.4;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37;37;;;28.1;46.9;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2014;2014;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST4_1;NMBR;GENDER;GENM;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.4;14.4;;;13.1;15.9;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.7;84.7;;;79.1;88.9;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.5;46.5;;;39.7;53.4;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.8;69.8;;;60.5;77.7;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;NMBR;RACE;API;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2014;2014;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.6;38.6;;;31.1;46.7;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.1;8.1;;;6.8;9.5;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2014;2014;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;80.6;80.6;;;73.1;86.4;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;79.7;79.7;;;70.3;86.7;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34;34;;;26.7;42.2;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;75.3;75.3;;;65.4;83.1;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2014;2014;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.3;87.3;;;75.8;93.8;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;NMBR;RACE;WHT;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.9;87.9;;;82.3;91.8;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;74;74;;;67.3;79.8;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2014;2014;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;NMBR;RACE;API;;;;
2014;2014;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2014;2014;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;CRDRATE;RACE;API;;;;
2014;2014;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;14.5;14.5;;;10.9;18.9;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;30.6;30.6;;;21.4;41.8;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2014;2014;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.907192, -77.036871);;11;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;81.2;81.2;;;68.3;89.6;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.5;70.5;;;57.5;80.8;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2014;2014;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.0;10;;;8.1;11.9;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2014;2014;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;UT;Utah;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;NMBR;RACE;BLK;;;;
2014;2014;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;CRDRATE;RACE;API;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.7;45.7;;;34.4;57.5;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.3;40.3;;;29.7;51.9;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.2;68.2;;;53.7;79.9;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.4;47.4;;;41.1;53.8;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.2;42.2;;;30.8;54.4;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2014;2014;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.9;6.9;;;5.6;8.6;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2014;2014;ME;Maine;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;NMBR;RACE;HIS;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.7;63.7;;;46.3;78.1;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.2;9.2;;;7.4;11.4;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.4;69.4;;;59.2;78;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2014;2014;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;NMBR;RACE;API;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.6;66.6;;;55;76.5;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.1;9.1;;;7.4;10.8;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2014;2014;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;CRDRATE;RACE;API;;;;
2014;2014;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.9;34.9;;;27.8;42.7;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35;35;;;29.4;41.1;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35;35;;;24.5;47.2;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.3;34.3;;;25.8;43.8;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.7;8.7;;;7.7;9.8;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;61.8;61.8;;;55;68.2;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.2;82.2;;;72.5;89;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.6;12.6;;;10.1;15.5;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;74;74;;;66.1;80.7;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2014;2014;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.4;10.4;;;8.6;12.3;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2014;2014;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2014;2014;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;;Number;56;56;;;;;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;NMBR;GENDER;GENF;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29.5;29.5;;;21.7;38.8;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2014;2014;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.9;11.9;;;7.7;17.5;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.5;45.5;;;37.7;53.6;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;58.3;58.3;;;45.6;70;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.4;40.4;;;34.4;46.7;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.6;8.6;;;5.2;13.4;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;NMBR;RACE;AIAN;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2014;2014;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2014;2014;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.8;37.8;*;50 States + DC: US Median;36.5;39.2;Overall;Overall;;;;;;;59;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;24.6;24.6;;;14;39.4;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;49.1;49.1;;;36.3;62;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.1;45.1;;;31.7;59.2;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;79;79;;;60.9;90.1;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.1;35.1;;;27.4;43.6;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;80.5;80.5;;;68.8;88.5;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2014;2014;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;;Number;96;96;;;;;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2014;2014;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;CRDRATE;RACE;API;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;54.9;54.9;;;42.1;67.1;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;;Number;41;41;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;NMBR;RACE;WHT;;;;
2014;2014;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.7;45.7;;;39.8;51.7;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.4;36.4;;;27.6;46.2;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.4;7.4;;;6.2;8.9;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.3;31.3;;;21.7;42.9;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;77.4;77.4;;;62.2;87.7;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;27.9;27.9;;;19.4;39;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;76.2;76.2;;;67.5;83.1;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.7;37.7;;;29.9;46.2;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2014;2014;CA;California;NVSS;Asthma;Asthma mortality rate;;;Number;74;74;;;;;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;NMBR;RACE;HIS;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.5;36.5;;;29.1;44.7;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66;66;;;50.9;78.5;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2014;2014;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2014;2014;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.5;42.5;;;33.6;52;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;1.9;1.9;;;1.1;3.3;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2014;2014;FL;Florida;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;NMBR;RACE;API;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;27.6;27.6;;;19.6;37.3;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2014;2014;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;73.3;73.3;;;65;80.3;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2014;2014;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.5;11.5;;;8.5;15.2;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.2;83.2;;;76.5;88.3;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;75.1;75.1;;;67.2;81.7;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;80.1;80.1;;;70.1;87.3;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;WA;Washington;NVSS;Asthma;Asthma mortality rate;;;Number;74;74;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;NMBR;RACE;WHT;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67.7;67.7;;;57.3;76.6;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29.7;29.7;;;21;40.3;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2013;2013;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.9;12.9;;;9.7;16.7;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.1;83.1;;;76.9;87.8;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.8;42.8;;;38.1;47.6;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.3;32.3;;;22.7;43.7;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2014;2014;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.1;42.1;;;31;54.1;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;51.1;51.1;;;33.8;68.1;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.3;83.3;;;75.6;88.9;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.4;72.4;;;57.5;83.6;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.2;62.2;;;51.5;71.8;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41;41;;;30.7;52.1;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2014;2014;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;79.4;79.4;;;72.3;85;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2014;2014;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35;35;;;22.9;49.3;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;45.9;45.9;;;37.4;54.6;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.4;71.4;;;64.5;77.4;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.1;46.1;;;36.2;56.2;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.5;70.5;;;62.1;77.6;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.4;44.4;;;38.8;50.2;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;NMBR;GENDER;GENF;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.9;84.9;;;79.2;89.2;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2014;2014;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;78.3;78.3;;;67.6;86.2;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2014;2014;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;76.6;76.6;;;68.8;82.9;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2014;2014;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.1;69.1;;;59.9;77;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;16.1;16.1;;;12.2;20.9;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.2;46.2;;;32.8;60.2;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.6;83.6;;;73.7;90.3;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;75.7;75.7;;;67.3;82.5;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.4;87.4;;;83.4;90.5;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67.3;67.3;;;60.2;73.7;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;74.3;74.3;;;63.5;82.7;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;NMBR;RACE;API;;;;
2013;2013;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;19982;19,982;;;;;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;NMBR;GENDER;GENF;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.7;70.7;;;63.9;76.7;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;;Number;37;37;;;;;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;NMBR;GENDER;GENF;;;;
2014;2014;FL;Florida;NVSS;Asthma;Asthma mortality rate;;;Number;104;104;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;NMBR;RACE;WHT;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45;45;;;39.5;50.6;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;75.8;75.8;;;60.9;86.3;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;59.9;59.9;;;49.7;69.4;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.6;70.6;;;59.2;79.9;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.9;86.9;;;80.2;91.6;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.8;36.8;;;27.8;46.7;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.8;85.8;;;80;90.1;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.4;38.4;;;33.3;43.8;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;NMBR;RACE;AIAN;;;;
2014;2014;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;19.4;19.4;;;15.3;24.2;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2014;2014;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2014;2014;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;NMBR;RACE;HIS;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.3;39.3;;;34.1;44.7;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33;33;;;23.5;44.3;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2014;2014;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;61.9;61.9;;;51.3;71.4;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.1;89.1;;;83.1;93.1;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38;38;;;31.4;45.1;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2014;2014;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;81.4;81.4;;;72.4;88;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.1;47.1;;;38.7;55.7;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2014;2014;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;16.5;16.5;;;10.7;24.3;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2014;2014;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;15.9;15.9;;;12.3;20.3;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2014;2014;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;3.6;3.6;;;2.6;5;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.2;39.2;;;30.2;49.1;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.3;5.3;;;4.5;6.4;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.5;87.5;;;80.9;92;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;58.6;58.6;;;47.6;68.9;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.3;31.3;;;22;42.3;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.9;69.9;;;62.1;76.7;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.9;34.9;;;20.3;52.9;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.4;36.4;;;29.5;43.9;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.7;38.7;;;28.8;49.7;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;52;52;;;;;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;NMBR;GENDER;GENF;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.7;40.7;;;30.6;51.6;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.9;11.9;;;10.7;13.2;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2014;2014;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;NMBR;RACE;HIS;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.5;33.5;;;23.6;45.1;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.1;86.1;;;75.3;92.6;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.3;62.3;;;47.3;75.2;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.2;39.2;;;26.7;53.2;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.4;35.4;;;29.1;42.1;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2014;2014;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;22.7;22.7;;;15.7;31.9;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.5;86.5;;;79;91.7;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2014;2014;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;;Number;87;87;;;;;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.5;38.5;;;32.7;44.7;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.7;38.7;;;33.4;44.3;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67;67;;;52.4;78.9;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;81.7;81.7;**;US estimate/number is based on fewer than 50 states and the District of Columbia;78.3;83.4;Gender;Male;;;;;;;59;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;73.2;73.2;;;61.6;82.3;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.7;86.7;;;82.1;90.3;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.5;39.5;;;35.7;43.5;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.5;42.5;;;33.3;52.1;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.8;41.8;;;32.5;51.8;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2014;2014;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.0;13;;;9.4;17.3;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;76.6;76.6;;;64.9;85.3;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50.2;50.2;;;43.5;56.8;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.4;62.4;;;45.3;77;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;TX;Texas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;NMBR;RACE;API;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;74.7;74.7;;;65.6;82;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.2;83.2;;;71;90.9;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;93.3;93.3;;;88.4;96.3;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40;40;;;31.9;48.7;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;60;60;;;50.7;68.7;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.3;85.3;;;78.7;90.1;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.2;48.2;;;39.1;57.4;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2014;2014;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45;45;*;50 States + DC: US Median;40.4;47.1;Gender;Female;;;;;;;59;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2014;2014;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;;Number;53;53;;;;;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;NMBR;GENDER;GENM;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.1;12.1;;;10.6;13.8;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;24.8;24.8;;;20.3;29.9;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;NY;New York;NVSS;Asthma;Asthma mortality rate;;;Number;65;65;;;;;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;NMBR;RACE;HIS;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.5;11.5;;;10;13.2;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;80;80;;;66.4;89;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;51.2;51.2;;;46.9;55.6;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;23.9;23.9;;;17.8;31.3;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;NY;New York;NVSS;Asthma;Asthma mortality rate;;;Number;124;124;;;;;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;NMBR;GENDER;GENM;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.7;33.7;;;27.9;40.1;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;50.9;50.9;;;43.6;58.1;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;;Number;111;111;;;;;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2014;2014;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;39;39;;;;;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;NMBR;GENDER;GENM;;;;
2014;2014;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2014;2014;TX;Texas;NVSS;Asthma;Asthma mortality rate;;;Number;38;38;;;;;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;NMBR;RACE;HIS;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.7;40.7;;;34.3;47.4;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;53.7;53.7;;;45.7;61.6;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.4;90.4;;;84.5;94.2;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.1;86.1;;;78.3;91.4;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2014;2014;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.9;11.9;;;8.9;15.6;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;30.8;30.8;;;19.2;45.5;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.7;37.7;;;30.1;45.9;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45;45;;;36.4;53.9;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;48.5;48.5;;;36.9;60.3;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.9;41.9;;;34.5;49.6;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2014;2014;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.5;9.5;;;7.7;11.6;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;;Number;91;91;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;NMBR;RACE;WHT;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.7;11.7;;;10.3;13.2;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2014;2014;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;73;73;;;60.8;82.5;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2014;2014;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.4;37.4;;;32.7;42.2;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83;83;;;76.4;88;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.6;62.6;;;50.1;73.6;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.2;5.2;;;4.1;6.5;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70;70;;;63.6;75.8;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;NY;New York;NVSS;Asthma;Asthma mortality rate;;;Number;302;302;;;;;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.3;46.3;;;40.9;51.8;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;NMBR;GENDER;GENM;;;;
2014;2014;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.9;33.9;;;27.5;41;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;17.6;17.6;;;13.3;22.8;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.9;42.9;;;33.5;52.7;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;;Number;31;31;;;;;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;NMBR;GENDER;GENM;;;;
2014;2014;FL;Florida;NVSS;Asthma;Asthma mortality rate;;;Number;114;114;;;;;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;NMBR;GENDER;GENF;;;;
2014;2014;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2014;2014;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;;Number;89;89;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;NMBR;RACE;WHT;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;15.4;15.4;;;11;21;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;16.9;16.9;;;9.8;27.6;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2014;2014;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.0;12;;;9.6;14.3;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;80.3;80.3;;;70.4;87.4;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.2;32.2;;;21;45.9;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;NMBR;RACE;HIS;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2014;2014;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.7;14.7;;;11.9;17.9;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40;40;;;30.3;50.5;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.5;38.5;;;27.6;50.7;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2014;2014;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;18.8;18.8;;;14.3;24.3;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;61.5;61.5;;;43.2;77.1;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.6;45.6;;;39.8;51.5;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.4;48.4;;;42;54.8;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;29.7;29.7;;;18.5;44;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;48.7;48.7;;;35.7;61.9;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2014;2014;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2014;2014;MT;Montana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;NMBR;RACE;AIAN;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.1;37.1;;;30.3;44.5;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.1;69.1;;;59;77.6;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.8;39.8;;;35.7;44.1;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;56.1;56.1;;;44.3;67.2;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2014;2014;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;CRDRATE;RACE;API;;;;
2014;2014;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.8;11.8;;;8.9;15.2;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.8;66.8;;;58.5;74.3;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40;40;;;33.9;46.4;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.6;42.6;;;37.8;47.5;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84;84;;;73.5;90.8;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.5;49.5;;;33.3;65.8;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;74.2;74.2;;;66.4;80.7;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.2;38.2;;;29.4;47.9;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.1;39.1;;;32.4;46.3;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.6;36.6;;;30.2;43.6;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;;Number;21;21;;;;;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;NMBR;GENDER;GENF;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.3;68.3;;;59.2;76.2;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.9;43.9;;;38.5;49.5;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;NMBR;RACE;AIAN;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.2;42.2;;;35.5;49.3;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;64.9;64.9;;;55.9;72.9;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.7;86.7;;;76.8;92.8;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.9;33.9;;;19.1;52.7;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2014;2014;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.7;37.7;;;27.2;49.4;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;81.2;81.2;;;70.3;88.8;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.6;37.6;;;30.4;45.4;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.8;40.8;;;29.7;53.1;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33;33;;;21.1;47.6;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;73.8;73.8;;;49.1;89.1;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;61.6;61.6;;;52.8;69.8;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.7;37.7;;;30.1;46;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.4;31.4;;;22.5;41.9;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2014;2014;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46;46;;;32.1;60.6;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.7;44.7;;;38.6;50.9;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.0;13;;;11;14.9;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.5;46.5;;;39.4;53.7;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.8;88.8;;;83.7;92.4;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.6;48.6;;;41.3;55.9;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.3;39.3;;;33;46;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;73.6;73.6;;;66.8;79.5;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2014;2014;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;78.9;78.9;;;64.7;88.4;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.5;44.5;;;36;53.3;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.5;44.5;;;37.8;51.4;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.9;84.9;;;78.9;89.4;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;NMBR;RACE;API;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.1;45.1;;;37.8;52.7;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.5;46.5;;;37;56.4;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2014;2014;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;CRDRATE;RACE;API;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.7;83.7;;;75;89.7;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.4;88.4;;;76.5;94.7;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;57.6;57.6;;;50.2;64.8;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2014;2014;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;WA;Washington;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;NMBR;RACE;HIS;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.3;37.3;;;24.9;51.5;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.6;40.6;;;30.8;51.2;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2014;2014;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;CA;California;NVSS;Asthma;Asthma mortality rate;;;Number;204;204;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;NMBR;RACE;WHT;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.2;43.2;;;36.8;49.8;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;79.1;79.1;;;66.2;88;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;17.4;17.4;;;11.3;25.9;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;81.9;81.9;;;74.4;87.6;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82;82;;;68.3;90.6;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.2;65.2;;;48.6;78.8;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;95.9;95.9;;;90.6;98.3;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.2;13.2;;;10.6;16.1;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2014;2014;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.5;64.5;;;58.2;70.4;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.9;38.9;;;35;43;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;37;37;;;28.2;46.8;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.5;82.5;;;74.4;88.5;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;24.1;24.1;;;14.4;37.4;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2014;2014;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2014;2014;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.1;38.1;;;32.6;43.9;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.9;86.9;;;80.7;91.3;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.9;69.9;;;63.4;75.7;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.5;6.5;;;5.6;7.6;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;8.6;8.6;;;6.2;11.8;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62;62;;;53.8;69.6;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.5;70.5;;;59.1;79.8;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2014;2014;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;;Number;33;33;;;;;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;NMBR;GENDER;GENM;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;79.4;79.4;;;62.5;89.9;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.3;67.3;*;50 States + DC: US Median;63.4;70.6;Gender;Female;;;;;;;59;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.1;45.1;;;35.3;55.3;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.3;10.3;;;8;13;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2014;2014;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.9;7.9;;;5.3;11.2;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2014;2014;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;NMBR;RACE;WHT;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.4;36.4;;;30.1;43.3;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;TX;Texas;NVSS;Asthma;Asthma mortality rate;;;Number;59;59;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;NMBR;RACE;BLK;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.8;87.8;;;82.8;91.5;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.9;62.9;;;54.2;70.7;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;29.9;29.9;;;22.9;37.8;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83;83;;;74.7;89;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.4;40.4;;;33.3;47.9;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.8;36.8;;;28.3;46.1;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;;Number;40;40;;;;;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;NMBR;GENDER;GENF;;;;
2014;2014;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.6;86.6;;;76.7;92.7;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;FL;Florida;NVSS;Asthma;Asthma mortality rate;;;Number;27;27;;;;;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;NMBR;RACE;HIS;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.9;38.9;;;32.4;45.8;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.6;62.6;;;44.3;77.9;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.7;33.7;;;26.8;41.3;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;51;51;;;45.9;56;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.3;40.3;;;31.3;50.2;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;NMBR;RACE;AIAN;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;74.7;74.7;;;66;81.8;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.3;72.3;;;61.8;80.9;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.1;82.1;;;71.8;89.2;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.3;10.3;;;7.3;14.2;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;NMBR;RACE;API;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;NMBR;RACE;API;;;;
2014;2014;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.1;33.1;;;27.5;39.3;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;51.2;51.2;;;46;56.4;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.4;69.4;;;61.7;76.1;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;NMBR;RACE;API;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2014;2014;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;CRDRATE;RACE;API;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.4;32.4;;;20;47.7;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2014;2014;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;NMBR;RACE;HIS;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.7;37.7;;;30.8;45.1;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.4;39.4;;;35;43.9;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.5;66.5;;;45.9;82.3;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.2;39.2;;;32;46.8;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;51.1;51.1;;;45.4;56.8;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2014;2014;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2014;2014;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.6;9.6;;;8.7;10.6;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33;33;;;27.4;39.2;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.9;88.9;;;80.3;94.1;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.7;37.7;;;32;43.8;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.4;87.4;;;83.7;90.3;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;76.7;76.7;;;64.7;85.6;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.9;41.9;;;33.4;50.9;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.8;86.8;;;73.7;94;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;61.8;61.8;;;53;69.9;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.5;66.5;;;59.5;72.8;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;50.4;50.4;;;46;54.9;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2014;2014;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.8;71.8;;;59.7;81.3;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.1;46.1;;;38.7;53.7;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2014;2014;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.5;11.5;;;8.1;16;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.3;48.3;;;42.6;53.9;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.9;87.9;;;82.6;91.8;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;NMBR;GENDER;GENF;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.7;88.7;;;82.3;93;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.1;38.1;;;30.6;46.3;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2014;2014;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.7;38.7;;;32.8;44.9;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.8;37.8;;;32.1;43.8;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.1;46.1;;;41.1;51.2;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;80.3;80.3;;;70.9;87.2;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;30.4;30.4;;;17.1;48.1;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.2;13.2;;;10.8;15.9;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.6;36.6;;;29.4;44.4;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.6;83.6;*;50 States + DC: US Median;83;85.2;Overall;Overall;;;;;;;59;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;76.7;76.7;;;57.9;88.8;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.8;45.8;;;39.2;52.5;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;39;39;;;30.9;47.7;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.4;36.4;;;25.3;49.1;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2014;2014;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;NMBR;RACE;AIAN;;;;
2014;2014;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;;Number;79;79;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;NMBR;RACE;BLK;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2014;2014;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;NMBR;RACE;WHT;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.7;70.7;;;52.6;83.9;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;61.5;61.5;;;52;70.2;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.8;72.8;;;52.6;86.6;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.9;11.9;;;8.3;16.7;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.9;62.9;;;54.5;70.6;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;64;64;;;46.6;78.4;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.1;89.1;;;80;94.3;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.1;34.1;;;26.3;42.9;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;CRDRATE;RACE;API;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.4;36.4;;;27.2;46.7;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.3;32.3;;;23;43.2;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2014;2014;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;41.9;41.9;;;33.2;52.2;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;23.6;23.6;;;15.7;34;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.6;40.6;;;20.7;64.1;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.7;65.7;;;56.3;73.9;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.9;34.9;;;23.8;47.9;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.5;32.5;;;20.4;47.5;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.4;42.4;;;30.6;55.1;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;55.4;55.4;;;47.6;63;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2014;2014;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;37;37;;;;;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;NMBR;GENDER;GENM;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.9;6.9;;;5.2;9;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.8;45.8;;;40.1;51.6;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2014;2014;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.8;87.8;;;77.8;93.7;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.9;14.9;;;13.5;16.5;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;UT;Utah;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;NMBR;RACE;HIS;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41;41;;;34;48.5;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;79;79;;;65.3;88.2;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.7;42.7;;;32.4;53.6;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.7;35.7;;;30.1;41.6;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2014;2014;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;72.9;72.9;;;64.3;80.2;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;NMBR;RACE;AIAN;;;;
2014;2014;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;NMBR;RACE;AIAN;;;;
2014;2014;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;NMBR;RACE;API;;;;
2014;2014;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.2;38.2;;;33.2;43.4;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.1;39.1;;;33.1;45.4;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;74.4;74.4;;;66.1;81.2;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;CRDRATE;RACE;API;;;;
2014;2014;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38;38;;;31.3;45.3;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;77.6;77.6;;;62.5;87.9;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.5;83.5;;;75.9;89.1;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.4;10.4;;;8;13.5;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.5;38.5;;;30.6;47;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.5;37.5;;;26.5;49.9;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.6;65.6;;;58.9;71.7;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.4;41.4;;;33.1;50.2;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;30.8;30.8;;;24.5;37.8;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;81.4;81.4;;;73.5;87.4;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.3;36.3;;;29.9;43.4;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.1;11.1;;;9.5;13;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2014;2014;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.4;36.4;;;28;45.7;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;73.1;73.1;;;64.6;80.2;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32;32;;;21;45.6;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2014;2014;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;NMBR;RACE;HIS;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84;84;;;72.6;91.2;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.9;46.9;;;36.5;57.6;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.6;44.6;;;39.2;50.1;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;80.1;80.1;;;69.6;87.6;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.2;86.2;*;50 States + DC: US Median;85.4;87.1;Gender;Female;;;;;;;59;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2014;2014;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.4;8.4;;;5.4;12.5;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2014;2014;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.1;85.1;;;78.1;90.1;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.6;83.6;;;77.3;88.4;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40;40;;;31.2;49.4;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.9;88.9;;;83.9;92.5;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89;89;;;74.6;95.7;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2014;2014;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.0;11;;;7.2;16.1;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.1;86.1;;;81.2;89.9;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.6;71.6;;;60;80.9;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.6;71.6;;;64.2;78;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87;87;;;74.2;94;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;73.2;73.2;;;65.2;80;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;50.4;50.4;;;39.9;60.9;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.4;49.4;;;35.6;63.3;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.7;37.7;;;29.8;46.2;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.5;43.5;;;38.5;48.7;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;28.5;28.5;;;21;38;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.4;38.4;;;33.6;43.4;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.1;37.1;;;30.9;43.7;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.8;42.8;;;25.9;61.6;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2014;2014;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.3;37.3;;;32.2;42.7;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2014;2014;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;NMBR;GENDER;GENF;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.8;40.8;;;34.3;47.6;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2014;2014;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2014;2014;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.5;86.5;;;80.8;90.7;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.6;46.6;;;32.4;61.4;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2014;2014;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.5;9.5;;;6.4;13.5;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2014;2014;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.7;83.7;;;77.2;88.6;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.7;47.7;;;36.5;59.1;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;72.9;72.9;;;59.2;83.2;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.2;35.2;;;29.6;41.2;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.8;32.8;;;26.7;39.6;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.7;68.7;;;46.7;84.7;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.1;84.1;;;77.4;89.1;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86;86;;;80.1;90.3;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;53.3;53.3;;;47.9;58.7;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2014;2014;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.8;49.8;;;38.5;61.1;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2014;2014;UT;Utah;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;NMBR;RACE;API;;;;
2014;2014;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.3;84.3;;;78;89;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;50.4;50.4;;;42.6;58.1;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;54.5;54.5;;;41;67.5;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2014;2014;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;103;103;;;;;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2014;2014;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;59.1;59.1;;;42.6;73.9;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;NMBR;RACE;BLK;;;;
2014;2014;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.5;39.5;;;34.7;44.5;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.2;40.2;;;33.8;46.9;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2014;2014;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.5;71.5;;;61.1;80.1;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;73.6;73.6;;;64.6;81;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.8;66.8;;;55.8;76.2;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.6;84.6;;;77.4;89.8;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;81.6;81.6;;;67.7;90.3;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.3;39.3;;;30.7;48.5;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2014;2014;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;22.2;22.2;;;13.8;34;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2014;2014;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.4;12.4;;;10.1;14.7;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;72.5;72.5;;;56.3;84.3;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;18.3;18.3;;;13.7;23.9;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.3;82.3;;;66.7;91.5;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2014;2014;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.6;41.6;;;27.9;56.8;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;NMBR;RACE;HIS;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;81.4;81.4;;;74.8;86.6;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2014;2014;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;;Number;107;107;;;;;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;NMBR;GENDER;GENF;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;49.3;49.3;;;42.4;56.2;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.9;37.9;;;30.4;46;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;27.5;27.5;;;14.8;45.3;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.2;63.2;;;54.4;71.3;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.5;66.5;;;51.1;79.1;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;NMBR;RACE;BLK;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;NMBR;RACE;API;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.8;33.8;;;25;44;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2014;2014;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.3;47.3;;;31.5;63.6;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2014;2014;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;NMBR;GENDER;GENM;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;73.3;73.3;;;64.9;80.3;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.9;11.9;;;10.8;13.1;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.3;45.3;;;32.7;58.6;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.1;40.1;;;34.4;46.1;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.1;33.1;;;27.6;39.1;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40;40;;;34.8;45.4;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.7;7.7;;;6.9;8.5;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.5;40.5;;;25.4;57.6;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.4;38.4;;;31;46.3;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;57.3;57.3;;;46.3;67.7;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.8;41.8;;;36.1;47.7;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;59.7;59.7;;;50.4;68.4;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.1;37.1;;;30.4;44.4;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.8;49.8;;;43.3;56.2;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.5;10.5;;;6.7;16;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.1;36.1;;;25.6;48.1;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.9;84.9;;;70.9;92.8;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;CRDRATE;RACE;API;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.2;48.2;;;32.6;64.1;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.1;91.1;;;86.4;94.4;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.5;40.5;;;27;55.6;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2014;2014;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;CRDRATE;RACE;API;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.5;45.5;;;37.9;53.4;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.7;47.7;;;40.2;55.2;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2014;2014;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2014;2014;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.7;11.7;;;9.8;13.5;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;CA;California;NVSS;Asthma;Asthma mortality rate;;;Number;407;407;;;;;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;13.6;13.6;;;10.8;16.8;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.6;36.6;;;26.2;48.4;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33;33;;;23.8;43.7;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.9;12.9;;;7.2;22;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.7;66.7;;;49.5;80.3;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2014;2014;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;;Number;70;70;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;NMBR;RACE;WHT;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.6;37.6;;;27.1;49.3;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45;45;;;30.4;60.5;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;73.6;73.6;;;60.4;83.6;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47;47;;;41.7;52.4;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.4;72.4;;;66;78;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.8;34.8;;;27.9;42.4;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.1;87.1;;;80.5;91.7;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.2;14.2;;;11.1;18;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.6;87.6;;;80.6;92.3;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;52.8;52.8;;;42.3;63;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;30.5;30.5;;;22.3;40.1;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2014;2014;WA;Washington;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;NMBR;RACE;BLK;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.4;37.4;;;29;46.7;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2014;2014;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.9;10.9;;;8.4;13.9;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.4;43.4;;;31.5;56.2;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.5;11.5;;;8.9;14.7;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.9;13.9;;;11.3;17;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;80.4;80.4;;;66.4;89.6;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2014;2014;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.1;9.1;;;5.5;14;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;27.3;27.3;;;20.5;35.3;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.3;35.3;;;26.7;44.9;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.5;7.5;;;4.8;11.2;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.6;82.6;;;69.7;90.7;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2014;2014;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;NMBR;RACE;API;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;74;74;;;67;79.8;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;36;36;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;NMBR;RACE;WHT;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.2;38.2;;;25.5;52.7;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2014;2014;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;CRDRATE;RACE;API;;;;
2014;2014;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2014;2014;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;17.4;17.4;;;12;24.3;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2014;2014;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;CRDRATE;RACE;API;;;;
2014;2014;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.5;13.5;;;8.4;20.4;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.0;10;;;7;13.9;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.2;35.2;;;28;43;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.9;9.9;;;9.1;10.8;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;73.2;73.2;;;64.2;80.6;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.3;46.3;;;33.1;60.1;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;NMBR;RACE;AIAN;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;15.3;15.3;;;13.6;17;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;78.4;78.4;;;67.3;86.4;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.2;85.2;;;79.6;89.4;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.9;45.9;;;40.3;51.5;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;50.4;50.4;;;43.6;57.2;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.4;42.4;;;35.9;49.1;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.2;37.2;;;31.7;43;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;5.6;5.6;;;3.7;8.2;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2014;2014;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;;Number;21;21;;;;;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;NMBR;GENDER;GENF;;;;
2014;2014;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.8;7.8;;;5.5;10.7;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.8;10.8;;;7.5;15;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;16.2;16.2;;;12.3;20.9;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.1;86.1;;;74.9;92.7;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.5;70.5;;;53.8;83;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.9;36.9;;;25;50.6;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.5;37.5;;;29.2;46.5;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2014;2014;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;64.2;64.2;;;53;74.1;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67.4;67.4;;;53.8;78.7;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.5;39.5;;;33;46.4;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.6;84.6;;;74.4;91.3;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.4;39.4;;;31.5;47.9;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;NMBR;RACE;AIAN;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84;84;;;78.2;88.5;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;77;77;;;60.6;87.9;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;49.2;49.2;;;42.9;55.6;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.7;83.7;;;73.6;90.4;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2014;2014;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.5;38.5;;;33.4;43.9;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.6;30.6;;;20;43.8;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.6;40.6;;;31.9;50;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;45.7;45.7;;;37.3;54.5;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.8;10.8;;;9.3;12.5;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;76.8;76.8;;;66.7;84.6;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2014;2014;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2014;2014;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.1;38.1;;;31.2;45.5;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2014;2014;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.6;11.6;;;9.2;14.4;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.2;38.2;;;28;49.6;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2014;2014;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;14.6;14.6;;;9.3;22;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;74.2;74.2;;;65;81.7;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.9;85.9;;;77.9;91.4;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.6;39.6;;;28.7;51.7;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2014;2014;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.2;48.2;;;40.9;55.6;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.4;68.4;;;56.9;78.1;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;80.3;80.3;;;68.7;88.4;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.5;34.5;;;23.5;47.4;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.7;48.7;;;39.6;57.9;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.7;87.7;;;84;90.6;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.3;45.3;;;38.7;52.1;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.9;41.9;;;34.3;49.9;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2014;2014;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.4;42.4;;;35.6;49.5;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.6;87.6;;;77.4;93.6;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.2;9.2;;;7.6;10.8;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.6;45.6;;;30.7;61.3;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.1;43.1;;;35.6;50.9;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2014;2014;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;23.3;23.3;;;18.3;29.1;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.6;38.6;;;34.2;43.1;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;;Number;62;62;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;NMBR;RACE;WHT;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.1;36.1;;;24.9;49.1;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.9;38.9;;;31.9;46.4;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2014;2014;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67;67;;;57.9;75;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.4;38.4;;;30.3;47.2;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.9;40.9;;;36.7;45.3;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2014;2014;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;24.3;24.3;;;17.2;33.3;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2014;2014;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.5;38.5;;;31.3;46.3;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;59.8;59.8;;;51.4;67.7;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.5;10.5;;;7.2;15;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2014;2014;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;72.5;72.5;;;62.9;80.3;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;NY;New York;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;NMBR;RACE;API;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.3;62.3;;;56.3;67.9;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.1;28.1;;;19.6;38.6;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.8;35.8;;;26.1;46.9;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;60.7;60.7;;;50.2;70.3;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.4;87.4;;;79.3;92.7;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.6;44.6;;;36.9;52.5;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.2;7.2;;;4.9;10.6;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.7;42.7;;;36.4;49.4;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.3;35.3;;;29.5;41.5;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.1;38.1;;;34.1;42.3;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70;70;;;61.7;77.1;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.4;34.4;;;29;40.2;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;29.4;29.4;;;20.6;40.1;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2014;2014;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.2;12.2;;;9.4;15.7;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.3;46.3;;;39.3;53.5;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.7;35.7;;;28;44.3;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.0;8;;;6.3;9.9;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;NMBR;RACE;WHT;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.1;83.1;;;76;88.4;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;51.1;51.1;;;40.7;61.4;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.3;44.3;;;39.7;49;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;80.3;80.3;;;70.5;87.4;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.4;35.4;;;28.3;43.3;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;;Number;62;62;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;NMBR;RACE;WHT;;;;
2014;2014;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2014;2014;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.8;12.8;;;10.2;15.8;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.4;11.4;;;8;15.6;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2014;2014;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.3;9.3;;;7.6;11;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.3;37.3;;;30.7;44.5;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;60.9;60.9;;;41.7;77.3;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.1;49.1;;;42.8;55.5;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.8;38.8;;;32.7;45.2;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.8;32.8;;;23.4;43.7;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;80.9;80.9;;;73.1;86.8;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.0;13;;;7.9;20.6;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.6;85.6;;;73.9;92.6;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.9;82.9;;;75.2;88.6;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.4;84.4;;;77.3;89.6;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.2;45.2;;;39.6;51;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2014;2014;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.6;30.6;;;24.5;37.4;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2014;2014;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.7;9.7;;;7.6;12.3;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.4;48.4;;;34.6;62.4;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87;87;;;76.4;93.3;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;NMBR;RACE;API;;;;
2014;2014;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;NMBR;RACE;HIS;;;;
2014;2014;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;CRDRATE;RACE;API;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.7;38.7;;;32.9;44.7;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.6;9.6;;;8.7;10.5;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.5;35.5;;;24.1;48.9;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;13.7;13.7;;;10.6;17.6;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.8;35.8;;;22.5;51.9;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2014;2014;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;;Number;58;58;;;;;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;NMBR;GENDER;GENF;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2014;2014;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.7;39.7;;;31.9;48.1;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.5;12.5;;;9.7;15.8;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.8;43.8;*;50 States + DC: US Median;40;46.3;Gender;Female;;;;;;;59;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;33.1;33.1;;;26.9;40.3;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.3;36.3;;;20.8;55.3;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2014;2014;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.7;34.7;;;27.9;42.3;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2014;2014;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;22.5;22.5;;;17.2;28.9;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.2;47.2;;;31.7;63.3;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.8;62.8;;;56.3;68.9;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50.7;50.7;;;45.1;56.2;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;64.6;64.6;;;58.2;70.4;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;;Number;36;36;;;;;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;NMBR;GENDER;GENF;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.5;38.5;;;32.4;45;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.8;84.8;;;77.1;90.2;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2014;2014;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;NMBR;RACE;BLK;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.3;33.3;;;26.7;40.7;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;NMBR;RACE;HIS;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2014;2014;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;NMBR;RACE;AIAN;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;73.4;73.4;;;58.1;84.6;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67.4;67.4;;;57.8;75.8;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.3;69.3;;;47.4;85;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.1;33.1;;;25.1;42.3;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2014;2014;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.8;7.8;;;5.6;10.6;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.2;30.2;;;22.8;38.9;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.5;69.5;;;54.2;81.4;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.8;87.8;;;76.4;94.2;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2014;2014;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.3;9.3;;;6.1;13.5;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36;36;;;27.2;45.9;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;23;23;;;16.8;30.7;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;TX;Texas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;NMBR;RACE;AIAN;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.9;48.9;;;38.2;59.7;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.3;89.3;;;84.6;92.7;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;;Number;42;42;;;;;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;NMBR;GENDER;GENM;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.6;65.6;;;57;73.2;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2014;2014;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35;35;;;26.8;44.2;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.8;37.8;;;28.9;47.7;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2014;2014;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;NMBR;RACE;HIS;;;;
2014;2014;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;;Number;32;32;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;NMBR;RACE;WHT;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;91.5;91.5;;;86.8;94.6;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.4;63.4;;;47.9;76.6;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.4;33.4;;;26.8;40.7;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;76.2;76.2;;;64.1;85.1;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.6;86.6;;;80;91.2;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;6.5;6.5;;;5.2;8;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;54.7;54.7;;;48.3;60.9;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2014;2014;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;NMBR;RACE;HIS;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38;38;;;30.8;45.7;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2014;2014;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2014;2014;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;15.6;15.6;;;11.7;20.5;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.1;32.1;;;23.2;42.5;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;NMBR;RACE;BLK;;;;
2014;2014;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.9;36.9;**;US estimate/number is based on fewer than 50 states and the District of Columbia;35.8;40.4;Gender;Male;;;;;;;59;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.6;14.6;;;11.7;18;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84;84;;;77.6;88.9;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.6;65.6;**;US estimate/number is based on fewer than 50 states and the District of Columbia;64.2;69.3;Gender;Male;;;;;;;59;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69;69;;;52.7;81.6;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;15.9;15.9;;;12;20.7;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.0;10;;;6.8;14.1;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2014;2014;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;NY;New York;NVSS;Asthma;Asthma mortality rate;;;Number;178;178;;;;;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;NMBR;GENDER;GENF;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36;36;;;28.7;44.1;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2014;2014;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;NMBR;RACE;HIS;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.4;70.4;;;63.3;76.6;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.7;36.7;;;26.9;47.8;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2014;2014;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2014;2014;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.5;9.5;;;7;12.6;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;NMBR;RACE;AIAN;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2014;2014;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;14.7;14.7;;;11.4;18.5;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.8;38.8;;;32.2;45.8;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.9;31.9;;;17.5;51;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2014;2014;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;6.7;6.7;;;5.3;8.3;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.6;39.6;;;30;50.2;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;26.2;26.2;;;17.4;37.3;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.1;70.1;;;63.3;76.1;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.6;34.6;;;23.8;47.3;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;NMBR;RACE;HIS;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;76.5;76.5;;;61.7;86.8;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.8;45.8;;;31.2;61.2;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2014;2014;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;NMBR;RACE;HIS;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2014;2014;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.3;44.3;;;36.1;52.8;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.5;32.5;;;22.7;44.2;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.5;32.5;;;26.7;39;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.3;85.3;;;79.4;89.8;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.2;71.2;;;61.9;79;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2014;2014;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;NMBR;RACE;WHT;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2014;2014;ME;Maine;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;NMBR;GENDER;GENF;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.0;9;;;5.7;14.1;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2014;2014;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;19.0;19;;;12.2;28.3;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;76.4;76.4;;;65.6;84.5;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;76;76;;;66.1;83.7;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.4;36.4;;;27.1;46.9;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;54;54;;;33.9;72.8;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.9;66.9;;;58.4;74.4;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.7;10.7;;;7.2;15.4;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;61.9;61.9;;;54.6;68.8;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.6;46.6;;;33.2;60.6;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.2;39.2;;;34.3;44.2;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.3;41.3;;;35;47.9;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;15.6;15.6;;;11.4;21;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;23.7;23.7;;;13.3;38.5;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;NMBR;RACE;BLK;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82;82;;;67.9;90.8;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2014;2014;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;80.6;80.6;**;US estimate/number is based on fewer than 50 states and the District of Columbia;77.4;81.9;Gender;Male;;;;;;;59;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;56.7;56.7;;;38.1;73.6;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.6;65.6;;;57.7;72.8;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;51.6;51.6;;;44.4;58.8;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.9;38.9;;;32.5;45.7;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;CRDRATE;RACE;API;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.6;88.6;;;82.4;92.8;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;79.8;79.8;;;70.6;86.6;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50.9;50.9;;;46.8;55;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2014;2014;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.5;38.5;;;31.8;45.7;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.6;35.6;;;28.7;43.2;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;60.4;60.4;;;51.5;68.7;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.4;44.4;;;34.5;54.7;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2014;2014;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;;Number;38;38;;;;;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;NMBR;GENDER;GENF;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.3;69.3;;;58.1;78.6;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.6;42.6;;;33.7;52;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.8;86.8;;;78.8;92;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.3;10.3;;;7.8;13.2;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;CRDRATE;RACE;API;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.1;45.1;;;37.1;53.3;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;16.0;16;;;12.6;20.1;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.5;72.5;;;61;81.6;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.1;13.1;;;10.2;16.7;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2014;2014;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;NMBR;RACE;HIS;;;;
2014;2014;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;;Number;53;53;;;;;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;NMBR;GENDER;GENF;;;;
2014;2014;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.4;9.4;;;6.6;13;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;16.6;16.6;;;14.1;19.5;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.5;44.5;;;35.7;53.6;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67;67;;;56.8;75.8;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.5;83.5;;;77.6;88.1;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.6;40.6;;;35;46.3;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.2;41.2;;;35;47.6;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;14.6;14.6;;;10.8;19.3;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.5;43.5;;;38.8;48.3;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.4;86.4;;;77.2;92.2;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.6;49.6;;;44.3;55;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.7;36.7;;;28.1;46.2;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.1;44.1;;;38.1;50.3;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.6;70.6;;;57.7;80.8;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.8;85.8;;;79.8;90.3;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.6;37.6;;;25.2;52;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.8;46.8;;;29.2;65.3;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2014;2014;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.8;39.8;;;31;49.4;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;NY;New York;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;NMBR;RACE;AIAN;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2014;2014;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.6;42.6;;;36.4;49.1;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.5;38.5;;;31.7;45.8;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.6;38.6;;;33;44.5;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.8;35.8;;;28.9;43.4;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;NMBR;RACE;AIAN;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2014;2014;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.7;84.7;*;50 States + DC: US Median;83.5;86.4;Overall;Overall;;;;;;;59;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.1;45.1;;;38.8;51.5;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;CRDRATE;RACE;API;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.5;35.5;;;23.6;49.4;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.6;9.6;;;8.2;11;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.6;41.6;;;34.4;49.2;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;16.3;16.3;;;8.8;28.2;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;61.6;61.6;;;46.6;74.7;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.9;32.9;;;23.8;43.5;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.9;43.9;;;35.5;52.6;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;74.6;74.6;;;66.5;81.3;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2014;2014;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;NMBR;RACE;HIS;;;;
2014;2014;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;NMBR;GENDER;GENM;;;;
2014;2014;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.1;10.1;;;7.6;13.1;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.9;82.9;;;70.4;90.8;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;;Number;23;23;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;NMBR;RACE;BLK;;;;
2014;2014;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.3;84.3;;;74.4;90.8;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.5;32.5;;;26.5;39.1;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.7;8.7;;;6.5;11.3;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;;Number;22;22;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;NMBR;RACE;BLK;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.6;83.6;;;78.2;87.8;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.5;63.5;;;53.1;72.8;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2014;2014;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.3;11.3;;;8.9;14.1;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;52.1;52.1;;;36.4;67.3;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2014;2014;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;21.8;21.8;;;16.4;28.5;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41;41;;;34.3;48.1;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;15.3;15.3;;;12;19.2;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;74.7;74.7;;;64.5;82.8;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2014;2014;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;NMBR;GENDER;GENM;;;;
2014;2014;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;NMBR;RACE;AIAN;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2014;2014;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;NMBR;GENDER;GENM;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.1;39.1;;;34.8;43.6;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.8;38.8;;;32.4;45.5;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.7;46.7;;;38.9;54.7;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.9;86.9;;;76.2;93.2;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;NMBR;RACE;BLK;;;;
2014;2014;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2014;2014;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40;40;;;35.1;45.1;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;NMBR;RACE;API;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2014;2014;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;;Number;33;33;;;;;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2014;2014;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;CRDRATE;RACE;API;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2014;2014;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.4;12.4;;;10;14.8;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.3;85.3;;;76.4;91.2;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.1;43.1;;;29.7;57.6;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.5;71.5;;;64;77.9;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.3;83.3;;;75.9;88.8;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;ME;Maine;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;NMBR;GENDER;GENM;;;;
2014;2014;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;CRDRATE;RACE;API;;;;
2014;2014;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;NMBR;RACE;BLK;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.3;45.3;;;40;50.8;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2014;2014;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;NMBR;RACE;AIAN;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.6;34.6;;;31.1;38.3;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;NMBR;RACE;BLK;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;7.5;7.5;;;4.8;11.7;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2014;2014;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;80.7;80.7;;;70;88.2;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.1;11.1;;;7.7;15.6;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.907192, -77.036871);;11;AST;AST4_1;NMBR;RACE;API;;;;
2014;2014;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;61.3;61.3;;;54.3;68;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2014;2014;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47;47;;;31.4;63.2;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;;Number;36;36;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;NMBR;RACE;BLK;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;64.5;64.5;;;58.6;70;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;80.4;80.4;;;71.2;87.2;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.3;6.3;;;3.8;10.3;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.2;13.2;;;11.8;14.6;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.4;82.4;;;74.2;88.5;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.8;86.8;;;80.3;91.4;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.4;40.4;;;35.9;45.1;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48;48;;;41.8;54.2;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.4;41.4;;;30.5;53.1;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2014;2014;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;CRDRATE;RACE;API;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.6;42.6;;;30.4;55.9;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;26.1;26.1;;;18.2;36.3;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;77.9;77.9;;;67.4;85.7;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.9;46.9;;;29.7;64.8;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.4;45.4;;;40;50.9;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;61.3;61.3;;;54.3;67.9;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.1;9.1;;;7.5;10.7;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.9;38.9;;;27.9;51;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.7;44.7;;;37.2;52.4;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;72.5;72.5;;;55.9;84.6;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2014;2014;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.3;41.3;;;36.1;46.8;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.3;38.3;;;32.6;44.3;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2014;2014;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.4;39.4;;;30.2;49.4;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.7;67.7;;;53.2;79.4;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2014;2014;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86;86;;;79.2;90.8;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2014;2014;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.5;67.5;;;58.2;75.5;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;61.5;61.5;;;48.6;73;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.9;46.9;;;40.7;53.2;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2014;2014;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;NMBR;RACE;HIS;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.3;46.3;;;40.3;52.4;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;75.9;75.9;;;65.9;83.6;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.1;88.1;;;82.4;92.2;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.3;63.3;;;54;71.7;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.4;85.4;;;76.5;91.3;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2014;2014;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2014;2014;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.9;40.9;;;34.8;47.2;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.4;37.4;;;29.3;46.3;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.7;43.7;;;36.4;51.2;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.6;87.6;;;82;91.6;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;51.9;51.9;;;46.1;57.6;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;NMBR;RACE;API;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;NMBR;RACE;API;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.3;64.3;;;53.5;73.7;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.8;46.8;;;40.9;52.7;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86;86;;;79.4;90.7;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2011;2011;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2014;2014;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.9;11.9;;;8.5;16.2;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2014;2014;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.2;13.2;;;11.4;15;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2014;2014;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2014;2014;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;NMBR;RACE;API;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2014;2014;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;79.3;79.3;;;69.4;86.6;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2014;2014;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;;Number;24;24;;;;;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;75.8;75.8;;;64.9;84.1;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2014;2014;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.2;10.2;;;7.1;14.1;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;64.8;64.8;;;53.3;74.8;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;73.7;73.7;;;65.6;80.4;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2014;2014;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84;84;;;76.8;89.2;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;NMBR;RACE;API;;;;
2014;2014;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2014;2014;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.0;10;;;6.7;14.4;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2014;2014;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;;Number;32;32;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;NMBR;RACE;BLK;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69;69;;;53.3;81.3;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.6;11.6;;;10.2;13.2;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.9;37.9;;;30;46.5;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.6;89.6;;;82.9;93.8;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2014;2014;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;NMBR;GENDER;GENM;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.6;38.6;;;33;44.6;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;64;64;;;52.9;73.7;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.1;38.1;;;30.3;46.5;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2014;2014;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2014;2014;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.4;89.4;;;83;93.6;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;31.9;31.9;;;22.4;44.2;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;27;27;;;15.9;41.8;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.6;35.6;;;29.1;42.8;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.4;43.4;;;37.7;49.3;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;NMBR;RACE;API;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.7;62.7;;;54.9;70;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;CRDRATE;RACE;API;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;14.3;14.3;;;12.7;15.9;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;59.1;59.1;;;46.9;70.2;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;45;45;;;29.3;61.7;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2014;2014;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.5;11.5;;;7.2;17.3;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2014;2014;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.4;38.4;;;29.1;48.5;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2014;2014;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;NMBR;RACE;HIS;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.2;84.2;;;76.2;89.8;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.1;87.1;;;78.9;92.4;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;28.2;28.2;;;19.4;39.1;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40;40;;;35.6;44.7;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.5;84.5;;;75.3;90.7;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.9;67.9;;;59.3;75.4;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.2;86.2;;;79.2;91.1;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;27.7;27.7;;;21.4;35.1;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.7;37.7;;;30.7;45.2;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90;90;;;84;93.9;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.2;35.2;;;26.5;45;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.7;41.7;;;27.9;57;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.8;43.8;;;36.7;51.2;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;27.6;27.6;;;19;38.3;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.1;43.1;;;36.2;50.2;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2011;2011;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.1;67.1;;;55.4;77;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2014;2014;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.9;7.9;;;6.8;8.9;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.4;68.4;;;56;78.6;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;UT;Utah;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;NMBR;GENDER;GENM;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.8;40.8;;;33.6;48.4;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.1;71.1;;;64;77.3;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2014;2014;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;94.4;94.4;;;87.2;97.7;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.6;31.6;;;23.1;41.7;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.0;9;;;7.8;10.4;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2014;2014;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;NMBR;RACE;BLK;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;52.5;52.5;;;43.8;61;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.5;32.5;;;24.7;41.5;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.4;88.4;;;82.7;92.4;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;75.8;75.8;;;60.6;86.4;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.8;89.8;;;82.2;94.4;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;30.3;30.3;;;20.8;41.8;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.5;83.5;;;72.9;90.5;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.4;40.4;;;36.4;44.6;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.3;34.3;;;27.6;41.7;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.9;9.9;;;8.3;11.6;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;NMBR;RACE;BLK;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;25.7;25.7;;;15.9;38.8;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.5;87.5;;;77.2;93.5;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2014;2014;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;51;51;;;43.8;58.3;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.2;65.2;;;48.8;78.7;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.1;38.1;;;30.2;46.7;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.9;35.9;;;28.9;43.6;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;50.5;50.5;;;45.1;55.8;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.5;42.5;;;33;52.7;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;75.5;75.5;;;59.9;86.4;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;60.9;60.9;;;52;69.1;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2014;2014;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36;36;;;26.2;47.2;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.8;38.8;;;30.2;48.2;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;WA;Washington;NVSS;Asthma;Asthma mortality rate;;;Number;57;57;;;;;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;NMBR;GENDER;GENF;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;28.6;28.6;;;20.3;38.5;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2014;2014;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.1;34.1;;;22.5;48;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;30.9;30.9;;;21.6;42;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2011;2011;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;22.4;22.4;;;17.4;28.3;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.6;44.6;;;29;61.2;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.1;36.1;**;US estimate/number is based on fewer than 50 states and the District of Columbia;35.1;39.3;Gender;Male;;;;;;;59;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;52.8;52.8;;;45.5;60;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.9;34.9;;;28.6;41.8;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.3;32.3;;;26.7;38.4;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.6;48.6;;;39.6;57.6;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.1;83.1;;;75.6;88.6;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.8;43.8;;;29.9;58.7;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.2;62.2;;;54;69.7;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.1;47.1;;;42.2;52.1;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2014;2014;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;NMBR;RACE;API;;;;
2014;2014;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.2;11.2;;;9.2;13.3;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2014;2014;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;NMBR;RACE;HIS;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.6;84.6;;;75.2;90.8;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;49.4;49.4;;;36.5;62.5;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31;31;;;25;37.9;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.8;48.8;;;41;56.6;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.6;40.6;;;31.5;50.4;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;58.1;58.1;;;46.7;68.8;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.8;84.8;;;79.1;89.2;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.3;10.3;;;7.1;14.3;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.3;89.3;;;84.5;92.7;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2014;2014;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.2;36.2;;;30;42.8;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;;Number;54;54;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;NMBR;RACE;WHT;;;;
2014;2014;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.9;43.9;;;37.3;50.8;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.9;31.9;;;21.4;44.6;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2014;2014;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.5;47.5;;;40;55.2;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.1;84.1;;;74.3;90.7;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2014;2014;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.7;7.7;;;5.5;10.4;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.4;40.4;;;27.9;54.2;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.2;38.2;;;28.1;49.3;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.5;41.5;;;36.7;46.5;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.1;46.1;;;30.8;62.2;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2014;2014;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;NMBR;RACE;BLK;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.6;69.6;;;63.2;75.4;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.9;86.9;;;74.6;93.7;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47;47;;;40.5;53.7;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2014;2014;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;18.6;18.6;;;13.8;24.6;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84;84;;;75.8;89.9;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.7;42.7;;;33.5;52.4;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;74;74;;;;;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2014;2014;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;NMBR;RACE;API;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.6;41.6;;;35.9;47.5;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.4;38.4;;;31.4;45.9;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.4;82.4;;;74.6;88.2;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.8;87.8;;;74.2;94.7;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.5;70.5;;;62.4;77.5;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;;Number;43;43;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;NMBR;RACE;WHT;;;;
2014;2014;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2014;2014;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.1;35.1;;;27.7;43.3;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.9;35.9;;;28.1;44.6;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;72.1;72.1;;;63.8;79.1;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2014;2014;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;19.9;19.9;;;14.6;26.5;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2014;2014;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.4;43.4;;;32.1;55.4;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;NMBR;RACE;API;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36;36;;;31.4;40.9;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.3;43.3;;;28.3;59.6;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;53.3;53.3;;;46.7;59.8;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.1;44.1;;;32.7;56.1;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2014;2014;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.8;8.8;;;7.7;10;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;59.9;59.9;;;49.7;69.3;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.4;40.4;;;29;52.9;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2014;2014;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2014;2014;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;52.7;52.7;;;48;57.4;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.6;36.6;;;29.8;44;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.9;7.9;;;4.4;14;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.8;46.8;;;30.3;64;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.4;37.4;;;32.1;43;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;61.2;61.2;;;47.4;73.4;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2014;2014;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.3;40.3;;;34.5;46.3;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;NMBR;RACE;API;;;;
2014;2014;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.3;10.3;;;6.5;15.4;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;79;79;;;69.6;86;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.4;63.4;;;53.4;72.4;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.7;36.7;;;27.9;46.5;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2014;2014;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.4;37.4;;;27.9;48;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2014;2014;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2014;2014;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;NMBR;GENDER;GENM;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.3;64.3;;;50.7;76;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2014;2014;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.9;35.9;;;22.5;52;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;FL;Florida;NVSS;Asthma;Asthma mortality rate;;;Number;56;56;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;NMBR;RACE;BLK;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.7;35.7;;;30.4;41.3;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.8;31.8;;;24.3;40.3;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29.9;29.9;;;19.6;42.7;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2014;2014;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.8;42.8;;;37.2;48.6;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;81.8;81.8;;;72.8;88.4;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2014;2014;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;NMBR;RACE;API;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.1;37.1;;;27.7;47.5;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;UT;Utah;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;NMBR;RACE;AIAN;;;;
2014;2014;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.2;64.2;;;46.8;78.5;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2014;2014;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;CRDRATE;RACE;API;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2014;2014;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.9;46.9;;;31.6;62.8;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2014;2014;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;8.2;8.2;;;6.1;11;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2014;2014;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2014;2014;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2014;2014;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2011;2011;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;6.1;6.1;;;4.1;8.7;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.7;10.7;;;8.6;12.7;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2014;2014;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;39.2;39.2;;;31.1;47.9;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2014;2014;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43;43;;;34;52.4;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2014;2014;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;NMBR;RACE;WHT;;;;
2014;2014;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;;Number;24;24;;;;;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;NMBR;GENDER;GENM;;;;
2011;2011;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.4;12.4;;;8.7;17.2;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2014;2014;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.7;87.7;;;82.1;91.7;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2014;2014;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;17.7;17.7;;;13.7;22.6;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2014;2014;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;;Number;29;29;;;;;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;NMBR;GENDER;GENM;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.1;87.1;;;83.2;90.2;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2014;2014;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2014;2014;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.4;85.4;;;78.8;90.1;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.6;40.6;*;50 States + DC: US Median;39.5;44.5;Overall;Overall;;;;;;;59;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;NMBR;GENDER;GENM;;;;
2014;2014;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2014;2014;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2014;2014;CA;California;NVSS;Asthma;Asthma mortality rate;;;Number;59;59;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;NMBR;RACE;API;;;;
2014;2014;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;CRDRATE;RACE;API;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.7;89.7;;;83;93.9;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2014;2014;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2014;2014;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;64.2;64.2;;;51.5;75.2;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2014;2014;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;81.3;81.3;;;71.4;88.3;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2014;2014;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33;33;;;25.5;41.4;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;78.3;78.3;;;61.8;88.9;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2014;2014;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.8;46.8;;;33.6;60.5;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;80.3;80.3;;;69.6;87.8;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2014;2014;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;CRDRATE;RACE;API;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2014;2014;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2014;2014;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2014;2014;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.9;9.9;;;6.8;13.9;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2014;2014;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2014;2014;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.8;36.8;;;30.4;43.8;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2014;2014;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2014;2014;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2014;2014;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.8;39.8;;;27.5;53.5;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2014;2014;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.8;35.8;;;29.9;42.1;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2014;2014;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;NMBR;RACE;HIS;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35;35;;;19.9;53.7;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2014;2014;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.1;71.1;;;64.3;77.2;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2014;2014;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90;90;;;82.7;94.4;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;57.4;57.4;;;47.2;67.1;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2014;2014;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.6;31.6;;;22.4;42.6;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2014;2014;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;16.3;16.3;;;10;25.2;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;NMBR;RACE;AIAN;;;;
2014;2014;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2014;2014;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71;71;;;65.1;76.2;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2014;2014;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;;Number;167;167;;;;;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;61;61;;;46.6;73.7;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.8;42.8;;;29.5;57.1;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;NMBR;RACE;AIAN;;;;
2014;2014;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2014;2014;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2014;2014;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2014;2014;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2014;2014;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;ME;Maine;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.8;40.8;;;35.2;46.6;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.9;36.9;;;31.6;42.6;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.5;12.5;;;7.9;18.7;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2013;2013;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;NMBR;RACE;API;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;30.1;30.1;;;18.9;44.3;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;CRDRATE;RACE;API;;;;
2013;2013;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;NMBR;RACE;AIAN;;;;
2013;2013;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.9;10.9;;;8.9;13;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2013;2013;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;NMBR;RACE;AIAN;;;;
2013;2013;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;42;42;;;;;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;NMBR;GENDER;GENM;;;;
2013;2013;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;6.07;6.07;;;5.54;6.59;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2013;2013;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;4486;4,486;;;;;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;NMBR;GENDER;GENM;;;;
2013;2013;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.4;11.4;;;8.1;15.7;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2013;2013;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;7.46;7.46;;;5.15;9.77;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.2;11.2;;;6.7;17.5;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;WA;Washington;NVSS;Asthma;Asthma mortality rate;;;Number;47;47;;;;;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;NMBR;GENDER;GENF;;;;
2013;2013;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;221;221;;;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;NMBR;RACE;HIS;;;;
2013;2013;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;6.3;6.3;;;4.5;8.6;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;AK;Alaska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;385;385;;;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;NMBR;RACE;HIS;;;;
2013;2013;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;26;26;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;NMBR;RACE;BLK;;;;
2013;2013;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;CRDRATE;RACE;API;;;;
2013;2013;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;130;130;;;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;NMBR;RACE;HIS;;;;
2013;2013;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2013;2013;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2013;2013;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2013;2013;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;8.78;8.78;;;8.4;9.16;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2013;2013;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;NMBR;RACE;WHT;;;;
2013;2013;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;4.89;4.89;;;4.7;5.09;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2013;2013;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;12.06;12.06;;;11.85;12.27;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;7.31;7.31;;;6.8;7.81;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2013;2013;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;17.3;17.3;;;11.7;24.7;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2013;2013;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;CRDRATE;RACE;API;;;;
2013;2013;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;NMBR;RACE;HIS;;;;
2013;2013;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;2649;2,649;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;NMBR;RACE;BLK;;;;
2013;2013;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;NMBR;RACE;BLK;;;;
2013;2013;CA;California;NVSS;Asthma;Asthma mortality rate;;;Number;222;222;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;NMBR;RACE;WHT;;;;
2013;2013;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;3.37;3.37;;;2.88;3.86;Race/Ethnicity;Asian or Pacific Islander;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2013;2013;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2013;2013;MO;Missouri;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;11.33;11.33;;;11.03;11.63;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;NMBR;RACE;BLK;;;;
2013;2013;MO;Missouri;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2013;2013;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;NMBR;RACE;API;;;;
2013;2013;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;19.82;19.82;;;19.06;20.57;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2013;2013;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;13.90;13.9;;;12.84;14.97;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2013;2013;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;9.01;9.01;;;8.62;9.4;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2013;2013;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;2715;2,715;;;;;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;NMBR;RACE;HIS;;;;
2013;2013;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;NMBR;RACE;API;;;;
2013;2013;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.9;11.9;;;7.7;17.6;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;5.66;5.66;;;5.34;5.98;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;6.3;6.3;;;4.4;8.7;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;40;40;;;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;NMBR;RACE;AIAN;;;;
2013;2013;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;11.15;11.15;;;10.6;11.71;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2013;2013;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.1;10.1;;;8.1;12.1;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;NMBR;RACE;AIAN;;;;
2013;2013;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;;Number;31;31;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;NMBR;RACE;WHT;;;;
2013;2013;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;NMBR;RACE;HIS;;;;
2013;2013;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2013;2013;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;;Number;39;39;;;;;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;NMBR;GENDER;GENM;;;;
2013;2013;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;NMBR;RACE;WHT;;;;
2013;2013;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;103;103;;;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;NMBR;RACE;HIS;;;;
2013;2013;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;4.94;4.94;;;4.27;5.61;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2013;2013;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.7;9.7;;;7.5;12.3;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;3.98;3.98;;;3.46;4.5;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2013;2013;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2013;2013;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2013;2013;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;11.52;11.52;;;10.14;12.91;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;;Number;59;59;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;NMBR;RACE;WHT;;;;
2013;2013;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;12.83;12.83;;;10.45;15.22;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2013;2013;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2013;2013;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;18.8;18.8;;;13.7;25.1;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2013;2013;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.7;9.7;;;7.2;12.7;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;WY;Wyoming;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2013;2013;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;8.55;8.55;;;8.08;9.01;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.7;10.7;;;9.7;11.7;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;209;209;;;;;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;NMBR;GENDER;GENF;;;;
2013;2013;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;CRDRATE;RACE;API;;;;
2013;2013;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.4;13.4;;;8.7;19.8;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;50;50;;;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;NMBR;RACE;AIAN;;;;
2013;2013;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;;Number;67;67;;;;;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;NMBR;GENDER;GENF;;;;
2013;2013;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;WA;Washington;NVSS;Asthma;Asthma mortality rate;;;Number;40;40;;;;;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;NMBR;GENDER;GENM;;;;
2013;2013;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;7.51;7.51;;;7.22;7.81;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;2969;2,969;;;;;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;NMBR;GENDER;GENF;;;;
2013;2013;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.8;10.8;;;7;15.9;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2013;2013;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;9.12;9.12;;;8.93;9.31;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;5.51;5.51;;;5.26;5.75;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;17.1;17.1;;;11.4;24.7;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;MT;Montana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;NMBR;RACE;HIS;;;;
2013;2013;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;6.68;6.68;;;6.17;7.18;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;216;216;;;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;NMBR;RACE;AIAN;;;;
2013;2013;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2013;2013;MT;Montana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;NMBR;GENDER;GENM;;;;
2013;2013;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.3;12.3;;;10.4;14.2;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.0;8;;;5;11.9;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;NMBR;RACE;BLK;;;;
2013;2013;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;NMBR;RACE;API;;;;
2013;2013;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;NMBR;RACE;WHT;;;;
2013;2013;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.8;9.8;;;7.3;13;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;4.77;4.77;;;4.12;5.41;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;37.47;37.47;;;36.37;38.58;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.3;12.3;;;9.4;15.9;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2013;2013;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2013;2013;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;513;513;;;;;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2013;2013;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;NMBR;RACE;HIS;;;;
2013;2013;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;NMBR;GENDER;GENM;;;;
2013;2013;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;NMBR;RACE;API;;;;
2013;2013;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;4.67;4.67;;;4.35;5;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;CRDRATE;RACE;API;;;;
2013;2013;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2013;2013;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2013;2013;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2013;2013;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;;Number;30;30;;;;;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;NMBR;GENDER;GENF;;;;
2013;2013;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;19.3;19.3;;;13.9;25.9;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;13.23;13.23;;;12.79;13.67;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.4;8.4;;;6.8;10.2;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2013;2013;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;6.13;6.13;;;5.3;6.96;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;7.73;7.73;;;7.56;7.89;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2013;2013;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2013;2013;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;18.87;18.87;;;18.47;19.27;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2013;2013;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.3;9.3;;;7.7;11;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2013;2013;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.5;10.5;;;6.7;15.8;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;11.20;11.2;;;8.75;13.66;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;17.45;17.45;;;17.08;17.82;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;13.3;13.3;;;8.4;20.2;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2013;2013;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.7;11.7;;;8.8;15.3;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2013;2013;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;NMBR;RACE;WHT;;;;
2013;2013;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;13.3;13.3;;;11;15.6;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;13.0;13;;;11.5;14.6;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2013;2013;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;39;39;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;NMBR;RACE;WHT;;;;
2013;2013;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;7.62;7.62;;;5.93;9.32;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;CA;California;NVSS;Asthma;Asthma mortality rate;;;Number;57;57;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;NMBR;RACE;API;;;;
2013;2013;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2013;2013;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;11.57;11.57;;;11.26;11.87;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2013;2013;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;NMBR;RACE;AIAN;;;;
2013;2013;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2013;2013;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;6.5;6.5;;;5.2;8.1;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2013;2013;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;CRDRATE;RACE;API;;;;
2013;2013;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.0;9;;;5.5;14;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2013;2013;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;NMBR;RACE;AIAN;;;;
2013;2013;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2013;2013;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;27.74;27.74;;;27.17;28.31;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.4;11.4;;;9.3;13.5;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;;Number;69;69;;;;;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2013;2013;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;NMBR;GENDER;GENM;;;;
2013;2013;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;21.8;21.8;;;13.7;33;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.0;8;;;6.7;9.2;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2013;2013;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;NMBR;RACE;API;;;;
2013;2013;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.1;8.1;;;7;9.1;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;4.92;4.92;;;4.01;5.84;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2013;2013;TX;Texas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;7.72;7.72;;;6.46;8.98;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;NMBR;RACE;BLK;;;;
2013;2013;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;4.87;4.87;;;4.61;5.12;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;13.3;13.3;;;11.2;15.4;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;17.0;17;;;12.7;22.3;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2013;2013;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;NMBR;RACE;BLK;;;;
2013;2013;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2013;2013;MN;Minnesota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;KS;Kansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2013;2013;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;2001;2,001;;;;;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;NMBR;GENDER;GENF;;;;
2013;2013;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;NY;New York;NVSS;Asthma;Asthma mortality rate;;;Number;66;66;;;;;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;NMBR;RACE;HIS;;;;
2013;2013;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.2;11.2;;;9.3;13.2;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;6.20;6.2;;;6.01;6.4;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2013;2013;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;NMBR;GENDER;GENF;;;;
2013;2013;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;3.82;3.82;;;2.85;4.8;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;CRDRATE;RACE;API;;;;
2013;2013;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;CRDRATE;RACE;API;;;;
2013;2013;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;NMBR;RACE;BLK;;;;
2013;2013;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;16.06;16.06;;;15.45;16.66;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2013;2013;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2013;2013;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;9.91;9.91;;;9.41;10.41;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2013;2013;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;NMBR;RACE;HIS;;;;
2013;2013;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2013;2013;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;NMBR;RACE;HIS;;;;
2013;2013;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2013;2013;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;32;32;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;NMBR;RACE;WHT;;;;
2013;2013;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2013;2013;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2013;2013;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;NMBR;RACE;BLK;;;;
2013;2013;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;NMBR;RACE;BLK;;;;
2013;2013;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;13.2;13.2;;;10.2;16.7;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2013;2013;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;4.06;4.06;;;3.28;4.85;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.7;11.7;;;8.9;15.1;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2013;2013;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;11.48;11.48;;;11.28;11.67;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2013;2013;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;;Number;24;24;;;;;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;NMBR;GENDER;GENM;;;;
2013;2013;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.1;12.1;;;7.9;17.8;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;NMBR;RACE;BLK;;;;
2013;2013;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2013;2013;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;NMBR;GENDER;GENM;;;;
2013;2013;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2013;2013;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;14.09;14.09;;;13.93;14.25;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;23.78;23.78;;;20.86;26.71;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;2.78;2.78;;;2.3;3.26;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2013;2013;FL;Florida;NVSS;Asthma;Asthma mortality rate;;;Number;188;188;;;;;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2013;2013;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;NMBR;RACE;HIS;;;;
2013;2013;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2013;2013;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;7.63;7.63;;;7.21;8.06;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;NMBR;GENDER;GENF;;;;
2013;2013;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;6.02;6.02;;;4.48;7.56;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2013;2013;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;23.96;23.96;;;22.04;25.88;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;NMBR;RACE;HIS;;;;
2013;2013;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;5.6;5.6;;;4.5;7;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2013;2013;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;NMBR;RACE;HIS;;;;
2013;2013;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;11.44;11.44;;;10.18;12.71;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.3;10.3;;;6.6;15.3;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.4;9.4;;;7.7;11.1;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2013;2013;ME;Maine;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;NMBR;RACE;HIS;;;;
2013;2013;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2013;2013;IL;Illinois;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2013;2013;NY;New York;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;NMBR;RACE;AIAN;;;;
2013;2013;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2013;2013;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.8;12.8;;;9.8;16.4;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;13.5;13.5;;;10.3;17.4;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;254;254;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;NMBR;RACE;BLK;;;;
2013;2013;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2013;2013;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;14.20;14.2;;;13.73;14.68;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2013;2013;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;7.49;7.49;;;7.19;7.78;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2013;2013;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1344;1,344;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;NMBR;RACE;BLK;;;;
2013;2013;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;CRDRATE;RACE;API;;;;
2013;2013;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.1;7.1;;;5.4;9.2;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;NMBR;RACE;API;;;;
2013;2013;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.8;7.8;;;4.9;11.6;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2013;2013;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.9;8.9;;;6;12.7;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.4;14.4;;;12.5;16.3;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2013;2013;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;;Number;36;36;;;;;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2013;2013;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2013;2013;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2013;2013;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;23.0;23;;;17.6;29.6;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;4.88;4.88;;;3.82;5.93;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2013;2013;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;6.66;6.66;;;6.34;6.98;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;NMBR;RACE;BLK;;;;
2013;2013;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;20.4;20.4;;;15.6;26.2;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2013;2013;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;NMBR;RACE;HIS;;;;
2013;2013;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2013;2013;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.3;9.3;;;6.7;12.6;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST4_1;NMBR;GENDER;GENM;;;;
2013;2013;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;NMBR;RACE;AIAN;;;;
2013;2013;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.9;13.9;;;10.8;17.5;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2013;2013;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;48;48;;;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;NMBR;RACE;AIAN;;;;
2013;2013;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.1;8.1;;;5.5;11.6;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2013;2013;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;5.42;5.42;;;5.04;5.79;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2013;2013;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1843;1,843;;;;;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2013;2013;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;CRDRATE;RACE;API;;;;
2013;2013;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;NMBR;RACE;API;;;;
2013;2013;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;19.4;19.4;;;12.7;28.5;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2013;2013;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2013;2013;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.5;10.5;;;8.8;12.2;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;NMBR;RACE;AIAN;;;;
2013;2013;OK;Oklahoma;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2013;2013;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;NMBR;RACE;BLK;;;;
2013;2013;MT;Montana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;NMBR;RACE;API;;;;
2013;2013;ND;North Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;210;210;;;;;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;NMBR;GENDER;GENM;;;;
2013;2013;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;5.48;5.48;;;5.15;5.81;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;8.52;8.52;;;8.19;8.84;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2013;2013;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;NMBR;RACE;AIAN;;;;
2013;2013;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;NMBR;RACE;AIAN;;;;
2013;2013;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;;Number;36;36;;;;;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2013;2013;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2013;2013;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;NMBR;RACE;BLK;;;;
2013;2013;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;15.67;15.67;;;15.32;16.01;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2013;2013;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2013;2013;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;LA;Louisiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;;Number;27;27;;;;;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;NMBR;GENDER;GENF;;;;
2013;2013;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1676;1,676;;;;;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;NMBR;GENDER;GENM;;;;
2013;2013;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;13597;13,597;;;;;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;NMBR;GENDER;GENM;;;;
2013;2013;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.6;9.6;;;6.3;14.1;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.5;8.5;;;6.6;10.9;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;7.82;7.82;;;6.54;9.09;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2013;2013;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;28769;28,769;;;;;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2013;2013;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;LA;Louisiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.907192, -77.036871);;11;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2013;2013;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.2;9.2;;;5.7;14.1;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;NMBR;GENDER;GENF;;;;
2013;2013;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;CRDRATE;RACE;API;;;;
2013;2013;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2013;2013;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;18.63;18.63;;;16.14;21.11;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.4;8.4;;;7.2;9.7;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;NMBR;GENDER;GENM;;;;
2013;2013;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2013;2013;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;15.23;15.23;;;14.97;15.48;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.3;9.3;;;6.5;12.9;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;NMBR;RACE;AIAN;;;;
2013;2013;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2013;2013;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.3;12.3;;;9.5;15.8;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2013;2013;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.2;7.2;;;4.9;10.3;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;NMBR;RACE;HIS;;;;
2013;2013;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2013;2013;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2013;2013;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2013;2013;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;NMBR;GENDER;GENF;;;;
2013;2013;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;NMBR;RACE;HIS;;;;
2013;2013;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2013;2013;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.5;9.5;;;7.3;12.2;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;CRDRATE;RACE;API;;;;
2013;2013;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;4094;4,094;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;NMBR;RACE;BLK;;;;
2013;2013;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;23.2;23.2;;;17.7;29.8;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;NMBR;RACE;AIAN;;;;
2013;2013;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;7.58;7.58;;;7.02;8.15;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2013;2013;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1470;1,470;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;NMBR;RACE;WHT;;;;
2013;2013;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;;Number;48;48;;;;;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;NMBR;GENDER;GENF;;;;
2013;2013;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;58;58;;;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;NMBR;RACE;HIS;;;;
2013;2013;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;389;389;;;;;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;NMBR;GENDER;GENM;;;;
2013;2013;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.7;7.7;;;5.5;10.6;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2013;2013;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;NMBR;RACE;BLK;;;;
2013;2013;NY;New York;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;NMBR;RACE;API;;;;
2013;2013;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;NMBR;RACE;AIAN;;;;
2013;2013;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2013;2013;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;CRDRATE;RACE;API;;;;
2013;2013;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;NMBR;GENDER;GENM;;;;
2013;2013;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2013;2013;LA;Louisiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2013;2013;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.3;13.3;;;8.1;20.5;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2013;2013;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;17.05;17.05;;;16.87;17.23;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;NMBR;RACE;WHT;;;;
2013;2013;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;36.9;36.9;;;26.7;49.7;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;;Number;34;34;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;NMBR;RACE;WHT;;;;
2013;2013;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;3538;3,538;;;;;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;NMBR;GENDER;GENF;;;;
2013;2013;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;4.00;4;;;3.57;4.43;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;CRDRATE;RACE;API;;;;
2013;2013;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;NMBR;RACE;BLK;;;;
2013;2013;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;7.99;7.99;;;7.69;8.3;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;NMBR;RACE;HIS;;;;
2013;2013;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;10.32;10.32;;;10.14;10.5;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;82;82;;;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;NMBR;RACE;HIS;;;;
2013;2013;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2013;2013;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.4;11.4;;;8.1;15.6;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2013;2013;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2013;2013;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;8.23;8.23;;;7.95;8.51;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2013;2013;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2013;2013;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;3.16;3.16;;;2.42;3.9;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;CRDRATE;RACE;API;;;;
2013;2013;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;3820;3,820;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;NMBR;RACE;WHT;;;;
2013;2013;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.3;8.3;;;6.2;11;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;NMBR;GENDER;GENF;;;;
2013;2013;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST4_1;NMBR;RACE;WHT;;;;
2013;2013;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;4.93;4.93;;;4.21;5.64;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2013;2013;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2013;2013;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;NMBR;RACE;API;;;;
2013;2013;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2013;2013;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;19.70;19.7;;;19.42;19.97;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2013;2013;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;;Number;23;23;;;;;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;NMBR;GENDER;GENF;;;;
2013;2013;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.2;10.2;;;6.9;14.6;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.6;8.6;;;7.4;9.8;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;NMBR;RACE;BLK;;;;
2013;2013;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;4.06;4.06;;;3.28;4.84;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2013;2013;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;20.8;20.8;;;16.1;26.5;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2013;2013;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;34.7;34.7;;;28;41.4;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2013;2013;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2013;2013;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2013;2013;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1448;1,448;;;;;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;NMBR;RACE;HIS;;;;
2013;2013;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.8;8.8;;;6.7;11.3;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.2;11.2;;;8.8;14;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.0;14;;;10.7;18;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2013;2013;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;NMBR;RACE;AIAN;;;;
2013;2013;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2013;2013;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.0;10;;;6.1;15.4;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2013;2013;AL;Alabama;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;ND;North Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2013;2013;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;CRDRATE;RACE;API;;;;
2013;2013;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;24.3;24.3;;;16.7;34.2;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;16.62;16.62;;;16.38;16.86;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;6.06;6.06;;;4.75;7.37;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;MO;Missouri;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;;Number;53;53;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;NMBR;RACE;BLK;;;;
2013;2013;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;13.7;13.7;;;11.1;16.8;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;NMBR;GENDER;GENF;;;;
2013;2013;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.6;9.6;;;6.3;14;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2013;2013;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;15.8;15.8;;;12.1;20.2;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;CRDRATE;RACE;API;;;;
2013;2013;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;85;85;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;NMBR;RACE;BLK;;;;
2013;2013;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2013;2013;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;NMBR;RACE;API;;;;
2013;2013;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;16.3;16.3;;;10.1;24.9;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2013;2013;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;8.54;8.54;;;8.3;8.78;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2013;2013;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;13.6;13.6;;;9;19.7;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1965;1,965;;;;;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2013;2013;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;CRDRATE;RACE;API;;;;
2013;2013;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.8;8.8;;;6.4;11.9;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2013;2013;NY;New York;NVSS;Asthma;Asthma mortality rate;;;Number;160;160;;;;;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;NMBR;GENDER;GENF;;;;
2013;2013;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;CRDRATE;RACE;API;;;;
2013;2013;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;NMBR;RACE;HIS;;;;
2013;2013;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.1;13.1;;;10.3;16.4;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;9.17;9.17;;;8.81;9.52;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.6;11.6;;;8.2;16.1;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;18.79;18.79;;;18.08;19.49;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;12.51;12.51;;;12.29;12.73;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.9;11.9;;;7.8;17.3;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2013;2013;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.4;14.4;;;12.7;16.1;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.7;7.7;;;5.6;10.2;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;4.4;4.4;;;2.9;6.6;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;;Number;21;21;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;NMBR;RACE;WHT;;;;
2013;2013;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;16.1;16.1;;;11.5;22.1;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;NMBR;RACE;API;;;;
2013;2013;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;97;97;;;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;NMBR;RACE;AIAN;;;;
2013;2013;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;NMBR;RACE;AIAN;;;;
2013;2013;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;NMBR;RACE;API;;;;
2013;2013;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.5;10.5;;;8.4;13;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;12.30;12.3;;;11.97;12.63;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2013;2013;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.2;14.2;;;10.5;18.8;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2013;2013;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;NMBR;RACE;HIS;;;;
2013;2013;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.9;12.9;;;10;16.4;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2013;2013;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.0;12;;;9.4;15.1;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;13.45;13.45;;;12.12;14.78;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;11.06;11.06;;;10.77;11.35;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2013;2013;US;United States;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.7;10.7;;;10.3;11;Overall;Overall;;;;;;;59;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.2;12.2;;;8.5;16.8;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;NMBR;RACE;BLK;;;;
2013;2013;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;2.92;2.92;;;2.19;3.65;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2013;2013;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2013;2013;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2013;2013;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;5.52;5.52;;;5.14;5.91;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2013;2013;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;14.3;14.3;;;10.4;19.1;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;62;62;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;NMBR;RACE;API;;;;
2013;2013;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;7.46;7.46;;;7.07;7.84;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;3.91;3.91;;;2.86;4.96;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2013;2013;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;CRDRATE;RACE;API;;;;
2013;2013;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;;Number;31;31;;;;;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;NMBR;GENDER;GENM;;;;
2013;2013;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;59;59;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;NMBR;RACE;API;;;;
2013;2013;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2013;2013;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;12.51;12.51;;;11.27;13.75;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2013;2013;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST4_1;NMBR;RACE;HIS;;;;
2013;2013;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2013;2013;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST4_1;NMBR;RACE;BLK;;;;
2013;2013;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;7.72;7.72;;;7.4;8.03;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.3;8.3;;;6.5;10.3;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2013;2013;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2013;2013;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;13.2;13.2;;;8.3;19.9;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1934;1,934;;;;;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;NMBR;GENDER;GENM;;;;
2013;2013;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2013;2013;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;16.7;16.7;;;12.5;21.9;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2013;2013;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;11.23;11.23;;;9.99;12.48;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2013;2013;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.4;14.4;;;9;21.8;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2013;2013;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;7.12;7.12;;;5.02;9.22;Race/Ethnicity;American Indian or Alaska Native;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;4.03;4.03;;;3.75;4.32;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;8.90;8.9;;;8.41;9.39;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;4.75;4.75;;;4.21;5.29;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2013;2013;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;105;105;;;;;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;NMBR;GENDER;GENM;;;;
2013;2013;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;17.1;17.1;;;13.9;20.2;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2013;2013;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;NMBR;GENDER;GENM;;;;
2013;2013;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.6;14.6;;;11.5;18.2;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2013;2013;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2013;2013;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;CRDRATE;RACE;API;;;;
2013;2013;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;NMBR;RACE;AIAN;;;;
2013;2013;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;7.06;7.06;;;6.45;7.68;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2013;2013;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;6.99;6.99;;;5.01;8.97;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2013;2013;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.1;11.1;;;8.7;14;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;7.19;7.19;;;6.95;7.43;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2013;2013;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2013;2013;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;CRDRATE;RACE;API;;;;
2013;2013;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;NMBR;GENDER;GENF;;;;
2013;2013;DE;Delaware;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2013;2013;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1205;1,205;;;;;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;NMBR;GENDER;GENF;;;;
2013;2013;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;7.56;7.56;;;7.02;8.09;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;NMBR;GENDER;GENF;;;;
2013;2013;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;9.83;9.83;;;9.23;10.43;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2013;2013;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;NMBR;RACE;BLK;;;;
2013;2013;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.0;11;;;8;14.6;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;5.63;5.63;;;5.11;6.16;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;NMBR;RACE;HIS;;;;
2013;2013;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;NMBR;RACE;API;;;;
2013;2013;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;4.51;4.51;;;4.28;4.74;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.9;12.9;;;9.5;17;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;TX;Texas;NVSS;Asthma;Asthma mortality rate;;;Number;66;66;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;NMBR;RACE;BLK;;;;
2013;2013;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.907192, -77.036871);;11;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2013;2013;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;NMBR;GENDER;GENM;;;;
2013;2013;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;NMBR;GENDER;GENM;;;;
2013;2013;WY;Wyoming;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2013;2013;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;6.78;6.78;;;6.48;7.08;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2013;2013;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;;Number;67;67;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;NMBR;RACE;WHT;;;;
2013;2013;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;13.4;13.4;;;10.2;17.3;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;;Number;20;20;;;;;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;NMBR;GENDER;GENM;;;;
2013;2013;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;NMBR;GENDER;GENF;;;;
2013;2013;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;33579;33,579;;;;;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2013;2013;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;;Number;71;71;;;;;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2013;2013;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.1;10.1;;;8.3;11.9;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2013;2013;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;NMBR;RACE;BLK;;;;
2013;2013;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;NMBR;RACE;HIS;;;;
2013;2013;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;17.6;17.6;;;13;23.3;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2013;2013;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;NMBR;RACE;AIAN;;;;
2013;2013;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;NMBR;RACE;API;;;;
2013;2013;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2013;2013;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;7.23;7.23;;;5.63;8.84;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2013;2013;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2013;2013;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;;Number;55;55;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;NMBR;RACE;WHT;;;;
2013;2013;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;18.6;18.6;;;12.4;26.9;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2013;2013;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;28;28;;;;;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;NMBR;GENDER;GENM;;;;
2013;2013;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;11.01;11.01;;;10.72;11.29;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2013;2013;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;37.1;37.1;;;26.9;49.8;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2013;2013;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2013;2013;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;19.88;19.88;;;19.12;20.64;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;16.8;16.8;;;13.7;20;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2013;2013;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.9;13.9;;;9.2;20.2;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2013;2013;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;5700;5,700;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;NMBR;RACE;WHT;;;;
2013;2013;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;5.42;5.42;;;5.05;5.8;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;NMBR;RACE;AIAN;;;;
2013;2013;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;8.57;8.57;;;6.88;10.26;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;7.66;7.66;;;7.32;7.99;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;CRDRATE;RACE;API;;;;
2013;2013;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;27.75;27.75;;;27.17;28.34;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.6;12.6;;;9.9;15.7;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;NMBR;RACE;AIAN;;;;
2013;2013;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;17.56;17.56;;;11.17;23.95;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;NMBR;RACE;AIAN;;;;
2013;2013;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;;Number;36;36;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;NMBR;RACE;BLK;;;;
2013;2013;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.2;12.2;;;8.9;16.4;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;6.30;6.3;;;6.07;6.52;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2013;2013;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;811;811;;;;;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;NMBR;RACE;HIS;;;;
2013;2013;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1300;1,300;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;NMBR;RACE;WHT;;;;
2013;2013;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.907192, -77.036871);;11;AST;AST4_1;NMBR;RACE;API;;;;
2013;2013;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;;Number;20;20;;;;;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;NMBR;RACE;HIS;;;;
2013;2013;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2013;2013;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2013;2013;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1016;1,016;;;;;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;NMBR;GENDER;GENM;;;;
2013;2013;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1953;1,953;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;NMBR;RACE;WHT;;;;
2013;2013;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;CRDRATE;RACE;API;;;;
2013;2013;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;21.4;21.4;;;13.7;31.8;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2013;2013;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;CRDRATE;RACE;API;;;;
2013;2013;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;NMBR;RACE;API;;;;
2013;2013;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;NMBR;GENDER;GENM;;;;
2013;2013;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;8.60;8.6;;;7.64;9.55;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2013;2013;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.3;9.3;;;6.6;12.7;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.4;8.4;;;6.5;10.7;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2013;2013;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2013;2013;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;6.76;6.76;;;6.48;7.03;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2013;2013;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2013;2013;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;NMBR;RACE;API;;;;
2013;2013;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;NMBR;RACE;AIAN;;;;
2013;2013;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;6.7;6.7;;;4.6;9.5;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2013;2013;WA;Washington;NVSS;Asthma;Asthma mortality rate;;;Number;87;87;;;;;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2013;2013;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;4.80;4.8;;;4.61;4.99;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.4;9.4;;;6.1;13.8;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;34.4;34.4;;;27.6;41.1;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;NMBR;GENDER;GENM;;;;
2013;2013;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;14.40;14.4;;;14.05;14.75;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2013;2013;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;2.92;2.92;;;2.15;3.69;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2013;2013;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;7.79;7.79;;;7.24;8.34;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2013;2013;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;;Number;35;35;;;;;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;NMBR;GENDER;GENF;;;;
2013;2013;ID;Idaho;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;7892;7,892;;;;;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;NMBR;GENDER;GENF;;;;
2013;2013;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2013;2013;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2013;2013;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2013;2013;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;13.3;13.3;;;10.6;15.9;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;CRDRATE;RACE;API;;;;
2013;2013;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.4;10.4;;;8.4;12.4;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;4.73;4.73;;;4.48;4.97;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2013;2013;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;4.45;4.45;;;3.62;5.27;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;CRDRATE;RACE;API;;;;
2013;2013;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2013;2013;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;6.45;6.45;;;5.73;7.18;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1492;1,492;;;;;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;NMBR;GENDER;GENF;;;;
2013;2013;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2013;2013;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;NMBR;RACE;API;;;;
2013;2013;NH;New Hampshire;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2013;2013;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;17.8;17.8;;;10.9;27.5;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;;Number;39;39;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;NMBR;RACE;BLK;;;;
2013;2013;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;11.31;11.31;;;11;11.62;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;NMBR;RACE;HIS;;;;
2013;2013;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;NMBR;GENDER;GENF;;;;
2013;2013;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2013;2013;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;313;313;;;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;NMBR;RACE;HIS;;;;
2013;2013;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;15.6;15.6;;;11.8;20.2;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;60;60;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;NMBR;RACE;WHT;;;;
2013;2013;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.1;11.1;;;7.6;15.6;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;NMBR;RACE;AIAN;;;;
2013;2013;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2013;2013;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;NMBR;RACE;API;;;;
2013;2013;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.3;14.3;;;9;21.4;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;2037;2,037;;;;;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;NMBR;GENDER;GENM;;;;
2013;2013;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;6.52;6.52;;;5.66;7.38;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;NMBR;RACE;AIAN;;;;
2013;2013;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2013;2013;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;NMBR;RACE;AIAN;;;;
2013;2013;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;NMBR;RACE;HIS;;;;
2013;2013;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;CRDRATE;RACE;API;;;;
2013;2013;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.4;10.4;;;6.4;15.9;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;US;United States;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.5;11.5;;;11.1;11.9;Overall;Overall;;;;;;;59;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;299;299;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;NMBR;RACE;WHT;;;;
2013;2013;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2013;2013;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2013;2013;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;18.19;18.19;;;15.76;20.61;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2013;2013;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;NMBR;RACE;API;;;;
2013;2013;ME;Maine;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;NMBR;RACE;API;;;;
2013;2013;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2013;2013;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;15.1;15.1;;;12.5;17.6;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2013;2013;MT;Montana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;NMBR;RACE;AIAN;;;;
2013;2013;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;;Number;80;80;;;;;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;NMBR;GENDER;GENF;;;;
2013;2013;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;1.89;1.89;;;1.27;2.51;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;CRDRATE;RACE;API;;;;
2013;2013;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.0;10;;;7.8;12.7;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;CRDRATE;RACE;API;;;;
2013;2013;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;CRDRATE;RACE;API;;;;
2013;2013;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2013;2013;NY;New York;NVSS;Asthma;Asthma mortality rate;;;Number;283;283;;;;;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2013;2013;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;13.3;13.3;;;8.4;19.9;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;CRDRATE;RACE;API;;;;
2013;2013;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;2.29;2.29;;;1.54;3.04;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2013;2013;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;;Number;21;21;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;NMBR;RACE;BLK;;;;
2013;2013;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;9.23;9.23;;;8.51;9.94;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2013;2013;US;United States;NVSS;Asthma;Asthma mortality rate;;;Number;3630;3,630;;;;;Overall;Overall;;;;;;;59;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2013;2013;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;;Number;21;21;;;;;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;NMBR;GENDER;GENM;;;;
2013;2013;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2013;2013;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;NMBR;RACE;HIS;;;;
2013;2013;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.2;10.2;;;8.2;12.3;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;NMBR;RACE;HIS;;;;
2013;2013;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.5;11.5;;;7.8;16.3;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2013;2013;MT;Montana;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2013;2013;VA;Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;NMBR;RACE;AIAN;;;;
2013;2013;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;2283;2,283;;;;;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2013;2013;CA;California;NVSS;Asthma;Asthma mortality rate;;;Number;152;152;;;;;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;NMBR;GENDER;GENM;;;;
2013;2013;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;15.9;15.9;;;11.9;20.8;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2013;2013;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;7.21;7.21;;;7.06;7.36;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;9.53;9.53;;;8.95;10.11;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;NMBR;RACE;WHT;;;;
2013;2013;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.8;13.8;;;10.7;17.4;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2013;2013;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;4.90;4.9;;;4.41;5.38;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;4906;4,906;;;;;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2013;2013;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;7.23;7.23;;;6.79;7.68;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2013;2013;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;NMBR;GENDER;GENM;;;;
2013;2013;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;4.23;4.23;;;3.81;4.66;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;5.03;5.03;;;4.46;5.6;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2013;2013;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;;Number;23;23;;;;;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;NMBR;GENDER;GENM;;;;
2013;2013;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.8;8.8;;;7.1;10.5;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2013;2013;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;NMBR;RACE;HIS;;;;
2013;2013;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;22.9;22.9;;;15.5;32.7;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;;Number;38;38;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;NMBR;RACE;WHT;;;;
2013;2013;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;NMBR;RACE;HIS;;;;
2013;2013;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;2628;2,628;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;NMBR;RACE;WHT;;;;
2013;2013;FL;Florida;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;NMBR;RACE;API;;;;
2013;2013;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;NMBR;RACE;AIAN;;;;
2013;2013;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;14.37;14.37;;;13.88;14.87;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2013;2013;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;NMBR;RACE;HIS;;;;
2013;2013;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2013;2013;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2013;2013;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.7;10.7;;;7.3;15.2;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;KS;Kansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;29.0;29;;;20.9;39.2;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2013;2013;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.7;8.7;;;6.3;11.7;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;NMBR;RACE;WHT;;;;
2013;2013;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;6.12;6.12;;;4.48;7.77;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2013;2013;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;;Number;28;28;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;NMBR;RACE;BLK;;;;
2013;2013;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2013;2013;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;14.58;14.58;;;14.26;14.9;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;37.06;37.06;;;36.37;37.75;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2013;2013;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2013;2013;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;13.3;13.3;;;8.8;19.4;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;NMBR;RACE;HIS;;;;
2013;2013;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.8;10.8;;;8.8;12.8;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2013;2013;TX;Texas;NVSS;Asthma;Asthma mortality rate;;;Number;213;213;;;;;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2013;2013;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;10.71;10.71;;;8.37;13.06;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2013;2013;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.1;11.1;;;9;13.2;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;14.71;14.71;;;14.47;14.96;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.0;8;;;5.2;11.8;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2013;2013;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;30;30;;;;;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2013;2013;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2013;2013;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;5.58;5.58;;;5.1;6.06;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;GA;Georgia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;7.20;7.2;;;6.39;8.02;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2013;2013;GA;Georgia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.8;14.8;;;12;18;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;CRDRATE;RACE;API;;;;
2013;2013;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;9.19;9.19;;;8.83;9.54;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;NMBR;RACE;HIS;;;;
2013;2013;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;643;643;;;;;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;NMBR;GENDER;GENF;;;;
2013;2013;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;8.83;8.83;;;8.43;9.23;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;DC;District of Columbia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;;Number;101;101;;;;;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2013;2013;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;5519;5,519;;;;;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2013;2013;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;;Number;110;110;;;;;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;NMBR;GENDER;GENF;;;;
2013;2013;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;672;672;;;;;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;NMBR;GENDER;GENF;;;;
2013;2013;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;NMBR;RACE;AIAN;;;;
2013;2013;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;NMBR;RACE;HIS;;;;
2013;2013;DC;District of Columbia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2013;2013;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;87;87;;;;;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2013;2013;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2013;2013;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;5.68;5.68;;;5.34;6.02;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;FL;Florida;NVSS;Asthma;Asthma mortality rate;;;Number;109;109;;;;;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;NMBR;GENDER;GENF;;;;
2013;2013;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;8.27;8.27;;;7.88;8.66;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;7.54;7.54;;;7.23;7.85;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;37.42;37.42;;;36.72;38.12;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.907192, -77.036871);;11;AST;AST4_1;CRDRATE;RACE;API;;;;
2013;2013;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;;Number;79;79;;;;;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2013;2013;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;10.10;10.1;;;7.3;12.9;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;MT;Montana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2013;2013;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;NMBR;RACE;API;;;;
2013;2013;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;;Number;29;29;;;;;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;NMBR;GENDER;GENF;;;;
2013;2013;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;6.8;6.8;;;5.4;8.3;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2013;2013;TX;Texas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;NMBR;RACE;API;;;;
2013;2013;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.3;10.3;;;6.3;15.9;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2013;2013;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;14.0;14;;;12;16;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;6.99;6.99;;;6.76;7.21;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2013;2013;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2013;2013;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;6.63;6.63;;;6.17;7.08;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;9.18;9.18;;;8.99;9.37;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;314;314;;;;;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2013;2013;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2013;2013;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;5.93;5.93;;;5.74;6.11;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2013;2013;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;NMBR;RACE;API;;;;
2013;2013;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;;Number;30;30;;;;;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;NMBR;GENDER;GENF;;;;
2013;2013;FL;Florida;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;NMBR;RACE;AIAN;;;;
2013;2013;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.3;10.3;;;6.2;16;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;4.80;4.8;;;4.45;5.14;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;10.27;10.27;;;9.9;10.64;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2013;2013;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;NMBR;RACE;HIS;;;;
2013;2013;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2013;2013;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2013;2013;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.0;8;;;5.2;11.9;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;180;180;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;NMBR;RACE;API;;;;
2013;2013;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.2;8.2;;;6.5;10.3;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.9;7.9;;;5.8;10.6;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2013;2013;UT;Utah;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;NMBR;RACE;BLK;;;;
2013;2013;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2013;2013;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;25.00;25;;;23.2;26.8;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2013;2013;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2013;2013;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;11.21;11.21;;;10.99;11.42;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2013;2013;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2013;2013;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.7;14.7;;;10.3;20.3;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2013;2013;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.5;8.5;;;5.2;12.9;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2013;2013;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;36;36;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;NMBR;RACE;API;;;;
2013;2013;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;28.6;28.6;;;20.1;39.4;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;NMBR;RACE;BLK;;;;
2013;2013;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.8;8.8;;;6.5;11.6;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;CRDRATE;RACE;API;;;;
2013;2013;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;2564;2,564;;;;;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2013;2013;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2013;2013;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;8.15;8.15;;;7.77;8.53;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2013;2013;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;14.4;14.4;;;9.5;20.9;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;7.33;7.33;;;6.88;7.78;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;;Number;23;23;;;;;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;NMBR;GENDER;GENF;;;;
2013;2013;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2013;2013;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;;Number;23;23;;;;;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;NMBR;GENDER;GENM;;;;
2013;2013;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;;Number;47;47;;;;;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;NMBR;GENDER;GENM;;;;
2013;2013;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2013;2013;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.0;13;;;9.6;17.1;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2013;2013;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;;Number;25;25;;;;;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2013;2013;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;NMBR;GENDER;GENM;;;;
2013;2013;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2013;2013;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;;Number;105;105;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;NMBR;RACE;WHT;;;;
2013;2013;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;NMBR;RACE;API;;;;
2013;2013;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.7;9.7;;;6.4;14.1;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.1;9.1;;;6.9;11.9;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.0;11;;;7;16.4;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;3986;3,986;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;NMBR;RACE;WHT;;;;
2013;2013;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;3684;3,684;;;;;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2013;2013;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.6;9.6;;;8.2;11;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;18.83;18.83;;;18.57;19.09;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2013;2013;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;;Number;20;20;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;NMBR;RACE;WHT;;;;
2013;2013;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2013;2013;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;16.6;16.6;;;12.2;22;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2013;2013;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2013;2013;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;47;47;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;NMBR;RACE;BLK;;;;
2013;2013;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;CRDRATE;RACE;API;;;;
2013;2013;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2013;2013;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;12839;12,839;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;NMBR;RACE;WHT;;;;
2013;2013;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;NMBR;RACE;API;;;;
2013;2013;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;NMBR;RACE;HIS;;;;
2013;2013;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2013;2013;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.1;12.1;;;9.4;15.3;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;6.33;6.33;;;6.03;6.64;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2013;2013;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;18.9;18.9;;;12.6;27.1;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2013;2013;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.8;8.8;;;6.6;11.5;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;ME;Maine;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;NMBR;GENDER;GENF;;;;
2013;2013;NY;New York;NVSS;Asthma;Asthma mortality rate;;;Number;103;103;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;NMBR;RACE;BLK;;;;
2013;2013;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;9.96;9.96;;;9.7;10.22;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1547;1,547;;;;;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;NMBR;GENDER;GENF;;;;
2013;2013;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;;Number;22;22;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;NMBR;RACE;WHT;;;;
2013;2013;TX;Texas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2013;2013;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2013;2013;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;;Number;38;38;;;;;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;NMBR;GENDER;GENM;;;;
2013;2013;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2013;2013;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;19.11;19.11;;;15.05;23.17;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;DC;District of Columbia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;15.39;15.39;;;14.59;16.18;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2013;2013;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;;Number;23;23;;;;;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2013;2013;WA;Washington;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;NMBR;RACE;AIAN;;;;
2013;2013;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;NMBR;RACE;WHT;;;;
2013;2013;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2013;2013;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;IN;Indiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;UT;Utah;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;NMBR;RACE;HIS;;;;
2013;2013;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;CRDRATE;RACE;API;;;;
2013;2013;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;;Number;31;31;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;NMBR;RACE;WHT;;;;
2013;2013;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;;Number;42;42;;;;;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2013;2013;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;NMBR;RACE;API;;;;
2013;2013;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.1;12.1;;;9.1;15.7;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1408;1,408;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;NMBR;RACE;WHT;;;;
2013;2013;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;NMBR;RACE;API;;;;
2013;2013;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;;Number;20;20;;;;;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;NMBR;GENDER;GENF;;;;
2013;2013;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2013;2013;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;8.77;8.77;;;8.37;9.17;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2013;2013;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;265;265;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;NMBR;RACE;BLK;;;;
2013;2013;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2013;2013;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;CRDRATE;RACE;API;;;;
2013;2013;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;17.7;17.7;;;13.3;23;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2013;2013;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;21.7;21.7;;;15.9;28.9;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2013;2013;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;;Number;26;26;;;;;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;NMBR;GENDER;GENM;;;;
2013;2013;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;NMBR;GENDER;GENM;;;;
2013;2013;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;6.9;6.9;;;4.6;10;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2013;2013;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;;Number;110;110;;;;;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2013;2013;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.8;11.8;;;8.4;16.2;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2013;2013;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;19.03;19.03;;;18.44;19.61;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;NMBR;RACE;HIS;;;;
2013;2013;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;NMBR;RACE;AIAN;;;;
2013;2013;PA;Pennsylvania;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;ME;Maine;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;NMBR;RACE;AIAN;;;;
2013;2013;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2013;2013;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2013;2013;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;4.64;4.64;;;4.41;4.87;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2013;2013;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2013;2013;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;CRDRATE;RACE;API;;;;
2013;2013;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;5.16;5.16;;;4.89;5.43;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2013;2013;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;61;61;;;;;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2013;2013;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.7;11.7;;;10.3;13.2;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;;Number;24;24;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;NMBR;RACE;BLK;;;;
2013;2013;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;46.6;46.6;;;37.4;57.4;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2013;2013;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;34.85;34.85;;;32.99;36.71;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1254;1,254;;;;;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2013;2013;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;29;29;;;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;NMBR;RACE;AIAN;;;;
2013;2013;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;;Number;29;29;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;NMBR;RACE;WHT;;;;
2013;2013;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.5;10.5;;;8.4;13;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;CRDRATE;RACE;API;;;;
2013;2013;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;6.9;6.9;;;5;9.3;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;9.83;9.83;;;9.16;10.49;Race/Ethnicity;Asian or Pacific Islander;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;CRDRATE;RACE;API;;;;
2013;2013;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.3;10.3;;;8.2;12.7;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2013;2013;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2013;2013;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;22.6;22.6;;;15.7;31.6;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2013;2013;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.2;7.2;;;5.8;9;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;WA;Washington;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;NMBR;RACE;BLK;;;;
2013;2013;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;70;70;;;;;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;NMBR;GENDER;GENF;;;;
2013;2013;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2013;2013;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2013;2013;WA;Washington;NVSS;Asthma;Asthma mortality rate;;;Number;70;70;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;NMBR;RACE;WHT;;;;
2013;2013;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2013;2013;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;13.1;13.1;;;10.3;16.4;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;CRDRATE;RACE;API;;;;
2013;2013;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;111;111;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;NMBR;RACE;API;;;;
2013;2013;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;9.06;9.06;;;8.83;9.28;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.3;12.3;;;10.1;14.5;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;DE;Delaware;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2013;2013;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;NMBR;GENDER;GENF;;;;
2013;2013;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;;Number;134;134;;;;;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2013;2013;FL;Florida;NVSS;Asthma;Asthma mortality rate;;;Number;79;79;;;;;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;NMBR;GENDER;GENM;;;;
2013;2013;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;;Number;49;49;;;;;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;NMBR;GENDER;GENF;;;;
2013;2013;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2013;2013;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;4.45;4.45;;;3.98;4.92;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2013;2013;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.1;8.1;;;6.5;10;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;NMBR;RACE;AIAN;;;;
2013;2013;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.9;7.9;;;6.2;10;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.4;10.4;;;7.1;14.6;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2013;2013;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2013;2013;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;;Number;27;27;;;;;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;NMBR;GENDER;GENF;;;;
2013;2013;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.8;7.8;;;6.2;9.4;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;4.91;4.91;;;4.38;5.44;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2013;2013;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;303;303;;;;;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;NMBR;GENDER;GENF;;;;
2013;2013;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;NMBR;GENDER;GENF;;;;
2013;2013;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;NMBR;GENDER;GENM;;;;
2013;2013;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2013;2013;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;33.23;33.23;;;32.29;34.18;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2013;2013;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;4.79;4.79;;;4.44;5.14;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2013;2013;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;13.5;13.5;;;10;17.8;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;8.99;8.99;;;8.34;9.63;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.9;7.9;;;5;11.9;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;3.1;3.1;;;2.1;4.3;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2013;2013;IN;Indiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;NMBR;GENDER;GENM;;;;
2013;2013;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;17.5;17.5;;;13.6;22.3;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2013;2013;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;CRDRATE;RACE;API;;;;
2013;2013;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;2487;2,487;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;NMBR;RACE;WHT;;;;
2013;2013;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;NMBR;RACE;BLK;;;;
2013;2013;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;8.09;8.09;;;5.7;10.49;Race/Ethnicity;American Indian or Alaska Native;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2013;2013;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2013;2013;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2013;2013;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;9.56;9.56;;;9.26;9.87;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2013;2013;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;10.09;10.09;;;9.76;10.43;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;;Number;88;88;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;NMBR;RACE;BLK;;;;
2013;2013;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;10.60;10.6;;;10.25;10.95;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2013;2013;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;;Number;93;93;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;NMBR;RACE;WHT;;;;
2013;2013;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;4976;4,976;;;;;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2013;2013;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.3;8.3;;;5.8;11.6;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.8;14.8;;;9.4;22.2;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2013;2013;PA;Pennsylvania;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2013;2013;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2013;2013;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2013;2013;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;;Number;61;61;;;;;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2013;2013;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2013;2013;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;NMBR;GENDER;GENM;;;;
2013;2013;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1036;1,036;;;;;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;NMBR;GENDER;GENF;;;;
2013;2013;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;NMBR;RACE;AIAN;;;;
2013;2013;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;6.07;6.07;;;5.73;6.41;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2013;2013;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;CRDRATE;RACE;API;;;;
2013;2013;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;3353;3,353;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;NMBR;RACE;WHT;;;;
2013;2013;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;CRDRATE;RACE;API;;;;
2013;2013;TX;Texas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;NMBR;RACE;AIAN;;;;
2013;2013;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;9.16;9.16;;;6.62;11.69;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2013;2013;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;836;836;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;NMBR;RACE;API;;;;
2013;2013;WA;Washington;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;NMBR;RACE;API;;;;
2013;2013;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2013;2013;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;8616;8,616;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;NMBR;RACE;BLK;;;;
2013;2013;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.5;11.5;;;7.5;16.8;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2013;2013;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;37;37;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;NMBR;RACE;BLK;;;;
2013;2013;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;4413;4,413;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;NMBR;RACE;BLK;;;;
2013;2013;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2013;2013;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;NMBR;RACE;BLK;;;;
2013;2013;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;CRDRATE;RACE;API;;;;
2013;2013;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;NMBR;RACE;AIAN;;;;
2013;2013;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1061;1,061;;;;;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2013;2013;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.8;10.8;;;8.1;14;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;NMBR;RACE;AIAN;;;;
2013;2013;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;30.7;30.7;;;22;41.6;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;19.21;19.21;;;15.13;23.3;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2013;2013;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;NMBR;RACE;API;;;;
2013;2013;CA;California;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;NMBR;RACE;AIAN;;;;
2013;2013;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;5347;5,347;;;;;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;NMBR;GENDER;GENM;;;;
2013;2013;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;;Number;56;56;;;;;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2013;2013;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;9.51;9.51;;;9.17;9.85;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2013;2013;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.9;13.9;;;8.5;21.4;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2013;2013;ME;Maine;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2013;2013;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;;Number;27;27;;;;;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2013;2013;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;22.0;22;;;16.1;29.5;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;NMBR;RACE;AIAN;;;;
2013;2013;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;;Number;67;67;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;NMBR;RACE;WHT;;;;
2013;2013;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2013;2013;VA;Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;ME;Maine;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;NMBR;GENDER;GENM;;;;
2013;2013;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;NMBR;RACE;AIAN;;;;
2013;2013;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;3.48;3.48;;;2.58;4.37;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2013;2013;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;13.0;13;;;9;18.2;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.1;12.1;;;7.3;18.9;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.6;9.6;;;6.3;14.1;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;NMBR;RACE;API;;;;
2013;2013;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2013;2013;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;;Number;20;20;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;NMBR;RACE;WHT;;;;
2013;2013;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.1;8.1;;;5.1;12.3;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.5;9.5;;;6.2;13.8;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2013;2013;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;NMBR;RACE;BLK;;;;
2013;2013;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2013;2013;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;17.29;17.29;;;10.99;23.58;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2013;2013;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2013;2013;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2013;2013;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;7.64;7.64;;;4.7;10.58;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;NMBR;RACE;HIS;;;;
2013;2013;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.5;10.5;;;8.2;13.3;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;21.2;21.2;;;15.2;28.6;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2013;2013;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;NMBR;RACE;API;;;;
2013;2013;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2013;2013;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;NMBR;RACE;AIAN;;;;
2013;2013;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;4.90;4.9;;;4.68;5.12;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;NY;New York;NVSS;Asthma;Asthma mortality rate;;;Number;95;95;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;NMBR;RACE;WHT;;;;
2013;2013;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;NMBR;RACE;API;;;;
2013;2013;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2013;2013;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2013;2013;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;NMBR;RACE;HIS;;;;
2013;2013;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;NMBR;RACE;HIS;;;;
2013;2013;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;78;78;;;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;NMBR;RACE;AIAN;;;;
2013;2013;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;CRDRATE;RACE;API;;;;
2013;2013;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;228;228;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;NMBR;RACE;API;;;;
2013;2013;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;;Number;157;157;;;;;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2013;2013;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2013;2013;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;3.45;3.45;;;2.07;4.83;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;CRDRATE;RACE;API;;;;
2013;2013;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2013;2013;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;;Number;34;34;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;NMBR;RACE;BLK;;;;
2013;2013;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;6.2;6.2;;;3.8;9.5;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2013;2013;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2013;2013;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;26;26;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;NMBR;RACE;BLK;;;;
2013;2013;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.907192, -77.036871);;11;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;NMBR;RACE;API;;;;
2013;2013;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.1;7.1;;;5.2;9.5;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;4.97;4.97;;;4.48;5.47;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;13.30;13.3;;;11.55;15.04;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2013;2013;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2013;2013;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.7;8.7;;;7;10.5;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2013;2013;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;6171;6,171;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;NMBR;RACE;WHT;;;;
2013;2013;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;NH;New Hampshire;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2013;2013;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;7.47;7.47;;;7.04;7.9;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2013;2013;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;CT;Connecticut;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2013;2013;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;27.3;27.3;;;19.4;37.3;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2013;2013;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.3;8.3;;;6;11.3;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;IL;Illinois;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2013;2013;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;CRDRATE;RACE;API;;;;
2013;2013;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;4.62;4.62;;;4.16;5.08;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2013;2013;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;CRDRATE;RACE;API;;;;
2013;2013;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;315;315;;;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;NMBR;RACE;AIAN;;;;
2013;2013;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;10.90;10.9;;;9.69;12.11;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.2;9.2;;;7;11.8;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;32.69;32.69;;;31.76;33.62;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2013;2013;AL;Alabama;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;;Number;73;73;;;;;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;NMBR;GENDER;GENF;;;;
2013;2013;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;NMBR;RACE;API;;;;
2013;2013;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2013;2013;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;6.90;6.9;;;6.59;7.21;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2013;2013;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;13.4;13.4;;;9;19.1;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;;Number;64;64;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;NMBR;RACE;WHT;;;;
2013;2013;ID;Idaho;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;;Number;49;49;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;NMBR;RACE;WHT;;;;
2013;2013;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2013;2013;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;;Number;60;60;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;NMBR;RACE;WHT;;;;
2013;2013;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;4.52;4.52;;;3.87;5.18;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;651;651;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;NMBR;RACE;BLK;;;;
2013;2013;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2013;2013;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2013;2013;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;CT;Connecticut;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;37.8;37.8;;;26.2;52.8;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.2;10.2;;;7.8;13.3;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;CRDRATE;RACE;API;;;;
2013;2013;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.7;9.7;;;6.4;14.1;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2013;2013;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2013;2013;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;3.43;3.43;;;2.78;4.09;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2013;2013;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;14.0;14;;;10.3;18.5;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.6;7.6;;;4.6;11.8;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2013;2013;OH;Ohio;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2013;2013;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2013;2013;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;PA;Pennsylvania;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2013;2013;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;18.91;18.91;;;18.33;19.49;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2013;2013;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.8;7.8;;;5.9;10.2;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1616;1,616;;;;;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;NMBR;GENDER;GENM;;;;
2013;2013;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;NMBR;RACE;API;;;;
2013;2013;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;NMBR;RACE;API;;;;
2013;2013;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;NMBR;GENDER;GENM;;;;
2013;2013;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;5.68;5.68;;;5.48;5.89;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;;Number;26;26;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;NMBR;RACE;WHT;;;;
2013;2013;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.4;14.4;;;9.3;21.3;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2013;2013;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1898;1,898;;;;;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2013;2013;MT;Montana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;NMBR;GENDER;GENF;;;;
2013;2013;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;NMBR;GENDER;GENM;;;;
2013;2013;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;24;24;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;NMBR;RACE;API;;;;
2013;2013;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;9.00;9;;;8.35;9.64;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2013;2013;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;14.5;14.5;;;11.7;17.2;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2013;2013;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;;Number;39;39;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;NMBR;RACE;WHT;;;;
2013;2013;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;TX;Texas;NVSS;Asthma;Asthma mortality rate;;;Number;104;104;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;NMBR;RACE;WHT;;;;
2013;2013;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;NMBR;GENDER;GENF;;;;
2013;2013;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2013;2013;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.5;13.5;;;10.7;16.8;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2013;2013;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;NMBR;RACE;BLK;;;;
2013;2013;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;10.65;10.65;;;10.2;11.1;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;2140;2,140;;;;;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2013;2013;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.9;10.9;;;7.2;15.8;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2013;2013;KS;Kansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;NMBR;RACE;AIAN;;;;
2013;2013;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;CRDRATE;RACE;API;;;;
2013;2013;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2013;2013;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;;Number;36;36;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;NMBR;RACE;BLK;;;;
2013;2013;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;NMBR;RACE;BLK;;;;
2013;2013;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2013;2013;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2013;2013;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;80;80;;;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;NMBR;RACE;AIAN;;;;
2013;2013;FL;Florida;NVSS;Asthma;Asthma mortality rate;;;Number;101;101;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;NMBR;RACE;WHT;;;;
2013;2013;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;18.5;18.5;;;13.7;24.4;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;8.26;8.26;;;7.62;8.9;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;CRDRATE;RACE;API;;;;
2013;2013;OH;Ohio;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2013;2013;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2013;2013;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;27;27;;;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;NMBR;RACE;AIAN;;;;
2013;2013;CT;Connecticut;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2013;2013;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2013;2013;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2013;2013;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;CRDRATE;RACE;API;;;;
2013;2013;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;CA;California;NVSS;Asthma;Asthma mortality rate;;;Number;83;83;;;;;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;NMBR;RACE;HIS;;;;
2013;2013;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1163;1,163;;;;;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;NMBR;GENDER;GENF;;;;
2013;2013;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2013;2013;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.7;9.7;;;6.6;13.9;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2013;2013;AK;Alaska;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2013;2013;MT;Montana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2013;2013;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;12.78;12.78;;;11.11;14.46;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;CRDRATE;RACE;API;;;;
2013;2013;UT;Utah;NVSS;Asthma;Asthma mortality rate;;;Number;27;27;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;NMBR;RACE;WHT;;;;
2013;2013;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;26;26;;;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;NMBR;RACE;AIAN;;;;
2013;2013;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;743;743;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;NMBR;RACE;BLK;;;;
2013;2013;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2013;2013;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;7.19;7.19;;;6.82;7.56;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2013;2013;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;ND;North Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;25.42;25.42;;;23.59;27.25;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;NMBR;RACE;API;;;;
2013;2013;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;6.53;6.53;;;6.27;6.8;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;13.49;13.49;;;13.02;13.96;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;UT;Utah;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;NMBR;RACE;API;;;;
2013;2013;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;10459;10,459;;;;;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;NMBR;GENDER;GENM;;;;
2013;2013;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.2;10.2;;;7.7;13.2;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2013;2013;TX;Texas;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2013;2013;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;10.60;10.6;;;10.32;10.87;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.8;7.8;;;5.5;10.7;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2013;2013;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;19.2;19.2;;;12.5;28.1;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;4.79;4.79;;;4.56;5.03;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2013;2013;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;CRDRATE;RACE;API;;;;
2013;2013;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.3;8.3;;;5.3;12.4;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;15.67;15.67;;;15.41;15.93;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;;Number;80;80;;;;;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;NMBR;GENDER;GENM;;;;
2013;2013;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;9.04;9.04;;;8.42;9.65;Race/Ethnicity;Asian or Pacific Islander;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2013;2013;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2013;2013;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;7.37;7.37;;;5.08;9.65;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2013;2013;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;111;111;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;NMBR;RACE;BLK;;;;
2013;2013;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;MT;Montana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2013;2013;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;44;44;;;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;NMBR;RACE;AIAN;;;;
2013;2013;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;NMBR;RACE;API;;;;
2013;2013;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;8.88;8.88;;;8.65;9.1;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;13.84;13.84;;;13.5;14.18;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2013;2013;OH;Ohio;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;20.6;20.6;;;14.3;28.8;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;ME;Maine;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;6.66;6.66;;;4.14;9.17;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.1;12.1;;;7.6;18.1;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2013;2013;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2013;2013;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;14.24;14.24;;;14;14.48;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2013;2013;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2013;2013;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.9;11.9;;;9.1;15.3;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;970;970;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;NMBR;RACE;BLK;;;;
2013;2013;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.9;10.9;;;7.5;15.2;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;NMBR;RACE;API;;;;
2013;2013;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.1;11.1;;;8.6;14.1;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2013;2013;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;19.7;19.7;;;14.4;26.1;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;;Number;44;44;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;NMBR;RACE;BLK;;;;
2013;2013;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;CRDRATE;RACE;API;;;;
2013;2013;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;735;735;;;;;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;NMBR;GENDER;GENM;;;;
2013;2013;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;NMBR;RACE;API;;;;
2013;2013;ME;Maine;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;10.12;10.12;;;6.23;14.01;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;13.64;13.64;;;10.93;16.36;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2013;2013;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;10.99;10.99;;;10.44;11.54;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;NMBR;RACE;AIAN;;;;
2013;2013;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2013;2013;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;22.31;22.31;;;19.56;25.05;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2013;2013;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;8.43;8.43;;;5.19;11.67;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2013;2013;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;14.80;14.8;;;13.66;15.93;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;NMBR;GENDER;GENM;;;;
2013;2013;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;18.27;18.27;;;18;18.53;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2013;2013;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.6;8.6;;;7.2;10;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;5.4;5.4;;;3.2;8.6;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;IN;Indiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2013;2013;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2013;2013;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2013;2013;IL;Illinois;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;NMBR;RACE;BLK;;;;
2013;2013;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;NMBR;RACE;HIS;;;;
2013;2013;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1444;1,444;;;;;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;NMBR;GENDER;GENF;;;;
2013;2013;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.907192, -77.036871);;11;AST;AST4_1;NMBR;RACE;AIAN;;;;
2013;2013;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;6.0;6;;;4.1;8.4;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;NMBR;RACE;HIS;;;;
2013;2013;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;ME;Maine;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;NMBR;RACE;WHT;;;;
2013;2013;MN;Minnesota;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2013;2013;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;;Number;62;62;;;;;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2013;2013;WY;Wyoming;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;5.57;5.57;;;5.02;6.12;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2013;2013;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;144;144;;;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;NMBR;RACE;AIAN;;;;
2013;2013;UT;Utah;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;NMBR;GENDER;GENM;;;;
2013;2013;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;3211;3,211;;;;;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;NMBR;GENDER;GENF;;;;
2013;2013;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;393;393;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;NMBR;RACE;BLK;;;;
2013;2013;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;9.48;9.48;;;9;9.96;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;OK;Oklahoma;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;;Number;98;98;;;;;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2013;2013;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2013;2013;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;NMBR;RACE;BLK;;;;
2013;2013;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;NMBR;RACE;API;;;;
2013;2013;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;9085;9,085;;;;;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;NMBR;RACE;HIS;;;;
2013;2013;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;10.91;10.91;;;6.72;15.11;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2013;2013;VA;Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2013;2013;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2013;2013;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;NMBR;RACE;API;;;;
2013;2013;MN;Minnesota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;7.01;7.01;;;4.36;9.65;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2013;2013;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;6.83;6.83;;;5.49;8.18;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2013;2013;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;3.91;3.91;;;3.63;4.19;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2013;2013;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.6;7.6;;;5.3;10.6;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;2358;2,358;;;;;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;NMBR;GENDER;GENF;;;;
2013;2013;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.1;11.1;;;8.1;14.9;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2013;2013;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;6.9;6.9;;;4.8;9.7;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2013;2013;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2013;2013;GA;Georgia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2013;2013;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;5.70;5.7;;;5.52;5.88;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;47.4;47.4;;;37.9;58.7;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;;Number;36;36;;;;;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2013;2013;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2013;2013;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;NMBR;GENDER;GENM;;;;
2013;2013;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;NMBR;RACE;API;;;;
2013;2013;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;14.8;14.8;;;8.5;24;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.3;12.3;;;8.8;16.9;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;13.4;13.4;;;10.1;17.3;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;7.19;7.19;;;6.96;7.43;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;7.45;7.45;;;7.26;7.63;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;NMBR;RACE;AIAN;;;;
2013;2013;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;17.01;17.01;;;16.83;17.19;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;4740;4,740;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;NMBR;RACE;BLK;;;;
2013;2013;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;2.05;2.05;;;1.51;2.59;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;CRDRATE;RACE;API;;;;
2013;2013;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;NMBR;RACE;HIS;;;;
2013;2013;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;396;396;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;NMBR;RACE;WHT;;;;
2013;2013;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;13.0;13;;;9.7;17.1;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;7.62;7.62;;;7.29;7.96;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2013;2013;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.7;10.7;;;7;15.5;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2013;2013;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;16.4;16.4;;;12.2;21.6;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2013;2013;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;3.59;3.59;;;3.12;4.06;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;CRDRATE;RACE;API;;;;
2013;2013;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;8782;8,782;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;NMBR;RACE;WHT;;;;
2013;2013;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;6.3;6.3;;;4.4;8.7;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;13.1;13.1;;;8;20.3;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.2;8.2;;;5.7;11.3;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;6.57;6.57;;;5.68;7.47;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2013;2013;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;;Number;84;84;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;NMBR;RACE;WHT;;;;
2013;2013;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2013;2013;AL;Alabama;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2013;2013;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;;Number;27;27;;;;;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;NMBR;GENDER;GENF;;;;
2013;2013;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2013;2013;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2013;2013;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;;Number;20;20;;;;;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;NMBR;GENDER;GENF;;;;
2013;2013;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2013;2013;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;18.9;18.9;;;12.3;28;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.6;12.6;;;10;15.7;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2013;2013;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.4;10.4;;;9.4;11.5;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.3;7.3;;;5.2;10;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2013;2013;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;3482;3,482;;;;;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;NMBR;GENDER;GENF;;;;
2013;2013;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.4;10.4;;;8.4;12.4;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2013;2013;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2013;2013;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2013;2013;NY;New York;NVSS;Asthma;Asthma mortality rate;;;Number;123;123;;;;;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;NMBR;GENDER;GENM;;;;
2013;2013;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;CRDRATE;RACE;API;;;;
2013;2013;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2013;2013;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;CRDRATE;RACE;API;;;;
2013;2013;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.9;9.9;;;8;12.1;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2013;2013;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;70;70;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;NMBR;RACE;API;;;;
2013;2013;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;NMBR;RACE;AIAN;;;;
2013;2013;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;NMBR;RACE;HIS;;;;
2013;2013;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;7.81;7.81;;;5.6;10.02;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2013;2013;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;;Number;44;44;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;NMBR;RACE;WHT;;;;
2013;2013;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2013;2013;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;NMBR;RACE;HIS;;;;
2013;2013;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;25.3;25.3;;;17.6;35.2;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2013;2013;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;NMBR;RACE;HIS;;;;
2013;2013;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;NMBR;RACE;AIAN;;;;
2013;2013;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;12.81;12.81;;;10.43;15.2;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.6;7.6;;;6.1;9.1;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;NMBR;RACE;API;;;;
2013;2013;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;NMBR;RACE;AIAN;;;;
2013;2013;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;NMBR;RACE;API;;;;
2013;2013;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;6431;6,431;;;;;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;NMBR;RACE;HIS;;;;
2013;2013;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;CRDRATE;RACE;API;;;;
2013;2013;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;223;223;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;NMBR;RACE;API;;;;
2013;2013;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;NMBR;RACE;HIS;;;;
2013;2013;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;4.02;4.02;;;2.41;5.63;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2013;2013;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2013;2013;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.6;10.6;;;7.1;15.3;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2013;2013;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;23.96;23.96;;;22.04;25.88;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2013;2013;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;37.10;37.1;;;36.01;38.2;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2013;2013;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.3;9.3;;;7.1;12;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2013;2013;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;183;183;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;NMBR;RACE;WHT;;;;
2013;2013;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;3.67;3.67;;;2.81;4.53;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2013;2013;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2013;2013;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;NMBR;RACE;AIAN;;;;
2013;2013;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2013;2013;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1514;1,514;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;NMBR;RACE;WHT;;;;
2013;2013;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.4;8.4;;;6;11.4;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;;Number;43;43;;;;;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;NMBR;GENDER;GENM;;;;
2013;2013;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2013;2013;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.1;14.1;;;10.7;18.1;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2013;2013;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;2468;2,468;;;;;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;NMBR;GENDER;GENM;;;;
2013;2013;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2013;2013;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2013;2013;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;16.2;16.2;;;10.9;23.1;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;15.8;15.8;;;13.4;18.3;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2013;2013;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.5;12.5;;;10;15.4;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;NMBR;RACE;AIAN;;;;
2013;2013;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;18.3;18.3;;;14.2;23.3;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2013;2013;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;;Number;43;43;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;NMBR;RACE;WHT;;;;
2013;2013;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2013;2013;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2013;2013;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;11.04;11.04;;;10.73;11.35;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2013;2013;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;;Number;51;51;;;;;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2013;2013;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2013;2013;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2013;2013;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;19.8;19.8;;;15.1;25.5;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;99;99;;;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;NMBR;RACE;HIS;;;;
2013;2013;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2013;2013;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;NMBR;RACE;AIAN;;;;
2013;2013;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;NMBR;RACE;AIAN;;;;
2013;2013;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;5.70;5.7;;;5.52;5.88;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2013;2013;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;34.59;34.59;;;32.74;36.44;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2013;2013;TX;Texas;NVSS;Asthma;Asthma mortality rate;;;Number;124;124;;;;;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;NMBR;GENDER;GENF;;;;
2013;2013;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;;Number;36;36;;;;;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2013;2013;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;NMBR;RACE;AIAN;;;;
2013;2013;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2013;2013;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;NMBR;RACE;AIAN;;;;
2013;2013;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2013;2013;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;CRDRATE;RACE;API;;;;
2013;2013;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2013;2013;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;;Number;192;192;;;;;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2013;2013;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.1;7.1;;;5.5;8.6;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;NMBR;RACE;API;;;;
2013;2013;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2013;2013;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2013;2013;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2013;2013;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;6.43;6.43;;;6.11;6.76;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.2;9.2;;;6.8;12.1;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2013;2013;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST4_1;NMBR;GENDER;GENF;;;;
2013;2013;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;10.03;10.03;;;9.72;10.35;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2013;2013;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;14.15;14.15;;;11.33;16.96;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.5;10.5;;;7.5;14.4;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2013;2013;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2013;2013;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;NMBR;RACE;API;;;;
2013;2013;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;3.89;3.89;;;2.89;4.89;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;VI;Virgin Islands;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;5.00;5;;;4.78;5.22;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;;Number;42;42;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;NMBR;RACE;BLK;;;;
2013;2013;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.9;12.9;;;10.6;15.2;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2013;2013;FL;Florida;NVSS;Asthma;Asthma mortality rate;;;Number;31;31;;;;;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;NMBR;RACE;HIS;;;;
2013;2013;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;2.15;2.15;;;1.61;2.68;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;CRDRATE;RACE;API;;;;
2013;2013;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2013;2013;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;NMBR;GENDER;GENM;;;;
2013;2013;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;NMBR;RACE;BLK;;;;
2013;2013;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2013;2013;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;PR;Puerto Rico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;11.57;11.57;;;10.18;12.97;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2013;2013;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2013;2013;MT;Montana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;NMBR;RACE;WHT;;;;
2013;2013;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.3;8.3;;;5.5;12;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;VI;Virgin Islands;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.6;7.6;;;4.9;11.3;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2013;2013;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;9.28;9.28;;;9.01;9.55;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;NMBR;RACE;AIAN;;;;
2013;2013;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;47514;47,514;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;NMBR;RACE;BLK;;;;
2013;2013;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;4.18;4.18;;;3.77;4.6;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2013;2013;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2013;2013;PR;Puerto Rico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2013;2013;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.5;7.5;;;5.5;10;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2013;2013;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;NMBR;RACE;BLK;;;;
2013;2013;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;14.68;14.68;;;14.51;14.85;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2013;2013;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;8.78;8.78;;;8.48;9.08;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2013;2013;GU;Guam;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2013;2013;GU;Guam;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;FL;Florida;NVSS;Asthma;Asthma mortality rate;;;Number;52;52;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;NMBR;RACE;BLK;;;;
2013;2013;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;770;770;;;;;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;NMBR;RACE;HIS;;;;
2013;2013;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;CRDRATE;RACE;API;;;;
2013;2013;VI;Virgin Islands;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;AK;Alaska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;GU;Guam;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;PR;Puerto Rico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;3011;3,011;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;NMBR;RACE;WHT;;;;
2013;2013;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.8;8.8;;;6.6;11.6;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2013;2013;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;CRDRATE;RACE;API;;;;
2013;2013;TN;Tennessee;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2013;2013;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;CRDRATE;RACE;API;;;;
2013;2013;VI;Virgin Islands;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2013;2013;TN;Tennessee;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;447;447;;;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;NMBR;RACE;HIS;;;;
2013;2013;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;6.97;6.97;;;6.36;7.58;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;PR;Puerto Rico;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2013;2013;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;NMBR;RACE;AIAN;;;;
2013;2013;PR;Puerto Rico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;ND;North Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST2_1;NMBR;GENDER;GENM;;;;
2013;2013;GU;Guam;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2013;2013;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;NMBR;RACE;AIAN;;;;
2013;2013;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2013;2013;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;VI;Virgin Islands;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2013;2013;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2013;2013;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;6.14;6.14;;;5.86;6.41;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;GU;Guam;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2013;2013;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;32.0;32;;;22.4;44.4;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2013;2013;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;;Number;27;27;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;NMBR;RACE;WHT;;;;
2013;2013;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;NMBR;RACE;API;;;;
2013;2013;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;12383;12,383;;;;;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2013;2013;GU;Guam;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;25.07;25.07;;;24.55;25.58;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2013;2013;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;27.47;27.47;;;26.89;28.05;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2013;2013;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.7;8.7;;;6.3;11.8;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2013;2013;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;NMBR;RACE;API;;;;
2013;2013;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;5.01;5.01;;;4.46;5.56;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;ID;Idaho;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2013;2013;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;CRDRATE;RACE;API;;;;
2013;2013;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;;Number;53;53;;;;;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2013;2013;PR;Puerto Rico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;VI;Virgin Islands;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST2_1;NMBR;GENDER;GENM;;;;
2013;2013;WA;Washington;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;NMBR;RACE;HIS;;;;
2013;2013;NH;New Hampshire;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1765;1,765;;;;;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;NMBR;GENDER;GENM;;;;
2013;2013;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.6;9.6;;;6.5;13.7;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.6;33.6;;;21.6;48.2;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;25;25;;;;;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;NMBR;GENDER;GENM;;;;
2013;2013;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2013;2013;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;UT;Utah;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;NMBR;RACE;AIAN;;;;
2013;2013;PR;Puerto Rico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST2_1;NMBR;GENDER;GENM;;;;
2013;2013;GU;Guam;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;3.41;3.41;;;2.82;3.99;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.0;9;;;7.3;10.8;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2013;2013;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.8;10.8;;;9.3;12.2;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;PR;Puerto Rico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST2_1;NMBR;GENDER;GENF;;;;
2013;2013;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;NMBR;RACE;API;;;;
2013;2013;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2013;2013;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;8.69;8.69;;;8.22;9.16;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2013;2013;VI;Virgin Islands;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;598;598;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;NMBR;RACE;BLK;;;;
2013;2013;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2013;2013;GU;Guam;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST2_1;NMBR;GENDER;GENF;;;;
2013;2013;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;NMBR;RACE;API;;;;
2013;2013;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.2;7.2;;;4.8;10.5;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;NMBR;RACE;HIS;;;;
2013;2013;VI;Virgin Islands;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;CRDRATE;RACE;API;;;;
2013;2013;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;;Number;62;62;;;;;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2013;2013;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2013;2013;PR;Puerto Rico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2013;2013;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;NMBR;RACE;HIS;;;;
2013;2013;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;;Number;27;27;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;NMBR;RACE;WHT;;;;
2013;2013;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;;Number;59;59;;;;;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;NMBR;GENDER;GENF;;;;
2013;2013;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2013;2013;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.2;8.2;;;5.7;11.3;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;GU;Guam;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST2_1;NMBR;GENDER;GENM;;;;
2013;2013;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;17.1;17.1;;;11;25.4;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;VI;Virgin Islands;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2013;2013;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2013;2013;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2013;2013;VI;Virgin Islands;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2013;2013;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;7.37;7.37;;;7.12;7.62;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2013;2013;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2013;2013;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;NMBR;GENDER;GENM;;;;
2013;2013;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;22.7;22.7;;;16;31.2;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2013;2013;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;25.74;25.74;;;24.12;27.36;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;59;59;;;;;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;NMBR;GENDER;GENF;;;;
2013;2013;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;11.55;11.55;;;11.06;12.03;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;NMBR;RACE;WHT;;;;
2013;2013;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2013;2013;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;NMBR;GENDER;GENF;;;;
2013;2013;VI;Virgin Islands;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.5;11.5;;;7.6;16.8;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2013;2013;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2013;2013;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;4.57;4.57;;;3.96;5.17;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2013;2013;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;8.25;8.25;;;8.02;8.48;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;CRDRATE;RACE;API;;;;
2013;2013;PR;Puerto Rico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;NMBR;RACE;HIS;;;;
2013;2013;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;15.4;15.4;;;9.6;23.6;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2013;2013;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2013;2013;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;CRDRATE;RACE;API;;;;
2013;2013;IL;Illinois;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST2_1;NMBR;GENDER;GENM;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.5;87.5;;;76.5;93.8;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.2;13.2;;;9.1;18.8;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.7;12.7;;;8.4;18.7;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.9;44.9;;;34.8;55.4;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.1;41.1;;;32.6;50.2;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.6;34.6;;;26;44.4;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;KS;Kansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.7;11.7;;;6.7;19.8;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;60.4;60.4;;;49.2;70.6;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.7;12.7;;;7.5;20.6;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38;38;;;23.7;54.6;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2013;2013;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.5;45.5;;;38.9;52.2;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.3;10.3;;;9.5;11.1;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.3;9.3;;;8;10.7;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2013;2013;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;141.90;141.9;;;137.7;146.1;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;DE;Delaware;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;7.1;7.1;;;5.4;9.3;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.4;6.4;;;5.5;7.3;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;TN;Tennessee;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.1;6.1;;;4.6;8.1;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;MS;Mississippi;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.3;7.3;;;6.1;8.8;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.0;8;;;6.5;9.8;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.4;13.4;;;11.8;15.1;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.8;6.8;;;4.3;10.8;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2013;2013;MA;Massachusetts;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.4;13.4;;;11.1;16.1;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;33.7;33.7;;;33.3;34;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.7;6.7;;;5.6;8;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.6;7.6;;;6.5;8.9;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.7;28.7;;;19.3;40.3;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;40.1;40.1;;;39.4;40.9;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;30.4;30.4;;;18.5;45.6;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.3;35.3;;;29.4;41.6;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;5.5;5.5;;;4.2;7.3;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.4;12.4;;;11.2;13.7;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;40.8;40.8;;;38.4;43.2;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;US;United States;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.3;11.3;*;50 States + DC: US Median;11;12.4;Gender;Female;;;;;;;59;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;DE;Delaware;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.8;45.8;;;33.1;59.1;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.8;13.8;;;11.1;17.1;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.7;40.7;;;35.6;46;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;15.1;15.1;;;13.5;16.9;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.9;39.9;;;28;53.1;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.1;8.1;;;7;9.3;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.2;12.2;;;10.4;14.2;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;SD;South Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;CA;California;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.7;9.7;;;8.2;11.4;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.7;46.7;;;42.2;51.2;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.9;9.9;;;9.1;10.9;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.1;6.1;;;3.7;9.9;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.4;6.4;;;5.5;7.5;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2013;2013;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;45.6;45.6;;;44.5;46.7;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;MA;Massachusetts;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST2_1;NMBR;GENDER;GENF;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;7.9;7.9;;;6.5;9.6;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.1;13.1;;;11.3;15.1;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.8;47.8;;;31.6;64.5;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.6;9.6;;;8.2;11.1;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2013;2013;SD;South Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.1;12.1;;;10.9;13.4;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.1;28.1;;;20.4;37.4;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.3;8.3;;;7;9.9;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.6;10.6;;;8.9;12.6;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.7;13.7;;;11;17.1;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;VA;Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.0;10;;;8.4;11.8;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.4;8.4;;;7.4;9.5;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;CA;California;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2013;2013;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;66.7;66.7;;;60.7;72.7;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2013;2013;ID;Idaho;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.4;12.4;;;11.1;13.8;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50;50;;;42.4;57.6;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.0;7;;;5.9;8.4;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;17.9;17.9;;;13.6;23.1;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.7;8.7;;;7.8;9.7;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;28.8;28.8;;;28.1;29.6;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;AL;Alabama;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.7;8.7;;;8.1;9.4;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.9;9.9;;;8.6;11.5;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.5;40.5;;;30.4;51.4;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;8.2;8.2;;;6.9;9.7;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2013;2013;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.9;6.9;;;5.8;8.2;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.8;11.8;;;6.8;19.5;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.7;6.7;;;4.1;10.8;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.9;34.9;;;27.7;42.8;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;NMBR;RACE;BLK;;;;
2013;2013;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;55.1;55.1;;;53.8;56.3;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;474;474;;;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;NMBR;RACE;AIAN;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.4;33.4;;;23.7;44.7;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.2;8.2;;;7.3;9.2;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.1;7.1;;;6.3;8;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.8;8.8;;;7.3;10.6;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.8;10.8;;;9.7;12;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;16.7;16.7;;;11.1;24.4;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.1;35.1;;;26.9;44.3;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;6.9;6.9;;;4.4;10.6;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2013;2013;ND;North Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.4;10.4;;;5.8;18.2;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.9;40.9;;;31.9;50.5;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.4;35.4;;;28.2;43.3;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;MI;Michigan;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.3;37.3;;;28.9;46.6;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2013;2013;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;18925;18,925;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;NMBR;RACE;BLK;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;7.3;7.3;;;4.6;11.4;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2013;2013;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;30003;30,003;;;;;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;NMBR;GENDER;GENM;;;;
2013;2013;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;243.0;243;;;241.2;244.7;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.7;32.7;;;26;40.2;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;23.7;23.7;;;16;33.6;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;19.1;19.1;;;17.3;20.9;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2013;2013;IL;Illinois;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.2;12.2;;;10.9;13.7;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2013;2013;OK;Oklahoma;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.4;44.4;;;37.2;51.9;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.1;8.1;;;7.3;9.1;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.7;10.7;;;8.7;13.1;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2013;2013;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;44.0;44;;;42.2;45.7;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;52.3;52.3;;;44.3;60.2;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.3;38.3;;;30.5;46.8;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.7;43.7;;;38.2;49.4;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.1;43.1;;;40;46.3;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;52.5;52.5;;;47.7;57.3;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.4;9.4;;;6.1;14.2;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.1;44.1;;;37.2;51.2;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.1;10.1;;;8.9;11.6;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.0;7;;;5.8;8.3;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.3;10.3;;;8.9;11.8;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.3;41.3;;;33.7;49.4;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;AR;Arkansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.3;36.3;;;27.7;45.8;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;41.7;41.7;;;41.1;42.4;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2013;2013;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;44.2;44.2;;;43.4;45;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.2;6.2;;;4.4;8.7;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2013;2013;DC;District of Columbia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST2_1;NMBR;GENDER;GENM;;;;
2013;2013;MN;Minnesota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST2_1;NMBR;GENDER;GENM;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.4;8.4;;;7.6;9.2;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.2;7.2;;;6.4;8.1;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.4;9.4;;;8.6;10.3;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.2;8.2;;;4.9;13.5;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;2232;2,232;;;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;NMBR;RACE;HIS;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.8;46.8;;;41;52.8;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.5;11.5;;;10.1;12.9;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.2;35.2;;;27.3;44;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.5;38.5;;;31.6;45.8;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.7;45.7;;;40.1;51.3;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;1410;1,410;;;;;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;NMBR;GENDER;GENF;;;;
2013;2013;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;3.6;3.6;;;2.1;5.8;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;50.2;50.2;;;49.5;50.8;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2013;2013;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;146.20;146.2;;;144.9;147.5;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;3.7;3.7;;;2.8;4.7;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2013;2013;MA;Massachusetts;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.9;13.9;;;11.8;16.3;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2013;2013;UT;Utah;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST2_1;NMBR;GENDER;GENF;;;;
2013;2013;ID;Idaho;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST2_1;NMBR;GENDER;GENM;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.4;14.4;;;12.3;16.8;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;DE;Delaware;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;PA;Pennsylvania;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.0;8;;;6.7;9.5;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2013;2013;ND;North Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST2_1;NMBR;GENDER;GENF;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.2;8.2;;;6.7;10;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.1;44.1;;;35;53.6;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.5;6.5;;;4.1;10.2;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.9;9.9;;;8.8;11.1;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2013;2013;NH;New Hampshire;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST2_1;NMBR;GENDER;GENM;;;;
2013;2013;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.7;8.7;;;7.6;9.9;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;55.8;55.8;;;54.8;56.7;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2013;2013;TX;Texas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50.7;50.7;;;43.9;57.5;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;DC;District of Columbia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.6;6.6;;;4.2;10.3;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.0;10;;;7.4;13.5;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;7.0;7;;;5.6;8.6;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.9;10.9;;;8;14.6;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;51.2;51.2;;;45.7;56.8;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;23.8;23.8;;;15.9;34;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2013;2013;MO;Missouri;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.0;7;;;4.3;11.2;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2013;2013;HI;Hawaii;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2013;2013;MI;Michigan;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST2_1;NMBR;GENDER;GENF;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.6;8.6;;;7.6;9.8;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.5;11.5;;;10.4;12.7;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2013;2013;DC;District of Columbia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;NH;New Hampshire;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;65.7;65.7;;;50.1;78.4;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.0;7;;;5.6;8.7;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;WV;West Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.0;8;;;7.2;9;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;8.2;8.2;;;6.6;10.2;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.3;11.3;;;9.4;13.5;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.7;31.7;;;26.6;37.2;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;50.6;50.6;;;42.2;59.1;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;67.7;67.7;;;60.9;74.5;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.2;9.2;;;7.7;10.9;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;7.2;7.2;;;5.4;9.6;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.7;9.7;;;8;11.6;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.7;11.7;;;10.6;13;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.3;11.3;;;10.2;12.5;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2013;2013;DC;District of Columbia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.5;43.5;;;38.4;48.8;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.8;46.8;;;39;54.8;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.7;10.7;;;8.7;13.1;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.4;37.4;;;31.9;43.2;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;WY;Wyoming;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST2_1;NMBR;GENDER;GENM;;;;
2013;2013;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;1916;1,916;;;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;NMBR;RACE;HIS;;;;
2013;2013;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;72357;72,357;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;NMBR;RACE;BLK;;;;
2013;2013;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;91.20;91.2;;;90.8;91.6;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;MS;Mississippi;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.2;9.2;;;7.9;10.7;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2013;2013;TN;Tennessee;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST2_1;NMBR;GENDER;GENM;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.7;11.7;;;9.6;14.1;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;CRDRATE;RACE;API;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;25.2;25.2;;;16.7;36.1;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2013;2013;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;36193;36,193;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;NMBR;RACE;WHT;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.5;7.5;;;6.7;8.3;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.0;9;;;7.7;10.6;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;CT;Connecticut;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.0;11;;;7.4;16;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.1;10.1;;;7.4;13.6;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;36215;36,215;;;;;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;NMBR;GENDER;GENF;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.7;6.7;;;5;8.9;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;49.9;49.9;;;42.4;57.4;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;196.7;196.7;;;192.4;201;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2013;2013;SD;South Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.4;49.4;;;43.6;55.2;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;31.8;31.8;;;31.5;32.2;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;AK;Alaska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.9;11.9;;;10.8;13.2;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2013;2013;MA;Massachusetts;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;244.7;244.7;;;242.9;246.5;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;KS;Kansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.7;8.7;;;8.1;9.4;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;MI;Michigan;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2013;2013;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;15.70;15.7;;;14;17.3;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;CRDRATE;RACE;API;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.4;41.4;;;28;56.2;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2013;2013;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;2385;2,385;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;NMBR;RACE;WHT;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.1;45.1;;;38.6;51.7;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;OR;Oregon;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2013;2013;VA;Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;AR;Arkansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;NH;New Hampshire;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;5.9;5.9;;;4.3;8.1;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2013;2013;DE;Delaware;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;25.3;25.3;;;13.4;42.5;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.7;38.7;;;26.2;52.9;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.1;9.1;;;8;10.4;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44;44;;;38.9;49.3;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;50.9;50.9;;;36.4;65.3;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;1134;1,134;;;;;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;NMBR;GENDER;GENM;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2013;2013;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;144.70;144.7;;;140.1;149.4;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.5;38.5;;;31.5;46;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;58.4;58.4;;;52.2;64.3;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.9;8.9;;;7.7;10.4;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.9;9.9;;;7.1;13.6;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.2;5.2;;;3.4;8;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;UT;Utah;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.2;9.2;;;7.9;10.7;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2013;2013;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;67.2;67.2;;;66.4;67.9;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.9;37.9;;;30.8;45.6;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.9;11.9;;;10.8;13.1;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;6.8;6.8;;;4.7;9.6;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.6;8.6;;;7.9;9.4;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29.1;29.1;;;20.9;38.9;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.4;41.4;;;35.3;47.8;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.6;32.6;;;26.4;39.5;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.9;48.9;;;43.4;54.4;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.6;35.6;;;28.5;43.4;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;22.8;22.8;;;12.5;38;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.6;34.6;;;28.2;41.6;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.8;39.8;;;30.7;49.6;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;53.1;53.1;;;46.2;59.9;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;4.6;4.6;;;3.4;6.2;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.4;11.4;;;6.9;18.2;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.7;8.7;;;7.6;9.9;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;NMBR;RACE;AIAN;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.6;7.6;;;6.7;8.6;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;24084;24,084;;;;;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;NMBR;GENDER;GENM;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.7;10.7;;;9.5;12.1;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.0;13;;;10.7;15.8;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;22.6;22.6;;;13.9;34.6;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;8.9;8.9;;;6.8;11.6;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.4;47.4;;;43.6;51.2;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2013;2013;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;40.1;40.1;;;38.5;41.7;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;8.2;8.2;;;6.1;11;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.1;9.1;;;5.1;15.7;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.4;9.4;;;8.5;10.4;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.2;43.2;;;35.4;51.3;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;8.8;8.8;;;7;10.9;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2013;2013;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.3;12.3;;;9.8;15.3;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;26.6;26.6;;;18.3;37;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.8;40.8;;;31.3;51;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.6;10.6;;;9.7;11.7;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;149.20;149.2;;;144.4;154;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;150.60;150.6;;;146.1;155;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.0;8;;;4.9;12.8;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.7;33.7;;;23.4;45.9;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.9;13.9;;;12;16;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.1;11.1;;;10.4;11.8;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.2;7.2;;;6.2;8.4;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.8;6.8;;;6.2;7.5;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.7;41.7;;;35.5;48.2;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;58.1;58.1;;;57.1;59.1;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;18.0;18;;;14.1;22.7;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.7;12.7;;;7.2;21.4;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.2;44.2;;;40.8;47.7;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;OR;Oregon;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.5;5.5;;;4.8;6.4;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;51.4;51.4;;;43.1;59.7;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.0;11;;;9.5;12.7;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2013;2013;ID;Idaho;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;18.2;18.2;;;10.9;28.7;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;15.4;15.4;;;12.4;19;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.8;38.8;;;32.1;45.9;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.4;6.4;;;4.1;9.8;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;MS;Mississippi;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;HI;Hawaii;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST2_1;NMBR;GENDER;GENM;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.8;7.8;;;6.7;9.1;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.5;35.5;;;26.7;45.4;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.9;43.9;;;36.8;51.2;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.0;14;;;11.3;17;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.4;46.4;;;39.5;53.4;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.3;10.3;;;9.3;11.4;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.0;10;;;6.1;16;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2013;2013;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;49.4;49.4;;;48.6;50.1;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.8;9.8;;;7;13.5;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.6;5.6;;;3.3;9.2;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;LA;Louisiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST2_1;NMBR;GENDER;GENF;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.0;9;;;8.3;9.8;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;1562;1,562;;;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;NMBR;RACE;AIAN;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.2;39.2;;;30.5;48.7;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.3;44.3;;;36.2;52.7;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.5;10.5;;;9.5;11.6;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47;47;;;40.3;53.9;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.1;12.1;;;8.6;16.8;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;98.60;98.6;;;98;99.3;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.3;13.3;;;11.7;15;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.2;11.2;;;8.4;14.8;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.5;11.5;;;10.7;12.4;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;32.5;32.5;;;31.3;33.6;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;CO;Colorado;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST2_1;NMBR;GENDER;GENF;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.6;8.6;;;7.8;9.4;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.0;8;;;5.7;11.1;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2013;2013;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;141.60;141.6;;;139.6;143.6;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.5;11.5;;;9.3;14.1;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.8;7.8;;;6.7;8.9;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2013;2013;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;65.9;65.9;;;65.1;66.6;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;10915;10,915;;;;;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;NMBR;GENDER;GENM;;;;
2013;2013;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;4.6;4.6;;;3.8;5.5;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2013;2013;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;33.1;33.1;;;30.4;35.9;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2013;2013;HI;Hawaii;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;VA;Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.2;13.2;;;12;14.4;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.1;9.1;;;8.6;9.7;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2013;2013;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;14.90;14.9;;;14;15.8;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.2;43.2;;;40.1;46.4;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.9;5.9;;;5;7;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;49.8;49.8;;;42.2;57.4;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;24.4;24.4;;;17.8;32.5;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;38.3;38.3;;;37.3;39.3;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.4;34.4;;;26.9;42.8;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.7;14.7;;;10.9;19.4;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.1;33.1;;;22.6;45.5;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2013;2013;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;3.3;3.3;;;2;5.4;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.8;9.8;;;8.1;11.9;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2013;2013;WA;Washington;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST2_1;NMBR;GENDER;GENM;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.7;14.7;;;8.9;23.3;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;24.8;24.8;;;16.1;36.2;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.5;37.5;;;22.1;56;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.7;5.7;;;4.9;6.6;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2013;2013;MD;Maryland;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2013;2013;HI;Hawaii;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;72.1;72.1;;;67.2;76.9;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.3;11.3;;;10.2;12.4;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.2;7.2;;;6.3;8.1;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2013;2013;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;43.8;43.8;;;42;45.6;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;US;United States;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.7;11.7;*;50 States + DC: US Median;11.2;12.9;Overall;Overall;;;;;;;59;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.9;8.9;;;7.6;10.4;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.8;42.8;;;36.1;49.7;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.9;46.9;;;40.7;53.1;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.1;11.1;;;8.8;13.9;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43;43;;;37.2;49;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2013;2013;IL;Illinois;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.8;38.8;;;31.1;47;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.3;11.3;;;7.6;16.5;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33;33;;;24.8;42.5;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;AL;Alabama;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST2_1;NMBR;GENDER;GENM;;;;
2013;2013;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.7;9.7;;;8.8;10.6;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.6;41.6;;;36.7;46.7;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.6;9.6;;;6.8;13.3;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.3;8.3;;;6.7;10.1;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;OR;Oregon;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST2_1;NMBR;GENDER;GENF;;;;
2013;2013;MO;Missouri;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.1;11.1;;;6.6;18;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.0;8;;;6.9;9.3;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;57;57;;;44.7;68.4;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.1;38.1;;;23.3;55.5;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.9;5.9;;;3.5;9.9;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.8;9.8;;;7.2;13.3;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.5;11.5;;;10.6;12.4;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39;39;;;29.3;49.8;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;5.0;5;;;2.9;8.4;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.3;6.3;;;5.5;7.3;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;7.7;7.7;;;5.9;10;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.7;43.7;;;36.9;50.7;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;KS;Kansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST2_1;NMBR;GENDER;GENM;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.4;7.4;;;6.2;8.8;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.4;46.4;;;37.4;55.7;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.5;5.5;;;4.6;6.7;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.1;13.1;;;9.4;17.9;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.9;12.9;;;8.8;18.6;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46;46;;;41.3;50.8;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.5;48.5;;;39.1;57.9;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.1;33.1;;;28;38.6;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;244;244;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;NMBR;RACE;API;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.3;47.3;;;42.1;52.6;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;35.0;35;;;34.5;35.4;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.2;12.2;;;6.8;20.9;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2013;2013;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;904;904;;;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;NMBR;RACE;HIS;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.4;13.4;;;8.7;20.2;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.9;9.9;;;7.2;13.4;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2013;2013;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.0;12;;;9.2;15.6;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.3;46.3;;;39.9;52.9;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.8;10.8;;;9.7;12.1;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;MN;Minnesota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.9;14.9;;;11.7;18.6;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;CT;Connecticut;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;28.3;28.3;;;17;43.3;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.2;6.2;;;4.8;8;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2013;2013;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;52.0;52;;;51.3;52.7;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;CT;Connecticut;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST2_1;NMBR;GENDER;GENF;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.1;35.1;;;26.2;45.1;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;17.1;17.1;;;10.2;27.3;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;PA;Pennsylvania;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.8;12.8;;;10.4;15.6;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.3;7.3;;;5.5;9.5;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.2;11.2;;;9.2;13.5;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.7;12.7;;;10.6;15.1;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2013;2013;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;52550;52,550;;;;;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2013;2013;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.5;11.5;;;9.4;14;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.6;6.6;;;4.9;8.8;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.6;7.6;;;6;9.6;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;62;62;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;NMBR;RACE;API;;;;
2013;2013;WY;Wyoming;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST2_1;NMBR;GENDER;GENF;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.9;6.9;;;5.7;8.4;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.9;9.9;;;9.2;10.7;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;MI;Michigan;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;8.3;8.3;;;7;9.8;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2013;2013;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;208.8;208.8;;;204.3;213.4;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.6;49.6;;;38.5;60.7;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.0;9;;;8;10.1;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2013;2013;TX;Texas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.0;11;;;7.1;16.8;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.1;36.1;;;28.9;44;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;17.0;17;;;12.6;22.5;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.1;8.1;;;7.1;9.2;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2013;2013;NM;New Mexico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32;32;;;27.1;37.3;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.9;13.9;;;11.4;16.8;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2013;2013;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;69.0;69;;;68.2;69.8;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.2;12.2;;;11.1;13.3;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;MA;Massachusetts;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.1;9.1;;;8.1;10.1;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;6.7;6.7;;;5;8.9;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.1;11.1;;;8.7;13.9;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;83146;83,146;;;;;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;NMBR;GENDER;GENM;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.9;12.9;;;8;20.1;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.2;12.2;;;10.1;14.8;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.4;34.4;;;22.3;49;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.5;13.5;;;12.2;14.9;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.3;8.3;;;6.5;10.6;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2013;2013;HI;Hawaii;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST2_1;NMBR;GENDER;GENF;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.9;32.9;;;22.9;44.8;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.3;47.3;;;38.9;55.8;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.0;9;;;8.4;9.7;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;MS;Mississippi;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST2_1;NMBR;GENDER;GENF;;;;
2013;2013;ND;North Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.2;39.2;;;33.1;45.7;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2013;2013;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;AR;Arkansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44;44;;;27.5;62;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.2;37.2;;;32.1;42.6;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.3;46.3;;;39.4;53.3;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2013;2013;WA;Washington;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;HI;Hawaii;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;4.3;4.3;;;3.4;5.3;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.9;37.9;;;26.5;50.9;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39;39;;;29.5;49.5;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;61.5;61.5;;;57.5;65.5;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;52.5;52.5;;;47.6;57.4;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;IL;Illinois;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2013;2013;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;32.7;32.7;;;32.2;33.1;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.6;6.6;;;4.2;10.4;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;23.2;23.2;;;17.3;30.4;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2013;2013;UT;Utah;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;RI;Rhode Island;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;US;United States;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.7;6.7;*;50 States + DC: US Median;6.2;7;Gender;Male;;;;;;;59;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2013;2013;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.7;9.7;;;8.9;10.6;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.1;10.1;;;8;12.7;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;38.3;38.3;;;37.6;39;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.1;45.1;;;29.5;61.8;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.1;10.1;;;8.8;11.6;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.0;10;;;5.6;17;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.4;10.4;;;9.4;11.4;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.6;32.6;;;24.4;42.1;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.0;13;;;8.4;19.6;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.1;10.1;;;7.9;12.8;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;PA;Pennsylvania;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST2_1;NMBR;GENDER;GENM;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.6;41.6;;;37.3;46;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;VA;Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.4;36.4;;;25.3;49.1;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.5;9.5;;;6;14.8;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.6;28.6;;;19.3;40.1;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.4;35.4;;;25.9;46.3;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.4;11.4;;;10.3;12.5;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.1;35.1;;;18.1;56.9;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.2;10.2;;;7.3;14;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.8;10.8;;;9.5;12.2;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2013;2013;MA;Massachusetts;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2013;2013;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.7;43.7;*;50 States + DC: US Median;41.4;46.3;Gender;Female;;;;;;;59;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.9;11.9;;;10.9;12.9;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.1;10.1;;;7.2;14.2;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;50;50;;;43.3;56.8;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;21.2;21.2;;;12.4;33.7;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;TX;Texas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST2_1;NMBR;GENDER;GENM;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.8;40.8;;;35.7;46.1;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.7;10.7;;;9.4;12.2;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.3;6.3;;;5.5;7.2;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.1;6.1;;;4.9;7.6;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.9;9.9;;;8.5;11.5;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;RI;Rhode Island;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;25;25;;;15.7;37.4;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2013;2013;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.2;42.2;;;36.6;48;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.8;41.8;;;32;52.4;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.1;14.1;;;11.9;16.6;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;20.7;20.7;;;14.5;28.8;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2013;2013;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.9;9.9;;;7.9;12.5;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.5;9.5;;;6.5;13.6;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;27.7;27.7;;;18.6;39;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.8;41.8;;;35.8;48;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.2;41.2;*;50 States + DC: US Median;38.6;43.5;Overall;Overall;;;;;;;59;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;CA;California;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;OR;Oregon;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST2_1;NMBR;GENDER;GENM;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.9;47.9;;;41.6;54.1;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2013;2013;UT;Utah;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2013;2013;GA;Georgia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;WV;West Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.0;12;;;7.8;18.1;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;49.4;49.4;;;44.2;54.7;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.5;37.5;;;30.7;44.8;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.9;9.9;;;8.9;11.1;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;TN;Tennessee;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.9;33.9;;;29;39.2;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;20.2;20.2;;;12.7;30.4;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;NH;New Hampshire;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.0;7;;;5.9;8.3;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2013;2013;VA;Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST2_1;NMBR;GENDER;GENF;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.4;8.4;;;7.7;9.2;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;74.3;74.3;;;73.8;74.9;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;SD;South Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.2;38.2;;;30.3;46.8;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.9;10.9;;;10.1;11.8;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2013;2013;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;14.80;14.8;;;11.8;17.8;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2013;2013;WV;West Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.3;6.3;;;5.4;7.4;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;8.4;8.4;;;7;10;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2013;2013;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;48.5;48.5;;;48;49;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;8.3;8.3;;;5.2;12.9;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2013;2013;CO;Colorado;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.6;7.6;;;6.3;9.3;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2013;2013;WY;Wyoming;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.1;14.1;;;11.5;17.1;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.4;6.4;;;5;8.3;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.7;7.7;;;4.7;12.4;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.2;9.2;;;5.7;14.5;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;OH;Ohio;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.5;45.5;;;39.6;51.6;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2013;2013;TX;Texas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2013;2013;MS;Mississippi;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST2_1;NMBR;GENDER;GENM;;;;
2013;2013;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;144;144;;;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;NMBR;RACE;AIAN;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.2;10.2;;;8.5;12.3;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;150.10;150.1;;;148.4;151.7;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;20.0;20;;;14.9;26.3;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.3;8.3;;;7.6;9;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.0;6;;;3.6;9.8;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.1;6.1;;;3.6;9.9;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;ID;Idaho;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.8;8.8;;;8;9.6;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.5;6.5;;;5.3;8;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50.5;50.5;;;44.5;56.5;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.2;43.2;;;32.8;54.3;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.2;28.2;;;18.2;40.8;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.9;45.9;;;36.8;55.3;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.1;39.1;;;31.7;47;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.8;7.8;;;7;8.6;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.2;6.2;;;3.7;10.2;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.5;11.5;;;9.4;14.1;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;MT;Montana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2013;2013;WA;Washington;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST2_1;NMBR;GENDER;GENF;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.8;46.8;;;41.3;52.4;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.7;44.7;;;32.5;57.6;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;56463;56,463;;;;;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;NMBR;GENDER;GENM;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.6;5.6;;;4.5;6.9;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.9;10.9;;;10.3;11.6;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;4.0;4;;;2.6;6.2;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.9;8.9;;;8.4;9.4;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.7;14.7;;;13.1;16.4;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.6;41.6;;;35.9;47.5;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;MN;Minnesota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST2_1;NMBR;GENDER;GENF;;;;
2013;2013;CT;Connecticut;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;44.2;44.2;;;43.3;45.1;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.3;5.3;;;3;9.2;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;52.8;52.8;;;47;58.5;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.8;38.8;;;34.2;43.6;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;24.6;24.6;;;17.1;34;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.4;12.4;;;11;13.9;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.9;36.9;;;23.2;53.1;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;8.2;8.2;;;6;11.2;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.4;8.4;;;6;11.8;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;GA;Georgia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST2_1;NMBR;GENDER;GENM;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.5;11.5;;;9.7;13.7;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;16.6;16.6;;;13.3;20.6;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;AK;Alaska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2013;2013;CT;Connecticut;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2013;2013;OH;Ohio;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;49.8;49.8;;;43.8;55.8;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.6;11.6;;;10.5;12.8;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;VA;Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.8;10.8;;;9.7;12.1;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.0;5;;;3.7;6.8;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2013;2013;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;12781;12,781;;;;;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;NMBR;GENDER;GENF;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.4;11.4;;;9.1;14.2;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.4;36.4;;;31.3;41.8;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;TN;Tennessee;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.8;13.8;;;7.7;23.7;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.8;9.8;;;6;15.7;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.8;14.8;;;13.2;16.7;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.1;9.1;;;8.2;10;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2013;2013;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;54.4;54.4;;;51.7;57.1;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.9;37.9;;;25.6;52.1;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.3;8.3;;;7.4;9.3;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.9;12.9;;;10.6;15.6;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2013;2013;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;15.80;15.8;;;13.8;17.8;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;CRDRATE;RACE;API;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.8;8.8;;;7.7;10.1;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.6;41.6;;;35;48.5;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50.3;50.3;;;39.4;61.2;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.5;8.5;;;7.6;9.5;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.3;8.3;;;6.8;10.1;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.4;36.4;*;50 States + DC: US Median;35;39.2;Gender;Male;;;;;;;59;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;IN;Indiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST2_1;NMBR;GENDER;GENF;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;26.7;26.7;;;25.7;27.8;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.1;40.1;;;34.1;46.5;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.2;6.2;;;4.7;8.2;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2013;2013;CO;Colorado;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.4;10.4;;;7.4;14.4;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49;49;;;40.7;57.2;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2013;2013;DC;District of Columbia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.1;14.1;;;11.3;17.4;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;RI;Rhode Island;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST2_1;NMBR;GENDER;GENM;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.7;10.7;;;9.8;11.8;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2013;2013;IL;Illinois;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;25.1;25.1;;;17.2;35;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;128;128;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;NMBR;RACE;API;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.4;11.4;;;6.8;18.6;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.2;41.2;;;35.8;46.9;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.1;42.1;;;28.9;56.5;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.7;37.7;;;30.6;45.5;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.3;37.3;;;31.2;43.8;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.9;41.9;;;27.2;58.1;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;139;139;;;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;NMBR;RACE;AIAN;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;6.7;6.7;;;4.4;10;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;7692;7,692;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;NMBR;RACE;WHT;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2013;2013;NH;New Hampshire;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.1;8.1;;;6.7;9.9;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.6;6.6;;;5.6;7.8;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;34.6;34.6;;;33.6;35.5;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.5;7.5;;;6.3;8.8;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;RI;Rhode Island;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.6;38.6;;;28.2;50.3;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.5;11.5;;;10.3;12.9;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.1;11.1;;;9.6;12.8;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.3;13.3;;;8.4;20.3;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43;43;;;36.3;50;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42;42;;;31.6;53.1;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;CA;California;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.4;9.4;;;5.6;15.4;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.6;8.6;;;7.8;9.5;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;4.9;4.9;;;3.6;6.7;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.5;35.5;;;25.1;47.4;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.9;8.9;;;7.1;11;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.4;6.4;;;4.7;8.7;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.7;13.7;;;11.7;16;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.1;37.1;;;31.5;43.2;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;21.2;21.2;;;12.3;34.1;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.2;37.2;;;32.5;42.2;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.1;45.1;;;39.2;51.2;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.2;6.2;;;5.4;7;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;70.8;70.8;;;70.4;71.2;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.2;43.2;;;37.9;48.7;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;AK;Alaska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.9;7.9;;;4.9;12.4;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.2;9.2;;;7.6;11;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.4;43.4;;;38.7;48.3;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;TN;Tennessee;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.1;9.1;;;7.1;11.6;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.1;12.1;;;6.7;20.8;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;8.5;8.5;;;6.5;11;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.4;10.4;;;8;13.3;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2013;2013;MN;Minnesota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.8;38.8;;;31.7;46.3;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.4;10.4;;;7.7;13.9;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;218.7;218.7;;;216.1;221.4;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;163.50;163.5;;;159.4;167.6;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.3;40.3;;;34.5;46.3;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;MD;Maryland;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.7;5.7;;;4.4;7.4;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.4;8.4;;;7.6;9.4;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.1;44.1;;;29.7;59.6;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.9;40.9;;;30.4;52.2;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2013;2013;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;17.5;17.5;;;14.4;21.1;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.7;37.7;;;33.6;42.1;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2013;2013;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;29.0;29;;;27.8;30.2;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.0;9;;;6.9;11.6;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.5;12.5;;;10.6;14.6;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.4;30.4;;;23.5;38.3;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.7;7.7;;;6.4;9.4;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.8;35.8;;;30.7;41.2;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2013;2013;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;78.7;78.7;;;68.2;89.1;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.0;10;;;8.6;11.5;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29.9;29.9;;;19.5;42.8;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.6;9.6;;;8.3;11.2;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;15.3;15.3;;;8.6;25.9;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.5;31.5;;;21.6;43.5;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;GA;Georgia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2013;2013;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;17.50;17.5;;;15.9;19.1;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;CRDRATE;RACE;API;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2013;2013;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;2545;2,545;;;;;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.8;10.8;;;7.2;16.1;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.9;47.9;;;41.5;54.4;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;51.8;51.8;;;36.9;66.4;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.6;11.6;;;10.4;13;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.2;41.2;;;36;46.5;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;OK;Oklahoma;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST2_1;NMBR;GENDER;GENF;;;;
2013;2013;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;95.40;95.4;;;94.9;95.8;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;MA;Massachusetts;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST2_1;NMBR;GENDER;GENM;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.2;9.2;;;8.4;10.1;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.7;7.7;;;6.3;9.3;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.1;34.1;;;28.9;39.7;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2013;2013;OK;Oklahoma;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2013;2013;SD;South Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.8;7.8;;;6.7;8.9;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2013;2013;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;41.5;41.5;;;41.1;41.9;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2013;2013;OR;Oregon;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;MT;Montana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.1;40.1;;;34;46.4;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;CA;California;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;AL;Alabama;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.9;7.9;;;6.8;9.2;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;1138;1,138;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;NMBR;RACE;API;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.9;10.9;;;8.4;13.9;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;14867;14,867;;;;;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;NMBR;GENDER;GENM;;;;
2013;2013;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;40.6;40.6;;;39;42.2;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;MD;Maryland;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;231;231;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;NMBR;RACE;API;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;16.0;16;;;12.2;20.8;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.7;6.7;;;5.6;8;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2013;2013;MD;Maryland;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.9;6.9;;;6;7.8;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;3723;3,723;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;NMBR;RACE;BLK;;;;
2013;2013;MT;Montana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST2_1;NMBR;GENDER;GENM;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;50.8;50.8;;;50;51.5;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;26.5;26.5;;;15.1;42.2;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;4.7;4.7;;;3.4;6.4;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2013;2013;OR;Oregon;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2013;2013;MS;Mississippi;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2013;2013;CA;California;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;6.5;6.5;;;5.2;8.2;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.3;7.3;;;6.6;8;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.1;47.1;;;41;53.3;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.5;9.5;;;8.6;10.5;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2013;2013;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;851;851;;;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;NMBR;RACE;AIAN;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.4;41.4;;;33.5;49.8;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.9;38.9;;;31.2;47.3;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;LA;Louisiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.4;10.4;;;8.6;12.5;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.6;11.6;;;10.7;12.7;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.3;11.3;;;10.3;12.4;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;DE;Delaware;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST2_1;NMBR;GENDER;GENM;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;99;99;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;NMBR;RACE;BLK;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.6;5.6;;;4.4;6.9;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;OR;Oregon;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.4;10.4;;;8.2;13.1;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.0;10;;;9;11;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;CA;California;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST2_1;NMBR;GENDER;GENM;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.9;5.9;;;4.7;7.5;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.3;7.3;;;6.6;8;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.3;12.3;;;8.7;17;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2013;2013;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;44.9;44.9;;;43.8;46;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.2;8.2;;;7.6;8.9;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;26.1;26.1;;;17.4;37.3;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.7;9.7;;;8.3;11.3;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;27.8;27.8;;;19.4;38;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;CRDRATE;RACE;API;;;;
2013;2013;AL;Alabama;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;8.4;8.4;;;6.6;10.8;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.6;5.6;;;4.7;6.7;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.8;12.8;;;11.6;14.1;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;NMBR;RACE;AIAN;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2013;2013;WY;Wyoming;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.5;42.5;;;36;49.2;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.5;10.5;;;8.9;12.4;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2013;2013;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;26060;26,060;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;NMBR;RACE;BLK;;;;
2013;2013;SD;South Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST2_1;NMBR;GENDER;GENM;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;CA;California;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;ME;Maine;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2013;2013;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;145.00;145;;;143.7;146.2;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2013;2013;MD;Maryland;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.8;9.8;;;6;15.7;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.3;11.3;;;6.4;19.3;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.6;40.6;;;23.5;60.3;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2013;2013;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;8.6;8.6;;;7.5;9.7;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;CRDRATE;RACE;API;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.7;10.7;;;9;12.5;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.9;13.9;;;11.4;16.9;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.7;35.7;;;30.2;41.6;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2013;2013;CT;Connecticut;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50.3;50.3;;;41.3;59.4;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;52.5;52.5;;;46.8;58.2;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.7;11.7;;;9.2;14.8;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;87.3;87.3;;;85.9;88.7;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;52.2;52.2;;;45;59.2;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.8;47.8;;;40.2;55.5;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;ME;Maine;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2013;2013;IN;Indiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.4;37.4;;;28.6;47.1;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;31.3;31.3;;;23.3;39.4;Race/Ethnicity;American Indian or Alaska Native;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.4;5.4;;;3.3;8.7;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.5;33.5;;;28.5;38.9;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.4;8.4;;;7.6;9.2;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.4;10.4;;;9.2;11.7;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;219.1;219.1;;;216.4;221.8;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2013;2013;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;204.7;204.7;;;196.7;212.7;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;MD;Maryland;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;PA;Pennsylvania;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.3;11.3;;;6.8;18;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;OH;Ohio;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.1;13.1;;;7.7;21.6;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;27.7;27.7;;;19;38.5;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.7;12.7;;;11.2;14.3;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;MS;Mississippi;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.2;41.2;;;35.5;47.1;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2013;2013;TN;Tennessee;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.4;12.4;;;11.1;13.7;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;GA;Georgia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.7;8.7;;;7.6;9.8;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.6;12.6;;;8.2;18.8;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.0;11;;;9.9;12.3;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.1;14.1;;;8.3;22.9;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.2;11.2;;;10.1;12.3;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47;47;;;41.9;52.1;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;ND;North Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;21.3;21.3;;;12.4;34.2;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.1;47.1;;;41.4;52.9;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.4;9.4;;;8.4;10.6;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;MI;Michigan;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST2_1;NMBR;GENDER;GENM;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.3;11.3;;;9.4;13.6;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;85.8;85.8;;;71.8;99.8;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.6;33.6;;;26.1;42.2;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;OH;Ohio;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.3;11.3;;;10.1;12.5;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;5.6;5.6;;;3.7;8.4;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.3;47.3;;;38.5;56.4;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2013;2013;AR;Arkansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2013;2013;AR;Arkansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2013;2013;NY;New York;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.2;11.2;;;9.2;13.4;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2013;2013;WV;West Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST2_1;NMBR;GENDER;GENM;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2013;2013;LA;Louisiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.2;10.2;;;9.4;11.1;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;14763;14,763;;;;;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;NMBR;RACE;HIS;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.9;41.9;;;32.7;51.7;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;4.7;4.7;;;3.2;6.7;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.0;9;;;8.4;9.7;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.2;39.2;;;33;45.8;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.4;33.4;;;25.7;42.1;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;16487;16,487;;;;;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;NMBR;GENDER;GENF;;;;
2013;2013;KS;Kansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;4.2;4.2;;;3.3;5.2;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2013;2013;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;14502;14,502;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;NMBR;RACE;WHT;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;44.1;44.1;;;26.9;62.9;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.6;14.6;;;10.9;19.2;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.3;11.3;;;10.1;12.6;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;38.4;38.4;;;26.2;50.7;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.0;11;;;9.6;12.6;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.3;13.3;;;8.8;19.7;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2013;2013;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;14.60;14.6;;;11.6;17.6;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;CRDRATE;RACE;API;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;8.6;8.6;;;7;10.6;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2013;2013;DC;District of Columbia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.8;7.8;;;4.6;12.9;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;IL;Illinois;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST2_1;NMBR;GENDER;GENF;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;LA;Louisiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.7;8.7;;;8;9.4;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.1;6.1;;;4.5;8.2;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;45.9;45.9;;;45.2;46.7;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;NY;New York;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2013;2013;TX;Texas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2013;2013;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;6211;6,211;;;;;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;NMBR;GENDER;GENM;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.3;40.3;;;34.9;45.9;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;ND;North Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.8;13.8;;;11.6;16.4;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;53.4;53.4;;;52.9;53.8;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.4;12.4;;;8.4;17.8;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.2;13.2;;;11.8;14.7;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.9;8.9;;;7.7;10.1;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2013;2013;OK;Oklahoma;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST2_1;NMBR;GENDER;GENM;;;;
2013;2013;RI;Rhode Island;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.4;9.4;;;5.7;15.2;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;SD;South Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.1;11.1;;;10.2;12.1;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.7;6.7;;;5.5;8.1;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.2;9.2;;;6.8;12.4;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;68.0;68;;;66.9;69;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2013;2013;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.6;30.6;;;23.5;38.7;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;19.9;19.9;;;11.2;32.7;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2013;2013;PA;Pennsylvania;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.8;10.8;;;8;14.5;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.7;34.7;;;28.7;41.2;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.2;5.2;;;4.2;6.3;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;151.50;151.5;;;150.1;152.8;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.2;10.2;;;7.5;13.7;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.1;45.1;;;39.6;50.7;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.8;11.8;;;6.5;20.6;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.8;9.8;;;8.6;11.2;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;MS;Mississippi;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.6;12.6;;;8.4;18.6;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.8;9.8;;;5.9;15.9;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2013;2013;TX;Texas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2013;2013;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;65.7;65.7;;;65.1;66.2;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.9;12.9;;;7.4;21.6;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2013;2013;MN;Minnesota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.1;32.1;;;27.5;37.1;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.1;7.1;;;6;8.4;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.0;10;;;9.2;10.8;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.7;6.7;;;3.8;11.5;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;NM;New Mexico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST2_1;NMBR;GENDER;GENF;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.7;7.7;;;6.6;9;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;ME;Maine;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST2_1;NMBR;GENDER;GENM;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40;40;;;32.1;48.5;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2013;2013;AL;Alabama;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST2_1;NMBR;GENDER;GENF;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;19.9;19.9;;;14.5;26.7;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.6;13.6;;;11.8;15.6;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.3;41.3;;;36.2;46.5;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.8;12.8;;;7.9;20.1;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.2;34.2;;;21.1;50.4;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.6;41.6;;;32.9;50.9;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2013;2013;OH;Ohio;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.8;48.8;;;43.6;54;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.8;9.8;;;8.1;11.9;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;51.7;51.7;;;44.1;59.2;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.6;9.6;;;8.5;11;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;5966;5,966;;;;;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;NMBR;GENDER;GENF;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.5;8.5;;;7.5;9.7;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.1;12.1;;;10.8;13.5;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.9;7.9;;;6.8;9.2;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2013;2013;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;57.4;57.4;;;56.7;58.1;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.2;34.2;;;22.6;48.2;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.6;10.6;;;9.3;12.1;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;16.7;16.7;;;10;26.4;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2013;2013;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;13415;13,415;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;NMBR;RACE;WHT;;;;
2013;2013;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;76.8;76.8;;;76.2;77.4;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;WA;Washington;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43;43;;;34.4;52.1;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.4;13.4;;;7.6;22.6;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2013;2013;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;75.3;75.3;;;74.7;75.8;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;IL;Illinois;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.7;7.7;;;6.2;9.6;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.0;10;;;8.7;11.6;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2013;2013;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;17.80;17.8;;;15.5;20;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.8;45.8;;;36.9;55;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.1;10.1;;;8.7;11.7;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.2;48.2;;;41.1;55.4;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.3;6.3;;;5.5;7.3;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2013;2013;AR;Arkansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.8;10.8;;;7.8;14.9;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2013;2013;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;38;38;;;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;NMBR;RACE;AIAN;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.8;12.8;;;10.9;14.9;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.3;11.3;;;9.8;13.1;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.5;42.5;;;36.6;48.5;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.5;44.5;;;39.2;49.9;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34;34;;;23.7;46;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.6;14.6;;;13.3;16.1;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2013;2013;RI;Rhode Island;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST2_1;NMBR;GENDER;GENF;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;27.8;27.8;;;17.2;41.8;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.4;39.4;;;34.7;44.2;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;15.6;15.6;;;10.2;23;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.6;8.6;;;7.8;9.5;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;GA;Georgia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2013;2013;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;NMBR;RACE;WHT;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.5;38.5;;;32;45.4;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.1;11.1;;;9.6;12.8;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.4;43.4;;;38.4;48.5;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2013;2013;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;58.9;58.9;;;58.4;59.4;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.1;5.1;;;3;8.4;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.9;6.9;;;6;8;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.6;38.6;;;33.9;43.6;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.4;8.4;;;7;10.1;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;IN;Indiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST2_1;NMBR;GENDER;GENM;;;;
2013;2013;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.6;30.6;;;21.2;41.8;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.2;44.2;;;39.1;49.4;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;30.2;30.2;;;18.7;44.8;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;5.5;5.5;;;3;9.8;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2013;2013;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;22.5;22.5;;;14.7;30.3;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46;46;;;39.2;53;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;30142;30,142;;;;;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.2;41.2;;;30.6;52.5;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39;39;;;33;45.4;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;24.6;24.6;;;20.5;28.7;Race/Ethnicity;American Indian or Alaska Native;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.1;10.1;;;8.8;11.6;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.9;9.9;;;8.8;11.2;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2013;2013;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;45.1;45.1;;;44.4;45.8;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.7;41.7;;;32.8;51.1;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2013;2013;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;27.7;27.7;;;25.6;29.7;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2013;2013;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;13.60;13.6;;;12.8;14.4;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;CRDRATE;RACE;API;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.5;5.5;;;3.5;8.7;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;IN;Indiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.2;8.2;;;7.4;9.1;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.8;6.8;;;5.8;8.1;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2013;2013;MI;Michigan;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.1;11.1;;;9.2;13.2;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;4.9;4.9;;;3.4;7;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;ID;Idaho;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;NMBR;RACE;API;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;15.4;15.4;;;9.6;23.7;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2013;2013;US;United States;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.7;6.7;*;50 States + DC: US Median;6.3;7;Gender;Male;;;;;;;59;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.9;8.9;;;8.5;9.4;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;MD;Maryland;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST2_1;NMBR;GENDER;GENF;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.7;14.7;;;8.4;24.3;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.7;11.7;;;9.1;14.9;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;8.4;8.4;;;4.7;14.4;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.2;14.2;;;9.7;20.1;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;31.3;31.3;;;30.2;32.4;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39;39;;;33.6;44.6;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.3;7.3;;;6.1;8.7;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;11.60;11.6;;;10.7;12.5;Race/Ethnicity;Asian or Pacific Islander;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2013;2013;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;26.6;26.6;;;25.5;27.7;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;NM;New Mexico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2013;2013;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;43.6;43.6;;;42.9;44.3;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.6;37.6;;;30.6;45.2;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;15.5;15.5;;;8.5;26.7;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.3;6.3;;;3.8;10.1;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2013;2013;KS;Kansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.9;11.9;;;10.4;13.6;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.6;39.6;;;31.4;48.5;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.0;13;;;7.2;22.4;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.8;37.8;;;31.5;44.5;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.8;8.8;;;7.9;9.7;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.6;37.6;;;23.8;53.8;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;5.9;5.9;;;3.3;10.3;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.2;48.2;;;42.3;54.2;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.9;9.9;;;8.2;11.9;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.5;9.5;;;8.9;10.2;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.5;12.5;;;7.6;19.7;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2013;2013;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;41.9;41.9;;;41.2;42.6;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;28;28;;;20.4;37.2;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.9;10.9;;;10;11.9;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.7;12.7;;;11.6;13.9;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.3;11.3;;;10.1;12.5;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;51;51;;;38.8;63;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.2;14.2;;;13.1;15.5;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2013;2013;WV;West Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.9;7.9;;;7.1;8.8;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2013;2013;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.9;41.9;;;32.7;51.6;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.1;46.1;;;33.2;59.6;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2013;2013;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;66250;66,250;;;;;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.6;9.6;;;5.2;16.8;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;IN;Indiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.3;13.3;;;11.8;14.9;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2013;2013;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;17.90;17.9;;;14.8;21.1;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.7;8.7;;;7.3;10.4;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2013;2013;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;559;559;;;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;NMBR;RACE;HIS;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.1;36.1;;;30.8;41.7;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.3;35.3;;;25.4;46.7;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.1;14.1;;;11.7;16.9;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;30.9;30.9;;;21.8;41.7;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;8.5;8.5;;;4.7;14.9;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;3.6;3.6;;;2.7;4.6;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;AR;Arkansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST2_1;NMBR;GENDER;GENF;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;3.7;3.7;;;2.7;5.1;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2013;2013;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;40.7;40.7;;;39.7;41.7;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.7;7.7;;;6.9;8.5;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;NH;New Hampshire;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.2;12.2;;;9.4;15.7;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2013;2013;MO;Missouri;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2013;2013;MT;Montana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.7;8.7;;;7.1;10.5;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.6;10.6;;;9.4;12;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;20994;20,994;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;NMBR;RACE;WHT;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.3;5.3;;;4.4;6.5;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.1;37.1;;;28.3;46.8;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.2;9.2;;;8.4;10.1;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.8;8.8;;;7.3;10.5;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.6;11.6;;;10.6;12.6;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.5;13.5;;;11.8;15.4;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;HI;Hawaii;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.1;33.1;;;21.9;46.6;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2013;2013;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;10871;10,871;;;;;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;NMBR;RACE;HIS;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.5;9.5;;;8.7;10.4;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;46.6;46.6;;;44.2;49.1;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.3;12.3;;;11.2;13.6;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;19.7;19.7;;;12.1;30.4;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.1;9.1;;;5.8;14.2;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;21070;21,070;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;NMBR;RACE;WHT;;;;
2013;2013;IL;Illinois;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;16.1;16.1;;;13.2;19.5;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.8;34.8;;;26.9;43.6;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2013;2013;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;31357;31,357;;;;;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;55.4;55.4;;;45.6;64.8;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.2;14.2;;;9.9;19.9;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2013;2013;DE;Delaware;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.9;30.9;;;22.5;40.8;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.4;39.4;;;29.2;50.7;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.8;42.8;;;38.1;47.6;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29.6;29.6;;;21.3;39.5;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.4;6.4;;;5.5;7.4;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40;40;;;27.2;54.4;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;6.2;6.2;;;4.5;8.6;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.3;10.3;;;7.6;13.7;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;67.8;67.8;;;67.1;68.6;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.2;32.2;;;22;44.4;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;GA;Georgia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;352;352;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;NMBR;RACE;API;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.6;13.6;;;9.9;18.4;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.1;12.1;;;8.5;16.8;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;20.3;20.3;;;14.7;27.3;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;IN;Indiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.9;33.9;;;27.8;40.6;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;56.3;56.3;;;47.7;64.6;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;49.6;49.6;;;42.7;56.6;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;SD;South Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2013;2013;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.1;11.1;;;10.1;12.2;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.4;5.4;;;4.4;6.5;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.3;8.3;;;7.5;9.2;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2013;2013;LA;Louisiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;LA;Louisiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.3;11.3;;;8;15.7;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.0;9;;;8;10.3;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.2;7.2;;;6.4;8.1;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;4.9;4.9;;;3.9;6.2;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.0;11;;;9.9;12.1;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;51.6;51.6;;;44.2;59;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;58;58;;;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;NMBR;RACE;AIAN;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.1;43.1;;;37.9;48.4;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.0;9;;;8.3;9.8;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.6;11.6;;;9.4;14.2;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.6;42.6;;;26.2;60.8;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2013;2013;DC;District of Columbia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.3;9.3;;;6.7;12.6;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;25.1;25.1;;;23.3;27;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.2;11.2;;;7.3;16.9;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;126267;126,267;;;;;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.9;11.9;;;9.3;15.2;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.9;10.9;;;9.8;12.1;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33;33;;;26.2;40.5;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.2;41.2;;;31;52.2;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;19.0;19;;;12.2;28.3;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;7.6;7.6;;;5.9;9.7;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2013;2013;CO;Colorado;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.7;14.7;;;12.8;16.8;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;50.1;50.1;;;49.4;50.8;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.4;9.4;;;6;14.4;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;7.0;7;;;4;11.7;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.9;5.9;;;3.8;8.9;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2013;2013;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.8;44.8;;;37.6;52.2;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2013;2013;MO;Missouri;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST2_1;NMBR;GENDER;GENF;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.2;10.2;;;9;11.6;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;60.6;60.6;;;59.5;61.6;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;8.9;8.9;;;5.3;14.5;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.7;12.7;;;7.1;21.5;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;LA;Louisiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.2;7.2;;;6.4;8;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;43.6;43.6;;;42.2;45;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2013;2013;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.7;46.7;;;40.7;52.8;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.2;5.2;;;3.1;8.7;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.8;11.8;;;10.4;13.4;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.1;6.1;;;4.8;7.8;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.8;13.8;;;8.3;22;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;NMBR;RACE;API;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42;42;;;33.2;51.4;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;15.2;15.2;;;9.9;22.5;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;MO;Missouri;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;4.6;4.6;;;2.8;7.3;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2013;2013;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.8;6.8;;;5.8;8;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.4;14.4;;;12.9;16.1;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2013;2013;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2013;2013;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.0;10;;;8.9;11.3;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;3801;3,801;;;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;NMBR;RACE;HIS;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.0;13;;;10.4;16.2;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2013;2013;MO;Missouri;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST2_1;NMBR;GENDER;GENM;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.6;8.6;;;7.6;9.8;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.7;8.7;;;7.2;10.4;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.1;9.1;;;8.3;9.9;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.2;7.2;;;5.8;8.9;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.0;12;;;10.9;13.1;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.1;5.1;;;2.9;8.8;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;CO;Colorado;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.8;10.8;;;9.6;12.1;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2013;2013;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;140.40;140.4;;;138.4;142.4;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.8;42.8;;;32.7;53.6;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.4;11.4;;;10.3;12.7;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.2;10.2;;;8.1;12.8;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.8;7.8;;;7;8.7;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.9;6.9;;;4.1;11.4;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.1;6.1;;;4.9;7.5;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2013;2013;NM;New Mexico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;NMBR;RACE;HIS;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.3;10.3;;;7.2;14.5;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.6;10.6;;;9.4;11.9;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.2;7.2;;;6.6;8;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;20.2;20.2;;;12.8;30.4;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2013;2013;AL;Alabama;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.5;9.5;;;5.3;16.3;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.4;37.4;;;26.5;49.6;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.0;10;;;7.4;13.3;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2013;2013;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;2941;2,941;;;;;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;NMBR;GENDER;GENF;;;;
2013;2013;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;17.00;17;;;15.2;18.8;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.8;11.8;;;9.1;15.2;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.3;13.3;;;11.7;15.1;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2013;2013;CA;California;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.9;7.9;;;6.9;8.9;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.2;10.2;;;7.8;13.2;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;17.9;17.9;;;10.3;29.2;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35;35;;;24.1;47.8;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;WV;West Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST2_1;NMBR;GENDER;GENF;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;37.7;37.7;;;37;38.4;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;5097;5,097;;;;;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;NMBR;GENDER;GENM;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.0;10;;;8.2;12.2;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;IN;Indiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.6;48.6;;;42.4;54.8;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.3;9.3;;;8.5;10.3;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.5;35.5;;;28.3;43.4;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;25.8;25.8;;;21.5;30;Race/Ethnicity;American Indian or Alaska Native;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.7;8.7;;;7.9;9.7;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.0;7;;;5.7;8.6;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;55.7;55.7;;;52.9;58.5;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.6;10.6;;;9.7;11.6;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;64.8;64.8;;;44.1;81.1;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2013;2013;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.6;9.6;;;8.9;10.4;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.2;13.2;;;11.2;15.5;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2013;2013;PA;Pennsylvania;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.7;33.7;;;26.1;42.2;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.2;7.2;;;6.6;7.8;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2013;2013;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;143.90;143.9;;;142.7;145.1;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.8;9.8;;;8.9;10.8;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;8.1;8.1;;;5.5;11.6;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.6;7.6;;;6.2;9.5;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.9;13.9;;;12.6;15.2;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2013;2013;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;36.6;36.6;;;35.9;37.3;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;27.7;27.7;;;19.6;37.7;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2013;2013;MN;Minnesota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.3;8.3;;;7.6;9;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;23701;23,701;;;;;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;16.7;16.7;;;9;28.9;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;8.7;8.7;;;6.6;11.3;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;53.3;53.3;;;41.1;65.2;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.9;8.9;;;8.4;9.4;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;17.9;17.9;;;9.6;30.8;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.9;7.9;;;4.4;13.8;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.5;9.5;;;7.3;12.2;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.2;14.2;;;13.1;15.3;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2013;2013;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;112.20;112.2;;;90.1;134.3;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2013;2013;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;95.10;95.1;;;94.5;95.7;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2013;2013;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;33.2;33.2;;;32.3;34.1;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.0;7;;;6.1;8.1;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;OK;Oklahoma;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.2;40.2;;;36.2;44.3;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;15.0;15;;;11.2;19.7;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;2450;2,450;;;;;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;NMBR;GENDER;GENM;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.6;9.6;;;8.9;10.3;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;24.4;24.4;;;16.4;34.6;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2013;2013;AR;Arkansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.8;7.8;;;6.7;9;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;71.7;71.7;;;66.8;76.5;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;53.8;53.8;;;42;65.2;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;OH;Ohio;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST2_1;NMBR;GENDER;GENM;;;;
2013;2013;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;13480;13,480;;;;;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;NMBR;GENDER;GENM;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2013;2013;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;11294;11,294;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;NMBR;RACE;WHT;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.2;6.2;;;5.5;7.1;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.0;12;;;8.7;16.3;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;219;219;;;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;NMBR;RACE;AIAN;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.2;39.2;;;28.5;51.1;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;4.6;4.6;;;3.8;5.5;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50.6;50.6;;;43.1;58.1;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2013;2013;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;87.1;87.1;;;86.5;87.6;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2013;2013;MN;Minnesota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.8;49.8;;;43.7;55.9;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.7;9.7;;;8.9;10.6;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.9;10.9;;;9.6;12.3;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.1;10.1;;;8.4;12.2;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.8;39.8;;;23.7;58.4;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.5;5.5;;;4.6;6.6;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2013;2013;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;2514;2,514;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;NMBR;RACE;BLK;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.4;44.4;;;33.1;56.3;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;WV;West Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.8;48.8;;;41;56.7;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.3;8.3;;;7.5;9.2;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.3;36.3;;;28.2;45.3;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;63.2;63.2;;;62.5;63.9;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2013;2013;DC;District of Columbia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST2_1;NMBR;GENDER;GENF;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.4;8.4;;;7.7;9.3;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;MA;Massachusetts;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;8.2;8.2;;;6.1;11;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;44.1;44.1;;;23.8;66.6;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2013;2013;OH;Ohio;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST2_1;NMBR;GENDER;GENF;;;;
2013;2013;AK;Alaska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST2_1;NMBR;GENDER;GENF;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36;36;;;23.1;51.4;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2013;2013;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.3;12.3;;;9.8;15.2;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.6;5.6;;;3.4;9.3;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.6;46.6;;;37.6;55.8;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;CA;California;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2013;2013;TX;Texas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;52539;52,539;;;;;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;NMBR;RACE;HIS;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;8.8;8.8;;;5.5;13.7;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2013;2013;DC;District of Columbia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2013;2013;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;18.4;18.4;;;15.2;21.6;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;CRDRATE;RACE;API;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;35.8;35.8;;;35.1;36.4;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.4;8.4;;;7.5;9.4;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;22.2;22.2;;;14.2;33;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.0;11;;;9.8;12.4;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.5;8.5;;;7.6;9.6;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2013;2013;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;4474;4,474;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;NMBR;RACE;BLK;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.5;8.5;;;5.3;13.6;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.0;9;;;8.2;9.8;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.2;8.2;;;6.5;10.4;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;MD;Maryland;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2013;2013;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;19.5;19.5;;;18.8;20.2;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.8;35.8;;;26.6;46.1;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.7;8.7;;;4.9;15.1;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.5;11.5;;;10.7;12.3;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.5;47.5;;;37;58.1;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;AL;Alabama;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;25.3;25.3;;;17.3;35.4;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.9;14.9;;;13.1;16.7;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;CA;California;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;5.5;5.5;;;3.6;8.2;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2013;2013;KS;Kansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.3;8.3;;;7.3;9.4;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.5;38.5;;;28.5;49.5;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;TN;Tennessee;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST2_1;NMBR;GENDER;GENF;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.5;11.5;;;10.4;12.8;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.8;11.8;;;10.6;13;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.3;42.3;;;30.7;54.8;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.1;10.1;;;9.2;11;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.3;5.3;;;4.2;6.8;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;41.3;41.3;;;40.7;41.8;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.2;11.2;;;7;17.4;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2013;2013;LA;Louisiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST2_1;NMBR;GENDER;GENM;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.7;10.7;;;9.6;11.9;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;18.8;18.8;;;11.9;28.5;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;57.8;57.8;;;56.8;58.8;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.5;13.5;;;11.3;16.2;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2013;2013;AK;Alaska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.8;9.8;;;8.6;11;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2013;2013;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;11065;11,065;;;;;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.6;34.6;;;27.5;42.4;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;8.9;8.9;;;7.1;11.2;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;AL;Alabama;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.6;5.6;;;4.7;6.7;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;16.1;16.1;;;12.3;20.9;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.5;34.5;;;22.7;48.5;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;UT;Utah;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;ID;Idaho;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;58.5;58.5;;;52.7;64.2;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;626;626;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;NMBR;RACE;API;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.9;10.9;;;9.9;12.1;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.6;10.6;;;9.4;11.9;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;40.7;40.7;;;39.7;41.8;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;85.8;85.8;;;71.8;99.9;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2013;2013;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;179657;179,657;;;;;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.0;8;;;5.2;12.1;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;WY;Wyoming;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.4;42.4;;;37.4;47.5;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.4;11.4;;;8.4;15.2;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.4;38.4;;;31.2;46.2;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.1;45.1;;;38.5;51.9;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;44.4;44.4;;;42;46.7;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.5;7.5;;;6.6;8.5;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.2;6.2;;;4.5;8.4;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.1;11.1;;;9.2;13.4;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.8;8.8;;;5.1;14.9;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.2;34.2;;;28.5;40.4;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;8.6;8.6;;;6.3;11.6;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.3;32.3;;;24.4;41.2;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.5;8.5;;;5;14;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.3;7.3;;;6.3;8.5;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;GA;Georgia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;17.2;17.2;;;9.6;29.1;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2013;2013;HI;Hawaii;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2013;2013;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;80.70;80.7;;;70.1;91.4;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;4.5;4.5;;;3;6.7;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.9;38.9;;;28.4;50.5;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.2;6.2;;;3.8;9.9;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;41.8;41.8;;;28.5;55.1;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;WA;Washington;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.7;5.7;;;4.9;6.6;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.7;13.7;;;12.5;15;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2013;2013;KS;Kansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2013;2013;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;31229;31,229;;;;;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;NMBR;RACE;HIS;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.1;33.1;;;26.3;40.8;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;MO;Missouri;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;29.2;29.2;;;28.7;29.7;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;90.90;90.9;;;90.3;91.5;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.5;9.5;;;7.7;11.5;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2013;2013;NM;New Mexico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2013;2013;VA;Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43;43;;;35.4;51.1;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.9;14.9;;;10.6;20.5;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.5;11.5;;;9;14.6;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2013;2013;WV;West Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2013;2013;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;6112;6,112;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;NMBR;RACE;BLK;;;;
2013;2013;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;87.1;87.1;;;85.7;88.5;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;11.00;11;;;10.1;11.8;Race/Ethnicity;Asian or Pacific Islander;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;CRDRATE;RACE;API;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.3;14.3;;;11.7;17.4;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.5;45.5;;;31.3;60.5;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;7.8;7.8;;;5.7;10.4;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.0;8;;;7;9.1;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.4;11.4;;;6.9;18.1;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.2;5.2;;;4.3;6.4;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.5;9.5;;;8.1;11.1;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2013;2013;NM;New Mexico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST2_1;NMBR;GENDER;GENM;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.2;10.2;;;8.6;12;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;68.8;68.8;;;61.9;75.7;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2013;2013;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;220.8;220.8;;;212.2;229.4;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;CRDRATE;RACE;BLK;;;;
2013;2013;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.9;6.9;;;5.9;8.1;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.4;5.4;;;3.3;8.6;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2013;2013;OR;Oregon;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2013;2013;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;437;437;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;NMBR;RACE;API;;;;
2013;2013;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;71.1;71.1;;;70.3;71.9;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.6;10.6;;;9.4;12;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40;40;;;34.2;46.2;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;ND;North Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.5;42.5;;;33.7;51.9;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2013;2013;MT;Montana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;TN;Tennessee;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.5;6.5;;;5.1;8.3;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.1;13.1;;;10.4;16.3;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;48.5;48.5;;;47.6;49.4;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;51.1;51.1;;;48.8;53.4;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;16.1;16.1;;;9.8;25.3;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;RI;Rhode Island;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.9;8.9;;;7.4;10.6;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;4.6;4.6;;;2.8;7.6;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.6;13.6;;;11.6;15.9;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;7.6;7.6;;;6.5;8.9;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;52.4;52.4;;;44.4;60.2;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.8;6.8;;;5.9;7.9;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.4;13.4;;;10.2;17.3;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;32.3;32.3;;;21.1;43.5;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;20.4;20.4;;;12.8;31.1;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.1;11.1;;;7;17.1;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2013;2013;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;93;93;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;NMBR;RACE;API;;;;
2013;2013;LA;Louisiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.4;9.4;;;8.5;10.2;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.0;11;;;9.1;13.3;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;NM;New Mexico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.2;48.2;;;41.7;54.7;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2013;2013;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;6092;6,092;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;NMBR;RACE;WHT;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.4;14.4;;;8.4;23.7;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.6;38.6;;;25;54.2;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;36.7;36.7;;;34.6;38.8;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.7;9.7;;;5.5;16.4;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;23.7;23.7;;;17.7;31.1;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.7;7.7;;;6.5;9.2;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.8;9.8;;;9.1;10.6;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.6;5.6;;;4.7;6.7;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.2;32.2;;;22.8;43.3;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.7;14.7;;;8.4;24.4;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;156.80;156.8;;;152.9;160.8;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;ID;Idaho;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2013;2013;US;United States;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.0;9;*;50 States + DC: US Median;8.6;9.5;Overall;Overall;;;;;;;59;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.5;10.5;;;8.7;12.6;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2013;2013;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;53.6;53.6;;;52.4;54.8;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.3;42.3;;;32.1;53.1;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.1;32.1;;;25.4;39.6;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.7;7.7;;;5.6;10.5;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.0;12;;;10.9;13.2;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.7;8.7;;;8.1;9.5;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.2;11.2;;;10.1;12.5;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;48.4;48.4;;;48;48.9;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.9;38.9;;;34.8;43.1;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.6;10.6;;;7;15.7;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2013;2013;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.9;9.9;;;8.9;11;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.2;42.2;;;33.8;51.2;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.1;9.1;;;6;13.7;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;23.7;23.7;;;13.4;38.4;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.6;6.6;;;5.2;8.4;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.5;5.5;;;4.6;6.6;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.5;8.5;;;7.5;9.5;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.2;39.2;;;33.6;45;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.9;9.9;;;8.5;11.4;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2013;2013;OH;Ohio;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.3;41.3;;;34.6;48.2;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;ME;Maine;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;111.30;111.3;;;89.3;133.2;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;43.0;43;;;42.4;43.5;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;CA;California;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.1;8.1;;;6.7;9.9;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.1;8.1;;;5.7;11.4;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50.1;50.1;;;42.3;57.8;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;29.6;29.6;;;28.9;30.4;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.7;8.7;;;7.9;9.6;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42;42;;;32;52.7;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.9;43.9;;;32.8;55.7;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2013;2013;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;10.10;10.1;;;8.8;11.4;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.1;12.1;;;10.9;13.4;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.7;44.7;;;39.9;49.5;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;66.6;66.6;;;56;75.8;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;AK;Alaska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.7;32.7;;;26.9;39;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.4;47.4;;;41.3;53.7;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;16.7;16.7;;;14.1;19.7;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.1;35.1;;;24.7;47.2;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.0;9;;;8.2;9.9;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.0;9;;;8.1;9.9;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2013;2013;MI;Michigan;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;16.8;16.8;;;9.4;28.3;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.1;10.1;;;8.9;11.5;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.2;8.2;;;7.2;9.3;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;17.2;17.2;;;12.9;22.6;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2013;2013;MT;Montana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2013;2013;ME;Maine;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST2_1;NMBR;GENDER;GENF;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.4;9.4;;;8.1;10.8;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;ND;North Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32;32;;;21.6;44.5;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2013;2013;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;55.4;55.4;;;54.7;56;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.7;34.7;;;27.4;42.7;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.7;36.7;;;29.2;44.8;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.1;12.1;;;9.1;15.9;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;15.1;15.1;;;9.2;23.9;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.5;11.5;;;10.3;12.7;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;NY;New York;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.1;10.1;;;7.2;14.1;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2013;2013;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;47.3;47.3;;;46.7;47.8;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.7;34.7;;;23.8;47.4;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;54.5;54.5;;;47.3;61.6;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.1;7.1;;;5.7;8.8;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;54.0;54;;;53;55;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;NH;New Hampshire;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST2_1;NMBR;GENDER;GENF;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.3;10.3;;;7.4;14;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;59.1;59.1;;;47.3;69.9;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.1;9.1;;;8.1;10.2;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.7;6.7;;;5.7;7.8;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;4.9;4.9;;;3.9;6.1;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.8;6.8;;;5.7;8.1;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.5;11.5;;;6.8;18.7;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.9;8.9;;;7.6;10.3;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;WA;Washington;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2013;2013;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;54.9;54.9;;;54.4;55.4;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.8;11.8;;;9.9;14;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2013;2013;US;United States;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.3;11.3;*;50 States + DC: US Median;10.9;12.3;Gender;Female;;;;;;;59;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2013;2013;UT;Utah;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;15.6;15.6;;;13.4;18.1;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.9;9.9;;;8.5;11.5;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;CA;California;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.3;10.3;;;8.6;12.5;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;4.2;4.2;;;2.6;6.9;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2013;2013;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;29.9;29.9;;;27.4;32.4;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.3;32.3;;;20.3;47.2;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.6;40.6;;;29.8;52.5;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.6;7.6;;;5.6;10.3;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.5;9.5;;;8.6;10.6;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;4.1;4.1;;;2.5;6.6;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;51;51;;;38.6;63.2;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.3;9.3;;;8.3;10.3;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2013;2013;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;70.3;70.3;;;69.2;71.4;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.1;43.1;;;36.2;50.2;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;15.6;15.6;;;12.8;18.8;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.0;9;;;8.2;9.9;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.6;11.6;;;9.8;13.7;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.9;14.9;;;13.4;16.6;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2013;2013;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;79.3;79.3;;;78.5;80.2;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.2;10.2;;;9.2;11.3;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;52.6;52.6;;;50.3;55;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2013;2013;MA;Massachusetts;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.9;7.9;;;6.6;9.5;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2013;2013;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;31.0;31;;;23;39;Race/Ethnicity;American Indian or Alaska Native;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.2;12.2;;;10.9;13.5;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.5;10.5;;;8.8;12.4;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.1;8.1;;;6.9;9.5;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.0;8;;;5.7;11;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.7;7.7;;;4.4;12.9;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;69720;69,720;;;;;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;NMBR;GENDER;GENF;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.6;35.6;;;29.3;42.5;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;8114;8,114;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;NMBR;RACE;BLK;;;;
2013;2013;RI;Rhode Island;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.9;10.9;;;9.8;12.2;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2013;2013;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;50.3;50.3;;;49.5;51.2;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.4;5.4;;;4.7;6.3;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.6;14.6;;;12;17.7;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;WA;Washington;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.6;12.6;;;11.3;14.1;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.5;9.5;;;8.7;10.3;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.6;5.6;;;3.6;8.7;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.8;9.8;;;6.3;15;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2013;2013;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;40.7;40.7;;;40.1;41.2;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2013;2013;MT;Montana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;NH;New Hampshire;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.5;38.5;;;23.6;55.9;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.4;13.4;;;7.7;22.3;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.2;40.2;;;26.5;55.7;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;KS;Kansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST2_1;NMBR;GENDER;GENF;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.2;12.2;;;9.6;15.3;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2013;2013;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;45.7;45.7;;;44.8;46.6;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;UT;Utah;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST2_1;NMBR;GENDER;GENM;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.9;5.9;;;4.9;7;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.1;13.1;;;10.1;16.8;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.2;44.2;;;40.8;47.6;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.8;7.8;;;6.3;9.5;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.1;7.1;;;6;8.4;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.8;8.8;;;7.7;10.1;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.8;40.8;;;33.2;48.9;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2013;2013;TX;Texas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;43.5;43.5;;;43;44.1;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.7;8.7;;;7;10.8;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.3;13.3;;;11.8;14.9;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;WA;Washington;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.1;6.1;;;3.7;9.8;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;NH;New Hampshire;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.7;37.7;;;33;42.6;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.6;12.6;;;7.4;20.8;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;UT;Utah;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;PA;Pennsylvania;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST2_1;NMBR;GENDER;GENF;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.9;7.9;;;6.7;9.3;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.2;8.2;;;6.4;10.5;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.7;9.7;;;8.4;11.2;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2013;2013;PA;Pennsylvania;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;49.5;49.5;;;43.5;55.5;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.8;9.8;;;8.7;11.1;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2013;2013;OH;Ohio;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;VA;Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST2_1;NMBR;GENDER;GENM;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;17.40;17.4;;;16.7;18;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;CRDRATE;RACE;API;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;50.8;50.8;;;44;57.6;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43;43;;;37.3;48.9;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.2;37.2;;;27;48.7;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2013;2013;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;69.6;69.6;;;69.1;70.1;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.0;14;;;11.1;17.4;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2013;2013;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;62.2;62.2;;;58.1;66.2;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;CRDRATE;RACE;HIS;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;20.4;20.4;;;12.3;31.9;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.7;7.7;;;6.6;9;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;2876;2,876;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;NMBR;RACE;API;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;29.9;29.9;;;29.3;30.6;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2013;2013;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;64.4;64.4;;;64.1;64.8;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.3;7.3;;;6.4;8.3;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2013;2013;ID;Idaho;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST2_1;NMBR;GENDER;GENF;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;ME;Maine;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.3;48.3;;;42.2;54.6;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.3;7.3;;;6.7;8;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.1;10.1;;;7.1;14.1;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.9;11.9;;;10.3;13.6;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;CT;Connecticut;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2013;2013;CT;Connecticut;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST2_1;NMBR;GENDER;GENM;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.6;6.6;;;4;10.7;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2013;2013;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;26.4;26.4;;;25.3;27.4;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;53.2;53.2;;;44.4;61.8;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;3.9;3.9;;;2.3;6.5;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.8;44.8;;;35.7;54.2;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.6;7.6;;;6.4;8.8;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.6;10.6;;;9.4;11.8;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.1;42.1;;;26.9;58.9;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.5;34.5;;;27.8;41.8;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;CO;Colorado;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;WY;Wyoming;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.4;11.4;;;8.9;14.4;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.1;9.1;;;8.2;10;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;15.0;15;;;11;20.2;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2013;2013;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;67.2;67.2;;;61.1;73.2;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;AGEADJRATE;RACE;AIAN;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.0;9;;;8.2;9.8;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;WA;Washington;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2013;2013;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.6;44.6;;;38.3;51;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.4;9.4;;;7.5;11.6;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.1;7.1;;;6.2;8.1;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.3;8.3;;;7.3;9.3;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.3;43.3;;;37.9;48.9;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;CA;California;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2013;2013;WY;Wyoming;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.0;10;;;8.1;12.2;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2013;2013;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.0;11;;;10;12.1;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.2;9.2;;;7.7;11;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.5;10.5;;;7.5;14.3;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.9;8.9;;;8;9.8;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.5;8.5;;;7;10.3;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.6;12.6;;;11.5;13.8;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2013;2013;OK;Oklahoma;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.7;36.7;;;28.6;45.7;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50.1;50.1;;;42.9;57.2;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;52.2;52.2;;;45.3;59.1;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;MI;Michigan;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;8.8;8.8;;;7.2;10.5;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.4;9.4;;;6.6;13.1;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.6;6.6;;;4.6;9.2;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;GU;Guam;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;55.8;55.8;;;45.8;65.5;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.8;9.8;;;5.9;15.8;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2013;2013;NM;New Mexico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.2;47.2;;;43.3;51;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.1;32.1;;;22.6;43.3;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2013;2013;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;702;702;;;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;NMBR;RACE;HIS;;;;
2013;2013;DE;Delaware;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;149.40;149.4;;;147.8;151.1;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;AGEADJRATE;RACE;BLK;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2013;2013;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.2;40.2;;;31.1;50.1;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2013;2013;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;44.2;44.2;;;43.1;45.3;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.8;8.8;;;7.7;10;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.1;12.1;;;10.4;14.1;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.1;41.1;;;29.4;53.9;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.2;10.2;;;8.5;12.3;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;AK;Alaska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST2_1;NMBR;GENDER;GENM;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;ID;Idaho;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2013;2013;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;382;382;;;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;NMBR;RACE;AIAN;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;8.1;8.1;;;6.4;10.2;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2013;2013;ME;Maine;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2013;2013;NY;New York;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.2;13.2;;;9.6;17.8;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.1;8.1;;;7.2;9.1;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;5.2;5.2;;;3.1;8.8;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.3;7.3;;;6.7;7.9;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.8;8.8;;;5.2;14.7;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.5;7.5;;;6.7;8.4;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.9;7.9;;;6.9;9.1;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.4;33.4;;;28.3;38.9;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2013;2013;DE;Delaware;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.9;8.9;;;8.1;9.7;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.6;5.6;;;4.4;7.2;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.8;48.8;;;40.2;57.4;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2013;2013;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;38.8;38.8;;;38.1;39.5;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;AGEADJRATE;RACE;WHT;;;;
2013;2013;OR;Oregon;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;53.9;53.9;;;46.9;60.7;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.6;32.6;;;25.1;41.2;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;17.2;17.2;;;12.1;23.8;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;CO;Colorado;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST2_1;NMBR;GENDER;GENM;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.7;9.7;;;8.4;11.3;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;16662;16,662;;;;;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;NMBR;GENDER;GENF;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.6;10.6;;;9.8;11.5;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.8;33.8;;;20;51.2;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.4;35.4;;;28.3;43.2;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;CA;California;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST2_1;NMBR;GENDER;GENF;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.3;10.3;;;6.1;16.9;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;8.5;8.5;;;7;10.3;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2013;2013;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;27959;27,959;;;;;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;NMBR;GENDER;GENF;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2013;2013;MN;Minnesota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.4;11.4;;;6.3;19.8;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.5;5.5;;;4.5;6.6;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.8;11.8;;;7.4;18.3;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.3;10.3;;;7.4;14.2;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.3;6.3;;;5.5;7.2;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;KS;Kansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.5;12.5;;;10.6;14.8;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2013;2013;CT;Connecticut;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;NY;New York;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.9;12.9;;;10.9;15.2;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;WV;West Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.8;6.8;;;6.1;7.5;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.7;9.7;;;8.7;10.9;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.4;11.4;;;7.1;18;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.3;34.3;;;23.5;47;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.1;44.1;;;30.5;58.6;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.9;42.9;;;36.3;49.7;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85;85;;;69.5;93.4;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.3;83.3;;;65.1;93;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.5;44.5;;;31.6;58.3;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;78.6;78.6;;;66.3;87.2;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.5;63.5;;;50.4;74.9;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.3;68.3;;;61.5;74.4;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.3;71.3;;;62.3;78.9;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.6;34.6;;;26.4;43.8;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.8;87.8;;;78;93.6;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.4;89.4;;;80.7;94.4;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.3;71.3;;;61.6;79.5;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;93;93;;;82.3;97.4;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.3;86.3;;;79.8;90.9;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.7;34.7;;;29.3;40.5;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.3;69.3;;;44.2;86.5;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.4;40.4;;;30.6;51;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29.7;29.7;;;19.2;42.8;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.1;86.1;;;75;92.7;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29.6;29.6;;;16.9;46.4;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.7;84.7;*;50 States + DC: US Median;83.6;86.1;Overall;Overall;;;;;;;59;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.8;39.8;;;34.2;45.6;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50;50;;;41.3;58.7;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.5;46.5;;;40.2;52.9;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.3;89.3;;;79.5;94.7;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.1;31.1;;;23.2;40.4;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.4;32.4;;;24.7;41.3;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.9;69.9;;;62.2;76.5;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;38.0;38;;;37.3;38.6;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.8;37.8;;;30;46.2;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.3;42.3;;;36;48.8;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;80.9;80.9;;;70.1;88.5;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.8;65.8;;;53;76.7;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;TN;Tennessee;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.5;32.5;;;27.3;38.1;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.8;86.8;;;79.1;91.9;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2013;2013;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.8;32.8;;;26.6;39.6;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.2;40.2;;;34.7;46;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68;68;;;58.9;75.9;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;61.4;61.4;;;50.2;71.5;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.1;31.1;;;25.2;37.7;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;78.5;78.5;;;69.9;85.2;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.4;31.4;;;22.8;41.6;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;73.1;73.1;;;63;81.3;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.8;84.8;;;77.5;90;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.7;7.7;;;6.5;9.1;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.7;72.7;;;57.8;83.8;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;76;76;;;67.9;82.6;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.5;69.5;;;58.2;78.9;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85;85;;;75.7;91.1;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30;30;;;16.8;47.6;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.6;43.6;;;30.3;58;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;64.1;64.1;;;51.5;75.1;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;74.1;74.1;;;65.8;80.9;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.4;86.4;;;77.8;92;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.9;33.9;;;27.7;40.6;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;8.2;8.2;;;6.2;10.2;Race/Ethnicity;Asian or Pacific Islander;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;CRDRATE;RACE;API;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.7;42.7;;;34.7;51;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;81.7;81.7;;;74.6;87.2;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.5;35.5;;;29.3;42.1;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;72.6;72.6;;;61.4;81.5;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.6;48.6;;;41.9;55.4;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2013;2013;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.7;69.7;;;61;77.2;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.4;39.4;;;33.1;46;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.3;36.3;;;27.7;45.9;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.5;69.5;;;60;77.5;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;34.9;34.9;;;27.1;43.5;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.8;88.8;;;78.3;94.6;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.9;40.9;;;34.2;47.9;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.1;45.1;;;35.1;55.5;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.4;67.4;;;57.3;76.1;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.7;9.7;;;8.9;10.6;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;50.3;50.3;;;35.4;65.2;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.2;69.2;;;58.8;78;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2013;2013;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.7;32.7;;;24.5;42.1;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.4;37.4;;;24.7;52.1;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.7;41.7;;;32.5;51.4;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.8;68.8;;;61.6;75.2;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86;86;;;73.3;93.2;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.3;42.3;;;35.2;49.8;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.9;35.9;;;30.3;41.9;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;74.5;74.5;;;63.3;83.1;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67.6;67.6;;;56.8;76.7;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.1;39.1;;;29.3;49.9;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.5;83.5;;;73.9;90;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.1;42.1;;;34;50.8;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43;43;;;36.1;50.1;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.8;44.8;*;50 States + DC: US Median;42.5;47.3;Gender;Female;;;;;;;59;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2013;2013;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.1;36.1;*;50 States + DC: US Median;34.6;39;Gender;Male;;;;;;;59;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87;87;;;78.1;92.6;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2013;2013;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.1;84.1;*;50 States + DC: US Median;80.7;85.2;Gender;Male;;;;;;;59;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;MN;Minnesota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.6;38.6;;;34.3;43.1;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.7;70.7;;;61.2;78.7;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.9;7.9;;;6.9;9;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.5;46.5;;;39;54;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.9;89.9;;;83.5;94;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.7;85.7;;;72.1;93.3;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85;85;;;78;90;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;79.5;79.5;;;65.8;88.7;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.2;37.2;;;34.1;40.4;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.3;68.3;;;59.2;76.2;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;75.4;75.4;;;62.7;84.9;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38;38;;;31.5;44.9;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.2;85.2;;;75.1;91.7;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.4;43.4;;;34.5;52.7;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.8;82.8;;;74.3;88.9;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;60.9;60.9;;;49.4;71.2;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;77.3;77.3;;;67.3;85;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;25.9;25.9;;;18.4;35.2;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.6;38.6;;;25.8;53.3;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.7;67.7;;;58;76;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2013;2013;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.2;35.2;;;30.1;40.6;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;92.5;92.5;;;86.1;96.1;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;92.9;92.9;;;85.4;96.7;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.8;66.8;;;56.4;75.8;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.3;47.3;;;35.3;59.7;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;75.9;75.9;;;65.8;83.7;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.2;69.2;;;53.3;81.6;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.1;39.1;;;27.1;52.6;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.1;82.1;;;71.1;89.5;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.2;83.2;;;73.9;89.6;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67.8;67.8;;;60;74.7;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.7;38.7;;;31.3;46.6;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.4;39.4;;;32.6;46.6;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;67.5;67.5;;;57.1;76.4;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.3;82.3;;;69.4;90.5;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84;84;;;74.9;90.2;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.7;40.7;;;28.4;54.3;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.9;35.9;;;29.9;42.4;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.7;71.7;;;61.9;79.8;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.2;39.2;;;24.7;56;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.6;63.6;;;56.5;70.2;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;74.8;74.8;;;56.5;87.2;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;50.7;50.7;;;34.3;66.9;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;77.1;77.1;;;67.4;84.6;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42;42;;;32.9;51.6;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;52.2;52.2;;;35.9;68.1;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.5;48.5;;;38.9;58.2;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67.6;67.6;;;58.9;75.2;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67.8;67.8;;;54.7;78.5;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.9;35.9;;;27.6;45.1;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.1;88.1;;;80.3;93;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.8;38.8;;;32.1;46.1;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.5;45.5;;;38.5;52.7;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.1;10.1;;;7;14.3;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.2;83.2;;;69.4;91.5;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.2;70.2;;;58.8;79.6;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.7;8.7;;;5.6;13.4;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.3;47.3;;;41;53.7;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.9;39.9;;;30;50.7;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.4;10.4;;;5.9;17.6;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.3;44.3;;;33.3;55.8;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;78.9;78.9;;;71.5;84.8;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.9;49.9;;;43.8;56;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.2;33.2;;;26.8;40.4;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;91.3;91.3;;;86.9;94.3;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.6;40.6;;;32.4;49.2;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2013;2013;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.6;69.6;;;53;82.3;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.7;66.7;;;58.2;74.3;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;75.1;75.1;;;60;85.8;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;61.1;61.1;;;52.5;69;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.1;44.1;;;38.5;49.8;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.8;36.8;;;27.5;47.2;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.5;87.5;;;80.2;92.4;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;50.7;50.7;;;34.5;66.9;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.6;82.6;;;71.4;90;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84;84;;;77.7;88.9;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.5;34.5;;;28.1;41.4;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.8;48.8;;;42;55.7;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.2;35.2;;;27.8;43.3;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.7;37.7;;;25.1;52.3;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.1;42.1;;;35.6;48.9;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;72.4;72.4;;;58;83.3;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2013;2013;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;81.3;81.3;;;72.1;87.9;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;75.5;75.5;;;63;84.8;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.3;42.3;;;35.7;49.2;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;64.1;64.1;;;54.9;72.5;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.3;84.3;;;77.6;89.2;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.4;36.4;;;28.7;45;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.1;65.1;;;55.4;73.7;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35;35;;;28.3;42.3;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90;90;;;82.6;94.5;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.3;64.3;;;48.3;77.7;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.2;66.2;;;58.1;73.4;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.9;39.9;;;32.7;47.6;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.7;34.7;;;24.8;46;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;92.5;92.5;;;86.5;95.9;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.8;66.8;;;52.1;78.9;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;96430;96,430;;;;;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;NMBR;GENDER;GENF;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;74;74;;;67;80;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.7;83.7;;;76.6;89;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.2;43.2;;;31;56.2;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.3;69.3;;;60.8;76.7;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.5;65.5;;;52.8;76.3;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;78.8;78.8;;;60.1;90.1;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;51.6;51.6;;;33.2;69.6;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2013;2013;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.6;69.6;*;50 States + DC: US Median;67.6;70.7;Overall;Overall;;;;;;;59;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;76.2;76.2;;;66.3;83.9;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.8;82.8;;;73.3;89.4;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.2;35.2;;;28.1;43.1;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;24.4;24.4;;;16.3;34.8;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41;41;;;36.1;46.1;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;73.8;73.8;;;63.7;81.9;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.6;87.6;;;77.3;93.7;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.6;49.6;;;38.1;61.2;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.1;65.1;;;57.3;72.2;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2013;2013;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42;42;;;31.9;53;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.3;10.3;;;9.3;11.4;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.8;44.8;;;31.7;58.7;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.9;66.9;;;52.4;78.8;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.1;62.1;;;45.1;76.6;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.9;70.9;;;62.4;78.2;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.2;35.2;;;27.7;43.6;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.4;85.4;;;75.4;91.8;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.1;34.1;;;29.1;39.6;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39;39;;;30;48.7;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.9;37.9;;;27.4;49.6;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.4;84.4;;;77.1;89.7;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.6;69.6;;;61;77.1;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.8;44.8;;;37.5;52.4;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.4;47.4;;;36.9;58.2;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.4;68.4;;;52.9;80.6;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.4;38.4;;;31;46.4;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44;44;;;34.4;54.1;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;24.5;24.5;;;17.6;33;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;51.1;51.1;;;45.2;57;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;30.2;30.2;;;17.4;47.1;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87;87;;;79.3;92.1;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.1;40.1;;;34.6;45.8;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.4;89.4;;;83.2;93.5;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.3;34.3;;;29.2;39.8;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.1;31.1;;;22.9;40.7;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;78.8;78.8;;;64.6;88.3;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.1;70.1;;;60.6;78.1;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.1;32.1;;;27.7;36.9;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;81.6;81.6;;;70.6;89.2;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.6;41.6;;;31;53.1;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36;36;;;27.1;46.1;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;51.3;51.3;;;43.7;58.9;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.2;84.2;;;70.8;92.2;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.2;48.2;;;40;56.5;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.9;38.9;;;33;45.3;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.3;84.3;;;76.9;89.6;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.1;30.1;;;21.5;40.4;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.9;45.9;;;40.6;51.4;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.6;39.6;;;32.8;46.8;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.9;40.9;;;30.9;51.8;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.2;41.2;;;23.8;61.1;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.2;37.2;;;32.3;42.3;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;73.5;73.5;;;56.3;85.6;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.2;39.2;;;33.4;45.3;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.3;41.3;;;35.7;47.2;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;55.7;55.7;;;47.2;63.8;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84;84;;;76.5;89.4;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;93.3;93.3;;;87.4;96.6;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;81.1;81.1;;;70.5;88.5;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;75.7;75.7;;;66.4;83;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.5;64.5;;;57.6;70.8;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.5;71.5;;;61.4;79.8;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.5;69.5;;;61.1;76.8;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.8;39.8;;;22.7;59.8;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2013;2013;IL;Illinois;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.2;41.2;;;31.3;51.9;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;60.2;60.2;;;49.1;70.4;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85;85;;;76.5;90.8;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.3;28.3;;;21.6;36.2;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.1;69.1;;;61.9;75.5;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2013;2013;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.4;88.4;;;77.4;94.5;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.1;45.1;;;37.2;53.3;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36;36;;;30.7;41.7;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.3;70.3;;;57.5;80.5;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.8;66.8;;;56.4;75.8;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;19.1;19.1;;;14.4;25.1;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2013;2013;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.9;37.9;;;29.2;47.5;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;51.6;51.6;;;36.2;66.7;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.3;35.3;;;27.8;43.7;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;94.1;94.1;;;88.5;97.1;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.2;39.2;;;27.7;52;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.3;69.3;;;55.3;80.5;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.9;68.9;;;54.3;80.6;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.7;88.7;;;78.9;94.3;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;24.8;24.8;;;18.4;32.5;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.7;38.7;;;33.5;44.2;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.7;63.7;;;48.2;76.8;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2013;2013;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;91.8;91.8;;;85.7;95.5;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.9;41.9;;;32.1;52.4;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.9;32.9;;;28.1;38;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.3;13.3;;;11.5;15.4;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.7;40.7;;;32.3;49.8;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2013;2013;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.5;33.5;;;22.6;46.6;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.7;63.7;;;56.1;70.6;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38;38;;;32.5;43.7;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.8;10.8;;;9.8;12;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.9;30.9;;;21.7;41.9;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66;66;;;52.3;77.4;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;58.8;58.8;;;45.7;70.8;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.2;35.2;;;29.8;41;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.4;66.4;;;57.2;74.6;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;18.0;18;;;14.1;22.8;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41;41;;;35;47.2;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.6;70.6;;;59;79.9;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2013;2013;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.7;37.7;;;28.1;48.5;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.3;7.3;;;6;8.8;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.3;40.3;;;28.2;53.6;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.5;44.5;;;39.6;49.6;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.7;40.7;;;36.2;45.3;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;79.3;79.3;;;72.5;84.8;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35;35;;;27;43.9;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90.6;90.6;;;82.2;95.2;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.2;42.2;;;26.8;59.3;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.9;65.9;;;43.2;83.1;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.3;38.3;;;29.2;48.2;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.9;46.9;;;42.2;51.8;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.1;65.1;;;55;73.9;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;81.70;81.7;;;80.9;82.5;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.3;31.3;;;21.9;42.6;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;73.1;73.1;;;66.4;78.8;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2013;2013;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;80.3;80.3;;;69.6;87.9;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.9;84.9;;;78.7;89.6;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.8;6.8;;;5.5;8.4;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;92;92;;;85.7;95.6;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41;41;;;33.2;49.3;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67;67;;;59.1;74;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.7;69.7;;;55.6;80.9;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.4;43.4;;;37.8;49.2;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.1;62.1;;;54.3;69.3;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2013;2013;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.3;37.3;*;50 States + DC: US Median;35.2;38.7;Overall;Overall;;;;;;;59;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2013;2013;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;NMBR;RACE;AIAN;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;75.2;75.2;;;65.8;82.8;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46;46;;;30.4;62.5;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2013;2013;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;9.00;9;;;6.8;11.3;Race/Ethnicity;Asian or Pacific Islander;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;AGEADJRATE;RACE;API;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.8;88.8;;;81.1;93.6;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40;40;;;30.9;49.9;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.8;85.8;;;77.3;91.5;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.4;82.4;;;72.7;89.2;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.7;37.7;;;32.8;42.7;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;29.5;29.5;;;20.1;41.2;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.8;32.8;;;25.9;40.6;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;75;75;;;65.9;82.2;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.6;38.6;;;30.5;47.5;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;76.7;76.7;;;68.5;83.3;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.7;7.7;;;6.9;8.5;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.4;68.4;;;60.3;75.5;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.3;45.3;;;39.2;51.5;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.2;71.2;;;63.4;77.9;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.7;41.7;;;31.5;52.7;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.3;34.3;;;25.8;43.9;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.4;41.4;;;34.8;48.5;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.9;70.9;;;62.9;77.7;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.3;67.3;;;58.7;74.9;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.5;70.5;;;61;78.6;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.8;82.8;;;75.6;88.3;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.3;69.3;;;59;77.9;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.9;65.9;;;53;76.7;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.4;66.4;;;49.8;79.7;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.6;40.6;;;33.9;47.7;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2013;2013;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.8;34.8;;;29;41;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;75;75;;;65.2;82.7;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85;85;;;74.1;91.8;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.8;38.8;;;30;48.4;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;36.5;36.5;;;28.5;45.3;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;75;75;;;64.3;83.4;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84;84;;;76.4;89.5;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.7;84.7;;;78.8;89.1;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.6;62.6;;;55.7;68.9;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;73.3;73.3;;;61.6;82.5;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.4;86.4;;;74.1;93.3;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;79.2;79.2;;;69.3;86.5;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;53.5;53.5;;;38.6;67.8;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2013;2013;OK;Oklahoma;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.1;87.1;;;80;91.9;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.2;85.2;;;70;93.4;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.2;39.2;;;27.5;52.3;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;80.2;80.2;;;70.9;87;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2013;2013;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.8;69.8;*;50 States + DC: US Median;66.5;72.7;Gender;Male;;;;;;;59;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.6;87.6;;;76.2;94;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.7;66.7;;;54.5;77;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;IN;Indiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.9;32.9;;;21.3;47.1;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2013;2013;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.1;43.1;;;37.1;49.3;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.5;44.5;;;36;53.2;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.5;84.5;;;78.9;88.8;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.7;70.7;;;57.4;81.1;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.1;49.1;;;40;58.2;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;77.8;77.8;;;68;85.3;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;75;75;;;68.2;80.7;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83;83;;;74.2;89.3;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;91.2;91.2;;;87.1;94.1;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2013;2013;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;76.5;76.5;;;68.3;83;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41;41;;;35.2;47;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.8;33.8;;;26.3;42.3;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.1;82.1;;;68.1;90.8;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.8;68.8;;;59.8;76.6;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.7;89.7;;;82.3;94.2;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;51.6;51.6;;;33.5;69.2;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;75.4;75.4;;;66.7;82.4;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2013;2013;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.6;66.6;;;56.2;75.5;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2013;2013;NY;New York;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.8;82.8;;;68.4;91.4;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2013;2013;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.5;38.5;;;31.5;46;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.0;12;;;10.9;13.1;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.4;38.4;;;34.8;42.2;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;80.7;80.7;;;69.1;88.6;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.1;43.1;;;35.9;50.7;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;59.9;59.9;;;41.4;76;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;CO;Colorado;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;76.6;76.6;;;67.4;83.8;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;79.3;79.3;;;60.3;90.6;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.4;72.4;;;62.2;80.7;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.1;35.1;;;27.8;43.2;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;29.5;29.5;;;20.9;39.9;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.7;42.7;;;33.2;52.7;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2013;2013;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;77.4;77.4;;;65.9;85.8;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;60.1;60.1;;;44.7;73.7;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.8;34.8;;;27.2;43.3;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;30.2;30.2;;;20;42.9;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;80.5;80.5;;;74.1;85.7;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.4;40.4;;;30.3;51.3;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.3;86.3;;;72.4;93.8;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;61.8;61.8;;;51.7;71;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.1;37.1;;;25.9;49.8;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.1;46.1;;;34.1;58.5;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.4;44.4;;;38;51;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.4;40.4;;;33.9;47.2;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86;86;;;79.9;90.5;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.7;64.7;;;55.6;72.9;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.6;44.6;;;39.2;50.3;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.6;45.6;;;34.6;57;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.6;40.6;;;34.5;47;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.7;90.7;;;84.5;94.5;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.3;40.3;;;36.2;44.6;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.6;66.6;;;58.6;73.7;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;57.6;57.6;;;49.8;65;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.1;70.1;;;60.9;78;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;78.2;78.2;;;67.6;86;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.1;88.1;;;84.2;91;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.2;72.2;;;53.4;85.4;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;50.3;50.3;;;43.9;56.7;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.3;85.3;;;75;91.8;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.9;64.9;;;49.1;78;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.5;83.5;;;76.1;89;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.4;84.4;;;76.5;90;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.8;69.8;;;61.9;76.6;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;75.4;75.4;;;57.4;87.4;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.2;82.2;;;69.8;90.2;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.7;37.7;;;29.9;46.2;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.3;45.3;;;30.9;60.4;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;50.6;50.6;;;33.2;67.8;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.4;36.4;;;31.4;41.7;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;PA;Pennsylvania;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.4;39.4;;;31.9;47.3;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;95.7;95.7;;;92.1;97.7;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67.4;67.4;;;57.5;76;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;55.3;55.3;;;47.3;63;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40;40;;;30.2;50.8;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2013;2013;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;75.7;75.7;;;62.6;85.2;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;35;35;;;27.2;43.7;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.1;86.1;;;76.7;92.1;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.5;30.5;;;21.1;41.7;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;18.2;18.2;;;13.5;24.1;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;92.8;92.8;;;86.9;96.2;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.1;39.1;;;33.8;44.6;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;76.7;76.7;;;68.5;83.2;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.7;86.7;;;75.7;93.1;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.2;47.2;;;39.9;54.7;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;91.3;91.3;;;81.7;96.1;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;72.9;72.9;;;64.3;80.1;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.6;71.6;;;61.2;80.2;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;7.6;7.6;;;5.7;10;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.8;86.8;;;83.1;89.8;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.2;70.2;;;62.5;76.9;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.1;34.1;;;24;45.8;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.4;41.4;;;29.2;54.7;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.1;86.1;;;71.9;93.7;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;80.5;80.5;;;67.4;89.2;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;61.3;61.3;;;50.2;71.4;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.4;32.4;;;19.1;49.3;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;21.7;21.7;;;13.1;33.9;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.6;63.6;;;53.7;72.4;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.1;39.1;;;31.1;47.8;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.9;69.9;;;53.8;82.1;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;61.2;61.2;;;50.3;71.1;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.9;39.9;;;33.9;46.2;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;47.2;47.2;;;32.7;62.2;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.1;86.1;;;71.5;93.9;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;72.3;72.3;;;57.3;83.6;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.5;88.5;;;80.3;93.5;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;71;71;;;51;85.2;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.3;10.3;;;5.6;18.1;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;30.2;30.2;;;23.4;38.1;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.7;82.7;;;76.2;87.7;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.4;47.4;;;38.9;56;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.1;37.1;;;31.5;43;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;58.8;58.8;;;50.8;66.3;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;81.7;81.7;;;73;88.1;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.3;47.3;;;41.6;53.1;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.7;84.7;;;77.4;90;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2013;2013;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50.7;50.7;;;43.4;58.1;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.3;42.3;;;35.8;49.1;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.8;70.8;;;56.1;82.1;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.4;34.4;;;25.8;44.1;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.2;30.2;;;23.2;38.3;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.2;44.2;;;37.3;51.4;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.8;41.8;;;35.8;48;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.7;40.7;;;32.2;49.8;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.1;71.1;;;56.8;82.1;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.6;43.6;;;35.3;52.2;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;81.1;81.1;;;71.6;87.9;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.6;43.6;;;38;49.4;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.3;84.3;;;77;89.6;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.6;38.6;;;32;45.6;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.5;41.5;;;28;56.4;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;60.1;60.1;;;43.5;74.7;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;92.8;92.8;;;85.5;96.6;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.8;71.8;;;63.1;79.1;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;76.6;76.6;;;67.5;83.7;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.1;70.1;;;62.5;76.8;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.7;64.7;;;53.9;74.2;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.9;46.9;;;32.4;62;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;61.3;61.3;;;42.9;77;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.3;42.3;;;32.1;53.1;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2013;2013;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.8;32.8;;;27.3;38.8;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.1;37.1;;;32;42.5;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.3;37.3;;;30.1;45;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43;43;;;28.1;59.3;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.6;66.6;;;58.7;73.6;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;26.4;26.4;;;19.7;34.5;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;92;92;;;81;96.8;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.3;67.3;;;57.7;75.6;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.2;42.2;;;36.9;47.7;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;79.1;79.1;;;69.4;86.4;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;92.3;92.3;;;85.3;96.2;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.7;68.7;;;64;73.1;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;78.6;78.6;;;70.2;85.1;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.8;30.8;;;24.2;38.4;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;92.3;92.3;;;85.8;96;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.7;33.7;;;28.2;39.6;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;58.2;58.2;;;48.6;67.2;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86;86;;;80;90.5;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.1;44.1;;;37.9;50.5;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.9;42.9;;;37.6;48.3;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2013;2013;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;81.4;81.4;;;73.5;87.3;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;78.6;78.6;;;70.2;85.1;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.8;36.8;;;26.3;48.7;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.4;35.4;;;24.7;47.8;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.7;85.7;;;79.2;90.3;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90.1;90.1;;;75.9;96.3;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.8;39.8;;;31.3;49;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.5;45.5;;;32.1;59.7;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.6;34.6;;;23.8;47.3;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;52.6;52.6;;;35;69.6;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.2;38.2;;;28.4;49.2;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.5;40.5;;;35;46.3;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.9;83.9;;;76.3;89.4;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;72.1;72.1;;;63.3;79.4;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.7;83.7;;;65.3;93.3;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2013;2013;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.4;89.4;;;80.5;94.5;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.9;42.9;;;35.8;50.2;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.2;33.2;;;22.1;46.6;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.9;37.9;;;32.2;43.9;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.5;83.5;;;76.4;88.8;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.1;34.1;;;29;39.5;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.7;33.7;;;26.2;42.1;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;72.4;72.4;;;65.7;78.2;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;60;60;;;51.4;68;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.4;35.4;;;32.1;38.8;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.7;36.7;;;32.3;41.4;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.4;42.4;;;32.4;53.1;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84;84;;;75.4;90.1;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.6;33.6;;;26.3;41.9;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;92.4;92.4;;;84.2;96.5;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;75.9;75.9;;;66.2;83.6;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.7;38.7;;;25.5;53.7;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.5;43.5;;;34.6;52.7;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;74.3;74.3;;;67.5;80.1;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.5;84.5;;;67.5;93.5;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.3;84.3;;;74.7;90.8;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;79.2;79.2;;;71;85.6;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.3;85.3;;;75.5;91.6;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.6;40.6;;;29.1;53.1;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.6;70.6;;;63.1;77.1;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89;89;;;81.4;93.7;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.3;89.3;;;82.5;93.7;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.4;83.4;;;75;89.3;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.7;39.7;;;33.5;46.2;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2013;2013;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90;90;;;82.1;94.6;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.2;71.2;;;60.4;80;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;30.1;30.1;;;21.8;39.9;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.2;36.2;;;30.6;42.1;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;81;81;;;71.1;88;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67.4;67.4;;;59.1;74.7;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;96.6;96.6;;;90.7;98.8;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;81.6;81.6;;;71.3;88.7;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;54.6;54.6;;;40.2;68.4;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88;88;;;80.3;93;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2013;2013;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;27;27;;;16.8;40.4;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.4;85.4;;;76.5;91.3;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.3;37.3;;;30.5;44.6;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.2;41.2;;;35.1;47.6;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;26.1;26.1;;;16.2;39.3;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.7;87.7;;;82.8;91.4;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.5;38.5;;;33.5;43.7;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;74.2;74.2;;;56.4;86.5;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.4;43.4;;;34.9;52.3;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.5;84.5;;;69.3;92.9;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.7;84.7;;;75.1;91;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.3;90.3;;;83.9;94.3;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;81.4;81.4;;;73.1;87.6;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2013;2013;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.1;38.1;*;50 States + DC: US Median;36.1;38.9;Gender;Female;;;;;;;59;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.2;49.2;;;42.7;55.7;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.6;40.6;;;32;49.9;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.7;41.7;;;36;47.7;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.1;67.1;;;58.1;75.1;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.7;87.7;;;79.5;92.9;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85;85;;;74;91.9;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67;67;;;57.3;75.5;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;29.6;29.6;;;21.8;38.8;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;73;73;;;64.2;80.3;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.8;91.8;;;82.8;96.3;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.6;31.6;;;26.6;37;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.2;86.2;;;78.1;91.6;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2013;2013;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;24;24;;;16.3;33.9;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.4;45.4;;;38.1;53;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29.3;29.3;;;22.4;37.4;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.6;44.6;;;36.9;52.5;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2013;2013;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68;68;*;50 States + DC: US Median;66.4;70;Gender;Female;;;;;;;59;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2013;2013;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.5;33.5;;;27.9;39.8;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.1;32.1;;;22.6;43.3;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.4;69.4;;;61.9;76;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;25.9;25.9;;;16.7;37.8;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.7;67.7;;;59.9;74.6;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.7;35.7;;;28.1;44.1;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.6;89.6;;;83.1;93.7;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.5;68.5;;;51.3;81.8;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.9;82.9;;;68.2;91.6;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.4;48.4;;;41.5;55.3;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.7;43.7;;;37.6;49.9;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;74.9;74.9;;;60.8;85.1;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.7;31.7;;;22;43.4;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;18.0;18;;;12.2;25.8;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.1;84.1;;;72.9;91.2;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;57.4;57.4;;;49.6;64.8;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;60.4;60.4;;;50.2;69.8;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.9;43.9;;;36.8;51.3;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.8;41.8;;;33.6;50.6;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71;71;;;62.5;78.2;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.9;69.9;;;62;76.7;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.7;43.7;;;35;52.9;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90.6;90.6;;;81.5;95.5;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.8;34.8;;;26.3;44.4;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;92.1;92.1;;;86.2;95.6;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.6;33.6;;;28.2;39.3;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.6;87.6;;;81.6;91.9;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.2;63.2;;;54.5;71.2;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.8;41.8;;;35.3;48.6;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.2;83.2;;;69.3;91.5;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.4;65.4;;;54.6;74.8;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.8;71.8;;;57;83.1;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;60.4;60.4;;;48.6;71.1;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.8;64.8;;;53.4;74.7;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.4;90.4;;;82;95.1;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;79.2;79.2;;;71.1;85.5;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.1;38.1;;;32.6;43.9;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.7;89.7;;;83.1;93.9;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.7;71.7;;;57.2;82.9;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.8;36.8;;;31.2;42.9;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;80.2;80.2;;;68.2;88.5;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;24.7;24.7;;;14.5;38.8;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;80.6;80.6;;;72.3;86.9;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.5;45.5;;;35.1;56.3;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;16.9;16.9;;;12.7;22.2;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.4;68.4;;;58.5;76.9;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.1;85.1;;;77.2;90.6;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;75.3;75.3;;;62.2;84.9;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.2;82.2;;;69;90.5;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.8;69.8;;;50.2;84.1;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;60.2;60.2;;;52.1;67.8;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.4;41.4;;;26.4;58.1;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.3;91.3;;;83.5;95.7;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.3;89.3;;;82.9;93.5;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.9;89.9;;;82.1;94.5;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.2;44.2;;;38.5;50.1;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2013;2013;UT;Utah;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.5;68.5;;;59.1;76.6;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40;40;*;50 States + DC: US Median;38.6;41.7;Overall;Overall;;;;;;;59;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.3;38.3;;;29.3;48.1;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.4;44.4;;;39.4;49.6;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;59.3;59.3;;;51.1;67.1;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;76.3;76.3;;;67.3;83.4;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;29.2;29.2;;;16.9;45.6;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;81.1;81.1;;;71.1;88.3;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;50.8;50.8;;;36.4;65.2;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;64.2;64.2;;;56.4;71.3;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;58.8;58.8;;;51.9;65.4;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.4;34.4;;;24.3;46.1;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.3;46.3;;;36.1;56.8;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;77.4;77.4;;;61.3;88.1;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.5;35.5;;;28.8;42.9;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;30.8;30.8;;;20.4;43.6;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.5;45.5;;;38.6;52.7;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.2;46.2;;;34.5;58.3;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.1;88.1;;;81;92.8;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.1;35.1;;;28.8;41.9;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.3;83.3;;;65.3;93;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.9;84.9;;;75.9;90.9;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.4;35.4;;;29.2;42.1;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;73.6;73.6;;;60.7;83.4;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.1;41.1;;;32.4;50.5;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.7;85.7;;;76.4;91.8;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.8;47.8;;;41.8;53.9;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;77.9;77.9;;;61.1;88.7;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.2;44.2;;;38.5;50;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;74.1;74.1;;;58.4;85.4;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29.1;29.1;;;18.7;42.1;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.5;42.5;;;34.9;50.6;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.1;83.1;;;71.5;90.6;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.6;41.6;;;33.9;49.8;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45;45;;;39.3;50.9;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.9;36.9;;;31.3;42.9;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.3;86.3;;;72;93.9;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.4;69.4;;;60.6;77;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;73.7;73.7;;;59.1;84.4;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.1;42.1;;;34.5;50;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.5;69.5;;;58.6;78.5;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.1;36.1;;;32.6;39.8;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.7;44.7;;;38;51.6;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;75.3;75.3;;;66.1;82.7;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.2;85.2;;;73.6;92.2;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.6;83.6;;;66.7;92.9;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.5;65.5;;;55.9;74;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;80.6;80.6;;;72.5;86.7;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.9;34.9;;;20.3;52.9;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.3;70.3;;;61.1;78.1;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.3;86.3;;;78.5;91.6;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.8;36.8;;;28;46.6;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.9;39.9;;;33.9;46.2;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.9;86.9;;;77.9;92.6;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2013;2013;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.5;72.5;;;62.7;80.6;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67;67;;;56.6;76;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;79.2;79.2;;;69.3;86.5;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.4;36.4;;;30.8;42.3;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;78.7;78.7;;;69.2;85.9;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;36.7;36.7;;;28.9;45.2;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.1;44.1;;;34.7;54;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.4;42.4;;;36.9;48.1;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.4;84.4;;;67.8;93.3;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86;86;;;79.6;90.6;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;74.3;74.3;;;58.1;85.8;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.2;65.2;;;52.7;75.9;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.4;66.4;;;57.2;74.6;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.4;40.4;;;33.4;47.9;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.8;34.8;;;29.4;40.7;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;92.5;92.5;;;82.6;97;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.4;86.4;;;80;91;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38;38;;;29.5;47.2;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2013;2013;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;32490;32,490;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;NMBR;RACE;BLK;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.3;41.3;;;34.7;48.1;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.6;69.6;;;61.2;76.8;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.3;82.3;;;71.1;89.8;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.3;85.3;;;77;90.9;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.3;34.3;;;27.8;41.5;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;78.2;78.2;;;68.1;85.8;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.3;86.3;;;80.4;90.7;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.8;34.8;;;27.9;42.4;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71;71;;;63;77.9;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.1;40.1;;;34.4;46;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;36.5;36.5;;;28.5;45.3;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.1;37.1;;;32.1;42.4;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.1;70.1;;;53.9;82.5;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.7;91.7;;;85.9;95.2;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.4;11.4;;;10.5;12.2;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2013;2013;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;CRDRATE;RACE;AIAN;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.6;38.6;;;33.2;44.3;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.8;41.8;;;33.6;50.5;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.4;35.4;;;25.6;46.5;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.9;85.9;;;72.4;93.4;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.1;38.1;;;24.2;54.1;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;27.9;27.9;;;19.5;38.1;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.5;86.5;*;50 States + DC: US Median;85.3;88.1;Gender;Female;;;;;;;59;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29.6;29.6;;;24.6;35.2;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;22.7;22.7;;;13.7;35.2;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;81.7;81.7;;;71.5;88.9;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;AK;Alaska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.6;44.6;;;37.9;51.5;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;94.3;94.3;;;89.1;97.1;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.6;33.6;;;23.8;45.1;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.9;85.9;;;82.1;89;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.3;87.3;;;78.9;92.6;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.6;36.6;;;30.8;42.9;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.4;40.4;;;34;47.2;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.8;43.8;;;35.7;52.3;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.8;32.8;;;24.7;42.2;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.4;36.4;;;29.7;43.7;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.2;41.2;;;30.1;53.2;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;50.8;50.8;;;44.2;57.5;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;20.7;20.7;;;12.9;31.5;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.6;86.6;;;78.3;92.1;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.2;68.2;;;55.1;78.9;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.9;32.9;;;22.2;45.6;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.1;44.1;;;34.1;54.6;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.4;42.4;;;30.9;54.7;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.2;42.2;;;31.8;53.3;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.8;41.8;;;35;49;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.8;38.8;;;33.3;44.5;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;AR;Arkansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST2_1;NMBR;GENDER;GENM;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;73.2;73.2;;;57.5;84.6;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;93.8;93.8;;;88.6;96.7;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89;89;;;77.9;94.9;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.7;38.7;;;33.9;43.8;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.2;37.2;;;30;45.1;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39;39;;;34.4;43.8;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;80.9;80.9;;;66.8;89.9;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;73.6;73.6;;;60.8;83.4;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.3;91.3;;;84.1;95.5;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;79.1;79.1;;;67.9;87.1;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.7;66.7;;;57.4;74.8;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;77.4;77.4;;;67.9;84.8;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.9;42.9;;;35.4;50.8;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;27.9;27.9;;;20.1;37.4;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.3;68.3;;;52.7;80.6;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.8;34.8;;;28.7;41.4;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.6;40.6;;;35.1;46.4;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.5;65.5;;;54.6;75;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.7;83.7;;;76.5;89;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.6;87.6;;;80.9;92.1;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;58;58;;;40.2;74;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89;89;;;77.9;94.9;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.7;45.7;;;34.1;57.7;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.3;86.3;;;78;91.9;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88;88;;;80.6;92.8;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.5;68.5;*;50 States + DC: US Median;66.9;70.2;Gender;Female;;;;;;;59;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.3;8.3;;;6.9;9.9;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.5;70.5;;;61;78.5;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2013;2013;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.6;40.6;;;34.6;46.8;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;73.6;73.6;;;65.2;80.6;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.1;42.1;;;37.7;46.6;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;73.1;73.1;;;65.3;79.8;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.9;41.9;;;36.1;48;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.7;46.7;;;37.9;55.6;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;57.9;57.9;;;50.8;64.6;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.8;34.8;;;24.8;46.5;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.1;85.1;;;76.4;91;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.1;41.1;;;30.6;52.5;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2013;2013;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.9;66.9;;;57.6;75;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.9;69.9;;;60.8;77.7;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.5;40.5;;;28.1;54.3;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84;84;;;76.5;89.4;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;77.7;77.7;;;63;87.7;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.8;39.8;;;31.2;49.2;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2013;2013;CO;Colorado;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69;69;;;60.9;76.1;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;30.1;30.1;;;17.7;46.3;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.7;41.7;;;27.6;57.3;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.2;85.2;;;71.2;93.1;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;77.6;77.6;;;69.7;84;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.7;40.7;;;28.7;53.8;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.4;87.4;;;81.1;91.7;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.8;68.8;;;61.2;75.5;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;79.5;79.5;;;71.2;85.8;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.7;36.7;;;28.7;45.5;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;55;55;;;40.5;68.7;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.6;67.6;;;56.6;77;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.6;38.6;;;30.3;47.5;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.5;41.5;;;36.1;47;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;30.9;30.9;;;21.5;42.2;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.3;43.3;;;36;50.9;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39;39;;;32.9;45.5;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.6;42.6;;;31.6;54.5;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.4;71.4;;;56.9;82.5;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;92.5;92.5;;;85.3;96.3;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.2;43.2;;;27.9;59.9;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.8;41.8;;;35;48.8;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;77.1;77.1;;;60.7;88;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;80.6;80.6;;;70.4;87.8;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.9;43.9;;;37.7;50.2;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;36.5;36.5;;;28.7;45;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85;85;;;74.8;91.6;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;78;78;;;67.4;85.9;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.2;84.2;;;75.7;90.1;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.4;31.4;;;17.4;50;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.1;89.1;;;82.4;93.4;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.8;41.8;;;35.5;48.3;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85;85;;;73.4;92.1;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.8;37.8;;;33.4;42.4;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.7;84.7;;;76.9;90.2;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.1;33.1;;;24.1;43.4;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;79.4;79.4;;;70.5;86.1;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;74.8;74.8;;;63.7;83.4;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.5;39.5;;;33.6;45.7;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.7;42.7;;;36;49.8;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.1;87.1;;;83.2;90.1;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67.9;67.9;;;58.9;75.7;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.2;69.2;;;60.4;76.9;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;96.5;96.5;;;93.2;98.2;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.1;69.1;;;57.7;78.5;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.8;71.8;;;61.3;80.3;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;95.2;95.2;;;87.6;98.2;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;96.3;96.3;;;89.8;98.7;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;75.5;75.5;;;67.1;82.3;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.2;41.2;;;36;46.7;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.8;68.8;;;63.1;73.9;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.9;84.9;;;74.4;91.6;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;73.7;73.7;;;66;80.2;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.8;37.8;;;32.8;43;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;77.9;77.9;;;62.4;88.2;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2013;2013;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.6;72.6;;;64.6;79.3;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.6;88.6;;;83.5;92.2;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2013;2013;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84;84;;;76.6;89.4;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.6;14.6;;;11.5;18.5;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.7;44.7;;;36.7;52.9;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;24.1;24.1;;;13.4;39.4;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.1;45.1;;;38.3;52.1;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.5;37.5;;;30.9;44.7;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.8;66.8;;;58.4;74.2;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;76;76;;;59.1;87.4;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.7;41.7;;;36.1;47.4;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;77.8;77.8;;;66.1;86.3;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.2;44.2;;;36.7;52;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.2;69.2;*;50 States + DC: US Median;64.3;71.4;Gender;Male;;;;;;;59;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;81.3;81.3;;;72.7;87.7;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;81.5;81.5;;;70.8;88.9;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.9;37.9;;;27.4;49.7;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;19.6;19.6;;;12.1;30.3;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;56.3;56.3;;;44.5;67.5;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;58.2;58.2;;;41;73.6;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.6;36.6;;;29.5;44.3;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;79.5;79.5;;;70.2;86.4;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.1;71.1;;;62.6;78.2;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.4;38.4;;;24.2;54.9;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.6;39.6;;;21.7;60.8;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65;65;;;54.1;74.5;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.5;41.5;;;34.2;49.1;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.5;35.5;;;18.6;57.1;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.2;69.2;;;59.3;77.6;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.4;82.4;;;73.7;88.7;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.7;39.7;;;33.9;45.9;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.4;9.4;;;6.8;12.7;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;24.8;24.8;;;17.6;33.8;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.8;72.8;;;60.8;82.2;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.9;38.9;;;32.5;45.8;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.1;84.1;;;74.2;90.7;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.8;43.8;;;34.6;53.3;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2013;2013;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.1;69.1;*;50 States + DC: US Median;66.7;70.1;Overall;Overall;;;;;;;59;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;MS;Mississippi;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;75.8;75.8;;;58.4;87.5;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;92.3;92.3;;;81.9;97;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;77.6;77.6;;;69.4;84.1;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.6;39.6;;;30.1;49.9;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.7;85.7;;;79.3;90.4;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.9;82.9;;;69.4;91.2;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;41.0;41;;;39.7;42.3;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;AGEADJRATE;RACE;HIS;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2013;2013;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;81.7;81.7;;;73.8;87.7;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.1;85.1;;;77.5;90.5;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;75.5;75.5;;;57.7;87.5;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.8;44.8;;;39.4;50.4;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.8;65.8;;;56.1;74.3;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.6;67.6;;;60.5;73.9;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.4;42.4;;;34.7;50.5;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.4;40.4;;;31.6;49.9;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2013;2013;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.9;37.9;*;50 States + DC: US Median;36.1;40.4;Gender;Male;;;;;;;59;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2013;2013;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.9;46.9;;;39.4;54.5;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;78.1;78.1;;;63.1;88.2;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.2;69.2;;;64.7;73.3;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38;38;;;33.5;42.8;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.6;35.6;;;29.4;42.3;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.6;86.6;;;79;91.8;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.6;42.6;;;34.9;50.5;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;26.7;26.7;;;17.6;38.4;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;46457;46,457;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;NMBR;RACE;WHT;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.7;85.7;;;73.1;92.9;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;61.5;61.5;;;54.3;68.2;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.9;31.9;;;26.5;37.8;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.1;71.1;;;56.9;82.1;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;MT;Montana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST2_1;NMBR;GENDER;GENF;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37;37;;;31.2;43.3;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.7;71.7;;;62.4;79.4;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40;40;;;35.1;45.1;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;75.3;75.3;;;65.7;82.9;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.8;69.8;;;61.4;77.1;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.1;9.1;;;8.1;10.2;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.8;7.8;;;6;10;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.4;37.4;;;25.5;51.1;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.8;34.8;;;26.8;43.7;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;VA;Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.7;86.7;;;73.2;94;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.9;85.9;;;73.1;93.1;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.1;86.1;;;76.2;92.3;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;78;78;;;51.2;92.3;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;61.8;61.8;;;54.7;68.4;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;72.1;72.1;;;63.6;79.3;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.9;36.9;;;30.7;43.6;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.5;84.5;;;69.6;92.8;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.3;47.3;;;38.2;56.7;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.2;38.2;;;30.3;46.8;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.4;38.4;;;32.1;45.1;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.6;83.6;;;75.7;89.3;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.8;82.8;;;75.2;88.4;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;15.8;15.8;;;11.8;20.7;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.6;39.6;;;33.2;46.5;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.4;31.4;;;21.1;44;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;64.8;64.8;;;57.9;71.1;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.2;83.2;;;75.1;89.1;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.2;83.2;;;75.5;88.8;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;33.7;33.7;;;25.9;42.4;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;6.3;6.3;;;4.6;8.7;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.1;34.1;;;25.9;43.3;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;80.5;80.5;;;70.1;87.9;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;77.4;77.4;;;68.3;84.5;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.8;37.8;;;27.3;49.5;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.2;39.2;;;33.1;45.6;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;28.2;28.2;;;27.6;28.8;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;CRDRATE;RACE;WHT;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;50.4;50.4;;;35.8;64.9;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.8;45.8;;;36.2;55.7;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50.8;50.8;;;41.7;59.7;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.2;41.2;;;35.4;47.3;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.5;35.5;;;27.2;44.8;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;74.6;74.6;;;55.4;87.4;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.6;83.6;;;74.6;89.8;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2013;2013;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;24.2;24.2;;;16.4;34.2;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71;71;;;61.3;79;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.7;10.7;;;9.2;12.5;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2013;2013;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.5;66.5;;;50.5;79.4;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.5;7.5;;;5.4;10.3;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.5;86.5;;;74.7;93.2;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;26.9;26.9;;;17.8;38.3;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.9;33.9;;;23.6;46;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90;90;;;81.2;94.9;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;49.9;49.9;;;35.6;64.2;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42;42;;;37;47.3;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;91.2;91.2;;;86.4;94.4;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;77.5;77.5;;;69;84.2;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;30.4;30.4;;;21;41.7;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.1;40.1;;;33.6;47;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;59.6;59.6;;;51.7;67.1;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2013;2013;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;81.7;81.7;;;72.7;88.2;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68;68;;;52.2;80.5;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.1;46.1;;;39.7;52.7;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.4;86.4;;;78.7;91.6;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;75.9;75.9;;;66.8;83.1;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.6;30.6;;;25.4;36.3;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.5;86.5;;;82.5;89.7;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.2;33.2;;;25.5;41.9;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.4;66.4;;;50.2;79.4;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;80;80;;;66.3;89.1;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67.6;67.6;;;49.5;81.6;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;75.1;75.1;;;64.9;83.2;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.9;65.9;;;56.6;74.1;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;74.6;74.6;;;58.7;85.8;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;94.6;94.6;;;89.6;97.3;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;27;27;;;20.1;35.1;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.7;44.7;;;40.2;49.3;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.6;83.6;;;77.4;88.4;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.7;38.7;;;33.5;44.3;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.3;82.3;;;68.1;91;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.4;41.4;;;33.5;49.8;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.5;63.5;;;55.7;70.7;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.5;42.5;;;36.5;48.7;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2013;2013;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.9;40.9;*;50 States + DC: US Median;39.3;41.7;Gender;Female;;;;;;;59;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.3;91.3;;;86.9;94.3;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.8;28.8;;;22.1;36.5;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;60.6;60.6;;;45.8;73.6;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.2;70.2;;;58.6;79.6;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.3;39.3;;;32.1;47.1;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.5;10.5;;;6.6;16.3;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45;45;;;37.9;52.2;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.1;82.1;;;74.1;88;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;23.3;23.3;;;15.3;33.9;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89;89;;;78.5;94.8;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;55.5;55.5;;;48;62.7;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.6;71.6;;;62.8;79;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.1;69.1;;;61.5;75.8;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.4;47.4;;;38.9;56;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;92.8;92.8;;;86;96.5;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.7;91.7;;;87.5;94.7;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.6;85.6;;;77.5;91.1;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85;85;;;78.1;90;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.9;40.9;;;36.2;45.9;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;74.2;74.2;;;62.5;83.2;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.8;86.8;;;74.3;93.7;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.1;7.1;;;5.9;8.5;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.6;86.6;;;75.3;93.2;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32;32;;;24.8;40.2;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2013;2013;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.2;43.2;;;38.2;48.3;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.4;32.4;;;21;46.5;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;80.1;80.1;;;71.2;86.7;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.1;39.1;;;28.2;51.3;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2013;2013;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.7;85.7;*;50 States + DC: US Median;84.3;87.3;Gender;Female;;;;;;;59;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;81.6;81.6;;;68.7;90;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.7;67.7;;;56.3;77.4;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.8;84.8;;;74.6;91.4;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;80.9;80.9;;;70.9;88.1;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.5;37.5;;;30.3;45.2;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.3;37.3;;;33.1;41.6;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.4;36.4;;;25.8;48.5;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.5;86.5;;;76.1;92.8;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;16.2;16.2;;;12.1;21.3;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.5;31.5;;;21.2;43.9;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.6;32.6;;;26.4;39.5;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.6;28.6;;;17.1;43.8;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.5;34.5;;;24.1;46.6;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;24.5;24.5;;;15.5;36.5;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.3;37.3;;;34;40.8;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.4;45.4;;;38.3;52.7;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33;33;;;24;43.4;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.9;38.9;;;33.5;44.5;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.7;83.7;;;72;91.1;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;38.4;38.4;;;30.4;47;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.3;47.3;;;40.2;54.6;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.9;82.9;;;73.2;89.5;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.8;90.8;;;82.1;95.5;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.4;42.4;;;34.7;50.4;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.9;87.9;;;81.3;92.4;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.5;69.5;;;49.1;84.3;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;73.2;73.2;;;65;80.1;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29.2;29.2;;;21.1;38.9;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.1;40.1;;;27.1;54.6;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;25.5;25.5;;;16.5;37.4;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.4;48.4;;;41.6;55.3;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.5;87.5;;;80.7;92.1;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.1;68.1;;;62.6;73.2;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90.5;90.5;;;84.7;94.3;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2013;2013;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;81.8;81.8;;;72.6;88.4;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.9;69.9;;;61.5;77.1;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.5;48.5;;;33.9;63.3;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;80.8;80.8;;;73.4;86.5;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.9;37.9;;;31.7;44.6;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.5;64.5;;;55.2;72.8;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;59.1;59.1;;;48;69.3;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;MD;Maryland;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST2_1;NMBR;GENDER;GENM;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.3;40.3;;;32.6;48.5;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;77.2;77.2;;;65.7;85.7;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2013;2013;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.8;39.8;;;34.8;45.1;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.9;82.9;;;74.5;88.9;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.5;64.5;;;57.2;71.2;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.3;39.3;;;29.7;49.8;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.5;43.5;;;25.3;63.5;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.7;45.7;;;40.2;51.3;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.7;30.7;;;24.9;37.2;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91;91;;;85.7;94.5;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.3;87.3;;;81.2;91.6;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.7;49.7;;;43.1;56.3;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.3;38.3;;;31.5;45.7;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.2;31.2;;;24.5;38.8;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.3;62.3;;;53.4;70.5;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;23.3;23.3;;;14.9;34.7;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;38.4;38.4;;;30.4;47;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67.3;67.3;;;45.9;83.3;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.4;44.4;;;33;56.4;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43;43;;;35;51.5;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.9;71.9;;;62.7;79.5;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50.9;50.9;;;44.2;57.5;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.7;41.7;;;35.7;48;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2013;2013;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.8;36.8;;;25.3;50;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.4;32.4;;;23.8;42.4;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.3;69.3;;;59.4;77.7;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.4;40.4;;;31.6;49.7;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.9;37.9;;;32.2;44.1;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.4;35.4;;;19.6;55.1;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.6;72.6;;;62.4;80.8;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.1;40.1;;;29.3;52;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;78.8;78.8;;;64.8;88.2;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67;67;;;52.9;78.5;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.3;66.3;;;57.6;73.9;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.1;41.1;;;35.3;47.2;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.6;86.6;;;80.3;91.1;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.2;67.2;;;45.8;83.2;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.3;38.3;;;30.2;47.2;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;53.2;53.2;;;34.5;71.1;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;81.9;81.9;;;70.2;89.7;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.3;91.3;;;73.3;97.6;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;59.3;59.3;;;50.9;67.2;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2013;2013;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;9567;9,567;;;;;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;NMBR;GENDER;GENM;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;76.7;76.7;;;66.8;84.3;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2013;2013;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.2;70.2;;;55.2;81.8;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.9;33.9;;;28.9;39.4;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.4;85.4;;;75.9;91.5;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.1;64.1;;;46;78.9;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;48.6;48.6;;;34.6;62.8;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.5;45.5;;;40.2;50.9;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.3;88.3;;;63.8;97;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2013;2013;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;45.6;45.6;;;44.8;46.4;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.6;69.6;;;65;73.8;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.6;38.6;;;33;44.5;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.7;46.7;;;41.3;52.2;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;72.3;72.3;;;62.3;80.4;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;78.1;78.1;;;68;85.7;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.9;69.9;;;61.2;77.5;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.5;34.5;;;28.7;40.9;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;61.2;61.2;;;53.4;68.5;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39;39;;;29.9;49;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.1;40.1;;;35;45.5;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.4;84.4;;;77.6;89.3;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34;34;;;25.6;43.6;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50.3;50.3;;;43.7;57;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;29.1;29.1;;;16.7;45.6;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;29.9;29.9;;;15.9;49.2;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.1;64.1;;;54.3;72.9;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2013;2013;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.9;86.9;;;82.6;90.2;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.4;84.4;;;68.1;93.2;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;76.9;76.9;;;63.3;86.6;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41;41;;;33.2;49.3;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.3;34.3;;;28;41.2;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.2;34.2;;;24.5;45.6;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.4;31.4;;;23.3;40.9;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.3;87.3;;;79.2;92.6;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.9;31.9;;;20.1;46.7;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.0;9;;;7.7;10.5;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.3;85.3;;;75.4;91.6;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;49.1;49.1;;;37.1;61.3;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.6;35.6;;;32.7;38.7;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.8;44.8;;;34.8;55.1;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.6;38.6;;;33.2;44.3;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86;86;;;76.8;91.9;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.7;31.7;;;26.4;37.5;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;79.6;79.6;;;73;85;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.2;71.2;;;60.7;79.8;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.8;62.8;;;55.5;69.5;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;78.8;78.8;;;68.7;86.4;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.3;32.3;;;20.8;46.5;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.6;30.6;;;24.1;38;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2013;2013;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.3;84.3;*;50 States + DC: US Median;83.2;85;Overall;Overall;;;;;;;59;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;76.6;76.6;;;67.9;83.5;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.5;12.5;;;11.1;14.1;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;74.8;74.8;;;66.1;81.9;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.2;71.2;;;60.7;79.8;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.8;87.8;;;80.8;92.5;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2013;2013;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.4;72.4;;;63.2;80;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.1;39.1;;;33.2;45.4;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.2;47.2;;;34.8;60.1;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.1;11.1;;;9.3;13.2;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.8;36.8;;;31.2;42.8;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;80.1;80.1;;;71.4;86.7;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;74.1;74.1;;;66.1;80.8;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.2;34.2;;;29;39.8;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.1;33.1;;;25.8;41.4;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;18.2;18.2;;;13.5;24.1;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.1;69.1;;;57.5;78.7;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.4;37.4;;;28.4;47.5;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41;41;;;28.7;54.4;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.6;40.6;;;30;52.1;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.2;34.2;;;25.5;44.1;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.9;70.9;;;60.7;79.3;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.9;85.9;;;76.8;91.9;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;51.2;51.2;;;35.7;66.4;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.5;67.5;;;52.1;79.8;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.6;30.6;;;25.3;36.4;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.2;84.2;;;77.4;89.2;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.6;84.6;;;78.3;89.3;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2013;2013;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;73.7;73.7;;;58.7;84.7;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.9;32.9;;;26.3;40.3;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.7;33.7;;;28.3;39.5;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.4;35.4;;;23.7;49.2;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90.3;90.3;;;84.1;94.3;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;94.8;94.8;;;90.2;97.4;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.6;88.6;;;82.2;92.9;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.8;32.8;;;21.2;46.9;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;78.5;78.5;;;67.7;86.3;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.2;72.2;;;64.2;79;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;54.6;54.6;;;40;68.4;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;60.3;60.3;;;45.4;73.5;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.9;70.9;;;54.4;83.3;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;78;78;;;67.4;85.9;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;61.2;61.2;;;51;70.5;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.4;37.4;;;26.7;49.5;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;78.3;78.3;;;68.5;85.6;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;58.9;58.9;;;45.9;70.6;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2013;2013;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;32.6;32.6;;;24.7;41.7;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;59;59;;;51.4;66.2;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;92.9;92.9;;;82.6;97.3;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.5;40.5;;;32.9;48.6;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;92.5;92.5;;;86.7;95.9;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;15.2;15.2;;;13.6;16.8;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.5;42.5;;;33.4;52.2;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.1;32.1;;;25.3;39.8;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;60.9;60.9;;;45.2;74.6;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.4;39.4;;;32.1;47.3;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;61;61;;;50.2;70.8;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29.6;29.6;;;20.5;40.7;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.8;30.8;;;22.4;40.8;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;7.1;7.1;;;4.5;11.1;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.3;33.3;;;22.7;46;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;26.6;26.6;;;16.4;40.1;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.9;37.9;;;32.4;43.7;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.7;83.7;;;74.7;89.9;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.7;91.7;;;87.6;94.5;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36;36;;;26.2;47.2;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;35;35;;;27.2;43.7;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.3;88.3;;;83.6;91.9;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.6;84.6;;;76.3;90.3;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.3;36.3;;;26.2;47.7;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;50.7;50.7;;;34.4;66.7;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.1;48.1;;;33.7;62.9;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;81.5;81.5;;;72.5;88.1;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67.2;67.2;;;56.9;76.2;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;72.3;72.3;;;62.3;80.4;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;33.4;33.4;;;25.2;42.7;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.9;44.9;;;39.1;50.9;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;77.9;77.9;;;68.3;85.3;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;70.6;70.6;;;48.2;86.2;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;28.4;28.4;;;16.8;43.7;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.1;36.1;;;25.5;48.2;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2013;2013;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;27.3;27.3;;;19.7;36.4;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.6;36.6;;;30.4;43.3;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.7;45.7;;;39.6;52;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.9;88.9;;;79.6;94.3;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.4;84.4;;;66.2;93.7;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.8;63.8;;;55.4;71.5;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.9;39.9;;;33.8;46.2;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.7;89.7;;;85.2;92.9;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.1;71.1;;;51.5;85.1;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;19.2;19.2;;;14.4;25.1;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;77.9;77.9;;;69.4;84.5;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;74.2;74.2;;;60.2;84.5;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.3;34.3;;;25.4;44.6;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;74.8;74.8;;;63.9;83.3;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;77.8;77.8;;;52.3;91.8;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.3;39.3;;;33.9;45;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2013;2013;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;79.7;79.7;;;68.4;87.6;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.2;69.2;;;60.4;76.9;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;74.5;74.5;;;62.5;83.7;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;58.2;58.2;;;42.9;72;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;81.8;81.8;;;71;89.1;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.3;70.3;;;61.3;78;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2013;2013;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.6;31.6;;;26.1;37.7;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.7;42.7;;;30.3;56;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.8;39.8;;;31.5;48.7;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.2;43.2;;;37.9;48.7;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;25.3;25.3;;;16.8;36.3;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;73.3;73.3;;;63.3;81.4;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.6;43.6;;;32.1;55.8;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.9;86.9;;;79.9;91.7;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;61;61;;;50.7;70.5;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37;37;;;30.9;43.6;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.8;68.8;;;60.6;76;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.1;69.1;;;61.5;75.8;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83;83;;;76.7;87.9;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.2;38.2;;;28.2;49.3;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;59.9;59.9;;;49.9;69.1;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.9;42.9;;;31.9;54.6;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47;47;;;34.8;59.6;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.4;70.4;;;59.5;79.4;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;80.4;80.4;;;70;87.8;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.5;39.5;;;34.8;44.5;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.2;88.2;;;81.3;92.8;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.6;84.6;;;76.3;90.3;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;73.6;73.6;;;66.5;79.6;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;79.1;79.1;;;70.3;85.8;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.8;87.8;;;78.4;93.5;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.6;86.6;;;76.3;92.9;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.5;65.5;;;56.9;73.1;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66;66;;;58;73.2;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70;70;;;60.7;78;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.3;44.3;;;39.2;49.5;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.6;63.6;;;46.8;77.6;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.1;34.1;;;23.6;46.5;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.8;43.8;;;29.9;58.7;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.4;70.4;;;54.2;82.7;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;79.3;79.3;;;72.7;84.7;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2013;2013;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.1;36.1;;;27.9;45.2;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70;70;;;60.6;78;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;73.1;73.1;;;58.8;83.8;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2013;2013;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.3;82.3;*;50 States + DC: US Median;78.3;84.4;Gender;Male;;;;;;;59;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.1;38.1;;;23.3;55.6;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;91.6;91.6;;;81.9;96.3;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.4;42.4;;;34.7;50.4;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;79.4;79.4;;;56.3;92;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2013;2013;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.3;38.3;;;30.9;46.3;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2013;2013;SD;South Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST2_1;NMBR;GENDER;GENF;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.6;34.6;;;25.6;44.8;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.2;40.2;;;34.7;46;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69;69;;;64.2;73.4;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;32;32;;;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;NMBR;RACE;HIS;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.2;65.2;;;39.2;84.5;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.1;42.1;;;33.8;50.8;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;91.6;91.6;;;79.6;96.8;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.3;72.3;;;63;80;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.2;38.2;;;31;46;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.1;39.1;;;32.9;45.7;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.1;39.1;;;32.3;46.3;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.2;68.2;;;43.9;85.4;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.4;69.4;;;56.3;80;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.6;83.6;;;72.9;90.6;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.2;48.2;;;41.9;54.6;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.1;42.1;;;37;47.5;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.3;69.3;;;60.2;77.1;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.6;41.6;;;29.4;54.8;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;54.4;54.4;;;45.7;62.8;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.4;82.4;;;73.4;88.8;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.7;38.7;;;28.8;49.6;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2013;2013;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;79.2;79.2;;;66.9;87.8;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;61.9;61.9;;;52;70.9;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;58.8;58.8;;;50.9;66.4;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2013;2013;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.9;42.9;*;50 States + DC: US Median;39.7;44.7;Overall;Overall;;;;;;;59;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.1;65.1;;;56.1;73.2;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;60.3;60.3;;;48.7;70.8;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.4;46.4;;;35.3;57.8;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;74.1;74.1;;;60.9;84;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;55.2;55.2;;;40;69.5;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;77.8;77.8;;;61.7;88.4;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2013;2013;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.7;39.7;;;34.8;44.9;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.7;66.7;;;56.1;75.8;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.9;70.9;;;60;79.9;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34;34;;;21.8;48.8;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;26.7;26.7;;;15.3;42.2;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;27.3;27.3;;;18.7;38.1;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.4;30.4;;;25;36.4;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;76.5;76.5;;;58.9;88;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2013;2013;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.7;40.7;;;32.1;49.9;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.7;40.7;;;34.6;47.2;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.9;38.9;;;31.2;47.2;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2013;2013;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.2;71.2;;;61.3;79.4;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.7;42.7;;;31.6;54.6;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.9;40.9;;;34.3;47.8;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2013;2013;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2013;2013;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.4;68.4;;;52.4;80.9;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;79.7;79.7;;;69.9;86.9;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2013;2013;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;19.3;19.3;;;15;24.4;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32;32;;;23.4;42.1;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2013;2013;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.7;38.7;*;50 States + DC: US Median;36.3;40.6;Gender;Male;;;;;;;59;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2013;2013;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;59.5;59.5;;;52;66.6;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.2;44.2;;;37.1;51.5;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2013;2013;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.9;43.9;;;35.8;52.2;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86;86;;;77.9;91.5;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.5;35.5;;;26.5;45.6;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2013;2013;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;73.4;73.4;;;63;81.7;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2013;2013;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.7;68.7;;;51.2;82.1;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.3;31.3;;;20.5;44.6;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.4;88.4;;;81.2;93;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.2;30.2;;;23.9;37.3;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.4;85.4;;;77.9;90.7;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39;39;;;31.8;46.7;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2013;2013;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63;63;;;56.3;69.3;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;76;76;;;60.5;86.7;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2013;2013;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;29.9;29.9;;;20.6;41.2;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2013;2013;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2013;2013;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34;34;;;27.5;41.2;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2013;2013;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.1;72.1;;;64.2;78.8;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.8;42.8;;;36.2;49.7;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2013;2013;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;52.1;52.1;;;44.9;59.2;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.2;36.2;;;30.2;42.8;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2013;2013;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;20.9;20.9;;;12.1;33.7;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2013;2013;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.8;28.8;;;22.1;36.4;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.7;86.7;;;80;91.4;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.1;85.1;;;76.2;91.1;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2013;2013;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;55.2;55.2;;;35.5;73.4;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2013;2013;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2013;2013;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2013;2013;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2013;2013;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;93.9;93.9;;;88.6;96.8;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2013;2013;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.1;82.1;;;71.1;89.5;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2013;2013;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.3;91.3;;;86.4;94.6;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2013;2013;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.5;87.5;;;81.6;91.6;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2013;2013;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2013;2013;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2013;2013;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2013;2013;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2013;2013;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2013;2013;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2013;2013;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2013;2013;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.3;30.3;;;26;35;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.1;9.1;;;6.5;12.6;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;;Number;47;47;;;;;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;NMBR;GENDER;GENF;;;;
2012;2012;NY;New York;NVSS;Asthma;Asthma mortality rate;;;Number;55;55;;;;;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;NMBR;RACE;HIS;;;;
2012;2012;NY;New York;NVSS;Asthma;Asthma mortality rate;;;Number;127;127;;;;;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;NMBR;GENDER;GENM;;;;
2012;2012;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;NMBR;GENDER;GENF;;;;
2012;2012;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.9;35.9;;;29.8;42.5;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;18.5;18.5;;;10.7;30.2;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29.5;29.5;;;18.7;43.1;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.9;86.9;;;67.7;95.5;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.2;47.2;;;41.9;52.5;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.4;84.4;;;75.3;90.6;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;64.6;64.6;;;55.2;73;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.4;36.4;;;28.3;45.5;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.0;10;;;8.8;11.2;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.2;10.2;;;8.5;12.1;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.0;11;;;9.3;12.9;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.0;36;;;30.7;41.6;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.0;41;;;36.2;46.1;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.9;66.9;;;57;75.4;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.6;37.6;;;33;42.3;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;77.4;77.4;;;60.9;88.3;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.7;72.7;;;63.9;80.1;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.2;35.2;;;23.7;48.7;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;55.8;55.8;;;42.4;68.4;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.7;8.7;;;7.4;10.3;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.6;8.6;;;7.4;10;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;61.6;61.6;;;51.4;70.9;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.9;37.9;;;27.9;49.1;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.5;39.5;;;33.4;46;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.3;8.3;;;7.1;9.7;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.0;9;;;8.3;9.9;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.1;14.1;;;8.5;22.4;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;60.7;60.7;;;50;70.5;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;CA;California;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.2;13.2;;;10.4;16.6;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.6;34.6;;;20.8;51.7;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.9;10.9;;;9.4;12.6;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.9;8.9;;;7.7;10.2;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.7;44.7;;;32;58.2;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;15.3;15.3;;;13.3;17.5;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.7;41.7;;;37.5;46;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.7;13.7;;;10.4;17.9;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;20.5;20.5;;;13.5;29.9;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.4;34.4;;;22.1;49.3;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.7;7.7;;;4.5;12.9;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.8;37.8;;;30.6;45.7;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.7;8.7;;;7.7;9.8;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.3;37.3;;;32.2;42.6;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.8;12.8;;;8.2;19.5;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.2;12.2;;;8.7;16.8;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.8;38.8;;;33.8;44.1;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.4;37.4;;;32.8;42.2;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.4;10.4;;;9.5;11.5;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.5;35.5;;;22.8;50.6;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.0;40;;;35.3;44.8;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;42.2;42.2;;;32;53.1;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.0;10;;;8.5;11.7;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;23.3;23.3;;;16.4;31.9;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.2;6.2;;;5;7.7;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;50.5;50.5;;;34.1;66.9;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.9;5.9;;;3.6;9.5;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2012;2012;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.5;83.5;;;74.5;89.8;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.6;35.6;;;26;46.5;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.6;38.6;;;34;43.4;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.8;5.8;;;4.2;7.9;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.9;12.9;;;9.9;16.6;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.6;38.6;;;33.2;44.2;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.3;6.3;;;5;7.9;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;79.5;79.5;;;73.2;84.7;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.8;86.8;;;79.8;91.7;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.6;40.6;;;35;46.4;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.0;38;;;31.3;45.1;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2012;2012;NY;New York;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;18.0;18;;;11.3;27.2;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.0;12;;;7.1;19.6;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;22.4;22.4;;;14.4;33;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;76.1;76.1;;;61.4;86.5;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;76.8;76.8;;;63.3;86.5;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;3.4;3.4;;;2.1;5.5;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.8;10.8;;;9.7;12;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;81.8;81.8;;;71.4;89.1;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.3;85.3;;;79.6;89.7;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.4;85.4;;;74.3;92.2;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.8;38.8;;;32.7;45.3;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;23.3;23.3;;;15.3;33.8;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.5;39.5;;;32.7;46.6;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;49.1;49.1;;;36.8;61.6;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.5;38.5;;;28;50.2;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.8;8.8;;;7.7;10;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.1;37.1;;;30.8;43.9;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;45.8;45.8;;;31.2;61.2;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.8;48.8;;;41;56.6;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.3;14.3;;;10.7;19;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;58.4;58.4;;;48.7;67.4;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.0;6;;;4.9;7.2;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;73.5;73.5;;;64.7;80.8;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.9;37.9;;;31.5;44.8;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.0;45;;;40.4;49.7;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.0;42;;;36.9;47.3;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.3;47.3;;;39.1;55.5;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.8;85.8;;;75.6;92.1;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.9;38.9;;;33.6;44.5;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.4;69.4;;;58.2;78.7;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.0;39;;;30.4;48.3;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.0;35;;;27.3;43.6;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;74.1;74.1;;;62.4;83.2;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;22.7;22.7;;;14.2;34.1;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.7;82.7;;;73.9;89;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.2;41.2;;;33.2;49.8;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;74.4;74.4;;;66.9;80.7;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.0;44;;;36.9;51.2;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.9;7.9;;;7.1;8.9;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;27.8;27.8;;;18.9;38.9;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;51.9;51.9;;;38.1;65.3;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.9;41.9;;;37.1;46.8;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2012;2012;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.7;35.7;;;30.3;41.5;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.3;85.3;;;76.1;91.4;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.0;9;;;7.9;10.3;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2012;2012;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.3;85.3;;;76.7;91.1;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.2;44.2;;;36.2;52.5;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.1;72.1;;;56.5;83.7;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.5;7.5;;;6.5;8.7;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;77.7;77.7;;;70.3;83.6;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.9;6.9;;;5.6;8.5;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.2;9.2;;;7.9;10.7;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.1;7.1;;;4.2;11.7;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.5;28.5;;;21.1;37.3;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.9;12.9;;;10.7;15.4;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.9;38.9;;;33.9;44.1;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.3;38.3;;;32.3;44.6;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.6;10.6;;;6.2;17.5;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;21.0;21;;;11.6;34.9;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.2;39.2;;;34.4;44.3;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.0;87;;;77.5;92.8;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.5;31.5;;;24.2;39.8;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.2;32.2;;;20.7;46.2;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.3;42.3;;;37.8;46.9;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.0;10;;;8.8;11.3;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.5;31.5;;;22.4;42.3;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;77.1;77.1;;;68.7;83.8;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2012;2012;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.9;69.9;;;63.3;75.8;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.5;8.5;;;7.4;9.8;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;73.3;73.3;;;58.2;84.4;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.7;39.7;;;34.2;45.5;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;51.2;51.2;;;38.8;63.5;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.6;40.6;;;28.9;53.4;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;45.0;45;;;30.3;60.6;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;57.3;57.3;;;39.9;73.1;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.1;30.1;;;23.2;38;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.5;82.5;;;73.5;88.9;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50.4;50.4;;;37;63.7;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;49.8;49.8;;;40;59.6;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.5;37.5;;;29.1;46.6;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;79.6;79.6;;;73.8;84.4;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.5;39.5;;;35;44.3;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.6;14.6;;;12.8;16.6;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.7;68.7;;;61.1;75.4;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.4;10.4;;;8.9;12.3;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;93.6;93.6;;;89.8;96.1;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.3;30.3;;;19;44.6;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.5;34.5;;;27.2;42.5;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.5;46.5;;;42.8;50.3;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.7;14.7;;;12.2;17.7;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.3;35.3;;;23.9;48.6;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.0;9;;;7.9;10.3;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;6.3;6.3;;;3.6;10.9;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.4;5.4;;;4.5;6.5;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.6;31.6;;;19.6;46.7;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.9;6.9;;;5.8;8.1;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.6;67.6;;;48.9;82;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.2;35.2;;;27.2;44.1;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.3;35.3;;;21.5;52.1;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.3;10.3;;;8.1;12.9;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.1;66.1;;;57;74.2;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.6;45.6;;;39.6;51.8;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.7;9.7;;;5.3;17.1;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.9;6.9;;;4.8;9.7;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;75.7;75.7;;;67;82.7;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.3;86.3;;;80.6;90.5;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.5;31.5;;;26.2;37.4;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.1;85.1;;;78.5;90;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.8;14.8;;;12.7;17.3;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.3;8.3;;;7.4;9.4;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.2;87.2;;;76.4;93.5;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.2;63.2;;;55.8;70;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.9;6.9;;;4.8;9.9;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.2;86.2;;;78.5;91.5;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.9;9.9;;;8.6;11.4;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;16.0;16;;;13.8;18.5;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.0;9;;;8.2;9.9;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2012;2012;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.3;44.3;;;38;50.7;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.4;33.4;;;25.6;42.2;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.7;91.7;;;86.3;95.1;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.5;83.5;;;77.4;88.3;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.1;33.1;;;21.9;46.6;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;93.4;93.4;;;80.7;98;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;81.6;81.6;;;73.2;87.8;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;26.8;26.8;;;16.5;40.4;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.1;37.1;;;31.7;42.8;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.4;37.4;;;33.5;41.4;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.6;8.6;;;7.3;10.2;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.7;85.7;;;80.2;89.9;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.0;32;;;23.6;41.7;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.8;37.8;;;23.9;54.1;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.1;11.1;;;7.9;15.4;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;74.8;74.8;;;62.5;84.1;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.1;40.1;;;35;45.3;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.7;86.7;;;80.6;91.1;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;15.1;15.1;;;12.3;18.4;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.7;41.7;;;33.3;50.6;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2012;2012;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.2;41.2;;;36;46.6;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;60.7;60.7;;;43.4;75.6;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.8;30.8;;;25.3;36.9;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.8;84.8;;;74.4;91.4;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.0;6;;;5;7.3;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.9;44.9;;;38.9;51.1;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;33.5;33.5;;;20.2;50.2;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.6;38.6;;;24.9;54.3;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;72.3;72.3;;;57.6;83.4;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.7;32.7;;;25;41.6;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.1;13.1;;;10.8;15.9;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;17.9;17.9;;;12.5;24.9;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.6;86.6;;;81;90.7;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.6;38.6;;;34.4;42.9;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.5;10.5;;;7.9;13.7;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.0;10;;;8.7;11.5;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;61.7;61.7;;;51.9;70.6;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.8;33.8;;;26;42.6;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29.5;29.5;;;21.4;39.2;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.0;10;;;5.8;16.7;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.1;12.1;;;8;17.9;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.8;85.8;;;78;91.1;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2012;2012;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.8;8.8;;;8.2;9.5;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.1;47.1;;;40.8;53.5;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;54.9;54.9;;;45.4;64.1;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.9;28.9;;;22.9;35.7;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.1;89.1;;;80.2;94.3;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;4.8;4.8;;;2.7;8.3;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;44.3;44.3;;;30.1;59.4;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;61.6;61.6;;;51.3;70.9;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.3;7.3;;;6.1;8.7;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.5;85.5;;;77.9;90.8;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90.7;90.7;;;84.9;94.4;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;51.5;51.5;;;41.6;61.3;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.8;36.8;;;26.7;48.1;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.6;9.6;;;5.3;16.8;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.1;33.1;;;27.8;38.9;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;74.5;74.5;;;48.2;90.2;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.6;71.6;;;63.7;78.3;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.2;86.2;;;78.2;91.6;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.1;10.1;;;9.1;11.1;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.4;42.4;;;36.9;48.1;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.1;37.1;;;32.8;41.6;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.8;6.8;;;6.1;7.6;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.9;70.9;;;63.6;77.3;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.4;48.4;;;40.9;55.9;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.5;88.5;;;83.5;92.1;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.8;7.8;;;6.9;8.8;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.5;35.5;;;27.1;44.9;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.6;66.6;**;US estimate/number is based on fewer than 50 states and the District of Columbia;61.6;68.7;Gender;Female;;;;;;;59;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.5;89.5;;;82.1;94.1;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.5;13.5;;;11.2;16.3;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.2;84.2;;;78.5;88.6;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.3;64.3;;;55;72.7;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.4;68.4;;;57.5;77.6;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.1;68.1;;;56.9;77.5;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.7;69.7;;;61.9;76.6;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.6;11.6;;;9.9;13.6;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.1;9.1;;;8.2;10.1;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.9;10.9;;;9.7;12.1;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.9;87.9;;;81.9;92.2;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;56.3;56.3;;;43.6;68.2;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.5;9.5;;;8.6;10.4;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.4;10.4;;;9.3;11.7;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;16.2;16.2;;;12.4;20.9;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.3;36.3;;;28.8;44.6;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;2.7;2.7;;;1.6;4.5;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;78.5;78.5;;;68.3;86.1;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.0;9;;;7.9;10.3;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.7;37.7;;;32.6;43.2;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.4;12.4;;;8.9;16.9;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.1;5.1;;;3.1;8.2;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.3;84.3;;;76.9;89.6;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.0;45;;;40.5;49.6;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.8;32.8;;;27.7;38.4;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.3;87.3;;;81.7;91.4;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.6;39.6;;;34.6;44.8;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.6;6.6;;;4.9;8.9;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.7;11.7;;;9.2;14.7;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;19.4;19.4;;;13.5;27.2;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.5;33.5;;;27.2;40.4;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.1;47.1;;;38.5;55.9;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;19.2;19.2;;;15.1;24;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.8;6.8;;;6.1;7.6;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;75.0;75;;;66.5;82;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.3;38.3;;;29.1;48.5;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.8;42.8;;;37.1;48.6;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.6;8.6;;;7.7;9.7;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.3;10.3;;;7.2;14.6;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.1;31.1;;;18.2;47.8;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.5;5.5;;;4.4;7;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.2;8.2;;;7.5;9;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.2;89.2;;;81.7;93.9;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.7;14.7;;;11.3;19.1;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.4;6.4;;;5.2;7.8;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.4;33.4;;;27.9;39.3;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.7;33.7;;;25.7;42.8;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.5;12.5;;;10.9;14.3;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.1;83.1;;;71.3;90.6;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.2;28.2;;;20.9;36.8;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;29.6;29.6;;;21;39.8;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.4;41.4;;;31;52.7;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.4;88.4;;;81.2;93.1;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;81.5;81.5;;;73.7;87.4;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.4;6.4;;;5.2;7.9;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2012;2012;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.0;9;;;8.4;9.7;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;21.8;21.8;;;15.6;29.6;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.3;10.3;;;9.3;11.5;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;52.2;52.2;;;45.7;58.6;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.1;45.1;;;36.5;53.9;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;51.4;51.4;;;41.5;61.2;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.7;47.7;;;39.5;56.1;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.4;47.4;;;35.1;60.1;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.2;12.2;;;9.9;15.1;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2012;2012;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.7;84.7;**;US estimate/number is based on fewer than 50 states and the District of Columbia;82.2;86.2;Gender;Female;;;;;;;59;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.2;38.2;;;31.9;45;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.2;11.2;;;10.1;12.5;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.0;35;;;25;46.4;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.4;87.4;;;78;93.1;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.1;35.1;;;30.8;39.7;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;22.4;22.4;;;12.5;36.9;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.4;83.4;*;50 States + DC: US Median;81.5;84.4;Overall;Overall;;;;;;;59;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.5;13.5;;;11.3;16;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;58.1;58.1;;;47.2;68.4;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.5;9.5;;;7.4;12;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.2;40.2;;;32.3;48.6;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2012;2012;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.4;66.4;**;US estimate/number is based on fewer than 50 states and the District of Columbia;61;72.3;Gender;Male;;;;;;;59;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.9;82.9;;;76.7;87.7;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.0;10;;;8.8;11.3;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.3;67.3;;;60.3;73.5;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.6;6.6;;;5.8;7.6;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;24.1;24.1;;;14.1;38.1;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.5;88.5;;;81.9;93;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.8;66.8;;;45.6;82.9;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.4;13.4;;;9;19.5;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.5;42.5;;;35.2;50;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.8;36.8;;;30.7;43.4;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.7;7.7;;;7;8.4;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;81.9;81.9;;;75.4;87.1;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.8;12.8;;;9.5;17;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.7;71.7;;;64.5;77.9;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.6;10.6;;;8.5;13.1;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;24.4;24.4;;;17;33.7;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;79.5;79.5;;;69.4;87;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.6;33.6;;;28;39.6;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.0;36;;;27.9;44.9;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.9;12.9;;;8.6;18.8;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;61.0;61;;;50.1;70.8;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.7;47.7;;;41.5;54;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;33.5;33.5;;;20.6;49.4;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.9;41.9;;;35.6;48.5;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.8;33.8;;;27.1;41.3;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;28.9;28.9;;;16.5;45.4;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.7;8.7;;;6.5;11.5;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.6;43.6;;;35.6;52;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;NY;New York;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.8;9.8;;;5.9;15.9;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.4;6.4;;;5;8.2;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.0;12;;;9.3;15.2;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.5;66.5;;;56;75.6;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.4;66.4;;;50.9;79;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.5;10.5;;;9.7;11.4;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.7;37.7;;;33.3;42.4;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;91.9;91.9;;;87;95.1;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.3;7.3;;;6.7;7.8;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;4.8;4.8;;;3.7;6.2;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2012;2012;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.8;48.8;;;33;64.8;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.8;43.8;;;37.2;50.7;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.6;41.6;;;30.1;54.2;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.9;39.9;;;28.5;52.5;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50.4;50.4;;;42.6;58.2;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.8;9.8;;;8.6;11;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;45.4;45.4;;;33.2;58.2;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.0;70;;;61.3;77.5;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.0;88;;;75.8;94.5;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;7.8;7.8;;;6;10;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.9;84.9;;;77.5;90.2;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.1;13.1;;;11.6;14.7;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;4.6;4.6;;;3.6;6;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.7;85.7;;;76.1;91.8;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.5;36.5;;;30.2;43.3;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.0;34;;;20;51.4;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2012;2012;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.1;84.1;;;78.5;88.4;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.4;46.4;;;30.6;62.9;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.0;40;;;30.5;50.4;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.4;8.4;;;7.1;9.8;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.0;38;;;32.4;44.1;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.7;6.7;;;4.8;9.1;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.9;66.9;;;53.8;77.9;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.4;63.4;;;53.3;72.4;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.0;85;;;77.7;90.1;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;17.0;17;;;10.2;27.2;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.1;34.1;;;22.4;48;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.0;9;;;7.8;10.3;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;51.0;51;;;46.3;55.6;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.2;36.2;;;31.8;40.9;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.0;13;;;10.2;16.4;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2012;2012;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.4;39.4;*;50 States + DC: US Median;37.8;41.5;Overall;Overall;;;;;;;59;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.5;8.5;;;7.4;9.6;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.2;37.2;;;31.5;43.3;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.7;38.7;;;28.7;49.8;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;54.8;54.8;;;37.3;71.1;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;81.3;81.3;;;73.8;87.1;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.1;82.1;;;73.1;88.6;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.5;10.5;;;8.8;12.5;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.5;5.5;;;4.5;6.8;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.1;49.1;;;43.1;55.1;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.3;6.3;;;5;7.9;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.7;36.7;;;28.6;45.6;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;18.2;18.2;;;9.8;31.3;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.4;35.4;;;24.5;48.1;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.9;66.9;;;60;73.1;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.2;10.2;;;8.3;12.3;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.1;28.1;;;22.9;34;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.0;33;;;25.7;41.2;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.8;70.8;;;62.8;77.6;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;29.9;29.9;;;18.4;44.6;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.1;82.1;;;72.2;89;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.5;7.5;;;6.5;8.6;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29.1;29.1;;;21.3;38.4;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.3;8.3;;;7.2;9.6;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2012;2012;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.4;33.4;;;23.8;44.5;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.0;66;;;51.5;78;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.9;35.9;;;27.4;45.3;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.3;10.3;;;8.7;12;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.0;12;;;8.7;16.4;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.2;9.2;;;8.5;10;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.0;13;;;11;15.3;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;52.7;52.7;;;45.1;60.2;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.8;37.8;;;31.1;45.1;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;26.9;26.9;;;20.4;34.4;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.4;13.4;;;12.3;14.6;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.6;86.6;;;74.1;93.6;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.9;38.9;;;32.4;45.9;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;53.2;53.2;;;42.8;63.4;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.8;9.8;;;7.9;12.2;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.3;85.3;;;76.9;91;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.8;41.8;;;34.9;49;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.1;8.1;;;7.3;9;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.6;5.6;;;4.4;7.1;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.9;86.9;;;72.7;94.3;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.7;32.7;;;24.2;42.5;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;91.6;91.6;;;85.8;95.1;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.9;36.9;;;28;46.9;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.3;87.3;;;72.4;94.7;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.0;7;;;6;8;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;77.9;77.9;;;60.7;88.9;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.8;13.8;;;11.4;16.5;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.4;84.4;;;68.1;93.2;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.1;10.1;;;9.3;11;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.6;10.6;;;9.2;12.3;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.4;66.4;;;57.1;74.5;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.6;12.6;;;11.3;14.1;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.3;36.3;;;30.8;42.2;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.5;35.5;;;28.2;43.5;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;29.4;29.4;;;22.8;37.1;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.8;89.8;;;83.5;93.9;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;60.0;60;;;52.7;67;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.4;31.4;;;27.1;36.1;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.3;65.3;;;52.7;76;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;74.2;74.2;;;64.9;81.7;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;19.8;19.8;;;15.6;24.7;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;25.0;25;;;17.6;34.2;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.7;40.7;;;28.6;54.1;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2012;2012;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.6;11.6;;;8.2;16.1;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;27.2;27.2;;;15.8;42.8;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;NY;New York;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.0;31;;;22;41.8;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.8;37.8;;;29.5;47;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.3;37.3;;;32.2;42.6;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.2;87.2;;;75;93.9;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.6;42.6;;;38.7;46.6;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;78.1;78.1;;;69;85.1;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.2;8.2;;;7.3;9.2;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.7;84.7;;;75.9;90.7;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.3;10.3;;;8.5;12.4;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.7;36.7;;;32.5;41.2;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.6;84.6;;;77.4;89.9;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.8;30.8;;;23;39.9;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.7;47.7;;;34;61.8;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;80.5;80.5;;;70.4;87.7;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;27.5;27.5;;;17.6;40.3;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.9;37.9;;;32.8;43.3;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.5;13.5;;;9.4;19;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.2;11.2;;;9.5;13.2;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.6;10.6;;;9.8;11.4;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;17.3;17.3;;;9.8;28.7;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;19.1;19.1;;;11.6;29.8;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.6;10.6;;;8.8;12.7;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.8;68.8;;;58.8;77.4;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;77.7;77.7;;;57.6;89.9;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;15.2;15.2;;;9;24.6;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.2;33.2;;;28.4;38.4;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.5;70.5;;;62.5;77.5;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.4;32.4;;;20.7;46.7;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.1;11.1;;;9.9;12.4;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2012;2012;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.2;11.2;;;8.6;14.6;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.6;91.6;;;85.8;95.1;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.8;85.8;;;76.8;91.7;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;81.2;81.2;;;73.1;87.4;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;61.0;61;;;49.8;71.1;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.6;9.6;;;7.6;12.1;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.7;43.7;;;38.3;49.2;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.3;6.3;;;5;8;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.5;6.5;;;5.2;8.1;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.2;46.2;;;42.5;50;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.4;83.4;;;76.4;88.6;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.2;71.2;;;54.9;83.4;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.3;63.3;;;57.3;68.8;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.8;8.8;;;7.5;10.2;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.6;13.6;;;12.4;14.9;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.1;44.1;;;38.1;50.3;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.1;69.1;;;60.1;76.9;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.5;62.5;;;55.9;68.7;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.7;35.7;;;30.9;40.7;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.0;13;;;9.3;17.8;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.7;37.7;;;27.9;48.6;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.0;35;;;29.2;41.4;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.4;37.4;;;29.3;46.2;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.2;10.2;;;8.5;12.3;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.3;8.3;;;7;9.7;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.9;87.9;;;82.8;91.6;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.0;34;;;26.4;42.6;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;77.5;77.5;;;69.3;84;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.7;42.7;;;36.6;49;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.6;82.6;;;71.1;90.2;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.9;8.9;;;8.2;9.6;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.2;8.2;;;7.1;9.6;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;4.5;4.5;;;3.3;6.2;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;74.0;74;;;65.9;80.8;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2012;2012;US;United States;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.9;8.9;*;50 States + DC: US Median;8.6;9.2;Overall;Overall;;;;;;;59;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.7;87.7;;;78.2;93.4;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.9;8.9;;;7.8;10.2;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.3;35.3;;;30.6;40.2;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.5;38.5;;;28.8;49.2;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2012;2012;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.6;37.6;*;50 States + DC: US Median;36.9;38.8;Overall;Overall;;;;;;;59;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.7;9.7;;;8.9;10.7;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.6;46.6;;;37.8;55.7;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.7;38.7;;;30.7;47.3;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.5;85.5;;;78.3;90.6;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.7;63.7;;;57.6;69.4;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.7;35.7;;;27.9;44.3;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;56.3;56.3;;;43.7;68.1;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.4;70.4;;;61.7;77.8;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;22.7;22.7;;;13.3;35.8;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.7;71.7;;;56.4;83.2;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2012;2012;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.7;11.7;;;10.7;12.7;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.2;41.2;;;37.1;45.3;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.4;37.4;;;28.8;46.8;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.5;14.5;;;11.9;17.5;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.3;39.3;;;32.4;46.6;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2012;2012;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.7;32.7;;;26;40.2;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.5;7.5;;;5.4;10.4;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;77.6;77.6;;;70.1;83.7;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.8;8.8;;;7.5;10.3;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;29.6;29.6;;;21.8;38.8;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.4;36.4;;;29.6;43.7;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;30.2;30.2;;;22.5;39.1;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;55.0;55;;;39.7;69.5;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.2;9.2;;;7.9;10.7;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;58.5;58.5;;;47.7;68.5;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.1;49.1;;;40.2;58.1;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.9;12.9;;;7.7;20.7;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.3;9.3;;;8.2;10.5;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.8;12.8;;;9.1;17.7;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.2;42.2;;;35.6;49.1;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;74.7;74.7;;;67.3;80.9;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;18.1;18.1;;;10.3;29.9;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.4;86.4;;;75.7;92.8;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.1;8.1;;;7;9.4;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.6;38.6;;;30;48.1;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.0;6;;;5;7.2;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.9;40.9;;;32.5;49.9;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.1;39.1;;;32.7;46;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;75.4;75.4;;;65.9;82.9;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;29.1;29.1;;;19.3;41.4;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;81.1;81.1;;;72.7;87.4;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.6;7.6;;;6.6;8.7;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.7;86.7;;;74.2;93.6;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.9;43.9;;;33.8;54.6;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.7;40.7;;;31.7;50.4;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.1;49.1;;;32.5;65.9;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.3;32.3;;;23.2;42.8;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.4;37.4;;;32.4;42.6;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;15.2;15.2;;;9.3;24;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;77.8;77.8;;;65.8;86.5;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;16.8;16.8;;;12.1;22.8;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.8;7.8;;;5.4;11.2;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.7;36.7;;;26.4;48.4;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;24.5;24.5;;;16.7;34.6;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;18.1;18.1;;;10.8;28.9;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;27.8;27.8;;;19.8;37.5;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.8;47.8;;;34.8;61.1;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;81.2;81.2;;;69.2;89.3;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.9;8.9;;;8.2;9.5;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;53.9;53.9;;;42.9;64.5;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.4;43.4;;;36.5;50.5;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.1;31.1;;;22.7;40.9;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.5;39.5;;;25.8;54.9;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;29.1;29.1;;;21.5;38.1;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.7;8.7;;;7.9;9.6;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.0;63;;;55.1;70.3;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.3;14.3;;;8.2;23.8;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.3;35.3;;;27.6;43.8;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.3;11.3;;;9.7;13.2;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2012;2012;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;54.5;54.5;;;37.1;70.9;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.8;87.8;;;81.3;92.3;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.9;85.9;;;74.3;92.7;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;75.7;75.7;;;65.6;83.6;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.7;8.7;;;7.9;9.4;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.0;40;;;34.9;45.4;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;15.8;15.8;;;11.5;21.4;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;75.4;75.4;;;60;86.3;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.0;66;;;58;73.1;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;64.3;64.3;;;54.9;72.7;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.0;12;;;9.5;15;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.4;9.4;;;8.1;11;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.6;10.6;;;9.9;11.4;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.1;35.1;;;26.7;44.7;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.5;36.5;;;30.2;43.3;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.2;40.2;;;31.1;50.1;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.2;35.2;;;20.4;53.6;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.3;14.3;;;12.2;16.7;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;49.0;49;;;42.4;55.5;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.4;33.4;;;27.1;40.4;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.4;36.4;;;31.9;41;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.0;11;;;10.2;11.9;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.6;38.6;;;32.7;44.8;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.4;89.4;;;82.6;93.7;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.2;45.2;;;39.5;51;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.7;9.7;;;8.9;10.6;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.7;39.7;;;31.5;48.4;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.3;34.3;;;28.5;40.5;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;95.0;95;;;84.4;98.6;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;4.7;4.7;;;2.6;8.4;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.7;49.7;;;44.4;55.1;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.3;83.3;;;74.4;89.5;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.9;87.9;;;82.5;91.8;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.7;8.7;;;7.9;9.5;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.4;32.4;;;25.3;40.5;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;19.7;19.7;;;13.3;28.2;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.5;86.5;;;77.9;92.1;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.0;9;;;7.8;10.4;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.6;40.6;;;34.5;46.9;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.9;36.9;;;32.2;41.9;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.1;9.1;;;7.9;10.3;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.4;9.4;;;8.7;10.2;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.1;36.1;;;29.2;43.6;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.3;7.3;;;5.7;9.4;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.0;84;;;77.3;88.9;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.7;12.7;;;10.5;15.2;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;27.5;27.5;;;22.3;33.5;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.6;7.6;;;6.6;8.8;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.0;12;;;7.7;18.4;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.4;8.4;;;6.4;11;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;30.2;30.2;;;23.7;37.7;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.0;9;;;8;10;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.5;44.5;;;36.1;53.2;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.4;9.4;;;5.6;15.3;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;41.1;41.1;;;28.5;55;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;58.5;58.5;;;45.7;70.2;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;17.8;17.8;;;12.7;24.3;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.6;7.6;;;6.8;8.5;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.8;48.8;;;43.6;54.1;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.7;8.7;;;8;9.4;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.5;44.5;;;38.1;51.1;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;78.1;78.1;;;67.9;85.8;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.7;84.7;;;76.2;90.5;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.6;12.6;;;9.1;17.3;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.1;7.1;;;4.3;11.6;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2012;2012;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.4;66.4;**;US estimate/number is based on fewer than 50 states and the District of Columbia;64.3;70;Gender;Female;;;;;;;59;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;18.9;18.9;;;11.1;30.3;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;75.6;75.6;;;66.3;83.1;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.6;85.6;;;77.6;91.1;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;58.5;58.5;;;49.4;67.1;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;78.5;78.5;;;67.3;86.6;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.2;82.2;;;63.2;92.6;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.6;37.6;;;28.8;47.2;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.5;36.5;;;25.9;48.5;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.6;39.6;;;32.4;47.4;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.2;34.2;;;29.6;39;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.3;41.3;;;32.3;51;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;60.6;60.6;;;47.9;72;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.6;84.6;;;73.2;91.7;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.2;32.2;;;24.9;40.4;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;76.3;76.3;;;62.5;86.1;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.0;85;;;72.1;92.5;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.3;11.3;;;6.2;19.7;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.2;85.2;;;75.8;91.4;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.3;72.3;;;58.1;83.2;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.2;39.2;;;25.8;54.4;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.4;6.4;;;5.5;7.3;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;27.1;27.1;;;17.2;39.9;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.8;6.8;;;5.3;8.6;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.2;5.2;;;4.1;6.6;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.3;71.3;;;61.5;79.4;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.1;44.1;;;39.2;49.2;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;58.5;58.5;;;49.2;67.1;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.1;10.1;;;9.2;11.2;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.8;32.8;;;24.6;42.1;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.8;9.8;;;8;12.1;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;73.7;73.7;;;65.8;80.3;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;7.7;7.7;;;6.1;9.7;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.6;43.6;;;37.7;49.8;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.1;8.1;;;7.4;8.8;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;3.5;3.5;;;2.3;5.1;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.0;45;;;25.3;66.5;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.4;82.4;;;68.7;90.9;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.0;9;;;8.3;9.7;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.1;10.1;;;9.1;11.2;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.1;12.1;;;6.8;20.4;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;29.6;29.6;;;16.3;47.6;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;15.2;15.2;;;12.5;18.5;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2012;2012;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.8;41.8;*;50 States + DC: US Median;39.5;42.5;Gender;Female;;;;;;;59;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.4;38.4;;;31.4;46;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;CA;California;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;8.3;8.3;;;6.6;10.5;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;80.6;80.6;;;68.1;89;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.8;85.8;;;77.7;91.3;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.7;8.7;;;7.5;10;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.0;42;;;35.7;48.6;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;15.2;15.2;;;10.6;21.3;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.5;33.5;;;26;41.9;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.6;9.6;;;8.5;10.8;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.5;32.5;;;19.5;48.8;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.8;43.8;;;37.6;50.2;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;15.2;15.2;;;12;19;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.1;6.1;;;5.2;7.2;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;22.2;22.2;;;13.9;33.6;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.1;63.1;;;48.7;75.5;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;57.1;57.1;;;40.2;72.5;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;79.0;79;;;60.3;90.4;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;53.2;53.2;;;32.1;73.2;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.8;8.8;;;8.1;9.5;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.5;10.5;;;6.4;16.7;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.7;88.7;;;78.4;94.5;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.3;42.3;;;34.7;50.2;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;80.8;80.8;;;70.2;88.2;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.3;11.3;;;10.4;12.2;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.4;7.4;;;6.3;8.7;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.1;43.1;;;37.3;49.2;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.6;64.6;;;51.7;75.6;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.1;88.1;;;81;92.8;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;81.7;81.7;;;75.4;86.7;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.3;42.3;;;32.2;53;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2012;2012;US;United States;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.2;11.2;*;50 States + DC: US Median;10.9;12.4;Gender;Female;;;;;;;59;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.8;5.8;;;5.1;6.6;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.1;8.1;;;4.8;13.5;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.5;6.5;;;5.1;8.2;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.8;37.8;;;30;46.4;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.8;37.8;;;29.5;46.9;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.8;8.8;;;7.6;10.2;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.9;62.9;;;54.8;70.3;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67.1;67.1;;;58.9;74.4;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.4;6.4;;;3.6;11;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.2;87.2;;;76.5;93.4;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.3;38.3;;;30.9;46.4;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.9;35.9;;;30.1;42.2;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.0;8;;;4.8;13.1;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.8;31.8;;;19.1;47.9;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.6;37.6;;;28.1;48;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.9;39.9;;;30.8;49.7;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.7;13.7;;;9.1;20.1;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29.3;29.3;;;20.8;39.5;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.2;42.2;;;37.7;47;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;52.0;52;;;44.9;59.1;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.0;7;;;4.9;9.8;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;27.8;27.8;;;20.3;36.9;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.3;7.3;;;6;8.8;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.1;69.1;;;60.8;76.3;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.1;34.1;;;26;43.1;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.2;14.2;;;12.2;16.4;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.3;41.3;;;28.2;55.9;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;74.3;74.3;;;60.7;84.3;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.4;7.4;;;6;9;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.4;6.4;;;4;10.1;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.8;6.8;;;5.5;8.5;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.6;66.6;;;56;75.8;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.9;85.9;;;74.3;92.7;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29.9;29.9;;;22.5;38.4;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.1;11.1;;;10.2;12.1;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.9;10.9;;;9.3;12.7;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;72.7;72.7;;;63.9;80;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.7;44.7;;;40.5;49;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;54.5;54.5;;;44.1;64.5;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.0;37;;;30.5;44.1;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.2;34.2;;;26.8;42.4;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.8;7.8;;;4.8;12.5;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.5;32.5;;;25.6;40.2;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.8;32.8;;;25.1;41.6;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.1;12.1;;;10.6;13.8;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.5;7.5;;;6.9;8.1;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.0;39;;;31.2;47.4;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.9;9.9;;;8.7;11.3;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;57.4;57.4;;;43.8;70.1;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;60.7;60.7;;;32.2;83.3;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50.3;50.3;;;42.2;58.5;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2012;2012;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.3;84.3;;;77.6;89.3;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.9;41.9;;;36.6;47.5;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.8;10.8;;;8;14.4;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.9;9.9;;;8.3;11.7;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.1;40.1;;;33.2;47.3;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.0;47;;;27;68.1;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.1;6.1;;;5;7.6;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;61.2;61.2;;;51.8;69.8;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.4;13.4;;;11.8;15.2;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.4;6.4;;;4.4;9.1;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;25.1;25.1;;;16;37.1;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;27.6;27.6;;;19.2;38;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.7;10.7;;;9.7;11.9;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;18.0;18;;;13.1;24.3;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;18.2;18.2;;;14.2;23.1;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.8;35.8;;;26.5;46.3;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.2;64.2;;;56.2;71.5;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.4;30.4;;;15.9;50.1;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;76.5;76.5;;;61.5;86.9;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.0;7;;;5.5;8.8;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.9;8.9;;;8.2;9.5;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.3;36.3;;;21.9;53.6;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.4;32.4;;;18.2;50.9;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.4;36.4;;;29.2;44.2;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.5;88.5;;;81.8;93;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.9;10.9;;;9.9;12.1;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;60.5;60.5;;;43.3;75.4;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.8;8.8;;;8;9.7;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.4;36.4;;;28.2;45.5;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.2;87.2;;;81;91.5;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.0;70;;;61.9;77;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.0;39;;;33.2;45;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;17.5;17.5;;;11.9;25.1;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.2;42.2;;;35.3;49.4;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.8;65.8;;;55.3;74.9;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.8;40.8;;;33.6;48.4;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.3;36.3;;;27.4;46.3;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2012;2012;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;27.6;27.6;;;19.9;37;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.7;45.7;;;38.1;53.5;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.1;36.1;;;24.5;49.6;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.8;66.8;;;53.3;78;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.8;10.8;;;9.6;12;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.7;7.7;;;7;8.4;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.4;33.4;;;28.2;39.1;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.1;7.1;;;5.6;9.1;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.8;36.8;;;24.7;50.9;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2012;2012;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;76.1;76.1;;;67.3;83.1;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2012;2012;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.1;35.1;;;21.7;51.4;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.2;39.2;;;34.3;44.2;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.0;8;;;7.3;8.6;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.1;35.1;;;25.7;46;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.6;33.6;;;25.2;43.2;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.7;85.7;;;78.2;90.9;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.7;12.7;;;11.6;14;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;80.8;80.8;;;70.3;88.3;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.3;38.3;;;33.6;43.3;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.2;44.2;;;35.7;53;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.5;44.5;;;40;49.1;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.1;7.1;;;5.3;9.5;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.0;33;;;27;39.7;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;75.0;75;;;68;80.9;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.3;42.3;;;37.3;47.5;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.6;39.6;;;34.4;45;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;59.4;59.4;;;48.8;69.2;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.2;40.2;;;29.3;52.1;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.4;34.4;;;26.9;42.6;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.7;6.7;;;5.3;8.4;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2012;2012;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.0;82;**;US estimate/number is based on fewer than 50 states and the District of Columbia;79;84.6;Gender;Male;;;;;;;59;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;4.7;4.7;;;2.9;7.5;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.5;9.5;;;8.6;10.5;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.7;45.7;;;31.3;60.9;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.4;88.4;;;81.3;93;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;58.3;58.3;;;48.8;67.1;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.1;71.1;;;64.1;77.1;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.8;38.8;;;33.4;44.4;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.9;30.9;;;22.2;41.2;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.7;39.7;;;33.2;46.6;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2012;2012;CA;California;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;16.9;16.9;;;9.3;28.9;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.6;32.6;;;22.5;44.7;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.9;36.9;;;31.2;43.1;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.5;7.5;;;6.8;8.2;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;75.9;75.9;;;65.6;83.8;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.9;6.9;;;6;7.9;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.0;64;;;56.3;71.1;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.2;14.2;;;12.6;15.9;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;22.0;22;;;12.2;36.3;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;27.2;27.2;;;19.9;36;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2012;2012;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.4;13.4;;;10.3;17.3;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.0;11;;;8.7;13.8;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.0;83;;;71.6;90.4;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.5;42.5;;;36.2;49;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.0;9;;;7.9;10.3;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.4;42.4;;;30.1;55.6;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.6;33.6;;;20.8;49.3;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.3;11.3;;;10.1;12.6;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.7;36.7;;;31.4;42.3;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.4;39.4;;;27.8;52.4;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.5;40.5;;;33.1;48.3;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.3;35.3;;;27.2;44.3;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;73.1;73.1;;;64.4;80.3;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;19.3;19.3;;;11.4;30.8;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.2;71.2;;;61.8;79;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;30.9;30.9;;;23.5;39.4;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.5;65.5;;;57.7;72.6;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.8;6.8;;;5.9;7.8;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;61.1;61.1;;;45.8;74.5;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.3;32.3;;;23.3;42.9;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.8;63.8;;;53.8;72.7;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;80.3;80.3;;;71.4;87;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;29.6;29.6;;;24.5;35.3;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.6;6.6;;;3.9;10.9;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.2;72.2;;;62.2;80.3;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.3;85.3;;;79.1;89.9;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;47.9;47.9;;;31.5;64.9;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.2;39.2;;;23.5;57.4;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2012;2012;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.5;13.5;;;10.4;17.3;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.7;8.7;;;7.3;10.4;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.4;43.4;;;38.8;48;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.2;33.2;;;25.8;41.5;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.7;7.7;;;6.7;8.9;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.6;40.6;;;33.2;48.4;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.8;13.8;;;11.7;16.1;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.3;67.3;;;58.2;75.2;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.7;9.7;;;9;10.3;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.2;6.2;;;4.7;8.2;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29.2;29.2;;;22.8;36.6;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.0;46;;;39.3;52.9;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.3;91.3;;;86;94.7;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.2;83.2;;;76.1;88.5;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.3;47.3;;;28.6;66.8;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.7;88.7;;;84;92.2;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.7;31.7;;;24.7;39.6;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.4;36.4;;;29.5;43.8;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.9;36.9;;;28.4;46.3;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.2;86.2;;;79.1;91.2;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.2;36.2;;;23.3;51.4;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.6;68.6;;;57.4;77.9;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.4;88.4;;;81.7;92.8;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.9;39.9;;;33.2;46.9;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.6;34.6;;;29.3;40.3;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;17.6;17.6;;;11.4;26;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;45.2;45.2;;;28.6;63;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.8;84.8;;;76.1;90.6;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.9;10.9;;;9.9;11.9;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;60.7;60.7;;;48.4;71.8;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.7;84.7;;;78.9;89.1;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.9;36.9;;;31;43.2;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.7;36.7;;;31.1;42.6;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.6;10.6;;;9.8;11.4;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;75.1;75.1;;;65.8;82.5;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.2;13.2;;;11.7;14.9;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;25.1;25.1;;;17.8;34.2;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;73.3;73.3;;;60.3;83.2;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.8;37.8;;;30;46.3;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.0;35;;;27.6;43.2;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.9;64.9;*;50 States + DC: US Median;62.9;68.3;Overall;Overall;;;;;;;59;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.5;40.5;;;34.7;46.6;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.0;37;;;30.9;43.5;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.8;34.8;;;23.6;48;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.0;46;;;38.4;53.7;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.8;62.8;;;50.7;73.4;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.6;32.6;;;25.3;40.8;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.7;35.7;;;27.4;45.1;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.7;32.7;;;27.3;38.5;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.3;12.3;;;9.4;16;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.6;12.6;;;9.9;15.9;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.1;34.1;;;26.3;42.8;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;17.8;17.8;;;10.7;27.9;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.2;70.2;;;61.7;77.5;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.1;41.1;;;34.7;47.8;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.7;8.7;;;7.9;9.7;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.5;8.5;;;7.7;9.5;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.9;41.9;;;35;49;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.0;38;;;31.4;45.1;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;57.6;57.6;;;30.4;81;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.4;35.4;;;27.8;43.8;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.5;10.5;;;8.8;12.5;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2012;2012;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.4;6.4;;;5.5;7.4;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.8;13.8;;;11;17.3;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.1;44.1;;;35.4;53.2;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.6;67.6;;;58.4;75.6;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.3;35.3;;;30.2;40.8;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.1;9.1;;;6.9;11.8;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;77.9;77.9;;;71.1;83.5;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;18.9;18.9;;;14.6;24.1;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.0;43;;;32.7;54;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.1;10.1;;;8.6;11.9;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.6;14.6;;;9;23;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.1;35.1;;;30;40.5;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.9;41.9;;;34.8;49.4;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.9;9.9;;;9;10.9;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.0;13;;;11;15.4;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.4;85.4;;;79.5;89.8;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;59.3;59.3;;;44.7;72.4;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;26.8;26.8;;;15.3;42.7;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.0;70;;;62;76.9;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.2;35.2;;;28.5;42.6;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.7;46.7;;;38.4;55.2;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;60.4;60.4;;;50;70;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.0;84;;;77.3;89;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.3;36.3;;;29.6;43.5;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.3;6.3;;;5.4;7.3;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2012;2012;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.1;9.1;;;5.1;15.9;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;77.3;77.3;;;66.5;85.5;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.3;28.3;;;17.2;42.9;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;77.8;77.8;;;64.5;87.1;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.6;6.6;;;5.4;8;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.0;40;;;25.4;56.5;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.2;39.2;;;34.7;43.8;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29.9;29.9;;;23.4;37.3;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.9;41.9;;;30.3;54.4;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.7;48.7;;;40;57.6;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.7;9.7;;;8.2;11.4;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.1;34.1;;;23.7;46.4;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.5;63.5;;;49.6;75.5;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.2;10.2;;;8.5;12.2;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.5;10.5;;;9.1;12;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.6;43.6;;;31.8;56.1;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.4;88.4;;;80.2;93.5;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.3;40.3;;;28.3;53.6;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.2;38.2;;;33.3;43.4;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.8;38.8;;;28.5;50.1;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;79.7;79.7;;;73.5;84.7;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;8.3;8.3;;;5.5;12.2;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;8.7;8.7;;;5;14.8;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;7.5;7.5;;;5.4;10.2;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;78.3;78.3;;;57.8;90.5;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;78.1;78.1;;;70;84.5;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;17.2;17.2;;;12.6;23.1;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.1;84.1;;;75.4;90.1;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;18.3;18.3;;;13;25.1;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.4;39.4;;;30.7;48.8;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;93.4;93.4;;;87.3;96.7;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.5;88.5;;;81.7;93;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.1;13.1;;;11.5;15;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2012;2012;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.6;35.6;**;US estimate/number is based on fewer than 50 states and the District of Columbia;33.1;37.8;Gender;Male;;;;;;;59;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.6;10.6;;;8.1;13.8;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;15.2;15.2;;;11.1;20.6;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.0;40;;;30.7;50.2;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.7;8.7;;;7.5;10;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.4;69.4;;;60.6;76.9;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.7;28.7;;;22.1;36.3;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;52.4;52.4;;;35.9;68.3;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.2;46.2;;;39.3;53.2;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.1;32.1;;;25.7;39.2;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;15.4;15.4;;;8.4;26.4;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.3;28.3;;;17.6;42.1;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.4;36.4;;;30.6;42.5;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;76.5;76.5;;;65.2;85;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;51.2;51.2;;;45.2;57.1;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.3;13.3;;;9.5;18.3;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.4;38.4;;;34.3;42.8;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.6;7.6;;;6.5;8.8;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.3;8.3;;;7;9.7;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.1;70.1;;;61.7;77.4;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;57.2;57.2;;;41.1;71.9;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.6;38.6;;;29.2;48.9;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29.0;29;;;21.5;37.9;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.1;88.1;;;80.6;93;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;61.1;61.1;;;37.2;80.6;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.7;34.7;;;26.6;43.7;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.3;68.3;;;60.7;75;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.9;35.9;;;28.7;43.7;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;57.1;57.1;;;43.2;69.9;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.5;11.5;;;7.4;17.3;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2012;2012;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.9;44.9;;;39.3;50.7;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;52.3;52.3;;;41.9;62.4;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.7;83.7;;;74.6;90.1;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.4;31.4;;;23.4;40.6;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.0;36;*;50 States + DC: US Median;34.7;36.9;Overall;Overall;;;;;;;59;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;58.0;58;;;45.8;69.3;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2012;2012;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.9;30.9;;;23.7;39.2;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.9;7.9;;;6.9;9;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;80.4;80.4;;;71.8;86.9;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2012;2012;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;92.9;92.9;;;86.7;96.3;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.3;36.3;;;30.4;42.7;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.8;34.8;;;30.7;39.1;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.5;37.5;;;29.3;46.5;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.6;11.6;;;8.2;16.1;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.0;10;;;8.8;11.4;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;22.4;22.4;;;14.1;33.6;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;18.0;18;;;12.1;25.8;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;73.2;73.2;;;60.9;82.8;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;77.3;77.3;;;60.9;88.1;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;15.5;15.5;;;13.7;17.5;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.5;46.5;;;40.8;52.3;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.3;38.3;;;32.8;44;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;33.3;33.3;;;20.6;49;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.6;38.6;;;27.9;50.5;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.5;33.5;;;26.7;41.2;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.1;32.1;;;27.6;37.1;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.6;31.6;;;25.8;37.9;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.6;6.6;;;5.7;7.6;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.4;42.4;;;28.6;57.6;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.1;39.1;;;35.2;43;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.2;86.2;;;72.7;93.6;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.3;33.3;;;23.8;44.4;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.7;8.7;;;7.7;9.9;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;79.5;79.5;;;69.2;87;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;23.8;23.8;;;15.2;35.2;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.8;38.8;;;26.7;52.5;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.8;41.8;;;36.7;47.2;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.0;8;;;6.1;10.5;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;18.1;18.1;;;14.1;23;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;80.8;80.8;;;66;90.1;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.2;10.2;;;9.3;11;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.2;8.2;;;7.3;9.1;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.7;7.7;;;6.6;8.8;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.6;84.6;;;73.3;91.7;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.5;64.5;;;52.4;75;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.4;45.4;;;38.4;52.6;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.8;85.8;;;77.3;91.5;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.1;82.1;;;73.2;88.5;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.8;9.8;;;6.5;14.5;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;51.4;51.4;;;38.8;63.8;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.9;85.9;;;79.9;90.3;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.4;84.4;;;72.4;91.8;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.5;33.5;;;24;44.5;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.3;11.3;;;10.3;12.5;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.6;8.6;;;7.1;10.5;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;18.1;18.1;;;12.6;25.3;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;79.5;79.5;;;70.1;86.5;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.8;63.8;;;55.8;71.2;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.7;37.7;;;32.2;43.5;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.4;13.4;;;12.3;14.5;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.7;8.7;;;7.8;9.6;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;49.4;49.4;;;35.6;63.3;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.6;10.6;;;9.5;11.9;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2012;2012;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.8;86.8;;;81.3;90.9;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;17.9;17.9;;;11.1;27.6;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.2;8.2;;;5.3;12.5;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.9;36.9;;;28.7;46;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.1;9.1;;;7;11.9;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2012;2012;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.4;71.4;;;56.5;82.8;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;79.8;79.8;;;69.2;87.4;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.5;10.5;;;8.7;12.7;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.0;41;;;36.7;45.5;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.2;10.2;;;9.3;11.3;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2012;2012;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.3;41.3;;;33.8;49.2;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;49.5;49.5;;;35.8;63.3;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.4;9.4;;;8.5;10.4;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.3;45.3;;;35.9;55.2;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.0;14;;;10.3;18.7;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;73.7;73.7;;;64.6;81.2;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.1;43.1;;;37.8;48.6;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.2;89.2;;;82.1;93.6;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.1;34.1;;;29.2;39.4;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.4;11.4;;;6.8;18.5;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;16.6;16.6;;;9.2;28;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.5;8.5;;;7.4;9.7;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;16.1;16.1;;;12.8;20.2;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.3;28.3;;;17.5;42.3;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.3;32.3;;;24.7;40.9;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.5;40.5;;;36;45;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.8;12.8;;;11.6;14.1;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.8;5.8;;;5;6.6;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.4;63.4;;;51.4;73.9;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.9;8.9;;;6.2;12.6;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;78.4;78.4;;;69.6;85.2;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.7;39.7;;;34.8;44.9;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;54.7;54.7;;;39;69.5;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;27.8;27.8;;;18;40.2;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.0;12;;;9.5;15;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.5;32.5;;;27;38.6;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.1;36.1;;;31.1;41.5;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;92.0;92;;;80.6;96.9;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.2;41.2;;;32.8;50.2;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.4;82.4;;;72.8;89.1;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.4;66.4;;;55.5;75.7;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.1;10.1;;;8.2;12.5;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;64.8;64.8;;;49.3;77.7;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.5;88.5;;;82.5;92.7;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.4;34.4;;;26.6;43.1;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.3;65.3;;;58.4;71.6;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.7;85.7;;;78.3;91;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.5;36.5;;;28.3;45.7;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.3;65.3;;;55;74.3;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;51.8;51.8;;;43.6;59.8;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.6;45.6;;;37.9;53.5;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.5;43.5;;;37.9;49.3;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.1;31.1;;;25.6;37.1;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.4;10.4;;;7.8;13.5;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.0;36;;;30.6;41.7;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.3;34.3;;;26.6;42.9;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.0;6;;;4.9;7.3;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.9;41.9;;;29.9;55;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2012;2012;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.4;33.4;;;28.8;38.3;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;73.4;73.4;;;58;84.6;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.1;36.1;;;28.7;44.3;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.9;34.9;;;23.3;48.7;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;25.9;25.9;;;20;32.7;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.7;84.7;;;78.5;89.3;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;92.9;92.9;;;89.3;95.4;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.1;41.1;;;36.1;46.4;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.6;62.6;;;54;70.5;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;75.3;75.3;;;68.5;81;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.1;42.1;;;34.5;50;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.5;8.5;;;7.8;9.2;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.5;8.5;;;6.2;11.6;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;61.9;61.9;;;46.7;75.1;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.5;10.5;;;8.8;12.6;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.1;35.1;;;27.2;43.8;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.3;41.3;;;34.9;48;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;81.4;81.4;;;69.9;89.2;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;23.2;23.2;;;16.7;31.3;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;77.0;77;;;56.5;89.6;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.6;85.6;;;76.8;91.5;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;3.6;3.6;;;2.2;5.6;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.7;34.7;;;28.9;41;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.4;43.4;;;36.7;50.4;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.2;40.2;;;35.7;44.9;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;17.9;17.9;;;9.8;30.4;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.2;82.2;;;73.3;88.6;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.9;42.9;;;38.2;47.7;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.7;7.7;;;5.6;10.4;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;26.4;26.4;;;22.1;31.2;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.8;7.8;;;5.4;11.1;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.4;10.4;;;7.4;14.4;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;56.1;56.1;;;43.1;68.3;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.7;43.7;;;29.2;59.3;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.2;5.2;;;3.6;7.6;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.4;72.4;;;58.3;83.2;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;49.6;49.6;;;32;67.2;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;17.1;17.1;;;9.9;27.9;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.6;6.6;;;5.4;8;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.9;43.9;;;35.7;52.4;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.1;9.1;;;5;16;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.7;12.7;;;8.2;19;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.7;91.7;;;86.1;95.2;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.3;44.3;;;38.1;50.8;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;18.4;18.4;;;10.4;30.3;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.7;82.7;;;72.1;89.8;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.9;31.9;;;19.5;47.5;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.3;32.3;;;26.5;38.6;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.9;10.9;;;7.8;14.9;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.5;43.5;;;35.9;51.4;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.6;10.6;;;9.4;11.9;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.5;62.5;;;51.1;72.7;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;US;United States;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.9;8.9;*;50 States + DC: US Median;8.6;9.3;Overall;Overall;;;;;;;59;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.4;39.4;;;31.8;47.5;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;60.1;60.1;;;53.6;66.2;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.6;6.6;;;5.6;7.7;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.6;37.6;;;31.4;44.4;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2012;2012;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.1;42.1;;;30.4;54.7;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.1;5.1;;;4.3;6;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.6;82.6;;;64;92.7;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.2;11.2;;;8.8;14.1;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.9;36.9;;;30.8;43.4;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.5;6.5;;;4.8;8.8;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;59.5;59.5;;;47.7;70.2;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;56.0;56;;;39.1;71.5;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.8;45.8;;;38.7;53.1;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2012;2012;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.2;82.2;**;US estimate/number is based on fewer than 50 states and the District of Columbia;77.7;84.6;Gender;Male;;;;;;;59;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.2;7.2;;;5.5;9.5;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.5;32.5;;;23.9;42.5;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.0;7;;;6.2;8;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.6;6.6;;;5.8;7.5;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.4;42.4;;;36.3;48.8;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;79.8;79.8;;;63.5;90;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.4;8.4;;;7.8;9.1;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.6;34.6;;;27.6;42.3;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;55.3;55.3;;;39.4;70.1;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.1;47.1;;;32.7;62;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.1;41.1;;;28.1;55.5;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;28.4;28.4;;;20.7;37.5;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;27.9;27.9;;;19.5;38.3;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.6;10.6;;;9.5;11.7;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.7;42.7;;;30.3;56.1;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;59.1;59.1;;;48.2;69.2;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;25.9;25.9;;;17.8;36;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.6;87.6;;;80.9;92.3;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.0;33;;;23.9;43.6;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.2;11.2;;;6.1;19.6;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.0;11;;;9.6;12.6;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.8;12.8;;;11.8;14;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;60.0;60;;;46.8;71.9;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.7;36.7;;;27.9;46.5;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.7;45.7;;;40.3;51.2;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.5;30.5;;;21.9;40.8;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.0;48;;;40.2;55.9;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.5;82.5;;;72.8;89.2;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;15.4;15.4;;;13.6;17.3;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;81.3;81.3;;;56.7;93.5;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.2;6.2;;;5.5;7;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;51.1;51.1;;;46.4;55.7;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.0;33;;;25.2;41.8;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.3;7.3;;;6.3;8.4;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.1;14.1;;;11.2;17.7;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.1;32.1;;;26.6;38.2;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;80.8;80.8;;;71.7;87.5;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.9;9.9;;;9;11;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.2;8.2;;;7.2;9.2;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;US;United States;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.5;6.5;*;50 States + DC: US Median;6.3;6.8;Gender;Male;;;;;;;59;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.5;12.5;;;10.4;15.1;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.2;8.2;;;7.1;9.4;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.8;83.8;;;71;91.7;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.0;11;;;9.5;12.6;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.6;6.6;;;4.5;9.4;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.0;7;;;6.1;8.1;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.7;7.7;;;6.8;8.6;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.4;7.4;;;6.6;8.3;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.6;40.6;;;29.9;52.2;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;91.0;91;;;84.7;94.9;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;78.5;78.5;;;63.3;88.6;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.9;70.9;;;62.1;78.3;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;51.6;51.6;;;35.2;67.8;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.7;12.7;;;10.4;15.3;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.9;41.9;;;31.6;53;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.8;31.8;;;25.8;38.4;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.5;37.5;;;31;44.6;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.0;40;;;30.2;50.6;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.5;7.5;;;6.2;9.2;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.5;35.5;;;28.6;43.1;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.2;31.2;;;17.5;49.3;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.2;41.2;*;50 States + DC: US Median;40.1;44.1;Gender;Female;;;;;;;59;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.1;38.1;;;32.8;43.7;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.4;83.4;;;66.5;92.7;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.9;44.9;;;38.3;51.6;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.8;88.8;;;79.9;94;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.8;6.8;;;5.3;8.7;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.1;35.1;;;30;40.5;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.1;82.1;;;72.3;88.9;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.6;43.6;;;29;59.3;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;52.1;52.1;;;37.4;66.5;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;76.9;76.9;;;67.6;84.2;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;29.0;29;;;20.4;39.4;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.9;44.9;;;29.2;61.6;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;30.6;30.6;;;25;36.8;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.7;39.7;;;31.3;48.8;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.3;40.3;;;35.5;45.3;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;24.3;24.3;;;17.3;33.1;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;74.3;74.3;;;64.5;82.1;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.0;10;;;6.8;14.3;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.6;39.6;;;34.6;44.7;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.7;12.7;;;7.9;19.9;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2012;2012;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;59.6;59.6;;;44.9;72.8;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.2;32.2;;;21.9;44.6;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.7;70.7;;;63.2;77.2;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.1;13.1;;;12.1;14.1;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.6;31.6;;;24.5;39.8;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;61.5;61.5;;;52.7;69.6;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2012;2012;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.1;31.1;;;23.8;39.4;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;60.5;60.5;;;42.5;76;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.6;42.6;;;33.2;52.6;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.0;9;;;8.1;10;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;58.5;58.5;;;41.9;73.4;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.7;7.7;;;6.3;9.4;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.3;43.3;;;31.4;55.9;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.9;8.9;;;7.3;10.9;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.4;46.4;;;33.8;59.6;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;81.2;81.2;;;72.4;87.7;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;93.0;93;;;87.7;96.2;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.5;6.5;;;5.6;7.6;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;19.7;19.7;;;11.3;32.1;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.1;14.1;;;10.4;18.7;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;26.5;26.5;;;19.1;35.4;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.9;31.9;;;22;43.8;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.8;39.8;;;33.8;46.2;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;50.7;50.7;;;39.9;61.5;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;4.7;4.7;;;3.7;6.1;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.2;5.2;;;4.1;6.5;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.7;44.7;;;37.9;51.8;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.8;7.8;;;6.8;8.9;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.9;31.9;;;24.1;40.8;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.7;36.7;;;29.9;44.2;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;81.2;81.2;;;71.3;88.2;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.1;11.1;;;10.3;11.9;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.1;88.1;;;78.9;93.6;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;79.8;79.8;;;69.4;87.4;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.6;7.6;;;6.6;8.8;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.9;89.9;;;76.5;96;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.9;10.9;;;10.2;11.6;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.4;13.4;;;11;16.2;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.7;7.7;;;6.8;8.7;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.5;9.5;;;8.6;10.6;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;21.5;21.5;;;11.5;36.5;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.8;85.8;;;74.2;92.7;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.9;32.9;;;23.2;44.3;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2012;2012;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.1;69.1;;;62.6;75;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.3;43.3;;;31.6;55.8;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.1;35.1;;;30.1;40.5;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.6;14.6;;;11.4;18.4;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.8;36.8;;;30;44.2;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.4;34.4;;;26.1;43.8;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.5;83.5;;;75.4;89.4;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.7;10.7;;;9.5;12;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.4;39.4;;;33;46.1;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.1;44.1;;;39.3;48.9;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.9;42.9;;;37.2;48.8;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.9;40.9;;;34.2;47.9;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.3;85.3;;;77.7;90.6;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.8;11.8;;;9.8;14.2;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.1;65.1;;;57.2;72.2;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.2;42.2;;;37.7;46.8;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.3;83.3;;;76.5;88.4;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;8.4;8.4;;;5.5;12.6;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.2;11.2;;;6.9;17.5;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;51.9;51.9;;;35.8;67.6;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.2;88.2;;;80.6;93.1;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.3;37.3;;;27.5;48.2;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.4;42.4;;;37.4;47.7;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;53.0;53;;;46.4;59.4;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;77.7;77.7;;;70.9;83.3;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;23.1;23.1;;;16.1;32.1;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.9;35.9;;;29.8;42.4;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.8;8.8;;;8;9.7;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.8;40.8;;;28.5;54.3;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;81.5;81.5;;;70.4;89.1;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.0;11;;;10.1;12;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.7;36.7;;;31.2;42.5;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.4;63.4;;;51.4;74;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;55.9;55.9;;;41.1;69.8;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.1;68.1;;;57.3;77.2;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.2;39.2;;;29.4;49.9;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.3;70.3;;;59.3;79.3;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;23.0;23;;;12.4;38.5;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2012;2012;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.2;38.2;;;24.4;54.3;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.6;44.6;;;29.6;60.7;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;21.6;21.6;;;13.6;32.5;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.8;82.8;;;70.8;90.6;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.9;34.9;;;26.4;44.5;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2012;2012;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;51.0;51;;;45.1;56.8;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;57.6;57.6;;;47.8;66.8;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.7;8.7;;;7.6;9.8;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;19.0;19;;;15.7;22.8;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.3;83.3;;;76.6;88.3;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.7;10.7;;;8.9;12.8;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.1;38.1;;;29.7;47.2;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.3;72.3;;;53.9;85.4;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.5;42.5;;;36.4;48.8;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.9;12.9;;;7.9;20.3;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.9;7.9;;;6;10.4;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;80.7;80.7;;;72.6;86.9;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.5;31.5;;;24.6;39.4;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.1;36.1;;;27.4;45.8;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.6;68.6;;;59.9;76.1;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;52.6;52.6;;;42.8;62.1;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.0;48;;;43.7;52.4;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.9;44.9;;;37.3;52.7;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.2;11.2;;;8.4;14.8;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.8;11.8;;;10.8;12.8;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;60.7;60.7;;;51.6;69.2;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;4.8;4.8;;;3.3;7;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;19.5;19.5;;;15.4;24.3;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;6.4;6.4;;;3.6;11.1;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.0;39;;;32.8;45.6;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.6;13.6;;;9.7;18.8;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.5;9.5;;;5.2;16.7;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.1;88.1;;;83.2;91.7;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.2;12.2;;;8.3;17.5;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;81.5;81.5;;;71.6;88.5;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;61.5;61.5;;;51.1;70.9;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;73.4;73.4;;;64.6;80.6;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.2;40.2;;;30.8;50.3;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.8;31.8;;;24.1;40.6;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.6;86.6;;;78.5;91.9;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;74.8;74.8;;;67.5;80.9;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.7;87.7;;;75.9;94.2;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.9;35.9;;;29.1;43.3;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.0;40;;;35.1;45.2;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.3;70.3;;;63.1;76.6;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.8;65.8;*;50 States + DC: US Median;63;68.7;Overall;Overall;;;;;;;59;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.5;7.5;;;6.2;9.1;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.5;85.5;;;78.9;90.3;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;17.3;17.3;;;12.9;22.8;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.0;6;;;5.1;7.2;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.4;44.4;;;37.6;51.5;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.4;35.4;;;25.7;46.4;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.6;5.6;;;4.5;6.8;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.5;45.5;;;39.1;52.1;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;80.4;80.4;;;66.5;89.5;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;29.3;29.3;;;20.7;39.7;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;26.5;26.5;;;19.1;35.4;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.9;5.9;;;4.9;7.2;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.7;34.7;;;23.6;47.7;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.9;39.9;;;33.3;46.9;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.7;9.7;;;9.1;10.4;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.6;10.6;;;9.7;11.6;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.3;39.3;;;31.5;47.8;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.1;13.1;;;10.3;16.7;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.8;68.8;;;61.7;75.2;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2012;2012;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.6;83.6;;;74.7;89.8;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.3;42.3;;;38.1;46.7;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;18.5;18.5;;;12.5;26.5;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.1;43.1;;;36.3;50.1;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.6;31.6;;;23.3;41.4;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.5;82.5;;;75.1;88;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.8;41.8;;;32.9;51.3;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.5;70.5;;;52.5;83.8;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.8;8.8;;;7.7;10.1;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;51.0;51;;;38;63.8;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.9;32.9;;;27.1;39.2;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;92.0;92;;;85;95.9;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;60.5;60.5;;;51.3;68.9;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.6;8.6;;;7.5;9.9;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.6;37.6;;;32;43.6;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.1;41.1;;;34.4;48.2;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.6;70.6;;;62.4;77.6;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.0;42;;;35.3;49;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.1;9.1;;;8;10.3;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.2;69.2;;;53.9;81.2;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;20.8;20.8;;;12.3;32.9;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.9;11.9;;;9.5;14.9;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.3;87.3;;;78.2;92.9;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.3;85.3;;;75.4;91.7;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.4;28.4;;;22;35.8;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.9;8.9;;;8.1;9.8;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.4;70.4;;;62.5;77.3;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.8;88.8;;;81.7;93.4;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.0;39;;;25.1;54.9;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;80.7;80.7;;;72.6;86.9;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;73.3;73.3;;;65.4;79.9;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.2;9.2;;;6.2;13.5;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;15.0;15;;;12.7;17.6;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.0;11;;;9.7;12.6;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.6;63.6;;;54.8;71.6;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2012;2012;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.8;84.8;;;78.2;89.6;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.4;11.4;;;10.2;12.7;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.9;41.9;;;31.6;53;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.5;14.5;;;10.8;19.1;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;27.4;27.4;;;22.9;32.5;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.0;7;;;6.1;8.1;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;41.6;41.6;;;31.5;52.4;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.0;13;;;8.8;18.7;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.3;49.3;;;33.8;64.9;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2012;2012;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.6;89.6;;;81.9;94.3;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;61.4;61.4;;;37.8;80.7;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;79.5;79.5;;;67.5;87.8;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.8;33.8;;;27.2;41.1;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.8;72.8;;;64.6;79.7;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.5;11.5;;;10.1;13.1;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.2;47.2;;;40;54.6;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;81.0;81;;;67.5;89.8;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2012;2012;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.0;36;**;US estimate/number is based on fewer than 50 states and the District of Columbia;34.8;37.8;Gender;Male;;;;;;;59;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.7;6.7;;;4.7;9.5;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.0;8;;;7.2;9;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;15.7;15.7;;;9.5;24.7;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;15.9;15.9;;;10.5;23.1;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.8;64.8;;;54;74.3;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;74.0;74;;;62.2;83.1;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.8;44.8;;;38.4;51.4;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.8;39.8;;;30.7;49.7;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2012;2012;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.9;8.9;;;8.1;9.8;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.5;35.5;;;28.2;43.4;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.6;32.6;;;21.7;45.7;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.6;40.6;;;35.2;46.3;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.7;89.7;;;83.3;93.8;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2012;2012;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.8;12.8;;;9.6;17;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.8;8.8;;;5.3;14.3;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;81.0;81;;;68.9;89.1;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.6;8.6;;;7.8;9.5;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.8;43.8;;;36.7;51.1;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;60.1;60.1;;;51.1;68.5;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.1;36.1;;;29.1;43.8;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.9;40.9;;;31.2;51.3;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.0;45;;;37.9;52.4;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.1;89.1;;;82.8;93.2;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.2;39.2;;;31.7;47.2;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.1;65.1;;;54.9;74.1;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;77.9;77.9;;;70.1;84.2;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.9;7.9;;;7.1;8.8;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.1;39.1;;;31.2;47.7;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.2;88.2;;;83.8;91.5;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.7;13.7;;;9.6;19;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.3;47.3;;;42.1;52.6;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2012;2012;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.5;66.5;**;US estimate/number is based on fewer than 50 states and the District of Columbia;60;72.3;Gender;Male;;;;;;;59;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;4.2;4.2;;;2.4;7.2;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.0;83;;;76.3;88.2;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.2;44.2;;;37.9;50.7;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.8;87.8;;;82.7;91.6;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.9;86.9;;;80.7;91.3;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.7;13.7;;;11.2;16.7;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.1;6.1;;;5.4;6.9;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.9;36.9;;;32.4;41.7;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.4;65.4;;;56.2;73.6;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.0;37;;;30.1;44.5;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.7;83.7;;;70.4;91.7;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;17.0;17;;;10.1;27.3;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.8;70.8;;;59.9;79.8;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.7;68.7;;;61.7;74.9;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.0;39;;;33;45.3;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.2;71.2;;;62.3;78.6;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.1;8.1;;;7.1;9.1;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;21.2;21.2;;;13.9;30.8;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.6;32.6;;;25.4;40.8;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;80.1;80.1;;;69;88;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.2;39.2;;;31.9;47.1;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;78.1;78.1;;;64.8;87.4;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.7;7.7;;;6.8;8.8;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.4;34.4;;;23.1;47.8;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.5;40.5;;;35.8;45.5;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.6;37.6;;;32.6;42.8;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;73.0;73;;;55.6;85.4;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.6;65.6;;;56.2;73.8;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;51.7;51.7;;;35.7;67.4;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.9;37.9;;;28.1;48.8;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.7;8.7;;;7.4;10.2;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;53.3;53.3;;;36.7;69.2;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2012;2012;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.0;11;;;9.4;12.8;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.6;14.6;;;9;22.7;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.2;34.2;;;28.8;40;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.2;41.2;;;35.4;47.2;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.5;10.5;;;9.5;11.5;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;51.9;51.9;;;41.2;62.5;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.4;32.4;;;20.9;46.5;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;80.7;80.7;;;70.5;88;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.1;42.1;;;34.3;50.4;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;81.0;81;;;68.5;89.3;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;78.5;78.5;;;71;84.4;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.0;70;;;61.3;77.4;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.3;41.3;;;32.4;50.9;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.3;11.3;;;7.2;17.5;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;52.2;52.2;;;39.4;64.8;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;81.7;81.7;;;73.5;87.9;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;52.8;52.8;;;39.5;65.6;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;64.3;64.3;;;42.4;81.6;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.8;35.8;;;26.8;45.9;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.1;42.1;;;36.3;48.2;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.5;35.5;;;27.9;43.9;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.6;36.6;;;30.6;43.1;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.7;82.7;;;75;88.3;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.0;10;;;8.7;11.4;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.8;11.8;;;10.5;13.1;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.4;7.4;;;6.8;8;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.3;37.3;;;25.3;51.2;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.8;7.8;;;6.9;8.8;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.5;6.5;;;5.2;8.2;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;79.6;79.6;;;69.9;86.8;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.1;13.1;;;8.6;19.4;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;25.5;25.5;;;20;31.8;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;73.0;73;;;57.7;84.3;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;30.5;30.5;;;21.6;41.2;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.5;12.5;;;11.5;13.6;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.2;88.2;;;80.8;93;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.6;11.6;;;9.8;13.7;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.3;65.3;;;52.1;76.4;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.4;31.4;;;25;38.6;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.7;31.7;;;25.2;39;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.8;42.8;;;37.4;48.3;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.3;83.3;;;70.8;91.2;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;57.4;57.4;;;47.8;66.5;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;30.1;30.1;;;18.5;44.9;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.5;34.5;;;25.1;45.4;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.2;6.2;;;5;7.7;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;16.0;16;;;9.5;25.7;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.8;83.8;;;75.5;89.6;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.9;35.9;;;27.3;45.4;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.2;36.2;;;26;47.8;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.9;31.9;;;21.9;43.9;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;81.7;81.7;;;73.6;87.8;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.1;8.1;;;7.3;9;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.2;32.2;;;23.3;42.8;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2012;2012;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.5;35.5;;;30;41.5;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.8;37.8;;;32;44;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.9;47.9;;;39.6;56.3;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;3.5;3.5;;;2.1;5.8;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2012;2012;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.5;38.5;*;50 States + DC: US Median;37.4;39.7;Overall;Overall;;;;;;;59;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.0;44;;;32.6;56.1;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;77.1;77.1;;;69.2;83.4;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.7;8.7;;;8;9.5;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;79.6;79.6;;;69.8;86.8;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.3;37.3;;;33.2;41.7;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.2;28.2;;;20.9;36.8;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.1;13.1;;;10.7;16;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2012;2012;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67.8;67.8;;;61;73.9;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.9;14.9;;;13.3;16.7;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.6;34.6;;;27.7;42.1;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.9;39.9;;;34.3;45.7;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.9;9.9;;;8.9;11.1;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.6;43.6;;;33.2;54.5;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;4.6;4.6;;;2.8;7.3;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;28.1;28.1;;;17.1;42.7;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;29.3;29.3;;;23.4;35.9;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2012;2012;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;78.1;78.1;;;69.5;84.8;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;55.9;55.9;;;46.4;64.9;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.9;10.9;;;9.6;12.3;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;54.0;54;;;41.7;65.8;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.9;5.9;;;4.1;8.4;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.6;35.6;;;19.7;55.5;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.1;40.1;;;31.7;49.1;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.2;65.2;;;58.2;71.5;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;76.5;76.5;;;67.3;83.7;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;4.6;4.6;;;3.5;5.9;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.7;30.7;;;18.3;46.8;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;81.1;81.1;;;69.1;89.2;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.7;34.7;;;28.6;41.4;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;25.0;25;;;16.7;35.6;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.3;38.3;;;29.8;47.6;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.5;38.5;;;34.3;42.8;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.7;30.7;;;23.5;38.9;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.1;40.1;;;33.8;46.9;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;15.0;15;;;11.3;19.7;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;73.6;73.6;;;61.7;82.9;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.1;28.1;;;19.3;38.8;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;74.2;74.2;;;64.5;81.9;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.4;88.4;;;81.3;93.1;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.3;12.3;;;9;16.5;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.8;41.8;;;34.2;49.9;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;79.4;79.4;;;73.5;84.3;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.2;7.2;;;5.9;8.7;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.4;65.4;;;52.9;76.1;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.0;35;;;24.4;47.2;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.4;7.4;;;5.5;10;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.8;33.8;;;26.9;41.4;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;3.9;3.9;;;2.4;6.4;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.8;34.8;;;29.1;40.8;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.8;37.8;;;28.9;47.5;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.9;33.9;;;26.7;41.9;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.7;48.7;;;44.3;53.1;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.0;37;;;30.1;44.4;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.2;88.2;;;81.1;92.9;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2012;2012;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.0;9;;;8.2;9.9;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.6;44.6;;;37.5;51.8;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.8;28.8;;;23.6;34.5;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.6;14.6;;;8.8;23.4;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29.1;29.1;;;21.7;37.8;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.9;32.9;;;25.1;41.7;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;53.4;53.4;;;45.5;61.1;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;78.1;78.1;;;70;84.5;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.6;37.6;;;26.3;50.3;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.5;6.5;;;5.5;7.7;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.9;34.9;;;29.2;41.2;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.7;6.7;;;5.5;8.1;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2012;2012;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.5;33.5;;;27.6;39.8;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;60.5;60.5;;;51.1;69.2;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.8;10.8;;;9.7;12;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;78.4;78.4;;;71;84.4;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.5;10.5;;;9.7;11.2;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.7;11.7;;;10;13.7;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;57.9;57.9;;;46.6;68.4;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.9;64.9;;;55.3;73.4;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.8;39.8;;;28.9;51.9;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;56.6;56.6;;;38.9;72.8;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.2;6.2;;;5;7.6;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;20.3;20.3;;;14.8;27.2;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;74.4;74.4;;;65.4;81.8;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;94.4;94.4;;;82.6;98.4;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;57.9;57.9;;;47.2;67.9;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.4;32.4;;;23.9;42.2;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.3;63.3;;;54.2;71.5;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.5;40.5;;;29.1;53.1;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.6;11.6;;;7.2;18.2;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.2;9.2;;;7.6;11.1;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;20.7;20.7;;;12.7;31.9;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.3;44.3;;;39.1;49.6;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.8;32.8;;;25.9;40.6;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.2;40.2;;;35.7;44.9;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.4;45.4;;;36;55.1;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.2;32.2;;;22.3;43.9;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;77.9;77.9;;;69.1;84.8;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.4;8.4;;;7;10;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.7;37.7;;;32;43.7;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.6;86.6;;;80.2;91.2;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.6;7.6;;;6.6;8.7;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.6;66.6;;;56.5;75.3;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;15.2;15.2;;;10.1;22.3;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;73.7;73.7;;;64.6;81.1;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.7;12.7;;;10.5;15.4;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29.3;29.3;;;20.9;39.5;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.9;8.9;;;7.9;10;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.6;7.6;;;6.5;9;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.7;62.7;;;42.3;79.3;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.8;38.8;;;26.9;52.3;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.4;46.4;;;29.7;64;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.1;36.1;*;50 States + DC: US Median;34.1;37.3;Gender;Male;;;;;;;59;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.4;13.4;;;9.7;18.1;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;75.7;75.7;;;65.7;83.5;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.7;9.7;;;8.7;10.8;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;80.7;80.7;;;72.4;86.9;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.5;37.5;;;32.5;42.7;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;49.7;49.7;;;39.2;60.1;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;54.2;54.2;;;44.4;63.6;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.9;42.9;;;34.3;52.1;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;17.4;17.4;;;14;21.5;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;53.3;53.3;;;39.8;66.3;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;59.6;59.6;;;47.9;70.2;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.4;10.4;;;9.6;11.4;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.0;14;;;10.5;18.4;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.1;31.1;;;20.8;43.8;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.1;13.1;;;11.9;14.4;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.1;41.1;;;27.6;56.1;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.4;65.4;;;55.3;74.3;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.0;83;;;71.7;90.4;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.0;41;;;24.9;59.2;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2012;2012;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;80.9;80.9;;;68.9;89;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.9;85.9;;;78.9;90.9;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;4.7;4.7;;;3.7;6;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;17.7;17.7;;;10.7;27.8;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.7;33.7;;;26.7;41.5;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.7;42.7;;;35.7;50;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.2;66.2;;;55.9;75.2;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.4;13.4;;;11;16.3;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.9;45.9;;;32.9;59.5;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.4;34.4;;;27.6;41.9;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;53.5;53.5;;;31.8;74;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.9;36.9;;;26.3;48.9;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;3.0;3;;;1.8;5.1;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.2;37.2;;;30.6;44.3;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.2;5.2;;;3.5;7.6;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;3.1;3.1;;;1.9;4.9;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.9;8.9;;;7.9;9.9;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.4;41.4;;;34.1;49.1;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.0;10;;;8.9;11.1;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.9;39.9;;;33.3;47;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.9;69.9;;;55.6;81.2;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.8;13.8;;;11.8;15.9;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;58.9;58.9;;;46.3;70.4;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.6;13.6;;;9.5;19;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;30.4;30.4;;;23.1;38.8;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.8;6.8;;;6;7.6;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;18.6;18.6;;;11.3;29;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;8.5;8.5;;;6.4;11.3;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;93.0;93;;;87.2;96.3;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.5;13.5;;;12.5;14.5;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.2;41.2;;;30.6;52.7;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.3;32.3;;;20.6;46.8;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.7;7.7;;;6.8;8.6;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.2;14.2;;;10.6;18.7;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.6;88.6;;;81.5;93.3;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.5;39.5;;;33;46.4;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.5;41.5;;;30.8;53.1;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.7;13.7;;;10.5;17.7;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.7;83.7;;;76.4;89.1;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.7;13.7;;;11.7;15.9;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.5;6.5;;;4.9;8.6;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.1;39.1;;;30.4;48.5;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.1;31.1;;;22.2;41.8;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;NY;New York;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.2;90.2;;;82.2;94.8;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.6;11.6;;;10.2;13;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;27.1;27.1;;;21.9;32.9;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.5;40.5;;;32.4;49.1;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;57.6;57.6;;;48.5;66.2;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.2;33.2;;;25.5;42;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.0;40;;;33.4;47.1;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.6;7.6;;;6.5;8.8;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;27.7;27.7;;;17.1;41.5;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.5;42.5;;;36.7;48.6;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;16.7;16.7;;;13.2;21;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.0;42;;;36.9;47.3;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;78.1;78.1;;;59.8;89.6;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;61.0;61;;;48.2;72.4;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.2;82.2;;;67.6;91.1;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.4;30.4;;;24.1;37.6;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.6;13.6;;;11.9;15.5;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;78.9;78.9;;;49.5;93.5;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;17.3;17.3;;;12.6;23.3;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.2;84.2;;;70.7;92.2;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.0;42;;;33;51.5;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.9;67.9;;;58.1;76.4;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.9;85.9;;;79.8;90.3;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.6;39.6;;;34.7;44.7;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.5;88.5;;;80.4;93.5;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.4;45.4;;;40.3;50.6;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.2;6.2;;;5.2;7.5;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.6;47.6;;;34.4;61.2;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;72.5;72.5;;;52.7;86.2;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2012;2012;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.0;82;;;69.9;89.9;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.9;70.9;;;61.5;78.7;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;17.8;17.8;;;10.1;29.5;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;79.1;79.1;;;71.3;85.2;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.5;10.5;;;9;12.2;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.8;8.8;;;6.8;11.5;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.8;45.8;;;37.7;54.1;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;46.2;46.2;;;31.7;61.4;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.3;33.3;;;23.2;45.2;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;15.9;15.9;;;11;22.4;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.4;10.4;;;9.4;11.5;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.9;35.9;;;30.4;41.7;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.5;8.5;;;7.1;10.2;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.1;71.1;;;63.7;77.5;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.1;42.1;;;36.1;48.4;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.3;33.3;;;26.5;40.8;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.5;7.5;;;6.4;8.7;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.7;10.7;;;8.8;13.1;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2012;2012;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.5;83.5;;;77.8;87.9;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.8;46.8;;;37;56.8;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.5;40.5;;;32.8;48.7;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.8;36.8;;;30.6;43.4;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.5;40.5;;;33.8;47.5;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.4;33.4;;;24.1;44.2;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;17.7;17.7;;;10;29.3;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.4;82.4;;;69.9;90.5;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.3;9.3;;;7.8;11;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.6;10.6;;;9.5;11.8;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.8;37.8;;;33.5;42.2;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.1;48.1;;;38.3;58;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.4;32.4;;;21.3;45.8;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.4;11.4;;;9.5;13.5;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.0;86;;;78.6;91.2;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.7;35.7;;;25.6;47.4;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.6;9.6;;;8.8;10.4;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.6;36.6;;;32.4;41;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.1;35.1;;;26.8;44.5;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.5;84.5;;;67.6;93.4;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.2;37.2;;;30.3;44.6;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67.7;67.7;;;58.7;75.7;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.8;9.8;;;8.8;11;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.7;6.7;;;6;7.6;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.6;9.6;;;7.1;13;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.2;11.2;;;10;12.5;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.7;9.7;;;8.3;11.3;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.1;31.1;;;24.8;38.1;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.2;37.2;;;29.6;45.4;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.9;5.9;;;4.8;7.2;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.8;39.8;;;32.7;47.5;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;15.4;15.4;;;9;25.2;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.1;5.1;;;4.3;6;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;59.6;59.6;;;49.2;69.3;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.3;82.3;;;74.9;87.8;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.1;82.1;;;75.2;87.3;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.4;37.4;;;32.8;42.2;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;19.5;19.5;;;15.4;24.4;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.4;28.4;;;19.2;39.8;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.1;9.1;;;5.5;14.7;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.1;90.1;;;83.5;94.3;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.9;32.9;;;25.7;41.1;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.3;37.3;;;30.2;45.1;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;US;United States;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.5;6.5;*;50 States + DC: US Median;6.3;6.8;Gender;Male;;;;;;;59;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2012;2012;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.8;43.8;;;36.6;51.3;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.8;33.8;;;29.2;38.6;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;93.3;93.3;;;88.3;96.3;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.0;7;;;5.9;8.3;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.7;8.7;;;6.1;12.3;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.0;39;;;31.7;46.7;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.1;40.1;;;34.1;46.4;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.8;37.8;;;32;43.9;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.1;8.1;;;7.2;9.1;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.1;37.1;;;25.4;50.7;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.4;34.4;;;24.9;45.3;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.1;36.1;;;28.9;43.9;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;91.4;91.4;;;84.4;95.5;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.7;86.7;;;78.9;91.9;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;15.4;15.4;;;11.8;19.9;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.1;49.1;;;42.3;55.9;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.5;7.5;;;6.6;8.5;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;57.8;57.8;;;39.4;74.3;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.1;5.1;;;4.1;6.5;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;81.7;81.7;;;67.7;90.5;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;41.9;41.9;;;29.5;55.3;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.4;89.4;;;82.9;93.7;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50.7;50.7;;;44.7;56.8;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.4;43.4;;;37.1;49.8;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.3;84.3;;;71.9;91.8;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.7;37.7;;;31.8;44.1;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.5;6.5;;;5.6;7.5;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.2;43.2;;;38.2;48.3;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;22.5;22.5;;;14.4;33.4;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;52.1;52.1;;;40.8;63.1;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;78.0;78;;;57.8;90.2;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.5;11.5;;;8.7;15;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2012;2012;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;25.5;25.5;;;17.5;35.7;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.4;7.4;;;6.5;8.3;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.2;69.2;;;61.9;75.7;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.0;86;;;78.1;91.3;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.7;46.7;;;40.2;53.3;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2012;2012;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.6;40.6;;;26.3;56.6;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.8;7.8;;;7;8.7;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.1;35.1;;;29.6;41.1;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;51.2;51.2;;;41.3;61;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.6;11.6;;;9.7;13.7;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.3;66.3;;;54.3;76.4;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2012;2012;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.3;28.3;;;20.5;37.6;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.1;85.1;;;75.6;91.3;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.5;45.5;;;41;50.1;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.6;70.6;;;62.7;77.3;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.5;39.5;;;32.6;46.9;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.4;36.4;*;50 States + DC: US Median;34.1;38.4;Gender;Female;;;;;;;59;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;16.7;16.7;;;13.6;20.4;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.9;82.9;;;75.4;88.4;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.9;31.9;;;25.2;39.5;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.4;42.4;;;37.4;47.4;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.9;10.9;;;9.5;12.4;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.6;8.6;;;7.5;9.8;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.0;11;;;7.9;15.2;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.0;13;;;11.6;14.6;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.1;8.1;;;7;9.4;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.4;38.4;;;33.5;43.5;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;80.0;80;;;69.3;87.6;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.7;38.7;;;28;50.7;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.1;13.1;;;8.5;19.6;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.7;40.7;;;36.3;45.2;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.1;10.1;;;8.7;11.7;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.6;85.6;;;68.4;94.2;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.5;38.5;;;34;43.2;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;51.2;51.2;;;30;72;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.7;28.7;;;20.5;38.5;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;54.8;54.8;;;43.5;65.6;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.0;86;;;79.7;90.6;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.9;47.9;;;40.4;55.5;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.3;9.3;;;8.5;10.2;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.2;71.2;;;57.1;82.1;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2012;2012;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;15.7;15.7;;;11.8;20.7;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;61.4;61.4;;;53.9;68.4;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.6;35.6;;;24.6;48.5;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.0;8;;;7.3;8.7;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;27.3;27.3;;;19.7;36.4;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;61.2;61.2;;;53.7;68.3;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;30.7;30.7;;;21.8;41.4;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.4;86.4;;;79.2;91.4;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.3;6.3;;;5.5;7.4;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2012;2012;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.2;41.2;;;35.4;47.2;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;74.2;74.2;;;64.7;81.9;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;17.6;17.6;;;10.3;28.4;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.1;31.1;;;23.1;40.4;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;CA;California;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.8;10.8;;;7.1;16.1;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.1;9.1;;;8.3;9.9;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.0;88;;;82.5;91.9;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;53.8;53.8;;;36.7;70;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.6;84.6;;;77.1;89.9;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;81.2;81.2;;;72.9;87.4;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.5;38.5;;;33.1;44.3;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.1;38.1;;;32.3;44.3;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.5;36.5;;;26.1;48.2;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;17.5;17.5;;;13.4;22.6;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;17.7;17.7;;;9.8;29.8;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2012;2012;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.0;8;;;6;10.5;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.3;13.3;;;11.1;15.7;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.8;70.8;;;62.4;78;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.6;33.6;;;27.5;40.2;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2012;2012;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.1;33.1;;;27.4;39.4;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.5;84.5;;;71.6;92.2;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;93.1;93.1;;;79.5;97.9;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;75.8;75.8;;;66.7;83;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;6.6;6.6;;;3.9;11.2;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.6;47.6;;;34.1;61.4;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;8.8;8.8;;;6.6;11.6;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.0;82;;;75.8;86.9;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.8;31.8;;;25.3;39.2;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;50.5;50.5;;;34.5;66.4;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.7;84.7;;;75.4;90.9;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;57.5;57.5;;;49;65.7;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.5;14.5;;;11.9;17.5;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.7;36.7;;;26.5;48.3;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.1;9.1;;;7.7;10.7;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;60.8;60.8;;;49.4;71.2;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.3;34.3;;;28.9;40.2;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.6;85.6;;;62.6;95.5;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50.6;50.6;;;33.8;67.2;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.9;6.9;;;5.9;8.1;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.0;10;;;8.5;11.9;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;92.2;92.2;;;80.9;97.1;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;61.6;61.6;;;52.4;70.1;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.1;32.1;;;25.5;39.6;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.1;66.1;;;57.1;74.1;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.4;45.4;;;35;56.3;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;81.7;81.7;;;74.5;87.3;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.9;62.9;;;57;68.5;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.5;44.5;;;40.4;48.8;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;50.1;50.1;;;42.7;57.5;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.2;41.2;;;35.4;47.3;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.1;37.1;;;23.9;52.5;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.5;83.5;;;76.8;88.5;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;91.4;91.4;;;85.6;95;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2012;2012;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.9;42.9;;;35;51.3;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.5;6.5;;;5.2;8.2;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.4;33.4;;;24.4;43.8;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2012;2012;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;75.6;75.6;;;65.5;83.5;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.3;36.3;;;23.7;51.2;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;80.8;80.8;;;68.6;89;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.0;82;;;72.7;88.6;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;17.5;17.5;;;11.4;25.9;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.4;10.4;;;8.6;12.3;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.5;84.5;;;78.2;89.2;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;49.7;49.7;;;42.2;57.2;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.5;12.5;;;10.1;15.5;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.1;11.1;;;10;12.2;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.8;38.8;;;30.1;48.3;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.7;89.7;;;83.4;93.8;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.1;47.1;;;39;55.4;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2012;2012;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.8;30.8;;;23;39.8;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;56.8;56.8;;;44.8;68.2;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;16.3;16.3;;;10;25.6;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;80.1;80.1;;;69.9;87.5;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.6;31.6;;;25.6;38.2;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.9;82.9;;;71;90.6;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.0;9;;;5.2;15;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.9;9.9;;;8.3;11.8;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.6;41.6;;;30.1;54.1;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.8;8.8;;;8;9.7;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.4;43.4;;;37.6;49.4;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;57.6;57.6;;;47.2;67.3;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50.2;50.2;;;35.5;64.9;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.3;32.3;;;24.5;41.3;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.1;11.1;;;9.8;12.4;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2012;2012;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;23.7;23.7;;;14;37;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.5;10.5;;;9.7;11.2;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;73.4;73.4;;;60;83.6;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.4;85.4;;;65.8;94.7;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.6;39.6;;;28.4;52.1;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;27.1;27.1;;;20.2;35.3;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;79.7;79.7;;;59.9;91.1;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.8;31.8;;;22.7;42.6;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2012;2012;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.8;68.8;;;60.5;76;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.3;37.3;;;28.3;47.4;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.0;38;;;25.5;52.3;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;19.8;19.8;;;14.1;27;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;29.5;29.5;;;18.4;43.7;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.1;43.1;;;37;49.5;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;28.6;28.6;;;18.2;42;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;27.3;27.3;;;17.2;40.4;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.8;31.8;;;24.7;40;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2012;2012;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.2;10.2;;;9.3;11.1;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.6;37.6;;;33.3;42.2;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.6;43.6;;;36.3;51.2;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.5;89.5;;;79.3;95;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.1;10.1;;;7;14.4;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.5;82.5;;;74.8;88.3;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;7.9;7.9;;;6;10.3;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.9;34.9;;;27.6;43.1;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;17.9;17.9;;;13.6;23.2;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.2;66.2;;;54.4;76.3;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.7;14.7;;;9.6;21.9;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.5;65.5;;;51.5;77.3;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;17.3;17.3;;;10.5;27.1;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.4;84.4;;;78.2;89.1;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.9;36.9;;;30.1;44.4;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.7;38.7;;;33.3;44.4;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.1;70.1;;;55.8;81.3;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.8;11.8;;;8.4;16.4;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;4.5;4.5;;;2.6;7.8;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.1;11.1;;;6.8;17.8;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;54.3;54.3;;;36.9;70.8;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;92.4;92.4;;;76;97.9;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.4;86.4;;;72.2;93.9;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.4;32.4;;;20.2;47.6;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.9;40.9;;;33.8;48.4;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.1;65.1;;;58.1;71.5;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.0;37;;;28.2;46.8;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.1;8.1;;;7.2;9.1;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.2;6.2;;;5;7.6;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67.4;67.4;;;49.3;81.5;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;80.6;80.6;;;66.8;89.5;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.5;6.5;;;5.6;7.5;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.6;68.6;;;60.4;75.7;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.5;67.5;;;58.8;75.1;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.5;45.5;;;35.5;55.9;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;78.3;78.3;;;61.8;88.9;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.9;72.9;;;58.1;83.9;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;79.5;79.5;;;69.6;86.8;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;57.6;57.6;;;39.7;73.8;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.8;35.8;;;30.7;41.3;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.9;39.9;;;34.4;45.7;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.3;38.3;;;33.1;43.7;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.5;71.5;;;62.3;79.2;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.0;9;;;7.4;10.9;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.4;7.4;;;6.5;8.3;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.6;35.6;;;27.9;44.1;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.6;7.6;;;6.6;8.8;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.4;38.4;;;29.3;48.3;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;55.6;55.6;;;42.4;68.1;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.2;86.2;;;79.1;91.1;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;18.1;18.1;;;13.3;24;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.3;10.3;;;9.3;11.3;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.2;82.2;;;71.5;89.5;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.8;87.8;;;79.8;92.9;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.1;37.1;;;29.6;45.3;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.1;9.1;;;5.6;14.2;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.7;34.7;;;29.4;40.5;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.7;42.7;;;31;55.3;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.0;65;;;53.2;75.2;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.6;37.6;;;30.2;45.6;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.2;69.2;;;61.1;76.3;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.0;44;;;35.7;52.6;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.3;11.3;;;9.7;13.2;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.7;11.7;;;7;18.9;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.7;6.7;;;4.9;9.1;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;57.9;57.9;;;47;68.1;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.3;38.3;;;31.5;45.6;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.2;39.2;;;26.1;54;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.6;8.6;;;7.5;10;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.9;33.9;;;25.1;44;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.3;38.3;;;31;46.1;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.4;89.4;;;79.2;94.9;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;4.7;4.7;;;3.6;6;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.3;9.3;;;8.3;10.3;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;19.3;19.3;;;15.8;23.3;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;23.5;23.5;;;15.2;34.4;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;19.9;19.9;;;13.2;28.8;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.1;35.1;;;29.7;40.9;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.0;41;;;33.6;48.7;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.6;31.6;;;23.3;41.2;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.3;43.3;;;29.3;58.5;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.6;31.6;;;22.9;41.9;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.2;10.2;;;9.2;11.3;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.7;62.7;;;43.7;78.4;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;60.6;60.6;;;42.4;76.3;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.2;84.2;;;76.9;89.5;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.2;7.2;;;5.9;8.7;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.4;32.4;;;25.7;39.8;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;80.7;80.7;;;70.8;87.7;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.7;10.7;;;9.7;11.8;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.8;38.8;;;33;44.9;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.6;10.6;;;9.6;11.7;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;4.6;4.6;;;3.3;6.5;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.1;39.1;;;33.6;44.9;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.7;41.7;;;28.2;56.6;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.3;37.3;;;30.4;44.8;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.0;89;;;80.8;94;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;61.4;61.4;;;51.8;70.2;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.6;39.6;;;30.3;49.7;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.1;65.1;;;46.9;79.8;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.9;28.9;;;18.3;42.4;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.4;7.4;;;6.9;7.9;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.6;13.6;;;11.6;15.9;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;15.8;15.8;;;11.5;21.3;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;78.0;78;;;66.4;86.4;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;51.2;51.2;;;45.4;57;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.3;69.3;;;60;77.3;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;55.1;55.1;;;38.1;71.1;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;73.1;73.1;;;60.3;83;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.4;39.4;;;35.3;43.6;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;41.6;41.6;;;30.3;53.9;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;81.6;81.6;;;71.8;88.6;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.5;31.5;;;24.2;39.7;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.6;13.6;;;11.4;16.1;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;78.9;78.9;;;66.7;87.5;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.8;33.8;;;25.7;42.9;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;16.6;16.6;;;10.2;25.9;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.4;38.4;;;22.3;57.6;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.1;11.1;;;8.7;14;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.0;88;;;80.1;93.1;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.5;44.5;;;37.6;51.5;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.1;72.1;;;62.1;80.3;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;22.2;22.2;;;15.7;30.5;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.0;14;;;8.6;21.9;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;81.2;81.2;;;73;87.4;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;8.0;8;;;6.3;10.3;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.0;70;;;62.4;76.7;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.8;6.8;;;4.5;10;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.1;87.1;;;78.1;92.8;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.8;42.8;;;34.2;51.8;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.1;11.1;;;8.9;13.9;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;NY;New York;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.6;12.6;;;9.5;16.4;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;54.3;54.3;;;44.4;63.8;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.9;12.9;;;8.1;19.9;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.7;7.7;;;4.6;12.6;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.1;40.1;;;35.4;45.1;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2012;2012;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.6;83.6;*;50 States + DC: US Median;82.1;84.8;Overall;Overall;;;;;;;59;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;19.1;19.1;;;15;24;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.9;39.9;;;35.4;44.5;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.7;33.7;*;50 States + DC: US Median;32.2;35.6;Gender;Male;;;;;;;59;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;41.9;41.9;;;31.7;52.8;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.5;33.5;;;22.3;46.9;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.0;36;;;26.2;47.1;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.6;10.6;;;7.9;14.1;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.0;47;;;39.2;55;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;57.8;57.8;;;47.4;67.5;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.3;35.3;;;30.6;40.3;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.9;33.9;;;29.5;38.6;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.5;46.5;;;36.6;56.7;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.1;85.1;;;74.9;91.6;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.8;8.8;;;7.8;9.8;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;28.7;28.7;;;21.7;36.9;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.1;87.1;;;71.3;94.9;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.4;12.4;;;11;14;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;73.0;73;;;63.2;80.9;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.9;71.9;;;62.1;80;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.3;11.3;;;8.3;15.2;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.1;65.1;;;49.3;78.1;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.1;84.1;;;75.7;90;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.9;43.9;;;36.9;51.2;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;52.8;52.8;;;39.5;65.6;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.3;68.3;;;57.6;77.4;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.3;11.3;;;10.4;12.2;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;57.6;57.6;;;47.4;67.3;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.6;48.6;;;42.9;54.5;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.8;84.8;;;76.9;90.4;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;41.9;41.9;;;31.8;52.6;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;80.7;80.7;;;69.7;88.3;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.6;43.6;;;39.2;48;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.8;13.8;;;11.2;17;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.4;6.4;;;5;8.2;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.1;39.1;;;32.4;46.2;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;61.5;61.5;;;53.1;69.2;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.9;39.9;;;33.3;46.8;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.1;43.1;;;35.8;50.7;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.9;41.9;;;35.6;48.5;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.0;70;;;53.9;82.3;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;76.9;76.9;;;58.7;88.6;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.4;11.4;;;8.6;14.9;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.6;44.6;;;39.3;49.9;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2012;2012;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.0;44;;;36.5;51.8;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.7;8.7;;;6.7;11.3;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.8;32.8;;;23.6;43.6;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.3;6.3;;;4.9;7.9;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;79.5;79.5;;;64.8;89.1;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.0;34;;;26.2;42.8;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.8;48.8;;;43.9;53.8;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.5;38.5;;;32.3;45.1;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.9;36.9;;;31.7;42.4;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.7;43.7;;;36.1;51.6;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.9;12.9;;;10.9;15.3;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.2;9.2;;;8.4;10;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;23.4;23.4;;;15.1;34.6;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2012;2012;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.9;39.9;;;23.3;59.1;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.7;9.7;;;5.3;17.1;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.3;66.3;;;52.6;77.7;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;19.8;19.8;;;14.3;26.6;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.9;10.9;;;9.5;12.4;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.7;86.7;;;80.9;90.8;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2012;2012;US;United States;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.3;11.3;*;50 States + DC: US Median;10.9;12.1;Gender;Female;;;;;;;59;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.4;44.4;;;38.4;50.6;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.1;7.1;;;5.9;8.4;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;78.9;78.9;;;69.3;86.1;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.1;11.1;;;10;12.3;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;93.4;93.4;;;90;95.7;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;41.5;41.5;;;30.4;53.5;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.2;31.2;;;18.7;47.2;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.7;10.7;;;8;14.2;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2012;2012;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;49.7;49.7;;;36;63.4;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.4;37.4;;;28.5;47.4;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.2;10.2;;;9.5;11;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.8;8.8;;;8.2;9.4;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.6;38.6;;;27.4;51;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;15.4;15.4;;;12.7;18.5;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.4;42.4;;;37.3;47.7;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;15.6;15.6;;;12.7;19.1;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.5;37.5;;;22;56;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;60.2;60.2;;;53.5;66.5;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;75.9;75.9;;;67.2;82.9;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.4;5.4;;;4.5;6.5;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.0;33;;;24.1;43.2;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.9;37.9;;;33.4;42.6;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;41.3;41.3;;;29.3;54.6;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.9;47.9;;;43.1;52.8;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.5;9.5;;;5.6;15.8;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.6;8.6;;;7.6;9.9;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.6;7.6;;;6.9;8.3;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.6;10.6;;;9.4;11.9;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.3;8.3;;;6.1;11.3;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.8;5.8;;;4.5;7.5;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.3;66.3;;;55.5;75.6;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.6;38.6;;;25.2;53.9;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;72.1;72.1;;;58.1;82.8;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;57.8;57.8;;;48.5;66.5;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.3;9.3;;;6.1;13.9;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.0;14;;;10.4;18.6;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;81.6;81.6;;;74;87.3;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.7;82.7;;;64;92.8;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.1;32.1;;;23.4;42.3;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.4;64.4;;;54.9;72.8;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.9;8.9;;;8.3;9.7;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.7;11.7;;;9.7;14;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.2;11.2;;;9.7;13;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.3;85.3;;;76.4;91.2;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;52.1;52.1;;;40.5;63.5;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.1;7.1;;;6.2;8.1;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.5;7.5;;;6.4;8.7;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;78.6;78.6;;;69;85.8;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.9;71.9;;;64.9;77.9;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.5;41.5;;;37.2;45.9;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.8;11.8;;;8.2;16.7;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.4;36.4;;;31.5;41.7;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;80.3;80.3;;;67.1;89.1;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.4;9.4;;;6.8;12.9;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.0;10;;;7.5;13.2;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.6;7.6;;;6.7;8.6;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.7;45.7;;;37.5;54.2;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.7;9.7;;;8.8;10.7;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.5;44.5;;;36.4;53;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.4;13.4;;;10;17.8;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.3;37.3;;;30.5;44.7;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.9;33.9;;;27;41.6;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.7;13.7;;;12.7;14.8;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.3;39.3;;;32.2;46.8;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.4;70.4;;;62.3;77.4;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.5;9.5;;;7;12.8;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.6;82.6;;;72.5;89.5;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;54.9;54.9;;;45.4;64.1;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;29.1;29.1;;;18.6;42.3;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;23.3;23.3;;;13;38.1;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.3;86.3;;;78.5;91.6;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.8;36.8;;;28.2;46.4;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.9;30.9;;;22.5;40.8;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.2;14.2;;;11.6;17.2;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;93.2;93.2;;;87.6;96.4;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.6;9.6;;;5.3;16.6;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.3;6.3;;;5.5;7.3;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.8;31.8;;;23.1;42.1;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.4;68.4;;;60.6;75.3;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.7;37.7;;;29.6;46.5;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;29.5;29.5;;;21.1;39.6;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;16.6;16.6;;;10.1;26.2;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2012;2012;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.6;71.6;;;60.6;80.4;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.5;41.5;;;32.3;51.4;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.9;30.9;;;23.4;39.7;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.3;36.3;;;24;50.7;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.1;41.1;;;33.7;49.1;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.1;12.1;;;7;20;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;57.0;57;;;36.6;75.3;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50.6;50.6;;;36.8;64.3;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.4;89.4;;;81.9;94;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.6;14.6;;;11.3;18.5;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;51.0;51;;;33.4;68.4;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90.3;90.3;;;81.8;95;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.8;37.8;;;27.3;49.6;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.2;43.2;;;37.1;49.6;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.9;88.9;;;81.7;93.5;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;60.6;60.6;;;52.8;67.9;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.3;10.3;;;7.8;13.5;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.6;12.6;;;8.3;18.6;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.4;6.4;;;3.8;10.6;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.0;6;;;5;7.3;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.5;10.5;;;9.4;11.8;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.2;65.2;;;47.7;79.4;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.3;11.3;;;8.7;14.7;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.7;70.7;;;62.4;77.9;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.5;31.5;;;23.5;40.9;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.1;34.1;;;28.8;39.7;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.1;46.1;;;37.6;54.9;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.9;45.9;;;35.3;56.9;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.6;9.6;;;8.9;10.4;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;64.6;64.6;;;53;74.7;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;NY;New York;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.7;11.7;;;9.5;14.3;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.6;37.6;;;30.8;44.9;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.1;44.1;;;32.8;56;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;28.2;28.2;;;16.8;43.3;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.0;8;;;7.2;8.8;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.9;38.9;;;32.4;45.9;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;81.4;81.4;;;71.5;88.4;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.4;84.4;;;78;89.2;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;75.6;75.6;;;63.3;84.7;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.7;9.7;;;6.5;14.3;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.5;35.5;;;21.3;52.7;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2012;2012;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.8;40.8;;;35.4;46.5;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.7;11.7;;;10.2;13.6;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.4;89.4;;;82;94;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2012;2012;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.4;85.4;;;77.2;90.9;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.2;42.2;;;34.9;49.9;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.6;6.6;;;4.7;9.2;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;44.9;44.9;;;29.8;61.1;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.5;7.5;;;5.5;10.3;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;19.0;19;;;14.8;23.9;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.0;8;;;7.2;8.9;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.3;82.3;;;69;90.7;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.5;37.5;;;30.8;44.6;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.9;62.9;;;56.2;69.1;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;22.5;22.5;;;14.2;33.8;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;75.9;75.9;;;64.5;84.5;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.1;11.1;;;10.3;11.9;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.3;32.3;;;17.4;51.8;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.5;8.5;;;7.4;9.7;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;51.8;51.8;;;36.6;66.7;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2012;2012;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;81.1;81.1;;;73;87.2;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.0;33;;;21;47.7;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.5;64.5;;;57.6;70.9;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.2;46.2;;;38;54.7;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.4;42.4;;;35.2;49.9;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;17.8;17.8;;;12.7;24.3;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;75.8;75.8;;;66.5;83.2;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.7;7.7;;;6.6;9;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2012;2012;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;17.3;17.3;;;12.8;23;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;CA;California;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;17.4;17.4;;;10.8;26.6;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.4;68.4;;;60;75.7;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;52.3;52.3;;;45.3;59.3;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.7;36.7;;;32.3;41.4;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.1;41.1;;;25.4;58.8;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.4;49.4;;;42;56.8;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67.4;67.4;;;60.4;73.7;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.6;37.6;;;30.8;44.9;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;54.1;54.1;;;42.3;65.4;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.8;38.8;;;30.4;47.9;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.2;41.2;;;34.7;48.1;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.9;14.9;;;8.7;24.3;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.4;69.4;;;61.6;76.2;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2012;2012;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;60.7;60.7;;;45.4;74.1;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;58.3;58.3;;;47.4;68.4;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.4;63.4;;;57.3;69.1;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2012;2012;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.6;66.6;;;57.7;74.5;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.3;10.3;;;9.3;11.4;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.9;64.9;;;53.2;75.1;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.6;8.6;;;7.9;9.4;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.8;87.8;;;79.3;93.1;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.7;38.7;;;28.4;50.1;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;77.4;77.4;;;64.6;86.5;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.7;14.7;;;12.6;17.2;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2012;2012;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.5;39.5;;;35.4;43.7;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.2;43.2;;;35.4;51.4;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.1;33.1;;;26;41;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.7;36.7;;;31.8;41.9;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.1;40.1;;;34.5;46.1;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.0;12;;;8.7;16.3;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;61.2;61.2;;;49.4;71.9;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2012;2012;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.3;6.3;;;5.5;7.3;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2012;2012;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.9;35.9;;;26.8;46.2;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.4;12.4;;;10.9;14.1;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;5.8;5.8;;;3.8;8.8;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;53.2;53.2;;;36.9;68.8;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.4;7.4;;;6.4;8.5;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.9;10.9;;;7.1;16.2;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2012;2012;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.6;6.6;;;4.9;8.8;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2012;2012;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2012;2012;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.3;85.3;**;US estimate/number is based on fewer than 50 states and the District of Columbia;83.7;86.6;Gender;Female;;;;;;;59;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2012;2012;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.9;65.9;;;52.1;77.4;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;19.0;19;;;13.9;25.4;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.5;87.5;;;82.9;91;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;76.3;76.3;;;67.7;83.2;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2012;2012;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;55.1;55.1;;;39.1;70.2;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.5;69.5;;;59.1;78.2;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.6;83.6;;;76;89.2;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.3;36.3;;;26;48;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2012;2012;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.8;10.8;;;9.7;12;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2012;2012;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.8;37.8;;;32.3;43.7;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2012;2012;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2012;2012;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;57.3;57.3;;;30.9;80.1;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;VA;Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.7;14.7;;;9.7;21.6;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2012;2012;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;57.2;57.2;;;46.3;67.5;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2012;2012;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.1;6.1;;;5;7.5;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.8;68.8;;;60.6;76;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.7;69.7;;;61.1;77.1;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2012;2012;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2012;2012;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.8;88.8;;;82.9;92.8;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.1;11.1;;;9.9;12.3;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.3;33.3;;;25.5;42.2;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2012;2012;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2012;2012;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2012;2012;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2012;2012;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2012;2012;TX;Texas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2012;2012;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;80.1;80.1;;;69.1;87.8;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2012;2012;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.0;30;;;22.3;39.1;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2012;2012;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2012;2012;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2012;2012;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2012;2012;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2012;2012;WY;Wyoming;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.9;9.9;;;7.1;13.6;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2012;2012;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.4;87.4;;;81.3;91.7;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.1;8.1;;;7.1;9.2;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2012;2012;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2012;2012;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.7;9.7;;;5.9;14.9;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2011;2011;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;;Number;46;46;;;;;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2011;2011;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;;Number;40;40;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;NMBR;RACE;WHT;;;;
2012;2012;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;NMBR;GENDER;GENF;;;;
2012;2012;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;15.9;15.9;;;10.1;23.8;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2012;2012;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;18.8;18.8;;;13.2;25.9;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2012;2012;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2012;2012;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;NMBR;RACE;API;;;;
2012;2012;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2012;2012;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.5;9.5;;;6.3;13.7;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2012;2012;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2012;2012;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2012;2012;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2012;2012;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2012;2012;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;;Number;109;109;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;NMBR;RACE;WHT;;;;
2012;2012;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2012;2012;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.5;12.5;;;9.8;15.6;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2012;2012;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.2;9.2;;;6.9;12.1;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2012;2012;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;CRDRATE;RACE;API;;;;
2012;2012;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2012;2012;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.907192, -77.036871);;11;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2012;2012;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2012;2012;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;;Number;21;21;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;NMBR;RACE;WHT;;;;
2012;2012;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;85;85;;;;;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;NMBR;GENDER;GENF;;;;
2012;2012;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;NMBR;RACE;BLK;;;;
2012;2012;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2012;2012;CA;California;NVSS;Asthma;Asthma mortality rate;;;Number;58;58;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;NMBR;RACE;BLK;;;;
2012;2012;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;;Number;34;34;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;NMBR;RACE;WHT;;;;
2012;2012;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;NMBR;GENDER;GENM;;;;
2012;2012;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2012;2012;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2012;2012;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.8;14.8;;;10.6;20.2;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2012;2012;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2012;2012;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2012;2012;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2012;2012;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;NMBR;RACE;HIS;;;;
2012;2012;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2012;2012;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2012;2012;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;CRDRATE;RACE;API;;;;
2012;2012;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;5.6;5.6;;;3.8;8;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2012;2012;ME;Maine;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;NMBR;RACE;API;;;;
2012;2012;CA;California;NVSS;Asthma;Asthma mortality rate;;;Number;220;220;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;NMBR;RACE;WHT;;;;
2012;2012;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;;Number;52;52;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;NMBR;RACE;WHT;;;;
2012;2012;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;15.1;15.1;;;11;20.2;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2012;2012;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;NMBR;RACE;API;;;;
2012;2012;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.1;12.1;;;7.9;17.5;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2012;2012;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2012;2012;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;5.2;5.2;;;3.2;8;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2012;2012;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.3;8.3;;;6.1;11.1;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2012;2012;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;;Number;54;54;;;;;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2012;2012;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;NMBR;RACE;API;;;;
2012;2012;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;30.1;30.1;;;22.6;39.4;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2012;2012;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2012;2012;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2012;2012;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;;Number;29;29;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;NMBR;RACE;WHT;;;;
2012;2012;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;NMBR;RACE;API;;;;
2012;2012;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2012;2012;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2012;2012;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2012;2012;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;NMBR;RACE;WHT;;;;
2012;2012;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.3;10.3;;;7.1;14.4;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2012;2012;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2012;2012;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;NMBR;RACE;AIAN;;;;
2012;2012;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2012;2012;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;5.7;5.7;;;3.7;8.4;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2012;2012;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2012;2012;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2012;2012;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2012;2012;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2012;2012;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;NMBR;GENDER;GENF;;;;
2012;2012;MT;Montana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;NMBR;RACE;BLK;;;;
2012;2012;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2012;2012;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;;Number;40;40;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;NMBR;RACE;WHT;;;;
2012;2012;CA;California;NVSS;Asthma;Asthma mortality rate;;;Number;59;59;;;;;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;NMBR;RACE;HIS;;;;
2012;2012;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;CRDRATE;RACE;API;;;;
2012;2012;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2012;2012;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2012;2012;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2012;2012;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.9;14.9;;;10.5;20.5;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2012;2012;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2012;2012;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;NMBR;RACE;AIAN;;;;
2012;2012;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;NMBR;RACE;BLK;;;;
2012;2012;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.8;9.8;;;6.6;14.1;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2012;2012;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2012;2012;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.5;9.5;;;6.4;13.5;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2012;2012;CA;California;NVSS;Asthma;Asthma mortality rate;;;Number;252;252;;;;;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;NMBR;GENDER;GENF;;;;
2012;2012;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2012;2012;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2012;2012;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.3;8.3;;;6.6;9.9;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2012;2012;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;;Number;63;63;;;;;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;NMBR;GENDER;GENF;;;;
2012;2012;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.1;12.1;;;7.5;18.5;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2012;2012;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;;Number;38;38;;;;;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;NMBR;GENDER;GENM;;;;
2012;2012;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2012;2012;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.1;8.1;;;5;12.3;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2012;2012;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.8;13.8;;;8.5;21;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2012;2012;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2012;2012;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;;Number;61;61;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;NMBR;RACE;WHT;;;;
2012;2012;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;NMBR;GENDER;GENM;;;;
2012;2012;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.3;8.3;;;5.8;11.6;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2012;2012;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2012;2012;NY;New York;NVSS;Asthma;Asthma mortality rate;;;Number;110;110;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;NMBR;RACE;WHT;;;;
2012;2012;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;21.4;21.4;;;13.7;31.9;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2012;2012;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;39;39;;;;;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;NMBR;GENDER;GENM;;;;
2012;2012;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;CRDRATE;RACE;API;;;;
2012;2012;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2012;2012;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;;Number;28;28;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;NMBR;RACE;BLK;;;;
2012;2012;NY;New York;NVSS;Asthma;Asthma mortality rate;;;Number;284;284;;;;;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2012;2012;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;NMBR;RACE;HIS;;;;
2012;2012;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2012;2012;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2012;2012;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.5;14.5;;;12.8;16.2;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2012;2012;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;NMBR;RACE;HIS;;;;
2012;2012;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.5;10.5;;;7;15.1;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2012;2012;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;NMBR;RACE;WHT;;;;
2012;2012;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;NMBR;RACE;HIS;;;;
2012;2012;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2012;2012;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;;Number;45;45;;;;;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2012;2012;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2012;2012;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;NMBR;RACE;HIS;;;;
2012;2012;FL;Florida;NVSS;Asthma;Asthma mortality rate;;;Number;107;107;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;NMBR;RACE;WHT;;;;
2012;2012;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2012;2012;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;NMBR;GENDER;GENF;;;;
2012;2012;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2012;2012;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;NMBR;RACE;API;;;;
2012;2012;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;CRDRATE;RACE;API;;;;
2012;2012;MT;Montana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;NMBR;GENDER;GENF;;;;
2012;2012;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2012;2012;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;CRDRATE;RACE;API;;;;
2012;2012;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;NMBR;GENDER;GENF;;;;
2012;2012;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2012;2012;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2012;2012;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.4;13.4;;;8.2;20.6;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2012;2012;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2012;2012;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;;Number;58;58;;;;;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2012;2012;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;NMBR;RACE;API;;;;
2012;2012;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;NMBR;RACE;AIAN;;;;
2012;2012;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.0;7;;;4.5;10.4;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2012;2012;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;;Number;57;57;;;;;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2012;2012;MT;Montana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;NMBR;GENDER;GENM;;;;
2012;2012;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;;Number;74;74;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;NMBR;RACE;WHT;;;;
2012;2012;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2012;2012;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.3;7.3;;;6;8.6;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2012;2012;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;123;123;;;;;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2012;2012;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2012;2012;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;;Number;21;21;;;;;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2012;2012;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2012;2012;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;NMBR;RACE;AIAN;;;;
2012;2012;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2012;2012;UT;Utah;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;NMBR;GENDER;GENM;;;;
2012;2012;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2012;2012;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.8;14.8;;;9;22.9;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2012;2012;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.3;9.3;;;7.5;11;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2012;2012;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;NMBR;RACE;HIS;;;;
2012;2012;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2012;2012;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2012;2012;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2012;2012;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;30.0;30;;;22.2;39.5;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2012;2012;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2012;2012;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;NMBR;RACE;HIS;;;;
2012;2012;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2012;2012;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;14.0;14;;;10.3;18.5;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2012;2012;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2012;2012;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.0;11;;;8.3;14.3;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2012;2012;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2012;2012;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.6;13.6;;;8.8;20.1;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2012;2012;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;;Number;21;21;;;;;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;NMBR;GENDER;GENM;;;;
2012;2012;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;;Number;40;40;;;;;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;NMBR;GENDER;GENM;;;;
2012;2012;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2012;2012;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;NMBR;RACE;API;;;;
2012;2012;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;15.2;15.2;;;12.1;18.8;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2012;2012;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2012;2012;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;CRDRATE;RACE;API;;;;
2012;2012;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2012;2012;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;NMBR;GENDER;GENF;;;;
2012;2012;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2012;2012;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2012;2012;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2012;2012;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;;Number;23;23;;;;;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;NMBR;GENDER;GENM;;;;
2012;2012;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.6;8.6;;;6.3;11.5;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2012;2012;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2012;2012;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;;Number;46;46;;;;;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;NMBR;GENDER;GENF;;;;
2012;2012;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2012;2012;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;NMBR;GENDER;GENF;;;;
2012;2012;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST4_1;NMBR;RACE;HIS;;;;
2012;2012;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2012;2012;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2012;2012;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;NMBR;GENDER;GENF;;;;
2012;2012;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2012;2012;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.5;10.5;;;8.3;13.2;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2012;2012;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.6;7.6;;;5.4;10.5;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2012;2012;UT;Utah;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;NMBR;RACE;BLK;;;;
2012;2012;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2012;2012;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.9;10.9;;;7.7;14.8;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2012;2012;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2012;2012;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.1;7.1;;;4.3;11.1;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2012;2012;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2012;2012;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;NMBR;RACE;AIAN;;;;
2012;2012;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2012;2012;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2012;2012;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.3;8.3;;;5.4;12.3;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2012;2012;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;;Number;35;35;;;;;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;NMBR;GENDER;GENF;;;;
2012;2012;UT;Utah;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;NMBR;RACE;API;;;;
2012;2012;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.9;10.9;;;8.2;14.2;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2012;2012;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2012;2012;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2012;2012;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;NMBR;RACE;AIAN;;;;
2012;2012;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.3;10.3;;;7.8;13.4;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2012;2012;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.5;9.5;;;6.5;13.3;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2012;2012;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2012;2012;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2012;2012;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;NMBR;RACE;BLK;;;;
2012;2012;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2012;2012;WA;Washington;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;NMBR;RACE;HIS;;;;
2012;2012;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;25.9;25.9;;;18.3;35.7;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2012;2012;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2012;2012;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;CRDRATE;RACE;API;;;;
2012;2012;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2012;2012;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;CRDRATE;RACE;API;;;;
2012;2012;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.6;10.6;;;6.8;15.7;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2012;2012;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.0;14;;;10.8;18;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2012;2012;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;28.8;28.8;;;19.9;40.2;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2012;2012;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2012;2012;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;NMBR;RACE;BLK;;;;
2012;2012;WA;Washington;NVSS;Asthma;Asthma mortality rate;;;Number;77;77;;;;;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2012;2012;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2012;2012;WA;Washington;NVSS;Asthma;Asthma mortality rate;;;Number;63;63;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;NMBR;RACE;WHT;;;;
2012;2012;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;CRDRATE;RACE;API;;;;
2012;2012;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2012;2012;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2012;2012;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;CRDRATE;RACE;API;;;;
2012;2012;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;44;44;;;;;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;NMBR;GENDER;GENF;;;;
2012;2012;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;15.5;15.5;;;11.7;20.2;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2012;2012;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.3;11.3;;;8.6;14.6;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2012;2012;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2012;2012;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2012;2012;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;NMBR;RACE;API;;;;
2012;2012;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2012;2012;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;NMBR;RACE;BLK;;;;
2012;2012;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.4;12.4;;;8;18.2;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2012;2012;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;29.0;29;;;17.5;45.4;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2012;2012;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;;Number;28;28;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;NMBR;RACE;BLK;;;;
2012;2012;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2012;2012;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2012;2012;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;;Number;145;145;;;;;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2012;2012;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2012;2012;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;NMBR;RACE;API;;;;
2012;2012;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;NMBR;RACE;BLK;;;;
2012;2012;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;;Number;21;21;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;NMBR;RACE;WHT;;;;
2012;2012;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.7;7.7;;;5.6;10.3;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2012;2012;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2012;2012;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;NMBR;RACE;WHT;;;;
2012;2012;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;CRDRATE;RACE;API;;;;
2012;2012;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.4;11.4;;;7.9;15.8;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2012;2012;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2012;2012;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.907192, -77.036871);;11;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2012;2012;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;NMBR;RACE;WHT;;;;
2012;2012;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;27.5;27.5;;;19.7;37.3;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2012;2012;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2012;2012;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2012;2012;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.7;7.7;;;5.1;11.2;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2012;2012;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.0;8;;;5.6;11.1;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2012;2012;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;;Number;25;25;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;NMBR;RACE;BLK;;;;
2012;2012;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2012;2012;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;NMBR;RACE;API;;;;
2012;2012;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.5;13.5;;;11.5;15.5;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2012;2012;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.2;10.2;;;6.9;14.5;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2012;2012;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;NMBR;RACE;AIAN;;;;
2012;2012;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2012;2012;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;CRDRATE;RACE;API;;;;
2012;2012;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;NMBR;RACE;API;;;;
2012;2012;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;NMBR;RACE;BLK;;;;
2012;2012;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.1;12.1;;;7.5;18.5;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2012;2012;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2012;2012;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.3;9.3;;;6.6;12.6;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2012;2012;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;;Number;20;20;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;NMBR;RACE;BLK;;;;
2012;2012;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;NMBR;RACE;API;;;;
2012;2012;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.0;11;;;6.9;16.4;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2012;2012;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2012;2012;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;;Number;80;80;;;;;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2012;2012;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2012;2012;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2012;2012;ME;Maine;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;NMBR;RACE;HIS;;;;
2012;2012;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;16.5;16.5;;;10.3;24.9;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2012;2012;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.4;9.4;;;6.7;13;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2012;2012;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2012;2012;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2012;2012;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;NMBR;RACE;HIS;;;;
2012;2012;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;NMBR;RACE;API;;;;
2012;2012;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2012;2012;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;;Number;27;27;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;NMBR;RACE;WHT;;;;
2012;2012;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2012;2012;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;NMBR;RACE;HIS;;;;
2012;2012;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;NMBR;RACE;API;;;;
2012;2012;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2012;2012;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;NMBR;GENDER;GENF;;;;
2012;2012;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;NMBR;RACE;HIS;;;;
2012;2012;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.4;9.4;;;6.2;13.7;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2012;2012;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2012;2012;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2012;2012;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2012;2012;UT;Utah;NVSS;Asthma;Asthma mortality rate;;;Number;28;28;;;;;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2012;2012;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;NMBR;RACE;BLK;;;;
2012;2012;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;CRDRATE;RACE;API;;;;
2012;2012;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;CRDRATE;RACE;API;;;;
2012;2012;NY;New York;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;NMBR;RACE;AIAN;;;;
2012;2012;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2012;2012;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;;Number;55;55;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;NMBR;RACE;WHT;;;;
2012;2012;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.1;10.1;;;8.7;11.6;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2012;2012;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2012;2012;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2012;2012;TX;Texas;NVSS;Asthma;Asthma mortality rate;;;Number;40;40;;;;;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;NMBR;RACE;HIS;;;;
2012;2012;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2012;2012;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2012;2012;MT;Montana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;NMBR;RACE;HIS;;;;
2012;2012;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2012;2012;UT;Utah;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;NMBR;GENDER;GENF;;;;
2012;2012;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2012;2012;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2012;2012;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;NMBR;RACE;HIS;;;;
2012;2012;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2012;2012;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.0;11;;;8.6;13.9;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2012;2012;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;;Number;146;146;;;;;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2012;2012;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;CRDRATE;RACE;API;;;;
2012;2012;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;;Number;28;28;;;;;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;NMBR;GENDER;GENM;;;;
2012;2012;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2012;2012;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2012;2012;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;34.5;34.5;;;27.8;41.2;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2012;2012;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2012;2012;UT;Utah;NVSS;Asthma;Asthma mortality rate;;;Number;27;27;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;NMBR;RACE;WHT;;;;
2012;2012;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2012;2012;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;NMBR;RACE;AIAN;;;;
2012;2012;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.7;9.7;;;5.8;15.1;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2012;2012;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;4.0;4;;;2.9;5.5;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2012;2012;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;;Number;47;47;;;;;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;NMBR;GENDER;GENM;;;;
2012;2012;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2012;2012;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;19.8;19.8;;;13;28.7;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2012;2012;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;NMBR;RACE;BLK;;;;
2012;2012;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2012;2012;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.5;7.5;;;5.1;10.7;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2012;2012;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;;Number;40;40;;;;;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;NMBR;GENDER;GENM;;;;
2012;2012;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;NMBR;GENDER;GENF;;;;
2012;2012;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;NMBR;RACE;API;;;;
2012;2012;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2012;2012;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;NMBR;RACE;BLK;;;;
2012;2012;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.4;12.4;;;9.5;15.9;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2012;2012;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;NMBR;RACE;API;;;;
2012;2012;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2012;2012;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2012;2012;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;NMBR;RACE;AIAN;;;;
2012;2012;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2012;2012;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2012;2012;TX;Texas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;NMBR;RACE;API;;;;
2012;2012;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;NMBR;RACE;API;;;;
2012;2012;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.8;9.8;;;8.8;10.8;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2012;2012;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2012;2012;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.2;8.2;;;5.1;12.6;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2012;2012;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2012;2012;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2012;2012;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2012;2012;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2012;2012;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2012;2012;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2012;2012;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2012;2012;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2012;2012;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.2;13.2;;;8.1;20.1;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2012;2012;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2012;2012;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.7;9.7;;;6.1;14.7;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2012;2012;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2012;2012;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2012;2012;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.3;8.3;;;6;11.1;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;CRDRATE;RACE;API;;;;
2012;2012;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;;Number;34;34;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;NMBR;RACE;BLK;;;;
2012;2012;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;NMBR;RACE;BLK;;;;
2012;2012;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2012;2012;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2012;2012;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2012;2012;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;29.6;29.6;;;20.5;41.4;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2012;2012;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.3;12.3;;;10.1;14.4;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2012;2012;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.1;14.1;;;10.2;19;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2012;2012;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;NMBR;GENDER;GENF;;;;
2012;2012;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;NMBR;RACE;WHT;;;;
2012;2012;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2012;2012;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;15.6;15.6;;;13.1;18;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2012;2012;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2012;2012;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2012;2012;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2012;2012;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.1;11.1;;;8.9;13.8;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2012;2012;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2012;2012;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2012;2012;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;NMBR;GENDER;GENM;;;;
2012;2012;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.2;7.2;;;4.4;11.2;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2012;2012;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2012;2012;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2012;2012;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2012;2012;ME;Maine;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;NMBR;GENDER;GENF;;;;
2012;2012;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2012;2012;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;6.5;6.5;;;5.2;8;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2012;2012;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2012;2012;US;United States;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.4;10.4;;;10.1;10.8;Overall;Overall;;;;;;;59;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2012;2012;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2012;2012;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.0;7;;;5.6;8.5;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2012;2012;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2012;2012;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.1;10.1;;;8.7;11.5;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2012;2012;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;NMBR;RACE;API;;;;
2012;2012;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2012;2012;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.0;8;;;5.8;10.9;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2012;2012;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;CRDRATE;RACE;API;;;;
2012;2012;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.4;9.4;;;6.6;12.9;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2012;2012;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;;Number;51;51;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;NMBR;RACE;WHT;;;;
2012;2012;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2012;2012;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2012;2012;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.6;11.6;;;9.1;14.6;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2012;2012;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2012;2012;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;NMBR;RACE;HIS;;;;
2012;2012;FL;Florida;NVSS;Asthma;Asthma mortality rate;;;Number;195;195;;;;;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2012;2012;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;25.1;25.1;;;15.9;37.6;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2012;2012;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;CRDRATE;RACE;API;;;;
2012;2012;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;NMBR;RACE;API;;;;
2012;2012;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2012;2012;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2012;2012;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.7;12.7;;;9.5;16.6;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2012;2012;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;15.5;15.5;;;12.5;19;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2012;2012;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2012;2012;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2012;2012;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;NMBR;GENDER;GENM;;;;
2012;2012;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2012;2012;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2012;2012;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2012;2012;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2012;2012;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.2;14.2;;;10.6;18.5;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2012;2012;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.7;9.7;;;6.9;13.3;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2012;2012;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;15.0;15;;;11.4;19.4;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2012;2012;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2012;2012;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;;Number;75;75;;;;;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2012;2012;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2012;2012;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2012;2012;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST4_1;NMBR;RACE;WHT;;;;
2012;2012;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;NMBR;RACE;API;;;;
2012;2012;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2012;2012;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;70;70;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;NMBR;RACE;WHT;;;;
2012;2012;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;CRDRATE;RACE;API;;;;
2012;2012;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.9;9.9;;;8;11.7;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2012;2012;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2012;2012;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2012;2012;TX;Texas;NVSS;Asthma;Asthma mortality rate;;;Number;109;109;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;NMBR;RACE;WHT;;;;
2012;2012;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2012;2012;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;NMBR;RACE;AIAN;;;;
2012;2012;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2012;2012;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.8;10.8;;;8.1;14.1;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2012;2012;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;40.7;40.7;;;32.1;50.9;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2012;2012;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;;Number;21;21;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;NMBR;RACE;WHT;;;;
2012;2012;UT;Utah;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;NMBR;RACE;HIS;;;;
2012;2012;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.0;12;;;8.4;16.7;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2012;2012;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2012;2012;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.7;7.7;;;4.9;11.5;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2012;2012;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2012;2012;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;;Number;20;20;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;NMBR;RACE;WHT;;;;
2012;2012;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2012;2012;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;15.5;15.5;;;10.7;21.6;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2012;2012;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.907192, -77.036871);;11;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2012;2012;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.6;9.6;;;7.8;11.5;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2012;2012;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;13.4;13.4;;;9.6;18.3;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2012;2012;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2012;2012;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.907192, -77.036871);;11;AST;AST4_1;CRDRATE;RACE;API;;;;
2012;2012;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;16.6;16.6;;;13.5;20.2;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2012;2012;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.4;9.4;;;7.6;11.5;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2012;2012;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;NMBR;GENDER;GENF;;;;
2012;2012;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2012;2012;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2012;2012;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2012;2012;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;;Number;58;58;;;;;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2012;2012;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.6;12.6;;;10.5;14.6;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2012;2012;WA;Washington;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;NMBR;RACE;BLK;;;;
2012;2012;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2012;2012;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;NMBR;GENDER;GENM;;;;
2012;2012;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;5.2;5.2;;;3.6;7.4;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2012;2012;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2012;2012;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2012;2012;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.9;14.9;;;11;19.7;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2012;2012;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2012;2012;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;CRDRATE;RACE;API;;;;
2012;2012;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2012;2012;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2012;2012;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;NMBR;RACE;BLK;;;;
2012;2012;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.6;11.6;;;9.1;14.6;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2012;2012;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2012;2012;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.7;8.7;;;6.6;11.3;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2012;2012;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;NMBR;RACE;BLK;;;;
2012;2012;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;17.6;17.6;;;13.2;23;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2012;2012;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2012;2012;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.9;11.9;;;9.3;15;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2012;2012;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;6.1;6.1;;;4.2;8.6;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2012;2012;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.2;13.2;;;9.1;18.4;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2012;2012;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;5.3;5.3;;;3.7;7.5;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2012;2012;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.7;8.7;;;6.5;11.5;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2012;2012;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2012;2012;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2012;2012;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.6;7.6;;;4.9;11.3;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2012;2012;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2012;2012;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2012;2012;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;18.8;18.8;;;14;24.7;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2012;2012;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;NMBR;GENDER;GENM;;;;
2012;2012;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2012;2012;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;6.9;6.9;;;4.4;10.3;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2012;2012;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2012;2012;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2012;2012;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2012;2012;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;;Number;75;75;;;;;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;NMBR;GENDER;GENM;;;;
2012;2012;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;NMBR;GENDER;GENM;;;;
2012;2012;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2012;2012;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.2;10.2;;;7.1;14.2;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2012;2012;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2012;2012;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2012;2012;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;34.3;34.3;;;27.6;41.1;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2012;2012;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2012;2012;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.9;13.9;;;10.7;17.8;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2012;2012;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST4_1;NMBR;GENDER;GENF;;;;
2012;2012;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.6;8.6;;;5.2;13.2;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2012;2012;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;15.3;15.3;;;11.5;20.1;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2012;2012;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.0;7;;;5.6;8.8;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2012;2012;FL;Florida;NVSS;Asthma;Asthma mortality rate;;;Number;31;31;;;;;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;NMBR;RACE;HIS;;;;
2012;2012;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;;Number;20;20;;;;;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2012;2012;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.6;11.6;;;9.4;13.9;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2012;2012;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;6.5;6.5;;;4.5;9.2;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2012;2012;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2012;2012;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2012;2012;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;NMBR;RACE;AIAN;;;;
2012;2012;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2012;2012;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;;Number;35;35;;;;;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;NMBR;GENDER;GENF;;;;
2012;2012;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2012;2012;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;NMBR;RACE;AIAN;;;;
2012;2012;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2012;2012;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;NMBR;RACE;API;;;;
2012;2012;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2012;2012;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2012;2012;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;16.9;16.9;;;11.7;23.4;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2012;2012;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2012;2012;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.6;9.6;;;8;11.2;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2012;2012;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2012;2012;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;NMBR;RACE;BLK;;;;
2012;2012;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2012;2012;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2012;2012;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;CRDRATE;RACE;API;;;;
2012;2012;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;NMBR;RACE;AIAN;;;;
2012;2012;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2012;2012;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.4;11.4;;;9.6;13.3;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2012;2012;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2012;2012;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2012;2012;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.7;12.7;;;10.2;15.1;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2012;2012;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.0;12;;;9.3;15.2;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2012;2012;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.9;7.9;;;6.8;9;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2012;2012;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;NMBR;RACE;HIS;;;;
2012;2012;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;13.7;13.7;;;8.4;21.2;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2012;2012;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;NMBR;RACE;BLK;;;;
2012;2012;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;NMBR;RACE;HIS;;;;
2012;2012;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;NMBR;RACE;API;;;;
2012;2012;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;13.2;13.2;;;8.2;20.2;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2012;2012;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2012;2012;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;;Number;174;174;;;;;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2012;2012;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2012;2012;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.0;14;;;9.2;20.5;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2012;2012;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2012;2012;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;;Number;72;72;;;;;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2012;2012;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;CRDRATE;RACE;API;;;;
2012;2012;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;;Number;104;104;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;NMBR;RACE;WHT;;;;
2012;2012;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;NMBR;RACE;HIS;;;;
2012;2012;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2012;2012;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.5;10.5;;;6.9;15.3;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2012;2012;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;;Number;41;41;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;NMBR;RACE;WHT;;;;
2012;2012;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;21.1;21.1;;;15.7;27.8;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2012;2012;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2012;2012;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.6;8.6;;;6.1;11.8;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2012;2012;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.7;13.7;;;10.7;17.4;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2012;2012;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2012;2012;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;NMBR;RACE;AIAN;;;;
2012;2012;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.9;8.9;;;5.4;13.7;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2012;2012;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;;Number;95;95;;;;;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;NMBR;GENDER;GENF;;;;
2012;2012;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;13.1;13.1;;;9.7;17.4;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2012;2012;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2012;2012;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;NMBR;RACE;API;;;;
2012;2012;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.5;10.5;;;8.4;12.6;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2012;2012;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;NMBR;RACE;HIS;;;;
2012;2012;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2012;2012;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2012;2012;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;;Number;22;22;;;;;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;NMBR;GENDER;GENF;;;;
2012;2012;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.3;11.3;;;8.1;15.3;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2012;2012;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;NMBR;RACE;AIAN;;;;
2012;2012;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2012;2012;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2012;2012;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2012;2012;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;;Number;37;37;;;;;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;NMBR;GENDER;GENF;;;;
2012;2012;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2012;2012;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;NMBR;GENDER;GENM;;;;
2012;2012;TX;Texas;NVSS;Asthma;Asthma mortality rate;;;Number;84;84;;;;;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;NMBR;GENDER;GENM;;;;
2012;2012;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;;Number;52;52;;;;;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;NMBR;GENDER;GENF;;;;
2012;2012;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;17.1;17.1;;;13.6;21.3;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2012;2012;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2012;2012;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;;Number;27;27;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;NMBR;RACE;BLK;;;;
2012;2012;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;CRDRATE;RACE;API;;;;
2012;2012;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.0;11;;;8.9;13.2;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2012;2012;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2012;2012;TX;Texas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;NMBR;RACE;AIAN;;;;
2012;2012;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.1;9.1;;;7.3;10.9;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2012;2012;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2012;2012;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2012;2012;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;;Number;51;51;;;;;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;NMBR;GENDER;GENF;;;;
2012;2012;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2012;2012;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;;Number;32;32;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;NMBR;RACE;WHT;;;;
2012;2012;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.1;11.1;;;6.8;17.1;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2012;2012;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2012;2012;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;;Number;49;49;;;;;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;NMBR;GENDER;GENF;;;;
2012;2012;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;24.6;24.6;;;18.2;32.5;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2012;2012;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.3;11.3;;;8.6;14.5;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2012;2012;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2012;2012;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;22.9;22.9;;;15;33.6;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2012;2012;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;NMBR;RACE;BLK;;;;
2012;2012;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2012;2012;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2012;2012;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2012;2012;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;NMBR;GENDER;GENF;;;;
2012;2012;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2012;2012;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;NMBR;RACE;API;;;;
2012;2012;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;CRDRATE;RACE;API;;;;
2012;2012;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.9;8.9;;;6;12.8;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2012;2012;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2012;2012;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2012;2012;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2012;2012;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;38;38;;;;;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;NMBR;GENDER;GENM;;;;
2012;2012;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2012;2012;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;;Number;24;24;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;NMBR;RACE;BLK;;;;
2012;2012;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;NMBR;RACE;HIS;;;;
2012;2012;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;NMBR;RACE;API;;;;
2012;2012;TX;Texas;NVSS;Asthma;Asthma mortality rate;;;Number;50;50;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;NMBR;RACE;BLK;;;;
2012;2012;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2012;2012;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;39;39;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;NMBR;RACE;BLK;;;;
2012;2012;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;4.1;4.1;;;3.1;5.2;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2012;2012;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2012;2012;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.6;11.6;;;9.2;14.5;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2012;2012;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2012;2012;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.8;11.8;;;8.8;15.5;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2012;2012;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.5;9.5;;;5.9;14.5;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2012;2012;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;15.1;15.1;;;12.3;18.4;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2012;2012;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;NMBR;RACE;API;;;;
2012;2012;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2012;2012;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;19.4;19.4;;;14.5;25.5;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2012;2012;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;CRDRATE;RACE;API;;;;
2012;2012;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2012;2012;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2012;2012;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2012;2012;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;NMBR;RACE;HIS;;;;
2012;2012;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2012;2012;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.1;13.1;;;9.7;17.4;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2012;2012;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;NMBR;RACE;API;;;;
2012;2012;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;NMBR;RACE;API;;;;
2012;2012;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2012;2012;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2012;2012;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2012;2012;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2012;2012;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;CRDRATE;RACE;API;;;;
2012;2012;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;NMBR;RACE;HIS;;;;
2012;2012;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;;Number;69;69;;;;;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;NMBR;GENDER;GENF;;;;
2012;2012;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2012;2012;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2012;2012;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2012;2012;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2012;2012;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.8;12.8;;;8.5;18.5;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2012;2012;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;NMBR;RACE;WHT;;;;
2012;2012;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.1;8.1;;;5.9;10.8;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2012;2012;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2012;2012;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2012;2012;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2012;2012;MT;Montana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;NMBR;RACE;API;;;;
2012;2012;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2012;2012;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2012;2012;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2012;2012;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;NMBR;RACE;API;;;;
2012;2012;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;NMBR;GENDER;GENM;;;;
2012;2012;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2012;2012;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2012;2012;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;16.1;16.1;;;11.9;21.2;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2012;2012;ME;Maine;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;NMBR;RACE;AIAN;;;;
2012;2012;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2012;2012;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.7;11.7;;;8.6;15.6;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2012;2012;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2012;2012;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;24.2;24.2;;;18.4;31.3;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2012;2012;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2012;2012;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;23.8;23.8;;;17.7;31.3;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2012;2012;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2012;2012;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.907192, -77.036871);;11;AST;AST4_1;NMBR;RACE;AIAN;;;;
2012;2012;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2012;2012;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.3;7.3;;;5.5;9.5;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2012;2012;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2012;2012;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;24.8;24.8;;;18.7;32.3;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2012;2012;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;;Number;37;37;;;;;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;NMBR;GENDER;GENM;;;;
2012;2012;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2012;2012;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;15.3;15.3;;;11.2;20.4;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2012;2012;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2012;2012;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2012;2012;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2012;2012;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;17.0;17;;;13.6;21;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2012;2012;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.2;9.2;;;6.6;12.6;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2012;2012;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2012;2012;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2012;2012;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.2;12.2;;;9.7;15.2;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2012;2012;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2012;2012;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;21.8;21.8;;;14.5;31.5;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2012;2012;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;NMBR;RACE;BLK;;;;
2012;2012;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2012;2012;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2012;2012;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;NMBR;RACE;HIS;;;;
2012;2012;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2012;2012;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2012;2012;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;;Number;93;93;;;;;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2012;2012;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;NMBR;GENDER;GENM;;;;
2012;2012;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2012;2012;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2012;2012;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.8;11.8;;;9;15.3;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2012;2012;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2012;2012;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2012;2012;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2012;2012;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;6.9;6.9;;;4.7;9.8;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2012;2012;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2012;2012;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;NMBR;RACE;API;;;;
2012;2012;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;NMBR;RACE;HIS;;;;
2012;2012;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2012;2012;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;NMBR;RACE;AIAN;;;;
2012;2012;ME;Maine;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;NMBR;GENDER;GENM;;;;
2012;2012;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;37;37;;;;;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;NMBR;GENDER;GENM;;;;
2012;2012;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;NMBR;RACE;AIAN;;;;
2012;2012;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;CRDRATE;RACE;API;;;;
2012;2012;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;16.1;16.1;;;11.3;22.2;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2012;2012;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2012;2012;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;NMBR;RACE;AIAN;;;;
2012;2012;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;;Number;40;40;;;;;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2012;2012;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.3;10.3;;;8;13;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2012;2012;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2012;2012;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.5;9.5;;;7.6;11.6;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2012;2012;NY;New York;NVSS;Asthma;Asthma mortality rate;;;Number;157;157;;;;;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;NMBR;GENDER;GENF;;;;
2012;2012;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2012;2012;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;;Number;56;56;;;;;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;NMBR;GENDER;GENF;;;;
2012;2012;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.4;8.4;;;7.3;9.6;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2012;2012;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;27.4;27.4;;;16.7;42.3;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2012;2012;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2012;2012;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;NMBR;RACE;BLK;;;;
2012;2012;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.2;14.2;;;8.9;21.5;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2012;2012;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.3;9.3;;;7.7;11;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2012;2012;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2012;2012;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;56;56;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;NMBR;RACE;WHT;;;;
2012;2012;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;;Number;35;35;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;NMBR;RACE;WHT;;;;
2012;2012;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.3;8.3;;;6.3;10.8;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2012;2012;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;13.7;13.7;;;9.1;20;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2012;2012;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;NMBR;GENDER;GENF;;;;
2012;2012;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.4;7.4;;;4.8;11;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2012;2012;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;NMBR;RACE;AIAN;;;;
2012;2012;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2012;2012;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;NMBR;RACE;AIAN;;;;
2012;2012;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;NMBR;RACE;WHT;;;;
2012;2012;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2012;2012;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;24.1;24.1;;;17.1;32.9;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2012;2012;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2012;2012;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.4;7.4;;;5;10.4;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2012;2012;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST4_1;NMBR;GENDER;GENM;;;;
2012;2012;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;NMBR;RACE;API;;;;
2012;2012;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;NMBR;RACE;BLK;;;;
2012;2012;FL;Florida;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;NMBR;RACE;API;;;;
2012;2012;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.4;13.4;;;11.1;15.7;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2012;2012;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.5;14.5;;;11.8;17.8;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2012;2012;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.8;8.8;;;5.3;13.8;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2012;2012;ME;Maine;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;NMBR;RACE;BLK;;;;
2012;2012;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2012;2012;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.2;11.2;;;8.8;14;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2012;2012;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;81;81;;;;;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2012;2012;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.3;14.3;;;9;21.7;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2012;2012;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;NMBR;RACE;API;;;;
2012;2012;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.6;13.6;;;10.8;17;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2012;2012;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;CRDRATE;RACE;API;;;;
2012;2012;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.7;7.7;;;6;9.8;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2012;2012;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;51;51;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;NMBR;RACE;BLK;;;;
2012;2012;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;5.5;5.5;;;3.4;8.4;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2012;2012;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2012;2012;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2012;2012;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;18.2;18.2;;;13.8;23.7;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2012;2012;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2012;2012;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;NMBR;RACE;AIAN;;;;
2012;2012;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;NMBR;RACE;API;;;;
2012;2012;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2012;2012;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;NMBR;RACE;HIS;;;;
2012;2012;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;NMBR;RACE;HIS;;;;
2012;2012;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.1;11.1;;;8.5;14.1;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2012;2012;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.4;13.4;;;10.5;16.9;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2012;2012;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;NMBR;RACE;AIAN;;;;
2012;2012;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2012;2012;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;;Number;21;21;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;NMBR;RACE;WHT;;;;
2012;2012;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2012;2012;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.5;9.5;;;6.5;13.5;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2012;2012;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2012;2012;FL;Florida;NVSS;Asthma;Asthma mortality rate;;;Number;74;74;;;;;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;NMBR;GENDER;GENM;;;;
2012;2012;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;NMBR;RACE;HIS;;;;
2012;2012;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.7;10.7;;;8.7;12.8;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2012;2012;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2012;2012;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2012;2012;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.3;9.3;;;7.7;11;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2012;2012;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;NMBR;RACE;HIS;;;;
2012;2012;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;CRDRATE;RACE;API;;;;
2012;2012;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2012;2012;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;16.4;16.4;;;12.2;21.6;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2012;2012;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2012;2012;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;NMBR;RACE;API;;;;
2012;2012;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;;Number;30;30;;;;;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2012;2012;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;CRDRATE;RACE;API;;;;
2012;2012;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2012;2012;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;NMBR;GENDER;GENM;;;;
2012;2012;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2012;2012;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;CRDRATE;RACE;API;;;;
2012;2012;US;United States;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.2;11.2;;;10.9;11.6;Overall;Overall;;;;;;;59;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2012;2012;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;16.2;16.2;;;12.8;20.2;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2012;2012;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;14.8;14.8;;;10.9;19.6;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2012;2012;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.1;9.1;;;7;11.6;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2012;2012;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;;Number;91;91;;;;;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2012;2012;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2012;2012;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;;Number;53;53;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;NMBR;RACE;WHT;;;;
2012;2012;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.1;9.1;;;6;13.4;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2012;2012;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2012;2012;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2012;2012;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.1;10.1;;;9.1;11.1;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2012;2012;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2012;2012;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;21.7;21.7;;;13.8;32.6;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2012;2012;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;NMBR;RACE;WHT;;;;
2012;2012;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2012;2012;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2012;2012;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2012;2012;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;CRDRATE;RACE;API;;;;
2012;2012;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.8;7.8;;;5.5;10.8;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2012;2012;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;NMBR;RACE;AIAN;;;;
2012;2012;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;;Number;56;56;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;NMBR;RACE;BLK;;;;
2012;2012;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;NMBR;RACE;HIS;;;;
2012;2012;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;;Number;41;41;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;NMBR;RACE;BLK;;;;
2012;2012;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;13.0;13;;;10.5;15.9;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2012;2012;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;CRDRATE;RACE;API;;;;
2012;2012;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;NMBR;RACE;AIAN;;;;
2012;2012;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;NMBR;RACE;WHT;;;;
2012;2012;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;;Number;44;44;;;;;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;NMBR;GENDER;GENF;;;;
2012;2012;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2012;2012;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2012;2012;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;NMBR;RACE;API;;;;
2012;2012;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;CRDRATE;RACE;API;;;;
2012;2012;WA;Washington;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;NMBR;RACE;API;;;;
2012;2012;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;;Number;22;22;;;;;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;NMBR;GENDER;GENF;;;;
2012;2012;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;CRDRATE;RACE;API;;;;
2012;2012;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2012;2012;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2012;2012;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2012;2012;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;NMBR;GENDER;GENM;;;;
2012;2012;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2012;2012;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;;Number;20;20;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;NMBR;RACE;BLK;;;;
2012;2012;MT;Montana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;NMBR;RACE;AIAN;;;;
2012;2012;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2012;2012;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;NMBR;RACE;HIS;;;;
2012;2012;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;NMBR;RACE;AIAN;;;;
2012;2012;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2012;2012;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2012;2012;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2012;2012;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;;Number;107;107;;;;;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2012;2012;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;NMBR;GENDER;GENM;;;;
2012;2012;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.0;8;;;5.7;11;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2012;2012;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.0;8;;;6.3;10;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2012;2012;CA;California;NVSS;Asthma;Asthma mortality rate;;;Number;45;45;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;NMBR;RACE;API;;;;
2012;2012;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;CRDRATE;RACE;API;;;;
2012;2012;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;NMBR;RACE;AIAN;;;;
2012;2012;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2012;2012;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2012;2012;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2012;2012;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.2;9.2;;;6.4;13;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2012;2012;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2012;2012;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2012;2012;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;14.6;14.6;;;10.6;19.6;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2012;2012;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;14.9;14.9;;;11.5;18.9;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2012;2012;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2012;2012;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2012;2012;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2012;2012;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2012;2012;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;16.3;16.3;;;12.7;20.7;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2012;2012;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2012;2012;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;NMBR;RACE;HIS;;;;
2012;2012;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;18.6;18.6;;;12.2;27;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2012;2012;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;CRDRATE;RACE;API;;;;
2012;2012;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2012;2012;NY;New York;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;NMBR;RACE;API;;;;
2012;2012;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;;Number;26;26;;;;;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;NMBR;GENDER;GENM;;;;
2012;2012;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;NMBR;GENDER;GENM;;;;
2012;2012;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2012;2012;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;107;107;;;;;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2012;2012;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;NMBR;GENDER;GENM;;;;
2012;2012;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;;Number;57;57;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;NMBR;RACE;WHT;;;;
2012;2012;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.6;10.6;;;8;13.8;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2012;2012;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;NMBR;RACE;HIS;;;;
2012;2012;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2012;2012;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;NMBR;RACE;AIAN;;;;
2012;2012;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.6;8.6;;;5.6;12.8;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2012;2012;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;;Number;31;31;;;;;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;NMBR;GENDER;GENM;;;;
2012;2012;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2012;2012;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.0;11;;;6.7;17;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2012;2012;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;NMBR;GENDER;GENM;;;;
2012;2012;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2012;2012;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;NMBR;RACE;AIAN;;;;
2012;2012;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;18.0;18;;;13.5;23.7;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2012;2012;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.6;9.6;;;7.8;11.4;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2012;2012;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.1;13.1;;;10.6;15.5;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2012;2012;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2012;2012;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;16.1;16.1;;;11.1;22.6;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2012;2012;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.7;12.7;;;9.2;17.1;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2012;2012;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2012;2012;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2012;2012;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2012;2012;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.6;12.6;;;10.5;14.6;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2012;2012;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2012;2012;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;NMBR;GENDER;GENF;;;;
2012;2012;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;;Number;56;56;;;;;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2012;2012;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2012;2012;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.3;10.3;;;7.7;13.4;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2012;2012;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2012;2012;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;NMBR;RACE;API;;;;
2012;2012;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;14.9;14.9;;;11.9;18.3;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2012;2012;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;NMBR;GENDER;GENF;;;;
2012;2012;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2012;2012;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.6;7.6;;;6.2;9.1;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2012;2012;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2012;2012;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;NMBR;RACE;AIAN;;;;
2012;2012;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;;Number;37;37;;;;;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;NMBR;GENDER;GENF;;;;
2012;2012;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;NMBR;RACE;BLK;;;;
2012;2012;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2012;2012;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2012;2012;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.7;8.7;;;7.4;9.9;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2012;2012;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;NMBR;RACE;AIAN;;;;
2012;2012;CA;California;NVSS;Asthma;Asthma mortality rate;;;Number;132;132;;;;;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;NMBR;GENDER;GENM;;;;
2012;2012;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;NMBR;RACE;WHT;;;;
2012;2012;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.3;9.3;;;5.8;14.3;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2012;2012;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;;Number;26;26;;;;;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2012;2012;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;CRDRATE;RACE;API;;;;
2012;2012;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2012;2012;FL;Florida;NVSS;Asthma;Asthma mortality rate;;;Number;121;121;;;;;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;NMBR;GENDER;GENF;;;;
2012;2012;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;19.7;19.7;;;13.1;28.5;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2012;2012;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;CRDRATE;RACE;API;;;;
2012;2012;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.6;9.6;;;7.8;11.4;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2012;2012;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.7;11.7;;;7.7;17;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2012;2012;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2012;2012;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;NMBR;GENDER;GENM;;;;
2012;2012;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.4;7.4;;;6;8.8;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2012;2012;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;28.7;28.7;;;20.5;39.1;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2012;2012;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2012;2012;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;NMBR;RACE;API;;;;
2012;2012;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;6.0;6;;;3.6;9.4;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2012;2012;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;NMBR;RACE;API;;;;
2012;2012;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2012;2012;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2012;2012;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST4_1;NMBR;RACE;BLK;;;;
2012;2012;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2012;2012;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;NMBR;RACE;HIS;;;;
2012;2012;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2012;2012;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2012;2012;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;NMBR;RACE;BLK;;;;
2012;2012;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;;Number;21;21;;;;;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;NMBR;GENDER;GENM;;;;
2012;2012;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;NMBR;RACE;AIAN;;;;
2012;2012;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;NMBR;RACE;WHT;;;;
2012;2012;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;NMBR;RACE;HIS;;;;
2012;2012;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2012;2012;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2012;2012;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;NMBR;RACE;AIAN;;;;
2012;2012;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;15.2;15.2;;;10.9;20.6;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2012;2012;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;;Number;21;21;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;NMBR;RACE;WHT;;;;
2012;2012;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2012;2012;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.8;7.8;;;6.2;9.8;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2012;2012;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2012;2012;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;;Number;23;23;;;;;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;NMBR;GENDER;GENM;;;;
2012;2012;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2012;2012;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2012;2012;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;NMBR;RACE;HIS;;;;
2012;2012;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2012;2012;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;CRDRATE;RACE;API;;;;
2012;2012;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;NMBR;RACE;AIAN;;;;
2012;2012;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2012;2012;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.0;9;;;5.9;13.2;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2012;2012;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;NMBR;RACE;BLK;;;;
2012;2012;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2012;2012;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;CRDRATE;RACE;API;;;;
2012;2012;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.8;12.8;;;10.6;15.1;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2012;2012;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;NMBR;RACE;AIAN;;;;
2012;2012;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2012;2012;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;NMBR;RACE;AIAN;;;;
2012;2012;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2012;2012;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.7;10.7;;;6.5;16.8;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2012;2012;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2012;2012;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;NMBR;RACE;AIAN;;;;
2012;2012;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;;Number;34;34;;;;;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;NMBR;GENDER;GENF;;;;
2012;2012;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2012;2012;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2012;2012;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;NMBR;RACE;WHT;;;;
2012;2012;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2012;2012;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.1;10.1;;;8.1;12.5;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2012;2012;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2012;2012;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2012;2012;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2012;2012;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;NMBR;RACE;BLK;;;;
2012;2012;FL;Florida;NVSS;Asthma;Asthma mortality rate;;;Number;54;54;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;NMBR;RACE;BLK;;;;
2012;2012;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;CRDRATE;RACE;API;;;;
2012;2012;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2012;2012;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2012;2012;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2012;2012;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2012;2012;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2012;2012;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2012;2012;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;NMBR;RACE;HIS;;;;
2012;2012;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2012;2012;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;13.3;13.3;;;10.7;16.4;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2012;2012;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2012;2012;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2012;2012;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;NMBR;GENDER;GENM;;;;
2012;2012;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;CRDRATE;RACE;API;;;;
2012;2012;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;22.5;22.5;;;14.6;33.2;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2012;2012;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2012;2012;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2012;2012;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;CRDRATE;RACE;API;;;;
2012;2012;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2012;2012;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;68;68;;;;;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;NMBR;GENDER;GENF;;;;
2012;2012;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;CRDRATE;RACE;API;;;;
2012;2012;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2012;2012;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2012;2012;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;CRDRATE;RACE;API;;;;
2012;2012;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2012;2012;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;NMBR;RACE;API;;;;
2012;2012;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.2;13.2;;;11.6;14.8;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2012;2012;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;NMBR;RACE;HIS;;;;
2012;2012;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2012;2012;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2012;2012;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;14.0;14;;;10;19.1;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2012;2012;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2012;2012;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;14.6;14.6;;;8.8;22.9;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2012;2012;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;;Number;72;72;;;;;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2012;2012;FL;Florida;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;NMBR;RACE;AIAN;;;;
2012;2012;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;16.8;16.8;;;12.5;22.1;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2012;2012;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.9;11.9;;;9.3;14.9;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2012;2012;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;43;43;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;NMBR;RACE;WHT;;;;
2012;2012;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;NMBR;RACE;AIAN;;;;
2012;2012;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2012;2012;WA;Washington;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;NMBR;RACE;AIAN;;;;
2012;2012;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2012;2012;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.6;12.6;;;10.4;14.8;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2012;2012;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;CRDRATE;RACE;API;;;;
2012;2012;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;NMBR;RACE;WHT;;;;
2012;2012;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2012;2012;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.5;10.5;;;7.9;13.6;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2012;2012;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2012;2012;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2012;2012;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;;Number;34;34;;;;;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;NMBR;GENDER;GENF;;;;
2012;2012;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;NMBR;RACE;HIS;;;;
2012;2012;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.907192, -77.036871);;11;AST;AST4_1;NMBR;RACE;API;;;;
2012;2012;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;NMBR;GENDER;GENF;;;;
2012;2012;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;;Number;55;55;;;;;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2012;2012;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;NMBR;RACE;HIS;;;;
2012;2012;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2012;2012;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2012;2012;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.0;9;;;6.8;11.6;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2012;2012;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;;Number;78;78;;;;;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2012;2012;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.8;9.8;;;6.5;14.2;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2012;2012;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;NMBR;RACE;BLK;;;;
2012;2012;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2012;2012;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2012;2012;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2012;2012;WA;Washington;NVSS;Asthma;Asthma mortality rate;;;Number;53;53;;;;;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;NMBR;GENDER;GENF;;;;
2012;2012;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2012;2012;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;18.2;18.2;;;12.7;25.3;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2012;2012;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2012;2012;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2012;2012;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2012;2012;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;;Number;77;77;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;NMBR;RACE;BLK;;;;
2012;2012;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;;Number;48;48;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;NMBR;RACE;WHT;;;;
2012;2012;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;42.7;42.7;;;33.6;53.6;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2012;2012;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2012;2012;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.0;12;;;9.9;14.2;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2012;2012;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2012;2012;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.2;8.2;;;6.1;10.8;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2012;2012;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2012;2012;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2012;2012;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2012;2012;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2012;2012;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;;Number;35;35;;;;;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2012;2012;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2012;2012;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.9;12.9;;;8.5;18.8;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2012;2012;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;NMBR;RACE;AIAN;;;;
2012;2012;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2012;2012;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2012;2012;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2012;2012;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.4;9.4;;;7.1;12.1;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2012;2012;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;27.1;27.1;;;19;37.5;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2012;2012;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2012;2012;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;NMBR;RACE;HIS;;;;
2012;2012;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.7;7.7;;;5.4;10.6;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2012;2012;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;NMBR;GENDER;GENF;;;;
2012;2012;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.0;14;;;10;19.1;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2012;2012;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2012;2012;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.8;10.8;;;8.8;12.9;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2012;2012;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;NMBR;RACE;HIS;;;;
2012;2012;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.0;7;;;5.8;8.2;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2012;2012;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2012;2012;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2012;2012;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.7;12.7;;;10.7;14.6;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2012;2012;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2012;2012;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;CRDRATE;RACE;API;;;;
2012;2012;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2012;2012;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;NMBR;RACE;AIAN;;;;
2012;2012;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.7;8.7;;;6.2;11.8;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2012;2012;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;CRDRATE;RACE;API;;;;
2012;2012;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2012;2012;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2012;2012;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2012;2012;ME;Maine;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2012;2012;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;;Number;83;83;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;NMBR;RACE;WHT;;;;
2012;2012;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;NMBR;GENDER;GENM;;;;
2012;2012;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2012;2012;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;13.0;13;;;11.5;14.6;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2012;2012;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2012;2012;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;NMBR;RACE;HIS;;;;
2012;2012;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;19.6;19.6;;;12.8;28.8;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2012;2012;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2012;2012;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2012;2012;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.6;10.6;;;8;13.8;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2012;2012;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2012;2012;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2012;2012;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2012;2012;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;29.1;29.1;;;20.1;40.9;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2011;2011;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;4.8;4.8;;;3.7;6.1;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2011;2011;MT;Montana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;NMBR;RACE;HIS;;;;
2011;2011;UT;Utah;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;NMBR;RACE;HIS;;;;
2011;2011;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;5.8;5.8;;;4.4;7.6;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2011;2011;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;NMBR;GENDER;GENF;;;;
2011;2011;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.2;13.2;;;11.6;14.8;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2011;2011;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;6.7;6.7;;;5.6;7.8;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2011;2011;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;NMBR;GENDER;GENM;;;;
2011;2011;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;NMBR;GENDER;GENF;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2011;2011;CA;California;NVSS;Asthma;Asthma mortality rate;;;Number;69;69;;;;;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;NMBR;RACE;HIS;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;92.6;92.6;;;86.4;96.1;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.2;91.2;;;81.2;96.1;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2011;2011;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;NMBR;RACE;AIAN;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.9;84.9;;;75.7;91;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.6;82.6;;;74.4;88.5;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.6;43.6;;;36.4;51.2;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2011;2011;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;NMBR;RACE;AIAN;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.5;44.5;;;38.1;51.2;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.5;33.5;;;23.5;45.3;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;NMBR;RACE;BLK;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.2;13.2;;;7.5;22.4;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.4;13.4;;;11.5;15.6;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.1;72.1;;;62.8;79.8;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.8;46.8;;;40.2;53.5;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.4;8.4;;;6.2;11;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2011;2011;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.5;7.5;;;6.8;8.2;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;;Number;43;43;;;;;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;NMBR;GENDER;GENM;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.2;91.2;;;85.9;94.7;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.4;12.4;;;9.1;16.6;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.4;84.4;;;66.5;93.7;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;31.2;31.2;;;22.9;40.9;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.2;42.2;;;34.1;50.7;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.3;64.3;;;49.9;76.5;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;74.9;74.9;;;62.9;84;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;18.1;18.1;;;9.9;30.9;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.5;11.5;;;9;14.5;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;77.8;77.8;;;62.3;88.2;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;NMBR;RACE;BLK;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.1;10.1;;;5.6;17.5;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2011;2011;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;17.4;17.4;;;10.9;26.6;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.3;41.3;;;34.9;47.9;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.2;7.2;;;5.9;8.8;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;NMBR;RACE;HIS;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.8;40.8;;;31.6;50.8;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.4;41.4;;;23.5;61.8;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;8.6;8.6;;;7.2;10.3;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.4;10.4;;;9.4;11.5;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;NMBR;RACE;API;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.9;88.9;;;84.6;92.1;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.2;46.2;;;36.6;56.1;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.6;41.6;;;25.8;59.4;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;NMBR;RACE;API;;;;
2011;2011;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.7;40.7;;;26.3;56.9;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.9;7.9;;;7;8.9;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.7;11.7;;;7;18.8;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.4;9.4;;;5.7;14.9;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2011;2011;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.0;8;;;5.8;10.7;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.6;42.6;;;35.9;49.6;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;;Number;176;176;;;;;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;28.5;28.5;;;22.7;35.1;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.9;13.9;;;11.7;16.4;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.3;30.3;;;23.6;38.1;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.8;7.8;;;4.9;11.7;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;74.4;74.4;;;64.8;82.1;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.3;43.3;;;36.5;50.4;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.0;9;;;7.1;11.2;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.9;83.9;;;76.6;89.3;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.1;39.1;;;34.1;44.4;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;79.4;79.4;;;66.9;88;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.7;40.7;;;35.9;45.6;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;47.4;47.4;;;38.5;56.5;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;76.9;76.9;;;64.8;85.8;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.0;7;;;6.1;8.1;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.9;45.9;;;38.7;53.4;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.7;37.7;;;27.8;48.8;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.3;12.3;;;10.7;14.1;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2011;2011;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.3;10.3;;;7.1;14.3;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;54.6;54.6;;;41.8;66.9;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.4;37.4;;;26.8;49.2;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2011;2011;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.4;66.4;;;49;80.3;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;17.0;17;;;10.1;26.9;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;32.4;32.4;;;24.8;41;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;19.4;19.4;;;11.9;30;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.907192, -77.036871);;11;AST;AST4_1;NMBR;RACE;API;;;;
2011;2011;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.0;7;;;5.6;8.8;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.9;9.9;;;7.5;13;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.5;13.5;;;7.5;22.9;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.1;6.1;;;4.8;7.9;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.6;11.6;;;10.5;12.9;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2011;2011;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.1;6.1;;;5.4;6.9;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.2;70.2;;;52.3;83.5;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.8;89.8;;;82.7;94.2;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2011;2011;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.5;72.5;;;62.9;80.3;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2011;2011;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.4;39.4;;;33.7;45.4;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.9;12.9;;;11.6;14.3;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2011;2011;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;NMBR;GENDER;GENF;;;;
2011;2011;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2011;2011;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2011;2011;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.2;39.2;;;28.5;51.1;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;16.5;16.5;;;10.4;25.3;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.8;9.8;;;8.6;11.1;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.5;8.5;;;7;10.1;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.8;12.8;;;11.4;14.4;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2011;2011;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.1;8.1;;;5.7;11.1;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2011;2011;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2011;2011;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;NMBR;RACE;BLK;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.5;37.5;;;31.9;43.4;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2011;2011;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;NMBR;GENDER;GENF;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;79.8;79.8;;;70.7;86.6;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;15.0;15;;;9;24;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;76.0;76;;;64.6;84.6;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.6;89.6;;;84;93.4;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.0;43;;;37.1;49.2;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;4.0;4;;;2.7;5.9;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2011;2011;ME;Maine;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;NMBR;GENDER;GENM;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.1;6.1;;;3.8;9.7;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.9;41.9;;;34;50.2;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.2;44.2;;;38.3;50.4;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.1;86.1;;;73.7;93.2;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.1;10.1;;;9.2;11.1;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.7;42.7;;;30.6;55.7;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.1;64.1;;;49;76.9;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.3;45.3;;;26.7;65.4;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;26.3;26.3;;;18.7;36;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2011;2011;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;CRDRATE;RACE;API;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.2;48.2;;;41.4;55.1;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.5;88.5;;;81.6;93;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90.8;90.8;;;85;94.6;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;NMBR;RACE;HIS;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.7;44.7;;;32.9;57.1;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.6;44.6;;;36.7;52.9;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.4;84.4;;;72.3;91.8;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;93.7;93.7;;;87.7;96.9;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2011;2011;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;NMBR;RACE;BLK;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.8;34.8;;;25.8;44.9;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.6;40.6;;;32.8;48.8;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;57.6;57.6;;;45.6;68.8;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.4;41.4;;;34.9;48.2;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.5;37.5;;;31;44.5;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.8;82.8;;;65.4;92.4;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.2;38.2;;;30.2;47;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.3;36.3;;;30.7;42.3;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.5;65.5;;;55;74.6;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.1;42.1;;;33.8;50.9;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;NMBR;RACE;HIS;;;;
2011;2011;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;;Number;33;33;;;;;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.5;63.5;;;51.2;74.2;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.2;11.2;;;10;12.5;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.6;9.6;;;5.8;14.9;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.0;38;;;28.9;48.1;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.5;13.5;;;9.8;18.2;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;56.9;56.9;;;46;67.1;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;20.6;20.6;;;11.3;34.5;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.9;8.9;;;7.4;10.7;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;74.5;74.5;;;69.8;78.8;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;NMBR;RACE;AIAN;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.0;8;;;6.9;9.2;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.2;72.2;;;63.8;79.2;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2011;2011;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2011;2011;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.4;7.4;;;6.1;9;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.9;89.9;;;79.9;95.3;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.0;89;;;80.2;94.2;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;21.8;21.8;;;11.7;37.1;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.4;12.4;;;7.8;19.2;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.6;9.6;;;7;13.1;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.8;41.8;;;31.9;52.3;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.7;38.7;;;29.4;48.9;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;US;United States;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.7;6.7;*;50 States + DC: US Median;6.3;7;Gender;Male;;;;;;;59;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.5;12.5;;;9.6;15.9;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.2;14.2;;;10.5;18.8;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.8;40.8;;;30.8;51.5;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;80.1;80.1;;;70.9;87;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.6;11.6;;;10.4;13;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.4;9.4;;;8.6;10.4;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;80.3;80.3;;;68.7;88.3;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2011;2011;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.6;7.6;;;5.5;10.3;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.9;6.9;;;5.9;8;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2011;2011;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.5;9.5;;;7.7;11.7;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.4;7.4;;;6.8;8.2;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;NMBR;RACE;API;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.4;46.4;;;35.1;58.2;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;91.0;91;;;84.2;95;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.9;36.9;;;27.6;47.3;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.1;40.1;;;33.4;47.2;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.7;9.7;;;8.6;10.9;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.0;11;;;9.3;12.8;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2011;2011;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.0;87;*;50 States + DC: US Median;84.4;89.5;Gender;Female;;;;;;;59;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.1;40.1;;;36;44.3;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.2;32.2;;;18.3;50.1;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.0;85;;;70.9;92.9;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.5;38.5;;;32.4;44.9;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;NMBR;RACE;API;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2011;2011;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.0;10;;;9.1;10.9;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.1;47.1;;;34.1;60.6;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.2;83.2;;;75.2;89;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;;Number;27;27;;;;;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;NMBR;GENDER;GENM;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;59.6;59.6;;;45.2;72.5;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.7;36.7;;;30.4;43.5;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2011;2011;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2011;2011;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.8;38.8;;;33.3;44.7;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.8;8.8;;;8.1;9.5;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;74.1;74.1;;;60.1;84.5;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2011;2011;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.6;32.6;;;27;38.7;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.5;11.5;;;7;17.8;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.9;6.9;;;6.1;7.8;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.6;39.6;;;24.5;57.1;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2011;2011;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2011;2011;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;NMBR;RACE;AIAN;;;;
2011;2011;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;NMBR;RACE;API;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;58.7;58.7;;;50.1;66.9;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2011;2011;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.9;37.9;*;50 States + DC: US Median;34.3;40.2;Gender;Male;;;;;;;59;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;27.6;27.6;;;21.7;34.6;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.8;9.8;;;7.7;12.4;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;64;64;;;;;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;NMBR;GENDER;GENF;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.4;71.4;;;56.3;82.9;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;NMBR;RACE;AIAN;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.8;37.8;;;29.2;47.3;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.5;5.5;;;3.4;8.6;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.5;10.5;;;7.8;14;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2011;2011;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.4;8.4;;;6;11.4;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.8;90.8;;;84;94.9;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.1;13.1;;;8.6;19.6;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;ME;Maine;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;NMBR;RACE;BLK;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.5;43.5;;;38.1;49;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.2;46.2;;;38.3;54.3;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.4;7.4;;;6.8;7.9;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;91.3;91.3;;;85.8;94.8;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.2;39.2;;;25.3;55.1;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2011;2011;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;21.5;21.5;;;17.3;26.5;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.8;40.8;;;35.3;46.6;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.7;42.7;;;39.1;46.5;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.6;35.6;;;30.7;40.7;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;75.8;75.8;;;63.7;84.9;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2011;2011;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29.6;29.6;;;20.4;40.8;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;CRDRATE;RACE;API;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.2;9.2;;;7.9;10.6;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2011;2011;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.3;12.3;;;10.1;14.5;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2011;2011;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;;Number;51;51;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;NMBR;RACE;WHT;;;;
2011;2011;TX;Texas;NVSS;Asthma;Asthma mortality rate;;;Number;119;119;;;;;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;NMBR;GENDER;GENF;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.9;63.9;;;56.2;71;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;4.1;4.1;;;2.9;5.7;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2011;2011;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.1;7.1;;;4.9;10.1;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;72.5;72.5;;;61.2;81.5;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.8;86.8;;;80.5;91.3;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2011;2011;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;6.0;6;;;4.7;7.5;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.6;43.6;;;36.2;51.3;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.1;10.1;;;8.1;12.5;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.8;5.8;;;3.8;8.7;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.5;36.5;;;29.5;44.1;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90.6;90.6;;;85;94.3;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2011;2011;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;NMBR;RACE;WHT;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.4;47.4;;;39.5;55.5;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;15.4;15.4;;;12.5;18.8;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.1;82.1;;;75.7;87.1;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.9;85.9;;;79;90.8;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.1;11.1;;;7.1;17.1;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.8;38.8;;;31.5;46.6;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;27.6;27.6;;;17.9;40.1;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.5;6.5;;;5.5;7.8;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.2;9.2;;;7.5;10.9;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.3;69.3;;;58.1;78.6;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.2;5.2;;;3.5;7.8;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.1;88.1;;;83.3;91.6;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.4;84.4;;;66.4;93.7;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2011;2011;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2011;2011;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;;Number;24;24;;;;;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.3;7.3;;;4.6;11.4;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;80.8;80.8;;;68.9;88.9;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;74.6;74.6;;;65.4;82.1;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2011;2011;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.4;37.4;;;26.7;49.6;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.0;38;;;28.5;48.7;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.5;9.5;;;7.6;12;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;25.7;25.7;;;16.1;38.3;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.9;6.9;;;3.9;11.8;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;24.3;24.3;;;17.4;32.8;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.6;11.6;;;10.3;13;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.0;88;;;80.9;92.7;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;NMBR;RACE;HIS;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2011;2011;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.1;10.1;;;7.7;13;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.8;31.8;;;26.2;38;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;MT;Montana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;NMBR;RACE;BLK;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.0;13;;;10.3;16.4;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;26.3;26.3;;;17.9;37.4;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2011;2011;ME;Maine;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;NMBR;RACE;WHT;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.5;7.5;;;6;9.3;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.5;9.5;;;8.5;10.7;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.7;28.7;;;17.6;43;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;CRDRATE;RACE;API;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2011;2011;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.1;9.1;;;7.6;10.7;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2011;2011;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.7;10.7;;;9.8;11.5;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.6;89.6;;;82.1;94.2;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;NMBR;RACE;BLK;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.0;34;;;28.2;40.2;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.4;9.4;;;7.5;11.7;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.2;30.2;;;24.3;36.7;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.6;82.6;;;65.6;92.2;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.3;63.3;;;50.1;74.8;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2011;2011;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2011;2011;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;CRDRATE;RACE;API;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;78.6;78.6;;;70.4;85;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.0;39;;;33.5;44.7;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;27.0;27;;;16.3;41.3;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.2;8.2;;;5.8;11.4;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2011;2011;CA;California;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.7;10.7;;;9.4;12.2;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;NMBR;RACE;API;;;;
2011;2011;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;42.5;42.5;;;33.3;53.3;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;51.9;51.9;;;36.5;67;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2011;2011;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;NMBR;GENDER;GENM;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;6.4;6.4;;;4.4;9.2;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2011;2011;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;CRDRATE;RACE;API;;;;
2011;2011;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2011;2011;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;NMBR;RACE;API;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.0;36;;;31;41.3;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;51.5;51.5;;;42.7;60.2;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;64.5;64.5;;;51.4;75.7;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;NMBR;RACE;API;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.5;47.5;;;40.7;54.4;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;26.0;26;;;18;36;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;73.6;73.6;;;58.9;84.4;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.5;13.5;;;12.2;15;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2011;2011;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.9;67.9;;;62;73.3;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;;Number;43;43;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;NMBR;RACE;WHT;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.6;37.6;;;24.1;53.3;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.1;12.1;;;8.8;16.5;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;51.1;51.1;;;44.1;58.1;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2011;2011;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;CA;California;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;5.3;5.3;;;4.4;6.5;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2011;2011;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.8;11.8;;;8.6;15.8;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2011;2011;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.6;37.6;;;33.5;41.8;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.2;9.2;;;7.3;11.5;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2011;2011;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.8;8.8;;;5.7;13;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.5;13.5;;;9.6;18.6;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.5;7.5;;;5.1;10.9;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2011;2011;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;NMBR;RACE;API;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;;Number;35;35;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;NMBR;RACE;WHT;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.9;6.9;;;6.4;7.6;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2011;2011;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;NMBR;GENDER;GENM;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.2;11.2;;;8.7;14.2;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.8;85.8;;;79.7;90.3;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.7;38.7;;;32.4;45.4;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2011;2011;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.1;14.1;;;11.7;16.4;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;7.3;7.3;;;5.1;10.3;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;26.5;26.5;;;15.8;40.9;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.0;12;;;11.3;12.9;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.9;86.9;;;76.2;93.2;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;NMBR;GENDER;GENM;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.8;11.8;;;8.1;16.9;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.1;9.1;;;8.1;10.3;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;NMBR;RACE;HIS;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.1;8.1;;;7.2;9.2;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.2;40.2;;;34.5;46.1;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;57.7;57.7;;;44.1;70.2;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.7;40.7;;;34.7;46.9;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.2;11.2;;;9.2;13.4;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;80.5;80.5;;;67.7;89.1;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2011;2011;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;16.6;16.6;;;10.1;25.6;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2011;2011;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;NMBR;RACE;WHT;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.3;89.3;;;85.1;92.4;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.8;71.8;;;57.6;82.6;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.9;65.9;;;56.9;74;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.3;39.3;;;33.5;45.5;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;4.2;4.2;;;3.3;5.3;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2011;2011;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.0;9;;;8.1;10;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;57.7;57.7;;;50.1;65;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.3;40.3;;;33.5;47.5;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.3;10.3;;;9;11.8;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;50.9;50.9;;;45.8;55.9;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;94.5;94.5;;;87.3;97.7;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;CRDRATE;RACE;API;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.8;38.8;;;32.7;45.3;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.3;34.3;;;28.6;40.5;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.9;36.9;;;31.8;42.4;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.2;87.2;;;81.5;91.4;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2011;2011;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;NMBR;RACE;AIAN;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;4.9;4.9;;;2.9;8.2;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.4;7.4;;;6;9.1;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;CA;California;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.9;13.9;;;7.9;23.1;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2011;2011;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;3.4;3.4;;;2;5.9;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.2;14.2;;;11.4;17.4;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.2;34.2;;;29;39.9;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2011;2011;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.3;12.3;;;10.2;14.8;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.3;83.3;;;75.3;89.1;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2011;2011;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;NMBR;RACE;HIS;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;92.4;92.4;;;85;96.3;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.7;35.7;;;30.9;40.8;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.7;41.7;;;37.5;46;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2011;2011;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.1;63.1;;;52.4;72.7;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2011;2011;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.5;10.5;;;9.5;11.5;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2011;2011;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;NMBR;RACE;BLK;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.0;63;;;54.7;70.6;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;21.7;21.7;;;17.4;26.7;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;CA;California;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;5.6;5.6;;;3.7;8.5;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.3;68.3;;;52.4;80.9;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;NMBR;RACE;API;;;;
2011;2011;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;26.1;26.1;;;16.8;38.1;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.9;64.9;;;44.5;81;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.7;11.7;;;9.4;14.3;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2011;2011;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.9;7.9;;;7;9;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.9;39.9;;;28.8;52.2;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST4_1;NMBR;RACE;BLK;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.5;65.5;;;59.1;71.5;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.1;45.1;;;31.4;59.5;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.8;40.8;;;34.4;47.6;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2011;2011;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;19.3;19.3;;;14.9;24.7;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.3;40.3;;;34.6;46.3;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;53.4;53.4;;;38.9;67.4;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.8;9.8;;;9;10.7;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.5;84.5;;;72.9;91.7;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.4;8.4;;;5.6;12.5;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.4;88.4;;;79.5;93.7;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.3;11.3;;;7.3;17.2;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;73.9;73.9;;;64.9;81.2;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;17.6;17.6;;;14.1;21.7;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.1;9.1;;;6.4;12.7;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;26.9;26.9;;;19.8;35.3;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.9;11.9;;;10;14.1;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;NMBR;GENDER;GENM;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.2;35.2;;;29.7;41.1;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;91.1;91.1;;;85.9;94.5;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2011;2011;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;NMBR;RACE;HIS;;;;
2011;2011;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.6;7.6;;;6.7;8.5;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;27;27;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;NMBR;RACE;BLK;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.7;11.7;;;9.3;14.6;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;53.7;53.7;;;31.1;74.8;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.4;7.4;;;4.9;10.6;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;NMBR;RACE;HIS;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.1;11.1;;;9.7;12.7;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.9;36.9;;;32.6;41.4;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.2;12.2;;;10.5;14.2;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.5;88.5;;;84.1;91.8;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;78.8;78.8;;;64.2;88.5;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.1;9.1;;;8;10.3;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.8;32.8;;;19.6;49.3;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2011;2011;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.9;35.9;;;31;41.2;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2011;2011;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.1;40.1;*;50 States + DC: US Median;38.8;41.8;Overall;Overall;;;;;;;59;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;15.9;15.9;;;11.8;21;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2011;2011;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.3;9.3;;;7.5;11.4;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29.7;29.7;;;23.5;36.8;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.7;82.7;;;67.7;91.6;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;7.1;7.1;;;5.8;8.7;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;73.9;73.9;;;59.3;84.6;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.9;35.9;;;29.3;43;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;53.8;53.8;;;38.5;68.4;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.4;33.4;;;27.9;39.3;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2011;2011;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;;Number;44;44;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;NMBR;RACE;WHT;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.2;11.2;;;8.6;14.3;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.3;6.3;;;3.5;11.2;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2011;2011;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50.0;50;;;42.7;57.3;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;NMBR;RACE;BLK;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.5;8.5;;;5.6;12.7;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.5;39.5;;;33.7;45.8;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.6;9.6;;;8.7;10.5;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.1;45.1;;;38.1;52.3;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;CRDRATE;RACE;API;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.0;40;;;26.7;55;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.3;12.3;;;7;20.7;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.4;35.4;;;29.4;41.8;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.4;69.4;;;61.8;76.1;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.0;87;;;81.2;91.1;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.9;41.9;;;36;48;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.1;37.1;;;28.7;46.4;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.5;82.5;;;65;92.3;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.7;65.7;;;52.3;77;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;56.0;56;;;39.7;71.1;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.5;10.5;;;9.3;11.8;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.6;38.6;;;25.9;53.2;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2011;2011;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.5;87.5;;;81.3;91.8;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.1;7.1;;;6;8.4;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.4;7.4;;;5.1;10.5;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.9;90.9;;;85;94.5;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.3;12.3;;;9.2;16.2;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;22.5;22.5;;;12.3;37.5;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2011;2011;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.0;11;;;10;12.2;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2011;2011;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.8;40.8;;;35.1;46.8;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.9;9.9;;;5.6;16.8;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;US;United States;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.1;10.1;;;9.8;10.5;Overall;Overall;;;;;;;59;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.2;11.2;;;10;12.4;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.4;84.4;;;76.9;89.8;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.4;9.4;;;8.5;10.5;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.6;6.6;;;5.2;8.3;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.9;86.9;;;80;91.7;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.4;39.4;;;33.6;45.4;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;NMBR;RACE;API;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.5;42.5;;;32.9;52.6;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;20.3;20.3;;;14.9;26.9;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.2;13.2;;;11.8;14.8;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.3;9.3;;;7.1;12;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;48.4;48.4;;;34.6;62.5;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.1;35.1;;;25.6;45.9;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.5;68.5;;;62.6;73.9;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.0;10;;;8.5;11.8;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2011;2011;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2011;2011;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.0;10;;;6.5;14.6;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.5;45.5;;;38.4;52.8;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2011;2011;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.8;7.8;;;4.8;12;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.6;42.6;;;35.9;49.7;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;NMBR;GENDER;GENM;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;;Number;22;22;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;NMBR;RACE;BLK;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.4;6.4;;;5.7;7.2;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.7;37.7;;;28.7;47.6;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2011;2011;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;NMBR;RACE;BLK;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.9;7.9;;;4.7;12.9;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.8;39.8;;;32.6;47.4;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2011;2011;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50.8;50.8;;;43.3;58.2;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2011;2011;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;72.9;72.9;;;64.2;80.1;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;NY;New York;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.2;10.2;;;8.1;12.7;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;25.5;25.5;;;14.3;41.3;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST4_1;NMBR;GENDER;GENF;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.6;11.6;;;9.7;13.8;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.2;11.2;;;7.4;16.5;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.1;33.1;;;26.8;40.2;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.8;8.8;;;5.4;14.2;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.5;43.5;;;37.1;50.1;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;NMBR;RACE;API;;;;
2011;2011;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.7;7.7;;;6.2;9.2;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.7;10.7;;;7.2;15.5;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2011;2011;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;NMBR;RACE;AIAN;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;58.1;58.1;;;44.7;70.5;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.1;9.1;;;8.1;10.2;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;75.2;75.2;;;66.9;82;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.2;70.2;;;61.3;77.7;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.0;85;;;76.1;90.9;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.8;33.8;;;26.8;41.7;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.1;88.1;;;81.7;92.5;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;72.8;72.8;;;55.4;85.3;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.2;8.2;;;5;13.3;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.6;9.6;;;8.8;10.5;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.9;31.9;;;26.8;37.4;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90.8;90.8;;;84.4;94.7;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.4;36.4;;;29.6;43.7;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2011;2011;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;;Number;32;32;;;;;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;4.9;4.9;;;3;7.9;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.4;40.4;;;33.1;48.2;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.4;66.4;;;49.1;80.1;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.8;8.8;;;7.3;10.5;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.7;12.7;;;10.1;15.8;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;NMBR;RACE;API;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.5;40.5;;;30.6;51.3;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.5;14.5;;;8.2;24.4;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2011;2011;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.2;11.2;;;8.5;14.5;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2011;2011;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90.4;90.4;;;84;94.4;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.8;36.8;;;30;44.2;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2011;2011;MT;Montana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;NMBR;GENDER;GENF;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;75.7;75.7;;;64.3;84.3;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.1;9.1;;;8.5;9.8;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.8;64.8;;;55.8;72.9;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.2;5.2;;;4.4;6.2;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2011;2011;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;7.2;7.2;;;4.3;11.8;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.5;6.5;;;5.1;8.3;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.9;11.9;;;10.2;14;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2011;2011;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.9;7.9;;;6.1;9.9;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.3;42.3;;;35.4;49.6;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2011;2011;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;;Number;31;31;;;;;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;NMBR;GENDER;GENF;;;;
2011;2011;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.0;7;;;5.5;8.9;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;25.9;25.9;;;16.4;38.5;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.8;85.8;;;73.7;92.9;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.2;41.2;;;34.6;48;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;NMBR;RACE;HIS;;;;
2011;2011;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2011;2011;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;;Number;131;131;;;;;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.6;70.6;;;60.8;78.8;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.3;12.3;;;10.7;14;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.8;13.8;;;12.2;15.5;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.0;9;;;7.7;10.4;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.4;33.4;;;26.6;40.9;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.2;38.2;;;32.3;44.5;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;3.6;3.6;;;2.1;6.3;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2011;2011;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;77.1;77.1;;;61.2;87.8;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.1;31.1;;;21.1;43.3;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2011;2011;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;24.3;24.3;;;16.6;34.2;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;79.6;79.6;;;68.8;87.4;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2011;2011;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;NMBR;RACE;AIAN;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90.1;90.1;;;79.1;95.7;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;77.7;77.7;;;68.5;84.8;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.2;33.2;;;24.5;43.3;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.5;36.5;;;30.3;43.2;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.8;90.8;;;83.9;94.9;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;73.9;73.9;;;65.9;80.5;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2011;2011;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;NMBR;GENDER;GENF;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.4;62.4;;;45.2;76.9;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.6;11.6;;;8.3;15.9;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.4;7.4;;;6.2;8.8;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.5;11.5;;;8.9;14.6;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;74.2;74.2;;;60.9;84.2;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.6;9.6;;;8.3;11.2;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2011;2011;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.5;41.5;;;33.6;49.9;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.0;43;;;32.9;53.8;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.8;41.8;;;26.7;58.6;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.3;8.3;;;7.5;9.2;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;16.6;16.6;;;9.1;28.3;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2011;2011;NY;New York;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.2;9.2;;;6.2;13.5;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.0;88;;;80.9;92.7;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.9;30.9;;;19.9;44.6;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.2;36.2;;;30.3;42.5;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2011;2011;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.9;35.9;*;50 States + DC: US Median;34.5;38.2;Gender;Male;;;;;;;59;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.4;47.4;;;39.1;55.8;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2011;2011;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.4;89.4;;;84.8;92.8;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;76.9;76.9;;;68.6;83.5;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.5;7.5;;;4.8;11.2;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2011;2011;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.6;8.6;;;5.9;12.1;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.4;36.4;;;29.8;43.6;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.2;33.2;;;28.4;38.3;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.6;43.6;;;37;50.4;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.0;85;;;72.8;92.3;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.9;45.9;;;36.4;55.8;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.0;68;;;61;74.2;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.3;90.3;;;85.4;93.7;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.5;42.5;;;30.8;55.1;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.0;69;;;61.2;75.8;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.0;84;;;77.4;88.9;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.1;85.1;;;77.8;90.4;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.9;43.9;;;38.1;49.9;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;6.2;6.2;;;4.4;8.6;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.8;6.8;;;3.8;11.7;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2011;2011;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;21.5;21.5;;;14.8;30.3;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.9;70.9;;;65;76.1;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;77.6;77.6;;;61.8;88.2;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.7;11.7;;;9.6;14.2;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.5;38.5;;;24.3;55;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2011;2011;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.7;71.7;;;60.5;80.7;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.8;82.8;;;68.7;91.4;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.2;89.2;;;81.3;94;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.0;43;;;35.9;50.5;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.5;34.5;;;22.9;48.2;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2011;2011;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.4;40.4;;;28.2;54;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.6;87.6;;;81.7;91.7;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.2;47.2;;;39.8;54.7;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.2;12.2;;;9.2;15.9;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67.9;67.9;;;57.2;77.1;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2011;2011;US;United States;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.7;11.7;*;50 States + DC: US Median;11.2;12.3;Overall;Overall;;;;;;;59;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;59.1;59.1;;;44.3;72.4;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.8;13.8;;;10.6;17.8;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.3;35.3;;;29.4;41.7;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.6;37.6;;;32.3;43.2;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;;Number;77;77;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;NMBR;RACE;BLK;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.8;28.8;;;19.8;39.8;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.2;84.2;;;76.4;89.7;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;13.1;13.1;;;9;18.4;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.4;38.4;;;32;45.3;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.6;70.6;;;53.7;83.3;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.3;85.3;;;77.7;90.6;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.7;9.7;;;7.9;12;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;NMBR;RACE;AIAN;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;27.0;27;;;15.1;43.5;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.5;48.5;;;40.7;56.3;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;61.1;61.1;;;51.5;69.9;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.6;48.6;;;38.4;59;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;NMBR;RACE;API;;;;
2011;2011;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.0;5;;;4.1;6.2;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2011;2011;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67.6;67.6;;;56.7;76.8;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;76.7;76.7;;;66.3;84.6;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.5;89.5;;;81.3;94.4;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.0;12;;;10.9;13.2;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.6;45.6;;;33.3;58.5;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2011;2011;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;NMBR;RACE;API;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.5;40.5;;;33.8;47.6;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.4;84.4;;;76.7;89.9;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.0;8;;;4.9;12.2;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;91.5;91.5;;;85.9;95;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.1;39.1;;;30.9;47.9;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;26.9;26.9;;;17.7;38.5;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.5;13.5;;;11.2;16.1;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.6;14.6;;;12;17.6;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.2;12.2;;;11.3;13.2;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.1;8.1;;;5.1;12.3;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2011;2011;CA;California;NVSS;Asthma;Asthma mortality rate;;;Number;241;241;;;;;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;NMBR;GENDER;GENF;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.3;44.3;;;32.8;56.5;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.0;46;;;38.6;53.6;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.8;85.8;;;79.6;90.3;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.2;7.2;;;6.1;8.5;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2011;2011;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.4;8.4;;;7.9;9;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.1;44.1;;;37.7;50.7;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;NMBR;RACE;HIS;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.7;6.7;;;4.7;9.5;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.3;72.3;;;59.5;82.2;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.9;85.9;*;50 States + DC: US Median;84;87.5;Overall;Overall;;;;;;;59;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.4;10.4;;;6.9;15.3;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2011;2011;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.9;6.9;;;6.1;8;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2011;2011;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2011;2011;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.4;6.4;;;4.9;8.3;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2011;2011;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.9;35.9;;;31.1;41;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.3;9.3;;;8.1;10.7;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.1;33.1;;;23.6;44.3;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.4;8.4;;;7.4;9.5;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;81.4;81.4;;;73.2;87.6;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2011;2011;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;41;41;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;NMBR;RACE;BLK;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;61.6;61.6;;;53.5;69.2;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.0;7;;;5.7;8.6;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2011;2011;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.5;9.5;;;7.5;11.9;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;26.5;26.5;;;19.6;34.8;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;15.0;15;;;11.1;19.9;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.6;7.6;;;6.8;8.4;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;17.9;17.9;;;12.5;24.9;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;15.9;15.9;;;10.4;23.5;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.2;68.2;;;58.5;76.5;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.4;13.4;;;11;16.2;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.6;40.6;;;34.8;46.8;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.6;31.6;;;21;44.5;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.5;38.5;;;31.8;45.7;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.7;49.7;;;35.8;63.7;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;58.8;58.8;;;49.8;67.2;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;NMBR;GENDER;GENM;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.6;41.6;;;31.8;52;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2011;2011;MT;Montana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.2;7.2;;;4.6;11;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2011;2011;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2011;2011;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2011;2011;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.3;66.3;;;58.3;73.5;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.2;71.2;;;61.2;79.5;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.5;63.5;;;54.6;71.6;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;30.7;30.7;;;18.2;46.9;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2011;2011;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.5;10.5;;;8.5;12.5;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.5;65.5;;;49.1;78.9;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.2;14.2;;;8.8;22.3;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;17.7;17.7;;;10.4;28.4;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2011;2011;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;NMBR;RACE;AIAN;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.3;7.3;;;6.8;7.8;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.6;10.6;;;8.1;13.9;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2011;2011;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.4;11.4;;;9;14.2;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;80.6;80.6;;;66.9;89.6;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2011;2011;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2011;2011;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;;Number;43;43;;;;;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;NMBR;GENDER;GENM;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.4;32.4;;;19.2;49;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;NMBR;RACE;API;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.3;32.3;;;19.6;48.3;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.4;40.4;;;35.6;45.3;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;CRDRATE;RACE;API;;;;
2011;2011;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;NMBR;GENDER;GENM;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.6;12.6;;;7.1;21.4;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.8;32.8;;;19.7;49.3;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;CRDRATE;RACE;API;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;91.4;91.4;;;84.1;95.5;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2011;2011;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;;Number;42;42;;;;;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;NMBR;GENDER;GENF;;;;
2011;2011;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;NMBR;RACE;BLK;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.3;10.3;;;6.6;15.8;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2011;2011;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;20.7;20.7;;;13.9;29.7;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2011;2011;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;NMBR;RACE;API;;;;
2011;2011;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.6;48.6;;;43.8;53.4;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.0;66;;;60.7;70.9;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;WA;Washington;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;NMBR;RACE;BLK;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.5;35.5;;;28.8;42.8;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.7;8.7;;;7.7;9.8;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.8;13.8;;;8.5;21.7;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;74.4;74.4;;;65.9;81.4;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.9;11.9;;;9.5;14.8;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.3;10.3;;;9.4;11.3;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;3.9;3.9;;;2.2;7;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.0;71;;;56.1;82.4;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.1;12.1;;;7.1;19.8;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2011;2011;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.2;47.2;;;37.8;56.9;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2011;2011;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;15.0;15;;;11.7;18.9;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.4;47.4;;;42.6;52.3;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.0;7;;;6.1;8;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;13.8;13.8;;;7.9;22.9;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.6;67.6;;;48.5;82.2;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.7;8.7;;;6.2;12;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.7;13.7;;;11.7;16.1;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.5;14.5;;;11.6;17.9;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;25.9;25.9;;;15.9;39.3;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;75.2;75.2;;;55.6;88;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.0;8;;;5;12.2;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.2;64.2;;;57.3;70.6;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.3;88.3;;;82.6;92.3;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;61.4;61.4;;;50.5;71.2;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.9;9.9;;;7.1;13.4;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2011;2011;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;NMBR;RACE;HIS;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.8;62.8;;;55.2;69.8;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2011;2011;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;30.9;30.9;;;20.3;44;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2011;2011;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;;Number;22;22;;;;;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;NMBR;GENDER;GENM;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.1;12.1;;;7.5;18.9;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.0;7;;;6.3;7.7;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.3;33.3;;;27;40.2;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.9;45.9;;;35.1;57;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2011;2011;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.2;70.2;;;60.2;78.5;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.2;86.2;;;78.7;91.4;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;8.9;8.9;;;7.8;10.2;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2011;2011;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.6;40.6;;;33.8;47.8;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.4;43.4;;;38.3;48.7;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.8;43.8;;;34.2;53.9;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;8.2;8.2;;;6.6;10;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2011;2011;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.8;8.8;;;7.7;10.1;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2011;2011;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;NMBR;RACE;API;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2011;2011;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2011;2011;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;NMBR;GENDER;GENF;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.5;43.5;;;35.5;51.8;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2011;2011;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.4;42.4;;;35.2;50.1;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2011;2011;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;NMBR;GENDER;GENF;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2011;2011;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.5;41.5;;;30.2;53.8;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.5;84.5;;;73.3;91.6;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.4;72.4;;;65.4;78.5;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.2;36.2;;;26.1;47.7;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2011;2011;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;;Number;84;84;;;;;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;NMBR;GENDER;GENF;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2011;2011;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;;Number;46;46;;;;;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;NMBR;RACE;HIS;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.7;36.7;;;29.5;44.6;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.6;6.6;;;5.3;8.1;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.7;34.7;;;19.1;54.5;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2011;2011;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.1;31.1;;;20.1;44.7;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2011;2011;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;38;38;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;NMBR;RACE;WHT;;;;
2011;2011;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2011;2011;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.5;9.5;;;7.5;11.8;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.3;13.3;;;11.7;15.1;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.2;7.2;;;6.2;8.4;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.1;8.1;;;7.1;9.2;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;64.5;64.5;;;54.2;73.5;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.6;84.6;;;76.2;90.4;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.3;36.3;;;22.6;52.6;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.5;66.5;;;59.8;72.6;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50.0;50;;;38.4;61.7;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.0;39;;;34.7;43.4;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.6;31.6;;;24.6;39.6;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;6.0;6;;;3.5;10.2;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.2;63.2;;;55.5;70.2;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.7;38.7;;;30.6;47.6;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.9;7.9;;;5.1;12.2;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2011;2011;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2011;2011;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;CRDRATE;RACE;API;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;79.2;79.2;;;70.4;85.9;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.4;31.4;;;24.1;39.8;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2011;2011;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.3;12.3;;;11;13.7;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.8;36.8;;;31.7;42.1;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;;Number;91;91;;;;;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;NMBR;GENDER;GENF;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;58.1;58.1;;;45.1;70.1;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.9;11.9;;;7.7;17.9;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.1;38.1;;;32.3;44.4;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.5;46.5;;;36.8;56.6;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.5;13.5;;;11.9;15.1;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2011;2011;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;19.1;19.1;;;11.5;29.8;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2011;2011;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2011;2011;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.5;35.5;;;26.8;45.3;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;22.5;22.5;;;12.9;36.1;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.7;40.7;;;34.9;46.8;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;NMBR;RACE;BLK;;;;
2011;2011;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.4;33.4;;;27.9;39.5;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.6;42.6;;;37.8;47.6;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.6;30.6;;;25.3;36.4;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.1;40.1;;;33.2;47.3;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.8;84.8;;;75.2;91.1;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.5;42.5;;;35.9;49.5;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.9;40.9;;;35.8;46.2;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.6;11.6;;;8.4;15.6;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.1;5.1;;;3.8;6.7;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.7;46.7;;;38.7;54.8;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2011;2011;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;NMBR;RACE;BLK;;;;
2011;2011;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;21.6;21.6;;;13.2;33.3;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.6;83.6;;;75.8;89.3;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;21.5;21.5;;;12;35.5;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;74.8;74.8;;;64.8;82.7;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.8;69.8;;;61.2;77.1;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;19.4;19.4;;;12;29.9;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.8;68.8;;;59.2;77;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.6;7.6;;;5.2;10.6;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.1;9.1;;;7.6;10.7;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.1;87.1;;;66.4;95.9;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2011;2011;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;81.1;81.1;;;73.6;86.8;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.9;48.9;;;31.8;66.2;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;59.8;59.8;;;43;74.6;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.1;40.1;;;30.5;50.5;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.0;41;;;32;50.7;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;NMBR;RACE;HIS;;;;
2011;2011;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.1;9.1;;;8.2;10.2;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.7;41.7;;;30.9;53.4;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;CRDRATE;RACE;API;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;15.1;15.1;;;12.2;18.5;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.6;69.6;;;55.6;80.6;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;49.1;49.1;;;42.4;55.9;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.2;9.2;;;7.4;11.4;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.2;13.2;;;11;15.8;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.2;37.2;;;30.8;44.2;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.7;90.7;;;79.9;96;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.9;10.9;;;7.8;14.9;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.7;10.7;;;6.9;16.1;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.3;9.3;;;5.3;15.8;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;18.8;18.8;;;10.8;30.8;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.0;34;;;28.1;40.4;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.1;65.1;;;53.1;75.4;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.1;83.1;;;60.7;94;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.5;8.5;;;7.6;9.5;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.4;10.4;;;7.7;13.6;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2011;2011;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2011;2011;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;NMBR;RACE;AIAN;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.7;36.7;;;30.4;43.5;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.0;12;;;10.7;13.5;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;ME;Maine;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;NMBR;RACE;AIAN;;;;
2011;2011;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.8;86.8;;;75.8;93.3;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.8;86.8;;;76.3;93.1;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.8;8.8;;;8.3;9.4;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.7;7.7;;;5.9;10;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.4;66.4;;;56.4;75.2;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.4;13.4;;;12;14.9;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.0;87;;;77.6;92.8;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.6;38.6;;;30.8;47;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.4;6.4;;;4;10.1;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2011;2011;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.4;8.4;;;7.8;8.9;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67.5;67.5;;;58.7;75.2;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.8;11.8;;;10.6;13.2;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.6;5.6;;;4.5;6.9;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2011;2011;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;5.2;5.2;;;3.5;7.6;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2011;2011;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;16.2;16.2;;;11;23;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.3;68.3;;;60.4;75.3;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.4;9.4;;;6.5;13.1;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.3;28.3;;;16.4;44.1;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.4;40.4;;;30.4;51.3;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.3;47.3;;;34.2;60.9;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.8;7.8;;;6.8;9;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2011;2011;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29.0;29;;;20.7;39;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.2;12.2;;;9.2;15.9;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2011;2011;UT;Utah;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;NMBR;GENDER;GENM;;;;
2011;2011;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;NMBR;RACE;API;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.1;33.1;;;25.4;41.8;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.3;10.3;;;7.5;14;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.1;28.1;;;18.4;40.3;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;16.4;16.4;;;13.5;19.7;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;59.7;59.7;;;49.5;69.2;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.9;34.9;;;21.3;51.5;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.7;45.7;;;35;56.9;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.6;82.6;;;72.5;89.6;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90.3;90.3;;;79.5;95.7;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2011;2011;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;;Number;21;21;;;;;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;NMBR;GENDER;GENM;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.9;63.9;;;53.4;73.2;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;17.4;17.4;;;10.8;27;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;;Number;92;92;;;;;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.5;89.5;;;83.6;93.5;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.5;63.5;;;47.8;76.8;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2011;2011;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2011;2011;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.0;8;;;5.2;11.8;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;59.9;59.9;;;42.5;75.2;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.9;63.9;;;54.7;72.2;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;70;70;;;;;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.2;66.2;;;56;75.1;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;61.8;61.8;;;40.7;79.3;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.8;11.8;;;11;12.7;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.0;63;;;54.5;70.7;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.4;82.4;;;73.6;88.8;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2011;2011;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;NMBR;RACE;BLK;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;59.7;59.7;;;49.7;69;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2011;2011;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;NMBR;RACE;BLK;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.7;42.7;;;32.3;53.6;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.7;33.7;;;28.3;39.5;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.7;70.7;;;64.7;76;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.4;41.4;;;33.6;49.6;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.7;36.7;;;30.8;43;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.8;37.8;;;30;46.2;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.7;45.7;;;41.7;49.9;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.9;32.9;;;25.4;41.4;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.1;89.1;;;80.1;94.3;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;27.0;27;;;20.3;35;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.8;36.8;;;30.8;43.2;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.6;44.6;;;31.1;59;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2011;2011;MT;Montana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;NMBR;RACE;API;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.1;45.1;;;39.5;50.8;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;72.7;72.7;;;63.5;80.3;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.0;90;;;85.4;93.3;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.8;38.8;;;32;46;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;28.1;28.1;;;15.8;44.8;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;28.9;28.9;;;19.3;40.9;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.7;31.7;;;25;39.3;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.9;8.9;;;5.2;14.7;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.6;35.6;;;27.8;44.3;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.5;10.5;;;9.5;11.6;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.1;9.1;;;7.4;11.3;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2011;2011;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.1;68.1;*;50 States + DC: US Median;65.7;70.7;Gender;Female;;;;;;;59;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.0;38;;;33.2;43.1;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;74.8;74.8;;;61;85;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;75.9;75.9;;;68.5;82.1;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.1;7.1;;;5.7;8.9;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.5;65.5;;;58.3;72;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;19.7;19.7;;;10.9;32.7;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;;Number;44;44;;;;;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;NMBR;GENDER;GENF;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;32.6;32.6;;;25;41.3;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;55.4;55.4;;;43.3;67;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.3;69.3;;;49.9;83.7;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.0;10;;;9.2;10.9;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.2;14.2;;;12.3;16.2;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.6;45.6;;;41.3;49.9;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2011;2011;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2011;2011;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.0;12;;;10.4;13.8;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.4;72.4;;;60.9;81.5;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;NMBR;RACE;AIAN;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.1;40.1;;;34.2;46.2;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2011;2011;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;NMBR;GENDER;GENM;;;;
2011;2011;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.2;48.2;;;40.8;55.6;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2011;2011;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.4;33.4;;;26.8;40.6;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;91.5;91.5;;;85.6;95.1;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.1;10.1;;;8.8;11.6;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;;Number;127;127;;;;;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.5;46.5;;;30.8;62.9;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2011;2011;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;19.5;19.5;;;14.1;26.2;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2011;2011;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;89;89;;;;;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.4;5.4;;;3.7;7.8;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.9;38.9;;;34.4;43.7;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.9;11.9;;;7.5;18.2;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2011;2011;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;CRDRATE;RACE;API;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.4;9.4;;;7.9;11.1;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;NMBR;RACE;WHT;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.1;41.1;;;28.7;54.7;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2011;2011;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.0;11;;;9.1;12.9;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.2;68.2;;;58.6;76.4;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;30.0;30;;;22.5;38.8;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.3;41.3;;;35.5;47.3;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.7;45.7;;;41.1;50.4;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2011;2011;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.7;8.7;;;6.2;11.7;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.3;89.3;;;81.5;94.1;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;76.3;76.3;;;67.9;83;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.1;11.1;;;8;14.9;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;15.0;15;;;8.8;24.3;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.7;65.7;;;57.1;73.4;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.5;9.5;;;8.3;10.8;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;20.1;20.1;;;12.3;31.1;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.7;44.7;;;38.1;51.6;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.5;6.5;;;5.5;7.8;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;3.7;3.7;;;2.1;6.5;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.2;63.2;;;51.7;73.4;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;NMBR;RACE;HIS;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.1;7.1;;;6;8.2;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;;Number;20;20;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;NMBR;RACE;WHT;;;;
2011;2011;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;20;20;;;;;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2011;2011;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;;Number;95;95;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;NMBR;RACE;WHT;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.6;44.6;;;38.5;50.9;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.6;9.6;;;8.2;11.2;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2011;2011;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;NMBR;RACE;AIAN;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;NMBR;RACE;HIS;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.9;41.9;;;34.8;49.4;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;NMBR;RACE;API;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.5;43.5;;;37.8;49.4;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;28.4;28.4;;;20;38.7;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.3;10.3;;;8.9;11.8;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;3.3;3.3;;;2.4;4.7;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.8;71.8;;;60.8;80.7;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2011;2011;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.0;49;;;42.4;55.7;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.1;70.1;;;60.4;78.3;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;4.3;4.3;;;3.3;5.5;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;CA;California;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.3;11.3;;;9.8;13;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.5;40.5;;;31.1;50.5;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.4;37.4;;;32.5;42.6;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2011;2011;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;20.7;20.7;;;14.1;29.4;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2011;2011;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;25.9;25.9;;;17.3;36.9;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.2;84.2;;;76.4;89.7;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.1;10.1;;;8.3;12.3;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.6;36.6;;;32.6;40.8;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.3;8.3;;;7.7;9;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.6;42.6;;;36.3;49.2;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;30.1;30.1;;;22.9;38.5;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.6;40.6;;;35.7;45.8;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2011;2011;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2011;2011;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.2;32.2;;;18.5;49.9;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.8;8.8;;;8;9.7;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;16.8;16.8;;;12.8;21.5;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.1;88.1;;;82.6;92;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2011;2011;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;72.6;72.6;;;66.7;77.8;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;61.6;61.6;;;42.1;78;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.0;8;;;6.4;9.8;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.2;39.2;;;33.1;45.6;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.3;42.3;;;35.1;49.9;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2011;2011;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.2;13.2;;;9.7;17.7;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2011;2011;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.6;14.6;;;11.6;18.3;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.4;31.4;;;19.8;45.9;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;13.2;13.2;;;9.5;17.8;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2011;2011;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;NMBR;RACE;AIAN;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.0;43;;;30.7;56.2;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;17.1;17.1;;;10.7;26.2;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.4;33.4;;;24.1;44.2;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;;Number;30;30;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;NMBR;RACE;WHT;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;29.0;29;;;20.5;39.1;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2011;2011;US;United States;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.7;6.7;*;50 States + DC: US Median;6.4;7;Gender;Male;;;;;;;59;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.8;7.8;;;6;10.1;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.9;46.9;;;40.7;53.2;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.7;10.7;;;8.8;13;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.3;40.3;;;30.8;50.6;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2011;2011;CA;California;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;NMBR;RACE;AIAN;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2011;2011;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.4;7.4;;;6.1;8.9;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.4;38.4;;;31.3;46;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.0;10;;;8.8;11.3;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.1;9.1;;;7.7;10.8;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.3;12.3;;;10.8;14;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2011;2011;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2011;2011;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.7;39.7;;;31.8;48.1;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2011;2011;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;;Number;44;44;;;;;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;NMBR;GENDER;GENM;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;75.3;75.3;;;67;82.1;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;27.9;27.9;;;19;38.9;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.5;7.5;;;6.7;8.3;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.1;33.1;;;26.1;41;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;;Number;31;31;;;;;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;NMBR;GENDER;GENF;;;;
2011;2011;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.5;39.5;;;29.4;50.6;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.5;9.5;;;7.9;11.4;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2011;2011;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.3;10.3;;;7.6;13.8;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.9;40.9;;;34.3;47.8;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2011;2011;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.8;48.8;;;35.5;62.3;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;14.5;14.5;;;8.4;23.8;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.3;10.3;;;8;13.1;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;91.0;91;;;82.6;95.6;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.8;8.8;;;7.3;10.5;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2011;2011;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.3;36.3;;;25.9;48.3;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2011;2011;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.8;36.8;;;27.9;46.6;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2011;2011;UT;Utah;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;NMBR;RACE;API;;;;
2011;2011;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2011;2011;WA;Washington;NVSS;Asthma;Asthma mortality rate;;;Number;82;82;;;;;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2011;2011;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;64.7;64.7;;;56.8;72;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.907192, -77.036871);;11;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.5;86.5;;;80.6;90.8;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.3;87.3;;;72.4;94.8;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.0;37;;;30.6;43.9;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;NMBR;RACE;WHT;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.6;42.6;;;30.8;55.2;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.8;9.8;;;8.3;11.5;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2011;2011;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.4;85.4;*;50 States + DC: US Median;82.9;87.2;Overall;Overall;;;;;;;59;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.2;12.2;;;10.6;14.1;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.8;87.8;;;75.2;94.4;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;50.4;50.4;;;45.4;55.4;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.0;6;;;3.9;9.2;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2011;2011;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.2;28.2;;;20.6;37.2;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.8;70.8;;;61.8;78.4;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.8;83.8;;;76.2;89.4;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.1;8.1;;;4.7;13.7;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;TX;Texas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;NMBR;RACE;AIAN;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.1;11.1;;;10.3;11.9;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.0;13;;;10.8;15.6;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.6;70.6;;;59.3;79.8;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.9;35.9;;;24.9;48.7;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.3;87.3;;;76.6;93.5;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.6;12.6;;;10.9;14.4;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.0;37;;;27.2;48;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2011;2011;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2011;2011;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.0;9;;;6;12.9;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2011;2011;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;CRDRATE;RACE;API;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.4;85.4;;;79.6;89.8;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.2;13.2;;;11.2;15.4;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.6;37.6;;;25.1;52;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;NMBR;RACE;WHT;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2011;2011;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;73.2;73.2;;;64.2;80.7;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;;Number;75;75;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;NMBR;RACE;WHT;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.0;45;;;31.3;59.6;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.4;34.4;;;27.8;41.6;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.0;14;;;8.8;21.3;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2011;2011;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;NMBR;RACE;AIAN;;;;
2011;2011;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.4;7.4;;;5.2;10.3;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2011;2011;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;NMBR;RACE;API;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.2;62.2;;;48.9;73.9;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.1;41.1;;;35.7;46.6;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.4;6.4;;;5.7;7.2;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.5;36.5;;;30.3;43.1;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.7;42.7;;;34.9;50.8;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2011;2011;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;NMBR;RACE;WHT;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;52.3;52.3;;;34.5;69.4;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;73.1;73.1;;;65.4;79.6;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.4;38.4;;;28.6;49.2;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;53.0;53;;;43;62.7;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.7;87.7;;;75.8;94.2;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.3;31.3;;;25.1;38.1;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2011;2011;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;NMBR;RACE;HIS;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;NMBR;RACE;AIAN;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;81.9;81.9;;;75;87.2;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.7;36.7;;;29.3;44.8;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.9;34.9;;;18.8;55.4;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.9;40.9;;;33.4;48.8;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;59.1;59.1;;;46.5;70.6;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;75.0;75;;;67.5;81.3;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.7;88.7;;;79.9;93.9;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;48.1;48.1;;;34.3;62.3;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.1;37.1;;;31.2;43.3;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.4;82.4;;;74.4;88.3;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.1;30.1;;;22.6;38.7;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;16.9;16.9;;;13;21.6;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2011;2011;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.9;85.9;;;81.8;89.2;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.2;47.2;;;38.7;55.8;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2011;2011;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;73.8;73.8;;;64.5;81.4;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.6;40.6;;;27.8;54.8;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;32.5;32.5;;;25;41.1;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.4;7.4;;;5.9;9.2;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.7;36.7;;;24.5;50.8;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29.9;29.9;;;20.3;41.7;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;15.7;15.7;;;10.4;23.1;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;73.1;73.1;;;63.6;80.8;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2011;2011;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;17.9;17.9;;;12.9;24.3;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.9;6.9;;;5.5;8.5;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2011;2011;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;NMBR;RACE;API;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.2;40.2;;;27.1;54.9;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.3;87.3;;;81.1;91.7;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.7;82.7;;;67.7;91.6;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;76.2;76.2;;;67.5;83.2;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.1;63.1;;;53.7;71.6;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.0;82;;;69.8;89.9;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.6;10.6;;;8;13.8;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.9;38.9;;;29.4;49.3;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.6;42.6;;;37.6;47.8;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.1;44.1;;;37.3;51.1;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.5;41.5;;;34.6;48.7;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.9;8.9;;;8.3;9.5;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2011;2011;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.4;35.4;;;30.2;40.9;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;80.8;80.8;;;68.9;88.9;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;MT;Montana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;NMBR;GENDER;GENM;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.6;7.6;;;6.5;8.7;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.3;31.3;;;22.7;41.4;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50.4;50.4;;;38.9;61.9;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.4;5.4;;;3.6;8.1;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2011;2011;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.7;13.7;;;10.5;17.6;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;30.9;30.9;;;25.3;37.2;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;31.3;31.3;;;23;40.9;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;49.8;49.8;;;42.1;57.5;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;NY;New York;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.7;91.7;;;85.8;95.2;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.1;10.1;;;9.2;11;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;CRDRATE;RACE;API;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.6;11.6;;;8.2;16.3;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2011;2011;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;16.3;16.3;;;12.7;20.6;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;NMBR;RACE;BLK;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.1;5.1;;;4.1;6.2;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.7;40.7;*;50 States + DC: US Median;39.6;42.4;Overall;Overall;;;;;;;59;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;57.0;57;;;45.9;67.4;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.8;33.8;;;25.3;43.5;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;;Number;34;34;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;NMBR;RACE;WHT;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;16.1;16.1;;;12.5;20.4;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.6;8.6;;;7.1;10.3;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.3;10.3;;;7.9;13.4;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;27.0;27;;;16.2;41.2;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.6;35.6;;;22.5;51.4;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2011;2011;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.4;10.4;;;9.5;11.3;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;23.0;23;;;13.1;37.3;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2011;2011;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;NMBR;RACE;AIAN;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.2;7.2;;;6;8.5;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.3;11.3;;;7.6;16.5;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.9;9.9;;;6;15.2;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2011;2011;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.7;11.7;;;8.8;15.4;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;4.9;4.9;;;2.8;8.6;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2011;2011;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.1;86.1;*;50 States + DC: US Median;84.2;88.9;Gender;Female;;;;;;;59;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;74.4;74.4;;;69.6;78.6;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.7;7.7;;;6.9;8.6;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;;Number;26;26;;;;;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2011;2011;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.6;7.6;;;5.5;10.2;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;21.1;21.1;;;12.1;34.3;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;6.4;6.4;;;3.6;11;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;52.7;52.7;;;37.5;67.4;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;55.1;55.1;;;37.6;71.4;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2011;2011;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.9;66.9;;;60.1;73;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.8;45.8;;;39.5;52.3;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.7;9.7;;;8.2;11.4;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;78.9;78.9;;;72.8;83.9;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;61.2;61.2;;;52;69.7;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.4;40.4;;;33.4;47.8;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;27.7;27.7;;;20.9;35.7;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.9;6.9;;;5.9;8.1;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2011;2011;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;91.0;91;;;83;95.5;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2011;2011;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;37.0;37;;;29.8;44.1;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.9;40.9;;;24.7;59.3;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;4.6;4.6;;;2.9;7.2;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.6;6.6;;;5.6;7.8;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2011;2011;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;NMBR;RACE;AIAN;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.2;88.2;;;79.2;93.6;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.8;83.8;;;76.9;89;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;25.0;25;;;15;38.6;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.5;89.5;;;78.1;95.4;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.4;33.4;;;27.4;40.1;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.7;33.7;;;27.9;40;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.6;7.6;;;6.5;8.9;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.6;12.6;;;11.3;14;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.2;38.2;;;23.7;55.2;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.1;5.1;;;3.8;6.8;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.5;11.5;;;10.2;13;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.5;7.5;;;5.2;10.8;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.9;63.9;;;53.6;73.1;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.4;39.4;;;34.8;44.3;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.0;8;;;5;12.6;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;81.1;81.1;;;70.8;88.3;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.0;10;;;8.8;11.5;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.8;42.8;;;38.7;47;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.8;5.8;;;4.8;7;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.7;47.7;;;37.8;57.7;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;15.3;15.3;;;11.3;20.5;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.5;88.5;;;82.4;92.7;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.7;64.7;;;50.1;77.1;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.6;34.6;;;27.1;43.1;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.4;40.4;;;36;45.1;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2011;2011;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;NMBR;RACE;BLK;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.3;12.3;;;11.1;13.5;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.9;70.9;;;51.3;85;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.6;9.6;;;8.2;11.1;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2011;2011;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2011;2011;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;NMBR;RACE;WHT;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.9;82.9;;;71.1;90.5;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;27.5;27.5;;;21.9;34;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.7;11.7;;;9.4;14.3;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.5;40.5;;;35.6;45.5;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;19.9;19.9;;;15.1;25.6;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.7;45.7;;;40;51.5;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2011;2011;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;16.0;16;;;10.4;23.6;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.0;9;;;7.3;11.1;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.9;8.9;;;7.9;10;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.1;13.1;;;9.8;17.1;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.2;44.2;;;38.4;50.1;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.6;10.6;;;9.1;12.4;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2011;2011;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.2;35.2;;;26.5;44.9;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2011;2011;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.0;37;;;30.4;44.2;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2011;2011;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2011;2011;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.2;9.2;;;8.5;10.1;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.2;8.2;;;7.1;9.5;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.2;42.2;;;36.8;47.9;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.3;45.3;;;34.1;57.1;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.6;71.6;;;57.5;82.4;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.9;88.9;;;84.1;92.4;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2011;2011;TX;Texas;NVSS;Asthma;Asthma mortality rate;;;Number;107;107;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;NMBR;RACE;WHT;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.4;43.4;;;37.4;49.5;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.8;68.8;;;55.1;79.9;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;60.9;60.9;;;51.9;69.3;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.7;39.7;;;28.5;52.2;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2011;2011;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;NMBR;RACE;API;;;;
2011;2011;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;NMBR;RACE;API;;;;
2011;2011;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;NMBR;RACE;API;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.3;64.3;;;50.4;76.2;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.4;8.4;;;7.4;9.4;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2011;2011;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2011;2011;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.1;12.1;;;10.1;14.2;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.8;62.8;;;51.4;72.9;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.8;40.8;;;33;49;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2011;2011;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.7;62.7;;;54.2;70.4;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;16.1;16.1;;;8.8;27.6;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.4;35.4;;;25.6;46.6;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.6;33.6;;;26;42.1;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;15.4;15.4;;;9.1;25.1;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2011;2011;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;29.1;29.1;;;18.8;42.2;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.7;44.7;;;38.6;50.9;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;ME;Maine;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;NMBR;GENDER;GENF;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.2;39.2;;;26.5;53.5;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.7;42.7;;;34.2;51.5;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.9;41.9;;;36.1;47.9;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.0;32;;;18.8;49.1;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.5;38.5;;;27.4;50.9;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2011;2011;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;CRDRATE;RACE;API;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.8;39.8;;;36;43.8;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.6;11.6;;;10.4;12.9;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;8.3;8.3;;;6.1;11.3;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.9;13.9;;;7.8;23.4;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;21.3;21.3;;;14.8;29.6;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2011;2011;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;16.2;16.2;;;12;21.4;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.7;44.7;;;37.6;52;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;20.5;20.5;;;15.6;26.4;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.1;5.1;;;3.8;6.7;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.6;31.6;;;26.4;37.3;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.6;11.6;;;9.1;14.7;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;15.7;15.7;;;11.6;20.9;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.5;40.5;;;32.8;48.7;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.1;35.1;;;26.2;45.2;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2011;2011;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;18.4;18.4;;;12;26.9;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90.6;90.6;;;85.4;94.1;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.4;9.4;;;7.7;11.5;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.1;38.1;;;30.4;46.5;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;;Number;27;27;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;NMBR;RACE;BLK;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.9;63.9;;;49.1;76.4;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.0;32;;;24.9;40;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;;Number;25;25;;;;;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;NMBR;GENDER;GENM;;;;
2011;2011;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;NMBR;RACE;HIS;;;;
2011;2011;CA;California;NVSS;Asthma;Asthma mortality rate;;;Number;162;162;;;;;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;NMBR;GENDER;GENM;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.2;12.2;;;9.7;15.2;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2011;2011;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2011;2011;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.1;40.1;;;34.7;45.8;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;TX;Texas;NVSS;Asthma;Asthma mortality rate;;;Number;76;76;;;;;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;NMBR;GENDER;GENM;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.8;62.8;;;51.1;73.2;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.2;11.2;;;8.5;14.5;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.9;70.9;;;54.7;83.1;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.1;38.1;;;27.9;49.6;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.2;40.2;;;32.7;48.2;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2011;2011;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;NMBR;RACE;HIS;;;;
2011;2011;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.7;11.7;;;8.2;16.2;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.8;38.8;;;31.4;46.6;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;59.4;59.4;;;45.1;72.3;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.5;33.5;;;27.6;40.1;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;72.8;72.8;;;60.8;82.2;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.7;34.7;;;25.1;45.7;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.7;68.7;;;61.2;75.4;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2011;2011;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.9;8.9;;;5.6;13.4;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.3;7.3;;;6;8.9;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2011;2011;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.6;68.6;;;60.4;75.8;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.7;6.7;;;4;10.9;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;92.3;92.3;;;84.9;96.3;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;15.0;15;;;11.2;19.8;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.5;47.5;;;38.4;56.8;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.2;87.2;;;81.6;91.2;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.7;8.7;;;7.9;9.4;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;29.2;29.2;;;16;47.3;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.3;35.3;;;26.2;45.6;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2011;2011;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;CRDRATE;RACE;API;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.0;14;;;8.4;22.3;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2011;2011;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;19.4;19.4;;;13.9;26.3;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2011;2011;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2011;2011;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;NMBR;RACE;BLK;;;;
2011;2011;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;73.6;73.6;;;59;84.4;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;NMBR;RACE;BLK;;;;
2011;2011;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.2;12.2;;;10.9;13.7;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.5;87.5;;;78;93.3;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.1;84.1;;;79.3;88;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2011;2011;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;NMBR;GENDER;GENF;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.4;9.4;;;7.7;11.4;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2011;2011;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.0;42;;;35.2;49.2;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2011;2011;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.4;34.4;;;24.7;45.6;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.8;6.8;;;5.7;8.1;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;79.4;79.4;;;72;85.3;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.8;38.8;;;25;54.7;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.2;5.2;;;3.2;8.6;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.7;90.7;;;86.3;93.9;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90.7;90.7;;;82.7;95.2;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2011;2011;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;;Number;70;70;;;;;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;NMBR;GENDER;GENF;;;;
2011;2011;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.4;39.4;;;35.3;43.7;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.2;36.2;;;30.2;42.5;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.5;46.5;;;36.9;56.3;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.3;8.3;;;5.3;12.3;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;24.0;24;;;15.4;35.3;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.4;12.4;;;9.9;15.3;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.0;35;;;22.5;49.9;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;28.1;28.1;;;20.2;37.7;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.8;8.8;;;7.8;10;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.7;41.7;;;36.1;47.6;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2011;2011;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.7;35.7;;;30.5;41.2;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;56.7;56.7;;;44.6;68;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.8;43.8;;;39.7;48;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.1;10.1;;;8.6;11.9;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;NMBR;RACE;API;;;;
2011;2011;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;78.0;78;;;68.9;85.1;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.2;39.2;;;34.7;43.9;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;CA;California;NVSS;Asthma;Asthma mortality rate;;;Number;205;205;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;NMBR;RACE;WHT;;;;
2011;2011;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;NMBR;RACE;AIAN;;;;
2011;2011;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.6;6.6;;;5.1;8.5;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.6;6.6;;;5.4;8.1;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2011;2011;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2011;2011;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.0;10;;;8.5;11.4;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;75.0;75;;;67.3;81.3;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.0;33;;;24.5;42.7;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.5;62.5;;;50.7;73;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.1;43.1;;;32.9;53.9;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.1;7.1;;;5.6;8.8;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2011;2011;NY;New York;NVSS;Asthma;Asthma mortality rate;;;Number;257;257;;;;;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.6;87.6;;;76.4;93.9;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.9;34.9;;;20;53.4;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2011;2011;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.5;44.5;;;37.7;51.6;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2011;2011;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.5;11.5;;;10.1;13;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2011;2011;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;NMBR;GENDER;GENM;;;;
2011;2011;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2011;2011;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;17.1;17.1;;;11.5;24.3;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2011;2011;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.2;12.2;;;9.5;15.4;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.8;38.8;;;32.9;45.1;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.6;70.6;;;61;78.7;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.2;10.2;;;8.8;11.7;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2011;2011;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67.0;67;;;57.8;75;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.7;44.7;;;31.6;58.5;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.5;7.5;;;6.6;8.6;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;74.4;74.4;;;61.5;84.1;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2011;2011;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;CRDRATE;RACE;API;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.8;42.8;;;26.7;60.7;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.6;42.6;;;38.8;46.5;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2011;2011;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;NMBR;RACE;API;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.4;8.4;;;7.6;9.4;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;50.1;50.1;;;34.5;65.7;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.6;9.6;;;8.6;10.6;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;19.6;19.6;;;12.9;28.7;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.4;8.4;;;7.4;9.6;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.4;11.4;;;10.3;12.6;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.5;48.5;;;43.7;53.4;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.3;7.3;;;6.8;7.8;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;28.0;28;;;18.1;40.6;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.5;32.5;;;27.5;37.9;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.6;12.6;;;11.1;14.3;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.1;10.1;;;8.2;12.4;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.8;12.8;;;9.5;17.1;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.5;83.5;;;72.7;90.5;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;NMBR;GENDER;GENM;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;17.5;17.5;;;14.8;20.7;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.7;40.7;;;34.7;47;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2011;2011;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;5.5;5.5;;;4.3;6.8;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.3;11.3;;;7.1;17.6;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.1;11.1;;;9.1;13.5;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.0;89;;;80.2;94.2;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.5;44.5;;;31.3;58.6;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2011;2011;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;;Number;64;64;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;NMBR;RACE;WHT;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.3;31.3;;;22.1;42.2;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.4;5.4;;;4.4;6.6;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.7;45.7;;;39.1;52.5;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.9;68.9;;;55;80;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2011;2011;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;CRDRATE;RACE;API;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.6;38.6;;;32.1;45.6;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.4;85.4;;;81.2;88.9;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;6.0;6;;;3.6;9.9;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.2;40.2;;;35;45.6;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.5;10.5;;;8.5;12.9;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2011;2011;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.3;10.3;;;7.4;14;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2011;2011;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;54.8;54.8;;;40;68.7;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;18.9;18.9;;;11.1;30.5;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.8;8.8;;;6.3;12.2;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.1;14.1;;;10;19.3;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.8;9.8;;;6.3;15;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;7.8;7.8;;;5.9;10.3;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.4;44.4;;;36.4;52.6;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.9;10.9;;;9;13.2;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;74.0;74;;;62.3;83;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.4;87.4;;;80;92.3;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;19.2;19.2;;;10.6;32.2;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.5;9.5;;;8.1;11;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.2;9.2;;;6.1;13.3;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.4;90.4;;;84.9;94;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;14.1;14.1;;;9.6;19.9;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.5;35.5;;;26.4;45.9;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.8;35.8;;;27.1;45.5;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.0;32;;;27.5;36.8;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.7;62.7;;;44.2;78.1;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.5;43.5;;;36.6;50.6;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.4;31.4;;;21.4;43.5;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2011;2011;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;CRDRATE;RACE;API;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;53.4;53.4;;;47.9;58.9;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.7;36.7;;;30.5;43.5;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.5;8.5;;;7.8;9.2;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.3;70.3;;;59.5;79.2;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.1;14.1;;;9.4;20.7;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.8;33.8;;;26.3;42.3;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.5;9.5;;;6.5;13.6;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2011;2011;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;NMBR;GENDER;GENM;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.3;32.3;;;23.6;42.4;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.3;38.3;;;33.3;43.7;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.7;33.7;;;25.3;43.2;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;80.6;80.6;;;73.2;86.4;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;23.3;23.3;;;14.2;35.9;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.2;42.2;;;33.6;51.2;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.3;90.3;;;84.8;93.9;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2011;2011;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.9;12.9;;;10;16.5;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.6;46.6;;;34.5;59.2;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.7;7.7;;;5.1;11.1;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.1;8.1;;;7.1;9.2;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.2;65.2;;;56.5;72.9;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;4.4;4.4;;;3.2;6;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2011;2011;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.5;9.5;;;7.1;12.6;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2011;2011;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;78.6;78.6;;;63.6;88.5;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2011;2011;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.5;8.5;;;7.5;9.5;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;27.4;27.4;;;19.1;37.8;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.8;42.8;;;34.8;51.1;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.9;46.9;;;38.4;55.7;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.8;40.8;;;33.4;48.6;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.8;9.8;;;7.6;12.7;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2011;2011;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;NMBR;RACE;HIS;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.0;65;;;56.2;72.9;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;27.7;27.7;;;22.3;33.9;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.8;67.8;;;56.9;77;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.1;88.1;;;79.2;93.5;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.7;11.7;;;9.2;14.8;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.3;5.3;;;3.9;7.1;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.5;43.5;;;34.4;53;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.0;86;;;78.4;91.1;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.7;10.7;;;9.6;11.7;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2011;2011;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;24.1;24.1;;;16.8;33.5;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.6;44.6;;;36.7;52.7;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.4;89.4;;;84.8;92.7;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.7;34.7;;;28.4;41.7;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;81.2;81.2;;;68.6;89.6;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;;Number;87;87;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;NMBR;RACE;WHT;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2011;2011;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;NMBR;GENDER;GENF;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.1;11.1;;;8;15.2;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;92.5;92.5;;;85;96.4;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;59.9;59.9;;;50.5;68.6;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.5;87.5;;;81.7;91.6;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2011;2011;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.2;8.2;;;6.9;9.7;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2011;2011;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;NMBR;RACE;WHT;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.6;91.6;;;84.6;95.6;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.2;70.2;;;51.8;83.7;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.0;41;;;35.6;46.6;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;20.9;20.9;;;16.7;25.7;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.7;43.7;;;34.5;53.4;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.3;89.3;;;74.5;96;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;61.9;61.9;;;45;76.3;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.9;39.9;;;33.8;46.3;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.1;70.1;;;63.7;75.9;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.7;40.7;;;33.8;47.9;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.1;11.1;;;7.8;15.3;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.5;83.5;;;72.7;90.5;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.7;43.7;;;36.4;51.2;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.3;86.3;;;75.4;92.8;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.0;9;;;7.9;10.2;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.1;41.1;;;27.4;56.3;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2011;2011;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;15.7;15.7;;;11.5;20.9;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;79.8;79.8;;;70.1;87;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2011;2011;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.6;42.6;;;36;49.5;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.3;40.3;;;29.2;52.5;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;73.0;73;;;62.7;81.3;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2011;2011;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.1;38.1;;;31.6;45.1;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.0;42;;;32.7;51.8;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.7;8.7;;;5.6;12.9;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.4;42.4;;;31.8;53.8;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;74.0;74;;;62.3;83.1;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.9;42.9;;;33.7;52.5;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;50.5;50.5;;;41.4;59.5;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.1;41.1;;;33;49.6;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.0;8;;;7;9.1;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.9;40.9;;;36.8;45.2;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.3;12.3;;;10.1;14.9;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;15.1;15.1;;;11.3;19.7;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.6;11.6;;;10.3;13;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2011;2011;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;;Number;37;37;;;;;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.2;39.2;;;33.6;45.1;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;91.5;91.5;;;85.7;95.1;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2011;2011;ME;Maine;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;NMBR;RACE;API;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.2;13.2;;;9.8;17.5;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2011;2011;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;NMBR;RACE;HIS;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2011;2011;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2011;2011;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;CRDRATE;RACE;API;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.3;28.3;;;22.3;35.1;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;17.1;17.1;;;10.4;26.9;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.2;82.2;;;71.5;89.4;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.0;35;;;24.6;47;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.1;6.1;;;5.4;6.8;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;76.6;76.6;;;63.5;86;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.6;13.6;;;7.9;22.2;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.6;10.6;;;9.4;11.9;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.3;48.3;;;36.4;60.4;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.0;10;;;8.8;11.4;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.5;41.5;;;35.2;48.2;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.0;71;;;63;77.9;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.8;36.8;;;30;44.2;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;27.4;27.4;;;19.6;36.7;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;27.2;27.2;;;18.4;38.9;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.8;86.8;;;80.2;91.5;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.1;41.1;;;31.3;51.7;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.8;38.8;;;32.9;45;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.7;49.7;;;40.9;58.6;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.1;8.1;;;7;9.3;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;54.9;54.9;;;40;69;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.8;70.8;;;61.9;78.4;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;NMBR;RACE;AIAN;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2011;2011;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.8;11.8;;;8.5;16;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.3;48.3;;;44.2;52.5;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.1;13.1;;;11;15.6;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.0;7;;;4.1;11.6;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.3;38.3;;;32.6;44.4;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.5;91.5;;;83.6;95.8;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;30.3;30.3;;;21.3;41;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.0;37;;;31.9;42.4;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.5;65.5;;;54.7;74.8;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2011;2011;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;NMBR;RACE;HIS;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.4;36.4;;;28.2;45.6;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.2;41.2;;;34.7;48;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.5;38.5;;;31.3;46.2;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.5;89.5;;;83.6;93.5;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.1;5.1;;;4.3;6.1;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.4;71.4;;;55.1;83.5;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.7;39.7;;;30.9;49.2;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.4;8.4;;;4.7;14.5;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.3;38.3;;;23.8;55.2;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.2;40.2;;;30.1;51.1;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.7;37.7;;;29.5;46.7;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.1;7.1;;;5.8;8.8;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;22.4;22.4;;;12.3;37.3;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2011;2011;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2011;2011;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.2;11.2;;;8.8;14.1;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;27.5;27.5;;;16.6;41.9;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2011;2011;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.9;12.9;;;10.2;16.2;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2011;2011;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.907192, -77.036871);;11;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.4;10.4;;;8.4;12.9;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;81.0;81;;;69;89.1;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.5;84.5;;;76.1;90.3;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.9;8.9;;;4.9;15.5;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.0;8;;;7.1;9;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2011;2011;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;6.1;6.1;;;3.9;9.1;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;18.2;18.2;;;12;26.5;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2011;2011;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.6;10.6;;;9.8;11.5;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50.8;50.8;;;45.8;55.7;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2011;2011;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;CRDRATE;RACE;API;;;;
2011;2011;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;92.9;92.9;;;85.7;96.6;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2011;2011;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.5;35.5;;;27.4;44.5;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;16.6;16.6;;;12;22.6;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;19.4;19.4;;;10.9;32.3;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.1;10.1;;;9.2;11.2;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.0;85;*;50 States + DC: US Median;81.3;86.1;Gender;Male;;;;;;;59;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;15.4;15.4;;;10.2;22.2;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2011;2011;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.3;7.3;;;4.6;10.9;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.0;87;;;79.5;92;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.0;41;;;33.2;49.2;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;15.4;15.4;;;14.3;16.6;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2011;2011;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.3;13.3;;;11.5;15.1;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2011;2011;CA;California;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;18.1;18.1;;;12.5;25.3;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.7;6.7;;;5.5;8.1;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;92.7;92.7;;;87.9;95.8;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.2;8.2;;;7.3;9.1;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.6;10.6;;;7.7;14.4;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.7;8.7;;;7.6;9.9;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2011;2011;TX;Texas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;NMBR;RACE;API;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;73.8;73.8;;;66;80.4;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2011;2011;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.4;7.4;;;5.4;9.9;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.1;39.1;;;30.6;48.4;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.0;87;;;74.4;93.9;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.5;43.5;;;38.5;48.6;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.3;13.3;;;12.3;14.4;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2011;2011;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.0;66;;;60.8;70.9;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2011;2011;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;;Number;45;45;;;;;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;NMBR;GENDER;GENF;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2011;2011;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.4;6.4;;;5.6;7.4;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.0;37;;;30.2;44.3;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2011;2011;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.0;12;;;9.5;14.9;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.3;10.3;;;9.3;11.5;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.1;9.1;;;8.3;10;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;29.3;29.3;;;18.4;43;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.5;91.5;;;86.6;94.7;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.2;34.2;;;28.6;40.4;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.1;10.1;;;8.9;11.4;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.8;8.8;;;6.7;11.4;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;5.3;5.3;;;3.4;8.1;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.6;68.6;;;61.1;75.2;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.8;35.8;;;28.5;43.9;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.8;46.8;;;38.4;55.3;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.4;35.4;;;28.8;42.7;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;64.1;64.1;;;53.5;73.5;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.5;72.5;;;60.5;81.9;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;5.5;5.5;;;3.4;8.6;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;4.2;4.2;;;2.4;7.5;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2011;2011;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.8;10.8;;;8.4;13.6;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;4.5;4.5;;;3.6;5.6;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2011;2011;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;81.7;81.7;;;75.2;86.8;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.9;71.9;;;64;78.7;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.7;39.7;;;34.5;45.1;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;;Number;20;20;;;;;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;NMBR;GENDER;GENM;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.8;83.8;;;79;87.7;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.4;10.4;;;6.6;15.5;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.9;39.9;;;31.5;49;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.9;6.9;;;5.2;9.2;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.3;8.3;;;7.3;9.4;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;NMBR;RACE;HIS;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.1;12.1;;;10.1;14.5;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.4;12.4;;;9;16.7;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;56.5;56.5;;;45.9;66.5;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.9;64.9;;;57.2;71.9;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.6;39.6;;;34;45.6;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.3;69.3;;;60.6;76.8;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.1;44.1;;;29.6;59.7;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.0;71;;;59.4;80.3;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.9;83.9;;;65.5;93.5;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2011;2011;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2011;2011;US;United States;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.1;9.1;*;50 States + DC: US Median;8.7;9.5;Overall;Overall;;;;;;;59;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.8;38.8;;;27;52;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.6;13.6;;;10.2;17.8;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2011;2011;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2011;2011;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;NMBR;RACE;BLK;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.9;9.9;;;7.9;12.4;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.0;87;;;80.8;91.5;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;51.4;51.4;;;38.7;63.9;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;NMBR;RACE;AIAN;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.7;85.7;;;73.4;92.8;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;78.9;78.9;;;66.2;87.7;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2011;2011;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.4;13.4;;;9.7;18;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.6;35.6;;;30;41.5;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2011;2011;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;NMBR;RACE;API;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.6;38.6;;;32.4;45.3;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.0;7;;;6.4;7.6;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2011;2011;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;22;22;;;;;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.4;71.4;;;55.9;83.1;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;15.4;15.4;;;13.8;17.1;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.8;40.8;;;31.9;50.4;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;48.9;48.9;;;39.8;58;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;77.8;77.8;;;68;85.3;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;52.5;52.5;;;43;61.9;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.5;7.5;;;6.4;8.8;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.4;8.4;;;6.4;10.9;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.3;63.3;;;52.4;73;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.6;9.6;;;8.7;10.5;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;80.4;80.4;;;69.4;88.2;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.0;71;;;62.8;77.9;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.3;10.3;;;8.5;12;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.5;85.5;;;78;90.8;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.6;66.6;;;57.3;74.7;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.6;44.6;;;34;55.8;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.2;36.2;;;29.8;43;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.5;63.5;;;54.5;71.6;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.9;69.9;;;61.1;77.4;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.0;44;;;36.5;51.9;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;NMBR;RACE;HIS;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2011;2011;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;NMBR;RACE;HIS;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.5;40.5;;;35.4;45.9;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;NMBR;RACE;AIAN;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;73.9;73.9;;;61.3;83.4;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2011;2011;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;NMBR;RACE;AIAN;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;92.9;92.9;;;86.9;96.3;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.2;71.2;;;60.1;80.2;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;5.8;5.8;;;3.5;9.5;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.3;40.3;;;32.5;48.6;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;78.4;78.4;;;72.6;83.3;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;78.4;78.4;;;68.8;85.7;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;58.8;58.8;;;44;72.1;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.4;47.4;;;37.2;57.8;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.5;45.5;;;39.1;52.1;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.0;69;;;50.7;82.9;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2011;2011;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;16.2;16.2;;;10.5;24.1;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;79.0;79;;;70;85.9;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2011;2011;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.1;9.1;;;8;10.2;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.4;33.4;;;20.5;49.4;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.7;37.7;;;29.3;46.9;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2011;2011;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.9;9.9;;;7.4;13;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.0;37;;;24.4;51.6;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2011;2011;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;NMBR;RACE;HIS;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.9;11.9;;;10.5;13.6;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2011;2011;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;;Number;53;53;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;NMBR;RACE;WHT;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.5;40.5;;;26.9;55.8;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.3;31.3;;;23.4;40.4;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.5;33.5;;;24.4;44;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.8;8.8;;;8;9.7;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2011;2011;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.5;10.5;;;7.8;14;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.8;89.8;;;84.8;93.3;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;4.0;4;;;2.9;5.5;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.8;41.8;;;36.6;47.3;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;15.3;15.3;;;8.5;26.2;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2011;2011;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;20.3;20.3;;;14.6;27.4;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.4;70.4;;;57.6;80.7;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;15.0;15;;;9.3;23.1;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.6;32.6;;;27.2;38.6;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.7;10.7;;;6.3;17.5;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.5;9.5;;;7.3;12.3;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.3;40.3;;;35.9;44.8;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;74.3;74.3;;;56.5;86.6;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.2;14.2;;;9.5;20.6;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.6;9.6;;;8.5;10.8;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.3;9.3;;;8.2;10.6;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2011;2011;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;NMBR;GENDER;GENM;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.8;85.8;;;70.8;93.8;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.3;89.3;;;80.9;94.3;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.7;67.7;;;55;78.3;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.8;68.8;;;54.4;80.3;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;4.3;4.3;;;3.4;5.5;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.4;83.4;;;75.5;89.1;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2011;2011;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.5;68.5;;;62.3;74;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2011;2011;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;NMBR;GENDER;GENM;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.7;36.7;;;30.7;43;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;;Number;40;40;;;;;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;NMBR;GENDER;GENF;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2011;2011;FL;Florida;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;NMBR;RACE;AIAN;;;;
2011;2011;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2011;2011;UT;Utah;NVSS;Asthma;Asthma mortality rate;;;Number;29;29;;;;;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;NMBR;GENDER;GENF;;;;
2011;2011;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;5.1;5.1;;;3.2;7.6;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;19.0;19;;;16.7;21.6;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.0;33;;;26.4;40.4;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.8;41.8;;;34.2;49.8;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.5;9.5;;;7.6;11.8;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2011;2011;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2011;2011;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2011;2011;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.8;42.8;;;37.4;48.3;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.8;43.8;;;36.6;51.2;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2011;2011;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;;Number;29;29;;;;;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;NMBR;GENDER;GENM;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;94.6;94.6;;;87.5;97.8;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.2;11.2;;;7;17.4;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.9;8.9;;;7;11.3;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.1;12.1;;;11;13.4;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.6;38.6;;;33;44.5;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2011;2011;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2011;2011;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.3;9.3;;;6.4;13;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.7;11.7;;;8;16.9;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2011;2011;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.5;33.5;;;28.4;39;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;NMBR;RACE;BLK;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.2;84.2;;;79.7;87.8;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;;Number;38;38;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;NMBR;RACE;WHT;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.1;12.1;;;10.1;14.5;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.9;11.9;;;9.9;14.2;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;93.3;93.3;;;86.7;96.8;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.7;11.7;;;9.1;15;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.9;8.9;;;6.8;11.5;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2011;2011;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.4;68.4;;;58.5;77;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;;Number;24;24;;;;;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;NMBR;GENDER;GENF;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.4;9.4;;;7.5;11.7;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.9;38.9;;;33.4;44.7;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.8;9.8;;;8.7;11;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.7;48.7;;;41.6;55.8;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2011;2011;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.2;6.2;;;5.3;7.1;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.6;33.6;;;21.9;47.7;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2011;2011;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.2;10.2;;;6.5;15.4;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;3.5;3.5;;;2;6.1;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2011;2011;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.8;7.8;;;6.5;9;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;93.9;93.9;;;86.2;97.4;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.2;40.2;;;28.8;52.7;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.0;11;;;9.9;12.2;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.9;87.9;;;79;93.3;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.3;10.3;;;8.3;12.5;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.9;88.9;;;82.4;93.2;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2011;2011;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;52.0;52;;;43.5;60.5;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.7;35.7;;;27.6;44.7;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.5;9.5;;;8.5;10.7;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.6;8.6;;;5.4;13.1;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2011;2011;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;25.8;25.8;;;17.5;36.6;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2011;2011;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;NMBR;GENDER;GENM;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.8;6.8;;;5.2;8.9;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;92.8;92.8;;;87.2;96;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.1;45.1;;;39.3;51;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.9;62.9;;;49.8;74.4;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.8;6.8;;;5.9;7.9;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;CRDRATE;RACE;API;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.8;46.8;;;33.8;60.2;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2011;2011;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;CRDRATE;RACE;API;;;;
2011;2011;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;23.9;23.9;;;16.5;33.4;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.9;39.9;;;32.8;47.5;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.5;66.5;;;58;74;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;15.5;15.5;;;9.6;24.1;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;16.1;16.1;;;9.9;25.2;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.7;40.7;;;33.1;48.8;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;17.4;17.4;;;11.9;24.5;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.3;40.3;;;34.8;46.1;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.1;10.1;;;7.7;13.3;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2011;2011;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;NMBR;GENDER;GENM;;;;
2011;2011;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST4_1;NMBR;RACE;WHT;;;;
2011;2011;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;NMBR;RACE;API;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.8;8.8;;;7.4;10.5;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2011;2011;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;;Number;20;20;;;;;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;NMBR;GENDER;GENM;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.3;45.3;;;33.4;57.8;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.9;8.9;;;7.8;10.2;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.8;12.8;;;8.2;19.3;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.9;11.9;;;7.4;18;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.7;62.7;;;49.6;74.2;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.2;6.2;;;5.2;7.3;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;7.2;7.2;;;5.7;9;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.3;30.3;;;21.2;41.3;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.1;41.1;;;23.5;61.3;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2011;2011;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;;Number;63;63;;;;;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;NMBR;GENDER;GENF;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;79.8;79.8;;;67.2;88.4;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.2;11.2;;;8.5;14.5;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.4;35.4;;;27.8;43.7;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.2;13.2;;;11.9;14.6;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.3;64.3;;;52.2;74.9;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.4;86.4;;;79.3;91.3;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.4;9.4;;;6.9;12.6;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2011;2011;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;58.0;58;;;50.5;65.2;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;20.5;20.5;;;13.8;29.3;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2011;2011;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;76.4;76.4;;;66.7;83.9;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;NMBR;RACE;BLK;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.7;33.7;;;27.6;40.4;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.7;86.7;;;77.1;92.7;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;91.0;91;;;84.5;95;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2011;2011;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.0;11;;;8.3;14.2;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;CRDRATE;RACE;API;;;;
2011;2011;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.3;14.3;;;11;18.3;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.1;48.1;;;40.5;55.7;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.4;65.4;;;51.5;77;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2011;2011;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;51;51;;;;;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;NMBR;GENDER;GENF;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2011;2011;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2011;2011;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.8;42.8;*;50 States + DC: US Median;41.5;44.7;Gender;Female;;;;;;;59;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67.0;67;;;61.5;72;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.0;88;;;78;93.8;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.1;88.1;;;83.5;91.5;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;75.0;75;;;66.7;81.8;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.0;38;;;31.7;44.8;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.2;40.2;;;27.3;54.5;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.9;7.9;;;6.7;9.2;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;CRDRATE;RACE;API;;;;
2011;2011;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;NMBR;RACE;HIS;;;;
2011;2011;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2011;2011;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.8;68.8;*;50 States + DC: US Median;65.5;74;Gender;Male;;;;;;;59;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.6;9.6;;;7.1;12.9;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;74.2;74.2;;;62.4;83.2;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;CRDRATE;RACE;API;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.8;39.8;;;34.5;45.4;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2011;2011;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.8;10.8;;;8.7;13.4;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.5;32.5;;;23.2;43.4;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2011;2011;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;92.2;92.2;;;86.7;95.5;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.3;12.3;;;10.8;13.8;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.1;10.1;;;5.9;17;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.6;10.6;;;6.2;17.4;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;MT;Montana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;NMBR;RACE;WHT;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.6;41.6;;;36.1;47.2;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.0;41;;;33;49.3;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;8.0;8;;;7.1;9;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2011;2011;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;NMBR;RACE;AIAN;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2011;2011;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.7;12.7;;;11.1;14.3;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.6;86.6;;;80.5;91.1;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.3;7.3;;;6.3;8.6;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;6.2;6.2;;;4.6;8.1;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.6;7.6;;;4.4;12.8;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;94.2;94.2;;;87.5;97.4;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.0;9;;;8.3;9.8;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;15.6;15.6;;;11.3;21;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.5;65.5;;;51.4;77.3;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;CRDRATE;RACE;API;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.3;70.3;;;54.7;82.3;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.0;41;;;27.8;55.8;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.9;33.9;;;26.2;42.5;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.4;40.4;;;32;49.3;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.0;72;;;58.5;82.5;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.4;84.4;;;74.9;90.8;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.9;34.9;;;29.9;40.2;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.8;9.8;;;8.1;11.8;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.9;68.9;;;60.1;76.5;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.5;31.5;;;23.7;40.6;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.7;9.7;;;8.3;11.3;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.5;9.5;;;7.8;11.4;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.9;7.9;;;6.7;9.2;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.8;42.8;;;38.9;46.8;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.3;8.3;;;7.6;9;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.7;68.7;;;53.6;80.7;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2011;2011;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;21.2;21.2;;;14.9;29.3;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.3;37.3;;;29.1;46.2;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.3;6.3;;;4.8;8.2;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;16.8;16.8;;;11.1;24.5;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.3;45.3;;;39.7;51.2;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;15.4;15.4;;;10.6;21.9;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;20.1;20.1;;;11.3;33.2;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.8;32.8;;;22.5;45;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.0;8;;;5.1;11.8;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2011;2011;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.8;8.8;;;6.1;12.2;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2011;2011;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.8;66.8;;;52.8;78.3;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.3;70.3;;;51.2;84.2;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2011;2011;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.7;9.7;;;8.7;10.8;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;7.1;7.1;;;4.4;11.2;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.2;84.2;;;76.5;89.6;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2011;2011;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;NMBR;RACE;AIAN;;;;
2011;2011;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.5;12.5;;;8.9;17;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2011;2011;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;;Number;35;35;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;NMBR;RACE;BLK;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.6;41.6;;;34.2;49.4;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;76.2;76.2;;;66.1;84;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;8.0;8;;;6;10.7;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.0;38;;;30.3;46.3;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2011;2011;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.1;66.1;;;51.3;78.3;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;58.3;58.3;;;42.8;72.3;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.5;40.5;;;30.7;51.2;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50.8;50.8;;;42;59.5;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;24.0;24;;;14.5;37;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.7;8.7;;;8;9.3;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;;Number;64;64;;;;;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.1;68.1;;;59;75.9;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;73.9;73.9;;;64;81.8;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2011;2011;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.9;6.9;;;5.8;8.3;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.8;6.8;;;4.4;10.4;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;15.5;15.5;;;10.3;22.7;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.6;87.6;;;82;91.6;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;4.9;4.9;;;2.7;8.7;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;8.4;8.4;;;6.6;10.5;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.9;14.9;;;10.2;21.3;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2011;2011;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.1;36.1;;;31.4;41.1;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.0;37;;;29.6;45;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.7;41.7;;;33.9;49.8;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;27.7;27.7;;;20.9;35.7;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2011;2011;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90.0;90;;;81.8;94.7;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.8;8.8;;;6.5;11.8;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.5;45.5;;;38.1;53.1;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;76.4;76.4;;;65.1;85;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.3;39.3;;;34.2;44.5;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.2;39.2;;;29.3;50.2;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2011;2011;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.6;7.6;;;6.5;8.8;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2011;2011;NY;New York;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.8;12.8;;;10.5;15.5;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.5;70.5;;;55;82.3;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.7;37.7;;;31;44.9;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;55.7;55.7;;;48.1;63.1;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2011;2011;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.0;41;;;35.2;47;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.9;39.9;;;32.5;47.7;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;53.9;53.9;;;43.4;64;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.7;89.7;;;84.7;93.2;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.6;35.6;;;29.8;41.9;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.4;34.4;;;25.4;44.8;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.4;46.4;;;35.3;57.8;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.0;42;;;35.3;48.9;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.7;10.7;;;9.7;11.8;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.1;7.1;;;5.7;8.8;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.4;38.4;;;28.7;49.2;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.5;9.5;;;8;11;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.0;87;;;78.8;92.3;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.5;34.5;;;24.4;46.1;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.0;34;;;28;40.4;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.4;65.4;;;59.1;71.3;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.6;33.6;;;23.2;45.8;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.0;41;;;35.4;46.8;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2011;2011;UT;Utah;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;NMBR;RACE;AIAN;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.7;9.7;;;8.7;10.8;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.8;10.8;;;10.1;11.6;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;74.7;74.7;;;60.1;85.3;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2011;2011;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.1;10.1;;;6.1;16.4;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.1;49.1;;;42.6;55.6;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;64.1;64.1;;;56.4;71.2;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.2;48.2;;;42.2;54.3;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2011;2011;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.4;66.4;;;58.5;73.5;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.6;41.6;;;37.3;46.1;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.9;71.9;;;55.2;84.1;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.4;91.4;;;85.6;95;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2011;2011;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.7;82.7;;;72.8;89.5;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.4;32.4;;;19.3;49.1;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.0;5;;;3.6;7;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2011;2011;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2011;2011;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.1;7.1;;;4.9;10.1;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2011;2011;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.7;14.7;;;10.5;20;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.2;11.2;;;10.2;12.4;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2011;2011;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;NMBR;RACE;API;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.1;11.1;;;10.1;12.2;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.5;7.5;;;5.2;10.6;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.8;11.8;;;7.9;17.1;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2011;2011;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.5;7.5;;;5.2;10.4;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.9;8.9;;;7.9;9.9;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.1;10.1;;;7.6;13;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.7;14.7;;;10.1;20.8;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.9;38.9;;;31.4;47;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.5;9.5;;;8.2;10.9;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.4;84.4;;;76.5;90;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.9;85.9;;;75.8;92.2;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.3;5.3;;;4;6.9;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.5;11.5;;;10.4;12.8;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.6;45.6;;;39;52.4;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2011;2011;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.8;9.8;;;8.1;11.6;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.7;38.7;;;25.6;53.6;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;21.0;21;;;16.9;25.9;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.5;38.5;;;27;51.4;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.5;8.5;;;7.1;10.3;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.2;91.2;;;85.9;94.6;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;51.8;51.8;;;41.8;61.7;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.0;69;;;51.1;82.7;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.7;48.7;;;41.5;56.1;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.6;9.6;;;8.7;10.6;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;77.4;77.4;;;66.3;85.6;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;NMBR;RACE;API;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.4;33.4;;;25;43;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.7;35.7;;;30.2;41.6;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.0;44;;;34.8;53.5;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.1;11.1;;;7.2;16.7;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;16.3;16.3;;;10.7;23.9;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.9;85.9;;;79.1;90.8;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;5.2;5.2;;;3.9;6.9;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.5;31.5;;;21.6;43.4;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;24.0;24;;;16.5;33.6;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.0;34;;;26.4;42.6;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.7;32.7;;;25.4;41;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.4;10.4;;;9.3;11.5;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2011;2011;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;NMBR;RACE;HIS;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.5;7.5;;;6.2;8.9;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2011;2011;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.9;7.9;;;6.2;9.9;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.907192, -77.036871);;11;AST;AST4_1;CRDRATE;RACE;API;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.4;45.4;;;38.5;52.4;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;20.4;20.4;;;14.9;27.3;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.0;14;;;12.4;15.7;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.6;6.6;;;5.4;8.1;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2011;2011;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.8;34.8;;;27.7;42.7;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.0;28;;;20.3;37.3;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;;Number;48;48;;;;;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2011;2011;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.2;68.2;*;50 States + DC: US Median;66;70.1;Overall;Overall;;;;;;;59;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;27.5;27.5;;;20.8;35.4;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.9;38.9;;;29.8;48.9;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.9;45.9;;;39;53;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.0;71;;;54.1;83.6;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.7;85.7;;;79.7;90.1;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;18.1;18.1;;;13.5;23.7;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;53.2;53.2;;;38;67.9;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.7;33.7;;;26.4;41.8;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.3;40.3;;;35.7;45.2;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.8;9.8;;;5.4;17.1;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.0;8;;;6.8;9.1;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.3;42.3;;;38.8;46;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.8;5.8;;;4.8;7;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.7;34.7;;;25.4;45.3;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.4;32.4;;;21.4;45.9;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2011;2011;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;NMBR;RACE;AIAN;;;;
2011;2011;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.4;37.4;*;50 States + DC: US Median;36.6;38.9;Gender;Female;;;;;;;59;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;;Number;28;28;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;NMBR;RACE;WHT;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.3;34.3;;;22.8;47.9;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.9;45.9;;;38.8;53.3;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.0;11;;;9.5;12.7;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.7;13.7;;;10;18.4;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2011;2011;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2011;2011;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;15.2;15.2;;;10;22.1;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.3;38.3;;;24.7;54;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.3;42.3;;;32.5;52.7;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.2;9.2;;;8;10.5;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2011;2011;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;CRDRATE;RACE;API;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.8;46.8;;;40.7;53;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;NMBR;RACE;AIAN;;;;
2011;2011;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2011;2011;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.2;11.2;;;9;13.8;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2011;2011;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.4;10.4;;;8.1;13.2;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2011;2011;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.6;14.6;;;10.5;19.7;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.1;9.1;;;5.3;15.2;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.9;82.9;;;75.5;88.3;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.9;39.9;;;34.2;45.9;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.5;43.5;;;37.7;49.5;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.1;9.1;;;8.1;10.3;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.7;87.7;;;82.8;91.4;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2011;2011;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.5;37.5;;;29.8;45.9;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;NMBR;RACE;AIAN;;;;
2011;2011;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;;Number;22;22;;;;;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;NMBR;GENDER;GENF;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;54.3;54.3;;;38.6;69.2;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.2;38.2;;;34.3;42.4;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;91.0;91;;;85.8;94.4;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.6;36.6;;;25;50;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.0;48;;;43.9;52.1;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;72.2;72.2;;;64;79.1;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.0;9;;;6.7;12.1;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.3;34.3;;;24;46.4;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.1;71.1;;;62.6;78.3;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.7;8.7;;;7.8;9.8;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.0;9;;;8.3;9.8;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.2;11.2;;;9.5;13.1;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2011;2011;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.5;8.5;;;7.8;9.3;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.6;10.6;;;7.8;14.4;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2011;2011;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.5;12.5;;;8.2;18.3;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;67.2;67.2;;;57.7;75.5;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;49.6;49.6;;;37.5;61.7;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.0;9;;;7.7;10.6;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.1;67.1;;;54.3;77.8;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2011;2011;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;;Number;69;69;;;;;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.2;71.2;;;55;83.3;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.2;45.2;;;35.1;55.7;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2011;2011;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;20.3;20.3;;;13.9;28.7;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.3;40.3;;;34;46.9;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2011;2011;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.8;10.8;;;7.4;15.1;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.4;84.4;;;69.4;92.8;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2011;2011;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2011;2011;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;15.1;15.1;;;10.9;20.4;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.3;89.3;;;83.1;93.4;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;53.4;53.4;;;38.3;67.9;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2011;2011;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;21.2;21.2;;;12.6;33.5;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2011;2011;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.6;10.6;;;9.6;11.8;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2011;2011;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;36.1;36.1;;;29.2;42.9;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;24.6;24.6;;;13.4;40.6;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.2;82.2;;;73.9;88.3;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.7;9.7;;;8.8;10.7;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.1;40.1;;;33;47.6;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;8.7;8.7;;;5.2;14.4;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.0;89;;;80.8;94;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;29.4;29.4;;;22.9;37.1;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2011;2011;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.1;34.1;;;27.9;41;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.6;35.6;;;28.5;43.4;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.8;9.8;;;8.8;11;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2011;2011;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.7;9.7;;;7.8;11.8;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;76.0;76;;;66.3;83.6;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.2;47.2;;;30.7;64.3;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.3;12.3;;;10.1;14.8;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;21.2;21.2;;;15.8;27.9;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.6;12.6;;;9.4;16.8;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;6.9;6.9;;;5.1;9.2;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.7;7.7;;;6.9;8.6;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2011;2011;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2011;2011;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;NMBR;RACE;BLK;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.8;39.8;;;35.9;43.8;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.9;39.9;*;50 States + DC: US Median;38.4;40.8;Gender;Female;;;;;;;59;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2011;2011;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.9;10.9;;;9.3;12.7;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;61.1;61.1;;;51.7;69.7;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;92.4;92.4;;;86.9;95.8;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2011;2011;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;NMBR;RACE;API;;;;
2011;2011;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.3;89.3;;;74.6;95.9;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.6;35.6;;;27.2;44.9;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;5.4;5.4;;;3.4;8.2;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.5;62.5;;;49.4;73.9;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.0;72;;;62.4;79.9;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;50.3;50.3;;;42.5;58.2;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.0;7;;;5.6;8.6;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.4;82.4;;;67;91.6;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2011;2011;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2011;2011;ME;Maine;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.1;33.1;;;23.7;44;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2011;2011;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.9;6.9;;;5.8;8.3;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.6;8.6;;;7.5;9.8;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2011;2011;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;CRDRATE;RACE;API;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2011;2011;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2011;2011;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.0;9;;;7.4;10.7;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.1;68.1;;;51.5;81;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.6;12.6;;;9.7;16.4;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.8;34.8;;;26.8;43.7;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2011;2011;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2011;2011;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.4;10.4;;;7.8;13.5;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.5;82.5;;;74.2;88.5;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2011;2011;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.6;33.6;;;28.1;39.5;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.8;32.8;;;24.7;41.9;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2011;2011;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.907192, -77.036871);;11;AST;AST4_1;NMBR;RACE;AIAN;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.4;38.4;;;32;45.2;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.0;91;;;84.9;94.8;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;19.8;19.8;;;10.9;33.1;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2011;2011;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2011;2011;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;92.0;92;;;83.9;96.2;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.7;66.7;;;55.5;76.3;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2011;2011;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.0;6;;;3.6;9.9;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.3;6.3;;;5.7;7.1;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.5;49.5;;;42.5;56.7;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.4;82.4;;;71.9;89.6;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;29.9;29.9;;;18;45.4;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2011;2011;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;NMBR;RACE;AIAN;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.7;9.7;;;5.4;16.9;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;16.2;16.2;;;14.9;17.6;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;73.0;73;;;63.6;80.7;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2011;2011;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.0;34;;;24.2;45.4;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.6;6.6;;;5.2;8.4;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.8;9.8;;;7.9;12;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;NMBR;RACE;HIS;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2011;2011;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;74.8;74.8;;;65.5;82.2;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2011;2011;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;6.7;6.7;;;4.3;10;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2011;2011;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;19.1;19.1;;;12.8;27.4;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.6;5.6;;;4.5;7;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.6;48.6;;;40.6;56.7;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.1;40.1;;;34.2;46.2;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.8;7.8;;;5.4;11.2;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;CRDRATE;RACE;API;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.0;12;;;7.8;17.9;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2011;2011;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.2;38.2;;;31.1;46;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.7;31.7;;;26.7;37.2;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2011;2011;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.5;41.5;;;35.1;48.3;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.2;89.2;;;83.3;93.3;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;49.6;49.6;;;40.3;58.9;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.7;38.7;;;31.9;46;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.6;68.6;;;59.4;76.5;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.0;67;;;61.6;72;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2011;2011;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2011;2011;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.4;41.4;;;31.8;51.6;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;51.9;51.9;;;35.2;68.1;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.1;82.1;;;73.6;88.2;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;64.4;64.4;;;49.6;76.8;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2011;2011;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.2;82.2;;;72.2;89.1;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.5;7.5;;;4.6;11.6;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.3;5.3;;;3.5;7.8;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;14.9;14.9;;;13.4;16.5;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2011;2011;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;NMBR;RACE;BLK;;;;
2011;2011;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2011;2011;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.8;5.8;;;4.8;6.9;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.1;9.1;;;8.4;9.9;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;;Number;50;50;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;NMBR;RACE;WHT;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;27.2;27.2;;;19.4;36.6;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;76.9;76.9;;;67.4;84.3;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.0;33;;;20;49.3;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.2;9.2;;;8.2;10.3;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.1;6.1;;;5.3;7;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.7;10.7;;;9.1;12.6;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;54.1;54.1;;;48.1;59.9;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.0;11;;;9.9;12.2;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;NMBR;RACE;AIAN;;;;
2011;2011;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.5;12.5;;;9.5;16.1;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.0;6;;;3.6;9.7;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.8;12.8;;;11.5;14.2;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;80.2;80.2;;;69.3;87.9;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2011;2011;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;NMBR;RACE;API;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.4;37.4;;;30.5;45;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2011;2011;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;54.1;54.1;;;39;68.5;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.7;39.7;;;32.8;47.1;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.6;71.6;;;63.5;78.6;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;23.0;23;;;15.4;33.1;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2011;2011;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.9;8.9;;;6.4;12;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.7;41.7;;;32.1;52;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.5;43.5;;;31.2;56.7;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.2;88.2;;;79.1;93.7;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.4;47.4;;;42.7;52.2;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.2;44.2;;;34.5;54.4;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.7;12.7;;;8.1;19.3;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.2;36.2;;;30.7;42;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.8;38.8;;;32.9;45;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;80.3;80.3;;;56.4;92.7;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.6;36.6;;;28.9;45.1;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.0;36;;;30.1;42.4;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.1;9.1;;;8;10.4;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.3;36.3;;;23.2;51.7;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.9;38.9;;;31.4;46.8;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.5;10.5;;;9.4;11.7;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;53.8;53.8;;;30.9;75.2;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.9;67.9;;;60.1;74.8;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2011;2011;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;CRDRATE;RACE;API;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.5;84.5;;;76.1;90.3;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2011;2011;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.9;32.9;;;21.7;46.5;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.1;11.1;;;8.5;14.4;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;92.6;92.6;;;88;95.5;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.6;43.6;;;37;50.5;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.9;6.9;;;6.3;7.6;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2011;2011;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2011;2011;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;CRDRATE;RACE;API;;;;
2011;2011;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;20.9;20.9;;;11.4;35.2;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.0;71;;;60.1;79.8;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.2;9.2;;;8.2;10.4;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;81.1;81.1;;;65.4;90.7;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.5;36.5;;;25.3;49.5;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.0;33;;;24;43.5;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.3;68.3;;;49;82.9;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.5;42.5;;;38;47.1;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;5.4;5.4;;;3.6;8;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.1;88.1;;;81.2;92.7;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.7;31.7;;;24.1;40.3;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;8.3;8.3;;;6.9;10;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;NMBR;RACE;BLK;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.6;9.6;;;5.9;15.3;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.5;37.5;;;26.4;50.2;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.6;84.6;;;76.2;90.4;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2011;2011;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;NMBR;GENDER;GENF;;;;
2011;2011;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;;Number;33;33;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;NMBR;RACE;BLK;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.5;40.5;;;31;50.8;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.5;63.5;;;46.9;77.4;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2011;2011;CA;California;NVSS;Asthma;Asthma mortality rate;;;Number;70;70;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;NMBR;RACE;BLK;;;;
2011;2011;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;29.8;29.8;;;18.5;44.2;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.0;87;;;80.4;91.6;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.6;40.6;;;34.7;46.8;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.4;13.4;;;11.9;15.1;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2011;2011;NY;New York;NVSS;Asthma;Asthma mortality rate;;;Number;81;81;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;NMBR;RACE;WHT;;;;
2011;2011;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.2;8.2;;;6.1;10.8;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.4;37.4;;;34;41;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.1;37.1;;;32.6;41.9;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.7;38.7;;;33.2;44.4;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.9;89.9;;;85.2;93.2;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.2;43.2;;;36;50.6;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.0;42;;;29;56.3;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2011;2011;UT;Utah;NVSS;Asthma;Asthma mortality rate;;;Number;41;41;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;NMBR;RACE;WHT;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.7;33.7;;;26.9;41.2;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2011;2011;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.4;12.4;;;11.5;13.3;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.0;11;;;8.8;13.5;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;80.2;80.2;;;67.2;88.9;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.4;64.4;;;50.8;76;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.5;12.5;;;9;17.1;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2011;2011;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;;Number;42;42;;;;;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2011;2011;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;;Number;24;24;;;;;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;NMBR;GENDER;GENM;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.4;39.4;;;34.2;44.9;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;US;United States;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.1;9.1;*;50 States + DC: US Median;8.7;9.6;Overall;Overall;;;;;;;59;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;75.6;75.6;;;64.1;84.3;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.6;11.6;;;10.2;13.2;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.7;38.7;;;27.2;51.6;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.0;39;;;32.2;46.3;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.0;36;;;29.9;42.4;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.8;33.8;;;24.9;44;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.7;36.7;;;30.7;43;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.2;37.2;;;25.7;50.4;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;78.6;78.6;;;70.1;85.1;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.1;48.1;;;34.2;62.3;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2011;2011;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.8;39.8;;;33.5;46.3;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.1;7.1;;;5.7;8.7;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;7.6;7.6;;;6.5;8.9;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.2;89.2;;;83.8;93;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;63.1;63.1;;;43.4;79.2;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.8;87.8;;;68.3;96;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.1;44.1;*;50 States + DC: US Median;41.7;45.6;Gender;Female;;;;;;;59;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;15.1;15.1;;;10.6;20.9;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.4;71.4;;;63.5;78.1;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;64.9;64.9;;;53.6;74.7;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.8;6.8;;;4;11.4;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.2;38.2;;;27.8;49.8;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;NMBR;RACE;HIS;;;;
2011;2011;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;58.1;58.1;;;37.5;76.2;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2011;2011;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;NMBR;RACE;API;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90.4;90.4;;;83.9;94.5;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.5;64.5;;;52.7;74.7;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2011;2011;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;CRDRATE;RACE;API;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.9;72.9;;;61.7;81.8;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2011;2011;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2011;2011;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.4;37.4;;;29;46.8;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.6;39.6;;;32.4;47.2;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;77.6;77.6;;;68.2;84.8;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2011;2011;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.9;6.9;;;5.4;8.9;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.5;11.5;;;7;18.4;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.8;41.8;;;31.3;53.1;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;47.9;47.9;;;33.7;62.5;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.9;11.9;;;9.9;14.3;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.4;7.4;;;5.2;10.3;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2011;2011;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.4;13.4;;;10.9;16.3;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.2;91.2;;;85.9;94.6;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.7;40.7;;;27.7;55.2;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2011;2011;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.0;8;;;5.9;10.6;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.5;6.5;;;5.3;7.9;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.5;43.5;;;37.5;49.7;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2011;2011;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.1;69.1;;;60.5;76.5;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.9;45.9;;;38.6;53.3;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;56;56;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;NMBR;RACE;WHT;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.6;44.6;;;36.1;53.4;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;27.9;27.9;;;21;36;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;16.0;16;;;9.6;25.6;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.4;12.4;;;11.3;13.6;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2011;2011;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;NMBR;GENDER;GENM;;;;
2011;2011;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;NMBR;RACE;HIS;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.6;39.6;;;31.3;48.5;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;35.3;35.3;;;24;50;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.2;65.2;;;58.2;71.5;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.8;40.8;;;36.6;45.3;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.7;40.7;;;31.2;51;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2011;2011;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;CRDRATE;RACE;API;;;;
2011;2011;NY;New York;NVSS;Asthma;Asthma mortality rate;;;Number;106;106;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;NMBR;RACE;BLK;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2011;2011;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.7;10.7;;;8.6;13;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.5;63.5;;;54.6;71.5;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2011;2011;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;CRDRATE;RACE;API;;;;
2011;2011;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.7;37.7;*;50 States + DC: US Median;35.5;40.5;Gender;Male;;;;;;;59;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2011;2011;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;27.8;27.8;;;14.9;45.9;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2011;2011;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2011;2011;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.5;68.5;*;50 States + DC: US Median;65.4;70.2;Gender;Female;;;;;;;59;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.4;85.4;;;78.8;90.1;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.1;42.1;;;37.7;46.7;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.5;88.5;;;84.1;91.8;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.7;13.7;;;12;15.5;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;;Number;71;71;;;;;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.7;9.7;;;8.7;10.8;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.0;9;;;7.7;10.6;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;76.0;76;;;64.3;84.8;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.2;70.2;;;59;79.4;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2011;2011;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;;Number;44;44;;;;;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;NMBR;GENDER;GENF;;;;
2011;2011;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;CRDRATE;RACE;API;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.5;90.5;;;82.5;95.1;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.1;44.1;;;37.2;51.2;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.2;88.2;;;81.3;92.8;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;21.7;21.7;;;13.4;33.2;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;26.0;26;;;19.8;33.4;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.5;68.5;;;60.3;75.7;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.3;65.3;;;54.8;74.5;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2011;2011;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.8;9.8;;;7.9;11.9;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2011;2011;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;CRDRATE;RACE;API;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.2;89.2;;;81.3;94;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2011;2011;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.5;42.5;;;37.2;48;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;72.4;72.4;;;60.5;81.8;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2011;2011;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.1;40.1;;;33.7;46.8;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.4;31.4;;;21.6;43.3;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;20.0;20;;;12.2;30.9;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;80.2;80.2;;;67.1;88.9;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.7;13.7;;;11.7;15.7;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.0;40;;;34.6;45.7;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;61.6;61.6;;;41;78.7;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.3;6.3;;;5.7;7.1;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.7;85.7;;;72.5;93.1;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.2;9.2;;;8.2;10.4;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.8;47.8;;;42;53.6;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;69.0;69;;;55.5;79.8;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2011;2011;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;75.7;75.7;;;70.8;80;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.3;82.3;;;75.1;87.7;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.9;45.9;;;37.9;54.2;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.4;41.4;;;34.4;48.8;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.0;42;;;35.3;49;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.3;62.3;;;45.1;76.8;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2011;2011;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;15.7;15.7;;;9.6;24.2;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2011;2011;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;;Number;31;31;;;;;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;NMBR;GENDER;GENF;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.5;84.5;;;78;89.4;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.5;49.5;;;38.9;60.1;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.8;36.8;;;26.1;49.1;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.9;8.9;;;7.6;10.4;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;75.4;75.4;;;67.5;82;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.2;45.2;;;34.8;56.1;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.6;11.6;;;10.3;13;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.7;12.7;;;9.6;16.7;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;74.2;74.2;;;64.2;82.2;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.6;65.6;;;57.9;72.6;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2011;2011;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;NMBR;GENDER;GENM;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.1;36.1;;;24.3;49.9;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2011;2011;WA;Washington;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;NMBR;RACE;AIAN;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.8;34.8;;;26.2;44.6;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.7;6.7;;;5.7;7.9;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.5;40.5;;;34.4;46.9;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.6;7.6;;;4.6;12.2;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2011;2011;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;CRDRATE;RACE;API;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.1;41.1;;;34.7;47.7;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;4.9;4.9;;;4.2;5.7;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.6;39.6;;;34.5;45;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.7;41.7;;;35.2;48.4;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2011;2011;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2011;2011;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.0;11;;;10;12.1;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.5;38.5;;;33.5;43.7;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.8;7.8;;;5.2;11.5;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;64.0;64;;;51.7;74.8;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;NMBR;RACE;WHT;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.3;91.3;;;83.9;95.5;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.5;7.5;;;5.5;9.9;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.7;83.7;;;74.2;90.2;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;15.1;15.1;;;11.7;19.2;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2011;2011;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.5;48.5;;;34.4;62.8;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;4.9;4.9;;;3.9;6.2;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.0;70;;;60;78.4;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.0;8;;;7.1;8.9;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.3;32.3;;;22.8;43.5;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;7.7;7.7;;;4.4;13.2;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2011;2011;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;21.4;21.4;;;12.3;34.6;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;80.6;80.6;;;69.2;88.5;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.2;43.2;;;36.6;49.9;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.6;8.6;;;7.1;10.3;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.9;9.9;;;6.1;15.1;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2011;2011;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.0;13;;;9.6;17.3;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.0;8;;;4.7;13.3;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.6;71.6;;;64.4;77.9;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;81.7;81.7;;;61.8;92.5;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.3;11.3;;;10.5;12.2;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.3;10.3;;;9.4;11.3;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2011;2011;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;NMBR;RACE;BLK;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.7;8.7;;;7.3;10.4;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.9;32.9;;;24;43.2;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2011;2011;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.4;5.4;;;4;7.4;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.6;36.6;;;27.4;46.9;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.7;11.7;;;10.6;13;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2011;2011;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.4;72.4;;;59.6;82.3;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.8;6.8;;;4.8;9.4;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;26.8;26.8;;;19.5;35.6;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.2;38.2;;;33.7;42.9;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.3;44.3;;;37.5;51.2;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2011;2011;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.9;39.9;;;32.5;47.9;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2011;2011;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;74.9;74.9;;;57.2;86.9;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;74.2;74.2;;;59.3;85;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2011;2011;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;19.5;19.5;;;12.8;28.6;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.0;85;;;76.4;90.8;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.3;32.3;;;19.5;48.6;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2011;2011;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.2;14.2;;;11.3;17.6;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.7;88.7;;;84.2;92.1;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.1;8.1;;;6.9;9.6;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;60.8;60.8;;;48.4;71.9;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.3;85.3;;;78.1;90.4;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2011;2011;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.0;7;;;4.1;11.5;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.9;63.9;;;54.3;72.5;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.8;28.8;;;17.4;43.7;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;6.4;6.4;;;4.2;9.3;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.1;83.1;;;73.4;89.8;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.8;71.8;;;59.2;81.7;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.8;48.8;;;37;60.9;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;64.0;64;;;56.8;70.6;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;NMBR;RACE;WHT;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.1;38.1;;;32.4;44.1;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.4;13.4;;;10.5;17;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2011;2011;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;NMBR;RACE;WHT;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.7;9.7;;;8.9;10.6;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;NMBR;RACE;API;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.4;40.4;;;33.6;47.6;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2011;2011;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;24.3;24.3;;;14.8;37.5;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;80.7;80.7;;;72.1;87.2;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.8;9.8;;;8.3;11.6;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.5;30.5;;;21.9;40.8;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.0;90;;;82.5;94.5;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;89.1;89.1;;;84.8;92.3;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.9;9.9;;;8.7;11.2;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.5;8.5;;;7.6;9.4;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;NMBR;RACE;AIAN;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.0;9;;;8.3;9.8;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.5;40.5;;;32;49.7;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.8;48.8;;;40.3;57.3;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;64.0;64;;;55.5;71.7;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.3;66.3;;;49.5;79.8;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.5;11.5;;;7;18.2;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2011;2011;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.1;8.1;;;5.3;11.9;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2011;2011;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.3;40.3;;;22.6;60.9;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2011;2011;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2011;2011;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.9;85.9;;;78.2;91.2;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.1;10.1;;;9;11.4;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.2;9.2;;;8;10.5;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.7;33.7;;;26.3;41.9;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.7;86.7;;;80.5;91.1;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2011;2011;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.2;38.2;;;26.2;51.9;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.8;44.8;;;38.4;51.3;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;81.4;81.4;;;71.6;88.3;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.9;40.9;;;31.2;51.4;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;NMBR;RACE;AIAN;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.8;5.8;;;3.4;9.6;Race/Ethnicity;Other, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2011;2011;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.5;66.5;;;56.3;75.4;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2011;2011;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.1;9.1;;;7;11.6;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;76.7;76.7;;;60.8;87.5;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;26.4;26.4;;;20.1;33.9;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.5;40.5;;;34.9;46.3;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.4;30.4;;;25.1;36.2;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;79.8;79.8;;;70.7;86.6;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2011;2011;NY;New York;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.4;14.4;;;10;20.2;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.4;84.4;;;76.2;90.2;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.4;36.4;;;31.4;41.6;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.0;82;;;73.2;88.3;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.4;47.4;;;42.2;52.7;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;NMBR;RACE;BLK;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.8;8.8;;;8.2;9.3;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.7;6.7;;;5.6;8.1;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.9;6.9;;;5.2;9.1;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.9;6.9;;;5.2;9.1;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.9;8.9;;;7.6;10.5;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;51.5;51.5;;;43;60;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2011;2011;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.7;9.7;;;8.8;10.7;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.1;8.1;;;7.1;9.2;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;81.4;81.4;;;68.7;89.8;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2011;2011;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;31.0;31;;;24;39.3;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2011;2011;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;;Number;47;47;;;;;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;NMBR;GENDER;GENF;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;WA;Washington;NVSS;Asthma;Asthma mortality rate;;;Number;63;63;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;NMBR;RACE;WHT;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.6;7.6;;;6.9;8.4;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.8;10.8;;;9.9;11.7;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;;Number;60;60;;;;;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.8;35.8;;;25.2;48.1;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.7;9.7;;;8.9;10.6;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.7;70.7;;;64.3;76.4;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2011;2011;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;;Number;20;20;;;;;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;NMBR;GENDER;GENF;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.2;6.2;;;5.2;7.3;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;24.5;24.5;;;17.6;33;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.3;37.3;;;28.3;47.3;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.3;45.3;;;39.5;51.3;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;52.7;52.7;;;42.4;62.8;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.0;9;;;8;10.1;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2011;2011;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.6;8.6;;;5.2;13.5;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.6;37.6;;;26.5;50.1;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.2;8.2;;;7.5;9.1;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2011;2011;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.9;84.9;;;74.9;91.5;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;79.6;79.6;;;65.5;88.9;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.1;7.1;;;6;8.4;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2011;2011;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.7;45.7;;;39;52.5;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.907192, -77.036871);;11;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2011;2011;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2011;2011;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.3;39.3;;;34;44.8;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.6;8.6;;;8;9.4;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2011;2011;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.3;84.3;;;77.2;89.5;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2011;2011;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.7;36.7;;;25;50.2;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.9;84.9;;;75.8;90.9;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2011;2011;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.8;35.8;;;29.4;42.7;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.3;88.3;;;77.4;94.3;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.4;10.4;;;7.8;13.9;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.8;86.8;;;79.8;91.7;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.2;9.2;;;7.4;10.9;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2011;2011;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2011;2011;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2011;2011;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;NMBR;RACE;AIAN;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.3;38.3;;;32.8;44.1;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2011;2011;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;54.8;54.8;;;43.5;65.6;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;51.0;51;;;45.8;56.2;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;81.9;81.9;;;74.6;87.4;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.9;6.9;;;4.7;10;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;85.8;85.8;;;75.2;92.4;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;73.1;73.1;;;63.8;80.7;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.2;44.2;;;34.8;54.1;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;FL;Florida;NVSS;Asthma;Asthma mortality rate;;;Number;54;54;;;;;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;NMBR;GENDER;GENM;;;;
2011;2011;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.2;9.2;;;7.1;11.7;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2011;2011;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2011;2011;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.6;11.6;;;10.4;12.9;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;61.3;61.3;;;52.3;69.6;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.3;12.3;;;9.8;15.4;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.8;45.8;;;38.7;53;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.4;38.4;;;33.3;43.8;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.6;8.6;;;7.8;9.5;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2011;2011;US;United States;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.6;11.6;*;50 States + DC: US Median;10.7;12.1;Gender;Female;;;;;;;59;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.2;11.2;;;10.1;12.3;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2011;2011;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;20.1;20.1;;;14.4;27.4;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.0;46;;;34.9;57.5;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.8;7.8;;;4.7;12.2;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2011;2011;UT;Utah;NVSS;Asthma;Asthma mortality rate;;;Number;44;44;;;;;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.3;62.3;;;52.8;71;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.5;41.5;;;33.2;50.2;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.6;62.6;;;52.5;71.8;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.6;10.6;;;8.8;12.6;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;78.2;78.2;;;62.1;88.7;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;81.1;81.1;;;67.8;89.7;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;8.5;8.5;;;7;10.4;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;72.2;72.2;;;63.1;79.8;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;4.6;4.6;;;2.8;7.3;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.7;37.7;;;31.6;44.2;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;63.8;63.8;;;54.4;72.3;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.1;10.1;;;9.2;11.1;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.5;90.5;;;82.4;95;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.4;8.4;;;5.2;13.4;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.9;68.9;*;50 States + DC: US Median;64.9;71.4;Gender;Male;;;;;;;59;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.1;48.1;;;35.8;60.6;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.4;84.4;;;78;89.1;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.8;41.8;;;33.4;50.6;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;79.9;79.9;;;71.5;86.3;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.0;7;;;5.6;8.7;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2011;2011;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;NMBR;RACE;HIS;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.1;7.1;;;5.8;8.8;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2011;2011;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.2;65.2;;;50;77.8;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2011;2011;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.3;11.3;;;9;14.1;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;79.7;79.7;;;65.1;89.2;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2011;2011;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;;Number;49;49;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;NMBR;RACE;BLK;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.0;36;;;25.6;48;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.8;38.8;;;32.6;45.5;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.6;43.6;;;37.7;49.8;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;16.1;16.1;;;12.5;20.5;Race/Ethnicity;Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2011;2011;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;NMBR;RACE;HIS;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.5;8.5;;;5.5;12.9;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;20.1;20.1;;;12.6;30.4;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.8;46.8;;;29.9;64.4;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;18.6;18.6;;;11.9;27.8;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.6;8.6;;;7.3;10;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.4;49.4;;;40.8;58;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.3;13.3;;;11.1;15.8;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;91.7;91.7;;;85.2;95.6;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.5;40.5;;;36.3;44.9;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;;Number;47;47;;;;;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;NMBR;GENDER;GENM;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.1;48.1;;;39.9;56.5;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.7;12.7;;;9.4;17;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.2;8.2;;;7.5;9;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.6;36.6;;;28.8;45.1;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2011;2011;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;NMBR;RACE;WHT;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.0;9;;;8.1;9.9;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2011;2011;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;5.0;5;;;3.9;6.3;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.2;45.2;;;36.1;54.7;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.5;34.5;;;26.9;43.1;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.8;43.8;;;37.7;50;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.3;40.3;;;32.1;49.2;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2011;2011;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2011;2011;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;15.4;15.4;;;10.5;21.9;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.4;43.4;;;33.4;53.9;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.2;30.2;;;20.1;42.7;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.1;41.1;;;33.2;49.5;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;27.7;27.7;;;19.3;38;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2011;2011;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;18.1;18.1;;;13.6;23.7;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.6;8.6;;;7.1;10.1;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2011;2011;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2011;2011;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.9;13.9;;;10.8;17.6;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.8;5.8;;;4.5;7.5;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2011;2011;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.6;7.6;;;4.4;12.7;Race/Ethnicity;Other, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2011;2011;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.5;38.5;;;31.2;46.3;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;24.9;24.9;;;16.6;35.6;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.4;42.4;;;35.9;49.1;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;NMBR;RACE;AIAN;;;;
2011;2011;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;NMBR;RACE;HIS;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;25.0;25;;;17.6;34.3;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;NMBR;RACE;WHT;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.0;62;;;52.6;70.5;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.0;86;;;79.1;90.9;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.1;9.1;;;8.1;10.1;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2011;2011;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.6;12.6;;;8.9;17.2;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.3;38.3;;;33.3;43.5;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;NMBR;RACE;API;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;8.9;8.9;;;6.9;11.4;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.2;38.2;;;30;47.1;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.9;35.9;;;28.2;44.5;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2011;2011;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.6;14.6;;;10.9;19.2;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2011;2011;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.8;47.8;;;39.1;56.5;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.5;37.5;*;50 States + DC: US Median;34.5;40.1;Gender;Male;;;;;;;59;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.5;11.5;;;9.3;14.1;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;86.9;86.9;;;80.1;91.6;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.9;35.9;;;24.9;48.6;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2011;2011;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.2;6.2;;;5;7.8;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;;Number;32;32;;;;;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;NMBR;GENDER;GENM;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;60.0;60;;;50.6;68.6;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2011;2011;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.9;83.9;;;75.9;89.5;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;WA;Washington;NVSS;Asthma;Asthma mortality rate;;;Number;35;35;;;;;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;NMBR;GENDER;GENM;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;4.1;4.1;;;2.4;6.9;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;79.7;79.7;;;71.5;86;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.1;44.1;;;31.6;57.5;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;;Number;62;62;;;;;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;NMBR;GENDER;GENF;;;;
2011;2011;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.9;40.9;;;33.8;48.4;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2011;2011;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.7;9.7;;;7.8;11.8;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;74.0;74;;;58.3;85.2;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.1;47.1;;;38;56.4;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2011;2011;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.2;83.2;;;74.5;89.4;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;45.5;45.5;;;35.3;56.2;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2011;2011;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.3;10.3;;;8.4;12.5;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2011;2011;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;19.7;19.7;;;13.5;27.8;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.1;65.1;;;55.2;73.9;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;;Number;43;43;;;;;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.8;49.8;;;44.2;55.4;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;4.9;4.9;;;4.2;5.7;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.0;11;;;7.5;15.9;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2011;2011;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;NMBR;RACE;API;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;40.6;40.6;;;32.1;50.8;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.9;70.9;;;60.1;79.8;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;US;United States;NVSS;Asthma;Asthma mortality rate;;;Number;3345;3,345;;;;;Overall;Overall;;;;;;;59;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2011;2011;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.7;40.7;;;30.7;51.5;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.5;88.5;;;81.8;92.9;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2011;2011;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2011;2011;MT;Montana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;NMBR;RACE;AIAN;;;;
2011;2011;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;NMBR;RACE;AIAN;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;80.0;80;;;72.9;85.7;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.6;13.6;;;12.5;14.8;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.5;42.5;;;30.6;55.4;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2011;2011;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2011;2011;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;CRDRATE;RACE;API;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2011;2011;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.2;8.2;;;5.9;11.1;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.8;70.8;;;53.8;83.5;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.3;90.3;;;85.6;93.6;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.6;9.6;;;8.1;11.4;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.5;34.5;;;25;45.4;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.5;10.5;;;9.7;11.3;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.2;9.2;;;8.2;10.2;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;92.8;92.8;;;87;96.1;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.4;11.4;;;8.7;14.8;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.7;10.7;;;10;11.4;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;13.2;13.2;;;9.1;18.6;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;NMBR;GENDER;GENM;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2011;2011;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.9;8.9;;;6.9;11.4;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;70.9;70.9;;;54.8;83.1;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;52.9;52.9;;;29.6;75;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;75.6;75.6;;;70.7;79.9;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.0;87;;;78.1;92.6;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;50.2;50.2;;;36.2;64.3;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.9;9.9;;;9;10.8;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.2;9.2;;;6.9;12;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2011;2011;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.0;33;;;26.7;40;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.6;71.6;;;62.7;79.1;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.8;42.8;;;39.5;46.3;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;;Number;50;50;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;NMBR;RACE;WHT;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2011;2011;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.5;13.5;;;10.8;16.6;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2011;2011;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.0;63;;;54.2;71;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2011;2011;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.9;10.9;;;8.6;13.9;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.0;9;;;7.8;10.4;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;27.7;27.7;;;16.5;42.6;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.3;82.3;;;75;87.8;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;7.8;7.8;;;6;10.1;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.1;11.1;;;9.6;12.7;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2011;2011;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;NMBR;RACE;API;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2011;2011;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.4;34.4;;;30.1;39;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.2;83.2;;;74.8;89.2;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;;Number;23;23;;;;;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;NMBR;GENDER;GENF;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.2;31.2;;;18.6;47.2;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.2;39.2;*;50 States + DC: US Median;38.3;40.4;Overall;Overall;;;;;;;59;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.6;42.6;;;34.3;51.3;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.4;65.4;;;57.1;72.8;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.2;37.2;;;31.9;42.8;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;US;United States;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.5;68.5;*;50 States + DC: US Median;66;70.6;Overall;Overall;;;;;;;59;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;TX;Texas;NVSS;Asthma;Asthma mortality rate;;;Number;59;59;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;NMBR;RACE;BLK;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;50.8;50.8;;;43.5;58.1;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.4;41.4;;;36;47.1;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;78.5;78.5;;;72.7;83.3;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.4;44.4;;;37.4;51.6;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;88.1;88.1;;;77.2;94.2;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2011;2011;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.0;37;*;50 States + DC: US Median;36.1;38.8;Overall;Overall;;;;;;;59;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.9;32.9;;;19.1;50.6;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2011;2011;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;6.9;6.9;;;4.8;9.6;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.8;14.8;;;10.3;21;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2011;2011;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;NMBR;RACE;API;;;;
2011;2011;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;4.3;4.3;;;3.3;5.5;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;55.6;55.6;;;40.1;70.1;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;5.1;5.1;;;3.5;7.4;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.7;6.7;;;5.7;7.9;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.3;11.3;;;6.9;17.8;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2011;2011;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;CRDRATE;RACE;API;;;;
2011;2011;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.9;13.9;;;10.1;18.7;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;6.3;6.3;;;4.4;9;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2011;2011;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;NMBR;RACE;AIAN;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.8;38.8;;;34.6;43.1;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2011;2011;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;CRDRATE;RACE;API;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.1;36.1;;;29.9;42.8;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;NMBR;RACE;AIAN;;;;
2011;2011;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;14.5;14.5;;;9.8;20.7;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2011;2011;FL;Florida;NVSS;Asthma;Asthma mortality rate;;;Number;148;148;;;;;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.5;8.5;;;7.3;9.9;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;29.6;29.6;;;20.4;41.6;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.9;14.9;;;12;18.5;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.6;44.6;;;35.6;53.9;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;74.0;74;;;64.2;81.9;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.1;8.1;;;4.9;12.7;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.0;43;;;38.1;48.1;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;37.7;37.7;;;23.2;54.8;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;17.9;17.9;;;10.8;28;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;78.4;78.4;;;63.6;88.3;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.9;6.9;;;4.1;11.4;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2011;2011;CA;California;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;15.0;15;;;10.6;20.7;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2011;2011;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;NMBR;RACE;API;;;;
2011;2011;TX;Texas;NVSS;Asthma;Asthma mortality rate;;;Number;195;195;;;;;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.3;5.3;;;3.3;8.2;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;29.7;29.7;;;19.1;42.9;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2011;2011;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.7;13.7;;;10.1;18.3;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;75.0;75;;;62.7;84.2;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.5;35.5;;;26.2;46;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2011;2011;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;19.2;19.2;;;12.6;27.9;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.2;7.2;;;6.1;8.5;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;WA;Washington;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;NMBR;RACE;API;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.5;34.5;;;29.1;40.3;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.3;88.3;;;83.8;91.7;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.4;82.4;;;74.4;88.2;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.5;6.5;;;5.5;7.6;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.2;6.2;;;5;7.7;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.9;38.9;;;28.9;49.9;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;25.8;25.8;;;15.4;40;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2011;2011;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;NMBR;RACE;AIAN;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.1;9.1;;;7.3;11.3;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.1;41.1;;;29.8;53.4;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.8;12.8;;;8.8;18.3;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;23.2;23.2;;;15.6;33;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.2;42.2;;;32.8;52.3;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.4;8.4;;;7.4;9.5;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2011;2011;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.2;14.2;;;10.4;18.9;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.1;68.1;;;53.6;79.7;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.7;66.7;;;56.8;75.3;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;4.5;4.5;;;3.5;5.9;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;NMBR;GENDER;GENM;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.1;32.1;;;22.8;43.2;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;74.1;74.1;;;65.8;81;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;79.8;79.8;;;66.9;88.5;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.3;9.3;;;7.4;11.5;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2011;2011;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2011;2011;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.6;7.6;;;5.6;10.1;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.4;10.4;;;9.6;11.4;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.2;7.2;;;5.4;9.4;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;29.6;29.6;;;22.1;38.5;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.6;31.6;;;24.2;40;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.0;46;;;41.1;50.9;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.1;9.1;;;7.5;11.1;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2011;2011;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.1;89.1;;;83.7;92.9;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.7;39.7;;;29.3;51.1;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.9;38.9;;;35;42.9;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.7;9.7;;;8.6;11;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.8;42.8;;;28.1;59;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;74.0;74;;;59.6;84.6;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2011;2011;FL;Florida;NVSS;Asthma;Asthma mortality rate;;;Number;78;78;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;NMBR;RACE;WHT;;;;
2011;2011;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.0;11;;;9.3;13;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.4;62.4;;;54.6;69.7;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.9;72.9;;;61.1;82.1;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2011;2011;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2011;2011;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.3;9.3;;;6.3;13.3;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;47.7;47.7;;;39.7;55.8;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;UT;Utah;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;NMBR;RACE;BLK;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.0;9;;;7.1;11.2;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.8;33.8;;;22.7;47.2;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.1;39.1;;;33.9;44.5;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.4;40.4;;;36.5;44.5;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.0;43;;;36.9;49.4;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.6;46.6;;;39;54.3;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.3;35.3;;;29.4;41.6;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;62.9;62.9;;;44.2;78.4;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;CRDRATE;RACE;API;;;;
2011;2011;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.1;11.1;;;8.4;14.3;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.9;36.9;;;23.6;52.4;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2011;2011;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.1;41.1;;;33.8;48.8;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.6;43.6;;;34.9;52.7;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;55.5;55.5;;;43.2;67.3;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;27.8;27.8;;;20.2;37;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;76.5;76.5;;;66.4;84.4;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;NMBR;RACE;BLK;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.3;47.3;;;40.9;53.7;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.9;44.9;;;31.6;58.9;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.1;41.1;;;25.3;59;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.6;45.6;;;38.5;52.8;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.9;28.9;;;24.2;34.2;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.2;41.2;;;33.7;49.1;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.1;10.1;;;9.3;11;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;CRDRATE;RACE;API;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;49.1;49.1;;;32.7;65.7;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;6.1;6.1;;;4.1;8.8;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.5;8.5;;;7.5;9.6;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.0;46;;;32.5;60.1;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;78.6;78.6;;;71.1;84.7;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.7;39.7;;;25.9;55.4;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.3;37.3;;;25.3;51.1;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.5;38.5;;;31.9;45.5;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.8;90.8;;;84.8;94.6;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;80.2;80.2;;;68.6;88.2;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2011;2011;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.7;66.7;;;54.9;76.7;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.0;44;;;39.7;48.4;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.5;9.5;;;8.1;11.1;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.9;37.9;;;27.1;50;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.6;11.6;;;7.6;17;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.3;87.3;;;83.2;90.4;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.9;82.9;;;74.7;88.9;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2011;2011;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;75.7;75.7;;;67.9;82;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.4;35.4;;;29;42.4;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;NMBR;GENDER;GENM;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.3;11.3;;;9.6;13.3;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.7;43.7;;;38;49.7;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;2.5;2.5;;;1.6;3.6;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;78.0;78;;;62;88.5;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.5;9.5;;;8.6;10.5;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;21.9;21.9;;;12.1;36.2;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;64.1;64.1;;;55.6;71.8;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;29.0;29;;;17.6;44;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.2;71.2;;;56.9;82.3;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2011;2011;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.5;8.5;;;7.4;9.7;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;CRDRATE;RACE;API;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;83.1;83.1;;;73.1;89.9;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2011;2011;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.4;8.4;;;6.1;11.3;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.4;65.4;;;55.7;74;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.1;37.1;;;32.6;41.8;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;90.6;90.6;;;86.2;93.8;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2011;2011;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;NMBR;RACE;BLK;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.6;13.6;;;7.5;23.3;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.8;66.8;;;55.5;76.5;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.9;12.9;;;10.3;15.9;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.9;42.9;;;35;51.2;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;24.4;24.4;;;14;38.9;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.5;14.5;;;9;22.2;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.5;42.5;;;36.7;48.5;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;16.2;16.2;;;11.5;22.4;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.9;43.9;;;32.1;56.3;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;NY;New York;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2011;2011;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;;Number;85;85;;;;;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;NMBR;GENDER;GENM;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.8;10.8;;;9.4;12.4;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;30.9;30.9;;;24.6;38;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.4;43.4;;;39;47.9;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;32;32;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;NMBR;RACE;BLK;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2011;2011;US;United States;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;11.6;11.6;*;50 States + DC: US Median;11;12;Gender;Female;;;;;;;59;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.3;36.3;;;26.5;47.5;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2011;2011;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.9;14.9;;;10.6;20.2;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;75.6;75.6;;;63.5;84.7;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;;Number;46;46;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;NMBR;RACE;WHT;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2011;2011;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2011;2011;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.7;44.7;;;35.7;54.1;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.3;84.3;;;79.8;87.9;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;17.5;17.5;;;10.5;27.8;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.8;11.8;;;10.8;13;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.5;44.5;;;30.6;59.3;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2011;2011;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;NMBR;GENDER;GENM;;;;
2011;2011;NY;New York;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;NMBR;RACE;AIAN;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.6;9.6;;;8.4;10.9;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;78.8;78.8;;;69.3;85.9;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.3;33.3;;;21.2;48;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;CRDRATE;RACE;API;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.5;49.5;;;41.3;57.7;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.6;12.6;;;10.5;15;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;74.9;74.9;;;62.1;84.4;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;26.5;26.5;;;20.2;33.8;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.2;30.2;;;23.7;37.5;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2011;2011;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2011;2011;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;NMBR;RACE;HIS;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;73.0;73;;;67.3;78.1;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.1;12.1;;;10.9;13.4;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.5;12.5;;;11.3;13.8;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.8;36.8;;;28.1;46.5;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.3;38.3;;;25.2;53.3;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;7.1;7.1;;;4.7;10.5;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2011;2011;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;15.8;15.8;;;11;22;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2011;2011;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;56.1;56.1;;;48.5;63.5;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;71.8;71.8;;;58.5;82.2;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.6;6.6;;;5.5;7.8;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;93.9;93.9;;;88.3;97;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.5;86.5;;;79.5;91.4;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2011;2011;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.4;9.4;;;8.5;10.4;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.0;43;;;35.3;51.1;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;71.5;71.5;;;57.6;82.2;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.8;36.8;;;30.3;43.9;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;28.3;28.3;;;18.9;39.9;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;51.3;51.3;;;41.1;61.4;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.0;10;;;9.2;11;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2011;2011;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;36.7;36.7;;;32;41.7;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.6;43.6;;;31.6;56.4;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.0;9;;;8.3;9.8;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.3;41.3;;;33.6;49.5;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.8;48.8;;;43.6;54;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.8;6.8;;;5.6;8.3;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2011;2011;NY;New York;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.2;9.2;;;8;10.6;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.7;14.7;;;9.9;21.3;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;21.1;21.1;;;11.5;35.5;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;81.1;81.1;;;71.1;88.3;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.9;7.9;;;7;9;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.3;7.3;;;4.5;11.3;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.0;7;;;6;8;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.2;12.2;;;8.5;17.1;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.1;7.1;;;5.8;8.5;Race/Ethnicity;Other, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.6;45.6;;;30;62.2;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2011;2011;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.8;40.8;;;34.4;47.5;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;28.2;28.2;;;21;36.7;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.0;6;;;5.4;6.7;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;13.3;13.3;;;10.7;16.4;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.7;43.7;;;32.1;56;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2011;2011;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;;Number;26;26;;;;;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;NMBR;GENDER;GENM;;;;
2011;2011;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;;Number;29;29;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;NMBR;RACE;WHT;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;NMBR;RACE;HIS;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.7;49.7;;;41.1;58.5;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2011;2011;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;NMBR;GENDER;GENM;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.6;7.6;;;6;9.6;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2011;2011;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.9;11.9;;;8.7;15.8;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2011;2011;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2011;2011;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;12.4;12.4;;;9.7;15.7;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.5;6.5;;;5.3;7.9;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;18.6;18.6;;;10.4;31;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;66.7;66.7;;;59.3;73.3;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;43.1;43.1;;;33.5;53.3;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.1;69.1;;;57.9;78.4;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;65.5;65.5;;;42.5;83;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;50.3;50.3;;;35.3;65.3;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2011;2011;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;;Number;30;30;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;NMBR;RACE;WHT;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.4;38.4;;;26.1;52.3;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.7;10.7;;;7.9;14;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.4;84.4;;;76.6;90;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.4;8.4;;;5.1;13.5;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.5;7.5;;;6;9.3;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2011;2011;CA;California;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.4;37.4;;;33.6;41.2;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;7.3;7.3;;;5.6;9.5;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.1;8.1;;;7.1;9.3;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.0;87;;;82.9;90.2;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;13.9;13.9;;;11;17.2;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.4;43.4;;;37.6;49.3;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.0;13;;;11.3;14.9;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.4;41.4;;;34.7;48.4;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;10.3;10.3;;;7.6;13.8;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.5;87.5;;;82.3;91.4;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST4_1;NMBR;GENDER;GENM;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2011;2011;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;18.2;18.2;;;13.3;24.3;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.4;9.4;;;6.1;14.1;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2011;2011;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.9;90.9;;;82.8;95.4;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2011;2011;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.1;12.1;;;9.9;14.4;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2011;2011;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;16.6;16.6;;;9.6;27.2;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2011;2011;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;NMBR;RACE;AIAN;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.7;31.7;;;24.6;39.7;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2011;2011;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.2;11.2;;;8.6;14.4;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2011;2011;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;54;54;;;;;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;NMBR;GENDER;GENF;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_2;CRDPREV;RACE;OTH;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.3;7.3;;;6.1;8.8;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;87.6;87.6;;;77.2;93.7;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.3;9.3;;;7.3;11.9;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.2;67.2;;;56.1;76.6;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2011;2011;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;20.1;20.1;;;13.6;28.5;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;77.4;77.4;;;65.4;86.2;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.7;90.7;;;82.1;95.4;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.9;8.9;;;7.8;10.2;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2011;2011;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.2;9.2;;;6.7;12.3;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;75.2;75.2;;;65.1;83.1;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;46.3;46.3;;;39.6;53.1;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.0;13;;;9.6;17.3;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;54.8;54.8;;;37.7;70.8;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.9;9.9;;;9;10.9;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;49.1;49.1;;;24.2;74.5;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2011;2011;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.1;12.1;;;7.1;19.9;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.3;39.3;;;32.7;46.4;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;13.5;13.5;;;8.8;20.1;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.0;7;;;5.5;9;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;76.7;76.7;;;68.3;83.4;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.5;46.5;;;39.1;54.1;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;32.3;32.3;;;25.8;39.6;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;76.6;76.6;;;67.4;83.8;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;91.5;91.5;;;83.5;95.8;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.7;87.7;;;81.6;92;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;15.3;15.3;;;13.5;17.4;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2011;2011;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;CRDRATE;RACE;API;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;80.7;80.7;;;67.7;89.3;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;WA;Washington;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;NMBR;RACE;HIS;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;52.7;52.7;;;37.5;67.4;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.9;35.9;;;23.4;50.8;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;87.8;87.8;;;77.8;93.6;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.1;12.1;;;10.8;13.5;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2011;2011;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.9;13.9;;;11.2;17;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2011;2011;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.1;40.1;;;29.7;51.4;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;74.4;74.4;;;64.4;82.4;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2011;2011;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;NMBR;RACE;WHT;;;;
2011;2011;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;;Number;39;39;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;NMBR;RACE;BLK;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;NMBR;GENDER;GENM;;;;
2011;2011;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2011;2011;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST4_1;NMBR;RACE;HIS;;;;
2011;2011;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;NMBR;GENDER;GENF;;;;
2011;2011;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;;Number;20;20;;;;;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;34.3;34.3;;;27.5;41.8;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;14.9;14.9;;;10.6;20.2;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;27.0;27;;;15.6;42.6;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.1;42.1;;;36.2;48.1;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2011;2011;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.8;9.8;;;7.7;12.3;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;7.4;7.4;;;5.9;9.2;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.6;35.6;;;24.5;48.4;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.8;44.8;;;38.8;50.9;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2011;2011;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.6;10.6;;;9.5;11.8;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2011;2011;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;28.3;28.3;;;22.7;34.8;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.4;5.4;;;4.4;6.7;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.9;41.9;;;34.2;50;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.2;9.2;;;8.3;10.2;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;FL;Florida;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;NMBR;RACE;API;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.9;11.9;;;7.7;18;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST1_2;CRDPREV;RACE;BLK;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.1;42.1;;;34;50.6;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;CRDRATE;RACE;API;;;;
2011;2011;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;NMBR;RACE;BLK;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;26.6;26.6;;;16.2;40.4;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2011;2011;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;30.7;30.7;;;25.1;36.9;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;;Number;37;37;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;NMBR;RACE;BLK;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;53.1;53.1;;;37.3;68.2;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;NMBR;GENDER;GENF;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.6;68.6;;;59.5;76.6;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2011;2011;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;NMBR;RACE;AIAN;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;12.6;12.6;;;9.5;16.4;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;NMBR;GENDER;GENF;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;70.2;70.2;;;53.5;82.9;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.8;31.8;;;22.4;42.8;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;18.8;18.8;;;10.5;31.5;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2011;2011;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.4;84.4;;;77.2;89.6;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;CA;California;NVSS;Asthma;Asthma mortality rate;;;Number;58;58;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;NMBR;RACE;API;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.4;48.4;;;41.7;55.2;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.9;5.9;;;4.6;7.4;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.2;36.2;;;29.2;43.8;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;74.3;74.3;;;58;85.8;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;10.9;10.9;;;8.3;14.1;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;80.5;80.5;;;72.7;86.5;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;NMBR;RACE;HIS;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.7;35.7;;;27.5;44.8;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;75.9;75.9;;;51;90.5;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;69.1;69.1;;;61.2;76;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;NMBR;RACE;AIAN;;;;
2011;2011;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;39.8;39.8;;;32.2;47.9;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2011;2011;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;54.8;54.8;;;36;72.4;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.1;41.1;;;26.4;57.6;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2011;2011;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2011;2011;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;CRDRATE;RACE;API;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;45.7;45.7;;;38.1;53.6;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;White, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.6;39.6;;;31.3;48.6;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;81.4;81.4;;;64.4;91.3;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.1;10.1;;;9;11.3;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;12.1;12.1;;;10.9;13.4;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;74.2;74.2;;;57.6;85.8;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;48.3;48.3;;;42.5;54.2;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2011;2011;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;44.5;44.5;;;38;51.2;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;49.0;49;;;42.7;55.4;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.6;38.6;;;29.6;48.4;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.220833, -66.590149);;72;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;64.1;64.1;;;41.8;81.6;Race/Ethnicity;Other, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.8;9.8;;;8.7;10.9;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;CRDPREV;RACE;MRC;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;77.7;77.7;;;69.5;84.3;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;59.7;59.7;;;50.6;68.1;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;48.5;48.5;;;42;55;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2011;2011;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.3;42.3;;;34.7;50.3;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_1;CRDPREV;RACE;WHT;;;;
2011;2011;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2011;2011;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.6;44.6;;;33.5;56.3;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;13.7;13.7;;;11;16.9;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.7;41.7;;;29.9;54.5;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST5_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.4;42.4;;;28.8;57.3;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.7;9.7;;;8.6;11;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.3;7.3;;;6.9;7.8;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2011;2011;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;CRDRATE;RACE;API;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2011;2011;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;;Number;44;44;;;;;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;16.5;16.5;;;9.8;26.4;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2011;2011;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.9;8.9;;;5.6;13.5;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;53.2;53.2;;;45.6;60.7;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;UT;Utah;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;72.6;72.6;;;60.7;82;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;20.5;20.5;;;15.4;26.7;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2011;2011;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;NMBR;GENDER;GENF;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.3;9.3;;;7.8;11.1;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.8;8.8;;;8;9.7;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.3;10.3;;;7.5;13.8;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;67.0;67;;;57.6;75.1;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2011;2011;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;;Number;78;78;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;NMBR;RACE;WHT;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;38.4;38.4;;;34.9;42.1;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;77.7;77.7;;;68.7;84.7;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.6;9.6;;;6.3;13.9;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2011;2011;NM;New Mexico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;85.9;85.9;;;79.6;90.5;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;82.1;82.1;;;67.6;91;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;AL;Alabama;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.6;39.6;;;33;46.5;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.1;32.1;;;26.3;38.4;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;8.9;8.9;;;5.7;13.6;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2011;2011;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;40.7;40.7;;;35.8;45.7;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.3;10.3;;;7.9;13.3;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST5_2;AGEADJPREV;RACE;MRC;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.4;35.4;;;23.5;49.5;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;VA;Virginia;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;11.9;11.9;;;9.3;15.2;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;CRDPREV;RACE;HIS;;;;
2011;2011;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2011;2011;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;4.4;4.4;;;2.7;6.8;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2011;2011;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2011;2011;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2011;2011;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_2;CRDPREV;RACE;OTH;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;63.9;63.9;;;53.9;72.8;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.2;9.2;;;8.4;10.2;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;7.0;7;;;5.7;8.6;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2011;2011;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.5;32.5;;;22;45.1;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;35.4;35.4;;;27.4;44.4;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_1;CRDPREV;GENDER;GENM;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;41.2;41.2;;;34.4;48.3;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;AZ;Arizona;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2011;2011;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;30.3;30.3;;;22.5;39.5;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2011;2011;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;NMBR;RACE;HIS;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;NH;New Hampshire;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;91.7;91.7;;;86.2;95.2;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;RI;Rhode Island;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST6_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;88.0;88;;;83.2;91.5;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST6_2;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;86.9;86.9;;;75.7;93.4;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2011;2011;TX;Texas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;NY;New York;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;33.6;33.6;;;21.2;48.9;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2011;2011;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;NMBR;RACE;WHT;;;;
2011;2011;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2011;2011;LA;Louisiana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;6.0;6;;;5.1;7;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;8.0;8;;;6.7;9.5;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST1_1;CRDPREV;RACE;WHT;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;KS;Kansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST5_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.4;9.4;;;5.4;16.1;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2011;2011;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.7;11.7;;;8.5;15.7;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;15.9;15.9;;;12.4;20.3;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;CRDRATE;RACE;API;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;7.6;7.6;;;5.4;10.7;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;31.8;31.8;;;26.3;37.9;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2011;2011;CT;Connecticut;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.9;9.9;;;8.9;11.1;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;75.8;75.8;;;52.1;90;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2011;2011;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2011;2011;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;26.4;26.4;;;17.3;38;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;NY;New York;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST5_2;CRDPREV;RACE;MRC;;;;
2011;2011;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;;Number;84;84;;;;;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;NMBR;GENDER;GENF;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;43.6;43.6;;;36.5;50.9;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.4;31.4;;;24.5;39.2;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.5;38.5;;;34;43.1;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;36.1;36.1;;;29;43.8;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;PR;Puerto Rico;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;32.2;32.2;;;24.7;40.7;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST6_1;CRDPREV;RACE;HIS;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.9;8.9;;;6.7;11.8;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST5_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_2;CRDPREV;RACE;HIS;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;9.4;9.4;;;8.2;10.7;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST1_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;65.3;65.3;;;56.4;73.2;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2011;2011;IN;Indiana;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST6_2;AGEADJPREV;RACE;HIS;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;51.4;51.4;;;39.3;63.3;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;5.5;5.5;;;3.1;9.8;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.8;37.8;;;31.7;44.3;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;41.4;41.4;;;35.4;47.6;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;14.7;14.7;;;12.7;16.9;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST1_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;34.8;34.8;;;25.2;45.9;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST5_1;CRDPREV;GENDER;GENM;;;;
2011;2011;TN;Tennessee;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.1;5.1;;;3.5;7.5;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;CRDPREV;GENDER;GENF;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;84.7;84.7;;;78.7;89.2;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST6_2;CRDPREV;OVERALL;OVR;;;;
2011;2011;FL;Florida;NVSS;Asthma;Asthma mortality rate;;;Number;94;94;;;;;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;NMBR;GENDER;GENF;;;;
2011;2011;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;23.2;23.2;;;13.2;37.5;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;;Number;69;69;;;;;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.9;6.9;;;5.1;9.2;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;74.0;74;;;56.2;86.3;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_2;AGEADJPREV;GENDER;GENM;;;;
2011;2011;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;;Number;22;22;;;;;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;NMBR;GENDER;GENF;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;89.7;89.7;;;84.7;93.2;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST6_2;CRDPREV;RACE;WHT;;;;
2011;2011;HI;Hawaii;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.8;38.8;;;30.2;48.2;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.7;7.7;;;6.9;8.6;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST1_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;7.7;7.7;;;6.6;8.9;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;75.7;75.7;;;65.5;83.7;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;79.0;79;;;73;84;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_2;CRDPREV;RACE;WHT;;;;
2011;2011;WY;Wyoming;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;26.6;26.6;;;19;35.9;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST1_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;MD;Maryland;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;84.5;84.5;;;76.6;90.1;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;14.0;14;;;11.9;16.4;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST1_2;CRDPREV;RACE;WHT;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST5_1;CRDPREV;RACE;MRC;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;CRDPREV;RACE;BLK;;;;
2011;2011;AR;Arkansas;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;90.7;90.7;;;84.3;94.6;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;NMBR;RACE;HIS;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;11.7;11.7;;;10.6;13;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST1_1;CRDPREV;GENDER;GENF;;;;
2011;2011;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;;Number;25;25;;;;;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;6.9;6.9;;;6;7.9;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;10.5;10.5;;;9.5;11.6;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;NY;New York;NVSS;Asthma;Asthma mortality rate;;;Number;141;141;;;;;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;NMBR;GENDER;GENF;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;1.9;1.9;;;1.1;3.3;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;20.5;20.5;;;12.7;31.3;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST1_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;VT;Vermont;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2011;2011;GA;Georgia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;42.6;42.6;;;32.6;53.3;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;47.3;47.3;;;33.1;61.9;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;5.9;5.9;;;4.5;7.5;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST1_1;CRDPREV;GENDER;GENM;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;44.8;44.8;;;38.2;51.5;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;MO;Missouri;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST6_1;CRDPREV;RACE;MRC;;;;
2011;2011;SC;South Carolina;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;9.0;9;;;5.1;15.3;Race/Ethnicity;Other, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST1_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;DC;District of Columbia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;45.4;45.4;;;29.9;61.7;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST5_2;CRDPREV;RACE;BLK;;;;
2011;2011;NC;North Carolina;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;42.4;42.4;;;36.2;48.9;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST6_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;NY;New York;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;NMBR;RACE;API;;;;
2011;2011;MA;Massachusetts;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.4;39.4;;;34.7;44.5;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST6_1;CRDPREV;GENDER;GENF;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;32.9;32.9;;;23.2;44.3;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;AGEADJPREV;RACE;BLK;;;;
2011;2011;MS;Mississippi;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;23.8;23.8;;;17.1;32;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.8;8.8;;;6.5;11.6;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST5_2;CRDPREV;RACE;HIS;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST1_1;CRDPREV;RACE;BLK;;;;
2011;2011;OH;Ohio;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;38.5;38.5;;;33.4;43.8;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.2;11.2;;;8.6;14.4;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2011;2011;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;21;21;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;NMBR;RACE;WHT;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;66.0;66;;;51.8;77.9;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST5_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.5;10.5;;;8.1;13.3;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2011;2011;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2011;2011;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;14.2;14.2;;;10.3;19;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2011;2011;OR;Oregon;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;CRDPREV;RACE;OTH;;;;
2011;2011;AK;Alaska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;33.4;33.4;;;24.6;43.5;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST6_1;AGEADJPREV;GENDER;GENF;;;;
2011;2011;WA;Washington;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.7;35.7;;;20.1;55;Race/Ethnicity;Other, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST5_1;AGEADJPREV;RACE;OTH;;;;
2011;2011;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;13.3;13.3;;;11.3;15.3;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2011;2011;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;;Number;36;36;;;;;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2011;2011;ND;North Dakota;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;35.3;35.3;;;24.5;47.8;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;68.5;68.5;;;60;76;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST5_2;CRDPREV;GENDER;GENF;;;;
2011;2011;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2011;2011;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2011;2011;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2011;2011;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;NMBR;RACE;BLK;;;;
2011;2011;CA;California;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2011;2011;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2011;2011;WI;Wisconsin;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;68.1;68.1;;;50.1;81.9;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST5_2;AGEADJPREV;GENDER;GENF;;;;
2011;2011;OK;Oklahoma;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST6_2;CRDPREV;RACE;BLK;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;55.1;55.1;;;48.9;61.1;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;CRDPREV;GENDER;GENF;;;;
2011;2011;NJ;New Jersey;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST6_2;CRDPREV;RACE;MRC;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_1;CRDPREV;RACE;HIS;;;;
2011;2011;MT;Montana;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;CRDPREV;RACE;OTH;;;;
2011;2011;IL;Illinois;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST5_2;CRDPREV;RACE;OTH;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST6_2;CRDPREV;RACE;HIS;;;;
2011;2011;IA;Iowa;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;39.1;39.1;;;32.6;46.1;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST6_1;CRDPREV;RACE;WHT;;;;
2011;2011;FL;Florida;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;83.6;83.6;;;76;89.1;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST6_2;AGEADJPREV;RACE;WHT;;;;
2011;2011;MI;Michigan;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;9.9;9.9;;;9.1;10.8;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST1_1;CRDPREV;OVERALL;OVR;;;;
2011;2011;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2011;2011;DE;Delaware;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST5_1;AGEADJPREV;RACE;MRC;;;;
2011;2011;SD;South Dakota;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST1_1;AGEADJPREV;RACE;HIS;;;;
2011;2011;ID;Idaho;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;37.7;37.7;;;31.2;44.7;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST5_1;AGEADJPREV;OVERALL;OVR;;;;
2011;2011;MN;Minnesota;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;53.1;53.1;;;47.6;58.5;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST5_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;CRDPREV;RACE;BLK;;;;
2011;2011;KY;Kentucky;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;31.5;31.5;;;22.2;42.5;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST6_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;WV;West Virginia;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Other, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST1_1;CRDPREV;RACE;OTH;;;;
2011;2011;PA;Pennsylvania;BRFSS;Asthma;Current asthma prevalence among adults aged >= 18 years;;%;Age-adjusted Prevalence;8.5;8.5;;;7.6;9.4;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST1_1;AGEADJPREV;RACE;WHT;;;;
2011;2011;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;18.9;18.9;;;12.4;27.7;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2011;2011;US;United States;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;82.6;82.6;*;50 States + DC: US Median;80.2;84.7;Gender;Male;;;;;;;59;AST;AST6_2;CRDPREV;GENDER;GENM;;;;
2011;2011;GU;Guam;BRFSS;Asthma;Asthma prevalence among women aged 18-44 years;;%;Crude Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(13.444304, 144.793731);;66;AST;AST1_2;CRDPREV;RACE;MRC;;;;
2011;2011;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.6;14.6;;;10.6;19.6;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2011;2011;VI;Virgin Islands;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;-;No data available;;;Race/Ethnicity;Other, non-Hispanic;;;;;(18.335765, -64.896335);;78;AST;AST6_2;AGEADJPREV;RACE;OTH;;;;
2011;2011;NE;Nebraska;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;40.5;40.5;;;28;54.4;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST6_1;AGEADJPREV;RACE;BLK;;;;
2011;2011;CO;Colorado;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma;;%;Age-adjusted Prevalence;46.9;46.9;;;39;54.9;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST5_1;AGEADJPREV;GENDER;GENM;;;;
2011;2011;ME;Maine;BRFSS;Asthma;Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Crude Prevalence;62.2;62.2;;;49.2;73.7;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST5_2;CRDPREV;GENDER;GENM;;;;
2011;2011;NV;Nevada;BRFSS;Asthma;Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma;;%;Age-adjusted Prevalence;;;****;Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%;;;Race/Ethnicity;Multiracial, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST6_2;AGEADJPREV;RACE;MRC;;;;
2010;2010;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;24;24;;;;;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2010;2010;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;446;446;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;NMBR;RACE;BLK;;;;
2010;2010;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;12958;12,958;;;;;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;NMBR;GENDER;GENM;;;;
2010;2010;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;317;317;;;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;NMBR;RACE;HIS;;;;
2010;2010;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;NMBR;RACE;BLK;;;;
2010;2010;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.0;11;;;9.9;12.1;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;NMBR;GENDER;GENF;;;;
2010;2010;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.9;12.9;;;10.3;16;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2010;2010;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.2;14.2;;;10.5;18.9;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2010;2010;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;;Number;44;44;;;;;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;NMBR;GENDER;GENM;;;;
2010;2010;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;32;32;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;NMBR;RACE;WHT;;;;
2010;2010;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.1;7.1;;;4.5;10.8;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2010;2010;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.1;10.1;;;7.4;13.6;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;97340;97,340;;;;;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;NMBR;GENDER;GENM;;;;
2010;2010;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;22.08;22.08;;;21.79;22.37;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2010;2010;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2010;2010;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;22280;22,280;;;;;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;NMBR;GENDER;GENF;;;;
2010;2010;LA;Louisiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST2_1;NMBR;GENDER;GENF;;;;
2010;2010;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;;Number;39;39;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;NMBR;RACE;WHT;;;;
2010;2010;OR;Oregon;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST2_1;NMBR;GENDER;GENM;;;;
2010;2010;NY;New York;NVSS;Asthma;Asthma mortality rate;;;Number;283;283;;;;;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2010;2010;MT;Montana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST2_1;NMBR;GENDER;GENM;;;;
2010;2010;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;31;31;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;NMBR;RACE;WHT;;;;
2010;2010;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;35;35;;;;;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;NMBR;GENDER;GENM;;;;
2010;2010;DC;District of Columbia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST2_1;NMBR;GENDER;GENF;;;;
2010;2010;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;14135;14,135;;;;;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2010;2010;HI;Hawaii;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;7328;7,328;;;;;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2010;2010;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;885;885;;;;;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;NMBR;GENDER;GENM;;;;
2010;2010;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.6;12.6;;;9.2;16.8;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;9.79;9.79;;;9.14;10.43;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;31;31;;;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;NMBR;RACE;HIS;;;;
2010;2010;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;30.9;30.9;;;24.8;38.1;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;30170;30,170;;;;;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2010;2010;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;227;227;;;;;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;NMBR;GENDER;GENM;;;;
2010;2010;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;8.40;8.4;;;8.13;8.66;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2010;2010;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;13.34;13.34;;;13.02;13.67;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2010;2010;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;5.38;5.38;;;5.11;5.65;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;GA;Georgia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;14.62;14.62;;;14.2;15.04;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2010;2010;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;12.03;12.03;;;11.73;12.34;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2010;2010;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;7.67;7.67;;;7.33;8.01;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2010;2010;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;13.3;13.3;;;11.7;14.9;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;7.44;7.44;;;6.91;7.97;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2010;2010;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;13.05;13.05;;;12.02;14.07;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;623;623;;;;;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;NMBR;GENDER;GENM;;;;
2010;2010;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;56;56;;;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;NMBR;RACE;AIAN;;;;
2010;2010;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;5.70;5.7;;;5.15;6.25;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2010;2010;LA;Louisiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.9;8.9;;;5.8;13.1;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;18.97;18.97;;;18.4;19.55;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2010;2010;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2010;2010;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;17.22;17.22;;;16.79;17.65;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;6.34;6.34;;;5.75;6.93;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2010;2010;CT;Connecticut;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;134;134;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;NMBR;RACE;BLK;;;;
2010;2010;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;11781;11,781;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;NMBR;RACE;BLK;;;;
2010;2010;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;8073;8,073;;;;;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2010;2010;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;57;57;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;NMBR;RACE;API;;;;
2010;2010;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;4.70;4.7;;;4.51;4.9;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2010;2010;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;3.33;3.33;;;2.77;3.89;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;WY;Wyoming;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2010;2010;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;43.8;43.8;;;34.5;54.7;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.0;10;;;7.6;12.8;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;3.60;3.6;;;2.64;4.56;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2010;2010;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;9798;9,798;;;;;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;NMBR;GENDER;GENF;;;;
2010;2010;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;3.64;3.64;;;2.6;4.68;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;CRDRATE;RACE;API;;;;
2010;2010;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2010;2010;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;871;871;;;;;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;NMBR;GENDER;GENM;;;;
2010;2010;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.3;8.3;;;6.5;10.5;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.6;9.6;;;6.6;13.4;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.5;12.5;;;10.9;14;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2010;2010;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;10.33;10.33;;;10.18;10.47;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2010;2010;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;35.48;35.48;;;30.76;40.2;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.6;7.6;;;6.2;9.1;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;19.37;19.37;;;18.98;19.76;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;10.04;10.04;;;9.9;10.18;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;5138;5,138;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;NMBR;RACE;BLK;;;;
2010;2010;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;31.02;31.02;;;29.21;32.82;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;21.51;21.51;;;20.92;22.1;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2010;2010;MT;Montana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;3.72;3.72;;;3.08;4.37;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;CRDRATE;RACE;API;;;;
2010;2010;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;6.04;6.04;;;4.84;7.24;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2010;2010;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;15.53;15.53;;;15.15;15.9;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2010;2010;PA;Pennsylvania;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;57;57;;;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;NMBR;RACE;HIS;;;;
2010;2010;PA;Pennsylvania;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2010;2010;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;6.58;6.58;;;6.12;7.03;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2010;2010;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;9.00;9;;;8.61;9.4;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2010;2010;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;NMBR;GENDER;GENM;;;;
2010;2010;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;NMBR;RACE;AIAN;;;;
2010;2010;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;18.65;18.65;;;18.17;19.13;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;10.23;10.23;;;9.86;10.6;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2010;2010;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;8.09;8.09;;;6.82;9.36;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;4.35;4.35;;;2.77;5.93;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2010;2010;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;IN;Indiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;15.9;15.9;;;10.6;23.1;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;6.34;6.34;;;6.04;6.64;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2010;2010;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;4.21;4.21;;;3.37;5.05;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;CRDRATE;RACE;API;;;;
2010;2010;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;34583;34,583;;;;;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2010;2010;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;3047;3,047;;;;;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;NMBR;RACE;HIS;;;;
2010;2010;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;2939;2,939;;;;;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;NMBR;GENDER;GENF;;;;
2010;2010;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.3;12.3;;;10.3;14.4;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;504;504;;;;;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;NMBR;GENDER;GENM;;;;
2010;2010;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;24.29;24.29;;;20.54;28.04;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;19.3;19.3;;;13.8;26.3;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2010;2010;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.8;9.8;;;7.7;12.2;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;16.81;16.81;;;15.61;18.01;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;4.69;4.69;;;2.69;6.7;Race/Ethnicity;Asian or Pacific Islander;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2010;2010;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;12.88;12.88;;;12.67;13.1;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2010;2010;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;15240;15,240;;;;;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2010;2010;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;13.2;13.2;;;9.4;18;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;7.97;7.97;;;7.37;8.57;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2010;2010;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;920;920;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;NMBR;RACE;BLK;;;;
2010;2010;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;6.67;6.67;;;5.93;7.4;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2010;2010;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;10.38;10.38;;;10.03;10.73;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;16.33;16.33;;;13.57;19.1;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;4.86;4.86;;;2.96;6.77;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;CRDRATE;RACE;API;;;;
2010;2010;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;10944;10,944;;;;;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;NMBR;GENDER;GENM;;;;
2010;2010;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;7.26;7.26;;;7.05;7.46;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;KS;Kansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;13.22;13.22;;;12.79;13.65;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;8.74;8.74;;;8.15;9.33;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;608;608;;;;;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;NMBR;RACE;HIS;;;;
2010;2010;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;2259;2,259;;;;;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;NMBR;GENDER;GENM;;;;
2010;2010;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;22100;22,100;;;;;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;NMBR;GENDER;GENF;;;;
2010;2010;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1807;1,807;;;;;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2010;2010;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;PA;Pennsylvania;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;22.17;22.17;;;19.63;24.71;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2010;2010;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;3013;3,013;;;;;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;NMBR;GENDER;GENM;;;;
2010;2010;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;7.74;7.74;;;7.18;8.29;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2010;2010;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.1;7.1;;;4.5;10.5;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2010;2010;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.3;8.3;;;6;11.1;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;CRDRATE;RACE;API;;;;
2010;2010;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;11.95;11.95;;;11.39;12.51;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;22;22;;;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;NMBR;RACE;AIAN;;;;
2010;2010;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.8;8.8;;;7;10.9;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;20.72;20.72;;;20.3;21.14;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2010;2010;ND;North Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;5.71;5.71;;;4.58;6.83;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2010;2010;AK;Alaska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;VA;Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2010;2010;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;NMBR;RACE;WHT;;;;
2010;2010;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;5.46;5.46;;;5.19;5.74;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;15.64;15.64;;;14.19;17.1;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2010;2010;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;5.31;5.31;;;4.73;5.88;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2010;2010;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.2;12.2;;;8.7;16.7;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;161;161;;;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;NMBR;RACE;AIAN;;;;
2010;2010;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;3.86;3.86;;;3.14;4.57;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;8.17;8.17;;;7.97;8.36;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1926;1,926;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;NMBR;RACE;WHT;;;;
2010;2010;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2010;2010;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1682;1,682;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;NMBR;RACE;WHT;;;;
2010;2010;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;7.65;7.65;;;7.1;8.2;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.4;9.4;;;6.8;12.7;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;54;54;;;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;NMBR;RACE;HIS;;;;
2010;2010;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1346;1,346;;;;;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2010;2010;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;16.75;16.75;;;16.48;17.01;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;2.81;2.81;;;2.31;3.31;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2010;2010;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;6.94;6.94;;;4.79;9.1;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;CRDRATE;RACE;API;;;;
2010;2010;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;33.41;33.41;;;31.69;35.13;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;6084;6,084;;;;;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;NMBR;GENDER;GENF;;;;
2010;2010;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;69;69;;;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;NMBR;RACE;AIAN;;;;
2010;2010;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;16.21;16.21;;;15.88;16.54;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1135;1,135;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;NMBR;RACE;BLK;;;;
2010;2010;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;40;40;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;NMBR;RACE;BLK;;;;
2010;2010;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;6.98;6.98;;;6.86;7.1;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2010;2010;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.9;11.9;;;9.3;14.9;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;18.27;18.27;;;17.91;18.64;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;18.5;18.5;;;13.4;24.9;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;7.38;7.38;;;6.73;8.02;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2010;2010;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;11.63;11.63;;;11.44;11.82;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;10.50;10.5;;;8.02;12.98;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;CRDRATE;RACE;API;;;;
2010;2010;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;8.78;8.78;;;8.57;8.99;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2010;2010;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;20;20;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;NMBR;RACE;BLK;;;;
2010;2010;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;13.11;13.11;;;12.78;13.43;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.2;12.2;;;8.7;16.5;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2010;2010;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;22;22;;;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;NMBR;RACE;AIAN;;;;
2010;2010;LA;Louisiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2010;2010;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;2914;2,914;;;;;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;NMBR;GENDER;GENF;;;;
2010;2010;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1585;1,585;;;;;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2010;2010;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;13.69;13.69;;;10.57;16.81;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2010;2010;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;6.2;6.2;;;4.2;8.9;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;30.74;30.74;;;29.37;32.1;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2010;2010;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;12.22;12.22;;;7.12;17.33;Race/Ethnicity;American Indian or Alaska Native;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2010;2010;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;7.84;7.84;;;7.38;8.3;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;19.1;19.1;;;13.7;25.9;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;3.70;3.7;;;2.74;4.66;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2010;2010;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;40.45;40.45;;;39.3;41.6;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2010;2010;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;288;288;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;NMBR;RACE;WHT;;;;
2010;2010;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;74;74;;;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;NMBR;RACE;AIAN;;;;
2010;2010;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;12.74;12.74;;;12.35;13.14;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2010;2010;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2010;2010;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;7.07;7.07;;;6.15;7.99;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2010;2010;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.5;7.5;;;5.2;10.6;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;NMBR;RACE;BLK;;;;
2010;2010;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;15.39;15.39;;;15.22;15.56;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;156;156;;;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;NMBR;RACE;AIAN;;;;
2010;2010;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;15.3;15.3;;;10.1;22.3;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.7;7.7;;;5.7;10.4;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;131;131;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;NMBR;RACE;API;;;;
2010;2010;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;7.28;7.28;;;6.91;7.65;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1156;1,156;;;;;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;NMBR;GENDER;GENM;;;;
2010;2010;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2010;2010;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;5.11;5.11;;;3.28;6.94;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;CRDRATE;RACE;API;;;;
2010;2010;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;2638;2,638;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;NMBR;RACE;BLK;;;;
2010;2010;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;10.26;10.26;;;9.81;10.72;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2010;2010;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.2;7.2;;;5.8;8.9;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2010;2010;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;6.52;6.52;;;6.29;6.75;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2010;2010;AK;Alaska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.7;9.7;;;6.2;14.5;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.3;9.3;;;7.5;11.1;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;7.86;7.86;;;7.72;8;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2010;2010;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;7.23;7.23;;;6.84;7.61;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;23.84;23.84;;;21.03;26.66;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2010;2010;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;11.48;11.48;;;10.2;12.76;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2010;2010;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;6.71;6.71;;;4.52;8.9;Race/Ethnicity;American Indian or Alaska Native;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;3117;3,117;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;NMBR;RACE;WHT;;;;
2010;2010;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;15.22;15.22;;;14.85;15.59;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.6;11.6;;;8.8;15.2;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2010;2010;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;10.52;10.52;;;10.16;10.88;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2010;2010;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;5.3;5.3;;;3.6;7.5;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.6;7.6;;;6;9.6;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2010;2010;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;12.36;12.36;;;11.59;13.12;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;19.45;19.45;;;18.76;20.14;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2010;2010;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;877;877;;;;;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;NMBR;GENDER;GENM;;;;
2010;2010;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;18.66;18.66;;;17.83;19.49;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;778;778;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;NMBR;RACE;API;;;;
2010;2010;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;5.83;5.83;;;5.36;6.29;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;NMBR;RACE;AIAN;;;;
2010;2010;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;NMBR;RACE;HIS;;;;
2010;2010;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;15.09;15.09;;;14.73;15.45;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;IN;Indiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2010;2010;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;11.08;11.08;;;10.59;11.58;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2010;2010;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;12.25;12.25;;;11.29;13.21;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2010;2010;ID;Idaho;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2010;2010;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.0;8;;;5.8;10.8;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;16.03;16.03;;;15.77;16.29;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.4;10.4;;;7.5;14;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;31.77;31.77;;;29.92;33.62;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2010;2010;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;1.33;1.33;;;0.81;1.85;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;NMBR;RACE;AIAN;;;;
2010;2010;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;NMBR;RACE;WHT;;;;
2010;2010;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;6.7;6.7;;;4.3;9.8;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;32.19;32.19;;;30.37;34.01;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;13.8;13.8;;;10;18.6;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;NMBR;RACE;AIAN;;;;
2010;2010;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;9.31;9.31;;;8.97;9.65;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2010;2010;LA;Louisiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;6.17;6.17;;;5.96;6.39;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;5.56;5.56;;;4.84;6.28;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2010;2010;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;18.68;18.68;;;18.01;19.36;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;16.15;16.15;;;13.41;18.88;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2010;2010;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.7;7.7;;;4.8;11.8;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.2;10.2;;;8.2;12.2;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2010;2010;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2010;2010;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;5717;5,717;;;;;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;NMBR;GENDER;GENM;;;;
2010;2010;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;99;99;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;NMBR;RACE;API;;;;
2010;2010;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;22.8;22.8;;;17;29.9;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;32.43;32.43;;;30.76;34.1;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2010;2010;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;13.0;13;;;8.9;18.4;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;26.55;26.55;;;23.31;29.79;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;OK;Oklahoma;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;29.0;29;;;20.6;39.7;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2010;2010;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;NMBR;RACE;AIAN;;;;
2010;2010;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;8.53;8.53;;;8.26;8.8;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;5866;5,866;;;;;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;NMBR;GENDER;GENF;;;;
2010;2010;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.907192, -77.036871);;11;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;5.80;5.8;;;4.81;6.79;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;CRDRATE;RACE;API;;;;
2010;2010;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.1;7.1;;;4.8;10.1;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;23.06;23.06;;;22.24;23.88;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.8;9.8;;;7;13.4;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2010;2010;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;25;25;;;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;NMBR;RACE;AIAN;;;;
2010;2010;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;29.2;29.2;;;20;41.2;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;NMBR;RACE;AIAN;;;;
2010;2010;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;4.83;4.83;;;4.55;5.12;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;13.2;13.2;;;8.7;19.3;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;5438;5,438;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;NMBR;RACE;BLK;;;;
2010;2010;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;112;112;;;;;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;NMBR;GENDER;GENM;;;;
2010;2010;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.1;9.1;;;5.5;14.2;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;TN;Tennessee;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;6.8;6.8;;;4.4;9.9;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;4889;4,889;;;;;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2010;2010;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.7;9.7;;;6.3;14.2;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;13.25;13.25;;;9.15;17.36;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;11.62;11.62;;;10.33;12.91;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;22.3;22.3;;;14.4;32.9;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;24.6;24.6;;;18.3;32.2;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2010;2010;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;8.27;8.27;;;7.79;8.75;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;6.04;6.04;;;5.48;6.6;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;13.58;13.58;;;13.23;13.94;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;9.08;9.08;;;8.47;9.7;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2010;2010;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;14504;14,504;;;;;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;NMBR;GENDER;GENM;;;;
2010;2010;OK;Oklahoma;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;15.54;15.54;;;15.23;15.84;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;4.98;4.98;;;4.49;5.47;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2010;2010;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.4;8.4;;;5.8;11.7;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;DC;District of Columbia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.8;8.8;;;5.7;13;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;NMBR;RACE;BLK;;;;
2010;2010;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.9;11.9;;;8.7;15.8;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;5.37;5.37;;;5.11;5.62;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;6.07;6.07;;;5.82;6.31;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;9.85;9.85;;;9.26;10.45;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.2;8.2;;;7;9.4;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.7;12.7;;;9.1;17.1;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2010;2010;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;292;292;;;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;NMBR;RACE;HIS;;;;
2010;2010;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;21.0;21;;;13.4;31.2;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;2426;2,426;;;;;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;NMBR;GENDER;GENM;;;;
2010;2010;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;637;637;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;NMBR;RACE;BLK;;;;
2010;2010;NH;New Hampshire;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;31.81;31.81;;;30.01;33.61;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2010;2010;CT;Connecticut;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2010;2010;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;29;29;;;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;NMBR;RACE;AIAN;;;;
2010;2010;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;NMBR;RACE;API;;;;
2010;2010;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;17.95;17.95;;;17.5;18.4;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2010;2010;DE;Delaware;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;MN;Minnesota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;WY;Wyoming;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;10.71;10.71;;;10.32;11.1;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;6.55;6.55;;;4.85;8.25;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2010;2010;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;19.47;19.47;;;19.09;19.86;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2010;2010;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;8.39;8.39;;;7.76;9.02;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.5;9.5;;;7.3;12;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;MT;Montana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.4;11.4;;;8;15.8;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;8.72;8.72;;;8.46;8.98;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;6.4;6.4;;;4.8;8.2;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2010;2010;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;3.39;3.39;;;2.42;4.36;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2010;2010;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;662;662;;;;;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;NMBR;GENDER;GENM;;;;
2010;2010;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;18.87;18.87;;;18.67;19.06;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;307;307;;;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;NMBR;RACE;HIS;;;;
2010;2010;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;NMBR;GENDER;GENM;;;;
2010;2010;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;7.36;7.36;;;6.96;7.75;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;33.98;33.98;;;31.79;36.18;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2010;2010;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;5.48;5.48;;;4.77;6.2;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.2;10.2;;;8.2;12.2;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;NMBR;RACE;AIAN;;;;
2010;2010;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;4665;4,665;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;NMBR;RACE;WHT;;;;
2010;2010;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2010;2010;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;123;123;;;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;NMBR;RACE;HIS;;;;
2010;2010;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;4.30;4.3;;;3.19;5.42;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2010;2010;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;12.59;12.59;;;12.32;12.87;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2010;2010;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.4;11.4;;;8.9;14.5;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;8.09;8.09;;;7.24;8.95;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;15.43;15.43;;;15.19;15.68;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;410;410;;;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;NMBR;RACE;HIS;;;;
2010;2010;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;741;741;;;;;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;NMBR;RACE;HIS;;;;
2010;2010;DE;Delaware;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;16.44;16.44;;;16.11;16.77;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;11.67;11.67;;;11.38;11.96;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;MT;Montana;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2010;2010;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;19215;19,215;;;;;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;NMBR;GENDER;GENF;;;;
2010;2010;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1942;1,942;;;;;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;NMBR;GENDER;GENM;;;;
2010;2010;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;8.45;8.45;;;8.08;8.82;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;137;137;;;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;NMBR;RACE;HIS;;;;
2010;2010;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;13.34;13.34;;;12.99;13.69;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2010;2010;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;4.71;4.71;;;4.18;5.25;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2010;2010;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;9.69;9.69;;;9.34;10.05;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;CRDRATE;RACE;API;;;;
2010;2010;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;3.63;3.63;;;2.96;4.31;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2010;2010;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;31.9;31.9;;;23;43.1;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;4.47;4.47;;;3.89;5.04;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2010;2010;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.6;7.6;;;6.2;9.1;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;217;217;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;NMBR;RACE;BLK;;;;
2010;2010;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;19.94;19.94;;;19.66;20.22;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2010;2010;GA;Georgia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;37.60;37.6;;;35.93;39.28;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;43;43;;;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;NMBR;RACE;HIS;;;;
2010;2010;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;16.28;16.28;;;15.89;16.68;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.6;12.6;;;9.9;15.9;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;7.31;7.31;;;7.1;7.51;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;7.74;7.74;;;6.66;8.81;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;11.35;11.35;;;11.05;11.65;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2010;2010;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;7.05;7.05;;;6.92;7.17;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;15.3;15.3;;;10.7;21.2;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1987;1,987;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;NMBR;RACE;WHT;;;;
2010;2010;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;2250;2,250;;;;;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2010;2010;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.2;10.2;;;7.5;13.6;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;4336;4,336;;;;;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2010;2010;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;30;30;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;NMBR;RACE;API;;;;
2010;2010;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.5;11.5;;;6.8;18.2;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;12.11;12.11;;;11.54;12.68;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2010;2010;MO;Missouri;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2010;2010;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.1;12.1;;;9.5;15.3;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;10.19;10.19;;;9.77;10.61;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.9;11.9;;;10;13.9;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1007;1,007;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;NMBR;RACE;WHT;;;;
2010;2010;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;13.9;13.9;;;11.8;15.9;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;5.20;5.2;;;4.69;5.71;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2010;2010;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;2235;2,235;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;NMBR;RACE;API;;;;
2010;2010;AL;Alabama;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;17.14;17.14;;;16.87;17.41;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;5.47;5.47;;;5.21;5.73;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2010;2010;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;10.02;10.02;;;9.6;10.43;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2010;2010;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;NMBR;RACE;HIS;;;;
2010;2010;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;6.5;6.5;;;4.8;8.6;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;17.18;17.18;;;16.1;18.27;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1727;1,727;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;NMBR;RACE;WHT;;;;
2010;2010;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;4.34;4.34;;;3.87;4.81;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;CRDRATE;RACE;API;;;;
2010;2010;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;21.80;21.8;;;21;22.59;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;12.27;12.27;;;6.89;17.65;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;18.23;18.23;;;17.97;18.49;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2010;2010;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.1;8.1;;;6.9;9.4;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;16.03;16.03;;;15.52;16.54;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2010;2010;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.8;10.8;;;7.5;15.2;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;19.7;19.7;;;13.1;28.5;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2010;2010;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;24.00;24;;;21.94;26.07;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2010;2010;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;6.69;6.69;;;6.26;7.11;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;11.22;11.22;;;10.86;11.59;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2010;2010;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;NMBR;RACE;API;;;;
2010;2010;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;6.8;6.8;;;5.2;8.8;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;10.74;10.74;;;10.35;11.13;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;14.40;14.4;;;13.87;14.93;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;15.78;15.78;;;15.33;16.23;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;9.68;9.68;;;9.04;10.32;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2010;2010;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.907192, -77.036871);;11;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2010;2010;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;14.99;14.99;;;14.75;15.23;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.0;9;;;6.2;12.6;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;12.81;12.81;;;12.21;13.41;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;20;20;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;NMBR;RACE;API;;;;
2010;2010;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;14.9;14.9;;;11.2;19.4;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;AL;Alabama;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2010;2010;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;14.2;14.2;;;8.7;21.9;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2010;2010;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;5.7;5.7;;;4;7.9;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;8377;8,377;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;NMBR;RACE;BLK;;;;
2010;2010;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;7.03;7.03;;;6.46;7.61;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;7.16;7.16;;;6.86;7.45;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.8;10.8;;;8.7;13.2;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;US;United States;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.5;10.5;;;10.1;10.8;Overall;Overall;;;;;;;59;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.8;9.8;;;7.1;13.2;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;3.03;3.03;;;2.52;3.54;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2010;2010;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;AK;Alaska;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2010;2010;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;14.64;14.64;;;9.12;20.16;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;19.23;19.23;;;18.54;19.93;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2010;2010;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;8.71;8.71;;;8.31;9.11;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2010;2010;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;10.36;10.36;;;9.85;10.87;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.9;9.9;;;6.5;14.4;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;1.22;1.22;;;0.74;1.69;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2010;2010;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;8.96;8.96;;;8.48;9.43;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2010;2010;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;NMBR;RACE;AIAN;;;;
2010;2010;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;NMBR;RACE;API;;;;
2010;2010;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;28.26;28.26;;;27.65;28.86;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2010;2010;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;10.43;10.43;;;9.97;10.89;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1201;1,201;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;NMBR;RACE;BLK;;;;
2010;2010;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;CRDRATE;RACE;API;;;;
2010;2010;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;6.26;6.26;;;4.02;8.5;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2010;2010;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;5.86;5.86;;;5.6;6.12;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2010;2010;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;14.20;14.2;;;13.8;14.61;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;13.42;13.42;;;13;13.83;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;19399;19,399;;;;;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;NMBR;GENDER;GENF;;;;
2010;2010;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;NMBR;RACE;API;;;;
2010;2010;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;10.61;10.61;;;10.27;10.96;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.3;11.3;;;8;15.6;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;IL;Illinois;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;15.21;15.21;;;14.65;15.77;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;28.06;28.06;;;25.88;30.24;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;6.9;6.9;;;5.4;8.3;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;3912;3,912;;;;;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;NMBR;GENDER;GENM;;;;
2010;2010;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;2932;2,932;;;;;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;NMBR;GENDER;GENF;;;;
2010;2010;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2010;2010;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1739;1,739;;;;;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;NMBR;GENDER;GENF;;;;
2010;2010;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;47;47;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;NMBR;RACE;API;;;;
2010;2010;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.5;9.5;;;7.1;12.5;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;6.70;6.7;;;6.28;7.13;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2010;2010;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;11.58;11.58;;;11.12;12.04;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2010;2010;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;OK;Oklahoma;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2010;2010;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.2;8.2;;;5.4;12;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;622;622;;;;;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;NMBR;GENDER;GENF;;;;
2010;2010;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;25;25;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;NMBR;RACE;API;;;;
2010;2010;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;5.59;5.59;;;3.86;7.32;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2010;2010;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;119;119;;;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;NMBR;RACE;AIAN;;;;
2010;2010;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;837;837;;;;;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;NMBR;GENDER;GENF;;;;
2010;2010;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2010;2010;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;6.02;6.02;;;5.73;6.3;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;5.80;5.8;;;5.59;6.01;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.7;7.7;;;5.7;10.3;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;15.97;15.97;;;9.3;22.65;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2010;2010;TX;Texas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;23.10;23.1;;;19.53;26.67;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2010;2010;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;443;443;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;NMBR;RACE;WHT;;;;
2010;2010;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;18.90;18.9;;;18.7;19.09;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2010;2010;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;8.61;8.61;;;8.3;8.93;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2010;2010;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;331;331;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;NMBR;RACE;API;;;;
2010;2010;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;CRDRATE;RACE;API;;;;
2010;2010;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;5438;5,438;;;;;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;NMBR;GENDER;GENM;;;;
2010;2010;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;2820;2,820;;;;;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2010;2010;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;NMBR;RACE;BLK;;;;
2010;2010;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;811;811;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;NMBR;RACE;API;;;;
2010;2010;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2010;2010;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;508;508;;;;;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;NMBR;GENDER;GENM;;;;
2010;2010;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.2;9.2;;;6.6;12.5;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;4.12;4.12;;;2.62;5.63;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;10.83;10.83;;;10.62;11.04;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;9.22;9.22;;;9.05;9.4;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2010;2010;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;5.76;5.76;;;5.38;6.15;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2010;2010;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.3;10.3;;;6.4;15.8;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.0;9;;;6.6;11.9;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;23.3;23.3;;;15.6;33.5;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;7.38;7.38;;;7.07;7.68;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2010;2010;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;8.77;8.77;;;8.6;8.94;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;2841;2,841;;;;;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2010;2010;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;3817;3,817;;;;;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;NMBR;GENDER;GENF;;;;
2010;2010;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2010;2010;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;4.78;4.78;;;4.23;5.33;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;12.29;12.29;;;11.53;13.05;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2010;2010;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;11.22;11.22;;;10.93;11.52;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2010;2010;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;6.43;6.43;;;5.33;7.53;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2010;2010;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1955;1,955;;;;;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;NMBR;RACE;HIS;;;;
2010;2010;OH;Ohio;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;25.2;25.2;;;17.9;34.5;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;8.46;8.46;;;8.22;8.7;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;17.24;17.24;;;10.74;23.75;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2010;2010;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;4194;4,194;;;;;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;NMBR;GENDER;GENF;;;;
2010;2010;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.6;10.6;;;8.3;13.4;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;6131;6,131;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;NMBR;RACE;WHT;;;;
2010;2010;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;5.55;5.55;;;4.78;6.32;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2010;2010;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.3;12.3;;;8;18.2;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;11.87;11.87;;;11.65;12.1;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2010;2010;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;4.37;4.37;;;3.75;5;Race/Ethnicity;Asian or Pacific Islander;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2010;2010;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;8.44;8.44;;;4.74;12.14;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;CRDRATE;RACE;API;;;;
2010;2010;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2010;2010;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.8;12.8;;;9.3;17.1;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;TX;Texas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;ND;North Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2010;2010;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.5;13.5;;;9.4;18.7;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2010;2010;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;40.95;40.95;;;40.21;41.69;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;23.97;23.97;;;23.05;24.88;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.9;9.9;;;6.9;13.7;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;7.31;7.31;;;7.18;7.44;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.0;10;;;7.4;13;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;6.29;6.29;;;5.86;6.72;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;8.75;8.75;;;8.35;9.15;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;NMBR;RACE;AIAN;;;;
2010;2010;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;11.64;11.64;;;8.59;14.69;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2010;2010;ME;Maine;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;NMBR;RACE;AIAN;;;;
2010;2010;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;258;258;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;NMBR;RACE;BLK;;;;
2010;2010;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;14.1;14.1;;;11.7;16.6;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2010;2010;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;2963;2,963;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;NMBR;RACE;WHT;;;;
2010;2010;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2010;2010;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;11.26;11.26;;;9.23;13.28;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2010;2010;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;NMBR;RACE;API;;;;
2010;2010;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2010;2010;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;4.31;4.31;;;3.47;5.14;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2010;2010;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;13.7;13.7;;;10.4;17.8;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;4717;4,717;;;;;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;NMBR;GENDER;GENF;;;;
2010;2010;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;16.09;16.09;;;14.6;17.59;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2010;2010;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2010;2010;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;6728;6,728;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;NMBR;RACE;WHT;;;;
2010;2010;ME;Maine;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2010;2010;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1128;1,128;;;;;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2010;2010;DC;District of Columbia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.6;7.6;;;6.6;8.7;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;31.7;31.7;;;19.1;49.6;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;NMBR;RACE;API;;;;
2010;2010;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;129;129;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;NMBR;RACE;API;;;;
2010;2010;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;10.53;10.53;;;10.06;11;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;200;200;;;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;NMBR;RACE;HIS;;;;
2010;2010;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.4;10.4;;;8.9;11.9;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.6;9.6;;;7.2;12.6;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;7.41;7.41;;;6.77;8.06;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;16.4;16.4;;;11.2;23.1;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;679;679;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;NMBR;RACE;WHT;;;;
2010;2010;NH;New Hampshire;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2010;2010;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;14.5;14.5;;;9;22.1;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2010;2010;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;4.70;4.7;;;4.17;5.24;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;2369;2,369;;;;;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2010;2010;MN;Minnesota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;5.37;5.37;;;4.62;6.13;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2010;2010;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;3352;3,352;;;;;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;NMBR;GENDER;GENM;;;;
2010;2010;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;8.46;8.46;;;8.15;8.77;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;10.78;10.78;;;10.51;11.04;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;11.34;11.34;;;10.89;11.79;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2010;2010;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2010;2010;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;12.53;12.53;;;8.65;16.42;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2010;2010;GA;Georgia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2010;2010;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;12.18;12.18;;;11.83;12.53;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;23.1;23.1;;;14.1;35.7;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1448;1,448;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;NMBR;RACE;BLK;;;;
2010;2010;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2010;2010;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;44;44;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;NMBR;RACE;API;;;;
2010;2010;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;7.90;7.9;;;7.55;8.25;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1967;1,967;;;;;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;NMBR;GENDER;GENM;;;;
2010;2010;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.3;9.3;;;7.6;11.1;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;19.21;19.21;;;14.89;23.52;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2010;2010;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;14.4;14.4;;;9.5;20.9;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;13.5;13.5;;;8.4;20.6;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;9.44;9.44;;;9.06;9.81;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;5.59;5.59;;;5.11;6.08;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2010;2010;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;29.03;29.03;;;28.41;29.66;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2010;2010;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;4902;4,902;;;;;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2010;2010;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2010;2010;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;10.23;10.23;;;5.75;14.71;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2010;2010;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;5072;5,072;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;NMBR;RACE;WHT;;;;
2010;2010;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;9.91;9.91;;;7.31;12.5;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;9361;9,361;;;;;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;NMBR;GENDER;GENF;;;;
2010;2010;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;9.25;9.25;;;9.15;9.35;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.1;12.1;;;9.3;15.4;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;21.72;21.72;;;21.13;22.32;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;CRDRATE;RACE;API;;;;
2010;2010;TN;Tennessee;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2010;2010;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.4;10.4;;;6.8;15.1;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;12.8;12.8;;;8;19.4;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;26.31;26.31;;;23.29;29.33;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;15.2;15.2;;;12.2;18.1;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;DE;Delaware;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2010;2010;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2010;2010;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;15.0;15;;;12.1;17.9;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;NMBR;RACE;HIS;;;;
2010;2010;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;2.22;2.22;;;1.57;2.88;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2010;2010;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;8.62;8.62;;;8.38;8.86;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;16.41;16.41;;;15.24;17.58;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2010;2010;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;21;21;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;NMBR;RACE;API;;;;
2010;2010;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2010;2010;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;4.29;4.29;;;4.11;4.47;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;CRDRATE;RACE;API;;;;
2010;2010;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;31.58;31.58;;;30.94;32.21;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.4;9.4;;;6.5;13.3;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;4.01;4.01;;;3.49;4.53;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;CRDRATE;RACE;API;;;;
2010;2010;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;5.61;5.61;;;5.12;6.1;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;520;520;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;NMBR;RACE;BLK;;;;
2010;2010;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;29.86;29.86;;;29.05;30.68;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.1;9.1;;;7.5;10.7;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.8;9.8;;;7.4;12.7;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;4.90;4.9;;;4.61;5.19;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2010;2010;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;9.14;9.14;;;8.42;9.85;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2010;2010;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;5.36;5.36;;;4.99;5.73;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;CRDRATE;RACE;API;;;;
2010;2010;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;97;97;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;NMBR;RACE;API;;;;
2010;2010;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2010;2010;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2010;2010;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;33.93;33.93;;;29.42;38.45;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2010;2010;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1048;1,048;;;;;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;NMBR;GENDER;GENF;;;;
2010;2010;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;3645;3,645;;;;;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;NMBR;GENDER;GENM;;;;
2010;2010;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1934;1,934;;;;;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;NMBR;GENDER;GENF;;;;
2010;2010;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;187;187;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;NMBR;RACE;API;;;;
2010;2010;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;9.26;9.26;;;9.17;9.36;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;27;27;;;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;NMBR;RACE;AIAN;;;;
2010;2010;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;15.4;15.4;;;11.1;20.7;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;3.16;3.16;;;2.6;3.71;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;10144;10,144;;;;;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2010;2010;KS;Kansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;18.23;18.23;;;14.13;22.32;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;27.64;27.64;;;27.08;28.2;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2010;2010;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;14.1;14.1;;;9.8;19.5;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;6201;6,201;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;NMBR;RACE;WHT;;;;
2010;2010;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;8.59;8.59;;;8.33;8.84;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;13.17;13.17;;;7.67;18.68;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;20.05;20.05;;;19.44;20.66;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2010;2010;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;13.02;13.02;;;12.6;13.44;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2010;2010;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2010;2010;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;3.13;3.13;;;2.22;4.05;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2010;2010;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;5.22;5.22;;;4.71;5.73;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;6.52;6.52;;;6.25;6.79;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;76;76;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;NMBR;RACE;BLK;;;;
2010;2010;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;MO;Missouri;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2010;2010;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;36;36;;;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;NMBR;RACE;AIAN;;;;
2010;2010;VA;Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2010;2010;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;25.34;25.34;;;14.23;36.44;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2010;2010;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;25.11;25.11;;;22.05;28.17;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2010;2010;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;2871;2,871;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;NMBR;RACE;WHT;;;;
2010;2010;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;21.15;21.15;;;20.87;21.43;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;6.83;6.83;;;6.27;7.39;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2010;2010;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;12172;12,172;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;NMBR;RACE;WHT;;;;
2010;2010;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;NMBR;RACE;AIAN;;;;
2010;2010;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2010;2010;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;7.60;7.6;;;7.38;7.81;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2010;2010;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;NMBR;RACE;HIS;;;;
2010;2010;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;2232;2,232;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;NMBR;RACE;WHT;;;;
2010;2010;NH;New Hampshire;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;VA;Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;7.40;7.4;;;6.87;7.93;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;9.50;9.5;;;9.15;9.85;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;13.37;13.37;;;13;13.74;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2010;2010;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.8;10.8;;;7.4;15.3;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;4.22;4.22;;;3.5;4.95;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2010;2010;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2010;2010;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;34.53;34.53;;;32.3;36.76;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2010;2010;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;18.25;18.25;;;17.69;18.8;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2010;2010;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;5.82;5.82;;;5.36;6.28;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2010;2010;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;7.28;7.28;;;4.42;10.13;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2010;2010;ME;Maine;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;15.18;15.18;;;14.7;15.66;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.6;8.6;;;6.3;11.4;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;8.60;8.6;;;7.25;9.95;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2010;2010;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;3.65;3.65;;;3.13;4.18;Race/Ethnicity;Asian or Pacific Islander;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;CRDRATE;RACE;API;;;;
2010;2010;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;3.05;3.05;;;1.98;4.13;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2010;2010;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;29.68;29.68;;;28.87;30.49;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2010;2010;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1747;1,747;;;;;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;NMBR;GENDER;GENM;;;;
2010;2010;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;4748;4,748;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;NMBR;RACE;BLK;;;;
2010;2010;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.5;8.5;;;5.5;12.4;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;12.40;12.4;;;12.13;12.68;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;6.17;6.17;;;5.93;6.42;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;23.30;23.3;;;21.3;25.3;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;CRDRATE;RACE;API;;;;
2010;2010;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.9;7.9;;;6;10.2;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;5.10;5.1;;;4.39;5.82;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2010;2010;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;ND;North Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;10454;10,454;;;;;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2010;2010;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1515;1,515;;;;;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2010;2010;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;4802;4,802;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;NMBR;RACE;WHT;;;;
2010;2010;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;11.73;11.73;;;11.44;12.03;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2010;2010;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;6.06;6.06;;;5.27;6.85;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;CRDRATE;RACE;API;;;;
2010;2010;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;7.13;7.13;;;6.81;7.44;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;4188;4,188;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;NMBR;RACE;BLK;;;;
2010;2010;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;6.67;6.67;;;4.49;8.84;Race/Ethnicity;American Indian or Alaska Native;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2010;2010;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;7.7;7.7;;;4.6;12;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;3.21;3.21;;;2.36;4.07;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.9;8.9;;;6;12.7;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.6;10.6;;;8.1;13.8;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;194;194;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;NMBR;RACE;WHT;;;;
2010;2010;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;4.95;4.95;;;3.97;5.93;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;CRDRATE;RACE;API;;;;
2010;2010;IN;Indiana;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;8.47;8.47;;;7.88;9.07;Race/Ethnicity;Asian or Pacific Islander;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2010;2010;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;4.75;4.75;;;4.39;5.11;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2010;2010;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;9.19;9.19;;;8.54;9.83;Race/Ethnicity;Asian or Pacific Islander;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;CRDRATE;RACE;API;;;;
2010;2010;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;7.25;7.25;;;7.05;7.45;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1876;1,876;;;;;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;NMBR;GENDER;GENF;;;;
2010;2010;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;12.91;12.91;;;12.59;13.23;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;14261;14,261;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;NMBR;RACE;WHT;;;;
2010;2010;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2010;2010;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;6.22;6.22;;;3.56;8.88;Race/Ethnicity;Asian or Pacific Islander;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;CRDRATE;RACE;API;;;;
2010;2010;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;14.64;14.64;;;8.52;20.75;Race/Ethnicity;American Indian or Alaska Native;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2010;2010;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;6.05;6.05;;;5.78;6.32;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;ID;Idaho;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;NE;Nebraska;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2010;2010;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;9.86;9.86;;;9.51;10.22;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2010;2010;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.2;9.2;;;7.7;10.7;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;2385;2,385;;;;;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;NMBR;GENDER;GENF;;;;
2010;2010;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;4.10;4.1;;;2.66;5.55;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2010;2010;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;12.39;12.39;;;12.03;12.74;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2010;2010;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;2.62;2.62;;;1.86;3.39;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;CRDRATE;RACE;API;;;;
2010;2010;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;4.19;4.19;;;3.1;5.28;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;CRDRATE;RACE;API;;;;
2010;2010;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2010;2010;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;13.9;13.9;;;10.7;17.8;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;12.61;12.61;;;12.04;13.18;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2010;2010;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;8.51;8.51;;;7.61;9.4;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2010;2010;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2010;2010;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;6.27;6.27;;;5.67;6.88;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;10.03;10.03;;;9.43;10.64;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2010;2010;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.8;8.8;;;7.1;10.4;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;574;574;;;;;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2010;2010;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;8.47;8.47;;;7.98;8.96;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2010;2010;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;1.71;1.71;;;1.21;2.22;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;CRDRATE;RACE;API;;;;
2010;2010;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;401;401;;;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;NMBR;RACE;HIS;;;;
2010;2010;MO;Missouri;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;4.62;4.62;;;4.31;4.93;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2010;2010;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2010;2010;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2010;2010;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;227;227;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;NMBR;RACE;API;;;;
2010;2010;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;6.22;6.22;;;5.96;6.47;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2010;2010;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;20.4;20.4;;;12.9;30.6;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;12.03;12.03;;;11.49;12.58;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;6.04;6.04;;;5.63;6.45;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2010;2010;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.4;10.4;;;8.1;13.3;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;27.63;27.63;;;25.49;29.78;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2010;2010;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;4.82;4.82;;;4.26;5.38;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2010;2010;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.2;11.2;;;8.5;14.6;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;IL;Illinois;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;OR;Oregon;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;7.67;7.67;;;7.28;8.06;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2010;2010;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2010;2010;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;6.43;6.43;;;6.3;6.56;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2010;2010;FL;Florida;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;12.15;12.15;;;11.92;12.38;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;21.87;21.87;;;21.07;22.67;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2010;2010;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;2.88;2.88;;;2.02;3.73;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;TX;Texas;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2010;2010;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;756;756;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;NMBR;RACE;BLK;;;;
2010;2010;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;834;834;;;;;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;NMBR;GENDER;GENF;;;;
2010;2010;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;18.3;18.3;;;13.2;24.8;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.1;9.1;;;6.6;12.2;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2010;2010;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;19.63;19.63;;;19.13;20.13;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2010;2010;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;NMBR;RACE;AIAN;;;;
2010;2010;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;4.42;4.42;;;4.08;4.76;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;AZ;Arizona;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;310;310;;;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST3_1;NMBR;RACE;AIAN;;;;
2010;2010;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;5.47;5.47;;;4.93;6.01;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;KY;Kentucky;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;6621;6,621;;;;;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2010;2010;NJ;New Jersey;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;41.20;41.2;;;40.03;42.38;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.6;11.6;;;8;16.2;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;15.60;15.6;;;15.16;16.05;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;9.42;9.42;;;7.2;11.64;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;CRDRATE;RACE;AIAN;;;;
2010;2010;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;20.58;20.58;;;19.66;21.49;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2010;2010;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;5090;5,090;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;NMBR;RACE;BLK;;;;
2010;2010;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;38.44;38.44;;;37.41;39.46;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;10.94;10.94;;;10.73;11.15;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;102;102;;;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;NMBR;RACE;HIS;;;;
2010;2010;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;8.50;8.5;;;8.05;8.95;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;5.4;5.4;;;3.8;7.4;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;5.72;5.72;;;5.51;5.93;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2010;2010;NM;New Mexico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2010;2010;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;15.9;15.9;;;11.7;21.1;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;NMBR;RACE;API;;;;
2010;2010;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;17.2;17.2;;;12.5;23.1;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;4.46;4.46;;;3.59;5.32;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1968;1,968;;;;;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;NMBR;GENDER;GENM;;;;
2010;2010;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;15.45;15.45;;;15.19;15.7;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2010;2010;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.6;8.6;;;6.2;11.7;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;15.05;15.05;;;14.31;15.79;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1947;1,947;;;;;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;NMBR;RACE;HIS;;;;
2010;2010;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2010;2010;MD;Maryland;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;3612;3,612;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST3_1;NMBR;RACE;WHT;;;;
2010;2010;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.8;8.8;;;5.9;12.6;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;9.72;9.72;;;9.36;10.08;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1109;1,109;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;NMBR;RACE;WHT;;;;
2010;2010;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;NMBR;RACE;AIAN;;;;
2010;2010;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;40.29;40.29;;;39.56;41.01;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2010;2010;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;IA;Iowa;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;5.77;5.77;;;5.39;6.15;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;9.7;9.7;;;5.8;15.2;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;8.53;8.53;;;8.04;9.02;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.1;11.1;;;6.8;16.9;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;MI;Michigan;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;37.53;37.53;;;36.53;38.52;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2010;2010;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.1;8.1;;;6.4;10.1;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;11.9;11.9;;;9.1;15.3;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;AR;Arkansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;2.30;2.3;;;1.61;2.99;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST3_1;CRDRATE;RACE;HIS;;;;
2010;2010;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;276;276;;;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;NMBR;RACE;AIAN;;;;
2010;2010;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.5;8.5;;;5.4;12.9;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;WY;Wyoming;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;36604;36,604;;;;;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2010;2010;CA;California;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;8.04;8.04;;;7.88;8.21;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST3_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2010;2010;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;6539;6,539;;;;;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;NMBR;GENDER;GENF;;;;
2010;2010;UT;Utah;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;40;40;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST3_1;NMBR;RACE;API;;;;
2010;2010;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;15.3;15.3;;;9.5;23.4;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;295;295;;;;;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2010;2010;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;6076;6,076;;;;;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2010;2010;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;16.5;16.5;;;10.2;25.2;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;24.57;24.57;;;21.67;27.47;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;SC;South Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;2864;2,864;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST3_1;NMBR;RACE;BLK;;;;
2010;2010;NC;North Carolina;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;12.77;12.77;;;12.46;13.08;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2010;2010;KS;Kansas;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2010;2010;AL;Alabama;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;8.6;8.6;;;6.5;11.1;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;1570;1,570;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;NMBR;RACE;WHT;;;;
2010;2010;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2010;2010;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;17.63;17.63;;;16.52;18.75;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2010;2010;MA;Massachusetts;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;15.45;15.45;;;15.15;15.75;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.6;8.6;;;6.7;10.9;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;29;29;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;NMBR;RACE;BLK;;;;
2010;2010;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2010;2010;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;NMBR;RACE;HIS;;;;
2010;2010;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.0;11;;;8.9;13.1;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2010;2010;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;NMBR;RACE;HIS;;;;
2010;2010;NY;New York;NVSS;Asthma;Asthma mortality rate;;;Number;90;90;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;NMBR;RACE;BLK;;;;
2010;2010;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.2;13.2;;;8.4;19.8;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2010;2010;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;NMBR;RACE;HIS;;;;
2010;2010;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2010;2010;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;6.6;6.6;;;4.3;9.7;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2010;2010;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;NMBR;RACE;API;;;;
2010;2010;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.1;13.1;;;11;15.2;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.1;10.1;;;6.6;14.6;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2010;2010;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.1;10.1;;;7.6;13.2;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2010;2010;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2010;2010;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;CRDRATE;RACE;API;;;;
2010;2010;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;66;66;;;;;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2010;2010;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;NMBR;RACE;AIAN;;;;
2010;2010;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2010;2010;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.4;10.4;;;8.3;12.8;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2010;2010;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;NMBR;RACE;HIS;;;;
2010;2010;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;NMBR;GENDER;GENM;;;;
2010;2010;TX;Texas;NVSS;Asthma;Asthma mortality rate;;;Number;111;111;;;;;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;NMBR;GENDER;GENF;;;;
2010;2010;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;NMBR;RACE;BLK;;;;
2010;2010;CA;California;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;NMBR;RACE;AIAN;;;;
2010;2010;NY;New York;NVSS;Asthma;Asthma mortality rate;;;Number;135;135;;;;;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;NMBR;GENDER;GENM;;;;
2010;2010;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2010;2010;TX;Texas;NVSS;Asthma;Asthma mortality rate;;;Number;192;192;;;;;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2010;2010;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2010;2010;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;;Number;22;22;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;NMBR;RACE;BLK;;;;
2010;2010;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;CRDRATE;RACE;API;;;;
2010;2010;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;;Number;36;36;;;;;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;NMBR;GENDER;GENF;;;;
2010;2010;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.6;11.6;;;8;16.2;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;NMBR;RACE;WHT;;;;
2010;2010;PR;Puerto Rico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2010;2010;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;NMBR;GENDER;GENM;;;;
2010;2010;NY;New York;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;10571;10,571;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST3_1;NMBR;RACE;WHT;;;;
2010;2010;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;;Number;73;73;;;;;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2010;2010;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2010;2010;GU;Guam;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2010;2010;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2010;2010;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;NMBR;RACE;BLK;;;;
2010;2010;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;3.7;3.7;;;2.6;5.1;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2010;2010;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;NMBR;RACE;HIS;;;;
2010;2010;WA;Washington;NVSS;Asthma;Asthma mortality rate;;;Number;60;60;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;NMBR;RACE;WHT;;;;
2010;2010;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;CRDRATE;RACE;API;;;;
2010;2010;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;NMBR;GENDER;GENF;;;;
2010;2010;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;NMBR;RACE;HIS;;;;
2010;2010;PR;Puerto Rico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;19.4;19.4;;;14.2;25.8;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2010;2010;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.5;11.5;;;7.5;16.8;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2010;2010;NY;New York;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;NMBR;RACE;AIAN;;;;
2010;2010;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST4_1;NMBR;RACE;WHT;;;;
2010;2010;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;NMBR;RACE;AIAN;;;;
2010;2010;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;NMBR;GENDER;GENM;;;;
2010;2010;VI;Virgin Islands;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST2_1;NMBR;GENDER;GENM;;;;
2010;2010;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2010;2010;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2010;2010;MT;Montana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;NMBR;GENDER;GENF;;;;
2010;2010;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;NMBR;RACE;HIS;;;;
2010;2010;US;United States;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.0;11;;;10.7;11.4;Overall;Overall;;;;;;;59;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;NMBR;GENDER;GENM;;;;
2010;2010;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;18.9;18.9;;;14.3;24.4;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2010;2010;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;CRDRATE;RACE;API;;;;
2010;2010;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;NMBR;RACE;BLK;;;;
2010;2010;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2010;2010;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;NMBR;RACE;API;;;;
2010;2010;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;5.8;5.8;;;4.6;7.2;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2010;2010;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2010;2010;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;CRDRATE;RACE;API;;;;
2010;2010;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;;Number;63;63;;;;;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2010;2010;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;CRDRATE;RACE;API;;;;
2010;2010;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2010;2010;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;NMBR;RACE;AIAN;;;;
2010;2010;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.3;11.3;;;8.5;14.7;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2010;2010;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2010;2010;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;;Number;29;29;;;;;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;NMBR;GENDER;GENF;;;;
2010;2010;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.8;11.8;;;9.2;14.8;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2010;2010;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2010;2010;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;NMBR;RACE;AIAN;;;;
2010;2010;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;14.45;14.45;;;11.16;17.74;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2010;2010;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;NMBR;GENDER;GENM;;;;
2010;2010;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2010;2010;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2010;2010;MT;Montana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;NMBR;RACE;BLK;;;;
2010;2010;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;;Number;33;33;;;;;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;NMBR;GENDER;GENF;;;;
2010;2010;PR;Puerto Rico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST2_1;NMBR;GENDER;GENF;;;;
2010;2010;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.3;10.3;;;7.3;14.2;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2010;2010;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;NMBR;RACE;BLK;;;;
2010;2010;PR;Puerto Rico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;NMBR;RACE;BLK;;;;
2010;2010;MT;Montana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;NMBR;RACE;HIS;;;;
2010;2010;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;15.0;15;;;9.4;22.7;Race/Ethnicity;Black, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2010;2010;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;CRDRATE;RACE;API;;;;
2010;2010;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2010;2010;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;NMBR;RACE;API;;;;
2010;2010;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2010;2010;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;CRDRATE;RACE;API;;;;
2010;2010;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;NMBR;RACE;AIAN;;;;
2010;2010;ME;Maine;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;NMBR;RACE;API;;;;
2010;2010;VI;Virgin Islands;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;NMBR;RACE;AIAN;;;;
2010;2010;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;NMBR;RACE;API;;;;
2010;2010;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2010;2010;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;;Number;26;26;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;NMBR;RACE;BLK;;;;
2010;2010;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;NMBR;GENDER;GENF;;;;
2010;2010;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;NMBR;RACE;AIAN;;;;
2010;2010;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;;Number;30;30;;;;;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;NMBR;GENDER;GENF;;;;
2010;2010;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2010;2010;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;;Number;74;74;;;;;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;NMBR;GENDER;GENM;;;;
2010;2010;VI;Virgin Islands;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.9;13.9;;;8.6;21.3;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2010;2010;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;;Number;46;46;;;;;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;NMBR;GENDER;GENF;;;;
2010;2010;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;CRDRATE;RACE;API;;;;
2010;2010;GU;Guam;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2010;2010;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;NMBR;RACE;AIAN;;;;
2010;2010;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;;Number;54;54;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;NMBR;RACE;WHT;;;;
2010;2010;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2010;2010;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2010;2010;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2010;2010;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;;Number;132;132;;;;;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2010;2010;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2010;2010;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2010;2010;VI;Virgin Islands;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2010;2010;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2010;2010;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;NMBR;RACE;BLK;;;;
2010;2010;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2010;2010;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;NMBR;RACE;AIAN;;;;
2010;2010;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.6;14.6;;;12.9;16.3;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2010;2010;ME;Maine;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;NMBR;RACE;BLK;;;;
2010;2010;TX;Texas;NVSS;Asthma;Asthma mortality rate;;;Number;46;46;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;NMBR;RACE;BLK;;;;
2010;2010;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2010;2010;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2010;2010;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2010;2010;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;NMBR;RACE;BLK;;;;
2010;2010;NY;New York;NVSS;Asthma;Asthma mortality rate;;;Number;115;115;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;NMBR;RACE;WHT;;;;
2010;2010;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;CRDRATE;RACE;API;;;;
2010;2010;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;NMBR;RACE;BLK;;;;
2010;2010;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;;Number;41;41;;;;;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;NMBR;GENDER;GENM;;;;
2010;2010;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;CRDRATE;RACE;API;;;;
2010;2010;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;;Number;54;54;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;NMBR;RACE;WHT;;;;
2010;2010;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;22.2;22.2;;;14.5;32.5;Race/Ethnicity;Black, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2010;2010;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2010;2010;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;19.0;19;;;12.2;28.2;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2010;2010;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;NMBR;RACE;AIAN;;;;
2010;2010;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;NMBR;RACE;WHT;;;;
2010;2010;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.3;12.3;;;9.6;15.5;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;PR;Puerto Rico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2010;2010;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2010;2010;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;NMBR;RACE;API;;;;
2010;2010;PR;Puerto Rico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;VI;Virgin Islands;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2010;2010;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST4_1;NMBR;RACE;BLK;;;;
2010;2010;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2010;2010;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;NMBR;RACE;API;;;;
2010;2010;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;16.7;16.7;;;13.5;19.8;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2010;2010;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;;Number;22;22;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;NMBR;RACE;BLK;;;;
2010;2010;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2010;2010;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.7;12.7;;;10;15.9;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;;Number;31;31;;;;;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;NMBR;GENDER;GENF;;;;
2010;2010;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2010;2010;ME;Maine;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;NMBR;GENDER;GENM;;;;
2010;2010;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2010;2010;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2010;2010;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;WI;Wisconsin;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;6.97;6.97;;;6.66;7.27;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST3_1;CRDRATE;GENDER;GENM;;;;
2010;2010;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2010;2010;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;CRDRATE;RACE;API;;;;
2010;2010;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;;Number;26;26;;;;;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;NMBR;GENDER;GENM;;;;
2010;2010;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.907192, -77.036871);;11;AST;AST4_1;CRDRATE;RACE;API;;;;
2010;2010;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;;Number;27;27;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;NMBR;RACE;WHT;;;;
2010;2010;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST4_1;NMBR;RACE;HIS;;;;
2010;2010;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;NMBR;RACE;AIAN;;;;
2010;2010;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.5;13.5;;;11.7;15.3;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2010;2010;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;NMBR;GENDER;GENM;;;;
2010;2010;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;NMBR;RACE;AIAN;;;;
2010;2010;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;NMBR;RACE;AIAN;;;;
2010;2010;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2010;2010;IL;Illinois;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2010;2010;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;NMBR;GENDER;GENM;;;;
2010;2010;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.3;10.3;;;6.5;15.7;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;NMBR;GENDER;GENF;;;;
2010;2010;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2010;2010;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;NMBR;RACE;API;;;;
2010;2010;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2010;2010;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;NMBR;GENDER;GENF;;;;
2010;2010;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;NMBR;RACE;HIS;;;;
2010;2010;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;NMBR;RACE;HIS;;;;
2010;2010;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;NMBR;RACE;API;;;;
2010;2010;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;11.57;11.57;;;9.49;13.65;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;AGEADJRATE;RACE;AIAN;;;;
2010;2010;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.0;14;;;10;19;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2010;2010;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2010;2010;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;CRDRATE;RACE;API;;;;
2010;2010;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2010;2010;VI;Virgin Islands;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST2_1;NMBR;GENDER;GENF;;;;
2010;2010;WA;Washington;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;NMBR;RACE;BLK;;;;
2010;2010;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;AGEADJRATE;RACE;WHT;;;;
2010;2010;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.4;13.4;;;11.7;15.1;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2010;2010;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2010;2010;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;NMBR;RACE;AIAN;;;;
2010;2010;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2010;2010;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2010;2010;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2010;2010;WA;Washington;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;NMBR;RACE;HIS;;;;
2010;2010;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;;Number;151;151;;;;;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2010;2010;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;;Number;76;76;;;;;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2010;2010;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;NMBR;RACE;API;;;;
2010;2010;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;NMBR;RACE;WHT;;;;
2010;2010;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2010;2010;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2010;2010;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;NMBR;RACE;API;;;;
2010;2010;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;18.3;18.3;;;12.3;26.3;Race/Ethnicity;Black, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2010;2010;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2010;2010;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2010;2010;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2010;2010;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2010;2010;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;NMBR;GENDER;GENM;;;;
2010;2010;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;NMBR;RACE;BLK;;;;
2010;2010;NY;New York;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;NMBR;RACE;API;;;;
2010;2010;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2010;2010;MT;Montana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;NMBR;RACE;API;;;;
2010;2010;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;101;101;;;;;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2010;2010;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.6;7.6;;;5.4;10.3;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2010;2010;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;NMBR;RACE;HIS;;;;
2010;2010;CA;California;NVSS;Asthma;Asthma mortality rate;;;Number;55;55;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;NMBR;RACE;API;;;;
2010;2010;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.2;8.2;;;6.9;9.5;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2010;2010;VI;Virgin Islands;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(18.335765, -64.896335);;78;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;;Number;27;27;;;;;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;NMBR;GENDER;GENM;;;;
2010;2010;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;NMBR;RACE;HIS;;;;
2010;2010;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.2;11.2;;;8.8;14;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;NMBR;RACE;API;;;;
2010;2010;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;NMBR;GENDER;GENM;;;;
2010;2010;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;396;396;;;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;NMBR;RACE;HIS;;;;
2010;2010;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2010;2010;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;NMBR;RACE;API;;;;
2010;2010;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;15.1;15.1;;;11.1;20.1;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2010;2010;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;;Number;20;20;;;;;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;NMBR;GENDER;GENF;;;;
2010;2010;WV;West Virginia;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2010;2010;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;CRDRATE;RACE;API;;;;
2010;2010;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;CRDRATE;RACE;API;;;;
2010;2010;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.3;10.3;;;7;14.7;Race/Ethnicity;White, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2010;2010;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;;Number;46;46;;;;;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2010;2010;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;NMBR;RACE;HIS;;;;
2010;2010;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.5;14.5;;;9.1;22;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2010;2010;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2010;2010;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.1;12.1;;;9.9;14.3;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2010;2010;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;NMBR;GENDER;GENM;;;;
2010;2010;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;CRDRATE;RACE;API;;;;
2010;2010;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;;Number;22;22;;;;;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;NMBR;GENDER;GENM;;;;
2010;2010;VI;Virgin Islands;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(18.335765, -64.896335);;78;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2010;2010;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;NMBR;RACE;HIS;;;;
2010;2010;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2010;2010;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;;Number;42;42;;;;;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;NMBR;GENDER;GENF;;;;
2010;2010;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2010;2010;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2010;2010;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.3;9.3;;;7.5;11.1;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2010;2010;GU;Guam;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2010;2010;NY;New York;NVSS;Asthma;Asthma mortality rate;;;Number;58;58;;;;;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;NMBR;RACE;HIS;;;;
2010;2010;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.8;12.8;;;9.8;16.4;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.6;8.6;;;5.3;13.3;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2010;2010;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.2;8.2;;;5.3;11.9;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2010;2010;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;NMBR;RACE;WHT;;;;
2010;2010;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2010;2010;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2010;2010;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;;Number;22;22;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;NMBR;RACE;WHT;;;;
2010;2010;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST4_1;NMBR;GENDER;GENF;;;;
2010;2010;VI;Virgin Islands;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2010;2010;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;CRDRATE;RACE;API;;;;
2010;2010;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2010;2010;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;;Number;107;107;;;;;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;NMBR;GENDER;GENF;;;;
2010;2010;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.6;10.6;;;7.6;14.2;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2010;2010;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;;Number;40;40;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;NMBR;RACE;WHT;;;;
2010;2010;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2010;2010;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2010;2010;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.6;10.6;;;8.5;12.7;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2010;2010;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2010;2010;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.1;12.1;;;9.3;15.6;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2010;2010;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2010;2010;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;NMBR;GENDER;GENM;;;;
2010;2010;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;22.8;22.8;;;17.2;29.8;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2010;2010;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;NMBR;RACE;AIAN;;;;
2010;2010;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;NMBR;RACE;WHT;;;;
2010;2010;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;NMBR;RACE;API;;;;
2010;2010;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;NMBR;RACE;WHT;;;;
2010;2010;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;NMBR;RACE;API;;;;
2010;2010;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2010;2010;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2010;2010;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;NMBR;RACE;API;;;;
2010;2010;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.7;10.7;;;6.7;16.2;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;;Number;21;21;;;;;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2010;2010;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2010;2010;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;;Number;48;48;;;;;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;NMBR;GENDER;GENM;;;;
2010;2010;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2010;2010;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2010;2010;PR;Puerto Rico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;GU;Guam;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST2_1;NMBR;GENDER;GENM;;;;
2010;2010;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;NMBR;RACE;API;;;;
2010;2010;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;17.7;17.7;;;11.7;25.7;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2010;2010;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;NMBR;RACE;AIAN;;;;
2010;2010;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.6;10.6;;;8.2;13.4;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2010;2010;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2010;2010;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;NMBR;RACE;BLK;;;;
2010;2010;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2010;2010;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.5;9.5;;;7;12.7;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.0;11;;;8.3;14.3;Race/Ethnicity;White, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2010;2010;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;CRDRATE;RACE;API;;;;
2010;2010;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2010;2010;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2010;2010;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.6;10.6;;;8;13.8;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;CRDRATE;RACE;API;;;;
2010;2010;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;;Number;50;50;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;NMBR;RACE;WHT;;;;
2010;2010;GU;Guam;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST2_1;NMBR;GENDER;GENF;;;;
2010;2010;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;;Number;44;44;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;NMBR;RACE;WHT;;;;
2010;2010;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;NMBR;RACE;HIS;;;;
2010;2010;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;NMBR;RACE;BLK;;;;
2010;2010;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;5.9;5.9;;;3.8;8.7;Race/Ethnicity;Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2010;2010;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;16.4;16.4;;;11;23.3;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2010;2010;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2010;2010;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;NMBR;RACE;HIS;;;;
2010;2010;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;27.6;27.6;;;19.7;37.6;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2010;2010;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;NMBR;RACE;API;;;;
2010;2010;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;;Number;95;95;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;NMBR;RACE;WHT;;;;
2010;2010;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;17.9;17.9;;;13;24;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2010;2010;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;NMBR;GENDER;GENM;;;;
2010;2010;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;NMBR;RACE;API;;;;
2010;2010;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;;Number;84;84;;;;;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;NMBR;GENDER;GENF;;;;
2010;2010;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;CRDRATE;RACE;API;;;;
2010;2010;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;ME;Maine;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2010;2010;TX;Texas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;NMBR;RACE;API;;;;
2010;2010;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2010;2010;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;17.0;17;;;12.9;21.9;Race/Ethnicity;Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2010;2010;ME;Maine;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;NMBR;GENDER;GENF;;;;
2010;2010;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.4;8.4;;;5.5;12.2;Race/Ethnicity;White, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2010;2010;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2010;2010;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2010;2010;UT;Utah;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;NMBR;GENDER;GENM;;;;
2010;2010;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;16.3;16.3;;;11.4;22.6;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2010;2010;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;NMBR;GENDER;GENF;;;;
2010;2010;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;NMBR;RACE;API;;;;
2010;2010;CO;Colorado;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;9.48;9.48;;;9.1;9.86;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST3_1;CRDRATE;GENDER;GENF;;;;
2010;2010;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;NMBR;RACE;API;;;;
2010;2010;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;NMBR;RACE;HIS;;;;
2010;2010;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2010;2010;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2010;2010;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2010;2010;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2010;2010;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2010;2010;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;CRDRATE;RACE;API;;;;
2010;2010;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;NMBR;RACE;HIS;;;;
2010;2010;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2010;2010;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;NMBR;RACE;AIAN;;;;
2010;2010;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;;Number;104;104;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;NMBR;RACE;WHT;;;;
2010;2010;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;NMBR;RACE;BLK;;;;
2010;2010;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2010;2010;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;NMBR;RACE;AIAN;;;;
2010;2010;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;;Number;20;20;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;NMBR;RACE;WHT;;;;
2010;2010;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;CRDRATE;RACE;API;;;;
2010;2010;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;;Number;27;27;;;;;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2010;2010;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;;Number;34;34;;;;;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;NMBR;GENDER;GENM;;;;
2010;2010;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.7;7.7;;;5.4;10.5;Race/Ethnicity;White, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2010;2010;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.7;12.7;;;8.4;18.4;Race/Ethnicity;White, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2010;2010;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.8;7.8;;;5.7;10.5;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2010;2010;US;United States;NVSS;Asthma;Asthma mortality rate;;;Number;3404;3,404;;;;;Overall;Overall;;;;;;;59;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2010;2010;GU;Guam;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;CRDRATE;RACE;API;;;;
2010;2010;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;CRDRATE;RACE;API;;;;
2010;2010;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;NMBR;RACE;AIAN;;;;
2010;2010;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST4_1;NMBR;GENDER;GENM;;;;
2010;2010;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;NMBR;RACE;AIAN;;;;
2010;2010;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2010;2010;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2010;2010;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2010;2010;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;NMBR;RACE;API;;;;
2010;2010;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.5;9.5;;;7.3;12.2;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2010;2010;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;;Number;49;49;;;;;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;NMBR;GENDER;GENF;;;;
2010;2010;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2010;2010;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.5;13.5;;;10.4;17.2;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2010;2010;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;18.1;18.1;;;14.7;21.6;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2010;2010;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.1;14.1;;;9.9;19.4;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2010;2010;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2010;2010;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2010;2010;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2010;2010;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;34;34;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;NMBR;RACE;BLK;;;;
2010;2010;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2010;2010;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;NMBR;RACE;HIS;;;;
2010;2010;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;15.6;15.6;;;11.4;20.8;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2010;2010;PR;Puerto Rico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST2_1;NMBR;GENDER;GENM;;;;
2010;2010;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;NMBR;RACE;BLK;;;;
2010;2010;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;CRDRATE;RACE;API;;;;
2010;2010;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;;Number;30;30;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;NMBR;RACE;BLK;;;;
2010;2010;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2010;2010;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;NMBR;RACE;BLK;;;;
2010;2010;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;NMBR;RACE;WHT;;;;
2010;2010;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2010;2010;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2010;2010;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2010;2010;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;NMBR;RACE;HIS;;;;
2010;2010;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.4;8.4;;;6.1;11.2;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2010;2010;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.0;10;;;6.6;14.5;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2010;2010;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2010;2010;HI;Hawaii;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;8.27;8.27;;;7.62;8.91;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;;Number;36;36;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;NMBR;RACE;WHT;;;;
2010;2010;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;NMBR;RACE;API;;;;
2010;2010;NY;New York;NVSS;Asthma;Asthma mortality rate;;;Number;148;148;;;;;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;NMBR;GENDER;GENF;;;;
2010;2010;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.1;8.1;;;5.2;12.2;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2010;2010;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;19.5;19.5;;;13.1;28.1;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2010;2010;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;NMBR;RACE;BLK;;;;
2010;2010;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.1;11.1;;;8.5;14.2;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;NMBR;RACE;HIS;;;;
2010;2010;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2010;2010;GU;Guam;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;NMBR;GENDER;GENM;;;;
2010;2010;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2010;2010;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;NMBR;RACE;API;;;;
2010;2010;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;;Number;22;22;;;;;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;NMBR;GENDER;GENM;;;;
2010;2010;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;;Number;46;46;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;NMBR;RACE;BLK;;;;
2010;2010;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.4;14.4;;;12;16.8;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2010;2010;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;NMBR;RACE;HIS;;;;
2010;2010;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2010;2010;UT;Utah;NVSS;Asthma;Asthma mortality rate;;;Number;28;28;;;;;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2010;2010;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2010;2010;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2010;2010;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;CRDRATE;RACE;API;;;;
2010;2010;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.8;13.8;;;10.1;18.5;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2010;2010;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2010;2010;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;NMBR;GENDER;GENM;;;;
2010;2010;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;NMBR;RACE;AIAN;;;;
2010;2010;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;CRDRATE;RACE;API;;;;
2010;2010;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2010;2010;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.5;7.5;;;5.2;10.5;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2010;2010;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;;Number;67;67;;;;;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2010;2010;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;NMBR;GENDER;GENM;;;;
2010;2010;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;NMBR;RACE;AIAN;;;;
2010;2010;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.8;8.8;;;7.1;10.4;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2010;2010;DC;District of Columbia;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2010;2010;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;NMBR;RACE;BLK;;;;
2010;2010;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.0;13;;;8.3;19.3;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2010;2010;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.7;13.7;;;9.9;18.6;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2010;2010;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2010;2010;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.6;7.6;;;5.7;10.1;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;NMBR;RACE;API;;;;
2010;2010;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2010;2010;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.6;9.6;;;6.5;13.7;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2010;2010;VI;Virgin Islands;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.1;13.1;;;9.4;17.6;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2010;2010;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.907192, -77.036871);;11;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2010;2010;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;;Number;61;61;;;;;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;NMBR;GENDER;GENF;;;;
2010;2010;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;;Number;37;37;;;;;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;NMBR;GENDER;GENM;;;;
2010;2010;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;;Number;37;37;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;NMBR;RACE;WHT;;;;
2010;2010;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2010;2010;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;15.8;15.8;;;10.9;22.3;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2010;2010;OK;Oklahoma;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST2_1;NMBR;GENDER;GENF;;;;
2010;2010;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;15.4;15.4;;;11.3;20.6;Race/Ethnicity;Black, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2010;2010;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.9;8.9;;;5.4;13.7;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2010;2010;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2010;2010;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;NMBR;RACE;HIS;;;;
2010;2010;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2010;2010;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2010;2010;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;16.5;16.5;;;12.2;21.8;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2010;2010;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;15.5;15.5;;;11.3;20.7;Race/Ethnicity;Black, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2010;2010;VI;Virgin Islands;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST3_1;NMBR;OVERALL;OVR;;;;
2010;2010;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;NMBR;RACE;WHT;;;;
2010;2010;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;26;26;;;;;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;NMBR;GENDER;GENM;;;;
2010;2010;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;NMBR;RACE;WHT;;;;
2010;2010;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;41.7;41.7;;;33;52;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2010;2010;UT;Utah;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;NMBR;RACE;AIAN;;;;
2010;2010;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;27.1;27.1;;;18.3;38.7;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2010;2010;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;NMBR;RACE;AIAN;;;;
2010;2010;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2010;2010;MT;Montana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;NMBR;GENDER;GENM;;;;
2010;2010;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.907192, -77.036871);;11;AST;AST4_1;NMBR;RACE;API;;;;
2010;2010;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.8;7.8;;;5.7;10.3;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2010;2010;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;;Number;20;20;;;;;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;NMBR;GENDER;GENF;;;;
2010;2010;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2010;2010;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;NMBR;RACE;WHT;;;;
2010;2010;CA;California;NVSS;Asthma;Asthma mortality rate;;;Number;209;209;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;NMBR;RACE;WHT;;;;
2010;2010;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;;Number;45;45;;;;;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;NMBR;GENDER;GENF;;;;
2010;2010;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;;Number;55;55;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;NMBR;RACE;WHT;;;;
2010;2010;PR;Puerto Rico;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(18.220833, -66.590149);;72;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;46;46;;;;;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;NMBR;GENDER;GENF;;;;
2010;2010;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;;Number;105;105;;;;;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2010;2010;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;;Number;36;36;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;NMBR;RACE;WHT;;;;
2010;2010;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2010;2010;GU;Guam;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;NMBR;RACE;AIAN;;;;
2010;2010;FL;Florida;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;NMBR;RACE;API;;;;
2010;2010;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;NMBR;RACE;API;;;;
2010;2010;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;NMBR;RACE;AIAN;;;;
2010;2010;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;NMBR;RACE;API;;;;
2010;2010;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;NMBR;RACE;API;;;;
2010;2010;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2010;2010;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2010;2010;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2010;2010;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;NMBR;RACE;AIAN;;;;
2010;2010;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;NMBR;RACE;BLK;;;;
2010;2010;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;NMBR;RACE;API;;;;
2010;2010;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2010;2010;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;NMBR;RACE;AIAN;;;;
2010;2010;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;NMBR;RACE;BLK;;;;
2010;2010;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;NMBR;RACE;AIAN;;;;
2010;2010;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;17.4;17.4;;;11.2;26;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2010;2010;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2010;2010;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.6;10.6;;;8.3;13.5;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.6;10.6;;;6.4;16.3;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2010;2010;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2010;2010;VT;Vermont;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;5.39;5.39;;;4.61;6.17;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST3_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;UT;Utah;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;NMBR;RACE;HIS;;;;
2010;2010;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;CRDRATE;RACE;API;;;;
2010;2010;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.5;10.5;;;8.2;13.3;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;CRDRATE;RACE;API;;;;
2010;2010;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;;Number;27;27;;;;;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;NMBR;GENDER;GENF;;;;
2010;2010;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;;Number;56;56;;;;;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;NMBR;GENDER;GENF;;;;
2010;2010;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;60;60;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;NMBR;RACE;WHT;;;;
2010;2010;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;NMBR;RACE;WHT;;;;
2010;2010;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;;Number;25;25;;;;;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;NMBR;GENDER;GENF;;;;
2010;2010;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2010;2010;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;20.4;20.4;;;12.8;30.9;Race/Ethnicity;Black, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2010;2010;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2010;2010;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;;Number;30;30;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;NMBR;RACE;BLK;;;;
2010;2010;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;23.8;23.8;;;17.4;31.7;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2010;2010;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2010;2010;UT;Utah;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;NMBR;RACE;API;;;;
2010;2010;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;NMBR;RACE;API;;;;
2010;2010;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.3;14.3;;;11;18.2;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2010;2010;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.0;12;;;7.9;17.4;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2010;2010;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;;Number;34;34;;;;;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2010;2010;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.8;7.8;;;6;10.1;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2010;2010;GU;Guam;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(13.444304, 144.793731);;66;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.1;9.1;;;6.6;12.2;Race/Ethnicity;White, non-Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2010;2010;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;NMBR;GENDER;GENM;;;;
2010;2010;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;CRDRATE;RACE;API;;;;
2010;2010;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.7;12.7;;;8.9;17.5;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;;Number;40;40;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;NMBR;RACE;WHT;;;;
2010;2010;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;;Number;43;43;;;;;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;NMBR;GENDER;GENF;;;;
2010;2010;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;NMBR;RACE;HIS;;;;
2010;2010;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2010;2010;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;15.3;15.3;;;9.6;23.1;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2010;2010;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;NMBR;RACE;HIS;;;;
2010;2010;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;NMBR;RACE;API;;;;
2010;2010;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2010;2010;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;;Number;42;42;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;NMBR;RACE;BLK;;;;
2010;2010;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;NMBR;RACE;API;;;;
2010;2010;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2010;2010;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;CRDRATE;RACE;API;;;;
2010;2010;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;NMBR;RACE;BLK;;;;
2010;2010;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;NMBR;RACE;BLK;;;;
2010;2010;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;NMBR;RACE;BLK;;;;
2010;2010;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;;Number;60;60;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;NMBR;RACE;WHT;;;;
2010;2010;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2010;2010;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;;Number;69;69;;;;;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2010;2010;CA;California;NVSS;Asthma;Asthma mortality rate;;;Number;152;152;;;;;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;NMBR;GENDER;GENM;;;;
2010;2010;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.9;13.9;;;8.5;21.5;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2010;2010;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2010;2010;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2010;2010;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;15.0;15;;;9.1;23.1;Race/Ethnicity;White, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2010;2010;RI;Rhode Island;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST3_1;AGEADJRATE;RACE;API;;;;
2010;2010;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;;Number;31;31;;;;;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;NMBR;GENDER;GENM;;;;
2010;2010;SD;South Dakota;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST3_1;NMBR;RACE;HIS;;;;
2010;2010;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;43;43;;;;;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;NMBR;GENDER;GENF;;;;
2010;2010;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;NMBR;RACE;HIS;;;;
2010;2010;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2010;2010;NV;Nevada;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;10.46;10.46;;;9.94;10.98;Race/Ethnicity;White, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST3_1;CRDRATE;RACE;WHT;;;;
2010;2010;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;NMBR;RACE;API;;;;
2010;2010;TX;Texas;NVSS;Asthma;Asthma mortality rate;;;Number;81;81;;;;;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;NMBR;GENDER;GENM;;;;
2010;2010;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;;Number;42;42;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;NMBR;RACE;WHT;;;;
2010;2010;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;NMBR;RACE;API;;;;
2010;2010;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2010;2010;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;15.4;15.4;;;11.1;20.8;Race/Ethnicity;White, non-Hispanic;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2010;2010;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;NMBR;RACE;HIS;;;;
2010;2010;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2010;2010;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;NMBR;RACE;AIAN;;;;
2010;2010;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2010;2010;FL;Florida;NVSS;Asthma;Asthma mortality rate;;;Number;177;177;;;;;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2010;2010;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;33;33;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;NMBR;RACE;BLK;;;;
2010;2010;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;;Number;40;40;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;NMBR;RACE;BLK;;;;
2010;2010;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2010;2010;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;24.3;24.3;;;17.5;32.9;Race/Ethnicity;Black, non-Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2010;2010;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.2;7.2;;;4.9;10.3;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2010;2010;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;NMBR;RACE;AIAN;;;;
2010;2010;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2010;2010;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;NMBR;RACE;HIS;;;;
2010;2010;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.4;10.4;;;7.2;14.4;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2010;2010;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;NMBR;RACE;BLK;;;;
2010;2010;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;CRDRATE;RACE;API;;;;
2010;2010;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;CRDRATE;RACE;API;;;;
2010;2010;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.7;11.7;;;8.5;15.7;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2010;2010;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;;Number;36;36;;;;;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2010;2010;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2010;2010;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;NMBR;RACE;BLK;;;;
2010;2010;UT;Utah;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;NMBR;RACE;BLK;;;;
2010;2010;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;NMBR;RACE;API;;;;
2010;2010;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.1;9.1;;;7.2;11.3;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;WA;Washington;State Inpatient Data;Asthma;Hospitalizations for asthma;;;Number;228;228;;;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST3_1;NMBR;RACE;API;;;;
2010;2010;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2010;2010;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.5;10.5;;;7.8;13.8;Race/Ethnicity;White, non-Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2010;2010;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;NMBR;RACE;AIAN;;;;
2010;2010;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;NMBR;RACE;AIAN;;;;
2010;2010;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;NMBR;GENDER;GENM;;;;
2010;2010;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2010;2010;MT;Montana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;NMBR;RACE;AIAN;;;;
2010;2010;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;;Number;20;20;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;NMBR;RACE;BLK;;;;
2010;2010;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2010;2010;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;7.9;7.9;;;5.6;11;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;NMBR;RACE;API;;;;
2010;2010;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.5;8.5;;;5.6;12.4;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2010;2010;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;NMBR;RACE;HIS;;;;
2010;2010;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.6;10.6;;;8.6;12.7;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;GU;Guam;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2010;2010;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2010;2010;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;CRDRATE;RACE;API;;;;
2010;2010;IA;Iowa;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2010;2010;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;NMBR;RACE;HIS;;;;
2010;2010;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;CRDRATE;RACE;API;;;;
2010;2010;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;NMBR;RACE;API;;;;
2010;2010;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2010;2010;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;CRDRATE;RACE;API;;;;
2010;2010;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;CRDRATE;RACE;API;;;;
2010;2010;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2010;2010;TN;Tennessee;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2010;2010;UT;Utah;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;7867;7,867;;;;;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2010;2010;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2010;2010;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;NMBR;RACE;AIAN;;;;
2010;2010;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2010;2010;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;CRDRATE;RACE;API;;;;
2010;2010;FL;Florida;NVSS;Asthma;Asthma mortality rate;;;Number;46;46;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;NMBR;RACE;BLK;;;;
2010;2010;UT;Utah;NVSS;Asthma;Asthma mortality rate;;;Number;27;27;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;NMBR;RACE;WHT;;;;
2010;2010;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;NMBR;RACE;HIS;;;;
2010;2010;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2010;2010;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;66;66;;;;;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;NMBR;GENDER;GENF;;;;
2010;2010;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2010;2010;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;;Number;79;79;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;NMBR;RACE;BLK;;;;
2010;2010;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.1;9.1;;;6.9;11.7;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.4;14.4;;;10.4;19.4;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2010;2010;WA;Washington;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;NMBR;RACE;AIAN;;;;
2010;2010;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;NMBR;RACE;WHT;;;;
2010;2010;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2010;2010;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2010;2010;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.2;13.2;;;9.1;18.5;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2010;2010;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;NMBR;GENDER;GENF;;;;
2010;2010;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;NMBR;RACE;API;;;;
2010;2010;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;23;23;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;NMBR;RACE;WHT;;;;
2010;2010;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2010;2010;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.0;12;;;9.1;15.4;Race/Ethnicity;White, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2010;2010;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;;Number;27;27;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;NMBR;RACE;WHT;;;;
2010;2010;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2010;2010;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;NMBR;RACE;HIS;;;;
2010;2010;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;;Number;50;50;;;;;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2010;2010;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2010;2010;TN;Tennessee;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST3_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;NMBR;RACE;BLK;;;;
2010;2010;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;CRDRATE;RACE;API;;;;
2010;2010;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.907192, -77.036871);;11;AST;AST4_1;NMBR;RACE;AIAN;;;;
2010;2010;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;31.1;31.1;;;20.7;44.9;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2010;2010;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.6;10.6;;;7.5;14.4;Race/Ethnicity;White, non-Hispanic;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2010;2010;IN;Indiana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST4_1;NMBR;RACE;BLK;;;;
2010;2010;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2010;2010;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.9;13.9;;;9.8;19.3;Race/Ethnicity;White, non-Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2010;2010;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;NMBR;GENDER;GENF;;;;
2010;2010;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2010;2010;MT;Montana;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;CRDRATE;RACE;API;;;;
2010;2010;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;;Number;97;97;;;;;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2010;2010;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;AGEADJRATE;RACE;BLK;;;;
2010;2010;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;6.1;6.1;;;4.1;8.6;Race/Ethnicity;White, non-Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2010;2010;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2010;2010;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2010;2010;TX;Texas;NVSS;Asthma;Asthma mortality rate;;;Number;35;35;;;;;Race/Ethnicity;Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;NMBR;RACE;HIS;;;;
2010;2010;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.9;10.9;;;8;14.4;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2010;2010;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;NMBR;RACE;BLK;;;;
2010;2010;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;NMBR;RACE;AIAN;;;;
2010;2010;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;NMBR;RACE;BLK;;;;
2010;2010;MT;Montana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2010;2010;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;NMBR;RACE;API;;;;
2010;2010;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;NMBR;RACE;HIS;;;;
2010;2010;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;NMBR;RACE;AIAN;;;;
2010;2010;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2010;2010;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2010;2010;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;NMBR;GENDER;GENM;;;;
2010;2010;CA;California;NVSS;Asthma;Asthma mortality rate;;;Number;81;81;;;;;Race/Ethnicity;Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;NMBR;RACE;HIS;;;;
2010;2010;WI;Wisconsin;NVSS;Asthma;Asthma mortality rate;;;Number;23;23;;;;;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST4_1;NMBR;GENDER;GENM;;;;
2010;2010;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;NMBR;RACE;AIAN;;;;
2010;2010;CA;California;NVSS;Asthma;Asthma mortality rate;;;Number;54;54;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;NMBR;RACE;BLK;;;;
2010;2010;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2010;2010;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;CRDRATE;RACE;API;;;;
2010;2010;GU;Guam;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(13.444304, 144.793731);;66;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;13.8;13.8;;;10.8;17.3;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;;Number;61;61;;;;;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2010;2010;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;NMBR;RACE;AIAN;;;;
2010;2010;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;;Number;44;44;;;;;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2010;2010;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;CRDRATE;RACE;API;;;;
2010;2010;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2010;2010;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;10.6;10.6;;;6.7;15.9;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;CT;Connecticut;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2010;2010;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;CRDRATE;RACE;API;;;;
2010;2010;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2010;2010;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;NMBR;GENDER;GENF;;;;
2010;2010;UT;Utah;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.1;10.1;;;6.7;14.6;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;AZ;Arizona;NVSS;Asthma;Asthma mortality rate;;;Number;44;44;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST4_1;NMBR;RACE;WHT;;;;
2010;2010;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;CRDRATE;RACE;API;;;;
2010;2010;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;;Number;35;35;;;;;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;NMBR;GENDER;GENF;;;;
2010;2010;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2010;2010;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.1;8.1;;;5.3;11.7;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2010;2010;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;;Number;60;60;;;;;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2010;2010;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;NMBR;GENDER;GENM;;;;
2010;2010;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2010;2010;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;NMBR;RACE;HIS;;;;
2010;2010;ME;Maine;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2010;2010;WA;Washington;NVSS;Asthma;Asthma mortality rate;;;Number;27;27;;;;;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;NMBR;GENDER;GENM;;;;
2010;2010;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2010;2010;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;NMBR;RACE;AIAN;;;;
2010;2010;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;AGEADJRATE;RACE;HIS;;;;
2010;2010;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2010;2010;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;15.7;15.7;;;12;20.2;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;;Number;49;49;;;;;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2010;2010;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;;Number;37;37;;;;;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2010;2010;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2010;2010;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;;Number;22;22;;;;;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2010;2010;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.0;10;;;8.2;11.9;Race/Ethnicity;White, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2010;2010;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;CRDRATE;RACE;API;;;;
2010;2010;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;MO;Missouri;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;27.7;27.7;;;16.9;42.8;Race/Ethnicity;Black, non-Hispanic;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2010;2010;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.3;14.3;;;12.2;16.3;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;NMBR;RACE;API;;;;
2010;2010;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2010;2010;FL;Florida;NVSS;Asthma;Asthma mortality rate;;;Number;103;103;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;NMBR;RACE;WHT;;;;
2010;2010;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.1;9.1;;;7.4;10.9;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2010;2010;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;;Number;58;58;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;NMBR;RACE;WHT;;;;
2010;2010;SC;South Carolina;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST4_1;NMBR;RACE;AIAN;;;;
2010;2010;WV;West Virginia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2010;2010;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;30.8;30.8;;;24.8;37.9;Race/Ethnicity;Black, non-Hispanic;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2010;2010;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2010;2010;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;11.1;11.1;;;7.8;15.4;Race/Ethnicity;White, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2010;2010;WA;Washington;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;NMBR;RACE;API;;;;
2010;2010;ME;Maine;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;NMBR;RACE;WHT;;;;
2010;2010;ID;Idaho;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2010;2010;RI;Rhode Island;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST4_1;NMBR;GENDER;GENF;;;;
2010;2010;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;NMBR;GENDER;GENM;;;;
2010;2010;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2010;2010;AK;Alaska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;21.5;21.5;;;14.5;30.7;Race/Ethnicity;Black, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2010;2010;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;NMBR;RACE;AIAN;;;;
2010;2010;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;;Number;26;26;;;;;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2010;2010;AR;Arkansas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2010;2010;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;;Number;46;46;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;NMBR;RACE;WHT;;;;
2010;2010;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Black, non-Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2010;2010;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.3;9.3;;;7.5;11.4;Race/Ethnicity;White, non-Hispanic;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2010;2010;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;NMBR;RACE;HIS;;;;
2010;2010;ME;Maine;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;NMBR;RACE;HIS;;;;
2010;2010;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;;Number;44;44;;;;;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;NMBR;GENDER;GENF;;;;
2010;2010;WY;Wyoming;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST4_1;NMBR;RACE;HIS;;;;
2010;2010;NY;New York;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;14.8;14.8;;;12.4;17.2;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST4_1;CRDRATE;GENDER;GENF;;;;
2010;2010;VA;Virginia;NVSS;Asthma;Asthma mortality rate;;;Number;69;69;;;;;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2010;2010;MS;Mississippi;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Crude Rate;23.81;23.81;;;22.9;24.72;Race/Ethnicity;Black, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST3_1;CRDRATE;RACE;BLK;;;;
2010;2010;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2010;2010;PR;Puerto Rico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(18.220833, -66.590149);;72;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;GU;Guam;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(13.444304, 144.793731);;66;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;PA;Pennsylvania;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.4;10.4;;;8.6;12.2;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;OR;Oregon;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2010;2010;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;NMBR;RACE;API;;;;
2010;2010;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;12.3;12.3;;;9.3;16;Race/Ethnicity;White, non-Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2010;2010;ND;North Dakota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2010;2010;MA;Massachusetts;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2010;2010;DC;District of Columbia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(38.907192, -77.036871);;11;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2010;2010;PR;Puerto Rico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(18.220833, -66.590149);;72;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2010;2010;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Age-adjusted Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;AGEADJRATE;RACE;API;;;;
2010;2010;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;6.6;6.6;;;5.1;8.5;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2010;2010;MI;Michigan;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST4_1;NMBR;RACE;AIAN;;;;
2010;2010;CA;California;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;10.8;10.8;;;9.8;11.9;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;WA;Washington;NVSS;Asthma;Asthma mortality rate;;;Number;48;48;;;;;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;NMBR;GENDER;GENF;;;;
2010;2010;HI;Hawaii;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST4_1;CRDRATE;RACE;API;;;;
2010;2010;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2010;2010;WA;Washington;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2010;2010;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;;Number;43;43;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;NMBR;RACE;BLK;;;;
2010;2010;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;NMBR;RACE;HIS;;;;
2010;2010;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;29.2;29.2;;;21.1;39.3;Race/Ethnicity;Black, non-Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;CRDRATE;RACE;BLK;;;;
2010;2010;FL;Florida;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.4;9.4;;;8;10.8;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;CO;Colorado;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST4_1;NMBR;RACE;API;;;;
2010;2010;AL;Alabama;NVSS;Asthma;Asthma mortality rate;;;Number;24;24;;;;;Race/Ethnicity;Black, non-Hispanic;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST4_1;NMBR;RACE;BLK;;;;
2010;2010;VT;Vermont;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;NMBR;RACE;WHT;;;;
2010;2010;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;NMBR;OVERALL;OVR;;;;
2010;2010;KS;Kansas;NVSS;Asthma;Asthma mortality rate;;;Number;26;26;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST4_1;NMBR;RACE;WHT;;;;
2010;2010;LA;Louisiana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST4_1;NMBR;GENDER;GENM;;;;
2010;2010;MN;Minnesota;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST4_1;CRDRATE;RACE;HIS;;;;
2010;2010;NV;Nevada;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2010;2010;NM;New Mexico;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST4_1;CRDRATE;RACE;API;;;;
2010;2010;MD;Maryland;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST4_1;CRDRATE;RACE;API;;;;
2010;2010;TX;Texas;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;NMBR;RACE;AIAN;;;;
2010;2010;NH;New Hampshire;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST4_1;NMBR;RACE;HIS;;;;
2010;2010;MD;Maryland;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;90.84;90.84;;;89.72;91.96;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2010;2010;IN;Indiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;34204;34,204;;;;;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;NMBR;GENDER;GENF;;;;
2010;2010;NM;New Mexico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST2_1;NMBR;GENDER;GENF;;;;
2010;2010;DE;Delaware;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST4_1;NMBR;GENDER;GENF;;;;
2010;2010;CT;Connecticut;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2010;2010;OK;Oklahoma;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;AR;Arkansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;NM;New Mexico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2010;2010;UT;Utah;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;28.04;28.04;;;27.42;28.65;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;TX;Texas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;CA;California;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;116571;116,571;;;;;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST2_1;NMBR;GENDER;GENF;;;;
2010;2010;OH;Ohio;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;ND;North Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2010;2010;AR;Arkansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST2_1;NMBR;GENDER;GENM;;;;
2010;2010;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;63.95;63.95;;;63.33;64.57;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;64.91;64.91;;;64.39;65.43;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;SD;South Dakota;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST4_1;NMBR;GENDER;GENF;;;;
2010;2010;OH;Ohio;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2010;2010;AK;Alaska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2010;2010;WV;West Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2010;2010;ID;Idaho;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST2_1;NMBR;GENDER;GENM;;;;
2010;2010;MD;Maryland;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;104.92;104.92;;;103.74;106.09;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;VA;Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2010;2010;HI;Hawaii;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;55.61;55.61;;;53.83;57.38;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2010;2010;OH;Ohio;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST2_1;NMBR;GENDER;GENM;;;;
2010;2010;CT;Connecticut;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2010;2010;TX;Texas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;18335;18,335;;;;;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;NMBR;GENDER;GENM;;;;
2010;2010;MO;Missouri;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;60447;60,447;;;;;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;NMBR;GENDER;GENM;;;;
2010;2010;MA;Massachusetts;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;81.34;81.34;;;80.65;82.03;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;LA;Louisiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;RI;Rhode Island;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;84.26;84.26;;;81.82;86.7;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2010;2010;NE;Nebraska;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST4_1;NMBR;GENDER;GENF;;;;
2010;2010;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;48.31;48.31;;;47.41;49.22;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2010;2010;NH;New Hampshire;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST2_1;NMBR;GENDER;GENF;;;;
2010;2010;TN;Tennessee;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2010;2010;LA;Louisiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;ME;Maine;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;MA;Massachusetts;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;30352;30,352;;;;;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST2_1;NMBR;GENDER;GENF;;;;
2010;2010;IL;Illinois;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;CO;Colorado;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2010;2010;CT;Connecticut;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2010;2010;CT;Connecticut;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;NH;New Hampshire;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2010;2010;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;55.14;55.14;;;54.13;56.14;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;MN;Minnesota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;ND;North Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2010;2010;LA;Louisiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;OK;Oklahoma;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2010;2010;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;53.62;53.62;;;52.44;54.8;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;KS;Kansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2010;2010;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;46.39;46.39;;;45.63;47.16;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;KS;Kansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST2_1;NMBR;GENDER;GENM;;;;
2010;2010;VA;Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;41.14;41.14;;;39.83;42.45;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2010;2010;KS;Kansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2010;2010;NH;New Hampshire;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;MT;Montana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;AR;Arkansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;FL;Florida;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST4_1;NMBR;RACE;AIAN;;;;
2010;2010;TX;Texas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST2_1;NMBR;GENDER;GENM;;;;
2010;2010;TX;Texas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;AL;Alabama;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2010;2010;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2010;2010;MS;Mississippi;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;37.22;37.22;;;36.34;38.11;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;ID;Idaho;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2010;2010;OR;Oregon;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;HI;Hawaii;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;53.77;53.77;;;52;55.54;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;OR;Oregon;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;MO;Missouri;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2010;2010;LA;Louisiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2010;2010;MO;Missouri;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;OH;Ohio;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;GA;Georgia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2010;2010;ME;Maine;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2010;2010;ND;North Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;PA;Pennsylvania;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;ME;Maine;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;NM;New Mexico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST2_1;NMBR;GENDER;GENM;;;;
2010;2010;NH;New Hampshire;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST2_1;NMBR;GENDER;GENM;;;;
2010;2010;OK;Oklahoma;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST2_1;NMBR;GENDER;GENM;;;;
2010;2010;NM;New Mexico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;DC;District of Columbia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST2_1;NMBR;GENDER;GENM;;;;
2010;2010;WA;Washington;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2010;2010;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;37.73;37.73;;;36.83;38.63;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;MI;Michigan;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;TX;Texas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST2_1;NMBR;GENDER;GENF;;;;
2010;2010;DE;Delaware;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST2_1;NMBR;GENDER;GENM;;;;
2010;2010;MA;Massachusetts;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;53257;53,257;;;;;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2010;2010;VA;Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;WA;Washington;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;OH;Ohio;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2010;2010;MA;Massachusetts;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;73.70;73.7;;;72.75;74.66;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;IN;Indiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2010;2010;MA;Massachusetts;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;90.38;90.38;;;89.37;91.4;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;MA;Massachusetts;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;22899;22,899;;;;;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST2_1;NMBR;GENDER;GENM;;;;
2010;2010;AK;Alaska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2010;2010;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;42.03;42.03;;;40.69;43.37;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;MA;Massachusetts;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;82.73;82.73;;;82.03;83.43;Overall;Overall;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;MN;Minnesota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST2_1;NMBR;GENDER;GENM;;;;
2010;2010;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;11526;11,526;;;;;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;NMBR;GENDER;GENM;;;;
2010;2010;SD;South Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;KS;Kansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;IN;Indiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST2_1;NMBR;GENDER;GENF;;;;
2010;2010;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;53.99;53.99;;;53;54.97;Gender;Male;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2010;2010;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;83.46;83.46;;;82.58;84.33;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;AR;Arkansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2010;2010;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;3785;3,785;;;;;Gender;Female;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;NMBR;GENDER;GENF;;;;
2010;2010;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;PA;Pennsylvania;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2010;2010;DE;Delaware;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2010;2010;ID;Idaho;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;VA;Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;IL;Illinois;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2010;2010;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2010;2010;DE;Delaware;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;WY;Wyoming;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2010;2010;CA;California;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;96999;96,999;;;;;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST2_1;NMBR;GENDER;GENM;;;;
2010;2010;NJ;New Jersey;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST4_1;NMBR;RACE;HIS;;;;
2010;2010;GA;Georgia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST2_1;NMBR;GENDER;GENF;;;;
2010;2010;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;104.41;104.41;;;103.46;105.36;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;ID;Idaho;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;TX;Texas;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;6.5;6.5;;;5.2;8.1;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2010;2010;DE;Delaware;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;IN;Indiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2010;2010;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;17326;17,326;;;;;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;NMBR;GENDER;GENF;;;;
2010;2010;UT;Utah;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;32.52;32.52;;;31.56;33.47;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2010;2010;WY;Wyoming;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;49.46;49.46;;;48.53;50.39;Gender;Male;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;HI;Hawaii;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;53.87;53.87;;;52.64;55.1;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;GA;Georgia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2010;2010;MI;Michigan;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;IN;Indiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;IL;Illinois;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;69.95;69.95;;;69.21;70.69;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2010;2010;AR;Arkansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST2_1;NMBR;GENDER;GENF;;;;
2010;2010;UT;Utah;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;3386;3,386;;;;;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST2_1;NMBR;GENDER;GENM;;;;
2010;2010;TN;Tennessee;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2010;2010;MS;Mississippi;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST2_1;NMBR;GENDER;GENF;;;;
2010;2010;DC;District of Columbia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;57.69;57.69;;;56.7;58.67;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;KS;Kansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;ME;Maine;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;GA;Georgia;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;8.7;8.7;;;6.2;11.8;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST4_1;CRDRATE;GENDER;GENM;;;;
2010;2010;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;57.87;57.87;;;57.17;58.56;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;MA;Massachusetts;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;72.31;72.31;;;71.38;73.25;Gender;Male;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2010;2010;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;75.31;75.31;;;74.92;75.71;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;OK;Oklahoma;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;AK;Alaska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2010;2010;ND;North Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST2_1;NMBR;GENDER;GENM;;;;
2010;2010;MA;Massachusetts;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;89.77;89.77;;;88.76;90.78;Gender;Female;;;;;(42.27687047000046, -72.08269067499964);;25;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2010;2010;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;42.31;42.31;;;41.25;43.36;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;DE;Delaware;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2010;2010;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;48.02;48.02;;;47.23;48.81;Overall;Overall;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;53.92;53.92;;;53.24;54.61;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;WV;West Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;ME;Maine;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2010;2010;PA;Pennsylvania;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;AK;Alaska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST2_1;NMBR;GENDER;GENM;;;;
2010;2010;ME;Maine;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST2_1;NMBR;GENDER;GENM;;;;
2010;2010;MI;Michigan;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2010;2010;CT;Connecticut;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;RI;Rhode Island;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;66.12;66.12;;;63.85;68.39;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;HI;Hawaii;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;3544;3,544;;;;;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST2_1;NMBR;GENDER;GENM;;;;
2010;2010;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;CRDRATE;RACE;AIAN;;;;
2010;2010;GA;Georgia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;OK;Oklahoma;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;UT;Utah;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;28.46;28.46;;;27.83;29.09;Overall;Overall;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;DC;District of Columbia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2010;2010;SD;South Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;AK;Alaska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;65.77;65.77;;;65.25;66.29;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2010;2010;MS;Mississippi;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;RI;Rhode Island;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;64.12;64.12;;;61.92;66.32;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2010;2010;PA;Pennsylvania;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST2_1;NMBR;GENDER;GENM;;;;
2010;2010;RI;Rhode Island;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;76.75;76.75;;;75.06;78.45;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;MD;Maryland;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;97.12;97.12;;;96.31;97.92;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;SD;South Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST2_1;NMBR;GENDER;GENM;;;;
2010;2010;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;62.99;62.99;;;62.24;63.74;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;AR;Arkansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2010;2010;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;NMBR;GENDER;GENM;;;;
2010;2010;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;NH;New Hampshire;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;MI;Michigan;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST2_1;NMBR;GENDER;GENF;;;;
2010;2010;CA;California;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;217637;217,637;;;;;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2010;2010;TX;Texas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;AK;Alaska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST2_1;NMBR;GENDER;GENF;;;;
2010;2010;ME;Maine;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST4_1;NMBR;RACE;AIAN;;;;
2010;2010;MD;Maryland;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;99.65;99.65;;;98.83;100.48;Overall;Overall;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;AL;Alabama;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST2_1;NMBR;GENDER;GENF;;;;
2010;2010;ME;Maine;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;NMBR;GENDER;GENM;;;;
2010;2010;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;69.27;69.27;;;68.36;70.18;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2010;2010;KY;Kentucky;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;American Indian or Alaska Native;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST4_1;NMBR;RACE;AIAN;;;;
2010;2010;VA;Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;SD;South Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST2_1;NMBR;GENDER;GENF;;;;
2010;2010;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;68.00;68;;;67.46;68.54;Gender;Male;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;WV;West Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST2_1;NMBR;GENDER;GENF;;;;
2010;2010;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;114.59;114.59;;;114.11;115.07;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;AL;Alabama;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;DE;Delaware;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2010;2010;GA;Georgia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;WY;Wyoming;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST2_1;NMBR;GENDER;GENF;;;;
2010;2010;MS;Mississippi;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2010;2010;PA;Pennsylvania;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2010;2010;WY;Wyoming;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2010;2010;SD;South Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2010;2010;MI;Michigan;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST2_1;NMBR;GENDER;GENM;;;;
2010;2010;OR;Oregon;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2010;2010;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;64.46;64.46;;;63.7;65.23;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;33.22;33.22;;;32.04;34.41;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;UT;Utah;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;24.39;24.39;;;23.57;25.21;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2010;2010;MT;Montana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2010;2010;MD;Maryland;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;92.64;92.64;;;91.5;93.78;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;WA;Washington;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2010;2010;MN;Minnesota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;WY;Wyoming;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST2_1;NMBR;GENDER;GENM;;;;
2010;2010;CA;California;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;52.64;52.64;;;52.31;52.98;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;13199;13,199;;;;;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;NMBR;GENDER;GENF;;;;
2010;2010;HI;Hawaii;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;3776;3,776;;;;;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST2_1;NMBR;GENDER;GENF;;;;
2010;2010;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;6224;6,224;;;;;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;NMBR;GENDER;GENM;;;;
2010;2010;NM;New Mexico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;WY;Wyoming;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;CA;California;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;58.47;58.47;;;58.23;58.72;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;SD;South Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2010;2010;WV;West Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2010;2010;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;41.25;41.25;;;40.23;42.28;Gender;Male;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2010;2010;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;126.51;126.51;;;125.81;127.21;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;107.03;107.03;;;106.35;107.7;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;WA;Washington;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST2_1;NMBR;GENDER;GENF;;;;
2010;2010;WV;West Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST2_1;NMBR;GENDER;GENM;;;;
2010;2010;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;57.73;57.73;;;56.9;58.57;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2010;2010;VA;Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST2_1;NMBR;GENDER;GENF;;;;
2010;2010;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;117.69;117.69;;;117.2;118.18;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;94.61;94.61;;;93.96;95.26;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;124.69;124.69;;;124;125.38;Gender;Female;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2010;2010;MN;Minnesota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST2_1;NMBR;GENDER;GENF;;;;
2010;2010;MT;Montana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST2_1;NMBR;GENDER;GENF;;;;
2010;2010;KS;Kansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;OR;Oregon;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2010;2010;CO;Colorado;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST2_1;NMBR;GENDER;GENF;;;;
2010;2010;MS;Mississippi;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST4_1;CRDRATE;RACE;WHT;;;;
2010;2010;TX;Texas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2010;2010;ID;Idaho;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;IN;Indiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2010;2010;CO;Colorado;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;MN;Minnesota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2010;2010;MO;Missouri;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;OR;Oregon;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2010;2010;AL;Alabama;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2010;2010;ID;Idaho;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2010;2010;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;55.57;55.57;;;54.62;56.52;Gender;Female;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2010;2010;OK;Oklahoma;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;9.1;9.1;;;6.3;12.7;Overall;Overall;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST4_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;IL;Illinois;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;AK;Alaska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2010;2010;TN;Tennessee;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;103.81;103.81;;;103.15;104.46;Gender;Male;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2010;2010;MT;Montana;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;White, non-Hispanic;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST4_1;NMBR;RACE;WHT;;;;
2010;2010;CA;California;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;62.22;62.22;;;61.86;62.57;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2010;2010;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;61.72;61.72;;;60.8;62.64;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;GA;Georgia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;ID;Idaho;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;141612;141,612;;;;;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2010;2010;MO;Missouri;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2010;2010;OH;Ohio;NVSS;Asthma;Asthma mortality rate;;;Number;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Hispanic;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST4_1;NMBR;RACE;HIS;;;;
2010;2010;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;57.25;57.25;;;56.56;57.94;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2010;2010;HI;Hawaii;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;52.02;52.02;;;50.31;53.74;Gender;Male;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2010;2010;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;81536;81,536;;;;;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2010;2010;SD;South Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2010;2010;MN;Minnesota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;52.05;52.05;;;51.39;52.71;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;30501;30,501;;;;;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2010;2010;DE;Delaware;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST2_1;NMBR;GENDER;GENF;;;;
2010;2010;RI;Rhode Island;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;85.89;85.89;;;83.4;88.38;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;RI;Rhode Island;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;4585;4,585;;;;;Gender;Female;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST2_1;NMBR;GENDER;GENF;;;;
2010;2010;CO;Colorado;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;WA;Washington;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;AK;Alaska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;TN;Tennessee;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;PA;Pennsylvania;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;WA;Washington;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;ND;North Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;WV;West Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;KS;Kansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST2_1;NMBR;GENDER;GENF;;;;
2010;2010;WY;Wyoming;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2010;2010;ME;Maine;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST2_1;NMBR;GENDER;GENF;;;;
2010;2010;WA;Washington;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST2_1;NMBR;GENDER;GENM;;;;
2010;2010;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;48.14;48.14;;;47.31;48.96;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;UT;Utah;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;4473;4,473;;;;;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST2_1;NMBR;GENDER;GENF;;;;
2010;2010;NM;New Mexico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2010;2010;NH;New Hampshire;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;60806;60,806;;;;;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2010;2010;OK;Oklahoma;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2010;2010;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;34983;34,983;;;;;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;NMBR;GENDER;GENM;;;;
2010;2010;CO;Colorado;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;MT;Montana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;ND;North Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST2_1;NMBR;GENDER;GENF;;;;
2010;2010;IN;Indiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST2_1;NMBR;GENDER;GENM;;;;
2010;2010;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;63.77;63.77;;;63.26;64.28;Overall;Overall;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;NM;New Mexico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;MS;Mississippi;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;WV;West Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2010;2010;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;92.74;92.74;;;92.1;93.38;Overall;Overall;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;TN;Tennessee;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2010;2010;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;57.27;57.27;;;56.44;58.1;Gender;Male;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;CO;Colorado;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2010;2010;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;26595;26,595;;;;;Gender;Male;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;NMBR;GENDER;GENM;;;;
2010;2010;WA;Washington;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(47.52227862900048, -120.47001078999972);;53;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;81.74;81.74;;;80.89;82.6;Gender;Male;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2010;2010;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;73.06;73.06;;;71.92;74.2;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;MS;Mississippi;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2010;2010;VI;Virgin Islands;State Inpatient Data;Asthma;Hospitalizations for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(18.335765, -64.896335);;78;AST;AST3_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;OK;Oklahoma;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;13172;13,172;;;;;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;NMBR;GENDER;GENM;;;;
2010;2010;AR;Arkansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;GA;Georgia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;51.43;51.43;;;50.3;52.56;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2010;2010;UT;Utah;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;33.23;33.23;;;32.26;34.21;Gender;Female;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;AL;Alabama;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2010;2010;MI;Michigan;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2010;2010;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;MS;Mississippi;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST2_1;NMBR;GENDER;GENM;;;;
2010;2010;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;NMBR;GENDER;GENF;;;;
2010;2010;AL;Alabama;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;TX;Texas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2010;2010;VA;Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST2_1;NMBR;GENDER;GENM;;;;
2010;2010;MI;Michigan;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2010;2010;MO;Missouri;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2010;2010;AR;Arkansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2010;2010;OR;Oregon;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST2_1;NMBR;GENDER;GENF;;;;
2010;2010;CO;Colorado;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST2_1;NMBR;GENDER;GENM;;;;
2010;2010;DE;Delaware;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;AL;Alabama;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;RI;Rhode Island;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;7845;7,845;;;;;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2010;2010;OR;Oregon;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;LA;Louisiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;VA;Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2010;2010;NV;Nevada;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(39.493240390000494, -117.07184056399967);;32;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2010;2010;DC;District of Columbia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(38.907192, -77.036871);;11;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;AL;Alabama;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST2_1;NMBR;GENDER;GENM;;;;
2010;2010;OH;Ohio;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;MO;Missouri;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST2_1;NMBR;GENDER;GENM;;;;
2010;2010;WY;Wyoming;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;ID;Idaho;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2010;2010;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;15805;15,805;;;;;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;NMBR;GENDER;GENF;;;;
2010;2010;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;40650;40,650;;;;;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2010;2010;ND;North Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;71.7;71.7;;;70.58;72.81;Gender;Female;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2010;2010;TN;Tennessee;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST2_1;NMBR;GENDER;GENM;;;;
2010;2010;NH;New Hampshire;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2010;2010;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;103.16;103.16;;;102.22;104.1;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2010;2010;NY;New York;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;222051;222,051;;;;;Overall;Overall;;;;;(42.82700103200045, -75.54397042699964);;36;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2010;2010;TN;Tennessee;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;PA;Pennsylvania;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2010;2010;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;63.59;63.59;;;62.98;64.21;Overall;Overall;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;HI;Hawaii;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;55.06;55.06;;;53.79;56.32;Overall;Overall;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;HI;Hawaii;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;56.31;56.31;;;54.52;58.11;Gender;Female;;;;;(21.304850435000446, -157.85774940299973);;15;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;MI;Michigan;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;TN;Tennessee;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST2_1;NMBR;GENDER;GENF;;;;
2010;2010;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;81148;81,148;;;;;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;NMBR;GENDER;GENF;;;;
2010;2010;CA;California;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;52.38;52.38;;;52.05;52.71;Gender;Male;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2010;2010;ID;Idaho;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(43.682630005000476, -114.3637300419997);;16;AST;AST2_1;NMBR;GENDER;GENF;;;;
2010;2010;KY;Kentucky;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;27334;27,334;;;;;Overall;Overall;;;;;(37.645970271000465, -84.77497104799966);;21;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2010;2010;RI;Rhode Island;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;3260;3,260;;;;;Gender;Male;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST2_1;NMBR;GENDER;GENM;;;;
2010;2010;MT;Montana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;AR;Arkansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(34.74865012400045, -92.27449074299966);;05;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;OK;Oklahoma;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(35.47203135600046, -97.52107021399968);;40;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2010;2010;MI;Michigan;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(44.6613195430005, -84.71439026999968);;26;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;NC;North Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;70.84;70.84;;;70.09;71.59;Gender;Female;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;CT;Connecticut;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;CT;Connecticut;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST2_1;NMBR;GENDER;GENF;;;;
2010;2010;IN;Indiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(39.766910452000445, -86.14996019399968);;18;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;IL;Illinois;NVSS;Asthma;Asthma mortality rate;;;Number;86;86;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST4_1;NMBR;RACE;WHT;;;;
2010;2010;NJ;New Jersey;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;46549;46,549;;;;;Gender;Female;;;;;(40.13057004800049, -74.27369128799967);;34;AST;AST2_1;NMBR;GENDER;GENF;;;;
2010;2010;PA;Pennsylvania;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST2_1;NMBR;GENDER;GENF;;;;
2010;2010;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;86.18;86.18;;;85.58;86.77;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;NM;New Mexico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2010;2010;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;77.58;77.58;;;77.18;77.98;Overall;Overall;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;OR;Oregon;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(44.56744942400047, -120.15503132599969);;41;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;AL;Alabama;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(32.84057112200048, -86.63186076199969);;01;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;LA;Louisiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST2_1;NMBR;GENDER;GENM;;;;
2010;2010;IA;Iowa;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;7910;7,910;;;;;Gender;Female;;;;;(42.46940091300047, -93.81649055599968);;19;AST;AST2_1;NMBR;GENDER;GENF;;;;
2010;2010;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;33.25;33.25;;;32.06;34.43;Gender;Male;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2010;2010;CT;Connecticut;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST2_1;NMBR;GENDER;GENM;;;;
2010;2010;TN;Tennessee;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(35.68094058000048, -85.77449091399967);;47;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;GA;Georgia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2010;2010;MN;Minnesota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;MD;Maryland;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;25360;25,360;;;;;Gender;Male;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST2_1;NMBR;GENDER;GENM;;;;
2010;2010;AZ;Arizona;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;70.08;70.08;;;69.16;71;Gender;Female;;;;;(34.865970280000454, -111.76381127699972);;04;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;RI;Rhode Island;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;74.53;74.53;;;72.88;76.18;Overall;Overall;;;;;(41.70828019300046, -71.52247031399963);;44;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;NC;North Carolina;NVSS;Asthma;Asthma mortality rate;;cases per 1,000,000;Crude Rate;;;~;Data not shown because of too few respondents or cases;;;Race/Ethnicity;Asian or Pacific Islander;;;;;(35.466220975000454, -79.15925046299964);;37;AST;AST4_1;CRDRATE;RACE;API;;;;
2010;2010;OH;Ohio;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2010;2010;MS;Mississippi;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;VT;Vermont;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(43.62538123900049, -72.51764079099962);;50;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2010;2010;IL;Illinois;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2010;2010;CO;Colorado;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;TX;Texas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2010;2010;MO;Missouri;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST2_1;NMBR;GENDER;GENF;;;;
2010;2010;UT;Utah;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;22.66;22.66;;;21.9;23.43;Gender;Male;;;;;(39.360700171000474, -111.58713063499971);;49;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;VA;Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(37.54268067400045, -78.45789046299967);;51;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2010;2010;NE;Nebraska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;6798;6,798;;;;;Overall;Overall;;;;;(41.6410409880005, -99.36572062299967);;31;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2010;2010;OH;Ohio;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(40.06021014100048, -82.40426005599966);;39;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;MT;Montana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2010;2010;PA;Pennsylvania;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(40.79373015200048, -77.86070029399963);;42;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;WY;Wyoming;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(43.23554134300048, -108.10983035299967);;56;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;GA;Georgia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(32.83968109300048, -83.62758034599966);;13;AST;AST2_1;NMBR;GENDER;GENM;;;;
2010;2010;DE;Delaware;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(39.008830667000495, -75.57774116799965);;10;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;CA;California;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;62.04;62.04;;;61.68;62.39;Gender;Female;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;SC;South Carolina;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;24076;24,076;;;;;Overall;Overall;;;;;(33.998821303000454, -81.04537120699968);;45;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2010;2010;ME;Maine;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(45.254228894000505, -68.98503133599962);;23;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2010;2010;DC;District of Columbia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(38.907192, -77.036871);;11;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;NH;New Hampshire;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Male;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST2_1;AGEADJRATE;GENDER;GENM;;;;
2010;2010;LA;Louisiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2010;2010;MS;Mississippi;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(32.745510099000455, -89.53803082499968);;28;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2010;2010;CT;Connecticut;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(41.56266102000046, -72.64984095199964);;09;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;AK;Alaska;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(64.84507995700051, -147.72205903599973);;02;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;FL;Florida;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;84.42;84.42;;;83.84;85;Gender;Female;;;;;(28.932040377000476, -81.92896053899966);;12;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2010;2010;MO;Missouri;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(38.635790776000476, -92.56630005299968);;29;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;ND;North Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2010;2010;LA;Louisiana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(31.31266064400046, -92.44568007099969);;22;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2010;2010;MD;Maryland;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;102.97;102.97;;;101.82;104.12;Gender;Female;;;;;(39.29058096400047, -76.60926011099963);;24;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2010;2010;CA;California;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;58.42;58.42;;;58.17;58.67;Overall;Overall;;;;;(37.63864012300047, -120.99999953799971);;06;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;WV;West Virginia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(38.66551020200046, -80.71264013499967);;54;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;MN;Minnesota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2010;2010;CO;Colorado;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(38.843840757000464, -106.13361092099967);;08;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2010;2010;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;53.63;53.63;;;53.03;54.23;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;TX;Texas;NVSS;Asthma;Asthma mortality rate;;;Number;106;106;;;;;Race/Ethnicity;White, non-Hispanic;;;;;(31.827240407000488, -99.42677020599967);;48;AST;AST4_1;NMBR;RACE;WHT;;;;
2010;2010;IL;Illinois;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;SD;South Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(44.353130053000484, -100.3735306369997);;46;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;KS;Kansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2010;2010;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;46.67;46.67;;;45.87;47.47;Gender;Male;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2010;2010;IL;Illinois;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST2_1;NMBR;GENDER;GENM;;;;
2010;2010;NH;New Hampshire;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(43.65595011300047, -71.50036091999965);;33;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2010;2010;MT;Montana;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Overall;Overall;;;;;(47.06652897200047, -109.42442064499971);;30;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;DC;District of Columbia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;MN;Minnesota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Female;;;;;(46.35564873600049, -94.79420050299967);;27;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2010;2010;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;55.04;55.04;;;54.42;55.66;Overall;Overall;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;AGEADJRATE;OVERALL;OVR;;;;
2010;2010;KS;Kansas;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Overall;Overall;;;;;(38.34774030000045, -98.20078122699965);;20;AST;AST2_1;CRDRATE;OVERALL;OVR;;;;
2010;2010;NM;New Mexico;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(34.52088095200048, -106.24058098499967);;35;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;IL;Illinois;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;;;-;No data available;;;Gender;Male;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST2_1;CRDRATE;GENDER;GENM;;;;
2010;2010;WI;Wisconsin;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Crude Rate;60.48;60.48;;;59.58;61.38;Gender;Female;;;;;(44.39319117400049, -89.81637074199966);;55;AST;AST2_1;CRDRATE;GENDER;GENF;;;;
2010;2010;DC;District of Columbia;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Overall;Overall;;;;;(38.907192, -77.036871);;11;AST;AST2_1;NMBR;OVERALL;OVR;;;;
2010;2010;ND;North Dakota;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;cases per 10,000;Age-adjusted Rate;;;-;No data available;;;Gender;Female;;;;;(47.47531977900047, -100.11842104899966);;38;AST;AST2_1;AGEADJRATE;GENDER;GENF;;;;
2010;2010;IL;Illinois;"SEDD; SID";Asthma;Emergency department visit rate for asthma;;;Number;;;-;No data available;;;Gender;Female;;;;;(40.48501028300046, -88.99771017799969);;17;AST;AST2_1;NMBR;GENDER;GENF;;;;